PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, HJ; Suk, JE; Patrick, C; Bae, EJ; Cho, JH; Rho, S; Hwang, D; Masliah, E; Lee, SJ				Lee, He-Jin; Suk, Ji-Eun; Patrick, Christina; Bae, Eun-Jin; Cho, Ji-Hoon; Rho, Sangchul; Hwang, Daehee; Masliah, Eliezer; Lee, Seung-Jae			Direct Transfer of alpha-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; LEWY BODIES; GLIAL-CELLS; CORTICOBASAL DEGENERATION; FILAMENTOUS INCLUSIONS; ACTIVATES MICROGLIA; MESSENGER-RNA; PICKS-DISEASE; HUMAN BRAIN; ASTROCYTES	Abnormal neuronal aggregation of alpha-synuclein is implicated in the development of many neurological disorders, including Parkinson disease and dementia with Lewy bodies. Glial cells also show extensive alpha-synuclein pathology and may contribute to disease progression. However, the mechanism that produces the glial alpha-synuclein pathology and the interaction between neurons and glia in the disease-inflicted microenvironment remain unknown. Here, we show that alpha-synuclein proteins released from neuronal cells are taken up by astrocytes through endocytosis and form inclusion bodies. The glial accumulation of alpha-synuclein through the transmission of the neuronal protein was also demonstrated in a transgenic mouse model expressing human alpha-synuclein. Furthermore, astrocytes that were exposed to neuronal alpha-synuclein underwent changes in the gene expression profile reflecting an inflammatory response. Induction of pro-inflammatory cytokines and chemokines correlated with the extent of glial accumulation of alpha-synuclein. Together, these results suggest that astroglial alpha-synuclein pathology is produced by direct transmission of neuronal alpha-synuclein aggregates, causing inflammatory responses. This transmission step is thus an important mediator of pathogenic glial responses and could qualify as a new therapeutic target.	[Suk, Ji-Eun; Bae, Eun-Jin; Lee, Seung-Jae] Konkuk Univ, Dept Biomed Sci & Technol, IBST, Seoul 143701, South Korea; [Lee, He-Jin] Konkuk Univ, Sch Med, Dept Anat, Seoul 143701, South Korea; [Patrick, Christina; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci & Pathol, La Jolla, CA 92093 USA; [Cho, Ji-Hoon; Rho, Sangchul; Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Kyoungbuk, South Korea; [Cho, Ji-Hoon; Rho, Sangchul; Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, Kyoungbuk, South Korea	Konkuk University; Konkuk University; Konkuk University Medical Center; University of California System; University of California San Diego; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Konkuk Univ, Dept Biomed Sci & Technol, IBST, 1 Hwayang Dong, Seoul 143701, South Korea.	sjlee@konkuk.ac.kr	Bae, Eun-Jin/N-3007-2019	Bae, Eun-Jin/0000-0002-4369-7405; Lee, Seung-Jae/0000-0002-5155-5335	National Institutes of Health [AG5131, AG18440]; Ministry of Education, Science and Technology, Republic of Korea [20090084180]; Korea government [20090083737]; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG018440, R37AG018440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government(Korean Government); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG5131 and AG18440. This work was also supported by the Disease Network Research Program (Grant 20090084180) from the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, Republic of Korea and by the Korea Science and Engineering Foundation funded by the Korea government (Grant 20090083737).	Arai T, 2001, ACTA NEUROPATHOL, V101, P167; Arima K, 1997, ACTA NEUROPATHOL, V93, P558, DOI 10.1007/s004010050652; Bien S, 2004, MOL PHARMACOL, V65, P1092, DOI 10.1124/mol.65.5.1092; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Ferrer I, 2001, J NEURAL TRANSM, V108, P1397, DOI 10.1007/s007020100016; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Hansen LA, 1998, J NEUROL NEUROSUR PS, V64, P653, DOI 10.1136/jnnp.64.5.653; Herrmann F, 2003, IMMUNOGENETICS, V55, P379, DOI 10.1007/s00251-003-0597-2; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Komori T, 1999, BRAIN PATHOL, V9, P663; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Miller DW, 2005, J NEURAL TRANSM, V112, P1613, DOI 10.1007/s00702-005-0378-1; Mori F, 2002, EXP NEUROL, V176, P98, DOI 10.1006/exnr.2002.7929; Ossendorp F, 2005, J IMMUNOL, V174, P7815, DOI 10.4049/jimmunol.174.12.7815; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Reynolds AD, 2008, J NEUROCHEM, V104, P1504, DOI 10.1111/j.1471-4159.2007.05087.x; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2002, J NEURAL TRANSM-SUPP, P327; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Schofield E, 2003, BRAIN, V126, P827, DOI 10.1093/brain/awg085; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin CY, 2001, BRAIN RES, V902, P198; Solano SM, 2000, ANN NEUROL, V47, P201, DOI 10.1002/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Terada S, 2003, ACTA NEUROPATHOL, V105, P163, DOI 10.1007/s00401-002-0622-9; Thomas MP, 2007, J NEUROCHEM, V100, P503, DOI 10.1111/j.1471-4159.2006.04315.x; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	64	564	575	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9262	9272		10.1074/jbc.M109.081125	http://dx.doi.org/10.1074/jbc.M109.081125			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071342	Green Published, hybrid			2022-12-25	WOS:000275553700074
J	Mallik, S; Yang, WB; Norstrom, EM; Mastrianni, JA				Mallik, Suparna; Yang, Wenbin; Norstrom, Eric M.; Mastrianni, James A.			Live Cell Fluorescence Resonance Energy Transfer Predicts an Altered Molecular Association of Heterologous PrPSc with PrPC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; HUMAN PRION PROTEIN; TRANSGENIC MICE; CONFORMATION; TRANSMISSION; SUSCEPTIBILITY; INSOMNIA	Prion diseases result from the accumulation of a misfolded isoform (PrPSc) of the normal host prion protein (PrPC). PrPSc propagates by templating its conformation onto resident PrPC to generate new PrPSc. Although the nature of the PrPSc-PrPC complex is unresolved, certain segments or specific residues are thought to feature critically in its formation. The polymorphic residue 129 is one such site under considerable study. We combined transmission studies with a novel live cell yeast-based fluorescence resonance energy transfer (FRET) system that models the molecular association of PrP in a PrPSc-like state, as a way to explore the role of residue 129 in this process. We show that a reduction in efficiency of prion transmission between donor PrPSc and recipient PrPC that are mismatched at residue 129 correlates with a reduction in FRET between PrP-129M and PrP-129V in our yeast model. We further show that this effect depends on the different secondary structure propensities of Met and Val, rather than the specific amino acids. Finally, introduction of the disease-associated P101L mutation (mouse-equivalent) abolished FRET with wild-type mouse PrP, whereas mutant PrP-P101L displayed high FRET with homologous PrP-P101L, as long as residue 129 matched. These studies provide the first evidence for a physical alteration in the molecular association of PrP molecules differing in one or more residues, and they further predict that the different secondary structure propensities of Met and Val define the impaired association observed between PrPSc and PrPC mismatched at residue 129.	[Mallik, Suparna; Yang, Wenbin; Norstrom, Eric M.; Mastrianni, James A.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of Chicago	Mastrianni, JA (corresponding author), Univ Chicago, Dept Neurol, MC2030,5841 S Maryland Ave, Chicago, IL 60637 USA.	jmastria@uchicago.edu	Yang, Wenbin/B-5303-2011		National Institutes of Health [R01NS046037, R01NS051480]; Brain Research Foundation; Pioneer Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051480, R01NS046037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation; Pioneer Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS046037 and R01NS051480, The Brain Research Foundation, The Pioneer Fund, and a gift from Barbara and Marc Posner.	Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COLLINGE J, 1993, BRIT MED J, V306, P301, DOI 10.1136/bmj.306.6873.301; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; KASCSAK RJ, 1993, DEV BIOL STAND, V80, P141; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Li XH, 2005, ANN NEUROL, V58, P858, DOI 10.1002/ana.20646; Ma JY, 1999, NAT CELL BIOL, V1, P358, DOI 10.1038/14053; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; Mastrianni JA, 2000, SEMIN NEUROL, V20, P337, DOI 10.1055/s-2000-9396; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Moore RA, 2005, ARCH VIROL, P187; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; OWEN F, 1990, AM J HUM GENET, V46, P1215; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1999, NEUROLOGY, V52, P1757, DOI 10.1212/WNL.52.9.1757; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932	24	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8967	8975		10.1074/jbc.M109.058107	http://dx.doi.org/10.1074/jbc.M109.058107			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086009	Green Published, hybrid			2022-12-25	WOS:000275553700048
J	Zhang, C; Browne, A; Child, D; DiVito, JR; Stevenson, JA; Tanzi, RE				Zhang, Can; Browne, Andrew; Child, Daniel; DiVito, Jason R.; Stevenson, Jesse A.; Tanzi, Rudolph E.			Loss of Function of ATXN1 Increases Amyloid beta-Protein Levels by Potentiating beta-Secretase Processing of beta-Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING ATAXIN-1; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; SPINOCEREBELLAR ATAXIA; APP; CELLS; SCA1; PRESENILIN-1; TRAFFICKING; ASSOCIATION	Alzheimer disease (AD) is a devastating neurodegenerative disease with complex and strong genetic inheritance. Four genes have been established to either cause familial early onset AD (APP, PSEN1, and PSEN2) or to increase susceptibility for late onset AD (APOE). To date similar to 80% of the late onset AD genetic variance remains elusive. Recently our genome-wide association screen identified four novel late onset AD candidate genes. Ataxin 1 (ATXN1) is one of these four AD candidate genes and has been indicated to be the disease gene for spinocerebellar ataxia type 1, which is also a neurodegenerative disease. Mounting evidence suggests that the excessive accumulation of A beta, the proteolytic product of beta-amyloid precursor protein (APP), is the primary AD pathological event. In this study, we ask whether ATXN1 may lead to AD pathogenesis by affecting A beta and APP processing utilizing RNA interference in a human neuronal cell model and mouse primary cortical neurons. We show that knock-down of ATXN1 significantly increases the levels of both A beta 40 and A beta 42. This effect could be rescued with concurrent overexpression of ATXN1. Moreover, overexpression of ATXN1 decreased A beta levels. Regarding the underlying molecular mechanism, we show that the effect of ATXN1 expression on A beta levels is modulated via beta-secretase cleavage of APP. Taken together, ATXN1 functions as a genetic risk modifier that contributes to AD pathogenesis through a loss-of-function mechanism by regulating beta-secretase cleavage of APP and A beta levels.	[Zhang, Can; Browne, Andrew; Child, Daniel; DiVito, Jason R.; Stevenson, Jesse A.; Tanzi, Rudolph E.] Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis,Dept Neurol, Genet & Aging Res Unit,Massachusetts Gen Hosp, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis,Dept Neurol, Genet & Aging Res Unit,Massachusetts Gen Hosp, 114 16th St, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Child, Daniel/0000-0002-4309-0144	NIMH; Cure Alzheimers Fund; Massachusetts General Hospital Fund for Medical Discovery (FMD); NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Cure Alzheimers Fund; Massachusetts General Hospital Fund for Medical Discovery (FMD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the NIMH, the Cure Alzheimers Fund, and the Massachusetts General Hospital Fund for Medical Discovery (FMD).	BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Bolger TA, 2007, J BIOL CHEM, V282, P29186, DOI 10.1074/jbc.M704182200; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gandy S, 2007, J NEUROCHEM, V102, P619, DOI 10.1111/j.1471-4159.2007.04587.x; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Goold R, 2007, HUM MOL GENET, V16, P2122, DOI 10.1093/hmg/ddm162; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Skinner PJ, 2001, AM J PATHOL, V159, P905, DOI 10.1016/S0002-9440(10)61766-X; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Xie ZC, 2005, J BIOL CHEM, V280, P15413, DOI 10.1074/jbc.M414353200; Xie ZC, 2007, J BIOL CHEM, V282, P4318, DOI 10.1074/jbc.M609293200; Zhang C, 2010, CURR ALZHEIMER RES, V7, P21, DOI 10.2174/156720510790274428; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15; Zhang Can, 2009, Discov Med, V8, P18; Zhang Can, 2007, Discov Med, V7, P113; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	35	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8515	8526		10.1074/jbc.M109.079079	http://dx.doi.org/10.1074/jbc.M109.079079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097758	hybrid, Green Published			2022-12-25	WOS:000275553700003
J	Jung, DJ; Jin, DH; Hong, SW; Kim, JE; Shin, JS; Kim, D; Cho, BJ; Hwang, YI; Kang, JS; Lee, WJ				Jung, Da-Jung; Jin, Dong-Hoon; Hong, Seung-Woo; Kim, Jee-Eun; Shin, Jae-Sik; Kim, DaeJin; Cho, Byung-Joo; Hwang, Young-Il; Kang, Jae-Seung; Lee, Wang-Jae			Foxp3 Expression in p53-dependent DNA Damage Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; BREAST-CANCER; P53; TRANSCRIPTION; SUPPRESSION; ACTIVATION; MECHANISMS; APOPTOSIS; PHOSPHORYLATION; INHIBITOR	The forkhead transcription factor, Foxp3, is thought to act as a master regulator that controls (suppresses) expression of the breast cancer oncogenes, SKP2 and HER-2/ErbB2. However, the mechanisms that regulate Foxp3 expression and thereby modulate tumor development remain largely unexplored. Here, we demonstrate that Foxp3 up-regulation requires p53 function, showing that Foxp3 expression is directly regulated by p53 upon DNA damage responses in human breast and colon carcinoma cells. Treatment with the genotoxic agents, doxorubicin or etoposide, induced Foxp3 expression in p53-positive carcinoma cells, but not in cells lacking p53 function. Furthermore, knock down of endogenous wild-type p53 using RNA interference abrogated Foxp3 induction by genotoxic agents, and exogenous expression of p53 in cells lacking p53 restored the responsiveness of Foxp3 to DNA-damaging stresses. In addition, Foxp3 knock down blunted the p53-mediated growth inhibitory response to DNA-damaging agents. These results suggest that induction of Foxp3 in the context of tumor suppression is regulated in a p53-dependent manner and implicate Foxp3 as a key determinant of cell fate in p53-dependent DNA damage responses.	[Hwang, Young-Il; Kang, Jae-Seung; Lee, Wang-Jae] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110744, South Korea; [Hwang, Young-Il; Kang, Jae-Seung; Lee, Wang-Jae] Seoul Natl Univ, Coll Med, Tumor Immun Med Res Ctr, Seoul 110744, South Korea; [Jung, Da-Jung; Jin, Dong-Hoon; Hong, Seung-Woo; Kim, Jee-Eun; Shin, Jae-Sik; Lee, Wang-Jae] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea; [Cho, Byung-Joo] Konkuk Univ, Konkuk Univ Hosp, Sch Med, Dept Ophthalmol, Seoul 143729, South Korea; [Kim, DaeJin] Chung Ang Univ, Coll Med, Dept Anat, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Konkuk University; Konkuk University Medical Center; Chung Ang University; Chung Ang University Hospital	Lee, WJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110744, South Korea.	kinglee@snu.ac.kr	Kang, Jae Seung/J-5363-2012; Lee, Wang Jae/J-5586-2012		Korean Science and Engineering Foundation through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine [R13-2002-025-02001-0]; Science Research Center Program through the Research Center for Women's Diseases [R11-2005-017-03001]	Korean Science and Engineering Foundation through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine; Science Research Center Program through the Research Center for Women's Diseases	This work was supported by the Korean Science and Engineering Foundation through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine Grant R13-2002-025-02001-0 and Science Research Center Program through the Research Center for Women's Diseases Grant R11-2005-017-03001.	Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Kojima K, 2006, BLOOD, V108, P993, DOI 10.1182/blood-2005-12-5148; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Liu Y, 2007, PHARMACOGENOMICS, V8, P1485, DOI 10.2217/14622416.8.11.1485; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Manzotti CN, 2002, EUR J IMMUNOL, V32, P2888, DOI 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F; MCILWRATH AJ, 1994, CANCER RES, V54, P3718; Nagaoka H, 2005, P NATL ACAD SCI USA, V102, P2022, DOI 10.1073/pnas.0409491102; Ou-Yang HF, 2009, MOL CELL BIOCHEM, V320, P109, DOI 10.1007/s11010-008-9912-4; Park WS, 2000, GASTROENTEROLOGY, V119, P691, DOI 10.1053/gast.2000.16483; Provinciali M, 2007, CANCER RES, V67, P2022, DOI 10.1158/0008-5472.CAN-06-2601; Taams LS, 2005, CURR TOP MICROBIOL, V293, P115, DOI 10.1007/3-540-27702-1_6; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Traub F, 2006, BREAST CANCER RES TR, V99, P185, DOI 10.1007/s10549-006-9202-3; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zuo T, 2007, J CLIN INVEST, V117, P3765, DOI 10.1172/JCI32538; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	33	48	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7995	8002		10.1074/jbc.M109.047985	http://dx.doi.org/10.1074/jbc.M109.047985			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075077	Green Published, hybrid			2022-12-25	WOS:000275413800017
J	Lee, JS; Lee, YM; Kim, JY; Park, HW; Grinstein, S; Orlowski, J; Kim, E; Kim, KH; Lee, MG				Lee, Jung-Soo; Lee, Young Mee; Kim, Joo Young; Park, Hyun Woo; Grinstein, Sergio; Orlowski, John; Kim, Eunjoon; Kim, Kyung Hwan; Lee, Min Goo			beta Pix Up-regulates Na+/H+ Exchanger 3 through a Shank2-mediated Protein-Protein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SHANK FAMILY; PROXIMAL TUBULE; APICAL MEMBRANE; RHO-GTPASES; KINASE-A; NHE3; LOCALIZATION; EXPRESSION; ISOFORM	Na+/H+ exchanger 3 (NHE3) plays an important role in neutral Na+ transport in mammalian epithelial cells. The Rho family of small GTPases and the PDZ (PSD-95/discs large/ZO-1) domain-based adaptor Shank2 are known to regulate the membrane expression and activity of NHE3. In this study we examined the role of beta Pix, a guanine nucleotide exchange factor for the Rho GTPase and a strong binding partner to Shank2, in NHE3 regulation using integrated molecular and physiological approaches. Immunoprecipitation and pulldown assays revealed that NHE3, Shank2, and beta Pix form a macromolecular complex when expressed heterologously in mammalian cells as well as endogenously in rat colon, kidney, and pancreas. In addition, these proteins co-segregated at the apical surface of rat colonic epithelial cells, as detected by immunofluorescence staining. When expressed in PS120/NHE3 cells, beta Pix increased membrane expression and basal activity of NHE3. Interestingly, the effects of beta Pix on NHE3 were abolished by cotransfection with dominant-negative Shank2 mutants and by treatment with Clostridium difficile toxin B, a Rho GTPase inhibitor, indicating that Shank2 and Rho GTPases are involved in beta Pix-mediated NHE3 regulation. Knockdown of endogenous beta Pix by RNA interference decreased Shank2-induced increase of NHE3 membrane expression in HEK 293T cells. These results indicate that beta Pix up-regulates NHE3 membrane expression and activity by Shank2-mediated protein-protein interaction and by activating Rho GTPases in the apical regions of epithelial cells.	[Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; [Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Inst Gastroenterol, Seoul 120752, South Korea; [Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; Korea Advanced Institute of Science & Technology (KAIST)	Lee, MG (corresponding author), Yonsei Univ, Coll Med, Dept Pharmacol, 134 Sinchon Dong, Seoul 120752, South Korea.	mlee@yuhs.ac	Lee, Min Goo/AAS-4636-2020; Kim, Joo Young/X-7562-2019; Lee, Min Goo/D-5635-2012; Kim, Eunjoon/C-1566-2011	Lee, Min Goo/0000-0001-7436-012X; Kim, Joo Young/0000-0003-2623-1491; Lee, Min Goo/0000-0001-7436-012X; Orlowski, John/0000-0001-7371-175X; Park, Hyun Woo/0000-0001-7736-2286	Korea Science and Engineering Foundation [R11-2007-040-01001-0, R01-2007-000-20710-0]; Ministry of Education, Science and Technology, Korea; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A070001]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This work was supported in part by Grants R11-2007-040-01001-0 and R01-2007-000-20710-0 from the Korea Science and Engineering Foundation, Ministry of Education, Science and Technology, Korea, and by Grant A070001 from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea.	Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bookstein C, 1997, AM J PHYSIOL-CELL PH, V273, pC1496, DOI 10.1152/ajpcell.1997.273.5.C1496; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Donowitz M, 2000, ANN NY ACAD SCI, V915, P30; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Fuster DG, 2008, J AM SOC NEPHROL, V19, P1547, DOI 10.1681/ASN.2007111245; Gawenis LR, 2002, AM J PHYSIOL-GASTR L, V282, pG776, DOI 10.1152/ajpgi.00297.2001; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Koh CG, 2001, J CELL SCI, V114, P4239; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Lee J, 2005, EXP CELL RES, V307, P315, DOI 10.1016/j.yexcr.2005.03.028; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; McWilliams RR, 2005, AM J PHYSIOL-CELL PH, V289, pC1042, DOI 10.1152/ajpcell.00568.2004; McWilliams RR, 2004, BIOCHEM J, V380, P181, DOI 10.1042/BJ20031577; MOE OW, 1995, J CLIN INVEST, V96, P2187, DOI 10.1172/JCI118273; Oh WK, 1997, BIOCHEM BIOPH RES CO, V235, P794, DOI 10.1006/bbrc.1997.6875; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Sheng M, 2000, J CELL SCI, V113, P1851; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Szaszi K, 2000, CELL PHYSIOL BIOCHEM, V10, P265, DOI 10.1159/000016358; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Weinman EJ, 2005, PFLUG ARCH EUR J PHY, V450, P137, DOI 10.1007/s00424-005-1384-8; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	42	16	16	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8104	8113		10.1074/jbc.M109.055079	http://dx.doi.org/10.1074/jbc.M109.055079			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080968	Green Published, hybrid			2022-12-25	WOS:000275413800028
J	Loseva, O; Jemth, AS; Bryant, HE; Schuler, H; Lehtio, L; Karlberg, T; Helleday, T				Loseva, Olga; Jemth, Ann-Sofie; Bryant, Helen E.; Schuler, Herwig; Lehtio, Lari; Karlberg, Tobias; Helleday, Thomas			PARP-3 Is a Mono-ADP-ribosylase That Activates PARP-1 in the Absence of DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE; CATALYTIC FRAGMENT; REPAIR; IDENTIFICATION; CELLS; INTERFERES; INHIBITOR; SUBSTRATE; RESIDUES; DOMAIN	The PARP-3 protein is closely related to the PARP-1 and PARP-2 proteins, which are involved in DNA repair and genome maintenance. Here, we characterized the biochemical properties of human PARP-3. PARP-3 is able to ADP-ribosylate itself as well as histone H1, a previously unknown substrate for PARP-3. PARP-3 is not activated upon binding to DNA and is a mono-ADP-ribosylase, in contrast to PARP-1 and PARP-2. PARP-3 interacts with PARP-1 and activates PARP-1 in the absence of DNA, resulting in synthesis of polymers of ADPribose. The N-terminal WGR domain of PARP-3 is involved in this activation. The functional interaction between PARP-3 and PARP-1 suggests that it may have a role in DNA repair. However, here we report that PARP-3 small interfering RNA-depleted cells are not sensitive to the topoisomerase I poison camptothecin, inducing DNA single-strand breaks, and repair these lesions as efficiently as wild-type cells. Altogether, these results suggest that the interaction between PARP-1 and PARP-3 is unrelated to DNA single-strand break repair.	[Helleday, Thomas] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Bryant, Helen E.] Univ Sheffield, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; [Schuler, Herwig; Lehtio, Lari; Karlberg, Tobias] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, S-17177 Stockholm, Sweden; [Helleday, Thomas] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, England	Stockholm University; University of Sheffield; Karolinska Institutet; University of Oxford	Helleday, T (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	helleday@gmt.su.se	Helleday, Thomas/D-5224-2013; Schuler, Herwig/E-5751-2011; bryant, helen/AHB-1139-2022	Schuler, Herwig/0000-0003-4059-3501; bryant, helen/0000-0003-2720-7020; Helleday, Thomas/0000-0002-7384-092X; Jemth, Ann-Sofie/0000-0002-7550-1833; Lehtio, Lari/0000-0001-7250-832X	Swedish Cancer Society; Swedish Children's Cancer Foundation; Swedish Research Council; Swedish Pain Relief Foundation; Medical Research Council; Lars Hierta Memorial Foundation; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Medical Research Council [G0700730] Funding Source: researchfish; MRC [G0700730] Funding Source: UKRI	Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Pain Relief Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lars Hierta Memorial Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Swedish Cancer Society, the Swedish Children's Cancer Foundation, the Swedish Research Council, the Swedish Pain Relief Foundation, and the Medical Research Council (to T. H.) and by the Lars Hierta Memorial Foundation (to A.-S.J.). The Structural Genomics Consortium is a registered charity (1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Allinson SL, 2003, ACTA BIOCHIM POL, V50, P169; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Jones P, 2009, J MED CHEM, V52, P7170, DOI 10.1021/jm901188v; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; LOESBERG C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P92, DOI 10.1016/0167-4838(90)90106-P; Mendoza-Alvarez H, 2004, J MOL BIOL, V336, P105, DOI 10.1016/j.jmb.2003.11.055; OGATA N, 1980, J BIOL CHEM, V255, P7610; OGATA N, 1980, J BIOL CHEM, V255, P7616; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; PANZETER PL, 1990, NUCLEIC ACIDS RES, V18, P2194, DOI 10.1093/nar/18.8.2194; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Rouleau M, 2009, J HISTOCHEM CYTOCHEM, V57, P675, DOI 10.1369/jhc.2009.953380; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Sallmann FR, 2000, J BIOL CHEM, V275, P15504, DOI 10.1074/jbc.275.20.15504; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Smith LM, 2005, CLIN CANCER RES, V11, P8449, DOI 10.1158/1078-0432.CCR-05-1224; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d	31	121	120	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8054	8060		10.1074/jbc.M109.077834	http://dx.doi.org/10.1074/jbc.M109.077834			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064938	Green Published, hybrid			2022-12-25	WOS:000275413800023
J	Tung, YCL; Ayuso, E; Shan, XY; Bosch, F; O'Rahilly, S; Coll, AP; Yeo, GSH				Tung, Yi-Chun Loraine; Ayuso, Eduard; Shan, Xiaoye; Bosch, Fatima; O'Rahilly, Stephen; Coll, Anthony P.; Yeo, Giles S. H.			Hypothalamic-Specific Manipulation of Fto, the Ortholog of the Human Obesity Gene FTO, Affects Food Intake in Rats	PLOS ONE			English	Article							BODY-MASS INDEX; ENERGY-INTAKE; CHILDREN; EXPENDITURE; VARIANT	Sequence variants in the first intron of FTO are strongly associated with human obesity and human carriers of the risk alleles show evidence for increased appetite and food intake. Mice globally lacking Fto display a complex phenotype characterised by both increased energy expenditure and increased food intake. The site of action of FTO on energy balance is unclear. Fasting reduces levels of Fto mRNA in the arcuate nucleus (ARC) of the hypothalamus, a site where Fto expression is particularly high. In this study, we have extended this nutritional link by demonstrating that consumption of a high fat diet (45%) results in a 2.5 fold increase in Arc Fto expression. We have further explored the role of hypothalamic Fto in the control of food intake by using stereotactic injections coupled with AAV technology to bi-directionally modulate Fto expression. An over expression of Fto protein by 2.5-fold in the ARC results in a 14% decrease in average daily food intake in the first week. In contrast, knocking down Arc Fto expression by 40% increases food intake by 16%. mRNA levels of Agrp, Pomc and Npy, ARC-expressed genes classically associated with the control of food intake, were not affected by the manipulation of Fto expression. However, over expression of Fto resulted in a 4-fold increase in the mRNA levels of Stat3, a signalling molecule critical for leptin receptor signalling, suggesting a possible candidate for the mediation of Fto's actions. These data provide further support for the notion that FTO itself can influence key components of energy balance, and is therefore a strong candidate for the mediation of the robust association between FTO intronic variants and adiposity. Importantly, this provide the first indication that selective alteration of FTO levels in the hypothalamus can influence food intake, a finding consistent with the reported effects of FTO alleles on appetite and food intake in man.	[Tung, Yi-Chun Loraine; Shan, Xiaoye; O'Rahilly, Stephen; Coll, Anthony P.; Yeo, Giles S. H.] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Addenbrookes Treatment Ctr,Inst Metab Sci, Cambridge CB2 2QQ, England; [Ayuso, Eduard; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Ctr Anim Biotechnol & Gene Therapy, E-08193 Barcelona, Spain; [Ayuso, Eduard; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Ayuso, Eduard; Bosch, Fatima] CIBER Diabet & Enfermedades Metab Asociadas, Barcelona, Spain	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Tung, YCL (corresponding author), Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Addenbrookes Treatment Ctr,Inst Metab Sci, Cambridge CB2 2QQ, England.	so104@medschl.cam.ac.uk; gshy2@cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; AYUSO LOPEZ, Eduardo/I-7686-2017	O'Rahilly, Stephen/0000-0003-2199-4449; BOSCH, FATIMA/0000-0002-7705-5515; Coll, Anthony Patrick/0000-0003-2594-7463; Yeo, Giles See How/0000-0001-8823-3615; Ayuso, Eduard/0000-0003-0811-2229	United Kingdom Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC-CORD); Wellcome Trust; European Union [LSHM-CT-2004-512013]; CLINIGENE; Ministerio de Ciencia e Innovacion [SAF2008-00962]; CIBER de Diabetes y Enfermedades Metabolicas Asociadas, Spain;  [LSHB-CT-2006-018933]; MRC [G0600717] Funding Source: UKRI; Medical Research Council [G0600717] Funding Source: researchfish	United Kingdom Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC-CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Union(European Commission); CLINIGENE(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBER de Diabetes y Enfermedades Metabolicas Asociadas, Spain; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the United Kingdom Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC-CORD), the Wellcome Trust, the European Union (FP6: EUGENE2, LSHM-CT-2004-512013 and CLINIGENE, LSHB-CT-2006-018933; FP7 EurOCHIP) and from Ministerio de Ciencia e Innovacion (SAF2008-00962), CIBER de Diabetes y Enfermedades Metabolicas Asociadas, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AYUSO E, GENE THER       1203; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; den Hoed M, 2009, AM J CLIN NUTR, V90, P1426, DOI 10.3945/ajcn.2009.28053; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; MEYRE D, 2009, DIABETES; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; SONESTEDT E, 2009, AM J CLIN NUTR; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; TANOFSKYKRAFF M, 2009, AM J CLIN NUTR; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wright JF, 2005, MOL THER, V12, P171, DOI 10.1016/j.ymthe.2005.02.021	25	125	134	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8771	10.1371/journal.pone.0008771	http://dx.doi.org/10.1371/journal.pone.0008771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098739	Green Published, gold			2022-12-25	WOS:000273778900015
J	Costa, DP; Robinson, PW; Arnould, JPY; Harrison, AL; Simmons, SE; Hassrick, JL; Hoskins, AJ; Kirkman, SP; Oosthuizen, H; Villegas-Amtmann, S; Crocker, DE				Costa, Daniel P.; Robinson, Patrick W.; Arnould, John P. Y.; Harrison, Autumn-Lynn; Simmons, Samantha E.; Hassrick, Jason L.; Hoskins, Andrew J.; Kirkman, Stephen P.; Oosthuizen, Herman; Villegas-Amtmann, Stella; Crocker, Daniel E.			Accuracy of ARGOS Locations of Pinnipeds at-Sea Estimated Using Fastloc GPS	PLOS ONE			English	Article							TURTLES CARETTA-CARETTA; SATELLITE TELEMETRY; FORAGING ECOLOGY; ELEPHANT SEALS; HABITAT USE; TRACKING; MOVEMENT; BEHAVIOR	Background: ARGOS satellite telemetry is one of the most widely used methods to track the movements of free-ranging marine and terrestrial animals and is fundamental to studies of foraging ecology, migratory behavior and habitat-use. ARGOS location estimates do not include complete error estimations, and for many marine organisms, the most commonly acquired locations (Location Class 0, A, B, or Z) are provided with no declared error estimate. Methodology/Principal Findings: We compared the accuracy of ARGOS locations to those obtained using Fastloc GPS from the same electronic tags on five species of pinnipeds: 9 California sea lions (Zalophus californianus), 4 Galapagos sea lions (Zalophus wollebaeki), 6 Cape fur seals (Arctocephalus pusillus pusillus), 3 Australian fur seals (A. p. doriferus) and 5 northern elephant seals (Mirounga angustirostris). These species encompass a range of marine habitats (highly pelagic vs coastal), diving behaviors (mean dive durations 2-21 min) and range of latitudes (equator to temperate). A total of 7,318 ARGOS positions and 27,046 GPS positions were collected. Of these, 1,105 ARGOS positions were obtained within five minutes of a GPS position and were used for comparison. The 68(th) percentile ARGOS location errors as measured in this study were LC-3 0.49 km, LC-2 1.01 km, LC-1 1.20 km, LC-0 4.18 km, LC-A 6.19 km, LC-B 10.28 km. Conclusions/Significance: The ARGOS errors measured here are greater than those provided by ARGOS, but within the range of other studies. The error was non-normally distributed with each LC highly right-skewed. Locations of species that make short duration dives and spend extended periods on the surface (sea lions and fur seals) had less error than species like elephant seals that spend more time underwater and have shorter surface intervals. Supplemental data (S1) are provided allowing the creation of density distributions that can be used in a variety of filtering algorithms to improve the quality of ARGOS tracking data.	[Costa, Daniel P.; Robinson, Patrick W.; Harrison, Autumn-Lynn; Simmons, Samantha E.; Hassrick, Jason L.; Villegas-Amtmann, Stella] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Arnould, John P. Y.; Hoskins, Andrew J.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Oosthuizen, Herman] Dept Environm Affairs, Cape Town, South Africa; [Kirkman, Stephen P.] Univ Cape Town, Dept Zool, Anim Demog Unit, ZA-7700 Rondebosch, South Africa; [Crocker, Daniel E.] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA	University of California System; University of California Santa Cruz; Deakin University; Department of Environment, Forestry & Fisheries; University of Cape Town; California State University System; Sonoma State University	Costa, DP (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	costa@biology.ucsc.edu	Kirkman, Stephen/AAA-9139-2021; Hoskins, Andrew/T-2694-2019; Hassrick, Jason/AAE-4905-2020; Costa, Daniel/E-2616-2013	Kirkman, Stephen/0000-0001-5428-7375; Hoskins, Andrew/0000-0001-8907-6682; Simmons, Samantha/0000-0003-0326-6990; Costa, Daniel/0000-0002-0233-5782; Harrison, Autumn-Lynn/0000-0002-6213-1765	Marine Biology Trust; Friends of Long Marine Lab; Charles Darwin station; UCMEXUS; Center For Remote Sensing (UCSC); National Ocean Partnership Program [N00014-02-1-1012]; Office of Naval Research [N00014-00-1-0880, N00014-03-1-0651, N00014-08-1-1195]; National Science Foundation OPP [ANT-0523332, ANT-0440687-02]; International Association of Oil and Gas Producers [JIP2207-23]; Moore Foundation; Packard Foundation; Sloan Foundation; Australian Research Council	Marine Biology Trust; Friends of Long Marine Lab; Charles Darwin station; UCMEXUS; Center For Remote Sensing (UCSC); National Ocean Partnership Program; Office of Naval Research(Office of Naval Research); National Science Foundation OPP(National Science Foundation (NSF)); International Association of Oil and Gas Producers; Moore Foundation(Gordon and Betty Moore Foundation); Packard Foundation(The David & Lucile Packard Foundation); Sloan Foundation(Alfred P. Sloan Foundation); Australian Research Council(Australian Research Council)	Funding: This research was conducted as part of the Tagging of Pacific Predators (TOPP) program, and was supported in part by the Dr. Earl H. Myers and Ethel M. Myers Oceanographic, Marine Biology Trust, the Friends of Long Marine Lab, the Charles Darwin station, UCMEXUS, Center For Remote Sensing (UCSC), the National Ocean Partnership Program (N00014-02-1-1012), the Office of Naval Research (N00014-00-1-0880, N00014-03-1-0651 and N00014-08-1-1195), National Science Foundation OPP grants ANT-0523332 and ANT-0440687-02, International Association of Oil and Gas Producers contract JIP2207-23, the Moore, Packard, and Sloan Foundations and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bekkby T, 2000, J SEA RES, V44, P267, DOI 10.1016/S1385-1101(00)00048-4; Bjorge A, 2002, MAR MAMMAL SCI, V18, P438, DOI 10.1111/j.1748-7692.2002.tb01047.x; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Burns JM, 2004, DEEP-SEA RES PT II, V51, P2279, DOI 10.1016/j.dsr2.2004.07.021; Burns JM, 2001, AM ZOOL, V41, P90, DOI 10.1668/0003-1569(2001)041[0090:HUBWSA]2.0.CO;2; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Eckert SA, 2002, J ZOOL, V257, P111, DOI 10.1017/S0952836902000705; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KEATING KA, 1991, J WILDLIFE MANAGE, V55, P160, DOI 10.2307/3809254; KUHN CE, 2006, MEASURING SEA FEEDIN; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; LEVANON N, 1985, IEEE T AERO ELEC SYS, V21, P783, DOI 10.1109/TAES.1985.310663; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Nicholls D. G., 2007, Notornis, V54, P137; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; RENAUD ML, 1994, B MAR SCI, V55, P1; Royer F, 2008, J EXP MAR BIOL ECOL, V359, P1, DOI 10.1016/j.jembe.2008.01.026; Shaffer SA, 2006, IEEE J OCEANIC ENG, V31, P82, DOI 10.1109/JOE.2006.872210; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Soutullo A, 2007, J WILDLIFE MANAGE, V71, P1010, DOI 10.2193/2006-042; STEWART BS, 1989, MAR MAMMAL SCI, V5, P361, DOI 10.1111/j.1748-7692.1989.tb00348.x; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Turchin Peter, 1998; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; WEIMERSKIRCH H, 1993, AUK, V110, P325; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616	45	178	180	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8677	10.1371/journal.pone.0008677	http://dx.doi.org/10.1371/journal.pone.0008677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090942	Green Submitted, gold, Green Published			2022-12-25	WOS:000273714900001
J	Adra, S; Sun, T; MacNeil, S; Holcombe, M; Smallwood, R				Adra, Salem; Sun, Tao; MacNeil, Sheila; Holcombe, Mike; Smallwood, Rod			Development of a Three Dimensional Multiscale Computational Model of the Human Epidermis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; EXTRACELLULAR-MATRIX; BINDING-PROTEIN; GENE-EXPRESSION; CELL-MIGRATION; MECHANISMS; KERATINOCYTES; ACTIVATION; TGF-BETA-1	Transforming Growth Factor (TGF-beta 1) is a member of the TGF-beta superfamily ligand-receptor network. and plays a crucial role in tissue regeneration. The extensive in vitro and in vivo experimental literature describing its actions nevertheless describe an apparent paradox in that during re-epithelialisation it acts as proliferation inhibitor for keratinocytes. The majority of biological models focus on certain aspects of TGF-beta 1 behaviour and no one model provides a comprehensive story of this regulatory factor's action. Accordingly our aim was to develop a computational model to act as a complementary approach to improve our understanding of TGF-beta 1. In our previous study, an agent-based model of keratinocyte colony formation in 2D culture was developed. In this study this model was extensively developed into a three dimensional multiscale model of the human epidermis which is comprised of three interacting and integrated layers: (1) an agent-based model which captures the biological rules governing the cells in the human epidermis at the cellular level and includes the rules for injury induced emergent behaviours, (2) a COmplex PAthway SImulator (COPASI) model which simulates the expression and signalling of TGF-beta 1 at the sub-cellular level and (3) a mechanical layer embodied by a numerical physical solver responsible for resolving the forces exerted between cells at the multi-cellular level. The integrated model was initially validated by using it to grow a piece of virtual epidermis in 3D and comparing the in virtuo simulations of keratinocyte behaviour and of TGF-beta 1 signalling with the extensive research literature describing this key regulatory protein. This research reinforces the idea that computational modelling can be an effective additional tool to aid our understanding of complex systems. In the accompanying paper the model is used to explore hypotheses of the functions of TGF-beta 1 at the cellular and subcellular level on different keratinocyte populations during epidermal wound healing.	[Adra, Salem; Holcombe, Mike; Smallwood, Rod] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Sun, Tao] Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland; [MacNeil, Sheila] Univ Sheffield, Dept Mat Engn, Sheffield, S Yorkshire, England	University of Sheffield; University of Glasgow; University of Sheffield	Adra, S (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	s.adra@sheffield.ac.uk; r.smallwood@sheffield.ac.uk	Smallwood, Rod/C-5583-2011	Smallwood, Rod/0000-0003-0134-0632	Engineering and Physical Siences Research Council United Kingdom; University of Sheffield [GR/S62321/01]; University of York [GR/S62338/01]; Engineering and Physical Sciences Research Council [GR/S62321/01] Funding Source: researchfish	Engineering and Physical Siences Research Council United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Sheffield; University of York(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is part of the Epitheliome Project, which is funded by the Engineering and Physical Siences Research Council United Kingdom through two grants, one to the University of Sheffield (GR/S62321/01), and the other to the University of York (GR/S62338/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendt C, 2002, J CELL SCI, V115, P2189; Anders RA, 1998, J BIOL CHEM, V273, P23118, DOI 10.1074/jbc.273.36.23118; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Aukhil I, 2000, PERIODONTOL 2000, V22, P44, DOI 10.1034/j.1600-0757.2000.2220104.x; Baker CTH, 1998, J MATH BIOL, V37, P341, DOI 10.1007/s002850050133; Barcellos-Hoff MH, 1996, J MAMMARY GLAND BIOL, V1, P353, DOI 10.1007/BF02017391; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; COAKLEY S, 2007, THESIS U SHEFFIELD S; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; Eglen SJ, 2002, DEVELOPMENT, V129, P5399, DOI 10.1242/dev.00118; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Fleischmajer R, 2000, MATRIX BIOL, V19, P637, DOI 10.1016/S0945-053X(00)00092-5; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; GAILIT J, 1994, J INVEST DERMATOL, V103, P221, DOI 10.1111/1523-1747.ep12393176; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Hakkinen L, 2004, AM J PATHOL, V164, P229, DOI 10.1016/S0002-9440(10)63113-6; HERTLE MD, 1992, J CLIN INVEST, V89, P1892, DOI 10.1172/JCI115794; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; Kutz SM, 2001, J CELL SCI, V114, P3905; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mazzieri R, 2005, J CELL SCI, V118, P2177, DOI 10.1242/jcs.02352; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Morel D, 2001, ACTA BIOTHEOR, V49, P219, DOI 10.1023/A:1014201805222; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Neurohr C, 2006, AM J RESP CELL MOL, V35, P252, DOI 10.1165/rcmb.2006-0013OC; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Olofsson A, 1995, J BIOL CHEM, V270, P31294, DOI 10.1074/jbc.270.52.31294; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Rashbass J, 1996, TRENDS CELL BIOL, V6, P280, DOI 10.1016/0962-8924(96)60028-2; SCHMID P, 1993, J PATHOL, V171, P191, DOI 10.1002/path.1711710307; SELLHEYER K, 1993, P NATL ACAD SCI USA, V90, P5237, DOI 10.1073/pnas.90.11.5237; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910; STREULI CH, 1993, J CELL BIOL, V120, P253, DOI 10.1083/jcb.120.1.253; Sun T, 2007, J R SOC INTERFACE, V4, P1077, DOI 10.1098/rsif.2007.0227; Vespa A, 2005, MOL BIOL CELL, V16, P4084, DOI 10.1091/mbc.e05-02-0087; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Wang XJ, 1997, P NATL ACAD SCI USA, V94, P2386, DOI 10.1073/pnas.94.6.2386; Wawersik MJ, 2001, MOL BIOL CELL, V12, P3439, DOI 10.1091/mbc.12.11.3439; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Woolley K, 2000, BIOESSAYS, V22, P911; Yamasaki M, 2008, AM J RESP CELL MOL, V38, P346, DOI 10.1165/rcmb.2007-0276OC; Yang LJ, 1999, AM J PATHOL, V154, P105, DOI 10.1016/S0002-9440(10)65256-X; Yang LJ, 2001, AM J PATHOL, V159, P2147, DOI 10.1016/S0002-9440(10)63066-0; YOUNG SJ, 2009, CELL PROLIFERAT, V42, P617; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	67	66	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8511	10.1371/journal.pone.0008511	http://dx.doi.org/10.1371/journal.pone.0008511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20076760	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000273714600001
J	Mustafi, SB; Chakraborty, PK; Raha, S				Mustafi, Soumyajit Banerjee; Chakraborty, Prabir K.; Raha, Sanghamitra			Modulation of Akt and ERK1/2 Pathways by Resveratrol in Chronic Myelogenous Leukemia (CML) Cells Results in the Downregulation of Hsp70	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; CHRONIC MYELOID-LEUKEMIA; SERINE PHOSPHORYLATION; GENE-TRANSCRIPTION; CANCER; HEAT-SHOCK-PROTEIN-70; APOPTOSIS; PROTEINS; KINASE; ACTIVATION	Background: Resveratrol is known to downregulate the high endogenous level of Heat shock protein 70 (Hsp70) in Chronic Myelogenous Leukemia (CML) K562 cells and induce apoptosis. Since Heat Shock Factor 1 (HSF1) controls transcription of Hsp70, we wanted to probe the signaling pathways responsible for transcriptional activation of HSF1. Methodology/Principal Findings: Cells exposed to 40 mu M Resveratrol rapidly abolished serine473 phosphorylation of Akt and significantly reduced its kinase activity. Inactivation of Akt pathway by Resveratrol subsequently blocked serine9 phosphorylation of Gsk3 beta. Active non-phosphorylated Gsk3b rendered HSF1 transcriptionally inactive and reduced Hsp70 production. Blocking PI3K/Akt activity also demonstrated similar effects on Hsp70 comparable to Resveratrol. Inactivation of Gsk3b activity by inhibitors SB261763 or LiCl upregulated Hsp70. Resveratrol significantly modulated ERK1/2 activity as evident from hyper phosphorylation at T302/Y304 residues and simultaneous upregulation in kinase activity. Blocking ERK1/2 activation resulted in induction of Hsp70. Therefore, increase in ERK1/2 activity by Resveratrol provided another negative influence on Hsp70 levels through negative regulation of HSF1 activity. 17-allylamino-17-demethoxygeldanamycin (17AAG), a drug that inhibits Hsp90 chaperone and degrades its client protein Akt concomitantly elevated Hsp70 levels by promoting nuclear translocation of HSF1 from the cytosol. This effect is predominantly due to inhibition of both Akt and ERK1/2 activation by 17AAG. Simultaneously treating K562 with Resveratrol and 17AAG maintained phosho-ERK1/2 levels close to untreated controls demonstrating their opposite effects on ERK1/2 pathway. Resveratrol was found not to interfere with Bcr-Abl activation in K562 cells. Conclusion/Significance: Thus our study comprehensively illustrates that Resveratrol acts downstream of Bcr-Abl and inhibits Akt activity but stimulates ERK1/2 activity. This brings down the transcriptional activity of HSF1 and Hsp70 production in K562 cells. Additionally, Resveratrol can be used in combination with chemotherapeutic agents such as 17AAG, an Hsp90 inhibitor reported to induce Hsp70 and hence compromise its chemotherapeutic potential.	[Mustafi, Soumyajit Banerjee; Chakraborty, Prabir K.; Raha, Sanghamitra] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics	Mustafi, SB (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India.	sanghamitra.raha@saha.ac.in			Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	The study was conducted with funds from the Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, EXP BIOL MED, V234, P825, DOI 10.3181/0902-MR-78; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Chakraborty PK, 2008, CANCER SCI, V99, P1109, DOI 10.1111/j.1349-7006.2008.00809.x; Chakraborty PK, 2008, PHARMACOL RES, V58, P281, DOI 10.1016/j.phrs.2008.08.007; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cotto JJ, 1996, J BIOL CHEM, V271, P3355; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Kantarjian HM, 2007, CLIN CANCER RES, V13, P1089, DOI 10.1158/1078-0432.CCR-06-2147; Kawauchi K, 2003, BLOOD CELL MOL DIS, V31, P11, DOI 10.1016/S1079-9796(03)00070-6; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005; Nguyen TK, 2007, BLOOD, V109, P4006, DOI 10.1182/blood-2006-09-045039; Parmiani G, 2004, CLIN CANCER RES, V10, P8142, DOI 10.1158/1078-0432.CCR-04-1194; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Pocaly M, 2007, LEUKEMIA, V21, P93, DOI 10.1038/sj.leu.2404463; Puissant A, 2008, FASEB J, V22, P1894, DOI 10.1096/fj.07-101394; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Roccaro AM, 2008, CLIN CANCER RES, V14, P1849, DOI 10.1158/1078-0432.CCR-07-1750; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Solit DB, 2003, CANCER RES, V63, P2139; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Tao MH, 2005, BRIT J CANCER, V92, P2059, DOI 10.1038/sj.bjc.6602609; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977	36	66	68	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8719	10.1371/journal.pone.0008719	http://dx.doi.org/10.1371/journal.pone.0008719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090934	Green Published, gold, Green Submitted			2022-12-25	WOS:000273714600019
J	Holland, PJ; Hollis, T				Holland, Paul J.; Hollis, Thomas			Structural and Mutational Analysis of Escherichia coli AlkB Provides Insight into Substrate Specificity and DNA Damage Searching	PLOS ONE			English	Article							OXIDATIVE DEMETHYLATION; CRYSTAL-STRUCTURES; ALKYLATION DAMAGE; REPAIR; BACTERIAL; 3-METHYLTHYMINE; LESIONS; 1-METHYLGUANINE; PROTEIN; RNA	Background: In Escherichia coli, cytotoxic DNA methyl lesions on the N1 position of purines and N3 position of pyrimidines are primarily repaired by the 2-oxoglutarate (2-OG) iron(II) dependent dioxygenase, AlkB. AlkB repairs 1-methyladenine (1-meA) and 3-methylcytosine (3-meC) lesions, but it also repairs 1-methylguanine (1-meG) and 3-methylthymine (3-meT) at a much less efficient rate. How the AlkB enzyme is able to locate and identify methylated bases in ssDNA has remained an open question. Methodology/Principal Findings: We determined the crystal structures of the E. coli AlkB protein holoenzyme and the AlkB-ssDNA complex containing a 1-meG lesion. We coupled this to site-directed mutagenesis of amino acids in and around the active site, and tested the effects of these mutations on the ability of the protein to bind both damaged and undamaged DNA, as well as catalyze repair of a methylated substrate. Conclusions/Significance: A comparison of our substrate-bound AlkB-ssDNA complex with our unliganded holoenzyme reveals conformational changes of residues within the active site that are important for binding damaged bases. Site-directed mutagenesis of these residues reveals novel insight into their roles in DNA damage recognition and repair. Our data support a model that the AlkB protein utilizes at least two distinct conformations in searching and binding methylated bases within DNA: a "searching'' mode and "repair'' mode. Moreover, we are able to functionally separate these modes through mutagenesis of residues that affect one or the other binding state. Finally, our mutagenesis experiments show that amino acid D135 of AlkB participates in both substrate specificity and catalysis.	[Holland, Paul J.; Hollis, Thomas] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center	Holland, PJ (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA.	thollis@wfubmc.edu			American Cancer Society [RSG-04-187-01-GMC]	American Cancer Society(American Cancer Society)	American Cancer Society (to TH) grant # RSG-04-187-01-GMC (http://www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Begley TJ, 2003, TRENDS BIOCHEM SCI, V28, P2, DOI 10.1016/S0968-0004(02)00010-5; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; WESTBYE MP, 2008, J BIOL CHEM; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561	32	49	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8680	10.1371/journal.pone.0008680	http://dx.doi.org/10.1371/journal.pone.0008680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084272	gold, Green Submitted, Green Published			2022-12-25	WOS:000273554600031
J	Lee, JH; Jo, J; Hardikar, AA; Periwal, V; Rane, SG				Lee, Ji-Hyeon; Jo, Junghyo; Hardikar, Anandwardhan A.; Periwal, Vipul; Rane, Sushil G.			Cdk4 Regulates Recruitment of Quiescent beta-Cells and Ductal Epithelial Progenitors to Reconstitute beta-Cell Mass	PLOS ONE			English	Article							ISLET PRECURSOR CELLS; DIABETIC MOUSE MODEL; PANCREATIC B-CELL; STEM-CELLS; INSULIN-RESISTANCE; BONE-MARROW; REGENERATION; MICE; PROLIFERATION; ENDOCRINE	Insulin-producing pancreatic islet beta cells (beta-cells) are destroyed, severely depleted or functionally impaired in diabetes. Therefore, replacing functional beta-cell mass would advance clinical diabetes management. We have previously demonstrated the importance of Cdk4 in regulating beta-cell mass. Cdk4-deficient mice display beta-cell hypoplasia and develop diabetes, whereas beta-cell hyperplasia is observed in mice expressing an active Cdk4R24C kinase. While beta-cell replication appears to be the primary mechanism responsible for beta-cell mass increase, considerable evidence also supports a contribution from the pancreatic ductal epithelium in generation of new beta-cells. Further, while it is believed that majority of beta-cells are in a state of 'dormancy', it is unclear if and to what extent the quiescent cells can be coaxed to participate in the beta-cell regenerative response. Here, we address these queries using a model of partial pancreatectomy (PX) in Cdk4 mutant mice. To investigate the kinetics of the regeneration process precisely, we performed DNA analog-based lineage-tracing studies followed by mathematical modeling. Within a week after PX, we observed considerable proliferation of islet beta-cells and ductal epithelial cells. Interestingly, the mathematical model showed that recruitment of quiescent cells into the active cell cycle promotes beta-cell mass reconstitution in the Cdk4R24C pancreas. Moreover, within 24-48 hours post-PX, ductal epithelial cells expressing the transcription factor Pdx-1 dramatically increased. We also detected insulin-positive cells in the ductal epithelium along with a significant increase of islet-like cell clusters in the Cdk4R24C pancreas. We conclude that Cdk4 not only promotes beta-cell replication, but also facilitates the activation of beta-cell progenitors in the ductal epithelium. In addition, we show that Cdk4 controls beta-cell mass by recruiting quiescent cells to enter the cell cycle. Comparing the contribution of cell proliferation and islet-like clusters to the total increase in insulin-positive cells suggests a hitherto uncharacterized large non-proliferative contribution.	[Lee, Ji-Hyeon; Rane, Sushil G.] NIDDK, Regenerat Biol Sect, Diabet Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; [Jo, Junghyo; Periwal, Vipul] NIDDK, Lab Biol Modeling, Natl Inst Hlth, Bethesda, MD USA; [Hardikar, Anandwardhan A.] Natl Ctr Cell Sci, Stem Cells & Diabet Sect, Pune, Maharashtra, India	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Lee, JH (corresponding author), NIDDK, Regenerat Biol Sect, Diabet Branch, Natl Inst Hlth, Bethesda, MD 20892 USA.	ranes@mail.nih.gov	Hardikar, Anandwardhan/ACF-7730-2022; Jo, Junghyo/D-4889-2011; Periwal, Vipul/I-1728-2012		National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health intramural program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055105, ZIADK075038] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health intramural program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2002, J PATHOL, V197, P519, DOI 10.1002/path.1158; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Georgia S, 2006, DIABETES, V55, P2950, DOI 10.2337/db06-0249; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gregory P., 2005, BAYESIAN LOGICAL DAT; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; HELLERSTROM C, 1984, DIABETOLOGIA, V26, P393; HELLERSTROM C, 1991, DIABETES, V40, P89, DOI 10.2337/diab.40.2.S89; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Liu YQ, 2000, AM J PHYSIOL-ENDOC M, V279, pE68, DOI 10.1152/ajpendo.2000.279.1.E68; Liu ZY, 2009, CELL, V138, P424, DOI 10.1016/j.cell.2009.07.022; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Marzo N, 2008, J IMMUNOL, V180, P1189, DOI 10.4049/jimmunol.180.2.1189; Mettus RV, 2003, ONCOGENE, V22, P8413, DOI 10.1038/sj.onc.1206888; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Offield MF, 1996, DEVELOPMENT, V122, P983; Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017; Rachdi L, 2006, DIABETES, V55, P3520, DOI 10.2337/db06-0861; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Rane SG, 2002, MOL CELL BIOL, V22, P644, DOI 10.1128/MCB.22.2.644-656.2002; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; SWENNE I, 1984, DIABETOLOGIA, V27, P464, DOI 10.1007/BF00273912; SWENNE I, 1983, DIABETES, V32, P14, DOI 10.2337/diabetes.32.1.14; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang XB, 2005, DIABETES, V54, P712, DOI 10.2337/diabetes.54.3.712; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	59	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8653	10.1371/journal.pone.0008653	http://dx.doi.org/10.1371/journal.pone.0008653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084282	Green Published, Green Submitted, gold			2022-12-25	WOS:000273554600012
J	Li, H; Greene, LH				Li, Hai; Greene, Lesley H.			Sequence and Structural Analysis of the Chitinase Insertion Domain Reveals Two Conserved Motifs Involved in Chitin-Binding	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINIDASE-H; EXPOSED AROMATIC RESIDUES; CRYSTAL-STRUCTURE; ENZYMATIC-PROPERTIES; FAMILY-18 CHITINASE; ANGSTROM RESOLUTION; AMINO-ACIDS; PROTEIN; MECHANISM; EVOLUTION	Background: Chitinases are prevalent in life and are found in species including archaea, bacteria, fungi, plants, and animals. They break down chitin, which is the second most abundant carbohydrate in nature after cellulose. Hence, they are important for maintaining a balance between carbon and nitrogen trapped as insoluble chitin in biomass. Chitinases are classified into two families, 18 and 19 glycoside hydrolases. In addition to a catalytic domain, which is a triosephosphate isomerase barrel, many family 18 chitinases contain another module, i.e., chitinase insertion domain. While numerous studies focus on the biological role of the catalytic domain in chitinase activity, the function of the chitinase insertion domain is not completely understood. Bioinformatics offers an important avenue in which to facilitate understanding the role of residues within the chitinase insertion domain in chitinase function. Results: Twenty-seven chitinase insertion domain sequences, which include four experimentally determined structures and span five kingdoms, were aligned and analyzed using a modified sequence entropy parameter. Thirty-two positions with conserved residues were identified. The role of these conserved residues was explored by conducting a structural analysis of a number of holo-enzymes. Hydrogen bonding and van der Waals calculations revealed a distinct subset of four conserved residues constituting two sequence motifs that interact with oligosaccharides. The other conserved residues may be key to the structure, folding, and stability of this domain. Conclusions: Sequence and structural studies of the chitinase insertion domains conducted within the framework of evolution identified four conserved residues which clearly interact with the substrates. Furthermore, evolutionary studies propose a link between the appearance of the chitinase insertion domain and the function of family 18 chitinases in the subfamily A.	[Li, Hai; Greene, Lesley H.] Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA 23529 USA	Old Dominion University	Li, H (corresponding author), Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA 23529 USA.	lgreene@odu.edu	LI, HAI/B-4052-2012; LI, HAI/G-3823-2012; Li, Hai/J-5419-2014		Old Dominion University Office of Research; Dominion Scholarship	Old Dominion University Office of Research; Dominion Scholarship	This work is supported by funding from the Old Dominion University Office of Research (to LHG) and Dominion Scholarship (to HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; Bortone K, 2002, J MOL BIOL, V320, P293, DOI 10.1016/S0022-2836(02)00444-8; Brameld KA, 1998, P NATL ACAD SCI USA, V95, P4276, DOI 10.1073/pnas.95.8.4276; BRANDEN C, 1998, INTRO PROTEIN STRUCT, P53; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cavada BS, 2006, FEBS J, V273, P3962, DOI 10.1111/j.1742-4658.2006.05400.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P255; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Daimon T, 2005, INSECT BIOCHEM MOLEC, V35, P1112, DOI 10.1016/j.ibmb.2005.05.005; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrandon S, 2003, BBA-GEN SUBJECTS, V1621, P31, DOI 10.1016/S0304-4165(03)00029-1; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Funkhouser JD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-96; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; GOODAY GW, 1990, ADV MICROB ECOL, V11, P387; Greene LH, 2003, FEBS LETT, V553, P39, DOI 10.1016/S0014-5793(03)00925-6; Guda C, 2001, Pac Symp Biocomput, P275; HENNIG M, 1995, J MOL BIOL, V254, P237, DOI 10.1006/jmbi.1995.0614; Hoell IA, 2006, FEBS J, V273, P4889, DOI 10.1111/j.1742-4658.2006.05487.x; Hollis T, 2000, PROTEIN SCI, V9, P544, DOI 10.1110/ps.9.3.544; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Kawase T, 2004, APPL ENVIRON MICROB, V70, P1135, DOI 10.1128/AEM.70.2.1135-1144.2004; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MELCHERS LS, 1994, PLANT J, V5, P469, DOI 10.1046/j.1365-313X.1994.5040469.x; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nagano N, 2001, PROTEIN ENG, V14, P845, DOI 10.1093/protein/14.11.845; Nakamura T, 2007, ACTA CRYSTALLOGR F, V63, P7, DOI 10.1107/S1744309106051773; NOZAKI Y, 1971, J BIOL CHEM, V246, P2211; Palermo NY, 2008, INT J QUANTUM CHEM, V108, P814, DOI 10.1002/qua.21521; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Payan F, 2003, BIOCHEM J, V372, P399, DOI 10.1042/BJ20021802; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; PESTSKO G, 2004, PROTEIN STRUCTURE FU, P33; Ramalho-Ortigao JM, 2003, INSECT BIOCHEM MOLEC, V33, P279, DOI 10.1016/S0965-1748(02)00209-6; Ranea JAG, 2006, J MOL EVOL, V63, P513, DOI 10.1007/s00239-005-0289-7; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; Rao V, 1999, PROTEIN SCI, V8, P2338; RAO VH, 1995, STRUCTURE, V3, P449, DOI 10.1016/S0969-2126(01)00178-2; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schueler-Furman O, 2003, PROTEINS, V52, P225, DOI 10.1002/prot.10365; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Srivastava DB, 2006, J STRUCT BIOL, V156, P505, DOI 10.1016/j.jsb.2006.05.008; Subramaniam V, 2001, J BIOL CHEM, V276, P21506, DOI 10.1074/jbc.M102292200; Suginta W, 2004, ARCH BIOCHEM BIOPHYS, V424, P171, DOI 10.1016/j.abb.2004.01.017; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Suzuki K, 2002, BIOSCI BIOTECH BIOCH, V66, P1075, DOI 10.1271/bbb.66.1075; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; Taira T, 2002, BIOSCI BIOTECH BIOCH, V66, P970, DOI 10.1271/bbb.66.970; Todd AE, 1999, CURR OPIN CHEM BIOL, V3, P548, DOI 10.1016/S1367-5931(99)00007-1; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2004, J BIOL CHEM, V279, P3612, DOI 10.1074/jbc.M310057200; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; vanScheltinga ACT, 1996, J MOL BIOL, V262, P243, DOI 10.1006/jmbi.1996.0510; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; Varela PF, 2002, J BIOL CHEM, V277, P13229, DOI 10.1074/jbc.M110502200; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Zees AC, 2009, BBA-PROTEINS PROTEOM, V1794, P23, DOI 10.1016/j.bbapap.2008.09.018	78	82	88	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8654	10.1371/journal.pone.0008654	http://dx.doi.org/10.1371/journal.pone.0008654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084296	gold, Green Submitted, Green Published			2022-12-25	WOS:000273554600013
J	Otkjaer, K; Holtmann, H; Kragstrup, TW; Paludan, SR; Johansen, C; Gaestel, M; Kragballe, K; Iversen, L				Otkjaer, Kristian; Holtmann, Helmut; Kragstrup, Tue Wenzel; Paludan, Soren Riis; Johansen, Claus; Gaestel, Matthias; Kragballe, Knud; Iversen, Lars			The p38 MAPK Regulates IL-24 Expression by Stabilization of the 3 ' UTR of IL-24 mRNA	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; AU-RICH ELEMENT; DIFFERENTIATION-ASSOCIATED GENE-7; HUMAN-MELANOMA CELLS; MDA-7 EXPRESSION; PSORIATIC EPIDERMIS; MDA-7/IL-24; APOPTOSIS; IDENTIFICATION; RECEPTORS	Background: IL-24 (melanoma differentiation-associated gene-7 (mda-7)), a member of the IL-10 cytokine family, possesses the properties of a classical cytokine as well as tumor suppressor effects. The exact role of IL-24 in the immune system has not been defined but studies have indicated a role for IL-24 in inflammatory conditions such as psoriasis. The tumor suppressor effects of IL-24 include inhibition of angiogenesis, sensitization to chemotherapy, and p38 mitogen-activated protein kinase (MAPK)mediated apoptosis. Current knowledge on the regulation of IL-24 expression is sparse. Previous studies have suggested that mRNA stabilization is of major importance to IL-24 expression. Yet, the mechanisms responsible for the regulation of IL-24 mRNA stability remain unidentified. As p38 MAPK is known to regulate gene expression by interfering with mRNA degradation we examined the role of p38 MAPK in the regulation of IL-24 gene expression in cultured normal human keratinocytes. Methodology/Principal Findings: In the present study we show that anisomycin- and IL-1 beta-induced IL-24 expression is strongly dependent on p38 MAPK activation. Studies of IL-24 mRNA stability in anisomycin-treated keratinocytes reveal that the p38 MAPK inhibitor SB 202190 accelerates IL-24 mRNA decay suggesting p38 MAPK to regulate IL-24 expression by mRNA-stabilizing mechanisms. The insertion of the 3' untranslated region (UTR) of IL-24 mRNA in a tet-off reporter construct induces degradation of the reporter mRNA. The observed mRNA degradation is markedly reduced when a constitutively active mutant of MAPK kinase 6 (MKK6), which selectively activates p38 MAPK, is co-expressed. Conclusions/Significance: Taken together, we here report p38 MAPK as a regulator of IL-24 expression and determine interference with destabilization mediated by the 39 UTR of IL-24 mRNA as mode of action. As discussed in the present work these findings have important implications for our understanding of IL-24 as a tumor suppressor protein as well as an immune modulating cytokine.	[Otkjaer, Kristian] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; [Otkjaer, Kristian; Johansen, Claus; Kragballe, Knud; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus, Denmark; [Holtmann, Helmut; Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-3000 Hannover, Germany; [Kragstrup, Tue Wenzel; Paludan, Soren Riis] Aarhus Univ, Inst Med Microbiol & Immunol, Aarhus, Denmark	Aarhus University; Aarhus University; Hannover Medical School; Aarhus University	Otkjaer, K (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark.	lars.iversen@ki.au.dk	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; Johansen, Claus/0000-0002-5665-5212; Johansen, Claus/0000-0003-0240-5127; Kragstrup, Tue Wenzel/0000-0002-6439-397X; Iversen, Lars/0000-0003-1816-4508	Novo Nordisk Foundation; Danish Cancer Society; Lundbeck Foundation; Danish Psoriasis Research Foundation; Aage Bang Foundation; Medical Research Council, Denmark; German Research Council [Ho 1116/4]; Deutsche Forschungsgemeinschaft	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Danish Psoriasis Research Foundation; Aage Bang Foundation; Medical Research Council, Denmark(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Council(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Novo Nordisk Foundation; the Danish Cancer Society; the Lundbeck Foundation; the Danish Psoriasis Research Foundation; the Aage Bang Foundation; the Medical Research Council, Denmark; and grant Ho 1116/4 of the German Research Council. The work of M. Gaestel was funded by Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cunningham CC, 2005, MOL THER, V11, P149, DOI 10.1016/j.ymthe.2004.09.019; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Ekmekcioglu S, 2001, INT J CANCER, V94, P54, DOI 10.1002/ijc.1437; Ellerhorst JA, 2002, J CLIN ONCOL, V20, P1069, DOI 10.1200/JCO.2002.20.4.1069; Funding AT, 2006, J INVEST DERMATOL, V126, P1784, DOI 10.1038/sj.jid.5700252; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gupta P, 2006, CANCER RES, V66, P8182, DOI 10.1158/0008-5472.CAN-06-0577; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; Jiang HP, 1995, ONCOGENE, V11, P2477; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Johansen C, 2005, BRIT J DERMATOL, V152, P37, DOI 10.1111/J.1365-2133.2004.06304.X; KRAGBALLE K, 1985, BRIT J DERMATOL, V112, P263, DOI 10.1111/j.1365-2133.1985.tb04852.x; Kragstrup TW, 2008, CYTOKINE, V41, P16, DOI 10.1016/j.cyto.2007.10.004; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Lebedeva IV, 2007, INT J ONCOL, V31, P985; Lebedeva IV, 2002, ONCOGENE, V21, P708, DOI 10.1038/sj.onc.1205116; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Madireddi MT, 2000, J CELL PHYSIOL, V185, P36, DOI 10.1002/1097-4652(200010)185:1<36::AID-JCP3>3.0.CO;2-V; Madireddi MT, 2000, ONCOGENE, V19, P1362, DOI 10.1038/sj.onc.1203424; Otkjaer K, 2005, BRIT J DERMATOL, V153, P911, DOI 10.1111/j.1365-2133.2005.06800.x; Otkjaer K, 2007, J INVEST DERMATOL, V127, P1326, DOI 10.1038/sj.jid.5700713; Poindexter NJ, 2005, J LEUKOCYTE BIOL, V78, P745, DOI 10.1189/jlb.0205116; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sainz-Perez A, 2006, LEUKEMIA, V20, P498, DOI 10.1038/sj.leu.2404073; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Sauane M, 2003, J CELL PHYSIOL, V196, P334, DOI 10.1002/jcp.10309; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Sauane M, 2008, P NATL ACAD SCI USA, V105, P9763, DOI 10.1073/pnas.0804089105; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Smalley KSM, 2002, MELANOMA RES, V12, P187, DOI 10.1097/00008390-200206000-00001; Tong AW, 2005, MOL THER, V11, P160, DOI 10.1016/j.ymthe.2004.09.021; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang R, 2000, J BIOL CHEM, V275, P24436, DOI 10.1074/jbc.M001958200	45	32	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8671	10.1371/journal.pone.0008671	http://dx.doi.org/10.1371/journal.pone.0008671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072629	Green Published, Green Submitted, gold			2022-12-25	WOS:000273554600023
J	Spigoni, G; Gedressi, C; Mallamaci, A				Spigoni, Giulia; Gedressi, Chiara; Mallamaci, Antonello			Regulation of Emx2 Expression by Antisense Transcripts in Murine Cortico-Cerebral Precursors	PLOS ONE			English	Article							GENE-EXPRESSION; NONCODING RNA; ENDOGENOUS SIRNAS; HOMEOBOX GENES; AREA IDENTITY; MOUSE-BRAIN; STEM-CELLS; ACTIVATION; CORTEX; DIFFERENTIATION	Background: Emx2 encodes for a transcription factor expressed in the embryonic intermediate mesoderm and central nervous system (CNS). It is implicated in several aspects of cerebral cortex development, including morphogenetic field specification, arealization, precursor proliferation and lamination. Four Emx2-associated antisense transcripts have been found in the urogenital system; one of them, Emx2OS, has been also detected in the adult brain. Until now, however, nothing is known about expression and function of Emx2OS in the developing CNS. Methodology/Principal Findings: By quantitative RT-PCR and in situ hybridization, we reconstructed the Emx2OS expression profile in the embryonic CNS, paying special attention to the developing cerebral cortex. Emx2OS was observed in a number of CNS structures expressing also Emx2. Within the cortex, Emx2OS was detectable in periventricular precursors, expressing the sense transcript, and peaked in newly born post-mitotic neurons not expressing such transcript. By integrating lentiviral gene delivery, RNAi, TetON technology, morpholino-mediated gene knock-down, drug-induced perturbation of gene expression, and quantitative RT-PCR, we addressed possible roles of Ex2 antisense RNA in Emx2 regulation, in primary CNS precursor cultures. We found that, in both cortical precursors and their neuronal progenies, Emx2 antisense RNA contributes to post-transcriptional down-regulation of its sense partner, possibly by a Dicer-promoted mechanism. The same RNA, when delivered to rhombo-spinal precursors, stimulates ectopic expression of Emx2, whereas Emx2 knock-out dramatically impairs Emx2OS transcription. This suggests that, within the developing CNS, a reciprocal Emx2/Emx2OS regulatory loop may normally sustain transcription at the Emx2 locus. Conclusions/Significance: This study shows that antisense transcripts may contribute to developmental regulation of a key transcription factor gene implicated in CNS patterning, possibly by complex and multilevel mechanisms. The activation of Emx2 by a short antisense transcript may be a prototype of a method for overexpressing single specific genes, without introducing additional copies of them into the genome.	[Spigoni, Giulia; Gedressi, Chiara; Mallamaci, Antonello] SISSA, ISAS, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA)	Spigoni, G (corresponding author), SISSA, ISAS, I-34014 Trieste, Italy.	amallama@sissa.it	Mallamaci, Antonello/A-2975-2015	Mallamaci, Antonello/0000-0002-3621-1307	intramural SISSA	intramural SISSA	This work was entirely supported by intramural SISSA funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano G, 2005, HUM MOL GENET, V14, P913, DOI 10.1093/hmg/ddi084; Babajko S, 2009, CELLS TISSUES ORGANS, V189, P115, DOI 10.1159/000151748; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Berdal A, 2002, CONNECT TISSUE RES, V43, P148, DOI 10.1080/03008200290000970; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Blin-Wakkach C, 2001, P NATL ACAD SCI USA, V98, P7336, DOI 10.1073/pnas.131497098; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Capowski EE, 2007, J NEUROSCI METH, V163, P338, DOI 10.1016/j.jneumeth.2007.02.022; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Chen Z, 2008, MOL CANCER THER, V7, P698, DOI 10.1158/1535-7163.MCT-07-2312; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Coudert AE, 2005, NUCLEIC ACIDS RES, V33, P5208, DOI 10.1093/nar/gki831; De Palma M, 2002, METHOD ENZYMOL, V346, P514; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Galli R, 2002, DEVELOPMENT, V129, P1633; Gangemi RMR, 2001, MECH DEVELOP, V109, P323, DOI 10.1016/S0925-4773(01)00546-9; Geng X, 2007, GENE EXPR PATTERNS, V7, P252, DOI 10.1016/j.modgep.2006.09.007; Gritti A, 1996, J NEUROSCI, V16, P1091; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Leupin O, 2005, EMBO REP, V6, P956, DOI 10.1038/sj.embor.7400502; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Li YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-18; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Mao QQ, 2008, BIOCHEM BIOPH RES CO, V375, P566, DOI 10.1016/j.bbrc.2008.08.059; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; Muzio L, 2005, CEREB CORTEX, V15, P2021, DOI 10.1093/cercor/bhi077; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Muzio L, 2002, NAT NEUROSCI, V5, P737, DOI 10.1038/nn892; Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005; Noonan FC, 2003, GENOMICS, V81, P58, DOI 10.1016/S0888-7543(02)00023-X; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Petit S, 2009, J CELL PHYSIOL, V220, P303, DOI 10.1002/jcp.21762; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Potenza N, 2009, CELL BIOL INT, V33, P734, DOI 10.1016/j.cellbi.2009.04.002; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rallu M, 2002, DEVELOPMENT, V129, P4963; *RIKEN GEN EXPL RE, SCIENCE, V309, P1564; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; SHEN G, 2002, J PHYS CONDENS MATT, V14, P1; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Theil T, 2002, DEVELOPMENT, V129, P3045; Theil T, 1999, DEVELOPMENT, V126, P3561; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yoshida M, 1997, DEVELOPMENT, V124, P101	71	36	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8658	10.1371/journal.pone.0008658	http://dx.doi.org/10.1371/journal.pone.0008658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20066053	Green Published, gold, Green Submitted			2022-12-25	WOS:000273456300008
J	Kessler, K; Gordon, L; Cessford, K; Lages, M				Kessler, Klaus; Gordon, Lucy; Cessford, Kari; Lages, Martin			Characteristics of Motor Resonance Predict the Pattern of Flash-Lag Effects for Biological Motion	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; FINGER MOVEMENTS; MIRROR NEURONS; MOVING STIMULI; EXTRAPOLATION; IMITATION; MECHANISMS; AREA; MODULATION; OBJECTS	Background: When a moving stimulus and a briefly flashed static stimulus are physically aligned in space the static stimulus is perceived as lagging behind the moving stimulus. This vastly replicated phenomenon is known as the Flash-Lag Effect (FLE). For the first time we employed biological motion as the moving stimulus, which is important for two reasons. Firstly, biological motion is processed by visual as well as somatosensory brain areas, which makes it a prime candidate for elucidating the interplay between the two systems with respect to the FLE. Secondly, discussions about the mechanisms of the FLE tend to recur to evolutionary arguments, while most studies employ highly artificial stimuli with constant velocities. Methodology/Principal Finding: Since biological motion is ecologically valid it follows complex patterns with changing velocity. We therefore compared biological to symbolic motion with the same acceleration profile. Our results with 16 observers revealed a qualitatively different pattern for biological compared to symbolic motion and this pattern was predicted by the characteristics of motor resonance: The amount of anticipatory processing of perceived actions based on the induced perspective and agency modulated the FLE. Conclusions/Significance: Our study provides first evidence for an FLE with non-linear motion in general and with biological motion in particular. Our results suggest that predictive coding within the sensorimotor system alone cannot explain the FLE. Our findings are compatible with visual prediction (Nijhawan, 2008) which assumes that extrapolated motion representations within the visual system generate the FLE. These representations are modulated by sudden visual input (e.g. offset signals) or by input from other systems (e.g. sensorimotor) that can boost or attenuate overshooting representations in accordance with biased neural competition (Desimone & Duncan, 1995).	[Kessler, Klaus] Univ Glasgow, Dept Psychol, CCNi, Glasgow, Lanark, Scotland	University of Glasgow	Kessler, K (corresponding author), Univ Glasgow, Dept Psychol, CCNi, Glasgow, Lanark, Scotland.	k.kessler@psy.gla.ac.uk		Lages, Martin/0000-0002-4962-3116; Kessler, Klaus/0000-0001-7307-9539	ESRC/MRC [RES-060-25-0010]; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish; Medical Research Council [MC_G1001214] Funding Source: researchfish; ESRC [ES/E020933/1] Funding Source: UKRI; MRC [MC_G1001214] Funding Source: UKRI	ESRC/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by ESRC/MRC funding (RES-060-25-0010) to Klaus Kessler and Martin Lages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andino SLG, 2000, HUM BRAIN MAPP, V11, P46; BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; Baldo MVC, 2002, PERCEPTION, V31, P17, DOI 10.1068/p3302; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Bertenthal BI, 2006, J EXP PSYCHOL HUMAN, V32, P210, DOI 10.1037/0096-1523.32.2.210; Biermann-Ruben K, 2008, EUR J NEUROSCI, V27, P1843, DOI 10.1111/j.1460-9568.2008.06146.x; BIERMANNRUBEN K, 2008, BRAIN COGN; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fu YX, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0003.2001; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Iacoboni M., 2005, PERSPECTIVES IMITATI, P77; Ichikawa M, 2006, VISION RES, V46, P2192, DOI 10.1016/j.visres.2005.12.021; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Jonas M, 2007, NEUROIMAGE, V36, pT44, DOI 10.1016/j.neuroimage.2007.03.028; Jonas M, 2007, EXP BRAIN RES, V177, P255, DOI 10.1007/s00221-006-0660-y; Kanai R, 2004, VISION RES, V44, P2605, DOI 10.1016/j.visres.2003.10.028; Kerzel D, 2008, BEHAV BRAIN SCI, V31, P206, DOI 10.1017/S0140525X08003907; Kessler K, 2005, CEREB CORTEX, V15, P1075, DOI 10.1093/cercor/bhh208; Kessler K, 2006, NEUROIMAGE, V33, P227, DOI 10.1016/j.neuroimage.2006.06.014; Kessler K, 2010, COGNITION, V114, P72, DOI 10.1016/j.cognition.2009.08.015; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Lages M, 1998, VISION RES, V38, P557, DOI 10.1016/S0042-6989(97)88333-2; Lestou V, 2008, J COGNITIVE NEUROSCI, V20, P324, DOI 10.1162/jocn.2008.20021; Marceglia S, 2009, NEUROSCIENCE, V161, P1027, DOI 10.1016/j.neuroscience.2009.04.018; Maus GW, 2006, VISION RES, V46, P4375, DOI 10.1016/j.visres.2006.08.028; Maus GW, 2008, PSYCHOL SCI, V19, P1087, DOI 10.1111/j.1467-9280.2008.02205.x; Maus GW, 2009, J EXP PSYCHOL HUMAN, V35, P611, DOI 10.1037/a0012317; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; Musseler J, 2002, VIS COGN, V9, P120, DOI 10.1080/13506280143000359; Nijhawan R, 2003, CURR BIOL, V13, P749, DOI 10.1016/S0960-9822(03)00248-3; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; POLIAKOFF E, 2009, EXP BRAIN RES; Poliakoff E, 2007, NEUROREPORT, V18, P483, DOI 10.1097/WNR.0b013e32805867a1; Ramachandran VS, 2008, MED HYPOTHESES, V70, P1233, DOI 10.1016/j.mehy.2008.01.008; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Ramnani N, 2004, NAT NEUROSCI, V7, P85, DOI 10.1038/nn1168; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Sundberg KA, 2006, NEURON, V49, P447, DOI 10.1016/j.neuron.2005.12.023; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257; Wojtach WT, 2008, P NATL ACAD SCI USA, V105, P16338, DOI 10.1073/pnas.0808916105	56	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8258	10.1371/journal.pone.0008258	http://dx.doi.org/10.1371/journal.pone.0008258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	541KN	20062543	gold, Green Published, Green Accepted			2022-12-25	WOS:000273414100001
J	Chakrabarti, S; Panchenko, AR				Chakrabarti, Saikat; Panchenko, Anna R.			Structural and Functional Roles of Coevolved Sites in Proteins	PLOS ONE			English	Article							INFORMATION-THEORETIC ANALYSIS; AMINO-ACID SUBSTITUTIONS; MUTUAL INFORMATION; CORRELATED MUTATIONS; RESIDUES; COEVOLUTION; EVOLUTION; IDENTIFICATION; COVARIATION; ALIGNMENTS	Background: Understanding the residue covariations between multiple positions in protein families is very crucial and can be helpful for designing protein engineering experiments. These simultaneous changes or residue coevolution allow protein to maintain its overall structural-functional integrity while enabling it to acquire specific functional modifications. Despite the significant efforts in the field there is still controversy in terms of the preferable locations of coevolved residues on different regions of protein molecules, the strength of coevolutionary signal and role of coevolution in functional diversification. Methodology: In this paper we study the scale and nature of residue coevolution in maintaining the overall functionality and structural integrity of proteins. We employed a large scale study to investigate the structural and functional aspects of coevolved residues. We found that the networks representing the coevolutionary residue connections within our dataset are in general of 'small-world' type as they have clustering coefficient values higher than random networks and also show smaller mean shortest path lengths similar and/or lower than random and regular networks. We also found that altogether 11% of functionally important sites are coevolved with any other sites. Active sites are found more frequently to coevolve with any other sites (15%) compared to protein (11%) and ligand (9%) binding sites. Metal binding and active sites are also found to be more frequently coevolved with other metal binding and active sites, respectively. Analysis of the coupling between coevolutionary processes and the spatial distribution of coevolved sites reveals that a high fraction of coevolved sites are located close to each other. Moreover, similar to 80% of charge compensatory substitutions within coevolved sites are found at very close spatial proximity (< = 5 angstrom), pointing to the possible preservation of salt bridges in evolution. Conclusion: Our findings show that a noticeable fraction of functionally important sites undergo coevolution and also point towards compensatory substitutions as a probable coevolutionary mechanism within spatially proximal coevolved functional sites.	[Chakrabarti, Saikat; Panchenko, Anna R.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Chakrabarti, S (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	chakraba@ncbi.nlm.nih.gov; panch@ncbi.nlm.nih.gov			National Library of Medicine at National Institutes of Health/DHHS	National Library of Medicine at National Institutes of Health/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine at National Institutes of Health/DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Bulka B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-329; Castoe TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002201; Chakrabarti S, 2007, PROTEIN SCI, V16, P4, DOI 10.1110/ps.062506407; Chakrabarti S, 2009, PROTEINS, V75, P231, DOI 10.1002/prot.22239; Chelvanayagam G, 1997, PROTEIN ENG, V10, P307, DOI 10.1093/protein/10.4.307; Choi SS, 2005, NAT GENET, V37, P1367, DOI 10.1038/ng1685; Daily MD, 2008, PROTEINS, V71, P455, DOI 10.1002/prot.21800; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; Ferrer-Costa C, 2007, J MOL BIOL, V365, P249, DOI 10.1016/j.jmb.2006.09.053; Fitch W M, 1971, J Mol Evol, V1, P84, DOI 10.1007/BF01659396; Fukami-Kobayashi K, 2002, J MOL BIOL, V319, P729, DOI 10.1016/S0022-2836(02)00239-5; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Gouveia-Oliveira R, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-12; Govindarajan S, 2003, J MOL BIOL, V328, P1061, DOI 10.1016/S0022-2836(03)00357-7; Henrick K, 2008, NUCLEIC ACIDS RES, V36, pD426, DOI 10.1093/nar/gkm937; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Mathias N, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021117; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Moore GL, 2003, P NATL ACAD SCI USA, V100, P5091, DOI 10.1073/pnas.0831190100; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Pritchard L, 2001, PROTEIN ENG, V14, P549, DOI 10.1093/protein/14.8.549; Saraf MC, 2003, PROTEIN ENG, V16, P1025, DOI 10.1093/protein/gzg129; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Voigt CA, 2001, J CELL BIOCHEM, V84, P58, DOI 10.1002/jcb.10066; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	48	44	44	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8591	10.1371/journal.pone.0008591	http://dx.doi.org/10.1371/journal.pone.0008591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066038	gold, Green Submitted, Green Published			2022-12-25	WOS:000273338600014
J	Hansen, KK; Stafflinger, E; Schneider, M; Hauser, F; Cazzamali, G; Williamson, M; Kollmann, M; Schachtner, J; Grimmelikhuijzen, CJP				Hansen, Karina K.; Stafflinger, Elisabeth; Schneider, Martina; Hauser, Frank; Cazzamali, Giuseppe; Williamson, Michael; Kollmann, Martin; Schachtner, Joachim; Grimmelikhuijzen, Cornelis J. P.			Discovery of a Novel Insect Neuropeptide Signaling System Closely Related to the Insect Adipokinetic Hormone and Corazonin Hormonal Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MALARIA MOSQUITO; MOLECULAR-IDENTIFICATION; NEUROHORMONE GPCRS; DROSOPHILA; GENOME; GENES; EXPRESSION; PEPTIDE; CLONING	Neuropeptides and their G protein-coupled receptors (GPCRs) play a central role in the physiology of insects. One large family of insect neuropeptides are the adipokinetic hormones (AKHs), which mobilize lipids and carbohydrates from the insect fat body. Other peptides are the corazonins that are structurally related to the AKHs but represent a different neuropeptide signaling system. We have previously cloned an orphan GPCR from the malaria mosquito Anopheles gambiae that was structurally intermediate between the A. gambiae AKH and corazonin GPCRs. Using functional expression of the receptor in cells in cell culture, we have now identified the ligand for this orphan receptor as being pQVTFSRD-WNAamide, a neuropeptide that is structurally intermediate between AKH and corazonin and that we therefore named ACP (AKH/corazonin-related peptide). ACP does not activate the A. gambiae AKH and corazonin receptors and, vice versa, AKH and corazonin do not activate the ACP receptor, showing that the ACP/receptor couple is an independent and so far unknown peptidergic signaling system. Because ACP is structurally intermediate between AKH and corazonin and the ACP receptor between the AKH and corazonin receptors, this is a prominent example of receptor/ligand co-evolution, probably originating from receptor and ligand gene duplications followed by mutations and evolutionary selection, thereby yielding three independent hormonal systems. The ACP signaling system occurs in the mosquitoes A. gambiae, Aedes aegypti, and Culex pipiens (Diptera), the silkworm Bombyx mori (Lepidoptera), the red flour beetle Tribolium castaneum (Coleoptera), the parasitic wasp Nasonia vitripennis (Hymenoptera), and the bug Rhodnius prolixus (Hemiptera). However, the ACP system is not present in 12 Drosophila species (Diptera), the honeybee Apis mellifera (Hymenoptera), the pea aphid Acyrthosiphon pisum (Hemiptera), the body louse Pediculus humanus (Phthiraptera), and the crustacean Daphnia pulex, indicating that it has been lost several times during arthropod evolution. In particular, this frequent loss of hormonal systems is unique for arthropods compared with vertebrates.	[Hansen, Karina K.; Stafflinger, Elisabeth; Schneider, Martina; Hauser, Frank; Cazzamali, Giuseppe; Williamson, Michael; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Ctr Funct & Comparat Insect Genom, Dept Biol, DK-2100 Copenhagen, Denmark; [Kollmann, Martin; Schachtner, Joachim] Univ Marburg, Dept Anim Physiol, D-35032 Marburg, Germany	University of Copenhagen; Philipps University Marburg	Grimmelikhuijzen, CJP (corresponding author), Univ Copenhagen, Ctr Funct & Comparat Insect Genom, Dept Biol, DK-2100 Copenhagen, Denmark.	cgrimmelikhuijzen@bio.ku.dk	Hauser, Frank/M-2952-2014; Schachtner, Joachim/D-5522-2009; Schachtner, Joachim/AAG-1101-2020	Hauser, Frank/0000-0001-5563-2345; Schachtner, Joachim/0000-0001-7268-0699; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046	Danish Research Agency; Novo Nordisk Foundation; Deutsche Forschungsgemeinschaft	Danish Research Agency; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Danish Research Agency, Novo Nordisk Foundation, and Deutsche Forschungsgemeinschaft.	Belmont M, 2006, BIOCHEM BIOPH RES CO, V344, P160, DOI 10.1016/j.bbrc.2006.03.117; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; Cazzamali G, 2003, BIOCHEM BIOPH RES CO, V303, P146, DOI 10.1016/S0006-291X(03)00302-4; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Glenner H, 2006, SCIENCE, V314, P1883, DOI 10.1126/science.1129844; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kaufmann C, 2006, INSECT BIOCHEM MOLEC, V36, P466, DOI 10.1016/j.ibmb.2006.03.009; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; KIMURA T, 1992, NATURE, V356, P526, DOI 10.1038/356526a0; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Salaneck E, 2008, GENE, V409, P61, DOI 10.1016/j.gene.2007.11.011; Siegert KJ, 1999, FEBS LETT, V447, P237, DOI 10.1016/S0014-5793(99)00299-9; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Zitnan D, 2007, GEN COMP ENDOCR, V153, P88, DOI 10.1016/j.ygcen.2007.04.002	33	113	116	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10736	10747		10.1074/jbc.M109.045369	http://dx.doi.org/10.1074/jbc.M109.045369			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20068045	Green Published, hybrid			2022-12-25	WOS:000276264600060
J	Zhou, XE; Suino-Powell, KM; Li, J; He, YZ; MacKeigan, JP; Melcher, K; Yong, EL; Xu, HE				Zhou, X. Edward; Suino-Powell, Kelly M.; Li, Jun; He, Yuanzheng; MacKeigan, Jeffrey P.; Melcher, Karsten; Yong, Eu-Leong; Xu, H. Eric			Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-PROLIFERATION; LIGAND-BINDING DOMAIN; PROSTATE-CANCER; BIOCHEMICAL BASIS; STRUCTURAL BASIS; GENE; BREAST; RECRUITMENT; MUTATIONS; COREGULATORS	Transcription activation by androgen receptor (AR), which depends on recruitment of coactivators, is required for the initiation and progression of prostate cancer, yet the mechanisms of how hormone-activated AR interacts with coactivators remain unclear. This is because AR, unlike any other nuclear receptor, prefers its own N-terminal FXXLF motif to the canonical LXXLL motifs of coactivators. Through biochemical and crystallographic studies, we identify that steroid receptor coactivator-3 (SRC3) (also named as amplified in breast cancer-1 or AIB1) interacts strongly with AR via synergistic binding of its first and third LXXLL motifs. Mutagenesis and functional studies confirm that SRC3 is a preferred coactivator for hormone-activated AR. Importantly, AR mutations found in prostate cancer patients correlate with their binding potency to SRC3, corroborating with the emerging role of SRC3 as a prostate cancer oncogene. These results provide a molecular mechanism for the selective utilization of SRC3 by hormone-activated AR, and they link the functional relationship between AR and SRC3 to the development and growth of prostate cancer.	[Zhou, X. Edward; Suino-Powell, Kelly M.; Li, Jun; He, Yuanzheng; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA; [Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Natl Univ Hosp, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Singapore 119077, Singapore	Van Andel Institute; Van Andel Institute; National University of Singapore	Xu, HE (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave,NE, Grand Rapids, MI 49503 USA.	eric.xu@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; He, Yuanzheng/0000-0001-9131-140X; MacKeigan, Jeffrey/0000-0002-0198-5679; Yong, Eu-Leong/0000-0001-6511-770X; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301]; Jay and Betty Van Andel Foundation; Department of Defense Prostate Cancer [W81XWH0510043]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Department of Defense Prostate Cancer(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662, DK066202, and HL089301 (to H. E. X.). This work was also supported in part by a grant from the Jay and Betty Van Andel Foundation and a Department of Defense Prostate Cancer Grant W81XWH0510043 (to H. E. X.).	Alen P, 1999, MOL CELL BIOL, V19, P6085; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002; Chen GC, 2005, PROSTATE, V63, P395, DOI 10.1002/pros.20191; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chung ACK, 2007, CANCER RES, V67, P5965, DOI 10.1158/0008-5472.CAN-06-3168; Culig Z, 2004, CURR CANCER DRUG TAR, V4, P455, DOI 10.2174/1568009043332925; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; Dehm SM, 2005, EXPERT REV ANTICANC, V5, P63, DOI 10.1586/14737140.5.1.63; Dubbink HJ, 2006, MOL ENDOCRINOL, V20, P1742, DOI 10.1210/me.2005-0348; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Glass CK, 2000, GENE DEV, V14, P121; Gottlieb B, 1998, NUCLEIC ACIDS RES, V26, P234, DOI 10.1093/nar/26.1.234; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; Kirkegaard T, 2007, CLIN CANCER RES, V13, P1405, DOI 10.1158/1078-0432.CCR-06-1933; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Li B, 2008, CANCER LETT, V261, P64, DOI 10.1016/j.canlet.2007.11.013; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Ma H, 1999, MOL CELL BIOL, V19, P6164; Marcelli M, 2000, CANCER RES, V60, P944; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Mononen N, 2000, CANCER RES, V60, P6479; Mussi P, 2006, MOL ENDOCRINOL, V20, P3105, DOI 10.1210/me.2005-0522; NAVAZA J, 1992, MOL REPLACEMENT; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; Rahman M, 2004, CLIN CANCER RES, V10, P2208, DOI 10.1158/1078-0432.CCR-0746-3; Sanchez D, 2006, BJU INT, V98, P1320, DOI 10.1111/j.1464-410X.2006.06438.x; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Su QB, 2008, ONCOLOGY-BASEL, V75, P159, DOI 10.1159/000159267; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Suino-Powell K, 2008, MOL CELL BIOL, V28, P1915, DOI 10.1128/MCB.01541-07; Taplin ME, 1999, CANCER RES, V59, P2511; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Tindall D J, 2000, Mayo Clin Proc, V75 Suppl, pS26; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zheng FHF, 2005, MOL CELL BIOL, V25, P8273, DOI 10.1128/MCB.25.18.8273-8284.2005; Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076; Zhou XE, 2010, PROTEIN EXPRES PURIF, V71, P21, DOI 10.1016/j.pep.2009.12.002; Zou JX, 2006, PROSTATE, V66, P1474, DOI 10.1002/pros.20477	65	63	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9161	9171		10.1074/jbc.M109.085779	http://dx.doi.org/10.1074/jbc.M109.085779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086010	hybrid, Green Published			2022-12-25	WOS:000275553700065
J	Kirino, Y; Vourekas, A; Kim, N; Alves, FD; Rappsilber, J; Klein, PS; Jongens, TA; Mourelatos, Z				Kirino, Yohei; Vourekas, Anastassios; Kim, Namwoo; Alves, Flavia de Lima; Rappsilber, Juri; Klein, Peter S.; Jongens, Thomas A.; Mourelatos, Zissimos			Arginine Methylation of Vasa Protein Is Conserved across Phyla	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERM-CELL FORMATION; SPLICEOSOMAL SM PROTEINS; DROSOPHILA POLE PLASM; METHYLTRANSFERASE CAPSULEEN; PROTEOMIC ANALYSIS; TUDOR DOMAINS; SOMATIC-CELLS; RNA HELICASE; LOCALIZATION; COMPONENT	Recent studies have uncovered an unexpected relationship between factors that are essential for germline development in Drosophila melanogaster: the arginine protein methyltransferase 5 (dPRMT5/Csul/Dart5) and its cofactor Valois, methylate the Piwi family protein Aub, enabling it to bind Tudor. The RNA helicase Vasa is another essential protein in germline development. Here, we report that mouse (mouse Vasa homolog), Xenopus laevis, and D. melanogaster Vasa proteins contain both symmetrical and asymmetrical dimethylarginines. We find that dPRMT5 is required for the production of sDMAs of Vasa in vivo. Furthermore, we find that the mouse Vasa homolog associates with Tudor domain-containing proteins, Tdrd1 and Tdrd6, as well as the Piwi proteins, Mili and Miwi. Arginine methylation is thus emerging as a conserved and pivotal post-translational modification of proteins that is essential for germline development.	[Mourelatos, Zissimos] Univ Penn, Sch Med, Dept Pathol & Lab Med, Div Neuropathol, Philadelphia, PA 19104 USA; [Jongens, Thomas A.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Alves, Flavia de Lima; Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH8 9YL, Midlothian, Scotland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Edinburgh	Mourelatos, Z (corresponding author), 613B Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	mourelaz@uphs.upenn.edu	Vourekas, Anastassios/J-6108-2017; Rappsilber, Juri/B-7265-2015; Vourekas, Anastasios/AAI-8278-2020; Rappsilber, Juri/ABF-3328-2020	Vourekas, Anastassios/0000-0002-1850-5635; Rappsilber, Juri/0000-0001-5999-1310; Mourelatos, Zissimos/0000-0002-9852-1845; Kirino, Yohei/0000-0001-5232-4742; Kim, Namwoo/0000-0002-1684-5417	National Institutes of Health [GM76621, MH086705, GM0720777, NS056070]; Human Frontier Science Program; The Institute for the Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); The Institute for the Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM76621 (to P. S. K.), MH086705 (to T. A. J.), GM0720777, and NS056070 (to Z. M.). This work was also supported by a Human Frontier Science Program Long Term fellowship (to Y. K.) and in part by The Institute for the Translational Medicine and Therapeutics grants (to Z. M.).	Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Bossi Elena, 2007, V375, P107; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Boulanger MC, 2004, BIOCHEM J, V379, P283, DOI 10.1042/BJ20031176; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Cavey M, 2005, DEVELOPMENT, V132, P459, DOI 10.1242/dev.01590; Chen C, 2009, P NATL ACAD SCI USA, V106, P20336, DOI 10.1073/pnas.0911640106; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Dansereau David A., 2008, V450, P3, DOI 10.1007/978-1-60327-214-8_1; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Ikenishi K, 2000, DEV GROWTH DIFFER, V42, P95; Ikenishi K, 1997, DEV GROWTH DIFFER, V39, P625; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Kirino Y, 2010, RNA, V16, P70, DOI 10.1261/rna.1869710; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lau NC, 2009, EMBO J, V28, P2945, DOI 10.1038/emboj.2009.237; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; LIANG L, 1994, DEVELOPMENT, V120, P1201; Liu NK, 2003, CURR BIOL, V13, P1905, DOI 10.1016/j.cub.2003.10.026; Nishida KM, 2009, EMBO J, V28, P3820, DOI 10.1038/emboj.2009.365; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Raz E, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Rongo C, 1996, TRENDS GENET, V12, P102, DOI 10.1016/0168-9525(96)81421-1; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Siomi MC, 2008, FEBS LETT, V582, P2473, DOI 10.1016/j.febslet.2008.06.018; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Tanaka SS, 2000, GENE DEV, V14, P841; Thomson T, 2005, CELL RES, V15, P281, DOI 10.1038/sj.cr.7290297; Thomson T, 2008, MECH DEVELOP, V125, P865, DOI 10.1016/j.mod.2008.06.005; Tinker R, 1998, DEV BIOL, V199, P1, DOI 10.1006/dbio.1998.8941; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Williamson A, 1996, ANNU REV CELL DEV BI, V12, P365, DOI 10.1146/annurev.cellbio.12.1.365	58	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8148	8154		10.1074/jbc.M109.089821	http://dx.doi.org/10.1074/jbc.M109.089821			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080973	hybrid, Green Published			2022-12-25	WOS:000275413800033
J	Sutter, R; Shakhova, O; Bhagat, H; Behesti, H; Sutter, C; Penkar, S; Santuccione, A; Bernays, R; Heppner, FL; Schuller, U; Grotzer, M; Moch, H; Schraml, P; Marino, S				Sutter, R.; Shakhova, O.; Bhagat, H.; Behesti, H.; Sutter, C.; Penkar, S.; Santuccione, A.; Bernays, R.; Heppner, F. L.; Schueller, U.; Grotzer, M.; Moch, H.; Schraml, P.; Marino, S.			Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas	ONCOGENE			English	Article						medulloblastoma; mouse model; CD133; Sox2; neural stem cells; tumor stem cells	SONIC HEDGEHOG; STEM/PROGENITOR CELLS; SOMATIC INACTIVATION; NERVOUS-SYSTEM; P53(-/-) MICE; HUMAN HOMOLOG; ADULT; EXPRESSION; PATHWAY; BRAIN	Cells with stem cell properties have been isolated from various areas of the postnatal mammalian brain, most recently from the postnatal mouse cerebellum. We show here that inactivation of the tumor suppressor genes Rb and p53 in these endogenous neural stem cells induced deregulated proliferation and resistance to apoptosis in vitro. Moreover, injection of these cells into mice formed medulloblastomas. Medulloblastomas are the most common malignant brain tumors of childhood, and despite recent advances in treatment they are associated with high morbidity and mortality. They are highly heterogeneous tumors characterized by a diverse genetic make-up and expression profile as well as variable prognosis. Here, we describe a novel ontogenetic pathway of medulloblastoma that significantly contributes to understanding their heterogeneity. Experimental medulloblastomas originating from neural stem cells preferentially expressed stem cell markers Nestin, Sox2 and Sox9, which were not expressed in medulloblastomas originating from granule-cell-restricted progenitors. Furthermore, the expression of these markers identified a subset of human medulloblastomas associated with a poorer clinical outcome. Oncogene (2010) 29, 1845-1856; doi:10.1038/onc.2009.472; published online 11 January 2010	[Sutter, R.; Shakhova, O.; Bhagat, H.; Behesti, H.; Penkar, S.; Marino, S.] Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Neurosci, London E1 2AT, England; [Sutter, C.; Santuccione, A.; Moch, H.; Schraml, P.] Univ Zurich Hosp, Dept Pathol, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Bernays, R.] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Heppner, F. L.] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Schueller, U.] Univ Munich, Ctr Neuropathol, Munich, Germany; [Grotzer, M.] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland	University of London; Queen Mary University London; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Munich; University Children's Hospital Zurich	Marino, S (corresponding author), Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Neurosci, 4 Newark St, London E1 2AT, England.	s.marino@qmul.ac.uk	Heppner, Frank/ABH-8393-2020; santuccione chadha, antonella/HDL-9230-2022; Sutter, Reto/D-6783-2013	Heppner, Frank/0000-0001-9816-8917; Sutter, Reto/0000-0001-6355-9838; Behesti, Hourinaz/0000-0001-9383-9929; Grotzer, Michael/0000-0002-1154-2732; Marino, Silvia/0000-0002-9612-2883; Santuccione Chadha, Antonella/0000-0002-4021-3129; Schuller, Ulrich/0000-0002-8731-1121	St Bartholomew's Charitable Foundation; Cancer Research UK; Ali's Dream and Charlie's Challenge Charities; Janggen-Pohn Foundation; Swiss National Science Foundation	St Bartholomew's Charitable Foundation; Cancer Research UK(Cancer Research UK); Ali's Dream and Charlie's Challenge Charities; Janggen-Pohn Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Rob Wechsler-Reya and James Briscoe for the gift of ptc+/- medulloblastoma pellets and Sox9 antibody respectively. We thank Gary Warnes for expert assistance with the flow cytometry analysis. This work was supported by grants of St Bartholomew's Charitable Foundation, Cancer Research UK, Ali's Dream and Charlie's Challenge Charities to SM and by personal fellowships of Janggen-Pohn Foundation and Swiss National Science Foundation to RS.	Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Behesti H, 2009, INT J BIOCHEM CELL B, V41, P435, DOI 10.1016/j.biocel.2008.06.017; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; DRESCHER DG, 1993, J NEUROCHEM, V61, P1167, DOI 10.1111/j.1471-4159.1993.tb03638.x; Eberhart CG, 2003, AM J PATHOL, V162, P7, DOI 10.1016/S0002-9440(10)63792-3; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577; Galli Rosselia, 2008, V438, P67, DOI 10.1007/978-1-59745-133-8_7; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Huang HT, 2000, AM J PATHOL, V156, P433, DOI 10.1016/S0002-9440(10)64747-5; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee Y, 2003, CANCER RES, V63, P5428; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Marino S, 2000, GENE DEV, V14, P994; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Phi JH, 2008, AM J SURG PATHOL, V32, P103, DOI 10.1097/PAS.0b013e31812f6ba6; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Shakhova O, 2006, CANCER RES, V66, P5190, DOI 10.1158/0008-5472.CAN-05-3545; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Tong WM, 2003, AM J PATHOL, V162, P343, DOI 10.1016/S0002-9440(10)63825-4; Weiss William A., 2002, Oncogene, V21, P7453, DOI 10.1038/sj.onc.1205936; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zurawel RH, 2000, GENE CHROMOSOME CANC, V27, P44, DOI 10.1002/(SICI)1098-2264(200001)27:1<44::AID-GCC6>3.0.CO;2-V	49	63	64	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2010	29	12					1845	1856		10.1038/onc.2009.472	http://dx.doi.org/10.1038/onc.2009.472			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20062081	Green Accepted			2022-12-25	WOS:000276022800013
J	Yamaguchi, K; Mandai, M; Oura, T; Matsumura, N; Hamanishi, J; Baba, T; Matsui, S; Murphy, SK; Konishi, I				Yamaguchi, K.; Mandai, M.; Oura, T.; Matsumura, N.; Hamanishi, J.; Baba, T.; Matsui, S.; Murphy, S. K.; Konishi, I.			Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes	ONCOGENE			English	Article						ovarian clear cell carcinoma; microarray; carcinogenesis; signature	EXPRESSION PROFILES; POOR-PROGNOSIS; CANCER-CELLS; MOLECULAR MARKER; BREAST-CANCER; CHEMORESISTANCE; METHYLATION; PATTERNS; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; ENDOMETRIOSIS	Ovarian clear cell carcinoma (OCCC) shows unique clinical features including an association with endometriosis and poor prognosis. We previously reported that the contents of endometriotic cysts, especially high concentrations of free iron, are a possible cause of OCCC carcinogenesis through iron-induced persistent oxidative stress. In this study, we conducted gene expression microarray analysis using 38 ovarian cancer cell lines and identified genes commonly expressed in both OCCC cell lines and clinical samples, which comprise an OCCC gene signature. The OCCC signature reproducibly predicts OCCC specimens in other microarray data sets, suggesting that this gene profile reflects the inherent biological characteristics of OCCC. The OCCC signature contains known markers of OCCC, such as hepatocyte nuclear factor-1 beta (HNF-1 beta) and versican (VCAN), and other genes that reflect oxidative stress. Expression of OCCC signature genes was induced by treatment of immortalized ovarian surface epithelial cells with the contents of endometriotic cysts, indicating that the OCCC signature is largely dependent on the tumor microenvironment. Induction of OCCC signature genes is at least in part epigenetically regulated, as we found hypomethylation of HNF-1 beta and VCAN in OCCC cell lines. This genome-wide study indicates that the tumor microenvironment induces specific gene expression profiles that contribute to the development of distinct cancer subtypes. Oncogene (2010) 29, 1741-1752; doi:10.1038/onc.2009.470; published online 11 January 2010	[Yamaguchi, K.; Mandai, M.; Matsumura, N.; Hamanishi, J.; Baba, T.; Konishi, I.] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Sakyo Ku, Kyoto 6068507, Japan; [Yamaguchi, K.; Murphy, S. K.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27710 USA; [Oura, T.] Kyoto Univ, Grad Sch Publ Hlth, Dept Biostat, Sakyo Ku, Kyoto 6068507, Japan; [Matsui, S.] Inst Stat Math, Dept Data Sci, Res Org Informat & Syst, Tokyo, Japan	Kyoto University; Duke University; Kyoto University; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Mandai, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	mandai@kuhp.kyoto-u.ac.jp	Yamaguchi, Ken/Y-6633-2018; Hamanishi, Junzo/AAX-3318-2020; Murphy, Susan/R-3903-2019	Yamaguchi, Ken/0000-0002-7669-1405; Murphy, Susan/0000-0001-8298-7272; BABA, Tsukasa/0000-0003-0066-3747; Hamanishi, Junzo/0000-0002-7750-0623; Matsumura, Noriomi/0000-0002-4512-7975				Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Garcia-Escudero R, 2008, MOL CARCINOGEN, V47, P573, DOI 10.1002/mc.20430; Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hawthorne VS, 2009, MOL CANCER RES, V7, P592, DOI 10.1158/1541-7786.MCR-08-0316; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Issa JPJ, 2001, CANCER RES, V61, P3573; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; Ito M, 2007, J UROLOGY, V178, P1073, DOI 10.1016/j.juro.2007.05.012; Kato N, 2008, HISTOPATHOLOGY, V52, P682, DOI 10.1111/j.1365-2559.2008.03006.x; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Lee S, 2007, GYNECOL ONCOL, V106, P311, DOI 10.1016/j.ygyno.2007.03.041; Maeda T, 2005, BRIT J CANCER, V93, P116, DOI 10.1038/sj.bjc.6602662; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Osada R, 2007, HUM PATHOL, V38, P1310, DOI 10.1016/j.humpath.2007.02.010; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Ramaswamy S, 2002, J CLIN ONCOL, V20, P1932, DOI 10.1200/JCO.2002.20.7.1932; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Schwartz DR, 2002, CANCER RES, V62, P4722; Shimizu M, 1999, CANCER, V85, P669, DOI 10.1002/(SICI)1097-0142(19990201)85:3<669::AID-CNCR17>3.0.CO;2-F; Skirnisdottir I, 2005, INT J ONCOL, V26, P177; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO;2-X; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Takano M, 2006, BRIT J CANCER, V94, P1369, DOI 10.1038/sj.bjc.6603116; Takemoto Y, 2004, CLIN CANCER RES, V10, P7418, DOI 10.1158/1078-0432.CCR-04-0279; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614; Zaffanello M, 2008, MED SCI MONITOR, V14, pRA78; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	46	124	126	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1741	1752		10.1038/onc.2009.470	http://dx.doi.org/10.1038/onc.2009.470			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20062075				2022-12-25	WOS:000276022800004
J	McConnell, JJ; Bragg, L; Shiboski, S; Grant, RM				McConnell, J. Jeff; Bragg, Larry; Shiboski, Stephen; Grant, Robert M.			Sexual Seroadaptation: Lessons for Prevention and Sex Research from a Cohort of HIV-Positive Men Who Have Sex with Men	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUAL BISEXUAL MEN; SAN-FRANCISCO; GAY MEN; SEROPOSITIVE GAY; SOCIAL NETWORKS; CONCURRENT PARTNERSHIPS; RISK BEHAVIOR; UNITED-STATES	Background: Surveillance data on sexually transmitted infections (STIs) and behavioral characteristics identified in studies of the risk of seroconversion are often used as to track sexual behaviors that spread HIV. However, such analyses can be confounded by "seroadaptation" - the restriction of unprotected anal intercourse (UAI), especially unprotected insertive UAI, to seroconcordant partnerships. Methods: We utilized sexual network methodology and repeated-measures statistics to test the hypothesis that seroadaptive strategies reduce the risk of HIV transmission despite numerous partnerships and frequent UAI. Principal Findings: In a prospective cohort study of HIV superinfection including 168 HIV-positive men who have sex with men (MSM), we found extensive seroadaptation. UAI was 15.5 times more likely to occur with a positive partner than a negative one (95% confidence interval [CI], 9.1-26.4). Receptive UAI was 4.3 times more likely in seroconcordant partnerships than with negative partners (95% CI, 2.8-6.6), but insertive UAI was 13.6 times more likely with positives (95% CI, 7.2-25.6). Our estimates suggest that seroadaptation reduced HIV transmissions by 98%. Conclusion: Potentially effective HIV prevention strategies, such as seroadaptation, have evolved in communities of MSM before they have been recognized in research or discussed in the public health forum. Thus, to be informative, studies of HIV risk must be designed to assess seroadaptive behaviors rather than be limited to individual characteristics, unprotected intercourse, and numbers of partners. STI surveillance is not an effective indicator of trends in HIV incidence where there are strong patterns of seroadaptation.	[McConnell, J. Jeff; Bragg, Larry; Grant, Robert M.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Shiboski, Stephen] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Grant, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McConnell, JJ (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	jmcconnell@gladstone.ucsf.edu		Grant, Robert/0000-0002-0851-7085	University of California San Francisco AIDS Research Institute Breakthrough Fund; University of California San Francisco-Gladstone Centers for AIDS Research Developmental Award (CFAR) [556232-29665]; Centers for Disease Control [U64/CCU917889-01]; University wide AIDS Research Program (UARP) Innovative Developmental Exploratory Award (IDEA) [ID01-GI-115]; National Institutes of Health [R01 AI056988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056988] Funding Source: NIH RePORTER	University of California San Francisco AIDS Research Institute Breakthrough Fund; University of California San Francisco-Gladstone Centers for AIDS Research Developmental Award (CFAR); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University wide AIDS Research Program (UARP) Innovative Developmental Exploratory Award (IDEA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	University of California San Francisco AIDS Research Institute Breakthrough Fund, University of California San Francisco-Gladstone Centers for AIDS Research Developmental Award (CFAR) # 556232-29665, Centers for Disease Control grant # U64/CCU917889-01, University wide AIDS Research Program (UARP) Innovative Developmental Exploratory Award (IDEA) award # ID01-GI-115, National Institutes of Health R01 AI056988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P229; ANDERSON RM, 1989, ANN NY ACAD SCI, V569, P240, DOI 10.1111/j.1749-6632.1989.tb27374.x; ANDERSON RM, 1988, NATURE, V333, P514, DOI 10.1038/333514a0; [Anonymous], 1994, ADV SOCIAL NETWORK A; Bell DC, 1999, SOC NETWORKS, V21, P1, DOI 10.1016/S0378-8733(98)00010-0; BERNARD HR, 1990, SOC NETWORKS, V12, P179, DOI 10.1016/0378-8733(90)90005-T; Blower SMSS, 1997, AIDS BEHAV, V1, P273; BLYTHE SP, 1989, MATH BIOSCI, V96, P221, DOI 10.1016/0025-5564(89)90060-6; Bogard CJ, 1999, J HEALTH SOC BEHAV, V40, P46, DOI 10.2307/2676378; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; Clatts MC, 2005, SEX TRANSM INFECT, V81, P373, DOI 10.1136/sti.2005.014894; Cox J, 2004, SEX TRANSM INFECT, V80, P518, DOI 10.1136/sti.2004.011288; Crepaz N, 2002, AIDS, V16, P135, DOI 10.1097/00002030-200201250-00002; DAWSON JM, 1994, AIDS, V8, P837, DOI 10.1097/00002030-199406000-00018; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Elford J, 2006, CURR OPIN INFECT DIS, V19, P26, DOI 10.1097/01.qco.0000199018.50451.e1; Fischer C, 1982, DWELL FRIENDS PERSON; Fox KK, 2001, AM J PUBLIC HEALTH, V91, P959, DOI 10.2105/AJPH.91.6.959; Fox KK, 1998, SEX TRANSM DIS, V25, P386, DOI 10.1097/00007435-199808000-00011; Friedman SR, 2001, J URBAN HEALTH, V78, P411, DOI 10.1093/jurban/78.3.411; GAGNON JH, 1989, DAEDALUS, V118, P47; GOEDERT JJ, 1984, LANCET, V2, P711; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; GRANT RM, 1987, J INFECT DIS, V156, P189, DOI 10.1093/infdis/156.1.189; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; HAGE P, 1995, SOC NETWORKS, V17, P57, DOI 10.1016/0378-8733(94)00248-9; Hoff CC, 1997, J ACQ IMMUN DEF SYND, V14, P72, DOI 10.1097/00042560-199701010-00012; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; KIPPAX S, 1993, AIDS, V7, P257, DOI 10.1097/00002030-199302000-00015; Kretzschmar M, 1996, MATH BIOSCI, V133, P165, DOI 10.1016/0025-5564(95)00093-3; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; LAUMANN EO, 1989, SCIENCE, V244, P1186, DOI 10.1126/science.2543079; Lemp GF, 1997, J ACQ IMMUN DEF SYND, V16, P182, DOI 10.1097/00042560-199711010-00007; LIEBOW E, 1995, SOC NETWORKS, V17, P257, DOI 10.1016/0378-8733(95)00266-Q; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; MARKS G, 1994, J ACQ IMMUN DEF SYND, V7, P866; MORRIS M, 1994, AM J EPIDEMIOL, V140, P217, DOI 10.1093/oxfordjournals.aje.a117241; MORRIS M, 1995, AIDS EDUC PREV, V7, P24; Morris M, 1997, AIDS, V11, pS209; MORRIS M, 1995, AIDS, V9, P507, DOI 10.1097/00002030-199509050-00014; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2000, AIDS, V14, P733, DOI 10.1097/00002030-200004140-00013; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Morris M, 1996, AIDS, V10, P1265, DOI 10.1097/00002030-199609000-00013; MORRIS M, 1994, ADV SOCIAL NETWORK A, P26; MOSS PM, 1998, THESIS RU US; NEEDLE RH, 1995, SOCIAL NETWORKS DRUG; Parsons JT, 2006, AIDS EDUC PREV, V18, P139, DOI 10.1521/aeap.2006.18.2.139; Parsons JT, 2005, AIDS, V19, pS87, DOI 10.1097/01.aids.0000167355.87041.63; Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Rothenberg R B, 1995, NIDA Res Monogr, V151, P3; ROTHENBERG RB, 1995, SOC NETWORKS, V17, P273, DOI 10.1016/0378-8733(95)00267-R; Rothenberg RB, 1998, SEX TRANSM DIS, V25, P154, DOI 10.1097/00007435-199803000-00009; *SAN FRANC DEP PUB, 2001, 2001 SAN FRANC HIV P; Schwarcz S, 2001, AM J EPIDEMIOL, V153, P925, DOI 10.1093/aje/153.10.925; SERVICE SK, 1995, P ROY SOC B-BIOL SCI, V260, P237, DOI 10.1098/rspb.1995.0086; Shilts R., 1988, BAND PLAYED POLITICS, P588; Stall RD, 2000, AIDS, V14, pS101; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wasserman S., 1994, SOCIAL NETWORK ANAL; WINKELSTEIN W, 1987, AM J PUBLIC HEALTH, V77, P685, DOI 10.2105/AJPH.77.6.685; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P1470, DOI 10.1001/jama.1987.03390110046011; Xia Q, 2006, AIDS, V20, P2081, DOI 10.1097/01.aids.0000247566.57762.b2; 2007, SEROADAPTATION CHEZ	71	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8831	10.1371/journal.pone.0008831	http://dx.doi.org/10.1371/journal.pone.0008831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	546AJ	20098616	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779100022
J	Edes, K; Cassidy, P; Shami, PJ; Moos, PJ				Edes, Kornelia; Cassidy, Pamela; Shami, Paul J.; Moos, Philip J.			JS-K, a Nitric Oxide Prodrug, Has Enhanced Cytotoxicity in Colon Cancer Cells with Knockdown of Thioredoxin Reductase 1	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; MOTEXAFIN GADOLINIUM; IN-VIVO; LIPOIC ACID; ELECTROPHILIC PROSTAGLANDINS; ANTICANCER AGENTS; TUMOR-SUPPRESSOR; LEUKEMIA CELLS; SYSTEM; EXPRESSION	Background: The selenoenzyme thioredoxin reductase 1 has a complex role relating to cell growth. It is induced as a component of the cellular response to potentially mutagenic oxidants, but also appears to provide growth advantages to transformed cells by inhibiting apoptosis. In addition, selenocysteine-deficient or alkylated forms of thioredoxin reductase 1 have also demonstrated oxidative, pro-apoptotic activity. Therefore, a greater understanding of the role of thioredoxin reductase in redox initiated apoptotic processes is warranted. Methodology: The role of thioredoxin reductase 1 in RKO cells was evaluated by attenuating endogenous thioredoxin reductase 1 expression with siRNA and then either inducing a selenium-deficient thioredoxin reductase or treatment with distinct redox challenges including, hydrogen peroxide, an oxidized lipid, 4-hydroxy-2-nonenol, and a nitric oxide donating prodrug. Thioredoxin redox status, cellular viability, and effector caspase activity were measured. Conclusions/Significance: In cells with attenuated endogenous thioredoxin reductase 1, a stably integrated selenocysteine-deficient form of the enzyme was induced but did not alter either the thioredoxin redox status or the cellular growth kinetics. The oxidized lipid and the nitric oxide donor demonstrated enhanced cytotoxicity when thioredoxin reductase 1 was knocked-down; however, the effect was more pronounced with the nitric oxide prodrug. These results are consistent with the hypothesis that attenuation of the thioredoxin-system can promote apoptosis in a nitric oxide-dependent manner.	[Edes, Kornelia; Cassidy, Pamela] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Cassidy, Pamela] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Shami, Paul J.] Univ Utah, Dept Med Oncol, Salt Lake City, UT USA; [Moos, Philip J.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; [Cassidy, Pamela] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Edes, K (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	philip.moos@utah.edu		Moos, Philip/0000-0002-8223-442X	USPHS [CA115616];  [P30 CA042014]; NATIONAL CANCER INSTITUTE [R01CA115616, P30CA042014] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by a USPHS Grant CA115616 (PJM). We also acknowledge the use of core facilities supported by P30 CA042014 awarded to the Huntsman Cancer Institute. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amato RJ, 2008, CLIN GENITOURIN CANC, V6, P73, DOI 10.3816/CGC.2008.n.011; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; Arivarasu NA, 2007, LIFE SCI, V81, P393, DOI 10.1016/j.lfs.2007.06.001; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Biaglow JE, 2005, CANCER BIOL THER, V4, P6; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; Bleys J, 2008, ARCH INTERN MED, V168, P404, DOI 10.1001/archinternmed.2007.74; Bracht K, 2007, ANTI-CANCER DRUG, V18, P389, DOI 10.1097/CAD.0b013e3280140001; Cassidy PB, 2006, CARCINOGENESIS, V27, P2538, DOI 10.1093/carcin/bgl111; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Ford JM, 2007, INT J RADIAT ONCOL, V69, P831, DOI 10.1016/j.ijrobp.2007.04.017; Grogan TM, 2000, HUM PATHOL, V31, P475, DOI 10.1053/hp.2000.6546; Hashemy SI, 2006, J BIOL CHEM, V281, P10691, DOI 10.1074/jbc.M511373200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hofman ER, 1998, MOL CELL BIOL, V18, P6493, DOI 10.1128/MCB.18.11.6493; Hu JD, 2001, ONCOGENE, V20, P4235, DOI 10.1038/sj.onc.1204585; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Kakolyris S, 2001, CLIN CANCER RES, V7, P3087; Kim KM, 2002, J BIOCHEM MOL BIOL, V35, P127; Kiziltepe T, 2007, BLOOD, V110, P709, DOI 10.1182/blood-2006-10-052845; Lamas S., 1998, Trends in Pharmacological Sciences, V19, P436, DOI 10.1016/S0165-6147(98)01265-6; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Lothrop AP, 2009, BIOCHEMISTRY-US, V48, P6213, DOI 10.1021/bi802146w; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; May JM, 2007, CLIN BIOCHEM, V40, P1135, DOI 10.1016/j.clinbiochem.2007.06.009; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moos PJ, 2000, P NATL ACAD SCI USA, V97, P9215, DOI 10.1073/pnas.160241897; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Nilsson J, 2000, BLOOD, V95, P1420, DOI 10.1182/blood.V95.4.1420.004k12_1420_1426; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Ravi D, 2004, CANCER CHEMOTH PHARM, V54, P449, DOI 10.1007/s00280-004-0833-y; Richards GM, 2007, EXPERT OPIN PHARMACO, V8, P351, DOI 10.1517/14656566.8.3.351; Rosenberg A, 2006, INT J RADIAT ONCOL, V64, P343, DOI 10.1016/j.ijrobp.2005.10.013; Rundlof AK, 2004, ANTIOXID REDOX SIGN, V6, P41, DOI 10.1089/152308604771978336; Saavedra JE, 2001, J ORG CHEM, V66, P3090, DOI 10.1021/jo0016529; Seemann S, 2005, ONCOGENE, V24, P3853, DOI 10.1038/sj.onc.1208549; Shami PJ, 2006, J MED CHEM, V49, P4356, DOI 10.1021/jm060022h; Shami PJ, 2003, MOL CANCER THER, V2, P409; Shao LE, 2001, CANCER RES, V61, P7333; Spyrou G, 1996, BIOCHEM BIOPH RES CO, V220, P42, DOI 10.1006/bbrc.1996.0353; SPYROU G, 1995, FEBS LETT, V368, P59, DOI 10.1016/0014-5793(95)00599-5; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Sun Y, 2008, CANCER RES, V68, P8269, DOI 10.1158/0008-5472.CAN-08-2010; Udupi V, 2006, LEUKEMIA RES, V30, P1279, DOI 10.1016/j.leukres.2005.12.007; Wang XF, 2007, TOXICOL APPL PHARM, V218, P88, DOI 10.1016/j.taap.2006.10.029; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; William WN, 2007, J THORAC ONCOL, V2, P745, DOI 10.1097/JTO.0b013e31811f4719; Witte AB, 2005, FREE RADICAL BIO MED, V39, P696, DOI 10.1016/j.freeradbiomed.2005.04.025; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112	56	14	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8786	10.1371/journal.pone.0008786	http://dx.doi.org/10.1371/journal.pone.0008786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098717	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779000015
J	Onken, B; Driscoll, M				Onken, Brian; Driscoll, Monica			Metformin Induces a Dietary Restriction-Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NEMATODE CAENORHABDITIS-ELEGANS; LIFE-SPAN EXTENSION; CALORIE RESTRICTION; CYTOPLASMIC LOCALIZATION; SIGNALING PATHWAY; INDUCED LONGEVITY; SKELETAL-MUSCLE; MAMMARY-TUMORS; FAMILY-MEMBER	Metformin, a biguanide drug commonly used to treat type-2 diabetes, has been noted to extend healthspan of nondiabetic mice, but this outcome, and the molecular mechanisms that underlie it, have received relatively little experimental attention. To develop a genetic model for study of biguanide effects on healthspan, we investigated metformin impact on aging Caenorhabditis elegans. We found that metformin increases nematode healthspan, slowing lipofuscin accumulation, extending median lifespan, and prolonging youthful locomotory ability in a dose-dependent manner. Genetic data suggest that metformin acts through a mechanism similar to that operative in eating-impaired dietary restriction (DR) mutants, but independent of the insulin signaling pathway. Energy sensor AMPK and AMPK-activating kinase LKB1, which are activated in mammals by metformin treatment, are essential for health benefits in C. elegans, suggesting that metformin engages a metabolic loop conserved across phyla. We also show that the conserved oxidative stress-responsive transcription factor SKN-1/Nrf2 is essential for metformin healthspan benefits in C. elegans, a mechanistic requirement not previously described in mammals. skn-1, which functions in nematode sensory neurons to promote DR longevity benefits and in intestines for oxidative stress resistance lifespan benefits, must be expressed in both neurons and intestines for metformin-promoted healthspan extension, supporting that metformin improves healthy middle-life aging by activating both DR and antioxidant defense longevity pathways. In addition to defining molecular players operative in metformin healthspan benefits, our data suggest that metformin may be a plausible pharmacological intervention to promote healthy human aging.	[Onken, Brian; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Onken, B (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA.	driscoll@biology.rutgers.edu			National Institutes of Health [R01AG024882]; Ellison Medical Foundation; National Institutes of Health Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome [1-P50 AT002776-01]; New Jersey Commission on Cancer Research; Ellison Medical Foundation/American Federation of Aging Research; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; Ellison Medical Foundation/American Federation of Aging Research(Lawrence Ellison Foundation); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work was supported by National Institutes of Health funding R01AG024882, the Ellison Medical Foundation, and the National Institutes of Health Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome, grant # 1-P50 AT002776-01. BO was supported by a grant from the New Jersey Commission on Cancer Research and by a Postdoctoral Fellowship in Aging Research from the Ellison Medical Foundation/American Federation of Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Anedda A, 2008, J ENDOCRINOL, V199, P33, DOI 10.1677/JOE-08-0278; Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Anisimov VN, 2005, B EXP BIOL MED+, V139, P721, DOI 10.1007/s10517-005-0389-9; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Anisimov VN, 2003, EXP GERONTOL, V38, P1041, DOI 10.1016/S0531-5565(03)00169-4; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Barzilai N, 2001, J NUTR, V131, p903S, DOI 10.1093/jn/131.3.903S; Beale EG, 2008, EXP BIOL MED, V233, P12, DOI 10.3181/0705-MR-117; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BOLANOWSKI MA, 1981, MECH AGEING DEV, V15, P279, DOI 10.1016/0047-6374(81)90136-6; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; BRENNER S, 1974, GENETICS, V77, P71; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; DeFronzo RA, 2000, ANN INTERN MED, V133, P73, DOI 10.7326/0003-4819-133-1-200007040-00016; Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005; Dirkswager E., 2002, TEACHERS OWNERS KEY; DORMAN JB, 1995, GENETICS, V141, P1399; DUHON SA, 1995, J GERONTOL A-BIOL, V50, pB254, DOI 10.1093/gerona/50A.5.B254; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; FRIEDMAN DB, 1988, GENETICS, V118, P75; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gami MS, 2006, AGING CELL, V5, P31, DOI 10.1111/j.1474-9726.2006.00188.x; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Glenn CF, 2004, J GERONTOL A-BIOL, V59, P1251, DOI 10.1093/gerona/59.12.1251; Greene AE, 2001, EPILEPSIA, V42, P1371, DOI 10.1046/j.1528-1157.2001.17601.x; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; HYUNG J, 2003, GENE DEV, V17, P1882; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lane MA, 2004, J GERONTOL A-BIOL, V59, P405; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Link CD, 2002, METHOD ENZYMOL, V353, P497; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; MORTON DG, 1992, GENETICS, V130, P771; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Rand JB, 1995, METHOD CELL BIOL, V48, P187; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Scarpello JHB, 2003, DIABETES METAB, V29, pS36; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Scott MP, 2002, J BIOL CHEM, V277, P28238, DOI 10.1074/jbc.M202783200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siegfried Z, 2003, PHYSIOL BEHAV, V79, P39, DOI 10.1016/S0031-9384(03)00103-3; Teale KFH, 1998, ANAESTHESIA, V53, P698, DOI 10.1046/j.1365-2044.1998.436-az0549.x; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; VOWELS JJ, 1992, GENETICS, V130, P105; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	96	440	470	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8758	10.1371/journal.pone.0008758	http://dx.doi.org/10.1371/journal.pone.0008758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090912	Green Published, gold, Green Submitted			2022-12-25	WOS:000273715000016
J	Rosada, RS; Moreira, AP; Frantz, FG; Puri, RK; Rahman, A; Standiford, TJ; Zarate-Blades, CR; Silva, CL; Hogaboam, CM				Rosada, Rogerio S.; Moreira, Ana P.; Frantz, Fabiani G.; Puri, Raj K.; Rahman, Aquilur; Standiford, Theodore J.; Zarate-Blades, Carlos R.; Silva, Celio L.; Hogaboam, Cory M.			Therapeutic Efficacy of Cintredekin Besudotox (IL13-PE38QQR) in Murine Lung Fibrosis Is Unaffected by Immunity to Pseudomonas aeruginosa Exotoxin A	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; PARACOCCIDIOIDES-BRASILIENSIS CONIDIA; ALLERGIC AIRWAY DISEASE; RECEPTOR ALPHA-2 CHAIN; IL-13 RECEPTOR; INTERLEUKIN-13 RECEPTOR; CHIMERIC PROTEIN; CARCINOMA-CELLS; PERIBRONCHIAL FIBROSIS; SIGNAL-TRANSDUCTION	Background: We have previously explored a therapeutic strategy for specifically targeting the profibrotic activity of IL-13 during experimental pulmonary fibrosis using a fusion protein comprised of human IL-13 and a mutated form of Pseudomonas aeruginosa exotoxin A (IL13-PE) and observed that the intranasal delivery of IL13-PE reduced bleomycin-induced pulmonary fibrosis through its elimination of IL-13-responsive cells in the lung. The aim of the present study was to determine whether the presence of an immune response to P. aeruginosa and/or its exotoxin A (PE) would diminish the anti-fibrotic properties of IL13-PE. Methodology/Principal Findings: Fourteen days after P. aeruginosa infection, C57BL/6 mice were injected with bleomycin via the intratracheal route. Other groups of mice received 4 doses of saline or IL13-PE by either intranasal or intraperitoneal application, and were challenged i.t. with bleomycin 28 days later. At day 21 after bleomycin, all mice received either saline vehicle or IL13-PE by the intranasal route and histopatological analyses of whole lung samples were performed at day 28 after bleomycin. Intrapulmonary P. aeruginosa infection promoted a neutralizing IgG2A and IgA antibody response in BALF and serum. Surprisingly, histological analysis showed that a prior P. aeruginosa infection attenuated the development of bleomycin-induced pulmonary fibrosis, which was modestly further attenuated by the intranasal administration of IL13-PE. Although prior intranasal administration of IL13-PE failed to elicit an antibody response, the systemic administration of IL13-PE induced a strong neutralizing antibody response. However, the prior systemic sensitization of mice with IL13-PE did not inhibit the anti-fibrotic effect of IL13-PE in fibrotic mice. Conclusions: Thus, IL13-PE therapy in pulmonary fibrosis works regardless of the presence of a humoral immune response to Pseudomonas exotoxin A. Interestingly, a prior infection with P. aeruginosa markedly attenuated the pulmonary fibrotic response suggesting that the immune elicitation by this pathogen exerts anti-fibrotic effects.	[Rosada, Rogerio S.; Frantz, Fabiani G.; Zarate-Blades, Carlos R.; Silva, Celio L.] Univ Sao Paulo, Dept Bioquim & Imunol, Nucleo Pesquisa Tuberculose, Sao Paulo, Brazil; [Moreira, Ana P.; Hogaboam, Cory M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Standiford, Theodore J.] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Puri, Raj K.] US FDA, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Bethesda, MD 20014 USA; [Rahman, Aquilur] NeoPharm Inc, Lake Bluff, IL USA	Universidade de Sao Paulo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Food & Drug Administration (FDA)	Rosada, RS (corresponding author), Univ Sao Paulo, Dept Bioquim & Imunol, Nucleo Pesquisa Tuberculose, Sao Paulo, Brazil.	hogaboam@umich.edu	Hogaboam, Cory M./AAI-1433-2021; Rosada, Rogerio/B-1396-2010; Silva, Celio/C-4639-2012; hogaboam, cory/M-3578-2014; Zárate-Bladés, Carlos R/C-9663-2015; Frantz, Fabiani Gai/B-9204-2016	Hogaboam, Cory M./0000-0003-3366-4850; Silva, Celio/0000-0002-0043-4568; Zárate-Bladés, Carlos R/0000-0002-7728-7869; Frantz, Fabiani Gai/0000-0001-6960-2438	National Institutes of Health (NIH); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); NeoPharm, Inc	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NeoPharm, Inc	Funding: These studies were supported by funding provided by the National Institutes of Health (NIH), the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), and NeoPharm, Inc. Neither the NIH nor the FAPESP had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Aquil Rahman is an employee of NeoPharm, Inc., and he was involved in the design of the experiments reported in this manuscript. Neither he nor NeoPharm, Inc. had any role in data collection and analysis, decision to publish, or preparation of the manuscript.	Belperio JA, 2002, AM J RESP CELL MOL, V27, P419, DOI 10.1165/rcmb.2002-0009OC; Blease K, 2001, J IMMUNOL, V167, P6583, DOI 10.4049/jimmunol.167.11.6583; Blease K, 2002, AM J PATHOL, V160, P481, DOI 10.1016/S0002-9440(10)64867-5; Debinski W, 1996, J BIOL CHEM, V271, P22428, DOI 10.1074/jbc.271.37.22428; DEBINSKI W, 1995, J BIOL CHEM, V270, P16775, DOI 10.1074/jbc.270.28.16775; Doucet C, 1998, J CLIN INVEST, V101, P2129, DOI 10.1172/JCI741; Franco L, 1998, AM J TROP MED HYG, V58, P424, DOI 10.4269/ajtmh.1998.58.424; Gharaee-Kermani M, 2001, CYTOKINE, V15, P138, DOI 10.1006/cyto.2001.0903; Gonzalez A, 2008, MYCOPATHOLOGIA, V165, P313, DOI 10.1007/s11046-007-9072-1; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Hogaboam CM, 2000, AM J PATHOL, V156, P723, DOI 10.1016/S0002-9440(10)64775-X; Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684; Jakubzick C, 2002, AM J PATHOL, V161, P1283, DOI 10.1016/S0002-9440(10)64405-7; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kawakami K, 2001, J EXP MED, V194, P1743, DOI 10.1084/jem.194.12.1743; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Kawakami K, 2001, CANCER RES, V61, P6194; Keane MP, 1999, J IMMUNOL, V163, P5686; Keane MP, 1999, J IMMUNOL, V162, P5511; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Kioi M, 2004, CLIN CANCER RES, V10, P6231, DOI 10.1158/1078-0432.CCR-04-0700; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Leland P, 2000, MOL MED, V6, P165, DOI 10.1007/BF03402112; Lukacs NW, 2001, CHEST, V120, p5S, DOI 10.1378/chest.120.1_suppl.S5; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mueller-Ortiz SL, 2006, AM J PHYSIOL-LUNG C, V291, pL157, DOI 10.1152/ajplung.00358.2005; Murata T, 1998, INT IMMUNOL, V10, P1103, DOI 10.1093/intimm/10.8.1103; Murata T, 1997, BIOCHEM BIOPH RES CO, V238, P90, DOI 10.1006/bbrc.1997.7248; Obiri NI, 1997, J IMMUNOL, V158, P756; Ojielo CI, 2003, J IMMUNOL, V171, P4416, DOI 10.4049/jimmunol.171.8.4416; PRESTON MJ, 1991, INFECT IMMUN, V59, P1984, DOI 10.1128/IAI.59.6.1984-1990.1991; PURI RK, 1991, CANCER RES, V51, P3011; Puri RK, 1996, BLOOD, V87, P4333, DOI 10.1182/blood.V87.10.4333.bloodjournal87104333; SEMPOWSKI GD, 1994, J IMMUNOL, V152, P3606; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; Toru H, 1998, J ALLERGY CLIN IMMUN, V102, P491, DOI 10.1016/S0091-6749(98)70140-X; WALLACE WAH, 1995, CLIN EXP IMMUNOL, V101, P436; Wallace WAH, 1999, J PATHOL, V187, P475, DOI 10.1002/(SICI)1096-9896(199903)187:4<475::AID-PATH268>3.0.CO;2-N; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	43	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8721	10.1371/journal.pone.0008721	http://dx.doi.org/10.1371/journal.pone.0008721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090941	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714900003
J	Becker, S; Wandel, E; Wobus, M; Schneider, R; Amasheh, S; Sittig, D; Kerner, C; Naumann, R; Hamann, J; Aust, G				Becker, Susann; Wandel, Elke; Wobus, Manja; Schneider, Rick; Amasheh, Salah; Sittig, Doreen; Kerner, Christiane; Naumann, Ronald; Hamann, Joerg; Aust, Gabriela			Overexpression of CD97 in Intestinal Epithelial Cells of Transgenic Mice Attenuates Colitis by Strengthening Adherens Junctions	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; BETA-CATENIN; TUMOR PROGRESSION; EXPRESSION; COMPLEX; CARCINOGENESIS; MIGRATION; CADHERINS; ADHESION	The adhesion G-protein-coupled receptor CD97 is present in normal colonic enterocytes but overexpressed in colorectal carcinoma. To investigate the function of CD97 in colorectal carcinogenesis, transgenic Tg(villin-CD97) mice overexpressing CD97 in enterocytes were generated and subjected to azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colitis-associated tumorigenesis. Unexpectedly, we found a CD97 cDNA copy number-dependent reduction of DSS-induced colitis in Tg compared to wild-type (WT) mice that was confirmed by applying a simple DSS protocol. Ultrastructural analysis revealed that overexpression of CD97 strengthened lateral cell-cell contacts between enterocytes, which, in contrast, were weakened in CD97 knockout (Ko) mice. Transepithelial resistance was not altered in Tg and Ko mice, indicating that tight junctions were not affected. In Tg murine and normal human colonic enterocytes as well as in colorectal cell lines CD97 was localized preferentially in E-cadherin-based adherens junctions. CD97 overexpression upregulated membrane-bound but not cytoplasmic or nuclear beta-catenin and reduced phospho-beta-catenin, labeled for degradation. This was associated with inactivation of glycogen synthase kinase-3 beta (GSK-3 beta) and activation of Akt. In summary, CD97 increases the structural integrity of enterocytic adherens junctions by increasing and stabilizing junctional b-catenin, thereby regulating intestinal epithelial strength and attenuating experimental colitis.	[Becker, Susann; Wandel, Elke; Wobus, Manja; Schneider, Rick; Sittig, Doreen; Kerner, Christiane; Aust, Gabriela] Univ Leipzig, Dept Surg, Res Labs, Leipzig, Germany; [Wandel, Elke] Univ Leipzig, Translat Ctr Regenerat Med, Leipzig, Germany; [Amasheh, Salah] Charite, Inst Clin Physiol, D-13353 Berlin, Germany; [Naumann, Ronald] MPI Mol Cell Biol & Genet, Transgen Core Facil, Dresden, Germany; [Hamann, Joerg] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	Leipzig University; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Amsterdam; Academic Medical Center Amsterdam	Becker, S (corresponding author), Univ Leipzig, Dept Surg, Res Labs, Leipzig, Germany.	gabriela.aust@medizin.uni-leipzig.de	Amasheh, Salah/AAG-4035-2021	Hamann, Jorg/0000-0002-9448-1727	Medical Faculty of the University of Leipzig; German Research Foundation (DFG); Netherlands Organization for Scientific Research (NWO)	Medical Faculty of the University of Leipzig; German Research Foundation (DFG)(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work was supported by a grant from the Medical Faculty of the University of Leipzig (to S. B.) and grants from the German Research Foundation (DFG) and the Netherlands Organization for Scientific Research (NWO) (to G. A. and J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Aust G, 1997, CANCER RES, V57, P1798; AUST G, 2007, CHIRURG FORUM, V36, P81; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; COOPER HS, 1993, LAB INVEST, V69, P238; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Fitzpatrick LR, 2006, DIGEST DIS SCI, V51, P1269, DOI 10.1007/s10620-006-8047-2; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Hamann J, 2000, INT IMMUNOL, V12, P439, DOI 10.1093/intimm/12.4.439; HORVAT B, 1990, HISTOCHEMISTRY, V93, P661, DOI 10.1007/BF00272210; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Johnson M, 2009, CELL SIGNAL, V21, P339, DOI 10.1016/j.cellsig.2008.11.004; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Kwakkenbos M.J., 2002, LEUCOCYTE TYPING, VVII, P381; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Mathew CG, 2004, HUM MOL GENET, V13, pR161, DOI 10.1093/hmg/ddh079; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Pelech S, 2008, J PROTEOME RES, V7, P2860, DOI 10.1021/pr800082a; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rivard N, 2009, FRONT BIOSCI-LANDMRK, V14, P510, DOI 10.2741/3259; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; Wong NACS, 2002, AM J PATHOL, V160, P389, DOI 10.1016/S0002-9440(10)64856-0; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zbar AP, 2004, J GASTROENTEROL, V39, P413, DOI 10.1007/s00535-004-1335-8; ZHANG L, 2004, HUM GEN M 2004 HGM 2	36	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8507	10.1371/journal.pone.0008507	http://dx.doi.org/10.1371/journal.pone.0008507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084281	Green Published, gold			2022-12-25	WOS:000273554600004
J	Vrba, L; Jensen, TJ; Garbe, JC; Heimark, RL; Cress, AE; Dickinson, S; Stampfer, MR; Futscher, BW				Vrba, Lukas; Jensen, Taylor J.; Garbe, James C.; Heimark, Ronald L.; Cress, Anne E.; Dickinson, Sally; Stampfer, Martha R.; Futscher, Bernard W.			Role for DNA Methylation in the Regulation of miR-200c and miR-141 Expression in Normal and Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN PROSTATIC-CARCINOMA; BREAST-CANCER; HISTONE METHYLTRANSFERASE; GENE-EXPRESSION; DOWN-REGULATION; CPG ISLANDS; E-CADHERIN; LINES; INVASION	Background: The microRNA-200 family participates in the maintenance of an epithelial phenotype and loss of its expression can result in epithelial to mesenchymal transition (EMT). Furthermore, the loss of expression of miR-200 family members is linked to an aggressive cancer phenotype. Regulation of the miR-200 family expression in normal and cancer cells is not fully understood. Methodology/Principal Findings: Epigenetic mechanisms participate in the control of miR-200c and miR-141 expression in both normal and cancer cells. A CpG island near the predicted mir-200c/mir-141 transcription start site shows a striking correlation between miR-200c and miR-141 expression and DNA methylation in both normal and cancer cells, as determined by MassARRAY technology. The CpG island is unmethylated in human miR-200/miR-141 expressing epithelial cells and in miR-200c/miR-141 positive tumor cells. The CpG island is heavily methylated in human miR-200c/miR-141 negative fibroblasts and miR-200c/miR-141 negative tumor cells. Mouse cells show a similar inverse correlation between DNA methylation and miR-200c expression. Enrichment of permissive histone modifications, H3 acetylation and H3K4 trimethylation, is seen in normal miR-200c/miR-141-positive epithelial cells, as determined by chromatin immunoprecipitation coupled to real-time PCR. In contrast, repressive H3K9 dimethylation marks are present in normal miR-200c/miR-141-negative fibroblasts and miR-200c/miR-141 negative cancer cells and the permissive histone modifications are absent. The epigenetic modifier drug, 5-aza-2'-deoxycytidine, reactivates miR-200c/miR-141 expression showing that epigenetic mechanisms play a functional role in their transcriptional control. Conclusions/Significance: We report that DNA methylation plays a role in the normal cell type-specific expression of miR-200c and miR-141 and this role appears evolutionarily conserved, since similar results were obtained in mouse. Aberrant DNA methylation of the miR-200c/141 CpG island is closely linked to their inappropriate silencing in cancer cells. Since the miR-200c cluster plays a significant role in EMT, our results suggest an important role for DNA methylation in the control of phenotypic conversions in normal cells.	[Vrba, Lukas; Jensen, Taylor J.; Heimark, Ronald L.; Cress, Anne E.; Dickinson, Sally; Stampfer, Martha R.; Futscher, Bernard W.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA; [Jensen, Taylor J.; Futscher, Bernard W.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Garbe, James C.; Stampfer, Martha R.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA; [Vrba, Lukas] ASCR, Ctr Biol, Vvi, Inst Plant Mol Biol, Ceske Budejovice, Czech Republic	Arizona Center Cancer Care; University of Arizona; University of Arizona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Vrba, L (corresponding author), Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA.	bfutscher@azcc.arizona.edu	Vrba, Lukas/J-9268-2015; Cress, Anne/V-6527-2019	Vrba, Lukas/0000-0003-3042-6275; Cress, Anne/0000-0001-6194-0061	BIO5 interdisciplinary biotechnology center; NIH [U54 CA112970]; DOD [BCRP BC060444, DE-AC03-76SF00098];  [R01CA65662];  [P30ES06694];  [P30CA023074]; NATIONAL CANCER INSTITUTE [R01CA065662, U54CA112970, P30CA023074, K07CA132956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	BIO5 interdisciplinary biotechnology center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grants R01CA65662 to B. W. F supported this work. Center Grants P30ES06694 and P30CA023074, and the BIO5 interdisciplinary biotechnology center at the UA supported the Genomics Shared Service. J.C.G. and M. R. S. were supported by NIH U54 CA112970, DOD BCRP BC060444, and the Office of Energy Research, Office of Health and Biological Research, U. S. Department of Energy under Contract No. DE-AC03-76SF00098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Du Y, 2009, J GASTROENTEROL, V44, P556, DOI 10.1007/s00535-009-0037-7; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta A, 1999, CARCINOGENESIS, V20, P2063, DOI 10.1093/carcin/20.11.2063; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Irizarry RA, 2009, MAMM GENOME; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jensen TJ, 2008, CARCINOGENESIS, V29, P1500, DOI 10.1093/carcin/bgn102; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Oshiro MM, 2005, NEOPLASIA, V7, P799, DOI 10.1593/neo.05274; Oshiro MM, 2003, ONCOGENE, V22, P3624, DOI 10.1038/sj.onc.1206545; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tran NL, 1999, AM J PATHOL, V155, P787, DOI 10.1016/S0002-9440(10)65177-2; VALERI N, 2009, MAMM GENOME; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vrba L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-486; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763	46	235	258	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8697	10.1371/journal.pone.0008697	http://dx.doi.org/10.1371/journal.pone.0008697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084174	Green Submitted, Green Published, gold			2022-12-25	WOS:000273554600042
J	Wang, LG; Xi, YX; Yu, J; Dong, LP; Yen, LS; Li, W				Wang, Liguo; Xi, Yuanxin; Yu, Jun; Dong, Liping; Yen, Laising; Li, Wei			A Statistical Method for the Detection of Alternative Splicing Using RNA-Seq	PLOS ONE			English	Article							TRANSCRIPTOME	Deep sequencing of transcriptome (RNA-seq) provides unprecedented opportunity to interrogate plausible mRNA splicing patterns by mapping RNA-seq reads to exon junctions (thereafter junction reads). In most previous studies, exon junctions were detected by using the quantitative information of junction reads. The quantitative criterion (e. g. minimum of two junction reads), although is straightforward and widely used, usually results in high false positive and false negative rates, owning to the complexity of transcriptome. Here, we introduced a new metric, namely Minimal Match on Either Side of exon junction (MMES), to measure the quality of each junction read, and subsequently implemented an empirical statistical model to detect exon junctions. When applied to a large dataset (>200M reads) consisting of mouse brain, liver and muscle mRNA sequences, and using independent transcripts databases as positive control, our method was proved to be considerably more accurate than previous ones, especially for detecting junctions originated from low-abundance transcripts. Our results were also confirmed by real time RT-PCR assay. The MMES metric can be used either in this empirical statistical model or in other more sophisticated classifiers, such as logistic regression.	[Wang, Liguo; Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Wang, Liguo; Xi, Yuanxin; Dong, Liping; Yen, Laising; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Dong, Liping; Yen, Laising] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Yu, Jun] Chinese Acad Sci, Beijing Genom Inst, Beijing, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Beijing Genomics Institute (BGI); Chinese Academy of Sciences	Wang, LG (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA.	WL1@bcm.edu	Li, Wei/A-8544-2009; 郑, 征/C-8514-2011	Li, Wei/0000-0001-9931-5990; Wang, Liguo/0000-0003-2072-4826	National Institutes of Health (NIH) Cancer Center [P30 CA125123]; Department of Defense [PC094421]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Institutes of Health (NIH) Cancer Center grant (P30 CA125123) and Department of Defense (PC094421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; CASTLE JC, 2008, NAT GENET; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Grasso C, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P29; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mortazavi A, 2008, NAT METHODS; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Sharov AA, 2005, GENOME RES, V15, P748, DOI 10.1101/gr.3269805; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; SULTAN M, 2008, SCIENCE; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang ET, 2008, NATURE	19	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8529	10.1371/journal.pone.0008529	http://dx.doi.org/10.1371/journal.pone.0008529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072613	Green Published, Green Submitted, gold			2022-12-25	WOS:000273414200006
J	Brooks-Pollock, E; Cohen, T; Murray, M				Brooks-Pollock, Ellen; Cohen, Ted; Murray, Megan			The Impact of Realistic Age Structure in Simple Models of Tuberculosis Transmission	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIC MODELS; RISKS; DISTRIBUTIONS; PERSISTENCE; INFECTIONS; DYNAMICS; PATTERNS; PERIOD; ERA	Background: Mathematical models of tuberculosis (TB) transmission have been used to characterize disease dynamics, investigate the potential effects of public health interventions, and prioritize control measures. While previous work has addressed the mathematical description of TB natural history, the impact of demography on the behaviour of TB models has not been assessed. Methods: A simple model of TB transmission, with alternative assumptions about survivorship, is used to explore the effect of age structure on the prevalence of infection, disease, basic reproductive ratio and the projected impact of control interventions. We focus our analytic arguments on the differences between constant and exponentially distributed lifespans and use an individual-based model to investigate the range of behaviour arising from realistic distributions of survivorship. Results: The choice of age structure and natural (non-disease related) mortality strongly affects steady-state dynamics, parameter estimation and predictions about the effectiveness of control interventions. Since most individuals infected with TB develop an asymptomatic latent infection and never progress to active disease, we find that assuming a constant mortality rate results in a larger reproductive ratio and an overestimation of the effort required for disease control in comparison to using more realistic age-specific mortality rates. Conclusions: Demographic modelling assumptions should be considered in the interpretation of models of chronic infectious diseases such as TB. For simple models, we find that assuming constant lifetimes, rather than exponential lifetimes, produces dynamics more representative of models with realistic age structure.	[Brooks-Pollock, Ellen; Cohen, Ted; Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cohen, Ted; Murray, Megan] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Murray, Megan] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Brooks-Pollock, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	ebrooks@hsph.harvard.edu	Cohen, Ted/G-8101-2011	Cohen, Ted/0000-0002-8091-7198; Brooks-Pollock, Ellen/0000-0002-5984-4932	National Institutes of Health (NIH) [U19 AI076217]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	EBP, TC and MM are funded by National Institutes of Health (NIH) grant U19 AI076217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1988, NATURE, V332, P228, DOI 10.1038/332228a0; ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X; BASU S, 2009, B MATH BIOL, P1; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hughes GR, 2006, PROCEEDINGS OF THE 2006 WINTER SIMULATION CONFERENCE, VOLS 1-5, P459, DOI 10.1109/WSC.2006.323116; Keeling MJ, 1998, MATH BIOSCI, V147, P207, DOI 10.1016/S0025-5564(97)00101-6; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; MAY RM, 1985, MATH BIOSCI, V77, P141, DOI 10.1016/0025-5564(85)90093-8; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Promislow DEL, 1999, J EVOLUTION BIOL, V12, P314; Salomon JA, 2006, PLOS MED, V3, P1302, DOI 10.1371/journal.pmed.0030273; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; *U CAL BERK US M P, HUM MORT DAT; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; Vynnycky E, 1998, EPIDEMIOL INFECT, V121, P309, DOI 10.1017/S0950268898001113; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; WAALER HT, 1969, B WORLD HEALTH ORGAN, V41, P75; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Williams JR, 2004, INT J EPIDEMIOL, V33, P566, DOI 10.1093/ije/dyh098; World Health Organization, 2009, GLOB TUB CONTR EP ST	38	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8479	10.1371/journal.pone.0008479	http://dx.doi.org/10.1371/journal.pone.0008479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062531	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000273414100002
J	He, YJ; Hakvoort, TBM; Kohler, SE; Vermeulen, JLM; de Waart, DR; de Theije, C; ten Have, GAM; van Eijk, HMH; Kunne, C; Labruyere, WT; Houten, SM; Sokolovic, M; Ruijter, JM; Deutz, NEP; Lamers, WH				He, Youji; Hakvoort, Theodorus B. M.; Kohler, S. Eleonore; Vermeulen, Jacqueline L. M.; de Waart, D. Rudi; de Theije, Chiel; ten Have, Gabrie A. M.; van Eijk, Hans M. H.; Kunne, Cindy; Labruyere, Wilhelmina T.; Houten, Sander M.; Sokolovic, Milka; Ruijter, Jan M.; Deutz, Nicolaas E. P.; Lamers, Wouter H.			Glutamine Synthetase in Muscle Is Required for Glutamine Production during Fasting and Extrahepatic Ammonia Detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE-DL-SULFOXIMINE; ACUTE LIVER-FAILURE; SKELETAL-MUSCLE; AMINO-ACIDS; PROTEIN BREAKDOWN; WHOLE-BODY; IN-VIVO; METABOLISM; EXPRESSION; RATS	The main endogenous source of glutamine is de novo synthesis in striated muscle via the enzyme glutamine synthetase (GS). The mice in which GS is selectively but completely eliminated from striated muscle with the Cre-loxP strategy (GS-KO/M mice) are, nevertheless, healthy and fertile. Compared with controls, the circulating concentration and net production of glutamine across the hindquarter were not different in fed GS-KO/M mice. Only a similar to 3-fold higher escape of ammonia revealed the absence of GS in muscle. However, after 20 h of fasting, GSKO/M mice were not able to mount the similar to 4-fold increase in glutamine production across the hindquarter that was observed in control mice. Instead, muscle ammonia production was similar to 5-fold higher than in control mice. The fasting-induced metabolic changes were transient and had returned to fed levels at 36 h of fasting. Glucose consumption and lactate and ketone-body production were similar in GS-KO/M and control mice. Challenging GS-KO/M and control mice with intravenous ammonia in stepwise increments revealed that normal muscle can detoxify similar to 2.5 mu mol ammonia/g muscle.h in a muscle GS-dependent manner, with simultaneous accumulation of urea, whereas GSKO/M mice responded with accumulation of glutamine and other amino acids but not urea. These findings demonstrate that GS in muscle is dispensable in fed mice but plays a key role in mounting the adaptive response to fasting by transiently facilitating the production of glutamine. Furthermore, muscle GS contributes to ammonia detoxification and urea synthesis. These functions are apparently not vital as long as other organs function normally.	[He, Youji; Hakvoort, Theodorus B. M.; Vermeulen, Jacqueline L. M.; de Waart, D. Rudi; Kunne, Cindy; Labruyere, Wilhelmina T.; Sokolovic, Milka; Ruijter, Jan M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Ctr Liver, NL-1105 BK Amsterdam, Netherlands; [He, Youji; Hakvoort, Theodorus B. M.; Vermeulen, Jacqueline L. M.; de Waart, D. Rudi; Kunne, Cindy; Labruyere, Wilhelmina T.; Sokolovic, Milka; Ruijter, Jan M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Dept Anat & Embryol, NL-1105 BK Amsterdam, Netherlands; [Kohler, S. Eleonore; de Theije, Chiel; Lamers, Wouter H.] Univ Maastricht, Dept Anat & Embryol, NL-6200 MD Maastricht, Netherlands; [ten Have, Gabrie A. M.; van Eijk, Hans M. H.; Deutz, Nicolaas E. P.] Univ Maastricht, Dept Surg, NL-6200 MD Maastricht, Netherlands; [Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	Lamers, WH (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Liver, Meibergdreef 69-71, NL-1105 BK Amsterdam, Netherlands.	w.h.lamers@amc.uva.nl	Sokolovic, Milka/C-2115-2009; Houten, Sander/Y-3599-2019; Sokolovic, Milka/AAY-1618-2020; Lamers, Wouter H./D-2965-2012; Deutz, Nicolaas E/J-5200-2012; Köhler, Eleonore/D-2915-2012	Houten, Sander/0000-0002-6167-9147; Sokolovic, Milka/0000-0002-3957-4656; Köhler, Eleonore/0000-0003-1977-9977; Deutz, Nicolaas/0000-0001-5845-6447	Netherlands Organization for Scientific Research (NWO) [SGC210009]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	l This work was supported by Netherlands Organization for Scientific Research (NWO) Grant SGC210009 (to W. H. L.).	APOSTOLAKIS M, 1989, BRAIN RES BULL, V23, P257, DOI 10.1016/0361-9230(89)90155-X; AROLA L, 1981, ARCH INT PHYSIOL BIO, V89, P189, DOI 10.3109/13813458109069465; BHANDARI B, 1986, MOL CELL ENDOCRINOL, V47, P49, DOI 10.1016/0303-7207(86)90015-8; Biolo G, 2000, CLIN SCI, V99, P189, DOI 10.1042/CS19990254; Biolo G, 2005, INT J BIOCHEM CELL B, V37, P2169, DOI 10.1016/j.biocel.2005.05.001; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; CHANG TW, 1978, J BIOL CHEM, V253, P3677; CHANG TW, 1978, J BIOL CHEM, V253, P3685; Chatauret N, 2006, J HEPATOL, V44, P1083, DOI 10.1016/j.jhep.2005.11.048; Clemmesen JO, 2000, GASTROENTEROLOGY, V118, P1131, DOI 10.1016/S0016-5085(00)70366-0; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Damink SWMO, 2002, NEUROCHEM INT, V41, P177, DOI 10.1016/S0197-0186(02)00040-2; Damink SWMO, 1999, CLIN SCI, V96, P639, DOI 10.1042/CS19980389; Danielyan L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004416; DARMAUN D, 1988, AM J PHYSIOL, V255, pE366, DOI 10.1152/ajpendo.1988.255.3.E366; deBlaauw I, 1996, CLIN SCI, V90, P457, DOI 10.1042/cs0900457; DEJONG CHC, 1993, J CLIN INVEST, V92, P2834, DOI 10.1172/JCI116903; Deprez RHL, 2002, ANAL BIOCHEM, V307, P63, DOI 10.1016/S0003-2697(02)00021-0; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Hallemeesch MM, 2001, LAB ANIM-UK, V35, P101, DOI 10.1258/0023677011911426; HE Y, 2010, GLIA IN PRESS, V58; He Y, 2007, DEV DYNAM, V236, P1865, DOI 10.1002/dvdy.21185; HEENEMAN S, 1993, CLIN NUTR, V12, P182, DOI 10.1016/0261-5614(93)90078-I; HICKSON RC, 1995, AM J PHYSIOL-ENDOC M, V268, pE730, DOI 10.1152/ajpendo.1995.268.4.E730; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; JEPSON MM, 1988, AM J PHYSIOL, V255, pE166, DOI 10.1152/ajpendo.1988.255.2.E166; Kuhn KS, 1999, AM J CLIN NUTR, V70, P484; Labow BI, 1999, AM J PHYSIOL-ENDOC M, V276, pE1136, DOI 10.1152/ajpendo.1999.276.6.E1136; LI B, 1979, AM J PHYSIOL-ENDOC M, V5, pE222; Lie-Venema H, 1998, PROG NUCLEIC ACID RE, V61, P243, DOI 10.1016/S0079-6603(08)60829-6; Listrom CD, 1997, BIOCHEM J, V328, P159; MACLENNAN PA, 1988, FEBS LETT, V237, P133, DOI 10.1016/0014-5793(88)80186-8; McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109; Melis GC, 2004, CURR OPIN CLIN NUTR, V7, P59, DOI 10.1097/00075197-200401000-00011; NURJHAN N, 1995, J CLIN INVEST, V95, P272, DOI 10.1172/JCI117651; RAO VLR, 1991, NEUROSCI LETT, V126, P13, DOI 10.1016/0304-3940(91)90359-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rutten EPA, 2005, CURR OPIN CLIN NUTR, V8, P41, DOI 10.1097/00075197-200501000-00007; SELLINGER OZ, 1982, J NEUROCHEM, V38, P1676, DOI 10.1111/j.1471-4159.1982.tb06649.x; SHANRONG S, 2000, ANTIGEN RETRIEVAL TE; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tang H, 2000, MOL CELL NEUROSCI, V16, P127, DOI 10.1006/mcne.2000.0864; THOMPSON JR, 1991, COMP BIOCHEM PHYS B, V100, P209, DOI 10.1016/0305-0491(91)90363-I; Tjader I, 2007, CRIT CARE MED, V35, pS553, DOI 10.1097/01.CCM.0000278602.41352.0E; van Acker BAC, 1998, CLIN SCI, V95, P339, DOI 10.1042/CS19980053; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x	50	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9516	9524		10.1074/jbc.M109.092429	http://dx.doi.org/10.1074/jbc.M109.092429			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20064933	Green Published, hybrid			2022-12-25	WOS:000276165900025
J	Kobayashi, M; AB, E; Bonvin, AMJJ; Siegal, G				Kobayashi, Masakazu; AB, Eiso; Bonvin, Alexander M. J. J.; Siegal, Gregg			Structure of the DNA-bound BRCA1 C-terminal Region from Human Replication Factor C p140 and Model of the Protein-DNA Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; LARGE SUBUNIT; PHOSPHOPEPTIDE RECOGNITION; BACH1 PHOSPHOPEPTIDE; BACKBONE DYNAMICS; ESCHERICHIA-COLI; CLAMP LOADER; LIGASE-III; CANCER; NMR	BRCA1 C-terminal domain (BRCT)-containing proteins are found widely throughout the animal and bacteria kingdoms where they are exclusively involved in cell cycle regulation and DNA metabolism. Whereas most BRCT domains are involved in protein-protein interactions, a small subset has bona fide DNA binding activity. Here, we present the solution structure of the BRCT region of the large subunit of replication factor C bound to DNA and a model of the structure-specific complex with 5'-phosphorylated double-stranded DNA. The replication factor C BRCT domain possesses a large basic patch on one face, which includes residues that are structurally conserved and ligate the phosphate in phosphopeptide binding BRCT domains. An extra alpha-helix at the N terminus, which is required for DNA binding, inserts into the major groove and makes extensive contacts to the DNA backbone. The model of the protein-DNA complex suggests 5'-phosphate recognition by the BRCT domains of bacterial NAD(+)-dependent ligases and a non-clamp loading role for the replication factor C complex in DNA transactions.	[Siegal, Gregg] Leiden Univ, Gorlaeus Lab, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [AB, Eiso; Bonvin, Alexander M. J. J.] Univ Utrecht, Dept NMR Spect, Bijvoet Ctr Biomol Res, NL-3584 Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Utrecht University	Siegal, G (corresponding author), Leiden Univ, Gorlaeus Lab, Leiden Inst Chem, Postbus 9502, NL-2300 RA Leiden, Netherlands.	g.siegal@chem.leidenuniv.nl	AB, Eiso/H-8177-2012; Bonvin, Alexandre M.J.J./A-5420-2009	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Siegal, Gregg/0000-0003-3806-4811; AB, Eiso/0000-0002-5758-0435				Allen BL, 1998, NUCLEIC ACIDS RES, V26, P3877, DOI 10.1093/nar/26.17.3877; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Caldecott KW, 2003, SCIENCE, V302, P579, DOI 10.1126/science.1091463; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; Feng H, 2004, BIOCHEMISTRY-US, V43, P12648, DOI 10.1021/bi049451c; Gaiser OJ, 2004, BIOCHEMISTRY-US, V43, P15983, DOI 10.1021/bi049550q; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HUBBARD SJ, 2008, NACCESS; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; Jeon HJ, 2004, FEMS MICROBIOL LETT, V237, P111, DOI 10.1016/j.femsle.2004.06.018; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Keller R., 2004, COMPUTER AIDED RESON, P15; Kobayashi M, 2006, J BIOL CHEM, V281, P4308, DOI 10.1074/jbc.M511090200; Kobayashi M, 2005, J BIOMOL NMR, V31, P183, DOI 10.1007/s10858-004-7913-5; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krishnan VV, 2001, BIOCHEMISTRY-US, V40, P13158, DOI 10.1021/bi010979g; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Levin DS, 2004, J BIOL CHEM, V279, P55196, DOI 10.1074/jbc.M409250200; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Pervushin K, 1996, J MOL BIOL, V264, P1002, DOI 10.1006/jmbi.1996.0692; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Wilkinson A, 2005, BBA-PROTEINS PROTEOM, V1749, P113, DOI 10.1016/j.bbapap.2005.03.003; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404	45	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10087	10097		10.1074/jbc.M109.054106	http://dx.doi.org/10.1074/jbc.M109.054106			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20081198	Green Published, hybrid			2022-12-25	WOS:000276165900076
J	Kim, KS; Yoon, YR; Lee, HJ; Yoon, S; Kim, SY; Shin, SW; An, JJ; Kim, MS; Choi, SY; Sun, W; Baik, JH				Kim, Kyu Seok; Yoon, Ye Ran; Lee, Hyo Jin; Yoon, Sehyoun; Kim, Sa-Yong; Shin, Seung Woo; An, Juan Ji; Kim, Min-Seon; Choi, Se-Young; Sun, Woong; Baik, Ja-Hyun			Enhanced Hypothalamic Leptin Signaling in Mice Lacking Dopamine D-2 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANIN-CONCENTRATING HORMONE; FOOD-INTAKE; GENE-EXPRESSION; NEUROPEPTIDE-Y; ENERGY HOMEOSTASIS; FEEDING-BEHAVIOR; TARGET NEURONS; MESSENGER-RNA; D2 RECEPTORS; LONG FORM	The dopamine D-2 receptor (D2R) plays a critical role in diverse neurophysiological functions. D2R knock-out mice (D2R(-/-)) show reduced food intake and body weight while displaying an increased basal energy expenditure level, compared with their wild type littermates. Thus, these mice show a lean phenotype. D2R(-/-) mice displayed increased leptin sensitivity, and leptin injection induced increased phosphorylation of the hypothalamic signal transducer and activator of transcription 3 (STAT3) in D2R(-/-) mice relative to wild type littermates. Using double immunofluorescence histochemistry, we have demonstrated that D2Rs are present in leptin-sensitive STAT3-positive cells in the arcuate nucleus of the hypothalamus and that leptin injection induces STAT3 phosphorylation in hypothalamic neurons expressing D2Rs. Stimulation of D2R by the D2R agonist quinpirole suppressed the leptin-induced STAT3 phosphorylation and nuclear trans-localization of phospho-STAT3 in the hypothalamus of wild type mice. However, this regulation was not detected in the D2R(-/-) mice. Treatment of D2R agonist and antagonist could modulate the leptin-induced food intake and body weight changes in wild type mice but not in D2R(-/-) mice. Together, our findings suggest that the interaction between the dopaminergic system and leptin signaling in hypothalamus is important in control of energy homeostasis.	[Baik, Ja-Hyun] Korea Univ, Mol Neurobiol Lab, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [An, Juan Ji] Yonsei Univ, Med Res Ctr, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Kim, Min-Seon] Univ Ulsan, Dept Internal Med, Coll Med, Seoul 138736, South Korea; [Choi, Se-Young] Seoul Natl Univ, Dept Physiol, Seoul 110749, South Korea; [Choi, Se-Young] Seoul Natl Univ, Mol & Cellular Neurosci Program, Coll Dent, Seoul 110749, South Korea; [Choi, Se-Young] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea; [Sun, Woong] Korea Univ, Dept Anat, Coll Med, Seoul 136705, South Korea	Korea University; Yonsei University; Yonsei University Health System; University of Ulsan; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Baik, JH (corresponding author), Korea Univ, Mol Neurobiol Lab, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	jahyunb@korea.ac.kr		sun, woong/0000-0003-1792-4894; Choi, Se-Young/0000-0001-7534-5167; Yoon, Sehyoun/0000-0001-6545-3615	Korean Government (MOEHRD) [KRF-2006-311-C00478]; Brain Research Center of the 21st Century Frontier Research [M103KV010015-07K2201-01510, M103KV010014-08K2201-01410]; Korea Science and Engineering Foundation [M1-0311-00-0069]; Korean Ministry of Science and Technology; AstraZeneca	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Brain Research Center of the 21st Century Frontier Research; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); AstraZeneca(AstraZeneca)	This work was supported by Korea Research Foundation Research Grant KRF-2006-311-C00478, funded by the Korean Government (MOEHRD), Grants M103KV010015-07K2201-01510 and M103KV010014-08K2201-01410 from the Brain Research Center of the 21st Century Frontier Research Program, Grant M1-0311-00-0069 from the Korea Science and Engineering Foundation, funded by the Korean Ministry of Science and Technology, and a grant award from the AstraZeneca VRI Program.	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; An JJ, 2004, MOL CELL NEUROSCI, V25, P732, DOI 10.1016/j.mcn.2003.12.010; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Comings DE, 1996, MOL PSYCHIATR, V1, P325; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/en.143.4.1270; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Fang YJ, 2005, INT J CARDIOL, V102, P111, DOI 10.1016/j.ijcard.2004.05.010; Fetissov SO, 2000, NEUROSCIENCE, V101, P657, DOI 10.1016/S0306-4522(00)00374-2; Fetissov SO, 2002, AM J PHYSIOL-REG I, V283, pR905, DOI 10.1152/ajpregu.00092.2002; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Hakansson ML, 1999, J NEUROENDOCRINOL, V11, P653; Hakansson ML, 1998, NEUROENDOCRINOLOGY, V68, P420, DOI 10.1159/000054392; Hakansson ML, 1998, J NEUROSCI, V18, P559; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; Jenkinson CP, 2000, INT J OBESITY, V24, P1233, DOI 10.1038/sj.ijo.0801381; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kim RY, 2005, BIOCHEM BIOPH RES CO, V329, P1178, DOI 10.1016/j.bbrc.2005.02.105; Kim SY, 2006, J NEUROSCI, V26, P4567, DOI 10.1523/JNEUROSCI.5236-05.2006; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kok P, 2006, J CLIN ENDOCR METAB, V91, P3236, DOI 10.1210/jc.2005-2529; Kokkotou EG, 2001, ENDOCRINOLOGY, V142, P680, DOI 10.1210/en.142.2.680; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Leshan RL, 2006, OBESITY, V14, P208, DOI 10.1038/oby.2006.310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; MANSOUR A, 1990, J NEUROSCI, V10, P2587; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Munzberg H, 2007, J NEUROSCI, V27, P69, DOI 10.1523/JNEUROSCI.3168-06.2007; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Sato T, 2001, AM J PHYSIOL-REG I, V281, pR1907, DOI 10.1152/ajpregu.2001.281.6.R1907; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Sindelar DK, 2004, ENDOCRINOLOGY, V145, P3363, DOI 10.1210/en.2003-1727; Smith DG, 2005, J NEUROSCI, V25, P914, DOI 10.1523/JNEUROSCI.4079-04.2005; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; STRICKER EM, 1984, INT J OBESITY, V8, P39; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tataranni PA, 2001, DIABETES, V50, P901, DOI 10.2337/diabetes.50.4.901; Thomas GN, 2000, HYPERTENSION, V36, P177, DOI 10.1161/01.HYP.36.2.177; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; YANG ZJ, 1995, NEUROREPORT, V6, P1191, DOI 10.1097/00001756-199505300-00029; Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; ZIGMOND MJ, 1980, PROG NEURO-PSYCHOPHA, V4, P351, DOI 10.1016/0364-7722(80)90005-3; ZIGMOND MJ, 1972, SCIENCE, V177, P1211	73	63	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8905	8917		10.1074/jbc.M109.079590	http://dx.doi.org/10.1074/jbc.M109.079590			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080963	Green Published, hybrid			2022-12-25	WOS:000275553700042
J	Ratchford, AM; Baker, OJ; Camden, JM; Rikka, S; Petris, MJ; Seye, CI; Erb, L; Weisman, GA				Ratchford, Ann M.; Baker, Olga J.; Camden, Jean M.; Rikka, Shivaji; Petris, Michael J.; Seye, Cheikh I.; Erb, Laurie; Weisman, Gary A.			P2Y(2) Nucleotide Receptors Mediate Metalloprotease-dependent Phosphorylation of Epidermal Growth Factor Receptor and ErbB3 in Human Salivary Gland Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ADHESION MOLECULE-1 EXPRESSION; FOCAL TYROSINE KINASE; SMOOTH-MUSCLE-CELLS; SUBMANDIBULAR-GLAND; EGF RECEPTOR; BRANCHING MORPHOGENESIS; UP-REGULATION; SIGNAL-TRANSDUCTION; P-2 PURINOCEPTORS	The G protein-coupled receptor P2Y(2) nucleotide receptor (P2Y(2)R) has been shown to be up-regulated in a variety of tissues in response to stress or injury. Recent studies have suggested that P2Y(2)Rs may play a role in immune responses, wound healing, and tissue regeneration via their ability to activate multiple signaling pathways, including activation of growth factor receptors. Here, we demonstrate that in human salivary gland (HSG) cells, activation of the P2Y(2)R by its agonist induces phosphorylation of ERK1/2 via two distinct mechanisms, a rapid, protein kinase C-dependent pathway and a slower and prolonged, epidermal growth factor receptor (EGFR)-dependent pathway. The EGFR-dependent stimulation of UTP-induced ERK1/2 phosphorylation in HSG cells is inhibited by the adamalysin inhibitor tumor necrosis factor-alpha protease inhibitor or by small interfering RNA that selectively silences ADAM10 and ADAM17 expression, suggesting that ADAM metalloproteases are required for P2Y(2)R-mediated activation of the EGFR. G-protein-coupled receptors have been shown to promote proteolytic release of EGFR ligands; however, neutralizing antibodies to known ligands of the EGFR did not inhibit UTP-induced EGFR phosphorylation. Immunoprecipitation experiments indicated that UTP causes association of the EGFR with another member of the EGF receptor family, ErbB3. Furthermore, stimulation of HSG cells with UTP induced phosphorylation of ErbB3, and silencing of ErbB3 expression inhibited UTP-induced phosphorylation of both ErbB3 and EGFR. UTP-induced phosphorylation of ErbB3 and EGFR was also inhibited by silencing the expression of the ErbB3 ligand neuregulin 1 (NRG1). These results suggest that P2Y(2)R activation in salivary gland cells promotes the formation of EGFR/ErbB3 heterodimers and metalloprotease-dependent neuregulin 1 release, resulting in the activation of both EGFR and ErbB3.	[Ratchford, Ann M.; Baker, Olga J.; Camden, Jean M.; Rikka, Shivaji; Petris, Michael J.; Seye, Cheikh I.; Erb, Laurie; Weisman, Gary A.] Univ Missouri, Dept Biochem, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Weisman, GA (corresponding author), Univ Missouri, Dept Biochem, Life Sci Ctr 540E, 1201 Rollins Rd, Columbia, MO 65211 USA.	weismang@missouri.edu		Erb, Laurie/0000-0001-6372-3378; Baker, Olga/0000-0002-0628-8645				Ahn JS, 2000, AM J PHYSIOL-CELL PH, V279, pC286, DOI 10.1152/ajpcell.2000.279.2.C286; Arthur DB, 2006, BIOCHEM BIOPH RES CO, V347, P678, DOI 10.1016/j.bbrc.2006.06.141; Arthur DB, 2006, J NEUROSCI, V26, P3798, DOI 10.1523/JNEUROSCI.5338-05.2006; Baker OJ, 2008, MOL IMMUNOL, V45, P65, DOI 10.1016/j.molimm.2007.05.009; Beldi G, 2008, GASTROENTEROLOGY, V135, P1751, DOI 10.1053/j.gastro.2008.07.025; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; BOARDER MR, 1995, TRENDS PHARMACOL SCI, V16, P133, DOI 10.1016/S0165-6147(00)89001-X; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Chang SJ, 2008, CELL SIGNAL, V20, P1248, DOI 10.1016/j.cellsig.2008.02.011; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Crooke A, 2009, MOL VIS, V15, P1169; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Erb L, 2001, J CELL BIOL, V153, P491, DOI 10.1083/jcb.153.3.491; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Frank GD, 2003, ANTIOXID REDOX SIGN, V5, P771, DOI 10.1089/152308603770380070; Frank GD, 2003, MOL CELL BIOL, V23, P1581, DOI 10.1128/MCB.23.5.1581-1589.2003; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 1996, J CELL SCI, V109, P2013; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hsieh M, 2005, TRENDS ENDOCRIN MET, V16, P320, DOI 10.1016/j.tem.2005.07.005; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kalmes A, 2000, CIRC RES, V87, P92, DOI 10.1161/01.RES.87.2.92; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; Keely SJ, 2000, J BIOL CHEM, V275, P12619, DOI 10.1074/jbc.275.17.12619; Kim HH, 1998, BIOCHEM J, V334, P189, DOI 10.1042/bj3340189; KNOWLES MR, 1992, CHEST, V101, pS60, DOI 10.1378/chest.101.3_Supplement.60S; Larsen M, 2003, DEV BIOL, V255, P178, DOI 10.1016/S0012-1606(02)00047-7; Li ZM, 2007, CELL SIGNAL, V19, P466, DOI 10.1016/j.cellsig.2006.07.020; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; McCole DF, 2002, J BIOL CHEM, V277, P42603, DOI 10.1074/jbc.M206487200; Mediero A, 2006, INVEST OPHTH VIS SCI, V47, P4500, DOI 10.1167/iovs.06-0209; Miyazaki Y, 2004, DEV DYNAM, V230, P591, DOI 10.1002/dvdy.20078; Moon Y, 2007, TOXICOL APPL PHARM, V223, P155, DOI 10.1016/j.taap.2007.04.018; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Noone PG, 1999, AM J RESP CRIT CARE, V160, P144, DOI 10.1164/ajrccm.160.1.9806146; Ohtsu H, 2005, ANTIOXID REDOX SIGN, V7, P1315, DOI 10.1089/ars.2005.7.1315; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schrader AM, 2005, ARCH ORAL BIOL, V50, P533, DOI 10.1016/j.archoralbio.2004.11.005; Seye CI, 2004, J BIOL CHEM, V279, P35679, DOI 10.1074/jbc.M401799200; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Shin SY, 2006, EXP MOL MED, V38, P677, DOI 10.1038/emm.2006.80; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Soltoff SP, 1998, J BIOL CHEM, V273, P23110, DOI 10.1074/jbc.273.36.23110; Tsai W, 1997, EMBO J, V16, P4597, DOI 10.1093/emboj/16.15.4597; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; Turner JT, 1997, AM J PHYSIOL-CELL PH, V273, pC1100, DOI 10.1152/ajpcell.1997.273.3.C1100; Ueno Y, 2008, INT J CANCER, V123, P340, DOI 10.1002/ijc.23465; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Wang M, 2005, J NEUROCHEM, V95, P630, DOI 10.1111/j.1471-4159.2005.03408.x; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Weisman GA, 1996, J PHARMACOL EXP THER, V277, P1; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Zheng CY, 1998, J CELL PHYSIOL, V177, P628, DOI 10.1002/(SICI)1097-4652(199812)177:4<628::AID-JCP13>3.0.CO;2-L; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767	79	43	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7545	7555		10.1074/jbc.M109.078170	http://dx.doi.org/10.1074/jbc.M109.078170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20064929	hybrid, Green Published			2022-12-25	WOS:000275415600066
J	Giroud, S; Perret, M; Stein, P; Goudable, J; Aujard, F; Gilbert, C; Robin, JP; Le Maho, Y; Zahariev, A; Blanc, S; Momken, I				Giroud, Sylvain; Perret, Martine; Stein, Peter; Goudable, Joelle; Aujard, Fabienne; Gilbert, Caroline; Robin, Jean Patrice; Le Maho, Yvon; Zahariev, Alexandre; Blanc, Stephane; Momken, Iman			The Grey Mouse Lemur Uses Season-Dependent Fat or Protein Sparing Strategies to Face Chronic Food Restriction	PLOS ONE			English	Article							MICROCEBUS-MURINUS; GROUND-SQUIRRELS; METABOLIC-RATE; BODY-MASS; TORPOR; WATER; SUPPRESSION; PHOTOPERIOD; HIBERNATION; INHIBITION	During moderate calorie restriction (CR) the heterotherm Microcebus murinus is able to maintain a stable energy balance whatever the season, even if only wintering animals enter into torpor. To understand its energy saving strategies to respond to food shortages, we assessed protein and energy metabolisms associated with wintering torpor expression or summering torpor avoidance. We investigated body composition, whole body protein turnover, and daily energy expenditure (DEE), during a graded (40 and 80%) 35-day CR in short-days (winter; SD40 and SD80, respectively) and long-days (summer; LD40 and LD80, respectively) acclimated animals. LD40 animals showed no change in fat mass (FM) but a 12% fat free mass (FFM) reduction. Protein balance being positive after CR, the FFM loss was early and rapid. The 25% DEE reduction, in LD40 group was mainly explained by FFM changes. LD80 animals showed a steady body mass loss and were excluded from the CR trial at day 22, reaching a survival-threatened body mass. No data were available for this group. SD40 animals significantly decreased their FM level by 21%, but maintained FFM. Protein sparing was achieved through a 35 and 39% decrease in protein synthesis and catabolism (protein turnover), respectively, overall maintaining nitrogen balance. The 21% reduction in energy requirement was explained by the 30% nitrogen flux drop but also by torpor as DEE FFM-adjusted remained 13% lower compared to ad-libitum. SD80 animals were unable to maintain energy and nitrogen balances, losing both FM and FFM. Thus summering mouse lemurs equilibrate energy balance by a rapid loss of active metabolic mass without using torpor, whereas wintering animals spare protein and energy through increased torpor expression. Both strategies have direct fitness implication: 1) to maintain activities at a lower body size during the mating season and 2) to preserve an optimal wintering muscle mass and function.	[Giroud, Sylvain; Gilbert, Caroline; Robin, Jean Patrice; Le Maho, Yvon; Zahariev, Alexandre; Blanc, Stephane; Momken, Iman] Univ Strasbourg, UMR 7178, Dept Ecol Physiol Ethol, Inst Pluridisciplinaire Hubert Curien,CNRS, Strasbourg, France; [Giroud, Sylvain; Perret, Martine; Aujard, Fabienne] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Stein, Peter] Univ Med & Dent New Jersey, Dept Surg, Stratford, NJ USA; [Goudable, Joelle] Hop Edouard Herriot, Inst Sci Pharmaceut & Biol, Fac Pharm, Lyon, France; [Gilbert, Caroline] Nancy Univ, Univ Henri Poincare, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Rutgers State University New Brunswick; Rutgers State University Medical Center; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lorraine	Giroud, S (corresponding author), Univ Strasbourg, UMR 7178, Dept Ecol Physiol Ethol, Inst Pluridisciplinaire Hubert Curien,CNRS, Strasbourg, France.	stephane.blanc@c-strasbourg.fr		Giroud, Sylvain/0000-0001-6621-7462; Gilbert, Caroline/0000-0002-9957-405X	MNRT; ANR AlimH	MNRT; ANR AlimH(French National Research Agency (ANR))	S. Giroud is supported by an MNRT fellowship. This work was supported by ANR AlimH (http://www.agence-nationale-recherche.fr), the FRM (http://www.frm.org) and the GIS Longevite (http://www.gis-longevite.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujard F, 1998, J COMP PHYSIOL B, V168, P540, DOI 10.1007/s003600050175; BACHMAN GC, 1994, PHYSIOL ZOOL, V67, P756, DOI 10.1086/physzool.67.3.30163769; Blanc S, 2005, J MED PRIMATOL, V34, P130, DOI 10.1111/j.1600-0684.2005.00106.x; Bozinovic F, 2007, J COMP PHYSIOL B, V177, P393, DOI 10.1007/s00360-006-0137-0; CONCON JM, 1973, ANAL BIOCHEM, V53, P35, DOI 10.1016/0003-2697(73)90405-3; Coward WA, 1990, DOUBLY LABELLED WATE, P48; Crawford FIJ, 2007, PHYSIOL GENOMICS, V31, P521, DOI 10.1152/physiolgenomics.00131.2007; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Evans MC, 2007, RESUSCITATION, V73, P296, DOI 10.1016/j.resuscitation.2006.08.029; Fietz J, 1998, FOLIA PRIMATOL, V69, P183, DOI 10.1159/000052712; Filaire E, 2002, INT J SPORTS MED, V23, P588, DOI 10.1055/s-2002-35531; French Alan R., 1992, P105; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Genin F, 2000, PHYSIOL BEHAV, V71, P315, DOI 10.1016/S0031-9384(00)00335-8; Genin F, 2003, AM J PHYSIOL-REG I, V284, pR811, DOI 10.1152/ajpregu.00525.2002; GIROUD S, 2008, AMERICAN J PHYSL REG, V294, P1958; Giroud S, 2009, AM J PHYSIOL-REG I, V297, pR950, DOI 10.1152/ajpregu.00214.2009; Grigg G, 2000, LIFE IN THE COLD, P5; HOWELL RR, 1961, J CLIN INVEST, V40, P2076, DOI 10.1172/JCI104433; KARMANN H, 1994, INT J OBESITY, V18, P351; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; LINDGARD K, 1992, J COMP PHYSIOL B, V162, P607, DOI 10.1007/BF00296641; Lohuis TD, 2007, COMP BIOCHEM PHYS B, V147, P20, DOI 10.1016/j.cbpb.2006.12.020; MCBRIDE BW, 1990, J ANIM SCI, V68, P2997; MICHENER GR, 1992, OECOLOGIA, V89, P397, DOI 10.1007/BF00317418; Migliorini RH, 1997, AM J PHYSIOL-REG I, V272, pR656, DOI 10.1152/ajpregu.1997.272.2.R656; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MROSOVSKY N, 1985, INT J OBESITY, V9, P93; NELSON RA, 1978, KIDNEY INT, pS177; NELSON RA, 1980, FED PROC, V39, P2955; Orr AL, 2009, COMP BIOCHEM PHYS A, V153, P213, DOI 10.1016/j.cbpa.2009.02.016; Perret M, 1995, CREATURES OF THE DARK, P377; PERRET M, 1987, J CHEM ECOL, V13, P495, DOI 10.1007/BF01880095; Perret M, 1998, COMP BIOCHEM PHYS A, V119, P981, DOI 10.1016/S1095-6433(98)00015-4; PERRET M, 1998, P INT C CHRON PAR FR, P415; Petter-Rousseaux A, 1980, NOCTURNAL MALAGASY P; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; Radespiel U, 2000, AM J PRIMATOL, V51, P21, DOI 10.1002/(SICI)1098-2345(200005)51:1<21::AID-AJP3>3.0.CO;2-C; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; RUF T, 1992, PHYSIOL ZOOL, V65, P994, DOI 10.1086/physzool.65.5.30158554; Schmid J, 1999, J MAMMAL, V80, P749, DOI 10.2307/1383244; Schmid J, 2000, BASIC APPL ECOL, V1, P133, DOI 10.1078/1439-1791-00019; Schmid Jutta, 1996, P47; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; Speakman JR, 2000, ADV ECOL RES, V30, P177; Speakman JR, 1997, DOUBLY LABELED WATER; van Breukelen F, 2004, AM J PHYSIOL-REG I, V287, pR349, DOI 10.1152/ajpregu.00728.2003; Van Breukelen F, 2001, AM J PHYSIOL-REG I, V281, pR1374, DOI 10.1152/ajpregu.2001.281.5.R1374; Velickovska V, 2005, J COMP PHYSIOL B, V175, P329, DOI 10.1007/s00360-005-0489-x; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Wang ZM, 2001, J NUTR, V131, P2967, DOI 10.1093/jn/131.11.2967; WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829; WATERLOW JC, 1978, AM J PHYSIOL, V235, pE165, DOI 10.1152/ajpendo.1978.235.2.E165; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Williams JB, 2001, J EXP BIOL, V204, P2301; WONG WW, 1987, AM J CLIN NUTR, V45, P905, DOI 10.1093/ajcn/45.5.905; Wunder Bruce A., 1996, P131; YOUNG JB, 1977, SCIENCE, V196, P1473, DOI 10.1126/science.867049	58	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8823	10.1371/journal.pone.0008823	http://dx.doi.org/10.1371/journal.pone.0008823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098678	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779100015
J	Simpson, DC; Kabyemela, E; Muehlenbachs, A; Ogata, Y; Mutabingwa, TK; Duffy, PE; Fried, M				Simpson, David C.; Kabyemela, Edward; Muehlenbachs, Atis; Ogata, Yuko; Mutabingwa, Theonest K.; Duffy, Patrick E.; Fried, Michal			Plasma Levels of Apolipoprotein A1 in Malaria-Exposed Primigravidae Are Associated with Severe Anemia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SHOTGUN PROTEOMICS; FALCIPARUM-MALARIA; PROTEIN EXPRESSION; GENE-EXPRESSION; DATABASE SEARCH; HUMAN PLACENTA; BIRTH-WEIGHT; FACTOR-ALPHA; TNF-ALPHA	Background: Plasmodium falciparum placental malaria (PM) contributes to 10,000 maternal deaths due to severe anemia (SA) each year in Africa, primarily among primigravid women who are most susceptible. Increased levels of proinflammatory cytokines like TNF-alpha are associated with maternal anemia in first time mothers but not in other women. Here we aimed to identify additional changes in the plasma proteome associated with pregnancy malaria that may contribute to the development of malaria-related maternal anemia. Principal Findings: A semi-quantitative mass spectrometry approach was used to compare the relative abundance of plasma proteins in anemic versus non-anemic women with PM. Levels of 24 proteins differed significantly between anemic and non-anemic primigravidae, including several lipid metabolism proteins and molecular transport proteins involved in the acute phase response signaling network. These differences were not observed in multigravid women who enjoy specific immunity that protect them from PM. In a confirmatory study of a larger cohort of primigravid women, levels of the lipid metabolism protein Apolipoprotein (Apo)-AI were significantly lower in PM+ women with SA. Conclusions: Apo-AI levels are significantly lower in severely anemic primigravidae with PM, and ApoA1 levels positively correlate with hemoglobin levels in primigravid but not multigravid women. Apo-AI is known to have anti-inflammatory effects, and thus Apo-AI reductions may contribute to the inflammatory processes that result in SA.	[Simpson, David C.; Kabyemela, Edward; Mutabingwa, Theonest K.; Duffy, Patrick E.; Fried, Michal] Seattle Biomed Res Inst, MOMS Project, Seattle, WA 98109 USA; [Kabyemela, Edward; Mutabingwa, Theonest K.; Duffy, Patrick E.; Fried, Michal] Muheza Designated Dist Hosp, Muheza, Tanzania; [Mutabingwa, Theonest K.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Muehlenbachs, Atis; Duffy, Patrick E.; Fried, Michal] Univ Washington, Seattle, WA 98195 USA	Center for Infectious Disease Research; National Institute of Medical Research; University of Washington; University of Washington Seattle	Simpson, DC (corresponding author), Seattle Biomed Res Inst, MOMS Project, 4 Nickerson St, Seattle, WA 98109 USA.	michal.fried@sbri.org	Simpson, David/D-4677-2009	Simpson, David/0000-0002-1189-0833	US National Institutes of Health [AI52059, 1HD049641, R01HD058005]; Bill & Melinda Gates Foundation [3035]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058005] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD049641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052059, ZIAAI001134] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the US National Institutes of Health (grants AI52059 to P. E. D and 1HD049641, R01HD058005 to M. F) and the Bill & Melinda Gates Foundation (grant 3035 to P. E. D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ C, 1986, CLIN CHEM, V32, P142; Beers A, 2006, BIOCHEMISTRY-US, V45, P2408, DOI 10.1021/bi0518040; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Burger Danielle, 2002, Autoimmunity Reviews, V1, P111, DOI 10.1016/S1568-9972(01)00018-0; Burger D, 2002, ARTHRITIS RES THER, V4, pS169, DOI 10.1186/ar558; Chenaud C, 2004, CRIT CARE MED, V32, P632, DOI 10.1097/01.CCM.0000114820.47460.0A; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; CLARK IA, 1987, J IMMUNOL, V139, P3493; DJOUMESSI S, 1989, PATHOL BIOL, V37, P909; Duffy P. E., 2001, Malaria in pregnancy: deadly parasite, susceptible host, P1, DOI 10.4324/9780203302255_chapter_1; Faucher JF, 2002, PARASITOL RES, V88, P1040, DOI 10.1007/s00436-002-0712-6; FLEMING AF, 1989, T ROY SOC TROP MED H, V83, P441, DOI 10.1016/0035-9203(89)90241-1; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gao J, 2003, J PROTEOME RES, V2, P643, DOI 10.1021/pr034038x; GERSZTEN RE, 2008, AM J PHYSL LUNG CELL; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Haas MJ, 2003, BBA-GEN SUBJECTS, V1623, P120, DOI 10.1016/j.bbagen.2003.08.004; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Kabyemela ER, 2008, INFECT IMMUN, V76, P1527, DOI 10.1128/IAI.00964-07; KABYEMELA ER, 2008, J INFECT DI IN PRESS; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kim JS, 2008, ACTA TROP, V106, P39, DOI 10.1016/j.actatropica.2008.01.002; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Mooser V, 2000, ARTERIOSCL THROM VAS, V20, P1137, DOI 10.1161/01.ATV.20.4.1137; NILSSONEHLE I, 1990, J INTERN MED, V227, P151, DOI 10.1111/j.1365-2796.1990.tb00136.x; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Pang JX, 2002, J PROTEOME RES, V1, P161, DOI 10.1021/pr015518w; Parola P, 2004, PARASITOL RES, V92, P464, DOI 10.1007/s00436-003-1012-5; ROBERTSON SA, 1994, CRIT REV IMMUNOL, V14, P239, DOI 10.1615/CritRevImmunol.v14.i3-4.30; Shulman CE, 2001, TROP MED INT HEALTH, V6, P770, DOI 10.1046/j.1365-3156.2001.00786.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zucker JR, 1996, AM J TROP MED HYG, V55, P655, DOI 10.4269/ajtmh.1996.55.655	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8822	10.1371/journal.pone.0008822	http://dx.doi.org/10.1371/journal.pone.0008822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098675	gold, Green Submitted, Green Published			2022-12-25	WOS:000273779100014
J	Castro, JE; Varea, E; Marquez, C; Cordero, MI; Poirier, G; Sandi, C				Castro, Jorge E.; Varea, Emilio; Marquez, Cristina; Cordero, Maria Isabel; Poirier, Guillaume; Sandi, Carmen			Role of the Amygdala in Antidepressant Effects on Hippocampal Cell Proliferation and Survival and on Depression-like Behavior in the Rat	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; DENTATE GYRUS; CHRONIC FLUOXETINE; ANIMAL-MODEL; ADULT NEUROGENESIS; UP-REGULATION; STRESS; MEMORY	The stimulation of adult hippocampal neurogenesis by antidepressants has been associated with multiple molecular pathways, but the potential influence exerted by other brain areas has received much less attention. The basolateral complex of the amygdala (BLA), a region involved in anxiety and a site of action of antidepressants, has been implicated in both basal and stress-induced changes in neural plasticity in the dentate gyrus. We investigated here whether the BLA modulates the effects of the SSRI antidepressant fluoxetine on hippocampal cell proliferation and survival in relation to a behavioral index of depression-like behavior (forced swim test). We used a lesion approach targeting the BLA along with a chronic treatment with fluoxetine, and monitored basal anxiety levels given the important role of this behavioral trait in the progress of depression. Chronic fluoxetine treatment had a positive effect on hippocampal cell survival only when the BLA was lesioned. Anxiety was related to hippocampal cell survival in opposite ways in sham-and BLA-lesioned animals (i.e., negatively in sham-and positively in BLA-lesioned animals). Both BLA lesions and low anxiety were critical factors to enable a negative relationship between cell proliferation and depression-like behavior. Therefore, our study highlights a role for the amygdala on fluoxetine-stimulated cell survival and on the establishment of a link between cell proliferation and depression-like behavior. It also reveals an important modulatory role for anxiety on cell proliferation involving both BLA-dependent and -independent mechanisms. Our findings underscore the amygdala as a potential target to modulate antidepressants' action in hippocampal neurogenesis and in their link to depression-like behaviors.	[Castro, Jorge E.; Varea, Emilio; Marquez, Cristina; Cordero, Maria Isabel; Poirier, Guillaume; Sandi, Carmen] Ecole Polytech Fed Lausanne, Lab Behav Genet, Brain Mind Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Castro, JE (corresponding author), Ecole Polytech Fed Lausanne, Lab Behav Genet, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	carmen.sandi@epfl.ch	Cordero, Maria Isabel/A-2532-2013; Varea, Emilio/ABF-6367-2021; Cordero, Maria Isabel/AAF-2935-2019; Poirier, Guillaume/F-5256-2010	Cordero, Maria Isabel/0000-0003-0692-8064; Cordero, Maria Isabel/0000-0003-0692-8064; Sandi, Carmen/0000-0001-7713-8321; Poirier, Guillaume/0000-0001-6126-1755; Marquez, Cristina/0000-0003-1948-2727; Varea, Emilio/0000-0002-1996-2870	European Union [FP7-HEALTH-F2M-2007-201600]; Swiss National Science Foundation [310000-120791]	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the European Union 7th Framework Programme (FP7-HEALTH-F2M-2007-201600; MemStick) and the Swiss National Science Foundation (310000-120791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Akirav I, 2004, LEARN MEMORY, V11, P188, DOI 10.1101/lm.61704; Akirav I, 2001, EUR J NEUROSCI, V14, P719, DOI 10.1046/j.0953-816x.2001.01687.x; Akirav I, 1999, J NEUROSCI, V19, P10530; Anderson IM, 2007, NEUROREPORT, V18, P1351, DOI 10.1097/WNR.0b013e3282742115; Balu DT, 2009, NEUROPSYCHOPHARMACOL, V34, P1764, DOI 10.1038/npp.2008.234; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bigos KL, 2008, NEUROPSYCHOPHARMACOL, V33, P3221, DOI 10.1038/npp.2008.52; Burghardt PR, 2004, BRAIN RES, V1019, P84, DOI 10.1016/j.brainres.2004.05.086; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Cowen DS, 2008, BRAIN RES, V1228, P14, DOI 10.1016/j.brainres.2008.06.059; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Doremus TL, 2006, PHARMACOL BIOCHEM BE, V83, P570, DOI 10.1016/j.pbb.2006.03.019; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drapier D, 2007, BEHAV BRAIN RES, V176, P202, DOI 10.1016/j.bbr.2006.10.002; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FAN X, 1996, ANN M AM ED RES ASS; FOURNIER NM, 2009, HIPPOCAMPUS; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Harmer CJ, 2006, BIOL PSYCHIAT, V59, P816, DOI 10.1016/j.biopsych.2005.10.015; Helfer V, 1996, NEUROSCIENCE, V73, P971, DOI 10.1016/0306-4522(96)00081-4; Herrero AI, 2006, NEUROBIOL LEARN MEM, V86, P150, DOI 10.1016/j.nlm.2006.02.001; HODES GE, 2009, NEUROSCIENCE; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Huang GJ, 2005, NEUROSCIENCE, V135, P803, DOI 10.1016/j.neuroscience.2005.05.056; IKEGAYA Y, 1994, BRAIN RES, V656, P157, DOI 10.1016/0006-8993(94)91377-3; Ikegaya Y, 1996, EUR J NEUROSCI, V8, P1833, DOI 10.1111/j.1460-9568.1996.tb01327.x; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Kim JJ, 2001, J NEUROSCI, V21, P5222, DOI 10.1523/JNEUROSCI.21-14-05222.2001; Kim JJ, 2005, J NEUROSCI, V25, P1532, DOI 10.1523/JNEUROSCI.4623-04.2005; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; Luksys G, 2009, NAT NEUROSCI, V12, P1180, DOI 10.1038/nn.2374; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Matsuzawa-Yanagida K, 2008, NEUROPSYCHOPHARMACOL, V33, P1952, DOI 10.1038/sj.npp.1301590; MCCORMICK CM, 2009, BEHAV BRAIN RES; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Muigg P, 2007, BIOL PSYCHIAT, V61, P782, DOI 10.1016/j.biopsych.2006.08.035; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Nakao K, 2004, P NATL ACAD SCI USA, V101, P14270, DOI 10.1073/pnas.0405709101; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; Parent JM, 1998, NEUROSCI LETT, V247, P9, DOI 10.1016/S0304-3940(98)00269-9; Poirier GL, 2008, J NEUROSCI, V28, P1034, DOI 10.1523/JNEUROSCI.4607-07.2008; Pollak DD, 2008, NEURON, V60, P149, DOI 10.1016/j.neuron.2008.07.041; Porsolt R. D., 2001, CURR PROTOC NEUROS A, V10A, DOI 10.1002/0471142301.ns0810as14; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; REVEST JM, 2009, MOL PSYCHIAT; Roche M, 2007, NEUROPSYCHOPHARMACOL, V32, P1312, DOI 10.1038/sj.npp.1301253; Roesler R, 2002, EUR J NEUROSCI, V15, P905, DOI 10.1046/j.1460-9568.2002.01924.x; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sairanen M, 2007, NEUROSCIENCE, V144, P368, DOI 10.1016/j.neuroscience.2006.08.069; Sandi C, 1997, PSYCHOPHARMACOLOGY, V133, P152, DOI 10.1007/s002130050385; Sandi C, 2008, EUR J NEUROSCI, V28, P1836, DOI 10.1111/j.1460-9568.2008.06451.x; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schauwecker PE, 2006, BRAIN RES, V1120, P83, DOI 10.1016/j.brainres.2006.08.086; Schiller D, 2006, J PSYCHIATR RES, V40, P167, DOI 10.1016/j.jpsychires.2005.03.002; Scott BW, 1998, NEUROSCI LETT, V248, P73, DOI 10.1016/S0304-3940(98)00355-3; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Shishkina GT, 2007, NEUROSCIENCE, V150, P404, DOI 10.1016/j.neuroscience.2007.09.017; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Smith PD, 2006, EUR J NEUROSCI, V24, P3195, DOI 10.1111/j.1460-9568.2006.05205.x; Smith PD, 2005, NEUROSCIENCE, V136, P405, DOI 10.1016/j.neuroscience.2005.07.055; Strauss CVA, 2003, PHYSIOL BEHAV, V78, P157, DOI 10.1016/S0031-9384(02)00960-5; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Varea E, 2007, EUR NEUROPSYCHOPHARM, V17, P546, DOI 10.1016/j.euroneuro.2007.01.001; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Woolley ML, 2006, BRAIN RES, V1078, P151, DOI 10.1016/j.brainres.2006.01.071; Wu XF, 2009, BIOL PSYCHIAT, V66, P5, DOI 10.1016/j.biopsych.2009.01.023; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Zoladz PR, 2009, DOSE-RESPONSE, V7, P132, DOI 10.2203/dose-response.08-015.Zoladz	96	54	56	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8618	10.1371/journal.pone.0008618	http://dx.doi.org/10.1371/journal.pone.0008618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062812	Green Published, gold			2022-12-25	WOS:000273414200009
J	Beurrier, C; Faideau, M; Bennouar, KE; Escartin, C; Kerkerian-Le Goff, L; Bonvento, G; Gubellini, P				Beurrier, Corinne; Faideau, Mathilde; Bennouar, Khaled-Ezaheir; Escartin, Carole; Kerkerian-Le Goff, Lydia; Bonvento, Gilles; Gubellini, Paolo			Ciliary Neurotrophic Factor Protects Striatal Neurons against Excitotoxicity by Enhancing Glial Glutamate Uptake	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUNTINGTONS-DISEASE; QUINOLINIC ACID; RAFT MICRODOMAINS; REACTIVE GLIOSIS; FACTOR-RECEPTOR; GENE-TRANSFER; RAT MODEL; IN-VIVO; CNTF	Ciliary neurotrophic factor (CNTF) is a potent neuroprotective cytokine in different animal models of glutamate-induced excitotoxicity, although its action mechanisms are still poorly characterized. We tested the hypothesis that an increased function of glial glutamate transporters (GTs) could underlie CNTF-mediated neuroprotection. We show that neuronal loss induced by in vivo striatal injection of the excitotoxin quinolinic acid (QA) was significantly reduced (by similar to 75%) in CNTF-treated animals. In striatal slices, acute QA application dramatically inhibited corticostriatal field potentials (FPs), whose recovery was significantly higher in CNTF rats compared to controls (similar to 40% vs similar to 7%), confirming an enhanced resistance to excitotoxicity. The GT inhibitor DL-threo-beta-benzyloxyaspartate greatly reduced FP recovery in CNTF rats, supporting the role of GT in CNTF-mediated neuroprotection. Whole-cell patch-clamp recordings from striatal medium spiny neurons showed no alteration of basic properties of striatal glutamatergic transmission in CNTF animals, but the increased effect of a low-affinity competitive glutamate receptor antagonist (gamma-D-glutamylglycine) also suggested an enhanced GT function. These data strongly support our hypothesis that CNTF is neuroprotective via an increased function of glial GTs, and further confirms the therapeutic potential of CNTF for the clinical treatment of progressive neurodegenerative diseases involving glutamate overflow.	[Beurrier, Corinne; Bennouar, Khaled-Ezaheir; Kerkerian-Le Goff, Lydia; Gubellini, Paolo] Univ Aix Marseille 2, IBDML, UMR6216, CNRS, Marseille, France; [Faideau, Mathilde; Escartin, Carole; Bonvento, Gilles] CEA, I2BM, Mol Imaging Res Ctr, Fontenay Aux Roses, France; [Faideau, Mathilde; Escartin, Carole; Bonvento, Gilles] CEA, CNRS, URA2210, Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Beurrier, C (corresponding author), Univ Aix Marseille 2, IBDML, UMR6216, CNRS, Marseille, France.	paolo.gubellini@ibdml.univ-mrs.fr	Bonvento, Gilles/F-6023-2013; Escartin, Carole/A-1952-2010	Bonvento, Gilles/0000-0002-2886-4228; Escartin, Carole/0000-0003-3613-4118; Kerkerian-Le Goff, Lydia/0000-0002-7951-3479	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Universite de la Mediterranee; Association Francaise contre les Myopathies; Fondation de France; Pathogenie de la maladie de Parkinson [2005-013853]; French Ministry of Education and Research [ANR-05-NEUR-013]	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation de France(Fondation de France); Pathogenie de la maladie de Parkinson; French Ministry of Education and Research	This work was supported by the Commissariat a l'Energie Atomique (CEA; http://www.cea.fr/), the Centre National de la Recherche Scientifique (CNRS; http://www.cnrs.fr/), the Universite de la Mediterranee (http://www.univmed.fr/), the Association Francaise contre les Myopathies (AFM; http://www.afm-telethon.fr/), the Fondation de France (http://www.fondationdefrance.org/) (project "Pathogenie de la maladie de Parkinson'', Engt. 2005-013853), and the French Ministry of Education and Research (http://www.agence-nationale-recherche.fr/) (project ANR-05-NEUR-013 "DYPLAGB''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberch J, 2004, PROG BRAIN RES, V146, P195, DOI 10.1016/S0079-6123(03)46014-7; Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; Arzberger T, 1997, J NEUROPATH EXP NEUR, V56, P440, DOI 10.1097/00005072-199704000-00013; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Beurrier C, 2002, J NEUROSCI, V22, P5817; Beurrier C, 2009, NEUROSCIENCE, V158, P1608, DOI 10.1016/j.neuroscience.2008.11.018; Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968; Brouillet E, 1999, PROG NEUROBIOL, V59, P427, DOI 10.1016/S0301-0082(99)00005-2; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; CONNICK JH, 1988, BRIT J PHARMACOL, V93, P868, DOI 10.1111/j.1476-5381.1988.tb11474.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Almeida LP, 2001, NEUROBIOL DIS, V8, P433, DOI 10.1006/nbdi.2001.0388; Emerich DF, 1997, NATURE, V386, P395, DOI 10.1038/386395a0; Emerich DF, 1996, J NEUROSCI, V16, P5168; Escartin C, 2007, J NEUROSCI, V27, P7094, DOI 10.1523/JNEUROSCI.0174-07.2007; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; Kordower JH, 1997, J COMP NEUROL, V377, P365, DOI 10.1002/(SICI)1096-9861(19970120)377:3<365::AID-CNE5>3.0.CO;2-0; Levison SW, 1996, EXP NEUROL, V141, P256, DOI 10.1006/exnr.1996.0160; Lievens JC, 1997, MOL BRAIN RES, V50, P181, DOI 10.1016/S0169-328X(97)00182-4; Lisovoski F, 1997, J NEUROSCI, V17, P7228; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Mallozzi C, 2007, J NEUROSCI RES, V85, P2770, DOI 10.1002/jnr.21178; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; Mathern GW, 1999, NEUROLOGY, V52, P453, DOI 10.1212/WNL.52.3.453; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Mittoux V, 2002, J NEUROSCI, V22, P4478, DOI 10.1523/JNEUROSCI.22-11-04478.2002; Mittoux V, 2000, HUM GENE THER, V11, P1177, DOI 10.1089/10430340050015220; Monville C, 2001, MOL CELL NEUROSCI, V17, P373, DOI 10.1006/mcne.2000.0926; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Orlando LR, 2001, EXP NEUROL, V167, P196, DOI 10.1006/exnr.2000.7542; Pintor A, 2006, NEUROPHARMACOLOGY, V51, P1004, DOI 10.1016/j.neuropharm.2006.06.013; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; SENDTNER M, 1994, J NEUROBIOL, V25, P1436, DOI 10.1002/neu.480251110; STONE TW, 1993, PHARMACOL REV, V45, P309; Tebano MT, 2002, EUR J PHARMACOL, V450, P253, DOI 10.1016/S0014-2999(02)02148-9; WINTER CG, 1995, P NATL ACAD SCI USA, V92, P5865, DOI 10.1073/pnas.92.13.5865	39	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8550	10.1371/journal.pone.0008550	http://dx.doi.org/10.1371/journal.pone.0008550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20062544	Green Published, Green Submitted, gold			2022-12-25	WOS:000273225000013
J	Mendez, MG; Kojima, SI; Goldman, RD				Mendez, Melissa G.; Kojima, Shin-Ichiro; Goldman, Robert D.			Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition	FASEB JOURNAL			English	Article							INTERMEDIATE-FILAMENT NETWORKS; MICE LACKING VIMENTIN; IN-VIVO; MICROMECHANICAL PROPERTIES; DYNAMIC PROPERTIES; FOCAL ADHESIONS; SHEAR-STRESS; CANCER-CELLS; PHOSPHORYLATION; EXPRESSION	Vimentin is used widely as a marker of the epithelial to mesenchymal transitions (EMTs) that take place during embryogenesis and metastasis, yet the functional implications of the expression of this type III intermediate filament (IF) protein are poorly understood. Using form factor analysis and quantitative Western blotting of normal, metastatic, and vimentin-null cell lines, we show that the level of expression of vimentin IFs (VIFs) correlates with mesenchymal cell shape and motile behavior. The reorganization of VIFs caused by expressing a dominant-negative mutant or by silencing vimentin with shRNA (neither of which alter microtubule or microfilament assembly) causes mesenchymal cells to adopt epithelial shapes. Following the microinjection of vimentin or transfection with vimentin cDNA, epithelial cells rapidly adopt mesenchymal shapes coincident with VIF assembly. These shape transitions are accompanied by a loss of desmosomal contacts, an increase in cell motility, and a significant increase in focal adhesion dynamics. Our results demonstrate that VIFs play a predominant role in the changes in shape, adhesion, and motility that occur during the EMT.-Mendez, M. G., Kojima, S.-I., Goldman, R. D. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 24, 1838-1851 (2010). www.fasebj.org	[Mendez, Melissa G.; Kojima, Shin-Ichiro; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Kojima, Shin-Ichiro] Gakushuin Univ, Fac Sci, Dept Life Sci, Tokyo 171, Japan	Northwestern University; Feinberg School of Medicine; Gakushuin University	Goldman, RD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave,Ward 11-145, Chicago, IL 60611 USA.	r-goldman@northwestern.edu	Mendez, Melissa G/B-1357-2014	Mendez, Melissa G/0000-0002-3995-2469	U.S. National Institutes of Health [R37 GM36806-27]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036806] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by a grant from the General Medical Sciences Institute of the U.S. National Institutes of Health (R37 GM36806-27). The authors also thank Brian Helfand, Ed Kuczmarski, Boris Grin, and Anne Goldman for helpful comments.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Barberis L, 2009, EUR J IMMUNOL, V39, P1136, DOI 10.1002/eji.200838884; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chang L, 2009, J CELL SCI, V122, P2914, DOI 10.1242/jcs.046789; Chou YH, 1996, J CELL SCI, V109, P817; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Davies PF, 1995, J BIOMECH, V28, P1553, DOI 10.1016/0021-9290(95)00102-6; Eckes B, 2000, J CELL SCI, V113, P2455; Flitney EW, 2009, FASEB J, V23, P2110, DOI 10.1096/fj.08-124453; FRANKE WW, 1983, P NATL ACAD SCI-BIOL, V80, P7113, DOI 10.1073/pnas.80.23.7113; Gilles C, 1999, J CELL SCI, V112, P4615; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; GREEN KJ, 1987, J CELL BIOL, V104, P1389, DOI 10.1083/jcb.104.5.1389; GYOEVA FK, 1991, NATURE, V353, P445, DOI 10.1038/353445a0; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Janmey P A, 1998, Subcell Biochem, V31, P381; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Santini D, 1996, J PATHOL, V179, P386, DOI 10.1002/(SICI)1096-9896(199608)179:4<386::AID-PATH631>3.0.CO;2-V; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Sin WC, 1998, MOL CELL BIOL, V18, P6325, DOI 10.1128/MCB.18.11.6325; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; SOLL DR, 1988, J CELL BIOCHEM, V37, P177, DOI 10.1002/jcb.240370205; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P3692, DOI 10.1073/pnas.78.6.3692; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Wei JC, 2008, ANTICANCER RES, V28, P327; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Woll S, 2005, EUR J CELL BIOL, V84, P311, DOI 10.1016/j.ejcb.2004.12.004; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656	61	603	627	0	96	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1838	1851		10.1096/fj.09-151639	http://dx.doi.org/10.1096/fj.09-151639			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20097873	Green Published			2022-12-25	WOS:000278200000020
J	Squillaro, T; Alessio, N; Cipollaro, M; Renieri, A; Giordano, A; Galderisi, U				Squillaro, Tiziana; Alessio, Nicola; Cipollaro, Marilena; Renieri, Alessandra; Giordano, Antonio; Galderisi, Umberto			Partial silencing of methyl cytosine protein binding 2 (MECP2) in mesenchymal stem cells induces senescence with an increase in damaged DNA	FASEB JOURNAL			English	Article						marrow stromal stem cells; differentiation; apoptosis; cell cycle; DNA repair	RETT-SYNDROME; STROMAL CELLS; REPAIR; MECHANISMS; OSTEOPENIA; APOPTOSIS; COMPLEX; GROWTH; CANCER; LINKS	DNA methylation is an epigenetic modification that occurs almost exclusively on CpG dinucleotides. MECP2 is a member of a family of proteins that preferentially bind to methylated CpGs. We analyzed the contribution of MECP2 to the physiology of mesenchymal stem cells (MSCs). Partial silencing of MECP2 in human MSCs induced a significant reduction of S-phase cells, along with an increase in G(1) cells. These changes were accompanied by a reduction of apoptosis, the triggering of senescence, a decrease in telomerase activity, and the down-regulation of genes involved in maintaining stem cell properties. Senescence appeared to rely on impairment of DNA damage repair and seemed to occur through RB- and P53-related pathways. The effects of MECP2 silencing could be related to the modification of the DNA methylation status. Our results indicate that the silencing of MECP2 induces an increase in methylated cytosines in the genome. Nevertheless, MECP2 partial silencing did not change the methylation of promoters, whose expression is affected by MECP2 down-regulation.-Squillaro, T., Alessio, N., Cipollaro, M., Renieri, A., Giordano, A., Galderisi, U. Partial silencing of methyl cytosine protein binding 2 (MECP2) in mesenchymal stem cells induces senescence with an increase in damaged DNA. FASEB J. 24, 1593-1603 (2010). www.fasebj.org	[Alessio, Nicola; Cipollaro, Marilena; Galderisi, Umberto] Univ Naples 2, Dept Expt Med, Biotechnol & Mol Biol Sect, I-80138 Naples, Italy; [Squillaro, Tiziana; Alessio, Nicola; Giordano, Antonio; Galderisi, Umberto] Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Philadelphia, PA 19122 USA; [Giordano, Antonio] Univ Siena, Dept Human Pathol & Oncol, Siena, Italy; [Squillaro, Tiziana; Renieri, Alessandra] Univ Siena, Dept Med Genet, Siena, Italy; [Giordano, Antonio] Human Hlth Fdn, Spoleto, Italy	Universita della Campania Vanvitelli; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena; University of Siena	Galderisi, U (corresponding author), Univ Naples 2, Dept Expt Med, Biotechnol & Mol Biol Sect, Via Costantinopoli 16, I-80138 Naples, Italy.	umberto.galderisi@unina2.it	Renieri, Alessandra/K-5950-2016; Alessio, Nicola/K-2119-2018; Giordano, Antonio/F-1927-2010	Renieri, Alessandra/0000-0002-0846-9220; Alessio, Nicola/0000-0002-5019-2130; Giordano, Antonio/0000-0002-5959-016X; GALDERISI, Umberto/0000-0003-0909-7403; Cipollaro, Marilena/0000-0003-4350-4324	Sbarro Health Research Organization funds	Sbarro Health Research Organization funds	This work was partially supported by Sbarro Health Research Organization funds to U.G. and A.G. The authors thank M.R. Cipollaro for technical assistance.	Ager S, 2006, J CHILD NEUROL, V21, P809, DOI 10.1177/08830738060210091501; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Budden SS, 2001, BRAIN DEV-JPN, V23, pS133, DOI 10.1016/S0387-7604(01)00338-2; Budden SS, 2003, J CHILD NEUROL, V18, P698, DOI 10.1177/08830738030180100401; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Diggle CP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng083; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Galderisi U, 1999, J CELL BIOCHEM, V73, P97, DOI 10.1002/(SICI)1097-4644(19990401)73:1<97::AID-JCB11>3.0.CO;2-M; Galderisi U, 2009, STEM CELLS DEV, V18, P1033, DOI 10.1089/scd.2008.0324; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Haas RH, 1997, J PEDIATR-US, V131, P771, DOI 10.1016/S0022-3476(97)70113-6; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; MULLERSIEBURG CE, 1995, STEM CELLS, V13, P477, DOI 10.1002/stem.5530130505; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; Napolitano MA, 2007, J CELL SCI, V120, P2904, DOI 10.1242/jcs.004002; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Ronen A, 2001, ENVIRON MOL MUTAGEN, V37, P241, DOI 10.1002/em.1033; Sambrook J, 2001, MOL CLONING LAB MANU; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Singh J, 2008, NUCLEIC ACIDS RES, V36, P6035, DOI 10.1093/nar/gkn591; SQUILLARO T, 2008, ISSCR ANN M 2008 PHI, P80; Squillaro T, 2008, WHAT IS NEW EUROPE F; Squillaro T, 2008, J CELL BIOCHEM, V103, P1877, DOI 10.1002/jcb.21582; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; von Zglinicki T, 2001, EXP GERONTOL, V36, P1049, DOI 10.1016/S0531-5565(01)00111-5; Weaving LS, 2005, J MED GENET, V42, P1, DOI 10.1136/jmg.2004.027730; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yu K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000129; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zysman L, 2006, THESCIENTIFICWORLDJO, V6, P1619, DOI 10.1100/tsw.2006.266	53	33	36	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1593	1603		10.1096/fj.09-143057	http://dx.doi.org/10.1096/fj.09-143057			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20065105				2022-12-25	WOS:000277158900031
J	Jolly, PS; Berkowitz, P; Bektas, M; Lee, HE; Chua, M; Diaz, LA; Rubenstein, DS				Jolly, Puneet S.; Berkowitz, Paula; Bektas, Meryem; Lee, Hua-En; Chua, Michael; Diaz, Luis A.; Rubenstein, David S.			p38MAPK Signaling and Desmoglein-3 Internalization Are Linked Events in Pemphigus Acantholysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-CELL LINE; VULGARIS-IGG; CULTURED KERATINOCYTES; E-CADHERIN; PHOSPHORYLATION; ENDOCYTOSIS; SKIN; INHIBITION; ACTIVATION; COMPLEX	Pemphigus vulgaris (PV) is an autoimmune blistering disease in which antibodies against the desmosomal cadherin, DSG3 (desmoglein-3), cause acantholysis. It has become increasingly clear that loss of cell-cell adhesion in PV is a complex and active process involving multiple signaling events such as activation of p38MAPK. It has also been demonstrated that incubating keratinocytes with PV IgG causes a redistribution of DSG3 from the cell surface to endosomes, which target these proteins for degradation. This study was undertaken to determine the relationship between p38MAPK and DSG3 endocytosis in pemphigus. In this work, we confirm that PV IgG causes internalization of cell-surface DSG3 into endosomes (as early as 4 h), which are then depleted from both detergent-soluble and detergent-insoluble pools. Cell-surface DSG3 internalization and depletion from both the detergent-soluble and detergent-insoluble fractions were blocked by the p38MAPK inhibitor SB202190. These data suggest that p38MAPK is capable of regulating PV IgG-mediated DSG3 internalization and that previously isolated mechanistic observations may be linked to a common pathway by which pemphigus autoantibodies lead to acantholysis.	[Rubenstein, David S.] Univ N Carolina, Sch Med, Dept Dermatol, Chapel Hill, NC 27599 USA; [Chua, Michael] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rubenstein, DS (corresponding author), Univ N Carolina, Sch Med, Dept Dermatol, Suite 3100,Thurston Bowles CB 7287, Chapel Hill, NC 27599 USA.	druben@med.unc.edu	Lee, Hua/AAC-9489-2021	Diaz, Luis/0000-0002-7079-8914; Bektas, Meryem/0000-0001-8080-7557	National Institutes of Health [RO1 AI49427, AR30281, AR32599]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI49427 (to D. S. R.) and Grants AR30281 and AR32599 (to L. A. D.). P. B., L. A. D., and D. S. R. are co-inventors on a patent application identifying p38MAPK and HSP27 as targets for the treatment of pemphigus. Neither licensing agreements nor financial benefits have accrued to the inventors.	Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Berkowitz P, 2008, AM J PATHOL, V173, P1628, DOI 10.2353/ajpath.2008.080391; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cirillo N, 2008, INT J IMMUNOPATH PH, V21, P189, DOI 10.1177/039463200802100121; Cirillo N, 2007, J CELL PHYSIOL, V210, P411, DOI 10.1002/jcp.20856; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; FUTAMURA S, 1989, J INVEST DERMATOL, V93, P480, DOI 10.1111/1523-1747.ep12284041; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Mao XM, 2009, J INVEST DERMATOL, V129, P908, DOI 10.1038/jid.2008.339; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; Sato M, 2000, LAB INVEST, V80, P1583, DOI 10.1038/labinvest.3780168; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; Sousa S, 2007, CELL MICROBIOL, V9, P2629, DOI 10.1111/j.1462-5822.2007.00984.x; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224	25	68	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8936	8941		10.1074/jbc.M109.087999	http://dx.doi.org/10.1074/jbc.M109.087999			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093368	Green Published, hybrid			2022-12-25	WOS:000275553700045
J	Lee, MC; Toh, LL; Yaw, LP; Luo, Y				Lee, Mei-Chin; Toh, Ling-Ling; Yaw, Lai-Ping; Luo, Yan			Drosophila Octamer Elements and Pdm-1 Dictate the Coordinated Transcription of Core Histone Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; COACTIVATOR OCA-B; DNA-BINDING; CAJAL BODIES; POU DOMAIN; EXPRESSION; REPLICATION; OCT-1; PHOSPHORYLATION; IDENTIFICATION	We reveal a set of divergent octamer elements in Drosophila melanogaster (dm) core histone gene promoters. These elements recruit transcription factor POU-domain protein in D. melanogaster 1 (Pdm-1), which along with co-activator dmOct-1 coactivator in S-phase (dmOCA-S), activates transcription from at least the Drosophila histone 2B (dmH2B) and 4 (dmH4) promoters in a fashion similar to the transcription of mammalian histone 2B (H2B) gene activated by octamer binding transcription factor 1 (Oct-1) and Oct-1 coactivator in S-phase (OCA-S). The expression of core histone genes in both kingdoms is coordinated; however, although the expression of mammalian histone genes involves subtype-specific transcription factors and/or co-activator(s), the expression of Drosophila core histone genes is regulated by a common module (Pdm-1/dmOCA-S) in a directly coordinated manner. Finally, dmOCA-S is recruited to the Drosophila histone locus bodies in the S-phase, marking S-phase-specific transcription activation of core histone genes.	[Luo, Yan] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; Inst Mol & Cell Biol, Singapore 138673, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Luo, Y (corresponding author), Natl Univ Singapore, Dept Biochem, 8 Med Dr, Singapore 117597, Singapore.	yluo@imcb.a-star.edu.sg		Lee, Mei Chin/0000-0001-7689-6446	Agency for Science, Technology, and Research, Singapore	Agency for Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research, Singapore.	Babb R, 1997, MOL CELL BIOL, V17, P7295, DOI 10.1128/MCB.17.12.7295; BHAT KM, 1995, MOL CELL BIOL, V15, P4052; Cepek KL, 1996, GENE DEV, V10, P2079, DOI 10.1101/gad.10.16.2079; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Hedges SB, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-31; HEINTZ N, 1991, BIOCHIM BIOPHYS ACTA, V1088, P327, DOI 10.1016/0167-4781(91)90122-3; HENTSCHEL CC, 1981, CELL, V25, P301, DOI 10.1016/0092-8674(81)90048-9; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Isogai Y, 2007, GENE DEV, V21, P2936, DOI 10.1101/gad.1608807; KITAMOTO T, 1995, J NEUROBIOL, V28, P70, DOI 10.1002/neu.480280107; KREMER H, 1990, NUCLEIC ACIDS RES, V18, P1573, DOI 10.1093/nar/18.6.1573; LIFTON RP, 1977, COLD SPRING HARB SYM, V42, P1047, DOI 10.1101/SQB.1978.042.01.105; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; LLOYD A, 1991, MECH DEVELOP, V36, P87, DOI 10.1016/0925-4773(91)90075-H; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Matera AG, 2006, J CELL BIOL, V172, P791, DOI 10.1083/jcb.200602002; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Neumann CJ, 1998, SCIENCE, V281, P409, DOI 10.1126/science.281.5375.409; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; PERRY M, 1985, J MOL BIOL, V185, P479, DOI 10.1016/0022-2836(85)90065-8; Roberts TG, 1998, MOL CELL BIOL, V18, P4409, DOI 10.1128/MCB.18.8.4409; Roeder RG, 2003, NAT MED, V9, P1239, DOI 10.1038/nm938; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Siegel R, 2006, CELL, V125, P761, DOI 10.1016/j.cell.2006.03.036; SMITH AV, 1993, GENETICS, V135, P817; Wang ZF, 1996, GENOME RES, V6, P688, DOI 10.1101/gr.6.8.688; White AE, 2007, MOL BIOL CELL, V18, P2491, DOI 10.1091/mbc.E06-11-1033; YEE SL, 1995, GENE DEV, V9, P1223; Yu FX, 2009, CELL CYCLE, V8, P773, DOI 10.4161/cc.8.5.7880; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	43	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9041	9053		10.1074/jbc.M109.075358	http://dx.doi.org/10.1074/jbc.M109.075358			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097756	hybrid, Green Published			2022-12-25	WOS:000275553700055
J	Cale, JM; Li, SH; Warnock, M; Su, EJ; North, PR; Sanders, KL; Puscau, MM; Emal, CD; Lawrence, DA				Cale, Jacqueline M.; Li, Shih-Hon; Warnock, Mark; Su, Enming J.; North, Paul R.; Sanders, Karen L.; Puscau, Maria M.; Emal, Cory D.; Lawrence, Daniel A.			Characterization of a Novel Class of Polyphenolic Inhibitors of Plasminogen Activator Inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAI-1 INHIBITOR; ENDOTHELIAL-CELLS; GENE-EXPRESSION; BINDING-SITE; TANNIC-ACID; IN-VITRO; TYPE-1; MECHANISM; MICE; THROMBOSIS	Plasminogen activator inhibitor type 1, (PAI-1) the primary inhibitor of the tissue-type (tPA) and urokinase-type (uPA) plasminogen activators, has been implicated in a wide range of pathological processes, making it an attractive target for pharmacologic inhibition. Currently available small-molecule inhibitors of PAI-1 bind with relatively low affinity and do not inactivate PAI-1 in the presence of its cofactor, vitronectin. To search for novel PAI-1 inhibitors with improved potencies and new mechanisms of action, we screened a library selected to provide a range of biological activities and structural diversity. Five potential PAI-1 inhibitors were identified, and all were polyphenolic compounds including two related, naturally occurring plant polyphenols that were structurally similar to compounds previously shown to provide cardiovascular benefit in vivo. Unique second generation compounds were synthesized and characterized, and several showed IC50 values for PAI-1 between 10 and 200 nM. This represents an enhanced potency of 10-1000-fold over previously reported PAI-1 inactivators. Inhibition of PAI-1 by these compounds was reversible, and their primary mechanism of action was to block the initial association of PAI-1 with a protease. Consistent with this mechanism and in contrast to previously described PAI-1 inactivators, these compounds inactivate PAI-1 in the presence of vitronectin. Two of the compounds showed efficacy in ex vivo plasma and one blocked PAI-1 activity in vivo in mice. These data describe a novel family of high affinity PAI-1-inactivating compounds with improved characteristics and in vivo efficacy, and suggest that the known cardiovascular benefits of dietary polyphenols may derive in part from their inactivation of PAI-1.	[Lawrence, Daniel A.] Univ Michigan, Sch Med, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [North, Paul R.; Sanders, Karen L.; Puscau, Maria M.; Emal, Cory D.] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA	University of Michigan System; University of Michigan; Eastern Michigan University	Lawrence, DA (corresponding author), 7301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	dlawrenc@umich.edu		Lawrence, Daniel/0000-0003-3126-1935	National Institutes of Health [HL55374, HL54710, HL089407]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089407, P01HL054710, R01HL055374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL55374, HL54710, and HL089407 (to D. A. L.).	Abou-Agag LH, 2001, ALCOHOL CLIN EXP RES, V25, P155, DOI 10.1111/j.1530-0277.2001.tb02193.x; Andreasen PA, 2007, CURR DRUG TARGETS, V8, P1030, DOI 10.2174/138945007781662346; Baxi S, 2008, THROMB HAEMOSTASIS, V99, P749, DOI 10.1160/TH07-11-0669; Bjorquist P, 1998, BIOCHEMISTRY-US, V37, P1227, DOI 10.1021/bi971554q; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Charlton PA, 1996, THROMB HAEMOSTASIS, V75, P808; Chen X, 2003, CLIN CANCER RES, V9, P3115; Clement Y, 2009, PREV MED, V49, P83, DOI 10.1016/j.ypmed.2009.05.005; Crandall DL, 2006, ARTERIOSCL THROM VAS, V26, P2209, DOI 10.1161/01.ATV.0000235605.51400.9d; Crandall DL, 2004, J THROMB HAEMOST, V2, P1422, DOI 10.1111/j.1538-7836.2004.00829.x; De Taeye BM, 2006, J BIOL CHEM, V281, P32796, DOI 10.1074/jbc.M606214200; Di Santo A, 2003, J THROMB HAEMOST, V1, P1089, DOI 10.1046/j.1538-7836.2003.00217.x; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Einholm AP, 2003, BIOCHEM J, V373, P723, DOI 10.1042/BJ20021880; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; FITZPATRICK DF, 1993, AM J PHYSIOL, V265, pH774; Folkes A, 2002, BIOORG MED CHEM LETT, V12, P1063, DOI 10.1016/S0960-894X(02)00078-1; Gardell SJ, 2007, MOL PHARMACOL, V72, P897, DOI 10.1124/mol.107.037010; Gils A, 2002, THROMB HAEMOSTASIS, V88, P137; Gohil R, 2009, THROMB HAEMOSTASIS, V102, P360, DOI 10.1160/TH09-01-0013; Gopalsamy A, 2004, BIOORG MED CHEM LETT, V14, P3477, DOI 10.1016/j.bmcl.2004.04.058; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Hennan JK, 2005, J PHARMACOL EXP THER, V314, P710, DOI 10.1124/jpet.105.084129; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Lawrence DA, 1997, J BIOL CHEM, V272, P7676, DOI 10.1074/jbc.272.12.7676; Leik CE, 2006, J THROMB HAEMOST, V4, P2710, DOI 10.1111/j.1538-7836.2006.02244.x; Liang A, 2005, THROMB RES, V115, P341, DOI 10.1016/j.thromres.2004.09.021; Lijnen HR, 2009, THROMB RES, V123, pS46, DOI 10.1016/S0049-3848(09)70143-4; Liu XQ, 2005, J NUTR, V135, P165, DOI 10.1093/jn/135.2.165; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Maquerlot F, 2006, AM J PATHOL, V169, P1624, DOI 10.2353/ajpath.2006.051053; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; Neve J, 1999, J NAT PROD, V62, P324, DOI 10.1021/np980286+; Pasten C, 2007, THROMB RES, V121, P59, DOI 10.1016/j.thromres.2007.02.001; Pinsky DJ, 1998, J CLIN INVEST, V102, P919, DOI 10.1172/JCI307; Rupin A, 2008, THROMB RES, V122, P265, DOI 10.1016/j.thromres.2007.11.006; Saremi A, 2008, AM J THER, V15, P265, DOI 10.1097/MJT.0b013e3180a5e61a; Schafer K, 2001, FASEB J, V15, P1840, DOI 10.1096/fj.00-0750fje; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Sobel BE, 2003, ARTERIOSCL THROM VAS, V23, P1979, DOI 10.1161/01.ATV.0000091250.53231.4D; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028; Van Gorkom BAP, 1999, ALIMENT PHARM THERAP, V13, P443; Vaughan DE, 2007, CURR DRUG TARGETS, V8, P962, DOI 10.2174/138945007781662364; Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741; Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019; Wu Qingyu, 2002, Current Drug Targets - Cardiovascular and Haematological Disorders, V2, P27, DOI 10.2174/1568006023337727; YEPES M, 2006, HEMOSTASIS THROMBOSI, P335	53	33	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7892	7902		10.1074/jbc.M109.067967	http://dx.doi.org/10.1074/jbc.M109.067967			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061381	Green Published, hybrid			2022-12-25	WOS:000275413800006
J	Cao, Y; Oswald, F; Wacker, SA; Bundschu, K; Knochel, W				Cao, Ying; Oswald, Franz; Wacker, Stephan A.; Bundschu, Karin; Knoechel, Walter			Reversal of Xenopus Oct25 Function by Disruption of the POU Domain Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; TRANSCRIPTION FACTOR; BETA-CATENIN; DNA-BINDING; MESODERM INDUCTION; EXPRESSION; GENE; PROTEINS; TRANSACTIVATION; REQUIREMENTS	Xenopus Oct25 is a POU family subclass V(POU-V) transcription factor with a distinct domain structure. To investigate the contribution of different domains to the function of Oct25, we have performed gain of function analyses. Deletions of the N- or C-terminal regions and of the Hox domain ( except its nuclear localization signal) result in mutants being indistinguishable from the wild type protein in the suppression of genes promoting germ layer formation. Deletion of the complete POU domain generates a mutant that has no effect on embryogenesis. However, disruption of the alpha-helical structures in the POU domain, even by a single amino acid mutation, causes reversal of protein function. Overexpression of such mutants leads to dorsalization of embryos and formation of secondary axial structures. The underlying mechanism is an enhanced transcription of genes coding for antagonists of the ligands for ventralizing bone morphogenetic protein and Wnt pathways. Corresponding deletion mutants of Xenopus Oct60, Oct91, or mouse Oct4 also exhibit such a dominant-negative effect. Therefore, our results reveal that the integrity of the POU domain is crucial for the function of POU-V transcription factors in the regulation of genes that promote germ layer formation.	[Cao, Ying; Wacker, Stephan A.; Knoechel, Walter] Univ Ulm, Inst Biochem, D-89081 Ulm, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; [Bundschu, Karin] Univ Ulm, Inst Biochem & Mol Biol, D-89081 Ulm, Germany; [Cao, Ying] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China	Ulm University; Ulm University; Ulm University; Nanjing University	Knochel, W (corresponding author), Univ Ulm, Inst Biochem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	walter.knoechel@uni-ulm.de	Oswald, Franz/AAO-9584-2020		Deutsche Forschungsgemeinschaft [SFB497/A1, SFB497/B9]; European Social Fund; Ministry of Science, Research; Arts Baden-Wurttemberg Margarete von Wrangell scholarship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Social Fund(European Social Fund (ESF)); Ministry of Science, Research; Arts Baden-Wurttemberg Margarete von Wrangell scholarship	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB497/A1 (to W. K.) and SFB497/B9 (to F. O.), the European Social Fund, and by the Ministry of Science, Research and the Arts Baden-Wurttemberg Margarete von Wrangell scholarship (to K. B.).	Agius E, 2000, DEVELOPMENT, V127, P1173; Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Cao Y, 2007, EMBO J, V26, P2942, DOI 10.1038/sj.emboj.7601736; Cao Y, 2006, MECH DEVELOP, V123, P614, DOI 10.1016/j.mod.2006.06.004; Cao Y, 2008, J BIOL CHEM, V283, P34168, DOI 10.1074/jbc.M803532200; Clements D, 1999, DEVELOPMENT, V126, P4903; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Frisch A, 1998, DEVELOPMENT, V125, P431; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; HINKLEY CS, 1992, MOL CELL BIOL, V12, P638, DOI 10.1128/MCB.12.2.638; Hussain SK, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-15; Hyde CE, 2000, DEVELOPMENT, V127, P1221; IMAGAWA M, 1991, NUCLEIC ACIDS RES, V19, P4503, DOI 10.1093/nar/19.16.4503; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 2003, BIOCHEM BIOPH RES CO, V302, P581, DOI 10.1016/S0006-291X(03)00218-3; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi S, 2000, DEVELOPMENT, V127, P5319; Vigano MA, 1996, NUCLEIC ACIDS RES, V24, P2112, DOI 10.1093/nar/24.11.2112; Wacker SA, 2004, DEV BIOL, V266, P123, DOI 10.1016/j.ydbio.2003.10.011; Wegner M, 1993, CURR OPIN CELL BIOL, V5, P488, DOI 10.1016/0955-0674(93)90015-I; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; White RJ, 2002, DEVELOPMENT, V129, P4867; WHITFIELD T, 1993, DEV BIOL, V155, P361, DOI 10.1006/dbio.1993.1035; WHITFIELD TT, 1995, DEV BIOL, V169, P759, DOI 10.1006/dbio.1995.1185; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	45	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8408	8421		10.1074/jbc.M109.064386	http://dx.doi.org/10.1074/jbc.M109.064386			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064932	hybrid, Green Published			2022-12-25	WOS:000275413800056
J	Chang, W; Wei, K; Jacobs, SS; Upadhyay, D; Weill, D; Rosen, GD				Chang, Wenteh; Wei, Ke; Jacobs, Susan S.; Upadhyay, Daya; Weill, David; Rosen, Glenn D.			SPARC Suppresses Apoptosis of Idiopathic Pulmonary Fibrosis Fibroblasts through Constitutive Activation of beta-Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LUNG FIBROBLASTS; PATHWAY; INHIBITOR-1; CELLS; MICE; MYOFIBROBLASTS; PROLIFERATION; TRANSITION; EXPRESSION	Idiopathic pulmonary fibrosis (IPF) is a poorly understood progressive disease characterized by the accumulation of scar tissue in the lung interstitium. A hallmark of the disease is areas of injury to type II alveolar epithelial cells with attendant accumulation of fibroblasts in areas called fibroblastic foci. In an effort to better characterize the lung fibroblast phenotype in IPF patients, we isolated fibroblasts from patients with IPF and looked for activation of signaling proteins, which could help explain the exaggerated fibrogenic response in IPF. We found that IPF fibroblasts constitutively expressed increased basal levels of SPARC, plasminogen activator inhibitor-1 (PAI-1), and active beta-catenin compared with control cells. Control of basal PAI-1 expression in IPF fibroblasts was regulated by SPARC-mediated activation of Akt, leading to inhibition of glycogen synthase kinase-3 beta and activation of beta-catenin. Additionally, IPF fibroblasts (but not control fibroblasts) were resistant to plasminogen-induced apoptosis and were sensitized to plasminogen-mediated apoptosis by inhibition of SPARC or beta-catenin. These findings uncover a newly discovered regulatory pathway in IPF fibroblasts that is characterized by elevated SPARC, giving rise to activated beta-catenin, which regulates expression of downstream genes, such as PAI-1, and confers an apoptosis-resistant phenotype. Disruption of this pathway may represent a novel therapeutic target in IPF.	[Chang, Wenteh; Wei, Ke; Jacobs, Susan S.; Upadhyay, Daya; Weill, David; Rosen, Glenn D.] Stanford Univ, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA	Stanford University	Rosen, GD (corresponding author), Stanford Univ, Med Ctr, Dept Med, Div Pulm & Crit Care Med, MC 5236,300 Pasteur Dr, Stanford, CA 94305 USA.	grosen@stanford.edu			SAMFUND, Division of Pulmonary and Critical Care, Department of Medicine, Stanford University	SAMFUND, Division of Pulmonary and Critical Care, Department of Medicine, Stanford University(Stanford University)	This work was supported by SAMFUND, Division of Pulmonary and Critical Care, Department of Medicine, Stanford University.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Cadigan KM, 2008, DEV CELL, V14, P322, DOI 10.1016/j.devcel.2008.02.006; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Clark CJ, 2008, J CELL BIOCHEM, V104, P721, DOI 10.1002/jcb.21688; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; HASSELAAR P, 1991, J BIOL CHEM, V266, P13178; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2008, AM J RESP CELL MOL, V38, P78, DOI 10.1165/rcmb.2007-0174OC; Huang SK, 2008, AM J RESP CRIT CARE, V177, P66, DOI 10.1164/rccm.200706-963OC; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jurukovski V, 2005, METH MOLEC MED, V117, P161; KAPANCI Y, 1995, AM J RESP CRIT CARE, V152, P2163, DOI 10.1164/ajrccm.152.6.8520791; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Kortlever RM, 2008, J BIOL CHEM, V283, P24308, DOI 10.1074/jbc.M803341200; Kortlever RM, 2006, CELL CYCLE, V5, P2697, DOI 10.4161/cc.5.23.3510; KUHN C, 1995, AM J PATHOL, V147, P1759; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Larsson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003220; Lazar MH, 2004, AM J RESP CELL MOL, V31, P672, DOI 10.1165/rcmb.2004-0025OC; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nie J, 2009, J BIOL CHEM, V284, P1279, DOI 10.1074/jbc.M808285200; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Ramasamy SK, 2007, DEV BIOL, V307, P237, DOI 10.1016/j.ydbio.2007.04.033; Shi-Wen Xu, 2006, Mol Cell Biol, V26, P5518, DOI 10.1128/MCB.00625-06; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhou XD, 2005, ARTHRITIS RHEUM-US, V52, P257, DOI 10.1002/art.20785; Zisman DA, 2005, METH MOLEC MED, V117, P3	45	82	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8196	8206		10.1074/jbc.M109.025684	http://dx.doi.org/10.1074/jbc.M109.025684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061390	Green Published, hybrid			2022-12-25	WOS:000275413800038
J	Kapeta, S; Chondrogianni, N; Gonos, ES				Kapeta, Suzanne; Chondrogianni, Niki; Gonos, Efstathios S.			Nuclear Erythroid Factor 2-mediated Proteasome Activation Delays Senescence in Human Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSIVE ELEMENTS; TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; SIGNALING PATHWAY; LIFE-SPAN; NF-E2-RELATED FACTOR-2; MOLECULAR-MECHANISMS; INDUCTION; KEAP1; EXPRESSION	Replicative senescence in human fibroblasts is accompanied with alterations of various biological processes, including the impaired function of the proteasome. The proteasome is responsible for the removal of both normal and damaged proteins. Due to its latter function, proteasome is also considered a representative secondary antioxidant cellular mechanism. Nrf2 is a basic transcription factor responsible for the regulation of the cellular antioxidant response that has also been shown to regulate several proteasome subunits in mice. We have established in this study the proteasome-related function of Nrf2 in human fibroblasts undergoing replicative senescence. We demonstrate that Nrf2 has a declined function in senescence, whereas its silencing leads to premature senescence. However, upon its activation by a novel Nrf2 inducer, elevated levels of proteasome activity and content are recorded only in cell lines possessing a functional Nrf2. Moreover, treatment by the Nrf2 inducer results in the enhanced survival of cells following oxidative stress, whereas continuous treatment leads to lifespan extension of human fibroblasts. Importantly the Nrf2-proteasome axis is functional in terminally senescent cultures as these cells retain their responsiveness to the Nrf2 stimuli. In conclusion, these findings open up new directions for future manipulation of the senescence phenotype.	[Kapeta, Suzanne; Chondrogianni, Niki; Gonos, Efstathios S.] Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, Athens 11635, Greece	National Hellenic Research Foundation	Chondrogianni, N (corresponding author), Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, 48 Vassileos Constantinou Ave, Athens 11635, Greece.	nikichon@eie.gr; sgonos@eie.gr			General Secretariat of Research and Technology [PENED 03EDelta9]; Ministry of Development; European Union [LSHM-CT-518230]	General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); Ministry of Development(Turkiye Cumhuriyeti Kalkinma Bakanligi); European Union(European Commission)	This work was supported by General Secretariat of Research and Technology Grant PENED 03E Delta 9 (75% from the European Union & 25% from the Ministry of Development, Measure 8.3/Operational Program "Competitiveness"/ 3rd Community Support Framework) and European Union "Proteomage" Grant LSHM-CT-518230 (to E. S. G.). Data presented in this article are patent protected (patent submission number 2009-0100242).	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048; Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Chondrogianni N, 2004, BIOGERONTOLOGY, V5, P55, DOI 10.1023/B:BGEN.0000017687.55667.42; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Chondrogianni N, 2000, EXP GERONTOL, V35, P721, DOI 10.1016/S0531-5565(00)00137-6; Chondrogianni N, 2008, AGING CELL, V7, P717, DOI 10.1111/j.1474-9726.2008.00425.x; Ciechanover A, 2005, ANGEW CHEM INT EDIT, V44, P5944, DOI 10.1002/anie.200501428; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dhawan V, 2004, MOL CELL BIOCHEM, V266, P109, DOI 10.1023/B:MCBI.0000049146.89059.53; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; DUGAN LL, 2005, SCI AGING KNOWLEDGE; Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Harlow E., 1999, USING ANTIBODIES LAB; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Katsiki M, 2007, REJUV RES, V10, P157, DOI 10.1089/rej.2006.0513; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kwak MK, 2007, FREE RADICAL BIO MED, V43, P809, DOI 10.1016/j.freeradbiomed.2007.05.029; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; Petropoulou C, 2000, ANN NY ACAD SCI, V908, P133; PLISKO A, 1983, J GERONTOL, V38, P513, DOI 10.1093/geronj/38.5.513; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Sakurai T, 2006, CHEM RES TOXICOL, V19, P1196, DOI 10.1021/tx0601105; Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wei P, 1998, J STEROID BIOCHEM, V64, P1, DOI 10.1016/S0022-1759(97)89907-3; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	58	152	158	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8171	8184		10.1074/jbc.M109.031575	http://dx.doi.org/10.1074/jbc.M109.031575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068043	Green Published, hybrid			2022-12-25	WOS:000275413800036
J	Priault, M; Hue, E; Marhuenda, F; Pilet, P; Oliver, L; Vallette, FM				Priault, Muriel; Hue, Erika; Marhuenda, Fanny; Pilet, Paul; Oliver, Lisa; Vallette, Francois M.			Differential Dependence on Beclin 1 for the Regulation of Pro-Survival Autophagy by Bcl-2 and Bcl-xL in HCT116 Colorectal Cancer Cells	PLOS ONE			English	Article							3-KINASE COMPLEX; APOPTOTIC DEATH; MECHANISMS; PROTEINS; DEPRIVATION; MACROAUTOPHAGY; NOMENCLATURE; PROGRESSION; INHIBITION; HOMOLOG	Autophagy is described to be involved in homeostasis, development and disease, both as a survival and a death process. Its involvement in cell death proceeds from interrelationships with the apoptotic pathway. We focused on survival autophagy and investigated its interplays with the apoptotic machinery. We found that while Mcl-1 remained ineffective, Bcl-2 and BclxL were required for starved cells to display a fully functional autophagic pathway as shown by proteolysis activity and detection of autophagic vesicles. Such pro-autophagic functions of Bcl-2 and Bcl-xL were independent of Bax. However they appeared to operate through non redundant mechanisms as Bcl-xL wielded a tighter control than Bcl-2 over the regulation of autophagy: unlike Bcl-2, Bcl-xL and Atg7 manipulation yielded identical phenotypes suggesting they could be components of the same signalling pathway; Bcl-xL subcellular localisation was modified upon starvation, and importantly Bcl-xL acted independently of Beclin 1. Still an intact BH3-binding site was required for Bcl-xL to stimulate a fully functional autophagic pathway. This study highlights that, in addition to their well-established anti-death function during apoptosis, Bcl-2 and Bcl-xL have a broader role in cell survival. Should Bcl-2 and Bcl-xL stand at the cross-roads between pro-survival and pro-death autophagy, this study introduces the new concept that the regulation of autophagy by Bcl-2 and Bcl-xL is adjusted according to its survival or death outcome.	[Priault, Muriel] CNRS, IBGC, UMR 5095, Bordeaux, France; [Priault, Muriel] Univ Bordeaux 2, F-33076 Bordeaux, France; [Hue, Erika; Marhuenda, Fanny; Oliver, Lisa; Vallette, Francois M.] INSERM, UMR 892, Nantes, France; [Hue, Erika; Marhuenda, Fanny; Oliver, Lisa; Vallette, Francois M.] Univ Nantes, Fac Med, Nantes, France; [Pilet, Paul] INSERM, UMR 791, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Priault, M (corresponding author), CNRS, IBGC, UMR 5095, Bordeaux, France.	muriel.priault@ibgc.cnrs.fr	Vallette, Francois/N-2361-2018; Oliver, Lisa J/L-3070-2015; Vallette, Francois M/K-9047-2015; Priault, Muriel/HHT-0658-2022; Paul, Pilet/A-3755-2015	Oliver, Lisa J/0000-0002-5588-7564; Vallette, Francois M/0000-0002-3296-8572; Priault, Muriel/0000-0001-8193-0389; Vallette, Francois/0000-0003-0802-0519; HUE, Erika/0000-0001-6930-3606	Institut National de la Santeet de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Universitede Nantes, Universitede Bordeaux, the Conseil Regional d'Aquitaine; Agence Nationale pour la Recherche	Institut National de la Santeet de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universitede Nantes, Universitede Bordeaux, the Conseil Regional d'Aquitaine; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Institut National de la Santeet de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), Universitede Nantes, Universitede Bordeaux, the Conseil Regional d'Aquitaine (to UMR 5095), and the Agence Nationale pour la Recherche (project MABA to F. V.). M. P. was supported by a post-doctoral fellowship from INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Canu N, 2005, J NEUROCHEM, V92, P1228, DOI 10.1111/j.1471-4159.2004.02956.x; Cardenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735; Ciechomska IA, 2009, ONCOGENE, V28, P2128, DOI 10.1038/onc.2009.60; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fengsrud M, 2000, BIOCHEM J, V352, P773, DOI 10.1042/0264-6021:3520773; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; LUO S, 2009, CELL DEATH DIFFER; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Niemann A, 2001, J HISTOCHEM CYTOCHEM, V49, P177, DOI 10.1177/002215540104900205; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735	43	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8755	10.1371/journal.pone.0008755	http://dx.doi.org/10.1371/journal.pone.0008755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090905	Green Submitted, gold, Green Published			2022-12-25	WOS:000273715000013
J	Coleman, SK; Cai, CL; Kalkkinen, N; Korpi, ER; Keinanen, K				Coleman, Sarah K.; Cai, Chunlin; Kalkkinen, Nisse; Korpi, Esa R.; Keinanen, Kari			Analysis of the Potential Role of GluA4 Carboxyl-Terminus in PDZ Interactions	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; SYNAPSE-ASSOCIATED PROTEIN-97; CALPAIN-MEDIATED PROTEOLYSIS; SURFACE EXPRESSION; POSTSYNAPTIC DENSITY; REGULATORY PROTEINS; HIPPOCAMPAL-NEURONS; GLUTAMATE-RECEPTOR; ACID RECEPTOR; GLUR1 SUBUNIT	Background: Specific delivery to synapses of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors with long-tailed subunits is believed to be a key event in many forms of activity-dependent changes in synaptic strength. GluA1, the best characterized long-tailed AMPA receptor subunit, contains a C-terminal class I PDZ binding motif, which mediates its interaction with scaffold and trafficking proteins, including synapse-associated protein 97 (SAP97). In GluA4, another long-tailed subunit implicated in synaptic plasticity, the PDZ motif is blocked by a single proline residue. This feature is highly conserved in vertebrates, whereas the closest invertebrate homologs of GluA4 have a canonical class I PDZ binding motif. In this work, we have examined the role of GluA4 in PDZ interactions. Methodology/Principal Findings: Deletion of the carboxy-terminal proline residue of recombinant GluA4 conferred avid binding to SAP97 in cultured cells as shown by coimmunoprecipitation, whereas wild-type GluA4 did not associate with SAP97. Native GluA4 and SAP97 coimmunoprecipitated from mouse brain independently of the GluA1 subunit, supporting the possibility of in vivo PDZ interaction. To obtain evidence for or against the exposure of the PDZ motif by carboxyterminal processing of native GluA4 receptors, we generated an antibody reagent specific for proline-deleted GluA4 C-terminus. Immunoprecipitation and mass spectrometric analyses indicated that the carboxyl-terminus of native GluA4 AMPA receptors is intact and that the postulated single-residue cleavage does not occur to any significant extent. Conclusion/Significance: We conclude that native GluA4 receptors are not capable of canonical PDZ interactions and that their association with SAP97 is likely to be indirect.	[Coleman, Sarah K.; Cai, Chunlin; Keinanen, Kari] Univ Helsinki, Dept Biosci, Div Biochem, Viikki Bioctr, Helsinki, Finland; [Kalkkinen, Nisse] Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland; [Korpi, Esa R.] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Coleman, SK (corresponding author), Univ Helsinki, Dept Biosci, Div Biochem, Viikki Bioctr, Helsinki, Finland.	kari.keinanen@helsinki.fi	Keinanen, Kari/E-9122-2010; Kalkkinen, Nisse EJ/B-3923-2010	Coleman, Sarah/0000-0002-1066-8296; Korpi, Esa R./0000-0003-0683-4009	Academy of Finland [110900]; Finnish Graduate School of Neurosciences	Academy of Finland(Academy of Finland); Finnish Graduate School of Neurosciences	This study was supported by the Academy of Finland, Grant number 110900 (K.K.) and by the Finnish Graduate School of Neurosciences (C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo IM, 2004, J NEUROCHEM, V91, P1322, DOI 10.1111/j.1471-4159.2004.02811.x; Bi XN, 1997, J NEUROCHEM, V68, P1484; Boehm J, 2006, LEARN MEMORY, V13, P562, DOI 10.1101/lm.253506; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Cai CL, 2006, J BIOL CHEM, V281, P4267, DOI 10.1074/jbc.M505886200; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2003, J NEUROSCI, V23, P798; Correia SS, 2003, J BIOL CHEM, V278, P6307, DOI 10.1074/jbc.M205587200; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; DeGiorgis JA, 2006, BRAIN CELL BIOL, V35, P239, DOI 10.1007/s11068-007-9017-0; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Jespersen LK, 2000, EUR J BIOCHEM, V267, P1382, DOI 10.1046/j.1432-1327.2000.01137.x; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Keifer J, 2003, EXP BRAIN RES, V151, P405, DOI 10.1007/s00221-003-1494-5; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Meyer EL, 2002, J BIOL CHEM, V277, P10869, DOI 10.1074/jbc.M106744200; Musleh W, 1997, P NATL ACAD SCI USA, V94, P9451, DOI 10.1073/pnas.94.17.9451; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Piccini A, 2002, J NEUROSCI, V22, P5387; QIN Y, GENES DEV, V19, P2000; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Thomas GM, 2008, EMBO J, V27, P361, DOI 10.1038/sj.emboj.7601969; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Uchino S, 2006, J NEUROCHEM, V97, P1203, DOI 10.1111/j.1471-4159.2006.03831.x; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	49	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8715	10.1371/journal.pone.0008715	http://dx.doi.org/10.1371/journal.pone.0008715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090852	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714600016
J	Kovalovsky, D; Pezzano, M; Ortiz, BD; Sant'Angelo, DB				Kovalovsky, Damian; Pezzano, Mark; Ortiz, Benjamin D.; Sant'Angelo, Derek B.			A Novel TCR Transgenic Model Reveals That Negative Selection Involves an Immediate, Bim-Dependent Pathway and a Delayed, Bim-Independent Pathway	PLOS ONE			English	Article							T-CELL-RECEPTOR; IMMATURE CD4(+)CD8(+) THYMOCYTES; AUTOREACTIVE THYMOCYTES; CLONAL DELETION; IN-VIVO; EXPRESSION; APOPTOSIS; NUR77; MICE; MECHANISMS	A complete understanding of negative selection has been elusive due to the rapid apoptosis and clearance of thymocytes in vivo. We report a TCR transgenic model in which expression of the TCR during differentiation occurs only after V(D) J-like recombination. TCR expression from this transgene closely mimics expression of the endogenous TCR alpha locus allowing for development that is similar to wild type thymocytes. This model allowed us to characterize the phenotypic changes that occurred after TCR-mediated signaling in self-reactive thymocytes prior to their deletion in a highly physiological setting. Self-reactive thymocytes were identified as being immature, activated and CD4(lo)CD8(lo). These cells had upregulated markers of negative selection and were apoptotic. Elimination of Bim reduced the apoptosis of self-reactive thymocytes, but it did not rescue their differentiation and the cells remained at the immature CD4(lo)CD8(lo) stage of development. These cells upregulate Nur77 and do not contribute to the peripheral T cell repertoire in vivo. Remarkably, development past the CD4(lo)CD8(lo) stage was possible once the cells were removed from the negatively selecting thymic environment. In vitro development of these cells occurred despite their maintenance of high intracellular levels of Nur77. Therefore, in vivo, negatively selected Bim-deficient thymocytes are eliminated after prolonged developmental arrest via a Bim-independent pathway that is dependent on the thymic microenvironment. These data newly reveal a layering of immediate, Bim-dependent, and delayed Bim-independent pathways that both contribute to elimination of self-reactive thymocytes in vivo.	[Kovalovsky, Damian; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA; [Pezzano, Mark] CUNY, Dept Biol, New York, NY 10021 USA; [Ortiz, Benjamin D.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); Memorial Sloan Kettering Cancer Center; Cornell University	Kovalovsky, D (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	santangd@mskcc.org			NIH/NCI [U56 CA96299]; NIH/NIAID [1SC1AI081527]; NCRR [RCMI G12RR0360]; NIH-NCRR [RR003037]; NCI [P30-CA 08748];  [T32-CA-09149-32];  [UL1RR024996]; NATIONAL CANCER INSTITUTE [R01CA196299, T32CA009149, U56CA096299, P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996, G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI081527, SC1AI104994] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH/NCI U56 CA96299 (M. P. and D. B. S); NIH/NIAID 1SC1AI081527; NCRR RCMI G12RR0360 (M. P.); T32-CA-09149-32 (D. K.), UL1RR024996 (B.D.O and D. B. S), NIH-NCRR grant RR003037 to Hunter College and NCI P30-CA 08748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN S, 2008, PLOS BIOL, V191, pCD4; Aifantis I, 2006, J EXP MED, V203, P1543, DOI 10.1084/jem.20051711; Amsen D, 1999, P NATL ACAD SCI USA, V96, P622, DOI 10.1073/pnas.96.2.622; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Baldwin TA, 2007, J IMMUNOL, V179, P837, DOI 10.4049/jimmunol.179.2.837; Blank C, 2003, J IMMUNOL, V171, P4574, DOI 10.4049/jimmunol.171.9.4574; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; CALNAN BJ, 1995, IMMUNITY, V3, P273; Cunningham NR, 2006, J IMMUNOL, V177, P6660, DOI 10.4049/jimmunol.177.10.6660; Dashtsoodol N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003688; Egawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001512; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Harrow F, 2005, J IMMUNOL, V175, P6659, DOI 10.4049/jimmunol.175.10.6659; HUGO P, 1991, EUR J IMMUNOL, V21, P835, DOI 10.1002/eji.1830210346; KERSH GJ, 1995, J IMMUNOL, V154, P1057; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Lu BF, 2006, IMMUNOL RES, V36, P275, DOI 10.1385/IR:36:1:275; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Mathis D, 2007, NAT REV IMMUNOL, V7, P645, DOI 10.1038/nri2136; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sohn SJ, 2008, EMBO J, V27, P1896, DOI 10.1038/emboj.2008.114; Sohn SJ, 2007, CURR OPIN IMMUNOL, V19, P510, DOI 10.1016/j.coi.2007.06.001; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; Strasser A, 2008, IMMUNOL CELL BIOL, V86, P57, DOI 10.1038/sj.icb.7100141; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; von Boehmer H, 2006, IMMUNOL REV, V209, P284, DOI 10.1111/j.0105-2896.2006.00346.x	43	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8675	10.1371/journal.pone.0008675	http://dx.doi.org/10.1371/journal.pone.0008675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072628	Green Published, gold			2022-12-25	WOS:000273554600027
J	Monteiro, S; Freitas, R; Rajasekhar, BT; Teixeira, AR; Ferreira, RB				Monteiro, Sara; Freitas, Regina; Rajasekhar, Baru T.; Teixeira, Artur R.; Ferreira, Ricardo B.			The Unique Biosynthetic Route from Lupinus beta-Conglutin Gene to Blad	PLOS ONE			English	Article							SEED STORAGE PROTEINS; UBIQUITIN-INTERACTING MOTIF; BEAN CANAVALIA-ENSIFORMIS; VIGNA-UNGUICULATA SEEDS; 3-DIMENSIONAL STRUCTURE; LEGUME SEEDS; GERMINATION; GLOBULINS; BINDING; MEMBERS	Background: During seed germination, beta-conglutin undergoes a major cycle of limited proteolysis in which many of its constituent subunits are processed into a 20 kDa polypeptide termed blad. Blad is the main component of a glycooligomer, accumulating exclusively in the cotyledons of Lupinus species, between days 4 and 12 after the onset of germination. Principal Findings: The sequence of the gene encoding b-conglutin precursor (1791 nucleotides) is reported. This gene, which shares 44 to 57% similarity and 20 to 37% identity with other vicilin-like protein genes, includes several features in common with these globulins, but also specific hallmarks. Most notable is the presence of an ubiquitin interacting motif (UIM), which possibly links the unique catabolic route of b-conglutin to the ubiquitin/proteasome proteolytic pathway. Significance: Blad forms through a unique route from and is a stable intermediary product of its precursor, b-conglutin, the major Lupinus seed storage protein. It is composed of 173 amino acid residues, is encoded by an intron-containing, internal fragment of the gene that codes for beta-conglutin precursor (nucleotides 394 to 913) and exhibits an isoelectric point of 9.6 and a molecular mass of 20,404.85 Da. Consistent with its role as a storage protein, blad contains an extremely high proportion of the nitrogen-rich amino acids.	[Monteiro, Sara; Freitas, Regina; Rajasekhar, Baru T.; Teixeira, Artur R.; Ferreira, Ricardo B.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Monteiro, Sara; Freitas, Regina; Ferreira, Ricardo B.] Univ Tecn Lisboa, Inst Super Agron, P-1100 Lisbon, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa	Monteiro, S (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	smonteiro@isa.utl.pt	Ferreira, Ricardo M S Boavida/B-9502-2011	Freitas, Regina/0000-0001-8605-2925; Monteiro, Sara/0000-0002-7069-0591; Ferreira, Ricardo Boavida/0000-0002-5027-7564	Fundacao para a Ciencia e a Tecnologia [XXI/BTL/6250/95, XXI/BPD/16398/98, PRAXIS/BPD/5712/2001, PRAXIS/3/3.2/HORT/2140/95]; Agencia de Inovacao	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Agencia de Inovacao	This work was financially supported by the Fundacao para a Ciencia e a Tecnologia (Grants nos. PRAXIS XXI/BTL/6250/95, PRAXIS XXI/BPD/16398/98 and PRAXIS/BPD/5712/2001, and project no. PRAXIS/3/3.2/HORT/2140/95) and the Agencia de Inovacao, S.A. (under project RESOIDIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOS P, 1985, EMBO J, V4, P1111, DOI 10.1002/j.1460-2075.1985.tb03747.x; Astwood JD, 2002, J ALLERGY CLIN IMMUN, V110, P26, DOI 10.1067/mai.2002.125690; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BLAGROVE R J, 1975, Australian Journal of Plant Physiology, V2, P13; BOYD SA, 1992, J MED CHEM, V35, P1735, DOI 10.1021/jm00088a007; CERLETTI P, 1983, PLANT FOOD HUM NUTR, V32, P145; CHLAN CA, 1986, PLANT MOL BIOL, V7, P475, DOI 10.1007/BF00020331; DECKERT JE, 1991, PLANT PHYSIOL BIOCH, V29, P269; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; DURANTI M, 1992, EUR J BIOCHEM, V206, P941, DOI 10.1111/j.1432-1033.1992.tb17004.x; Dure L 3rd, 1990, New Biol, V2, P487; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; FERREIRA RB, 1995, AUST J PLANT PHYSIOL, V22, P373, DOI 10.1071/PP9950373; FERREIRA RB, 2003, RECENT DEV CURR TOPI, V4, P139; FERREIRA RMB, 1995, J EXP BOT, V46, P211, DOI 10.1093/jxb/46.2.211; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Franco E, 1997, J AGR FOOD CHEM, V45, P3908, DOI 10.1021/jf9702813; Freitas RL, 2007, FOOD CHEM, V102, P323, DOI 10.1016/j.foodchem.2006.05.023; Frigerio L, 2000, PLANT PHYSIOL, V123, P1483, DOI 10.1104/pp.123.4.1483; Gallardo K, 2006, MEDICAGO TRUNCATULA; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GAYLER KR, 1984, BIOCHEM J, V221, P333, DOI 10.1042/bj2210333; Gomes VM, 1997, J AGR FOOD CHEM, V45, P4110, DOI 10.1021/jf960942g; Gruis D, 2002, PLANT CELL, V14, P2863, DOI 10.1105/tpc.005009; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; KERMODE AR, 1995, PLANTA, V197, P501, DOI 10.1007/BF00196672; KO TP, 1993, PLANT PHYSIOL, V101, P729, DOI 10.1104/pp.101.3.729; LAWRENCE MC, 1990, EMBO J, V9, P9, DOI 10.1002/j.1460-2075.1990.tb08074.x; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; Lilley GG, 1999, SEED PROTEINS, P315; MACEDO MLR, 1995, BRAZ J MED BIOL RES, V28, P183; MELO TS, 1994, PHYTOCHEMISTRY, V37, P641, DOI 10.1016/S0031-9422(00)90331-5; Monteiro S, 2001, J AGR FOOD CHEM, V49, P3999, DOI 10.1021/jf0013914; Mosse J., 1983, CHEM BIOCH LEGUMES, P111; NG JD, 1993, PLANT PHYSIOL, V101, P713, DOI 10.1104/pp.101.3.713; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Ramos Paula Cristina Rodrigues Dos, 1997, Planta (Heidelberg), V203, P26; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sales MP, 1996, BRAZ J MED BIOL RES, V29, P319; Santos CN, 1997, J AGR FOOD CHEM, V45, P3821, DOI 10.1021/jf970075v; Shutov AD, 1995, J MOL EVOL, V41, P1057, DOI 10.1007/BF00173187; Shutov AD, 2003, J EXP BOT, V54, P1645, DOI 10.1093/jxb/erg165; SPENCER ME, 1992, PLANTA, V186, P567, DOI 10.1007/BF00198037; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	47	20	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8542	10.1371/journal.pone.0008542	http://dx.doi.org/10.1371/journal.pone.0008542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066045	Green Published, gold			2022-12-25	WOS:000273338600006
J	Diavatopoulos, DA; Short, KR; Price, JT; Wilksch, JJ; Brown, LE; Briles, DE; Strugnell, RA; Wijburg, OL				Diavatopoulos, Dimitri A.; Short, Kirsty R.; Price, John T.; Wilksch, Jonathan J.; Brown, Lorena E.; Briles, David E.; Strugnell, Richard A.; Wijburg, Odilia L.			Influenza A virus facilitates Streptococcus pneumoniae transmission and disease	FASEB JOURNAL			English	Article						viral-bacterial interactions; pneumococcal disease; pandemic; respiratory infectious disease	NASOPHARYNGEAL COLONIZATION; PNEUMOCOCCAL PNEUMONIA; LETHAL SYNERGISM; INFECTION; MICE; SUSCEPTIBILITY; CHILDREN; ASSOCIATION; ANTIBODIES; RESOLUTION	Streptococcus pneumoniae (the pneumococcus) kills similar to 1.6 million people annually. Pneumococcal infections predominantly manifest as pneumonia, sepsis, meningitis, and otitis media. S. pneumoniae is also a member of the normal nasopharyngeal flora, colonizing up to 80% of children. Infection with influenza A virus (IAV) has been associated with both pneumococcal disease and transmission. However, to date no animal model has been available to investigate the role of IAV in the spread of S. pneumoniae. Here we investigate pneumococcal-influenza synergism with a particular focus on the role of IAV on pneumococcal transmission. Infant mice were colonized with S. pneumoniae and subsequently infected with IAV 3 d later. Using this novel model we show increased pneumococcal colonization and disease in the presence of IAV. Notably, in vivo imaging showed that IAV was essential for the transmission of S. pneumoniae from colonized ("index") mice to their naive cohoused littermates ("contacts"). Transmission occurred only when all mice were infected with IAV and was prevented when an IAV-neutralizing antibody was used to inhibit IAV replication in either index mice or contact mice. Together, these data provide novel insights into pneumococcal-influenza synergism and may indicate a previously unappreciated role of IAV in the spread of S. pneumoniae.-Diavatopoulos, D. A., Short, K. R., Price, J. T., Wilksch, J. J., Brown, L. E., Briles, D. E., Strugnell, R. A., Wijburg, O. L. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J. 24, 1789-1798 (2010). www.fasebj.org	[Diavatopoulos, Dimitri A.; Short, Kirsty R.; Wilksch, Jonathan J.; Brown, Lorena E.; Strugnell, Richard A.; Wijburg, Odilia L.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Price, John T.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Briles, David E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Strugnell, Richard A.; Wijburg, Odilia L.] Univ Melbourne, Australian Bacterial Pathogenesis Program, Parkville, Vic 3052, Australia	University of Melbourne; Monash University; University of Alabama System; University of Alabama Birmingham; University of Melbourne	Diavatopoulos, DA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Kapittelweg 29, NL-6525 EN Nijmegen, Netherlands.	d.diavatopoulos@cukz.umcn.nl	Diavatopoulos, Dimitri A/L-4269-2015	Diavatopoulos, Dimitri A/0000-0001-7065-7807; Short, Kirsty/0000-0003-4963-6184; Brown, Lorena/0000-0001-9342-909X; Price, John/0000-0002-8244-1023; Strugnell, Richard/0000-0003-0614-5641	National Health and Medical Research Council of Australia (NHMRC) [400011, 284214]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Mrs. Emily Fairmaid (University of Melbourne, Melbourne, VIC, Australia) for assistance with the HI tests, Dr. Reinhold Bruckner (University of Kaiserslautern, Kaiserslautern, Germany) for the kind gift of the pPP2 plasmid, Dr. Vyvyan Salisbury (University of the West of England, Bristol, UK) for providing the pAL2 plasmid, and Prof. J. Paton and Dr. D. Ogunniyi (University of Adelaide, Adelaide, SA, Australia) for technical help and advice. This work was supported by the National Health and Medical Research Council of Australia (NHMRC) grants 400011 and 284214. O.L.W. is an NHMRC R. D. Wright Fellow.	Adegbola RA, 2001, PEDIATR INFECT DIS J, V20, P718, DOI 10.1097/00006454-200107000-00018; [Anonymous], 2003, Weekly Epidemiological Record, V78, P110; Baumann M, 2000, MACROMOL MATER ENG, V280, P1, DOI 10.1002/1439-2054(20000801)280:1<1::AID-MAME1>3.0.CO;2-U; Beard SJ, 2002, ANTIMICROB AGENTS CH, V46, P538, DOI 10.1128/AAC.46.2.538-542.2002; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; BROWN LE, 1990, ARCH VIROL, V114, P1, DOI 10.1007/BF01311008; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Burghout P, 2007, J BACTERIOL, V189, P6540, DOI 10.1128/JB.00573-07; CONVERSE GM, 1977, J CLIN MICROBIOL, V5, P293; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; GWALTNEY JM, 1975, J INFECT DIS, V132, P62, DOI 10.1093/infdis/132.1.62; Halfmann A, 2007, FEMS MICROBIOL LETT, V268, P217, DOI 10.1111/j.1574-6968.2006.00584.x; Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035; Jansen AGSC, 2008, EPIDEMIOL INFECT, V136, P1448, DOI 10.1017/S0950268807000271; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Joyce EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-404; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Malley R, 1998, J INFECT DIS, V178, P878, DOI 10.1086/597600; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030028; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Mozdzanowska K, 2003, J VIROL, V77, P8322, DOI 10.1128/JVI.77.15.8322-8328.2003; NOVAK M, 1993, VACCINE, V11, P55, DOI 10.1016/0264-410X(93)90339-Y; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; ODIE EL, 1921, EPIDEMIC RESP DIS PN; OSLER W, 1901, PRINCIPLES PRACTICE; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; RYTEL MW, 1969, J GEN VIROL, V5, P429, DOI 10.1099/0022-1317-5-3-429; Sa-Leado R, 2008, J CLIN MICROBIOL, V46, P225, DOI 10.1128/JCM.01551-07; Sambrook J, 2001, MOL CLONING LAB MANU; SCHULMAN JL, 1962, NATURE, V195, P1129, DOI 10.1038/1951129a0; SCHULMAN JL, 1963, J EXP MED, V118, P257, DOI 10.1084/jem.118.2.257; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Smith-Vaughan Heidi, 2008, BMC Res Notes, V1, P112, DOI 10.1186/1756-0500-1-112; Speshock JL, 2007, INFECT IMMUN, V75, P3102, DOI 10.1128/IAI.01943-06; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; WADOWSKY RM, 1995, INFECT IMMUN, V63, P1153, DOI 10.1128/IAI.63.4.1153-1157.1995; Wu R, 2010, VET MICROBIOL, V142, P211, DOI 10.1016/j.vetmic.2009.09.068; Yagupsky P, 1998, J INFECT DIS, V177, P1003, DOI 10.1086/515239; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	45	134	134	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1789	1798		10.1096/fj.09-146779	http://dx.doi.org/10.1096/fj.09-146779			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20097876				2022-12-25	WOS:000278200000016
J	Dalton, WB; Yu, B; Yang, VW				Dalton, W. B.; Yu, B.; Yang, V. W.			p53 suppresses structural chromosome instability after mitotic arrest in human cells	ONCOGENE			English	Article						p53; cell cycle arrest; chromosomal instability; DNA damage; mitotic checkpoint; polypoidization	SPINDLE-ASSEMBLY CHECKPOINT; WILD-TYPE P53; DNA-DAMAGE; CYTOKINESIS FAILURE; CYCLE PROGRESSION; MAMMALIAN-CELLS; TP53 MUTATIONS; CANCER-CELLS; POSTMITOTIC CHECKPOINT; TELOMERE DYSFUNCTION	The p53 tumor suppressor inhibits the proliferation of cells that undergo prolonged activation of the mitotic checkpoint. However, the function of this antiproliferative response is not well defined. Here, we report that p53 suppresses structural chromosome instability after mitotic arrest in human cells. In both HCT116 colon cancer cells and normal human fibroblasts, DNA breaks occurred during mitotic arrest in a p53-independent manner, but p53 was required to suppress the proliferation and structural chromosome instability of the resulting polyploid cells. In contrast, cells made polyploid without mitotic arrest exhibited neither significant structural chromosome instability nor p53-dependent cell cycle arrest. We also observed that p53 suppressed both the frequency and structural chromosome instability of spontaneous polyploids in HCT116 cells. Furthermore, time-lapse videomicroscopy revealed that polyploidization of p53(-/-) HCT116 cells is frequently accompanied by mitotic arrest. These data suggest that a function of the p53-dependent postmitotic response is the prevention of structural chromosome instability after prolonged activation of the mitotic checkpoint. Accordingly, our study suggests a novel mechanism of tumor suppression for p53, as well as a potential function for p53 in the outcome of antimitotic chemotherapy. Oncogene (2010) 29, 1929-1940; doi:10.1038/onc.2009.477; published online 11 January 2010	[Dalton, W. B.; Yu, B.; Yang, V. W.] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Dalton, W. B.; Yu, B.; Yang, V. W.] Emory Univ, Sch Med, Biochem Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA; [Yang, V. W.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Yang, VW (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, 201 Whitehead Res Bldg,615 Michael St, Atlanta, GA 30322 USA.	vyang@emory.edu	yu, bing/B-3078-2009; Yu, Bing/AAF-9459-2019; Dalton, William/M-7944-2017	yu, bing/0000-0002-7259-8190; Yu, Bing/0000-0002-7259-8190; Dalton, William/0000-0002-1314-0534	National Institutes of Health [DK52230, DK64399, CA84197, 5T32GM008367-18, 5T32GM008367]; NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK052230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169, T32GM008367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D Pallas, P Doetsch, D Jones, A Corbett, G Davis, and M Wiltenburg for discussion and support, and B Vogelstein for providing cell lines. This work was supported in part by grants from the National Institutes of Health to VWY (DK52230, DK64399, and CA84197) and to WBD (5T32GM008367-18). This work was supported in part by grants from the National Institutes of Health to VWY (DK52230, DK64399, and CA84197) and to WBD (5T32GM008367).	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; BISCHOFF FZ, 1990, CANCER RES, V50, P7979; Blagosklonny MV, 2006, CELL CYCLE, V5, P971, DOI 10.4161/cc.5.9.2711; BOUFFLER SD, 1995, CANCER RES, V55, P3883; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bunz F, 2002, CANCER RES, V62, P1129; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; Chan YW, 2008, J BIOL CHEM, V283, P15716, DOI 10.1074/jbc.M800629200; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Curtis LJ, 2000, J PATHOL, V192, P440; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Dalton WB, 2009, FUTURE ONCOL, V5, P1363, DOI 10.2217/FON.09.118; De Angelis PM, 1999, BRIT J CANCER, V80, P526; Di Leonardo A, 1997, CANCER RES, V57, P1013; Eshleman JR, 1998, ONCOGENE, V17, P719, DOI 10.1038/sj.onc.1201986; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galmarini CM, 2001, BRIT J CANCER, V85, P902, DOI 10.1054/bjoc.2001.2017; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Hastak K, 2008, P NATL ACAD SCI USA, V105, P6314, DOI 10.1073/pnas.0802080105; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; IKEUCHI T, 1972, J CELL BIOL, V52, P97, DOI 10.1083/jcb.52.1.97; Jong YJ, 2004, CANCER GENET CYTOGEN, V148, P55, DOI 10.1016/S0165-4608(03)00205-X; KATO H, 1967, J CELL BIOL, V34, P35, DOI 10.1083/jcb.34.1.35; Kienitz A, 2005, ONCOGENE, V24, P4301, DOI 10.1038/sj.onc.1208589; Kim KT, 2004, J BIOL CHEM, V279, P38597, DOI 10.1074/jbc.M400781200; Kleivi K, 2005, J PATHOL, V207, P14, DOI 10.1002/path.1812; Koller E, 2006, CANCER RES, V66, P2059, DOI 10.1158/0008-5472.CAN-05-1531; LALLE P, 1995, ONCOGENE, V10, P2447; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Pantic M, 2006, ONCOGENE, V25, P4413, DOI 10.1038/sj.onc.1209486; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SAVAGE JRK, 1976, J MED GENET, V13, P103, DOI 10.1136/jmg.13.2.103; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stevens JB, 2007, CANCER RES, V67, P7686, DOI 10.1158/0008-5472.CAN-07-0472; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Stukenberg PT, 2004, J CELL BIOL, V165, P607, DOI 10.1083/jcb.200405089; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Tao WK, 2007, MOL CELL BIOL, V27, P689, DOI 10.1128/MCB.01505-06; THIBODEAU A, 1991, EXP CELL RES, V195, P145, DOI 10.1016/0014-4827(91)90510-2; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Uetake Y, 2007, CURR BIOL, V17, P2081, DOI 10.1016/j.cub.2007.10.065; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vogel C, 2004, ONCOGENE, V23, P6845, DOI 10.1038/sj.onc.1207860; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Wang ZZ, 2007, MUTAT RES-FUND MOL M, V617, P98, DOI 10.1016/j.mrfmmm.2007.01.003; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Westra JL, 2005, GENE CHROMOSOME CANC, V43, P194, DOI 10.1002/gcc.20148; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yoon HS, 2005, ONCOGENE, V24, P4017, DOI 10.1038/sj.onc.1208576; Zhang H, 2002, J BIOL CHEM, V277, P43648, DOI 10.1074/jbc.M203214200	76	29	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	13					1929	1940		10.1038/onc.2009.477	http://dx.doi.org/10.1038/onc.2009.477			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20062083	Green Accepted			2022-12-25	WOS:000276199600006
J	Kwak, YD; Wang, B; Pan, W; Xu, HX; Jiang, XJ; Liao, FF				Kwak, Young-Don; Wang, Bin; Pan, Wei; Xu, Huaxi; Jiang, Xuejun; Liao, Francesca-Fang			Functional Interaction of Phosphatase and Tensin Homologue (PTEN) with the E3 Ligase NEDD4-1 during Neuronal Response to Zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; PYRROLIDINE DITHIOCARBAMATE; PROTEIN STABILITY; UBIQUITIN LIGASE; NUCLEAR PTEN; CELL-DEATH; KAPPA-B; PHOSPHORYLATION; ACTIVATION; EXPRESSION	The contribution of zinc-mediated neuronal death in the process of both acute and chronic neurodegeneration has been increasingly appreciated. Phosphatase and tensin homologue, deleted on chromosome 10 (PTEN), the major tumor suppressor and key regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, plays a critical role in neuronal death in response to various insults. NEDD4-1-mediated PTEN ubiquitination and subsequent degradation via the ubiquitin proteosomal system have recently been demonstrated to be the important regulatory mechanism for PTEN in several cancer types. We now demonstrate that PTEN is also the key mediator of the PI3K/Akt pathway in the neuronal response to zinc insult. We used primary cortical neurons and neuroblastoma N2a cells to show that zinc treatment results in a reduction of the PTEN protein level in parallel with increased NEDD4-1 gene/protein expression. The reduced PTEN level is associated with an activated PI3K pathway as determined by elevated phosphorylation of both Akt and GSK-3 as well as by the attenuating effect of a specific PI3K inhibitor (wortmannin). The reduction of PTEN can be attributed to increased protein degradation via the ubiquitin proteosomal system, as we show NEDD4-1 to be the major E3 ligase responsible for PTEN ubiquitination in neurons. Moreover, PTEN and NEDD4-1 appear to be able to counter-regulate each other to mediate the neuronal response to zinc. This reciprocal regulation requires the PI3K signaling pathway, suggesting a feedback loop mechanism. This study demonstrates that NEDD4-1-mediated PTEN ubiquitination is crucial in the regulation of PI3K/Akt signaling by PTEN during the neuronal response to zinc, which may represent a common mechanism in neurodegeneration.	[Wang, Bin; Liao, Francesca-Fang] Univ Tennessee, Dept Pharmacol, Hlth Sci Ctr, Coll Med, Memphis, TN 38163 USA; [Kwak, Young-Don; Xu, Huaxi] Burnham Inst Med Res, Neurodegenerat Dis Program, La Jolla, CA 92037 USA; [Pan, Wei; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	University of Tennessee System; University of Tennessee Health Science Center; Sanford Burnham Prebys Medical Discovery Institute; Memorial Sloan Kettering Cancer Center	Liao, FF (corresponding author), Univ Tennessee, Dept Pharmacol, Hlth Sci Ctr, Coll Med, 874 Union Ave, Memphis, TN 38163 USA.	ykwak@uthsc.edu; fliao@uthsc.edu	Xu, Huaxi/AAV-7177-2021; Wang, Bin/K-3986-2015	Wang, Bin/0000-0001-9032-5009	National Institutes of Health [R01 NS054880, AG031893]; American Cancer Society; Geoffrey Beene Cancer Research Fund; Alzheimer Association Investigator Initiated Research [IIRG-06-26070]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046673, R01NS054880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030197, R01AG021173, R01AG031893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Geoffrey Beene Cancer Research Fund; Alzheimer Association Investigator Initiated Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS054880 and AG031893 (to F.-F.L.). This work was also supported by American Cancer Society grant (to X.J.), Geoffrey Beene Cancer Research Fund (to X.J.), and the Alzheimer Association Investigator Initiated Research Award IIRG-06-26070 (to F.-F.L.).	Alirezaei M, 1999, J BIOL CHEM, V274, P32433, DOI 10.1074/jbc.274.45.32433; Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Chung KC, 2000, J NEUROSCI RES, V59, P117, DOI 10.1002/(SICI)1097-4547(20000101)59:1<117::AID-JNR14>3.0.CO;2-Q; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; FREDERICKSON CJ, 1983, BRAIN RES, V273, P335, DOI 10.1016/0006-8993(83)90858-2; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Hwang SR, 2008, FEBS LETT, V582, P2527, DOI 10.1016/j.febslet.2008.06.017; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Kim JH, 2000, ARCH BIOCHEM BIOPHYS, V382, P72, DOI 10.1006/abbi.2000.1996; Kim S, 2000, J BIOL CHEM, V275, P25979, DOI 10.1074/jbc.M001975200; Kim SS, 2008, APMIS, V116, P779, DOI 10.1111/j.1600-0463.2008.00999.x; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Ma T, 2009, J NEUROSCI, V29, P11226, DOI 10.1523/JNEUROSCI.6150-08.2009; Min YK, 2003, J NEUROSCI RES, V71, P689, DOI 10.1002/jnr.10520; Min YK, 2007, EXP CELL RES, V313, P312, DOI 10.1016/j.yexcr.2006.10.013; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Qian AQ, 2006, J NEUROSCI, V26, P10899, DOI 10.1523/JNEUROSCI.3453-06.2006; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samet JM, 1998, AM J PHYSIOL-LUNG C, V275, pL551, DOI 10.1152/ajplung.1998.275.3.L551; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Tachibana M, 2002, CANCER-AM CANCER SOC, V94, P1955, DOI 10.1002/cncr.0678; Teng DHF, 1997, CANCER RES, V57, P5221; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891; Zhou MX, 2003, CANCER RES, V63, P6357	57	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9847	9857		10.1074/jbc.M109.091637	http://dx.doi.org/10.1074/jbc.M109.091637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100827	Green Published, hybrid			2022-12-25	WOS:000276165900056
J	Birukou, I; Schweers, RL; Olson, JS				Birukou, Ivan; Schweers, Rachel L.; Olson, John S.			Distal Histidine Stabilizes Bound O-2 and Acts as a Gate for Ligand Entry in Both Subunits of Adult Human Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURES; SITE-DIRECTED MUTAGENESIS; RATE CONSTANTS; CO BINDING; CARBON-MONOXIDE; HEME-PROTEINS; BETA-SUBUNITS; R-STATE; MYOGLOBIN; OXYGEN	The role of the distal histidine in regulating ligand binding to adult human hemoglobin (HbA) was re-examined systematically by preparing His(E7) to Gly, Ala, Leu, Gln, Phe, and Trp mutants of both Hb subunits. Rate constants for O-2, CO, and NO binding were measured using rapid mixing and laser photolysis experiments designed to minimize autoxidation of the unstable apolar E7 mutants. Replacing His(E7) with Gly, Ala, Leu, or Phe causes 20-500-fold increases in the rates of O-2 dissociation from either Hb subunit, demonstrating unambiguously that the native His(E7) imidazole side chain forms a strong hydrogen bond with bound O-2 in both the alpha and beta chains (Delta G(His(E7)H-bond) approximate to -8 kJ/mol). As the size of the E7 amino acid is increased from Gly to Phe, decreases in k(O2)', k(NO)', and calculated bimolecular rates of CO entry (k(entry)') are observed. Replacing His(E7) with Trp causes further decreases in k(O2)', k(NO)', and k(entry)' to 1-2 mu M-1 s(-1) in beta subunits, whereas ligand rebinding to alpha Trp(E7) subunits after photolysis is markedly biphasic, with fast k(O2)', k(CO)', and k(NO)' values approximate to 150 mu M-1 s(-1) and slow rate constants approximate to 0.1 to 1 mu M-1 s(-1). Rapid bimolecular rebinding to an open alpha subunit conformation occurs immediately after photolysis of the alpha Trp(E7) mutant at high ligand concentrations. However, at equilibrium the closed alpha Trp(E7) side chain inhibits the rate of ligand binding > 200-fold. These data suggest strongly that the E7 side chain functions as a gate for ligand entry in both HbA subunits.	[Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, WM Keck Ctr Computat Biol, Houston, TX 77005 USA	Rice University; Rice University	Olson, JS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA.	olson@rice.edu		Olson, John/0000-0002-0760-5403	National Institutes of Health [GM035649, HL047020]; Robert A. Welch Foundation [C0612]; Welch Foundation; Houston Area Molecular Biophysics [GM 80820]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, F32GM080820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Welch Foundation(The Welch Foundation); Houston Area Molecular Biophysics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM035649 and HL047020. This work was also supported by Grant C0612 from The Robert A. Welch Foundation (to J. S. O.), a Welch Foundation predoctoral fellowship (to I. B.), and Predoctoral Training Fellowship Grant GM 80820 from the Houston Area Molecular Biophysics (to R. L. S.).	CARLSON ML, 1994, BIOCHEMISTRY-US, V33, P10597, DOI 10.1021/bi00201a005; CARVER TE, 1990, J BIOL CHEM, V265, P20007; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; Elber R, 2008, J PHYS CHEM B, V112, P6147, DOI 10.1021/jp0769779; Franzen S, 2002, J AM CHEM SOC, V124, P13271, DOI 10.1021/ja017708d; FRIEDMAN JM, 1985, SCIENCE, V229, P187, DOI 10.1126/science.4012316; GIBSON QH, 1986, J BIOL CHEM, V261, P228; Hargrove MS, 1997, J MOL BIOL, V266, P1032, DOI 10.1006/jmbi.1996.0833; Hvitved AN, 2001, J BIOL CHEM, V276, P34714, DOI 10.1074/jbc.M105175200; IKEDASAITO M, 1993, J BIOL CHEM, V268, P6855; JAMESON GB, 1980, J AM CHEM SOC, V102, P3224, DOI 10.1021/ja00529a055; JONGEWARD KA, 1988, J AM CHEM SOC, V110, P380, DOI 10.1021/ja00210a011; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; LIN SH, 1990, BIOCHEMISTRY-US, V29, P5562, DOI 10.1021/bi00475a021; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; Lukin JA, 2000, P NATL ACAD SCI USA, V97, P10354, DOI 10.1073/pnas.190254697; Maillett DH, 2008, BIOCHEMISTRY-US, V47, P10551, DOI 10.1021/bi800816v; MATHEWS AJ, 1991, J BIOL CHEM, V266, P21631; MATHEWS AJ, 1989, J BIOL CHEM, V264, P16573; MATHEWS AJ, 1994, METHOD ENZYMOL, V232, P363; MCKINNIE RE, 1981, J BIOL CHEM, V256, P8928; MOMENTEAU M, 1994, CHEM REV, V94, P659, DOI 10.1021/cr00027a006; MORIKIS D, 1989, BIOCHEMISTRY-US, V28, P4791, DOI 10.1021/bi00437a041; Nienhaus K, 2005, J AM CHEM SOC, V127, P40, DOI 10.1021/ja0466917; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; OLSON JS, 1987, J BIOL CHEM, V262, P12930; Olson JS, 2003, METH MOLEC MED, V82, P65; OLSON JS, 1983, J AM CHEM SOC, V105, P1522, DOI 10.1021/ja00344a019; OLSON JS, 1988, NATURE, V336, P265, DOI 10.1038/336265a0; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; Park ES, 2002, J PHYS CHEM B, V106, P5800, DOI 10.1021/jp0203043; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PARKHURST KM, 1992, INT J BIOCHEM, V24, P993, DOI 10.1016/0020-711X(92)90109-E; PAULING L, 1964, NATURE, V203, P182, DOI 10.1038/203182b0; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1966, J MOL BIOL, V21, P199, DOI 10.1016/0022-2836(66)90088-X; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Salter MD, 2008, J BIOL CHEM, V283, P35689, DOI 10.1074/jbc.M805727200; Scherlis DA, 2001, J AM CHEM SOC, V123, P8436, DOI 10.1021/ja015665v; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Slebodnick C, 1997, J BIOL INORG CHEM, V2, P521, DOI 10.1007/s007750050165; Smagghe BJ, 2009, BIOPOLYMERS, V91, P1083, DOI 10.1002/bip.21256; Spiro TG, 2001, ACCOUNTS CHEM RES, V34, P137, DOI 10.1021/ar000108j; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; Thorsteinsson MV, 1999, BIOCHEMISTRY-US, V38, P2117, DOI 10.1021/bi9819172; TIAN WD, 1993, J MOL BIOL, V233, P155, DOI 10.1006/jmbi.1993.1491; Tian WD, 1996, BIOCHEMISTRY-US, V35, P3487, DOI 10.1021/bi952474u; TRAYLOR TG, 1983, J BIOL CHEM, V258, P2147; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Unno M, 1998, J AM CHEM SOC, V120, P2670, DOI 10.1021/ja973293d; Unzai S, 1998, J BIOL CHEM, V273, P23150, DOI 10.1074/jbc.273.36.23150; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123	64	82	82	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8840	8854		10.1074/jbc.M109.053934	http://dx.doi.org/10.1074/jbc.M109.053934			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080971	Green Published, hybrid			2022-12-25	WOS:000275553700036
J	Piccinini, AM; Knebl, K; Rek, A; Wildner, G; Diedrichs-Mohring, M; Kungl, AJ				Piccinini, Anna Maria; Knebl, Kerstin; Rek, Angelika; Wildner, Gerhild; Diedrichs-Moehring, Maria; Kungl, Andreas J.			Rationally Evolving MCP-1/CCL2 into a Decoy Protein with Potent Anti-inflammatory Activity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CC-CHEMOKINE; GLYCOSAMINOGLYCAN BINDING; CHEMOTACTIC PROTEIN-1; HEPARAN-SULFATE; EXPRESSION; RECEPTOR; MICE; ANTAGONIST; ARTHRITIS	Leukocyte recruitment from the blood into injured tissues during inflammatory diseases is the result of sequential events involving chemokines binding to their GPC receptors as well as to their glycosaminoglycan (GAG) co-receptors. The induction and the crucial role of MCP-1/CCL2 in the course of diseases that feature monocyte-rich infiltrates have been validated in many animal models, and several MCP-1/CCL2 as well as CCR2 antagonists have since been generated. However, despite some of them being shown to be efficacious in a number of animal models, many failed in clinical trials, and therapeutically interfering with the activity of this chemokine is not yet possible. We have therefore generated novel MCP-1/CCL2 mutants with increased GAG binding affinity and knocked out CCR2 activity, which were designed to interrupt the MCP-1/CCL2-related signaling cascade. We provide evidence that our lead mutant MCP-1(Y13A/S21K/Q23R) exhibits a 4-fold higher affinity toward the natural MCP-1 GAG ligand heparan sulfate and that it shows a complete deficiency in activating CCR2 on THP-1 cells. Furthermore, a significantly longer residual time on GAG ligands was observed by surface plasmon resonance. Finally, we were able to show that MCP-1(Y13A/S21K/Q23R) had a mild ameliorating effect on experimental autoimmune uveitis and that a marginal effect on oral tolerance in the group co-fed with Met-MCP-1(Y13A/S21K/Q23R) plus immunogenic peptide PDSAg was observed. These results suggest that disrupting wild type chemokine-GAG interactions by a chemokine-based antagonist can result in anti-inflammatory activity that could have potential therapeutic implications.	[Piccinini, Anna Maria; Knebl, Kerstin; Rek, Angelika; Kungl, Andreas J.] ProtAffin Biotechnol AG, A-8020 Graz, Austria; [Wildner, Gerhild; Diedrichs-Moehring, Maria] Clin Ludwig Maximilians Univ, Dept Ophthalmol, Immunobiol Sect, D-80336 Munich, Germany; [Kungl, Andreas J.] Graz Univ, Inst Pharmaceut Sci, A-8010 Graz, Austria	University of Munich; University of Graz	Kungl, AJ (corresponding author), ProtAffin Biotechnol AG, Reininghausstr 13A, A-8020 Graz, Austria.	akungl@protaffin.com		Kungl, Andreas/0000-0003-3362-797X; Piccinini, Anna Maria/0000-0002-7588-0415	Austrian Science Fund, FWF [P17872-B09]	Austrian Science Fund, FWF(Austrian Science Fund (FWF))	2This work was supported by the Austrian Science Fund, FWF Project P17872-B09.	Alcami A, 1998, J IMMUNOL, V160, P624; Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boring L, 1996, J BIOL CHEM, V271, P7551, DOI 10.1074/jbc.271.13.7551; Brodmerkel CM, 2005, J IMMUNOL, V175, P5370, DOI 10.4049/jimmunol.175.8.5370; Bruhl H, 2004, J IMMUNOL, V172, P890, DOI 10.4049/jimmunol.172.2.890; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; DESMET MD, 1993, J AUTOIMMUN, V6, P587, DOI 10.1006/jaut.1993.1048; Diedrichs-Mohring M, 2005, J NEUROIMMUNOL, V164, P22, DOI 10.1016/j.jneuroim.2005.02.023; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Gong JH, 2004, RHEUMATOLOGY, V43, P39, DOI 10.1093/rheumatology/keg459; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Grewal IS, 1997, J IMMUNOL, V159, P401; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hohensinner PJ, 2006, FEBS LETT, V580, P3532, DOI 10.1016/j.febslet.2006.05.043; Horvath C, 2002, CIRC RES, V90, P488, DOI 10.1161/hh0402.105956; HOSAKA S, 1994, CLIN EXP IMMUNOL, V97, P451; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MacDermott RP, 1999, J CLIN IMMUNOL, V19, P266, DOI 10.1023/A:1020583306627; Mo JS, 1999, EXP EYE RES, V68, P333, DOI 10.1006/exer.1998.0618; Nakano K, 2007, ATHEROSCLEROSIS, V194, P309, DOI 10.1016/j.atherosclerosis.2006.10.029; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Parish CR, 2005, NAT IMMUNOL, V6, P861, DOI 10.1038/ni0905-861; Potzinger H, 2006, BIOCHEM SOC T, V34, P435, DOI 10.1042/BST0340435; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; ROBINSON E, 1995, CLIN EXP IMMUNOL, V101, P398; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Thurau SR, 2004, INT IMMUNOL, V16, P1573, DOI 10.1093/intimm/dxh158; Tuaillon N, 2002, INVEST OPHTH VIS SCI, V43, P1493; YLA HS, 1991, P NATL ACAD SCI USA, V88, P5252; Yoshida Y, 2007, BRIT J OPHTHALMOL, V91, P737, DOI 10.1136/bjo.2006.109843; Yu YH, 2005, J BIOL CHEM, V280, P32200, DOI 10.1074/jbc.M505738200	53	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8782	8792		10.1074/jbc.M109.043299	http://dx.doi.org/10.1074/jbc.M109.043299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097750	Green Published, hybrid			2022-12-25	WOS:000275553700030
J	Reed, JR; Eyer, M; Backes, WL				Reed, James R.; Eyer, Marilyn; Backes, Wayne L.			Functional Interactions between Cytochromes P450 1A2 and 2B4 Require Both Enzymes to Reside in the Same Phospholipid Vesicle EVIDENCE FOR PHYSICAL COMPLEX FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CATALYTIC-ACTIVITY; P-450 REDUCTASE; LIVER-MICROSOMES; NADPH-CYTOCHROME-P-450 REDUCTASE; RABBIT LIVER; MOLECULAR-INTERACTIONS; CROSS-LINKING; LIVING CELLS; NADPH	Previous studies have shown that the combined presence of two cytochrome P450 enzymes (P450s) can affect the function of both enzymes, results that are consistent with the formation of heteromeric P450.P450 complexes. The goal of this study was to provide direct evidence for a physical interaction between P450 1A2 (CYP1A2) and P450 2B4 (CYP2B4), by determining if the interactions required both enzymes to reside in the same lipid vesicles. When NADPH-cytochrome P450 reductase (CPR) and a single P450 were incorporated into separate vesicles, extremely slow reduction rates were observed, demonstrating that the enzymes were anchored in the vesicles. Next, several reconstituted systems were prepared: 1) CPR.CYP1A2, 2) CPR.CYP2B4, 3) a mixture of CPR.CYP1A2 vesicles with CPR.CYP2B4 vesicles, and 4) CPR.CYP1A2.CYP2B4 in the same vesicles (ternary system). When in the ternary system, CYP2B4-mediated metabolism was significantly inhibited, and CYP1A2 activities were stimulated by the presence of the alternate P450. In contrast, P450s in separate vesicles were unable to interact. These data demonstrate that P450s must be in the same vesicles to alter metabolism. Additional evidence for a physical interaction among CPR, CYP1A2, and CYP2B4 was provided by cross-linking with bis(sulfosuccinimidyl) suberate. The results showed that after cross-linking, antibody to CYP1A2 was able to co-immunoprecipitate CYP2B4 but only when both proteins were in the same phospholipid vesicles. These results clearly demonstrate that the alterations in P450 function require both P450s to be present in the same vesicles and support a mechanism whereby P450s form a physical complex in the membrane.	[Backes, Wayne L.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Backes, WL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, 533 Bolivar St, New Orleans, LA 70112 USA.				National Institutes of Health, NIEHS, United States Public Health Service [R01-ES004344]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004344] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS, United States Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)United States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, United States Public Health Service Grant R01-ES004344.	ALSTON K, 1991, J BIOL CHEM, V266, P735; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Backes WL, 1998, BIOCHEMISTRY-US, V37, P12852, DOI 10.1021/bi980674a; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; BASKIN LS, 1982, BIOCHIM BIOPHYS ACTA, V684, P263, DOI 10.1016/0005-2736(82)90015-3; BASKIN LS, 1980, BIOCHEMISTRY-US, V19, P2260, DOI 10.1021/bi00551a041; CAUSEY KM, 1990, MOL PHARMACOL, V38, P134; CAWLEY GF, 1995, BIOCHEMISTRY-US, V34, P1244, DOI 10.1021/bi00004a018; Coon M J, 1978, Methods Enzymol, V52, P109; Davydov DR, 2000, BIOCHEM BIOPH RES CO, V276, P1005, DOI 10.1006/bbrc.2000.3596; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; Davydov DR, 1996, BIOCHIMIE, V78, P734, DOI 10.1016/S0300-9084(97)82531-X; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; de Andrade JB, 1996, AM LAB, V28, P56; DEAN WL, 1982, J BIOL CHEM, V257, P4679; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; GUT J, 1982, J BIOL CHEM, V257, P7030; Hanna IH, 2000, ARCH BIOCHEM BIOPHYS, V376, P206, DOI 10.1006/abbi.2000.1708; Hazai E, 2005, J COMPUT AID MOL DES, V19, P271, DOI 10.1007/s10822-005-4995-4; Hazai E, 2005, DRUG METAB DISPOS, V33, P157, DOI 10.1124/dmd.104.001578; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; INGELMANSUNDBERG M, 1980, BIOCHIM BIOPHYS ACTA, V599, P417, DOI 10.1016/0005-2736(80)90188-1; INGELMANSUNDBERG M, 1983, EUR J BIOCHEM, V134, P157, DOI 10.1111/j.1432-1033.1983.tb07546.x; INGELMANSUNDBERG M, 1980, BIOCHEMISTRY-US, V19, P4004, DOI 10.1021/bi00558a018; Jamakhandi AP, 2007, BIOCHEMISTRY-US, V46, P10192, DOI 10.1021/bi7003476; KAMINSKY LS, 1985, EUR J BIOCHEM, V149, P479, DOI 10.1111/j.1432-1033.1985.tb08950.x; KANAEVA IP, 1992, ARCH BIOCHEM BIOPHYS, V298, P395, DOI 10.1016/0003-9861(92)90427-X; KAWATO S, 1982, J BIOL CHEM, V257, P7023; Kelley RW, 2006, BIOCHEMISTRY-US, V45, P15807, DOI 10.1021/bi061803n; Kelley RW, 2005, BIOCHEMISTRY-US, V44, P2632, DOI 10.1021/bi0477900; Li DN, 1999, J PHARMACOL EXP THER, V289, P661; LUBET RA, 1985, ARCH BIOCHEM BIOPHYS, V238, P43, DOI 10.1016/0003-9861(85)90138-9; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Reed JR, 2008, DRUG METAB DISPOS, V36, P582, DOI 10.1124/dmd.107.018473; Reed JR, 2006, DRUG METAB DISPOS, V34, P660, DOI 10.1124/dmd.105.006825; STROBEL HW, 1970, J BIOL CHEM, V245, P4851; Szczesna-Skorupa E, 2003, J BIOL CHEM, V278, P31269, DOI 10.1074/jbc.M301489200; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; Tan YZ, 1997, ARCH BIOCHEM BIOPHYS, V342, P82, DOI 10.1006/abbi.1997.9995; WAGNER SL, 1984, J BIOL CHEM, V259, P2390; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125	48	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8942	8952		10.1074/jbc.M109.076885	http://dx.doi.org/10.1074/jbc.M109.076885			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071338	Green Published, hybrid			2022-12-25	WOS:000275553700046
J	Zhao, CY; Datta, S; Mandal, P; Xu, SQ; Hamilton, T				Zhao, Chenyang; Datta, Shyamasree; Mandal, Palash; Xu, Shuqing; Hamilton, Thomas			Stress-sensitive Regulation of IFRD1 mRNA Decay Is Mediated by an Upstream Open Reading Frame	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; TRANSLATIONAL CONTROL; GENE-EXPRESSION; MAMMALIAN-CELLS; TIS7; INITIATION; PATHWAY; PC4; TRANSCRIPTION	In this report, we demonstrate that cellular stress regulates expression of IFRD1 by a post-transcriptional control mechanism. IFRD1 mRNA and protein are elevated in tunicamycin-treated human kidney epithelial cells via stabilization of the mRNA. IFRD1 mRNA instability in resting cells requires translation of an upstream open reading frame (ORF) that represses translation of the major ORF. During stress response, the mRNA is stabilized via inhibition of translational initiation mediated by phosphorylated eIF2 alpha. Translation of the major ORF of IFRD1 involves both leaky scanning at the upstream AUG codon and re-initiation at the major AUG codon and is not altered during stress. Finally, the instability mechanism depends upon UPF1, suggesting that it is related to nonsense-mediated decay. Importantly, the sequence and length of the upstream ORF are critical but do not need to code for a specific peptide. Moreover the sequence environment of the upstream ORF termination site is not an essential feature of instability. These features of decay collectively define a distinct upstream ORF-mediated instability mechanism whereby cellular stress can modulate specific gene expression through alteration of mRNA half-life.	[Hamilton, Thomas] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hamilton, T (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, NE40,9500 Euclid Ave, Cleveland, OH 44195 USA.	hamiltt@ccf.org	MANDAL, PALASH/I-5238-2019	MANDAL, PALASH/0000-0001-6612-3773; Hamilton, Thomas/0000-0002-9817-242X; Zhao, Chenyang/0000-0002-4716-2002	National Institutes of Health [CA62220]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA62220 from USPHS.	ARENANDER AT, 1989, J NEUROSCI RES, V23, P247, DOI 10.1002/jnr.490230302; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811; GUARDAVACCARO D, 1995, CELL GROWTH DIFFER, V6, P159; Gurova KV, 2004, CANCER RES, V64, P1951, DOI 10.1158/0008-5472.CAN-03-1541; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; Iacopetti P, 1996, BRAIN RES, V707, P293; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Matsui M, 2007, FEBS LETT, V581, P4184, DOI 10.1016/j.febslet.2007.07.057; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Micheli L, 2005, MOL CELL BIOL, V25, P2242, DOI 10.1128/MCB.25.6.2242-2259.2005; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nelson DP, 2002, ANN THORAC SURG, V73, P156, DOI 10.1016/S0003-4975(01)03303-3; Novotny M, 2005, J BIOL CHEM, V280, P30166, DOI 10.1074/jbc.M502280200; Perkins DJ, 2004, MOL CELL BIOL, V24, P2025, DOI 10.1128/MCB.24.5.2025-2040.2004; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roth A, 2003, MOL CELL NEUROSCI, V22, P353, DOI 10.1016/S1044-7431(02)00039-8; Rubin DC, 1998, AM J PHYSIOL-GASTR L, V275, pG506, DOI 10.1152/ajpgi.1998.275.3.G506; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Ruiz-Echevarria MJ, 1998, EMBO J, V17, P575, DOI 10.1093/emboj/17.2.575; Sachs MS, 2006, GENE DEV, V20, P915, DOI 10.1101/gad.1427006; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stockklausner C, 2006, NUCLEIC ACIDS RES, V34, P2355, DOI 10.1093/nar/gkl277; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021; Vadivelu SK, 2004, MOL CELL BIOL, V24, P3514, DOI 10.1128/MCB.24.8.3514-3525.2004; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vietor I, 2005, J BIOL CHEM, V280, P39795, DOI 10.1074/jbc.M509836200; Vietor I, 2002, EMBO J, V21, P4621, DOI 10.1093/emboj/cdf461; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; Vilela C, 1998, NUCLEIC ACIDS RES, V26, P1150, DOI 10.1093/nar/26.5.1150; Vilela C, 1999, EMBO J, V18, P3139, DOI 10.1093/emboj/18.11.3139; Wang Y, 2005, J BIOL CHEM, V280, P34764, DOI 10.1074/jbc.M507058200; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wick N, 2004, J MOL BIOL, V336, P589, DOI 10.1016/j.jmb.2003.11.060; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao CY, 2007, J BIOL CHEM, V282, P20230, DOI 10.1074/jbc.M700180200; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	63	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8552	8562		10.1074/jbc.M109.070920	http://dx.doi.org/10.1074/jbc.M109.070920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080976	Green Published, hybrid			2022-12-25	WOS:000275553700007
J	Dennison, JB; Ayres, ML; Kaluarachchi, K; Plunkett, W; Gandhi, V				Dennison, Jennifer B.; Ayres, Mary L.; Kaluarachchi, Kumar; Plunkett, William; Gandhi, Varsha			Intracellular Succinylation of 8-Chloroadenosine and Its Effect on Fumarate Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIQUID-CHROMATOGRAPHY METHOD; MULTIPLE-MYELOMA CELLS; RENAL-CANCER; INHIBITION; HYDRATASE; 8-CHLORO-ADENOSINE; ADENYLOSUCCINASE; DEFICIENCY; ATP; 8-AMINO-ADENOSINE	8-Chloroadenosine (8-Cl-Ado) is a ribosyl nucleoside analog currently in phase I testing for the treatment of chronic lymphocytic leukemia (CLL). 8-Cl-Ado activity is dependent on adenosine kinase and requires intracellular accumulation of 8-Cl-Ado as mono-, di-, and tri-phosphates. In the current study with four mantle cell lymphoma cell lines, we report a new major metabolic pathway for 8-Cl-Ado intracellular metabolism, the formation of succinyl-8-chloro-adenosine (S-8-Cl-Ado) and its monophosphate (S-8-Cl-AMP). 8-Cl-AMP levels were highly associated with S-8-Cl- AMP levels and reached a steady-state prior to the secondary metabolites, 8-Cl-ATP and S-8-Cl-Ado. Consistent with fumarate as a required substrate for formation of succinyl-8-Cl-adenylate metabolites, the S-8-Cl- adenylate concentrations in multiple cell lines were associated with fumarate loss. The distribution of metabolites was also altered using the energy metabolism modifiers, metformin and oligomycin. The rates of succinyl-8-Cl-adenylate metabolism were enhanced by increasing the intracellular fumarate concentrations after metformin co-treatment. In addition, the S-8-Cl-AMP concentrations were increased after acute inhibition of ATP synthase by oligomycin. We conclude that 8-Cl-Ado metabolism not only affects intracellular purine metabolism; 8-Cl-Ado conversion to succinyl analogs ties its metabolism to the citric acid cycle by reduction of the fumarate pool.	Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Plunkett, William; Gandhi, Varsha] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gandhi, V (corresponding author), 1515 Holcombe Blvd,Unit 71, Houston, TX 77030 USA.	vgandhi@mdanderson.org			National Institutes of Health, NCI [CA 85915]; Lymphoma SPORE [CA136411]; NATIONAL CANCER INSTITUTE [R01CA085915, P50CA136411, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lymphoma SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 85915 from the NCI and Lymphoma SPORE CA136411.	[Anonymous], SPECTROMETRIC IDENTI; Balakrishnan K, 2005, BLOOD, V105, P4455, DOI 10.1182/blood-2004-05-1699; BENNETT LL, 1985, NUCLEOS NUCLEOT, V4, P107, DOI 10.1080/07328318508077834; Bosi E, 2009, DIABETES OBES METAB, V11, P3, DOI 10.1111/j.1463-1326.2008.01031.x; CARTER CE, 1956, J BIOL CHEM, V222, P17; Carvajal-Carmona LG, 2006, J CLIN ENDOCR METAB, V91, P3071, DOI 10.1210/jc.2006-0183; Chen LS, 2009, BIOCHEM PHARMACOL, V78, P583, DOI 10.1016/j.bcp.2009.05.019; Chen LS, 2004, J BIOL CHEM, V279, P40405, DOI 10.1074/jbc.M401752200; DEKORTE D, 1985, CLIN CHIM ACTA, V148, P185, DOI 10.1016/0009-8981(85)90145-7; Dennison JB, 2009, BRIT J HAEMATOL, V147, P297, DOI 10.1111/j.1365-2141.2009.07850.x; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Gandhi V, 2002, CANCER CHEMOTH PHARM, V50, P85, DOI 10.1007/S00280-002-0456-0; Gandhi V, 2001, CANCER RES, V61, P5474; Ghias K, 2005, MOL CANCER THER, V4, P569, DOI 10.1158/1535-7163.MCT-04-0303; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Krett NL, 2004, MOL CANCER THER, V3, P1411; Liu R, 2009, MOL CELL PROTEOMICS, V8, P70, DOI 10.1074/mcp.M800195-MCP200; Rodriguez CO, 2000, J CHROMATOGR B, V745, P421, DOI 10.1016/S0378-4347(00)00303-0; STELLRECHT C, 2009, BREAST CANC RES TREA; Stellrecht CM, 2007, CANCER RES, V67, P9913, DOI 10.1158/0008-5472.CAN-07-0770; Stellrecht CM, 2003, CANCER RES, V63, P7968; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; TORTORA G, 1995, CLIN CANCER RES, V1, P377; VANDENBERGH F, 1991, ANAL BIOCHEM, V193, P287, DOI 10.1016/0003-2697(91)90023-M; VandenBerghe G, 1997, J INHERIT METAB DIS, V20, P193, DOI 10.1023/A:1005304722259; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Zeman J, 2000, J INHERIT METAB DIS, V23, P371, DOI 10.1023/A:1005639516342	32	10	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8022	8030		10.1074/jbc.M109.085803	http://dx.doi.org/10.1074/jbc.M109.085803			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064937	Green Published, hybrid			2022-12-25	WOS:000275413800020
J	Feranchak, AP; Lewis, MA; Kresge, C; Sathe, M; Bugde, A; Luby-Phelps, K; Antich, PP; Fitz, JG				Feranchak, Andrew P.; Lewis, Matthew A.; Kresge, Charles; Sathe, Meghana; Bugde, Abhijit; Luby-Phelps, Kate; Antich, Peter P.; Fitz, J. Gregory			Initiation of Purinergic Signaling by Exocytosis of ATP-containing Vesicles in Liver Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATE; RELEASE; CELL; SECRETION; MECHANISM; CHOLANGIOCYTES; NUCLEOTIDES; CONDUCTANCE; CONTRIBUTES; TRANSPORT	Extracellular ATP represents an important autocrine/ paracrine signaling molecule within the liver. The mechanisms responsible for ATP release are unknown, and alternative pathways have been proposed, including either conductive ATP movement through channels or exocytosis of ATP-enriched vesicles, although direct evidence from liver cells has been lacking. Utilizing dynamic imaging modalities (confocal and total internal reflection fluorescence microscopy and luminescence detection utilizing a high sensitivity CCD camera) at different scales, including confluent cell populations, single cells, and the intracellular submembrane space, we have demonstrated in a model liver cell line that (i) ATP release is not uniform but reflects point source release by a defined subset of cells; (ii) ATP within cells is localized to discrete zones of high intensity that are similar to 1 mu m in diameter, suggesting a vesicular localization; (iii) these vesicles originate from a bafilomycin A(1)-sensitive pool, are depleted by hypotonic exposure, and are not rapidly replenished from recycling of endocytic vesicles; and (iv) exocytosis of vesicles in response to cell volume changes depends upon a complex series of signaling events that requires intact microtubules as well as phosphoinositide 3-kinase and protein kinase C. Collectively, these findings are most consistent with an essential role for exocytosis in regulated release of ATP and initiation of purinergic signaling in liver cells.	Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Lewis, Matthew A.; Antich, Peter P.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Bugde, Abhijit; Luby-Phelps, Kate] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Fitz, J. Gregory] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Feranchak, AP (corresponding author), Univ Texas SW Med Sch, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	drew.feranchak@UTSouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409	National Institutes of Health, NIDDK [DK078587, DK43278, DK46082]; Cystic Fibrosis Foundation [FERANC08G0]; Children's Medical Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046082, R01DK043278, R01DK046082, R01DK078587] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Children's Medical Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants DK078587 (to A. P. F.), DK43278, and DK46082 (to J.G.F.). This study was also supported by the Cystic Fibrosis Foundation (FERANC08G0) and the Children's Medical Center Foundation.	ALUND M, 1979, BRAIN RES, V166, P121, DOI 10.1016/0006-8993(79)90654-1; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bankston LA, 1996, J BIOL CHEM, V271, P17132, DOI 10.1074/jbc.271.29.17132; Bodily K, 1997, HEPATOLOGY, V25, P403; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; Braunstein GM, 2001, J BIOL CHEM, V276, P6621, DOI 10.1074/jbc.M005893200; Camacho M, 2006, J NEUROCHEM, V96, P324, DOI 10.1111/j.1471-4159.2005.03526.x; Carabelli V, 1998, NEURON, V20, P1255, DOI 10.1016/S0896-6273(00)80505-X; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; COSTA JL, 1984, RES COMMUN CHEM PATH, V45, P389; Doctor RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1042, DOI 10.1152/ajpcell.00367.2001; Feranchak AP, 2007, GASTROENTEROLOGY, V133, P1726, DOI 10.1053/j.gastro.2007.09.050; Feranchak AP, 1999, J BIOL CHEM, V274, P30979, DOI 10.1074/jbc.274.43.30979; Feranchak AP, 2000, J HEPATOL, V33, P174, DOI 10.1016/S0168-8278(00)80357-8; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Gatof D, 2004, AM J PHYSIOL-GASTR L, V286, pG538, DOI 10.1152/ajpgi.00355.2003; Knight GE, 2002, AM J PHYSIOL-RENAL, V282, pF281, DOI 10.1152/ajprenal.00293.2000; Koyama T, 2001, J PHYSIOL-LONDON, V532, P759, DOI 10.1111/j.1469-7793.2001.0759e.x; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Maroto R, 2001, J BIOL CHEM, V276, P23867, DOI 10.1074/jbc.M101500200; MILLER B, 2007, J NUCL MED S2, V48; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; PAINTER GR, 1989, P NATL ACAD SCI USA, V86, P2239, DOI 10.1073/pnas.86.7.2239; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pryazhnikov E, 2008, GLIA, V56, P38, DOI 10.1002/glia.20590; Roman RM, 1999, AM J PHYSIOL-GASTR L, V276, pG1391, DOI 10.1152/ajpgi.1999.276.6.G1391; Roman RM, 2001, J MEMBRANE BIOL, V183, P165, DOI 10.1007/s00232-001-0064-7; Roman RM, 2001, AM J PHYSIOL-GASTR L, V280, pG344, DOI 10.1152/ajpgi.2001.280.3.G344; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Schlosser SF, 1996, P NATL ACAD SCI USA, V93, P9948, DOI 10.1073/pnas.93.18.9948; Schock SC, 2008, BIOCHEM BIOPH RES CO, V368, P138, DOI 10.1016/j.bbrc.2008.01.054; Soesbe TC, 2007, IEEE T NUCL SCI, V54, P1516, DOI 10.1109/TNS.2007.906408; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; UEDA I, 1994, BIOPHYS J, V66, P2107, DOI 10.1016/S0006-3495(94)81005-7; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; WHITE PN, 1995, HEARING RES, V90, P97, DOI 10.1016/0378-5955(95)00151-1; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015	44	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8138	8147		10.1074/jbc.M109.065482	http://dx.doi.org/10.1074/jbc.M109.065482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071341	hybrid, Green Published			2022-12-25	WOS:000275413800032
J	Nomura, T; Kutchan, TM				Nomura, Taiji; Kutchan, Toni M.			Three New O-Methyltransferases Are Sufficient for All O-Methylation Reactions of Ipecac Alkaloid Biosynthesis in Root Culture of Psychotria ipecacuanha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANGIUM-LAMARCKII THW; STRICTOSIDINE SYNTHASE; MOLECULAR-CLONING; COPTIS-JAPONICA; CATHARANTHUS-ROSEUS; OPIUM POPPY; PAPAVER-SOMNIFERUM; RAUVOLFIA-SERPENTINA; N-METHYLTRANSFERASE; PURIFICATION	The medicinal plant Psychotria ipecacuanha produces ipecac alkaloids, a series of monoterpenoid-isoquinoline alkaloids such as emetine and cephaeline, whose biosynthesis derives from condensation of dopamine and secologanin. Here, we identified three cDNAs, IpeOMT1-IpeOMT3, encoding ipecac alkaloid O-methyltransferases (OMTs) from P. ipecacuanha. They were coordinately transcribed with the recently identified ipecac alkaloid beta-glucosidase Ipeglu1. Their amino acid sequences were closely related to each other and rather to the flavonoid OMTs than to the OMTs involved in benzylisoquinoline alkaloid biosynthesis. Characterization of the recombinant IpeOMT enzymes with integration of the enzymatic properties of the IpeGlu1 revealed that emetine biosynthesis branches off from N-deacetylisoipecoside through its 6-O-methylation by IpeOMT1, with a minor contribution by IpeOMT2, followed by deglucosylation by IpeGlu1. The 7-hydroxy group of the isoquinoline skeleton of the aglycon is methylated by IpeOMT3 prior to the formation of protoemetine that is condensed with a second dopamine molecule, followed by sequential O-methylations by IpeOMT2 and IpeOMT1 to form cephaeline and emetine, respectively. In addition to this central pathway of ipecac alkaloid biosynthesis, formation of all methyl derivatives of ipecac alkaloids in P. ipecacuanha could be explained by the enzymatic activities of IpeOMT1-IpeOMT3, indicating that they are sufficient for all O-methylation reactions of ipecac alkaloid biosynthesis.	[Nomura, Taiji; Kutchan, Toni M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Kutchan, TM (corresponding author), Toyama Prefectural Univ, Dept Biotechnol, Fac Engn, 5180 Kurokawa, Toyama 9390398, Japan.	tnomura@pu-toyama.ac.jp	Kutchan, Toni/L-4625-2013	Nomura, Taiji/0000-0003-4876-9866	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported by a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad. Present address: Dept. of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama 939-0398, Japan.	BRACHER D, 1992, ARCH BIOCHEM BIOPHYS, V294, P717, DOI 10.1016/0003-9861(92)90746-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cacace S, 2003, PHYTOCHEMISTRY, V62, P127, DOI 10.1016/S0031-9422(02)00483-1; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; De-Eknamkul W, 2000, PHYTOCHEMISTRY, V55, P177, DOI 10.1016/S0031-9422(00)00260-0; DeEknamkul W, 1997, PHYTOCHEMISTRY, V45, P477, DOI 10.1016/S0031-9422(96)00828-X; DEWAAL A, 1989, BIOCHEM J, V306, P571; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; Frick S, 1999, PLANT J, V17, P329, DOI 10.1046/j.1365-313X.1999.00379.x; Fujii T, 1998, ALKALOIDS CHEM BIOL, V51, P271; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; HAMPP N, 1988, PHYTOCHEMISTRY, V27, P3811, DOI 10.1016/0031-9422(88)83023-1; Inui T, 2007, PLANT CELL PHYSIOL, V48, P252, DOI 10.1093/pcp/pcl062; ITOH A, 1995, J NAT PRODUCTS, V58, P1228, DOI 10.1021/np50122a011; Itoh A, 1999, PHYTOCHEMISTRY, V52, P1169, DOI 10.1016/S0031-9422(99)00361-1; JANOT MM, 1953, ALKALOIDS-CHEM BIOL, V3, P363; Jonczyk R, 2008, PLANT PHYSIOL, V146, P1053, DOI 10.1104/pp.107.111237; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; Levac D, 2008, PLANT J, V53, P225, DOI 10.1111/j.1365-313X.2007.03337.x; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; MCKNIGHT TD, 1991, PLANTA, V185, P148, DOI 10.1007/BF00194055; Morishige T, 2000, J BIOL CHEM, V275, P23398, DOI 10.1074/jbc.M002439200; Morishige T, 2002, EUR J BIOCHEM, V269, P5659, DOI 10.1046/j.1432-1033.2002.03275.x; NAGAKURA N, 1978, PLANTA MED, V34, P381, DOI 10.1055/s-0028-1097467; NAGAKURA N, 1978, J CHEM SOC CHEM COMM, P896, DOI 10.1039/c39780000896; Nomura T, 2008, J BIOL CHEM, V283, P34650, DOI 10.1074/jbc.M806953200; Ounaroon A, 2003, PLANT J, V36, P808, DOI 10.1046/j.1365-313X.2003.01928.x; PFITZNER U, 1989, PLANTA MED, P525, DOI 10.1055/s-2006-962086; Pienkny S, 2009, PLANT J, V60, P56, DOI 10.1111/j.1365-313X.2009.03937.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidlin L, 2008, PLANT PHYSIOL, V148, P1630, DOI 10.1104/pp.108.126003; SHOEB A, 1975, J CHEM SOC PERK T 1, P1245, DOI 10.1039/p19750001245; STEVENS LH, 1993, PLANT CELL REP, V12, P573, DOI 10.1007/BF00233063; STEVENS LH, 1993, PHYTOCHEMISTRY, V33, P99, DOI 10.1016/0031-9422(93)85403-E; TAKESHITA N, 1995, PLANT CELL PHYSIOL, V36, P29; TREIMER JF, 1979, EUR J BIOCHEM, V101, P225, DOI 10.1111/j.1432-1033.1979.tb04235.x; Weid M, 2004, P NATL ACAD SCI USA, V101, P13957, DOI 10.1073/pnas.0405704101; Yamazaki Y, 2003, PLANT CELL PHYSIOL, V44, P395, DOI 10.1093/pcp/pcg051; Yazaki K, 2005, CURR OPIN PLANT BIOL, V8, P301, DOI 10.1016/j.pbi.2005.03.011	41	28	32	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7722	7738		10.1074/jbc.M109.086157	http://dx.doi.org/10.1074/jbc.M109.086157			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20061395	Green Published, hybrid			2022-12-25	WOS:000275415600081
J	Xue, L; Sun, Y; Chiang, L; He, B; Kang, C; Nolla, H; Winoto, A				Xue, Ling; Sun, Yuefang; Chiang, Leslie; He, Bo; Kang, Chulho; Nolla, Hector; Winoto, Astar			Coupling of the Cell Cycle and Apoptotic Machineries in Developing T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED THYMOCYTE APOPTOSIS; THYMIC NEGATIVE SELECTION; TRANSCRIPTION FACTOR; POSITIVE SELECTION; DEPENDENT KINASES; TUMOR SUPPRESSION; GENE-EXPRESSION; DISTINCT ROLES; TCR-ALPHA; DEATH	Proliferation and apoptosis are diametrically opposite processes. Expression of certain genes like c-Myc, however, can induce both, pointing to a possible linkage between them. Developing CD4(+)CD8(+) thymocytes are intrinsically sensitive to apoptosis, but the molecular basis is not known. We have found that these noncycling cells surprisingly express many cell cycle proteins. We generated transgenic mice expressing a CDK2 kinase-dead (CDK2-DN) protein in the T cell compartment. Analysis of these mice showed that the CDK2-DN protein acts as a dominant negative mutant in mature T cells as expected, but surprisingly, it acts as a dominant active protein in CD4(+)CD8(+) thymocytes. The levels of CDK2 kinase activity, cyclin E, cyclin A, and other cell cycle proteins in transgenic CD4(+)CD8(+) thymocytes are increased. Concurrently, caspase levels are elevated, and apoptosis is significantly enhanced in vitro and in vivo. E2F-1, the unique E2F member capable of inducing apoptosis when overexpressed, is specifically up-regulated in transgenic CD4(+)CD8(+) thymocytes but not in other T cell populations. These results demonstrate that the cell cycle and apoptotic machineries are normally linked, and expression of cell cycle proteins in developing T cells contributes to their inherent 1 sensitivity to apoptosis.	[Winoto, Astar] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Winoto, A (corresponding author), Univ Calif Berkeley, Canc Res Lab, 465 LSA, Berkeley, CA 94720 USA.	winoto@berkeley.edu			National Institutes of Health [CA66236]; NATIONAL CANCER INSTITUTE [R01CA066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA66236 ( to A. W.).	Abrams JM, 2004, CURR OPIN CELL BIOL, V16, P634, DOI 10.1016/j.ceb.2004.09.010; Abrams JM, 2002, CELL, V110, P403, DOI 10.1016/S0092-8674(02)00904-2; Adlam M, 2003, IMMUNITY, V18, P173, DOI 10.1016/S1074-7613(03)00021-9; Berthet C, 2007, MOL CELL BIOL, V27, P5079, DOI 10.1128/MCB.00029-07; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Ferguson KL, 2000, J BIOL CHEM, V275, P33593, DOI 10.1074/jbc.M004879200; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; GOLSTEIN P, 1991, IMMUNOL REV, V121, P29, DOI 10.1111/j.1600-065X.1991.tb00822.x; Granes F, 2004, EUR J IMMUNOL, V34, P2781, DOI 10.1002/eji.200425154; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; Hofmann F, 1996, GENE DEV, V10, P851, DOI 10.1101/gad.10.7.851; Hu B, 2001, MOL CELL BIOL, V21, P2755, DOI 10.1128/MCB.21.8.2755-2766.2001; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Osborn SL, 2007, J BIOL CHEM, V282, P22786, DOI 10.1074/jbc.M703163200; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Pellicciari C, 1996, EXP CELL RES, V229, P370, DOI 10.1006/excr.1996.0382; PENIT C, 1986, J IMMUNOL, V137, P2115; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rudolph B, 2000, ONCOGENE, V19, P1891, DOI 10.1038/sj.onc.1203508; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHAN B, 1994, MOL CELL BIOL, V14, P299, DOI 10.1128/MCB.14.1.299; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; THOMPSON SD, 1990, J IMMUNOL, V145, P2347; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Williams O, 2000, EUR J IMMUNOL, V30, P709; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xue L, 2008, P NATL ACAD SCI USA, V105, P2022, DOI 10.1073/pnas.0712059105; Xue L, 2008, EUR J IMMUNOL, V38, P3200, DOI 10.1002/eji.200838614; Zhu JW, 1999, CELL GROWTH DIFFER, V10, P829	67	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7556	7565		10.1074/jbc.M109.035535	http://dx.doi.org/10.1074/jbc.M109.035535			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20068041	hybrid, Green Published			2022-12-25	WOS:000275415600067
J	Breuer, P; Haacke, A; Evert, BO; Wullner, U				Breuer, Peter; Haacke, Annette; Evert, Bernd O.; Wuellner, Ullrich			Nuclear Aggregation of Polyglutamine-expanded Ataxin-3 FRAGMENTS ESCAPE THE CYTOPLASMIC QUALITY CONTROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCA1 TRANSGENIC MICE; IN-VIVO; MAMMALIAN-CELLS; INTRANUCLEAR INCLUSIONS; MOLECULAR CHAPERONES; HUNTINGTONS-DISEASE; PROTEIN; LOCALIZATION; PROTEASOME; STRESS	Expansion of a polymorphic polyglutamine segment is the common denominator of neurodegenerative polyglutamine diseases. The expanded proteins typically accumulate in large intranuclear inclusions and induce neurodegeneration. However, the mechanisms that determine the subcellular site and rate of inclusion formation are largely unknown. We found that the conserved putative nuclear localization sequence Arg-Lys-Arg-Arg, which is retained in a highly aggregation-prone fragment of ataxin-3, did not affect the site and degree of inclusion formation in a cell culture model of spinocerebellar ataxia type 3. Addition of synthetic nuclear export or import signals led to the expected localization of ataxin-3 and determined the subcellular site of aggregate formation. Triggering a cellular stress response by heat shock transcription factor Delta HSF1 coexpression abrogated aggregation in the cytoplasm but not in the nucleus. These findings indicate that native aggregation-prone fragments derived from expanded ataxin-3 may eventually escape the cytoplasmic quality control, resulting in aggregation in the nuclear compartment.	[Breuer, Peter; Evert, Bernd O.; Wuellner, Ullrich] Univ Bonn, Dept Neurol, D-53105 Bonn, Germany; [Haacke, Annette] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Bonn; Max Planck Society	Breuer, P (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	peter.breuer@ukb.uni-bonn.de	Wüllner, Ullrich/R-6790-2019		Deutsche Forschungsgemeinschaft [HA 1466/2, WU 184/6-1]; European Union (EUROSCA); National Ataxia Foundation; University of Bonn Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (EUROSCA)(European Commission); National Ataxia Foundation; University of Bonn Center	This work was supported by Deutsche Forschungsgemeinschaft Grants HA 1466/2 and WU 184/6-1, the European Union (EUROSCA), the National Ataxia Foundation, and a University of Bonn Center (BONFOR) grant.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bader N, 2007, EXP GERONTOL, V42, P864, DOI 10.1016/j.exger.2007.03.010; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; Chen M, 2008, J CELL BIOL, V180, P697, DOI 10.1083/jcb.200708131; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Fujigasaki H, 2000, EXP NEUROL, V165, P248, DOI 10.1006/exnr.2000.7479; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Guigas G, 2007, FEBS LETT, V581, P5094, DOI 10.1016/j.febslet.2007.09.054; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Haacke A, 2007, J BIOL CHEM, V282, P18851, DOI 10.1074/jbc.M611914200; Hageman J, 2007, J BIOL CHEM, V282, P34334, DOI 10.1074/jbc.M703876200; Hands S, 2008, BBA-GENE REGUL MECH, V1779, P507, DOI 10.1016/j.bbagrm.2008.05.008; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lepock JR, 2001, CELL STRESS CHAPERON, V6, P136, DOI 10.1379/1466-1268(2001)006<0136:TNMIAT>2.0.CO;2; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; MICHELS AA, 1995, EUR J BIOCHEM, V234, P382, DOI 10.1111/j.1432-1033.1995.382_b.x; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sieradzan KA, 2001, NEUROPATH APPL NEURO, V27, P1, DOI 10.1046/j.0305-1846.2001.00299.x; Skinner PJ, 2002, NEUROMOL MED, V1, P33, DOI 10.1385/NMM:1:1:33; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Winklhofer KF, 2001, J BIOL CHEM, V276, P45160, DOI 10.1074/jbc.M104873200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zourlidou A, 2007, HUM MOL GENET, V16, P1078, DOI 10.1093/hmg/ddm057; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	35	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6532	6537		10.1074/jbc.M109.036335	http://dx.doi.org/10.1074/jbc.M109.036335			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20064935	Green Published, hybrid			2022-12-25	WOS:000275367500058
J	Conway, JO; Sherwood, LJ; Collazo, MT; Garza, JA; Hayhurst, A				Conway, Jerry O.; Sherwood, Laura J.; Collazo, M. Thelma; Garza, John A.; Hayhurst, Andrew			Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; IMMUNOLOGICAL CHARACTERIZATION; IMMUNE-RESPONSE; BINDING DOMAIN; A NEUROTOXIN; TOXIN; FRAGMENTS; CHAIN; SEQUENCE; COMPLEX	Background: There are currently 7 known serotypes of botulinum neurotoxin (BoNT) classified upon non-cross reactivity of neutralizing immunoglobulins. Non-neutralizing immunoglobulins, however, can exhibit cross-reactivities between 2 or more serotypes, particularly mosaic forms, which can hamper the development of highly specific immunoassays, especially if based on polyclonal antisera. Here we employ facile recombinant antibody technology to subtractively select ligands to each of the 7 BoNT serotypes, resulting in populations with very high specificity for their intended serotype. Methods and Findings: A single llama was immunized with a cocktail of 7 BoNT toxoids to generate a phage display library of single domain antibodies (sdAb, VHH or nanobodies) which were selected on live toxins. Resulting sdAb were capable of detecting both toxin and toxin complex with the best combinations able to detect 100s-10s of pg per 50 mu L sample in a liquid bead array. The most sensitive sdAb were combined in a heptaplex assay to identify each of the BoNT serotypes in buffer and milk and to a lesser extent in carrot juice, orange juice and cola. Several anti-A(1) sdAb recognized A2 complex, showing that subtype cross-reactivity within a serotype was evident. Many of our sdAb could act as both captor and tracer for several toxin and toxin complexes suggesting sdAb can be used as architectural probes to indicate BoNT oligomerisation. Six of 14 anti-A clones exhibited inhibition of SNAP-25 cleavage in the neuro-2A assay indicating some sdAb had toxin neutralizing capabilities. Many sdAb were also shown to be refoldable after exposure to high temperatures in contrast to polyclonal antisera, as monitored by circular dichroism. Conclusions: Our panel of molecularly flexible antibodies should not only serve as a good starting point for ruggedizing assays and inhibitors, but enable the intricate architectures of BoNT toxins and complexes to be probed more extensively.	[Conway, Jerry O.; Sherwood, Laura J.; Collazo, M. Thelma; Garza, John A.; Hayhurst, Andrew] SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX USA	Texas Biomedical Research Institute	Conway, JO (corresponding author), SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX USA.	ahayhurst@sfbr.org		Hayhurst, Andrew/0000-0003-4612-8707	Defense Threat Reduction Agency (DTRA) [HDTRA 1-07-C-0018]; National Institutes of Health (NIH) [C06 RR12087]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012087] Funding Source: NIH RePORTER	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Defense Threat Reduction Agency (DTRA) Medical Program (HDTRA 1-07-C-0018) and National Institutes of Health (NIH) construction grant C06 RR12087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SFBR is a non-profit organization devoted to improving global human health through innovative biomedical research.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Amersdorfer P, 2002, VACCINE, V20, P1640, DOI 10.1016/S0264-410X(01)00482-0; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bagramyan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002041; Baldwin MR, 2008, INFECT IMMUN, V76, P1314, DOI 10.1128/IAI.01025-07; Baldwin MR, 2005, INFECT IMMUN, V73, P6998, DOI 10.1128/IAI.73.10.6998-7005.2005; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Chames Patrick, 2002, Methods Mol Biol, V178, P147; Chen F, 1998, INFECT IMMUN, V66, P2420, DOI 10.1128/IAI.66.6.2420-2425.1998; Chen F, 1997, INFECT IMMUN, V65, P1626, DOI 10.1128/IAI.65.5.1626-1630.1997; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Curran RM, 2009, VET IMMUNOL IMMUNOP, V130, P1, DOI 10.1016/j.vetimm.2008.11.018; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; Dertzbaugh MT, 1996, VACCINE, V14, P1538, DOI 10.1016/S0264-410X(96)00094-1; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Fischer A, 2008, J BIOL CHEM, V283, P3997, DOI 10.1074/jbc.M707917200; FRANZ DR, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P473; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GIMENEZ DF, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P421; Goldman ER, 2008, ANAL CHEM, V80, P8583, DOI 10.1021/ac8014774; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; Goodnough MC, 2002, FEBS LETT, V513, P163, DOI 10.1016/S0014-5793(02)02268-8; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harmsen MM, 2005, VACCINE, V23, P4926, DOI 10.1016/j.vaccine.2005.05.017; HARMSEN MM, 2006, APPL MICROBIOL BIOT, P1; Hasegawa K, 2004, PROTEIN J, V23, P371, DOI 10.1023/B:JOPC.0000039551.42676.4c; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Henkel JS, 2009, BIOCHEMISTRY-US, V48, P2522, DOI 10.1021/bi801686b; HERRERO BA, 1967, EXP MOL PATHOL, V6, P84, DOI 10.1016/0014-4800(67)90007-X; Hines HB, 2008, APPL ENVIRON MICROB, V74, P653, DOI 10.1128/AEM.01690-07; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Jacobson MJ, 2008, APPL ENVIRON MICROB, V74, P2778, DOI 10.1128/AEM.02828-07; Jones RGA, 2008, J IMMUNOL METHODS, V337, P42, DOI 10.1016/j.jim.2008.05.009; Kalb SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005355; KASTELIC D, 2009, J IMMUNOL METHODS; Keller JE, 2008, CLIN VACCINE IMMUNOL, V15, P1374, DOI 10.1128/CVI.00117-08; Kiyatkin N, 1997, INFECT IMMUN, V65, P4586, DOI 10.1128/IAI.65.11.4586-4591.1997; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; KOZAKI S, 1991, INFECT IMMUN, V59, P457, DOI 10.1128/IAI.59.1.457-459.1991; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; LAMANNA C, 1959, SCIENCE, V130, P763, DOI 10.1126/science.130.3378.763; LEDOUX DN, 1994, TOXICON, V32, P1095, DOI 10.1016/0041-0101(94)90393-X; Lee MS, 2008, HYBRIDOMA, V27, P18, DOI 10.1089/hyb.2007.0532; Marks James D, 2004, Anesthesiol Clin North Am, V22, P509, DOI 10.1016/j.atc.2004.05.010; Min D, 2004, P NATL ACAD SCI USA, V101, P14701, DOI 10.1073/pnas.0404107101; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; NEU HC, 1965, J BIOL CHEM, V240, P3685; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; OGUMA K, 1980, INFECT IMMUN, V30, P656; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Pier CL, 2008, INFECT IMMUN, V76, P437, DOI 10.1128/IAI.00843-07; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; SCOTT AB, 1988, MOVEMENT DISORD, V3, P333, DOI 10.1002/mds.870030409; Sharma SK, 2006, APPL ENVIRON MICROB, V72, P1231, DOI 10.1128/AEM.72.2.1231-1238.2006; Sherwood LJ, 2007, J INFECT DIS, V196, pS213, DOI 10.1086/520586; Singh BR, 2000, NAT STRUCT BIOL, V7, P617, DOI 10.1038/77900; SINGH BR, 1995, J PROTEIN CHEM, V14, P7, DOI 10.1007/BF01902839; SINGH BR, 1990, BIOPHYS CHEM, V38, P123, DOI 10.1016/0301-4622(90)80047-B; SINGH BR, 1989, TOXICON, V27, P403, DOI 10.1016/0041-0101(89)90202-X; Singh BR, 1996, TOXICON, V34, P267, DOI 10.1016/0041-0101(95)00113-1; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; SONNABEND O, 1981, J INFECT DIS, V143, P22, DOI 10.1093/infdis/143.1.22; SONNABEND OAR, 1985, LANCET, V1, P237; Stahl C, 2009, VACCINE, V27, P5661, DOI 10.1016/j.vaccine.2009.07.021; Tanha J, 2002, J IMMUNOL METHODS, V263, P97, DOI 10.1016/S0022-1759(02)00027-3; THOMPSON DE, 1993, FEMS MICROBIOL LETT, V108, P175, DOI 10.1111/j.1574-6968.1993.tb06095.x; TSUZUKI K, 1988, INFECT IMMUN, V56, P898, DOI 10.1128/IAI.56.4.898-902.1988; van der Linden R, 2000, J IMMUNOL METHODS, V240, P185, DOI 10.1016/S0022-1759(00)00188-5; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Volland H, 2008, J IMMUNOL METHODS, V330, P120, DOI 10.1016/j.jim.2007.11.006; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Webb RP, 2007, VACCINE, V25, P4273, DOI 10.1016/j.vaccine.2007.02.081; Webb RP, 2009, VACCINE, V27, P4490, DOI 10.1016/j.vaccine.2009.05.030; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Zhou HY, 2009, BIOORG MED CHEM LETT, V19, P662, DOI 10.1016/j.bmcl.2008.12.055	86	58	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8818	10.1371/journal.pone.0008818	http://dx.doi.org/10.1371/journal.pone.0008818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098614	gold, Green Published, Green Submitted			2022-12-25	WOS:000273779100011
J	Denton, PW; Krisko, JF; Powell, DA; Mathias, M; Kwak, YT; Martinez-Torres, F; Zou, W; Payne, DA; Estes, JD; Garcia, JV				Denton, Paul W.; Krisko, John F.; Powell, Daniel A.; Mathias, Melissa; Kwak, Youn Tae; Martinez-Torres, Francisco; Zou, Wei; Payne, Deborah A.; Estes, Jacob D.; Garcia, J. Victor			Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VAGINAL SHIV CHALLENGE; PREEXPOSURE PROPHYLAXIS; REVERSE-TRANSCRIPTASE; SEXUAL TRANSMISSION; IMMUNE-RESPONSES; SIV INFECTION; MACAQUES; CHEMOPROPHYLAXIS; VACCINE	Successful antiretroviral pre-exposure prophylaxis (PrEP) for mucosal and intravenous HIV-1 transmission could reduce new infections among targeted high-risk populations including discordant couples, injection drug users, high-risk women and men who have sex with men. Targeted antiretroviral PrEP could be particularly effective at slowing the spread of HIV-1 if a single antiretroviral combination were found to be broadly protective across multiple routes of transmission. Therefore, we designed our in vivo preclinical study to systematically investigate whether rectal and intravenous HIV-1 transmission can be blocked by antiretrovirals administered systemically prior to HIV-1 exposure. We performed these studies using a highly relevant in vivo model of mucosal HIV-1 transmission, humanized Bone marrow/Liver/Thymus mice (BLT). BLT mice are susceptible to HIV-1 infection via three major physiological routes of viral transmission: vaginal, rectal and intravenous. Our results show that BLT mice given systemic antiretroviral PrEP are efficiently protected from HIV-1 infection regardless of the route of exposure. Specifically, systemic antiretroviral PrEP with emtricitabine and tenofovir disoproxil fumarate prevented both rectal (Chi square = 8.6, df = 1, p = 0.003) and intravenous (Chi square = 13, df = 1, p = 0.0003) HIV-1 transmission. Our results indicate that antiretroviral PrEP has the potential to be broadly effective at preventing new rectal or intravenous HIV transmissions in targeted high risk individuals. These in vivo preclinical findings provide strong experimental evidence supporting the potential clinical implementation of antiretroviral based pre-exposure prophylactic measures to prevent the spread of HIV/AIDS.	[Denton, Paul W.; Krisko, John F.; Powell, Daniel A.; Mathias, Melissa; Kwak, Youn Tae; Martinez-Torres, Francisco; Zou, Wei; Garcia, J. Victor] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Payne, Deborah A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Estes, Jacob D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Denton, PW (corresponding author), Univ N Carolina, Ctr AIDS Res, Div Infect Dis, Chapel Hill, NC 27515 USA.	victor_garcia@med.unc.edu		Denton, Paul/0000-0003-2458-8147; Powell, Daniel/0000-0003-0503-3330	National Institutes of Health [AI073146, AI071940, 5T32AI005284, HHSN266200400088C]; Foundation for AIDS Research (amfAR) [107183-44-RFRL]; UT Southwestern Summer Medical Student Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073146, T32AI005284, R33AI071940, R21AI071940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for AIDS Research (amfAR); UT Southwestern Summer Medical Student Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part with federal funds from National Institute of Allergy and Infectious Diseases, National Institutes of Health grants AI073146 and AI071940 (J. V. G.), 5T32AI005284 (J. F. K.), and the National Cancer Institute, National Institutes of Health, under contract HHSN266200400088C (J. E. D.). This work was supported in part by fellowship number 107183-44-RFRL from The Foundation for AIDS Research (amfAR) (P. W. D.). M. M. was supported by the UT Southwestern Summer Medical Student Research Program. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Derdelinckx I, 2006, PLOS MED, V3, P1999, DOI 10.1371/journal.pmed.0030454; Emau Peter, 2006, AIDS Res Ther, V3, P29, DOI 10.1186/1742-6405-3-29; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Ferrantelli F, 2007, VIROLOGY, V358, P69, DOI 10.1016/j.virol.2006.07.056; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; FRICK LW, 1994, ANTIMICROB AGENTS CH, V38, P2722, DOI 10.1128/AAC.38.12.2722; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Gay CL, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P107, DOI 10.1016/B978-0-12-374235-3.00005-4; Grant RM, 2005, SCIENCE, V309, P2170, DOI 10.1126/science.1116204; GU ZX, 1994, ANTIMICROB AGENTS CH, V38, P275, DOI 10.1128/AAC.38.2.275; Gupta K, 2006, PLOS MED, V3, P181, DOI 10.1371/journal.pmed.0030079; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Johnson Victoria A, 2008, Top HIV Med, V16, P138; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Landovitz Raphael J, 2007, Top HIV Med, V15, P99; Lederman MM, 2006, NAT REV IMMUNOL, V6, P371, DOI 10.1038/nri1848; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Liu AY, 2006, JAMA-J AM MED ASSOC, V296, P863, DOI 10.1001/jama.296.7.863; Mascolini Mark, 2009, J Int AIDS Soc, V12 Suppl 1, pS4, DOI 10.1186/1758-2652-12-S1-S4; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McGowan I, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P85, DOI 10.1016/B978-0-12-374235-3.00004-2; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Misegades L, 2001, AIDS, V15, P534, DOI 10.1097/00002030-200103090-00017; Naesens L, 1998, ANTIMICROB AGENTS CH, V42, P1568, DOI 10.1128/AAC.42.7.1568; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000; Paxton LA, 2007, LANCET, V370, P89, DOI 10.1016/S0140-6736(07)61053-8; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000655; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Tsai CC, 2000, J MED PRIMATOL, V29, P248, DOI 10.1034/j.1600-0684.2000.290318.x; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; *US CDC, 2007, HIV AIDS SURV REP, V19; Veazey RS, 2005, NAT MED, V11, P1293, DOI 10.1038/nm1321; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Wainberg MA, 1999, ANTIVIR THER, V4, P87; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; *WHO UNAIDS, 2008, 2008 REP GLOB AIDS E, P95; *WHO UNAIDS, 2006, 2006 REP GLOB AIDS E, P124; Youle M, 2003, AIDS, V17, P937, DOI 10.1097/00002030-200304110-00027; Zeitlin L, 2001, SEX TRANSM DIS, V28, P417, DOI 10.1097/00007435-200107000-00010	56	118	121	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8829	10.1371/journal.pone.0008829	http://dx.doi.org/10.1371/journal.pone.0008829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098623	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100020
J	Sarig, R; Fuchs, O; Tencer, L; Panski, A; Nudel, U; Yaffe, D				Sarig, Rachel; Fuchs, Ora; Tencer, Lilach; Panski, Avi; Nudel, Uri; Yaffe, David			Cloned Myogenic Cells Can Transdifferentiate In Vivo into Neuron-Like Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; SKELETAL-MUSCLE; DIFFERENTIATION; TRANSPLANTATION; MARROW; PLURIPOTENCY; EXPRESSION; LINEAGES; PROMOTER; BRAIN	Background: The question of whether intact somatic cells committed to a specific differentiation fate, can be reprogrammed in vivo by exposing them to a different host microenvironment is a matter of controversy. Many reports on transdifferentiation could be explained by fusion with host cells or reflect intrinsic heterogeneity of the donor cell population. Methodology/Principal Findings: We have tested the capacity of cloned populations of mouse and human muscle progenitor cells, committed to the myogenic pathway, to transdifferentiate to neurons, following their inoculation into the developing brain of newborn mice. Both cell types migrated into various brain regions, and a fraction of them gained a neuronal morphology and expressed neuronal or glial markers. Likewise, inoculated cloned human myogenic cells expressed a human specific neurofilament protein. Brain injected donor cells that expressed a YFP transgene controlled by a neuronal specific promoter, were isolated by FACS. The isolated cells had a wild-type diploid DNA content. Conclusions: These and other results indicate a genuine transdifferentiation phenomenon induced by the host brain microenvironment and not by fusion with host cells. The results may potentially be relevant to the prospect of autologous cell therapy approach for CNS diseases.	[Sarig, Rachel; Fuchs, Ora; Tencer, Lilach; Nudel, Uri; Yaffe, David] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Panski, Avi] Kaplan Hosp, Dept Orthoped, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Kaplan Medical Center	Sarig, R (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	david.yaffe@weizmann.ac.il			Association Francaise Contre les Myopathies (AFM)	Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	Supported by an Association Francaise Contre les Myopathies (AFM) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONI R, 2009, NEUROIMMUNOL, V215, P73; Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; CARNEY RS, 2002, J NEUROSCI, V26, P11562; Comi AM, 2008, PEDIATR NEUROL, V38, P86, DOI 10.1016/j.pediatrneurol.2007.10.007; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; ERDO F, 2003, HOST DEPENDENT TUMOR; FENG G, 2000, NEURON, P141; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; KONIGSBERG IR, 1963, SCIENCE, V140, P1273, DOI 10.1126/science.140.3573.1273; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Mignon L, 2005, J COMP NEUROL, V491, P96, DOI 10.1002/cne.20685; Romero-Ramos M, 2002, J NEUROSCI RES, V69, P894, DOI 10.1002/jnr.10374; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; Sarig R, 2006, STEM CELLS, V24, P1769, DOI 10.1634/stemcells.2005-0547; Schultz SS, 2006, WOUND REPAIR REGEN, V14, P224, DOI 10.1111/j.1743-6109.2006.00114.x; Sigurjonsson OE, 2005, P NATL ACAD SCI USA, V102, P5227, DOI 10.1073/pnas.0501029102; Steffel J, 2003, STEM CELLS, V21, P181, DOI 10.1634/stemcells.21-2-181; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Vourc'h P, 2004, BIOCHEM BIOPH RES CO, V317, P893, DOI 10.1016/j.bbrc.2004.03.121; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477; Yaffe D, 1969, Curr Top Dev Biol, V4, P37, DOI 10.1016/S0070-2153(08)60480-9; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8814	10.1371/journal.pone.0008814	http://dx.doi.org/10.1371/journal.pone.0008814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098686	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779100008
J	van Batenburg, MF; Li, HL; Polman, JA; Lachize, S; Datson, NA; Bussemaker, HJ; Meijer, OC				van Batenburg, Marinus F.; Li, Hualing; Polman, J. Annelies; Lachize, Servane; Datson, Nicole A.; Bussemaker, Harmen J.; Meijer, Onno C.			Paired Hormone Response Elements Predict Caveolin-1 as a Glucocorticoid Target Gene	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DNA-BINDING; TRANSCRIPTIONAL SYNERGY; PLASMA-MEMBRANE; PROTEIN-BINDING; IN-VIVO; IDENTIFICATION; EXPRESSION; CELLS; SEQUENCE	Glucocorticoids act in part via glucocortocoid receptor binding to hormone response elements (HREs), but their direct target genes in vivo are still largely unknown. We developed the criterion that genomic occurrence of paired HREs at an inter-HRE distance less than 200 bp predicts hormone responsiveness, based on synergy of multiple HREs, and HRE information from known target genes. This criterion predicts a substantial number of novel responsive genes, when applied to genomic regions 10 kb upstream of genes. Multiple-tissue in situ hybridization showed that mRNA expression of 6 out of 10 selected genes was induced in a tissue-specific manner in mice treated with a single dose of corticosterone, with the spleen being the most responsive organ. Caveolin-1 was strongly responsive in several organs, and the HRE pair in its upstream region showed increased occupancy by glucocorticoid receptor in response to corticosterone. Our approach allowed for discovery of novel tissue specific glucocorticoid target genes, which may exemplify responses underlying the permissive actions of glucocorticoids.	[van Batenburg, Marinus F.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [van Batenburg, Marinus F.; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Polman, J. Annelies; Lachize, Servane; Datson, Nicole A.; Meijer, Onno C.] Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Amsterdam, Netherlands; [Polman, J. Annelies; Lachize, Servane; Datson, Nicole A.; Meijer, Onno C.] Leiden Univ, Med Ctr, Amsterdam, Netherlands; [Li, Hualing] Nanjing Agr Univ, Life Sci Coll, Dept Biochem & Mol Biol, Nanjing, Peoples R China; [Li, Hualing] Yangzhou Univ, Coll Med, Dept Biochem & Mol Biol, Yangzhou, Peoples R China; [Bussemaker, Harmen J.] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY USA	University of Amsterdam; Academic Medical Center Amsterdam; Columbia University; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Nanjing Agricultural University; Yangzhou University; Columbia University	van Batenburg, MF (corresponding author), Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	o.meijer@lacdr.leidenuniv.nl	Datson, Nicole A./O-8797-2014; meijer, onno c/D-8070-2018	meijer, onno c/0000-0002-8394-6859; Datson, Nicole/0000-0003-2887-0238	Netherlands Organization for Scientific Research (NWO) [BMI-050.50.201, 050.71.404, 917.36.381]; Dutch Royal Academy of Arts and Sciences; NSFC of China [30370851, 30871461]; National Institutes of Health [R01HG003008, U54CA121852]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Royal Academy of Arts and Sciences; NSFC of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	M. F. v. B was supported by grants BMI-050.50.201 and 050.71.404 from the Netherlands Organization for Scientific Research (NWO). O. C. M. was supported by NWO VIDI grant 917.36.381, and the Dutch Royal Academy of Arts and Sciences. H. L was supported by grants 30370851, 30871461 from NSFC of China. H. J. B. was supported by National Institutes of Health grants R01HG003008 and U54CA121852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Chandrasekhar S, 1999, AM J PHYSIOL-LUNG C, V276, pL319, DOI 10.1152/ajplung.1999.276.2.L319; Chavez S, 1997, P NATL ACAD SCI USA, V94, P2885, DOI 10.1073/pnas.94.7.2885; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; DAYNES RA, 1990, J EXP MED, V171, P979, DOI 10.1084/jem.171.4.979; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Gaudreault SB, 2004, NEUROBIOL AGING, V25, P753, DOI 10.1016/j.neurobiolaging.2003.07.004; Gershenzon NI, 2005, NUCLEIC ACIDS RES, V33, P2290, DOI 10.1093/nar/gki519; Geserick C, 2003, MOL ENDOCRINOL, V17, P1738, DOI 10.1210/me.2002-0379; Grenier J, 2004, MOL ENDOCRINOL, V18, P2866, DOI 10.1210/me.2004-0241; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; JEFFERIES WM, 1991, MED HYPOTHESES, V34, P198, DOI 10.1016/0306-9877(91)90212-H; Karst H, 2000, NAT NEUROSCI, V3, P977, DOI 10.1038/79910; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Liu WH, 1996, MOL ENDOCRINOL, V10, P1399, DOI 10.1210/me.10.11.1399; LUND SD, 1991, MOL CELL BIOL, V11, P5426, DOI 10.1128/MCB.11.11.5426; Meijer OC, 2006, STRESS, V9, P61, DOI 10.1080/10253890600799669; Meijer OC, 2000, ENDOCRINOLOGY, V141, P2192, DOI 10.1210/en.141.6.2192; Meijer OC, 2005, ENDOCRINOLOGY, V146, P1438, DOI 10.1210/en.2004-0411; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; RHODES C, 1995, NUCLEIC ACIDS RES, V23, P2305, DOI 10.1093/nar/23.12.2305; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SALATINO M, 2006, ONCOGENE; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SCHMID W, 1989, EMBO J, V8, P2257, DOI 10.1002/j.1460-2075.1989.tb08350.x; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Tausk M., 1951, HORMON, V3, P1; Tonko M, 2001, FASEB J, V15, P693, DOI 10.1096/fj.00-0327com; VANDERLAAN S, 2008, J NEUROCHEM; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; WIEGERS GJ, 1994, ENDOCRINOLOGY, V135, P2351, DOI 10.1210/en.135.6.2351; Wu DQ, 2002, J BIOL CHEM, V277, P40449, DOI 10.1074/jbc.M206270200	48	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8839	10.1371/journal.pone.0008839	http://dx.doi.org/10.1371/journal.pone.0008839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098621	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100030
J	Barrias, ES; Reignault, LC; De Souza, W; Carvalho, TMU				Barrias, Emile S.; Reignault, Lissa C.; De Souza, Wanderley; Carvalho, Tecia M. U.			Dynasore, a Dynamin Inhibitor, Inhibits Trypanosoma cruzi Entry into Peritoneal Macrophages	PLOS ONE			English	Article							INVASION; PHAGOCYTOSIS; INFECTION; SUPERFAMILY; ACTIVATION; TRANSPORT; CELLS	Background: Trypanosoma cruzi is an intracellular parasite that, like some other intracellular pathogens, targets specific proteins of the host cell vesicular transport machinery, leading to a modulation of host cell processes that results in the generation of unique phagosomes. In mammalian cells, several molecules have been identified that selectively regulate the formation of endocytic transport vesicles and the fusion of such vesicles with appropriate acceptor membranes. Among these, the GTPase dynamin plays an important role in clathrin-mediated endocytosis, and it was recently found that dynamin can participate in a phagocytic process. Methodology/Principal Findings: We used a compound called dynasore that has the ability to block the GTPase activity of dynamin. Dynasore acts as a potent inhibitor of endocytic pathways by blocking coated vesicle formation within seconds of its addition. Here, we investigated whether dynamin is involved in the entry process of T. cruzi in phagocytic and non-phagocytic cells by using dynasore. In this aim, peritoneal macrophages and LLC-MK2 cells were treated with increasing concentrations of dynasore before interaction with trypomastigotes, amastigotes or epimastigotes. We observed that, in both cell lines, the parasite internalization was drastically diminished (by greater than 90% in LLC-MK2 cells and 70% in peritoneal macrophages) when we used 100 mu M dynasore. The T. cruzi adhesion index, however, was unaffected in either cell line. Analyzing these interactions by scanning electron microscopy and comparing peritoneal macrophages to LLC-MK2 cells revealed differences in the stage at which cell entry was blocked. In LLC-MK2 cells, this blockade is observed earlier than it is in peritoneal macrophages. In LLC-MK2 cells, the parasites were only associated with cellular microvilli, whereas in peritoneal macrophages, trypomastigotes were not completely engulfed by a host cell plasma membrane. Conclusions/Significance: Taken together our results demonstrate that dynamin is an essential molecule necessary for cell invasion and specifically parasitophorous vacuole formation by host cells during interaction with Trypanosoma cruzi.	[Barrias, Emile S.; Reignault, Lissa C.; De Souza, Wanderley; Carvalho, Tecia M. U.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Barrias, ES (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, CCS Bloco G, BR-21941 Rio De Janeiro, Brazil.	tecia@biof.ufrj.br		Reignault, Lissa Catherine/0000-0003-2553-9312	Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Conselho Nacional de Pesquisa (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazeed ME, 2005, J BIOL CHEM, V280, P4442, DOI 10.1074/jbc.M412553200; Abban CY, 2008, AM J THER, V15, P304, DOI 10.1097/MJT.0b013e3181754134; Alves Maria Julia M., 2008, V47, P58; ALVES MJM, 1986, MOL BIOCHEM PARASIT, V21, P75, DOI 10.1016/0166-6851(86)90081-2; Barrias ES, 2007, BIOCHEM BIOPH RES CO, V363, P828, DOI 10.1016/j.bbrc.2007.09.068; Calvet CM, 2003, J EUKARYOT MICROBIOL, V50, P97, DOI 10.1111/j.1550-7408.2003.tb00240.x; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; DOHERTY GJ, 2009, ANN REV BIO IN PRESS; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Huynh KK, 2008, CURR BIOL, V18, pR563, DOI 10.1016/j.cub.2008.05.032; Lu WB, 2009, J BIOL CHEM, V284, P1930, DOI 10.1074/jbc.M803691200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; Otsuka A, 2009, BIOCHEM BIOPH RES CO, V378, P478, DOI 10.1016/j.bbrc.2008.11.066; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rittig MG, 1998, TRENDS MICROBIOL, V6, P384, DOI 10.1016/S0966-842X(98)01343-2; Rosestolato CTF, 2002, CELL STRUCT FUNCT, V27, P91, DOI 10.1247/csf.27.91; ROTH J, 1983, TECHNIQUES IMMUNOCYT, V2, P217; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Todorov AG, 2000, J BIOL CHEM, V275, P32182, DOI 10.1074/jbc.M909440199; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Vieira M, 2002, HISTOCHEM CELL BIOL, V118, P491, DOI 10.1007/s00418-002-0477-0; Wilkowsky SE, 2002, BIOCHEM BIOPH RES CO, V291, P516, DOI 10.1006/bbrc.2002.6474; Wilkowsky SE, 2001, EXP CELL RES, V264, P211, DOI 10.1006/excr.2000.5123	28	50	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e7764	10.1371/journal.pone.0007764	http://dx.doi.org/10.1371/journal.pone.0007764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098746	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000001
J	Hampton, M; Xu, WW; Kram, BW; Chambers, EM; Ehrnriter, JS; Gralewski, JH; Joyal, T; Carter, CJ				Hampton, Marshall; Xu, Wayne W.; Kram, Brian W.; Chambers, Emily M.; Ehrnriter, Jerad S.; Gralewski, Jonathan H.; Joyal, Teresa; Carter, Clay J.			Identification of Differential Gene Expression in Brassica rapa Nectaries through Expressed Sequence Tag Analysis	PLOS ONE			English	Article							ARABIDOPSIS; OLERACEA; ANATOMY	Background: Nectaries are the floral organs responsible for the synthesis and secretion of nectar. Despite their central roles in pollination biology, very little is understood about the molecular mechanisms underlying nectar production. This project was undertaken to identify genes potentially involved in mediating nectary form and function in Brassica rapa. Methodology and Principal Findings: Four cDNA libraries were created using RNA isolated from the median and lateral nectaries of B. rapa flowers, with one normalized and one non-normalized library being generated from each tissue. Approximately 3,000 clones from each library were randomly sequenced from the 5' end to generate a total of 11,101 high quality expressed sequence tags (ESTs). Sequence assembly of all ESTs together allowed the identification of 1,453 contigs and 4,403 singleton sequences, with the Basic Localized Alignment Search Tool ( BLAST) being used to identify 4,138 presumptive orthologs to Arabidopsis thaliana genes. Several genes differentially expressed between median and lateral nectaries were initially identified based upon the number of BLAST hits represented by independent ESTs, and later confirmed via reverse transcription polymerase chain reaction (RT PCR). RT PCR was also used to verify the expression patterns of eight putative orthologs to known Arabidopsis nectary-enriched genes. Conclusions/Significance: This work provided a snapshot of gene expression in actively secreting B. rapa nectaries, and also allowed the identification of differential gene expression between median and lateral nectaries. Moreover, 207 orthologs to known nectary-enriched genes from Arabidopsis were identified through this analysis. The results suggest that genes involved in nectar production are conserved amongst the Brassicaceae, and also supply clones and sequence information that can be used to probe nectary function in B. rapa.	[Hampton, Marshall] Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA; [Xu, Wayne W.] Univ Minnesota, Minnesota Supercomp Inst, Duluth, MN 55812 USA; [Kram, Brian W.; Chambers, Emily M.; Ehrnriter, Jerad S.; Gralewski, Jonathan H.; Joyal, Teresa; Carter, Clay J.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth	Hampton, M (corresponding author), Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA.	cjcarter@d.umn.edu	xu, wayne/ABA-1961-2020	xu, wayne/0000-0003-0484-7340; Hampton, Marshall/0000-0002-9725-3316	United States Department of Agriculture [2006-35301-16887]; National Science Foundation [0820730]	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the United States Department of Agriculture (www.csrees.usda.gov; 2006-35301-16887 to CJC) and the National Science Foundation (www.nsf.gov; 0820730 to CJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderle P, 2003, BIOTECHNIQUES, P36; BAKER H G, 1978, P57; Bernardello G., 2007, NECTARIES NECTAR, P129; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Carter C, 2006, NATURWISSENSCHAFTEN, V93, P72, DOI 10.1007/s00114-005-0062-1; Davis AR, 1998, PLANTA, V205, P305, DOI 10.1007/s004250050325; Davis AR, 1996, ANN BOT-LONDON, V77, P223, DOI 10.1006/anbo.1996.0026; DAVIS AR, 1986, CAN J BOT, V64, P2508, DOI 10.1139/b86-333; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; Fahn A., 1979, SECRETORY TISSUES PL; Kram BW, 2009, SEX PLANT REPROD, V22, P235, DOI 10.1007/s00497-009-0112-5; Kram BW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-92; Mckim SM, 2008, DEVELOPMENT, V135, P1537, DOI 10.1242/dev.012807; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nepi Massimo, 2007, P129, DOI 10.1007/978-1-4020-5937-7_3; Nicolson S.W., 2007, NECTARIES NECTAR; NIEUWHOF M, 1963, EUPHYTICA, V12, P17, DOI 10.1007/BF00022355; NIEUWHOF M, 1969, COLE CROPS; Pacini Ettore, 2007, P167, DOI 10.1007/978-1-4020-5937-7_4; RUHLMANN JM, 2009, J EXP BOT; Simpson B.B., 1983, P142; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Soares Marcelo Bento, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3_6; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; TAIR9 PROTEIN BLAST	27	22	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8782	10.1371/journal.pone.0008782	http://dx.doi.org/10.1371/journal.pone.0008782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098697	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000011
J	Sanchez, MS; Lloyd-Smith, JO; Getz, WM				Sanchez, Maria S.; Lloyd-Smith, James O.; Getz, Wayne M.			Monitoring Linked Epidemics: The Case of Tuberculosis and HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AFRICAN GOLD MINERS; INFECTION; IMPACT; PREVALENCE; STRAINS; EXAMPLE; MODELS; RISK; NEED	Background: The tight epidemiological coupling between HIV and its associated opportunistic infections leads to challenges and opportunities for disease surveillance. Methodology/Principal Findings: We review efforts of WHO and collaborating agencies to track and fight the TB/HIV coepidemic, and discuss modeling-via mathematical, statistical, and computational approaches-as a means to identify disease indicators designed to integrate data from linked diseases in order to characterize how co-epidemics change in time and space. We present RTB/HIV, an index comparing changes in TB incidence relative to HIV prevalence, and use it to identify those sub-Saharan African countries with outlier TB/HIV dynamics. RTB/HIV can also be used to predict epidemiological trends, investigate the coherency of reported trends, and cross-check the anticipated impact of public health interventions. Identifying the cause(s) responsible for anomalous RTB/HIV values can reveal information crucial to the management of public health. Conclusions/Significance: We frame our suggestions for integrating and analyzing co-epidemic data within the context of global disease monitoring. Used routinely, joint disease indicators such as RTB/HIV could greatly enhance the monitoring and evaluation of public health programs.	[Sanchez, Maria S.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Lloyd-Smith, James O.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Sanchez, MS (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	mssanchezgm1@gmail.com	Lloyd-Smith, James/AAG-4463-2021; /K-4080-2012; Getz, Wayne/I-4521-2013	/0000-0001-7941-502X; Getz, Wayne/0000-0001-8784-9354	National Institutes of Health [R01 DA013510-05]; National Science Foundation [DEB-0090323]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (2000-2006 NIH/NIDA R01 DA013510-05) and National Science Foundation (DEB-0090323) to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; [Anonymous], GUID PREV TUB HLTH C; [Anonymous], 2009, TB HIV FACTS 2009; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Brooks JT, 2009, CLIN INFECT DIS, V48, P609, DOI 10.1086/596756; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Caribbean Epidemiology Centre, 2002, GUID UPGR HIV AIDS S; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; DeRiemer K, 2007, AM J RESP CRIT CARE, V176, P936, DOI 10.1164/rccm.200603-440OC; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; ESCOMBE AR, 2009, 5036 WHO WC; GANDHI NR, 2009, AM J RESP CRIT  1015; Kettenring KM, 2006, BIOSCIENCE, V56, P59, DOI 10.1641/0006-3568(2006)056[0059:GPFSEM]2.0.CO;2; Lalloo Umesh G, 2008, Curr HIV/AIDS Rep, V5, P132, DOI 10.1007/s11904-008-0021-5; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lifson AR, 2008, HIV CLIN TRIALS, V9, P177, DOI 10.1310/hct0903-177; Lloyd-Smith JO, 2008, PARASITOLOGY, V135, P795, DOI 10.1017/S0031182008000292; Mansoer J, 2009, B WORLD HEALTH ORGAN, V87, P186, DOI 10.2471/BLT.08.051474; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; RIEDNER G, 1999, HIV AIDS SURVEILLANC; Salomon JA, 2006, PLOS MED, V3, P1302, DOI 10.1371/journal.pmed.0030273; Saltelli A., 2000, SENSITIVITY ANAL; Sanchez MS, 2008, AIDS, V22, P963, DOI 10.1097/QAD.0b013e3282f7cb4b; Sanchez MS, 2009, EPIDEMICS-NETH, V1, P14, DOI 10.1016/j.epidem.2008.08.001; Sanchez MS, 2006, EMERG INFECT DIS, V12, P191; Sanchez MS, 2005, B MATH BIOL, V67, P761, DOI 10.1016/j.bulm.2004.10.001; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS, 2006, UNAIDS ANN REP 2006; *WHO, 2002, STRAT FRAM DECR BURD; *WHO, 2006, GLOB TUB CONTR SURV; WHO, 2005, TB HIV RES PRIOR RES; WHO, 2007, TUB CAR TB HIV COM; WHO, 2004, INT POL COLL TB HIV; *WHO, 2004, GUID MON EV COLL TB; WHO, 2007, IMPR DIAGN TREATM SM; WHO, 2009, WHOHTMTB2009411; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Wilson DP, 2006, P NATL ACAD SCI USA, V103, P14228, DOI 10.1073/pnas.0509689103; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2003, GUID IMPL COLL TB HI; World Health Organization, 2004, GUID HIV SURV TUB PA; World Health Organization, 2007, NETW POL CHANG TB HI; World Health Organization, 2007, GLOB MDR TB XDR TB R; World Health Organization, 2006, WHO GLOB TB DAT	50	6	6	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8796	10.1371/journal.pone.0008796	http://dx.doi.org/10.1371/journal.pone.0008796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098716	Green Published, gold			2022-12-25	WOS:000273779000023
J	Liu, BY; Soloviev, I; Chang, P; Lee, J; Huang, XD; Zhong, CL; Ferrara, N; Polakis, P; Sakanaka, C				Liu, Bob Y.; Soloviev, Irina; Chang, Peter; Lee, John; Huang, XiaoDong; Zhong, Cuiling; Ferrara, Napoleone; Polakis, Paul; Sakanaka, Chie			Stromal Cell-Derived Factor-1/CXCL12 Contributes to MMTV-Wnt1 Tumor Growth Involving Gr1(+)CD11b(+) Cells	PLOS ONE			English	Article							BETA-CATENIN; BREAST CARCINOMAS; MYELOID CELLS; WNT PATHWAY; ANGIOGENESIS; EXPRESSION; RECRUITMENT; RECEPTOR; IDENTIFICATION; MACROPHAGES	Background: Histological examinations of MMTV-Wnt1 tumors reveal drastic differences in the tumor vasculature when compared to MMTV-Her2 tumors. However, these differences have not been formally described, nor have any angiogenic factors been implicated to be involved in the Wnt1 tumors. Methodology/Principal Findings: Here, we show that MMTV-Wnt1 tumors were more vascularized than MMTV-Her2 tumors, and this correlated with significantly higher expression of a CXC chemokine, stromal cell-derived factor-1 (SDF1/CXCL12) but not with VEGFA. Isolation of various cell types from Wnt1 tumors revealed that SDF1 was produced by both tumor myoepithelial cells and stromal cells, whereas Her2 tumors lacked myoepithelial cells and contained significantly less stroma. The growth of Wnt1 tumors, but not Her2 tumors, was inhibited by a neutralizing antibody to SDF1, but not by neutralization of VEGFA. Anti-SDF1 treatment decreased the proportion of infiltrating Gr1(+) myeloid cells in the Wnt1 tumors, which correlated with a decrease in the percentage of endothelial cells. The involvement of Gr1(+) cells was evident from the retardation of Wnt1 tumor growth following in vivo depletion of these cells with an anti-Gr1-specific antibody. This degree of inhibition on Wnt1 tumor growth was comparable, but not additive, to the effect observed with anti-SDF1, indicative of overlapping mechanisms of inhibition. In contrast, Her2 tumors were not affected by the depletion of Gr1(+) cells. Conclusions/Significance: We demonstrated that SDF1 is important for Wnt1, but not for HER2, in inducing murine mammary tumor and the role of SDF1 in tumorigenesis involves Gr1(+) myeloid cells to facilitate growth and/or angiogenesis.	[Liu, Bob Y.; Soloviev, Irina; Chang, Peter; Lee, John; Zhong, Cuiling; Ferrara, Napoleone; Polakis, Paul; Sakanaka, Chie] Genentech Inc, Res Oncol, San Francisco, CA 94080 USA; [Huang, XiaoDong] Genentech Inc, Physiol Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Liu, BY (corresponding author), Genentech Inc, Res Oncol, San Francisco, CA 94080 USA.	chies@gene.com			Genentech Inc	Genentech Inc(Roche HoldingGenentech)	This work was supported by Genentech Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Easwaran V, 2003, CANCER RES, V63, P3145; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; FOX SB, 1994, BREAST CANCER RES TR, V29, P109, DOI 10.1007/BF00666186; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kim YC, 2008, CANCER RES, V68, P10145, DOI 10.1158/0008-5472.CAN-08-2992; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kovacs A, 2003, J CLIN PATHOL, V56, P139, DOI 10.1136/jcp.56.2.139; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Michaelson JS, 2001, ONCOGENE, V20, P5093, DOI 10.1038/sj.onc.1204586; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	38	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8611	10.1371/journal.pone.0008611	http://dx.doi.org/10.1371/journal.pone.0008611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20087418	Green Published, Green Submitted, gold			2022-12-25	WOS:000273778900003
J	Takesono, A; Heasman, SJ; Wojciak-Stothard, B; Garg, R; Ridley, AJ				Takesono, Aya; Heasman, Sarah J.; Wojciak-Stothard, Beata; Garg, Ritu; Ridley, Anne J.			Microtubules Regulate Migratory Polarity through Rho/ROCK Signaling in T Cells	PLOS ONE			English	Article							NEUTROPHIL POLARIZATION; ACTIN CYTOSKELETON; ALPHA-TUBULIN; RHO-GTPASES; IN-VIVO; CHEMOTAXIS; MOTILITY; LYMPHOCYTES; DYNAMICS; MYOSIN	Background: Migrating leukocytes normally have a polarized morphology with an actin-rich lamellipodium at the front and a uropod at the rear. Microtubules (MTs) are required for persistent migration and chemotaxis, but how they affect cell polarity is not known. Methodology/Principal Findings: Here we report that T cells treated with nocodazole to disrupt MTs are unable to form a stable uropod or lamellipodium, and instead often move by membrane blebbing with reduced migratory persistence. However, uropod-localized receptors and ezrin/radixin/moesin proteins still cluster in nocodazole-treated cells, indicating that MTs are required specifically for uropod stability. Nocodazole stimulates RhoA activity, and inhibition of the RhoA target ROCK allows nocodazole-treated cells to re-establish lamellipodia and uropods and persistent migratory polarity. ROCK inhibition decreases nocodazole-induced membrane blebbing and stabilizes MTs. The myosin inhibitor blebbistatin also stabilizes MTs, indicating that RhoA/ROCK act through myosin II to destabilize MTs. Conclusions/Significance: Our results indicate that RhoA/ROCK signaling normally contributes to migration by affecting both actomyosin contractility and MT stability. We propose that regulation of MT stability and RhoA/ROCK activity is a mechanism to alter T-cell migratory behavior from lamellipodium-based persistent migration to bleb-based migration with frequent turning.	[Takesono, Aya; Ridley, Anne J.] UCL, Dept Biochem & Mol Biol, London, England; [Takesono, Aya; Ridley, Anne J.] UCL, Ludwig Inst Canc Res, London, England; [Takesono, Aya] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Heasman, Sarah J.; Garg, Ritu; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Wojciak-Stothard, Beata] Univ London Imperial Coll Sci Technol & Med, Dept Expt Med & Toxicol, London, England	University of London; University College London; Ludwig Institute for Cancer Research; University of London; University College London; University of Exeter; University of London; King's College London; Imperial College London	Takesono, A (corresponding author), UCL, Dept Biochem & Mol Biol, London, England.	anne.ridley@kcl.ac.uk		Ridley, Anne/0000-0001-8186-5708	Biotechnology and Biological Sciences Research Council (BBSRC) [31/C14420]; Leukaemia Research Fund United Kingdom [04021]; Cancer Research United Kingdom [C6620/A8833]; MRC [G0600806] Funding Source: UKRI; Medical Research Council [G0600806] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia Research Fund United Kingdom; Cancer Research United Kingdom(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant 31/C14420, Leukaemia Research Fund United Kingdom grant 04021 and Cancer Research United Kingdom grant C6620/A8833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; BORNENS M, 1989, J CELL BIOL, V109, P1071, DOI 10.1083/jcb.109.3.1071; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; Burridge K, 2006, NAT CELL BIOL, V8, P781, DOI 10.1038/ncb0806-781; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; DANOWSKI BA, 1989, J CELL SCI, V93, P255; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Eddy RJ, 2002, MOL BIOL CELL, V13, P4470, DOI 10.1091/mbc.E02-04-0241; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; GLASGOW JE, 1994, CELL MOTIL CYTOSKEL, V27, P88, DOI 10.1002/cm.970270110; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grigoriev I, 2006, CELL MOTIL CYTOSKEL, V63, P29, DOI 10.1002/cm.20107; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Hogg N, 2004, IMMUNOL LETT, V92, P51, DOI 10.1016/j.imlet.2003.10.014; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kanthou C, 2002, BLOOD, V99, P2060, DOI 10.1182/blood.V99.6.2060; KELLER HU, 1993, CELL MOTIL CYTOSKEL, V25, P10, DOI 10.1002/cm.970250103; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Ling L, 2004, J BIOL CHEM, V279, P32737, DOI 10.1074/jbc.M400601200; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Mseka T, 2007, J CELL SCI, V120, P4332, DOI 10.1242/jcs.017640; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ratner S, 1997, J IMMUNOL, V159, P1063; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; UEDA M, 1994, J CELL SCI, V107, P2071; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Verma NK, 2008, J MOL MED-JMM, V86, P457, DOI 10.1007/s00109-008-0312-8; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2001, J CELL SCI, V114, P3795; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	72	126	127	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8774	10.1371/journal.pone.0008774	http://dx.doi.org/10.1371/journal.pone.0008774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098744	gold, Green Published, Green Submitted			2022-12-25	WOS:000273778900017
J	Singer, BB; Scheffrahn, I; Kammerer, R; Suttorp, N; Ergun, S; Slevogt, H				Singer, Bernhard B.; Scheffrahn, Inka; Kammerer, Robert; Suttorp, Norbert; Ergun, Suleyman; Slevogt, Hortense			Deregulation of the CEACAM Expression Pattern Causes Undifferentiated Cell Growth in Human Lung Adenocarcinoma Cells	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN CEA; ADHESION MOLECULE CEACAM1; BILIARY GLYCOPROTEIN; EPITHELIAL-CELLS; C-CAM; PANCREATIC ADENOCARCINOMA; ELEVATED EXPRESSION; GENE-EXPRESSION; USPA1 PROTEIN; CANCER	CEACAM1, CEA/CEACAM5, and CEACAM6 are cell adhesion molecules (CAMs) of the carcinoembryonic antigen (CEA) family that have been shown to be deregulated in lung cancer and in up to 50% of all human cancers. However, little is known about the functional impact of these molecules on undifferentiated cell growth and tumor progression. Here we demonstrate that cell surface expression of CEACAM1 on confluent A549 human lung adenocarcinoma cells plays a critical role in differentiated, contact-inhibited cell growth. Interestingly, CEACAM1-L, but not CEACAM1-S, negatively regulates proliferation via its ITIM domain, while in proliferating cells no CEACAM expression is detectable. Furthermore, we show for the first time that CEACAM6 acts as an inducer of cellular proliferation in A549 cells, likely by interfering with the contact-inhibiting signal triggered by CEACAM1-4L, leading to undifferentiated anchorage-independent cell growth. We also found that A549 cells expressed significant amounts of non-membrane anchored variants of CEACAM5 and CEACAM6, representing a putative source for the increased CEACAM5/6 serum levels frequently found in lung cancer patients. Taken together, our data suggest that post-confluent contact inhibition is established and maintained by CEACAM1-4L, but disturbances of CEACAM1 signalling by CEACAM1-4S and other CEACAMs lead to undifferentiated cell growth and malignant transformation.	[Singer, Bernhard B.; Scheffrahn, Inka; Ergun, Suleyman] Univ Hosp Essen, Inst Anat, Essen, Germany; [Kammerer, Robert] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany; [Suttorp, Norbert; Slevogt, Hortense] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany	University of Duisburg Essen; Friedrich Loeffler Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Singer, BB (corresponding author), Univ Hosp Essen, Inst Anat, Essen, Germany.	BBSinger@gmx.de	Kammerer, Robert/AAQ-1338-2021; Singer, Bernhard B./AAP-9999-2020	Kammerer, Robert/0000-0003-3038-8205; Suttorp, Norbert/0000-0002-3958-1151	Deutsche Forschungsgesellschaf [SFB366, TPC1, DFG Er 276/4-4, SL 153/1-1]	Deutsche Forschungsgesellschaf	This work was supported by grants from the Deutsche Forschungsgesellschaft to BBS (SFB366, Zellulaere Signalerkennung und Umsetzung, TPC1), to SE (DFG Er 276/4-4), and to HS (SL 153/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberger AM, 1998, AM J PATHOL, V152, P1401; Brooks MJ, 2008, INFECT IMMUN, V76, P5322, DOI 10.1128/IAI.00572-08; Brummer J, 1996, TISSUE ANTIGENS, V48, pMC306; Camacho-Leal P, 2008, ONCOGENE, V27, P1545, DOI 10.1038/sj.onc.1210789; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; CHEVINSKY AH, 1991, SEMIN SURG ONCOL, V7, P162, DOI 10.1002/ssu.2980070309; Croce M V, 1999, Pathol Oncol Res, V5, P197, DOI 10.1053/paor.1999.0212; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; Duxbury MS, 2005, ANN SURG, V241, P491, DOI 10.1097/01.sla.0000154455.86404.e9; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; ENGER MD, 1986, AM J PHYSIOL, V250, pC256, DOI 10.1152/ajpcell.1986.250.2.C256; Fahlgren A, 2003, SCAND J IMMUNOL, V58, P628, DOI 10.1111/j.1365-3083.2003.01342.x; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; GRUNERT F, 1995, INT J CANCER, V63, P349, DOI 10.1002/ijc.2910630308; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Horst AK, 2004, HANDB EXP PHARM, V165, P283, DOI 10.1007/978-3-540-68170-0_10; HSIEH JT, 1995, CANCER RES, V55, P190; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Ieta K, 2006, BRIT J CANCER, V95, P532, DOI 10.1038/sj.bjc.6603276; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Kleinerman DI, 1996, CANCER RES, V56, P3431; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kunath T, 1995, ONCOGENE, V11, P2375; Laack E, 2002, J CLIN ONCOL, V20, P4279, DOI 10.1200/JCO.2002.08.067; Litkouhi B, 2008, GYNECOL ONCOL, V109, P234, DOI 10.1016/j.ygyno.2008.01.031; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; N'Guessan PD, 2007, J INFECT DIS, V195, P1651, DOI 10.1086/514820; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Obrink B, 2008, LUNG CANCER, V60, P309, DOI 10.1016/j.lungcan.2008.03.020; OHWADA A, 1994, AM J RESP CELL MOL, V11, P214, DOI 10.1165/ajrcmb.11.2.8049082; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Ordonez C, 2000, CANCER RES, V60, P3419; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Rubin H, 2007, ADV CANCER RES, V98, P117, DOI 10.1016/S0065-230X(06)98004-X; Scheffrahn I, 2005, EXP CELL RES, V307, P427, DOI 10.1016/j.yexcr.2005.03.030; Sienel W, 2003, CLIN CANCER RES, V9, P2260; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; Singer BB, 2000, CANCER RES, V60, P1236; SINGER BB, 2005, CEACAM1 UCSD NATURE, DOI DOI 10.1038/MPA00359701; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Travis WD, 2006, J THORAC ONCOL, V1, pS13, DOI 10.1097/01243894-200611001-00004; Wang L, 2000, CLIN CANCER RES, V6, P2988; Watanabe N, 2002, AM J PHYSIOL-LUNG C, V283, pL726, DOI 10.1152/ajplung.00025.2002	52	64	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8747	10.1371/journal.pone.0008747	http://dx.doi.org/10.1371/journal.pone.0008747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090913	Green Submitted, Green Published, gold			2022-12-25	WOS:000273715000007
J	Canavese, M; Altruda, F; Silengo, L				Canavese, Miriam; Altruda, Fiorella; Silengo, Lorenzo			Therapeutic Efficacy and Immunological Response of CCL5 Antagonists in Models of Contact Skin Reaction	PLOS ONE			English	Article							CHEMOKINE SYSTEM; MET-RANTES; PSORIASIS; KERATINOCYTES; INTERFERENCE; DERMATITIS; RECEPTORS; DISEASE	Skin-infiltrating T-cells play a predominant role in allergic and inflammatory skin diseases such as atopic dermatitis, psoriasis and allergic contact dermatitis. These T-cells are attracted by several chemotactic factors including the chemokine CCL5/RANTES, a CC chemokine inducing both the migration and activation of specific leukocyte subsets. CCL5 has been found to be associated with various cell-mediated hypersensitive disorders such as psoriasis, atopic dermatitis and irritant contact dermatitis. We have used two antagonists, the first, Met-CCL5, a dual CCR1/CCR5 antagonist and the second, a variant in which GAG binding is abrogated, 44 AANA 47-CCL5, which acts as a dominant negative inhibitor of CCL5. The antagonists were tested in two models of contact skin reaction. The first, irritant contact dermatitis (ICD) is a pathological non-specific inflammatory skin condition arising from the release of pro-inflammatory cytokines by keratinocytes in response to haptens, usually chemicals. The second, contact hypersensitivity (CHS) is a T-cell dependent model, mimicking in part the T-cell-mediated skin diseases such as psoriasis. In both models, the CCL5 antagonists showed therapeutic efficacy by reducing swelling by 50% as well as the reduction of soluble mediators in homogenates derived from challenged ears. These results demonstrate that blocking the receptor or the ligand are both effective strategies to inhibit skin inflammation.	[Canavese, Miriam; Altruda, Fiorella; Silengo, Lorenzo] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	University of Turin	Canavese, M (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	miriamcanavese@yahoo.com			Merck Serono International	Merck Serono International	Funding: This work was supported by a Research Grant from Merck Serono International S. A. The funders supported study design, data collection and analysis, but they had no role in decision to publish and preparation of the manuscript.	Akahira-Azuma M, 2004, IMMUNOLOGY, V111, P306, DOI 10.1111/j.0019-2805.2004.01818.x; Asadullah K, 2002, TRENDS IMMUNOL, V23, P47, DOI 10.1016/S1471-4906(01)02119-6; Dahl M V, 1988, Adv Dermatol, V3, P261; Elsner J, 1999, INT ARCH ALLERGY IMM, V118, P462, DOI 10.1159/000024164; GILLITZER R, 1993, J INVEST DERMATOL, V101, P127, DOI 10.1111/1523-1747.ep12363613; Glass WG, 2004, J IMMUNOL, V172, P4018, DOI 10.4049/jimmunol.172.7.4018; Grabbe S, 1996, J CLIN INVEST, V98, P1158, DOI 10.1172/JCI118899; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Johnson Z, 2005, TRENDS IMMUNOL, V26, P268, DOI 10.1016/j.it.2005.03.001; Kapuscinska Renata, 2004, Wiad Lek, V57, P599; Loffler H, 2000, HAUTARZT, V51, P203, DOI 10.1007/s001050051023; Matsui M, 2002, J NEUROIMMUNOL, V128, P16, DOI 10.1016/S0165-5728(02)00121-2; MCKAY IA, 1995, CLIN DERMATOL, V13, P105, DOI 10.1016/0738-081X(95)93817-8; NICKOLOFF BJ, 1994, AM J PATHOL, V144, P820; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Pastore S, 2004, EUR J DERMATOL, V14, P203; Proudfoot AEI, 1999, J BIOL CHEM, V274, P32478, DOI 10.1074/jbc.274.45.32478; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Schon MP, 2001, NAT IMMUNOL, V2, P91, DOI 10.1038/84293; Teixeira MM, 1997, J CLIN INVEST, V100, P1657, DOI 10.1172/JCI119690	22	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8725	10.1371/journal.pone.0008725	http://dx.doi.org/10.1371/journal.pone.0008725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090949	Green Submitted, gold, Green Published			2022-12-25	WOS:000273714900006
J	Murray, RJ; Robinson, JO; White, JN; Hughes, F; Coombs, GW; Pearson, JC; Tan, HL; Chidlow, G; Williams, S; Christiansen, KJ; Smith, DW				Murray, Ronan J.; Robinson, James O.; White, Jodi N.; Hughes, Frank; Coombs, Geoffrey W.; Pearson, Julie C.; Tan, Hui-Leen; Chidlow, Glenys; Williams, Simon; Christiansen, Keryn J.; Smith, David W.			Community-Acquired Pneumonia Due to Pandemic A(H1N1)2009 Influenzavirus and Methicillin Resistant Staphylococcus aureus Co-Infection	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; BACTERIAL PNEUMONIA; H1N1 INFLUENZA; UNITED-STATES; ELECTROPHORESIS; CHILDREN; CRITERIA; STRAINS; ASSAY	Background: Bacterial pneumonia is a well described complication of influenza. In recent years, community-onset methicillin-resistant Staphylococcus aureus (cMRSA) infection has emerged as a contributor to morbidity and mortality in patients with influenza. Since the emergence and rapid dissemination of pandemic A(H1N1) 2009 influenzavirus in April 2009, initial descriptions of the clinical features of patients hospitalized with pneumonia have contained few details of patients with bacterial co-infection. Methodology/Principal Findings: Patients with community-acquired pneumonia (CAP) caused by co-infection with pandemic A(H1N1) 2009 influenzavirus and cMRSA were prospectively identified at two tertiary hospitals in one Australian city during July to September 2009, the period of intense influenza activity in our region. Detailed characterization of the cMRSA isolates was performed. 252 patients with pandemic A(H1N1) 2009 influenzavirus infection were admitted at the two sites during the period of study. Three cases of CAP due to pandemic A(H1N1) 2009/cMRSA co-infection were identified. The clinical features of these patients were typical of those with S. aureus co-infection or sequential infection following influenza. The 3 patients received appropriate empiric therapy for influenza, but inappropriate empiric therapy for cMRSA infection; all 3 survived. In addition, 2 fatal cases of CAP caused by pandemic A(H1N1) 2009/cMRSA co-infection were identified on postmortem examination. The cMRSA infections were caused by three different cMRSA clones, only one of which contained genes for Panton-Valentine Leukocidin (PVL). Conclusions/Significance: Clinicians managing patients with pandemic A(H1N1) 2009 influenzavirus infection should be alert to the possibility of co-infection or sequential infection with virulent, antimicrobial-resistant bacterial pathogens such as cMRSA. PVL toxin is not necessary for the development of cMRSA pneumonia in the setting of pandemic A(H1N1) 2009 influenzavirus co-infection.	[Murray, Ronan J.; Chidlow, Glenys; Williams, Simon; Smith, David W.] Queen Elizabeth II Med Ctr, PathW Lab Med WA, Div Microbiol & Infect Dis, Perth, WA, Australia; [Robinson, James O.; Coombs, Geoffrey W.; Pearson, Julie C.; Tan, Hui-Leen; Christiansen, Keryn J.] Royal Perth Hosp, PathW Lab Med WA, Dept Microbiol & Infect Dis, Perth, WA, Australia; [White, Jodi N.; Hughes, Frank] Queen Elizabeth II Med Ctr, PathW Lab Med WA, Div Forens Pathol, Perth, WA, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Murray, RJ (corresponding author), Queen Elizabeth II Med Ctr, PathW Lab Med WA, Div Microbiol & Infect Dis, Perth, WA, Australia.	ronan.murray@health.wa.gov.au	Robinson, Owen/GNP-1638-2022	Smith, David/0000-0002-3107-5182; Williams, Simon/0000-0002-6276-4685; Coombs, Geoffrey/0000-0003-1635-6506	PathWest Laboratory Medicine WA; Health Department of Western Australia	PathWest Laboratory Medicine WA; Health Department of Western Australia	The study was funded by PathWest Laboratory Medicine WA and the Health Department of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	*AUSTR GOV DEP HLT, 2009, 24 AUSTR GOV DEP HLT; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Cheng VCC, 2009, J INFECTION, V59, P366, DOI 10.1016/j.jinf.2009.08.021; Chickering HT, 1919, J AMER MED ASSOC, V72, P617, DOI 10.1001/jama.1919.02610090001001; *CLIN LAB STAND I, 2009, M02A10 CLIN LAB STAN; Clinical and Laboratory Standards Institute, 2009, M100S18 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2007, M7A7 CLIN LAB STAND; Costa AM, 2005, DIAGN MICR INFEC DIS, V51, P13, DOI 10.1016/j.diagmicrobio.2004.08.014; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; Finlay JE, 1997, ANTIMICROB AGENTS CH, V41, P1137, DOI 10.1128/AAC.41.5.1137; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gonzalez BE, 2005, CLIN INFECT DIS, V41, P583, DOI 10.1086/432475; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kallen AJ, 2009, ANN EMERG MED, V53, P358, DOI 10.1016/j.annemergmed.2008.04.027; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Murata Y, 2007, J INFECT DIS, V195, P1029, DOI 10.1086/512160; *NAT HLTH MRC, 2003, DOES QUAL ASS HEALTH; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; O'Brien FG, 2006, NAT PROTOC, V1, P3028, DOI 10.1038/nprot.2006.382; Reed C, 2009, PEDIATR INFECT DIS J, V28, P572, DOI 10.1097/INF.0b013e31819d8b71; ROBERTSON L, 1958, LANCET, V2, P233; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; The National Health and Medical Research Council, 2007, NAT STAT ETH COND HU; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WEHRHAHN MC, 2010, EUR J CLIN IN PRESS; Whiley DM, 2005, DIAGN MICR INFEC DIS, V53, P335, DOI 10.1016/j.diagmicrobio.2005.08.002; Witte W, 2007, J ANTIMICROB CHEMOTH, V60, P1258, DOI 10.1093/jac/dkm384; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; [No title captured]	42	67	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8705	10.1371/journal.pone.0008705	http://dx.doi.org/10.1371/journal.pone.0008705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090931	gold, Green Published			2022-12-25	WOS:000273714600008
J	Bellone, M; Ceccon, M; Grioni, M; Jachetti, E; Calcinotto, A; Napolitano, A; Freschi, M; Casorati, G; Dellabona, P				Bellone, Matteo; Ceccon, Monica; Grioni, Matteo; Jachetti, Elena; Calcinotto, Arianna; Napolitano, Anna; Freschi, Massimo; Casorati, Giulia; Dellabona, Paolo			iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells	PLOS ONE			English	Article							INVARIANT NKT CELLS; PROSTATE-CANCER; TRANSGENIC ADENOCARCINOMA; ALPHA-GALACTOSYLCERAMIDE; IMMUNE-RESPONSE; DENDRITIC CELLS; ANTITUMOR IMMUNITY; ANTIGEN; MICE; TOLERANCE	Background: CD1d-restricted invariant NKT (iNKT) cells are a subset of T lymphocytes endowed with innate effector functions that aid in the establishment of adaptive T and B cell immune responses. iNKT cells have been shown to play a spontaneous protective role against experimental tumors. Yet, the interplay between iNKT and tumor-specific T cells in cancer immune surveillance/editing has never been addressed. The transgenic adenocarcinoma of the mouse prostate (TRAMP) is a realistic model of spontaneous oncogenesis, in which the tumor-specific cytotoxic T cell (CTL) response undergoes full tolerance upon disease progression. Principal Findings: We report here that lack of iNKT cells in TRAMP mice resulted in the appearance of more precocious and aggressive tumors that significantly reduced animal survival. TRAMP mice bearing or lacking iNKT cells responded similarly to a tumor-specific vaccination and developed tolerance to a tumor-associated antigen at comparable rate. Conclusions: Hence, our data argue for a critical role of iNKT cells in the immune surveillance of carcinoma that is independent of tumor-specific CTL.	[Bellone, Matteo; Ceccon, Monica; Grioni, Matteo; Jachetti, Elena; Calcinotto, Arianna] Ist Sci San Raffaele, Cellular Immunol Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Napolitano, Anna; Casorati, Giulia; Dellabona, Paolo] Ist Sci San Raffaele, Expt Immunol Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Freschi, Massimo] Ist Sci San Raffaele, Unita Operat Anat Patol, Milan, Italy; [Jachetti, Elena; Napolitano, Anna] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Bellone, M (corresponding author), Ist Sci San Raffaele, Cellular Immunol Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy.	bellone.matteo@hsr.it; casorati.giulia@hsr.it; paolo.dellabona@hsr.it	Bellone, Matteo/B-6922-2013; Dellabona, Paolo/G-5416-2012; Matteo, Grioni/AAN-5912-2020; Jachetti, Elena/C-2145-2017; Casorati, Giulia/J-7141-2018	Bellone, Matteo/0000-0002-2586-2569; Dellabona, Paolo/0000-0002-1414-633X; Matteo, Grioni/0000-0002-9930-042X; Jachetti, Elena/0000-0001-6483-7350; Calcinotto, Arianna/0000-0003-1746-6424; Casorati, Giulia/0000-0002-5102-4112; Napolitano, Anna/0000-0001-8946-8002	Associazione Italiana per la Ricerca sul Cancro; Ministero del lavoro, della salute e delle politiche sociali; Fondazione CARIPLO; Association for International Cancer Research	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero del lavoro, della salute e delle politiche sociali(Ministry of Health, Italy); Fondazione CARIPLO(Fondazione Cariplo); Association for International Cancer Research	ssociazione Italiana per la Ricerca sul Cancro: www.airc.it Ministero del lavoro, della salute e delle politiche sociali:www.ministerosalute.it/ Fondazione CARIPLO: fondazionecariplo.it Association for International Cancer Research: www.aicr.org.uk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BERTILACCIO S, 2008, PROSTATE        0424; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Camporeale A, 2003, CANCER RES, V63, P3688; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Degl'Innocenti E, 2005, EUR J IMMUNOL, V35, P66, DOI 10.1002/eji.200425531; Degl'Innocenti E, 2008, CANCER RES, V68, P292, DOI 10.1158/0008-5472.CAN-07-2429; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Dhodapkar KM, 2004, INT J CANCER, V109, P893, DOI 10.1002/ijc.20050; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Drake CG, 2005, CANCER CELL, V7, P239, DOI 10.1016/j.ccr.2005.01.027; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; Fiedler T, 2002, INT J CANCER, V98, P389, DOI 10.1002/ijc.10141; Foster BA, 1997, CANCER RES, V57, P3325; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hayakawa Y, 2003, P NATL ACAD SCI USA, V100, P9464, DOI 10.1073/pnas.1630663100; Iezzi G, 2006, J IMMUNOL, V177, P2131, DOI 10.4049/jimmunol.177.4.2131; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Metelitsa LS, 2003, LEUKEMIA, V17, P1068, DOI 10.1038/sj.leu.2402943; Miller AM, 2007, CANCER IMMUNOL IMMUN, V56, P81, DOI 10.1007/s00262-005-0110-x; Molling JW, 2007, J CLIN ONCOL, V25, P862, DOI 10.1200/JCO.2006.08.5787; Mylin LM, 2000, J VIROL, V74, P6922, DOI 10.1128/JVI.74.15.6922-6934.2000; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Song LP, 2009, J CLIN INVEST, V119, P1524, DOI 10.1172/JCI37869; Swann J, 2004, IMMUNOL CELL BIOL, V82, P323, DOI 10.1111/j.1440-1711.2004.01254.x; SWANN JB, 2009, BLOOD           0220; Tachibana T, 2005, CLIN CANCER RES, V11, P7322, DOI 10.1158/1078-0432.CCR-05-0877; TANAKA Y, 1988, J IMMUNOL, V140, P4348; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Tonti E, 2009, BLOOD, V113, P370, DOI 10.1182/blood-2008-06-166249; Yanagisawa K, 2006, CANCER RES, V66, P11441, DOI 10.1158/0008-5472.CAN-06-0944; Zheng XC, 2002, J IMMUNOL, V169, P4761, DOI 10.4049/jimmunol.169.9.4761	52	54	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8646	10.1371/journal.pone.0008646	http://dx.doi.org/10.1371/journal.pone.0008646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072624	Green Submitted, Green Published, gold			2022-12-25	WOS:000273554600009
J	Diallo, A; Kane, N; Agharbaoui, Z; Badawi, M; Sarhan, F				Diallo, Amadou; Kane, Ndjido; Agharbaoui, Zahra; Badawi, Mohamed; Sarhan, Fathey			Heterologous Expression of Wheat VERNALIZATION 2 (TaVRN2) Gene in Arabidopsis Delays Flowering and Enhances Freezing Tolerance	PLOS ONE			English	Article							MADS BOX GENE; MAJOR DETERMINANT; LOW-TEMPERATURE; LOCUS; TIME; PHOTOPERIOD; REPRESSOR; WINTER; TRANSCRIPTION; CONSERVATION	The vernalization gene 2 (VRN2), is a major flowering repressor in temperate cereals that is regulated by low temperature and photoperiod. Here we show that the gene from Triticum aestivum (TaVRN2) is also regulated by salt, heat shock, dehydration, wounding and abscissic acid. Promoter analysis indicates that TaVRN2 regulatory region possesses all the specific responsive elements to these stresses. This suggests pleiotropic effects of TaVRN2 in wheat development and adaptability to the environment. To test if TaVRN2 can act as a flowering repressor in species different from the temperate cereals, the gene was ectopically expressed in the model plant Arabidopsis. Transgenic plants showed no alteration in morphology, but their flowering time was significantly delayed compared to controls plants, indicating that TaVRN2, although having no ortholog in Brassicaceae, can act as a flowering repressor in these species. To identify the possible mechanism by which TaVRN2 gene delays flowering in Arabidopsis, the expression level of several genes involved in flowering time regulation was determined. The analysis indicates that the late flowering of the 35S::TaVRN2 plants was associated with a complex pattern of expression of the major flowering control genes, FCA, FLC, FT, FVE and SOC1. This suggests that heterologous expression of TaVRN2 in Arabidopsis can delay flowering by modulating several floral inductive pathways. Furthermore, transgenic plants showed higher freezing tolerance, likely due to the accumulation of CBF2, CBF3 and the COR genes. Overall, our data suggests that TaVRN2 gene could modulate a common regulator of the two interacting pathways that regulate flowering time and the induction of cold tolerance. The results also demonstrate that TaVRN2 could be used to manipulate flowering time and improve cold tolerance in other species.	[Diallo, Amadou; Kane, Ndjido; Agharbaoui, Zahra; Badawi, Mohamed; Sarhan, Fathey] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Diallo, A (corresponding author), Univ Quebec, Dept Sci Biol, CP 8888, Montreal, PQ H3C 3P8, Canada.	sarhan.fathey@uqam.ca	Kane, Ndjido Ardo/AAM-7656-2020	Kane, Ndjido Ardo/0000-0002-1879-019X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam H, 2007, PLANT CELL PHYSIOL, V48, P1192, DOI 10.1093/pcp/pcm089; Allaby RC, 1999, GENOME, V42, P296, DOI 10.1139/gen-42-2-296; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Fowler DB, 2001, PLANT PHYSIOL, V127, P1676, DOI 10.1104/pp.010483; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Geraldo N, 2009, PLANT PHYSIOL, V150, P1611, DOI 10.1104/pp.109.137448; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Henderson IR, 2003, ANNU REV GENET, V37, P371, DOI 10.1146/annurev.genet.37.110801.142640; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kane NA, 2005, PLANT PHYSIOL, V138, P2354, DOI 10.1104/pp.105.061762; Kane NA, 2007, PLANT J, V51, P670, DOI 10.1111/j.1365-313X.2007.03172.x; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; KOORNNEEF M, 1994, PLANT J, V6, P911, DOI 10.1046/j.1365-313X.1994.6060911.x; Lee JH, 2005, PLANT MOL BIOL, V58, P823, DOI 10.1007/s11103-005-8105-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANDEL MA, 1995, PLANT CELL, V7, P1763, DOI 10.1105/tpc.7.11.1763; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Murai K, 2003, PLANT CELL PHYSIOL, V44, P1255, DOI 10.1093/pcp/pcg171; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; PUGSLEY AT, 1972, EUPHYTICA, V21, P547, DOI 10.1007/BF00039355; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Tadege M, 2003, PLANT BIOTECHNOL J, V1, P361, DOI 10.1046/j.1467-7652.2003.00034.x; Thomashow M. F., 1990, Advances in Genetics, V28, P99; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	37	14	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8690	10.1371/journal.pone.0008690	http://dx.doi.org/10.1371/journal.pone.0008690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084169	Green Submitted, Green Published, gold			2022-12-25	WOS:000273554600038
J	Wong, PP; Pickard, A; McCance, DJ				Wong, Ping-Pui; Pickard, Adam; McCance, Dennis J.			p300 Alters Keratinocyte Cell Growth and Differentiation through Regulation of p21(Waf1/CIP1)	PLOS ONE			English	Article							GENE-EXPRESSION; UP-REGULATION; DNA-BINDING; IN-VIVO; CYCLE; P53; TRANSCRIPTION; CDK; ACETYLATION; PROTEIN	Background: p300 functions as a transcriptional co-activator to regulate many cellular responses such as cell growth, transformation, development and differentiation. It has been shown to affect the transcriptional activity of p53 which regulates p21(Waf1/CIP1) expression, however, the role of p300 in differentiation remains unclear. Methodology and Principal Findings: Knockdown of p300 protein with short hairpin RNA (shRNA) molecules delays human neonatal foreskin keratinocyte (HFKs) differentiation. Moreover, depletion of p300 increases the proliferative capacity of HFKs, extends the life span of cells and allows differentiated HFKs to re-enter the cell cycle. Studies indicate that depletion of p300 down-regulates the acetylation and expression of p53, and chromatin immunoprecipitation (ChIP) analysis shows that induction of p21(Waf1/CIP1) in early differentiation is a result of p300 dependent activation of p53 and that depletion of p21(Waf1/CIP1) results in the delay of differentiation and a phenotype similar to p300 depletion. Conclusions: p300 has a direct role in the control of cell growth and differentiation in primary epithelial cells, and p21(Waf1/CIP1) is an important mediator of these p300 functions.	[Wong, Ping-Pui; Pickard, Adam; McCance, Dennis J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	Wong, PP (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	d.mccance@qub.ac.uk		Wong, Ping Pui/0000-0003-1592-4823; pickard, adam/0000-0001-9757-143X	Medical Research Council (MRC) [G0700754]; Medical Research Council [G0700754] Funding Source: researchfish; MRC [G0700754] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Medical Research Council (MRC) grant G0700754, URL:http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Howell MD, 2008, J INVEST DERMATOL, V128, P2248, DOI 10.1038/jid.2008.74; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Iyer NG, 2007, ONCOGENE, V26, P21, DOI 10.1038/sj.onc.1209771; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kasten MM, 1998, CELL DEATH DIFFER, V5, P132, DOI 10.1038/sj.cdd.4400323; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MacPartlin M, 2005, J BIOL CHEM, V280, P30604, DOI 10.1074/jbc.M503352200; MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okuyama R, 2004, J INVEST DERM SYMP P, V9, P248, DOI 10.1111/j.1087-0024.2004.09308.x; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stiegler P, 1998, J CELL BIOCHEM, P30; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Turchi L, 2009, CELL DEATH DIFFER, V16, P728, DOI 10.1038/cdd.2009.2; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Westbrook TF, 2002, MOL CELL BIOL, V22, P7041, DOI 10.1128/MCB.22.20.7041-7052.2002; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	40	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8369	10.1371/journal.pone.0008369	http://dx.doi.org/10.1371/journal.pone.0008369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084294	Green Published, gold, Green Submitted			2022-12-25	WOS:000273554600002
J	Yamamoto, Y; Hino, H; Ueda, H				Yamamoto, Yuzo; Hino, Hiroshi; Ueda, Hiroshi			Olfactory Imprinting of Amino Acids in Lacustrine Sockeye Salmon	PLOS ONE			English	Article							PARR-SMOLT TRANSFORMATION; LONG-TERM POTENTIATION; COHO SALMON; RAINBOW-TROUT; ONCORHYNCHUS-KISUTCH; STREAM WATER; ODORANT RECEPTOR; PACIFIC SALMON; MASU SALMON; GENE	Juvenile salmon have an olfactory ability to imprint their natal stream odors, but neither the odor properties of natal stream water nor the imprinting timing and duration have been clarified as yet. Here we show, using electrophysiological and behavioral experiments, that one-year-old lacustrine sockeye salmon (Oncorhynchus nerka) can be imprinted around the stage of parr-smolt transformation (PST) by a single amino acid, 1 mu M L-proline (Pro), or L-glutamic acid (Glu). We also show by real-time PCR that changes occur in mRNA levels of the salmon olfactory imprinting-related gene (SOIG) around PST. The electro-olfactogram (EOG) responses of test fish exposed to Pro in March (before PST) and April-June (during PST) for 2 weeks were significantly (1.7-fold) greater than those of non-exposed control fish, but not those of test fish exposed in July (after PST). When Pro and control water were added to the water inlets of a two-choice test tank during the spawning season 2 years after the test water exposure, 80% of maturing and matured test fish exposed before and during PST showed a preference for Pro, whereas those exposed after PST did not. The EOG response of test fish exposed to Pro or Glu for 1 hour, 6 hours, 1 day, 7 days, or 14 days in May revealed that only the response after 14 days of exposure was significantly (1.8-fold) greater than the control. The expression levels of SOIG mRNA increased before and during PST, and decreased after PST. We conclude that one-year-old lacustrine sockeye salmon can be imprinted by a single amino acid before and during PST, and that imprinting requires exposure for at least 14 days.	[Yamamoto, Yuzo] Hokkaido Univ, Grad Sch Environm Earth Sci, Lab Aquat Bioresources & Ecosyst, Field Sci Ctr No Biosphere, Sapporo, Hokkaido 060, Japan; Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosphere Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Yamamoto, Y (corresponding author), Hokkaido Univ, Grad Sch Environm Earth Sci, Lab Aquat Bioresources & Ecosyst, Field Sci Ctr No Biosphere, Sapporo, Hokkaido 060, Japan.	hueda@fsc.hokudai.ac.jp	Ueda, Hiroshi/G-4446-2010	Ueda, Hiroshi/0000-0002-4706-8665	Japanese Society for the Promotion of Science (JSPS) [17009156, 18208017]; Mitsubishi Foundation [35-4]; Mitsui Co. Ltd [08-A10]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation; Mitsui Co. Ltd(Mitsui & Co., LTD.)	This study was supported by a Research Fellowship for Young Scientists to YY from the Japanese Society for the Promotion of Science (JSPS, 17009156), as well as partly by Grant-in-Aid for Scientific Research (A) (18208017) from JSPS, a natural science grant (35-4) from the Mitsubishi Foundation, and an environmental research grant (08-A10) from the Mitsui & Co. Ltd to HU. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BICKMORE WA, 1993, GENOMICS, V17, P129, DOI 10.1006/geno.1993.1293; BROWMAN HI, 1994, VISION RES, V34, P1397, DOI 10.1016/0042-6989(94)90139-2; Chou JH, 2001, GENETICS, V157, P211; COOPER JC, 1976, J FISH RES BOARD CAN, V33, P703, DOI 10.1139/f76-087; COOPER JC, 1974, WISC ACAD SCI ARTS L, V62, P165; Dickhoff W.W., 1987, AM FISH SOC S, V1, P197; DICKHOFF WW, 1978, GEN COMP ENDOCR, V36, P229, DOI 10.1016/0016-6480(78)90027-8; Dittman AH, 1997, NEURON, V19, P381, DOI 10.1016/S0896-6273(00)80947-2; Dittman AH, 1996, CAN J FISH AQUAT SCI, V53, P434, DOI 10.1139/cjfas-53-2-434; Dittman AH, 1996, J EXP BIOL, V199, P83; Dukes JP, 2004, MOL ECOL, V13, P2851, DOI 10.1111/j.1365-294X.2004.02252.x; Ebbesson LOE, 2003, AQUACULTURE, V222, P59, DOI 10.1016/S0044-8486(03)00102-9; Ebbesson SOE, 1996, BRAIN RES, V742, P339, DOI 10.1016/S0006-8993(96)00993-6; Galloway H., 1994, THYROID INDUCED CHEM; Hasler A.D., 1983, OLFACTORY IMPRINTING; Hino H, 2007, AQUACULTURE, V273, P200, DOI 10.1016/j.aquaculture.2007.10.003; Jarrard HE, 1997, BRAIN BEHAV EVOLUT, V49, P249, DOI 10.1159/000112996; Kinoshita M, 2005, J COMP NEUROL, V484, P249, DOI 10.1002/cne.20473; Kudo H., 1994, Aquaculture and Fisheries Management, V25, P171; Lema SC, 2004, J EXP BIOL, V207, P3317, DOI 10.1242/jeb.01143; Matsuoka I, 1998, BBA-GENE STRUCT EXPR, V1395, P220, DOI 10.1016/S0167-4781(97)00164-4; MCKENZIE IFC, 1977, TRANSPLANT P, V9, P667; Morinishi F, 2007, COMP BIOCHEM PHYS B, V148, P329, DOI 10.1016/j.cbpb.2007.06.010; Nam RH, 2004, NEUROSCI LETT, V370, P248, DOI 10.1016/j.neulet.2004.08.037; NEVITT GA, 1994, P NATL ACAD SCI USA, V91, P4288, DOI 10.1073/pnas.91.10.4288; NORDENG H, 1971, NATURE, V233, P411, DOI 10.1038/233411a0; NORDENG H, 1977, OIKOS, V28, P155, DOI 10.2307/3543965; Quinn TP, 2005, BEHAV ECOLOGY PACIFI, P85; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Sato A, 1997, ZOOL SCI, V14, P1009, DOI 10.2108/zsj.14.1009; Satou M, 2006, J COMP PHYSIOL A, V192, P135, DOI 10.1007/s00359-005-0056-7; SCHOLZ AT, 1976, SCIENCE, V192, P1247, DOI 10.1126/science.1273590; Shimizu M, 1995, J FISH BIOL, V47, P1044, DOI 10.1111/j.1095-8649.1995.tb06028.x; Shoji T, 2000, CHEM SENSES, V25, P533, DOI 10.1093/chemse/25.5.533; Shoji T, 2003, FISH PHYSIOL BIOCHEM, V28, P249, DOI 10.1023/B:FISH.0000030544.64774.f6; SUH TT, 1994, J BIOL CHEM, V269, P25992; TILSON MB, 1995, ARTIFICIAL IMPRINTIN; Ueda H, 2007, AM FISH S S, V54, P5; Ueda K, 1985, NOAA TECH REP NMFS, V27, P97; WISBY WARREN J., 1954, JOUR FISH RES BD CANADA, V11, P472; Yamada H, 1997, GEN COMP ENDOCR, V106, P181, DOI 10.1006/gcen.1996.6861; Yamamoto Y, 2009, ZOOL SCI, V26, P778, DOI 10.2108/zsj.26.778	42	57	62	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8633	10.1371/journal.pone.0008633	http://dx.doi.org/10.1371/journal.pone.0008633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062811	Green Published, gold			2022-12-25	WOS:000273414200011
J	Crawford, AC; Riggins, RB; Shajahan, AN; Zwart, A; Clarke, R				Crawford, Anatasha C.; Riggins, Rebecca B.; Shajahan, Ayesha N.; Zwart, Alan; Clarke, Robert			Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis	PLOS ONE			English	Article							BREAST-CANCER CELLS; REGULATORY FACTOR-I; FACTOR-KAPPA-B; POSTMENOPAUSAL WOMEN; ACQUIRED-RESISTANCE; INDEPENDENT GROWTH; ENDOCRINE THERAPY; MCF-7 CELLS; APOPTOSIS; DEATH	BCL2 family members affect cell fate decisions in breast cancer but the role of BCL-W (BCL2L2) is unknown. We now show the integrated roles of the antiapoptotic BCL-W and BCL2 in affecting responsiveness to the antiestrogen ICI 182,780 (ICI; Fulvestrant Faslodex), using both molecular (siRNA; shRNA) and pharmacologic (YC137) approaches in three breast cancer variants; MCF-7/LCC1 (ICI sensitive), MCF-7/LCC9 (ICI resistant), and LY2 (ICI resistant). YC137 inhibits BCL-W and BCL2 and restores ICI sensitivity in resistant cells. Co-inhibition of BCL-W and BCL2 is both necessary and sufficient to restore sensitivity to ICI, and explains mechanistically the action of YC137. These data implicate functional cooperation and/or redundancy in signaling between BCL-W and BCL2, and suggest that broad BCL2 family member inhibitors will have greater therapeutic value than targeting only individual proteins. Whereas ICI sensitive MCF-7/LCC1 cells undergo increased apoptosis in response to ICI following BCL-W +/- BCL2 co-inhibition, the consequent resensitization of resistant MCF-7/LCC9 and LY2 cells reflects increases in autophagy (LC3 cleavage; p62/SQSTM1 expression) and necrosis but not apoptosis or cell cycle arrest. Thus, de novo sensitive cells and resensitized resistant cells die through different mechanisms. Following BCL-W+BCL2 co-inhibition, suppression of functional autophagy by 3-methyladenine or BECN1 shRNA reduces ICI-induced necrosis but restores the ability of resistant cells to die through apoptosis. These data demonstrate the plasticity of cell fate mechanisms in breast cancer cells in the context of antiestrogen responsiveness. Restoration of ICI sensitivity in resistant cells appears to occur through an increase in autophagy-associated necrosis. BCL-W, BCL2, and BECN1 integrate important functions in determining antiestrogen responsiveness, and the presence of functional autophagy may influence the balance between apoptosis and necrosis.	[Crawford, Anatasha C.] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC USA; Georgetown Univ, Sch Med, Dept Oncol, Washington, DC USA	Georgetown University; Georgetown University	Crawford, AC (corresponding author), Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC USA.	clarker@georgetown.edu	Clarke, Robert/A-6485-2008; Riggins, Rebecca/GQH-4466-2022	Clarke, Robert/0000-0002-9278-0854; Shajahan-Haq, Ayesha/0000-0001-7616-320X; Riggins, Rebecca/0000-0002-1555-4431; Zwart, Alan/0000-0001-6834-9290	Department of Defense Breast Cancer Research Program [BC050389]; U.S. Department of Health and Human Services [R01-CA131465]; Department of Defense [BC073977]; Flow Cytometry, Microscopy and Imaging, and Tissue Culture Shared Resources [P30-CA-51008-16]; NATIONAL CANCER INSTITUTE [R01CA131465, P30CA051008] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); U.S. Department of Health and Human Services; Department of Defense(United States Department of Defense); Flow Cytometry, Microscopy and Imaging, and Tissue Culture Shared Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by awards from the Department of Defense Breast Cancer Research Program (BC050389) to Dr. Anatasha Crawford, and from the U.S. Department of Health and Human Services (R01-CA131465) and Department of Defense (BC073977) to Dr. R. Clarke. Flow Cytometry, Microscopy and Imaging, and Tissue Culture Shared Resources are supported by P30-CA-51008-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Brunner N, 1997, CANCER RES, V57, P3486; BRUNNER N, 1993, CANCER RES, V53, P283; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cameron DA, 2000, EUR J CANCER, V36, P845, DOI 10.1016/S0959-8049(00)00013-7; CLARKE R, 1989, J ENDOCRINOL, V122, P331, DOI 10.1677/joe.0.1220331; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Clarke R, 2001, PHARMACOL REV, V53, P25; Clarke R, 2009, J STEROID BIOCHEM, V114, P8, DOI 10.1016/j.jsbmb.2008.12.023; Cui Q, 2007, BIOL PHARM BULL, V30, P859, DOI 10.1248/bpb.30.859; Dowsett M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1798; Ellis PA, 1998, BREAST CANCER RES TR, V48, P107, DOI 10.1023/A:1005933815809; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; GEE JMW, 1994, INT J CANCER, V59, P619, DOI 10.1002/ijc.2910590508; Gjertsen BT, 2007, CURR PHARM BIOTECHNO, V8, P373, DOI 10.2174/138920107783018381; Gomez BP, 2007, FASEB J, V21, P4013, DOI 10.1096/fj.06-7990com; Gu ZP, 2002, CANCER RES, V62, P3428; Heckman CA, 2000, J BIOL CHEM, V275, P6499, DOI 10.1074/jbc.275.9.6499; Howell A, 2002, J CLIN ONCOL, V20, P3396, DOI 10.1200/JCO.2002.10.057; Huang ZW, 2000, ONCOGENE, V19, P6627, DOI 10.1038/sj.onc.1204087; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kessel D, 2007, CANCER LETT, V249, P294, DOI 10.1016/j.canlet.2006.09.009; Kim R, 2004, CANCER-AM CANCER SOC, V101, P2491, DOI 10.1002/cncr.20696; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; O'Reilly LA, 2001, CELL DEATH DIFFER, V8, P486, DOI 10.1038/sj.cdd.4400835; Osborne CK, 2002, J CLIN ONCOL, V20, P3386, DOI 10.1200/JCO.2002.10.058; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Real PJ, 2004, CANCER RES, V64, P7947, DOI 10.1158/0008-5472.CAN-04-0945; Riggins RB, 2005, MOL CANCER THER, V4, P33; Romanelli S, 1998, CANCER CHEMOTH PHARM, V41, P385, DOI 10.1007/s002800050755; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Samara C, 2008, CURR PHARM DESIGN, V14, P97, DOI 10.2174/138161208783378770; Sung KF, 2009, EXP CELL RES, V315, P1975, DOI 10.1016/j.yexcr.2009.01.009; Thompson A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1983; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Wilson JW, 2000, BRIT J CANCER, V82, P178, DOI 10.1054/bjoc.1999.0897; Yan W, 2000, MOL ENDOCRINOL, V14, P682, DOI 10.1210/me.14.5.682; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yao MZ, 2007, J NEUROSCI, V27, P1422, DOI 10.1523/JNEUROSCI.2382-06.2007; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	47	52	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8604	10.1371/journal.pone.0008604	http://dx.doi.org/10.1371/journal.pone.0008604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062536	Green Submitted, gold, Green Published			2022-12-25	WOS:000273338600022
J	Teramitsu, I; Poopatanapong, A; Torrisi, S; White, SA				Teramitsu, Ikuko; Poopatanapong, Amy; Torrisi, Salvatore; White, Stephanie A.			Striatal FoxP2 Is Actively Regulated during Songbird Sensorimotor Learning	PLOS ONE			English	Article							ZEBRA FINCH SONG; BASAL GANGLIA; FOREBRAIN NUCLEUS; LANGUAGE DISORDER; AUDITORY-FEEDBACK; INHERITED SPEECH; GENE-EXPRESSION; HUMAN BRAIN; BIRDSONG; LESIONS	Background: Mutations in the FOXP2 transcription factor lead to language disorders with developmental onset. Accompanying structural abnormalities in cortico-striatal circuitry indicate that at least a portion of the behavioral phenotype is due to organizational deficits. We previously found parallel FoxP2 expression patterns in human and songbird cortico/pallio-striatal circuits important for learned vocalizations, suggesting that FoxP2's function in birdsong may generalize to speech. Methodology/Principal Findings: We used zebra finches to address the question of whether FoxP2 is additionally important in the post-organizational function of these circuits. In both humans and songbirds, vocal learning depends on auditory guidance to achieve and maintain optimal vocal output. We tested whether deafening prior to or during the sensorimotor phase of song learning disrupted FoxP2 expression in song circuitry. As expected, the songs of deafened juveniles were abnormal, however basal FoxP2 levels were unaffected. In contrast, when hearing or deaf juveniles sang for two hours in the morning, FoxP2 was acutely down-regulated in the striatal song nucleus, area X. The extent of down-regulation was similar between hearing and deaf birds. Interestingly, levels of FoxP2 and singing were correlated only in hearing birds. Conclusions/Significance: Hearing appears to link FoxP2 levels to the amount of vocal practice. As juvenile birds spent more time practicing than did adults, their FoxP2 levels are likely to be low more often. Behaviorally-driven reductions in the mRNA encoding this transcription factor could ultimately affect downstream molecules that function in vocal exploration, especially during sensorimotor learning.	[Teramitsu, Ikuko; White, Stephanie A.] Univ Calif Los Angeles, Interdept Program Mol Cellular & Integrat, Los Angeles, CA USA; [Torrisi, Salvatore; White, Stephanie A.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA; [Poopatanapong, Amy; White, Stephanie A.] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Teramitsu, I (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	sawhite@ucla.edu	Torrisi, Salvatore/L-8603-2019; White, Stephanie Ann/AAE-7683-2019	White, Stephanie Ann/0000-0002-3490-2294	University of California Los Angeles Edith Hyde; UCLA Tennenbaum Family Creativity Initiative and Center [RO1 MH070712]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070712] Funding Source: NIH RePORTER	University of California Los Angeles Edith Hyde; UCLA Tennenbaum Family Creativity Initiative and Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the University of California Los Angeles Edith Hyde and dissertation year fellowships (IT), UCLA Tennenbaum Family Creativity Initiative and Center for Autism Research and Treatment awards and by RO1 MH070712 (SAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Brainard MS, 2001, J NEUROSCI, V21, P2501, DOI 10.1523/JNEUROSCI.21-07-02501.2001; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Brenowitz EA, 1997, J NEUROBIOL, V33, P495, DOI 10.1002/(SICI)1097-4695(19971105)33:5<495::AID-NEU1>3.3.CO;2-D; Bruce HA, 2002, HUM GENET, V111, P136, DOI 10.1007/s00439-002-0768-5; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; Immelmann K., 1969, P61; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Konishi M., 1969, BIRD VOCALIZATIONS; Kurt S, 2009, BRAIN RES, V1289, P30, DOI 10.1016/j.brainres.2009.06.092; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Livingston FS, 2000, NAT NEUROSCI, V3, P482, DOI 10.1038/74857; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Miller JE, 2008, J NEUROPHYSIOL, V100, P2015, DOI 10.1152/jn.90415.2008; NixdorfBergweiler BE, 1996, J COMP NEUROL, V375, P445, DOI 10.1002/(SICI)1096-9861(19961118)375:3<445::AID-CNE7>3.0.CO;2-2; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; OKUHATA S, 1987, BRAIN RES BULL, V18, P35, DOI 10.1016/0361-9230(87)90031-1; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Perkel DJ, 2002, BRAIN RES BULL, V57, P529, DOI 10.1016/S0361-9230(01)00690-6; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; Rochefort C, 2007, DEV NEUROBIOL, V67, P809, DOI 10.1002/dneu.20393; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; WILD JM, 1993, BRAIN RES, V606, P319, DOI 10.1016/0006-8993(93)91001-9	49	57	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8548	10.1371/journal.pone.0008548	http://dx.doi.org/10.1371/journal.pone.0008548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062527	gold, Green Published			2022-12-25	WOS:000273338600007
J	Chen, W; Jarzyna, PA; van Tilborg, GAF; Nguyen, VA; Cormode, DP; Klink, A; Griffioen, AW; Randolph, GJ; Fisher, EA; Mulder, WJM; Fayad, ZA				Chen, Wei; Jarzyna, Peter A.; van Tilborg, Geralda A. F.; Nguyen, Van Anh; Cormode, David P.; Klink, Ahmed; Griffioen, Arjan W.; Randolph, Gwendalyn J.; Fisher, Edward A.; Mulder, Willem J. M.; Fayad, Zahi A.			RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe	FASEB JOURNAL			English	Article						angiogenesis; optical imaging; magnetic resonance imaging	HIGH-RISK PLAQUE; CONTRAST AGENT; QUANTUM DOTS; ATHEROSCLEROTIC PLAQUES; CHOLESTERYL ESTERS; SELECTIVE UPTAKE; IN-VIVO; CANCER; ANGIOGENESIS; MACROPHAGES	High density lipoprotein (HDL), an endogenous nanoparticle, transports fat throughout the body and is capable of transferring cholesterol from atheroma in the vessel wall to the liver. In the present study, we utilized HDL as a multimodal nanoparticle platform for tumor targeting and imaging via nonspecific accumulation and specific binding to angiogenically activated blood vessels. We reconstituted HDL (rHDL) with amphiphilic gadolinium chelates and fluorescent dyes. To target angiogenic endothelial cells, rHDL was functionalized with alpha v beta 3-integrin-specific RGD peptides (rHDL-RGD). Nonspecific RAD peptides were conjugated to rHDL nanoparticles as a control (rHDL-RAD). It was observed in vitro that all 3 nanoparticles were phagocytosed by macrophages, while alpha v beta 3-integrin-specific rHDL-RGD nanoparticles were preferentially taken up by endothelial cells. The uptake of nanoparticles in mouse tumors was evaluated in vivo using near infrared (NIR) and MR imaging. All nanoparticles accumulated in tumors but with very different accumulation/binding kinetics as observed by NIR imaging. Moreover, confocal microscopy revealed rHDL-RGD to be associated with tumor endothelial cells, while rHDL and rHDL-RAD nanoparticles were mainly found in the interstitial space. This study demonstrates the ability to reroute HDL from its natural targets to tumor blood vessels and its potential for multimodal imaging of tumor-associated processes.-Chen, W., Jarzyna, P. A., van Tilborg, G. A. F., Nguyen, V. A., Cormode, D. P., Klink, A., Griffioen, A. W., Randolph, G. J., Fisher, E. A., Mulder, W. J. M., Fayad, Z. A. RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB J. 24, 1689-1699 (2010). www.fasebj.org	[Chen, Wei; Jarzyna, Peter A.; Cormode, David P.; Klink, Ahmed; Mulder, Willem J. M.; Fayad, Zahi A.] Mt Sinai Sch Med, Translat & Mol Imaging Inst, Imaging Sci Labs, Dept Radiol, New York, NY 10029 USA; [Chen, Wei; Jarzyna, Peter A.; Cormode, David P.; Klink, Ahmed; Mulder, Willem J. M.; Fayad, Zahi A.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Nguyen, Van Anh; Randolph, Gwendalyn J.; Mulder, Willem J. M.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Fayad, Zahi A.] Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; [Fayad, Zahi A.] Mt Sinai Sch Med, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, New York, NY 10029 USA; [van Tilborg, Geralda A. F.] Univ Utrecht, Image Sci Inst, Utrecht, Netherlands; [Klink, Ahmed] Hop Europeen Georges Pompidou, AP HP, INSERM, Paris Cardiovasc Res Ctr, Paris, France; [Griffioen, Arjan W.] Maastricht Univ & Hosp, Res Inst Growth & Dev, Dept Pathol, Angiogenesis Lab, Maastricht, Netherlands; [Fisher, Edward A.] NYU, Sch Med, Ctr Prevent Cardiovasc Dis, Leon H Charney Div Cardiol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Utrecht University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Maastricht University; Maastricht University Medical Centre (MUMC); New York University	Mulder, WJM (corresponding author), Mt Sinai Sch Med, Translat & Mol Imaging Inst, Imaging Sci Labs, Dept Radiol, Atran BM-24,Box 1234,1 Gustave L Levy Pl, New York, NY 10029 USA.	willem.mulder@mountsinai.org; zahi.fayad@mssm.edu	Fisher, Edward/ABE-7469-2020; van Tilborg, Geralda/H-1229-2011; Mulder, Willem J.M./B-7232-2009; Cormode, David/C-6440-2008; Fayad, Zahi/Z-3272-2019; Nguyen, Anh/C-5389-2013	Mulder, Willem J.M./0000-0001-8665-3878; Fayad, Zahi/0000-0002-3439-7347; Fisher, Edward/0000-0001-9802-143X; Cormode, David/0000-0002-8391-9500; Nguyen, Anh/0000-0001-6703-2291	U.S. National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute [R01 H-71021, R01 H-78667]; NIH/National Institute of Biomedical Imaging and Bioengineering [EB-009638]; NIH-National Cancer Institute [5R24 CA-095823-04, 1 S10 RR-09145-01]; National Science Foundation [DBI-9724504]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009638] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Partial support was provided by U.S. National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute grants R01 H-71021 and R01 H-78667 and NIH/National Institute of Biomedical Imaging and Bioengineering grant EB-009638 (to Z.A.F.). We thank CSL Behring (Bern, Switzerland) for the kind gift of apoA-I. Confocal microscopy was performed at the Mount Sinai School of Medicine Microscopy Shared Resource Facility and supported by NIH-National Cancer Institute grant 5R24 CA-095823-04, National Science Foundation grant DBI-9724504, and NIH grant 1 S10 RR-09145-01.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brekke C, 2007, NMR BIOMED, V20, P77, DOI 10.1002/nbm.1077; Brundert M, 2006, J LIPID RES, V47, P2408, DOI 10.1194/jlr.M600136-JLR200; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen J, 2007, J AM CHEM SOC, V129, P5798, DOI 10.1021/ja069336k; Chen W, 2008, CONTRAST MEDIA MOL I, V3, P233, DOI 10.1002/cmmi.257; Conca P, 2008, NUTR METAB CARDIOVAS, V18, P329, DOI 10.1016/j.numecd.2007.11.001; Corbin IR, 2007, J BIOMED NANOTECHNOL, V3, P367, DOI 10.1166/jbn.2007.053; Cormode DP, 2008, NANO LETT, V8, P3715, DOI 10.1021/nl801958b; Cormode DP, 2008, SMALL, V4, P1437, DOI 10.1002/smll.200701285; De Grand AM, 2003, TECHNOL CANCER RES T, V2, P553, DOI 10.1177/153303460300200607; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Forrester JS, 2006, AM J CARDIOL, V98, P1542, DOI 10.1016/j.amjcard.2006.06.059; Frias JC, 2004, J AM CHEM SOC, V126, P16316, DOI 10.1021/ja044911a; Frias JC, 2006, NANO LETT, V6, P2220, DOI 10.1021/nl061498r; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Fuster V, 2005, J AM COLL CARDIOL, V46, P1209, DOI 10.1016/j.jacc.2005.03.075; Hu G, 2007, INT J CANCER, V120, P1951, DOI 10.1002/ijc.22581; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Kok MB, 2009, MAGN RESON MED, V61, P1022, DOI 10.1002/mrm.21910; Kok RJ, 2002, BIOCONJUGATE CHEM, V13, P128, DOI 10.1021/bc015561+; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Koole R, 2008, BIOCONJUGATE CHEM, V19, P2471, DOI 10.1021/bc800368x; Lacko AG, 2007, EXPERT OPIN DRUG DEL, V4, P665, DOI 10.1517/17425247.4.6.665; Matveev S, 1999, J LIPID RES, V40, P1647; Modo M, 2005, MOL IMAGING, V4, P143; Mulder WJM, 2009, ANGIOGENESIS, V12, P17, DOI 10.1007/s10456-008-9124-2; Mulder WJM, 2006, NANO LETT, V6, P1, DOI 10.1021/nl051935m; Mulder WJM, 2005, FASEB J, V19, P2008, DOI 10.1096/fj.05-4145fje; Nakayama Akira, 2002, Mol Imaging, V1, P365, DOI 10.1162/153535002321093972; RINNINGER F, 1994, ATHEROSCLEROSIS, V105, P145, DOI 10.1016/0021-9150(94)90044-2; Shaish A, 2001, PATHOBIOLOGY, V69, P225, DOI 10.1159/000055947; Song LP, 2007, INT J NANOMED, V2, P767; Stefflova K, 2007, BIOCONJUGATE CHEM, V18, P379, DOI 10.1021/bc0602578; Strijkers GJ, 2009, MAGN RESON MED, V61, P1049, DOI 10.1002/mrm.21919; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Terreno E, 2006, MAGN RESON MED, V55, P491, DOI 10.1002/mrm.20793; van Tilborg GAF, 2008, NEOPLASIA, V10, P1459, DOI 10.1593/neo.08858; Williams KJ, 2007, CURR OPIN LIPIDOL, V18, P443, DOI 10.1097/MOL.0b013e32823bcb15; Winter PM, 2008, FASEB J, V22, P2758, DOI 10.1096/fj.07-103929; Zheng G, 2005, P NATL ACAD SCI USA, V102, P17757, DOI 10.1073/pnas.0508677102	42	92	95	0	45	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1689	1699		10.1096/fj.09-139865	http://dx.doi.org/10.1096/fj.09-139865			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20075195	Green Published			2022-12-25	WOS:000278200000007
J	Dainese, E; Angelucci, CB; Sabatucci, A; De Filippis, V; Mei, G; Maccarrone, M				Dainese, Enrico; Angelucci, Clotilde B.; Sabatucci, Annalaura; De Filippis, Vincenzo; Mei, Giampiero; Maccarrone, Mauro			A novel role for iron in modulating the activity and membrane-binding ability of a trimmed soybean lipoxygenase-1	FASEB JOURNAL			English	Article						limited proteolysis; metal substitution; enzyme activity; enzyme structure; pathogen infection	X-RAY-SCATTERING; CRYSTAL-STRUCTURE; TYROSINE-HYDROXYLASE; MANGANESE LIPOXYGENASE; ORGANELLE DEGRADATION; ANGSTROM RESOLUTION; HUMAN CERULOPLASMIN; NONHEME IRON; METAL-IONS; CALCIUM	Lipoxygenases (LOXs) are iron-containing enzymes that play critical roles in plants and animals. As yet, metal atom extraction, reconstitution, and substitution have not been successfully applied to soybean LOX-1 [Glycine max (L.) Merrill], a prototype member of the LOX family that is widely used in structural and kinetic studies. Here, tryptic digestion of native LOX-1, used as a control, allowed us to isolate the 60-kDa C-terminal region (termed miniLOX), that retains the catalytically active iron in a more accessible position. Then, iron was removed to obtain an unprecedented apo-miniLOX, which was reconstituted and substituted with different metal ions. These forms of miniLOX were characterized vs. native LOX-1 by kinetic analysis, near UV circular dichroism, steady-state fluorescence, and fluorescence resonance energy transfer. MiniLOX showed a 2-fold increase in the membrane-binding affinity compared with native LOX-1 and a remarkable 4-fold increase compared with apo-miniLOX (K(d) = 9.2 +/- 1.0, 17.9 +/- 2.0, and 45.4 +/- 4.3 mu M, respectively). Furthermore, miniLOX reconstituted with Fe(II) or Fe(III) partially recovered its membrane-binding ability (K(d) = 21.4 +/- 2.4 and 18.9 +/- 5.5 mu M, respectively), overall supporting a novel noncatalytic role for iron in the LOX family.-Dainese, E., Angelucci, C. B., Sabatucci, A., De Filippis, V., Mei, M., Maccarrone, M. A novel role for iron in modulating the activity and membrane-binding ability of a trimmed soybean lipoxygenase-1. FASEB J. 24, 1725-1736 (2010). www.fasebj.org	[Dainese, Enrico; Angelucci, Clotilde B.; Sabatucci, Annalaura; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, I-64100 Teramo, Italy; [De Filippis, Vincenzo] Univ Padua, Dept Pharmacol Sci, Padua, Italy; [Mei, Giampiero] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Maccarrone, Mauro] European Ctr Brain Res Santa Lucia Fdn, Rome, Italy	University of Teramo; University of Padua; University of Rome Tor Vergata	Dainese, E (corresponding author), Univ Teramo, Dept Biomed Sci, Piazzo Aldo Moro N 45, I-64100 Teramo, Italy.	edainese@unite.it; mmaccarrone@unite.it	Maccarrone, Mauro/K-5398-2012; SABATUCCI, Annalaura/E-9996-2013	Maccarrone, Mauro/0000-0002-3990-2963; Dainese, Enrico/0000-0001-7163-9344; SABATUCCI, Annalaura/0000-0002-8004-2547	University of Rome Tor Vergata, Rome, Italy; Ministero dell'Universita e della Ricerca [PRIN 2005]; Ministero della Salute (Progetto Ricerca Corrente) [IZS LT 08/07 RC]; Italian Space Agency (ASI); Fondazione TERCAS	University of Rome Tor Vergata, Rome, Italy; Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute (Progetto Ricerca Corrente)(Ministry of Health, Italy); Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Fondazione TERCAS(Fondazione CarifeFondazione Caritro)	The authors thank Professor Alessandro Finazzi-Agro (University of Rome Tor Vergata, Rome, Italy) for his continuing support. The kind assistance of Dr. Maria Luisa Salucci (University of L'Aquila, L'Aquila, Italy) in the preliminary experiments on apo-miniLOX isolation and that of Dr. Annamaria Draghi, Dr. Daniela Galla, and Dr. Paolo Di Muro (University of Padua, Padua, Italy) in CD and atomic absorption measurements, respectively, are gratefully acknowledged. This work was supported by Ministero dell'Universita e della Ricerca (PRIN 2005) and by Ministero della Salute (Progetto Ricerca Corrente, IZS LT 08/07 RC to E. D.), by the Italian Space Agency (ASI) (MoMa contract 2006), and by Fondazione TERCAS (project 2005-2008 to M. M.).	AULD DS, 1988, METHOD ENZYMOL, V158, P71, DOI 10.1016/0076-6879(88)58048-5; BABA A, 1989, J BIOL CHEM, V264, P15790; BLECHERT S, 1995, P NATL ACAD SCI USA, V92, P4099, DOI 10.1073/pnas.92.10.4099; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; BOYINGTON JC, 1994, ANN NY ACAD SCI, V744, P310; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; BUBACCO L, 1992, BIOCHEMISTRY-US, V31, P9294, DOI 10.1021/bi00153a024; Carlile AJ, 2000, MOL PLANT MICROBE IN, V13, P538, DOI 10.1094/MPMI.2000.13.5.538; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026; Dainese E, 2005, J MOL BIOL, V349, P143, DOI 10.1016/j.jmb.2005.03.027; Decker H, 1998, J BIOL CHEM, V273, P25889, DOI 10.1074/jbc.273.40.25889; Di Venere A, 2003, J BIOL CHEM, V278, P18281, DOI 10.1074/jbc.M212122200; Ducros V, 1998, NAT STRUCT BIOL, V5, P310, DOI 10.1038/nsb0498-310; FINAZZIAGRO A, 1973, BIOCHIM BIOPHYS ACTA, V326, P462, DOI 10.1016/0005-2760(73)90146-X; Forneris F, 2008, SCIENCE, V321, P213, DOI 10.1126/science.1151118; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Grullich C, 2001, FEBS LETT, V489, P51, DOI 10.1016/S0014-5793(01)02080-4; HAAVIK J, 1992, EUR J BIOCHEM, V210, P23, DOI 10.1111/j.1432-1033.1992.tb17386.x; HAAVIK J, 1991, EUR J BIOCHEM, V199, P371, DOI 10.1111/j.1432-1033.1991.tb16133.x; Hammel M, 2004, J MOL BIOL, V343, P917, DOI 10.1016/j.jmb.2004.08.076; Hornsten L, 2002, EUR J BIOCHEM, V269, P2690, DOI 10.1046/j.1432-1033.2002.02936.x; Kariapper MST, 2001, BIOCHEM BIOPH RES CO, V284, P563, DOI 10.1006/bbrc.2001.5011; Kim ES, 2003, PLANT MOL BIOL, V52, P1203, DOI 10.1023/B:PLAN.0000004331.94803.b0; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Komoda T, 2004, BIOSCI BIOTECH BIOCH, V68, P903, DOI 10.1271/bbb.68.903; Kuhn H, 1999, ADV EXP MED BIOL, V447, P5; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Maccarrone M, 1999, EUR J BIOCHEM, V265, P27, DOI 10.1046/j.1432-1327.1999.00630.x; Maccarrone M, 2001, CELL DEATH DIFFER, V8, P776, DOI 10.1038/sj.cdd.4400908; Maccarrone M, 2001, BIOCHEMISTRY-US, V40, P6819, DOI 10.1021/bi010187m; MARTINEZ A, 1993, BIOCHEMISTRY-US, V32, P6381, DOI 10.1021/bi00076a011; MATSUDA S, 1991, BIOCHIM BIOPHYS ACTA, V1084, P202; Mei G, 2008, BIOCHEMISTRY-US, V47, P9234, DOI 10.1021/bi800638v; MESSERSCHMIDT A, 1992, J MOL BIOL, V224, P179, DOI 10.1016/0022-2836(92)90583-6; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; MYERS JS, 1975, J BIOL CHEM, V250, P3785; Nillius D, 2008, FEBS LETT, V582, P749, DOI 10.1016/j.febslet.2008.01.056; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Pande AH, 2005, BIOPHYS J, V88, P4084, DOI 10.1529/biophysj.104.056788; Qin S, 2004, J MOL BIOL, V344, P71, DOI 10.1016/j.jmb.2004.09.034; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; SALVATO B, 1989, BIOCHIM BIOPHYS ACTA, V998, P14, DOI 10.1016/0167-4838(89)90112-X; SCHILSTRA MJ, 1994, BIOCHEMISTRY-US, V33, P3974, DOI 10.1021/bi00179a025; SkrzypczakJankun E, 1996, ACTA CRYSTALLOGR D, V52, P959, DOI 10.1107/S0907444996005239; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Solomon EI, 1997, CHEM BIOL, V4, P795, DOI 10.1016/S1074-5521(97)90113-7; Sreerama N, 2001, ANAL BIOCHEM, V299, P271, DOI 10.1006/abio.2001.5420; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Taccone-Gallucci M, 2008, NEW ENGL J MED, V358, P746, DOI 10.1056/NEJMc073333; Tatulian SA, 1998, BIOCHEMISTRY-US, V37, P15481, DOI 10.1021/bi981062t; Timasheff S.N., 1989, PROTEIN STRUCTURE PR, P331; Titus GP, 2000, NAT STRUCT BIOL, V7, P542; Vachette P, 2002, J BIOL CHEM, V277, P40823, DOI 10.1074/jbc.M207188200; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; VANDERHEIJDT LM, 1995, EUR J BIOCHEM, V231, P186, DOI 10.1111/j.1432-1033.1995.tb20685.x; Vassiliev VB, 1997, J INORG BIOCHEM, V65, P167, DOI 10.1016/S0162-0134(96)00119-5; Walther M, 2004, J BIOL CHEM, V279, P3717, DOI 10.1074/jbc.M309564200; WATSON A, 1994, BIOCHEM J, V298, P377, DOI 10.1042/bj2980377; Welch KD, 2002, ARCH BIOCHEM BIOPHYS, V397, P360, DOI 10.1006/abbi.2001.2694; Xiao K, 2002, BIOL CONTROL, V23, P285, DOI 10.1006/bcon.2001.1015; Yamanaka K, 2005, MICROBIOL-SGM, V151, P2899, DOI 10.1099/mic.0.28139-0	68	21	22	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2010	24	6					1725	1736		10.1096/fj.09-141390	http://dx.doi.org/10.1096/fj.09-141390			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20081094	Green Submitted			2022-12-25	WOS:000278200000010
J	Gabai, VL; Sherman, MY; Yaglom, JA				Gabai, V. L.; Sherman, M. Y.; Yaglom, J. A.			HSP72 depletion suppresses gamma H2AX activation by genotoxic stresses via p53/p21 signaling	ONCOGENE			English	Article						Hsp72; senescence; radiation; doxorubicine; nutlin-3	HEAT-SHOCK PROTEINS; DNA-DAMAGE; CELLS; CANCER; SENESCENCE; REPAIR; INSTABILITY; KINASES	Knockout of heat shock protein Hsp72 was shown to promote chromosomal instability and increase radiation sensitivity of mouse fibroblasts. Here, we report that downregulation of Hsp72 in human tumor cells leads to suppression of a specific branch of the DNA damage response (DDR) that facilitates DNA repair following genotoxic insults, that is, reduced accumulation of the phosphorylated form of histone H2AX (gamma H2AX). This inhibition was due to decreased expression of H2AX as well as higher rate of gamma H2AX dephosphorylation. Formation of gamma H2AX and MDC1 radiation-induced foci was impaired in Hsp72-depleted cells, which in turn enhanced DNA damage, resulting in sensitization of cells to gamma-radiation and doxorubicin. These effects of Hsp72 knockdown were dependent on activation of the p53/p21-signaling pathway. Overall, permanent activation of the p53/p21 signaling in Hsp72-depleted cells specifically impaired the gamma H2AX pathway of the DDR, enhanced DNA damage following genotoxic insults, and led to further stimulation of the p53/p21 pathway, thus creating a positive feedback loop. The resulting strong induction of p21 precipitated senescence following exposure to DNA-damaging agents, thus accounting for higher sensitivity of cells to genotoxic stresses. Oncogene (2010) 29, 1952-1962; doi:10.1038/onc.2009.480; published online 11 January 2010	[Gabai, V. L.; Sherman, M. Y.; Yaglom, J. A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Gabai, VL (corresponding author), Boston Univ, Sch Med, Dept Biochem, 15 Stoughton St, Boston, MA 02118 USA.	gabai@bu.edu; yaglom@bu.edu	Gabai, Vladimir L/I-1650-2013; qiao, zhixin/I-3408-2012	Gabai, Vladimir L/0000-0003-4505-4718; Yaglom, Julia/0000-0002-8723-3506	American Cancer Society Institutional; NIH; Grunnen-baum Award	American Cancer Society Institutional(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grunnen-baum Award	This work was supported by American Cancer Society Institutional Grant (VLG); NIH grant (MYS) and Grunnen-baum Award (JAY).	Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cao C, 2006, MOL CANCER THER, V5, P411, DOI 10.1158/1535-7163.MCT-05-0356; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Efeyan A, 2007, CANCER RES, V67, P7350, DOI 10.1158/0008-5472.CAN-07-0200; Gabai VL, 2008, CANCER RES, V68, P1834, DOI 10.1158/0008-5472.CAN-07-5656; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Kabakov AE, 2006, RADIAT RES, V165, P410, DOI 10.1667/RR3514.1; Li L, 2005, J CELL BIOCHEM, V94, P298, DOI 10.1002/jcb.20355; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; O'Callaghan-Sunol Cornelia, 2007, V2, P169; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yaglom J, 2003, MOL CELL BIOL, V23, P3813, DOI 10.1128/MCB.23.11.3813-3824.2003; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796	24	21	24	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	13					1952	1962		10.1038/onc.2009.480	http://dx.doi.org/10.1038/onc.2009.480			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20062073				2022-12-25	WOS:000276199600008
J	Kim, JH; Konieczkowski, M; Mukherjee, A; Schechtman, S; Khan, S; Schelling, JR; Ross, MD; Bruggeman, LA; Sedor, JR				Kim, Jane H.; Konieczkowski, Martha; Mukherjee, Amitava; Schechtman, Sam; Khan, Shenaz; Schelling, Jeffrey R.; Ross, Michael D.; Bruggeman, Leslie A.; Sedor, John R.			Podocyte Injury Induces Nuclear Translocation of WTIP via Microtubule-dependent Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; AXONAL-TRANSPORT; RETROGRADE TRANSPORT; ACTIN CYTOSKELETON; GENE-EXPRESSION; LIM DOMAIN; PROTEIN; KINASE; AJUBA; NEPHRIN	Podocyte structural and transcriptional phenotype plasticity characterizes glomerular injury. Transcriptional activity of WT1 (Wilm's tumor 1) is required for normal podocyte structure and is repressed by the podocyte adherens junction protein, WTIP (WT1 interacting protein). Here we show that WTIP translocated into podocyte nuclei in lipopolysaccharide (LPS)-treated mice, a model of transient nephrotic syndrome. Cultured podocytes, which stably expressed an epitope-tagged WTIP, were treated with LPS. Imaging and cellular fractionation studies demonstrated that WTIP translocated from podocyte cell contacts into nuclei within 6 h and relocalized to cell contacts within 24 h after LPS treatment. LPS-stimulated WTIP nuclear translocation required JNK activity, which assembled a multiprotein complex of the scaffolding protein JNK-interacting protein 3 and the molecular motor dynein. Intact microtubule networks and dynein activity were necessary for LPS-stimulated WTIP translocation. Podocytes expressing sh-Wtip change morphology and demonstrate altered actin assembly in cell spreading assays. Stress signaling pathways initiate WTIP nuclear translocation, and the concomitant loss of WTIP from cell contacts changes podocyte morphology and dynamic actin assembly, suggesting a mechanism that transmits changes in podocyte morphology to the nucleus.	[Schelling, Jeffrey R.; Bruggeman, Leslie A.; Sedor, John R.] Case Western Reserve Univ, Dept Med, Sch Med, Cleveland, OH 44109 USA; [Konieczkowski, Martha; Mukherjee, Amitava; Schechtman, Sam; Khan, Shenaz; Schelling, Jeffrey R.; Bruggeman, Leslie A.; Sedor, John R.] Case Western Reserve Univ, Ctr Study Kidney Dis & Biol, Sch Med, Cleveland, OH 44109 USA; [Kim, Jane H.; Sedor, John R.] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44109 USA; [Ross, Michael D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital	Sedor, JR (corresponding author), 2500 MetroHealth Dr,R415, Cleveland, OH 44109 USA.	john.sedor@case.edu	Mukherjee, Amitava/AAK-4002-2020	Mukherjee, Amitava/0000-0001-5603-5147	National Institutes of Health [DK-07470, P50 DK-054178, DK-064719, F30 DK083897]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK054178, T32DK007470, F30DK083897, R01DK067528, R01DK059997, R01DK064719, R01DK072348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-07470, P50 DK-054178, DK-064719, and F30 DK083897.	Arndt PG, 2004, J BIOL CHEM, V279, P10883, DOI 10.1074/jbc.M309901200; Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GUNSTREAM JD, 1995, J NEUROSCI, V15, P439; Hauser PV, 2009, NEPHRON EXP NEPHROL, V112, pE43, DOI 10.1159/000213505; Jeon YJ, 2008, MOL BIOL CELL, V19, P5116, DOI 10.1091/mbc.E08-06-0576; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kanungo J, 2000, MOL BIOL CELL, V11, P3299, DOI 10.1091/mbc.11.10.3299; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lindwall C, 2005, MOL CELL NEUROSCI, V29, P269, DOI 10.1016/j.mcn.2005.03.002; Liu G, 2006, J BIOL CHEM, V281, P39681, DOI 10.1074/jbc.M606664200; Matsuguchi T, 2003, EMBO J, V22, P4455, DOI 10.1093/emboj/cdg438; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Montoya-Durango DE, 2008, J BIOL CHEM, V283, P32056, DOI 10.1074/jbc.M802320200; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Rastaldi MP, 2006, FASEB J, V20, P976, DOI 10.1096/fj.05-4962fje; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Ronco P, 2007, J CLIN INVEST, V117, P2079, DOI 10.1172/JCI32966; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Smoyer WE, 1998, J MOL MED, V76, P172, DOI 10.1007/s001090050206; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Srichai MB, 2004, J BIOL CHEM, V279, P14398, DOI 10.1074/jbc.M314155200; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Verhey KJ, 2007, CURR BIOL, V17, pR804, DOI 10.1016/j.cub.2007.07.005	44	23	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9995	10004		10.1074/jbc.M109.061671	http://dx.doi.org/10.1074/jbc.M109.061671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20086015	Green Published, hybrid			2022-12-25	WOS:000276165900068
J	Li, DQ; Pakala, SB; Reddy, SDN; Ohshiro, K; Peng, SH; Lian, Y; Fu, SW; Kumar, R				Li, Da-Qiang; Pakala, Suresh B.; Reddy, Sirigiri Divijendra Natha; Ohshiro, Kazufumi; Peng, Shao-Hua; Lian, Yi; Fu, Sidney W.; Kumar, Rakesh			Revelation of p53-independent Function of MTA1 in DNA Damage Response via Modulation of the p21(WAF1)-Proliferating Cell Nuclear Antigen Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; TRANSCRIPTIONAL REPRESSION; INDIVIDUAL CELLS; EXCISION-REPAIR; HISTONE H2AX; PCNA; P21; P53; EXPRESSION; REPLICATION	Although metastasis-associated protein 1 (MTA1), a component of the nucleosome remodeling and deacetylase (NuRD) complex, is a DNA-damage response protein and regulates p53-dependent DNA repair, it remains unknown whether MTA1 also participates in p53-independent DNA damage response. Here, we provide evidence that MTA1 is a p53-independent transcriptional corepressor of p21(WAF1), and the underlying mechanism involves recruitment of MTA1-histone deacetylase 2 (HDAC2) complexes onto two selective regions of the p21(WAF1) promoter. Accordingly, MTA1 depletion, despite its effect on p53 down-regulation, superinduces p21(WAF1), increases p21(WAF1) binding to proliferating cell nuclear antigen (PCNA), and decreases the nuclear accumulation of PCNA in response to ionizing radiation. In support of a p53-independent role of MTA1 in DNA damage response, we further demonstrate that induced expression of MTA1 in p53-null cells inhibits p21(WAF1) promoter activity and p21(WAF1) binding to PCNA. Consequently, MTA1 expression in p53-null cells results in increased induction of gamma H2AX foci and DNA double strand break repair, and decreased DNA damage sensitivity following ionizing radiation treatment. These findings uncover a new target of MTA1 and the existence of an additional p53-independent role of MTA1 in DNA damage response, at least in part, by modulating the p21(WAF1)-PCNA pathway, and thus, linking two previously unconnected NuRD complex and DNA-damage response pathways.	[Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; George Washington Univ, Med Ctr, Inst Coregulator Biol, Washington, DC 20037 USA	George Washington University; George Washington University	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendra reddy/E-1031-2017; sirigiri, divijendranathareddy/A-9857-2010	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 (to R.K.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; de Rozieres S, 2000, ONCOGENE, V19, P1691, DOI 10.1038/sj.onc.1203468; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; HARPER JW, 1993, CELL, V75, P805; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; MICHIELI P, 1994, CANCER RES, V54, P3391; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Savio M, 1998, CARCINOGENESIS, V19, P591, DOI 10.1093/carcin/19.4.591; SHIVJI MKK, 1994, CURR BIOL, V4, P1062, DOI 10.1016/S0960-9822(00)00244-X; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Tom S, 2001, J BIOL CHEM, V276, P48781, DOI 10.1074/jbc.M109626200; TOSCHI L, 1988, J CELL BIOL, V107, P1623, DOI 10.1083/jcb.107.5.1623; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Zeng YX, 1996, ONCOGENE, V12, P1557	39	48	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10044	10052		10.1074/jbc.M109.079095	http://dx.doi.org/10.1074/jbc.M109.079095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20071335	Green Published, hybrid			2022-12-25	WOS:000276165900072
J	Limapichat, W; Lester, HA; Dougherty, DA				Limapichat, Walrati; Lester, Henry A.; Dougherty, Dennis A.			Chemical Scale Studies of the Phe-Pro Conserved Motif in the Cys Loop of Cys Loop Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; UNNATURAL AMINO-ACIDS; GATED ION-CHANNEL; SUPPRESSOR TRANSFER-RNAS; CIS-TRANS ISOMERIZATION; IN-VIVO INCORPORATION; X-RAY-STRUCTURE; PROLINE RESIDUES; AGONIST BINDING; PEPTIDE-BONDS	The functions of two conserved residues, Phe(135) and Pro(136), located at the apex of the Cys loop of the nicotinic acetylcholine receptor are investigated. Both residues were substituted with natural and unnatural amino acids, focusing on the role of aromaticity at Phe(135), backbone conformation at Pro(136), side chain polarity and volume, and the specific interaction between the aromatic side chain and the proline. NMR spectroscopy studies of model peptides containing proline and unnatural proline analogues following a Phe show a consistent increase in the population of the cis conformer relative to peptides lacking the Phe. In the receptor, a strong interaction between the Phe and Pro residues is evident, as is a strong preference for aromaticity and hydrophobicity at the Phe site. A similar influence of hydrophobicity is observed at the proline site. In addition, across a simple homologous series of proline analogues, the results reveal a correlation between receptor function and cis bias at the proline backbone. This could suggest a significant role for the cis proline conformer at this site in receptor function.	[Limapichat, Walrati; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health [NS-34407, NS-11756]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756, R01NS034407, R37NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-34407 and NS-11756.	Bhattacharyya R, 2003, J MOL BIOL, V331, P925, DOI 10.1016/S0022-2836(03)00759-9; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2005, J AM CHEM SOC, V127, P350, DOI 10.1021/ja0461771; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Deane CM, 2001, J BIOL CHEM, V276, P37962; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Fu DX, 1996, J BIOL CHEM, V271, P31479, DOI 10.1074/jbc.271.49.31479; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; McMenimen KA, 2006, ACS CHEM BIOL, V1, P227, DOI 10.1021/cb6000944; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Paulsen IM, 2009, J NEUROCHEM, V110, P870, DOI 10.1111/j.1471-4159.2009.06180.x; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; RICKERT KW, 1995, CHEM BIOL, V2, P751, DOI 10.1016/1074-5521(95)90103-5; Rodriguez EA, 2007, RNA, V13, P1715, DOI 10.1261/rna.667607; Rodriguez EA, 2007, RNA, V13, P1703, DOI 10.1261/rna.666807; Saks ME, 1996, J BIOL CHEM, V271, P23169, DOI 10.1074/jbc.271.38.23169; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Thomas KM, 2006, J AM CHEM SOC, V128, P2216, DOI 10.1021/ja057901y; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wu WJ, 1998, J ORG CHEM, V63, P6689, DOI 10.1021/jo981340u	39	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8976	8984		10.1074/jbc.M109.060939	http://dx.doi.org/10.1074/jbc.M109.060939			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20068044	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000275553700049
J	Volkmann, G; Murphy, PW; Rowland, EE; Cronan, JE; Liu, XQ; Blouin, C; Byers, DM				Volkmann, Gerrit; Murphy, Peter W.; Rowland, Elden E.; Cronan, John E., Jr.; Liu, Xiang-Qin; Blouin, Christian; Byers, David M.			Intein-mediated Cyclization of Bacterial Acyl Carrier Protein Stabilizes Its Folded Conformation but Does Not Abolish Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MOLECULAR-DYNAMICS; IN-VIVO; RESIDUES; BINDING; REVEAL; SITE; IDENTIFICATION; MUTAGENESIS; FORMS	Bacterial acyl carrier protein (ACP) is essential for the synthesis of fatty acids and serves as the major acyl donor for the formation of phospholipids and other lipid products. Acyl-ACP encloses attached fatty acyl groups in a hydrophobic pocket within a four-helix bundle, but must at least partially unfold to present the acyl chain to the active sites of its multiple enzyme partners. To further examine the constraints of ACP structure and function, we have constructed a cyclic version of Vibrio harveyi ACP, using split-intein technology to covalently join its closely apposed N and C termini. Cyclization stabilized ACP in a folded helical conformation as indicated by gel electrophoresis, circular dichroism, fluorescence, and mass spectrometry. Molecular dynamics simulations also indicated overall decreased polypeptide chain mobility in cyclic ACP, although no major conformational rearrangements over a 10-ns period were noted. In vivo complementation assays revealed that cyclic ACP can functionally replace the linear wild-type protein and support growth of an Escherichia coli ACP-null mutant strain. Cyclization of a folding-deficient ACP mutant (F50A) both restored its ability to adopt a folded conformation and enhanced complementation of growth. Our results thus suggest that ACP must be able to adopt a folded conformation for biological activity, and that its function does not require complete unfolding of the protein.	[Volkmann, Gerrit; Murphy, Peter W.; Liu, Xiang-Qin; Blouin, Christian; Byers, David M.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada; [Murphy, Peter W.; Rowland, Elden E.; Byers, David M.] Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada; [Cronan, John E., Jr.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E., Jr.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Blouin, Christian] Dalhousie Univ, Fac Comp Sci, Halifax, NS B3H 1W5, Canada	Dalhousie University; Dalhousie University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Dalhousie University	Byers, DM (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, 5850 Coll St, Halifax, NS B3H 1X5, Canada.	david.byers@dal.ca	Cronan, John/V-6626-2019	Blouin, Christian/0000-0002-4434-4142	National Institutes of Health [AI15650]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; IWK Health Centre Studentship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); IWK Health Centre Studentship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650 (to J.E.C.). This work was also supported by the Natural Sciences and Engineering Research Council of Canada (to D. M. B.), Canadian Institutes of Health Research (to X. Q. L.), and by an IWK Health Centre Studentship (to P. W. M.).	ANDREC M, 1995, PROTEIN SCI, V4, P983; Battesti A, 2009, J BACTERIOL, V191, P616, DOI 10.1128/JB.01195-08; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; Colizzi F, 2008, J CHEM INF MODEL, V48, P2289, DOI 10.1021/ci800297v; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dennis JJ, 1998, BIOTECHNIQUES, V25, P772, DOI 10.2144/98255bm04; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Gong H, 2003, BIOCHEM BIOPH RES CO, V302, P35, DOI 10.1016/S0006-291X(03)00108-6; Gong HS, 2008, BBA-PROTEINS PROTEOM, V1784, P1835, DOI 10.1016/j.bbapap.2008.07.017; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KATTA V, 1991, RAPID COMMUN MASS SP, V5, P214, DOI 10.1002/rcm.1290050415; Keating MM, 2002, BBA-PROTEINS PROTEOM, V1601, P208, DOI 10.1016/S1570-9639(02)00470-3; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Konermann L, 1997, BIOCHEMISTRY-US, V36, P12296, DOI 10.1021/bi971266u; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Murphy PW, 2007, J AM SOC MASS SPECTR, V18, P1525, DOI 10.1016/j.jasms.2007.05.012; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Watt SJ, 2007, J AM SOC MASS SPECTR, V18, P1605, DOI 10.1016/j.jasms.2007.06.004; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; Wu BN, 2009, PROTEIN SCI, V18, P240, DOI 10.1002/pro.11; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	41	18	23	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8605	8614		10.1074/jbc.M109.060863	http://dx.doi.org/10.1074/jbc.M109.060863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20083605	Green Published, hybrid			2022-12-25	WOS:000275553700012
J	Allgaier, M; Reddy, A; Park, JI; Ivanova, N; D'haeseleer, P; Lowry, S; Sapra, R; Hazen, TC; Simmons, BA; VanderGheynst, JS; Hugenholtz, P				Allgaier, Martin; Reddy, Amitha; Park, Joshua I.; Ivanova, Natalia; D'haeseleer, Patrik; Lowry, Steve; Sapra, Rajat; Hazen, Terry C.; Simmons, Blake A.; VanderGheynst, Jean S.; Hugenholtz, Philip			Targeted Discovery of Glycoside Hydrolases from a Switchgrass-Adapted Compost Community	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; BOVINE RUMEN; BIOFUELS; BIOMASS; DEGRADATION; DECOMPOSITION; STRAW; METAGENOMICS; ENVIRONMENT; MICROBIOME	Development of cellulosic biofuels from non-food crops is currently an area of intense research interest. Tailoring depolymerizing enzymes to particular feedstocks and pretreatment conditions is one promising avenue of research in this area. Here we added a green-waste compost inoculum to switchgrass (Panicum virgatum) and simulated thermophilic composting in a bioreactor to select for a switchgrass-adapted community and to facilitate targeted discovery of glycoside hydrolases. Small-subunit (SSU) rRNA-based community profiles revealed that the microbial community changed dramatically between the initial and switchgrass-adapted compost (SAC) with some bacterial populations being enriched over 20-fold. We obtained 225 Mbp of 454-titanium pyrosequence data from the SAC community and conservatively identified 800 genes encoding glycoside hydrolase domains that were biased toward depolymerizing grass cell wall components. Of these, similar to 10% were putative cellulases mostly belonging to families GH5 and GH9. We synthesized two SAC GH9 genes with codon optimization for heterologous expression in Escherichia coli and observed activity for one on carboxymethyl cellulose. The active GH9 enzyme has a temperature optimum of 50 degrees C and pH range of 5.5 to 8 consistent with the composting conditions applied. We demonstrate that microbial communities adapt to switchgrass decomposition using simulated composting condition and that full-length genes can be identified from complex metagenomic sequence data, synthesized and expressed resulting in active enzyme.	[Allgaier, Martin; Reddy, Amitha; Park, Joshua I.; D'haeseleer, Patrik; Sapra, Rajat; Hazen, Terry C.; Simmons, Blake A.; VanderGheynst, Jean S.; Hugenholtz, Philip] Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA; [Reddy, Amitha; VanderGheynst, Jean S.] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA; [Allgaier, Martin; Ivanova, Natalia; Lowry, Steve; Hugenholtz, Philip] Joint Genome Inst, Dept Energy DOE, Walnut Creek, CA USA; [D'haeseleer, Patrik] Lawrence Livermore Natl Lab, Microbial Syst Biol Grp, Livermore, CA USA; [Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Park, Joshua I.; Sapra, Rajat; Simmons, Blake A.] Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories	Allgaier, M (corresponding author), Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA.	phugenholtz@lbl.gov	Hugenholtz, Philip/AAD-9138-2019; Simmons, Blake/N-6022-2016; Hazen, Terry C/C-1076-2012	Hugenholtz, Philip/0000-0001-5386-7925; Simmons, Blake/0000-0002-1332-1810; Hazen, Terry C/0000-0002-2536-9993; D'haeseleer, Patrik/0000-0003-0007-8150; Ivanova, Natalia/0000-0002-5802-9485	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouton JH, 2007, CURR OPIN GENET DEV, V17, P553, DOI 10.1016/j.gde.2007.08.012; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DESHPANDE MV, 1984, ANAL BIOCHEM, V138, P481, DOI 10.1016/0003-2697(84)90843-1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; EHRMAN T, 1996, 004 NREL CAT TASK LA; Eiland F, 2001, MICROBIAL ECOL, V41, P272, DOI 10.1007/s002480000071; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x; Gura T, 2009, CELL, V138, P9, DOI 10.1016/j.cell.2009.06.038; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horwath WR, 1996, BIOL FERT SOILS, V21, P227, DOI 10.1007/BF00334896; Johnson JMF, 2007, SOIL SCI SOC AM J, V71, P155, DOI 10.2136/sssaj2005.0419; Kirby R, 2006, ADV APPL MICROBIOL, V58, P125, DOI 10.1016/S0065-2164(05)58004-3; KUNIN V, 2009, ENV MICROBIOL; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Margeot A, 2009, CURR OPIN BIOTECH, V20, P372, DOI 10.1016/j.copbio.2009.05.009; Marshall M. N., 2004, Resource recovery and reuse in organic solid waste management, P193; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; NAKASAKI K, 1985, APPL ENVIRON MICROB, V50, P1526, DOI 10.1128/AEM.50.6.1526-1530.1985; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Reddy AP, 2009, T ASABE, V52, P673, DOI 10.13031/2013.26806; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; RUIZ R, 1996, 002 NREL CAT TASK LA; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Takaku H, 2006, J BIOSCI BIOENG, V101, P42, DOI 10.1263/jbb.101.42; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; TEMPLETON D, 1995, 003 NREL CAT TASK LA; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; TWIDWELL EK, 1990, CROP SCI, V30, P1321, DOI 10.2135/cropsci1990.0011183X003000060033x; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WATANABE H, 2009, ANN REV ENTOMOL; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; Xie H, 2007, BIOMACROMOLECULES, V8, P3740, DOI 10.1021/bm700679s; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8	44	129	132	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8812	10.1371/journal.pone.0008812	http://dx.doi.org/10.1371/journal.pone.0008812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098679	gold, Green Published, Green Submitted			2022-12-25	WOS:000273779100006
J	Liu, MY; Rakowski, B; Gershburg, E; Weisend, CM; Lucas, O; Schmidt, EE; Halford, WP				Liu, Mingyu; Rakowski, Brandon; Gershburg, Edward; Weisend, Carla M.; Lucas, Olivier; Schmidt, Edward E.; Halford, William P.			ICP0 Antagonizes ICP4-Dependent Silencing of the Herpes Simplex Virus ICP0 Gene	PLOS ONE			English	Article							REGULATORY PROTEIN ICP0; GREEN FLUORESCENT PROTEIN; RNA-POLYMERASE-II; BINDING PROTEIN; LATENT INFECTION; DNA-BINDING; FUNCTIONAL INTERACTION; MONOCLONAL-ANTIBODIES; HISTONE DEACETYLASES; VIRAL TRANSCRIPTION	ICP0 is a regulatory protein that plays a critical role in the replication-latency balance of herpes simplex virus (HSV). Absence of ICP0 renders HSV prone to establish quiescent infections, and thus cellular repressor(s) are believed to silence HSV mRNA synthesis when ICP0 fails to accumulate. To date, an ICP0-antagonized repressor has not been identified that restricts HSV mRNA synthesis by more than 2-fold. We report the unexpected discovery that HSV's major transcriptional regulator, ICP4, meets the criteria of a bona fide ICP0-antagonized repressor of viral mRNA synthesis. Our study began when we noted a repressive activity that restricted ICP0 mRNA synthesis by up to 30-fold in the absence of ICP0. When ICP0 accumulated, the repressor only restricted ICP0 mRNA synthesis by 3-fold. ICP4 proved to be necessary and sufficient to repress ICP0 mRNA synthesis, and did so in an ICP4-binding-site-dependent manner. ICP4 co-immunoprecipitated with FLAG-tagged ICP0; thus, a physical interaction likely explains how ICP0 antagonizes ICP4's capacity to silence the ICP0 gene. These findings suggest that ICP0 mRNA synthesis is differentially regulated in HSV-infected cells by the virus-encoded repressor activity embedded in ICP4, and a virus-encoded antirepressor, ICP0. Bacteriophage lambda relies on a similar repression-antirepression regulatory scheme to "decide'' whether a given infection will be productive or silent. Therefore, our findings appear to add to the growing list of inexplicable similarities that point to a common evolutionary ancestry between the herpesviruses and tailed bacteriophage.	[Liu, Mingyu; Rakowski, Brandon; Gershburg, Edward; Halford, William P.] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA; [Weisend, Carla M.; Lucas, Olivier; Schmidt, Edward E.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Southern Illinois University System; Southern Illinois University; Montana State University System; Montana State University Bozeman	Liu, MY (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu		Gershburg, Edward/0000-0003-3584-9947	Central Research Committee; Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health [R01 AI51414, R21 AI081072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072, R01AI051414] Funding Source: NIH RePORTER	Central Research Committee; Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds and internal grants from the Central Research Committee and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine, and by grants from the National Institutes of Health (R01 AI51414 and R21 AI081072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN M, 1984, J VIROL, V52, P108, DOI 10.1128/JVI.52.1.108-118.1984; Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; APRHYS CMJ, 1989, J VIROL, V63, P2798, DOI 10.1128/JVI.63.6.2798-2812.1989; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Balliet JW, 2007, VIROLOGY, V361, P372, DOI 10.1016/j.virol.2006.11.022; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; CAMPBELL A, 1994, ANNU REV MICROBIOL, V48, P193, DOI 10.1146/annurev.micro.48.1.193; Carrozza MJ, 1996, MOL CELL BIOL, V16, P3085; Chee AV, 2003, J VIROL, V77, P7101, DOI 10.1128/JVI.77.12.7101-7105.2003; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; Cheng H, 2004, PROTEIN SCI, V13, P2260, DOI 10.1110/ps.04726004; Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08; Danaher RJ, 2000, J NEUROVIROL, V6, P296, DOI 10.3109/13550280009030755; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DELUCA NA, 1988, J VIROL, V62, P732, DOI 10.1128/JVI.62.3.732-743.1988; DIXON RAF, 1980, J VIROL, V36, P189, DOI 10.1128/JVI.36.1.189-203.1980; ELSHIEKH NA, 1991, J VIROL, V65, P6430, DOI 10.1128/JVI.65.12.6430-6437.1991; Everett RD, 2000, J VIROL, V74, P9994, DOI 10.1128/JVI.74.21.9994-10005.2000; Everett RD, 2004, J VIROL, V78, P1763, DOI 10.1128/JVI.78.4.1763-1774.2004; EVERETT RD, 1993, VIROLOGY, V197, P751, DOI 10.1006/viro.1993.1651; Everett RD, 1998, EMBO J, V17, P7161, DOI 10.1093/emboj/17.24.7161; EVERETT RD, 1989, J GEN VIROL, V70, P1185, DOI 10.1099/0022-1317-70-5-1185; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Everett RD, 1999, EMBO J, V18, P1526, DOI 10.1093/emboj/18.6.1526; EVERETT RD, 1991, VIROLOGY, V180, P509, DOI 10.1016/0042-6822(91)90064-I; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; Everett RD, 2008, J VIROL, V82, P2661, DOI 10.1128/JVI.02308-07; Everett RD, 2007, J VIROL, V81, P10991, DOI 10.1128/JVI.00705-07; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; GELMAN IH, 1986, J MOL BIOL, V191, P395, DOI 10.1016/0022-2836(86)90135-X; Gu HD, 2007, P NATL ACAD SCI USA, V104, P17134, DOI 10.1073/pnas.0707266104; Gu HD, 2009, J VIROL, V83, P181, DOI 10.1128/JVI.01940-08; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Hancock MH, 2006, VIROLOGY, V352, P237, DOI 10.1016/j.virol.2006.04.021; HARRIS RA, 1989, J VIROL, V63, P3513, DOI 10.1128/JVI.63.8.3513-3515.1989; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Jordan Robert, 1997, Journal of Virology, V71, P6850; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Kuddus RH, 2007, J VIROL, V81, P9230, DOI 10.1128/JVI.01054-07; Kwun Hyun Jin, 2000, Molecular Cell Biology Research Communications, V3, P15, DOI 10.1006/mcbr.2000.0179; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lee LY, 1998, J VIROL, V72, P4250, DOI 10.1128/JVI.72.5.4250-4264.1998; LeesMiller SP, 1996, J VIROL, V70, P7471, DOI 10.1128/JVI.70.11.7471-7477.1996; LILLYCROP KA, 1991, NEURON, V7, P381, DOI 10.1016/0896-6273(91)90290-G; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Little JW, 2005, P NATL ACAD SCI USA, V102, P5310, DOI 10.1073/pnas.0501645102; Lium EK, 1996, J VIROL, V70, P3488, DOI 10.1128/JVI.70.6.3488-3496.1996; Lomonte P, 2004, J VIROL, V78, P6744, DOI 10.1128/JVI.78.13.6744-6757.2004; Lomonte P, 2007, FEBS LETT, V581, P658, DOI 10.1016/j.febslet.2007.01.027; Lopez P, 2002, J VIROL, V76, P9355, DOI 10.1128/JVI.76.18.9355-9367.2002; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McMahon R, 2008, J VIROL, V82, P10218, DOI 10.1128/JVI.00859-08; MICHAEL N, 1993, P NATL ACAD SCI USA, V90, P2286, DOI 10.1073/pnas.90.6.2286; Minaker RL, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-85; MULLEN MA, 1995, J VIROL, V69, P476, DOI 10.1128/JVI.69.1.476-491.1995; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Preston CM, 1998, J GEN VIROL, V79, P117, DOI 10.1099/0022-1317-79-1-117; Preston CM, 2000, J GEN VIROL, V81, P1; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; RESNICK J, 1989, J VIROL, V63, P2497, DOI 10.1128/JVI.63.6.2497-2503.1989; RICE SA, 1990, J VIROL, V64, P1704, DOI 10.1128/JVI.64.4.1704-1715.1990; RICE SA, 1995, J VIROL, V69, P5550, DOI 10.1128/JVI.69.9.5550-5559.1995; Roizman B, 2005, CELL CYCLE, V4, P1019, DOI 10.4161/cc.4.8.1902; SACKS WR, 1987, J VIROL, V61, P829, DOI 10.1128/JVI.61.3.829-839.1987; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Sampath P, 2008, J VIROL, V82, P2339, DOI 10.1128/JVI.02459-07; SHEPARD AA, 1989, J VIROL, V63, P3714, DOI 10.1128/JVI.63.9.3714-3728.1989; SHOWALTER SD, 1981, INFECT IMMUN, V34, P684, DOI 10.1128/IAI.34.3.684-692.1981; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Soboleski MR, 2005, FASEB J, V19, P440, DOI 10.1096/fj.04-3180fje; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; Sun YH, 2000, J MOL BIOL, V297, P1195, DOI 10.1006/jmbi.2000.3620; TANG S, 2008, J VIROL; Terry-Allison T, 2007, J VIROL, V81, P12394, DOI 10.1128/JVI.01068-07; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; WU CL, 1990, NUCLEIC ACIDS RES, V18, P531, DOI 10.1093/nar/18.3.531; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yang WC, 2002, J VIROL, V76, P12758, DOI 10.1128/JVI.76.24.12758-12774.2002; YAO F, 1994, J VIROL, V68, P8158, DOI 10.1128/JVI.68.12.8158-8168.1994; Zabierowski SE, 2008, J VIROL, V82, P3546, DOI 10.1128/JVI.02560-07	88	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8837	10.1371/journal.pone.0008837	http://dx.doi.org/10.1371/journal.pone.0008837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098619	gold, Green Submitted, Green Published			2022-12-25	WOS:000273779100028
J	Carrasquillo, MM; Belbin, O; Zou, FG; Allen, M; Ertekin-Taner, N; Ansari, M; Wilcox, SL; Kashino, MR; Ma, L; Younkin, LH; Younkin, SG; Younkin, CS; Dincman, TA; Howard, ME; Howell, CC; Stanton, CM; Watson, CM; Crump, M; Vitart, V; Hayward, C; Hastie, ND; Rudan, I; Campbell, H; Polasek, O; Brown, K; Passmore, P; Craig, D; McGuinness, B; Todd, S; Kehoe, PG; Mann, DM; Smith, AD; Beaumont, H; Warden, D; Holmes, C; Heun, R; Kolsch, H; Kalsheker, N; Pankratz, VS; Dickson, DW; Graff-Radford, NR; Petersen, RC; Wright, AF; Younkin, SG; Morgan, K				Carrasquillo, Minerva M.; Belbin, Olivia; Zou, Fanggeng; Allen, Mariet; Ertekin-Taner, Nilufer; Ansari, Morad; Wilcox, Samantha L.; Kashino, Mariah R.; Ma, Li; Younkin, Linda H.; Younkin, Samuel G.; Younkin, Curtis S.; Dincman, Toros A.; Howard, Melissa E.; Howell, Chanley C.; Stanton, Chloe M.; Watson, Christopher M.; Crump, Michael; Vitart, Veronique; Hayward, Caroline; Hastie, Nicholas D.; Rudan, Igor; Campbell, Harry; Polasek, Ozren; Brown, Kristelle; Passmore, Peter; Craig, David; McGuinness, Bernadette; Todd, Stephen; Kehoe, Patrick G.; Mann, David M.; Smith, A. David; Beaumont, Helen; Warden, Donald; Holmes, Clive; Heun, Reinhard; Koelsch, Heike; Kalsheker, Noor; Pankratz, V. Shane; Dickson, Dennis W.; Graff-Radford, Neill R.; Petersen, Ronald C.; Wright, Alan F.; Younkin, Steven G.; Morgan, Kevin			Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, A beta, and Alzheimer's Disease	PLOS ONE			English	Article							BLOCK SPANNING IDE; APOLIPOPROTEIN-E; HAPLOTYPE BLOCK; IN-VIVO; EXTRACELLULAR LEVELS; WIDE ASSOCIATION; NO ASSOCIATION; ONSET; PROTEIN; RISK	Background: The insulin-degrading enzyme gene (IDE) is a strong functional and positional candidate for late onset Alzheimer's disease (LOAD). Methodology/Principal Findings: We examined conserved regions of IDE and its 10 kb flanks in 269 AD cases and 252 controls thereby identifying 17 putative functional polymorphisms. These variants formed eleven haplotypes that were tagged with ten variants. Four of these showed significant association with IDE transcript levels in samples from 194 LOAD cerebella. The strongest, rs6583817, which has not previously been reported, showed unequivocal association (p = 1.5 x 10(-8), fold-increase = 2.12,); the eleven haplotypes were also significantly associated with transcript levels (global p = 0.003). Using an in vitro dual luciferase reporter assay, we found that rs6583817 increases reporter gene expression in Be(2)-C (p = 0.006) and HepG2 (p = 0.02) cell lines. Furthermore, using data from a recent genome-wide association study of two Croatian isolated populations (n = 1,879), we identified a proxy for rs6583817 that associated significantly with decreased plasma A beta 40 levels (beta = 20.124, p = 0.011) and total measured plasma A beta levels (b = 20.130, p = 0.009). Finally, rs6583817 was associated with decreased risk of LOAD in 3,891 AD cases and 3,605 controls. (OR = 0.87, p = 0.03), and the eleven IDE haplotypes (global p = 0.02) also showed significant association. Conclusions: Thus, a previously unreported variant unequivocally associated with increased IDE expression was also associated with reduced plasma A beta 40 and decreased LOAD susceptibility. Genetic association between LOAD and IDE has been difficult to replicate. Our findings suggest that targeted testing of expression SNPs (eSNPs) strongly associated with altered transcript levels in autopsy brain samples may be a powerful way to identify genetic associations with LOAD that would otherwise be difficult to detect.	[Carrasquillo, Minerva M.; Belbin, Olivia; Zou, Fanggeng; Allen, Mariet; Ertekin-Taner, Nilufer; Wilcox, Samantha L.; Kashino, Mariah R.; Ma, Li; Younkin, Linda H.; Younkin, Samuel G.; Younkin, Curtis S.; Dincman, Toros A.; Howard, Melissa E.; Howell, Chanley C.; Stanton, Chloe M.; Watson, Christopher M.; Crump, Michael; Dickson, Dennis W.; Younkin, Steven G.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Allen, Mariet; Ansari, Morad; Vitart, Veronique; Hayward, Caroline; Hastie, Nicholas D.; Wright, Alan F.] Western Gen Hosp, MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Ertekin-Taner, Nilufer; Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Coll Med, Jacksonville, FL 32224 USA; [Rudan, Igor; Campbell, Harry; Polasek, Ozren] Univ Edinburgh, Sch Med, Dept Publ Hlth Sci, Edinburgh, Midlothian, Scotland; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor; Polasek, Ozren] Univ Hosp Sestre Milosrdnice, Ctr Clin Med Res, Zagreb, Croatia; [Brown, Kristelle; Kalsheker, Noor; Morgan, Kevin] Univ Nottingham, Inst Genet, Sch Mol Med Sci, Queens Med Ctr, Nottingham NG7 2RD, England; [Passmore, Peter; Craig, David; McGuinness, Bernadette; Todd, Stephen] Queens Univ Belfast, Sch Med & Dent, Div Psychiat & Neurosci, Belfast, Antrim, North Ireland; [Kehoe, Patrick G.] Univ Bristol, Frenchay Hosp, Dept Clin Sci N Bristol, Bristol, Avon, England; [Mann, David M.] Univ Manchester, Greater Manchester Neurosci Ctr, Manchester, Lancs, England; [Smith, A. David; Beaumont, Helen; Warden, Donald] Univ Dept Physiol Anat & Genet, Oxford Project Investigate Memory & Ageing OPTIMA, Oxford, England; [Holmes, Clive] Univ Southampton, Memory Assessment & Res Ctr, Southampton, Hants, England; [Heun, Reinhard] Univ Birmingham, Div Neurosci, Birmingham, W Midlands, England; [Koelsch, Heike] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [Pankratz, V. Shane] Mayo Clin & Mayo Fdn, Dept Biostat, Rochester, MN 55905 USA; [Petersen, Ronald C.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; [Petersen, Ronald C.] Mayo Clin, Coll Med, Mayo Alzheimer Dis Res Ctr, Rochester, MN USA	Mayo Clinic; University of Edinburgh; Mayo Clinic; University of Edinburgh; University of Split; University of Nottingham; Queens University Belfast; University of Bristol; University of Manchester; University of Oxford; University of Southampton; University of Birmingham; University of Bonn; Mayo Clinic; Mayo Clinic; Mayo Clinic	Carrasquillo, MM (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.	younkin.steven@mayo.edu	McGuinness, Bernadette/AAH-2755-2021; Campbell, Harry/E-2959-2010; Polasek, Ozren/B-6002-2011; Hayward, Caroline/M-8818-2016; Todd, Stephen/A-4299-2009; Smith, Anthony D./A-4233-2010; Rudan, Igor/I-1467-2012; Kehoe, Patrick/P-8760-2018	McGuinness, Bernadette/0000-0002-7028-5633; Campbell, Harry/0000-0002-6169-6262; Polasek, Ozren/0000-0002-5765-1862; Hayward, Caroline/0000-0002-9405-9550; Smith, Anthony D./0000-0002-1095-6722; Rudan, Igor/0000-0001-6993-6884; Dickson, Dennis W/0000-0001-7189-7917; Todd, Stephen/0000-0002-2312-9195; Dincman, Toros/0000-0002-4449-0510; Belbin, Olivia/0000-0002-9805-8408; Watson, Christopher Mark/0000-0003-2371-1844; Holmes, Clive/0000-0003-1999-6912; Belbin, Olivia/0000-0002-6109-6371; Morgan, Kevin/0000-0002-8217-2396; Kehoe, Patrick/0000-0002-7542-1139; Ansari, Morad/0000-0002-8905-5379	National Institutes of Health [R01 AG18023, KL2 RR024151]; National Institute on Aging [AG25711, AG17216, AG03949, U24 AG21886, F32 AG20903]; Mayo Alzheimer's Disease Research Center [P50 AG16574]; Mayo Alzheimer's Disease Patient Registry [U01 AG06576]; Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research; Johnnie B. Byrd and Siragusa Foundation; Medical Research Council UK [108-1080315-0302]; European Commission [018947 LSHG-CT-2006-01947]; Alzheimer's Research Trust; Charles Wolfson Charitable Trust; Norman Collisson Foundation; Alzheimer's Research Trust and Merck and Co. Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG020903, P01AG003949, P50AG016574, R01AG032990, R01AG018023, U24AG021886, P01AG017216, P50AG025711] Funding Source: NIH RePORTER; MRC [MC_U127561128] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2008A-3, ART-NCG2008A-1, ART-BIG2009-1, ART-SB2010A-1, ART-NCG2006-1] Funding Source: researchfish; Medical Research Council [G0700704B, MC_U127561128] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mayo Alzheimer's Disease Research Center; Mayo Alzheimer's Disease Patient Registry; Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research; Johnnie B. Byrd and Siragusa Foundation; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Alzheimer's Research Trust; Charles Wolfson Charitable Trust; Norman Collisson Foundation; Alzheimer's Research Trust and Merck and Co. Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institutes of Health [R01 AG18023 to N. R. G.-R. and S. G. Y., KL2 RR024151 to N. E.-T.]; National Institute on Aging [AG25711, AG17216, AG03949 to D. W. D., U24 AG21886 to N. C. R. A. D., F32 AG20903 to N. E.-T.]; Mayo Alzheimer's Disease Research Center [P50 AG16574 to R. C. P., D. W. D., N. R. G.-R. and S. G. Y.]; Mayo Alzheimer's Disease Patient Registry [U01 AG06576 to R. C. P.]; Robert and Clarice Smith Postdoctoral Fellowship to M. M. C.; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program to R. C. P., D. W. D., N. R. G.-R., S. G. Y.; the Palumbo Professorship in Alzheimer's Disease Research to S. G. Y.; the Johnnie B. Byrd and Siragusa Foundation grants to N. E.-T.; the Medical Research Council UK to H. C., A. F. W. and I. R.; the Ministry of Science, Education and Sports of the Republic of Croatia [108-1080315-0302] and from the European Commission FP6 STRP [018947 LSHG-CT-2006-01947] to I. R., and K. M. holds Network Centre, collaborative and project grants from the Alzheimer's Research Trust. Oxford Project to Investigate Memory and Ageing (OPTIMA) is supported by grants from the Charles Wolfson Charitable Trust, Norman Collisson Foundation, Alzheimer's Research Trust and Merck and Co. Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2001, HUM GENET, V109, P646, DOI 10.1007/s00439-001-0614-1; Ait-Ghezala G, 2002, NEUROSCI LETT, V325, P87, DOI 10.1016/S0304-3940(02)00243-4; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264; Bertram L, 2004, PHARMACOL RES, V50, P385, DOI 10.1016/j.phrs.2003.11.018; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bian L, 2004, NEUROLOGY, V63, P241, DOI 10.1212/01.WNL.0000129987.70037.DB; BJORK BF, 2006, NEUROBIOL AGING; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blomqvist MEL, 2005, NEUROBIOL AGING, V26, P795, DOI 10.1016/j.neurobiolaging.2004.07.011; Blomqvist MEL, 2004, NEUROGENETICS, V5, P115, DOI 10.1007/s10048-004-0173-4; Boussaha M, 2002, NEUROSCI LETT, V329, P121, DOI 10.1016/S0304-3940(02)00586-4; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Cellini E, 2005, ALZ DIS ASSOC DIS, V19, P246, DOI 10.1097/01.wad.0000189030.50826.86; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Edland SD, 2004, J MOL NEUROSCI, V23, P213, DOI 10.1385/JMN:23:3:213; Edland SD, 2003, NEUROSCI LETT, V345, P21, DOI 10.1016/S0304-3940(03)00488-9; Ertekin-Taner N, 2004, HUM MUTAT, V23, P334, DOI 10.1002/humu.20016; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Feuk L, 2005, AM J MED GENET B, V136B, P69, DOI 10.1002/ajmg.b.30172; Gatz M, 1997, J GERONTOL A-BIOL, V52, pM117, DOI 10.1093/gerona/52A.2.M117; HAROLD D, 2009, NAT GENET       0906; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; LAMBERT JC, 2009, NAT GENET       0906; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Mueller JC, 2007, NEUROBIOL AGING, V28, P727, DOI 10.1016/j.neurobiolaging.2006.03.009; Nowotny P, 2005, AM J MED GENET B, V136B, P62, DOI 10.1002/ajmg.b.30186; Ozturk A, 2006, NEUROSCI LETT, V406, P265, DOI 10.1016/j.neulet.2006.07.054; Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sakai A, 2004, AM J MED GENET B, V125B, P87, DOI 10.1002/ajmg.b.20106; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Zemunik T, 2009, CROAT MED J, V50, P23, DOI 10.3325/cmj.2009.50.23	52	42	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8764	10.1371/journal.pone.0008764	http://dx.doi.org/10.1371/journal.pone.0008764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098734	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000273778900008
J	Zhang, SZ; Dai, HH; Wan, N; Moore, Y; Dai, ZH				Zhang, Shuzi; Dai, Hehua; Wan, Ni; Moore, Yolonda; Dai, Zhenhua			Manipulating IL-2 Availability Amid Presentation of Donor MHC Antigens Suppresses Murine Alloimmune Responses by Inducing Regulatory T Cells	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; LONG-TERM ACCEPTANCE; BONE-MARROW-CELLS; TRANSPLANTATION TOLERANCE; ALLOGRAFT SURVIVAL; HEART ALLOGRAFTS; ANTI-CD154 ANTIBODY; MONOCLONAL-ANTIBODY; BLOOD-TRANSFUSION; INTERFERON-GAMMA	Background: Major histocompatibility complex (MHC) antigens are important for alloimmune responses as well as immune tolerance. Previous studies have shown that presentation of donor MHC antigens by donor-specific transfusion prior to or upon transplantation promotes transplant tolerance induced by other agents. However, it is unclear whether presentation of donor MHC antigens by DNA vaccination induces long-term allograft survival. Methodology/Principal Findings: We investigated whether presentation of MHC class-II and/or class-I donor antigens by DNA vaccination suppresses alloimmune responses and promotes long-term allograft acceptance. We initially found that presentation of both MHC donor antigens by DNA vaccination itself prior to transplantation fails to significantly prolong islet allograft survival in otherwise untreated mice. However, islet allograft survival was significantly prolonged when MHC class-II DNA vaccination was accompanied with IL-2 administration (MHCII + IL-2) while MHC class-I DNA vaccination was followed by IL-2 and subsequent neutralizing anti-IL-2 treatments (MHCI + IL-2/anti-IL-2). Especially, this protocol promoted long-term allograft survival in the majority of recipients (57%) when combined with low doses of rapamycin post-transplantation. Importantly, MHCII + IL-2 induced FoxP3+ Treg cells in both spleens and grafts and suppressed graft-infiltrating CD4+ cell proliferation, whereas MHCI + IL-2/anti-IL-2 mainly inhibited graft-infiltrating CD8+ cell proliferation and donor-specific CTL activity. The combined protocol plus rapamycin treatment further reduced both CD4+ and CD8+ T cell proliferation as well as donor-specific CTL activity but spared FoxP3+ Treg cells. Depleting CD25+ Treg cells or adoptive transfer of pre-sensitized CD8+ T cells abolished this long-term allograft survival. Conclusions/Significance: Manipulating IL-2 availability during presentation of MHC class-II and class-I donor antigens by DNA vaccination pre-transplantation induces Treg cells, suppresses alloimmune responses and promotes long-term allograft survival.	[Zhang, Shuzi; Dai, Hehua; Wan, Ni; Moore, Yolonda; Dai, Zhenhua] Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Tyler, TX USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Zhang, SZ (corresponding author), Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Tyler, TX USA.	zhenhua.dai@uthct.edu			American Diabetes Association [ADA 1-06-RA-36]; Juvenile Diabetes Research Foundation International [JDRF 1-2008-583]	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation)	This study was supported by research grants from American Diabetes Association (ADA 1-06-RA-36) and Juvenile Diabetes Research Foundation International (JDRF 1-2008-583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Chiang KC, 2009, J IMMUNOL, V182, P4282, DOI 10.4049/jimmunol.0800641; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; Dai ZH, 1998, J IMMUNOL, V161, P1659; Dai ZH, 2000, J IMMUNOL, V165, P3031, DOI 10.4049/jimmunol.165.6.3031; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Itoh M, 1999, J IMMUNOL, V162, P5317; Iwakoshi NN, 2000, J IMMUNOL, V164, P512, DOI 10.4049/jimmunol.164.1.512; Jones TR, 2002, J IMMUNOL, V168, P1123, DOI 10.4049/jimmunol.168.3.1123; Kang HG, 2007, AM J TRANSPLANT, V7, P1907, DOI 10.1111/j.1600-6143.2007.01881.x; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2572, DOI 10.1002/eji.1830250925; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; Liu ZW, 2007, J IMMUNOL, V178, P4260, DOI 10.4049/jimmunol.178.7.4260; Margenthaler JA, 2003, TRANSPLANTATION, V75, P2119, DOI 10.1097/01.TP.0000069043.57679.85; Markees TG, 2004, TRANSPLANTATION, V78, P1601, DOI 10.1097/01.TP.0000140847.29917.65; Markees TG, 1998, J CLIN INVEST, V101, P2446, DOI 10.1172/JCI2703; MEDAWAR PB, 1963, TRANSPLANTATION, V1, P21, DOI 10.1097/00007890-196301010-00004; Murphy B, 1999, J CLIN INVEST, V103, P859, DOI 10.1172/JCI5734; Murphy B, 2003, J AM SOC NEPHROL, V14, P1053, DOI 10.1097/01.ASN.0000057541.69641.F8; Nakamura T, 2003, J IMMUNOL, V171, P1266, DOI 10.4049/jimmunol.171.3.1266; Nasr IW, 2005, J IMMUNOL, V174, P6161, DOI 10.4049/jimmunol.174.10.6161; PAINEAU J, 1991, J HEART LUNG TRANSPL, V10, P424; Peche H, 2004, TRANSPLANTATION, V77, P733, DOI 10.1097/01.TP.0000114613.70156.DB; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Ringers J, 2002, TRANSPLANTATION, V73, P862, DOI 10.1097/00007890-200203270-00006; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SAYEGH MH, 1993, TRANSPLANTATION, V56, P461, DOI 10.1097/00007890-199308000-00040; Schenk S, 2005, J IMMUNOL, V174, P3741, DOI 10.4049/jimmunol.174.6.3741; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Sonntag KC, 2001, J CLIN INVEST, V107, P65, DOI 10.1172/JCI11015; Sonoda KH, 2002, J IMMUNOL, V168, P2028, DOI 10.4049/jimmunol.168.4.2028; SOULILLOU JP, 1984, TRANSPLANTATION, V38, P63, DOI 10.1097/00007890-198407000-00015; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Umemura A, 2000, J IMMUNOL, V164, P4452, DOI 10.4049/jimmunol.164.9.4452; Walker WE, 2006, J IMMUNOL, V177, P5307, DOI 10.4049/jimmunol.177.8.5307; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Wan N, 2008, J IMMUNOL, V180, P113, DOI 10.4049/jimmunol.180.1.113; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Wu K, 2008, TRANSPL P, V40, P3699, DOI 10.1016/j.transproceed.2008.06.084; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Zang W, 2008, J IMMUNOL, V181, P7499, DOI 10.4049/jimmunol.181.11.7499; Zang WP, 2005, J AM SOC NEPHROL, V16, P3661, DOI 10.1681/ASN.2005050523; Zhai Y, 1999, CURR OPIN IMMUNOL, V11, P497, DOI 10.1016/S0952-7915(99)00007-2; Zhai YA, 2006, J IMMUNOL, V176, P5988, DOI 10.4049/jimmunol.176.10.5988	58	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8756	10.1371/journal.pone.0008756	http://dx.doi.org/10.1371/journal.pone.0008756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090908	Green Published, Green Submitted, gold			2022-12-25	WOS:000273715000014
J	Gregory, JA; Becker, EC; Jung, J; Tuwatananurak, I; Pogliano, K				Gregory, James A.; Becker, Eric C.; Jung, James; Tuwatananurak, Ida; Pogliano, Kit			Transposon Assisted Gene Insertion Technology (TAGIT): A Tool for Generating Fluorescent Fusion Proteins	PLOS ONE			English	Article							PHOTOACTIVATED LOCALIZATION MICROSCOPY; SITE-SPECIFIC RECOMBINATION; ESCHERICHIA-COLI K-12; BACILLUS-SUBTILIS; LAC REPRESSOR; POLAR LOCALIZATION; CELL-DIVISION; BACTERIA; GFP; ENGULFMENT	We constructed a transposon (transposon assisted gene insertion technology, or TAGIT) that allows the random insertion of gfp (or other genes) into chromosomal loci without disrupting operon structure or regulation. TAGIT is a modified Tn5 transposon that uses Kan(R) to select for insertions on the chromosome or plasmid, beta-galactosidase to identify in-frame gene fusions, and Cre recombinase to excise the kan and lacZ genes in vivo. The resulting gfp insertions maintain target gene reading frame (to the 59 and 39 of gfp) and are integrated at the native chromosomal locus, thereby maintaining native expression signals. Libraries can be screened to identify GFP insertions that maintain target protein function at native expression levels, allowing more trustworthy localization studies. We here use TAGIT to generate a library of GFP insertions in the Escherichia coli lactose repressor (LacI). We identified fully functional GFP insertions and partially functional insertions that bind DNA but fail to repress the lacZ operon. Several of these latter GFP insertions localize to lacO arrays integrated in the E. coli chromosome without producing the elongated cells frequently observed when functional LacI-GFP fusions are used in chromosome tagging experiments. TAGIT thereby faciliates the isolation of fully functional insertions of fluorescent proteins into target proteins expressed from the native chromosomal locus as well as potentially useful partially functional proteins.	[Gregory, James A.; Becker, Eric C.; Jung, James; Tuwatananurak, Ida; Pogliano, Kit] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gregory, JA (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	kpogliano@ucsd.edu		Gregory, James/0000-0002-7733-3212; Pogliano, Kit/0000-0002-7868-3345	National Institutes of Health [GM 57045]; University of California at San Diego Academic Senate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at San Diego Academic Senate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This research was supported by a grant from the National Institutes of Health ( GM 57045) and from the University of California at San Diego Academic Senate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; ABREMSKI K, 1986, J BIOL CHEM, V261, P391; ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; Aung S, 2007, MOL MICROBIOL, V65, P1534, DOI 10.1111/j.1365-2958.2007.05887.x; AUSEBEL FM, 1992, CURRENT PROTOCOLS MO; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BOENEMAN K, 2009, MOL MICROBIOL; Broder DH, 2006, CELL, V126, P917, DOI 10.1016/j.cell.2006.06.053; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; EHRMANN M, 1990, P NATL ACAD SCI USA, V87, P7574, DOI 10.1073/pnas.87.19.7574; Goryshin IY, 1998, P NATL ACAD SCI USA, V95, P10716, DOI 10.1073/pnas.95.18.10716; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heintzmann R, 2007, METHOD CELL BIOL, V81, P561, DOI 10.1016/S0091-679X(06)81026-5; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; KARMAZYNCAMPELLI C, 1992, BIOCHIMIE, V74, P689, DOI 10.1016/0300-9084(92)90141-Z; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; KOLTER R, 1978, CELL, V15, P1199, DOI 10.1016/0092-8674(78)90046-6; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; LOPILATO J, 1986, MOL GEN GENET, V205, P285, DOI 10.1007/BF00430440; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Margolin W, 2000, METHODS, V20, P62, DOI 10.1006/meth.1999.0906; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Merkulov GV, 1998, GENE, V222, P213, DOI 10.1016/S0378-1119(98)00503-4; Miller J.H., 1972, EXPT MOL GENETICS; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nelson BD, 1997, J BACTERIOL, V179, P3721, DOI 10.1128/jb.179.11.3721-3728.1997; Osawa M, 2005, MICROBIOL-SGM, V151, P4033, DOI 10.1099/mic.0.28219-0; Pinheiro LB, 2008, APPL MICROBIOL BIOT, V77, P1287, DOI 10.1007/s00253-007-1253-9; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Sharp MD, 2002, SCIENCE, V295, P137, DOI 10.1126/science.1066274; Sheridan DL, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-17; Sheridan DL, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-7; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Wang XD, 2008, BIOCHEM SOC T, V36, P749, DOI 10.1042/BST0360749; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z; WU F, 1992, NUCLEIC ACIDS RES, V20, P811, DOI 10.1093/nar/20.4.811; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	53	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8731	10.1371/journal.pone.0008731	http://dx.doi.org/10.1371/journal.pone.0008731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090956	Green Published, Green Submitted, gold			2022-12-25	WOS:000273714900012
J	LeClair, EE; Topczewski, J				LeClair, Elizabeth E.; Topczewski, Jacek			Development and Regeneration of the Zebrafish Maxillary Barbel: A Novel Study System for Vertebrate Tissue Growth and Repair	PLOS ONE			English	Article							TASTE BUD DEVELOPMENT; CALRETININ IMMUNOREACTIVITY; TAIL REGENERATION; ADULT ZEBRAFISH; XENOPUS-LAEVIS; DANIO-RERIO; BROWN TROUT; FISH; CYPRINIDAE; PHYLOGENY	Background: Barbels are integumentary sense organs found in fishes, reptiles and amphibians. The zebrafish, Danio rerio, develops paired nasal and maxillary barbels approximately one month post fertilization. Small in diameter and optically clear, these adult appendages offer a window on the development, maintenance and function of multiple cell types including skin cells, neural-crest derived pigment cells, circulatory vessels, taste buds and sensory nerves. Importantly, barbels in other otophysan fishes (e. g., catfish) are known to regenerate; however, this capacity has not been tested in zebrafish. Methodology/Principal Findings: We describe the development of the maxillary barbel in a staged series of wild type and transgenic zebrafish using light microscopy, histology and immunohistochemistry. By imaging transgenic zebrafish containing fluorescently labeled endothelial cells (Tg(fli1a: EGFP)), we demonstrate that the barbel contains a long (similar to 2 3 mm) closed-end vessel that we interpret as a large lymphatic. The identity of this vessel was further supported by live imaging of the barbel circulation, extending recent descriptions of the lymphatic system in zebrafish. The maxillary barbel can be induced to regenerate by proximal amputation. After more than 750 experimental surgeries in which approximately 85% of the barbel's length was removed, we find that wound healing is complete within hours, followed by blastema formation (similar to 3 days), epithelial redifferentiation (3-5 days) and appendage elongation. Maximum regrowth occurs within 2 weeks of injury. Although superficially normal, the regenerates are shorter and thicker than the contralateral controls, have abnormally organized mesenchymal cells and extracellular matrix, and contain prominent connective tissue "stumps'' at the plane of section-a mode of regeneration more typical of mammalian scarring than other zebrafish appendages. Finally, we show that the maxillary barbel can regenerate after repeated injury and also in senescent fish (> 2 years old). Conclusions/Significance: Although the teleost barbel has no human analog, the cell types it contains are highly conserved. Thus "barbology'' may be a useful system for studying epithelial-mesenchymal interactions, angiogenesis and lymphangiogenesis, neural pathfinding, wound healing, scar formation and other key processes in vertebrate physiology.	[LeClair, Elizabeth E.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Topczewski, Jacek] Northwestern Univ, Feinberg Sch Med, Dept Pediat, CMRC, Chicago, IL 60611 USA	DePaul University; Northwestern University; Feinberg School of Medicine	LeClair, EE (corresponding author), Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA.	eleclair@depaul.edu	Topczewski, Jacek/D-5895-2016	Topczewski, Jacek/0000-0001-6023-9556	DePaul University Research Council; NIH [R01(DE016678)]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016678] Funding Source: NIH RePORTER	DePaul University Research Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding: This work was supported in part by a paid sabbatical leave to E. E. LeClair from the DePaul University Research Council and an NIH R01(DE016678) to J. Topczweski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens D, 1997, J ZOOL, V241, P117, DOI 10.1111/j.1469-7998.1997.tb05503.x; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; ARAI R, 2003, BULLETIN, V40, P1; Ausoni S, 2009, J CELL BIOL, V184, P357, DOI 10.1083/jcb.200810094; BARMAN RP, 1991, 137 ZOOL SURV IND; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2007, J NEUROSCI RES, V85, P2793, DOI 10.1002/jnr.21121; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Briolay J, 1998, MOL PHYLOGENET EVOL, V9, P100, DOI 10.1006/mpev.1997.0441; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Brockes JP, 2001, J ANAT, V199, P3; Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Bryant SV, 2002, INT J DEV BIOL, V46, P887; Castro A, 2006, J COMP NEUROL, V494, P792, DOI 10.1002/cne.20843; Castro A, 2006, J COMP NEUROL, V494, P435, DOI 10.1002/cne.20782; Castro A, 2003, J COMP NEUROL, V467, P254, DOI 10.1002/cne.10923; Castro A, 2008, J CHEM NEUROANAT, V35, P306, DOI 10.1016/j.jchemneu.2008.03.005; COLLINS MR, 1994, PROG FISH CULT, V56, P250, DOI 10.1577/1548-8640(1994)056<0250:EOSMFM>2.3.CO;2; Diaz-Regueira SM, 2005, BRAIN RES, V1031, P297, DOI 10.1016/j.brainres.2004.10.039; DIMMICK WW, 1988, COPEIA, P72; Dufourcq P, 2006, MOL CELL NEUROSCI, V33, P180, DOI 10.1016/j.mcn.2006.07.005; Eakin RR, 2006, POLAR BIOL, V30, P45, DOI 10.1007/s00300-006-0158-x; Fadaee B, 2006, J APPL ICHTHYOL, V22, P160, DOI 10.1111/j.1439-0426.2007.00945.x; Fox H, 1999, HYDROBIOLOGIA, V403, P153, DOI 10.1023/A:1003778125517; Germana A, 2007, BRAIN RES, V1162, P48, DOI 10.1016/j.brainres.2007.05.070; GHIOT F, 1984, Annales de la Societe Royale Zoologique de Belgique, V114, P261; GOSS RJ, 1955, AM J ANAT, V97, P59, DOI 10.1002/aja.1000970103; GOTO T, 1994, JPN J ICHTHYOL, V41, P167; Hansen A, 2002, DEV DYNAM, V223, P483, DOI 10.1002/dvdy.10074; Harlow DE, 2007, DEV BIOL, V310, P317, DOI 10.1016/j.ydbio.2007.07.042; Hata S, 2007, DEV GROWTH DIFFER, V49, P163, DOI 10.1111/j.1440-169x.2007.00910.x; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Howe JC, 2002, FISH RES, V56, P1, DOI 10.1016/S0165-7836(01)00312-5; Humason G., 1967, ANIMAL TISSUE TECHNI; JOYCE EC, 1978, J MORPHOL, V158, P109, DOI 10.1002/jmor.1051580202; Kiyohara S, 2002, P ROY SOC B-BIOL SCI, V269, P1773, DOI 10.1098/rspb.2002.2086; Kotrschal K, 2000, PFLUG ARCH EUR J PHY, V439, pR178, DOI 10.1007/s004240000137; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LeClair E. E., 2009, J VIS EXP, DOI 1510.3791/1558; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; Liu Q, 2004, DEV BRAIN RES, V150, P63, DOI 10.1016/j.devbrainres.2004.03.002; MCCORMICK MI, 1993, ENVIRON BIOL FISH, V37, P269, DOI 10.1007/BF00004634; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Mochii M, 2007, DEV GROWTH DIFFER, V49, P155, DOI 10.1111/j.1440-169X.2007.00912.x; Nakatani Y, 2007, DEV GROWTH DIFFER, V49, P145, DOI 10.1111/j.1440-169x.2007.00917.x; Northcutt RG, 2005, J COMP NEUROL, V482, P1, DOI 10.1002/cne.20425; Ogawa K, 1997, CHEM SENSES, V22, P477, DOI 10.1093/chemse/22.4.477; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Raya A, 2004, CLONING STEM CELLS, V6, P345, DOI 10.1089/clo.2004.6.345; Saadatfar Z, 2007, J APPL ANIM RES, V32, P65, DOI 10.1080/09712119.2007.9706848; Sakata Y, 2001, FISHERIES SCI, V67, P1136, DOI 10.1046/j.1444-2906.2001.00371.x; SATO MITSUO, 1966, JAP J ICHTHYOL, V13, P169; SCHMIDT RE, 1983, J FRESHWATER ECOL, V2, P239, DOI 10.1080/02705060.1983.9664600; SHIBA Y, 1982, DEV GROWTH DIFFER, V24, P199; Tseng AS, 2008, J DENT RES, V87, P806, DOI 10.1177/154405910808700909; Webb AE, 2004, METH MOL B, V289, P137; WILSON SW, 1991, DEVELOPMENT, V112, P723; WINOKUR RM, 1982, J MORPHOL, V172, P59, DOI 10.1002/jmor.1051720106; Yoshii Y, 2005, DEV GROWTH DIFFER, V47, P563	60	54	54	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8737	10.1371/journal.pone.0008737	http://dx.doi.org/10.1371/journal.pone.0008737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090899	Green Published, Green Submitted, gold			2022-12-25	WOS:000273714900017
J	Tancevski, I; Demetz, E; Eller, P; Duwensee, K; Hoefer, J; Heim, C; Stanzl, U; Wehinger, A; Auer, K; Karer, R; Huber, J; Schgoer, W; Van Eck, M; Vanhoutte, J; Fievet, C; Stellaard, F; Rudling, M; Patsch, JR; Ritsch, A				Tancevski, Ivan; Demetz, Egon; Eller, Philipp; Duwensee, Kristina; Hoefer, Julia; Heim, Christiane; Stanzl, Ursula; Wehinger, Andreas; Auer, Kristina; Karer, Regina; Huber, Julia; Schgoer, Wilfried; Van Eck, Miranda; Vanhoutte, Jonathan; Fievet, Catherine; Stellaard, Frans; Rudling, Mats; Patsch, Josef R.; Ritsch, Andreas			The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; RECEPTOR CLASS-B; DENSITY-LIPOPROTEIN RECEPTOR; IN-VIVO; LESION DEVELOPMENT; LDL CHOLESTEROL; SR-BI; OVEREXPRESSION; ABSORPTION; EXPRESSION	Background: Liver-selective thyromimetics have been reported to efficiently reduce plasma cholesterol through the hepatic induction of both, the low-density lipoprotein receptor (LDLr) and the high-density lipoprotein (HDL) receptor; the scavenger receptor class B type I (SR-BI). Here, we investigated the effect of the thyromimetic T-0681 on reverse cholesterol transport (RCT) and atherosclerosis, and studied the underlying mechanisms using different mouse models, including mice lacking LDLr, SR-BI, and apoE, as well as CETP transgenic mice. Methodology/Principal Findings: T-0681 treatment promoted bile acid production and biliary sterol secretion consistently in the majority of the studied mouse models, which was associated with a marked reduction of plasma cholesterol. Using an assay of macrophage RCT in mice, we found T-0681 to significantly increase fecal excretion of macrophage-derived neutral and acidic sterols. No positive effect on RCT was found in CETP transgenic mice, most likely due to the observed decrease in plasma CETP mass. Studies in SR-BI KO and LDLr KO mice suggested hepatic LDLr to be necessary for the action of T-0681 on lipid metabolism, as the compound did not have any influence on plasma cholesterol levels in mice lacking this receptor. Finally, prolonged treatment with T-0681 reduced the development of atherosclerosis by 60% in apoE KOs on Western type diet. In contrast, at an earlier time-point T-0681 slightly increased small fatty streak lesions, in part due to an impaired macrophage cholesterol efflux capacity, when compared to controls. Conclusions/Significance: The present results show that liver-selective thyromimetics can promote RCT and that such compounds may protect from atherosclerosis partly through induction of bile acid metabolism and biliary sterol secretion. On-going clinical trials will show whether selective thyromimetics do prevent atherosclerosis also in humans.	[Tancevski, Ivan; Demetz, Egon; Eller, Philipp; Duwensee, Kristina; Hoefer, Julia; Heim, Christiane; Stanzl, Ursula; Wehinger, Andreas; Auer, Kristina; Karer, Regina; Huber, Julia; Schgoer, Wilfried; Patsch, Josef R.; Ritsch, Andreas] Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria; [Van Eck, Miranda] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Gorlaeus Labs, Div Biopharmaceut, Leiden, Netherlands; [Stellaard, Frans] Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, NL-9713 AV Groningen, Netherlands; [Vanhoutte, Jonathan; Fievet, Catherine] Inst Pasteur, Dept Atherosclerose, F-59019 Lille, France; [Rudling, Mats] Karolinska Univ Hosp, Karolinska Inst, Ctr Endocrinol Metab & Diabet, Mol Nutr Unit,Dept Med, Stockholm, Sweden; [Rudling, Mats] Karolinska Univ Hosp, Karolinska Inst, Ctr Endocrinol Metab & Diabet, Mol Nutr Unit,Dept Biosci & Nutr, Stockholm, Sweden	Medical University of Innsbruck; Leiden University; Leiden University - Excl LUMC; University of Groningen; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Tancevski, I (corresponding author), Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria.	ivan.tancevski@i-med.ac.at	Tancevski, Ivan/AID-5169-2022	Tancevski, Ivan/0000-0001-5116-8960; Demetz, Egon/0000-0002-5723-927X; Ritsch, Andreas/0000-0002-0417-5161; Hoefer, Julia/0000-0003-1138-3134; van Eck, Miranda/0000-0003-3936-3194	Hans und Blanca Moser Stiftung [61-1994/95]; Medizinische Forschungsforderung Innsbruck (MFI) [4316]; Jubilaumsfonds der Oesterreichischen Nationalbank (OENB) [12156]; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P19999-B05]	Hans und Blanca Moser Stiftung; Medizinische Forschungsforderung Innsbruck (MFI); Jubilaumsfonds der Oesterreichischen Nationalbank (OENB); Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF))	Funding: This work was supported by the Hans und Blanca Moser Stiftung (No. 61-1994/95 to I. T.), by the Medizinische Forschungsforderung Innsbruck (MFI No. 4316 to I. T.), by the Jubilaumsfonds der Oesterreichischen Nationalbank (OENB, No. 12156 to I. T. and A. R.) and by the Fonds zur Forderung der wissenschaftlichen Forschung (FWF, P19999-B05 to A. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; [Anonymous], 1972, JAMA, V220, P996; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Berkenstam A, 2008, P NATL ACAD SCI USA, V105, P663, DOI 10.1073/pnas.0705286104; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; Grover GJ, 2003, P NATL ACAD SCI USA, V100, P10067, DOI 10.1073/pnas.1633737100; Hayashi M, 2004, ARCH TOXICOL, V78, P460, DOI 10.1007/s00204-004-0561-4; Hennuyer N, 2005, ARTERIOSCL THROM VAS, V25, P1897, DOI 10.1161/01.ATV.0000175756.56818.ee; Hulten Lillemor Mattsson, 2005, Lipids Health Dis, V4, P6, DOI 10.1186/1476-511X-4-6; Johansson L, 2005, P NATL ACAD SCI USA, V102, P10297, DOI 10.1073/pnas.0504379102; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; LUTJOHANN D, 1995, J LIPID RES, V36, P1763; MASHIGE F, 1976, CLIN CHIM ACTA, V70, P79, DOI 10.1016/0009-8981(76)90007-3; Mason RL, 1930, NEW ENGL J MED, V203, P1273, DOI 10.1056/NEJM193012252032601; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; Morkin E, 2004, J MOL CELL CARDIOL, V37, P1137, DOI 10.1016/j.yjmcc.2004.09.013; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nijstad N, 2009, CIRCULATION, V120, pS443; Ritsch A, 2003, CURR OPIN LIPIDOL, V14, P173, DOI 10.1097/00041433-200304000-00009; RITSCH A, 1993, J LIPID RES, V34, P673; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Spady DK, 1998, J BIOL CHEM, V273, P126, DOI 10.1074/jbc.273.1.126; Tancevski I, 2005, J MOL MED, V83, P927, DOI 10.1007/s00109-005-0695-8; Tancevski I, 2008, ENDOCRINOLOGY, V149, P3708, DOI 10.1210/en.2007-1387; Tancevski I, 2009, CURR OPIN INVEST DR, V10, P912; Tancevski I, 2009, J LIPID RES, V50, P938, DOI 10.1194/jlr.M800553-JLR200; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; van der Veen JN, 2005, J LIPID RES, V46, P526, DOI 10.1194/jlr.M400400-JLR200; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Van Eck M, 2007, CIRC RES, V100, P678, DOI 10.1161/01.RES.0000260202.79927.4f; Wang X, 2006, CIRCULATION, V114, P146; Wu JE, 2004, J BIOL CHEM, V279, P22913, DOI 10.1074/jbc.M402838200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0	39	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8722	10.1371/journal.pone.0008722	http://dx.doi.org/10.1371/journal.pone.0008722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090943	gold, Green Published			2022-12-25	WOS:000273714900004
J	Wang, SS; Gonzalez, P; Yu, K; Porras, C; Li, QZ; Safaeian, M; Rodriguez, AC; Sherman, ME; Bratti, C; Schiffman, M; Wacholder, S; Burk, RD; Herrero, R; Chanock, SJ; Hildesheim, A				Wang, Sophia S.; Gonzalez, Paula; Yu, Kai; Porras, Carolina; Li, Qizhai; Safaeian, Mahboobeh; Cecilia Rodriguez, Ana; Sherman, Mark E.; Bratti, Concepcion; Schiffman, Mark; Wacholder, Sholom; Burk, Robert D.; Herrero, Rolando; Chanock, Stephen J.; Hildesheim, Allan			Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; DNA-REPAIR GENES; COSTA-RICA; HEPARAN-SULFATE; NEOPLASIA; HOST	HPV infrequently persists and progresses to cervical cancer. We examined host genetic factors hypothesized to play a role in determining which subset of individuals infected with oncogenic human papillomavirus (HPV) have persistent infection and further develop cervical pre-cancer/cancer compared to the majority of infected individuals who will clear infection. We evaluated 7140 tag single nucleotide polymorphisms (SNPs) from 305 candidate genes hypothesized to be involved in DNA repair, viral infection and cell entry in 416 cervical intraepithelial neoplasia 3 (CIN3)/cancer cases, 356 HPV persistent women (median: 25 months), and 425 random controls (RC) from the 10,049 women Guanacaste Costa Rica Natural History study. We used logistic regression to compute odds ratios and p-trend for CIN3/cancer and HPV persistence in relation to SNP genotypes and haplotypes (adjusted for age). We obtained pathway and gene-level summary of associations by computing the adaptive combination of p-values. Genes/regions statistically significantly associated with CIN3/cancer included the viral infection and cell entry genes 29,59 oligoadenylate synthetase gene 3 (OAS3), sulfatase 1 (SULF1), and interferon gamma (IFNG); the DNA repair genes deoxyuridine triphosphate (DUT), dosage suppressor of mck 1 homolog (DMC1), and general transcription factor IIH, polypeptide 3 (GTF2H4); and the EVER1 and EVER2 genes (p<0.01). From each region, the single most significant SNPs associated with CIN3/cancer were OAS3 rs12302655, SULF1 rs4737999, IFNG rs11177074, DUT rs3784621, DMC1 rs5757133, GTF2H4 rs2894054, EVER1/EVER2 rs9893818 (p-trends <= 0.001). SNPs for OAS3, SULF1, DUT, and GTF2H4 were associated with HPV persistence whereas IFNG and EVER1/EVER2 SNPs were associated with progression to CIN3/cancer. We note that the associations observed were less than two-fold. We identified variations DNA repair and viral binding and cell entry genes associated with CIN3/cancer. Our results require replication but suggest that different genes may be responsible for modulating risk in the two critical transition steps important for cervical carcinogenesis: HPV persistence and disease progression.	[Wang, Sophia S.] City Hope Natl Med Ctr, Div Etiol, Duarte, CA 91010 USA; [Gonzalez, Paula; Porras, Carolina; Cecilia Rodriguez, Ana; Bratti, Concepcion; Herrero, Rolando] Fdn INCIENSA, San Jose, Costa Rica; [Wang, Sophia S.; Yu, Kai; Li, Qizhai; Safaeian, Mahboobeh; Sherman, Mark E.; Schiffman, Mark; Wacholder, Sholom; Hildesheim, Allan] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Li, Qizhai] Chinese Acad Sci, Acad Math & Syst Sci, Key Lab Syst & Control, Beijing, Peoples R China; [Burk, Robert D.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Chanock, Stephen J.] NCI, Core Genotyping Facil, Div Canc Epidemiol & Genet, Adv Technol Program,SAIC Frederick Inc, Frederick, MD 21701 USA	City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Wang, SS (corresponding author), City Hope Natl Med Ctr, Div Etiol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	sowang@coh.org	Hildesheim, Allan/B-9760-2015; Schiffman, Mark/B-9766-2015	Hildesheim, Allan/0000-0003-0257-2363; WANG, SOPHIA/0000-0003-2597-9393	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R01 CA078527, CO-12400, U01 CA078527, CA-78527, CP-21081, CP-31061, N01CO12400] Funding Source: Medline; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP021081] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078527, U01CA078527] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brehin AC, 2009, VIROLOGY, V384, P216, DOI 10.1016/j.virol.2008.10.021; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Castle D, 2003, AM J BIOETHICS, V3, P28, DOI 10.1162/15265160360706499; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Magnusson PKE, 2000, INT J CANCER, V88, P698, DOI 10.1002/1097-0215(20001201)88:5<698::AID-IJC3>3.0.CO;2-J; Orth G, 2008, CURR TOP MICROBIOL, V321, P59; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Wang SS, 2009, J INFECT DIS, V199, P20, DOI 10.1086/595563; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Yu K, 2009, GENET EPIDEMIOL	20	84	86	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8667	10.1371/journal.pone.0008667	http://dx.doi.org/10.1371/journal.pone.0008667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084279	Green Published, Green Submitted, gold			2022-12-25	WOS:000273554600020
J	Sasco, AJ; Jaquet, A; Boidin, E; Ekouevi, DK; Thouillot, F; LeMabec, T; Forstin, MA; Renaudier, P; N'Dom, P; Malvy, D; Dabis, F				Sasco, Annie J.; Jaquet, Antoine; Boidin, Emilie; Ekouevi, Didier K.; Thouillot, Fabian; LeMabec, Thomas; Forstin, Marie-Anna; Renaudier, Philippe; N'Dom, Paul; Malvy, Denis; Dabis, Francois			The Challenge of AIDS-Related Malignancies in Sub-Saharan Africa	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS INFECTION; NON-HODGKIN-LYMPHOMA; INVASIVE CERVICAL-CANCER; LIVER-RELATED MORTALITY; SWISS HIV COHORT; KAPOSIS-SARCOMA; LUNG-CANCER; HOMOSEXUAL-MEN	Background: With the lengthening of life expectancy among HIV-positive subjects related to the use of highly active antiretroviral treatments, an increased risk of cancer has been described in industrialized countries. The question is to determine what occurs now and will happen in the future in the low income countries and particularly in sub-Saharan Africa where more than two-thirds of all HIV-positive people live in the world. The objective of our paper is to review the link between HIV and cancer in sub-Saharan Africa, putting it in perspective with what is already known in Western countries. Methods and Findings: Studies for this review were identified from several bibliographical databases including Pubmed, Scopus, Cochrane, Pascal, Web of Science and using keywords "HIV, neoplasia, epidemiology and Africa'' and related MesH terms. A clear association was found between HIV infection and AIDS-classifying cancers. In case-referent studies, odds ratios (OR) were ranging from 21.9 (95% Confidence Interval (CI) 12.5-38.6) to 47.1 (31.9-69.8) for Kaposi sarcoma and from 5.0 (2.7-9.5) to 12.6 (2.2-54.4) for non Hodgkin lymphoma. The association was less strong for invasive cervical cancer with ORs ranging from 1.1 (0.7-1.2) to 1.6 (1.1-2.3), whereas ORs for squamous intraepithelial lesions were higher, from 4.4 (2.3-8.4) to 17.0 (2.2-134.1). For non AIDS-classifying cancers, squamous cell conjunctival carcinoma of the eye was associated with HIV in many case-referent studies with ORs from 2.6 (1.4-4.9) to 13.0 (4.5-39.4). A record-linkage study conducted in Uganda showed an association between Hodgkin lymphoma and HIV infection with a standardized incidence ratio of 5.7 (1.2-17) although OR in case-referent studies ranged from 1.4 (0.7-2.8) to 1.6 (1.0-2.7). Other cancer sites found positively associated with HIV include lung, liver, anus, penis, vulva, kidney, thyroid and uterus and a decreased risk of female breast cancer. These results so far based on a relatively small number of studies warrant further epidemiological investigations, taking into account other known risk factors for these tumors. Conclusion: Studies conducted in sub-Saharan Africa show that HIV infection is not only strongly associated with AIDS-classifying cancers but also provided some evidence of association for other neoplasia. African countries need now to implement well designed population-based studies in order to better describe the spectrum of AIDS-associated malignancies and the most effective strategies for their prevention, screening and treatment.	[Sasco, Annie J.; Jaquet, Antoine; Boidin, Emilie; Thouillot, Fabian; LeMabec, Thomas; Forstin, Marie-Anna] INSERM, U897, Bordeaux, France; [Sasco, Annie J.; Malvy, Denis; Dabis, Francois] Univ Victor Segalen Bordeaux 2, Bordeaux, France; [Jaquet, Antoine; Ekouevi, Didier K.; Dabis, Francois] Inst Publ Hlth, HIV Africa, INSERM, U897, Bordeaux, France; [Renaudier, Philippe] Hosp Civils Lyon, Hemovigilance Unit, Lyon, France; [N'Dom, Paul] Yaounde Gen Hosp, Dept Med Oncol, Yaounde, Cameroon; [Malvy, Denis] Hop St Andre, Trop Med Unit, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Lyon; CHU Bordeaux	Sasco, AJ (corresponding author), INSERM, U897, Bordeaux, France.	Annie.Sasco@isped.u-bordeaux2.fr	MALVY, Denis/T-7930-2019; DABIS, FRANCOIS/S-9298-2019; EKOUEVI, Didier K/E-7960-2014; Jaquet, Antoine/T-2794-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Jaquet, Antoine/0000-0002-3426-9492	US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study has been provided by the US National Institutes of Health in the framework of the IeDEA Regional Centre for West Africa awarded to Pr Francois Dabis (National Cancer Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Institute of Allergy and Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir H, 2001, ONCOL REP, V8, P659; Amir H, 2000, J NATL MED ASSOC, V92, P301; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1987, MMWR-MORBID MORTAL W, V36, p1S; Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; ATEENYIAGABA C, 1995, LANCET, V345, P695, DOI 10.1016/S0140-6736(95)90870-6; BASSETT MT, 1995, INT J CANCER, V63, P29, DOI 10.1002/ijc.2910630107; BERAL V, 1991, LANCET, V337, P805, DOI 10.1016/0140-6736(91)92513-2; Biggar RJ, 2007, J NATL CANCER I, V99, P962, DOI 10.1093/jnci/djm010; Biggar RJ, 2006, BLOOD, V108, P3786, DOI 10.1182/blood-2006-05-024109; Blossom DB, 2007, J MED VIROL, V79, P758, DOI 10.1002/jmv.20817; Blumenthal PD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.031; Bonnet F, 2006, REV MED INTERNE, V27, P227, DOI 10.1016/j.revmed.2005.10.003; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Bower M, 2004, JAIDS-J ACQ IMM DEF, V37, P1563, DOI 10.1097/00126334-200412150-00004; Bower M, 2005, J CLIN ONCOL, V23, P5224, DOI 10.1200/JCO.2005.14.597; Bower M, 2003, AIDS, V17, P371, DOI 10.1097/00002030-200302140-00011; Burgi A, 2005, CANCER-AM CANCER SOC, V104, P1505, DOI 10.1002/cncr.21334; Busnach G, 2006, TRANSPLANT P, V38, P3533, DOI 10.1016/j.transproceed.2006.10.144; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chaturvedi AK, 2007, AIDS, V21, P207, DOI 10.1097/QAD.0b013e3280118fca; Chirenje ZM, 2005, BEST PRACT RES CL OB, V19, P269, DOI 10.1016/j.bpobgyn.2004.10.002; Chokunonga E, 1999, AIDS, V13, P2583, DOI 10.1097/00002030-199912240-00012; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Cook-Mozaffari P, 1998, BRIT J CANCER, V78, P1521, DOI 10.1038/bjc.1998.717; Dal Maso L, 2001, INT J CANCER, V93, P430, DOI 10.1002/1097-0215(20010801)93:3&lt;430::AID-IJC1344&gt;3.0.CO;2-K; Dal Maso L, 2001, EUR J CANCER, V37, P1188, DOI 10.1016/S0959-8049(01)00120-4; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; De Vuyst H, 2003, SEX TRANSM DIS, V30, P137, DOI 10.1097/00007435-200302000-00009; Dhir AA, 2008, CANCER CAUSE CONTROL, V19, P147, DOI 10.1007/s10552-007-9080-y; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; DOLL DC, 1982, LANCET, V1, P1026; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Franceschi S, 1995, TUMORI, V81, P308, DOI 10.1177/030089169508100502; Franceschi S, 1998, BRIT J CANCER, V78, P966, DOI 10.1038/bjc.1998.610; Franceschi S, 2003, JAIDS-J ACQ IMM DEF, V34, P84, DOI 10.1097/00126334-200309010-00013; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gerard L, 2003, AIDS, V17, P81, DOI 10.1097/00002030-200301030-00011; Gichangi P, 2002, INT J GYNECOL OBSTET, V76, P55, DOI 10.1016/S0020-7292(01)00560-4; Goedert JJ, 2006, BRIT J CANCER, V95, P642, DOI 10.1038/sj.bjc.6603282; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Grulich AE, 1999, AIDS, V13, P839, DOI 10.1097/00002030-199905070-00014; Grulich AE, 2002, AIDS, V16, P1155, DOI 10.1097/00002030-200205240-00009; Guech-Ongey M, 2008, INT J CANCER, V122, P2590, DOI 10.1002/ijc.23384; Guth AA, 2003, J WOMEN HEALTH GEN-B, V12, P227, DOI 10.1089/154099903321667564; Hawes SE, 2003, J INFECT DIS, V188, P555, DOI 10.1086/376996; Hentrich M, 2006, ANN ONCOL, V17, P914, DOI 10.1093/annonc/mdl063; HESSOL NA, 1992, ANN INTERN MED, V117, P309, DOI 10.7326/0003-4819-117-4-309; HYMES KB, 1981, LANCET, V2, P598; *IARC WORK GROUP E, 1996, IARC MON EV CARC RIS, V67; *IARC WORK GROUP E, 2007, IARC MON EV CARC RIS, V90; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. World Health Organization, 1997, IARC MON EV CARC RIS, V70; Jaffe ES, 2001, WHO CLASSIFICATION T; Kaaya Ephata E, 2006, Afr Health Sci, V6, P69; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; KESTELYN P, 1990, LANCET, V336, P51, DOI 10.1016/0140-6736(90)91562-O; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; La Ruche G, 1998, CANCER-AM CANCER SOC, V82, P2401, DOI 10.1002/(SICI)1097-0142(19980615)82:12&lt;2401::AID-CNCR14&gt;3.3.CO;2-H; Langley CL, 1996, AIDS, V10, P413, DOI 10.1097/00002030-199604000-00010; Launay O, 2003, B CANCER, V90, P387; Leroy V, 1999, SEX TRANSM INFECT, V75, P103, DOI 10.1136/sti.75.2.103; Lessells RJ, 2008, LANCET, V371, P1504, DOI 10.1016/S0140-6736(08)60652-2; Levine A M, 1998, J Natl Cancer Inst Monogr, P37; LEVINE AM, 1993, JNCI-J NATL CANCER I, V85, P1382, DOI 10.1093/jnci/85.17.1382; LUCAS SB, 1994, INT J CANCER, V59, P20, DOI 10.1002/ijc.2910590106; LUO KH, 1995, AIDS, V9, P57, DOI 10.1097/00002030-199501000-00008; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Mocroft A, 2004, CANCER-AM CANCER SOC, V100, P2644, DOI 10.1002/cncr.20309; Moodley JR, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-135; Moodley M, 2001, INT J GYNECOL CANCER, V11, P194, DOI 10.1046/j.1525-1438.2001.01022.x; Newton R, 2001, INT J CANCER, V92, P622, DOI 10.1002/1097-0215(20010601)92:5&lt;622::AID-IJC1256&gt;3.0.CO;2-K; NEWTON R, 1995, LANCET, V345, P1378, DOI 10.1016/S0140-6736(95)92583-X; Newton R, 2002, BRIT J CANCER, V87, P301, DOI 10.1038/sj.bjc.6600451; Olsen SJ, 1998, AIDS, V12, P1921, DOI 10.1097/00002030-199814000-00024; Orem J, 2004, CURR OPIN ONCOL, V16, P468, DOI 10.1097/00001622-200409000-00010; Parkin DM, 2000, AIDS, V14, P2929, DOI 10.1097/00002030-200012220-00015; Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010; Parkin DM, 2003, IARC SCI PUBLICATION, V153; PARKIN DM, 2005, IARC NONSERIAL PUBLI; Polesel J, 2008, AIDS, V22, P301, DOI 10.1097/QAD.0b013e3282f2705d; Powles T, 2003, INT J STD AIDS, V14, P647, DOI 10.1258/095646203322387875; Rosenthal E, 2007, J VIRAL HEPATITIS, V14, P183, DOI 10.1111/j.1365-2893.2006.00791.x; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Schulz TF, 1996, LANCET, V348, P587, DOI 10.1016/S0140-6736(95)11033-X; Sekirime WK, 2007, GYNECOL OBSTET INVES, V63, P222, DOI 10.1159/000098197; Simonart T, 2006, CANCER LETT, V244, P1, DOI 10.1016/j.canlet.2006.02.005; Sinfield RL, 2007, PEDIATR BLOOD CANCER, V48, P515, DOI 10.1002/pbc.20917; Sitas F, 2000, INT J CANCER, V88, P489, DOI 10.1002/1097-0215(20001101)88:3&lt;489::AID-IJC25&gt;3.0.CO;2-Q; Stebbing J, 2004, J CLIN ONCOL, V22, P2177, DOI 10.1200/JCO.2004.11.097; Stein L, 2008, INT J CANCER, V122, P2260, DOI 10.1002/ijc.23391; Sun EC, 1997, CANCER EPIDEM BIOMAR, V6, P73; Temmerman M, 1999, INT J GYNECOL OBSTET, V65, P171, DOI 10.1016/S0020-7292(99)00043-0; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Thomas JO, 2004, BRIT J CANCER, V90, P638, DOI 10.1038/sj.bjc.6601515; *UNAIDS, 2007, AIDS EP UPD; VERNON SD, 1995, CLIN INFECT DIS, V21, pS121, DOI 10.1093/clinids/21.Supplement_1.S121; WABINGA HR, 1993, INT J CANCER, V54, P26, DOI 10.1002/ijc.2910540106; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Waddell KM, 1996, BRIT J OPHTHALMOL, V80, P503, DOI 10.1136/bjo.80.6.503; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; World Health Organization, 2002, CERVICAL CANC SCREEN; Yamada R, 2008, J MED VIROL, V80, P847, DOI 10.1002/jmv.21170; ZIEGLER JL, 1984, NEW ENGL J MED, V311, P565, DOI 10.1056/NEJM198408303110904; 1985, MMWR MORB MORTAL WKL, V34, P373	108	56	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8621	10.1371/journal.pone.0008621	http://dx.doi.org/10.1371/journal.pone.0008621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20066157	Green Submitted, gold, Green Published			2022-12-25	WOS:000273456300004
J	Okorokov, AL; Chaban, YL; Bugreev, DV; Hodgkinson, J; Mazin, AV; Orlova, EV				Okorokov, Andrei L.; Chaban, Yuriy L.; Bugreev, Dmitry V.; Hodgkinson, Julie; Mazin, Alexander V.; Orlova, Elena V.			Structure of the hDmc1-ssDNA Filament Reveals the Principles of Its Architecture	PLOS ONE			English	Article							ESCHERICHIA-COLI RECA; N-TERMINAL DOMAIN; PROTEIN BINDS DNA; DOUBLE-STRAND BREAK; HUMAN DMC1 PROTEIN; MEIOTIC RECOMBINATION; CRYSTAL-STRUCTURE; HELICAL FILAMENTS; CHROMOSOME SYNAPSIS; SINGLE PARTICLES	In eukaryotes, meiotic recombination is a major source of genetic diversity, but its defects in humans lead to abnormalities such as Down's, Klinefelter's and other syndromes. Human Dmc1 (hDmc1), a RecA/Rad51 homologue, is a recombinase that plays a crucial role in faithful chromosome segregation during meiosis. The initial step of homologous recombination occurs when hDmc1 forms a filament on single-stranded (ss) DNA. However the structure of this presynaptic complex filament for hDmc1 remains unknown. To compare hDmc1-ssDNA complexes to those known for the RecA/Rad51 family we have obtained electron microscopy (EM) structures of hDmc1-ssDNA nucleoprotein filaments using single particle approach. The EM maps were analysed by docking crystal structures of Dmc1, Rad51, RadA, RecA and DNA. To fully characterise hDmc1-DNA complexes we have analysed their organisation in the presence of Ca(2+), Mg(2+), ATP, AMP-PNP, ssDNA and dsDNA. The 3D EM structures of the hDmc1-ssDNA filaments allowed us to elucidate the principles of their internal architecture. Similar to the RecA/Rad51 family, hDmc1 forms helical filaments on ssDNA in two states: extended (active) and compressed (inactive). However, in contrast to the RecA/Rad51 family, and the recently reported structure of hDmc1-double stranded (ds) DNA nucleoprotein filaments, the extended (active) state of the hDmc1 filament formed on ssDNA has nine protomers per helical turn, instead of the conventional six, resulting in one protomer covering two nucleotides instead of three. The control reconstruction of the hDmc1-dsDNA filament revealed 6.4 protein subunits per helical turn indicating that the filament organisation varies depending on the DNA templates. Our structural analysis has also revealed that the N-terminal domain of hDmc1 accomplishes its important role in complex formation through domain swapping between adjacent protomers, thus providing a mechanistic basis for coordinated action of hDmc1 protomers during meiotic recombination.	[Okorokov, Andrei L.] UCL, Wolfson Inst Biomed Res, London, England; [Chaban, Yuriy L.; Hodgkinson, Julie; Orlova, Elena V.] Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; [Bugreev, Dmitry V.; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Bugreev, Dmitry V.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia	University of London; University College London; University of London; Birkbeck University London; Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Okorokov, AL (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London, England.	a.okorokov@ucl.ac.uk; e.orlova@mail.cryst.bbk.ac.uk	Orlova, Elena/CAF-8290-2022	Orlova, Elena/0000-0003-3371-415X; Okorokov, Andrei/0000-0003-2477-3254	the Leukemia and Lymphoma Society [1054-09]	the Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	AVM is supported by the Leukemia and Lymphoma Society Scholar Award 1054-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Bannister LA, 2007, PLOS BIOL, V5, P1016, DOI 10.1371/journal.pbio.0050105; BENSON FE, 1994, EMBO J, V13, P576; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bishop DK, 2006, CELL, V127, P1095, DOI 10.1016/j.cell.2006.11.029; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Chang YC, 2005, BIOCHEMISTRY-US, V44, P6052, DOI 10.1021/bi048897q; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Chen XG, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/01/002; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Egelman EH, 2001, J MOL BIOL, V309, P539, DOI 10.1006/jmbi.2001.4686; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; Gupta RC, 2001, P NATL ACAD SCI USA, V98, P8433, DOI 10.1073/pnas.121005298; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kinebuchi T, 2005, J BIOL CHEM, V280, P28382, DOI 10.1074/jbc.M503372200; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Kurumizaka H, 1996, J BIOL CHEM, V271, P33515, DOI 10.1074/jbc.271.52.33515; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Nishinaka T, 1997, P NATL ACAD SCI USA, V94, P6623, DOI 10.1073/pnas.94.13.6623; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; Saxton W O, 1986, J Mol Biol, V187, P251, DOI 10.1016/0022-2836(86)90232-9; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Seitz EM, 2001, ADV APPL MICROBIOL, V50, P101, DOI 10.1016/S0065-2164(01)50005-2; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xing X, 2004, J MOL BIOL, V342, P1471, DOI 10.1016/j.jmb.2004.07.091; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	56	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8586	10.1371/journal.pone.0008586	http://dx.doi.org/10.1371/journal.pone.0008586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062530	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000273338600010
J	Berezniuk, I; Sironi, J; Callaway, MB; Castro, LM; Hirata, IY; Ferro, ES; Fricker, LD				Berezniuk, Iryna; Sironi, Juan; Callaway, Myrasol B.; Castro, Leandro M.; Hirata, Izaura Y.; Ferro, Emer S.; Fricker, Lloyd D.			CCP1/Nna1 functions in protein turnover in mouse brain: Implications for cell death in Purkinje cell degeneration mice	FASEB JOURNAL			English	Article						proteasome; carboxypeptidase; aminopeptidase; protein degradation; neurodegeneration	CEREBELLAR MUTANT MOUSE; PCD MUTANT; THIMET OLIGOPEPTIDASE; RETINAL DEGENERATION; MASS-SPECTROMETRY; WILD-TYPE; PEPTIDES; NNA1; NEUROPEPTIDOMICS; DEGRADATION	Purkinje cell degeneration (pcd) mice have a mutation within the gene encoding cytosolic carboxypeptidase 1 (CCP1/Nna1), which has homology to metallocarboxypeptidases. To assess the function of CCP1/Nna1, quantitative proteomics and peptidomics approaches were used to compare proteins and peptides in mutant and wild-type mice. Hundreds of peptides derived from cytosolic and mitochondrial proteins are greatly elevated in pcd mouse hypothalamus, amygdala, cortex, prefrontal cortex, and striatum. However, the major proteins detected on 2-D gel electrophoresis were present in mutant and wild-type mouse cortex and hypothalamus at comparable levels, and proteasome activity is normal in these brain regions of pcd mice, suggesting that the increase in cellular peptide levels in the pcd mice is due to reduced degradation of the peptides downstream of the proteasome. Both nondegenerating and degenerating regions of pcd mouse brain, but not wild-type mouse brain, show elevated autophagy, which can be triggered by a decrease in amino acid levels. Taken together with previous studies on CCP1/Nna1, these data suggest that CCP1/Nna1 plays a role in protein turnover by cleaving proteasome-generated peptides into amino acids and that decreased peptide turnover in the pcd mice leads to cell death.-Berezniuk, I., Sironi, J., Callaway, M. B., Castro, L. M., Hirata, I. Y., Ferro, E. S., Fricker, L. D. CCP1/Nna1 functions in protein turnover in mouse brain: Implications for cell death in Purkinje cell degeneration mice. FASEB J. 24, 1813-1823 (2010). www.fasebj.org	[Sironi, Juan; Callaway, Myrasol B.; Fricker, Lloyd D.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Berezniuk, Iryna; Fricker, Lloyd D.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Castro, Leandro M.; Ferro, Emer S.] Univ Sao Paulo, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Hirata, Izaura Y.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Fricker, LD (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu	Castro, Leandro/ABI-5520-2020; Castro, Leandro/O-6762-2019; Ferro, Emer S/D-3908-2012; Castro, Leandro M/E-5654-2014	Castro, Leandro/0000-0002-7156-2006; Castro, Leandro/0000-0002-7156-2006; Ferro, Emer S/0000-0003-1651-9192; 	National Institutes of Health [DK-51271, DA-04494]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/04933-2, 04/14846-0]; Financiadora de Estudos e Projetos [A-03/134]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Universidade de Campinas, Campinas, SP, Brazil; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade de Campinas, Campinas, SP, Brazil; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grants DK-51271 and DA-04494 (to L. D. F.), and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 04/04933-2, 04/14846-0 and Financiadora de Estudos e Projetos A-03/134 (to E. S. F.). Thanks are also due to fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (E. S. F. and L. M. C.). Mass spectrometry was performed through the Rede de Proteoma do Estado de Sao Paulo in the Laboratorio Nacional de Luz Sincrotron (Campinas, SP, Brazil). We are thankful to Prof. Fabio Gozzo (Universidade de Campinas, Campinas, SP, Brazil) for his immeasurable support with mass spectrometry. Thanks are due to Julia Grushko and Jonathan Wardman for assistance with the handling of the pcd mice. Fluorescence microscopy was performed in the laboratory of Dr. Jonathan M. Backer (Department of Molecular Pharmacology), and confocal microscopy was performed in the Analytical Imaging Facility of the Albert Einstein College of Medicine.	Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; BLANKS JC, 1982, J COMP NEUROL, V212, P231, DOI 10.1002/cne.902120303; BLANKS JC, 1992, EXP EYE RES, V54, P637, DOI 10.1016/0014-4835(92)90019-O; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Chang A C, 1993, Chin J Physiol, V36, P141; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; Che FY, 2005, J MASS SPECTROM, V40, P227, DOI 10.1002/jms.742; CONDORELLI DF, 1990, J NEUROSCI RES, V26, P251, DOI 10.1002/jnr.490260216; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Ford GD, 2008, BIOCHEM BIOPH RES CO, V377, P556, DOI 10.1016/j.bbrc.2008.10.033; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 2007, ENDOCRINOLOGY, V148, P4185, DOI 10.1210/en.2007-0123; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Hepp R, 1999, GLIA, V27, P181, DOI 10.1002/(SICI)1098-1136(199908)27:2<181::AID-GLIA8>3.0.CO;2-9; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kwak MK, 2007, LIFE SCI, V80, P2411, DOI 10.1016/j.lfs.2007.04.014; Kyuhou S, 2006, NEUROSCI LETT, V396, P91, DOI 10.1016/j.neulet.2005.11.023; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; MCBRIDE WJ, 1988, NEUROCHEM RES, V13, P121, DOI 10.1007/BF00973323; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; OGORMAN S, 1985, J COMP NEUROL, V234, P277, DOI 10.1002/cne.902340302; OKUBO A, 1995, JPN J OPHTHALMOL, V39, P152; Petiot A, 2002, CELL STRUCT FUNCT, V27, P431, DOI 10.1247/csf.27.431; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Rong YQ, 2004, MOL BRAIN RES, V132, P128, DOI 10.1016/j.molbrainres.2004.10.015; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Schiaffino S, 2008, AUTOPHAGY, V4, P727, DOI 10.4161/auto.6143; Svensson M, 2007, BIOCHEM SOC T, V35, P588, DOI 10.1042/BST0350588; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Valero J, 2006, MOL CELL NEUROSCI, V33, P283, DOI 10.1016/j.mcn.2006.08.002; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Xiao R, 2005, MOL CELLS, V20, P219; Zhang RJ, 2002, ANAL CHEM, V74, P3662, DOI 10.1021/ac025614w; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	49	40	41	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1813	1823		10.1096/fj.09-147942	http://dx.doi.org/10.1096/fj.09-147942			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20061535	Green Published			2022-12-25	WOS:000278200000018
J	Jacob, A; Hack, B; Chiang, E; Garcia, JGN; Quigg, RJ; Alexander, JJ				Jacob, Alexander; Hack, Bradley; Chiang, Eddie; Garcia, Joe G. N.; Quigg, Richard J.; Alexander, Jessy J.			C5a alters blood-brain barrier integrity in experimental lupus	FASEB JOURNAL			English	Article						endothelium; complement system; systemic lupus erythematosus; neurodegeneration	CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE PRODUCTION; NEUROPSYCHIATRIC LUPUS; COMPLEMENT ACTIVATION; AUTOIMMUNE-DISEASE; CEREBROSPINAL-FLUID; GLUTAMATE-RECEPTOR; ENDOTHELIAL-CELLS; EMERGING CONCEPTS; VASCULAR INJURY	The blood-brain barrier (BBB) is a crucial anatomic location in the brain. Its dysfunction complicates many neurodegenerative diseases, from acute conditions, such as sepsis, to chronic diseases, such as systemic lupus erythematosus (SLE). Several studies suggest an altered BBB in lupus, but the underlying mechanism remains unknown. In the current study, we observed a definite loss of BBB integrity in MRL/MpJ-Tnfrsf6(lpr) (MRL/lpr) lupus mice by IgG infiltration into brain parenchyma. In line with this result, we examined the role of complement activation, a key event in this setting, in maintenance of BBB integrity. Complement activation generates C5a, a molecule with multiple functions. Because the expression of the C5a receptor (C5aR) is significantly increased in brain endothelial cells treated with lupus serum, the study focused on the role of C5a signaling through its G-protein-coupled receptor C5aR in brain endothelial cells, in a lupus setting. Reactive oxygen species production increased significantly in endothelial cells, in both primary cells and the bEnd3 cell line treated with lupus serum from MRL/lpr mice, compared with those treated with control serum from MRL+/+ mice. In addition, increased permeability monitored by changes in transendothelial electrical resistance, cytoskeletal remodeling caused by actin fiber rearrangement, and increased iNOS mRNA expression were observed in bEnd3 cells. These disruptive effects were alleviated by pretreating cells with a C5a receptor antagonist (C5aRant) or a C5a antibody. Furthermore, the structural integrity of the vasculature in MRL/lpr brain was maintained by C5aR inhibition. These results demonstrate the regulation of BBB integrity by the complement system in a neuroinflammatory setting. For the first time, a novel role of C5a in the maintenance of BBB integrity is identified and the potential of C5a/C5aR blockade highlighted as a promising therapeutic strategy in SLE and other neurodegenerative diseases.-Jacob, A., Hack, B., Chiang, E., Garcia, J. G. N., Quigg, R. J., Alexander, J. J. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. 24, 1682-1688 (2010). www.fasebj.org	[Jacob, Alexander; Hack, Bradley; Chiang, Eddie; Garcia, Joe G. N.; Quigg, Richard J.; Alexander, Jessy J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Alexander, JJ (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC5100, Chicago, IL 60637 USA.	jalexand@medicine.bsd.uchicago.edu	Garcia, Joe GN/E-8862-2010; Alexander, Jessy/ABA-7664-2020		U.S. National Institutes of Health [R01DK055357, P01 HL58064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055357] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants R01DK055357 (to R.J.Q.) and P01 HL58064 (to J.G.N.G.).	Abbott NJ, 2003, LUPUS, V12, P908, DOI 10.1191/0961203303lu501oa; ABEL T, 1980, J RHEUMATOL, V7, P325; ABRAMSON S, 1987, J RHEUMATOL, V14, P43; Alexander JJ, 2007, EUR J IMMUNOL, V37, P1691, DOI 10.1002/eji.200636638; Alexander JJ, 2007, NEUROCHEM INT, V50, P5, DOI 10.1016/j.neuint.2006.08.005; Alexander JJ, 2005, J IMMUNOL, V175, P8312, DOI 10.4049/jimmunol.175.12.8312; Alexander JJ, 2005, NEUROCHEM INT, V47, P143, DOI 10.1016/j.neuint.2005.04.016; Alexander JJ, 2003, BBA-MOL BASIS DIS, V1639, P169, DOI 10.1016/j.bbadis.2003.09.005; Appenzeller S, 2005, ARTHRITIS RHEUM-US, V52, P2783, DOI 10.1002/art.21271; Arora V, 2004, MOL IMMUNOL, V41, P449, DOI 10.1016/j.molimm.2004.03.004; Ballok DA, 2004, HIPPOCAMPUS, V14, P649, DOI 10.1002/hipo.10205; Ballok DA, 2003, BEHAV BRAIN RES, V140, P119, DOI 10.1016/S0166-4328(02)00276-0; Ballok DA, 2007, BRAIN RES REV, V54, P67, DOI 10.1016/j.brainresrev.2006.12.003; Bao LH, 2005, EUR J IMMUNOL, V35, P2496, DOI 10.1002/eji.200526327; Barnum SR, 2002, IMMUNOL RES, V26, P7, DOI 10.1385/IR:26:1-3:007; Belmont HM, 1997, ARTHRITIS RHEUM, V40, P1810, DOI 10.1002/art.1780401013; BELMONT HM, 1986, ARTHRITIS RHEUM, V29, P1085, DOI 10.1002/art.1780290905; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; BOUMPAS DT, 1995, ANN INTERN MED, V123, P42, DOI 10.7326/0003-4819-123-1-199507010-00007; BOUMPAS DT, 1995, ANN INTERN MED, V122, P940, DOI 10.7326/0003-4819-122-12-199506150-00009; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Brey RL, 1997, ANN NY ACAD SCI, V823, P97, DOI 10.1111/j.1749-6632.1997.tb48382.x; Brown GC, 2006, BIOCHEM SOC T, V34, P953, DOI 10.1042/BST0340953; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Carroll MC, 1997, CURR OPIN IMMUNOL, V9, P64, DOI 10.1016/S0952-7915(97)80160-4; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Carroll MC, 1998, NAT GENET, V19, P3, DOI 10.1038/ng0598-3; Coisne C, 2005, LAB INVEST, V85, P734, DOI 10.1038/labinvest.3700281; Daha MR, 2006, NEPHROL DIAL TRANSPL, V21, P3374, DOI 10.1093/ndt/gfl515; Davson H, 1995, PHYSL CSF BLOOD BRAI; Davson Hugh, 1993, INTRO BLOOD BRAIN BA; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; DENBURG JA, 1988, ISRAEL J MED SCI, V24, P754; Diamond B, 2006, ADV IMMUNOL, V89, P289, DOI 10.1016/S0065-2776(05)89007-8; Diamond B, 2003, ARTHRITIS RHEUM, V48, P2710, DOI 10.1002/art.11278; Dixon F J, 1978, Arthritis Rheum, V21, pS64, DOI 10.1002/art.1780210909; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Easton AS, 2002, BRAIN RES, V953, P157, DOI 10.1016/S0006-8993(02)03281-X; Farkas I, 2003, J IMMUNOL, V170, P5764, DOI 10.4049/jimmunol.170.11.5764; Farrell M, 1997, LUPUS, V6, P268, DOI 10.1177/096120339700600310; Flierl MA, 2009, CRIT CARE, V13, DOI 10.1186/cc7710; GOLOMBEK SJ, 1986, ARTHRITIS RHEUM, V29, P1090, DOI 10.1002/art.1780290906; Gotze O, 1976, Adv Immunol, V24, P1, DOI 10.1016/S0065-2776(08)60328-4; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hahn BH, 2001, LUPUS, V10, P589, DOI 10.1191/096120301682430140; Hanly JG, 2006, J RHEUMATOL, V33, P1553; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; HESS DC, 1993, J RHEUMATOL, V20, P610; HOPKINS P, 1988, ARTHRITIS RHEUM, V31, P632, DOI 10.1002/art.1780310508; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Huerta PT, 2006, P NATL ACAD SCI USA, V103, P678, DOI 10.1073/pnas.0510055103; HUGHES GRV, 1988, POSTGRAD MED J, V64, P517, DOI 10.1136/pgmj.64.753.517; James WG, 2006, CLIN EXP IMMUNOL, V144, P299, DOI 10.1111/j.1365-2249.2006.03056.x; Jongen PJH, 2000, ACTA NEUROL SCAND, V101, P116, DOI 10.1034/j.1600-0404.2000.101002116.x; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Lossinsky AS, 2004, HISTOL HISTOPATHOL, V19, P535, DOI 10.14670/HH-19.535; Ma XX, 2006, J NEUROIMMUNOL, V179, P26, DOI 10.1016/j.jneuroim.2006.06.023; Moller T, 1997, J NEUROSCI, V17, P615; Mukherjee P, 2001, J NEUROCHEM, V77, P43, DOI 10.1046/j.1471-4159.2001.00167.x; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Nishiura H, 2009, LAB INVEST, V89, P676, DOI 10.1038/labinvest.2009.27; Pytel P, 2009, CURR OPIN NEUROL, V22, P283, DOI 10.1097/WCO.0b013e32832b3101; QUIGG RJ, 1995, IMMUNOGENETICS, V42, P362, DOI 10.1007/BF00179397; Rice A, 2005, J MED CHEM, V48, P832, DOI 10.1021/jm040114b; Sakic B, 1996, BRAIN RES BULL, V41, P305, DOI 10.1016/S0361-9230(96)00190-6; Sayah S, 2003, MOL BRAIN RES, V112, P53, DOI 10.1016/S0169-328X(03)00046-9; Szechtman H, 1997, LUPUS, V6, P223, DOI 10.1177/096120339700600302; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; THEOFILOPOULOS AN, 1989, ADV IMMUNOL, V46, P61, DOI 10.1016/S0065-2776(08)60651-3; VOGELWEID CM, 1991, J NEUROIMMUNOL, V35, P89, DOI 10.1016/0165-5728(91)90164-3; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com	73	77	81	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1682	1688		10.1096/fj.09-138834	http://dx.doi.org/10.1096/fj.09-138834			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20065106	Green Published			2022-12-25	WOS:000278200000006
J	Heller, B; Adu-Gyamfi, E; Smith-Kinnaman, W; Babbey, C; Vora, M; Xue, Y; Bittman, R; Stahelin, RV; Wells, CD				Heller, Brigitte; Adu-Gyamfi, Emmanuel; Smith-Kinnaman, Whitney; Babbey, Cliff; Vora, Mohsin; Xue, Yi; Bittman, Robert; Stahelin, Robert V.; Wells, Clark D.			Amot Recognizes a Juxtanuclear Endocytic Recycling Compartment via a Novel Lipid Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DIFFERENTIAL SUBCELLULAR-LOCALIZATION; PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; ENDOTHELIAL-CELL MIGRATION; GPI-ANCHORED PROTEINS; TRANS-GOLGI NETWORK; EPITHELIAL-CELLS; MEMBRANE CURVATURE; PLASMA-MEMBRANE; LIVING CELLS	Polarity proteins promote the asymmetric organization of cells by orienting intracellular sorting mechanisms, such as protein trafficking and cytoskeletal assembly. The localization of individual polarity proteins in turn is often determined by association with factors that mediate contact with other cells or the substratum. This arrangement for the Par and Crb apical polarity complexes at the tight junction is disrupted by the adaptor protein Amot. Amot directly binds the scaffolding proteins Patj and Mupp1 and redistributes them and their binding partners from the plasma membrane to endosomes. However, the mechanism by which Amot is targeted to endosomes is unknown. Here, a novel lipid binding domain within Amot is shown to selectively bind with high affinity to membranes containing monophosphorylated phosphatidylinositols and cholesterol. With similar lipid specificity, Amot inserts into and tubulates membranes in vitro and enlarges perinuclear endosomal compartments in cells. Based on the similar distribution of Amot with cholesterol, Rab11, and Arf6, such membrane interactions are identified at juxtanuclear endocytic recycling compartments. Taken together, these findings indicate that Amot is targeted along with associated apical polarity proteins to the endocytic recycling compartment via this novel membrane binding domain.	[Wells, Clark D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Babbey, Cliff; Wells, Clark D.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Vora, Mohsin; Xue, Yi; Stahelin, Robert V.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Bittman, Robert] CUNY, Dept Chem, Queens Coll, Flushing, NY 11367 USA; [Adu-Gyamfi, Emmanuel; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Walther Ctr Canc Res, Notre Dame, IN 46556 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University South Bend; City University of New York (CUNY) System; Queens College NY (CUNY); University of Notre Dame; University of Notre Dame; Walther Cancer Institute	Stahelin, RV (corresponding author), 143 Raclin Carmichael Hall,1234 Notre Dame Ave, South Bend, IN 46617 USA.	rstaheli@iupui.edu; wells4@iupui.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	American Cancer Society [IRG-84-002-22]; Notre Dame Integrated Imaging Facility; Show-alter Foundation, American Cancer Society [IRG-81-003-20]; United States Department of Defense [W81XWH]	American Cancer Society(American Cancer Society); Notre Dame Integrated Imaging Facility; Show-alter Foundation, American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense)	This work was supported by an Indiana University School of Medicine Biomedical research grant, American Cancer Society Grant IRG-84-002-22, and the Notre Dame Integrated Imaging Facility (to R.V.S.) and by the Show-alter Foundation, American Cancer Society Grant IRG-81-003-20, and United States Department of Defense Grant W81XWH (to C.D.W.).	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Halet G, 2005, BIOL CELL, V97, P501; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hirose T, 2002, J CELL SCI, V115, P2485; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Jones SM, 1998, J BIOL CHEM, V273, P10349, DOI 10.1074/jbc.273.17.10349; KIRBY C, 1990, DEV BIOL, V142, P203, DOI 10.1016/0012-1606(90)90164-E; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Mobius W, 2003, TRAFFIC, V4, P222; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Naslavsky N, 2007, BIOCHEM BIOPH RES CO, V357, P792, DOI 10.1016/j.bbrc.2007.04.022; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; ORCI L, 1983, LAB INVEST, V48, P80; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Ross JW, 2009, PHYSIOL GENOMICS, V36, P140, DOI 10.1152/physiolgenomics.00022.2008; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Schweitzer JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005193; Shimono A, 2003, CURR BIOL, V13, P613, DOI 10.1016/S0960-9822(03)00204-5; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Simon JP, 1998, P NATL ACAD SCI USA, V95, P11181, DOI 10.1073/pnas.95.19.11181; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang Q, 2007, MOL BIOL CELL, V18, P874, DOI 10.1091/mbc.E06-07-0651; Wang WC, 2007, BIOPHYS J, V92, P2819, DOI 10.1529/biophysj.106.097923; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; WOLFE DH, 1988, P NATL ACAD SCI USA, V85, P4285, DOI 10.1073/pnas.85.12.4285; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015; Yu CJ, 2005, J LIPID RES, V46, P1678, DOI 10.1194/jlr.M500060-JLR200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	91	37	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12308	12320		10.1074/jbc.M109.096230	http://dx.doi.org/10.1074/jbc.M109.096230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20080965	Green Published, hybrid			2022-12-25	WOS:000276787100060
J	Moss, SC; Lightell, DJ; Marx, SO; Marks, AR; Woods, TC				Moss, Stephanie C.; Lightell, Daniel J., Jr.; Marx, Steven O.; Marks, Andrew R.; Woods, T. Cooper			Rapamycin Regulates Endothelial Cell Migration through Regulation of the Cyclin-dependent Kinase Inhibitor p27(Kip1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; SIROLIMUS-ELUTING STENTS; BARE-METAL STENTS; MAMMALIAN TARGET; BINDING PARTNER; IN-VITRO; PHOSPHORYLATION; MTOR; P27; TEMSIROLIMUS	Rapamycin is a macrolide antibiotic that inhibits vascular smooth muscle cell proliferation and migration and that is used clinically on drug-eluting stents to inhibit in-stent restenosis. Although inhibition of cell migration is an asset in preventing restenosis, it also leads to impaired stent endothelialization, a significant limitation of current drug-eluting stent technology that necessitates prolonged antiplatelet therapy. We measured the ability of rapamycin to inhibit the migration of human umbilical vein endothelial cells (HUVECs) and human coronary artery endothelial cells (HCAEC) toward the chemoattractant vascular endothelial cell growth factor. Although acute administration of rapamycin had no effect, exposure for 24 h inhibited HUVEC and HCAEC migration. Disruption of the mTORC2 via small interfering RNA was also effective in inhibiting HCAEC migration. Treatment of HCAECs for this period with rapamycin produced an increase in the cyclin-dependent kinase inhibitor p27(Kip), through a decrease in the targeting of the protein for degradation by phosphorylation at Thr(187). ECs isolated from a knock-in mouse expressing p27(Kip1) with a mutation of this residue to an alanine, blocking this phosphorylation, exhibited reduced migration compared with wild-type controls. Silencing of p27(Kip1) with small interfering RNA blocked the effects of rapamycin on migration and tube formation as well as RhoA activation and cytoskeletal reorganization. We conclude that prolonged exposure of ECs to rapamycin increases p27(Kip1) and in turn inhibits RhoA activation, blocking cell migration and differentiation. These data elucidate the molecular mechanism underlying regulation of p27(Kip1) protein and cell migration by rapamycin.	[Moss, Stephanie C.; Lightell, Daniel J., Jr.; Woods, T. Cooper] Ochsner Clin Fdn, Mol Cardiol Lab, New Orleans, LA 70121 USA; [Marx, Steven O.; Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Div Cardiol, Dept Med, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA; [Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA; [Woods, T. Cooper] LSU Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	Ochsner Health System; Columbia University; Columbia University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Woods, TC (corresponding author), Ochsner Clin Fdn, Mol Cardiol Lab, Biomed Res Bldg,1N412,1514 Jefferson Highway, New Orleans, LA 70121 USA.	twoods@ochsner.org			National Institutes of Health, National Center for Research Resources [P20RR018766]; American Heart Association [0665320B, 0855316E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Award P20RR018766 from the National Center for Research Resources. This work was also supported by Grants 0665320B and 0855316E from the Greater SE Affiliate of the American Heart Association.	Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Braun-Dullaeus RC, 2001, ARTERIOSCL THROM VAS, V21, P1152, DOI 10.1161/hq0701.092104; Castro C, 2003, J BIOL CHEM, V278, P4482, DOI 10.1074/jbc.M204716200; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Diez-Juan A, 2003, CIRC RES, V92, P402, DOI 10.1161/01.RES.0000059306.71961.ED; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Koff A, 1995, Prog Cell Cycle Res, V1, P141; Luo Y, 1996, MOL CELL BIOL, V16, P6744; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; McAndrew CW, 2007, CELL CYCLE, V6, P1937, DOI 10.4161/cc.6.15.4520; Nakayama M, 2005, GENES CELLS, V10, P107, DOI 10.1111/j.1365-2443.2005.00823.x; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; RASBAND WS, 1997, IMAGE J NAT I HLTH B; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roque M, 2001, LAB INVEST, V81, P895, DOI 10.1038/labinvest.3780298; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Sun J, 2001, CIRCULATION, V103, P2967, DOI 10.1161/01.CIR.103.24.2967; Tossidou I, 2008, CELL CYCLE, V7, P3858, DOI 10.4161/cc.7.24.7260; Witzig TE, 2005, J CLIN ONCOL, V23, P5347, DOI 10.1200/JCO.2005.13.466	39	48	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11991	11997		10.1074/jbc.M109.066621	http://dx.doi.org/10.1074/jbc.M109.066621			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20097763	Green Published, hybrid			2022-12-25	WOS:000276787100028
J	Buser, R; Lazar, Z; Kaser, S; Kunzler, M; Aebi, M				Buser, Reto; Lazar, Zbigniew; Kaeser, Sonja; Kuenzler, Markus; Aebi, Markus			Identification, Characterization, and Biosynthesis of a Novel N-Glycan Modification in the Fruiting Body of the Basidiomycete Coprinopsis cinerea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-SYNTHESIS; COPRINUS-CINEREUS; GOLGI-APPARATUS; GLYCOSYLATION; ACETYLGLUCOSAMINYLTRANSFERASE; TRANSFORMATION; EXPRESSION; ENZYME; GENE	Coprinopsis cinerea is a model organism for fruiting body development in homobasidiomycetes. Here, we focused on N-linked oligosaccharides (NLO) of cell wall proteins in the hyphae of two developmental stages, vegetative mycelium and fruiting body. High mannose-type glycans were the most commonly found structures. In addition, we observed a novel glycan, predominantly present in fruiting body. This oligosaccharide structure was of the high mannose type with at least five mannoses and a bisecting alpha 1-4 N-acetylglucosamine (GlcNAc) at the beta-mannose of the N-glycan core. The transferase responsible for this modification, CcGnt1 (C. cinerea GlcNAc transferase 1), was identified and expressed in insect cells. In vitro activity of CcGnt1 was demonstrated. This novel glycosyltransferase belongs to the glycosyltransferase family 8 (GT8) and is predicted to be a type II membrane protein. Expression of the CcGnt1 locus was up-regulated in fruiting body, but down-regulation of expression by means of RNAi decreased the level of bisected NLO; however had no apparent effect on fruiting body formation.	[Buser, Reto; Lazar, Zbigniew; Kaeser, Sonja; Kuenzler, Markus; Aebi, Markus] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland; [Lazar, Zbigniew] WUELS, Dept Biotechnol & Food Microbiol, PL-50375 Wroclaw, Poland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Wroclaw University of Environmental & Life Sciences	Aebi, M (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	aebi@micro.biol.ethz.ch	Lazar, Zbigniew/A-2744-2017; Lazar, Zbigniew/AAA-1972-2020	Lazar, Zbigniew/0000-0001-7315-1983; Lazar, Zbigniew/0000-0001-7315-1983; Kunzler, Markus/0000-0003-1275-0629	ETH Zurich; ESKAS Swiss Federal Scholarship	ETH Zurich(ETH Zurich); ESKAS Swiss Federal Scholarship	This work was supported in part by ETH Zurich and by an ESKAS Swiss Federal Scholarship (to Z. L.).	Berends E, 2009, APPL ENVIRON MICROB, V75, P4648, DOI 10.1128/AEM.00352-09; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Granado JD, 1997, MOL GEN GENET, V256, P28, DOI 10.1007/s004380050542; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; GRUBENMANN CE, 2004, THESIS U ZURICH ZURI; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Guillen E, 1999, J BIOL CHEM, V274, P6641, DOI 10.1074/jbc.274.10.6641; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herscovics A, 1999, BBA-GEN SUBJECTS, V1473, P96, DOI 10.1016/S0304-4165(99)00171-3; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kaiser C., 1994, METHODS YEAST GENETI; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MAY G, 1991, GENETICS, V128, P529; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; SMITH WL, 1975, J BIOL CHEM, V250, P3426; Stanley P., 2009, ESSENTIALS GLYCOBIOL; SWAMY S, 1984, J GEN MICROBIOL, V130, P3219; TAI T, 1977, J BIOL CHEM, V252, P6687; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Wallis GLF, 2001, EUR J BIOCHEM, V268, P4134, DOI 10.1046/j.1432-1327.2001.02322.x; Walti MA, 2006, EUKARYOT CELL, V5, P732, DOI 10.1128/EC.5.4.732-744.2006; Yoko-o T, 2003, GLYCOBIOLOGY, V13, P581, DOI 10.1093/glycob/cwg063	36	18	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10715	10723		10.1074/jbc.M109.076075	http://dx.doi.org/10.1074/jbc.M109.076075			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20061575	hybrid, Green Published			2022-12-25	WOS:000276264600058
J	Dong, MQ; Lam, PCH; Pinon, DI; Orry, A; Sexton, PM; Abagyan, R; Miller, LJ				Dong, Maoqing; Lam, Polo C-H.; Pinon, Delia I.; Orry, Andrew; Sexton, Patrick M.; Abagyan, Ruben; Miller, Laurence J.			Secretin Occupies a Single Protomer of the Homodimeric Secretin Receptor Complex INSIGHTS FROM PHOTOAFFINITY LABELING STUDIES USING DUAL SITES OF COVALENT ATTACHMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE; CORTICOTROPIN-RELEASING-FACTOR; GLUCAGON-LIKE PEPTIDE-1; AMINO-TERMINUS; SPATIAL APPROXIMATION; EXTRACELLULAR DOMAIN; CALCITONIN RECEPTOR; MOLECULAR RECOGNITION; PARATHYROID-HORMONE	The secretin receptor, a prototypic family B G protein-coupled receptor, forms a constitutive homodimeric complex that is stable even in the presence of hormone. Recently, a model of this agonist-bound receptor was built based on high resolution structures reported for amino-terminal domains of other family members. Although this model provided the best solution for all extant data, including 10 photoaffinity labeling constraints, a new such constraint now obtained with a position 16 photo-labile probe was inconsistent with this model. As the secretin receptor forms constitutive homodimers, we explored whether secretin might dock across both protomers of the complex, an observation that could also contribute to the negative cooperativity observed. To directly explore this, we prepared six secretin analogue probes that simultaneously incorporated two photo-labile benzoylphenylalanines as sites of covalent attachment, in positions known to label distinct receptor subdomains. Each bifunctional probe was a full agonist that labeled the receptor specifically and saturably, with electrophoretic migration consistent with labeling a single protomer of the homodimeric secretin receptor. No band representing radiolabeled receptor dimer was observed with any bifunctional probe. The labeled monomeric receptor bands were cleaved with cyanogen bromide to demonstrate that both of the photolabile benzoylphenylalanines within a single probe had established covalent adducts with a single receptor in the complex. These data are consistent with a model of secretin occupying a single secretin receptor protomer within the homodimeric receptor complex. A new molecular model accommodating all constraints is now proposed.	[Dong, Maoqing; Pinon, Delia I.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C-H.; Orry, Andrew; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA; [Lam, Polo C-H.; Orry, Andrew; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Sexton, Patrick M.] Monash Univ, Drug Discovery Biol Lab, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	Mayo Clinic; Mayo Clinic Phoenix; University of California System; University of California San Diego; Monash University; Monash University	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473	National Institutes of Health [DK46577]; Fiterman Foundation; Mayo Clinic; National Health and Medical Research Council of Australia [436781, 519461]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fiterman Foundation; Mayo Clinic; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577. This work was also supported by the Fiterman Foundation and Mayo Clinic and by National Health and Medical Research Council of Australia Grants 436781 and 519461.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; De Meyts P, 2009, ANN NY ACAD SCI, V1160, P45, DOI 10.1111/j.1749-6632.2009.03837.x; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2006, MOL PHARMACOL, V70, P206, DOI 10.1124/mol.105.021840; Dong MQ, 2009, J BIOL CHEM, V284, P21839, DOI 10.1074/jbc.M109.011924; Dong MQ, 2000, J BIOL CHEM, V275, P26032, DOI 10.1074/jbc.M000612200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; GARDNER JD, 1977, GASTROENTEROLOGY, V73, P52; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hadac EM, 1999, J MED CHEM, V42, P2105, DOI 10.1021/jm980732q; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar KG, 2007, J BIOL CHEM, V282, P32834, DOI 10.1074/jbc.M704563200; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2008, J MOL NEUROSCI, V36, P279, DOI 10.1007/s12031-008-9060-z; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Harikurnar KG, 2008, BBA-BIOMEMBRANES, V1778, P2555, DOI 10.1016/j.bbamem.2008.07.008; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; KOFOD H, 1991, INT J PEPT PROT RES, V37, P185; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; STROOP SD, 1995, BIOCHEMISTRY-US, V34, P1050, DOI 10.1021/bi00003a040; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993	46	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9919	9931		10.1074/jbc.M109.089730	http://dx.doi.org/10.1074/jbc.M109.089730			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100828	hybrid, Green Published			2022-12-25	WOS:000276165900062
J	Featherstone, K; Wood, AL; Bowen, AJ; Corcoran, AE				Featherstone, Karen; Wood, Andrew L.; Bowen, Adam J.; Corcoran, Anne E.			The Mouse Immunoglobulin Heavy Chain V-D Intergenic Sequence Contains Insulators That May Regulate Ordered V(D)J Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; ALLELIC EXCLUSION; INTRONIC ENHANCER; LYMPHOCYTE DEVELOPMENT; CHROMATIN-STRUCTURE; GENE REARRANGEMENT; BONE-MARROW; CTCF SITES; IGH LOCUS; 3' END	During immunoglobulin heavy chain (Igh) V(D)J recombination, D to J precedes V to DJ recombination in an ordered manner, controlled by differential chromatin accessibility of the V and DJ regions and essential for correct antibody assembly. However, with the exception of the intronic enhancer E mu, which regulates D to J recombination, cis-acting regulatory elements have not been identified. We have assembled the sequence of a strategically located 96-kb V-D intergenic region in the mouse Igh and analyzed its activity during lymphocyte development. We show that E mu-dependent D antisense transcription, proposed to open chromatin before D to J recombination, extends into the V-D region for more than 30 kb in B cells before, during, and after V(D) J recombination and in T cells but terminates 40 kb from the first V gene. Thus, subsequent V antisense transcription before V to DJ recombination is actively prevented and must be independently activated. To find cis-acting elements that regulate this differential chromatin opening, we identified six DNase I-hypersensitive sites (HSs) in the V-D region. One conserved HS upstream of the first D gene locally regulates D genes. Two further conserved HSs near the D region mark a sharp decrease in antisense transcription, and both HSs bind CTCF in vivo. Further, they both possess enhancer-blocking activity in vivo. Thus, we propose that they are enhancer-blocking insulators preventing E mu-dependent chromatin opening extending into the V region. Thus, they are the first elements identified that may control ordered V(D) J recombination and correct assembly of antibody genes.	[Featherstone, Karen; Wood, Andrew L.; Bowen, Adam J.; Corcoran, Anne E.] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Corcoran, AE (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge CB22 3AT, England.	anne.corcoran@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C163] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by Biotechnology and Biological Sciences Research Council (BBSRC) Ph.D. studentships.	Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; ALESSANDRINI A, 1991, MOL CELL BIOL, V11, P2096, DOI 10.1128/MCB.11.4.2096; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Bates JG, 2007, J EXP MED, V204, P3247, DOI 10.1084/jem.20071787; Bolland DJ, 2007, MOL CELL BIOL, V27, P5523, DOI 10.1128/MCB.02407-06; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; BORN W, 1988, J IMMUNOL, V140, P3228; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Choi IC, 2004, GENOMICS, V83, P636, DOI 10.1016/j.ygeno.2003.10.001; Chou WC, 2006, BLOOD, V108, P3005, DOI 10.1182/blood-2006-05-024430; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Corcoran AE, 2005, SEMIN IMMUNOL, V17, P141, DOI 10.1016/j.smim.2005.01.002; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Daly J, 2007, EMBO J, V26, P4273, DOI 10.1038/sj.emboj.7601846; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hawwari A, 2005, J EXP MED, V202, P467, DOI 10.1084/jem.20050680; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Maes J, 2006, J IMMUNOL, V176, P5409, DOI 10.4049/jimmunol.176.9.5409; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Nitschke L, 2001, J IMMUNOL, V166, P2540, DOI 10.4049/jimmunol.166.4.2540; Pawlitzky I, 2006, J IMMUNOL, V176, P6839, DOI 10.4049/jimmunol.176.11.6839; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; RALPH P, 1973, J IMMUNOL, V110, P1470; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Senoo M, 2003, J IMMUNOL, V171, P829, DOI 10.4049/jimmunol.171.2.829; Sieh P, 2001, J IMMUNOL, V167, P2121, DOI 10.4049/jimmunol.167.4.2121; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; THOMPSON A, 1995, EUR J IMMUNOL, V25, P257, DOI 10.1002/eji.1830250142; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005; Ye J, 2004, IMMUNOGENETICS, V56, P399, DOI 10.1007/s00251-004-0712-z; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	65	56	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9327	9338		10.1074/jbc.M109.098251	http://dx.doi.org/10.1074/jbc.M109.098251			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100833	hybrid, Green Published			2022-12-25	WOS:000276165900004
J	Liu, Z; Lin, L; Yuan, C; Nicolaes, GAF; Chen, LQ; Meehan, EJ; Furie, B; Furie, B; Huang, MD				Liu, Zhuo; Lin, Lin; Yuan, Cai; Nicolaes, Gerry A. F.; Chen, Liqing; Meehan, Edward J.; Furie, Bruce; Furie, Barbara; Huang, Mingdong			Trp(2313)-His(2315) of Factor VIII C2 Domain Is Involved in Membrane Binding STRUCTURE OF A COMPLEX BETWEEN THE C2 DOMAIN AND AN INHIBITOR OF MEMBRANE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; VON-WILLEBRAND-FACTOR; HUMAN-FACTOR-V; CRYSTAL-STRUCTURE; PROTEIN; IDENTIFICATION; HEMOPHILIA; ACTIVATION; MUTATION; SURFACE	Factor VIII (FVIII) plays a critical role in blood coagulation by forming the tenase complex with factor IXa and calcium ions on a membrane surface containing negatively charged phospholipids. The tenase complex activates factor X during blood coagulation. The carboxyl-terminal C2 domain of FVIII is the main membrane-binding and von Willebrand factor-binding region of the protein. Mutations of FVIII cause hemophilia A, whereas elevation of FVIII activity is a risk factor for thromboembolic diseases. The C2 domain-membrane interaction has been proposed as a target of intervention for regulation of blood coagulation. A number of molecules that interrupt FVIII or factor V (FV) binding to cell membranes have been identified through high throughput screening or structure-based design. We report crystal structures of the FVIII C2 domain under three new crystallization conditions, and a high resolution (1.15 angstrom) crystal structure of the FVIII C2 domain bound to a small molecular inhibitor. The latter structure shows that the inhibitor binds to the surface of an exposed beta-strand of the C2 domain, Trp(2313)-His(2315). This result indicates that the Trp(2313)-His(2315) segment is an important constituent of the membrane binding motif and provides a model to understand the molecular mechanism of the C2 domain membrane interaction.	[Liu, Zhuo; Yuan, Cai; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Lin, Lin; Furie, Bruce; Furie, Barbara; Huang, Mingdong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; [Nicolaes, Gerry A. F.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6229 ER Maastricht, Netherlands; [Chen, Liqing; Meehan, Edward J.] Univ Alabama, Dept Chem, Struct Biol Lab, Huntsville, AL 35899 USA; [Liu, Zhuo] Chinese Acad Sci, Grad Univ, Beijing 10039, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Maastricht University; University of Alabama System; University of Alabama Huntsville; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China.	mhuang@fjirsm.ac.cn	Nicolaes, Gerry A.F./A-8421-2016; Huang, Mingdong/J-4278-2017	Nicolaes, Gerry A.F./0000-0002-2482-0412; Huang, Mingdong/0000-0003-0085-9141	National Institutes of Health [HL086584]; Natural Science Foundation of China [30811130467, 30625011]; Ministry of Science and Technology [2006AA02A313, 2007CB914304]; Chinese Academy of Sciences [KSCX2-YW-R-082]; National Science Foundation (NSF-EPSCoR); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation (NSF-EPSCoR)(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL086584. This work was also supported by grants from the Natural Science Foundation of China (30811130467 and 30625011), the Ministry of Science and Technology (2006AA02A313 and 2007CB914304), the Chinese Academy of Sciences (KSCX2-YW-R-082), and the National Science Foundation (NSF-EPSCoR).; Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. We thank the staff of the Argonne Advanced Photon Source Southeast Regional Collaborative Access Team beamline 22ID for help during data collection.	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; FAY PJ, 1991, J BIOL CHEM, V266, P2172; FOSTER PA, 1990, BLOOD, V75, P1999; FURIE B, 1990, SEMIN HEMATOL, V27, P270; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; Lin L, 2007, J MOL BIOL, V371, P717, DOI 10.1016/j.jmb.2007.05.054; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Mollica L, 2006, PROTEINS, V64, P363, DOI 10.1002/prot.20986; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; PITTMAN DD, 1988, P NATL ACAD SCI USA, V85, P2429, DOI 10.1073/pnas.85.8.2429; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; SAENKO EL, 1995, J BIOL CHEM, V270, P13826, DOI 10.1074/jbc.270.23.13826; Schatz SM, 2004, BRIT J HAEMATOL, V125, P629, DOI 10.1111/j.1365-2141.2004.04959.x; Segers K, 2007, P NATL ACAD SCI USA, V104, P12697, DOI 10.1073/pnas.0701051104; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Spiegel PC, 2004, CHEM BIOL, V11, P1413, DOI 10.1016/j.chembiol.2004.08.006; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Stoilova-McPhie S, 2002, BLOOD, V99, P1215, DOI 10.1182/blood.V99.4.1215; Tagariello G, 2000, HAEMATOLOGICA, V85, P525; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	25	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8824	8829		10.1074/jbc.M109.080168	http://dx.doi.org/10.1074/jbc.M109.080168			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089867	Green Published, hybrid			2022-12-25	WOS:000275553700034
J	Xu, JL; Maurer, LM; Hoffmann, BR; Annis, DS; Mosher, DF				Xu, Jielin; Maurer, Lisa M.; Hoffmann, Brian R.; Annis, Douglas S.; Mosher, Deane F.			iso-DGR Sequences Do Not Mediate Binding of Fibronectin N-terminal Modules to Adherent Fibronectin-null Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM BETA-ZIPPER; STREPTOCOCCUS-PYOGENES; BORRELIA-BURGDORFERI; INTEGRIN BINDING; MATRIX; SITES; POLYMERIZATION; FIBRILLOGENESIS; CONFORMATION; DOMAIN	Fibronectin (FN) without an RGD sequence (FN-RGE), and thus lacking the principal binding site for alpha 5 beta 1 integrin, is deposited into the extracellular matrix of mouse embryos. Spontaneous conversion of (263)NGR and/or (501)NGR to iso-DGR possibly explains this enigma, i.e. ligation of iso-DGR by alpha v beta 3 integrin may allow cells to assemble FN. Partial modification of (263)NGR to DGR or iso-DGR was detected in purified plasma FN by mass spectrometry. To test functions of the conversion, one or both NGR sequences were mutated to QGR in recombinant N-terminal 70-kDa construct of FN (70K), full-length FN, or FN-RGE. The mutations did not affect the binding of soluble 70K to already adherent fibroblasts or the ability of soluble 70K to compete with non-mutant FN or FN-RGE for binding to FN assembly sites. Non-mutant FN and FN-N263Q/N501Q with both NGRs mutated to QGRs were assembled equally well by adherent fibroblasts. FN-RGE and FN-RGE-N263Q/N501Q were also assembled equally well. Although substrate-bound 70K mediated cell adhesion in the presence of 1 mM Mn2+ by a mechanism that was inhibited by cyclic RGD peptide, the peptide did not inhibit 70K binding to cell surface. Mutations of the NGR sequences had no effect on Mn2+-enhanced cell adhesion to adsorbed 70K but caused a decrease in cell adhesion to reduced and alkylated 70K. These results demonstrate that iso-DGR sequences spontaneously converted from NGR are cryptic and do not mediate the interaction of the 70K region of FN with the cell surface during FN assembly.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), 4285 Med Sci Ctr, 1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu		Maurer, Lisa/0000-0003-0492-9805	National Institutes of Health [HL021644, T32-HL007899]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644, T32HL007899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL021644 (to D. F. M.) and National Institutes of Health Training Grant T32-HL007899 (to L. M. M. and B. R. H.).	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Bae E, 2004, J BIOL CHEM, V279, P35749, DOI 10.1074/jbc.M406283200; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BITTORF SV, 1993, J BIOL CHEM, V268, P24838; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x; Cho J, 2006, J THROMB HAEMOST, V4, P943, DOI 10.1111/j.1538-7836.2006.01862.x; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Curnis F, 2008, CANCER RES, V68, P7073, DOI 10.1158/0008-5472.CAN-08-1272; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Di Matteo P, 2006, MOL IMMUNOL, V43, P1509, DOI 10.1016/j.molimm.2005.10.009; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; GODYNA S, 1995, MATRIX BIOL, V14, P467, DOI 10.1016/0945-053X(95)90004-7; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Ohashi T, 2002, J CELL SCI, V115, P1221; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 2000, J CELL SCI, V113, P1491; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Sottile J, 2000, J CELL SCI, V113, P4287; Spitaleri A, 2008, J BIOL CHEM, V283, P19757, DOI 10.1074/jbc.M710273200; SUN X, 1991, J CLIN INVEST, V87, P171, DOI 10.1172/JCI114967; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607	56	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8563	8571		10.1074/jbc.M109.062646	http://dx.doi.org/10.1074/jbc.M109.062646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097751	hybrid, Green Published			2022-12-25	WOS:000275553700008
J	Han, Q; Ding, HZ; Robinson, H; Christensen, BM; Li, JY				Han, Qian; Ding, Haizhen; Robinson, Howard; Christensen, Bruce M.; Li, Jianyong			Crystal Structure and Substrate Specificity of Drosophila 3,4-Dihydroxyphenylalanine Decarboxylase	PLOS ONE			English	Article							DOPA-DECARBOXYLASE; HYPERSENSITIVE GENE; ACID DECARBOXYLASE; PARKINSONS-DISEASE; LOCOMOTOR-ACTIVITY; AMINO-ACIDS; MELANOGASTER; ENZYMES; MELANIZATION; INDUCTION	Background: 3,4-Dihydroxyphenylalanine decarboxylase (DDC), also known as aromatic L-amino acid decarboxylase, catalyzes the decarboxylation of a number of aromatic L-amino acids. Physiologically, DDC is responsible for the production of dopamine and serotonin through the decarboxylation of 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan, respectively. In insects, both dopamine and serotonin serve as classical neurotransmitters, neuromodulators, or neurohormones, and dopamine is also involved in insect cuticle formation, eggshell hardening, and immune responses. Principal Findings: In this study, we expressed a typical DDC enzyme from Drosophila melanogaster, critically analyzed its substrate specificity and biochemical properties, determined its crystal structure at 1.75 Angstrom resolution, and evaluated the roles residues T82 and H192 play in substrate binding and enzyme catalysis through site-directed mutagenesis of the enzyme. Our results establish that this DDC functions exclusively on the production of dopamine and serotonin, with no activity to tyrosine or tryptophan and catalyzes the formation of serotonin more efficiently than dopamine. Conclusions: The crystal structure of Drosophila DDC and the site-directed mutagenesis study of the enzyme demonstrate that T82 is involved in substrate binding and that H192 is used not only for substrate interaction, but for cofactor binding of drDDC as well. Through comparative analysis, the results also provide insight into the structure-function relationship of other insect DDC-like proteins.	[Han, Qian; Ding, Haizhen; Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Christensen, Bruce M.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Wisconsin System; University of Wisconsin Madison	Han, Q (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	lij@vt.edu	Han, Qian/AAS-2134-2020; Han, Qian/J-8696-2014	Han, Qian/0000-0001-6245-5252	NIH [AI 19769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019769, R01AI019769, R22AI019769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	NIH AI 19769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Bertoldi M, 2000, BIOCHEM J, V352, P533, DOI 10.1042/0264-6021:3520533; BLACK BC, 1987, MOL GEN GENET, V209, P306, DOI 10.1007/BF00329658; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; Chentsova NA, 2002, J COMP PHYSIOL B, V172, P643, DOI 10.1007/s00360-002-0293-9; CLARK WC, 1978, MOL GEN GENET, V162, P287, DOI 10.1007/BF00268854; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Davis MM, 2008, MOL CELL BIOL, V28, P4883, DOI 10.1128/MCB.02074-07; DeLano W.L., PYMOL MOL GRAPHICS S; Ferdig MT, 1996, INSECT MOL BIOL, V5, P119, DOI 10.1111/j.1365-2583.1996.tb00046.x; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hardie SL, 2007, DEV NEUROBIOL, V67, P1396, DOI 10.1002/dneu.20459; HIRSH J, 1986, MOL CELL BIOL, V6, P4548, DOI 10.1128/MCB.6.12.4548; Hodgetts RB, 2006, ANNU REV ENTOMOL, V51, P259, DOI 10.1146/annurev.ento.51.110104.151143; Huang CY, 2005, INSECT MOL BIOL, V14, P237, DOI 10.1111/j.1365-2583.2004.00552.x; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Johnson BN, 2009, NEUROSCIENCE, V159, P1233, DOI 10.1016/j.neuroscience.2009.01.067; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kack H, 1999, J MOL BIOL, V291, P857, DOI 10.1006/jmbi.1999.2997; Kandel E.R., 2000, PRINCIPLES NEURAL SC, V4th; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI LS, 1994, J IMMUNOL, V152, P930; LIVINGSTONE MS, 1983, NATURE, V303, P67, DOI 10.1038/303067a0; Macey TA, 2005, J NEUROCHEM, V93, P128, DOI 10.1111/j.1471-4159.2004.02998.x; MARSH JL, 1986, GENETICS, V112, P249; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; MEHTA PK, 1993, EUR J BIOCHEM, V211, P373, DOI 10.1111/j.1432-1033.1993.tb19907.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAPPI AJ, 1992, COMP BIOCHEM PHYS B, V101, P453, DOI 10.1016/0305-0491(92)90027-O; Nassel DR, 1996, PROG NEUROBIOL, V48, P325, DOI 10.1016/0301-0082(95)00048-8; Neckameyer Wendi S., 2002, P141; Neff NH, 1995, PROG BRAIN RES, V106, P91; Osborne RH, 1996, PHARMACOL THERAPEUT, V69, P117, DOI 10.1016/0163-7258(95)02054-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paskewitz SM, 2008, COMP BIOCHEM PHYS B, V150, P403, DOI 10.1016/j.cbpb.2008.04.010; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Sideri M, 2008, IMMUNOLOGY, V123, P528, DOI 10.1111/j.1365-2567.2007.02722.x; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; SOURKES TL, 1966, PHARMACOL REV, V18, P53; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WANG DG, 1995, DEV BIOL, V168, P598, DOI 10.1006/dbio.1995.1105	45	42	42	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8826	10.1371/journal.pone.0008826	http://dx.doi.org/10.1371/journal.pone.0008826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098687	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779100018
J	Mehta, S; Giovannucci, E; Mugusi, FM; Spiegelman, D; Aboud, S; Hertzmark, E; Msamanga, GI; Hunter, D; Fawzi, WW				Mehta, Saurabh; Giovannucci, Edward; Mugusi, Ferdinand M.; Spiegelman, Donna; Aboud, Said; Hertzmark, Ellen; Msamanga, Gernard I.; Hunter, David; Fawzi, Wafaie W.			Vitamin D Status of HIV-Infected Women and Its Association with HIV Disease Progression, Anemia, and Mortality	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REGRESSION-MODELS; 1,25-DIHYDROXYVITAMIN-D3; DEFICIENCY; 25-HYDROXYVITAMIN-D; TUBERCULOSIS; EXPRESSION; INDUCTION; MONOCYTES; EXPOSURE	Background: Vitamin D has a potential role in slowing HIV disease progression and preventing mortality based on its extensive involvement in the immune system; however, this relationship has not been examined in large studies or in resource-limited settings. Methodology/Principal Findings: Vitamin D levels were assessed in 884 HIV-infected pregnant women at enrollment in a trial of multivitamin supplementation (not including vitamin D) in Tanzania. Women were followed up for a median of 69.5 months, and information on hemoglobin levels, HIV disease progression, and mortality was recorded. Proportional hazard models and generalized estimating equations were used to assess the relationship of these outcomes with vitamin D status. Conclusions/Significance: Low vitamin D status (serum 25-hydroxyvitamin D<32ng/mL) was significantly associated with progression to WHO HIV disease stage III or greater in multivariate models (incidence rate ratio [RR]: 1.25; 95% confidence intervals [CI]: 1.05, 1.50). No significant relationship was observed between vitamin D status and T-cell counts during follow-up. Women with low vitamin D status had 46% higher risk of developing severe anemia during follow-up, compared to women with adequate vitamin D levels (RR: 1.46; 95% CI: 1.09, 1.96). Women in the highest vitamin D quintile had a 42% lower risk of all-cause mortality, compared to the lowest quintile (RR: 0.58; 95% CI: 0.40, 0.84). Vitamin D status had a protective association with HIV disease progression, all-cause mortality, and development of anemia during follow-up in HIV-infected women. If confirmed in randomized trials, vitamin D supplementation could represent a simple and inexpensive method to prolonging the time to initiation of antiretroviral therapy in HIV-infected patients, particularly in resource-limited settings.	[Mehta, Saurabh; Giovannucci, Edward; Spiegelman, Donna; Hertzmark, Ellen; Hunter, David; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mehta, Saurabh; Giovannucci, Edward; Hunter, David; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward; Hunter, David] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Giovannucci, Edward; Hunter, David] Harvard Univ, Sch Med, Boston, MA USA; [Mugusi, Ferdinand M.] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Aboud, Said] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Msamanga, Gernard I.] Muhimbili Univ Hlth & Allied Sci, Dept Community Hlth, Dar Es Salaam, Tanzania; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Muhimbili University of Health & Allied Sciences; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Mehta, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	smehta@hsph.harvard.edu	Mehta, Saurabh/A-7874-2009; Mehta, Saurabh/L-8490-2017	Mehta, Saurabh/0000-0003-3788-0665	National Institute of Child Health and Human Development [NICHD R01 32257]; Fogarty International Center [NIH D43 TW00004]; Harvard School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032257] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Harvard School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study is supported by the National Institute of Child Health and Human Development (NICHD R01 32257), the Fogarty International Center (NIH D43 TW00004), and the Harvard School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; [Anonymous], 1985, THEORETICAL EPIDEMIO; BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-1308; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; CONNOR RI, 1991, BIOCHEM BIOPH RES CO, V176, P852, DOI 10.1016/S0006-291X(05)80264-5; COX DR, 1972, J R STAT SOC B, V34, P187; Dacie J.V., 1991, PRACTICAL HEMATOLOGY, pVIII +556; DELUCA HF, 1982, BIOCHEM SOC T, V10, P147, DOI 10.1042/bst0100147; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fawzi WW, 1999, CONTROL CLIN TRIALS, V20, P75, DOI 10.1016/S0197-2456(98)00045-2; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Govindarajulu US, 2007, STAT MED, V26, P3735, DOI 10.1002/sim.2848; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; GRINDULIS H, 1986, ARCH DIS CHILD, V61, P843, DOI 10.1136/adc.61.9.843; HAUG C, 1994, J INFECT DIS, V169, P889, DOI 10.1093/infdis/169.4.889; HELDENBERG D, 1992, AM J CLIN NUTR, V56, P533, DOI 10.1093/ajcn/56.3.533; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; JAEGER P, 1994, J CLIN ENDOCR METAB, V79, P1701, DOI 10.1210/jc.79.6.1701; Kendrick J, 2008, NAT KIDN FDN SPRING; Lawson M, 1999, BRIT MED J, V318, P28, DOI 10.1136/bmj.318.7175.28; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; RIGBY WFC, 1990, BLOOD, V76, P189, DOI 10.1182/blood.V76.1.189.bloodjournal761189; SCHLESINGER M, 1989, IMMUNOL LETT, V22, P307, DOI 10.1016/0165-2478(89)90170-3; STRODER J, 1975, IMMUNITY VITAMIN D D, P675; Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109; Urassa W, 1994, Clin Diagn Virol, V2, P1, DOI 10.1016/0928-0197(94)90030-2; Villamor E, 2006, NUTR REV, V64, P226, DOI 10.1111/j.1753-4887.2006.tb00205.x; YETGIN S, 1989, J PEDIATR-US, V114, P213, DOI 10.1016/S0022-3476(89)80785-1; 1993, AIDS, V7, P711	31	148	152	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8770	10.1371/journal.pone.0008770	http://dx.doi.org/10.1371/journal.pone.0008770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098738	Green Published, Green Submitted, gold			2022-12-25	WOS:000273778900014
J	Panguluri, SK; Bhatnagar, S; Kumar, A; McCarthy, JJ; Srivastava, AK; Cooper, NG; Lundy, RF; Kumar, A				Panguluri, Siva K.; Bhatnagar, Shephali; Kumar, Akhilesh; McCarthy, John J.; Srivastava, Apurva K.; Cooper, Nigel G.; Lundy, Robert F.; Kumar, Ashok			Genomic Profiling of Messenger RNAs and MicroRNAs Reveals Potential Mechanisms of TWEAK-Induced Skeletal Muscle Wasting in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; MYOGENIC DIFFERENTIATION; MUSCULAR-DYSTROPHY; SARCOMERIC PROTEIN; CANCER CACHEXIA; WEAK INDUCER; CELL FATE; ACTIVATION; EXPRESSION	Background: Skeletal muscle wasting is a devastating complication of several physiological and pathophysiological conditions. Inflammatory cytokines play an important role in the loss of skeletal muscle mass in various chronic diseases. We have recently reported that proinflammatory cytokine TWEAK is a major muscle-wasting cytokine. Emerging evidence suggests that gene expression is regulated not only at transcriptional level but also at post-transcriptional level through the expression of specific non-coding microRNAs (miRs) which can affect the stability and/or translation of target mRNA. However, the role of miRs in skeletal muscle wasting is unknown. Methodology/Principal Findings: To understand the mechanism of action of TWEAK in skeletal muscle, we performed mRNA and miRs expression profile of control and TWEAK-treated myotubes. TWEAK increased the expression of a number of genes involved in inflammatory response and fibrosis and reduced the expression of few cytoskeletal gene (e. g. Myh4, Ankrd2, and TCap) and metabolic enzymes (e. g. Pgam2). Low density miR array demonstrated that TWEAK inhibits the expression of several miRs including muscle-specific miR-1-1, miR-1-2, miR-133a, miR-133b and miR-206. The expression of a few miRs including miR-146a and miR-455 was found to be significantly increased in response to TWEAK treatment. Ingenuity pathway analysis showed that several genes affected by TWEAK are known/putative targets of miRs. Our cDNA microarray data are consistent with miRs profiling. The levels of specific mRNAs and miRs were also found to be similarly regulated in atrophying skeletal muscle of transgenic mice (Tg) mice expressing TWEAK. Conclusions/Significance: Our results suggest that TWEAK affects the expression of several genes and microRNAs involved in inflammatory response, fibrosis, extracellular matrix remodeling, and proteolytic degradation which might be responsible for TWEAK-induced skeletal muscle loss.	[Panguluri, Siva K.; Bhatnagar, Shephali; Kumar, Akhilesh; Cooper, Nigel G.; Lundy, Robert F.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [McCarthy, John J.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY USA; [Srivastava, Apurva K.] NCI, Lab Human Toxicol & Pharmacol, Appl & Dev Res Directorate SAIC Frederick, Frederick, MD 21701 USA	University of Louisville; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Panguluri, SK (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	ashok.kumar@louisville.edu	Panguluri, Siva Kumar/A-3084-2008	Kumar, Ashok/0000-0001-8571-2848	National Institutes of Health [RO1 AG129623]; NCRR [P20RR16481]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant RO1 AG129623 to AK. Support from NCRR award P20RR16481 is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Dalla Libera L, 2004, CURR OPIN CLIN NUTR, V7, P435, DOI 10.1097/01.mco.0000134374.24181.5b; DIMAURO S, 1981, SCIENCE, V212, P1277, DOI 10.1126/science.6262916; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; FOTHERGILLGILMORE LA, 1989, ADV ENZYMOL RAMB, V62, P227; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; JOHANSEN KM, 1989, J CELL BIOL, V109, P2427, DOI 10.1083/jcb.109.5.2427; Kandarian SC, 2002, EXERC SPORT SCI REV, V30, P111, DOI 10.1097/00003677-200207000-00004; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; KURIHARA Y, METHODS MOL BIOL, V592, P231; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Li YP, 1998, FASEB J, V12, P871, DOI 10.1096/fasebj.12.10.871; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Markert CD, 2008, NEUROMUSCULAR DISORD, V18, P413, DOI 10.1016/j.nmd.2008.03.010; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Miller SM, 1998, MOL BIOL CELL, V9, p292A; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Rodrigues ADC, 2007, MICROSURG, V27, P664, DOI 10.1002/micr.20428; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; TSAI LM, 2009, CLIN EXP PHARM PHYSL; Valle G, 1997, FEBS LETT, V415, P163, DOI 10.1016/S0014-5793(97)01108-3; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhang N, 2009, J GLOB INF MANAG, V17, P49, DOI 10.4018/jgim.2009010103; Zhang RL, 2009, HUM MOL GENET, V18, P4130, DOI 10.1093/hmg/ddp362	77	62	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8760	10.1371/journal.pone.0008760	http://dx.doi.org/10.1371/journal.pone.0008760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098732	Green Published, Green Submitted, gold			2022-12-25	WOS:000273778900006
J	Guex, N; Migliavacca, E; Xenarios, I				Guex, Nicolas; Migliavacca, Eugenia; Xenarios, Ioannis			Multiple Imputations Applied to the DREAM3 Phosphoproteomics Challenge: A Winning Strategy	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; RECEPTOR; NETWORK	DREAM is an initiative that allows researchers to assess how well their methods or approaches can describe and predict networks of interacting molecules [1]. Each year, recently acquired datasets are released to predictors ahead of publication. Researchers typically have about three months to predict the masked data or network of interactions, using any predictive method. Predictions are assessed prior to an annual conference where the best predictions are unveiled and discussed. Here we present the strategy we used to make a winning prediction for the DREAM3 phosphoproteomics challenge. We used Amelia II, a multiple imputation software method developed by Gary King, James Honaker and Matthew Blackwell[2] in the context of social sciences to predict the 476 out of 4624 measurements that had been masked for the challenge. To chose the best possible multiple imputation parameters to apply for the challenge, we evaluated how transforming the data and varying the imputation parameters affected the ability to predict additionally masked data. We discuss the accuracy of our findings and show that multiple imputations applied to this dataset is a powerful method to accurately estimate the missing data. We postulate that multiple imputations methods might become an integral part of experimental design as a mean to achieve cost savings in experimental design or to increase the quantity of samples that could be handled for a given cost.	[Guex, Nicolas; Xenarios, Ioannis] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Migliavacca, Eugenia] Swiss Inst Bioinformat, Bioinformat Core Facil, Lausanne, Switzerland	Swiss Institute of Bioinformatics; Swiss Institute of Bioinformatics	Guex, N (corresponding author), Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland.	nicolas.guex@isb-sib.ch	Xenarios, Ioannis/ABD-5045-2021	Xenarios, Ioannis/0000-0002-3413-6841; GUEX, Nicolas/0000-0001-6023-0519	European Commission [LSHG-CT-2005-518254]; Swiss Institute of Bioinformatics	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss Institute of Bioinformatics	This work was supported in part by the Experimental Network for Functional INtegration (ENFIN; http://www.enfin.org), a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area "Life sciences, genomics and biotechnology for health'', contract number LSHG-CT-2005-518254. The research was funded in part by the Integrated Computational Genomics Resources of the Swiss Institute of Bioinformatics (http://www.isb-sib.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS LG, 2009, COMP PATHWAY M UNPUB; de Brevern AG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-114; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Gruenewald TL, 2006, P NATL ACAD SCI USA, V103, P14158, DOI 10.1073/pnas.0606215103; Kahlem P, 2007, ANN NY ACAD SCI, V1115, P23, DOI 10.1196/annals.1407.016; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009; Lappe M, 2004, NAT BIOTECHNOL, V22, P98, DOI 10.1038/nbt921; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Moult J, 2005, PROTEINS, V61, P3, DOI 10.1002/prot.20716; Moult J, 2003, PROTEINS, V53, P334, DOI 10.1002/prot.10556; Moult J, 2001, PROTEINS, P2; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; MOULT J, 1997, PROTEINS, V1, P1; Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Team RDC, 2019, R LANG ENV STAT COMP; Teshima S, 2004, J HEPATOL, V40, P616, DOI 10.1016/j.jhep.2003.12.018	19	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8012	10.1371/journal.pone.0008012	http://dx.doi.org/10.1371/journal.pone.0008012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090915	Green Published, Green Submitted, gold			2022-12-25	WOS:000273715000001
J	Lux, H; Flammann, H; Hafner, M; Lux, A				Lux, Heike; Flammann, Heiko; Hafner, Mathias; Lux, Andreas			Genetic and Molecular Analyses of PEG10 Reveal New Aspects of Genomic Organization, Transcription and Translation	PLOS ONE			English	Article							IMPRINTED GENE; HEPATOCELLULAR-CARCINOMA; MESSENGER-RNAS; TRANSPOSABLE ELEMENTS; FRAMESHIFT SIGNAL; MAMMALIAN GENOMES; START SITES; RETROTRANSPOSON; EXPRESSION; INITIATION	The paternally expressed gene PEG10 is a retrotransposon derived gene adapted through mammalian evolution located on human chromosome 7q21. PEG10 codes for at least two proteins, PEG10-RF1 and PEG10-RF1/2, by -1 frameshift translation. Overexpression or reinduced PEG10 expression was seen in malignancies, like hepatocellular carcinoma or B-cell acute and chronic lymphocytic leukemia. PEG10 was also shown to promote adipocyte differentiation. Experimental evidence suggests that the PEG10-RF1 protein is an inhibitor of apoptosis and mediates cell proliferation. Here we present new data on the genomic organization of PEG10 by identifying the major transcription start site, a new splice variant and report the cloning and analysis of 1.9 kb of the PEG10 promoter. Furthermore, we show for the first time that PEG10 translation is initiated at a non-AUG start codon upstream of the previously predicted AUG codon as well as at the AUG codon. The finding that PEG10 translation is initiated at different sides adds a new aspect to the already interesting feature of PEG10's 21 frameshift translation mechanism. It is now important to unravel the cellular functions of the PEG10 protein variants and how they are related to normal or pathological conditions. The generated promoter-reporter constructs can be used for future studies to investigate how PEG10 expression is regulated. In summary, our study provides new data on the genomic organization as well as expression and translation of PEG10, a prerequisite in order to study and understand the role of PEG10 in cancer, embryonic development and normal cell homeostasis.	[Lux, Heike; Flammann, Heiko; Hafner, Mathias; Lux, Andreas] Mannheim Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany; [Hafner, Mathias; Lux, Andreas] Univ Heidelberg, Fac Med, D-6800 Mannheim, Germany	Ruprecht Karls University Heidelberg	Lux, H (corresponding author), Mannheim Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany.	a.lux@hs-mannheim.de			MWK-Baden Wuerttemberg, Germany [2006.002-Hafner]; BMBF [Q5504.00]	MWK-Baden Wuerttemberg, Germany; BMBF(Federal Ministry of Education & Research (BMBF))	This research was supported by MWK-Baden Wuerttemberg, Germany, Grant No. 2006.002-Hafner to H. F. and M. H. and BMBF Grant No. Q5504.00 to M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; Brandt J, 2005, CYTOGENET GENOME RES, V110, P307, DOI 10.1159/000084963; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cho K, 2008, SHOCK, V30, P105, DOI 10.1097/SHK.0b013e31816a363f; Clark MB, 2007, J BIOL CHEM, V282, P37359, DOI 10.1074/jbc.M705676200; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Hishida T, 2007, FEBS LETT, V581, P4272, DOI 10.1016/j.febslet.2007.07.074; Hu CS, 2004, CELL MOL IMMUNOL, V1, P280; Ip WK, 2007, CANCER LETT, V250, P284, DOI 10.1016/j.canlet.2006.10.012; JIE X, 2007, ONCOGENE; KAINZ B, 2007, INT J CANC; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Li CM, 2006, CANCER RES, V66, P665, DOI 10.1158/0008-5472.CAN-05-1553; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Mount SM, 2000, AM J HUM GENET, V67, P788, DOI 10.1086/303098; Okabe H, 2003, CANCER RES, V63, P3043; Okita C, 2003, GENOMICS, V81, P556, DOI 10.1016/S0888-7543(03)00052-1; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; Sun BW, 2006, HUM MOL GENET, V15, P65, DOI 10.1093/hmg/ddi427; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Tsou AP, 2003, J BIOMED SCI, V10, P625, DOI 10.1159/000073528; Volff JN, 2001, MOL BIOL EVOL, V18, P266, DOI 10.1093/oxfordjournals.molbev.a003801; Wang CC, 2008, FEBS LETT, V582, P2793, DOI 10.1016/j.febslet.2008.07.009; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; Wills NM, 2006, J BIOL CHEM, V281, P7082, DOI 10.1074/jbc.M511629200; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Zhang DY, 2004, HEPATOLOGY, V39, P954, DOI 10.1002/hep.20135; Zhang FW, 2007, J ANIM SCI, V85, P886, DOI 10.2527/jas.2006-278; Zhou QY, 2007, GENES GENET SYST, V82, P265, DOI 10.1266/ggs.82.265; 2004, NATURE, V431, P931	48	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8686	10.1371/journal.pone.0008686	http://dx.doi.org/10.1371/journal.pone.0008686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084274	Green Submitted, gold, Green Published			2022-12-25	WOS:000273554600035
J	Bulfer, SL; Scott, EM; Pillus, L; Trievel, RC				Bulfer, Stacie L.; Scott, Erin M.; Pillus, Lorraine; Trievel, Raymond C.			Structural Basis for L-Lysine Feedback Inhibition of Homocitrate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE PATHWAY; SACCHAROMYCES-CEREVISIAE; MYCOBACTERIUM-TUBERCULOSIS; ISOPROPYLMALATE SYNTHASE; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; BIOSYNTHESIS; MECHANISM; ENZYME; FUNGI	The alpha-aminoadipate pathway of lysine biosynthesis is modulated at the transcriptional and biochemical levels by feedback inhibition. The first enzyme in the alpha-aminoadipate pathway, homocitrate synthase (HCS), is the target of the feedback regulation and is strongly inhibited by L-lysine. Here we report the structure of Schizosaccharomyces pombe HCS (SpHCS) in complex with L-lysine. The structure illustrates that the amino acid directly competes with the substrate 2-oxoglutarate for binding within the active site of HCS. Differential recognition of the substrate and inhibitor is achieved via a switch position within the (alpha/beta) 8 TIM barrel of the enzyme that can distinguish between the C5-carboxylate group of 2-oxoglutarate and the epsilon-ammonium group of L-lysine. In vitro and in vivo assays demonstrate that mutations of the switch residues, which interact with the L-lysine epsilon-ammonium group, abrogate feedback inhibition, as do substitutions of residues within the C-terminal domain that were identified in a previous study of L-lysine-insensitive HCS mutants in Saccharomyces cerevisiae. Together, these results yield new insights into the mechanism of feedback regulation of an enzyme central to lysine biosynthesis.	[Trievel, Raymond C.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Scott, Erin M.; Pillus, Lorraine] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Scott, Erin M.; Pillus, Lorraine] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Trievel, RC (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu			National Institutes of Health [GM090177, GM073839]; University of Michigan Biomedical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353, R01GM090177, R01GM073839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Biomedical Research Council(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM090177 (to L. P.) and GM073839 (to R. C. T.). Research for this project was funded in part through a University of Michigan Biomedical Research Council Pilot Grant (to R. C. T.).	Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Andi B, 2004, BIOCHEMISTRY-US, V43, P11790, DOI 10.1021/bi048766p; Becker B, 1998, MOL MICROBIOL, V29, P151, DOI 10.1046/j.1365-2958.1998.00916.x; BHATTACHARJEE JK, 1985, CRC CR REV MICROBIOL, V12, P131, DOI 10.3109/10408418509104427; Bulfer SL, 2009, J BIOL CHEM, V284, P35769, DOI 10.1074/jbc.M109.046821; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Carvalho LPS, 2005, J AM CHEM SOC, V127, P10004, DOI 10.1021/ja052513h; de Carvalho LPS, 2006, BIOCHEMISTRY-US, V45, P8988, DOI 10.1021/bi0606602; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller A, 1999, EUR J BIOCHEM, V261, P163, DOI 10.1046/j.1432-1327.1999.00262.x; GAILLARDIN CM, 1976, BIOCHIM BIOPHYS ACTA, V422, P390, DOI 10.1016/0005-2744(76)90150-9; GARRAD RC, 1992, J BACTERIOL, V174, P7379, DOI 10.1128/jb.174.22.7379-7384.1992; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hans MA, 2001, APPL MICROBIOL BIOT, V56, P776, DOI 10.1007/s002530100708; JAKLITSCH WM, 1990, BIOCHEM J, V269, P247, DOI 10.1042/bj2690247; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Kosuge T, 1998, FEMS MICROBIOL LETT, V169, P361, DOI 10.1016/S0378-1097(98)00502-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada T, 2010, J BIOL CHEM, V285, P4195, DOI 10.1074/jbc.M109.086330; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAMOS F, 1988, EUR J BIOCHEM, V171, P171, DOI 10.1111/j.1432-1033.1988.tb13773.x; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; URRESTARAZU LA, 1985, CURR GENET, V9, P341, DOI 10.1007/BF00421603; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; WOLFNER M, 1975, J MOL BIOL, V96, P273, DOI 10.1016/0022-2836(75)90348-4; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d	31	21	21	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10446	10453		10.1074/jbc.M109.094383	http://dx.doi.org/10.1074/jbc.M109.094383			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20089861	Green Published, hybrid			2022-12-25	WOS:000276264600030
J	Caromile, LA; Oganesian, A; Coats, SA; Seifert, RA; Bowen-Pope, DF				Caromile, Leslie A.; Oganesian, Anush; Coats, Scott A.; Seifert, Ronald A.; Bowen-Pope, Daniel F.			The Neurosecretory Vesicle Protein Phogrin Functions as a Phosphatidylinositol Phosphatase to Regulate Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTEN TUMOR-SUPPRESSOR; SECRETAGOGUE-DEPENDENT PHOSPHORYLATION; PLECKSTRIN HOMOLOGY DOMAIN; PANCREATIC BETA-CELLS; TYROSINE-PHOSPHATASE; MEMBRANE-PROTEIN; TRANSMEMBRANE PROTEIN; PHOSPHOINOSITIDE PHOSPHATASES; LIPID 2ND-MESSENGER; DIABETES-MELLITUS	Phogrin is a transmembrane protein expressed in cells with stimulus-coupled peptide hormone secretion, including pancreatic beta cells, in which it is localized to the membrane of insulin-containing dense-core vesicles. By sequence, phogrin is a member of the family of receptor-like protein-tyrosine phosphatases, but it contains substitutions in conserved catalytic sequences, and no significant enzymatic activity for phogrin has ever been reported. We report here that phogrin is able to dephosphorylate specific inositol phospholipids, including phosphatidylinositol (PI) 3-phosphate and PI 4,5-diphosphate but not PI 3,4,5-trisphosphate. The phosphatidylinositol phosphatase (PIPase) activity of phogrin was measurable but low when evaluated by the ability of a catalytic domain fusion protein to hydrolyze soluble short-chain phosphatidylinositol phospholipids. Unlike most PIPases, which are cytoplasmic proteins that associate with membranes, mature phogrin is a transmembrane protein. When the transmembrane form of phogrin was overexpressed in mammalian cells, it reduced plasma membrane phosphatidylinositol 4,5-disphosphate levels in a dose-dependent manner. When purified and assayed in vitro, the transmembrane form had a specific activity of 142 mol/min/mol, 75-fold more active than the catalytic domain fusion protein and comparable with the specific activities of the other PIPases. The PIPase activity of phogrin depended on the catalytic site cysteine and correlated with effects on glucose-stimulated insulin secretion. We propose that phogrin functions as a phosphatidylinositol phosphatase that contributes to maintaining subcellular differences in levels of PIP that are important for regulating stimulus-coupled exocytosis of insulin.	[Caromile, Leslie A.; Coats, Scott A.; Seifert, Ronald A.; Bowen-Pope, Daniel F.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Oganesian, Anush] Univ Washington, Dept Anesthesiol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bowen-Pope, DF (corresponding author), 815 Mercer St, Seattle, WA 98109 USA.	bp@uw.edu	Caromile, Leslie A/Q-2980-2016	Caromile, Leslie A/0000-0003-2193-5190; Seifer, Ronald/0000-0003-4879-2839	National Institutes of Health [HL69066, HL007312]; Juvenile Diabetes Research Foundation; Samuel and Althea Stroum Endowed Diabetes Fellowship; Ruth L. Kirschstein National Research Service Award [DK081307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312, R01HL069066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK081307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Samuel and Althea Stroum Endowed Diabetes Fellowship; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL69066 (to D. F. B.-P.) and Training Grant HL007312 (to L. A. C.). This work was also supported by a grant from the Juvenile Diabetes Research Foundation (to D. F. B.-P.) and by a Samuel and Althea Stroum Endowed Diabetes Fellowship and Ruth L. Kirschstein National Research Service Award DK081307 (to L. A. C.).	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Bonifacio E, 1998, J IMMUNOL, V161, P2648; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Chi YL, 2004, J BIOL CHEM, V279, P44987, DOI 10.1074/jbc.M406416200; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Cremona O, 2001, J CELL SCI, V114, P1041; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Dirkx R Jr, 1998, Adv Pharmacol, V42, P243; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Drake PG, 2003, BIOCHEM J, V373, P393, DOI 10.1042/BJ20021851; Fitzgerald LR, 1997, J NEUROCHEM, V68, P1820; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Georgescu MM, 2000, CANCER RES, V60, P7033; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Gromada J, 2005, P NATL ACAD SCI USA, V102, P10303, DOI 10.1073/pnas.0504487102; Guipponi M, 2001, HUM GENET, V109, P569, DOI 10.1007/s004390100607; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Henquin JC, 2008, J ENDOCRINOL, V196, P573, DOI 10.1677/JOE-07-0496; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Hu Yafang, 2009, Diabetes, V58, pe8, DOI 10.2337/db09-0168; Hu YF, 2005, DIABETOLOGIA, V48, P2576, DOI 10.1007/s00125-005-0037-y; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jiang SX, 1998, GENE, V215, P345, DOI 10.1016/S0378-1119(98)00282-0; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Kumanovics A, 2002, FASEB J, V16, P1623, DOI 10.1096/fj.02-0238hyp; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; Lan MS, 1996, P NATL ACAD SCI USA, V93, P6367, DOI 10.1073/pnas.93.13.6367; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Liao H, 2007, BIOCHEMISTRY-US, V46, P10909, DOI 10.1021/bi701121j; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; LU J, 1994, BIOCHEM BIOPH RES CO, V204, P930, DOI 10.1006/bbrc.1994.2549; Lu J, 1996, P NATL ACAD SCI USA, V93, P2307, DOI 10.1073/pnas.93.6.2307; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Magistrelli G, 1996, BIOCHEM BIOPH RES CO, V227, P581, DOI 10.1006/bbrc.1996.1549; Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8; Martin MM, 2001, MOL CELL ENDOCRINOL, V183, P81, DOI 10.1016/S0303-7207(01)00595-0; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Taraska JW, 2004, P NATL ACAD SCI USA, V101, P8780, DOI 10.1073/pnas.0401316101; Taylor GS, 2001, ANAL BIOCHEM, V295, P122, DOI 10.1006/abio.2001.5179; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Torii S, 2005, TRAFFIC, V6, P1213, DOI 10.1111/j.1600-0854.2005.00353.x; Torii S, 2009, DIABETES, V58, P682, DOI 10.2337/db08-0970; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Wasmeier C, 1999, BIOCHEM J, V341, P563, DOI 10.1042/0264-6021:3410563; Wasmeier C, 2005, TRAFFIC, V6, P474, DOI 10.1111/j.1600-0854.2005.00292.x; Wasmeier C, 1996, J BIOL CHEM, V271, P18161, DOI 10.1074/jbc.271.30.18161; Wasmeier C, 2002, TRAFFIC, V3, P654, DOI 10.1034/j.1600-0854.2002.30907.x; Wasmeier C, 2001, J BIOL CHEM, V276, P31919, DOI 10.1074/jbc.M102580200; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Whisstock JC, 2002, IUBMB LIFE, V53, P15, DOI 10.1080/15216540210814; Wu Y, 2001, J BIOL CHEM, V276, P21745, DOI 10.1074/jbc.M101480200; Xie H, 1996, CANCER RES, V56, P2742	69	33	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10487	10496		10.1074/jbc.M109.066563	http://dx.doi.org/10.1074/jbc.M109.066563			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20097759	Green Published, hybrid			2022-12-25	WOS:000276264600035
J	Reed, D; Shen, Y; Shelat, AA; Arnold, LA; Ferreira, AM; Zhu, FY; Mills, N; Smithson, DC; Regni, CA; Bashford, D; Cicero, SA; Schulman, BA; Jochemsen, AG; Guy, RK; Dyer, MA				Reed, Damon; Shen, Ying; Shelat, Anang A.; Arnold, Leggy A.; Ferreira, Antonio M.; Zhu, Fangyi; Mills, Nicholas; Smithson, David C.; Regni, Catherine A.; Bashford, Donald; Cicero, Samantha A.; Schulman, Brenda A.; Jochemsen, Aart G.; Guy, R. Kiplin; Dyer, Michael A.			Identification and Characterization of the First Small Molecule Inhibitor of MDMX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STABILITY; P53 ACTIVATION; RING DOMAIN; ANTAGONISTS; APOPTOSIS; BINDING; OVEREXPRESSION; AMPLIFICATION; INACTIVATION; P53-MDM2	The p53 pathway is disrupted in virtually every human tumor. In similar to 50% of human cancers, the p53 gene is mutated, and in the remaining cancers, the pathway is dysregulated by genetic lesions in other genes that modulate the p53 pathway. One common mechanism for inactivation of the p53 pathway in tumors that express wild-type p53 is increased expression of MDM2 or MDMX. MDM2 and MDMX bind p53 and inhibit its function by distinct nonredundant mechanisms. Small molecule inhibitors and small peptides have been developed that bind MDM2 in the p53-binding pocket and displace the p53 protein, leading to p53-mediated cell cycle exit and apoptosis. To date, peptide inhibitors of MDMX have been developed, but no small molecule inhibitors have been reported. We have developed biochemical and cell-based assays for high throughput screening of chemical libraries to identify MDMX inhibitors and identified the first MDMX inhibitor SJ-172550. This compound binds reversibly to MDMX and effectively kills retinoblastoma cells in which the expression of MDMX is amplified. The effect of SJ-172550 is additive when combined with an MDM2 inhibitor. Results from a series of biochemical and structural modeling studies suggest that SJ-172550 binds the p53-binding pocket of MDMX, thereby displacing p53. This lead compound is a useful chemical scaffold for further optimization of MDMX inhibitors that may eventually be used to treat pediatric cancers and various adult tumors that overexpress MDMX or have similar genetic lesions. When combined with selective MDM2 inhibitors, SJ-172550 may also be useful for treating tumors that express wild-type p53.	[Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Shelat, Anang A.; Arnold, Leggy A.; Zhu, Fangyi; Mills, Nicholas; Smithson, David C.; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Ferreira, Antonio M.; Regni, Catherine A.; Bashford, Donald; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Schulman, Brenda A.; Dyer, Michael A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Jochemsen, Aart G.] Leiden Univ, Med Ctr, Dept Mol & Cellular Biol, NL-2333 ZA Leiden, Netherlands	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, MS323,262 Danny Thomas Pl, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Ferreira, Antonio/I-4423-2013; Shelat, Anang/J-4995-2013; Guy, Rodney/J-7107-2013; Dyer, Michael/N-8134-2018; Bashford, Donald/F-5905-2011; Reed, Damon/R-8179-2019	Shelat, Anang/0000-0002-6266-2910; Guy, Rodney/0000-0002-9638-2060; Bashford, Donald/0000-0001-5776-3744; Reed, Damon/0000-0002-8238-2465; Ferreira, Antonio/0000-0002-6581-6233; Arnold, Leggy/0000-0003-1411-1572	NCI, Cancer Center Support; Howard Hughes Medical Institute; American Cancer Society; Research to Prevent Blindness; Pearle Vision Foundation; International Retinal Research Foundation; Pew Charitable Trust; American Lebanese Syrian Associated Charities; NATIONAL EYE INSTITUTE [R01EY014867] Funding Source: NIH RePORTER	NCI, Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Pearle Vision Foundation; International Retinal Research Foundation; Pew Charitable Trust; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health grants from NCI, Cancer Center Support. This work was also supported by Howard Hughes Medical Institute, American Cancer Society, Research to Prevent Blindness, Pearle Vision Foundation, International Retinal Research Foundation, Pew Charitable Trust, and American Lebanese Syrian Associated Charities (to M. A. D.).	Anderson JJ, 2007, INT J ONCOL, V31, P545; Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Dang JJ, 2002, CANCER RES, V62, P1222; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Laurie NA, 2007, CURR CANCER DRUG TAR, V7, P689, DOI 10.2174/156800907782418266; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Levine EM, 1997, J COMP NEUROL, V387, P439; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lor LA, 2007, J BIOMOL SCREEN, V12, P881, DOI 10.1177/1087057107304113; Lu F, 2006, J COMB CHEM, V8, P315, DOI 10.1021/cc050142v; Marine JC, 2004, CELL CYCLE, V3, P900; Marine JE, 2006, HEART RHYTHM, V3, P342, DOI 10.1016/j.hrthm.2006.01.010; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Senisterra GA, 2008, J BIOMOL SCREEN, V13, P337, DOI 10.1177/1087057108317825; Senisterra GA, 2009, MOL BIOSYST, V5, P217, DOI 10.1039/b814377c; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Stricher F, 2005, BIOCHEM J, V390, P29, DOI 10.1042/BJ20041953; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Udayakumar TS, 2008, MOL CANCER RES, V6, P1742, DOI 10.1158/1541-7786.MCR-08-0102; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864	39	154	163	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10786	10796		10.1074/jbc.M109.056747	http://dx.doi.org/10.1074/jbc.M109.056747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20080970	Green Published, hybrid			2022-12-25	WOS:000276264600064
J	Lampe, JN; Brandman, R; Sivaramakrishnan, S; de Montellano, PRO				Lampe, Jed N.; Brandman, Relly; Sivaramakrishnan, Santhosh; de Montellano, Paul R. Ortiz			Two-dimensional NMR and All-atom Molecular Dynamics of Cytochrome P450 CYP119 Reveal Hidden Conformational Substates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIAL FUNCTIONS; INTRINSIC DYNAMICS; CRYSTAL-STRUCTURES; LIGAND-BINDING; INDUCED FIT; PROTEIN; P450CAM; MODEL; SITE; 3A4	Cytochrome P450 enzymes are versatile catalysts involved in a wide variety of biological processes from hormonal regulation and antibiotic synthesis to drug metabolism. A hallmark of their versatility is their promiscuous nature, allowing them to recognize a wide variety of chemically diverse substrates. However, the molecular details of this promiscuity have remained elusive. Here, we have utilized two-dimensional heteronuclear single quantum coherence NMR spectroscopy to examine a series of mutants site-specific labeled with the unnatural amino acid, [C-13] p-methoxyphenylalanine, in conjunction with all-atom molecular dynamics simulations to examine substrate and inhibitor binding to CYP119, a P450 from Sulfolobus acidocaldarius. The results suggest that tight binding hydrophobic ligands tend to lock the enzyme into a single conformational substate, whereas weak binding low affinity ligands bind loosely in the active site, resulting in a distribution of localized conformers. Furthermore, the molecular dynamics simulations suggest that the ligand-free enzyme samples ligand-bound conformations of the enzyme and, therefore, that ligand binding may proceed largely through a process of conformational selection rather than induced fit.	[Lampe, Jed N.; Sivaramakrishnan, Santhosh; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Brandman, Relly] Simprota Corp, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Lampe, Jed N./J-8930-2019	Lampe, Jed N./0000-0003-0794-2263	National Institutes of Health [GM25515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025515, R01GM025515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health Grant GM25515.	Altarsha M, 2009, J PHYS CHEM B, V113, P9577, DOI 10.1021/jp809838k; Arnold GE, 1997, BIOPHYS J, V73, P1147, DOI 10.1016/S0006-3495(97)78147-5; Asciutto EK, 2009, J MOL BIOL, V388, P801, DOI 10.1016/j.jmb.2009.03.046; Atkins WM, 2001, CHEM RES TOXICOL, V14, P338, DOI 10.1021/tx0002132; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Cellitti SE, 2008, J AM CHEM SOC, V130, P9268, DOI 10.1021/ja801602q; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cupp-Vickery J, 2000, P NATL ACAD SCI USA, V97, P3050, DOI 10.1073/pnas.050406897; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Ferscht A., 1999, STRUCTURE MECH PROTE, P54; Fishelovitch D, 2007, J AM CHEM SOC, V129, P1602, DOI 10.1021/ja066007j; Gogonea V, 2006, J PHYS CHEM B, V110, P22861, DOI 10.1021/jp061653q; Groves J. T., 2005, CYTOCHROME P450, P1, DOI DOI 10.1007/0-387-27447-2_1; Hansen DF, 2008, J BIOMOL NMR, V41, P113, DOI 10.1007/s10858-008-9251-5; Hays AMA, 2004, J MOL BIOL, V344, P455, DOI 10.1016/j.jmb.2004.09.046; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jones DH, 2010, J BIOMOL NMR, V46, P89, DOI 10.1007/s10858-009-9365-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Karkola S, 2009, MOL CELL ENDOCRINOL, V301, P235, DOI 10.1016/j.mce.2008.10.003; KOLEY AP, 1995, J BIOL CHEM, V270, P5014, DOI 10.1074/jbc.270.10.5014; Koo LS, 2000, J BIOL CHEM, V275, P14112, DOI 10.1074/jbc.275.19.14112; Lamb DC, 2007, CURR OPIN BIOTECH, V18, P504, DOI 10.1016/j.copbio.2007.09.010; Lampe JN, 2008, J AM CHEM SOC, V130, P16168, DOI 10.1021/ja8071463; Liu CC, 2006, NAT BIOTECHNOL, V24, P1436, DOI 10.1038/nbt1254; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Mestres J, 2005, PROTEINS, V58, P596, DOI 10.1002/prot.20354; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; Nishida CR, 2005, BIOCHEM BIOPH RES CO, V338, P437, DOI 10.1016/j.bbrc.2005.08.093; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Pochapsky SS, 2009, BIOCHEMISTRY-US, V48, P4254, DOI 10.1021/bi900002k; Pochapsky TC, 2001, BIOCHEMISTRY-US, V40, P5602, DOI 10.1021/bi0028845; Ravindranathan KP, 2006, J AM CHEM SOC, V128, P5786, DOI 10.1021/ja058465i; Ringe D, 2008, SCIENCE, V320, P1428, DOI 10.1126/science.1159747; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Strickler M, 2003, BIOCHEMISTRY-US, V42, P11943, DOI 10.1021/bi034833o; Sun H, 2009, DRUG METAB DISPOS, V37, P672, DOI 10.1124/dmd.108.022707; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wade RC, 2005, BBA-PROTEINS PROTEOM, V1754, P239, DOI 10.1016/j.bbapap.2005.07.044; Wester MR, 2003, BIOCHEMISTRY-US, V42, P9335, DOI 10.1021/bi034556l; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yano JK, 2003, J BIOL CHEM, V278, P608, DOI 10.1074/jbc.M206568200; Yao H, 2007, PROTEINS, V69, P125, DOI 10.1002/prot.21508; Zhang HM, 2009, J BIOL CHEM, V284, P25678, DOI 10.1074/jbc.M109.032748	64	40	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9594	9603		10.1074/jbc.M109.087593	http://dx.doi.org/10.1074/jbc.M109.087593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097757	Green Published, hybrid			2022-12-25	WOS:000276165900032
J	Asahi, T; Kondo, H; Masuda, M; Nishino, H; Aratani, Y; Naito, Y; Yoshikawa, T; Hisaka, S; Kato, Y; Osawa, T				Asahi, Takashi; Kondo, Hajime; Masuda, Mitsuharu; Nishino, Hoyoku; Aratani, Yasuaki; Naito, Yuji; Yoshikawa, Toshikazu; Hisaka, Shinsuke; Kato, Yoji; Osawa, Toshihiko			Chemical and Immunochemical Detection of 8-Halogenated Deoxyguanosines at Early Stage Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; LOW-DENSITY-LIPOPROTEIN; EOSINOPHIL PEROXIDASE; HUMAN NEUTROPHILS; NITRIC-OXIDE; LIPID HYDROPEROXIDE; MONOCLONAL-ANTIBODY; ENDOGENOUS MUTAGEN; OXIDATIVE STRESS; MYELOPEROXIDASE	Myeloperoxidase (MPO) generates reactive halogenating species that can modify DNA. The aim of this study was to investigate the formation of 8-halogenated 2'-deoxyguanosines (8-halo-dGs) during inflammatory events. 8-Bromo-2'-dG (8-BrdG) and 8-chloro-2'-dG (8-CldG) were generated by treatment of MPO with hydrogen peroxide at physiological concentrations of Cl- and Br-. The formation of 8-halo-dGs with other oxidative stress biomarkers in lipopolysaccharide-treated rats was assessed by liquid chromatography tandem mass spectrometry and immunohistochemistry using a novel monoclonal antibody (mAb8B3) to 8-BrdG-conjugated keyhole limpet hemocyanin. The antibody recognized both 8-BrdG and 8-CldG. In the liver of lipopolysaccharide-treated rats, immunostaining for 8-halo-dGs, halogenated tyrosines, and MPO were increased at 8 h, whereas those of 8-oxo-2'-dG (8-OxodG) and 3-nitrotyrosine were increased at 24 h. Urinary excretion of both 8-CldG and 8-BrdG was also observed earlier than those of 8-OxodG and modified tyrosines (3-nitrotyrosine, 3-chlorotyrosine, and 3-bromotyrosine). Moreover, the levels of the 8-halo-dGs in urine from human diabetic patients were 8-fold higher than in healthy subjects (n = 10, healthy and diabetic, p < 0.0001), whereas there was a moderate difference in 8-OxodG between the two groups (p < 0.001). Interestingly, positive mAb8B3 antibody staining was observed in liver tissue from hepatocellular carcinoma patients but not in liver tissue from human cirrhosis patients. These data suggest that 8-halo-dGs may be potential biomarkers of early inflammation.	[Kato, Yoji] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan; [Asahi, Takashi; Kondo, Hajime; Hisaka, Shinsuke; Osawa, Toshihiko] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; [Masuda, Mitsuharu] Kyoto Prefectural Univ Med, Dept Hlth Sci & Prevent Med, Kyoto 6028566, Japan; [Nishino, Hoyoku] Kyoto Prefectural Univ Med, Ctr Canc, Kyoto 6028566, Japan; [Aratani, Yasuaki] Yokohama City Univ, Grad Sch Nanobiosci, Dept Genome Syst Sci, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Naito, Yuji; Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto 6028566, Japan	University of Hyogo; Nagoya University; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Yokohama City University; Kyoto Prefectural University of Medicine	Kato, Y (corresponding author), Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan.	yojikato@shse.u-hyogo.ac.jp	Kato, Yoji/W-4779-2019	Kato, Yoji/0000-0002-8295-7337	Ministry of Education, Culture, Sports, Science, and Technology; COE Program; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology, by the COE Program in the 21st Century in Japan, and by research fellowships of the Japan Society for the Promotion of Science.	Akaike T, 2003, P NATL ACAD SCI USA, V100, P685, DOI 10.1073/pnas.0235623100; Albert CJ, 2003, J BIOL CHEM, V278, P8942, DOI 10.1074/jbc.M211634200; Aratani Y, 1999, INFECT IMMUN, V67, P1828; Badouard C, 2005, J CHROMATOGR B, V827, P26, DOI 10.1016/j.jchromb.2005.03.025; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; BHATNAGAR SK, 1991, J BIOL CHEM, V266, P9050; Brown KE, 2001, AM J PATHOL, V159, P2081, DOI 10.1016/S0002-9440(10)63059-3; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Byun J, 2003, ANAL BIOCHEM, V317, P201, DOI 10.1016/S0003-2697(03)00093-9; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Fabrega C, 2001, NUCLEOS NUCLEOT NUCL, V20, P251, DOI 10.1081/NCN-100002085; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Haghdoost S, 2006, FREE RADICAL BIO MED, V41, P620, DOI 10.1016/j.freeradbiomed.2006.05.003; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Heineman D, 2002, J HIST SEXUALITY, V11, P22; Henderson JP, 1999, J BIOL CHEM, V274, P33440, DOI 10.1074/jbc.274.47.33440; Henderson JP, 2003, J BIOL CHEM, V278, P23522, DOI 10.1074/jbc.M303928200; Henderson JP, 2001, P NATL ACAD SCI USA, V98, P1631, DOI 10.1073/pnas.041146998; Henderson JP, 2001, BIOCHEMISTRY-US, V40, P2052, DOI 10.1021/bi002015f; Huang X, 2001, FREE RADICAL BIO MED, V31, P1341, DOI 10.1016/S0891-5849(01)00681-5; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; ITOH K, 1993, GASTROENTEROL JPN, V28, P541; Kato Y, 2005, FREE RADICAL BIO MED, V38, P24, DOI 10.1016/j.freeradbiomed.2004.09.013; Kato Y, 1999, J BIOL CHEM, V274, P20406, DOI 10.1074/jbc.274.29.20406; Kato Y, 1997, J LIPID RES, V38, P1334; Kato Y, 2009, J CLIN BIOCHEM NUTR, V44, P67, DOI 10.3164/jcbn.08-185; Kawai Y, 2004, J BIOL CHEM, V279, P51241, DOI 10.1074/jbc.M408210200; Kimura S, 2006, BASIC CLIN PHARMACOL, V98, P496, DOI 10.1111/j.1742-7843.2006.pto_217.x; Kobayashi Y, 1998, CARCINOGENESIS, V19, P1809, DOI 10.1093/carcin/19.10.1809; Masuda M, 2001, J BIOL CHEM, V276, P40486, DOI 10.1074/jbc.M102700200; OHSHIMA H, 1994, MUTAT RES, V305, P253, DOI 10.1016/0027-5107(94)90245-3; Shen ZZ, 2001, BIOCHEMISTRY-US, V40, P2041, DOI 10.1021/bi001961t; Suzuki T, 2002, FEBS LETT, V516, P67, DOI 10.1016/S0014-5793(02)02503-6; Takeshita J, 2006, J BIOL CHEM, V281, P3096, DOI 10.1074/jbc.M509236200; Thukkani AK, 2003, J BIOL CHEM, V278, P36365, DOI 10.1074/jbc.M305449200; Toyokuni S, 1997, LAB INVEST, V76, P365; WEITZMAN SA, 1990, BLOOD, V76, P655; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Yoshitake J, 2004, J VIROL, V78, P8709, DOI 10.1128/JVI.78.16.8709-8719.2004; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	45	50	50	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9282	9291		10.1074/jbc.M109.054213	http://dx.doi.org/10.1074/jbc.M109.054213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20081197	Green Published, hybrid			2022-12-25	WOS:000275553700076
J	Nedumaran, B; Kim, GS; Hong, S; Yoon, YS; Kim, YH; Lee, CH; Lee, YC; Koo, SH; Choi, HS				Nedumaran, Balachandar; Kim, Gwang Sik; Hong, Sungpyo; Yoon, Young-Sil; Kim, Yong-Hoon; Lee, Chul-Ho; Lee, Young Chul; Koo, Seung-Hoi; Choi, Hueng-Sik			Orphan Nuclear Receptor DAX-1 Acts as a Novel Corepressor of Liver X Receptor alpha and Inhibits Hepatic Lipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITA CRITICAL REGION; ELEMENT-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; SHP; LXR; TRANSACTIVATION; ACTIVATION; CHROMOSOME; REPRESSES	DAX-1 (dosage-sensitive sex reversal adrenal hypoplasia congenital critical regionon X chromosome, gene1) is a member of the nuclear receptor superfamily that can repress diverse nuclear receptors and has a key role in adreno-gonadal development. Our previous report has demonstrated that DAX-1 can inhibit hepatocyte nuclear factor 4 alpha transactivity and negatively regulate gluconeogenic gene expression (Nedumaran, B., Hong, S., Xie, Y. B., Kim, Y. H., Seo, W. Y., Lee, M. W., Lee, C. H., Koo, S. H., and Choi, H. S. (2009) J. Biol. Chem. 284, 27511-27523). Here, we further expand the role of DAX-1 in hepatic energy metabolism. Transfection assays have demonstrated that DAX-1 can inhibit the transcriptional activity of nuclear receptor liver X receptor alpha (LXR alpha). Physical interaction between DAX-1 and LXR alpha was confirmed Immunofluorescent staining in mouse liver shows that LXR alpha and DAX-1 are colocalized in the nucleus. Domain mapping analysis shows that the entire region of DAX-1 is involved in the interaction with the ligand binding domain region of LXR alpha. Competition analyses demonstrate that DAX1 competes with the coactivator SRC-1 for repressing LXR alpha transactivity. Chromatin immunoprecipitation assay showed that endogenous DAX-1 recruitment on the SREBP-1c gene promoter was decreased in the presence of LXR alpha agonist. Overexpression of DAX-1 inhibits T7-induced LXR alpha target gene expression, whereas knockdown of endogenous DAX-1 significantly increases T7-induced LXR alpha target gene expression in HepG2 cells. Finally, overexpression of DAX-1 in mouse liver decreases T7-induced LXR alpha target gene expression, liver triglyceride level, and lipid accumulation. Overall, this study suggests that DAX-1, a novel corepressor of LXR alpha, functions as a negative regulator of lipogenic enzyme gene expression in liver.	[Nedumaran, Balachandar; Kim, Gwang Sik; Lee, Young Chul; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biomed Sci, Kwangju 501746, South Korea; [Hong, Sungpyo; Yoon, Young-Sil; Koo, Seung-Hoi; Choi, Hueng-Sik] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Kim, Yong-Hoon; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, 300 Chunchun Dong, Suwon 440746, South Korea.	shkoo@med.skku.ac.kr	Nedumaran, Balachandar/V-9958-2019; Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	Ministry of Science and Technology [M10500000047-06J0000-04710]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported in part by the Korea Science and Engineering Foundation through the National Research Laboratory Program funded by the Ministry of Science and Technology Grant M10500000047-06J0000-04710.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; Delvecchio CJ, 2008, J ENDOCRINOL, V197, P121, DOI 10.1677/JOE-07-0525; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gobinet J, 2005, BIOCHEMISTRY-US, V44, P6312, DOI 10.1021/bi047308d; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; Iyer AK, 2006, MOL ENDOCRINOL, V20, P2326, DOI 10.1210/me.2005-0383; Jakobsson T, 2007, BIOCHEM J, V405, P31, DOI 10.1042/BJ20070004; Kawajiri K, 2003, MOL ENDOCRINOL, V17, P994, DOI 10.1210/me.2002-0360; Kim GS, 2008, BIOCHEM BIOPH RES CO, V370, P264, DOI 10.1016/j.bbrc.2008.03.098; Kim KH, 2009, MOL ENDOCRINOL, V23, P466, DOI 10.1210/me.2008-0295; Kim SW, 2003, MOL CELL BIOL, V23, P3583, DOI 10.1128/MCB.23.10.3583-3592.2003; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2002, MOL ENDOCRINOL, V16, P506, DOI 10.1210/me.16.3.506; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Nedumaran B, 2009, J BIOL CHEM, V284, P27511, DOI 10.1074/jbc.M109.034660; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Smith CA, 2000, J MOL ENDOCRINOL, V24, P23, DOI 10.1677/jme.0.0240023; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Sugita J, 2001, GENE, V280, P67, DOI 10.1016/S0378-1119(01)00739-9; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Wang DS, 2002, BIOCHEM BIOPH RES CO, V297, P632, DOI 10.1016/S0006-291X(02)02252-0; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang H, 2000, J BIOL CHEM, V275, P39855, DOI 10.1074/jbc.C000567200; Zhou J, 2008, MOL ENDOCRINOL, V22, P1521, DOI 10.1210/me.2007-0273	44	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9221	9232		10.1074/jbc.M109.073650	http://dx.doi.org/10.1074/jbc.M109.073650			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080977	Green Published, hybrid			2022-12-25	WOS:000275553700071
J	Sun, W; Jin, JF; Xu, RJ; Hu, W; Szulc, ZM; Bielawski, J; Obeid, LM; Mao, CG				Sun, Wei; Jin, Junfei; Xu, Ruijuan; Hu, Wei; Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui			Substrate Specificity, Membrane Topology, and Activity Regulation of Human Alkaline Ceramidase 2 (ACER2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; ACID CERAMIDASE; GOLGI-APPARATUS; SPHINGOSINE; ENZYME; PUMP	Human alkaline ceramidase 2 (ACER2) plays an important role in cellular responses by regulating the hydrolysis of ceramides in cells. Here we report its biochemical characterization, membrane topology, and activity regulation. Recombinant ACER2 was expressed in yeast mutant cells (Delta ypc1 Delta ydc1) that lack endogenous ceramidase activity, and microsomes from ACER2-expressiong yeast cells were used to biochemically characterize ACER2. ACER2 catalyzed the hydrolysis of various ceramides and followed Michaelis-Menten kinetics. ACER2 required Ca2+ for both its in vitro and cellular activities. ACER2 has 7 putative transmembrane domains, and its amino (N) and carboxyl (C) termini were found to be oriented in the lumen of the Golgi complex and cytosol, respectively. ACER2 mutant (ACER2 Delta N36) lacking the N-terminal tail (the first 36 amino acid residues) exhibited undetectable activity and was mislocalized to the endoplasmic reticulum, suggesting that the N-terminal tail is necessary for both ACER2 activity and Golgi localization. ACER2 mutant (ACER2 Delta N13) lacking the first 13 residues was also mislocalized to the endoplasmic reticulum although it retained ceramidase activity. Overexpression of ACER2, ACER2 Delta N13, but not ACER2 Delta N36 increased the release of sphingosine 1-phosphate from cells, suggesting that its mislocalization does not affect the ability of ACER2 to regulate sphingosine 1-phosphate secretion. However, overexpression of ACER2 but not ACER2 Delta N13 or ACER2 Delta N36 inhibited the glycosylation of integrin beta 1 subunit and Lamp1, suggesting that its mistargeting abolishes the ability of ACER2 to regulation protein glycosylation. These data suggest that ACER2 has broad substrate specificity and requires Ca2+ for its activity and that ACER2 has the cytosolic C terminus and luminal N terminus, which are essential for its activity, correct cellular localization, and regulation for protein glycosylation.	[Sun, Wei; Jin, Junfei; Xu, Ruijuan; Hu, Wei; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Med, Div Gen Internal Med, Charleston, SC 29425 USA; [Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Ralph H Johnson Vet Affairs Hosp, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mao, CG (corresponding author), Med Univ S Carolina, Dept Med, Div Gen Internal Med, 114 Doughty St,Rm 646,STB,POB 250779, Charleston, SC 29425 USA.	maoc@musc.edu	xu, rui/GRX-5734-2022	obeid, lina/0000-0002-0734-0847; Jin, Junfei/0000-0002-9237-9024	National Institutes of Health [R01CA104834]; Veterans Affairs Merit award; NATIONAL CANCER INSTITUTE [R01CA104834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA104834 (to C. M.) and a Veterans Affairs Merit award (to L.M.O.).	Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 2002, J LIPID RES, V43, P141; el Bawab Samer, 2002, Subcell Biochem, V36, P187; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Luo X, 2008, BIOCHEM J, V414, P399, DOI 10.1042/BJ20080948; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876; Mao CG, 2001, J BIOL CHEM, V276, P26577, DOI 10.1074/jbc.M102818200; Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Spiegel S, 1999, J LEUKOCYTE BIOL, V65, P341, DOI 10.1002/jlb.65.3.341; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Sun W, 2009, FASEB J, V23, P656, DOI 10.1096/fj.08-115634; Usta J, 2001, BIOCHEMISTRY-US, V40, P9657, DOI 10.1021/bi010535k; Van Baelen K, 2003, BIOCHEM BIOPH RES CO, V306, P430, DOI 10.1016/S0006-291X(03)00977-X; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P1779, DOI 10.1093/bioinformatics/btn309; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com	26	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8995	9007		10.1074/jbc.M109.069203	http://dx.doi.org/10.1074/jbc.M109.069203			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089856	hybrid, Green Published			2022-12-25	WOS:000275553700051
J	Huang, YJ; Chen, IC; Yu, CM; Lee, YC; Hsu, HJ; Ching, ATC; Chang, HJ; Yang, AS				Huang, Yi-Jen; Chen, Ing-Chien; Yu, Chung-Ming; Lee, Yu-Ching; Hsu, Hung-Ju; Ching, Anna Tung Ching; Chang, Hung-Ju; Yang, An-Suei			Engineering Anti-vascular Endothelial Growth Factor Single Chain Disulfide-stabilized Antibody Variable Fragments (sc-dsFv) with Phage-displayed sc-dsFv Libraries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TRANSLOCATION CHANNEL; SIGNAL SEQUENCES; FV FRAGMENTS; FILAMENTOUS PHAGE; ESCHERICHIA-COLI; AFFINITY; DOMAINS; FAB; MACHINERY; EVOLUTION	Phage display of antibody fragments from natural or synthetic antibody libraries with the single chain constructs combining the variable fragments (scFv) has been one of the most prominent technologies in antibody engineering. However, the nature of the artificial single chain constructs results in unstable proteins expressed on the phage surface or as soluble proteins secreted in the bacterial culture medium. The stability of the variable domain structures can be enhanced with interdomain disulfide bond, but the single chain disulfide-stabilized constructs (sc-dsFv) have yet to be established as a feasible format for bacterial phage display due to diminishing expression levels on the phage surface in known phage display systems. In this work, biological combinatorial searches were used to establish that the c-region of the signal sequence is critically responsible for effective expression and functional folding of the sc-dsFv on the phage surface. The optimum signal sequences increase the expression of functional sc-dsFv by 2 orders of magnitude compared with wild-type signal sequences, enabling the construction of phage-displayed synthetic antivascular endothelial growth factor sc-dsFv libraries. Comparison of the scFv and sc-dsFv variants selected from the phage-displayed libraries for vascular endothelial growth factor binding revealed the sequence preference differences resulting from the interdomain disulfide bond. These results underlie a new phage display format for antibody fragments with all the benefits from the scFv format but without the downside due to the instability of the dimeric interface in scFv.	[Huang, Yi-Jen; Chen, Ing-Chien; Yu, Chung-Ming; Lee, Yu-Ching; Hsu, Hung-Ju; Ching, Anna Tung Ching; Chang, Hung-Ju; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Huang, Yi-Jen] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hsu, Hung-Ju] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Chang, Hung-Ju] Acad Sinica, Taiwan Int Grad Program, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Defense Medical Center; Academia Sinica - Taiwan	Yang, AS (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	yangas@gate.sinica.edu.tw	Ching, Ana T. C./J-4718-2015	Yang, An-Suei/0000-0002-4699-873X; Chang, Hung-Ju/0000-0003-2062-9212	National Health Research Institutes [NHRI-EX98-9802EI]; National Science Council [96-2311-B-001-030-MY3]; Genomics Research Center at Academia Sinica, Taipei, Taiwan	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Genomics Research Center at Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	This work was supported by National Health Research Institutes Grant NHRI-EX98-9802EI, National Science Council Grant 96-2311-B-001-030-MY3, and the Genomics Research Center at Academia Sinica, Taipei, Taiwan.	BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; BRINKMANN U, 1995, J IMMUNOL METHODS, V182, P41, DOI 10.1016/0022-1759(95)00016-4; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chang HJ, 2009, STRUCTURE, V17, P620, DOI 10.1016/j.str.2009.01.011; Chen CT, 2008, BIOINFORMATICS, V24, P2691, DOI 10.1093/bioinformatics/btn538; Clerico EM, 2008, BIOPOLYMERS, V90, P307, DOI 10.1002/bip.20856; DELANO WL, 2004, PHAGE DISPLAY, P85; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hsu HJ, 2008, J BIOL CHEM, V283, P12343, DOI 10.1074/jbc.M708843200; Hsu HJ, 2006, STRUCTURE, V14, P1499, DOI 10.1016/j.str.2006.08.006; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Jestin JL, 2001, RES MICROBIOL, V152, P187, DOI 10.1016/S0923-2508(01)01191-3; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Michnick SW, 2008, NAT CHEM BIOL, V4, P326, DOI 10.1038/nchembio0608-326; RAAG R, 1995, FASEB J, V9, P73, DOI 10.1096/fasebj.9.1.7821762; Rajagopal V, 1997, PROTEIN ENG, V10, P1453, DOI 10.1093/protein/10.12.1453; RAPOZA MP, 1993, J BACTERIOL, V175, P1856, DOI 10.1128/JB.175.6.1856-1859.1993; Reiter Y, 1995, PROTEIN ENG, V8, P1323, DOI 10.1093/protein/8.12.1323; Reiter Y, 1996, NAT BIOTECHNOL, V14, P1239, DOI 10.1038/nbt1096-1239; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Sidhu SS, 2004, PHAGE DISPLAY, V1st, P27; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; Thie H, 2008, NEW BIOTECHNOL, V25, P49, DOI 10.1016/j.nbt.2008.01.001; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Wark KL, 2006, ADV DRUG DELIVER REV, V58, P657, DOI 10.1016/j.addr.2006.01.025; Winter G, 1998, FEBS LETT, V430, P92, DOI 10.1016/S0014-5793(98)00628-0; Worn A, 1999, BIOCHEMISTRY-US, V38, P8739, DOI 10.1021/bi9902079; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; YOKOTA T, 1992, CANCER RES, V52, P3402; Young NM, 1995, FEBS LETT, V377, P135, DOI 10.1016/0014-5793(95)01325-3; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	47	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7880	7891		10.1074/jbc.M109.061457	http://dx.doi.org/10.1074/jbc.M109.061457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068035	hybrid, Green Published			2022-12-25	WOS:000275413800005
J	See, WL; Miller, JP; Squatrito, M; Holland, E; Resh, MD; Koff, A				See, W. L.; Miller, J. P.; Squatrito, M.; Holland, E.; Resh, M. D.; Koff, A.			Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas	ONCOGENE			English	Article						p27; tumor suppressor; DNA repair; glioma; mouse model	CYCLIN-DEPENDENT KINASES; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; TUMOR SUPPRESSION; NUCLEAR FOCI; FACTOR-B; P27(KIP1); P27; EXPRESSION; DAMAGE	The tumor suppressive activities of the Kip-family of cyclin-dependent kinase (cdk) inhibitors often go beyond their role directly regulating the cell cycle. In this study, we show that p27 enhances Rad51 accumulation during repair of double-strand DNA breaks. Progression of platelet-derived growth factor (PDGF)-induced oligodendrogliomas was accelerated in mice lacking the cyclin-cdk binding activities of p27(kip1). To understand how p27 deficiency contributes, cell lines were developed from RCAS-PDGF infection of nestin-tv-a brain progenitor cells in culture. p27 deficiency did not affect cell proliferation in early passage cell lines; however, the absence of p27 affected chromosomal stability. In p27-deficient cells, the activation of Atm and Chk2 and the accumulation of gamma-H2AX was unaffected when compared with wild-type cells, and the number of phospho-histone H3 staining mitotic cells was decreased, consistent with G2/M checkpoint activation. However, the percentage of Rad51 foci-positive cells was decreased, and the kinase activity that targets the C-terminus of BRCA2, regulating BRCA2/Rad51 interactions, was increased in lysates derived from p27-deficient cells. Increased numbers of chromatid breaks in p27-deficient cells that adapted to the checkpoint were also observed. These findings suggest that Rad51-dependent repair of double-stranded breaks was hindered in p27-deficient cells, leading to chromosomal instability, a hallmark of cancers with poor prognosis. Oncogene (2010) 29, 1720-1731; doi:10.1038/onc.2009.465; published online 11 January 2010	[See, W. L.; Resh, M. D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Miller, J. P.; Koff, A.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Squatrito, M.; Holland, E.] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, RRL917C,Box 207,1275 York Ave, New York, NY 10021 USA.	m-resh@ski.mskcc.org; a-koff@ski.mskcc.org	Squatrito, Massimo/F-4149-2016	Squatrito, Massimo/0000-0002-4593-3790; Resh, Marilyn/0000-0001-6118-9466; Koff, Andrew/0000-0003-3271-3067	US National Institutes of Health [CA96582, CA89563]; Golfers Against Cancer Foundation; Institutional Core Grant; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA096582, R01CA089563] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Golfers Against Cancer Foundation; Institutional Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Travis Stracker, John Petrini, Yossi Shiloh, Yuhui Liu, Nancy Yeh, Daniel Ciznadija, Dolores Hambardzumyan, Oren Becher, Elena Fomchenko, and Robert Finney, Katia Manova, Lei Zhang, Kalyani Chadalavada, Margaret Leversha, Jan Hendrix and Diane Domingo. This research was supported by the US National Institutes of Health Grant CA96582 (to MR, AK and EH), CA89563 (to AK) and funds from The Golfers Against Cancer Foundation (to AK). Additional support was provided by an Institutional Core Grant to Memorial Sloan-Kettering Cancer Center.	Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; Carneiro C, 2003, ONCOGENE, V22, P361, DOI 10.1038/sj.onc.1206163; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Cavalla P, 1999, ACTA NEUROPATHOL, V98, P629, DOI 10.1007/s004010051128; Chibazakura T, 2004, P NATL ACAD SCI USA, V101, P4465, DOI 10.1073/pnas.0400655101; Cipriano SC, 2001, MOL ENDOCRINOL, V15, P985, DOI 10.1210/me.15.6.985; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Di Rocco F, 1998, NEUROSURGERY, V42, P341, DOI 10.1097/00006123-199802000-00080; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 1997, J NEUROSCI, V17, P5046; Durand B, 1998, CURR BIOL, V8, P431, DOI 10.1016/S0960-9822(98)70177-0; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Foster ER, 2005, FEBS J, V272, P3231, DOI 10.1111/j.1742-4658.2005.04741.x; Gibbs E, 1996, J BIOL CHEM, V271, P22847, DOI 10.1074/jbc.271.37.22847; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Holland EC, 2001, CURR OPIN NEUROL, V14, P683, DOI 10.1097/00019052-200112000-00002; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Jin KL, 2003, EXP NEUROL, V184, P78, DOI 10.1016/S0014-4886(03)00133-X; Kamiya M, 2002, CLIN NEUROPATHOL, V21, P52; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Koff A, 2006, CANCER CELL, V9, P75, DOI 10.1016/j.ccr.2006.01.020; Korshunov A, 2002, J NEURO-ONCOL, V58, P237, DOI 10.1023/A:1016270101321; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Musgrove EA, 2004, J MAMMARY GLAND BIOL, V9, P55, DOI 10.1023/B:JOMG.0000023588.55733.84; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Park MS, 1999, P NATL ACAD SCI USA, V96, P6382, DOI 10.1073/pnas.96.11.6382; Payne SR, 2008, MOL CELL BIOL, V28, P258, DOI 10.1128/MCB.01536-07; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Powell SN, 2009, DNA REPAIR, V8, P1153, DOI 10.1016/j.dnarep.2009.04.011; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shaffer DR, 2005, P NATL ACAD SCI USA, V102, P210, DOI 10.1073/pnas.0407362102; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Uhrbom L, 2001, J NEURO-ONCOL, V53, P297, DOI 10.1023/A:1012208314436; Uhrbom L, 1998, CANCER RES, V58, P5275; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028	52	30	34	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1720	1731		10.1038/onc.2009.465	http://dx.doi.org/10.1038/onc.2009.465			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20062078	Bronze, Green Accepted			2022-12-25	WOS:000276022800002
J	Cardinaud, S; Starck, SR; Chandra, P; Shastri, N				Cardinaud, Sylvain; Starck, Shelley R.; Chandra, Piyanka; Shastri, Nilabh			The Synthesis of Truncated Polypeptides for Immune Surveillance and Viral Evasion	PLOS ONE			English	Article							MHC CLASS-I; EPSTEIN-BARR-VIRUS; ANTIGEN-PROCESSING PATHWAY; DEFECTIVE RIBOSOMAL PRODUCTS; T-CELL RECOGNITION; NUCLEAR ANTIGEN-1; ENDOGENOUS PRESENTATION; PROTEIN-DEGRADATION; GENE-EXPRESSION; GENERATION	Background: Cytotoxic T cells detect intracellular pathogens by surveying peptide loaded MHC class I molecules (pMHC I) on the cell surface. Effective immune surveillance also requires infected cells to present pMHC I promptly before viral progeny can escape. Rapid pMHC I presentation apparently occurs because infected cells can synthesize and present peptides from antigenic precursors called defective ribosomal products (DRiPs). The molecular characteristics of DRiPs are not known. Methodology/Principal Findings: Here, using a novel method for detecting antigenic precursors and proteolytic intermediates, we tracked the synthesis and processing of Epstein-Barr Virus encoded nuclear antigen 1 (EBNA1). We find that ribosomes initiated translation appropriately, but rapidly produced DRiPs representing similar to 120 amino acid truncated EBNA1 polypeptides by premature termination. Moreover, specific sequences in EBNA1 mRNA strongly inhibited the generation of truncated DRiPs and pMHC I presentation. Significance: Our results reveal the first characterization of virus DRiPs as truncated translation products. Furthermore, production of EBNA1-derived DRiPs is down-regulated in cells, possibly limiting the antigenicity of EBNA1.	[Cardinaud, Sylvain; Starck, Shelley R.; Chandra, Piyanka; Shastri, Nilabh] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Cardinaud, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	nshastri@berkeley.edu		CARDINAUD, Sylvain/0000-0002-2650-1108	National Institutes of Health [AI039548]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S. R. S. was supported in part by a National Institutes of Health training grant, a postdoctoral fellowship from the Cancer Research Institute and the NRSA fellowship from the National Institutes of Health. This research was supported by grant AI039548 from the National Institutes of Health to N. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apcher S, 2009, J VIROL, V83, P1289, DOI 10.1128/JVI.01369-08; Bennett NJ, 2005, PLOS BIOL, V3, P638, DOI 10.1371/journal.pbio.0030120; Cresswell P, 2005, IMMUNOL REV, V207, P5, DOI 10.1111/j.0105-2896.2005.00320.x; Cristillo AD, 2001, J THEOR BIOL, V208, P475, DOI 10.1006/jtbi.2000.2233; Daskalogianni C, 2008, J BIOL CHEM, V283, P30090, DOI 10.1074/jbc.M803290200; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gao JY, 2009, J VIROL, V83, P273, DOI 10.1128/JVI.01532-08; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goth S, 1996, J IMMUNOL, V157, P1894; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Lee SP, 2004, J EXP MED, V199, P1409, DOI 10.1084/jem.20040121; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; Tellam J, 2004, J EXP MED, V199, P1421, DOI 10.1084/jem.20040191; Tellam J, 2008, P NATL ACAD SCI USA, V105, P9319, DOI 10.1073/pnas.0801968105; Tellam J, 2007, J EXP MED, V204, P525, DOI 10.1084/jem.20062508; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Voo KS, 2004, J EXP MED, V199, P459, DOI 10.1084/jem.20031219; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zaldumbide A, 2007, MOL IMMUNOL, V44, P1352, DOI 10.1016/j.molimm.2006.05.012	43	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8692	10.1371/journal.pone.0008692	http://dx.doi.org/10.1371/journal.pone.0008692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098683	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779100002
J	Kleemann, R; van Erk, M; Verschuren, L; van den Hoek, AM; Koek, M; Wielinga, PY; Jie, A; Pellis, L; Bobeldijk-Pastorova, I; Kelder, T; Toet, K; Wopereis, S; Cnubben, N; Evelo, C; van Ommen, B; Kooistra, T				Kleemann, Robert; van Erk, Marjan; Verschuren, Lars; van den Hoek, Anita M.; Koek, Maud; Wielinga, Peter Y.; Jie, Annie; Pellis, Linette; Bobeldijk-Pastorova, Ivana; Kelder, Thomas; Toet, Karin; Wopereis, Suzan; Cnubben, Nicole; Evelo, Chris; van Ommen, Ben; Kooistra, Teake			Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MIGRATION INHIBITORY FACTOR; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION DATA; FATTY-ACIDS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; METABOLOMICS ANALYSIS; RECEPTOR ANTAGONIST; ABDOMINAL ANEURYSM	Background: The sequence of events leading to the development of insulin resistance (IR) as well as the underlying pathophysiological mechanisms are incompletely understood. As reductionist approaches have been largely unsuccessful in providing an understanding of the pathogenesis of IR, there is a need for an integrative, time-resolved approach to elucidate the development of the disease. Methodology/Principal Findings: Male ApoE3Leiden transgenic mice exhibiting a humanized lipid metabolism were fed a high-fat diet (HFD) for 0, 1, 6, 9, or 12 weeks. Development of IR was monitored in individual mice over time by performing glucose tolerance tests and measuring specific biomarkers in plasma, and hyperinsulinemic-euglycemic clamp analysis to assess IR in a tissue-specific manner. To elucidate the dynamics and tissue-specificity of metabolic and inflammatory processes key to IR development, a time-resolved systems analysis of gene expression and metabolite levels in liver, white adipose tissue (WAT), and muscle was performed. During HFD feeding, the mice became increasingly obese and showed a gradual increase in glucose intolerance. IR became first manifest in liver (week 6) and then in WAT (week 12), while skeletal muscle remained insulin-sensitive. Microarray analysis showed rapid upregulation of carbohydrate (only liver) and lipid metabolism genes (liver, WAT). Metabolomics revealed significant changes in the ratio of saturated to polyunsaturated fatty acids (liver, WAT, plasma) and in the concentrations of glucose, gluconeogenesis and Krebs cycle metabolites, and branched amino acids (liver). HFD evoked an early hepatic inflammatory response which then gradually declined to near baseline. By contrast, inflammation in WAT increased over time, reaching highest values in week 12. In skeletal muscle, carbohydrate metabolism, lipid metabolism, and inflammation was gradually suppressed with HFD. Conclusions/Significance: HFD-induced IR is a time- and tissue-dependent process that starts in liver and proceeds in WAT. IR development is paralleled by tissue-specific gene expression changes, metabolic adjustments, changes in lipid composition, and inflammatory responses in liver and WAT involving p65-NFkB and SOCS3. The alterations in skeletal muscle are largely opposite to those in liver and WAT.	[Kleemann, Robert; Verschuren, Lars; van den Hoek, Anita M.; Wielinga, Peter Y.; Jie, Annie; Toet, Karin; Kooistra, Teake] TNO, Leiden, Netherlands; [Kleemann, Robert; Verschuren, Lars] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands; [van Erk, Marjan; Koek, Maud; Pellis, Linette; Bobeldijk-Pastorova, Ivana; Wopereis, Suzan; Cnubben, Nicole; van Ommen, Ben] TNO, NL-3700 AJ Zeist, Netherlands; [Kleemann, Robert; Wielinga, Peter Y.; Toet, Karin] Top Inst Food & Nutr, Wageningen, Netherlands; [Kelder, Thomas; Evelo, Chris] Maastricht Univ, Dept Bioinformat, Maastricht, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Top Institute Food & Nutrition; Maastricht University	Kleemann, R (corresponding author), TNO, Leiden, Netherlands.	Robert.Kleemann@tno.nl	Evelo, Chris TA/D-2914-2009	Evelo, Chris TA/0000-0002-5301-3142	TNO; European Nutrigenomics Organisation (NuGO) [CT-2004-505944]; Top Institute Food and Nutrition	TNO; European Nutrigenomics Organisation (NuGO); Top Institute Food and Nutrition	This present study was mainly sponsored by the TNO research program Personalized Health (to R. K., M. v. E., L. V., N. C., A. J., I. B- P., M. K., L. P., B. v. O., and T. K.; animal work; transcriptomics; metabolomics). The authors gratefully acknowledge additional grant support from the European Nutrigenomics Organisation (NuGO, CT-2004-505944; Proof-of-Principle Study PPS1 to R. K., M. v. E., C. E., and T. K.) and from the Top Institute Food and Nutrition (SAA, fibrinogen, E-selectin, VCAM-1, vWF measurements; Top Institute Food and Nutrition work package A1004 to K. T., P. Y. W., and R. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussien H, 2007, AM J PATHOL, V170, P809, DOI 10.2353/ajpath.2007.060522; Baccini M, 2008, GENES NUTR, V3, P147, DOI 10.1007/s12263-008-0102-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobeldijk I, 2008, J CHROMATOGR B, V871, P306, DOI 10.1016/j.jchromb.2008.05.008; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carlsen H, 2009, GENES NUTR, V4, P215, DOI 10.1007/s12263-009-0133-6; CHISHOLM KW, 1987, J NUTR SCI VITAMINOL, V33, P377, DOI 10.3177/jnsv.33.377; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De Groot PJ, 2008, GENES NUTR, V3, P143, DOI 10.1007/s12263-008-0093-2; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Gervois P, 2004, J BIOL CHEM, V279, P16154, DOI 10.1074/jbc.M400346200; Guerra B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003466; Haslinger B, 2003, KIDNEY INT, V63, P2065, DOI 10.1046/j.1523-1755.2003.t01-2-00004.x; Herder C, 2008, DIABETOLOGIA, V51, P276, DOI 10.1007/s00125-007-0800-3; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kato K, 1999, BIOCHEM BIOPH RES CO, V258, P431, DOI 10.1006/bbrc.1999.0648; Kawaguchi T, 2008, INT J MOL MED, V22, P105; Kleemann R, 2003, BLOOD, V101, P545, DOI 10.1182/blood-2002-06-1762; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Koek MM, 2008, J CHROMATOGR A, V1186, P420, DOI 10.1016/j.chroma.2007.11.107; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Montecucco F, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/767623; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Pettinella C, 2007, J CHROMATOGR B, V850, P168, DOI 10.1016/j.jchromb.2006.11.023; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rein D, 2006, J NUTR, V136, P2331, DOI 10.1093/jn/136.9.2331; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Singh U, 2004, CLIN SCI, V106, P421, DOI 10.1042/CS20030375; Somm E, 2006, DIABETOLOGIA, V49, P387, DOI 10.1007/s00125-005-0046-x; Steinberg GR, 2006, J CLIN ENDOCR METAB, V91, P3592, DOI 10.1210/jc.2006-0638; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Warensjo E, 2006, AM J CLIN NUTR, V84, P442; Wu Y, 2005, BRIT J PHARMACOL, V146, P234, DOI 10.1038/sj.bjp.0706306; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391; Zhou YE, 2009, METABOLISM, V58, P158, DOI 10.1016/j.metabol.2008.09.008	58	114	116	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8817	10.1371/journal.pone.0008817	http://dx.doi.org/10.1371/journal.pone.0008817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098690	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100010
J	Scolamacchia, F; Handel, IG; Fevre, EM; Morgan, KL; Tanya, VN; Bronsvoort, BMD				Scolamacchia, Francesca; Handel, Ian G.; Fevre, Eric M.; Morgan, Kenton L.; Tanya, Vincent N.; Bronsvoort, Barend M. de C.			Serological Patterns of Brucellosis, Leptospirosis and Q Fever in Bos indicus Cattle in Cameroon	PLOS ONE			English	Article							COXIELLA-BURNETII; RISK-FACTORS; BOVINE BRUCELLOSIS; CENTRAL-AFRICA; DAIRY-CATTLE; ANTIBODIES; PREVALENCE; INFECTION; LIVESTOCK; SEROPREVALENCE	Brucellosis, leptospirosis and Q fever are important infections of livestock causing a range of clinical conditions including abortions and reduced fertility. In addition, they are all important zoonotic infections infecting those who work with livestock and those who consume livestock related products such as milk, producing non-specific symptoms including fever, that are often misdiagnosed and that can lead to severe chronic disease. This study used banked sera from the Adamawa Region of Cameroon to investigate the seroprevalences and distributions of seropositive animals and herds. A classical statistical and a multi-level prevalence modelling approach were compared. The unbiased estimates were similar to 20% of herds were seropositive for Brucella spp. compared to similar to 95% for Leptospira spp. and similar to 68% for Q fever. The within-herd seroprevalences were similar to 16%, similar to 35% and similar to 39% respectively. There was statistical evidence of clustering of seropositive brucellosis and Q fever herds. The modelling approach has the major advantage that estimates of seroprevalence can be adjusted for the sensitivity and specificity of the diagnostic test used and the multi-level structure of the sampling. The study found a low seroprevalence of brucellosis in the Adamawa Region compared to a high proportion of leptospirosis and Q fever seropositive herds. This represents a high risk to the human population as well as potentially having a major impact on animal health and productivity in the region.	[Scolamacchia, Francesca; Handel, Ian G.; Bronsvoort, Barend M. de C.] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Roslin Bioctr, Roslin, Midlothian, Scotland; [Fevre, Eric M.] Univ Edinburgh, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Morgan, Kenton L.] Univ Liverpool, Dept Vet Clin Sci, Leahurst Vet Teaching Hosp, Wirral L64 7TE, Merseyside, England; [Tanya, Vincent N.] Minist Sci Res & Innovat, Yaounde, Cameroon	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Liverpool	Scolamacchia, F (corresponding author), Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Roslin Bioctr, Roslin, Midlothian, Scotland.	mark.bronsvoort@ed.ac.uk		Bronsvoort, Mark/0000-0002-3271-8485; Fevre, Eric/0000-0001-8931-4986	Wellcome Trust [053840, 085308]; DEFRA/SHEFC VTRI [VT101]; BBSRC [338BDD RA0762]	Wellcome Trust(Wellcome TrustEuropean Commission); DEFRA/SHEFC VTRI(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Dr Bronsvoort would like to thank the Wellcome Trust, grant no. 053840, for funding the original research project in Cameroon, DEFRA/SHEFC VTRI, grant no. VT101, for the MSc studentship for F. Scolamacchia and two summer studentships for B. Koterwas and F. Land who helped test the sera. Eric Fevre is funded by the Wellcome Trust grant no. 085308 and Ian Handel is funded by the BBSRC Programme Grant No. 338BDD RA0762. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoel T, 2008, VET MICROBIOL, V130, P312, DOI 10.1016/j.vetmic.2008.01.009; Abdoel TH, 2007, DIAGN MICR INFEC DIS, V57, P123, DOI 10.1016/j.diagmicrobio.2006.08.017; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Bertherat E, 1999, AM J TROP MED HYG, V60, P610, DOI 10.4269/ajtmh.1999.60.610; Bildfell RJ, 2000, J VET DIAGN INVEST, V12, P419, DOI 10.1177/104063870001200505; BORNAREL P, 1987, REV MED VET-TOULOUSE, V138, P55; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Bronsvoort BMD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005221; Bronsvoort BMD, 2003, TROP ANIM HEALTH PRO, V35, P491, DOI 10.1023/A:1027302525301; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; CACCIAPUOTI B, 1982, T ROY SOC TROP MED H, V76, P178, DOI 10.1016/0035-9203(82)90270-X; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; CUZICK J, 1990, J ROY STAT SOC B MET, V52, P73; DOMENECH J, 1980, REV ELEV MED VET PAY, V33, P277; DOMENECH J, 1982, REV ELEV MED VET PAY, V35, P15; ELLIS WA, 1986, VET REC, V118, P63, DOI 10.1136/vr.118.3.63; FERESU SB, 1992, VET REC, V130, P446, DOI 10.1136/vr.130.20.446; FERESU SB, 1987, TROP ANIM HEALTH PRO, V19, P209, DOI 10.1007/BF02242118; GHIROTTI M, 1991, VET RES COMMUN, V15, P25, DOI 10.1007/BF00497787; Greiner M, 2000, PREV VET MED, V45, P43, DOI 10.1016/S0167-5877(00)00116-1; Guatteo R, 2006, VET RES, V37, P827, DOI 10.1051/vetres:2006038; GUMMOW B, 1987, ONDERSTEPOORT J VET, V54, P569; HANSON LE, 1982, J AM VET MED ASSOC, V181, P278; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; HUNTER P, 2004, INFECT DIS LIVESTOCK, V3, pCH136; Jordan D, 1998, PREV VET MED, V36, P187, DOI 10.1016/S0167-5877(98)00087-7; KELLY PJ, 1993, S AFR MED J, V83, P21; KELLY PJ, 2004, INFECT DIS LIVESTOCK, V1, pCH43; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lloyd-Smith JO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-125; Lohr S.L., 1999, SAMPLING DESIGN ANAL; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Muma JB, 2006, TROP ANIM HEALTH PRO, V38, P195, DOI 10.1007/s11250-006-4320-9; MYBURGH JG, 1989, ONDERSTEPOORT J VET, V56, P285; Nakoune E, 2004, ACTA TROP, V92, P147, DOI 10.1016/j.actatropica.2004.06.007; NIANG M, 1994, PREV VET MED, V18, P259, DOI 10.1016/0167-5877(94)90050-7; Nicoletti P, 2002, VET MICROBIOL, V90, P5, DOI 10.1016/S0378-1135(02)00209-2; Omer MK, 2000, EPIDEMIOL INFECT, V125, P447, DOI 10.1017/S0950268899004501; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Plummer M, 2009, RJAGS BAYESIAN GRAPH; Potts AD, 1995, ONDERSTEPOORT J VET, V62, P281; Rodolakis A, 2007, J DAIRY SCI, V90, P5352, DOI 10.3168/jds.2006-815; SAMARTINO LE, 1993, COMP IMMUNOL MICROB, V16, P95, DOI 10.1016/0147-9571(93)90001-L; SANKALE M, 1976, African Journal of Medicine and Medical Sciences, V5, P213; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Schelling E, 2007, EMERG INFECT DIS, V13, P373, DOI 10.3201/eid1303.060391; Shey-Njila O., 2005, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V58, P139; Sofian M, 2008, INT J INFECT DIS, V12, P157, DOI 10.1016/j.ijid.2007.04.019; Stack JA, 1999, VET REC, V145, P735, DOI 10.1136/vr.145.25.735; STALEY GP, 1989, ONDERSTEPOORT J VET, V56, P205; Steinmann P, 2005, TROP MED INT HEALTH, V10, P612, DOI 10.1111/j.1365-3156.2005.01420.x; Swai ES, 2009, ZOONOSES PUBLIC HLTH, V56, P183, DOI 10.1111/j.1863-2378.2008.01175.x; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Weinhaupl I, 2000, TROP ANIM HEALTH PRO, V32, P147, DOI 10.1023/A:1005231514467; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001; Yan KT, 1999, VET MICROBIOL, V69, P173, DOI 10.1016/S0378-1135(99)00103-0	59	38	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8623	10.1371/journal.pone.0008623	http://dx.doi.org/10.1371/journal.pone.0008623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098670	Green Published, gold			2022-12-25	WOS:000273779100001
J	Glattard, E; Welters, ID; Lavaux, T; Muller, AH; Laux, A; Zhang, D; Schmidt, AR; Delalande, F; Laventie, BJ; Dirrig-Grosch, S; Colin, DA; Van Dorsselaer, A; Aunis, D; Metz-Boutigue, MH; Schneider, F; Goumon, Y				Glattard, Elise; Welters, Ingeborg D.; Lavaux, Thomas; Muller, Arnaud H.; Laux, Alexis; Zhang, Dan; Schmidt, Alexander R.; Delalande, Francois; Laventie, Benoit-Joseph; Dirrig-Grosch, Sylvie; Colin, Didier A.; Van Dorsselaer, Alain; Aunis, Dominique; Metz-Boutigue, Marie-Helene; Schneider, Francis; Goumon, Yannick			Endogenous Morphine Levels Are Increased in Sepsis: A Partial Implication of Neutrophils	PLOS ONE			English	Article							MU-OPIOID-RECEPTOR; WHITE BLOOD-CELLS; PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; OPIATE RECEPTOR; NITRIC-OXIDE; SPLICE VARIANTS; SEPTIC SHOCK; SYNTHESIZE MORPHINE; INDUCED SUPPRESSION	Background: Mammalian cells synthesize morphine and the respective biosynthetic pathway has been elucidated. Human neutrophils release this alkaloid into the media after exposure to morphine precursors. However, the exact role of endogenous morphine in inflammatory processes remains unclear. We postulate that morphine is released during infection and can be determined in the serum of patients with severe infection such as sepsis. Methodology: The presence and subcellular immunolocalization of endogenous morphine was investigated by ELISA, mass spectrometry analysis and laser confocal microscopy. Neutrophils were activated with Interleukin-8 (IL-8) or lipopolysaccharide (LPS). Morphine secretion was determined by a morphine-specific ELISA. m opioid receptor expression was assessed with flow cytometry. Serum morphine concentrations of septic patients were determined with a morphine-specific ELISA and morphine identity was confirmed in human neutrophils and serum of septic patients by mass spectrometry analysis. The effects of the concentration of morphine found in serum of septic patients on LPS-induced release of IL-8 by human neutrophils were tested. Principal Findings: We confirmed the presence of morphine in human neutrophil extracts and showed its colocalisation with lactoferrin within the secondary granules of neutrophils. Morphine secretion was quantified in the supernatant of activated human polymorphonuclear neutrophils in the presence and absence of Ca2+. LPS and IL-8 were able to induce a significant release of morphine only in presence of Ca2+. LPS treatment increased m opioid receptor expression on neutrophils. Low concentration of morphine (8 nM) significantly inhibited the release of IL-8 from neutrophils when coincubated with LPS. This effect was reversed by naloxone. Patients with sepsis, severe sepsis and septic shock had significant higher circulating morphine levels compared to patients with systemic inflammatory response syndrome and healthy controls. Mass spectrometry analysis showed that endogenous morphine from serum of patient with sepsis was identical to poppy-derived morphine. Conclusions: Our results indicate that morphine concentrations are increased significantly in the serum of patients with systemic infection and that morphine is, at least in part, secreted from neutrophils during sepsis. Morphine concentrations equivalent to those found in the serum of septic patients significantly inhibited LPS-induced IL-8 secretion in neutrophils.	[Glattard, Elise; Lavaux, Thomas; Muller, Arnaud H.; Laux, Alexis; Zhang, Dan; Delalande, Francois; Dirrig-Grosch, Sylvie; Aunis, Dominique; Metz-Boutigue, Marie-Helene; Goumon, Yannick] Univ Strasbourg, Physiopathol Syst Nerveux & Nocicept & Pain Dept, Inst Neurosci Cellulaires & Integrat, CNRS,INSERM,U575, Strasbourg, France; [Welters, Ingeborg D.] Univ Liverpool, Sch Clin Sci, Crit Care Res Unit, Liverpool L69 3BX, Merseyside, England; [Lavaux, Thomas; Schneider, Francis] Hop Univ, Serv Reanimat Med, Strasbourg, France; [Lavaux, Thomas; Schneider, Francis] Univ Strasbourg, Hop Hautepierre, Fac Med, Strasbourg, France; [Laventie, Benoit-Joseph; Colin, Didier A.] Univ Strasbourg, Inst Bacteriol, Lab Physiopathol Interact Hote Bacterie, EA3432, Strasbourg, France; [Welters, Ingeborg D.; Schmidt, Alexander R.] Univ Klinikum Giessen & Marburg, Abt Anaesthesiol Intens Med & Schmerztherapie, Giessen, Germany; [Van Dorsselaer, Alain] CNRS, UMR7178, ULP, Lab Spectrometrie Masse BioOrgan,IPHC DSA, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Liverpool; CHU Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University Hospital of Giessen & Marburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Glattard, E (corresponding author), Univ Strasbourg, Physiopathol Syst Nerveux & Nocicept & Pain Dept, Inst Neurosci Cellulaires & Integrat, CNRS,INSERM,U575, Strasbourg, France.	Ingeborg.D.Welters@chiru.med.uni-giessen.de	LAVENTIE, Benoît-Joseph/H-5260-2011; Dominique, Aunis/W-1419-2019	LAVENTIE, Benoît-Joseph/0000-0003-0205-0944; Delalande, Francois/0000-0003-3590-9874; , Elise/0000-0002-4501-9675; Laux-Biehlmann, Alexis/0000-0003-0508-3047; Goumon, Yannick/0000-0003-4336-3437; Welters, Ingeborg/0000-0002-3408-8798	Inserm; Universite de Strasbourg; Fondation de France; French Ministere de la Recherche et de l'Enseignement Superieur; Fondation Transplantation; Fondation pour la Recherche Medicale	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; Fondation de France(Fondation de France); French Ministere de la Recherche et de l'Enseignement Superieur; Fondation Transplantation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This study was funded by Inserm, the Universite de Strasbourg, the Fondation de France (to Y.G.), the French Ministere de la Recherche et de l'Enseignement Superieur (Ph.D. fellowships to E.G., A.M. and A.L.), the Fondation Transplantation (to Y.G., D.Z., and D.A.) and the Fondation pour la Recherche Medicale (to Y.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Atmanene C, 2009, MED SCI MONITOR, V15, pBR178; Beck M, 2002, PAIN, V98, P187, DOI 10.1016/S0304-3959(02)00044-1; Boettcher C, 2006, J IMMUNOL, V176, P5703, DOI 10.4049/jimmunol.176.10.5703; Boettcher C, 2005, P NATL ACAD SCI USA, V102, P8495, DOI 10.1073/pnas.0503244102; Brix-Christensen V, 2000, ACTA ANAESTH SCAND, V44, P1204, DOI 10.1034/j.1399-6576.2000.441004.x; Brix-Christensen V, 1997, INT J CARDIOL, V62, P191, DOI 10.1016/S0167-5273(97)00229-5; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; BRYANT HU, 1991, ENDOCRINOLOGY, V128, P3253, DOI 10.1210/endo-128-6-3253; BUSSIERE JL, 1993, J PHARMACOL EXP THER, V264, P591; Cadet P, 2003, J IMMUNOL, V170, P5118, DOI 10.4049/jimmunol.170.10.5118; Cadet P, 2004, MED SCI MONITOR, V10, pBR351; Cadet P, 2004, MED SCI MONITOR, V10, pMS28; Cadet P, 2000, ENDOTHELIUM-J ENDOTH, V7, P185, DOI 10.3109/10623320009165316; Cadet P, 2007, J IMMUNOL, V179, P5839, DOI 10.4049/jimmunol.179.9.5839; CASSATELLA MA, 1992, J IMMUNOL, V148, P3216; Chang SLL, 2001, ADV EXP MED BIOL, V493, P187; Choi HS, 2006, BIOCHEM BIOPH RES CO, V343, P1132, DOI 10.1016/j.bbrc.2006.03.084; Doyle GA, 2007, GENE, V395, P98, DOI 10.1016/j.gene.2007.02.004; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fecho K, 2002, INFLAMMATION, V26, P259, DOI 10.1023/A:1021408500630; FECHO K, 1995, J PHARMACOL EXP THER, V272, P477; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; FLORES LR, 1995, J PHARMACOL EXP THER, V272, P1246; Gaveriaux-Ruff C, 1998, P NATL ACAD SCI USA, V95, P6326, DOI 10.1073/pnas.95.11.6326; Gein S V, 2009, Neurosci Behav Physiol, V39, P591, DOI 10.1007/s11055-009-9166-y; GINTZLER AR, 1978, SCIENCE, V199, P447, DOI 10.1126/science.339350; GOLDSTEIN A, 1985, P NATL ACAD SCI USA, V82, P5203, DOI 10.1073/pnas.82.15.5203; Gomez-Flores R, 1999, J INTERF CYTOK RES, V19, P625, DOI 10.1089/107999099313767; Goumon Y, 2000, NEUROSCI LETT, V293, P135, DOI 10.1016/S0304-3940(00)01507-X; Goumon Y, 2000, MOL BRAIN RES, V77, P267, DOI 10.1016/S0169-328X(00)00056-5; Goumon Y, 2006, J BIOL CHEM, V281, P8082, DOI 10.1074/jbc.M502298200; Goumon Y, 2004, J BIOL CHEM, V279, P13054, DOI 10.1074/jbc.M308533200; Goumon Y, 2000, MOL BRAIN RES, V81, P177, DOI 10.1016/S0169-328X(00)00141-8; Goumon Y, 2009, AN REAL ACAD NAC F, V75, P389; Hedou G, 2000, J COMP NEUROL, V426, P549, DOI 10.1002/1096-9861(20001030)426:4<549::AID-CNE4>3.0.CO;2-Y; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; KOIVURANTAVAARA P, 1987, INFECT IMMUN, V55, P2956, DOI 10.1128/IAI.55.12.2956-2961.1987; Lauriat S, 1998, SEMIN NEPHROL, V18, P498; Legrand D, 2005, CELL MOL LIFE SCI, V62, P2549, DOI 10.1007/s00018-005-5370-2; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; LOPKER A, 1980, BIOCHEM PHARMACOL, V29, P1361, DOI 10.1016/0006-2952(80)90431-1; Lotsch J, 2001, CLIN PHARMACOKINET, V40, P485; LOVSTAD RZ, 1996, CLIN INTENSIVE CARE, V7, P282; Magazine HI, 2000, J IMMUNOL, V165, P102, DOI 10.4049/jimmunol.165.1.102; Magazine HI, 1996, J IMMUNOL, V156, P4845; MAKMAN MH, 1995, J IMMUNOL, V154, P1323; Makman MH, 1998, ADV EXP MED BIOL, V437, P137; Matejec R, 2009, SHOCK, V31, P553, DOI 10.1097/SHK.0b013e318188dfb8; McCourt M, 2001, EUR J SURG ONCOL, V27, P396, DOI 10.1053/ejso.2001.1133; Meijerink WJHJ, 1999, SHOCK, V12, P165, DOI 10.1097/00024382-199909000-00001; Molina PE, 2002, CLIN EXP PHARMACOL P, V29, P248, DOI 10.1046/j.1440-1681.2002.03638.x; MOLINA PE, 1995, BIOCHEM BIOPH RES CO, V207, P312, DOI 10.1006/bbrc.1995.1189; Muller A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001641; Neri C, 2008, J NEUROCHEM, V106, P2337, DOI 10.1111/j.1471-4159.2008.05572.x; Ocana MG, 2008, MOL IMMUNOL, V45, P2087, DOI 10.1016/j.molimm.2007.10.013; Olszyna DP, 2001, INFECT IMMUN, V69, P2736, DOI 10.1128/IAI.69.4.2736-2738.2001; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pan YX, 2005, MOL PHARMACOL, V68, P866, DOI 10.1124/mol.105.011858; Pasternak GW, 2007, J CLIN INVEST, V117, P3185, DOI 10.1172/JCI34035; Pellme S, 2006, J LEUKOCYTE BIOL, V79, P564, DOI 10.1189/jlb.0505248; PETERS WP, 1981, LANCET, V1, P529; Poeaknapo C, 2004, P NATL ACAD SCI USA, V101, P14091, DOI 10.1073/pnas.0405430101; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittner HL, 2007, BRAIN BEHAV IMMUN, V21, P1021, DOI 10.1016/j.bbi.2007.05.002; Roy S, 1999, J NEUROIMMUNOL, V95, P107, DOI 10.1016/S0165-5728(98)00265-3; Roy S, 1998, ADV EXP MED BIOL, V437, P21; ROZENFELD R, 2007, FASEB J; Sabroe I, 2004, BIOCHEM SOC T, V32, P468, DOI 10.1042/BST0320468; Stefano GB, 2000, TRENDS NEUROSCI, V23, P436, DOI 10.1016/S0166-2236(00)01611-8; Stefano GB, 2008, NEUROCHEM RES, V33, P1933, DOI 10.1007/s11064-008-9674-0; Stefano GB, 2007, INT J MOL MED, V20, P837; STERNBERG EM, 1992, ANN INTERN MED, V117, P854, DOI 10.7326/0003-4819-117-10-854; Suzuki S, 2000, BIOCHEM BIOPH RES CO, V279, P621, DOI 10.1006/bbrc.2000.4006; Tsiotou AG, 2005, MED SCI MONITOR, V11, pRA76; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; Vassou D, 2008, INT IMMUNOPHARMACOL, V8, P634, DOI 10.1016/j.intimp.2008.01.002; WEITZ CJ, 1986, P NATL ACAD SCI USA, V83, P9784, DOI 10.1073/pnas.83.24.9784; WEITZ CJ, 1987, NATURE, V330, P674, DOI 10.1038/330674a0; Welters ID, 2007, EUR J ANAESTH, V24, P958, DOI 10.1017/S026502150700083X; Welters ID, 2000, ANESTHESIOLOGY, V92, P1677, DOI 10.1097/00000542-200006000-00027; Welters ID, 2003, CURR OPIN ANESTHESIO, V16, P509, DOI 10.1097/00001503-200310000-00011; Yokota T, 2000, CAN J ANAESTH, V47, P303, DOI 10.1007/BF03020942; Yoshida S, 2000, SURG ENDOSC-ULTRAS, V14, P137, DOI 10.1007/s004649900085; Zhu W, 2007, INT J IMMUNOPATH PH, V20, P229, DOI 10.1177/039463200702000203; Zhu W, 2005, J IMMUNOL, V175, P7357, DOI 10.4049/jimmunol.175.11.7357; Zhu W, 2006, MED SCI MONITOR, V12, pBR350	91	54	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8791	10.1371/journal.pone.0008791	http://dx.doi.org/10.1371/journal.pone.0008791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098709	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000019
J	Fernandez-Marcos, PJ; Pantoja, C; Gonzalez-Rodriguez, A; Martin, N; Flores, JM; Valverde, AM; Hara, E; Serrano, M				Fernandez-Marcos, Pablo J.; Pantoja, Cristina; Gonzalez-Rodriguez, Agueda; Martin, Nicholas; Flores, Juana M.; Valverde, Angela M.; Hara, Eiji; Serrano, Manuel			Normal Proliferation and Tumorigenesis but Impaired Pancreatic Function in Mice Lacking the Cell Cycle Regulator Sei1	PLOS ONE			English	Article							MURINE FIBROBLASTS LACKING; CDK INHIBITORS; BETA-CELL; TRIP-BR; P27(KIP1); ACTIVATION; P34(SEI-1); FAMILY; GROWTH; CANCER	Sei1 is a positive regulator of proliferation that promotes the assembly of Cdk4-cyclin D complexes and enhances the transcriptional activity of E2f1. The potential oncogenic role of Sei1 is further suggested by its overexpression in various types of human cancers. To study the role of Sei1, we have generated a mouse line deficient for this gene. Sei1-null fibroblasts did not show abnormalities regarding proliferation or susceptibility to neoplastic transformation, nor did we observe defects on Cdk4 complexes or E2f activity. Sei1-null mice were viable, did not present overt pathologies, had a normal lifespan, and had a normal susceptibility to spontaneous and chemically-induced cancer. Pancreatic insulin-producing cells are known to be particularly sensitive to Cdk4-cyclin D and E2f activities, and we have observed that Sei1 is highly expressed in pancreatic islets compared to other tissues. Interestingly, Sei1-null mice present lower number of islets, decreased beta-cell area, impaired insulin secretion, and glucose intolerance. These defects were associated to nuclear accumulation of the cell-cycle inhibitors p21(Cip1) and p27(Kip1) in islet cells. We conclude that Sei1 plays an important role in pancreatic beta-cells, which supports a functional link between Sei1 and the core cell cycle regulators specifically in the context of the pancreas.	[Fernandez-Marcos, Pablo J.; Pantoja, Cristina; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid, Spain; [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] UAM, CSIC, Inst Biomed Alberto Sols, Madrid, Spain; [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] ISCIII, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Martin, Nicholas; Hara, Eiji] Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan; [Flores, Juana M.] Univ Complutense Madrid, Dept Anim Surg & Med, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Japanese Foundation for Cancer Research; Complutense University of Madrid	Fernandez-Marcos, PJ (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid, Spain.	mserrano@cnio.es	González-Rodróguez, Águeda/D-7651-2012; Serrano, Manuel/H-2634-2015; Fernandez, Pablo J/F-1840-2016	González-Rodróguez, Águeda/0000-0001-6559-0847; Serrano, Manuel/0000-0001-7177-9312; Fernandez, Pablo J/0000-0003-3515-4125; Gonzalez-Rodriguez, Agueda/0000-0003-2851-2318; Pantoja, Cristina/0000-0003-0180-5823	Centro Nacional de Investigaciones Oncologicas (CNIO); Spanish Ministry of Science; Regional Government of Madrid; European Union; European Research Council (ERC); "Marcelino Botin" Foundation [BFU2008- 02420]; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	Centro Nacional de Investigaciones Oncologicas (CNIO); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); "Marcelino Botin" Foundation; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	Work in the laboratory of M. S. is funded by the Centro Nacional de Investigaciones Oncologicas (CNIO) and by grants from the Spanish Ministry of Science (SAF and CONSOLIDER), the Regional Government of Madrid (GsSTEM), the European Union (PROTEOMAGE), the European Research Council (ERC), and the "Marcelino Botin'' Foundation. Work in the laboratory of A. M. V. was funded by the Ministry of Science (BFU2008- 02420) and by the Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Hong SW, 2009, CANCER RES, V69, P741, DOI 10.1158/0008-5472.CAN-08-1189; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Jones N C, 1990, Semin Cancer Biol, V1, P425; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lai IL, 2007, GENE, V388, P102, DOI 10.1016/j.gene.2006.10.008; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Li FX, 2003, P NATL ACAD SCI USA, V100, P12935, DOI 10.1073/pnas.2231861100; Li JN, 2005, BIOCHEMISTRY-US, V44, P13246, DOI 10.1021/bi0504658; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; Olashaw N, 2004, CELL CYCLE, V3, P263; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Rachdi L, 2006, DIABETES, V55, P3520, DOI 10.2337/db06-0861; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Sugimoto M, 1999, GENE DEV, V13, P3027, DOI 10.1101/gad.13.22.3027; Sugimoto M, 2002, ONCOGENE, V21, P8067, DOI 10.1038/sj.onc.1206019; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Suzuki M, 1997, DIABETES, V46, P1440, DOI 10.2337/diabetes.46.9.1440; Tang DJ, 2005, CANCER RES, V65, P6504, DOI 10.1158/0008-5472.CAN-05-0351; Tang TCM, 2002, CANCER RES, V62, P7157; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; van Dekken H, 2001, AM J PATHOL, V158, P1961, DOI 10.1016/S0002-9440(10)64666-4; Zhong LW, 2007, J CLIN INVEST, V117, P2869, DOI 10.1172/JCI32198	32	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8744	10.1371/journal.pone.0008744	http://dx.doi.org/10.1371/journal.pone.0008744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090907	Green Published, gold, Green Submitted			2022-12-25	WOS:000273715000005
J	Lebesgue, D; Traub, M; De Butte-Smith, M; Chen, C; Zukin, RS; Kelly, MJ; Etgen, AM				Lebesgue, Diane; Traub, Michael; De Butte-Smith, Maxine; Chen, Christopher; Zukin, R. Suzanne; Kelly, Martin J.; Etgen, Anne M.			Acute Administration of Non-Classical Estrogen Receptor Agonists Attenuates Ischemia-Induced Hippocampal Neuron Loss in Middle-Aged Female Rats	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; GLOBAL-ISCHEMIA; G-PROTEIN; POSTMENOPAUSAL WOMEN; EXPERIMENTAL STROKE; MEMBRANE-RECEPTOR; BREAST-CANCER; CA1 NEURONS; CELL-DEATH; ESTRADIOL	Background: Pretreatment with 17 beta-estradiol (E2) is profoundly neuroprotective in young animals subjected to focal and global ischemia. However, whether E2 retains its neuroprotective efficacy in aging animals, especially when administered after brain insult, is largely unknown. Methodology/Principal Findings: We examined the neuroprotective effects of E2 and two agonists that bind to non-classical estrogen receptors, G1 and STX, when administered after ischemia in middle-aged rats after prolonged ovarian hormone withdrawal. Eight weeks after ovariectomy, middle-aged female rats underwent 10 minutes of global ischemia by four vessel occlusion. Immediately after reperfusion, animals received a single infusion of either E2 (2.25 mu g), G1 (50 mu g) or STX (50 mu g) into the lateral ventricle (ICV) or a single systemic injection of E2 (100 mu g/kg). Surviving pyramidal neurons in the hippocampal CA1 were quantified 1 week later. E2 and both agonists that target non-classical estrogen receptors (G1 and STX) administered ICV at the time of reperfusion provided significant levels of neuroprotection, with 55-60% of CA1 neurons surviving vs 15% survival in controls. A single systemic injection of a pharmacological dose of E2 also rescued approximately 50% of CA1 pyramidal neurons destined to die. To determine if E2 and G1 have similar mechanisms of action in hippocampal neurons, we compared the ability of E2 and G1 to modify CA1 pyramidal neuron responses to excitatory inputs from the Schaffer collaterals recorded in hippocampal slices derived from female rats not subjected to global ischemia. E2 and G1 (10 nM) significantly potentiated pyramidal neuron responses to excitatory inputs when applied to hippocampal slices. Conclusions/Significance: These findings suggest (1) that middle-aged female rats retain their responsiveness to E2 even after a long period of hormone withdrawal, (2) that non-classical estrogen receptors may mediate the neuroprotective actions of E2 when given after ischemia, and (3) that the neuroprotective efficacy of estrogens may be related to their modulation of synaptic activity in hippocampal slices.	[Lebesgue, Diane; De Butte-Smith, Maxine; Chen, Christopher; Zukin, R. Suzanne; Etgen, Anne M.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Traub, Michael] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Kelly, Martin J.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Oregon Health & Science University	Lebesgue, D (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	anne.etgen@einstein.yu.edu			NIH [R37 MH41414, RO1 AG027702]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH041414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants R37 MH41414 and RO1 AG027702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI F, 1993, BRAIN RES, V603, P87, DOI 10.1016/0006-8993(93)91302-9; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Barrera-Ocampo AA, 2008, REV NEUROLOGIA, V46, P32, DOI 10.33588/rn.4601.2007094; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Brown CM, 2009, SEMIN REPROD MED, V27, P240, DOI 10.1055/s-0029-1216277; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; De Butte-Smith M, 2009, HORM BEHAV, V55, P442, DOI 10.1016/j.yhbeh.2008.11.011; DONCARLOS LL, 2009, PSYCHONEURO IN PRESS; Dubal DB, 2001, ENDOCRINOLOGY, V142, P43, DOI 10.1210/en.142.1.43; Farr TD, 2008, J NEUROENDOCRINOL, V20, P366, DOI 10.1111/j.1365-2826.2008.01648.x; Fugger HN, 2001, NEUROSCI LETT, V309, P207, DOI 10.1016/S0304-3940(01)02083-3; Gulinello M, 2006, HORM BEHAV, V49, P246, DOI 10.1016/j.yhbeh.2005.07.010; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; Jordan VC, 2007, STEROIDS, V72, P7, DOI 10.1016/j.steroids.2006.10.009; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Kim MT, 2006, NEUROSCIENCE, V141, P391, DOI 10.1016/j.neuroscience.2006.03.075; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Liang HW, 2008, NEUROSCI LETT, V438, P116, DOI 10.1016/j.neulet.2008.04.058; Lin ZC, 2009, J CHIN SOC MECH ENG, V30, P1; Liu R, 2007, NEUROSCI LETT, V415, P237, DOI 10.1016/j.neulet.2007.01.074; Lobo RA, 2007, CLIMACTERIC, V10, P27, DOI 10.1080/13697130701550903; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; Otto C, 2009, BIOL REPROD, V80, P34, DOI 10.1095/biolreprod.108.071175; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Plahta WC, 2004, NEUROSCIENCE, V129, P187, DOI 10.1016/j.neuroscience.2004.07.037; Prossnitz ER, 2009, PROSTAG OTH LIPID M, V89, P89, DOI 10.1016/j.prostaglandins.2009.05.001; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Qiu J, 2003, J NEUROSCI, V23, P9529; Qiu J, 2008, STEROIDS, V73, P985, DOI 10.1016/j.steroids.2007.11.008; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Saleh TM, 2001, AM J PHYSIOL-REG I, V281, pR1531, DOI 10.1152/ajpregu.2001.281.5.R1531; SELVAMANI A, 2008, NEUROBIOL A IN PRESS; Simpkins JW, 2005, ANN NY ACAD SCI, V1052, P233, DOI 10.1196/annals.1347.019; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Strom JO, 2009, J CEREBR BLOOD F MET, V29, P1359, DOI 10.1038/jcbfm.2009.66; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tobias SC, 2006, CHEMMEDCHEM, V1, P565, DOI 10.1002/cmdc.200500098; Toung TJ, 2004, J CEREBR BLOOD F MET, V24, P1160, DOI 10.1097/01.WCB.0000135594.13576.D2; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Traub ML, 2009, J NEUROENDOCRINOL, V21, P1038, DOI 10.1111/j.1365-2826.2009.01927.x; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; WONG M, 1992, J NEUROSCI, V12, P3217, DOI 10.1523/JNEUROSCI.12-08-03217.1992; Wren BG, 2009, MED J AUSTRALIA, V190, P321, DOI 10.5694/j.1326-5377.2009.tb02423.x; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Zhang HQ, 2009, BRAIN RES, V1247, P196, DOI 10.1016/j.brainres.2008.10.015; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015	53	116	120	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8642	10.1371/journal.pone.0008642	http://dx.doi.org/10.1371/journal.pone.0008642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062809	Green Submitted, gold, Green Published			2022-12-25	WOS:000273414200019
J	Price, LB; Liu, CM; Johnson, KE; Aziz, M; Lau, MK; Bowers, J; Ravel, J; Keim, PS; Serwadda, D; Wawer, MJ; Gray, RH				Price, Lance B.; Liu, Cindy M.; Johnson, Kristine E.; Aziz, Maliha; Lau, Matthew K.; Bowers, Jolene; Ravel, Jacques; Keim, Paul S.; Serwadda, David; Wawer, Maria J.; Gray, Ronald H.			The Effects of Circumcision on the Penis Microbiome	PLOS ONE			English	Article							HIV-1 TARGET-CELLS; LANGERHANS-CELLS; PSEUDOMONAS-AERUGINOSA; INFECTION; TRANSMISSION; BACTERIA; MEN; SUSCEPTIBILITY; COMMUNITIES; PREVENTION	Background: Circumcision is associated with significant reductions in HIV, HSV-2 and HPV infections among men and significant reductions in bacterial vaginosis among their female partners. Methodology/Principal Findings: We assessed the penile (coronal sulci) microbiota in 12 HIV-negative Ugandan men before and after circumcision. Microbiota were characterized using sequence-tagged 16S rRNA gene pyrosequencing targeting the V3-V4 hypervariable regions. Taxonomic classification was performed using the RDP Naive Bayesian Classifier. Among the 42 unique bacterial families identified, Pseudomonadaceae and Oxalobactericeae were the most abundant irrespective of circumcision status. Circumcision was associated with a significant change in the overall microbiota (PerMANOVA p = 0.007) and with a significant decrease in putative anaerobic bacterial families (Wilcoxon Signed-Rank test p = 0.014). Specifically, two families-Clostridiales Family XI (p = 0.006) and Prevotellaceae (p = 0.006)-were uniquely abundant before circumcision. Within these families we identified a number of anaerobic genera previously associated with bacterial vaginosis including: Anaerococcus spp., Finegoldia spp., Peptoniphilus spp., and Prevotella spp. Conclusions/Significance: The anoxic microenvironment of the subpreputial space may support pro-inflammatory anaerobes that can activate Langerhans cells to present HIV to CD4 cells in draining lymph nodes. Thus, the reduction in putative anaerobic bacteria after circumcision may play a role in protection from HIV and other sexually transmitted diseases.	[Price, Lance B.; Liu, Cindy M.; Aziz, Maliha; Bowers, Jolene; Keim, Paul S.] Translat Genom Res Inst TGen, Flagstaff, AZ USA; [Liu, Cindy M.; Lau, Matthew K.; Keim, Paul S.] No Arizona Univ, Flagstaff, AZ 86011 USA; [Johnson, Kristine E.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Wawer, Maria J.; Gray, Ronald H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Translational Genomics Research Institute; Northern Arizona University; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Price, LB (corresponding author), Translat Genom Res Inst TGen, Flagstaff, AZ USA.	lprice@tgen.org	Rohlf, F J/A-8710-2008; Ravel, Jacques/D-2530-2009; Liu, Cindy/ABF-7427-2020; Keim, Paul S/A-2269-2010	Ravel, Jacques/0000-0002-0851-2233	National Institutes of Allergy and Infectious Disease (NIAID) [UO1AI11171-01-02]; Division of AIDS; Translational Genomics Research Institute (TGen)	National Institutes of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Translational Genomics Research Institute (TGen)	This project was funded with a grant (UO1AI11171-01-02) from the National Institutes of Allergy and Infectious Disease (NIAID), Division of AIDS, National Institutes of Health and with funding from the Translational Genomics Research Institute (TGen). TGen is a 501(C)(3) non-profit research institute. TGen funds were provided as part of Dr. Price's institutional start-up package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2007, REPROD HEALTH MATTER, V15, P11; [Anonymous], 2007, LABDSV ORDINATION MU; Aroutcheva A, 2008, ANAEROBE, V14, P256, DOI 10.1016/j.anaerobe.2008.08.002; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blanc DS, 2004, INTENS CARE MED, V30, P1964, DOI 10.1007/s00134-004-2389-z; Bostanci N, 2007, ORAL MICROBIOL IMMUN, V22, P52; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Chow E. D., 2007, ELLIPSE FUNCTIONS DR; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crivaro V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-70; de Jong MAWP, 2009, J INTERN MED, V265, P18, DOI 10.1111/j.1365-2796.2008.02046.x; de Jong MAWP, 2008, J CLIN INVEST, V118, P3440, DOI 10.1172/JCI34721; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Franco-Vidal V, 2007, OTOL NEUROTOL, V28, P771, DOI 10.1097/MAO.0b013e31805153bd; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Goslee SC, 2005, J TORREY BOT SOC, V132, P471, DOI 10.3159/1095-5674(2005)132[471:IOEHAV]2.0.CO;2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guggenheim M, 2009, BURNS, V35, P553, DOI 10.1016/j.burns.2008.09.004; Hazlett Linda D, 2007, Chem Immunol Allergy, V92, P185, DOI 10.1159/000099269; HOLMES C, 2009, AM J INFECT CONTROL; Kawamura T, 2005, J DERMATOL SCI, V40, P147, DOI 10.1016/j.jdermsci.2005.08.009; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Kikkert R, 2007, ORAL MICROBIOL IMMUN, V22, P145, DOI 10.1111/j.1399-302X.2007.00335.x; Kim SJ, 2007, FEMS IMMUNOL MED MIC, V51, P407, DOI 10.1111/j.1574-695X.2007.00318.x; Kindt R., 2005, WORLD; LAU MK, 2009, DIVERSITYSAMPLER FUN; Mahiane SG, 2009, AIDS, V23, P377, DOI 10.1097/QAD.0b013e32831c5497; MAULDIN PD, 2009, ANTIMICROB AGENTS CH; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; Mena KD, 2009, REV ENVIRON CONTAM T, V201, P71, DOI 10.1007/978-1-4419-0032-6_3; MESTECKY J, 2009, J REPROD IMMUNOL; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Ogawa Y, 2009, BLOOD, V113, P5157, DOI 10.1182/blood-2008-10-185728; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Paiardini M, 2008, AIDS REV, V10, P36; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Peiser M, 2008, J LEUKOCYTE BIOL, V83, P1118, DOI 10.1189/jlb.0807567; PEIX A, 2009, INFECT GENET EVOL; Price LB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006462; R Development Core Team, 2009, R FDN STAT COMP; Sanchez-Carrillo C, 2009, AM J INFECT CONTROL, V37, P150, DOI 10.1016/j.ajic.2008.04.259; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Song YL, 2007, J CLIN MICROBIOL, V45, P1746, DOI 10.1128/JCM.00213-07; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Trautmann M, 2008, AM J INFECT CONTROL, V36, P421, DOI 10.1016/j.ajic.2007.09.012; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	66	160	168	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8422	10.1371/journal.pone.0008422	http://dx.doi.org/10.1371/journal.pone.0008422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066050	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338600003
J	Noorbakhsh, F; Ramachandran, R; Barsby, N; Ellestad, KK; LeBlanc, A; Dickie, P; Baker, G; Hollenberg, MD; Cohen, EA; Power, C				Noorbakhsh, Farshid; Ramachandran, Rithwik; Barsby, Nicola; Ellestad, Kristofor K.; LeBlanc, Andrea; Dickie, Peter; Baker, Glen; Hollenberg, Morley D.; Cohen, Eric A.; Power, Christopher			MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival	FASEB JOURNAL			English	Article						cell death; HIV encephalitis; caspases; microRNA; viral protein R	CENTRAL-NERVOUS-SYSTEM; AMINO-ACID OXIDASE; TRANSGENIC MICE; NEURONAL DEATH; D-SERINE; APOPTOSIS; EXPRESSION; VPR; ACTIVATION; TAT	MicroRNAs (miRNAs) are small noncoding RNA molecules, which are known to regulate gene expression in physiological and pathological conditions. miRNA profiling was performed using brain tissue from patients with HIV encephalitis (HIVE), a neuroinflammatory/degenerative disorder caused by HIV infection of the brain. Microarray analysis showed differential expression of multiple miRNAs in HIVE compared to control brains. Target prediction and gene ontology enrichment analysis disclosed targeting of several gene families/biological processes by differentially expressed miRNAs (DEMs), with cell death-related genes, including caspase-6, showing a bias toward down-regulated DEMs. Consistent with the miRNA data, HIVE brains exhibited higher levels of caspase-6 transcripts compared with control patients. Immunohistochemical analysis showed localization of the cleaved form of caspase-6 in astrocytes in HIVE brain sections. Exposure of cultured human primary astrocytes to HIV viral protein R (Vpr) induced p53 up-regulation, loss of mitochondrial membrane potential, and caspase-6 activation followed by cell injury. Transgenic mice, expressing Vpr in microglial cells, demonstrated astrocyte apoptosis in brain, which was associated with caspase-6 activation and neurobehavioral abnormalities. Overall, these data point to previously unrecognized alterations in miRNA profile in the brain during HIV infection, which contribute to cell death through dysregulation of cell death machinery.-Noorbakhsh, F., Ramachandran, R., Barsby, N., Ellestad, K. K., LeBlanc, A., Dickie, P., Baker, G., Hollenberg, M. D., Cohen, E. A., Power, C. MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J. 24, 1799-1812 (2010). www.fasebj.org	[Power, Christopher] Univ Alberta, Dept Med Neurol, Heritage Med Res Ctr 6 11, Edmonton, AB T6G 2S2, Canada; [Barsby, Nicola; Dickie, Peter] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Baker, Glen; Power, Christopher] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2S2, Canada; [Ramachandran, Rithwik; Hollenberg, Morley D.] Univ Calgary, Dept Pharmacol & Expt Therapeut, Calgary, AB, Canada; [LeBlanc, Andrea] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Cohen, Eric A.] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada	University of Alberta; University of Alberta; University of Alberta; University of Calgary; Lady Davis Institute; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Power, C (corresponding author), Univ Alberta, Dept Med Neurol, Heritage Med Res Ctr 6 11, Edmonton, AB T6G 2S2, Canada.	chris.power@ualberta.ca	Hollenberg, Morley/AFV-6966-2022; Ramachandran, Rithwik/N-7815-2015; Power, Christopher/C-7181-2013	Ramachandran, Rithwik/0000-0001-9557-9905; Power, Christopher/0000-0002-5131-9711	Canadian Institutes for Health Research (CIHR); Alberta Heritage Foundation for Medical Research (AHFMR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	The authors thank Leah DeBlock for assistance with manuscript preparation. The expert technical assistance of Gail Rauw is greatly appreciated. F.N. is supported by Canadian Institutes for Health Research (CIHR) and Alberta Heritage Foundation for Medical Research (AHFMR) fellowships. E. A. C., C. P., and G. B. hold Canada Research Chairs (Tier 1) in Retrovirology, Neurological Infection and Immunity, and Neurochemistry and Drug Development, respectively. C. P. is an AHFMR Senior Scholar. These studies were supported by the CIHR.	Al-Ani B, 1999, BRIT J PHARMACOL, V128, P1105, DOI 10.1038/sj.bjp.0702834; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen JL, 2005, CURR HIV RES, V3, P43, DOI 10.2174/1570162052772988; Bansal AK, 2000, BRAIN RES, V879, P42, DOI 10.1016/S0006-8993(00)02725-6; Berglund CMD, 2004, J NEUROSCI RES, V78, P580, DOI 10.1002/jnr.20273; BERRADA F, 1995, J VIROL, V69, P6770, DOI 10.1128/JVI.69.11.6770-6778.1995; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; Dickie P, 2004, VIROLOGY, V322, P69, DOI 10.1016/j.virol.2004.01.026; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; Garden GA, 2004, FASEB J, V18, P1141, DOI 10.1096/fj.04-1676fje; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Grant SL, 2006, J CHROMATOGR B, V844, P278, DOI 10.1016/j.jchromb.2006.07.022; Gray F, 2001, CLIN NEUROPATHOL, V20, P146; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hayes DJ, 2009, BEHAV BRAIN RES, V197, P323, DOI 10.1016/j.bbr.2008.08.034; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Kitayama H, 2008, J VIROL, V82, P2528, DOI 10.1128/JVI.02094-07; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Noorbakhsh F, 2009, TRENDS NEUROSCI, V32, P88, DOI 10.1016/j.tins.2008.10.003; Park HK, 2006, J BIOCHEM, V139, P295, DOI 10.1093/jb/mvj036; Pomerantz RJ, 2004, DNA CELL BIOL, V23, P227, DOI 10.1089/104454904773819815; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Sabri F, 2003, BRAIN PATHOL, V13, P84, DOI 10.1111/j.1750-3639.2003.tb00009.x; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Singh IN, 2004, J NEUROVIROL, V10, P141, DOI 10.1080/13550280490441103; Thompson KA, 2001, ANN NEUROL, V49, P745, DOI 10.1002/ana.1011; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Urai Y, 2002, NEUROSCI LETT, V324, P101, DOI 10.1016/S0304-3940(02)00184-2; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Wesselingh SL, 2001, CURR OPIN NEUROL, V14, P375, DOI 10.1097/00019052-200106000-00018; Zhang N, 2000, J NEUROSURG, V93, P6, DOI 10.3171/jns.2000.93.supplement_3.0006; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819	52	67	70	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1799	1812		10.1096/fj.09-147819	http://dx.doi.org/10.1096/fj.09-147819			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20097875				2022-12-25	WOS:000278200000017
J	Arlehamn, CSL; Petrilli, V; Gross, O; Tschopp, J; Evans, TJ				Arlehamn, Cecilia S. Lindestam; Petrilli, Virginie; Gross, Olaf; Tschopp, Juerg; Evans, Tom J.			The Role of Potassium in Inflammasome Activation by Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; PSEUDOMONAS-AERUGINOSA; NALP3 INFLAMMASOME; CASPASE-1 ACTIVATION; GENE FAMILY; CELL-DEATH; IPAF; IDENTIFICATION; SECRETION; RECEPTOR	Many Gram-negative bacteria possess a type III secretion system (TTSS center dot) that can activate the NLRC4 inflammasome, process caspase-1 and lead to secretion of mature IL-1 beta. This is dependent on the presence of intracellular flagellin. Previous reports have suggested that this activation is independent of extracellular K+ and not accompanied by leakage of K+ from the cell, in contrast to activation of the NLRP3 inflammasome. However, non-flagellated strains of Pseudomonas aeruginosa are able to activate NLRC4, suggesting that formation of a pore in the cell membrane by the TTSS apparatus may be sufficient for inflammasome activation. Thus, we set out to determine if extracellular K+ influenced P. aeruginosa inflammasome activation. We found that raising extracellular K+ prevented TTSS NLRC4 activation by the non-flagellated P. aeruginosa strain PA103 Delta U Delta T at concentrations above 90mM, higher than those reported to inhibit NLRP3 activation. Infection was accompanied by efflux of K+ from a minority of cells as determined using the K+-sensitive fluorophore PBFI, but no formation of a leaky pore. We obtained exactly the same results following infection with Salmonella typhimurium, previously described as independent of extracellular K+. The inhibitory effect of raised extracellular K+ on NLRC4 activation thus reflects a requirement for a decrease in intracellular K+ for this inflammasome component as well as that described for NLRP3.	[Arlehamn, Cecilia S. Lindestam; Evans, Tom J.] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Petrilli, Virginie; Gross, Olaf; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Glasgow; University of Lausanne	Evans, TJ (corresponding author), Glasgow Biomed Res Ctr, Level 4,120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	t.evans@clinmed.gla.ac.uk	Gross, Olaf/E-4570-2010; Petrilli, Virginie/ABI-8199-2020	Gross, Olaf/0000-0001-8660-3619; Petrilli, Virginie/0000-0001-8502-6979; Lindestam Arlehamn, Cecilia/0000-0001-7302-8002	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Arora SK, 2000, INFECT IMMUN, V68, P1474, DOI 10.1128/IAI.68.3.1474-1479.2000; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brodsky IE, 2009, SEMIN IMMUNOL, V21, P199, DOI 10.1016/j.smim.2009.05.007; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Evans TJ, 2009, FUTURE MICROBIOL, V4, P65, DOI 10.2217/17460913.4.1.65; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; FROM WWW, THOMSON; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jacob T, 2002, INFECT IMMUN, V70, P6399, DOI 10.1128/IAI.70.11.6399-6408.2002; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McGuffie EM, 1998, INFECT IMMUN, V66, P2607, DOI 10.1128/IAI.66.6.2607-2613.1998; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; MINTA A, 1989, J BIOL CHEM, V264, P8171; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stirling FR, 2006, CELL MICROBIOL, V8, P1294, DOI 10.1111/j.1462-5822.2006.00710.x; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	43	78	86	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10508	10518		10.1074/jbc.M109.067298	http://dx.doi.org/10.1074/jbc.M109.067298			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20097760	hybrid, Green Published			2022-12-25	WOS:000276264600037
J	Yamasaki, N; Miyazaki, K; Nagamachi, A; Koller, R; Oda, H; Miyazaki, M; Sasaki, T; Honda, Z; Wolff, L; Inaba, T; Honda, H				Yamasaki, N.; Miyazaki, K.; Nagamachi, A.; Koller, R.; Oda, H.; Miyazaki, M.; Sasaki, T.; Honda, Z-i; Wolff, L.; Inaba, T.; Honda, H.			Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia	ONCOGENE			English	Article						E2A-HLF; inducible knock-in mice; retrovirus insertional mutagenesis; Zfp521/ZNF521	RETROVIRAL INSERTIONAL MUTAGENESIS; DOWNSTREAM TARGET; CELL DEVELOPMENT; BLAST CRISIS; E2A GENE; EXPRESSION; TRANSFORMATION; MYC; DIFFERENTIATION; LYMPHOMAGENESIS	E2A-hepatic leukemia factor (HLF) is a chimeric protein found B-lineage acute lymphoblastic leukemia (ALL) with t(17;19). To analyze the leukemogenic process and to create model mice for t(17;19)-positive leukemia, we generated inducible knock-in (iKI) mice for E2A-HLF. Despite the induced expression of E2A-HLF in the hematopoietic tissues, no disease was developed during the long observation period, indicating that additional gene alterations are required to develop leukemia. To elucidate this process, E2A-HLF iKI and control littermates were subjected to retroviral insertional mutagenesis. Virus infection induced acute leukemias in E2A-HLF iKI mice with higher morbidity and mortality than in control mice. Inverse PCR detected three common integration sites specific for E2A-HLF iKI leukemic mice, which induced overexpression of zinc-finger transcription factors: growth factor independent 1 (Gfi1), zinc-finger protein subfamily 1A1 isoform a (Zfp1a1, also known as Ikaros) and zinc-finger protein 521 (Zfp521). Interestingly, tumors with Zfp521 integration exclusively showed B-lineage ALL, which corresponds to the phenotype of human t(17;19)-positive leukemia. In addition, ZNF521 (human counterpart of Zfp521) was found to be over-expressed in human leukemic cell lines harboring t(17;19). Moreover, both iKI for E2A-HLF and transgenic for Zfp521 mice frequently developed B-lineage ALL. These results indicate that a set of transcription factors promote leukemic transformation of E2A-HLF-expressing hematopoietic progenitors and suggest that aberrant expression of Zfp521/ZNF521 may be clinically relevant to t(17;19)positive B-lineage ALL. Oncogene (2010) 29, 1963-1975; doi:10.1038/onc.2009.475; published online 11 January 2010	[Yamasaki, N.; Miyazaki, K.; Sasaki, T.; Honda, H.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dev Biol, Minami Ku, Hiroshima 7348553, Japan; [Nagamachi, A.; Inaba, T.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Minami Ku, Hiroshima 7348553, Japan; [Koller, R.; Wolff, L.] NCI, Leukemogenosis Sect, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Oda, H.] Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo, Japan; [Miyazaki, M.] Hiroshima Univ, Grad Sch Biomed Sci, Dept Immunol, Minami Ku, Hiroshima 7348553, Japan; [Honda, Z-i] Univ Tokyo, Grad Sch Med, Fac Med, Dept Allergy & Rheumatol,Bunkyo Ku, Tokyo, Japan	Hiroshima University; Hiroshima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tokyo Women's Medical University; Hiroshima University; University of Tokyo	Honda, H (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dev Biol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	hhonda@hiroshima-u.ac.jp			Ministry of Education, Science and Culture of Japan; Ministry of Health, Labour and Welfare of Japan [13-2]; Takeda Science Foundation; Astellas Foundation	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation(Astellas Pharmaceuticals)	We thank Yuki Sakai, Kayoko Hashimoto, Yuko Tsukawaki and Rika Tai, for the care of the mice and technical assistance, Dr Nobuaki Yoshida for E14 ES cells, Dr Soren Warming, Dr Neal G Copeland and Dr Nancy A Jenkins for mouse Zfp521 cDNA, Dr Koichi Ikuta for mouse TCRJb probe, Dr Hirotaka Matsui for statistical analysis and Dr Takuro Nakamura for helpful discussion. This work was in part supported by a grant-in-aid from the Ministry of Education, Science and Culture of Japan, a grant-in-aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (13-2), Takeda Science Foundation, Astellas Foundation for Research on Metabolic Disorders, the Japan Leukaemia Research Fund and Tsuchiya Foundation.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Aspland SE, 2001, ONCOGENE, V20, P5708, DOI 10.1038/sj.onc.1204592; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Dang JJ, 2001, MOL CELL BIOL, V21, P5935, DOI 10.1128/MCB.21.17.5935-5945.2001; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Hentges KE, 2005, ONCOGENE, V24, P1220, DOI 10.1038/sj.onc.1208243; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Honda H, 1999, BLOOD, V93, P2780; HONDA H, 1995, BLOOD, V85, P2853, DOI 10.1182/blood.V85.10.2853.bloodjournal85102853; Hunger SP, 1996, BLOOD, V87, P1211, DOI 10.1182/blood.V87.4.1211.bloodjournal8741211; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Inaba T, 1996, NATURE, V382, P541, DOI 10.1038/382541a0; Inukai T, 1997, MOL CELL BIOL, V17, P1417, DOI 10.1128/MCB.17.3.1417; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kurosawa H, 1999, BLOOD, V93, P321, DOI 10.1182/blood.V93.1.321.401k05_321_332; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Matsunaga T, 2004, BLOOD, V103, P3185, DOI 10.1182/blood-2003-09-3022; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Miyazaki K, 2009, BLOOD, V113, P4702, DOI 10.1182/blood-2007-05-088724; Mizuno T, 2008, ONCOGENE, V27, P3465, DOI 10.1038/sj.onc.1211007; Nakamura T, 2005, CANCER SCI, V96, P7, DOI 10.1111/j.1349-7006.2005.00011.x; Nakayama H, 1999, CANCER RES, V59, P3931; ROSENBAUM H, 1990, EMBO J, V9, P897, DOI 10.1002/j.1460-2075.1990.tb08187.x; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; Seidel MG, 2001, ONCOGENE, V20, P5718, DOI 10.1038/sj.onc.1204591; SHINTO Y, 1995, ONCOGENE, V11, P1729; Smith KS, 2002, MOL CELL BIOL, V22, P7678, DOI 10.1128/MCB.22.21.7678-7688.2002; Smith KS, 1999, MOL CELL BIOL, V19, P4443; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Wolff L, 2003, ONCOGENE, V22, P9265, DOI 10.1038/sj.onc.1207092; Wolff L, 2003, J VIROL, V77, P4965, DOI 10.1128/JVI.77.8.4965-4971.2003; Yamashita N, 2005, BRIT J HAEMATOL, V131, P495, DOI 10.1111/j.1365-2141.2005.05793.x; YOSHIHARA T, 1995, MOL CELL BIOL, V15, P3247; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zornig M, 1996, ONCOGENE, V12, P1789	43	30	31	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	13					1963	1975		10.1038/onc.2009.475	http://dx.doi.org/10.1038/onc.2009.475			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20062079				2022-12-25	WOS:000276199600009
J	Fujimori, K; Ueno, T; Nagata, N; Kashiwagi, K; Aritake, K; Amano, F; Urade, Y				Fujimori, Ko; Ueno, Toshiyuki; Nagata, Nanae; Kashiwagi, Kaori; Aritake, Kosuke; Amano, Fumio; Urade, Yoshihiro			Suppression of Adipocyte Differentiation by Aldo-keto Reductase 1B3 Acting as Prostaglandin F-2 alpha Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; BOVINE LUNG; F SYNTHASE; PREADIPOCYTE DIFFERENTIATION; PROSTANOID RECEPTORS; SIGNALING PATHWAY; E-2 BIOSYNTHESIS; GENE-EXPRESSION; 3T3-L1 CELLS; SUPERFAMILY	Prostaglandin (PG) F-2 alpha suppresses adipocyte differentiation by inhibiting the function of peroxisome proliferator-activated receptor gamma. However, PGF(2 alpha) synthase (PGFS) in adipocytes remains to be identified. Here, we studied the expression of members of the aldo-keto reductase (AKR) 1B family acting as PGFS during adipogenesis of mouse 3T3-L1 cells. AKR1B3 mRNA was expressed in preadipocytes, and its level increased about 4-fold at day 1 after initiation of adipocyte differentiation, and then quickly decreased the following day to a level lower than that in the preadipocytes. In contrast, the mRNA levels of Akr1b8 and 1b10 were clearly lower than that level of Akr1b3 in preadipocytes and remained unchanged during adipogenesis. The transient increase in Akr1b3 during adipogenesis was also observed by Western blot analysis. The mRNA for the FP receptor, which is selective for PGF(2 alpha), was also expressed in preadipocytes. Its level increased about 2-fold within 1 h after the initiation of adipocyte differentiation and was maintained at almost the same level throughout adipocyte differentiation. The small interfering RNA for Akr1b3, but not for Akr1b8 or 1b10, suppressed PGF(2 alpha) production and enhanced the expression of adipogenic genes such as peroxisome proliferator-activated receptor gamma, fatty acid-binding protein 4 (aP2), and stearoyl-CoA desaturase. Moreover, an FP receptor agonist, Fluprostenol, suppressed the expression of those adipogenic genes in 3T3-L1 cells; whereas an FP receptor antagonist, AL-8810, efficiently inhibited the suppression of adipogenesis caused by the endogenous PGF(2 alpha). These results indicate that AKR1B3 acts as the PGFS in adipocytes and that AKR1B3-produced PGF(2 alpha) suppressed adipocyte differentiation by acting through FP receptors.	[Fujimori, Ko; Ueno, Toshiyuki; Amano, Fumio] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Osaka 5691094, Japan; [Nagata, Nanae; Kashiwagi, Kaori; Aritake, Kosuke; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan	Osaka University of Pharmaceutical Sciences	Fujimori, K (corresponding author), Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, 4-20-1 Nasahara, Osaka 5691094, Japan.	fujimori@gly.oups.ac.jp	Fujimori, Ko/AAD-5428-2021	Fujimori, Ko/0000-0002-2506-0769	Ministry of Education, Culture, Sports, Science and Technology of Japan; Research for Promoting Technological Seeds from Japan Science and Technology Agency; Suzuken Memorial Foundation; Sumitomo Foundation; Gushinkai Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research for Promoting Technological Seeds from Japan Science and Technology Agency; Suzuken Memorial Foundation; Sumitomo Foundation; Gushinkai Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. F. and K. A.) and by grants from the Research for Promoting Technological Seeds from Japan Science and Technology Agency, the Suzuken Memorial Foundation, the Sumitomo Foundation, the Gushinkai Foundation (to K. F.), and the Takeda Science Foundation (to K. F. and Y. U.).	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Casimir DA, 1996, DIFFERENTIATION, V60, P203, DOI 10.1046/j.1432-0436.1996.6040203.x; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fujimori K, 2005, J BIOL CHEM, V280, P18452, DOI 10.1074/jbc.M411755200; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujino H, 2001, J BIOL CHEM, V276, P12489, DOI 10.1074/jbc.C100039200; Griffin BW, 1999, J PHARMACOL EXP THER, V290, P1278; Hayaishi O, 1988, Prog Clin Biol Res, V274, P577; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 1997, BIOCHEM PHARMACOL, V54, P639, DOI 10.1016/S0006-2952(97)84253-0; Kabututu Z, 2009, J BIOCHEM, V145, P161, DOI 10.1093/jb/mvn152; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kubata BK, 2000, J EXP MED, V192, P1327, DOI 10.1084/jem.192.9.1327; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Lambert-Langlais S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007309; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Madore E, 2003, J BIOL CHEM, V278, P11205, DOI 10.1074/jbc.M208318200; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; Moriuchi H, 2008, J BIOL CHEM, V283, P792, DOI 10.1074/jbc.M705638200; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakashima K, 2003, BBA-MOL CELL BIOL L, V1633, P96, DOI 10.1016/S1388-1981(03)00092-1; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Pierce KL, 1999, J BIOL CHEM, V274, P35944, DOI 10.1074/jbc.274.50.35944; Serrero G, 1997, BIOCHEM BIOPH RES CO, V233, P200, DOI 10.1006/bbrc.1997.6433; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Svensson PA, 2008, CELL MOL BIOL LETT, V13, P599, DOI 10.2478/s11658-008-0025-6; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tirard J, 2007, ENDOCRINOLOGY, V148, P1996, DOI 10.1210/en.2006-1707; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; WATANABE K, 1986, P NATL ACAD SCI USA, V83, P1583, DOI 10.1073/pnas.83.6.1583; WATANABE K, 1985, J BIOL CHEM, V260, P7035; WATANABE K, 1988, P NATL ACAD SCI USA, V85, P11, DOI 10.1073/pnas.85.1.11; WATANABE T, 1994, J BIOL CHEM, V269, P17619	38	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8880	8886		10.1074/jbc.M109.077164	http://dx.doi.org/10.1074/jbc.M109.077164			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093363	Green Published, hybrid			2022-12-25	WOS:000275553700039
J	Chowdhury, G; Calcutt, MW; Guengerich, FP				Chowdhury, Goutam; Calcutt, M. Wade; Guengerich, F. Peter			Oxidation of N-Nitrosoalkylamines by Human Cytochrome P450 2A6 SEQUENTIAL OXIDATION TO ALDEHYDES AND CARBOXYLIC ACIDS AND ANALYSIS OF REACTION STEPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL CYTOCHROME-P-450; NUCLEAR-MAGNETIC-RESONANCE; HIV-1 REVERSE-TRANSCRIPTASE; ELECTRON-TRANSFER; IN-VIVO; METABOLIC-ACTIVATION; SUCCESSIVE REACTIONS; ALIPHATIC-ALDEHYDES; KINETIC-ANALYSIS; RAT-LIVER	Cytochrome P450 (P450) 2A6 activates nitrosamines, including N,N-dimethylnitrosamine (DMN) and N,N-diethylnitrosamine (DEN), to alkyl diazohydroxides (which are DNA-alkylating agents) and also aldehydes (HCHO from DMN and CH3CHO from DEN). The N-dealkylation of DMN had a high intrinsic kinetic deuterium isotope effect ((D)k(app) similar to 10), which was highly expressed in a variety of competitive and non-competitive experiments. The (D)k(app) for DEN was similar to 3 and not expressed in non-competitive experiments. DMN and DEN were also oxidized to HCO2H and CH3CO2H, respectively. In neither case was a lag observed, which was unexpected considering the k(cat) and K-m parameters measured for oxidation of DMN and DEN to the aldehydes and for oxidation of the aldehydes to the carboxylic acids. Spectral analysis did not indicate strong affinity of the aldehydes for P450 2A6, but pulse-chase experiments showed only limited exchange with added (unlabeled) aldehydes in the oxidations of DMN and DEN to carboxylic acids. Substoichiometric kinetic bursts were observed in the pre-steady-state oxidations of DMN and DEN to aldehydes. A minimal kinetic model was developed that was consistent with all of the observed phenomena and involves a conformational change of P450 2A6 following substrate binding, equilibrium of the P450-substrate complex with a non-productive form, and oxidation of the aldehydes to carboxylic acids in a process that avoids relaxation of the conformation following the first oxidation (i.e. of DMN or DEN to an aldehyde).	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R37 CA090426, T32 ES007028, F32 ES012123, P30 ES000267]; Merck fellowship; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267, F32ES012123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426 and T32 ES007028 (to M. W. C.), F32 ES012123 (to M. W. C.), and P30 ES000267 (to G. C.). This work was also supported by a Merck fellowship (to G.C.)	BARTSCH H, 1990, MUTAT RES, V238, P255, DOI 10.1016/0165-1110(90)90017-6; Bell LC, 1997, J BIOL CHEM, V272, P29643, DOI 10.1074/jbc.272.47.29643; Bell R., 1966, ADV PHYS ORG CHEM, V4, P1, DOI DOI 10.1016/S0065-3160(08)60351-2; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; Carey F. A., 1990, ADV ORGANIC CHEM A, P683; COOK PF, 1993, BIOCHEMISTRY-US, V32, P1795, DOI 10.1021/bi00058a013; CRESPI CL, 1990, CARCINOGENESIS, V11, P1293, DOI 10.1093/carcin/11.8.1293; Fersht A., 1999, STRUCTURE MECH PROTE, P98; FISHMAN J, 1982, CANCER RES, V42, P3277; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; GREENZAID P, 1967, J AM CHEM SOC, V89, P756, DOI 10.1021/ja00980a005; GREENZAID P, 1967, J AM CHEM SOC, V89, P749, DOI 10.1021/ja00980a004; GROGAN J, 1993, BIOCHEMISTRY-US, V32, P12007, DOI 10.1021/bi00096a010; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 1996, J BIOL CHEM, V271, P27321, DOI 10.1074/jbc.271.44.27321; GUENGERICH FP, 1984, J AM CHEM SOC, V106, P6446, DOI 10.1021/ja00333a071; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HANZLIK RP, 1985, J AM CHEM SOC, V107, P7164, DOI 10.1021/ja00310a066; HANZLIK RP, 1993, J AM CHEM SOC, V115, P9363, DOI 10.1021/ja00074a001; Harrelson JP, 2008, BIOCHEMISTRY-US, V47, P2978, DOI 10.1021/bi702020y; Harrelson JP, 2007, BIOCHEM BIOPH RES CO, V352, P843, DOI 10.1016/j.bbrc.2006.11.071; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; HJELMELAND LM, 1977, BIOCHEM BIOPH RES CO, V76, P541, DOI 10.1016/0006-291X(77)90758-6; Imai T, 1998, BIOCHEMISTRY-US, V37, P8097, DOI 10.1021/bi9802768; Jalas JR, 2003, CHEM RES TOXICOL, V16, P794, DOI 10.1021/tx034022l; Johnson EF, 2005, BIOCHEM BIOPH RES CO, V338, P331, DOI 10.1016/j.bbrc.2005.08.190; Johnson Kenneth A., 2003, P1; KEEFER LK, 1973, J NATL CANCER I, V51, P299, DOI 10.1093/jnci/51.1.299; KOOP DR, 1982, J BIOL CHEM, V257, P8472; Kunitoh S, 1997, J PHARMACOL EXP THER, V280, P527; LEVIN W, 1986, ARCH BIOCHEM BIOPHYS, V248, P158, DOI 10.1016/0003-9861(86)90412-1; LIJINSKY W, 1972, J NATL CANCER I, V49, P1239; LIJINSKY W, 1972, NATURE-NEW BIOL, V236, P177, DOI 10.1038/newbio236177a0; LOEPPKY RN, 1982, IARC SCI PUBL, V41, P41; Mariano P, 1993, ADV ELECT T, V3, P191; Matsson O, 1998, ADV PHYS ORG CHEM, V31, P143; Mesic M, 1996, J AM CHEM SOC, V118, P7412, DOI 10.1021/ja961178h; MICO BA, 1985, CANCER RES, V45, P6280; MIWA GT, 1987, BIOESSAYS, V7, P215, DOI 10.1002/bies.950070506; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; PALMER G, 1992, J BIOL CHEM, V267, P665; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Poulos T. L., 2005, CYTOCHROME P450 STRU, P87; PREUSSMANN R, 1984, CHEM CARCINOGENS, V2, P643; RYAN DE, 1986, ARCH BIOCHEM BIOPHYS, V246, P633, DOI 10.1016/0003-9861(86)90319-X; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Shaik S, 2004, J BIOL INORG CHEM, V9, P661, DOI 10.1007/s00775-004-0576-6; SHIMADA T, 1986, J BIOL CHEM, V261, P909; Soucek P, 1999, ARCH BIOCHEM BIOPHYS, V370, P190, DOI 10.1006/abbi.1999.1388; Soucy P, 2000, EUR J BIOCHEM, V267, P3243, DOI 10.1046/j.1432-1327.2000.01349.x; Spence RA, 1996, BIOCHEMISTRY-US, V35, P1054, DOI 10.1021/bi952058+; SUGIYAMA K, 1994, DRUG METAB DISPOS, V22, P584; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; SUZUKI E, 1980, CHEM PHARM BULL, V28, P979; SWANN PF, 1983, CARCINOGENESIS, V4, P821, DOI 10.1093/carcin/4.7.821; TERELIUS Y, 1991, BIOCHEM BIOPH RES CO, V179, P689, DOI 10.1016/0006-291X(91)91427-E; TU YY, 1985, ARCH BIOCHEM BIOPHYS, V242, P32, DOI 10.1016/0003-9861(85)90476-X; VAZ ADN, 1994, BIOCHEMISTRY-US, V33, P13651, DOI 10.1021/bi00250a015; Vaz ADN, 1996, P NATL ACAD SCI USA, V93, P4644, DOI 10.1073/pnas.93.10.4644; WADE D, 1987, CANCER RES, V47, P3373; WALSH C, 1979, ENZYMATIC REACTION M, P122; Wang Q, 2009, J AM CHEM SOC, V131, P10629, DOI 10.1021/ja9031105; Wayner DDM, 1997, J AM CHEM SOC, V119, P8925, DOI 10.1021/ja971365v; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; WRIGHTON SA, 1986, BIOCHEMISTRY-US, V25, P6731, DOI 10.1021/bi00370a001; WRIGHTON SA, 1987, ARCH BIOCHEM BIOPHYS, V258, P292, DOI 10.1016/0003-9861(87)90347-X; YAMAZAKI H, 1992, CARCINOGENESIS, V13, P1789, DOI 10.1093/carcin/13.10.1789; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; YANG CS, 1991, CHEM RES TOXICOL, V4, P408, DOI 10.1021/tx00022a002; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; YOO JSH, 1988, CANCER RES, V48, P1499; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Yun CH, 2001, BIOCHEMISTRY-US, V40, P4521, DOI 10.1021/bi002906n	84	41	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8031	8044		10.1074/jbc.M109.088039	http://dx.doi.org/10.1074/jbc.M109.088039			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061389	Green Published, hybrid			2022-12-25	WOS:000275413800021
J	Frelet-Barrand, A; Boutigny, S; Moyet, L; Deniaud, A; Seigneurin-Berny, D; Salvi, D; Bernaudat, F; Richaud, P; Pebay-Peyroula, E; Joyard, J; Rolland, N				Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Deniaud, Aurelien; Seigneurin-Berny, Daphne; Salvi, Daniel; Bernaudat, Florent; Richaud, Pierre; Pebay-Peyroula, Eva; Joyard, Jacques; Rolland, Norbert			Lactococcus lactis, an Alternative System for Functional Expression of Peripheral and Intrinsic Arabidopsis Membrane Proteins	PLOS ONE			English	Article							CHLOROPLAST ENVELOPE MEMBRANES; HEAVY-METAL TRANSPORT; P-TYPE ATPASE; HETEROLOGOUS EXPRESSION; P-1B-TYPE ATPASE; SCALE PRODUCTION; BINDING DOMAIN; PURIFICATION; GENE; ATHMA4	Background: Despite their functional and biotechnological importance, the study of membrane proteins remains difficult due to their hydrophobicity and their low natural abundance in cells. Furthermore, into established heterologous systems, these proteins are frequently only produced at very low levels, toxic and mis- or unfolded. Lactococcus lactis, a Gram-positive lactic bacterium, has been traditionally used in food fermentations. This expression system is also widely used in biotechnology for large-scale production of heterologous proteins. Various expression vectors, based either on constitutive or inducible promoters, are available for this system. While previously used to produce bacterial and eukaryotic membrane proteins, the ability of this system to produce plant membrane proteins was until now not tested. Methodology/Principal Findings: The aim of this work was to test the expression, in Lactococcus lactis, of either peripheral or intrinsic Arabidopsis membrane proteins that could not be produced, or in too low amount, using more classical heterologous expression systems. In an effort to easily transfer genes from Gateway-based Arabidopsis cDNA libraries to the L. lactis expression vector pNZ8148, we first established a cloning strategy compatible with Gateway entry vectors. Interestingly, the six tested Arabidopsis membrane proteins could be produced, in Lactococcus lactis, at levels compatible with further biochemical analyses. We then successfully developed solubilization and purification processes for three of these proteins. Finally, we questioned the functionality of a peripheral and an intrinsic membrane protein, and demonstrated that both proteins were active when produced in this system. Conclusions/Significance: Altogether, these data suggest that Lactococcus lactis might be an attractive system for the efficient and functional production of difficult plant membrane proteins.	[Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Seigneurin-Berny, Daphne; Salvi, Daniel; Joyard, Jacques; Rolland, Norbert] CNRS, UMR5168, Physiol Cellulaire Vegetale Lab, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Seigneurin-Berny, Daphne; Salvi, Daniel; Joyard, Jacques; Rolland, Norbert] CEA, DSV, iRTSV, LPCV, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Seigneurin-Berny, Daphne; Salvi, Daniel; Joyard, Jacques; Rolland, Norbert] INRA, Physiol Cellulaire Vegetale Lab, UMR1200, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Seigneurin-Berny, Daphne; Salvi, Daniel; Joyard, Jacques; Rolland, Norbert] Univ Grenoble 1, Physiol Cellulaire Vegetale Lab, Grenoble, France; [Deniaud, Aurelien; Bernaudat, Florent; Pebay-Peyroula, Eva] CEA, IBS Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Deniaud, Aurelien; Bernaudat, Florent; Pebay-Peyroula, Eva] CNRS, IBS Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Deniaud, Aurelien; Bernaudat, Florent; Pebay-Peyroula, Eva] Univ Grenoble 1, IBS Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Richaud, Pierre] CEA, DSV, iBEB, Lab Echanges Membranaires & Signalisat, St Paul Les Durance, France; [Richaud, Pierre] CNRS, UMR 6191, St Paul Les Durance, France; [Richaud, Pierre] Univ Aix Marseille, St Paul Les Durance, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Frelet-Barrand, A (corresponding author), CNRS, UMR5168, Physiol Cellulaire Vegetale Lab, Grenoble, France.	daphne.berny@cea.fr	FRELET-BARRAND, Annie/AFX-2878-2022; frelet barrand, annie/E-5479-2015; ROLLAND, Norbert/B-4405-2012; Deniaud, Aurelien/L-5093-2019; Frelet-Barrand, Annie/S-1951-2017; SEIGNEURIN-BERNY, Daphne/C-8412-2017	FRELET-BARRAND, Annie/0000-0002-0849-9040; ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885	CEA (Commissariat a l'Energie Atomique); CNRS (Centre National de la Recherche Scientifique); AFM (Association Francaise contre les Myopathies); E.U.	CEA (Commissariat a l'Energie Atomique)(French Atomic Energy Commission); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); E.U.(European Commission)	This work has been supported by the CEA (Commissariat a l'Energie Atomique, funding of the CEA-PM project and Post-Doc fellowship to AFB), by the CNRS (Centre National de la Recherche Scientifique, PhD fellowship to SB and Post-Doc fellowship to AFB), by the AFM (Association Francaise contre les Myopathies) and E.U. Specific Targeted Research Project IMPS ( Innovative tools for Membrane Protein Structural proteomics) (AD and EPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI P, 1993, BIOCHEM J, V292, P863, DOI 10.1042/bj2920863; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Batard Y, 2000, ARCH BIOCHEM BIOPHYS, V379, P161, DOI 10.1006/abbi.2000.1867; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chigri F, 2006, P NATL ACAD SCI USA, V103, P16051, DOI 10.1073/pnas.0607150103; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Gasson MJ., 1994, GENETICS BIOTECHNOLO; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Hernandez I, 2007, APPL ENVIRON MICROB, V73, P1544, DOI 10.1128/AEM.01870-06; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; INGRAM LO, 1977, APPL ENVIRON MICROB, V33, P1233, DOI 10.1128/AEM.33.5.1233-1236.1977; JagerVottero P, 1997, P NATL ACAD SCI USA, V94, P1597, DOI 10.1073/pnas.94.4.1597; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; KAMPFENKEL K, 1995, FEBS LETT, V374, P351, DOI 10.1016/0014-5793(95)01143-3; Kim YY, 2009, PLANT J, V58, P737, DOI 10.1111/j.1365-313X.2009.03818.x; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; Kunji ERS, 2005, CURR OPIN BIOTECH, V16, P546, DOI 10.1016/j.copbio.2005.08.006; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Lacapere JJ, 2007, TRENDS BIOCHEM SCI, V32, P259, DOI 10.1016/j.tibs.2007.04.001; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Martinez-Cuesta MC, 2005, LETT APPL MICROBIOL, V40, P44, DOI 10.1111/j.1472-765X.2004.01621.x; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-15; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-16; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Miras S, 2007, J BIOL CHEM, V282, P29482, DOI 10.1074/jbc.M611112200; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; Neuhaus HE, 1997, PLANT J, V11, P73, DOI 10.1046/j.1365-313X.1997.11010073.x; Nguyen HD, 2007, CURR MICROBIOL, V55, P89, DOI 10.1007/s00284-006-0419-5; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Rahman M, 2007, MOL MEMBR BIOL, V24, P407, DOI 10.1080/09687860701243998; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHLEIFER KH, 1985, SYST APPL MICROBIOL, V6, P183, DOI 10.1016/S0723-2020(85)80052-7; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Thuswaldner S, 2007, J BIOL CHEM, V282, P8848, DOI 10.1074/jbc.M609130200; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; Tjaden J, 1998, J BIOL CHEM, V273, P9630, DOI 10.1074/jbc.273.16.9630; Tortech L, 2001, BBA-BIOMEMBRANES, V1514, P76, DOI 10.1016/S0005-2736(01)00370-4; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Trentmann O, 2008, J BIOL CHEM, V283, P36486, DOI 10.1074/jbc.M806903200; Ueda S, 2004, ANAL BIOCHEM, V332, P84, DOI 10.1016/j.ab.2004.04.035; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Vos W. M. de, 1994, Genetics and biotechnology of lactic acid bacteria., P52; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Wood BJB, 2003, GENETICS LACTIC ACID; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zhou XX, 2006, BIOTECHNOL ADV, V24, P285, DOI 10.1016/j.biotechadv.2005.11.001	77	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8746	10.1371/journal.pone.0008746	http://dx.doi.org/10.1371/journal.pone.0008746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098692	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779000007
J	Krasnova, IN; Justinova, Z; Ladenheim, B; Jayanthi, S; McCoy, MT; Barnes, C; Warner, JE; Goldberg, SR; Cadet, JL				Krasnova, Irina N.; Justinova, Zuzana; Ladenheim, Bruce; Jayanthi, Subramaniam; McCoy, Michael T.; Barnes, Chanel; Warner, John E.; Goldberg, Steven R.; Cadet, Jean Lud			Methamphetamine Self-Administration Is Associated with Persistent Biochemical Alterations in Striatal and Cortical Dopaminergic Terminals in the Rat	PLOS ONE			English	Article							BRAIN-SEROTONIN TRANSPORTER; INDUCED NEUROTOXICITY; INTRAVENOUS METHAMPHETAMINE; NEUROCHEMICAL CONSEQUENCES; TYROSINE-HYDROXYLASE; AMPHETAMINE ABUSE; OXIDATIVE STRESS; NULL MUTATION; USERS; IMPAIRMENT	Methamphetamine (meth) is an illicit psychostimulant that is abused throughout the world. Repeated passive injections of the drug given in a single day or over a few days cause significant and long-term depletion of dopamine and serotonin in the mammalian brain. Because meth self-administration may better mimic some aspects of human drug-taking behaviors, we examined to what extent this pattern of drug treatment might also result in damage to monoaminergic systems in the brain. Rats were allowed to intravenously self-administer meth (yoked control rats received vehicle) 15 hours per day for 8 days before being euthanized at either 24 hours or at 7 and 14 days after cessation of drug taking. Meth self-administration by the rats was associated with a progressive escalation of daily drug intake to 14 mg/kg per day. Animals that self-administered meth exhibited dose-dependent decreases in striatal dopamine levels during the period of observation. In addition, there were significant reductions in the levels of striatal dopamine transporter and tyrosine hydroxylase proteins. There were also significant decreases in the levels of dopamine, dopamine transporter, and tyrosine hydroxylase in the cortex. In contrast, meth self-administration caused only transient decreases in norepinephrine and serotonin levels in the two brain regions, with these values returning to normal at seven days after cessation of drug taking. Importantly, meth self-administration was associated with significant dose-dependent increases in glial fibrillary acidic protein in both striatum and cortex, with these changes being of greater magnitude in the striatum. These results suggest that meth self-administration by rats is associated with long-term biochemical changes that are reminiscent of those observed in post-mortem brain tissues of chronic meth abusers.	[Krasnova, Irina N.; Justinova, Zuzana; Ladenheim, Bruce; Jayanthi, Subramaniam; McCoy, Michael T.; Barnes, Chanel; Warner, John E.; Goldberg, Steven R.; Cadet, Jean Lud] NIDA, NIH, Baltimore, MD USA; [Justinova, Zuzana] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University System of Maryland; University of Maryland Baltimore	Krasnova, IN (corresponding author), NIDA, NIH, Baltimore, MD USA.	jcadet@intra.nida.nih.gov	Jayanthi, Subramaniam/ABI-4023-2020; Justinova, Zuzana/A-9109-2011	Justinova, Zuzana/0000-0001-5793-7484; Jayanthi, Subramaniam/0000-0002-5209-303X	National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services of the United States of America; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000552, ZIADA000003, ZIADA000001, ZIADA000174] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services of the United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Albertson TE, 1999, WESTERN J MED, V170, P214; BARDSLEY ME, 1981, BIOCHEM PHARMACOL, V30, P1543, DOI 10.1016/0006-2952(81)90379-8; BITTNER SE, 1981, PHARMACOL BIOCHEM BE, V14, P481, DOI 10.1016/0091-3057(81)90306-3; BRAY GA, 1993, ANN INTERN MED, V119, P707, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00016; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; Cadet JL, 2009, NEUROTOX RES, V15, P252, DOI 10.1007/s12640-009-9026-0; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; CHERNER M, 2009, DRUG ALCOHOL DEPEND; Cho AK, 2002, J ADDICT DIS, V21, P21; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Davidson C, 2005, NEUROCHEM INT, V46, P189, DOI 10.1016/j.neuint.2004.11.004; Degenhardt L, 2008, DRUG ALCOHOL REV, V27, P243, DOI 10.1080/09595230801950572; Deng XL, 1999, J NEUROSCI, V19, P10107; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Ernst T, 2000, NEUROLOGY, V54, P1344, DOI 10.1212/WNL.54.6.1344; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Friedman SD, 1998, PHARMACOL BIOCHEM BE, V61, P35, DOI 10.1016/S0091-3057(98)00066-5; Fumagalli F, 1998, J NEUROSCI, V18, P4861; Graham DL, 2008, J NEUROCHEM, V105, P1873, DOI 10.1111/j.1471-4159.2008.05269.x; Griffiths P, 2008, DRUG ALCOHOL REV, V27, P236, DOI 10.1080/09595230801932588; Hadlock GC, 2009, J PHARMACOL EXP THER, V329, P169, DOI 10.1124/jpet.108.145631; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hamill Cecily E, 2005, Clin Neurosurg, V52, P29; Homer BD, 2008, PSYCHOL BULL, V134, P301, DOI 10.1037/0033-2909.134.2.301; Johanson CE, 2006, PSYCHOPHARMACOLOGY, V185, P327, DOI 10.1007/s00213-006-0330-6; Johnson-Davis KL, 2003, EUR J PHARMACOL, V482, P151, DOI 10.1016/j.ejphar.2003.09.063; Kish S, 2009, PSYCHOPHARMACOLOGY, V202, P649, DOI 10.1007/s00213-008-1346-x; Kitamura O, 2006, PSYCHOPHARMACOLOGY, V186, P48, DOI 10.1007/s00213-006-0353-z; Kitamura O, 2007, INT J LEGAL MED, V121, P163, DOI 10.1007/s00414-006-0087-9; KRAMER JC, 1967, J AMER MED ASSOC, V201, P305, DOI 10.1001/jama.201.5.305; Krasnova IN, 2005, FASEB J, V19, P851, DOI 10.1096/fj.04-2881fje; Krasnova IN, 2007, NEUROTOX RES, V11, P107, DOI 10.1007/BF03033390; Krasnova IN, 2009, NEUROSCI RES, V65, P160, DOI 10.1016/j.neures.2009.06.007; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Ladenheim B, 2000, MOL PHARMACOL, V58, P1247, DOI 10.1124/mol.58.6.1247; Mandyam CD, 2007, J NEUROSCI, V27, P11442, DOI 10.1523/JNEUROSCI.2505-07.2007; Mandyam CD, 2008, BIOL PSYCHIAT, V64, P958, DOI 10.1016/j.biopsych.2008.04.010; Maxwell JC, 2008, DRUG ALCOHOL REV, V27, P229, DOI 10.1080/09595230801919460; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Mcketin R, 2008, DRUG ALCOHOL REV, V27, P220, DOI 10.1080/09595230801923710; Moszczynska A, 2004, BRAIN, V127, P363, DOI 10.1093/brain/awh046; Neale A, 2009, INT J EAT DISORDER, V42, P188, DOI 10.1002/eat.20587; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Ricca V, 2009, APPETITE, V52, P405, DOI 10.1016/j.appet.2008.11.013; Schwendt M, 2009, J PHARMACOL EXP THER, V331, P555, DOI 10.1124/jpet.109.155770; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Segal DS, 2005, PSYCHOPHARMACOLOGY, V180, P501, DOI 10.1007/s00213-005-2188-4; Segal DS, 2003, NEUROPSYCHOPHARMACOL, V28, P1730, DOI 10.1038/sj.npp.1300247; Sekine Y, 2006, ARCH GEN PSYCHIAT, V63, P90, DOI 10.1001/archpsyc.63.1.90; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Shepard JD, 2006, PSYCHOPHARMACOLOGY, V185, P505, DOI 10.1007/s00213-006-0316-4; Sim T, 2002, J ADDICT DIS, V21, P75; Simon SL, 2000, AM J ADDICTION, V9, P222; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stefanski R, 2002, EUR J PHARMACOL, V439, P59, DOI 10.1016/S0014-2999(02)01301-8; Stephans S, 1996, NEUROSCIENCE, V72, P593, DOI 10.1016/0306-4522(95)00587-0; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Thomas DM, 2008, J NEUROCHEM, V105, P605, DOI 10.1111/j.1471-4159.2007.05155.x; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wee S, 2007, NEUROPSYCHOPHARMACOL, V32, P2238, DOI 10.1038/sj.npp.1301353; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; WOOLVERTON WL, 1989, BRAIN RES, V486, P73, DOI 10.1016/0006-8993(89)91279-1; Xu WJ, 2005, SYNAPSE, V58, P110, DOI 10.1002/syn.20185; Zhu JPQ, 2005, BRAIN RES, V1049, P171, DOI 10.1016/j.brainres.2005.04.089	68	94	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8790	10.1371/journal.pone.0008790	http://dx.doi.org/10.1371/journal.pone.0008790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098750	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000018
J	Mitchell, IC; Brown, TS; Terada, LS; Amatruda, JF; Nwariaku, FE				Mitchell, Ian C.; Brown, Timothy S.; Terada, Lance S.; Amatruda, James F.; Nwariaku, Fiemu E.			Effect of Vascular Cadherin Knockdown on Zebrafish Vasculature during Development	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL FORMATION; VE-CADHERIN; MESENCHYMAL TRANSFORMATION; EMBRYOS; PHOSPHORYLATION; EXPRESSION; ADHESION; CELLS; GENE	Background: Vascular endothelial cadherin (VE-cad) is essential for endothelial barrier integrity and vascular sprouting. However, the role of this important protein in cardiovascular development is only recently becoming apparent. Methodology/Principal Findings: To characterize the role of VE-cadherin in cardiovascular development, we analyzed cardiovascular development in a zebrafish VE-cad knockdown model. Embryos deficient in VE-cad show profoundly impaired cardiac development despite having apparently normal peripheral vasculature. Initial formation of the heart proceeds normally in knockdown embryos, but subsequent looping morphogenesis is impaired. Consistent with these results, VE-cad knockdown embryos demonstrate impaired cardiac function and early circulatory arrest. Histologic examination of knockdown embryos shows persistent, abnormal separation of the endocardial and myocardial layers. Using transmission electron microscopy, we demonstrate that endocardial junctions form poorly in VE-cad knockdown embryos, with resulting leak across the endothelial layer and reduction in the density of the cardiac jelly. Conclusions: Our results demonstrate a significant role for VE-cadherin in cardiac development independent of its effects on the formation of the peripheral vasculature.	[Mitchell, Ian C.; Brown, Timothy S.; Nwariaku, Fiemu E.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA; [Terada, Lance S.; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mitchell, IC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA.	james.amatruda@UTSouthwestern.edu; fiemu.nwariaku@UTSouthwestern.edu		Terada, Lance/0000-0001-7441-9734; Brown, Timothy/0000-0002-5404-0433	National Institutes of Health [NIGMS GM067674-01]; Department of Surgery at the University of Texas Southwestern Medical Center; Horchow Family Endowed Scholarship in Pediatrics at UT Southwestern Medical Center; Lance Armstrong Foundation; Amon G. Carter Foundation; NATIONAL CANCER INSTITUTE [R01CA135731] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery at the University of Texas Southwestern Medical Center; Horchow Family Endowed Scholarship in Pediatrics at UT Southwestern Medical Center; Lance Armstrong Foundation; Amon G. Carter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	FEN is supported by the National Institutes of Health (NIGMS GM067674-01), by the Malcom O Perry MD Professorship in Surgery and the Department of Surgery at the University of Texas Southwestern Medical Center. JFA is supported by the Horchow Family Endowed Scholarship in Pediatrics at UT Southwestern Medical Center and by grants from the Lance Armstrong Foundation and the Amon G. Carter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Esser S, 1998, J CELL SCI, V111, P1853; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Kim KH, 2007, DEV BIOL, V308, P494, DOI 10.1016/j.ydbio.2007.06.005; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Nwariaku FE, 2004, BLOOD, V104, P3214, DOI 10.1182/blood-2004-05-1868; POTTS JD, 1991, P NATL ACAD SCI USA, V88, P1516, DOI 10.1073/pnas.88.4.1516; THISSE C, 1993, DEVELOPMENT, V119, P1203; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE	23	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8807	10.1371/journal.pone.0008807	http://dx.doi.org/10.1371/journal.pone.0008807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098718	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000033
J	Sanchez-Guajardo, V; Febbraro, F; Kirik, D; Romero-Ramos, M				Sanchez-Guajardo, Vanesa; Febbraro, Fabia; Kirik, Deniz; Romero-Ramos, Marina			Microglia Acquire Distinct Activation Profiles Depending on the Degree of alpha-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR-ALPHA; SUBSTANTIA-NIGRA; MOUSE MODEL; TARGETED OVEREXPRESSION; DOPAMINERGIC-NEURONS; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; TRANSGENIC MICE; VIRAL VECTOR	Post-mortem analysis of brains from Parkinson's disease (PD) patients strongly supports microglia activation and adaptive immunity as factors contributing to disease progression. Such responses may be triggered by alpha-synuclein (alpha-syn), which is known to be the main constituent of the aggregated proteins found in Lewy bodies in the brains of PD patients. To investigate this we used a recombinant viral vector to express human alpha-syn in rat midbrain at levels that induced neuronal pathology either in the absence or the presence of dopaminergic cell death, thereby mimicking early or late stages of the disease. Microglia activation was assessed by stereological quantification of Mac1+ cells, as well as the expression patterns of CD68 and MCH II. In our study, when alpha-syn induced neuronal pathology but not cell death, a fast transient increase in microglia cell numbers resulted in the long-term induction of MHC II+ microglia, denoting antigen-presenting ability. On the other hand, when alpha-syn induced both neuronal pathology and cell death, there was a delayed increase in microglia cell numbers, which correlated with long-lasting CD68 expression and a morphology reminiscent of peripheral macrophages. In addition T-lymphocyte infiltration, as judged by the presence of CD4+ and CD8+ cells, showed distinct kinetics depending on the degree of neurodegeneration, and was significantly higher when cell death occurred. We have thus for the first time shown that the microglial response differs depending on whether alpha-syn expression results on cell death or not, suggesting that microglia may play different roles during disease progression. Furthermore, our data suggest that the microglial response is modulated by early events related to alpha-syn expression in substantia nigra and persists at the long term.	[Sanchez-Guajardo, Vanesa; Febbraro, Fabia; Romero-Ramos, Marina] Aarhus Univ, Dept Med Biochem, Cent Nervous Syst Dis Modeling Grp, Aarhus, Denmark; [Kirik, Deniz; Romero-Ramos, Marina] Lund Univ, Dept Expt Med Sci Brain Repair & Imaging Neural S, Lund, Sweden	Aarhus University; Lund University	Sanchez-Guajardo, V (corresponding author), Aarhus Univ, Dept Med Biochem, Cent Nervous Syst Dis Modeling Grp, Aarhus, Denmark.	mrr@biokemi.au.dk	Romero-Ramos, Marina/J-6834-2014; Febbraro, Fabia/AAO-9454-2020; Kirik, Deniz/E-5156-2011; Febbraro, Fabia/G-9097-2016	Romero-Ramos, Marina/0000-0003-0970-578X; Sanchez-Guajardo, Vanesa/0000-0002-3290-2047; Febbraro, Fabia/0000-0001-8336-2776	Swedish Research Council [K2007-61X-14552-05-3]; Lundbeck Foundation [R9-A1061, R17-A1564]; Danish Research Council [271-06-0261]; Danish Parkinson Foundation; Nordic Center of Excellence in Neurodegeneration	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lundbeck Foundation(Lundbeckfonden); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Parkinson Foundation; Nordic Center of Excellence in Neurodegeneration	This work was supported by grants from, The Swedish Research Council (K2007-61X-14552-05-3 to DK, www.vr.se), Lundbeck Foundation (R9-A1061 to MRR and R17-A1564 to VSG, www.lundbeckfonden.dk), the Danish Research Council (271-06-0261 to MRR, en.fi.dk/councils-commissions/the-danish-council-for-independent-research/scientific-research-councils/medical-sciences), Danish Parkinson Foundation (to MRR, www.parkinson.dk), Nordic Center of Excellence in Neurodegeneration (to DK and MRR). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Austin SA, 2006, J NEUROSCI, V26, P10558, DOI 10.1523/JNEUROSCI.1799-06.2006; Baba Y, 2005, PARKINSONISM RELAT D, V11, P493, DOI 10.1016/j.parkreldis.2005.07.005; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Brodacki B, 2008, NEUROSCI LETT, V441, P158, DOI 10.1016/j.neulet.2008.06.040; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Cabanas C, 1999, J BIOL REG HOMEOS AG, V13, P130; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; DEGUEURCE AM, 1986, ACTA PHYSIOL SCAND, V126, P313, DOI 10.1111/j.1748-1716.1986.tb07821.x; Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Ferrer I, 2001, J NEURAL TRANSM, V108, P1383, DOI 10.1007/s007020100015; FUCHS J, 2007, NEUROLOGY; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Gomez-Isla T, 2003, NEUROBIOL AGING, V24, P245, DOI 10.1016/S0197-4580(02)00091-X; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hartmann A, 2001, J NEUROSCI, V21, P2247, DOI 10.1523/JNEUROSCI.21-07-02247.2001; Hunot S, 1999, J NEUROSCI, V19, P3440; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jin JJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-2; Kim S, 2009, J NEUROCHEM, V109, P1483, DOI 10.1111/j.1471-4159.2009.06075.x; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; MCGEER PL, 1988, ANN NEUROL, V24, P574, DOI 10.1002/ana.410240415; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Mogi M, 2000, J NEURAL TRANSM, V107, P335, DOI 10.1007/s007020050028; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; MOGI M, 1995, J NEURAL TRANSM-PARK, V9, P87, DOI 10.1007/BF02252965; Nagatsu T, 2007, J NEURAL TRANSM-SUPP, P113; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; REYNOLDS AD, 2008, J NEUROIMMUNE PHARM; REYNOLDS AD, 2007, J NEUROCHEM; Reynolds AD, 2009, J IMMUNOL, V182, P4137, DOI 10.4049/jimmunol.0803982; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; Rowe DB, 1998, J NEUROSCI RES, V53, P551, DOI 10.1002/(SICI)1097-4547(19980901)53:5<551::AID-JNR5>3.3.CO;2-T; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Shavali S, 2006, NEUROCHEM RES, V31, P85, DOI 10.1007/s11064-005-9233-x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Su XM, 2009, NEUROTOX RES, V16, P238, DOI 10.1007/s12640-009-9053-x; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Thomas MP, 2007, J NEUROCHEM, V100, P503, DOI 10.1111/j.1471-4159.2006.04315.x; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Xu LF, 2001, HUM GENE THER, V12, P563, DOI 10.1089/104303401300042500; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	73	174	177	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8784	10.1371/journal.pone.0008784	http://dx.doi.org/10.1371/journal.pone.0008784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098715	Green Published, gold			2022-12-25	WOS:000273779000013
J	Taylor, PJ; Betts, GA; Maroulis, S; Gilissen, C; Pedersen, RL; Mowat, DR; Johnston, HM; Buckley, MF				Taylor, Peter J.; Betts, Grant A.; Maroulis, Sarah; Gilissen, Christian; Pedersen, Robyn L.; Mowat, David R.; Johnston, Heather M.; Buckley, Michael F.			Dystrophin Gene Mutation Location and the Risk of Cognitive Impairment in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; MENTAL-RETARDATION; INTELLECTUAL IMPAIRMENT; CARBOXY-TERMINUS; POINT MUTATIONS; DP71; DP140; INTELLIGENCE; DMD; ASSOCIATION	Background: A significant component of the variation in cognitive disability that is observed in Duchenne muscular dystrophy (DMD) is known to be under genetic regulation. In this study we report correlations between standardised measures of intelligence and mutational class, mutation size, mutation location and the involvement of dystrophin isoforms. Methods and Results: Sixty two male subjects were recruited as part of a study of the cognitive spectrum in boys with DMD conducted at the Sydney Children's Hospital (SCH). All 62 children received neuropsychological testing from a single clinical psychologist and had a defined dystrophin gene (DMD) mutation; including DMD gene deletions, duplications and DNA point mutations. Full Scale Intelligence Quotients (FSIQ) in unrelated subjects with the same mutation were found to be highly correlated (r = 0.83, p = 0.0008), in contrast to results in previous publications. In 58 cases (94%) it was possible to definitively assign a mutation as affecting one or more dystrophin isoforms. A strong association between the risk of cognitive disability and the involvement of groups of DMD isoforms was found. In particular, improvements in the correlation of FSIQ with mutation location were identified when a new classification system for mutations affecting the Dp140 isoform was implemented. Significance: These data represent one of the largest studies of FSIQ and mutational data in DMD patients and is among the first to report on a DMD cohort which has had both comprehensive mutational analysis and FSIQ testing through a single referral centre. The correlation between FSIQ results with the location of the dystrophin gene mutation suggests that the risk of cognitive deficit is a result of the cumulative loss of central nervous system (CNS) expressed dystrophin isoforms, and that correct classification of isoform involvement results in improved estimates of risk.	[Taylor, Peter J.; Maroulis, Sarah; Buckley, Michael F.] Prince Wales Hosp, Mol & Cytogenet Unit, Dept Haematol & Genet, Sydney, NSW, Australia; [Taylor, Peter J.; Betts, Grant A.; Pedersen, Robyn L.; Mowat, David R.; Johnston, Heather M.] Sydney Childrens Hosp, Sydney Neuromuscular Ctr, Sydney, NSW, Australia; [Gilissen, Christian; Buckley, Michael F.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Mowat, David R.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	University of Sydney; Radboud University Nijmegen; University of New South Wales Sydney	Taylor, PJ (corresponding author), Prince Wales Hosp, Mol & Cytogenet Unit, Dept Haematol & Genet, Sydney, NSW, Australia.	michael.buckley@sesiahs.health.nsw.gov.au	Gilissen, Christian/E-5246-2012	Gilissen, Christian/0000-0003-1693-9699; buckley, michael/0000-0002-8298-8758	Muscular Dystrophy Association of New South Wales; European Science Directorate	Muscular Dystrophy Association of New South Wales; European Science Directorate	Funding for genetic testing was generously provided by the Muscular Dystrophy Association of New South Wales (http://mdnsw.org.au/). MFB is a recipient of a Marie Curie Fellowship from the European Science Directorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Bardoni A, 2000, NEUROMUSCULAR DISORD, V10, P194, DOI 10.1016/S0960-8966(99)00108-X; Billard C, 1998, DEV MED CHILD NEUROL, V40, P12, DOI 10.1111/j.1469-8749.1998.tb15351.x; BILLARD C, 1992, NEUROMUSCULAR DISORD, V2, P371, DOI 10.1016/S0960-8966(06)80008-8; BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071; BRESOLIN N, 1994, NEUROMUSCULAR DISORD, V4, P359, DOI 10.1016/0960-8966(94)90072-8; BUSHBY KMD, 1993, J NEUROL, V240, P105, DOI 10.1007/BF00858726; BUSHBY KMD, 1995, DEV MED CHILD NEUROL, V37, P260; Ceccarini M, 1997, DEV BRAIN RES, V103, P77, DOI 10.1016/S0165-3806(97)00122-3; Cotton S, 2001, DEV MED CHILD NEUROL, V43, P497, DOI 10.1017/S0012162201000913; Cotton SM, 2005, DEV MED CHILD NEUROL, V47, P257, DOI 10.1017/S0012162205000496; DAOUD F, 2009, HUM MOL GENET; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; *DUCH BOUL GBA, 1973, NEUR CLASS, P60; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Felisari G, 2000, NEUROLOGY, V55, P559, DOI 10.1212/WNL.55.4.559; Florencia G, 2004, NEUROL RES, V26, P83, DOI 10.1179/016164104773026589; Greenwood J, 1996, J NEUROIMMUNOL, V71, P51, DOI 10.1016/S0165-5728(96)00130-0; Haenggi T, 2004, NEUROSCIENCE, V129, P403, DOI 10.1016/j.neuroscience.2004.06.079; Hinton VJ, 2007, DEV MED CHILD NEUROL, V49, P123, DOI 10.1111/j.1469-8749.2007.00123.x; Hinton VJ, 2001, J INT NEUROPSYCH SOC, V7, P45, DOI 10.1017/S1355617701711058; Hinton VJ, 2000, NEUROLOGY, V54, P2127, DOI 10.1212/WNL.54.11.2127; HODGSON SV, 1992, NEUROMUSCULAR DISORD, V2, P269, DOI 10.1016/0960-8966(92)90059-F; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; KARAGAN NJ, 1978, DEV MED CHILD NEUROL, V20, P435; KOCHLING S, 1995, HUM GENET, V95, P475; LEIBOWITZ D, 1981, DEV MED CHILD NEUROL, V23, P577; LENK U, 1993, HUM MOL GENET, V2, P1877, DOI 10.1093/hmg/2.11.1877; LIDOV HGW, 1995, HUM MOL GENET, V4, P329, DOI 10.1093/hmg/4.3.329; MARSH GG, 1974, ARCH DIS CHILD, V49, P118, DOI 10.1136/adc.49.2.118; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; MORRIS GE, 1995, BIOCHEM BIOPH RES CO, V215, P361, DOI 10.1006/bbrc.1995.2474; MORROW R S, 1954, J Child Psychiatry, V3, P70; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; NICHOLSON LVB, 1993, J MED GENET, V30, P737, DOI 10.1136/jmg.30.9.737; OGASAWARA A, 1989, AM J MENT RETARD, V93, P544; Pillers DAH, 1999, HUM GENET, V105, P2, DOI 10.1007/s004390051056; PROSSER EJ, 1969, ARCH DIS CHILD, V44, P221, DOI 10.1136/adc.44.234.221; RAPAPORT D, 1991, AM J MED GENET, V39, P437, DOI 10.1002/ajmg.1320390414; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; SMITH RA, 1990, DEV MED CHILD NEUROL, V32, P519; SOLLEE ND, 1985, J CLIN EXP NEUROPSYC, V7, P486, DOI 10.1080/01688638508401280; Taylor PJ, 2007, J MED GENET, V44, P368, DOI 10.1136/jmg.2006.047464; Tokarz SA, 1998, MOL GENET METAB, V65, P272, DOI 10.1006/mgme.1998.2763; TUFFERY S, 1995, HUM MUTAT, V6, P126, DOI 10.1002/humu.1380060205; Young HK, 2008, J CHILD NEUROL, V23, P155, DOI 10.1177/0883073807307975	47	111	113	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8803	10.1371/journal.pone.0008803	http://dx.doi.org/10.1371/journal.pone.0008803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098710	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779000029
J	Welch, JJ				Welch, John J.			The "Island Rule" and Deep-Sea Gastropods: Re-Examining the Evidence	PLOS ONE			English	Article							REPAIRED SHELL DAMAGE; BODY-SIZE EVOLUTION; MAMMALS; PATTERNS; AREA; BIOGEOGRAPHY; DIVERSITY; PRIMATES	Background: One of the most intriguing patterns in mammalian biogeography is the "island rule'', which states that colonising species have a tendency to converge in body size, with larger species evolving decreased sizes and smaller species increased sizes. It has recently been suggested that an analogous pattern holds for the colonisation of the deep-sea benthos by marine Gastropoda. In particular, a pioneering study showed that gastropods from the Western Atlantic showed the same graded trend from dwarfism to gigantism that is evident in island endemic mammals. However, subsequent to the publication of the gastropod study, the standard tests of the island rule have been shown to yield false positives at a very high rate, leaving the result open to doubt. Methodology/Principal Findings: The evolution of gastropod body size in the deep sea is reexamined. Using an extended and updated data set, and improved statistical methods, it is shown that some results of the previous study may have been artifactual, but that its central conclusion is robust. It is further shown that the effect is not restricted to a single gastropod clade, that its strength increases markedly with depth, but that it applies even in the mesopelagic zone. Conclusions/Significance: The replication of the island rule in a distant taxonomic group and a partially analogous ecological situation could help to uncover the causes of the patterns observed-which are currently much disputed. The gastropod pattern is evident at intermediate depths, and so cannot be attributed to the unique features of abyssal ecology.	[Welch, John J.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Welch, JJ (corresponding author), Univ Montpellier 2, Pl Eugene Bataillon, Montpellier, France.	J.J.Welch10@gmail.com			BBSRC [DO17750]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Some preliminary work undertaken when JW was funded by BBSRC grant DO17750 awarded to Andrew Rambaut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchet P, 2005, MALACOLOGIA, V47, P1; Bromham L, 2007, BIOL LETTERS, V3, P398, DOI 10.1098/rsbl.2007.0113; Clegg SM, 2002, P ROY SOC B-BIOL SCI, V269, P1359, DOI 10.1098/rspb.2002.2024; DAYTON PK, 1972, DEEP-SEA RES, V19, P199, DOI 10.1016/0011-7471(72)90031-9; De Souza Paulino J.S., 2002, Zootaxa, V49, P1; Duncan RP, 2004, GLOBAL ECOL BIOGEOGR, V13, P509, DOI 10.1111/j.1466-822X.2004.00132.x; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Gage J.D., 2005, P273, DOI 10.1002/9780470995129.ch7; Gage J. D., 1991, DEEP SEA BIOL NATURA; Guo H, 2007, MOL BIOL EVOL, V24, P352, DOI 10.1093/molbev/msl165; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOMOLINO MV, 1984, AM NAT, V123, P468, DOI 10.1086/284217; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Marquet PA, 1998, EVOL ECOL, V12, P127, DOI 10.1023/A:1006567227154; MARTIN RD, 1989, FOLIA PRIMATOL, V53, P65, DOI 10.1159/000156409; McClain CR, 2005, MAR ECOL PROG SER, V297, P181, DOI 10.3354/meps297181; McClain CR, 2006, J BIOGEOGR, V33, P1578, DOI 10.1111/j.1365-2699.2006.01545.x; MCCOLLOM TM, 1999, OCEANOGRAPHIC RES PA, V47, P85; McNab BK, 2002, ECOL LETT, V5, P693, DOI 10.1046/j.1461-0248.2002.00365.x; Meiri S, 2005, ECOL LETT, V8, P1211, DOI 10.1111/j.1461-0248.2005.00825.x; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Meiri S, 2007, GLOBAL ECOL BIOGEOGR, V16, P702, DOI 10.1111/j.1466-8238.2007.00327.x; Palkovacs EP, 2003, OIKOS, V103, P37, DOI 10.1034/j.1600-0706.2003.12502.x; Price TD, 2007, J BIOGEOGR, V34, P1998, DOI 10.1111/j.1365-2699.2007.01796.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Raia P, 2006, EVOLUTION, V60, P1731; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; REYMENT RA, 1983, OIKOS, V41, P299, DOI 10.2307/3544089; ROSENBERG G, 1993, AM MALACOL BULL, V10, P257; ROSENDAHL CO, 1909, MINNESOTA BOT STUDIE, V4, P1; Roth V.L., 1992, Oxford Surveys in Evolutionary Biology, V8, P259; Schmidt NM, 2003, CONSERV ECOL, V7; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; SMITH FA, 1992, FUNCT ECOL, V6, P265, DOI 10.2307/2389516; Sokal R. R., 2012, BIOMETRY; VALE FK, 1988, MALACOLOGIA, V28, P65; VALE FK, 1989, NAUTILUS, V103, P105; Van Valen L, 1973, EVOL THEORY, V49, P31, DOI DOI 10.1007/S13398-014-0173-7.2; WALKER SE, 1994, PALAIOS, V9, P48, DOI 10.2307/3515078; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; WASSERSUG RJ, 1979, AM NAT, V114, P287, DOI 10.1086/283475; Welch JJ, 2009, P ROY SOC B-BIOL SCI, V276, P675, DOI 10.1098/rspb.2008.1180; WILLIAMS GC, NATURAL SELECTION DO	45	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8776	10.1371/journal.pone.0008776	http://dx.doi.org/10.1371/journal.pone.0008776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098740	Green Submitted, Green Published, gold			2022-12-25	WOS:000273778900019
J	Movassagh, M; Choy, MK; Goddard, M; Bennett, MR; Down, TA; Foo, RSY				Movassagh, Mehregan; Choy, Mun-Kit; Goddard, Martin; Bennett, Martin R.; Down, Thomas A.; Foo, Roger S. -Y.			Differential DNA Methylation Correlates with Differential Expression of Angiogenic Factors in Human Heart Failure	PLOS ONE			English	Article							HISTONE DEACETYLASES; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; CANCER; GENOME; METHYLOME; DISEASE; HYPERMETHYLATION; DEMETHYLATION; INFLAMMATION	Epigenetic mechanisms such as microRNA and histone modification are crucially responsible for dysregulated gene expression in heart failure. In contrast, the role of DNA methylation, another well-characterized epigenetic mark, is unknown. In order to examine whether human cardiomyopathy of different etiologies are connected by a unifying pattern of DNA methylation pattern, we undertook profiling with ischaemic and idiopathic end-stage cardiomyopathic left ventricular (LV) explants from patients who had undergone cardiac transplantation compared to normal control. We performed a preliminary analysis using methylated-DNA immunoprecipitation-chip (MeDIP-chip), validated differential methylation loci by bisulfite-(BS) PCR and high throughput sequencing, and identified 3 angiogenesis-related genetic loci that were differentially methylated. Using quantitative RT-PCR, we found that the expression of these genes differed significantly between CM hearts and normal control (p<0.01). Moreover, for each individual LV tissue, differential methylation showed a predicted correlation to differential expression of the corresponding gene. Thus, differential DNA methylation exists in human cardiomyopathy. In this series of heterogenous cardiomyopathic LV explants, differential DNA methylation was found in at least 3 angiogenesis-related genes. While in other systems, changes in DNA methylation at specific genomic loci usually precede changes in the expression of corresponding genes, our current findings in cardiomyopathy merit further investigation to determine whether DNA methylation changes play a causative role in the progression of heart failure.	[Movassagh, Mehregan; Choy, Mun-Kit; Bennett, Martin R.; Foo, Roger S. -Y.] Univ Cambridge, Addenbrookes Ctr Clin Invest, Div Cardiovasc Med, Cambridge, England; [Goddard, Martin] Papworth Hosp, Dept Histopathol, Cambridge CB3 8RE, England; [Down, Thomas A.] Univ Cambridge, Canc Res UK Gurdon Inst, Cambridge, England	University of Cambridge; Papworth Hospital; Cancer Research UK; University of Cambridge	Movassagh, M (corresponding author), Univ Cambridge, Addenbrookes Ctr Clin Invest, Div Cardiovasc Med, Cambridge, England.	rsyf2@cam.ac.uk	Choy, Mun-Kit/C-2741-2014	Choy, Mun-Kit/0000-0003-3998-0774; Foo, Roger/0000-0002-8079-4618; Bennett, Martin/0000-0002-2565-1825	British Heart Foundations [FS/07/035, PG 06/101/21461, RG04/001]; NIHR Cambridge Biomedical Research Centre; British Heart Foundation [RG/08/009/25841] Funding Source: researchfish	British Heart Foundations; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This study was supported by British Heart Foundations grants FS/07/035 (to RS-YF), PG 06/101/21461 (to MRB and RS-YF) and RG04/001 (to MRB), and the NIHR Cambridge Biomedical Research Centre. Support was also received through Dr Steve Baker from Roche Ltd for 454 FLX sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DL, 2000, J MOL CELL CARDIOL, V32, P1353, DOI 10.1006/jmcc.2000.1171; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Backdahl L, 2009, INT J BIOCHEM CELL B, V41, P176, DOI 10.1016/j.biocel.2008.08.023; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Cao GY, 2009, AM J PATHOL, V175, P903, DOI 10.2353/ajpath.2009.090206; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Dorn GW, 2008, CIRCULATION, V118, P216, DOI 10.1161/CIRCULATIONAHA.108.789933; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; ENVER T, 1988, GENE DEV, V2, P698, DOI 10.1101/gad.2.6.698; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Flanagan JM, 2009, HUM MOL GENET, V18, P1332, DOI 10.1093/hmg/ddp033; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Heidecker B, 2008, CIRCULATION, V118, P238, DOI 10.1161/CIRCULATIONAHA.107.756544; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rakyan VK, 2006, CURR OPIN GENET DEV, V16, P573, DOI 10.1016/j.gde.2006.09.002; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Su ZJ, 2004, P NATL ACAD SCI USA, V101, P12212, DOI 10.1073/pnas.0404631101; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	43	138	151	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8564	10.1371/journal.pone.0008564	http://dx.doi.org/10.1371/journal.pone.0008564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084101	gold, Green Published, Green Submitted			2022-12-25	WOS:000273554600005
J	Mercer, F; Kozhaya, L; Unutmaz, D				Mercer, Frances; Kozhaya, Lina; Unutmaz, Derya			Expression and Function of TNF and IL-1 Receptors on Human Regulatory T Cells	PLOS ONE			English	Article							X-LINKED INHERITANCE; INTERLEUKIN-1 RECEPTOR; IMMUNE DYSREGULATION; FOXP3; EXPANSION; CD4(+); POLYENDOCRINOPATHY; IDENTIFICATION; ENTEROPATHY; SUPPRESSION	Regulatory T cells (Tregs) suppress immune activation and are critical in preventing autoimmune diseases. While the ability of Tregs to inhibit proliferation of other T cells is well established, it is not yet clear whether Tregs also modulate inflammatory cytokines during an immune response. Here, we show that the expression of inflammatory cytokine receptors IL-1R1 and TNFR2 were higher on resting mature Tregs compared to naive or memory T cells. While upon activation through the T cell receptor (TCR), expression of IL-1R1 and TNFR2 were upregulated on all T cell subsets, IL-1R1 maintained significantly higher expression on activated Tregs as compared to other T cell subsets. The decoy receptor for IL-1 (IL-1R2) was not expressed by any of the resting T cells but was rapidly upregulated and preferentially expressed upon TCR-stimulation on Tregs. In addition, we found that Tregs also expressed high levels of mRNA for IL-1 antagonist, IL-1RA. TCR-stimulation of naive T cells in the presence of TGF beta, which induces FOXP3 expression, however did not result in upregulation of IL-1R1 or IL-1R2. In addition, ectopic expression of FOXP3 in non-Tregs, while causing significant upregulation of IL-1R1 and IL-1R2, did not achieve the levels seen in bona fide Tregs. We also determined that resting human Tregs expressing IL-1R1 did not have higher suppressive capacity compared to IL-1R1- Tregs, suggesting that IL-1R1 does not discriminate suppressive resting Tregs in healthy individuals. Functionally, activated human Tregs displayed a capacity to neutralize IL-1 beta, which suggests a physiological significance for the expression of IL-1 decoy receptor on Tregs. In conclusion, our findings that human Tregs preferentially express receptors for TNF and IL-1 suggest a potential function in sensing and dampening local inflammation.	[Mercer, Frances; Kozhaya, Lina; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY USA	New York University; New York University	Mercer, F (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Derya@mac.com			National Institutes of Health (NIH) [R01 AI065303, T32 AI00718026A2, T32 AI007647-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007647, R01AI065303] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant R01 AI065303 to DU and NIH training grants T32 AI00718026A2 and T32 AI007647-10 to FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoum A, 2007, HUM REPROD, V22, P1464, DOI 10.1093/humrep/dem021; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; AREND WP, 1994, J IMMUNOL, V153, P4766; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Belkaid Y, 2008, EUR J IMMUNOL, V38, P918, DOI 10.1002/eji.200738120; Bellehumeur C, 2005, HUM REPROD, V20, P1177, DOI 10.1093/humrep/deh749; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Brinster C, 2008, J LEUKOCYTE BIOL, V84, P480, DOI 10.1189/jlb.0208085; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Deknuydt F, 2009, CLIN IMMUNOL, V131, P298, DOI 10.1016/j.clim.2008.12.008; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Herrmann-Lavoie C, 2007, ENDOCRINOLOGY, V148, P5377, DOI 10.1210/en.2007-0368; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2008, EUR J IMMUNOL, V38, P928, DOI 10.1002/eji.200838147; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lang D, 1998, J IMMUNOL, V161, P6871; Lim A, 2009, JAIDS-J ACQ IMM DEF, V51, P248, DOI 10.1097/QAI.0b013e3181a74fad; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Maitra U, 2009, J IMMUNOL, V182, P5763, DOI 10.4049/jimmunol.0900124; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Ochs HD, 2007, ADV EXP MED BIOL, V601, P27; Orlando S, 1997, J IMMUNOL, V158, P3861; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Powrie Fiona, 2003, Novartis Found Symp, V252, P92; Preas HL, 1996, BLOOD, V88, P2465; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tran DQ, 2009, BLOOD, V113, P5125, DOI 10.1182/blood-2009-01-199950; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; van Mierlo GJD, 2008, J IMMUNOL, V180, P2747, DOI 10.4049/jimmunol.180.5.2747; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Ware CF, 2008, CYTOKINE GROWTH F R, V19, P183, DOI 10.1016/j.cytogfr.2008.05.001; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929	45	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8639	10.1371/journal.pone.0008639	http://dx.doi.org/10.1371/journal.pone.0008639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20066156	Green Submitted, gold, Green Published			2022-12-25	WOS:000273456300006
J	Byrne, K; Colgrave, ML; Vuocolo, T; Pearson, R; Bidwell, CA; Cockett, NE; Lynn, DJ; Fleming-Waddell, JN; Tellam, RL				Byrne, Keren; Colgrave, Michelle L.; Vuocolo, Tony; Pearson, Roger; Bidwell, Christopher A.; Cockett, Noelle E.; Lynn, David J.; Fleming-Waddell, Jolena N.; Tellam, Ross L.			The Imprinted Retrotransposon-Like Gene PEG11 (RTL1) Is Expressed as a Full-Length Protein in Skeletal Muscle from Callipyge Sheep	PLOS ONE			English	Article							POLAR OVERDOMINANCE; TRANS-INTERACTION; LOCUS; DLK1; HYPERTROPHY; GROWTH; PHENOTYPE; MAMMALS; GENOME; LAMBS	Members of the Ty3-Gypsy retrotransposon family are rare in mammalian genomes despite their abundance in invertebrates and some vertebrates. These elements contain a gag-pol-like structure characteristic of retroviruses but have lost their ability to retrotranspose into the mammalian genome and are thought to be inactive relics of ancient retrotransposition events. One of these retrotransposon-like elements, PEG11 (also called RTL1) is located at the distal end of ovine chromosome 18 within an imprinted gene cluster that is highly conserved in placental mammals. The region contains several conserved imprinted genes including BEGAIN, DLK1, DAT, GTL2 (MEG3), PEG11 (RTL1), PEG11as, MEG8, MIRG and DIO3. An intergenic point mutation between DLK1 and GTL2 causes muscle hypertrophy in callipyge sheep and is associated with large changes in expression of the genes linked in cis between DLK1 and MEG8. It has been suggested that over-expression of DLK1 is the effector of the callipyge phenotype; however, PEG11 gene expression is also strongly correlated with the emergence of the muscling phenotype as a function of genotype, muscle type and developmental stage. To date, there has been no direct evidence that PEG11 encodes a protein, especially as its anti-sense transcript (PEG11as) contains six miRNA that cause cleavage of the PEG11 transcript. Using immunological and mass spectrometry approaches we have directly identified the full-length PEG11 protein from postnatal nuclear preparations of callipyge skeletal muscle and conclude that its over-expression may be involved in inducing muscle hypertrophy. The developmental expression pattern of the PEG11 gene is consistent with the callipyge mutation causing recapitulation of the normal fetal-like gene expression program during postnatal development. Analysis of the PEG11 sequence indicates strong conservation of the regions encoding the antisense microRNA and in at least two cases these correspond with structural or functional domains of the protein suggesting co-evolution of the sense and antisense genes.	[Byrne, Keren; Colgrave, Michelle L.; Vuocolo, Tony; Pearson, Roger; Tellam, Ross L.] CSIRO Livestock Ind, St Lucia, Qld, Australia; [Bidwell, Christopher A.; Fleming-Waddell, Jolena N.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Cockett, Noelle E.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Lynn, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Utah System of Higher Education; Utah State University; Simon Fraser University	Byrne, K (corresponding author), CSIRO Livestock Ind, St Lucia, Qld, Australia.	Ross.Tellam@csiro.au	Tellam, Ross/T-2423-2019; Tellam, Ross/H-2798-2013; Colgrave, Michelle/A-5710-2012; Byrne, Keren A/H-7552-2013; Vuocolo, Tony/H-7533-2013	Tellam, Ross/0000-0003-2353-1640; Colgrave, Michelle/0000-0001-8463-805X; Byrne, Keren A/0000-0003-4759-0645; Lynn, David/0000-0003-4664-1404; Vuocolo, Tony/0000-0002-5574-8126	SheepGenomics Australia	SheepGenomics Australia	The research was funded by SheepGenomics Australia (www.sheepgenomics.com), which is a joint initiative of Meat and Livestock Australia and Australian Wool Innovation Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Birchler JA, 2000, CURR OPIN GENET DEV, V10, P211, DOI 10.1016/S0959-437X(00)00065-4; Brandt J, 2005, CYTOGENET GENOME RES, V110, P307, DOI 10.1159/000084963; Butler M, 2001, J MOL EVOL, V52, P260, DOI 10.1007/s002390010154; Carpenter E, 1996, J ANIM SCI, V74, P388; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; COCKETT NE, 1994, P NATL ACAD SCI USA, V91, P3019, DOI 10.1073/pnas.91.8.3019; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; DERYCKERE F, 1994, BIOTECHNIQUES, V16, P405; Druker R, 2004, J INHERIT METAB DIS, V27, P319, DOI 10.1023/B:BOLI.0000031096.81518.66; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Freking BA, 1998, J ANIM SCI, V76, P2062; Freking BA, 1998, J ANIM SCI, V76, P2549; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Harlow E., 1988, ANTIBODIES LAB MANUA; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Jackson SP, 1997, J ANIM SCI, V75, P14; Kawahara M, 2009, J BIOL CHEM, V284, P17751, DOI 10.1074/jbc.M109.000299; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim KS, 2004, MAMM GENOME, V15, P552, DOI 10.1007/s00335-004-2341-0; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lorenzen CL, 2000, J ANIM SCI, V78, P78; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Pask AJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r1; Perkins AC, 2006, ANIM GENET, V37, P535, DOI 10.1111/j.1365-2052.2006.01518.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smit M, 2003, GENETICS, V163, P453; Smit MA, 2005, MAMM GENOME, V16, P801, DOI 10.1007/s00335-004-2415-z; Vuocolo T, 2005, AUST J EXP AGR, V45, P879, DOI 10.1071/EA05049; Vuocolo T, 2003, COMP BIOCHEM PHYS B, V134, P315, DOI 10.1016/S1096-4959(02)00265-8; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; WHITE JD, 2007, DIFFERENTIATION; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Youngson NA, 2005, J MOL EVOL, V61, P481, DOI 10.1007/s00239-004-0332-0	53	31	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8638	10.1371/journal.pone.0008638	http://dx.doi.org/10.1371/journal.pone.0008638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072617	Green Published, Green Submitted, gold			2022-12-25	WOS:000273414200016
J	London, R; Schwedock, J; Sage, A; Valley, H; Meadows, J; Waddington, M; Straus, D				London, Roanna; Schwedock, Julie; Sage, Andrew; Valley, Heather; Meadows, Jamie; Waddington, Michael; Straus, Don			An Automated System for Rapid Non-Destructive Enumeration of Growing Microbes	PLOS ONE			English	Article							AUTOFLUORESCENCE; FLUORESCENCE; STATE	Background: The power and simplicity of visual colony counting have made it the mainstay of microbiological analysis for more than 130 years. A disadvantage of the method is the long time required to generate visible colonies from cells in a sample. New rapid testing technologies generally have failed to maintain one or more of the major advantages of culture-based methods. Principal Findings: We present a new technology and platform that uses digital imaging of cellular autofluorescence to detect and enumerate growing microcolonies many generations before they become visible to the eye. The data presented demonstrate that the method preserves the viability of the microcolonies it detects, thus enabling generation of pure cultures for microbial identification. While visual colony counting detects Escherichia coli colonies containing about 5 x 10(6) cells, the new imaging method detects E. coli microcolonies when they contain about 120 cells and microcolonies of the yeast Candida albicans when they contain only about 12 cells. We demonstrate that digital imaging of microcolony autofluorescence detects a broad spectrum of prokaryotic and eukaryotic microbes and present a model for predicting the time to detection for individual strains. Results from the analysis of environmental samples from pharmaceutical manufacturing plants containing a mixture of unidentified microbes demonstrate the method's improved test turnaround times. Conclusion: This work demonstrates a new technology and automated platform that substantially shortens test times while maintaining key advantages of the current methods.	[London, Roanna; Schwedock, Julie; Sage, Andrew; Valley, Heather; Meadows, Jamie; Straus, Don] Rapid Micro Biosyst Inc, Bedford, MA USA; [Waddington, Michael] Accugenix Inc, Newark, DE USA		London, R (corresponding author), Rapid Micro Biosyst Inc, Bedford, MA USA.	don@firstlightbio.com			Rapid Micro Biosystems	Rapid Micro Biosystems	The work was funded by Rapid Micro Biosystems which is a privately financed company. All of the authors ( except for Michael Waddington of Accugenix) are employees of Rapid Micro Biosystems. The project concept, study design, data collection, data analysis, interpretation of the data, manuscript writing, and decision to submit took place at Rapid Micro Biosystems. The one exception is the 16S rDNA sequencing work which was carried out at Accugenix.	AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; CHANCE B, 1959, J BIOL CHEM, V234, P3044; DALTERIO RA, 1987, APPL SPECTROSC, V41, P234, DOI 10.1366/000370287774986804; DAWES CJ, 1979, BIOL TECHNIQUES TRAN, P241; ENWEMEKA CS, 2009, PHOTOMED LASER SURG, P1; Estes C, 2003, BIOSENS BIOELECTRON, V18, P511, DOI 10.1016/S0956-5663(03)00008-3; *EUR PHARM, 2006, EUR DIR QUAL MED; FDA, 2004, FOOD DRUG ADM, P32; Finney D.J., 1971, PROBIT ANAL; FROST WD, 1920, AGR BACTERIOLOGY LAB, P176; JONES DL, 1999, SOLID PHASE LASER SC, P7626; Kielbassa C, 2000, METHOD ENZYMOL, V319, P436; Limentani GB, 2005, ANAL CHEM, V77, p221A, DOI 10.1021/ac053390m; Metcalf R. L., 1943, ARCH BIOCHEM, V2, P55; Mills CE, 2006, PLOS MED, V3, P769, DOI 10.1371/journal.pmed.0030135; Oliver JD, 2005, J MICROBIOL, V43, P93; *PAR DRUG ASS, 2000, J PHARM SCI TECHNO S, P1; Shapiro HM., 2003, PRACTICAL FLOW CYTOM, P681; STEGER A, 2005, ENCY RAPID MICROBIOL, P379; U.S. Food and Drug Administration, 2004, GUID IND STER DRUG P; *US PHARM CONV, 2008, US PHARM, P681; *US PHARM TNF, 2008, PDA J PHARM SCI TECH; VOGT RF, 1989, CYTOMETRY, V10, P294, DOI 10.1002/cyto.990100308; WADDINGTON MG, 2003, RAPID ANAL MICROBIOL, P59; WANG L, 2002, J RES NATL INST STAN, P339; WESCHLER T, 2004, IND MICROBIOLOGY MAR	28	24	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8609	10.1371/journal.pone.0008609	http://dx.doi.org/10.1371/journal.pone.0008609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062794	Green Submitted, gold, Green Published			2022-12-25	WOS:000273414100006
J	Wang, LP; Li, F; Shen, XM; Tsien, JZ				Wang, Lei Phillip; Li, Fei; Shen, Xiaoming; Tsien, Joe Z.			Conditional Knockout of NMDA Receptors in Dopamine Neurons Prevents Nicotine-Conditioned Place Preference	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; GENETIC ENHANCEMENT; NUCLEUS-ACCUMBENS; MEMORY; ACTIVATION; DEPRESSION; SUBTYPES; SUBUNIT; BRAIN	Nicotine from smoking tobacco produces one of the most common forms of addictive behavior and has major societal and health consequences. It is known that nicotine triggers tobacco addiction by activating nicotine acetylcholine receptors (nAChRs) in the midbrain dopaminergic reward system, primarily via the ventral tegmental area. Heterogeneity of cell populations in the region has made it difficult for pharmacology-based analyses to precisely assess the functional significance of glutamatergic inputs to dopamine neurons in nicotine addiction. By generating dopamine neuron-specific NR1 knockout mice using cre/loxP-mediated method, we demonstrate that genetic inactivation of the NMDA receptors in ventral tegmental area dopamine neurons selectively prevents nicotine-conditioned place preference. Interestingly, the mutant mice exhibit normal performances in the conditioned place aversion induced by aversive air puffs. Therefore, this selective effect on addictive drug-induced reinforcement behavior suggests that NMDA receptors in the dopamine neurons are critical for the development of nicotine addiction.	[Wang, Lei Phillip; Li, Fei; Tsien, Joe Z.] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Wang, Lei Phillip; Li, Fei; Tsien, Joe Z.] Med Coll Georgia, Dept Neurol, Sch Med, Augusta, GA 30912 USA; [Wang, Lei Phillip] Yunnan Xishuang Banna Primate Model Res Ctr, Xishuang Banna, Yunnan, Peoples R China; [Li, Fei; Shen, Xiaoming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Shanghai Jiao Tong University	Wang, LP (corresponding author), Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.	jtsien@mcg.edu			NIMH; NIA; ECNU; Georgia Research Alliance; NATIONAL INSTITUTE ON AGING [R01AG034663] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ECNU; Georgia Research Alliance; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from NIMH, NIA, ECNU Award, and Georgia Research Alliance ( all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schilstrom B, 1998, NEUROSCIENCE, V82, P781; Tang JR, 2009, NEURON, V63, P673, DOI 10.1016/j.neuron.2009.07.025; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	25	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8616	10.1371/journal.pone.0008616	http://dx.doi.org/10.1371/journal.pone.0008616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062537	Green Published, gold, Green Submitted			2022-12-25	WOS:000273414100010
J	Adeghate, E; Fernandez-Cabezudo, M; Hameed, R; El-Hasasna, H; El Wasila, M; Abbas, T; al-Ramadi, B				Adeghate, Ernest; Fernandez-Cabezudo, Maria; Hameed, Rashed; El-Hasasna, Hussain; El Wasila, Mohamed; Abbas, Tariq; al-Ramadi, Basel			Orexin-1 Receptor Co-Localizes with Pancreatic Hormones in Islet Cells and Modulates the Outcome of Streptozotocin-Induced Diabetes Mellitus	PLOS ONE			English	Article							INSULIN-SECRETION; B-CELL; RAT; POLYPEPTIDE; INHIBITION; EXPRESSION; PEPTIDE; BRAIN	Recent studies have shown that orexins play a critical role in the regulation of sleep/wake states, feeding behaviour, and reward processes. The exocrine and endocrine pancreas are involved in the regulation of food metabolism and energy balance. This function is deranged in diabetes mellitus. This study examined the pattern of distribution of orexin-1 receptor (OX1R) in the endocrine cells of the pancreas of normal and diabetic Wistar (a model of type 1 diabetes), Goto-Kakizaki (GK, a model of type 2 diabetes) rats and in orexin-deficient (OX-/-) and wild type mice. Diabetes mellitus (DM) was induced in Wistar rats and mice by streptozotocin (STZ). At different time points (12 h, 24 h, 4 weeks, 8 months and 15 months) after the induction of DM, pancreatic fragments of normal and diabetic rats were processed for immunohistochemistry and Western blotting. OX1R-immunoreactive nerves were observed in the pancreas of normal and diabetic Wistar rats. OX1R was also discernible in the pancreatic islets of normal and diabetic Wistar and GK rats, and wild type mice. OX1R co-localized with insulin (INS) and glucagon (GLU) in the pancreas of Wistar and GK rats. The number of OX1R-positive cells in the islets increased markedly (p < 0.0001) after the onset of DM. The increase in the number of OX1R-positive cells is associated with a high degree of co-localization with GLU. The number of GLU-positive cells expressing OX1R was significantly (p < 0.0001) higher after the onset of DM. The tissue level of OX1R protein increased with the duration of DM especially in type 1 diabetes where it co-localized with cleaved caspase 3 in islet cells. In comparison to STZ-treated wild type mice, STZ-treated OX-/- animals exhibited reduced hyperglycemia and handled glucose more efficiently in glucose tolerance test. The findings suggest an important role for the OX-OX1R pathway in STZ-induced experimental diabetes.	[Adeghate, Ernest; Hameed, Rashed] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Anat, Al Ain, U Arab Emirates; [Fernandez-Cabezudo, Maria] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [El-Hasasna, Hussain; al-Ramadi, Basel] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Med Microbiol, Al Ain, U Arab Emirates; [El Wasila, Mohamed] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pharmacol, Al Ain, U Arab Emirates; [Abbas, Tariq] Dept Agr, Vet Lab, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; United Arab Emirates University	Adeghate, E (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Anat, Al Ain, U Arab Emirates.	eadeghate@uaeu.ac.ae	Adeghate, Ernest A/A-9939-2012	Adeghate, Ernest/0000-0002-1439-1562	United Arab Emirates University, Al Ain, UAE	United Arab Emirates University, Al Ain, UAE	This study was supported by a research grant from the United Arab Emirates University, Al Ain, UAE. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E., 2005, Biogenic Amines, V19, P347, DOI 10.1163/156939105774647402; Adeghate E, 2004, PANCREAS, V29, P311, DOI 10.1097/00006676-200411000-00011; Adeghate E, 2004, MOL CELL BIOCHEM, V261, P187, DOI 10.1023/B:MCBI.0000028755.86521.11; Adeghate E, 2001, PEPTIDES, V22, P99, DOI 10.1016/S0196-9781(00)00361-2; Adeghate E, 2000, TISSUE CELL, V32, P266, DOI 10.1054/tice.2000.0107; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; BERNARDIS LL, 1993, NEUROSCI BIOBEHAV R, V17, P141, DOI 10.1016/S0149-7634(05)80149-6; Bingham S, 2001, PAIN, V92, P81, DOI 10.1016/S0304-3959(00)00470-X; BRAY GA, 1984, INT J OBESITY, V8, P119; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; Ehrstrom M, 2003, AM J PHYSIOL-GASTR L, V285, pG688, DOI 10.1152/ajpgi.00061.2003; El Firar A, 2009, FASEB J, V23, P4069, DOI 10.1096/fj.09-131367; GIROIX MH, 1993, ENDOCRINOLOGY, V132, P815, DOI 10.1210/en.132.2.815; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harrold Joanne A, 2006, Recent Pat CNS Drug Discov, V1, P305, DOI 10.2174/157488906778773616; Johren O, 2001, ENDOCRINOLOGY, V142, P3324, DOI 10.1210/en.142.8.3324; KAMBOJ SS, 2009, J NEUROCHEM; Katsuura G, 2002, PEPTIDES, V23, P323, DOI 10.1016/S0196-9781(01)00604-0; Kirchgessner AL, 1999, NEURON, V24, P941, DOI 10.1016/S0896-6273(00)81041-7; Kiwaki K, 2004, AM J PHYSIOL-ENDOC M, V286, pE551, DOI 10.1152/ajpendo.00126.2003; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; LABURTHE M, 2009, ACTA PHYSL OXF; LAMBERT DG, 1989, J ENDOCRINOL, V121, P479, DOI 10.1677/joe.0.1210479; Lu XY, 2000, HORM BEHAV, V37, P335, DOI 10.1006/hbeh.2000.1584; Madsen OD, 1996, EUR J BIOCHEM, V242, P435, DOI 10.1111/j.1432-1033.1996.435rr.x; Marciano C. R., 2001, Revista Brasileira de Ciencia do Solo, V25, P1, DOI 10.1590/S0100-06832001000100001; Matsuki Taizo, 2008, V46, P27, DOI 10.1007/400_2007_047; Miyasaka K, 2002, PANCREAS, V25, P400, DOI 10.1097/00006676-200211000-00013; Mondal MS, 1999, BIOCHEM BIOPH RES CO, V256, P495, DOI 10.1006/bbrc.1999.0362; Naslund E, 2002, AM J PHYSIOL-GASTR L, V282, pG470, DOI 10.1152/ajpgi.00219.2001; Nowak KW, 1999, LIFE SCI, V66, P449; Ouedraogo R, 2003, DIABETES, V52, P111, DOI 10.2337/diabetes.52.1.111; Randeva HS, 2001, J CLIN ENDOCR METAB, V86, P4808, DOI 10.1210/jc.86.10.4808; Russo F, 2008, ANAT REC, V291, P169, DOI 10.1002/ar.20641; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sinton CM, 2004, SEMIN NEUROL, V24, P211, DOI 10.1055/s-2004-835067; Voisin T, 2003, CELL MOL LIFE SCI, V60, P72, DOI 10.1007/s000180300005; Voisin T, 2008, FASEB J, V22, P1993, DOI 10.1096/fj.07-098723; Yamada H, 2000, BIOCHEM BIOPH RES CO, V267, P527, DOI 10.1006/bbrc.1999.1998; ZAMBONI L, 1967, J CELL BIOL, V35, pA148; Zhang X. F., 2000, SMJ, V41, P9	41	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8587	10.1371/journal.pone.0008587	http://dx.doi.org/10.1371/journal.pone.0008587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062799	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338600011
J	Wang, HY; Moreau, F; Hirota, CL; MacNaughton, WK				Wang, Hongying; Moreau, France; Hirota, Christina L.; MacNaughton, Wallace K.			Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation	FASEB JOURNAL			English	Article						inflammation; chemokine; epithelium; NF-kappa B; transcription	NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; NUCLEAR-LOCALIZATION; ULCERATIVE-COLITIS; OXIDATIVE STRESS; GENE-EXPRESSION; BETA-CATENIN; CANCER CELLS; PHOSPHORYLATION; MECHANISM	Proteinase-activated receptors (PARs) are involved in both inflammation and tumorigenesis in epithelial cells. Interleukin (IL)-8 is a potent chemoattractant and is also involved in angiogenesis. The molecular mechanism whereby PARs induce epithelial IL-8 expression is not known. In HT-29 colonic epithelial cells, PAR(1) or PAR(2) agonists stimulated the expression of IL-8 through a NF-kappa B-dependent pathway without inducing I kappa B degradation and disassociation of I kappa B from NF-kappa B. Further studies revealed that PAR activation induced the phosphorylation of p65 at Ser-276 in the nucleus, which increased the recruitment of histone acetyltransferase (HAT) p300 to p50. Inhibition of ERK activation completely blocked PAR-induced IL-8 expression, phosphorylation of p65 and HAT activity. We also demonstrated that RSK p90 was the downstream kinase that mediated ERK-induced nuclear p65 phosphorylation. In conclusion, activation of either PAR(1) or PAR(2) stimulated the transcriptional up-regulation of IL-8 in HT-29 colonic epithelial cells through a pathway that involved ERK/RSK p90, NF-kappa B phosphorylation, and HAT activity. These studies provide evidence of a new role for serine proteinases and PARs in the regulation of gene expression in colonic inflammation and tumorigenesis.-Wang, H., Moreau, F., Hirota, C. L., MacNaughton, W. K. Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation. FASEB J. 24, 1971-1980 (2010). www.fasebj.org	[Moreau, France; Hirota, Christina L.; MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Wang, Hongying; Moreau, France; Hirota, Christina L.; MacNaughton, Wallace K.] Univ Calgary, Inflammat Res Network, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	MacNaughton, WK (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	wmacnaug@ucalgary.ca	Hirota, Christina/AAS-8585-2020	Hirota, Christina/0000-0003-0799-2041; Wang, Hongying/0000-0001-8443-3839	Crohn's and Colitis Foundation of Canada (CCFC); CIHR; Canadian Association of Gastroenterology (CAG); CCFC; Abbott Laboratories	Crohn's and Colitis Foundation of Canada (CCFC); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology (CAG); CCFC; Abbott Laboratories(Abbott Laboratories)	This work was supported by a grant from the Crohn's and Colitis Foundation of Canada (CCFC) to W.K.M. H.W. was the recipient of a postdoctoral award from the CIHR, the Canadian Association of Gastroenterology (CAG) and CCFC. C.L.H. was the recipient of a postdoctoral award from the CIHR, CAG and Abbott Laboratories. The authors gratefully acknowledge Dr. Andrew Keates (Beth Israel Deaconess Medical Center, Boston, MA, USA) and Dr. Joan Boyes (Leeds University, Leeds, UK) for providing the constructs for the IL-8 luciferase reporter and p300, respectively.	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Brannigan AE, 2000, SHOCK, V13, P361, DOI 10.1097/00024382-200005000-00003; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chiu YC, 2008, MOL IMMUNOL, V45, P1587, DOI 10.1016/j.molimm.2007.10.004; Danese S, 2007, CURR MED CHEM, V14, P649, DOI 10.2174/092986707780059599; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; ECKMANN L, 1993, GASTROENTEROLOGY, V105, P1689, DOI 10.1016/0016-5085(93)91064-O; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Grimm MC, 1996, GUT, V38, P90, DOI 10.1136/gut.38.1.90; Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hou L, 1998, IMMUNOLOGY, V94, P356, DOI 10.1046/j.1365-2567.1998.00528.x; IZZO RS, 1992, AM J GASTROENTEROL, V87, P1447; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim JA, 2003, INFLAMM BOWEL DIS, V9, P224, DOI 10.1097/00054725-200307000-00002; Koutroubakis IE, 2006, INFLAMM BOWEL DIS, V12, P515, DOI 10.1097/00054725-200606000-00012; LEBERRE N, 1995, J CLIN PATHOL, V48, P749, DOI 10.1136/jcp.48.8.749; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MacNaughton WK, 2005, MEM I OSWALDO CRUZ, V100, P211, DOI 10.1590/S0074-02762005000900036; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Page K, 2005, AM J RESP CELL MOL, V32, P225, DOI 10.1165/rcmb.2004-0231OC; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Tomita K, 2003, BIOCHEM BIOPH RES CO, V301, P572, DOI 10.1016/S0006-291X(02)03029-2; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Vergnolle N, 2004, J CLIN INVEST, V114, P1444, DOI 10.1172/JCI200421689; Wang H, 2002, AM J PHYSIOL-CELL PH, V283, pC1351, DOI 10.1152/ajpcell.00001.2002; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; Wang HY, 2005, CANCER RES, V65, P8604, DOI 10.1158/0008-5472.CAN-05-1169; Yoza BK, 1996, J BIOL CHEM, V271, P18306, DOI 10.1074/jbc.271.31.18306; Zhang LP, 2005, ARTERIOSCL THROM VAS, V25, P1148, DOI 10.1161/01.ATV.0000164624.00099.e7; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	48	33	33	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1971	1980		10.1096/fj.09-137646	http://dx.doi.org/10.1096/fj.09-137646			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20065107				2022-12-25	WOS:000278200000031
J	Boysen, A; Moller-Jensen, J; Kallipolitis, B; Valentin-Hansen, P; Overgaard, M				Boysen, Anders; Moller-Jensen, Jakob; Kallipolitis, Birgitte; Valentin-Hansen, Poul; Overgaard, Martin			Translational Regulation of Gene Expression by an Anaerobically Induced Small Non-coding RNA in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERODIMERIC ABC TRANSPORTER; SM-LIKE PROTEIN; OUTER-MEMBRANE; FNR PROTEIN; SUPEROXIDE-DISMUTASE; TARGET RECOGNITION; OXIDATIVE STRESS; HFQ; TRANSCRIPTION; MANGANESE	Small non-coding RNAs (sRNA) have emerged as important elements of gene regulatory circuits. In enterobacteria such as Escherichia coli and Salmonella many of these sRNAs interact with the Hfq protein, an RNA chaperone similar to mammalian Sm-like proteins and act in the post-transcriptional regulation of many genes. A number of these highly conserved ribo-regulators are stringently regulated at the level of transcription and are part of major regulons that deal with the immediate response to various stress conditions, indicating that every major transcription factor may control the expression of at least one sRNA regulator. Here, we extend this view by the identification and characterization of a highly conserved, anaerobically induced small sRNA in E. coli, whose expression is strictly dependent on the anaerobic transcriptional fumarate and nitrate reductase regulator (FNR). The sRNA, named FnrS, possesses signatures of base-pairing RNAs, and we show by employing global proteomic and transcriptomic profiling that the expression of multiple genes is negatively regulated by the sRNA. Intriguingly, many of these genes encode enzymes with "aerobic" functions or enzymes linked to oxidative stress. Furthermore, in previous work most of the potential target genes have been shown to be repressed by FNR through an undetermined mechanism. Collectively, our results provide insight into the mechanism by which FNR negatively regulates genes such as sodA, sodB, cydDC, and metE, thereby demonstrating that adaptation to anaerobic growth involves the action of a small regulatory RNA.	[Boysen, Anders; Moller-Jensen, Jakob; Kallipolitis, Birgitte; Valentin-Hansen, Poul; Overgaard, Martin] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Southern Denmark	Valentin-Hansen, P (corresponding author), Campusvej 55, DK-5230 Odense M, Denmark.	valentin@bmb.sdu.dk	Møller-Jensen, Jakob/AAO-8480-2020	Møller-Jensen, Jakob/0000-0002-6008-3771; Kallipolitis, Birgitte H./0000-0003-1233-9776; Overgaard, Martin/0000-0003-2277-590X; Boysen, Anders/0000-0001-9171-6669	Danish National Research Foundation; Lundbeck Foundation; Danish Natural Science Research Council	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Danish Natural Science Research Council(Danish Natural Science Research Council)	This work was supported by the Danish National Research Foundation (Grundforskningsfonden), The Lundbeck Foundation, and the Danish Natural Science Research Council.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arluison V, 2007, NUCLEIC ACIDS RES, V35, P999, DOI 10.1093/nar/gkl1124; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BEAUMONT MD, 1993, J GEN MICROBIOL, V139, P2677, DOI 10.1099/00221287-139-11-2677; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; COMPAN I, 1993, J BACTERIOL, V175, P1687, DOI 10.1128/JB.175.6.1687-1696.1993; COMPAN I, 1994, MOL MICROBIOL, V11, P955, DOI 10.1111/j.1365-2958.1994.tb00374.x; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Cook GM, 1997, J BACTERIOL, V179, P6525, DOI 10.1128/jb.179.20.6525-6530.1997; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; Delihas N, 2001, J MOL BIOL, V313, P1, DOI 10.1006/jmbi.2001.5029; DURAND S, 2010, MOL MICROBI IN PRESS; Franch T, 1997, J MOL BIOL, V273, P38, DOI 10.1006/jmbi.1997.1294; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; GUEST RJ, 1996, REGULATION GENE EXPR, P317; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; HASSAN HM, 1992, P NATL ACAD SCI USA, V89, P3217, DOI 10.1073/pnas.89.8.3217; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; HOPKIN KA, 1992, J BIOL CHEM, V267, P24253; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Li B, 1998, NUCLEIC ACIDS RES, V26, P2075, DOI 10.1093/nar/26.9.2075; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Melville SB, 1996, P NATL ACAD SCI USA, V93, P1226, DOI 10.1073/pnas.93.3.1226; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; POOLE RK, 1994, FEMS MICROBIOL LETT, V117, P217, DOI 10.1111/j.1574-6968.1994.tb06768.x; Prokhorova TA, 2006, VACCINE, V24, P6446, DOI 10.1016/j.vaccine.2006.05.085; Rasmussen AA, 2009, MOL MICROBIOL, V72, P566, DOI 10.1111/j.1365-2958.2009.06688.x; Rogowska-Wrzesinska A, 2001, COMP FUNCT GENOM, V2, P207, DOI 10.1002/cfg.94; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Sambrook J., 1989, MOL CLONING LAB MANU, P3; SAWERS RG, 1988, ARCH MICROBIOL, V149, P240, DOI 10.1007/BF00422011; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; SMITH MW, 1983, J BACTERIOL, V154, P336, DOI 10.1128/JB.154.1.336-343.1983; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Urban Johannes H., 2009, V540, P301, DOI 10.1007/978-1-59745-558-9_22; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vanderpool CK, 2007, CURR OPIN MICROBIOL, V10, P146, DOI 10.1016/j.mib.2007.03.011; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	83	90	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10690	10702		10.1074/jbc.M109.089755	http://dx.doi.org/10.1074/jbc.M109.089755			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20075074	Green Published, hybrid			2022-12-25	WOS:000276264600056
J	Zhu, XG; Zhao, L; Willingham, MC; Cheng, SY				Zhu, X-G; Zhao, L.; Willingham, M. C.; Cheng, S-Y			Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma	ONCOGENE			English	Article						thyroid cancer; mouse model; mutations of thyroid hormone receptors	DOMINANT-NEGATIVE ACTIVITY; SECRETING PITUITARY-TUMOR; TRANSFORMING GENE PTTG; CLEAR-CELL CARCINOMA; LINKED KINASE ILK; BETA-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; NUCLEAR RECEPTORS; TRANSGENIC MICE; V-ERBA	Aberrant expression and mutations of thyroid hormone receptor genes (TRs) are closely associated with several types of human cancers. To test the hypothesis that TRs could function as tumor suppressors, we took advantage of mice with deletion of all functional TRs (TR alpha 1(-/-)TR beta(-/-) mice). As these mice aged, they spontaneously developed follicular thyroid carcinoma with pathological progression from hyperplasia to capsular invasion, vascular invasion, anaplasia and metastasis to the lung, similar to human thyroid cancer. Detailed molecular analysis revealed that known tumor promoters such as pituitary tumor-transforming gene were activated and tumor suppressors such as peroxisome proliferator-activated receptor gamma and p53 were suppressed during carcinogenesis. In addition, consistent with the human cancer, AKT-mTOR-p70(S6K) signaling and vascular growth factor and its receptor were activated to facilitate tumor progression. This report presents in vivo evidence that functional loss of both TR alpha 1 and TR beta genes promotes tumor development and metastasis. Thus, TRs could function as tumor suppressors in a mouse model of metastatic follicular thyroid cancer. Oncogene (2010) 29, 1909-1919; doi:10.1038/onc.2009.476; published online 11 January 2010	[Zhu, X-G; Zhao, L.; Cheng, S-Y] NCI, Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Willingham, M. C.] Wake Forest Univ, Dept Pathol, Winston Salem, NC 27109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Wake Forest University	Cheng, SY (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, 37 Convent Dr,Room 5128, Bethesda, MD 20892 USA.	chengs@mail.nih.gov			Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC008752, ZIABC011191] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. We thank Drs H Ying and Y Kato for the analyses of survival curves and thyroid growth in the early phase of the present work.	Ando S, 2001, MOL ENDOCRINOL, V15, P1529, DOI 10.1210/me.15.9.1529; Ando S, 2001, J CLIN ENDOCR METAB, V86, P5572, DOI 10.1210/jc.86.11.5572; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; CHEN HW, 1993, MOL CELL BIOL, V13, P5970, DOI 10.1128/MCB.13.10.5970; Davis PJ, 2008, FRONT NEUROENDOCRIN, V29, P211, DOI 10.1016/j.yfrne.2007.09.003; Fagin JA, 2002, MOL ENDOCRINOL, V16, P903, DOI 10.1210/me.16.5.903; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Furuya F, 2009, STEROIDS, V74, P628, DOI 10.1016/j.steroids.2008.10.009; Garcia-Silva S, 2004, MOL CELL BIOL, V24, P7514, DOI 10.1128/MCB.24.17.7514-7523.2004; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Guigon CJ, 2008, MOL CELL BIOL, V28, P4598, DOI 10.1128/MCB.02192-07; Heaney AP, 2001, J CLIN ENDOCR METAB, V86, P5025, DOI 10.1210/jc.86.10.5025; Herwig S, 1997, EUR J BIOCHEM, V246, P581, DOI 10.1111/j.1432-1033.1997.t01-2-00581.x; Kamiya Y, 2002, CARCINOGENESIS, V23, P25, DOI 10.1093/carcin/23.1.25; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Kato Y, 2006, ONCOGENE, V25, P2736, DOI 10.1038/sj.onc.1209299; Kato Y, 2004, ENDOCRINOLOGY, V145, P4430, DOI 10.1210/en.2004-0612; Kim CS, 2007, CARCINOGENESIS, V28, P932, DOI 10.1093/carcin/bgl231; Kim DS, 2006, J CLIN ENDOCR METAB, V91, P4603, DOI 10.1210/jc.2006-1291; Kim DS, 2003, CLIN OTOLARYNGOL, V28, P386, DOI 10.1046/j.1365-2273.2003.00732.x; Lawal O, 2001, EUR J SURG ONCOL, V27, P157, DOI 10.1053/ejso.2000.1085; LEDENT C, 1992, EMBO J, V11, P537, DOI 10.1002/j.1460-2075.1992.tb05084.x; Li Z, 2002, CANCER RES, V62, P1939; Lin KH, 1999, MOL CARCINOGEN, V26, P53, DOI 10.1002/(SICI)1098-2744(199909)26:1<53::AID-MC7>3.0.CO;2-Z; MAEDA K, 1995, J CLIN ONCOL, V13, P477, DOI 10.1200/JCO.1995.13.2.477; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; McCabe CJ, 2002, J CLIN ENDOCR METAB, V87, P4238, DOI 10.1210/jc.2002-020309; MEIER CA, 1992, MOL ENDOCRINOL, V6, P248, DOI 10.1210/me.6.2.248; MICHIELS FM, 1994, P NATL ACAD SCI USA, V91, P10488, DOI 10.1073/pnas.91.22.10488; Miyakawa M, 2003, ENDOCR J, V50, P77, DOI 10.1507/endocrj.50.77; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Puzianowska-Kuznicka M, 2002, J CLIN ENDOCR METAB, V87, P1120, DOI 10.1210/jc.87.3.1120; Puzianowska-Kuznicka M, 2000, CANCER LETT, V155, P145, DOI 10.1016/S0304-3835(00)00416-X; Puzianowska-Kuznicka M, 2006, ACTA BIOCHIM POL, V53, P641, DOI 10.18388/abp.2006_3292; Ringel MD, 2001, CANCER RES, V61, P6105; Safer JD, 2001, THYROID, V11, P281, DOI 10.1089/105072501750159750; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shen WT, 2005, THYROID, V15, P594, DOI 10.1089/thy.2005.15.594; Suzuki H, 2003, MOL ENDOCRINOL, V17, P895, DOI 10.1210/me.2002-0326; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Takano T, 2003, J CLIN ENDOCR METAB, V88, P3447, DOI 10.1210/jc.2003-030012; Teresi RE, 2008, PPAR RES, V2008, DOI 10.1155/2008/932632; Thormeyer D, 1999, INT J MOL MED, V4, P351; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 2000, ONCOGENE, V19, P5444, DOI 10.1038/sj.onc.1203928; Turpeenniemi-Hujanen T, 2005, BIOCHIMIE, V87, P287, DOI 10.1016/j.biochi.2005.01.014; Ward J M, 1986, Adv Exp Med Biol, V206, P529; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Weiss R E, 2000, Rev Endocr Metab Disord, V1, P97, DOI 10.1023/A:1010072605757; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; YEN PM, 1994, J BIOL CHEM, V269, P903; Ying H, 2003, CANCER RES, V63, P5274; Ying H, 2003, CARCINOGENESIS, V24, P1467, DOI 10.1093/carcin/bgg111; Ying H, 2006, J CLIN INVEST, V116, P2972, DOI 10.1172/JCI28598; Zeiger MA, 1997, ENDOCRINOLOGY, V138, P3133, DOI 10.1210/en.138.8.3133; Zhang XY, 2002, MOL ENDOCRINOL, V16, P2077, DOI 10.1210/me.2002-0080; Zimonjic DB, 2005, CANCER GENET CYTOGEN, V161, P104, DOI 10.1016/j.cancergencyto.2005.02.007	63	41	42	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	13					1909	1919		10.1038/onc.2009.476	http://dx.doi.org/10.1038/onc.2009.476			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20062085	Green Accepted			2022-12-25	WOS:000276199600004
J	Jang, PG; Namkoong, C; Kang, GM; Hur, MW; Kim, SW; Kim, GH; Kang, Y; Jeon, MJ; Kim, EH; Lee, MS; Karin, M; Baik, JH; Park, JY; Lee, KU; Kim, YB; Kim, MS				Jang, Pil-Geum; Namkoong, Cherl; Kang, Gil Myoung; Hur, Man-Wook; Kim, Seung-Whan; Kim, Geun Hyang; Kang, Yeoungsup; Jeon, Min-Jae; Kim, Eun Hee; Lee, Myung-Shik; Karin, Michael; Baik, Ja-Hyun; Park, Joong-Yeol; Lee, Ki-Up; Kim, Young-Bum; Kim, Min-Seon			NF-kappa B Activation in Hypothalamic Pro-opiomelanocortin Neurons Is Essential in Illness- and Leptin-induced Anorexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOOD-INTAKE; RECEPTOR; ALPHA; CACHEXIA; PROTEIN; LIPOPOLYSACCHARIDE; PHOSPHORYLATION; SUPPRESSION; EXPRESSION; CYTOKINES	Anorexia and weight loss are prevalent in infectious diseases. To investigate the molecular mechanisms underlying these phenomena, we established animal models of infection-associated anorexia by administrating bacterial and viral products, lipopolysaccharide (LPS) and human immunodeficiency virus-1 transactivator protein (Tat). In these models, we found that the nuclear factor-kappa B (NF-kappa B), a pivotal transcription factor for inflammation-related proteins, was activated in the hypothalamus. In parallel, administration of LPS and Tat increased hypothalamic pro-inflammatory cytokine production, which was abrogated by inhibition of hypothalamic NF-kappa B. In vitro, NF-kappa B activation directly stimulated the transcriptional activity of proopiomelanocortin (POMC), a precursor of anorexigenic melanocortin, and mediated the stimulatory effects of LPS, Tat, and pro-inflammatory cytokines on POMC transcription, implying the involvement of NF-kappa B in controlling feeding behavior. Consistently, hypothalamic injection of LPS and Tat caused a significant reduction in food intake and body weight, which was prevented by blockade of NF-kappa B and melanocortin. Furthermore, disruption of I kappa B kinase-beta, an upstream kinase of NF-kappa B, in POMC neurons attenuated LPS- and Tat-induced anorexia. These findings suggest that infection-associated anorexia and weight loss are mediated via NF-kappa B activation in hypothalamic POMC neurons. In addition, hypothalamic NF-kappa B was activated by leptin, an important anorexigenic hormone, and mediates leptin-stimulated POMC transcription, indicating that hypothalamic NF-kappa B also serves as a downstream signaling pathway of leptin.	[Kim, Min-Seon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Seoul 138736, South Korea; [Jang, Pil-Geum; Namkoong, Cherl; Kang, Gil Myoung; Kang, Yeoungsup; Jeon, Min-Jae] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea; [Kim, Seung-Whan; Kim, Geun Hyang] Univ Ulsan, Coll Med, Dept Pharmacol, Seoul 138736, South Korea; [Hur, Man-Wook] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 120752, South Korea; [Lee, Myung-Shik] Sungkyunkwan Univ, Sch Med, Dept Med, Seoul 135710, South Korea; [Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Baik, Ja-Hyun] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA 02215 USA	University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); University of California System; University of California San Diego; Korea University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kim, MS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Endocrinol & Metab, 388-1 Pungnap Dong, Seoul 138736, South Korea.	mskim@amc.seoul.kr	Choi, Hyung Jin/AAU-9629-2020; Lee, Myung Shik/C-9606-2011	Lee, Myung-Shik/0000-0003-3292-1720; Kim, Seung-Whan/0000-0001-6983-0481; Hur, Man-Wook/0000-0002-3416-1334; NamKoong, Cherl/0000-0002-1869-4405	Korean Ministry of Health Welfare [A06-2363]; Korea government [2006-0050225, 2007-0056866, 2009-0079566, KRF-2008-313-E00083, 2009-0084114]; Asan Institute for Life Science [06-326]	Korean Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea government(Korean Government); Asan Institute for Life Science	This work was supported by the Korean Ministry of Health & Welfare (Grant A06-2363), the National Research Foundation of Korea funded by the Korea government (Grants 2006-0050225, 2007-0056866, 2009-0079566, KRF-2008-313-E00083, and 2009-0084114), and the Asan Institute for Life Science (Grant 06-326).	AUBERT A, 1995, PHYSIOL BEHAV, V57, P869, DOI 10.1016/0031-9384(94)00391-H; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Catania A, 2000, TRENDS ENDOCRIN MET, V11, P304, DOI 10.1016/S1043-2760(00)00296-4; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; DeBoer MD, 2007, CURR OPIN CLIN NUTR, V10, P457, DOI 10.1097/MCO.0b013e328108f441; Ellacott KLJ, 2006, PHILOS T R SOC B, V361, P1265, DOI 10.1098/rstb.2006.1861; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Grinspoon S, 2003, CLIN INFECT DIS, V36, pS69, DOI 10.1086/367561; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864; Joppa MA, 2007, PEPTIDES, V28, P636, DOI 10.1016/j.peptides.2006.11.021; Joppa MA, 2005, PEPTIDES, V26, P2294, DOI 10.1016/j.peptides.2005.03.002; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kawamura I, 1999, GENE THER, V6, P91, DOI 10.1038/sj.gt.3300819; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; LANGHANS W, 1990, PHYSIOL BEHAV, V47, P805, DOI 10.1016/0031-9384(90)90001-K; Lawrence CB, 2001, J NEUROENDOCRINOL, V13, P490, DOI 10.1046/j.1365-2826.2001.00660.x; Marks DL, 2003, ENDOCRINOLOGY, V144, P1513, DOI 10.1210/en.2002-221099; MCCARTHY DO, 1984, AM J CLIN NUTR, V40, P310, DOI 10.1093/ajcn/40.2.310; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; MURRAY MJ, 1979, AM J CLIN NUTR, V32, P593, DOI 10.1093/ajcn/32.3.593; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Plata-Salaman C, 2001, INT J OBESITY, V25, pS48, DOI 10.1038/sj.ijo.0801911; Plata-Salaman CR, 1998, AM J PHYSIOL-REG I, V275, pR566, DOI 10.1152/ajpregu.1998.275.2.R566; Raso GM, 2006, NEUROSCI LETT, V396, P121, DOI 10.1016/j.neulet.2005.11.022; RICE AP, 1988, NATURE, V332, P551, DOI 10.1038/332551a0; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wisse BE, 2003, ANN NY ACAD SCI, V994, P275, DOI 10.1111/j.1749-6632.2003.tb03190.x; Wisse BE, 2007, ENDOCRINOLOGY, V148, P5230, DOI 10.1210/en.2007-0394; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yang Li, 2007, Neurosci Bull, V23, P307, DOI 10.1007/s12264-007-0046-6; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	42	67	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9706	9715		10.1074/jbc.M109.070706	http://dx.doi.org/10.1074/jbc.M109.070706			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097762	Green Published, hybrid			2022-12-25	WOS:000276165900043
J	Mao, AP; Li, S; Zhong, B; Li, Y; Yan, J; Li, Q; Teng, CW; Shu, HB				Mao, Ai-Ping; Li, Shu; Zhong, Bo; Li, Ying; Yan, Jie; Li, Qi; Teng, Chengwen; Shu, Hong-Bing			Virus-triggered Ubiquitination of TRAF3/6 by cIAP1/2 Is Essential for Induction of Interferon-beta (IFN-beta) and Cellular Antiviral Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NEGATIVE REGULATION; SIGNALING COMPLEX; ADAPTER PROTEIN; ACTIVATION PATHWAYS; I INTERFERON; LIGASE; INNATE; KINASE; TRANSDUCTION	Viral infection causes activation of transcription factors NF-kappa B and IRF3, which collaborate to induce type I interferons (IFNs) and cellular antiviral response. Here we show that knockdown of the E3 ubiquitin ligases cIAP1 and cIAP2 markedly inhibited virus-triggered activation of IRF3 and NF-kappa B as well as IFN-beta induction. Knockdown of cIAP1 and cIAP2 also inhibited cytoplasmic dsRNA-triggered cellular antiviral response. Endogenous coimmunoprecipitation experiments indicated that viral infection caused recruitment of cIAP1 and cIAP2 to TRAF3, TRAF6, and VISA. Furthermore, we demonstrated that cIAP1- and cIAP2-mediated virus-triggered ubiquitination of TRAF3 and TRAF6. These findings suggest that virus-triggered ubiquitination of TRAF3 and TRAF6 by cIAP1 and cIAP2 is essential for type I IFN induction and cellular antiviral response.	[Mao, Ai-Ping; Li, Shu; Zhong, Bo; Li, Ying; Yan, Jie; Li, Qi; Teng, Chengwen; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn	Teng, Chengwen/G-8393-2019	Teng, Chengwen/0000-0001-9239-2125	Chinese 973 Program [2006CB504301, 2010CB911802]; National Natural Science Foundation of China [30630019, 30921001]; Chinese Science and Technology Key Project [2008ZX10002-014]; Chinese 111 project [B06018]	Chinese 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Science and Technology Key Project; Chinese 111 project(Ministry of Education, China - 111 Project)	This work was supported by grants from the Chinese 973 Program (2006CB504301, 2010CB911802), the National Natural Science Foundation of China (30630019 and 30921001), the Chinese Science and Technology Key Project (2008ZX10002-014), and the Chinese 111 project (B06018).	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang Y, 2008, T NONFERR METAL SOC, V18, P1094, DOI 10.1016/S1003-6326(08)60187-9; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	36	105	113	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9470	9476		10.1074/jbc.M109.071043	http://dx.doi.org/10.1074/jbc.M109.071043			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097753	hybrid, Green Published			2022-12-25	WOS:000276165900020
J	Sunagawa, Y; Morimoto, T; Takaya, T; Kaichi, S; Wada, H; Kawamura, T; Fujita, M; Shimatsu, A; Kita, T; Hasegawa, K				Sunagawa, Yoichi; Morimoto, Tatsuya; Takaya, Tomohide; Kaichi, Shinji; Wada, Hiromichi; Kawamura, Teruhisa; Fujita, Masatoshi; Shimatsu, Akira; Kita, Toru; Hasegawa, Koji			Cyclin-dependent Kinase-9 Is a Component of the p300/GATA4 Complex Required for Phenylephrine-induced Hypertrophy in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE ACETYLTRANSFERASE ACTIVITY; TRANSCRIPTION FACTOR GATA-4; P-TEFB; CARDIAC MYOCYTES; HEART-FAILURE; IN-VIVO; COACTIVATOR P300; GENE-EXPRESSION; CDK9/CYCLIN T2	A zinc finger protein GATA4 is one of the hypertrophy-responsive transcription factors and forms a complex with an intrinsic histone acetyltransferase, p300. Disruption of this complex results in the inhibition of cardiomyocyte hypertrophy and heart failure in vivo. By tandem affinity purification and mass spectrometric analyses, we identified cyclin-dependent kinase-9 (Cdk9) as a novel GATA4-binding partner. Cdk9 also formed a complex with p300 as well as GATA4 and cyclin T1. We showed that p300 was required for the interaction of GATA4 with Cdk9 and for the kinase activity of Cdk9. Conversely, Cdk9 kinase activity was required for the p300-induced transcriptional activities, DNA binding, and acetylation of GATA4. Furthermore, the kinase activity of Cdk9 was required for the phosphorylation of p300 as well as for cardiomyocyte hypertrophy. These findings demonstrate that Cdk9 forms a functional complex with the p300/GATA4 and is required for p300/GATA4-transcriptional pathway during cardiomyocyte hypertrophy.	[Sunagawa, Yoichi; Morimoto, Tatsuya; Takaya, Tomohide; Kaichi, Shinji; Wada, Hiromichi; Kawamura, Teruhisa; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Fushimi Ku, Kyoto 6128555, Japan; [Shimatsu, Akira] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Fushimi Ku, Kyoto 6128555, Japan; [Takaya, Tomohide; Kita, Toru] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan; [Kaichi, Shinji] Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Morimoto, T (corresponding author), Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	mori@kuhp.kyoto-u.ac.jp	Sunagawa, Yoichi/AAU-6354-2021; Shimatsu, Akira/I-3856-2019; Takaya, Tomohide/D-6372-2012	Takaya, Tomohide/0000-0002-3610-0906; Wada, Hiromichi/0000-0002-8980-224X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Science and Medical Care	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Ichiro Kanehara Foundation for the Promotion of Medical Science and Medical Care	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.H. and T.M.) and by grants (to T.M.) from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, Takeda Science Foundation, Mitsubishi Pharma Research Foundation, The Uehara Memorial Foundation, and The Ichiro Kanehara Foundation for the Promotion of Medical Science and Medical Care.	Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Chan HM, 2001, J CELL SCI, V114, P2363; Charron F, 1999, MOL CELL BIOL, V19, P4355; Dai YS, 2001, J BIOL CHEM, V276, P37178, DOI 10.1074/jbc.M103731200; Dominguez L J, 1999, Cardiologia, V44, P801; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Fu JHJ, 2007, MOL CELL BIOL, V27, P4641, DOI 10.1128/MCB.00857-06; Giacinti C, 2006, J CELL PHYSIOL, V206, P807, DOI 10.1002/jcp.20523; Hirai M, 2004, J BIOL CHEM, V279, P37640, DOI 10.1074/jbc.M401737200; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Kakita T, 1999, J BIOL CHEM, V274, P34096, DOI 10.1074/jbc.274.48.34096; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Kawamura T, 2004, BIOCHEM BIOPH RES CO, V315, P733, DOI 10.1016/j.bbrc.2004.01.105; Li HL, 2008, J CLIN INVEST, V118, P879, DOI 10.1172/JCI32865; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liou LY, 2002, J VIROL, V76, P10579, DOI 10.1128/JVI.76.21.10579-10587.2002; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morimoto T, 2000, J BIOL CHEM, V275, P13721, DOI 10.1074/jbc.275.18.13721; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tanaka T, 2006, J BIOL CHEM, V281, P15320, DOI 10.1074/jbc.M510954200; Temsah R, 2005, REGUL PEPTIDES, V128, P177, DOI 10.1016/j.regpep.2004.12.026; Tian YN, 2003, J BIOL CHEM, V278, P44041, DOI 10.1074/jbc.M306443200; Verdecchia P, 2001, J AM COLL CARDIOL, V38, P1829, DOI 10.1016/S0735-1097(01)01663-1; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009	50	58	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9556	9568		10.1074/jbc.M109.070458	http://dx.doi.org/10.1074/jbc.M109.070458			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20081228	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000276165900029
J	Fernandez-Messina, L; Ashiru, O; Boutet, P; Aguera-Gonzalez, S; Skepper, JN; Reyburn, HT; Vales-Gomez, M				Fernandez-Messina, Lola; Ashiru, Omodele; Boutet, Philippe; Aguera-Gonzalez, Sonia; Skepper, Jeremy N.; Reyburn, Hugh T.; Vales-Gomez, Mar			Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-RELATED MOLECULES; CLASS-I; EXPRESSION; NK; RECEPTOR; RELEASE; MICA; PROTEINS; IMMUNORECEPTOR; CYTOTOXICITY	Tumor cells release NKG2D ligands to evade NKG2D-mediated immune surveillance. The purpose of our investigation was to explore the cellular mechanisms of release used by various members of the ULBP family. Using biochemical and cellular approaches in both transfectant systems and tumor cell lines, this paper shows that ULBP1, ULBP2, and ULBP3 are released from cells with different kinetics and by distinct mechanisms. Whereas ULBP2 is mainly shed by metalloproteases, ULBP3 is abundantly released as part of membrane vesicles known as exosomes. Interestingly, exosomal ULBP3 protein is much more potent for down-modulation of the NKG2D receptor than soluble ULBP2 protein. This is the first report showing functionally relevant differences in the biochemistry of the three members of the ULBP family and confirms that in depth study of the biochemical features of individual NKG2D ligands will be necessary to understand and manipulate the biology of these proteins for therapy.	[Fernandez-Messina, Lola; Ashiru, Omodele; Boutet, Philippe; Aguera-Gonzalez, Sonia; Reyburn, Hugh T.; Vales-Gomez, Mar] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Skepper, Jeremy N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QP, England	University of Cambridge; University of Cambridge	Vales-Gomez, M (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mv231@cam.ac.uk	Vales-Gomez, Mar/ABG-7808-2020; Fernández-Messina, Lola/ABH-4496-2020; Ashiru, Omodele/AAD-1193-2020; Reyburn, Hugh T/B-4338-2009; Valés-Gómez, Mar/F-5351-2012	Vales-Gomez, Mar/0000-0001-7424-3206; Fernández-Messina, Lola/0000-0002-2163-8746; Reyburn, Hugh T/0000-0003-2855-1595; Valés-Gómez, Mar/0000-0001-7424-3206	Medical Research Council; Medical Research Council [G0601165, G9800943] Funding Source: researchfish; MRC [G9800943, G0601165] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Medical Research Council.	Aguera-Gonzalez S, 2009, J IMMUNOL, V182, P4800, DOI 10.4049/jimmunol.0800713; Apps R, 2008, HUM REPROD, V23, P2535, DOI 10.1093/humrep/den223; Boissel N, 2006, J IMMUNOL, V176, P5108, DOI 10.4049/jimmunol.176.8.5108; Borchers MT, 2006, AM J PHYSIOL-LUNG C, V291, pL222, DOI 10.1152/ajplung.00327.2005; Boutet P, 2009, J IMMUNOL, V182, P49, DOI 10.4049/jimmunol.182.1.49; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; DELALUNA S, 1992, METHOD ENZYMOL, V216, P376; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eleme K, 2004, J EXP MED, V199, P1005, DOI 10.1084/jem.20032194; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Holdenrieder S, 2006, CANCER IMMUNOL IMMUN, V55, P1584, DOI 10.1007/s00262-006-0167-1; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Lopez-Botet M, 2004, TISSUE ANTIGENS, V63, P195, DOI 10.1111/j.1399-0039.2004.00210.x; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Onda H, 2001, BIOCHEM BIOPH RES CO, V285, P235, DOI 10.1006/bbrc.2001.5149; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Raffaghello L, 2004, NEOPLASIA, V6, P558, DOI 10.1593/neo.04316; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Vales-Gomez M, 2008, CANCER RES, V68, P1546, DOI 10.1158/0008-5472.CAN-07-2973; Vales-Gomez Mar, 2003, BMC Immunol, V4, P4, DOI 10.1186/1471-2172-4-4; Vetter CS, 2004, BRIT J CANCER, V91, P1495, DOI 10.1038/sj.bjc.6602123; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wills MR, 2005, J IMMUNOL, V175, P7457, DOI 10.4049/jimmunol.175.11.7457; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206; Wu JD, 2009, CLIN CANCER RES, V15, P632, DOI 10.1158/1078-0432.CCR-08-1305; Zwirner NW, 1999, HUM IMMUNOL, V60, P323, DOI 10.1016/S0198-8859(98)00128-1	46	118	120	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8543	8551		10.1074/jbc.M109.045906	http://dx.doi.org/10.1074/jbc.M109.045906			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080967	Green Published, hybrid			2022-12-25	WOS:000275553700006
J	Osakabe, Y; Mizuno, S; Tanaka, H; Maruyama, K; Osakabe, K; Todaka, D; Fujita, Y; Kobayashi, M; Shinozaki, K; Yamaguchi-Shinozaki, K				Osakabe, Yuriko; Mizuno, Shinji; Tanaka, Hidenori; Maruyama, Kyonoshin; Osakabe, Keishi; Todaka, Daisuke; Fujita, Yasunari; Kobayashi, Masatomo; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Overproduction of the Membrane-bound Receptor-like Protein Kinase 1, RPK1, Enhances Abiotic Stress Tolerance in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN GENE NETWORK; ABSCISIC-ACID; FATTY-ACID; OXIDATIVE STRESS; PLANT HORMONE; WATER-STRESS; DROUGHT; COLD; DEHYDRATION; VERSATILE	RPK1 (receptor-like protein kinase 1) localizes to the plasma membrane and functions as a regulator of abscisic acid (ABA) signaling in Arabidopsis. In our current study, we investigated the effect of RPK1 disruption and overproduction upon plant responses to drought stress. Transgenic Arabidopsis overexpressing the RPK1 protein showed increased ABA sensitivity in their root growth and stomatal closure and also displayed less transpirational water loss. In contrast, a mutant lacking RPK1 function, rpk1-1, was found to be resistant to ABA during these processes and showed increased water loss. RPK1 overproduction in these transgenic plants thus increased their tolerance to drought stress. We performed microarray analysis of RPK1 transgenic plants and observed enhanced expression of several stress-responsive genes, such as Cor15a, Cor15b, and rd29A, in addition to H2O2-responsive genes. Consistently, the expression levels of ABA/stress-responsive genes in rpk1-1 had decreased compared with wild type. The results suggest that the overproduction of RPK1 enhances both the ABA and drought stress signaling pathways. Furthermore, the leaves of the rpk1-1 plants exhibit higher sensitivity to oxidative stress upon ABA-pretreatment, whereas transgenic plants overproducing RPK1 manifest increased tolerance to this stress. Our current data suggest therefore that RPK1 overproduction controls reactive oxygen species homeostasis and enhances both water and oxidative stress tolerance in Arabidopsis.	[Osakabe, Yuriko; Tanaka, Hidenori; Todaka, Daisuke; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Mizuno, Shinji; Maruyama, Kyonoshin; Fujita, Yasunari; Yamaguchi-Shinozaki, Kazuko] JIRCAS, Biol Resources Div, Tsukuba, Ibaraki 3058686, Japan; [Mizuno, Shinji] Chiba Univ, Grad Sch Sci & Technol, Chiba 2638522, Japan; [Osakabe, Keishi] Natl Inst Agrobiol Sci, Dept Plant Biotechnol, Tsukuba, Ibaraki 3058602, Japan; [Kobayashi, Masatomo] RIKEN Bioresource Ctr, Expt Plant Div, Tsukuba, Ibaraki 3050074, Japan; [Shinozaki, Kazuo] RIKEN Plant Sci Ctr, Gene Discovery Res Grp, Kanagawa 2300045, Japan	University of Tokyo; Japan International Research Center for Agricultural Sciences; Chiba University; National Institute of Agrobiological Sciences - Japan; RIKEN; RIKEN	Yamaguchi-Shinozaki, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akys@mail.ecc.u-tokyo.ac.jp	åè, æé/ABH-5084-2020; Mizuno, Shinji/HGC-6716-2022; Maruyama, Kyonoshin/I-9191-2012; Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Osakabe, Yuriko/GRI-9818-2022; Fujita, Yasunari/P-9861-2018; Shinozaki, Kazuo/AAB-4945-2019; Shinozaki, Kazuo/G-4202-2013; Osakabe, Yuriko/Y-2507-2019; Kobayashi, Masatomo/A-5945-2016	Maruyama, Kyonoshin/0000-0001-7725-0380; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Osakabe, Yuriko/0000-0001-5503-1427; Fujita, Yasunari/0000-0002-5036-8319; Shinozaki, Kazuo/0000-0002-6317-9867; Shinozaki, Kazuo/0000-0002-6317-9867; Osakabe, Yuriko/0000-0001-5503-1427; Tanaka, Hidenori/0000-0003-0266-1745	Japan Society for the Promotion of Science [21580125]; Ministry of Agriculture, Forestry and Fisheries, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by Japan Society for the Promotion of Science Grant-in aid for Scientific Research C 21580125 (to Y.O.) and by the Ministry of Agriculture, Forestry and Fisheries, Japan.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Franke R, 2007, CURR OPIN PLANT BIOL, V10, P252, DOI 10.1016/j.pbi.2007.04.004; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hong SW, 1997, PLANT PHYSIOL, V113, P1203, DOI 10.1104/pp.113.4.1203; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Lim PO, 2007, PLANT J, V52, P1140, DOI 10.1111/j.1365-313X.2007.03317.x; Lopez MA, 2008, CURR OPIN PLANT BIOL, V11, P420, DOI 10.1016/j.pbi.2008.05.002; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nodine MD, 2007, DEV CELL, V12, P943, DOI 10.1016/j.devcel.2007.04.003; Osakabe Y, 2005, PLANT CELL, V17, P1105, DOI 10.1105/tpc.104.027474; Osakabe Y, 2002, BIOCHEM BIOPH RES CO, V293, P806, DOI 10.1016/S0006-291X(02)00286-3; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Schippers JHM, 2008, PLANT CELL, V20, P2909, DOI 10.1105/tpc.107.056341; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263	57	95	106	1	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9190	9201		10.1074/jbc.M109.051938	http://dx.doi.org/10.1074/jbc.M109.051938			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089852	hybrid, Green Published			2022-12-25	WOS:000275553700068
J	Chandra, A; Chen, L; Liang, HY; Madura, K				Chandra, Abhishek; Chen, Li; Liang, Huiyan; Madura, Kiran			Proteasome Assembly Influences Interaction with Ubiquitinated Proteins and Shuttle Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PARTICLE; SACCHAROMYCES-CEREVISIAE; CORE PARTICLE; MITOCHONDRIAL MORPHOLOGY; TERMINAL DOMAIN; SUBSTRATE ENTRY; BINDING PROTEIN; 20S PROTEASOMES; 26S PROTEASOME; SUBUNIT RPN11	A major fraction of intracellular protein degradation is mediated by the proteasome. Successful degradation of these substrates requires ubiquitination and delivery to the proteasome followed by protein unfolding and disassembly of the multiubiquitin chain. Enzymes, such as Rpn11, dismantle multiubiquitin chains, and mutations can affect proteasome assembly and activity. We report that different rpn11 mutations can affect proteasome interaction with ubiquitinated proteins. Moreover, proteasomes are unstable in rpn11-1 and do not form productive interactions with multiubiquitinated proteins despite high levels in cell extracts. However, increased levels of ubiquitinated proteins were found associated with shuttle factors. In contrast to rpn11-1, proteasomes expressing a catalytically inactive mutant (rpn11(AXA)) were more stable and bound very high amounts of ubiquitinated substrates. Expression of the carboxyl-terminal domain of Rpn11 partially suppressed the growth and proteasome stability defects of rpn11-1. These results indicate that ubiquitinated substrates are preferentially delivered to intact proteasome.	[Chandra, Abhishek; Chen, Li; Liang, Huiyan; Madura, Kiran] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Madura, K (corresponding author), SPH 383,683 Hoes Lane, Piscataway, NJ 08854 USA.	maduraki@umdnj.edu	Chandra, Abhishek/AAG-8781-2020	Chandra, Abhishek/0000-0001-9423-9669	National Institutes of Health [CA83875, GM083321]; NATIONAL CANCER INSTITUTE [R01CA083875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83875 and GM083321 (to K. M.).	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chuang SM, 2005, GENETICS, V171, P1477, DOI 10.1534/genetics.105.046888; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lambertson D, 1999, GENETICS, V153, P69; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001; Rinaldi T, 1998, MOL BIOL CELL, V9, P2917, DOI 10.1091/mbc.9.10.2917; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rinaldi T, 2002, GENE, V286, P43, DOI 10.1016/S0378-1119(01)00799-5; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014	40	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8330	8339		10.1074/jbc.M109.076786	http://dx.doi.org/10.1074/jbc.M109.076786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061387	Green Published, hybrid			2022-12-25	WOS:000275413800049
J	Akkers, RC; van Heeringen, SJ; Manak, JR; Green, RD; Stunnenberg, HG; Veenstra, GJC				Akkers, Robert C.; van Heeringen, Simon J.; Manak, J. Robert; Green, Roland D.; Stunnenberg, Hendrik G.; Veenstra, Gert Jan C.			ChIP-Chip Designs to Interrogate the Genome of Xenopus Embryos for Transcription Factor Binding and Epigenetic Regulation	PLOS ONE			English	Article							GENE-REGULATION; STEM-CELLS; HISTONE MODIFICATIONS; CHROMATIN STATE; HIGH-RESOLUTION; MAPS; TBP; METHYLATIONS; ROLES; DNA	Background: Chromatin immunoprecipitation combined with genome tile path microarrays or deep sequencing can be used to study genome-wide epigenetic profiles and the transcription factor binding repertoire. Although well studied in a variety of cell lines, these genome-wide profiles have so far been little explored in vertebrate embryos. Principal Findings: Here we report on two genome tile path ChIP-chip designs for interrogating the Xenopus tropicalis genome. In particular, a whole-genome microarray design was used to identify active promoters by close proximity to histone H3 lysine 4 trimethylation. A second microarray design features these experimentally derived promoter regions in addition to currently annotated 5' ends of genes. These regions truly represent promoters as shown by binding of TBP, a key transcription initiation factor. Conclusions: A whole-genome and a promoter tile path microarray design was developed. Both designs can be used to study epigenetic phenomena and transcription factor binding in developing Xenopus embryos.	[Akkers, Robert C.; van Heeringen, Simon J.; Stunnenberg, Hendrik G.; Veenstra, Gert Jan C.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, NL-6525 ED Nijmegen, Netherlands; [Manak, J. Robert; Green, Roland D.] Roche Nimblegen Inc, Madison, WI USA; [Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	Radboud University Nijmegen; Roche Holding; University of Iowa	Akkers, RC (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, NL-6525 ED Nijmegen, Netherlands.	g.veenstra@ncmls.ru.nl	Veenstra, Gert Jan C./D-4963-2012; van Heeringen, Simon/Q-8530-2017; Stunnenberg, Hendrik G./D-6875-2012	Veenstra, Gert Jan C./0000-0002-7787-4940; van Heeringen, Simon/0000-0002-0411-3219; Stunnenberg, Hendrik G./0000-0002-0066-1576; Manak, John/0000-0002-6562-7694	United States National Institutes of Health [5 R01 HD054356]; Netherlands Organization of Scientific Research [864.03.002]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054356] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the United States National Institutes of Health (grant 5 R01 HD054356, www.nih.gov) and the Netherlands Organization of Scientific Research (NWO-ALW VIDI grant 864.03.002, www.nwo.nl) to GJCV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Jacobi UG, 2007, EMBO J, V26, P3900, DOI 10.1038/sj.emboj.7601822; Jallow Z, 2004, P NATL ACAD SCI USA, V101, P13525, DOI 10.1073/pnas.0405536101; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roh Tae-Young, 2008, V387, P95; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8820	10.1371/journal.pone.0008820	http://dx.doi.org/10.1371/journal.pone.0008820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098671	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779100012
J	Zhou, Y; Hancock, JF; Lichtenberger, LM				Zhou, Yong; Hancock, John F.; Lichtenberger, Lenard M.			The Nonsteroidal Anti-Inflammatory Drug Indomethacin Induces Heterogeneity in Lipid Membranes: Potential Implication for Its Diverse Biological Action	PLOS ONE			English	Article							PLASMA-MEMBRANE; DOMAIN FORMATION; H-RAS; RAFTS; ACTIVATION; MECHANISMS; PROTEINS; PHASES; AGENTS; NSAIDS	Background: The nonsteroidal anti-inflammatory drug (NSAID), indomethacin (Indo), has a large number of divergent biological effects, the molecular mechanism(s) for which have yet to be fully elucidated. Interestingly, Indo is highly amphiphilic and associates strongly with lipid membranes, which influence localization, structure and function of membrane-associating proteins and actively regulate cell signaling events. Thus, it is possible that Indo regulates diverse cell functions by altering micro-environments within the membrane. Here we explored the effect of Indo on the nature of the segregated domains in a mixed model membrane composed of dipalmitoyl phosphatidyl-choline (di16:0 PC, or DPPC) and dioleoyl phosphatidyl-choline (di18:1 PC or DOPC) and cholesterol that mimics biomembranes. Methodology/Principal Findings: Using a series of fluorescent probes in a fluorescence resonance energy transfer (FRET) study, we found that Indo induced separation between gel domains and fluid domains in the mixed model membrane, possibly by enhancing the formation of gel-phase domains. This effect originated from the ability of Indo to specifically target the ordered domains in the mixed membrane. These findings were further confirmed by measuring the ability of Indo to affect the fluidity-dependent fluorescence quenching and the level of detergent resistance of membranes. Conclusion/Significance: Because the tested lipids are the main lipid constituents in cell membranes, the observed formation of gel phase domains induced by Indo potentially occurs in biomembranes. This marked Indo-induced change in phase behavior potentially alters membrane protein functions, which contribute to the wide variety of biological activities of Indo and other NSAIDs.	[Zhou, Yong; Hancock, John F.; Lichtenberger, Lenard M.] Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Zhou, Y (corresponding author), Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX USA.	Lenard.M.Lichtenberger@uth.tmc.edu		Hancock, John/0000-0003-0542-4710; Zhou, Yong/0000-0002-0214-8151	Digestive Disease Center, Texas Medical Center, Houston, Texas [T32 - DK07664, DK56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007664, P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	Digestive Disease Center, Texas Medical Center, Houston, Texas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by National Institutes of Health (NIH) grant T32 - DK07664 and Public Health Service (PHS) grant DK56338 from the Digestive Disease Center, Texas Medical Center, Houston, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 2006, TOHOKU J EXPT MED, V135, P205; Aouad SM, 2004, J IMMUNOL, V172, P2316, DOI 10.4049/jimmunol.172.4.2316; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Gerli R, 1998, BLOOD, V92, P2389, DOI 10.1182/blood.V92.7.2389.2389_2389_2398; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Keller S, 2005, J AM CHEM SOC, V127, P11469, DOI 10.1021/ja052764q; LASONDER E, 1990, J COLLOID INTERF SCI, V139, P469, DOI 10.1016/0021-9797(90)90119-9; Leidy G, 2001, BIOPHYS J, V80, P1819, DOI 10.1016/S0006-3495(01)76152-8; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lichtenberger LM, 2006, J PHARM PHARMACOL, V58, P1421, DOI 10.1211/jpp.58.10.0001; LICHTENBERGER LM, 1995, NAT MED, V1, P154, DOI 10.1038/nm0295-154; Lucio M, 2008, LANGMUIR, V24, P4132, DOI 10.1021/la703584s; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; Silvius JR, 2003, BIOPHYS J, V85, P1034, DOI 10.1016/S0006-3495(03)74542-1; SKLAR LA, 1979, BIOCHEMISTRY-US, V18, P1707, DOI 10.1021/bi00576a012; Soh JW, 2003, PROG EXP TUMOR RES, V37, P261; SPINK CH, 1990, BIOCHIM BIOPHYS ACTA, V1023, P25, DOI 10.1016/0005-2736(90)90005-9; STADLER P, 1991, DIGEST DIS SCI, V36, P594, DOI 10.1007/BF01297025; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Zhou Y, 2005, BIOPHYS J, V89, P1789, DOI 10.1529/biophysj.104.054510	26	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8811	10.1371/journal.pone.0008811	http://dx.doi.org/10.1371/journal.pone.0008811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098676	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779100005
J	Forsberg, EC; Passegue, E; Prohaska, SS; Wagers, AJ; Koeva, M; Stuart, JM; Weissman, IL				Forsberg, E. Camilla; Passegue, Emmanuelle; Prohaska, Susan S.; Wagers, Amy J.; Koeva, Martina; Stuart, Joshua M.; Weissman, Irving L.			Molecular Signatures of Quiescent, Mobilized and Leukemia-Initiating Hematopoietic Stem Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; MYELOPROLIFERATIVE DISORDER; PROGENITOR CELLS; SELF-RENEWAL; NF-Y; MARROW; DIFFERENTIATION; RECEPTOR; PBX1	Hematopoietic stem cells (HSC) are rare, multipotent cells capable of generating all specialized cells of the blood system. Appropriate regulation of HSC quiescence is thought to be crucial to maintain their lifelong function; however, the molecular pathways controlling stem cell quiescence remain poorly characterized. Likewise, the molecular events driving leukemogenesis remain elusive. In this study, we compare the gene expression profiles of steady-state bone marrow HSC to non-self-renewing multipotent progenitors; to HSC treated with mobilizing drugs that expand the HSC pool and induce egress from the marrow; and to leukemic HSC in a mouse model of chronic myelogenous leukemia. By intersecting the resulting lists of differentially regulated genes we identify a subset of molecules that are downregulated in all three circumstances, and thus may be particularly important for the maintenance and function of normal, quiescent HSC. These results identify potential key regulators of HSC and give insights into the clinically important processes of HSC mobilization for transplantation and leukemic development from cancer stem cells.	[Forsberg, E. Camilla; Koeva, Martina; Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Inst Biol Stem Cells, Santa Cruz, CA 95064 USA; [Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Prohaska, Susan S.; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Prohaska, Susan S.; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Joslin Diabet Ctr, Cambridge, MA 02138 USA; [Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; Stanford University; Stanford University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University	Forsberg, EC (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Inst Biol Stem Cells, Santa Cruz, CA 95064 USA.	cforsber@ucsc.edu		Passegue, Emmanuelle/0000-0002-3516-297X; Stuart, Joshua/0000-0002-2171-565X	California Institute for Regenerative Medicine; American Society of Hematology (ASH); Burroughs Wellcome Fund; National Institutes of Health (NIH) [1RO1HL092471-01, 1RO1HL088582-01, R01CA086017, R01HL058770, R01CA086065, P01DK053074]; California Institute for Regenerative Medicine (CIRM); Department of Biomolecular Engineering, University of California Santa Cruz; National Science Foundation's Division of Biological Infrastructure [DBI-0543197]; Alfred P. Sloan Foundation; NATIONAL CANCER INSTITUTE [R01CA086017, R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770, R01HL092471, R01HL088582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); American Society of Hematology (ASH); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Department of Biomolecular Engineering, University of California Santa Cruz; National Science Foundation's Division of Biological Infrastructure(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a New Faculty Award from the California Institute for Regenerative Medicine (ECF); by an American Society of Hematology (ASH) Scholar Award (EP), by grants from the Burroughs Wellcome Fund (AJW) and the National Institutes of Health (NIH) (1RO1HL092471-01 (EP) and 1RO1HL088582-01 (AJW)); a predoctoral fellowship from the California Institute for Regenerative Medicine (CIRM) stem cell training program at the Institute for Biology of Stem Cells, Department of Biomolecular Engineering, University of California Santa Cruz (MK); the National Science Foundation's Division of Biological Infrastructure DBI-0543197 (JMS) and by a fellowship from the Alfred P. Sloan Foundation (JMS); and by NIH grants R01CA086017, R01HL058770, R01CA086065, and P01DK053074 (ILW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Choo A, 2006, CURR GENE THER, V6, P543, DOI 10.2174/156652306778520683; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gitler AD, 2004, PEDIATR RES, V55, P581, DOI 10.1203/01.PDR.0000113462.98851.2E; Guzman Monica L, 2004, Cancer Control, V11, P97; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim A, 2007, BLOOD, V109, P1687, DOI 10.1182/blood-2006-05-025395; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Mikkola H, 2009, BLOOD, V113, P2871, DOI 10.1182/blood-2009-01-199794; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; NEBEN S, 1993, BLOOD, V81, P1960; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Ooi AGL, 2009, STEM CELLS, V27, P653, DOI 10.1634/stemcells.2008-0824; Papayannopoulou T, 2003, CURR OPIN HEMATOL, V10, P214, DOI 10.1097/00062752-200305000-00004; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Praetor A, 2009, BLOOD, V113, P1919, DOI 10.1182/blood-2008-06-159574; Preisler HD, 2001, AM J HEMATOL, V68, P23, DOI 10.1002/ajh.1144; Quentmeier H, 2005, LEUKEMIA, V19, P1488, DOI 10.1038/sj.leu.2403820; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; SANTAGUIDA M, 2009, CANC CELL IN PRESS; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; Sato T, 2008, CANCER SCI, V99, P1407, DOI 10.1111/j.1349-7006.2008.00842.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Sugano Y, 2008, BLOOD, V111, P1167, DOI 10.1182/blood-2007-03-081554; Svensson E, 2007, DNA CELL BIOL, V26, P589, DOI 10.1089/dna.2007.0586; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Testa U, 2004, LEUKEMIA, V18, P1864, DOI 10.1038/sj.leu.2403472; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchida K, 1997, CYTOGENET CELL GENET, V78, P209, DOI 10.1159/000134658; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251	83	95	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8785	10.1371/journal.pone.0008785	http://dx.doi.org/10.1371/journal.pone.0008785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098702	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779000014
J	Lamba, DA; McUsic, A; Hirata, RK; Wang, PR; Russell, D; Reh, TA				Lamba, Deepak A.; McUsic, Andrew; Hirata, Roli K.; Wang, Pei-Rong; Russell, David; Reh, Thomas A.			Generation, Purification and Transplantation of Photoreceptors Derived from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							RETINOID-BINDING PROTEIN; FIBROBLASTS; DIFFERENTIATION; INDUCTION; MOUSE	Background: Inherited and acquired retinal degenerations are frequent causes of visual impairment and photoreceptor cell replacement therapy may restore visual function to these individuals. To provide a source of new retinal neurons for cell based therapies, we developed methods to derive retinal progenitors from human ES cells. Methodology/Physical Findings: In this report we have used a similar method to direct induced pluripotent stem cells (iPS) from human fibroblasts to a retinal progenitor fate, competent to generate photoreceptors. We also found we could purify the photoreceptors derived from the iPS cells using fluorescence activated cell sorting (FACS) after labeling photoreceptors with FACS purified iPSC derived photoreceptors, they were able to integrate into a normal mouse retina and express photoreceptor markers. Conclusions: This report provides evidence that enriched populations of human photoreceptors can be derived from iPS cells.	[Lamba, Deepak A.; McUsic, Andrew; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Hirata, Roli K.; Wang, Pei-Rong; Russell, David] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Russell, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Lamba, Deepak A.; McUsic, Andrew; Russell, David; Reh, Thomas A.] Univ Washington, Inst Stem Cells & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lamba, DA (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	tomreh@u.washington.edu			Foundation Fighting Blindness [TA-CBT-0608-0464-UWA-EW, TACBT-0507-0377-UWA]; National Institute of General Medical Sciences (NIGMS) [5P01GM081619]; National Institutes of Health (NIH); National Science Foundation (NSF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a gift from an anonymous donor and support from the Foundation Fighting Blindness (TA-CBT-0608-0464-UWA-EW and TACBT-0507-0377-UWA) and National Institute of General Medical Sciences (NIGMS) 5P01GM081619 to T. A. R, National Institutes of Health (NIH) funds to D.W.R and a National Science Foundation (NSF) Fellowship to A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin E, 2006, STEM CELLS, V24, P246, DOI 10.1634/stemcells.2005-0009; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; EISENFELD AJ, 1985, INVEST OPHTH VIS SCI, V26, P775; Gharwan H, 2007, MOL THER, V15, P1827, DOI 10.1038/sj.mt.6300244; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YOKOYAMA T, 1992, EXP EYE RES, V55, P225, DOI 10.1016/0014-4835(92)90186-V; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	288	313	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8763	10.1371/journal.pone.0008763	http://dx.doi.org/10.1371/journal.pone.0008763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098701	gold, Green Published, Green Submitted			2022-12-25	WOS:000273779000009
J	Genung, MA; Lessard, JP; Brown, CB; Bunn, WA; Cregger, MA; Reynolds, WN; Felker-Quinn, E; Stevenson, ML; Hartley, AS; Crutsinger, GM; Schweitzer, JA; Bailey, JK				Genung, Mark A.; Lessard, Jean-Philippe; Brown, Claire B.; Bunn, Windy A.; Cregger, Melissa A.; Reynolds, Wm Nicholas; Felker-Quinn, Emmi; Stevenson, Mary L.; Hartley, Amanda S.; Crutsinger, Gregory M.; Schweitzer, Jennifer A.; Bailey, Joseph K.			Non-Additive Effects of Genotypic Diversity Increase Floral Abundance and Abundance of Floral Visitors	PLOS ONE			English	Article							SOLIDAGO-ALTISSIMA; POLLINATOR COMMUNITIES; ECOSYSTEM GENETICS; GOLDENROD SOLIDAGO; PLANT GENOTYPE; SEED-SET; SELECTION; FITNESS; TRAITS; BEES	Background: In the emerging field of community and ecosystem genetics, genetic variation and diversity in dominant plant species have been shown to play fundamental roles in maintaining biodiversity and ecosystem function. However, the importance of intraspecific genetic variation and diversity to floral abundance and pollinator visitation has received little attention. Methodology/Principal Findings: Using an experimental common garden that manipulated genotypic diversity (the number of distinct genotypes per plot) of Solidago altissima, we document that genotypic diversity of a dominant plant can indirectly influence flower visitor abundance. Across two years, we found that 1) plant genotype explained 45% and 92% of the variation in flower visitor abundance in 2007 and 2008, respectively; and 2) plant genotypic diversity had a positive and non-additive effect on floral abundance and the abundance of flower visitors, as plots established with multiple genotypes produced 25% more flowers and received 45% more flower visits than would be expected under an additive model. Conclusions/Significance: These results provide evidence that declines in genotypic diversity may be an important but little considered factor for understanding plant-pollinator dynamics, with implications for the global decline in pollinators due to reduced plant diversity in both agricultural and natural ecosystems.	[Genung, Mark A.; Lessard, Jean-Philippe; Brown, Claire B.; Bunn, Windy A.; Cregger, Melissa A.; Reynolds, Wm Nicholas; Felker-Quinn, Emmi; Stevenson, Mary L.; Hartley, Amanda S.; Crutsinger, Gregory M.; Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Genung, MA (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	mgenung@utk.edu	Genung, Mark/K-5897-2012; Cregger, Melissa/D-7142-2018	Cregger, Melissa/0000-0001-8329-366X; Genung, Mark/0000-0002-9383-667X	Environmental Protection Agency (EPA) STAR; National Science Foundation (NSF); Department of Ecology and Evolutionary Biology at the University of Tennessee	Environmental Protection Agency (EPA) STAR(United States Environmental Protection Agency); National Science Foundation (NSF)(National Science Foundation (NSF)); Department of Ecology and Evolutionary Biology at the University of Tennessee	G. Crutsinger was funded by an Environmental Protection Agency (EPA) STAR fellowship and a National Science Foundation (NSF) Graduate Research Fellowship. Special thanks to Chris Boake and the Department of Ecology and Evolutionary Biology at the University of Tennessee for class support and funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2005, PLANT ECOL, V177, P43, DOI 10.1007/s11258-005-2069-2; BAILEY JK, 2009, PHILOS T A IN PRESS; BARBOUR RC, 2009, ECOLOGY IN PRESS; Becker WA, 1985, MANUAL QUANTITATIVE, P190; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; CALLAWAY RM, 1995, BOT REV, V61, P304; Committee on the Status of Pollinators in North America, 2007, STAT POLL N AM; Craig TP, 2007, EVOLUTION, V61, P1137, DOI 10.1111/j.1558-5646.2007.00099.x; Cronin JT, 1999, OECOLOGIA, V121, P392, DOI 10.1007/s004420050944; Crutsinger GM, 2008, OIKOS, V117, P255, DOI 10.1111/j.2007.0030-1299.16276.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Feldman TS, 2004, OIKOS, V105, P197, DOI 10.1111/j.0030-1299.2004.12845.x; Frankie GW, 2005, J KANSAS ENTOMOL SOC, V78, P227, DOI 10.2317/0407.08.1; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; GROSS RS, 1983, ECOL MONOGR, V53, P95, DOI 10.2307/1942589; Haddad NM, 2000, OECOLOGIA, V124, P73, DOI 10.1007/s004420050026; Halverson K, 2008, OECOLOGIA, V154, P755, DOI 10.1007/s00442-007-0863-3; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; HOLTSFORD TP, 1992, EVOLUTION, V46, P216, DOI 10.1111/j.1558-5646.1992.tb01996.x; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Irwin RE, 2005, AM NAT, V165, P225, DOI 10.1086/426714; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kevan PG, 2001, CONSERV ECOL, V5; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Lazaro A, 2009, OIKOS, V118, P691, DOI 10.1111/j.1600-0706.2008.17168.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MADDOX GD, 1989, AM J BOT, V76, P318, DOI 10.2307/2444674; MADDOX GD, 1990, ECOLOGY, V71, P2115, DOI 10.2307/1938625; Madritch M, 2006, ECOSYSTEMS, V9, P528, DOI 10.1007/s10021-006-0008-2; Madritch MD, 2002, ECOLOGY, V83, P2084, DOI 10.1890/0012-9658(2002)083[2084:PDIEFI]2.0.CO;2; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.2307/2409632; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Schweitzer JA, 2002, AM J BOT, V89, P981, DOI 10.3732/ajb.89.6.981; Schweitzer JA, 2008, ECOLOGY, V89, P773, DOI 10.1890/07-0337.1; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Stinchcombe JR, 2002, AM NAT, V160, P511, DOI 10.1086/342069; TEPEDINO VJ, 1982, OIKOS, V3, P384; THOMPSON JN, 1988, ANNU REV ECOL SYST, V19, P65, DOI 10.1146/annurev.es.19.110188.000433; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; WEIS AE, 1986, AM NAT, V127, P681, DOI 10.1086/284513; WEIS AE, 1990, EVOLUTION, V44, P820, DOI 10.1111/j.1558-5646.1990.tb03807.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wimp GM, 2005, EVOLUTION, V59, P61, DOI 10.1111/j.0014-3820.2005.tb00894.x	53	48	52	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8711	10.1371/journal.pone.0008711	http://dx.doi.org/10.1371/journal.pone.0008711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090850	Green Published, gold			2022-12-25	WOS:000273714600014
J	Rynda, A; Maddaloni, M; Ochoa-Reparaz, J; Callis, G; Pascual, DW				Rynda, Agnieszka; Maddaloni, Massimo; Ochoa-Reparaz, Javier; Callis, Gayle; Pascual, David W.			IL-28 Supplants Requirement for T-reg Cells in Protein sigma 1-Mediated Protection against Murine Experimental Autoimmune Encephalomyelitis (EAE)	PLOS ONE			English	Article							TOXIN B-SUBUNIT; MYELIN BASIC-PROTEIN; ORAL TOLERANCE; CUTTING EDGE; TGF-BETA; ANTIBODY-RESPONSES; INDUCTION; IL-10; SUPPRESSION; MECHANISMS	Conventional methods to induce tolerance in humans have met with limited success. Hence, efforts to redirect tolerogen uptake using reovirus adhesin, protein sigma 1 (p sigma 1), may circumvent these shortcomings based upon the recent finding that when reovirus ps1 is engineered to deliver chicken ovalbumin (OVA) mucosally, tolerance is obtained, even with a single dose. To test whether single-dose tolerance can be induced to treat EAE, proteolipid protein (PLP130-151) was genetically fused to OVA to p sigma 1 (PLP: OVA-p sigma 1) and shown to significantly ameliorate EAE, suppressing proinflammatory cytokines by IL-10(+) forkhead box P3 (FoxP3)(+) CD25(+)CD4(+) T-reg and IL-4(+)CD25(-)CD4(+) Th2 cells. IL-10R or IL-4 neutralization reversed protection to EAE conferred by PLP:OVA-p sigma 1, and adoptive transfer of Ag-specific Treg or Th2 cells restored protection against EAE in recipients. Upon assessment of each relative participant, functional inactivation of CD25 impaired PLP: OVA-p sigma 1's protective capacity, triggering TGF-beta-mediated inflammation; however, concomitant inactivation of TGF-beta and CD25 reestablished PLP:OVA-p sigma 1-mediated protection by IL-28-producing FoxP3(+)CD25(-)CD4(+)T cells. Thus, p sigma 1-based therapy can resolve EAE independently of or dependently upon CD25 and assigns IL-28 as an alternative therapy for autoimmunity.	[Rynda, Agnieszka; Maddaloni, Massimo; Ochoa-Reparaz, Javier; Callis, Gayle; Pascual, David W.] Montana State Univ, Bozeman, MT 59717 USA; [Rynda, Agnieszka; Ochoa-Reparaz, Javier] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH USA	Montana State University System; Montana State University Bozeman; Dartmouth College	Rynda, A (corresponding author), Montana State Univ, Bozeman, MT 59717 USA.	dpascual@montana.edu	Pascual, David/AAC-2248-2022	Ochoa-Reparaz, Javier/0000-0001-9610-3175	National Institutes of Health (NIH) [1R01 AI-078938]; Montana Agricultural Station; United States Department of Agriculture Formula Funds; NIH/National Center for Research Resources; Centers of Biomedical Excellence [P20 RR-020185]; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078938] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana Agricultural Station; United States Department of Agriculture Formula Funds; NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers of Biomedical Excellence; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (NIH) grant 1R01 AI-078938 and, in part, by Montana Agricultural Station and United States Department of Agriculture Formula Funds. The VMB flow cytometry facility was, in part, supported by NIH/National Center for Research Resources, Centers of Biomedical Excellence P20 RR-020185, and an equipment grant from the M.J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Aspord C, 2002, CLIN EXP IMMUNOL, V130, P204, DOI 10.1046/j.1365-2249.2002.01988.x; BERGQUIST C, 1995, INFECT IMMUN, V63, P2021, DOI 10.1128/IAI.63.5.2021-2025.1995; Bergquist C, 1997, INFECT IMMUN, V65, P2676, DOI 10.1128/IAI.65.7.2676-2684.1997; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Faria AMC, 2003, J AUTOIMMUN, V20, P135, DOI 10.1016/S0896-8411(02)00112-9; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Fujihashi K, 2001, P NATL ACAD SCI USA, V98, P3310, DOI 10.1073/pnas.061412598; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; Gonnella PA, 2004, J AUTOIMMUN, V23, P193, DOI 10.1016/j.jaut.2004.08.001; Gonnet Florence, 2003, Proteome Sci, V1, P2, DOI 10.1186/1477-5956-1-2; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Jun SM, 2005, J IMMUNOL, V175, P6733, DOI 10.4049/jimmunol.175.10.6733; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Kim WU, 2002, ARTHRITIS RHEUM-US, V46, P1109, DOI 10.1002/art.10198; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Lycke N, 2004, ANN NY ACAD SCI, V1029, P193, DOI 10.1196/annals.1309.036; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Masuda K, 2002, MICROBIOL IMMUNOL, V46, P55, DOI 10.1111/j.1348-0421.2002.tb02677.x; Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129; Min B, 1998, J EXP MED, V188, P2007, DOI 10.1084/jem.188.11.2007; Miyamoto K, 2005, J IMMUNOL, V175, P7341, DOI 10.4049/jimmunol.175.11.7341; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; O'Hehir RE, 2007, CURR MED CHEM, V14, P2235, DOI 10.2174/092986707781696609; Ochoa-Reparaz J, 2008, J IMMUNOL, V181, P954, DOI 10.4049/jimmunol.181.2.954; Ochoa-Reparaz J, 2007, J IMMUNOL, V178, P1791, DOI 10.4049/jimmunol.178.3.1791; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Passalacqua G, 2004, ANN ALLERG ASTHMA IM, V93, P3, DOI 10.1016/S1081-1206(10)61440-8; Pillemer BBL, 2009, J IMMUNOL, V183, P155, DOI 10.4049/jimmunol.0803733; Rynda A, 2008, J IMMUNOL, V180, P5187, DOI 10.4049/jimmunol.180.8.5187; SCADDING GK, 1986, CLIN ALLERGY, V16, P483, DOI 10.1111/j.1365-2222.1986.tb01983.x; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Sharif MN, 2004, J IMMUNOL, V172, P6476, DOI 10.4049/jimmunol.172.10.6476; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Stohlman SA, 1999, J IMMUNOL, V163, P6338; SUN JB, 1994, P NATL ACAD SCI USA, V91, P10795, DOI 10.1073/pnas.91.23.10795; Sun JB, 1996, P NATL ACAD SCI USA, V93, P7196, DOI 10.1073/pnas.93.14.7196; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; TURNER DL, 1992, VIROLOGY, V186, P219, DOI 10.1016/0042-6822(92)90076-2; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Weiner HL, 2004, ANN NY ACAD SCI, V1029, P211, DOI 10.1196/annals.1309.053; Weiner HL, 1997, IMMUNOL TODAY, V18, P335, DOI 10.1016/S0167-5699(97)01053-0; Wildbaum G, 2002, J CLIN INVEST, V110, P701, DOI 10.1172/JCI200215176; Yokoyama Y, 2002, INT J PEDIATR OTORHI, V63, P235, DOI 10.1016/S0165-5876(02)00021-6; Yuki Y, 2001, BIOTECHNOL BIOENG, V74, P62, DOI 10.1002/bit.1095; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112	56	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8720	10.1371/journal.pone.0008720	http://dx.doi.org/10.1371/journal.pone.0008720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090936	Green Published, gold, Green Submitted			2022-12-25	WOS:000273714600020
J	Jahnke, VE; Sabido, O; Defour, A; Castells, J; Lefai, E; Roussel, D; Freyssenet, D				Jahnke, Vanessa E.; Sabido, Odile; Defour, Aurelia; Castells, Josiane; Lefai, Etienne; Roussel, Damien; Freyssenet, Damien			Evidence for Mitochondrial Respiratory Deficiency in Rat Rhabdomyosarcoma Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; ALVEOLAR RHABDOMYOSARCOMA; MYOBLAST DIFFERENTIATION; GENE-EXPRESSION; CARDIOLIPIN; BIOGENESIS; PAX3; DNA; REGENERATION; STIMULATION	Background: Mitochondria can sense signals linked to variations in energy demand to regulate nuclear gene expression. This retrograde signaling pathway is presumed to be involved in the regulation of myoblast proliferation and differentiation. Rhabdomyosarcoma cells are characterized by their failure to both irreversibly exit the cell cycle and complete myogenic differentiation. However, it is currently unknown whether mitochondria are involved in the failure of rhabdomyosarcoma cells to differentiate. Methodology/Principal Findings: Mitochondrial biogenesis and metabolism were studied in rat L6E9 myoblasts and R1H rhabdomyosacoma cells during the cell cycle and after 36 hours of differentiation. Using a combination of flow cytometry, polarographic and molecular analyses, we evidenced a marked decrease in the cardiolipin content of R1H cells cultured in growth and differentiation media, together with a significant increase in the content of mitochondrial biogenesis factors and mitochondrial respiratory chain proteins. Altogether, these data indicate that the mitochondrial inner membrane composition and the overall process of mitochondrial biogenesis are markedly altered in R1H cells. Importantly, the dysregulation of protein-to-cardiolipin ratio was associated with major deficiencies in both basal and maximal mitochondrial respiration rates. This deficiency in mitochondrial respiration probably contributes to the inability of R1H cells to decrease mitochondrial H2O2 level at the onset of differentiation. Conclusion/Significance: A defect in the regulation of mitochondrial biogenesis and mitochondrial metabolism may thus be an epigenetic mechanism that may contribute to the tumoral behavior of R1H cells. Our data underline the importance of mitochondria in the regulation of myogenic differentiation.	[Jahnke, Vanessa E.; Sabido, Odile; Defour, Aurelia; Castells, Josiane; Freyssenet, Damien] Univ St Etienne, Univ Lyon, Lab Physiol Exercice, EA4338, St Etienne, France; [Sabido, Odile] Univ St Etienne, Univ Lyon, Ctr Commun Cytometrie Flux, St Etienne, France; [Lefai, Etienne] Univ Lyon 1, INSERM, Regulat Metab Nutr & Diabet U870, F-69622 Villeurbanne, France; [Roussel, Damien] Univ Lyon 1, CNRS, Lab Physiol Integrat Cellulaire & Mol, U5123, F-69622 Villeurbanne, France	Universite Jean Monnet; Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Jahnke, VE (corresponding author), Univ St Etienne, Univ Lyon, Lab Physiol Exercice, EA4338, St Etienne, France.	damien.freyssenet@univ-st-etienne.fr	Lefai, Etienne/L-7961-2019; Lefai, Etienne/E-9615-2019	Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; defour, aurelia/0000-0002-9114-0054; Roussel, Damien/0000-0002-8865-5428	Ligue Contre le Cancer Comite de la Loire; Ligue Contre le Cancer	Ligue Contre le Cancer Comite de la Loire; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Ligue Contre le Cancer Comite de la Loire (grant to D. Freyssenet). V. E. Jahnke was supported by an Allocation Doctorale de Recherche from the Ligue Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barani AE, 2003, EXP CELL RES, V283, P196, DOI 10.1016/S0014-4827(02)00030-7; BARENDSEN GW, 1969, EUR J CANCER, V5, P373, DOI 10.1016/0014-2964(69)90051-6; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Brubacher JL, 2001, J IMMUNOL METHODS, V251, P81, DOI 10.1016/S0022-1759(01)00308-8; Cavalli LR, 1997, CELL GROWTH DIFFER, V8, P1189; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Desquiret V, 2006, BBA-BIOENERGETICS, V1757, P21, DOI 10.1016/j.bbabio.2005.11.005; DIAS P, 1992, CANCER RES, V52, P6431; Duguez S, 2004, EXP CELL RES, V299, P27, DOI 10.1016/j.yexcr.2004.05.017; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FLEISCHER S, 1967, J LIPID RES, V8, P170; Freyssenet D, 1996, ARCH PHYSIOL BIOCHEM, V104, P129, DOI 10.1076/apab.104.2.129.12878; Freyssenet D, 2007, J APPL PHYSIOL, V102, P529, DOI 10.1152/japplphysiol.01126.2005; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Grandemange S, 2005, CANCER RES, V65, P4282, DOI 10.1158/0008-5472.CAN-04-3652; HEDDI A, 1993, J BIOL CHEM, V268, P12156; Jahnke VE, 2009, AM J PHYSIOL-CELL PH, V296, pC1185, DOI 10.1152/ajpcell.00377.2008; Kuhnt T, 2007, NEUROCHEM RES, V32, P973, DOI 10.1007/s11064-006-9254-0; Langen RCJ, 2002, AM J PHYSIOL-CELL PH, V283, pC714, DOI 10.1152/ajpcell.00418.2001; LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265; Lugli E, 2005, CYTOM PART A, V68A, P28, DOI 10.1002/cyto.a.20188; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; OHTSUKA T, 1993, J BIOL CHEM, V268, P22914; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031; REINHOLD H. S., 1965, EUR J CANCER, V1, P67, DOI 10.1016/0014-2964(65)90081-2; REMELS AH, 2009, MOL CELL ENDOCR 1003; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; SHAPIRO DN, 1993, CANCER RES, V53, P5108; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; TONIN PN, 1991, CANCER RES, V51, P5100; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	41	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8637	10.1371/journal.pone.0008637	http://dx.doi.org/10.1371/journal.pone.0008637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072609	gold, Green Published, Green Submitted			2022-12-25	WOS:000273414200015
J	Chen, XW; Hackett, CA; Niks, RE; Hedley, PE; Booth, C; Druka, A; Marcel, TC; Vels, A; Bayer, M; Milne, I; Morris, J; Ramsay, L; Marshall, D; Cardle, L; Waugh, R				Chen, Xinwei; Hackett, Christine A.; Niks, Rients E.; Hedley, Peter E.; Booth, Clare; Druka, Arnis; Marcel, Thierry C.; Vels, Anton; Bayer, Micha; Milne, Iain; Morris, Jenny; Ramsay, Luke; Marshall, David; Cardle, Linda; Waugh, Robbie			An eQTL Analysis of Partial Resistance to Puccinia hordei in Barley	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; DENSITY CONSENSUS MAP; FALSE DISCOVERY RATE; GENE-EXPRESSION; POWDERY MILDEW; LEAF RUST; FLOWERING-TIME; STEM RUST; BASAL DEFENSE; ARABIDOPSIS	Background: Genetic resistance to barley leaf rust caused by Puccinia hordei involves both R genes and quantitative trait loci. The R genes provide higher but less durable resistance than the quantitative trait loci. Consequently, exploring quantitative or partial resistance has become a favorable alternative for controlling disease. Four quantitative trait loci for partial resistance to leaf rust have been identified in the doubled haploid Steptoe (St)/Morex (Mx) mapping population. Further investigations are required to study the molecular mechanisms underpinning partial resistance and ultimately identify the causal genes. Methodology/Principal Findings: We explored partial resistance to barley leaf rust using a genetical genomics approach. We recorded RNA transcript abundance corresponding to each probe on a 15K Agilent custom barley microarray in seedlings from St and Mx and 144 doubled haploid lines of the St/Mx population. A total of 1154 and 1037 genes were, respectively, identified as being P. hordei-responsive among the St and Mx and differentially expressed between P. hordei-infected St and Mx. Normalized ratios from 72 distant-pair hybridisations were used to map the genetic determinants of variation in transcript abundance by expression quantitative trait locus (eQTL) mapping generating 15685 eQTL from 9557 genes. Correlation analysis identified 128 genes that were correlated with resistance, of which 89 had eQTL co-locating with the phenotypic quantitative trait loci (pQTL). Transcript abundance in the parents and conservation of synteny with rice allowed us to prioritise six genes as candidates for Rphq11, the pQTL of largest effect, and highlight one, a phospholipid hydroperoxide glutathione peroxidase (HvPHGPx) for detailed analysis. Conclusions/Significance: The eQTL approach yielded information that led to the identification of strong candidate genes underlying pQTL for resistance to leaf rust in barley and on the general pathogen response pathway. The dataset will facilitate a systems appraisal of this host-pathogen interaction and, potentially, for other traits measured in this population.	[Chen, Xinwei; Hedley, Peter E.; Booth, Clare; Druka, Arnis; Bayer, Micha; Milne, Iain; Morris, Jenny; Ramsay, Luke; Marshall, David; Cardle, Linda; Waugh, Robbie] Scottish Crop Res Inst, Genet Programme, Dundee DD2 5DA, Scotland; [Niks, Rients E.; Marcel, Thierry C.; Vels, Anton] Wageningen Univ, Grad Sch Expt Plant Sci, Lab Plant Breeding, Wageningen, Netherlands	James Hutton Institute; Wageningen University & Research	Chen, XW (corresponding author), Scottish Crop Res Inst, Genet Programme, Dundee DD2 5DA, Scotland.	xinwei.chen@scri.ac.uk; Robbie.Waugh@scri.ac.uk	Druka, Arnis/E-9701-2011; Hackett, Christine/F-1196-2011; Milne, Iain/A-3614-2010; Hedley, Peter/F-1149-2011; chen, xinwei/L-2582-2013; Niks, Rients/Y-4720-2019; Marcel, Thierry/ABI-2242-2020; Bayer, Micha/F-2255-2013	Hedley, Peter/0000-0003-0866-324X; Niks, Rients/0000-0002-3912-3775; Marcel, Thierry/0000-0002-7452-4013; Bayer, Micha/0000-0003-0041-3115; Marshall, David/0000-0001-9309-2570; Milne, Linda/0000-0002-1798-8022; Milne, Iain/0000-0002-4126-0859; Chen, Xinwei/0000-0003-1507-2253	European Union [513959]; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	European Union(European Commission); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	Funding for this experiment was provided by the European Union Bioexploit Grant No. 513959 (FOOD) to RW and RN (www. bioexploit. net) and by Scottish Government Rural and Environment Research and Analysis Directorate (RERAD) Programme 1, Work Package 1 (http://www.programme1.net/programmes.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arfaoui A, 2007, PLANT PHYSIOL BIOCH, V45, P470, DOI 10.1016/j.plaphy.2007.04.004; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger S, 2004, PHYSIOL PLANTARUM, V122, P419, DOI 10.1111/j.1399-3054.2004.00433.x; Boddu J, 2006, MOL PLANT MICROBE IN, V19, P407, DOI 10.1094/MPMI-19-0407; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Caldo RA, 2004, PLANT CELL, V16, P2514, DOI 10.1105/tpc.104.023382; Caldo RA, 2006, MOL PLANT MICROBE IN, V19, P939, DOI 10.1094/MPMI-19-0939; Chen SR, 2004, PLANT PHYSIOL, V135, P1630, DOI 10.1104/pp.103.038091; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Collinge DB, 2008, EUR J PLANT PATHOL, V121, P257, DOI 10.1007/s10658-008-9271-8; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Druka A, 2008, THEOR APPL GENET, V117, P261, DOI 10.1007/s00122-008-0771-x; Druka Arnis, 2006, Functional & Integrative Genomics, V6, P202, DOI 10.1007/s10142-006-0025-4; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Field B, 2006, NEW PHYTOL, V172, P193, DOI 10.1111/j.1469-8137.2006.01863.x; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fu JY, 2006, GENETICS, V172, P1993, DOI 10.1534/genetics.105.047001; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Halterman DA, 2003, PLANT PHYSIOL, V131, P558, DOI 10.1104/pp.014407; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hansen BG, 2008, TRENDS PLANT SCI, V13, P72, DOI 10.1016/j.tplants.2007.11.008; Holub EB, 2004, TRENDS PLANT SCI, V9, P211, DOI 10.1016/j.tplants.2004.03.002; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Jukanti AK, 2008, NEW PHYTOL, V177, P333, DOI 10.1111/j.1469-8137.2007.02270.x; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kunzel G, 2000, GENETICS, V154, P397; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; LAURENCE J, 2008, J EXPT BOT, V59, P4219; LI Y, 2006, PLOS GENETICS, V2; Luo ZW, 2007, GENETICS, V176, P789, DOI 10.1534/genetics.106.067843; Mammadov JA, 2003, CROP SCI, V43, P388, DOI 10.2135/cropsci2003.0388; Marcel TC, 2007, THEOR APPL GENET, V114, P487, DOI 10.1007/s00122-006-0448-2; Meng Y, 2009, PLANT PHYSIOL, V149, P271, DOI 10.1104/pp.108.129031; Niks RE, 2000, AGRONOMIE, V20, P769, DOI 10.1051/agro:2000174; NIKS RE, 1986, PHYSIOL MOL PLANT P, V28, P309, DOI 10.1016/S0048-4059(86)80073-X; Panstruga R, 2002, MOL PLANT PATHOL, V3, P495, DOI 10.1046/j.1364-3703.2002.00145.x; Parrott DL, 2007, NEW PHYTOL, V176, P56, DOI 10.1111/j.1469-8137.2007.02158.x; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Potokina E, 2008, PLANT J, V56, P287, DOI 10.1111/j.1365-313X.2008.03601.x; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; ROHRINGER R, 1977, PHYTOPATHOLOGY, V67, P808, DOI 10.1094/Phyto-67-808; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Weerasena JS, 2004, THEOR APPL GENET, V108, P712, DOI 10.1007/s00122-003-1470-2; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang L, 2006, THEOR APPL GENET, V113, P847, DOI 10.1007/s00122-006-0342-y; Zhang L, 2008, FUNCT INTEGR GENOMIC, V8, P187, DOI 10.1007/s10142-007-0069-0; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	70	58	59	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8598	10.1371/journal.pone.0008598	http://dx.doi.org/10.1371/journal.pone.0008598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066049	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338600017
J	Festa, RA; McAllister, F; Pearce, MJ; Mintseris, J; Burns, KE; Gygi, SP; Darwin, KH				Festa, Richard A.; McAllister, Fiona; Pearce, Michael J.; Mintseris, Julian; Burns, Kristin E.; Gygi, Steven P.; Darwin, K. Heran			Prokayrotic Ubiquitin-Like Protein (Pup) Proteome of Mycobacterium tuberculosis	PLOS ONE			English	Article							PROTEASOME; GENE; PHOP; EXPRESSION; VIRULENCE; SYSTEM; STRAIN; GROWTH; PURIFICATION; PERSISTENCE	Prokaryotic ubiquitin-like protein (Pup) in Mycobacterium tuberculosis (Mtb) is the first known post-translational small protein modifier in prokaryotes, and targets several proteins for degradation by a bacterial proteasome in a manner akin to ubiquitin (Ub) mediated proteolysis in eukaryotes. To determine the extent of pupylation in Mtb, we used tandem affinity purification to identify its "pupylome''. Mass spectrometry identified 55 out of 604 purified proteins with confirmed pupylation sites. Forty-four proteins, including those with and without identified pupylation sites, were tested as substrates of proteolysis in Mtb. Under steady state conditions, the majority of the test proteins did not accumulate in degradation mutants, suggesting not all targets of pupylation are necessarily substrates of the proteasome under steady state conditions. Four proteins implicated in Mtb pathogenesis, Icl (isocitrate lyase), Ino1 (inositol-1-phosphate synthase), MtrA (Mtb response regulator A) and PhoP (phosphate response regulator P), showed altered levels in degradation defective Mtb. Icl, Ino1 and MtrA accumulated in Mtb degradation mutants, suggesting these proteins are targeted to the proteasome. Unexpectedly, PhoP was present in wild type Mtb but undetectable in the degradation mutants. Taken together, these data demonstrate that pupylation regulates numerous proteins in Mtb and may not always lead to degradation.	[Festa, Richard A.; Pearce, Michael J.; Burns, Kristin E.; Darwin, K. Heran] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [McAllister, Fiona; Mintseris, Julian; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	New York University; Harvard University; Harvard Medical School	Festa, RA (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	steven_gygi@hms.harvard.edu; heran.darwin@med.nyu.edu		Darwin, K Heran/0000-0002-5043-7548	National Institutes of Health (NIH) [GM67945, HG3456, HG3616, AI065437, HL092774]; Center for AIDS Research Pilot Project [A1027742-17, 5T32AI07189-25]; Jan T. Vilcek Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003616, R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI007189, R56AI065437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research Pilot Project; Jan T. Vilcek Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM67945, HG3456, and HG3616 awarded to S. P. G., and AI065437, HL092774 and a Center for AIDS Research Pilot Project grant (A1027742-17) awarded to K.H.D. M.J.P. received support from 5T32AI07189-25 and R. A. F. was the recipient of a Jan T. Vilcek Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; CHONG SR, 1994, BIOTECHNIQUES, V17, P686; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Darwin KH, 2009, NAT REV MICROBIOL, V7, P485, DOI 10.1038/nrmicro2148; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Denison C, 2005, CURR OPIN CHEM BIOL, V9, P69, DOI 10.1016/j.cbpa.2004.10.010; Festa RA, 2007, J BACTERIOL, V189, P3044, DOI 10.1128/JB.01597-06; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Groisman EA, 1997, NAT MED, V3, P1190, DOI 10.1038/nm1197-1190; Hatfull GF, 2000, MOL GENETICS MYCOBAC; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; HOUGH R, 1986, J BIOL CHEM, V261, P2391; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Lamichhane G, 2006, J INFECT DIS, V194, P1233, DOI 10.1086/508288; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIAO S, 2009, BIOCH J IN PRESS; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Movahedzadeh F, 2004, MOL MICROBIOL, V51, P1003, DOI 10.1046/j.1365-2958.2003.03900.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; NATHAN C, 2003, TUBERCULOSIS; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; STRIEBEL F, 2009, NAT STRUCT MOL BIOL; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000	53	111	217	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8589	10.1371/journal.pone.0008589	http://dx.doi.org/10.1371/journal.pone.0008589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066036	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338600012
J	Pendergast, JS; Friday, RC; Yamazaki, S				Pendergast, Julie S.; Friday, Rio C.; Yamazaki, Shin			Distinct Functions of Period2 and Period3 in the Mouse Circadian System Revealed by In Vitro Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; BEHAVIORAL RHYTHMS; CLOCK; OSCILLATIONS; COMPONENTS; HOMOLOGS; MUTATION; CULTURE; MPER3; MICE	The mammalian circadian system, which is composed of a master pacemaker in the suprachiasmatic nuclei (SCN) as well as other oscillators in the brain and peripheral tissues, controls daily rhythms of behavior and physiology. Lesions of the SCN abolish circadian rhythms of locomotor activity and transplants of fetal SCN tissue restore rhythmic behavior with the periodicity of the donor's genotype, suggesting that the SCN determines the period of the circadian behavioral rhythm. According to the model of timekeeping in the SCN, the Period (Per) genes are important elements of the transcriptional/translational feedback loops that generate the endogenous circadian rhythm. Previous studies have investigated the functions of the Per genes by examining locomotor activity in mice lacking functional PERIOD proteins. Variable behavioral phenotypes were observed depending on the line and genetic background of the mice. In the current study we assessed both wheel-running activity and Per1-promoter-driven luciferase expression (Per1-luc) in cultured SCN, pituitary, and lung explants from Per2(-/-) and Per3(-/-) mice congenic with the C57BL/6J strain. We found that the Per2(-/-) phenotype is enhanced in vitro compared to in vivo, such that the period of Per1-luc expression in Per2(-/-) SCN explants is 1.5 hours shorter than in Per2(+/+) SCN, while the free-running period of wheel-running activity is only 11 minutes shorter in Per2(-/-) compared to Per2(+/+) mice. In contrast, circadian rhythms in SCN explants from Per3(-/-) mice do not differ from Per3(+/+) mice. Instead, the period and phase of Per1-luc expression are significantly altered in Per3(-/-) pituitary and lung explants compared to Per3(+/+) mice. Taken together these data suggest that the function of each Per gene may differ between tissues. Per2 appears to be important for period determination in the SCN, while Per3 participates in timekeeping in the pituitary and lung.	[Pendergast, Julie S.; Friday, Rio C.; Yamazaki, Shin] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Pendergast, JS (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	shin.yamazaki@vanderbilt.edu		Yamazaki, Shin/0000-0002-6691-1531	National Institutes of Health [NS051278]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a National Institutes of Health grant (NS051278 to S. Y.). R. C. F. was supported by the Vanderbilt Undergraduate Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Andrews R V, 1971, Gegenbaurs Morphol Jahrb, V117, P89; ANDREWS RV, 1964, COMP BIOCHEM PHYSIOL, V11, P393, DOI 10.1016/0010-406X(64)90006-4; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; HARDELAND R, 1973, INT J BIOCHEM, V4, P581, DOI 10.1016/0020-711X(73)90037-2; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LANGNER R, 1972, Z NATURFORSCH PT B, VB 27, P1117; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Pendergast JS, 2009, J NEUROSCI, V29, P14681, DOI 10.1523/JNEUROSCI.3261-09.2009; POSSIDENTE B, 1988, BEHAV GENET, V18, P109, DOI 10.1007/BF01067080; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SAWAKI Y, 1984, Neuroscience Research, V1, P67, DOI 10.1016/0168-0102(84)90031-2; Schibler Ueli, 2007, Dialogues Clin Neurosci, V9, P257; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takahashi J. S., 2001, CIRCADIAN CLOCKS; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	44	53	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8552	10.1371/journal.pone.0008552	http://dx.doi.org/10.1371/journal.pone.0008552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20072700	gold, Green Published, Green Submitted			2022-12-25	WOS:000273225000015
J	Hu, YS; Xu, P; Pigino, G; Brady, ST; Larson, J; Lazarov, O				Hu, Yuan-Shih; Xu, Peng; Pigino, Gustavo; Brady, Scott T.; Larson, John; Lazarov, Orly			Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1 Delta E9 mice	FASEB JOURNAL			English	Article						neural stem cells; oligomeric beta-amyloid; tau; long-term potentiation; axonal transport; kinesin	LONG-TERM POTENTIATION; AMYLOID-BETA-PROTEIN; ADULT HIPPOCAMPAL NEUROGENESIS; FAST AXONAL-TRANSPORT; ENRICHMENT IMPROVES COGNITION; TRANSGENIC MOUSE MODEL; RAT DENTATE GYRUS; SPATIAL MEMORY; CELL-PROLIFERATION; PHYSICAL-ACTIVITY	Experience in complex environments induces numerous forms of brain plasticity, improving structure and function. It has been long debated whether brain plasticity can be induced under neuropathological conditions, such as Alzheimer's disease (AD), to an extent that would reduce neuropathology, rescue brain structure, and restore its function. Here we show that experience in a complex environment rescues a significant impairment of hippocampal neurogenesis in transgenic mice harboring familial AD-linked mutant APPswe/PS1 Delta E9. Proliferation of hippocampal cells is enhanced significantly after enrichment, and these proliferating cells mature to become new neurons and glia. Enhanced neurogenesis was accompanied by a significant reduction in levels of hyperphosphorylated tau and oligomeric A beta, the precursors of AD hallmarks, in the hippocampus and cortex of enriched mice. Interestingly, enhanced expression of the neuronal anterograde motor kinesin-1 was observed, suggesting enhanced axonal transport in hippocampal and cortical neurons after enrichment. Examination of synaptic physiology revealed that environmental experience significantly enhanced hippocampal long-term potentiation, without notable alterations in basal synaptic transmission. This study suggests that environmental modulation can rescue the impaired phenotype of the Alzheimer's brain and that induction of brain plasticity may represent therapeutic and preventive avenues in AD.-Y.-S. Hu, P. Xu, G. Pigino, S. T. Brady, J. Larson, O. Lazarov. Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1 Delta E9 mice. FASEB J. 24, 1667-1681 (2010). www.fasebj.org	[Hu, Yuan-Shih; Pigino, Gustavo; Brady, Scott T.; Lazarov, Orly] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Xu, Peng; Larson, John] Univ Illinois, Coll Med, Dept Psychiat, Inst Psychiat, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lazarov, O (corresponding author), Univ Illinois, Coll Med, Dept Anat & Cell Biol, 808 S Wood St,M-C 512, Chicago, IL 60612 USA.	olazarov@uic.edu	Lazarov, Orly/F-9406-2015; Hu, Jennifer Yuan-Shih/AAL-5876-2020; Pigino, Gustavo/L-7002-2019	Lazarov, Orly/0000-0002-5887-948X	Alzheimer's Association; Illinois Department of Public Health Alzheimer's Disease Research Fund; NATIONAL INSTITUTE ON AGING [R01AG033570] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); Illinois Department of Public Health Alzheimer's Disease Research Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Fan-Lu Kung (School of Pharmacy, National Taiwan University, Taipei, Taiwan) for reviewing the manuscript. This study was supported by the Alzheimer's Association Young Investigator Award (O.L.) and the Illinois Department of Public Health Alzheimer's Disease Research Fund award (O.L and J.L.). The authors thank Dr. Sangram S. Sisodia (University of Chicago, Chicago, IL, USA) for providing the transgenic animals and APP369 antibodies.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Ambree O, 2006, AM J PATHOL, V169, P544, DOI 10.2353/ajpath.2006.051107; ANTONIAN E, 1987, BRAIN RES, V400, P403, DOI 10.1016/0006-8993(87)90643-3; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; Arendash GW, 2001, DNA CELL BIOL, V20, P737, DOI 10.1089/10445490152717604; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Billings LM, 2007, J NEUROSCI, V27, P751, DOI 10.1523/JNEUROSCI.4800-06.2007; BRAAK H, 1985, ACTA NEUROPATHOL, V68, P325, DOI 10.1007/BF00690836; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Catlow BJ, 2009, BRAIN RES, V1256, P173, DOI 10.1016/j.brainres.2008.12.028; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DEMARS M, 2010, J NEUROSCI IN PRESS; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301; Ermini FV, 2008, AM J PATHOL, V172, P1520, DOI 10.2353/ajpath.2008.060520; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; Frick KM, 2003, NEUROBIOL AGING, V24, P615, DOI 10.1016/S0197-4580(02)00138-0; Frick KM, 2003, LEARN MEMORY, V10, P187, DOI 10.1101/lm.50703; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gordon MN, 2001, NEUROBIOL AGING, V22, P377, DOI 10.1016/S0197-4580(00)00249-9; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMMERSCHLAG R, 1992, MOL NEUROBIOL, V6, P191, DOI 10.1007/BF02780552; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Herring A, 2009, EXP NEUROL, V216, P184, DOI 10.1016/j.expneurol.2008.11.027; HOLLOWAY RALPH L., 1966, BRAIN RES, V2, P393, DOI 10.1016/0006-8993(66)90009-6; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Janus C, 2000, NEUROBIOL AGING, V21, P541, DOI 10.1016/S0197-4580(00)00107-X; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lazarov O, 2006, J NEUROSCI, V26, P429, DOI 10.1523/JNEUROSCI.3961-05.2006; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; LAZAROV O, 2007, RES PROGR ALZHEIMERS, V3, P303; Lazarov O, 2007, J NEUROSCI, V27, P7011, DOI 10.1523/JNEUROSCI.4272-06.2007; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lee VMY, 2006, J ALZHEIMERS DIS, V9, P257; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Mirochnic S, 2009, HIPPOCAMPUS, V19, P1008, DOI 10.1002/hipo.20560; Moreno H, 2009, P NATL ACAD SCI USA, V106, P5901, DOI 10.1073/pnas.0900944106; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Niidome T, 2008, NEUROREPORT, V19, P1361, DOI 10.1097/WNR.0b013e32830e6dd6; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; PACTEAU C, 1989, BEHAV BRAIN RES, V34, P79, DOI 10.1016/S0166-4328(89)80092-0; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; Pigino G, 2003, J NEUROSCI, V23, P4499; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Pigino G, 2001, J NEUROSCI, V21, P834, DOI 10.1523/JNEUROSCI.21-03-00834.2001; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Puolivali J, 2002, NEUROBIOL DIS, V9, P339, DOI 10.1006/nbdi.2002.0481; Renner M.J., 1987, ENRICHED IMPOVERISHE; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; ROSENZWEIG MR, 1964, J COMP PHYSIOL PSYCH, V57, P438, DOI 10.1037/h0046387; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Thal DR, 2000, EXP NEUROL, V163, P98, DOI 10.1006/exnr.2000.7380; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wen PH, 2002, NEUROBIOL DIS, V10, P8, DOI 10.1006/nbdi.2002.0490; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WEST RW, 1972, BEHAV BIOL, V7, P279, DOI 10.1016/S0091-6773(72)80207-4; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018; Zhao B, 2008, PANMINERVA MED, V50, P55	99	134	140	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1667	1681		10.1096/fj.09-136945	http://dx.doi.org/10.1096/fj.09-136945			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20086049	Green Published			2022-12-25	WOS:000278200000005
J	Penno, A; Reilly, MM; Houlden, H; Laura, M; Rentsch, K; Niederkofler, V; Stoeckli, ET; Nicholson, G; Eichler, F; Brown, RH; von Eckardstein, A; Hornemann, T				Penno, Anke; Reilly, Mary M.; Houlden, Henry; Laura, Matilde; Rentsch, Katharina; Niederkofler, Vera; Stoeckli, Esther T.; Nicholson, Garth; Eichler, Florian; Brown, Robert H., Jr.; von Eckardstein, Arnold; Hornemann, Thorsten			Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PALMITOYLTRANSFERASE; CERAMIDE SYNTHASE; NERVOUS-SYSTEM; CELL-SURFACE; IN-VIVO; HSAN-I; SPTLC1; METABOLISM; MUTATIONS; 1-PHOSPHATE	HSAN1 is an inherited neuropathy found to be associated with several missense mutations in the SPTLC1 subunit of serine palmitoyltransferase (SPT). SPT catalyzes the condensation of serine and palmitoyl-CoA, the initial step in the de novo synthesis of sphingolipids. Here we show that the HSAN1 mutations induce a shift in the substrate specificity of SPT, which leads to the formation of the two atypical deoxy-sphingoid bases (DSBs) 1-deoxy-sphinganine and 1-deoxymethyl-sphinganine. Both metabolites lack the C-1 hydroxyl group of sphinganine and can therefore neither be converted to complex sphingolipids nor degraded. Consequently, they accumulate in the cell, as demonstrated in HEK293 cells over-expressing mutant SPTLC1 and lymphoblasts of HSAN1 patients. Elevated DSB levels were also found in the plasma of HSAN1 patients and confirmed in three groups of HSAN1 patients with different SPTLC1mutations. The DSBs show pronounced neurotoxic effects on neurite formation in cultured sensory neurons. The neurotoxicity co-occurs with a disturbed neurofilament structure in neurites when cultured in the presence of DSBs. Based on these observations, we conclude that HSAN1 is caused by a gain of function mutation, which results in the formation of two atypical and neurotoxic sphingolipid metabolites.	[Penno, Anke; Rentsch, Katharina; von Eckardstein, Arnold; Hornemann, Thorsten] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Penno, Anke; von Eckardstein, Arnold; Hornemann, Thorsten] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Reilly, Mary M.; Houlden, Henry; Laura, Matilde] Natl Hosp Neurol & Neurosurg, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England; [Reilly, Mary M.; Houlden, Henry; Laura, Matilde] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Niederkofler, Vera; Stoeckli, Esther T.] Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; [Nicholson, Garth] Concord Repatriat Gen Hosp, Mol Med Lab, Sydney, NSW 2139, Australia; [Nicholson, Garth] Concord Repatriat Gen Hosp, Australian & New Zealand Army Corps Res Inst, Sydney, NSW 2139, Australia; [Eichler, Florian; Brown, Robert H., Jr.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Neurosci,Day Lab Neuromuscular Res, Boston, MA 02115 USA; [Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Zurich; Concord Repatriation General Hospital; Concord Repatriation General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester	Hornemann, T (corresponding author), Univ Zurich Hosp, Inst Clin Chem, Raemistr 100, CH-8091 Zurich, Switzerland.	thorsten.hornemann@usz.ch	Houlden, Henry J/C-1532-2008	Houlden, Henry J/0000-0002-2866-7777; Stoeckli, Esther/0000-0002-8485-0648; Reilly, Mary/0000-0003-0686-905X; Nicholson, Garth/0000-0001-9694-066X	National Institutes of Health through the NINDS [K08NS52550]; Deater Foundation; MRC; Muscular Dystrophy Campaign; Hartmann Muller Foundation; Herzog-Egli Foundation; Olga Mayenfisch Foundation; Foundation for Scientific Research (University of Zurich); German Society for Clinical Chemistry; Laboratory Medicine (DGKL); European Commission [LSHM-CT-2006-037631]; MRC [G0601943, G0802760] Funding Source: UKRI; Medical Research Council [G0802760, G0601943] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS052550, R01NS072446] Funding Source: NIH RePORTER	National Institutes of Health through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deater Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Hartmann Muller Foundation; Herzog-Egli Foundation; Olga Mayenfisch Foundation; Foundation for Scientific Research (University of Zurich); German Society for Clinical Chemistry; Laboratory Medicine (DGKL); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant K08NS52550 (to F. E.) through the NINDS. This work was also supported by grants from the Deater Foundation (to R. H. B. and F. E.) and from the MRC (to M. M. R. and H. H.) and the Muscular Dystrophy Campaign (to M. M. R. and M. L.). The work undertaken at the University Hospital of Zurich and was supported by grants from the Hartmann Muller Foundation, the Herzog-Egli Foundation, the Olga Mayenfisch Foundation, and the Foundation for Scientific Research (University of Zurich) as well as the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) and the European Commission (LSHM-CT-2006-037631).	Auer-Grumbach M, 2006, NEUROMOL MED, V8, P147, DOI 10.1385/NMM:8:1:147; Auer-Grumbach M, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-7; Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Bejaoui K, 2002, J CLIN INVEST, V110, P1301, DOI 10.1172/JCI200216450; Bi H, 2007, NEUROPATHOLOGY, V27, P429, DOI 10.1111/j.1440-1789.2007.00808.x; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; Cuadros R, 2000, CANCER LETT, V152, P23, DOI 10.1016/S0304-3835(99)00428-0; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Dedov VN, 2004, BBA-MOL BASIS DIS, V1688, P168, DOI 10.1016/j.bbadis.2003.12.005; Du L, 2008, J IND MICROBIOL BIOT, V35, P455, DOI 10.1007/s10295-008-0316-y; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200; Geraldes R, 2004, J NEUROL SCI, V227, P35, DOI 10.1016/j.jns.2004.08.002; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hornemann T, 2009, NEUROGENETICS, V10, P135, DOI 10.1007/s10048-008-0168-7; Houlden H, 2006, BRAIN, V129, P411, DOI 10.1093/brain/awh712; Humpf HU, 1998, J BIOL CHEM, V273, P19060, DOI 10.1074/jbc.273.30.19060; Klein CJ, 2005, J NEUROL NEUROSUR PS, V76, P1022, DOI 10.1136/jnnp.2004.050062; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Milstien S, 2007, ACTA PAEDIATR, V96, P40, DOI 10.1111/j.1651-2227.2007.00206.x; Okada T, 2009, CELL SIGNAL, V21, P7, DOI 10.1016/j.cellsig.2008.07.011; Riley RT, 1999, NAT TOXINS, V7, P407, DOI 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Salcedo M, 2007, APOPTOSIS, V12, P395, DOI 10.1007/s10495-006-0573-z; Sanchez AM, 2008, EUR J PHARMACOL, V584, P237, DOI 10.1016/j.ejphar.2008.02.011; Stoeckli ET, 1996, DEV BIOL, V177, P15, DOI 10.1006/dbio.1996.0141; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Verhoeven K, 2004, NEUROLOGY, V62, P1001, DOI 10.1212/01.WNL.0000115388.10828.5C; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	33	230	235	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11178	11187		10.1074/jbc.M109.092973	http://dx.doi.org/10.1074/jbc.M109.092973			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20097765	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000276286200023
J	Yun, HM; Baik, JH; Kang, I; Jin, C; Rhim, H				Yun, Hyung-Mun; Baik, Ja-Hyun; Kang, Insug; Jin, Changbae; Rhim, Hyewhon			Physical Interaction of Jab1 with Human Serotonin 6 G-protein-coupled Receptor and Their Possible Roles in Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATE AP-1 ACTIVITY; HUMAN 5-HT6 RECEPTOR; CYTOPLASMIC LOCALIZATION; ACTIVATOR PROTEIN-1; COP9 SIGNALOSOME; ENERGY-TRANSFER; DEGRADATION; ANTAGONIST; EXPRESSION; BINDING	The 5-HT6 receptor (5-HT6R) is one of the most recently cloned serotonin receptors, and it plays important roles in Alzheimer disease, depression, and learning and memory disorders. However, unlike the other serotonin receptors, the cellular mechanisms of 5-HT6R are poorly elucidated relative to its significance in human brain diseases. Here, using a yeast two-hybrid assay, we found that the human 5-HT6R interacts with Jun activation domain-binding protein-1 (Jab1). We also confirmed a physical interaction between 5-HT6R and Jab1 using glutathione S-transferase pulldown, fluorescence resonance energy transfer, co-immunoprecipitation, and immunocyto(histo)-chemistry assays. The manipulation of Jab1 expression using Jab1 small interference RNA decreased 5-HT6R-mediated activity and cell membrane expression of 5-HT6R, whereas overexpression of Jab1 produced no significant effect. In addition, we demonstrated that the activation of 5-HT6R induced the translocation of Jab1 into the nucleus and increased c-Jun phosphorylation and the interaction between Jab1 and c-Jun. Furthermore, we found that 5-HT6R and Jab1 were up-regulated in middle cerebral artery occlusion-induced focal cerebral ischemic rats and in cultured cells exposed to hypoxic insults, suggesting possible protective roles for 5-HT6R and Jab1. These findings suggest that Jab1 provides a novel signal transduction pathway for 5-HT6R and may play an important role in 5-HT6R mediated behavior changes in the brain.	[Yun, Hyung-Mun; Rhim, Hyewhon] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [Yun, Hyung-Mun; Baik, Ja-Hyun] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kang, Insug] Kyung Hee Univ, Coll Med, Seoul 130702, South Korea; [Jin, Changbae] Korea Inst Sci & Technol, Doping Control Ctr, Seoul 136791, South Korea	Korea Institute of Science & Technology (KIST); Korea University; Kyung Hee University; Korea Institute of Science & Technology (KIST)	Rhim, H (corresponding author), Korea Inst Sci & Technol, Div Life Sci, 39-1 Hawholgok Dong, Seoul 136791, South Korea.	hrhim@kist.re.kr			Korea Science and Engineering Foundation [20090079000, 2009-0081531]; Ministry of Education, Science, and Technology, Korea [2009K001265]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation Grant 20090079000, Pioneer Grant 2009-0081531, and the Brain Research Center of the 21st Century Frontier Research Program (Grant 2009K001265 to H. R.) from Ministry of Education, Science, and Technology, Korea.	Ahn J, 2009, ENDOCR J, V56, P707, DOI 10.1507/endocrj.K08E-372; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bockaert J, 2006, CELL TISSUE RES, V326, P553, DOI 10.1007/s00441-006-0286-1; Branchek TA, 2000, ANNU REV PHARMACOL, V40, P319, DOI 10.1146/annurev.pharmtox.40.1.319; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CH, 2007, J NEUROCHEM, V102, P1831, DOI 10.1111/j.1471-4159.2007.04652.x; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Dawson LA, 2001, NEUROPSYCHOPHARMACOL, V25, P662, DOI 10.1016/S0893-133X(01)00265-2; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Foley AG, 2004, NEUROPSYCHOPHARMACOL, V29, P93, DOI 10.1038/sj.npp.1300332; Fukumoto A, 2006, FEBS LETT, V580, P5836, DOI 10.1016/j.febslet.2006.09.042; Hayashi M, 2005, J CLIN ENDOCR METAB, V90, P1712, DOI 10.1210/jc.2004-1547; Hsu MC, 2008, MODERN PATHOL, V21, P609, DOI [10.1038/modpathol.2008.23, 10.1038/mpath.2008.23]; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Kang HT, 2005, BIOCHEM BIOPH RES CO, V329, P684, DOI 10.1016/j.bbrc.2005.02.040; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kim HJ, 2008, COMB CHEM HIGH T SCR, V11, P316, DOI 10.2174/138620708784246059; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kohen R, 1996, J NEUROCHEM, V66, P47; Larsen M, 2005, ADV EXP MED BIOL, V566, P203; Lee EW, 2006, MOL CELLS, V22, P133; Li SH, 2000, J BIOL CHEM, V275, P13386, DOI 10.1074/jbc.275.18.13386; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Luo WB, 2006, J BIOL CHEM, V281, P7927, DOI 10.1074/jbc.M510784200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mitchell ES, 2005, PHARMACOL THERAPEUT, V108, P320, DOI 10.1016/j.pharmthera.2005.05.001; Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Oono K, 2004, NEUROCHEM INT, V45, P765, DOI 10.1016/j.neuint.2004.01.003; Osoegawa A, 2006, CANCER, V107, P154, DOI 10.1002/cncr.21961; Riemer C, 2003, J MED CHEM, V46, P1273, DOI 10.1021/jm021085c; ROTH BL, 1994, J PHARMACOL EXP THER, V268, P1403; Schechter Lee E, 2005, NeuroRx, V2, P590, DOI 10.1602/neurorx.2.4.590; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3188, DOI 10.1073/pnas.052712699; Svenningsson P, 2007, J NEUROSCI, V27, P4201, DOI 10.1523/JNEUROSCI.3110-06.2007; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Upton N, 2008, NEUROTHERAPEUTICS, V5, P458, DOI 10.1016/j.nurt.2008.05.008; WARD RP, 1995, NEUROSCIENCE, V64, P1105, DOI 10.1016/0306-4522(94)00439-C; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wesolowska A, 2007, BEHAV PHARMACOL, V18, P439, DOI 10.1097/FBP.0b013e3282d28f9c; Wesolowska A, 2007, NEUROPHARMACOLOGY, V52, P1274, DOI 10.1016/j.neuropharm.2007.01.007; WOOLLEY ML, 2004, CURR DRUG TARGETS CN, V33, P59; Yun HM, 2007, J BIOL CHEM, V282, P5496, DOI 10.1074/jbc.M606215200	48	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10016	10029		10.1074/jbc.M109.068759	http://dx.doi.org/10.1074/jbc.M109.068759			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093369	Green Published, hybrid			2022-12-25	WOS:000276165900070
J	Curnis, F; Cattaneo, A; Longhi, R; Sacchi, A; Gasparri, AM; Pastorino, F; Di Matteo, P; Traversari, C; Bachi, A; Ponzoni, M; Rizzardi, GP; Corti, A				Curnis, Flavio; Cattaneo, Angela; Longhi, Renato; Sacchi, Angelina; Gasparri, Anna Maria; Pastorino, Fabio; Di Matteo, Paola; Traversari, Catia; Bachi, Angela; Ponzoni, Mirco; Rizzardi, Gian-Paolo; Corti, Angelo			Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; TARGETING AGENT VTA; AMINOPEPTIDASE N; FACTOR-ALPHA; PHASE-II; PATIENTS PTS; VASCULATURE; PEPTIDES; DELIVERY; BINDING	Various NGR-containing peptides have been exploited for targeted delivery of drugs to CD13-positive tumor neovasculature. Recent studies have shown that compounds containing this motif can rapidly deamidate and generate isoaspartate-glycinearginine (isoDGR), a ligand of alpha v beta 3-integrin that can be also exploited for drug delivery to tumors. We have investigated the role of NGR and isoDGR peptide scaffolds on their biochemical and biological properties. Peptides containing the cyclic CNGRC sequence could bind CD13-positive endothelial cells more efficiently than those containing linear GNGRG. Peptide degradation studies showed that cyclic peptides mostly undergo NGR-to-isoDGR transition and CD13/integrin switching, whereas linear peptides mainly undergo degradation reactions involving the alpha-amino group, which generate non-functional six/seven-membered ring compounds, unable to bind alpha v beta 3, and small amount of isoDGR. Structure-activity studies showed that cyclic isoDGR could bind alpha v beta 3 with an affinity >100-fold higher than that of linear isoDGR and inhibited endothelial cell adhesion and tumor growth more efficiently. Cyclic isoDGR could also bind other integrins (alpha v beta 5, alpha v beta 6, alpha v beta 8, and alpha 5 beta 1), although with 10-100-fold lower affinity. Peptide linearization caused loss of affinity for all integrins and loss of specificity, whereas alpha-amino group acetylation increased the affinity for all tested integrins, but caused loss of specificity. These results highlight the critical role of molecular scaffold on the biological properties of NGR/isoDGR peptides. These findings may have important implications for the design and development of anticancer drugs or tumor neovasculature-imaging compounds, and for the potential function of different NGR/isoDGR sites in natural proteins.	[Curnis, Flavio; Cattaneo, Angela; Sacchi, Angelina; Gasparri, Anna Maria; Bachi, Angela; Corti, Angelo] Ist Sci San Raffaele, Div Mol Oncol, I-20132 Milan, Italy; [Curnis, Flavio; Cattaneo, Angela; Sacchi, Angelina; Gasparri, Anna Maria; Bachi, Angela; Corti, Angelo] Ist Sci San Raffaele, IIT Network Res Unit Mol Neurosci, I-20132 Milan, Italy; [Longhi, Renato] CNR, Ist Chim Riconoscimento Mol, I-20131 Milan, Italy; [Pastorino, Fabio; Ponzoni, Mirco] G Gaslini Childrens Hosp, Lab Oncol, I-16148 Genoa, Italy; [Di Matteo, Paola; Traversari, Catia; Rizzardi, Gian-Paolo] MolMed SpA, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Corti, A (corresponding author), Ist Sci San Raffaele, Div Mol Oncol, Via Olgettina 58, I-20132 Milan, Italy.	corti.angelo@hsr.it	Pastorino, Fabio/I-4491-2018; Corti, Angelo/F-7046-2012; Ponzoni, Mirco/J-7713-2016; Pastorino, Fabio/Z-6245-2019; Curnis, Flavio/AAK-3542-2020; Gasparri, Anna Maria/AAN-5071-2020; bachi, angela/B-3527-2015	Pastorino, Fabio/0000-0002-8312-808X; Corti, Angelo/0000-0002-0893-6191; Ponzoni, Mirco/0000-0002-6164-4286; Pastorino, Fabio/0000-0002-8312-808X; Curnis, Flavio/0000-0002-7231-9569; Gasparri, Anna Maria/0000-0002-1757-8699; bachi, angela/0000-0003-4842-6556; SACCHI, ANGELINA/0000-0002-6594-0277; Subba, Rajkrishna/0000-0003-0051-0062	Associazione Italiana per la Ricerca sul Cancro (AIRC); Alleanza Contro il Cancro (ISS)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Alleanza Contro il Cancro (ISS)	This work was supported in part by the Associazione Italiana per la Ricerca sul Cancro (AIRC) and Alleanza Contro il Cancro (ISS).	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bieker R, 2009, BLOOD, V113, P5019, DOI 10.1182/blood-2008-04-150318; Buehler A, 2006, ARTERIOSCL THROM VAS, V26, P2681, DOI 10.1161/01.ATV.0000245807.65714.0b; Ceresoli GL, 2008, ANN ONCOL, V19, P119; Citterio G, 2008, ANN ONCOL, V19, P178; Colombo G, 2002, J BIOL CHEM, V277, P47891, DOI 10.1074/jbc.M207500200; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; Curnis F, 2005, CANCER RES, V65, P2906, DOI 10.1158/0008-5472.CAN-04-4282; Curnis F, 2002, J CLIN INVEST, V110, P475, DOI 10.1172/JCI200215223; Curnis F, 2002, CANCER RES, V62, P867; Curnis F, 2008, CANCER RES, V68, P7073, DOI 10.1158/0008-5472.CAN-08-1272; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Dehart MP, 2007, J PHARM SCI-US, V96, P2667, DOI 10.1002/jps.20905; Di Matteo P, 2006, MOL IMMUNOL, V43, P1509, DOI 10.1016/j.molimm.2005.10.009; Dirksen A, 2004, ORG LETT, V6, P4857, DOI 10.1021/ol048084u; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Gasparri A, 1999, CANCER RES, V59, P2917; Gasparri AM, 2008, MOL CANCER THER, V7, P3859, DOI 10.1158/1535-7163.MCT-08-0538; GEIGER T, 1987, J BIOL CHEM, V262, P785; Grifman M, 2001, MOL THER, V3, P964, DOI 10.1006/mthe.2001.0345; Holle L, 2004, ONCOL REP, V11, P613; Liu LQ, 2000, J VIROL, V74, P5320, DOI 10.1128/JVI.74.11.5320-5328.2000; LURA R, 1988, BIOCHEMISTRY-US, V27, P7671, DOI 10.1021/bi00420a015; Majhen D, 2006, BIOCHEM BIOPH RES CO, V348, P278, DOI 10.1016/j.bbrc.2006.07.051; Meng J, 2007, CYTOTHERAPY, V9, P60, DOI 10.1080/14653240601094322; Meng JR, 2006, J BIOCHEM, V140, P299, DOI 10.1093/jb/mvj152; Moffatt S, 2005, HUM GENE THER, V16, P57, DOI 10.1089/hum.2005.16.57; Moffatt S, 2006, INT J PHARMACEUT, V321, P143, DOI 10.1016/j.ijpharm.2006.05.007; Ostendorp M, 2008, CANCER RES, V68, P7676, DOI 10.1158/0008-5472.CAN-08-0689; Pasqualini R, 2000, CANCER RES, V60, P722; Pastorino F, 2003, CANCER RES, V63, P7400; Pastorino F, 2006, CANCER RES, V66, P10073, DOI 10.1158/0008-5472.CAN-06-2117; Rimassa L, 2008, ANN ONCOL, V19, P136; Sacchi A, 2004, CANCER RES, V64, P7150, DOI 10.1158/0008-5472.CAN-04-1445; Spitaleri A, 2008, J BIOL CHEM, V283, P19757, DOI 10.1074/jbc.M710273200; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; von Wallbrunn A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839046; Yokoyama Y, 2005, CANCER-AM CANCER SOC, V104, P321, DOI 10.1002/cncr.21149; Zarovni N, 2004, HUM GENE THER, V15, P373, DOI 10.1089/104303404322959524; Zhang Z, 2005, PEPTIDES, V26, P2182, DOI 10.1016/j.peptides.2005.03.049	42	75	80	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9114	9123		10.1074/jbc.M109.044297	http://dx.doi.org/10.1074/jbc.M109.044297			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20064928	hybrid, Green Published			2022-12-25	WOS:000275553700061
J	David, Y; Ziv, T; Admon, A; Navon, A				David, Yael; Ziv, Tamar; Admon, Arie; Navon, Ami			The E2 Ubiquitin-conjugating Enzymes Direct Polyubiquitination to Preferred Lysines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-DEGRADATION; ANAPHASE-PROMOTING COMPLEX; STRUCTURAL BASIS; CHAIN LINKAGES; E3 LIGASE; MULTIUBIQUITIN CHAIN; HECT DOMAIN; DNA-REPAIR; PROTEASOME; DETERMINANTS	The ubiquitin-proteasome pathway plays a crucial role in many cellular processes by degrading substrates tagged by polyubiquitin chains, linked mostly through lysine 48 of ubiquitin. Although polymerization of ubiquitin via its six other lysine residues exists in vivo as part of various physiological pathways, the molecular mechanisms that determine the type of polyubiquitin chains remained largely unknown. We under took a systematic, in vitro, approach to evaluate the role of E2 enzymes in determining the topology of polyubiquitin. Because this study was performed in the absence of an E3 enzyme, our data indicate that the E2 enzymes are capable of directing the ubiquitination process to distinct subsets of ubiquitin lysines, depending on the specific E2 utilized. Moreover, our findings are in complete agreement with prior analyses of lysine preference assigned to certain E2s in the context of E3 (in vitro and in vivo). Finally, our findings support the rising notion that the functional unit of E2 is a dimer. To our knowledge, this is the first systematic indication for the involvement of E2 enzymes in specifying polyubiquitin chain assembly.	[David, Yael; Ziv, Tamar; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Admon, Arie] Technion Israel Inst Technol, Dept Biol, IL-31096 Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology	Navon, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	ami.navon@weizmann.ac.il		Ziv, Tamar/0000-0003-4299-7454; Admon, Arie/0000-0003-0504-3950	Israel Science Foundation [916/05]	Israel Science Foundation(Israel Science Foundation)	Supported by Israel Science Foundation Grant 916/05.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; BUSCH H, 1981, MOL CELL BIOCHEM, V40, P173; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Fujimuro M, 2005, BIOL PHARM BULL, V28, P2315, DOI 10.1248/bpb.28.2315; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; GOLDBERG AL, 1995, SCIENCE, V268, P522, DOI 10.1126/science.7725095; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; HERSHKO A, 1981, J BIOL CHEM, V256, P1525; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lewis MJ, 2006, J BIOMOL NMR, V34, P89, DOI 10.1007/s10858-005-5583-6; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2002, NATURE, V419, P120, DOI 10.1038/419120a; Raimondo D, 2008, BIOCHEM PHARMACOL, V76, P1620, DOI 10.1016/j.bcp.2008.08.026; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wen R, 2006, PLANT MOL BIOL, V61, P241, DOI 10.1007/s11103-006-0007-x; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	58	118	143	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8595	8604		10.1074/jbc.M109.089003	http://dx.doi.org/10.1074/jbc.M109.089003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20061386	Green Published, hybrid			2022-12-25	WOS:000275553700011
J	Gopalakrishnan, J; Guichard, P; Smith, AH; Schwarz, H; Agard, DA; Marco, S; Avidor-Reiss, T				Gopalakrishnan, Jayachandran; Guichard, Paul; Smith, Andrew H.; Schwarz, Heinz; Agard, David A.; Marco, Sergio; Avidor-Reiss, Tomer			Self-assembling SAS-6 Multimer Is a Core Centriole Building Block	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL BODY; INTRAFLAGELLAR TRANSPORT; CENTROSOME DUPLICATION; 9-FOLD SYMMETRY; HUMAN-CELLS; DROSOPHILA; BIOGENESIS; PROTEIN; CYCLE; PROCENTRIOLE	Centrioles are conserved microtubule-based organelles with 9-fold symmetry that are essential for cilia and mitotic spindle formation. A conserved structure at the onset of centriole assembly is a "cartwheel" with 9-fold radial symmetry and a central tubule in its core. It remains unclear how the cartwheel is formed. The conserved centriole protein, SAS-6, is a cartwheel component that functions early in centriole formation. Here, combining biochemistry and electron microscopy, we characterize SAS-6 and show that it self-assembles into stable tetramers, which serve as building blocks for the central tubule. These results suggest that SAS-6 self-assembly may be an initial step in the formation of the cartwheel that provides the 9-fold symmetry. Electron microscopy of centrosomes identified 25-nm central tubules with repeating subunits and show that SAS-6 concentrates at the core of the cartwheel. Recombinant and native SAS-6 self-oligomerizes into tetramers with similar to 6-nm subunits, and these tetramers are components of the centrosome, suggesting that tetramers are the building blocks of the central tubule. This is further supported by the observation that elevated levels of SAS-6 in Drosophila cells resulted in higher order structures resembling central tubule morphology. Finally, in the presence of embryonic extract, SAS-6 tetramers assembled into high density complexes, providing a starting point for the eventual in vitro reconstruction of centrioles.	[Gopalakrishnan, Jayachandran; Smith, Andrew H.; Avidor-Reiss, Tomer] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Guichard, Paul; Marco, Sergio] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Guichard, Paul; Marco, Sergio] INSERM, U759, F-91405 Orsay, France; [Schwarz, Heinz] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; [Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Harvard University; Harvard Medical School; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Avidor-Reiss, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	tomer_avidor-reiss@hms.harvard.edu	Guichard, Paul/AAL-8603-2020; marco, SERGIO/E-4875-2017; Avidor-Reiss, Tomer/AAK-6153-2020; marco garrido, sergio/F-5876-2013	Guichard, Paul/0000-0002-0363-1049; Avidor-Reiss, Tomer/0000-0003-0918-526X; Smith, Andrew/0000-0002-9710-0096	William F. Milton and Stewart Trust	William F. Milton and Stewart Trust	This work was supported in part by a grant from the bequest of the William F. Milton and Stewart Trust Pilot Projects.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALVEY PL, 1986, CELL BIOL INT REP, V10, P589, DOI 10.1016/0309-1651(86)90136-0; ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Azimzadeh J., 2004, CENTROSOMES DEV DIS, P93; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Callaini G, 1997, EXP CELL RES, V234, P183, DOI 10.1006/excr.1997.3618; CAVALIER.T, 1974, J CELL SCI, V16, P529; CROWTHER RA, 1971, J MOL BIOL, V60, P123, DOI 10.1016/0022-2836(71)90452-9; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; DIPPELL RV, 1968, P NATL ACAD SCI USA, V61, P461, DOI 10.1073/pnas.61.2.461; Fernandez JJ, 2003, J STRUCT BIOL, V144, P152, DOI 10.1016/j.jsb.2003.09.010; Gonzalez C, 1998, J CELL SCI, V111, P2697; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS DM, 1967, J CELL BIOL, V33, P73, DOI 10.1083/jcb.33.1.73; Riparbelli MG, 2009, CELL MOTIL CYTOSKEL, V66, P1100, DOI 10.1002/cm.20417; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rosenbaum J, 2002, CURR BIOL, V12, pR125, DOI 10.1016/S0960-9822(02)00703-0; SATIR P, 1964, J THEOR BIOL, V7, P123, DOI 10.1016/0022-5193(64)90045-1; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938	37	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8759	8770		10.1074/jbc.M109.092627	http://dx.doi.org/10.1074/jbc.M109.092627			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20083610	Green Published, hybrid			2022-12-25	WOS:000275553700028
J	Christensen, B; Schack, L; Klaning, E; Sorensen, ES				Christensen, Brian; Schack, Lotte; Klaning, Eva; Sorensen, Esben S.			Osteopontin Is Cleaved at Multiple Sites Close to Its Integrin-binding Motifs in Milk and Is a Novel Substrate for Plasmin and Cathepsin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; SECRETED PHOSPHOPROTEINS; IN-VITRO; THROMBIN; IDENTIFICATION; PHOSPHORYLATION; PROTEINS; FRAGMENT; URINE; ALPHA(9)BETA(1)	Osteopontin (OPN) is a highly modified integrin-binding protein present in most tissues and body fluids where it has been implicated in numerous biological processes. A significant regulation of OPN function is mediated through phosphorylation and proteolytic processing. Proteolytic cleavage by thrombin and matrix metalloproteinases close to the integrin-binding Arg-Gly-Asp sequence modulates the function of OPN and its integrin binding properties. In this study, seven N-terminal OPN fragments originating from proteolytic cleavage have been characterized from human milk. Identification of the cleavage sites revealed that all fragments contained the Arg-Gly-Asp(145) sequence and were generated by cleavage of the Leu(151)-Arg(152),Arg(152)- Ser(153), Ser(153)-Lys(154), Lys(154)-Ser(155), Ser(155)-Lys(156), Lys(156)-Lys(157), or Phe(158)-Arg(159) peptide bonds. Six cleavages cannot be ascribed to thrombin or matrix metalloproteinase activity, whereas the cleavage at Arg(152)-Ser(153) matches thrombin specificity for OPN. The principal protease in milk, plasmin, hydrolyzed the same peptide bond as thrombin, but its main cleavage site was identified to be Lys(154)-Ser(155). Another endogenous milk protease, cathepsin D, cleaved the Leu(151)-Arg(152) bond. OPN fragments corresponding to plasmin activity were also identified in urine showing that plasmin cleavage of OPN is not restricted to milk. Plasmin, but not cathepsin D, cleavage of OPN increased cell adhesion mediated by the alpha(V)beta(3)- or alpha(5)beta(1)-integrins. Similar cellular adhesion was mediated by plasmin and thrombin-cleaved OPN showing that plasmin can be a potent regulator of OPN activity. These data show that OPN is highly susceptible to cleavage near its integrin-binding motifs, and the protein is a novel substrate for plasmin and cathepsin D.	[Christensen, Brian; Schack, Lotte; Klaning, Eva; Sorensen, Esben S.] Univ Aarhus, Dept Mol Biol, Prot Chem Lab, DK-8000 Aarhus C, Denmark	Aarhus University	Sorensen, ES (corresponding author), Univ Aarhus, Dept Mol Biol, Prot Chem Lab, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	ess@mb.au.dk		Sorensen, Esben Skipper/0000-0002-7050-3354	The Carlsberg Foundation; Novo Nordisk Foundation; The Danish Dairy Research Foundation; Arla Foods amba; The Milk Protein Research Consortium	The Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); The Danish Dairy Research Foundation; Arla Foods amba; The Milk Protein Research Consortium	This work was supported by grants from The Carlsberg Foundation, The Novo Nordisk Foundation, The Danish Dairy Research Foundation, Arla Foods amba, and The Milk Protein Research Consortium.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Cao YH, 2000, INT J MOL MED, V5, P547; Chatterton DEW, 2004, TRENDS FOOD SCI TECH, V15, P373, DOI 10.1016/j.tifs.2003.12.004; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Ferranti P, 2004, J DAIRY RES, V71, P74, DOI 10.1017/S0022029903006599; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Heegaard CW, 1997, J PEDIATR GASTR NUTR, V25, P159, DOI 10.1097/00005176-199708000-00006; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kelly AL, 2006, INT DAIRY J, V16, P563, DOI 10.1016/j.idairyj.2005.10.019; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P15326, DOI 10.1073/pnas.0903704106; Kitamoto Y, 2004, ANN CLIN BIOCHEM, V41, P133, DOI 10.1258/000456304322880023; Koldas M, 2001, THROMB RES, V102, P221, DOI 10.1016/S0049-3848(01)00257-2; KORYCKADAHL M, 1983, J DAIRY SCI, V66, P704, DOI 10.3168/jds.S0022-0302(83)81848-7; LINDBERG T, 1982, PEDIATR RES, V16, P479, DOI 10.1203/00006450-198206000-00016; Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396; Nemir M, 2000, J BIOL CHEM, V275, P969, DOI 10.1074/jbc.275.2.969; Oda T, 2008, NEPHROL DIAL TRANSPL, V23, P2254, DOI 10.1093/ndt/gfm937; Ohba T, 1996, J RHEUMATOL, V23, P1505; Palmer DJ, 2006, PROTEOMICS, V6, P2208, DOI 10.1002/pmic.200500558; Piwnica D, 2006, MOL ENDOCRINOL, V20, P3263, DOI 10.1210/me.2006-0044; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; Schnolzer M, 1996, ELECTROPHORESIS, V17, P945, DOI 10.1002/elps.1150170517; SCHONHEYDER F., 1942, Acta Physiologica Scandinavica, V4, P309, DOI 10.1111/j.1748-1716.1942.tb01464.x; SENGER DR, 1989, BIOCHIM BIOPHYS ACTA, V996, P43, DOI 10.1016/0167-4838(89)90092-7; SENGER DR, 1988, CANCER RES, V48, P5770; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sohar N, 2002, BIOL CHEM, V383, P865, DOI 10.1515/BC.2002.093; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Sorensen S, 2003, PROTEIN EXPRES PURIF, V30, P238, DOI 10.1016/S1046-5928(03)00102-5; SORENSEN S, 1995, UROL RES, V23, P327, DOI 10.1007/BF00300022; Taguchi O, 1996, CLIN CHIM ACTA, V244, P69, DOI 10.1016/0009-8981(95)06196-7; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; VAZIRI ND, 1984, AM J MED, V77, P433, DOI 10.1016/0002-9343(84)90098-6; VETVICKA V, 1993, BIOCHEM MOL BIOL INT, V30, P921; VINAZZER H, 1988, Haemostasis, V18, P41; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; WEINSTEI.MJ, 1972, BIOCHIM BIOPHYS ACTA, V258, P577, DOI 10.1016/0005-2744(72)90250-1; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; ZHANG R, 1990, J BIOL CHEM, V265, P15375	51	86	89	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7929	7937		10.1074/jbc.M109.075010	http://dx.doi.org/10.1074/jbc.M109.075010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071328	Green Published, hybrid			2022-12-25	WOS:000275413800010
J	Cooper, EA; Whittall, JB; Hodges, SA; Nordborg, M				Cooper, Elizabeth A.; Whittall, Justen B.; Hodges, Scott A.; Nordborg, Magnus			Genetic Variation at Nuclear Loci Fails to Distinguish Two Morphologically Distinct Species of Aquilegia	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DROSOPHILA-PSEUDOOBSCURA; HAPLOTYPE RECONSTRUCTION; LINKAGE DISEQUILIBRIUM; HELIANTHUS-ANNUUS; ANNUAL SUNFLOWERS; POPULATION SIZES; SPECIATION; FLOW; HYBRIDIZATION	Aquilegia formosa and pubescens are two closely related species belonging to the columbine genus. Despite their morphological and ecological differences, previous studies have revealed a large degree of intercompatibility, as well as little sequence divergence between these two taxa [1,2]. We compared the inter- and intraspecific patterns of variation for 9 nuclear loci, and found that the two species were practically indistinguishable at the level of DNA sequence polymorphism, indicating either very recent speciation or continued gene flow. As a comparison, we also analyzed variation at two loci across 30 other Aquilegia taxa; this revealed slightly more differentiation among taxa, which seemed best explained by geographic distance. By contrast, we found no evidence for isolation by distance on a more local geographic scale. We conclude that the extremely low levels of genetic differentiation between A. formosa and A. pubescens at neutral loci will facilitate future genome-wide scans for speciation genes.	[Cooper, Elizabeth A.] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; [Whittall, Justen B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Hodges, Scott A.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Nordborg, Magnus] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria	University of Southern California; Santa Clara University; University of California System; University of California Santa Barbara; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Cooper, EA (corresponding author), Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA.	eacooper@usc.edu		Hodges, Scott/0000-0002-0401-6072; Cooper, Elizabeth/0000-0002-2688-7418; Nordborg, Magnus/0000-0001-7178-9748	NSF [EF-0412727]	NSF(National Science Foundation (NSF))	This work was supported by an NSF grant: EF-0412727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; CHASE VC, 1975, EVOLUTION, V29, P474, DOI [10.2307/2407260, 10.1111/j.1558-5646.1975.tb00837.x]; Clarke B, 1996, PHILOS T R SOC B, V351, P773, DOI 10.1098/rstb.1996.0072; Coyne JA, 2004, SPECIATION, V37; Crow KD, 2007, BIOL J LINN SOC, V91, P135, DOI 10.1111/j.1095-8312.2007.00786.x; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fulton M, 1999, P ROY SOC B-BIOL SCI, V266, P2247, DOI 10.1098/rspb.1999.0915; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GRANT VERNE, 1952, ALISO, V2, P341; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; Hodges SA, 2004, NEW PHYTOL, V161, P113, DOI 10.1046/j.1469-8137.2003.00950.x; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P2493, DOI 10.1073/pnas.91.7.2493; HUDSON RR, 1992, GENETICS, V132, P583; JUKES T H, 1969, P21; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kolkman JM, 2007, GENETICS, V177, P457, DOI 10.1534/genetics.107.074054; Lawton-Rauh A, 2007, MOL ECOL, V16, P3995, DOI 10.1111/j.1365-294X.2007.03445.x; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; MANTEL N, 1967, CANCER RES, V27, P209; Munz Philip A., 1946, GENTES HERBARUM, V7, P1; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; PRAZMO W., 1965, ACTA SOC BOT POL, V34, P667; Pritchard JK, 2000, GENETICS, V155, P945; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rosenberg N.A, 2002, DISTRUCT PROGRAM GRA; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Scotti-Saintagne C, 2004, GENETICS, V168, P1615, DOI 10.1534/genetics.104.026849; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strasburg JL, 2008, EVOLUTION, V62, P1936, DOI 10.1111/j.1558-5646.2008.00415.x; TAJIMA F, 1983, GENETICS, V105, P437; TAYLOR RJ, 1967, BRITTONIA, V19, P374, DOI 10.2307/2805535; TEAM RDC, 2007, R LANGUAGE ENV STAT; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Wang RL, 1997, GENETICS, V147, P1091; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1986, AM J HUM GENET, V38, P776; Whittall JB, 2006, MOL PHYLOGENET EVOL, V39, P124, DOI 10.1016/j.ympev.2005.10.010; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang JY, 2005, MOL ECOL NOTES, V5, P317, DOI 10.1111/j.1471-8286.2005.00913.x; Yatabe Y, 2007, GENETICS, V175, P1883, DOI 10.1534/genetics.106.064469; Zhu YL, 2003, GENETICS, V163, P1123	55	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8655	10.1371/journal.pone.0008655	http://dx.doi.org/10.1371/journal.pone.0008655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098727	Green Published, Green Submitted, gold			2022-12-25	WOS:000273778900005
J	Tan, PT; Heiny, AT; Miotto, O; Salmon, J; Marques, ETA; Lemonnier, F; August, JT				Tan, Paul ThiamJoo; Heiny, A. T.; Miotto, Olivo; Salmon, Jerome; Marques, Ernesto T. A., Jr.; Lemonnier, Francois; August, J. Thomas			Conservation and Diversity of Influenza A H1N1 HLA-Restricted T Cell Epitope Candidates for Epitope-Based Vaccines	PLOS ONE			English	Article							DOUBLE-KNOCKOUT MICE; CLASS-I SUPERTYPES; TRANSGENIC MICE; MEDIATED PROTECTION; LETHAL INFLUENZA; VIRUS INFECTION; CTL EPITOPES; HIGH-AVIDITY; LYMPHOCYTE; PEPTIDE	Background: The immune-related evolution of influenza viruses is exceedingly complex and current vaccines against influenza must be reformulated for each influenza season because of the high degree of antigenic drift among circulating influenza strains. Delay in vaccine production is a serious problem in responding to a pandemic situation, such as that of the current H1N1 strain. Immune escape is generally attributed to reduced antibody recognition of the viral hemagglutinin and neuraminidase proteins whose rate of mutation is much greater than that of the internal non-structural proteins. As a possible alternative, vaccines directed at T cell epitope domains of internal influenza proteins, that are less susceptible to antigenic variation, have been investigated. Methodology/Principal Findings: HLA transgenic mouse strains expressing HLA class I A*0201, A*2402, and B*0702, and class II DRB1*1501, DRB1*0301 and DRB1*0401 were immunized with 196 influenza H1N1 peptides that contained residues of highly conserved proteome sequences of the human H1N1, H3N2, H1N2, H5N1, and avian influenza A strains. Fifty-four (54) peptides that elicited 63 HLA-restricted peptide-specific T cell epitope responses were identified by IFN-gamma ELISpot assay. The 54 peptides were compared to the 2007-2009 human H1N1 sequences for selection of sequences in the design of a new candidate H1N1 vaccine, specifically targeted to highly-conserved HLA-restricted T cell epitopes. Conclusions/Significance: Seventeen (17) T cell epitopes in PB1, PB2, and M1 were selected as vaccine targets based on sequence conservation over the past 30 years, high functional avidity, non-identity to human peptides, clustered localization, and promiscuity to multiple HLA alleles. These candidate vaccine antigen sequences may be applicable to any avian or human influenza A virus.	[Tan, Paul ThiamJoo; Salmon, Jerome; August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Heiny, A. T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Miotto, Olivo] Univ Oxford, Ctr Genom & Global Hlth, Oxford, England; [Miotto, Olivo] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok, Thailand; [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Marques, Ernesto T. A., Jr.] LaVITE, FIOCRUZ Dept Virol, Ctr Pesquisa Aggeu Magalhaes, Recife, PE, Brazil; [Lemonnier, Francois] Inst Pasteur, Unite Immunite Cellulaire Antivirale, Paris, France	Johns Hopkins University; National University of Singapore; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fundacao Oswaldo Cruz; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tan, PT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	ptan4@jhmi.edu	Marques, Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013; Publica, Inct Saude/J-9544-2013; Miotto, Olivo/AAE-7124-2019	Marques, Ernesto T. A/0000-0003-3826-9358; Marques, Ernesto/0000-0003-3826-9358; Miotto, Olivo/0000-0001-8060-6771; Francois, Lemonnier/0000-0002-6741-2742	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, USA [5 U19 AI56541, HHSN2662-00400085C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part with Federal Funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, USA under Grant No. 5 U19 AI56541 and Contract No. HHSN2662-00400085C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Berkhoff EGM, 2006, VACCINE, V24, P6594, DOI 10.1016/j.vaccine.2006.05.051; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; BIDDISON WE, 2001, CURR PROTOC IMMUNOL; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Carson RT, 1999, J IMMUNOL, V162, P1; Derby MA, 2001, J IMMUNOL, V166, P1690, DOI 10.4049/jimmunol.166.3.1690; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 1998, J IMMUNOL, V160, P322; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; FUGGER L, 1994, P NATL ACAD SCI USA, V91, P6151, DOI 10.1073/pnas.91.13.6151; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lalvani A, 1997, J IMMUNOL METHODS, V210, P65, DOI 10.1016/S0022-1759(97)00177-4; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Li X, 2006, CLIN EXP RHEUMATOL, V24, P148; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Mirshahidi S, 2004, J IMMUNOL, V172, P5346, DOI 10.4049/jimmunol.172.9.5346; Mozdzanowska K, 2005, J VIROL, V79, P5943, DOI 10.1128/JVI.79.10.5943-5951.2005; Niedermann G, 2002, CURR TOP MICROBIOL, V268, P91; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Richards KA, 2009, J VIROL, V83, P6566, DOI 10.1128/JVI.00302-09; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Rohrlich PS, 2003, INT IMMUNOL, V15, P765, DOI 10.1093/intimm/dxg073; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; STRAUSS G, 1994, IMMUNOGENETICS, V40, P104; Strutt TM, 2009, J CLIN IMMUNOL, V29, P145, DOI 10.1007/s10875-008-9266-4; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Tobery TW, 2001, J IMMUNOL METHODS, V254, P59, DOI 10.1016/S0022-1759(01)00397-0; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Tsitoura DC, 1996, J IMMUNOL, V156, P2801; Vandenbark AA, 2003, J IMMUNOL, V171, P127, DOI 10.4049/jimmunol.171.1.127	50	35	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8754	10.1371/journal.pone.0008754	http://dx.doi.org/10.1371/journal.pone.0008754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090904	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000273715000012
J	Fedele, G; Spensieri, F; Palazzo, R; Nasso, M; Cheung, GYC; Coote, JG; Ausiello, CM				Fedele, Giorgio; Spensieri, Fabiana; Palazzo, Raffaella; Nasso, Maria; Cheung, Gordon Yiu Chong; Coote, John Graham; Ausiello, Clara Maria			Bordetella pertussis Commits Human Dendritic Cells to Promote a Th1/Th17 Response through the Activity of Adenylate Cyclase Toxin and MAPK-Pathways	PLOS ONE			English	Article							IL-17-PRODUCING T-CELLS; IMMUNE-RESPONSE; MOLECULAR PATHOGENESIS; DEPENDENT PATHWAY; INFECTION; ACTIVATION; INDUCTION; INNATE; IL-12; INFLAMMATION	The complex pathology of B. pertussis infection is due to multiple virulence factors having disparate effects on different cell types. We focused our investigation on the ability of B. pertussis to modulate host immunity, in particular on the role played by adenylate cyclase toxin (CyaA), an important virulence factor of B. pertussis. As a tool, we used human monocyte derived dendritic cells (MDDC), an ex vivo model useful for the evaluation of the regulatory potential of DC on T cell immune responses. The work compared MDDC functions after encounter with wild-type B. pertussis (BpWT) or a mutant lacking CyaA (BpCyaA(-)), or the BpCyaA(-) strain supplemented with either the fully functional CyaA or a derivative, CyaA*, lacking adenylate cyclase activity. As a first step, MDDC maturation, cytokine production, and modulation of T helper cell polarization were evaluated. As a second step, engagement of Toll-like receptors (TLR) 2 and TLR4 by B. pertussis and the signaling events connected to this were analyzed. These approaches allowed us to demonstrate that CyaA expressed by B. pertussis strongly interferes with DC functions, by reducing the expression of phenotypic markers and immunomodulatory cytokines, and blocking IL-12p70 production. B. pertussis-treated MDDC promoted a mixed Th1/Th17 polarization, and the activity of CyaA altered the Th1/Th17 balance, enhancing Th17 and limiting Th1 expansion. We also demonstrated that Th1 effectors are induced by B. pertussis-MDDC in the absence of IL-12p70 through an ERK1/2 dependent mechanism, and that p38 MAPK is essential for MDDC-driven Th17 expansion. The data suggest that CyaA mediates an escape strategy for the bacterium, since it reduces Th1 immunity and increases Th17 responses thought to be responsible, when the response is exacerbated, for enhanced lung inflammation and injury.	[Fedele, Giorgio; Spensieri, Fabiana; Palazzo, Raffaella; Nasso, Maria; Ausiello, Clara Maria] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Cheung, Gordon Yiu Chong; Coote, John Graham] Univ Glasgow, Glasgow Biomed Res Ctr, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow, Lanark, Scotland	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Glasgow	Fedele, G (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	clara.ausiello@iss.it	FEDELE, GIORGIO/M-4357-2015; fedele, giorgio/N-4681-2015; Cheung, Yiu Chong/K-3565-2012; Ausiello, Clara/G-3232-2011; PALAZZO, RAFFAELLA/M-4364-2015	FEDELE, GIORGIO/0000-0003-0017-6711; 	Istituto Superiore di Sanita (ISS) Italy-USA [28C6]; Italian Ministry of Health Ricerca Finalizzata [8ABF/1, 8AGF]; Commission of the European Communities; ChildINNOVAC [201502]	Istituto Superiore di Sanita (ISS) Italy-USA; Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy); Commission of the European Communities(European Commission); ChildINNOVAC	Funding: This work was supported by grants from Istituto Superiore di Sanita (ISS) Italy-USA scientific cooperation agreement (# 28C6); Italian Ministry of Health Ricerca Finalizzata (8ABF/1, 8AGF); and from the Commission of the European Communities, contract # 201502 ChildINNOVAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author has any financial, personal, or professional interests that could be construed to have influenced the paper.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ausiello CM, 2000, J INFECT DIS, V181, P1989, DOI 10.1086/315509; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Bassinet L, 2000, INFECT IMMUN, V68, P1934, DOI 10.1128/IAI.68.4.1934-1941.2000; BOUHSS A, 1993, J BIOL CHEM, V268, P1690; Boyd AP, 2005, J IMMUNOL, V175, P730, DOI 10.4049/jimmunol.175.2.730; Carbonetti NH, 2007, CURR OPIN PHARMACOL, V7, P272, DOI 10.1016/j.coph.2006.12.004; Cheung GYC, 2006, INFECT IMMUN, V74, P6797, DOI 10.1128/IAI.01104-06; Fedele G, 2005, INFECT IMMUN, V73, P1590, DOI 10.1128/IAI.73.3.1590-1597.2005; Fedele G, 2004, EUR J IMMUNOL, V34, P1342, DOI 10.1002/eji.200324728; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Fedele G, 2007, MICROBES INFECT, V9, P855, DOI 10.1016/j.micinf.2007.03.002; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; Hickey FB, 2008, J LEUKOCYTE BIOL, V84, P234, DOI 10.1189/jlb.0208113; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; KHELEF N, 1992, MICROB PATHOGENESIS, V12, P227, DOI 10.1016/0882-4010(92)90057-U; KHELEF N, 1994, INFECT IMMUN, V62, P2893, DOI 10.1128/IAI.62.7.2893-2900.1994; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; KHELEF N, 1995, FEMS MICROBIOL LETT, V134, P27, DOI 10.1016/0378-1097(95)00375-F; Locht C, 2001, CURR OPIN MICROBIOL, V4, P82, DOI 10.1016/S1369-5274(00)00169-7; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mascart F, 2003, J IMMUNOL, V170, P1504, DOI 10.4049/jimmunol.170.3.1504; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Nasso M, 2009, J IMMUNOL, V183, P1892, DOI 10.4049/jimmunol.0901071; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Rescigno M, 2002, TRENDS MICROBIOL, V10, P425, DOI 10.1016/S0966-842X(02)02425-3; Ross PJ, 2004, INFECT IMMUN, V72, P1568, DOI 10.1128/IAI.72.3.1568-1579.2004; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; Siciliano NA, 2006, J IMMUNOL, V177, P7131, DOI 10.4049/jimmunol.177.10.7131; Spensieri F, 2006, INFECT IMMUN, V74, P2831, DOI 10.1128/IAI.74.5.2831-2838.2006; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Westrop GD, 1996, GENE, V180, P91, DOI 10.1016/S0378-1119(96)00412-X; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497	48	61	63	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8734	10.1371/journal.pone.0008734	http://dx.doi.org/10.1371/journal.pone.0008734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090944	Green Published, Green Submitted, gold			2022-12-25	WOS:000273714900014
J	Krebs, RM; Woldorff, MG; Tempelmann, C; Bodammer, N; Noesselt, T; Boehler, CN; Scheich, H; Hopf, JM; Duzel, E; Heinze, HJ; Schoenfeld, MA				Krebs, Ruth M.; Woldorff, Marty G.; Tempelmann, Claus; Bodammer, Nils; Noesselt, Toemme; Boehler, Carsten N.; Scheich, Henning; Hopf, Jens-Max; Duzel, Emrah; Heinze, Hans-Jochen; Schoenfeld, Mircea A.			High-Field fMRI Reveals Brain Activation Patterns Underlying Saccade Execution in the Human Superior Colliculus	PLOS ONE			English	Article							EVENT-RELATED FMRI; POSTERIOR PARIETAL CORTEX; FRONTAL EYE FIELD; PREPARATION SIGNALS; NEURONAL RESPONSES; LATERAL GENICULATE; FUNCTIONAL-ANATOMY; OCULOMOTOR SYSTEM; SPATIAL ATTENTION; COVERT SHIFTS	Background: The superior colliculus (SC) has been shown to play a crucial role in the initiation and coordination of eye-and head-movements. The knowledge about the function of this structure is mainly based on single-unit recordings in animals with relatively few neuroimaging studies investigating eye-movement related brain activity in humans. Methodology/Principal Findings: The present study employed high-field (7 Tesla) functional magnetic resonance imaging (fMRI) to investigate SC responses during endogenously cued saccades in humans. In response to centrally presented instructional cues, subjects either performed saccades away from (centrifugal) or towards (centripetal) the center of straight gaze or maintained fixation at the center position. Compared to central fixation, the execution of saccades elicited hemodynamic activity within a network of cortical and subcortical areas that included the SC, lateral geniculate nucleus (LGN), occipital cortex, striatum, and the pulvinar. Conclusions/Significance: Activity in the SC was enhanced contralateral to the direction of the saccade (i.e., greater activity in the right as compared to left SC during leftward saccades and vice versa) during both centrifugal and centripetal saccades, thereby demonstrating that the contralateral predominance for saccade execution that has been shown to exist in animals is also present in the human SC. In addition, centrifugal saccades elicited greater activity in the SC than did centripetal saccades, while also being accompanied by an enhanced deactivation within the prefrontal default-mode network. This pattern of brain activity might reflect the reduced processing effort required to move the eyes toward as compared to away from the center of straight gaze, a position that might serve as a spatial baseline in which the retinotopic and craniotopic reference frames are aligned.	[Krebs, Ruth M.; Tempelmann, Claus; Bodammer, Nils; Noesselt, Toemme; Hopf, Jens-Max; Duzel, Emrah; Heinze, Hans-Jochen; Schoenfeld, Mircea A.] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Boehler, Carsten N.; Scheich, Henning; Hopf, Jens-Max; Heinze, Hans-Jochen; Schoenfeld, Mircea A.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Krebs, Ruth M.; Woldorff, Marty G.; Boehler, Carsten N.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Woldorff, Marty G.] Duke Univ, Dept Psychiat, Durham, NC USA; [Schoenfeld, Mircea A.] Kliniken Schmieder, Allensbach, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Duke University; Duke University	Krebs, RM (corresponding author), Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany.	ruth.krebs@duke.edu	Schoenfeld, Mircea Ariel/G-2096-2013; Duzel, Emrah/A-1794-2010; Schoenfeld, Ariel/O-7513-2019; Boehler, Carsten/J-8619-2015; Krebs, Ruth M/E-9042-2016	Schoenfeld, Ariel/0000-0001-9003-4092; Boehler, Carsten/0000-0001-5963-2780; Krebs, Ruth M/0000-0002-0676-7611; Tempelmann, Claus/0000-0001-8570-4960; Woldorff, Marty/0000-0002-2683-4551; Noesselt, Toemme/0000-0002-9611-9713; Duzel, Emrah/0000-0002-0139-5388	Deutsche Forschungsgemeinschaft (DFG) [Scho 1217/1-1, SFB 779 A1]; National Institutes of Health [NIMH R01-MH060415, NINDS P01-NS41328]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041328] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG Scho 1217/1-1 and SFB 779 A1) awarded to M. A. S, and from the National Institutes of Health (NIMH R01-MH060415 and NINDS P01-NS41328 Proj. 1) to M. G. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Bergeron A, 2000, NAT NEUROSCI, V3, P932, DOI 10.1038/78847; Boehnke SE, 2008, CURR OPIN NEUROBIOL, V18, P544, DOI 10.1016/j.conb.2008.11.004; Brett M, 2002, NEUROIMAGE, V16; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Campos M, 2006, J NEUROPHYSIOL, V95, P505, DOI 10.1152/jn.00639.2005; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 2007, J NEUROSCI, V27, P5053, DOI 10.1523/JNEUROSCI.4212-06.2007; DuBois RM, 2000, NEUROIMAGE, V12, P63, DOI 10.1006/nimg.2000.0590; EVDOKIMIDIS I, 1991, ELECTROEN CLIN NEURO, V79, P503, DOI 10.1016/0013-4694(91)90169-5; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Field CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003928; FRIES W, 1984, J COMP NEUROL, V230, P55, DOI 10.1002/cne.902300106; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fuller JH, 1996, EXP BRAIN RES, V109, P457; Gagnon D, 2002, BRAIN, V125, P123, DOI 10.1093/brain/awf005; Gitelman DR, 2002, NEUROIMAGE, V15, P970, DOI 10.1006/nimg.2001.1006; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Heide W, 2001, EUR J NEUROSCI, V13, P1177, DOI 10.1046/j.0953-816x.2001.01472.x; Himmelbach M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-66; Hinrichs H, 2000, J COGNITIVE NEUROSCI, V12, P76, DOI 10.1162/089892900564082; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Kalesnykas RP, 1996, VISION RES, V36, P3195, DOI 10.1016/0042-6989(96)00029-6; Kanowski M, 2007, J NEUROSCI METH, V160, P10, DOI 10.1016/j.jneumeth.2006.08.001; Kardamakis AA, 2009, J NEUROSCI, V29, P7723, DOI 10.1523/JNEUROSCI.5518-08.2009; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; Konen CS, 2008, J NEUROSCI, V28, P8361, DOI 10.1523/JNEUROSCI.1930-08.2008; Konen CS, 2004, NEUROIMAGE, V22, P304, DOI 10.1016/j.neuroimage.2003.12.039; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Marino RA, 2008, J NEUROPHYSIOL, V100, P2564, DOI 10.1152/jn.90688.2008; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Moschovakis AK, 2001, NAT NEUROSCI, V4, P1026, DOI 10.1038/nn727; Moschovakis AK, 1996, BRAIN RES BULL, V40, P337, DOI 10.1016/0361-9230(96)00124-4; Moschovakis AK, 1996, CURR OPIN NEUROBIOL, V6, P811, DOI 10.1016/S0959-4388(96)80032-8; Munoz DP, 2000, CAN J PHYSIOL PHARM, V78, P934, DOI 10.1139/cjpp-78-11-934; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Perry RJ, 2000, BRAIN, V123, P2273, DOI 10.1093/brain/123.11.2273; Petit L, 2003, J NEUROPHYSIOL, V89, P2516, DOI 10.1152/jn.00988.2002; Populin LC, 2004, J NEUROPHYSIOL, V92, P2151, DOI 10.1152/jn.00453.2004; Raemaekers M, 2005, NEUROREPORT, V16, P1043, DOI 10.1097/00001756-200507130-00003; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rieger JW, 2008, BRAIN RES, V1233, P89, DOI 10.1016/j.brainres.2008.07.108; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schiller PH, 2001, PROG BRAIN RES, V134, P127; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; Schmitz B, 2004, HUM BRAIN MAPP, V23, P40, DOI 10.1002/hbm.20046; Schneider KA, 2005, J NEUROPHYSIOL, V94, P2491, DOI 10.1152/jn.00288.2005; Schneider KA, 2009, J NEUROSCI, V29, P1784, DOI 10.1523/JNEUROSCI.4452-08.2009; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2001, J NEUROPHYSIOL, V85, P1673, DOI 10.1152/jn.2001.85.4.1673; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; STRASCHILL M, 1977, EXP BRAIN RES, V27, P131; STRYKER MP, 1975, EXP BRAIN RES, V23, P103; Sylvester R, 2005, CURR BIOL, V15, P37, DOI 10.1016/j.cub.2004.12.061; Sylvester R, 2007, J NEUROPHYSIOL, V97, P1495, DOI 10.1152/jn.00835.2006; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; VANOPSTAL AJ, 1995, J NEUROPHYSIOL, V74, P1593, DOI 10.1152/jn.1995.74.4.1593; Wall MB, 2009, NEUROIMAGE, V47, P1620, DOI 10.1016/j.neuroimage.2009.05.094; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; WURTZ RH, 1972, INVEST OPHTH VISUAL, V11, P441; WURTZ RH, 1971, SCIENCE, V171, P82, DOI 10.1126/science.171.3966.82; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261	76	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8691	10.1371/journal.pone.0008691	http://dx.doi.org/10.1371/journal.pone.0008691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084170	Green Published, gold			2022-12-25	WOS:000273554600039
J	Todaka, N; Inoue, T; Saita, K; Ohkuma, M; Nalepa, CA; Lenz, M; Kudo, T; Moriya, S				Todaka, Nemuri; Inoue, Tetsushi; Saita, Kanako; Ohkuma, Moriya; Nalepa, Christine A.; Lenz, Michael; Kudo, Toshiaki; Moriya, Shigeharu			Phylogenetic Analysis of Cellulolytic Enzyme Genes from Representative Lineages of Termites and a Related Cockroach	PLOS ONE			English	Article							ACTIVE-SITE; PSEUDOTRICHONYMPHA-GRASSII; CELLOBIOHYDROLASE-I; MOLECULAR-CLONING; SYMBIOTIC PROTIST; CRYSTAL-STRUCTURE; CATALYTIC CORE; CELLULASE; COPTOTERMES; LIGNOCELLULOSE	The relationship between xylophagous termites and the protists resident in their hindguts is a textbook example of symbiosis. The essential steps of lignocellulose degradation handled by these protists allow the host termites to thrive on a wood diet. There has never been a comprehensive analysis of lignocellulose degradation by protists, however, as it has proven difficult to establish these symbionts in pure culture. The trends in lignocellulose degradation during the evolution of the host lineage are also largely unknown. To clarify these points without any cultivation technique, we performed meta-expressed sequence tag (EST) analysis of cDNA libraries originating from symbiotic protistan communities in four termite species and a wood-feeding cockroach. Our results reveal the establishment of a degradation system with multiple enzymes at the ancestral stage of termite-protistan symbiosis, especially GHF5 and 7. According to our phylogenetic analyses, the enzymes comprising the protistan lignocellulose degradation system are coded not only by genes innate to the protists, but also genes acquired by the protists via lateral transfer from bacteria. This gives us a fresh perspective from which to understand the evolutionary dynamics of symbiosis.	[Todaka, Nemuri; Inoue, Tetsushi; Saita, Kanako; Kudo, Toshiaki; Moriya, Shigeharu] Yokohama City Univ, Grad Sch, Lab Environm Mol Biol, Kanagawa, Japan; [Ohkuma, Moriya] RIKEN Tsukuba Inst, Bio Resource Ctr, Wako, Saitama, Japan; [Nalepa, Christine A.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Lenz, Michael] CSIRO Entomol, Canberra, ACT, Australia; [Moriya, Shigeharu] RIKEN Adv Sci Inst, Biosphere Oriented Biol Res Unit, Kanagawa, Japan	Yokohama City University; RIKEN; University of North Carolina; North Carolina State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); RIKEN	Todaka, N (corresponding author), Toyota Cent Res & Dev Labs Inc, Sustainable Mat Div, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.	smoriya@riken.jp	Ohkuma, Moriya/A-8100-2011; Moriya, Shigeharu/AGY-8351-2022; Moriya, Shigeharu/F-4604-2014; Moriya, Shigeharu/H-1656-2011	Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874	New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Science, Sports and Culture [16770182]; Program for the Promotion of Basic Research Activity for Innovative Biosciences (PROBRAIN)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Promotion of Basic Research Activity for Innovative Biosciences (PROBRAIN)	This research was partly supported by the New Energy and Industrial Technology Development Organization (NEDO) program for the development of elemental technology for bioenergy conversion; by a Grant-in-Aid for Scientific Research (# 16770182, 2004) from the Ministry of Education, Science, Sports and Culture and the Bio Recycle Project (JST), Eco-molecular research program (RIKEN), and Bio-architect research program (RIKEN); and by the Program for the Promotion of Basic Research Activity for Innovative Biosciences (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; DAVIES GJ, 1993, NATURE, V365, P362, DOI 10.1038/365362a0; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Girard C, 1999, INSECT BIOCHEM MOLEC, V29, P1129, DOI 10.1016/S0965-1748(99)00104-6; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Inoue T, 2005, GENE, V349, P67, DOI 10.1016/j.gene.2004.11.048; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lee SJ, 2004, COMP BIOCHEM PHYS B, V139, P107, DOI 10.1016/j.cbpc.2004.06.015; Li L, 2003, EUKARYOT CELL, V2, P1091, DOI 10.1128/EC.2.5.1091-1098.2003; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; MARUYAMA K, 1994, GENE, V138, P171; Nakashima K, 2002, CELL MOL LIFE SCI, V59, P1554, DOI 10.1007/s00018-002-8528-1; OBRIEN DA, 1985, APPL ENVIRON MICROB, V49, P614; OBRIEN DA, 1985, APPL ENVIRON MICROB, V49, P622; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Ohtoko K, 2000, EXTREMOPHILES, V4, P343, DOI 10.1007/s007920070003; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Slomovic S, 2006, CRIT REV PLANT SCI, V25, P65, DOI 10.1080/07352680500391337; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SUGIMOTO A, MJA TERMITES EVOLUTI, P409; Todaka N, 2007, FEMS MICROBIOL ECOL, V59, P592, DOI 10.1111/j.1574-6941.2006.00237.x; TULL D, 1991, J BIOL CHEM, V266, P15621; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; WANG QP, 1993, J BIOL CHEM, V268, P14096; Watanabe H, 2002, CELL MOL LIFE SCI, V59, P1983, DOI 10.1007/PL00012520; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; YAMIN MA, 1978, J PROTOZOOL, V25, P535, DOI 10.1111/j.1550-7408.1978.tb04181.x; YAMIN MA, 1981, SCIENCE, V211, P58, DOI 10.1126/science.211.4477.58	36	54	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8636	10.1371/journal.pone.0008636	http://dx.doi.org/10.1371/journal.pone.0008636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072608	Green Submitted, Green Published, gold			2022-12-25	WOS:000273414200014
J	Hasan, MR; Rahman, M; Jaques, S; Purwantini, E; Daniels, L				Hasan, Mohammad Rubayet; Rahman, Mahbuba; Jaques, Sandford; Purwantini, Endang; Daniels, Lacy			Glucose 6-Phosphate Accumulation in Mycobacteria IMPLICATIONS FOR A NOVEL F-420-DEPENDENT ANTI-OXIDANT DEFENSE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS; TUBERCULOSIS; SMEGMATIS; IDENTIFICATION; DEHYDROGENASE; PURIFICATION; BACTERIA; GENE; MACROPHAGES; METABOLISM	Glucose 6-phosphate (G6P) is a metabolic intermediate with many possible cellular fates. In mycobacteria, G6P is a substrate for an enzyme, F-420-dependent glucose-6-phosphate dehydrogenase (Fgd), found in few bacterial genera. Intracellular G6P levels in six Mycobacterium sp. were remarkably higher (similar to 17-130-fold) than Escherichia coli and Bacillus megaterium. The high G6P level in Mycobacterium smegmatis may result from 10-25-fold higher activity of the gluconeogenic enzyme fructose-1,6-bisphosphatase when grown on glucose, glycerol, or acetate compared with B. megaterium and E. coli. In M. smegmatis this coincided with up-regulation of the first gluconeogenic enzyme, phosphoenolpyruvate carboxykinase, when acetate was the carbon source, suggesting a cellular program for maintaining high G6P levels. G6P was depleted in cells under oxidative stress induced by redox cycling agents plumbagin and menadione, whereas an fgd mutant of M. smegmatis used G6P less well under such conditions. The fgd mutant was more sensitive to these agents and, in contrast to wild type, was defective in its ability to reduce extracellular plumbagin and menadione. These data suggest that intracellular G6P in mycobacteria serves as a source of reducing power and, with the mycobacteria-specific Fgd-F-420 system, plays a protective role against oxidative stress.	[Hasan, Mohammad Rubayet; Rahman, Mahbuba; Jaques, Sandford; Daniels, Lacy] Texas A&M Hlth Sci Ctr, Irma Lerma Rangel Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA; [Purwantini, Endang] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Virginia Polytechnic Institute & State University	Daniels, L (corresponding author), Texas A&M Hlth Sci Ctr, Irma Lerma Rangel Coll Pharm, Dept Pharmaceut Sci, 1010 W Ave B, Kingsville, TX 78363 USA.	ldaniels@tamhsc.edu	Rahman, Mahbuba/AAR-2085-2020; Hasan, Mohammad/AAR-2093-2020	Rahman, Mahbuba/0000-0003-4586-4067; Hasan, Mohammad/0000-0002-4658-7949	National Institutes of Health [2R42GM073965-02A1]; Texas Advanced Research Program [000089-0023-2006]; United States Department of Agriculture [2006-34188-17123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R42GM073965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Advanced Research Program; United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R42GM073965-02A1. This work was also supported by Texas Advanced Research Program Grant 000089-0023-2006 and United States Department of Agriculture Agreement 2006-34188-17123.	Albers E, 2007, APPL ENVIRON MICROB, V73, P4839, DOI 10.1128/AEM.00425-07; Bergmeyer H., 1985, METHODS ENZYMATIC AN, VVI; BERGMEYER HU, 1985, METHODS ENZYMATIC AN, V7; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; DANIELS L, 1985, SYST APPL MICROBIOL, V6, P12, DOI 10.1016/S0723-2020(85)80004-7; de Orduna Ramon Mira, 2000, Journal of Biotechnology, V77, P209; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; DIETZLER DN, 1979, J BIOL CHEM, V254, P8308; Dominguez H, 1998, EUR J BIOCHEM, V254, P96, DOI 10.1046/j.1432-1327.1998.2540096.x; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; EIRICH LD, 1979, J BACTERIOL, V140, P20, DOI 10.1128/JB.140.1.20-27.1979; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Gupta S, 2005, IUBMB LIFE, V57, P149, DOI 10.1080/15216540500090611; HARTZELL PL, 1985, BIOCHEM BIOPH RES CO, V133, P884, DOI 10.1016/0006-291X(85)91218-5; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JONES JB, 1980, J BIOL CHEM, V255, P1049; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; MOAT AG, 1995, MICROBIAL PHYSL; Mukhopadhyay B, 2000, BBA-GEN SUBJECTS, V1475, P191, DOI 10.1016/S0304-4165(00)00064-7; Mukhopadhyay B, 2001, J BIOL CHEM, V276, P16137, DOI 10.1074/jbc.M008960200; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; NARAOKA T, 1984, BIOCHIM BIOPHYS ACTA, V797, P377, DOI 10.1016/0304-4165(84)90260-5; Nathan C., 2004, TUBERCULOSIS, V84, P215; O Gaora P, 1998, METH MOL B, V101, P261; Paget T, 2004, MICROBIOL-SGM, V150, P1231, DOI 10.1099/mic.0.26836-0; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; Purwantini E, 1998, J BACTERIOL, V180, P2212, DOI 10.1128/JB.180.8.2212-2219.1998; PURWANTINI E, 1992, ANAL BIOCHEM, V205, P342, DOI 10.1016/0003-2697(92)90446-E; Purwantini E, 1997, FEMS MICROBIOL LETT, V146, P129, DOI 10.1016/S0378-1097(96)00465-X; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shankar S, 1997, MOL MICROBIOL, V24, P477, DOI 10.1046/j.1365-2958.1997.3491724.x; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tuckman D, 1997, J BACTERIOL, V179, P2724, DOI 10.1128/jb.179.8.2724-2730.1997; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WIDDEL F, 1989, ARCH MICROBIOL, V152, P322, DOI 10.1007/BF00425168; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	43	47	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19135	19144		10.1074/jbc.M109.074310	http://dx.doi.org/10.1074/jbc.M109.074310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20075070	hybrid, Green Published			2022-12-25	WOS:000278727800023
J	Dai, W; Kamei, H; Zhao, Y; Ding, J; Du, Z; Duan, CM				Dai, Wei; Kamei, Hiroyasu; Zhao, Yang; Ding, Jun; Du, Zhou; Duan, Cunming			Duplicated zebrafish insulin-like growth factor binding protein-5 genes with split functional domains: evidence for evolutionarily conserved IGF binding, nuclear localization, and transactivation activity	FASEB JOURNAL			English	Article						IGFBP; IGF-independent action; gene expression; subfunctionalization	AMINO-ACIDS; FACTOR-I; HEPARIN-BINDING; IGFBP-5; ROLES; DIVERGENCE; TRANSPORT	Insulin-like growth factor binding protein (IGFBP)-5 is a secreted protein that binds to IGF and modulates IGF actions. IGFBP-5 is also found in the nucleus of mammalian cells and has transactivation activity. The structural basis of this transactivation activity and its role in mediating IGF-independent actions are not clear. Here we report that there are 2 igfbp-5 genes in zebrafish and other teleost fish. In zebrafish, igfbp-5a and -5b are expressed in spatially restricted, mostly nonoverlapping domains during early development. The IGF binding site is conserved in both zebrafish IGFBP-5s, and they are both secreted and capable of IGF binding. Both proteins contain a consensus bipartite nuclear localization signal and were found in the nucleus when introduced into cultured cells. Although zebrafish IGFBP-5b possesses transactivation activity, zebrafish IGFBP-5a lacks this activity. Mutational analysis demonstrated that 2 unique amino acids in positions 22 and 56 of IGFBP-5a are responsible for its lack of transactivation activity. These findings suggest that the duplicated zebrafish IGFBP-5s have evolved divergent regulatory mechanisms and distinct biological properties by partitioning of ancestral structural domains and provide new evidence for a conserved role of the IGF binding, nuclear localization, and transactivation domain of this multifunctional IGFBP.-Dai, W., Kamei, H., Zhao, Y., Ding, J., Du, Z., Duan, C. Duplicated zebrafish insulin-like growth factor binding protein-5 genes with split functional domains: evidence for evolutionarily conserved IGF binding, nuclear localization, and transactivation activity. FASEB J. 24, 2020-2029 (2010). www.fasebj.org	[Dai, Wei; Kamei, Hiroyasu; Zhao, Yang; Ding, Jun; Du, Zhou; Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Duan, CM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	cduan@umich.edu		KAMEI, HIROYASU/0000-0001-7123-040X; Dai, Wei/0000-0001-6069-9616	U.S. National Institutes of Health [2RO1HL60679]; National Science Foundation [IOB 0110864]; Japan Society for the Promotion of Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060679] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank John Allard for critical reading of this manuscript. This study was supported by U.S. National Institutes of Health grant 2RO1HL60679 and National Science Foundation research grant IOB 0110864 to C. D. H. K. is supported in part by a postdoctoral fellowship from the Japan Society for the Promotion of Science.	Abrass CK, 1997, AM J PHYSIOL-RENAL, V273, pF899, DOI 10.1152/ajprenal.1997.273.6.F899; Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; Arai T, 1996, J BIOL CHEM, V271, P6099, DOI 10.1074/jbc.271.11.6099; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Berfield AK, 2000, KIDNEY INT, V57, P1991, DOI 10.1046/j.1523-1755.2000.00049.x; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Firth SM, 2001, ENDOCRINOLOGY, V142, P2147, DOI 10.1210/en.142.5.2147; Force A, 1999, GENETICS, V151, P1531; Hsieh T, 2003, J BIOL CHEM, V278, P42886, DOI 10.1074/jbc.M303835200; Jaques G, 1997, ENDOCRINOLOGY, V138, P1767, DOI 10.1210/en.138.4.1767; Kalus W, 1998, EMBO J, V17, P6558, DOI 10.1093/emboj/17.22.6558; Kamei H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003091; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WL, 1997, ENDOCRINOLOGY, V138, P1763, DOI 10.1210/en.138.4.1763; Li Y, 2005, J BIOL CHEM, V280, P3613, DOI 10.1074/jbc.M411479200; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; McClintock JM, 2002, DEVELOPMENT, V129, P2339; Miyakoshi N, 2001, J CLIN INVEST, V107, P73, DOI 10.1172/JCI10459; MOHAN S, 1995, J BIOL CHEM, V270, P20424, DOI 10.1074/jbc.270.35.20424; Ning Y, 2007, ENDOCRINOLOGY, V148, P2138, DOI 10.1210/en.2006-0041; Parker A, 1998, MOL BIOL CELL, V9, P2383, DOI 10.1091/mbc.9.9.2383; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rozen F, 1997, J NATL CANCER I, V89, P652, DOI 10.1093/jnci/89.9.652; Salih DAM, 2004, P NATL ACAD SCI USA, V101, P4314, DOI 10.1073/pnas.0400230101; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Shimizu M, 2000, GEN COMP ENDOCR, V119, P26, DOI 10.1006/gcen.2000.7498; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tripathi G, 2009, FASEB J, V23, P2616, DOI 10.1096/fj.08-114124; Wang XL, 2009, AM J PHYSIOL-REG I, V296, pR1348, DOI 10.1152/ajpregu.90969.2008; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF; Zhao Y, 2006, J BIOL CHEM, V281, P14184, DOI 10.1074/jbc.M506941200; Zhou JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003926; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	42	39	40	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2020	2029		10.1096/fj.09-149435	http://dx.doi.org/10.1096/fj.09-149435			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20081093	Green Published, Green Submitted			2022-12-25	WOS:000278200000036
J	Schopfer, FJ; Cole, MP; Groeger, AL; Chen, CS; Khoo, NKH; Woodcock, SR; Golin-Bisello, F; Motanya, UN; Li, Y; Zhang, JF; Garcia-Barrio, MT; Rudolph, TK; Rudolph, V; Bonacci, G; Baker, PRS; Xu, HE; Batthyany, CI; Chen, YE; Hallis, TM; Freeman, BA				Schopfer, Francisco J.; Cole, Marsha P.; Groeger, Alison L.; Chen, Chen-Shan; Khoo, Nicholas K. H.; Woodcock, Steven R.; Golin-Bisello, Franca; Motanya, U. Nkiru; Li, Yong; Zhang, Jifeng; Garcia-Barrio, Minerva T.; Rudolph, Tanja K.; Rudolph, Volker; Bonacci, Gustavo; Baker, Paul R. S.; Xu, H. Eric; Batthyany, Carlos I.; Chen, Y. Eugene; Hallis, Tina M.; Freeman, Bruce A.			Covalent Peroxisome Proliferator-activated Receptor gamma Adduction by Nitro-fatty Acids SELECTIVE LIGAND ACTIVITY AND ANTI-DIABETIC SIGNALING ACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; INSULIN-RESISTANCE; THIAZOLIDINEDIONES; MELLITUS; IDENTIFICATION; ROSIGLITAZONE; DERIVATIVES; GENERATION; PROTEINS; OBESITY	The peroxisome proliferator-activated receptor-gamma (PPAR gamma) binds diverse ligands to transcriptionally regulate metabolism and inflammation. Activators of PPAR gamma include lipids and anti-hyperglycemic drugs such as thiazolidinediones (TZDs). Recently, TZDs have raised concern after being linked with increased risk of peripheral edema, weight gain, and adverse cardiovascular events. Most reported endogenous PPAR gamma ligands are intermediates of lipid metabolism and oxidation that bind PPAR gamma with very low affinity. In contrast, nitro derivatives of unsaturated fatty acids (NO2-FA) are endogenous products of nitric oxide ((NO)-N-center dot) and nitrite (NO2-)-mediated redox reactions that activate PPAR gamma at nanomolar concentrations. We report that NO2-FA act as partial agonists of PPAR gamma and covalently bind PPAR gamma at Cys-285 via Michael addition. NO2-FA show selective PPAR gamma modulator characteristics by inducing coregulator protein interactions, PPAR gamma-dependent expression of key target genes, and lipid accumulation is distinctively different from responses induced by the TZD rosiglitazone. Administration of this class of signaling mediators to ob/ob mice revealed that NO2-FA lower insulin and glucose levels without inducing adverse side effects such as the increased weight gain induced by TZDs.	[Schopfer, Francisco J.; Cole, Marsha P.; Groeger, Alison L.; Chen, Chen-Shan; Khoo, Nicholas K. H.; Woodcock, Steven R.; Golin-Bisello, Franca; Motanya, U. Nkiru; Rudolph, Tanja K.; Bonacci, Gustavo; Baker, Paul R. S.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Rudolph, Tanja K.; Rudolph, Volker] Univ Heart Ctr Hamburg, Dept Cardiol, D-20246 Hamburg, Germany; [Batthyany, Carlos I.] Inst Pasteur Montevideo, Montevideo 11400, Uruguay; [Li, Yong; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Hallis, Tina M.] Invitrogen Discovery Sci, Madison, WI 53719 USA; [Garcia-Barrio, Minerva T.] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Van Andel Institute; University of Michigan System; University of Michigan; Morehouse School of Medicine	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	freerad@pitt.edu	Freeman, Bruce A/H-9342-2012; Woodcock, Steven/AAE-9199-2020; Schopfer, Francisco Jose/AAE-8125-2020; Xu, H. Eric/ABD-7487-2021; Schopfer, Francisco/AAW-6505-2021	Schopfer, Francisco Jose/0000-0001-9526-695X; Batthyany, Carlos/0000-0002-0627-1982; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [R01 HL58115, R01 HL64937, P30 DK046204-15, T32DK007052-34, DK071662, DK066202, HL089301, HL68878, HL089544, HL75397]; The Hartwell Foundation; American Diabetes Association [7-08-JF-52]; American Heart Association [0665418U, 0840025N]; Deutsche Forschungsgemeinschaft; Deutsche Herzstiftung; Jay and Betty Van Andel Foundation; Complexa, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075397, R01HL089544, R37HL058115, R01HL089301, R01HL064937, R01HL068878, R01HL058115, K99HL095769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046204, T32DK007052, R01DK071662, R01DK066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hartwell Foundation; American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Herzstiftung; Jay and Betty Van Andel Foundation; Complexa, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL58115 and R01 HL64937 (to B. A. F.), P30 DK046204-15 and T32DK007052-34 (to M. P. C.), DK071662 and DK066202 (to H. E. X.), HL089301 (to H. E. X. and to Y.L.), and HL68878, HL089544, and HL75397. This work was also supported by The Hartwell Foundation (M. P. C.), American Diabetes Association Grant 7-08-JF-52 (to F. J. S.), American Heart Association Grants 0665418U (to F. J. S.) and 0840025N (to Y. E. C.), Deutsche Forschungsgemeinschaft (to T. K. R.), Deutsche Herzstiftung (to V. R.), and Jay and Betty Van Andel Foundation (to H. E. X.). B. A. F. acknowledges financial interest in Complexa, Inc.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BOUVIER G, 1994, J LEUKOCYTE BIOL, V55, P729, DOI 10.1002/jlb.55.6.729; Carmona MC, 2007, DIABETES, V56, P2797, DOI 10.2337/db06-1734; Cerghizan Anca, 2007, Exp Clin Cardiol, V12, P83; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hu X, 2006, ACTA PHARMACOL SIN, V27, P1346, DOI 10.1111/j.1745-7254.2006.00427.x; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Kelley EE, 2008, J BIOL CHEM, V283, P36176, DOI 10.1074/jbc.M802402200; Khanderia U, 2008, ANN PHARMACOTHER, V42, P1466, DOI 10.1345/aph.1K666; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li Y, 2008, J BIOL CHEM, V283, P9168, DOI 10.1074/jbc.M800104200; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; McGuire DK, 2008, CIRCULATION, V117, P440, DOI 10.1161/CIRCULATIONAHA.107.704080; Nettles KW, 2008, NAT STRUCT MOL BIOL, V15, P893, DOI 10.1038/nsmb0908-893; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Shiraki T, 2006, BIOCHEM J, V393, P749, DOI 10.1042/BJ20050930; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsikas D, 2009, LIPIDS, V44, P855, DOI 10.1007/s11745-009-3332-4; Tsikas D, 2009, J CHROMATOGR B, V877, P2895, DOI 10.1016/j.jchromb.2008.12.062; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Wigren J, 2003, J ENDOCRINOL, V177, P207, DOI 10.1677/joe.0.1770207; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; Young PW, 1998, J PHARMACOL EXP THER, V284, P751; Zhang F, 2007, PPAR RES, V2007, DOI 10.1155/2007/32696	42	132	144	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12321	12333		10.1074/jbc.M109.091512	http://dx.doi.org/10.1074/jbc.M109.091512			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20097754	Green Published, hybrid			2022-12-25	WOS:000276787100061
J	Chen, SL; Liu, DM; Finley, RL; Greenberg, ML				Chen, Shuliang; Liu, Dongmei; Finley, Russell L., Jr.; Greenberg, Miriam L.			Loss of Mitochondrial DNA in the Yeast Cardiolipin Synthase crd1 Mutant Leads to Up-regulation of the Protein Kinase Swe1p That Regulates the G(2)/M Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSES TEMPERATURE SENSITIVITY; NUCLEAR GENE-EXPRESSION; CYTOCHROME-C REDUCTASE; CELL-DIVISION CYCLE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; RESPIRATORY-CHAIN; PHOSPHATIDYLGLYCEROLPHOSPHATE SYNTHASE; OXIDATIVE-PHOSPHORYLATION; SEPTIN ORGANIZATION	The anionic phospholipid cardiolipin and its precursor phosphatidylglycerol are synthesized and localized in the mitochondrial inner membrane of eukaryotes. They are required for structural integrity and optimal activities of a large number of mitochondrial proteins and complexes. Previous studies showed that loss of anionic phospholipids leads to cell inviability in the absence of mitochondrial DNA. However, the mechanism linking loss of anionic phospholipids to petite lethality was unclear. To elucidate the mechanism, we constructed a crd1 Delta rho degrees mutant, which is viable and mimics phenotypes of pgs1 Delta in the petite background. We found that loss of cardiolipin in rho degrees cells leads to elevated expression of Swe1p, a morphogenesis checkpoint protein. Moreover, the retrograde pathway is activated in crd1 Delta rho degrees cells, most likely due to the exacerbation of mitochondrial dysfunction. Interestingly, the expression of SWE1 is dependent on retrograde regulation as elevated expression of SWE1 is suppressed by deletion of RTG2 or RTG3. Taken together, these findings indicate that activation of the retrograde pathway leads to up-regulation of SWE1 in crd1 Delta rho degrees cells. These results suggest that anionic phospholipids are required for processes that are essential for normal cell division in rho degrees cells.	[Chen, Shuliang; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Liu, Dongmei; Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu	Chen, Shuliang/N-9498-2013	Chen, Shuliang/0000-0002-7175-7604; Finley, Russ/0000-0003-1144-6887	National Institutes of Health [HL62263]; Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL62263. This work was also supported by a grant from the Barth Syndrome Foundation.	Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Beyer K, 1996, BIOCHEMISTRY-US, V35, P15784, DOI 10.1021/bi9610055; Boldogh IR, 2001, TRAFFIC, V2, P368, DOI 10.1034/j.1600-0854.2001.002006368.x; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cabib E, 2004, ARCH BIOCHEM BIOPHYS, V426, P201, DOI 10.1016/j.abb.2004.02.030; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chelstowska A, 1999, YEAST, V15, P1377, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1377::AID-YEA473>3.0.CO;2-0; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; DEVIN AB, 1990, YEAST, V6, P231, DOI 10.1002/yea.320060308; DREES M, 1988, BIOCHEMISTRY-US, V27, P8584, DOI 10.1021/bi00423a012; Dzugasova V, 1998, CURR GENET, V34, P297, DOI 10.1007/s002940050399; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; GAYNOR PM, 1991, J BACTERIOL, V173, P6124, DOI 10.1128/jb.173.19.6124-6131.1991; GBELSKA Y, 1983, EUR J BIOCHEM, V130, P281, DOI 10.1111/j.1432-1033.1983.tb07148.x; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Hasek Jiri, 2006, Methods Mol Biol, V313, P85; HAYERHARTL M, 1992, EUR J BIOCHEM, V209, P423, DOI 10.1111/j.1432-1033.1992.tb17305.x; Hermann GJ, 1998, ANNU REV CELL DEV BI, V14, P265, DOI 10.1146/annurev.cellbio.14.1.265; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; Jensen RE, 2000, MICROSC RES TECHNIQ, V51, P573, DOI 10.1002/1097-0029(20001215)51:6<573::AID-JEMT7>3.0.CO;2-2; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 1999, MOL MICROBIOL, V31, P373, DOI 10.1046/j.1365-2958.1999.01181.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kirchman PA, 1999, GENETICS, V152, P179; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1111/j.1574-6976.2002.tb00613.x; Koltovaya NA, 1998, YEAST, V14, P133, DOI 10.1002/(SICI)1097-0061(19980130)14:2<133::AID-YEA206>3.0.CO;2-0; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; LISOWSKY T, 1994, CURR GENET, V26, P15, DOI 10.1007/BF00326299; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; MCCONNELL SJ, 1992, J CELL BIOL, V118, P385, DOI 10.1083/jcb.118.2.385; McNulty JJ, 2005, CURR BIOL, V15, P2190, DOI 10.1016/j.cub.2005.11.039; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; NEWLON CS, 1975, CELL, V5, P423; NEWLON CS, 1979, MOL GEN GENET, V169, P189, DOI 10.1007/BF00271670; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne D, 2000, J CELL SCI, V113, P571; Richman TJ, 1999, J BIOL CHEM, V274, P16861, DOI 10.1074/jbc.274.24.16861; ROBERTS RL, 1983, MOL CELL BIOL, V3, P922, DOI 10.1128/MCB.3.5.922; ROBINSON NC, 1990, BIOCHEMISTRY-US, V29, P8962, DOI 10.1021/bi00490a012; ROTHERMEL BA, 1995, J BIOL CHEM, V270, P29476, DOI 10.1074/jbc.270.49.29476; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schmidt M, 2003, MOL BIOL CELL, V14, P2128, DOI 10.1091/mbc.E02-08-0547; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; STEWART LC, 1991, J CELL BIOL, V115, P1249, DOI 10.1083/jcb.115.5.1249; SUBIK J, 1974, FEBS LETT, V42, P309, DOI 10.1016/0014-5793(74)80753-2; Suzuki M, 2004, NAT CELL BIOL, V6, P861, DOI 10.1038/ncb1162; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; YU CA, 1980, BIOCHEMISTRY-US, V19, P5715, DOI 10.1021/bi00566a008; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhao M, 1998, J BIOL CHEM, V273, P2402, DOI 10.1074/jbc.273.4.2402; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2003, J BIOL CHEM, V278, P33978, DOI 10.1074/jbc.M305242200; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200	95	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10397	10407		10.1074/jbc.M110.100784	http://dx.doi.org/10.1074/jbc.M110.100784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20086012	Green Published, hybrid			2022-12-25	WOS:000276264600025
J	Wu, J; Zhang, YC; Suo, WH; Liu, XB; Shen, WW; Tian, H; Fu, GH				Wu, J.; Zhang, Y-C; Suo, W-H; Liu, X-B; Shen, W-W; Tian, H.; Fu, G-H			Induction of anion exchanger-1 translation and its opposite roles in the carcinogenesis of gastric cancer cells and differentiation of K562 cells	ONCOGENE			English	Article						anion exchanger-1; band-3; miR-24; erythropoiesis; gastric carcinogenesis	ERYTHROID-DIFFERENTIATION; NONERYTHROID CELLS; PROGENITOR CELLS; ALPHA-SPECTRIN; BETA-SPECTRIN; KIDNEY BAND-3; PROTEIN 4.1; AE1 GENE; EXPRESSION; CLONING	Anion exchanger-1 (AE1), an erythroid-specific membrane protein, mediates the Cl(-)/HCO(3)(-) exchange across the plasma membrane and regulates intracellular pH. We have found that AE1 was unexpectedly expressed in gastric cancer cells and participated in the tumorigenesis of the cancer. Here, we focus on the induction of AE1 expression and its role in gastric carcinogenesis as well as in the differentiation of K562 cells. The results show that expression of AE1 is not related to genetic mutation or the mRNA level, but rather, that it is modulated by miR-24. miR-24 decreases the expression of AE1 through binding to the 3'UTR of AE1 mRNA. Transfection of an miR-24 into gastric cancer cells reduced the elevation of the AE1 protein, which resulted in return of AE1-sequestrated p16 to the nucleus, thereby inhibiting proliferation of the cells. Furthermore, the miR-24 inhibitor cooperated with hemin to induce the expression of AE1 in K562 cells and differentiation of the cells, which is consistent with results obtained from the cells cultured at pH 7.6 or from forced stable expression of AE1. These findings establish a novel regulation of miR-24-related AE1 expression in gastric carcinogenesis and erythropoiesis. Oncogene (2010) 29, 1987-1996; doi:10.1038/onc.2009.481; published online 11 January 2010	[Wu, J.; Zhang, Y-C; Suo, W-H; Shen, W-W; Tian, H.; Fu, G-H] Shanghai Jiao Tong Univ, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Sch Med,Inst Med Sci,Dept Pathol, Shanghai 200025, Peoples R China; [Liu, X-B] Harbin Med Coll, Oncol Affiliated Hosp 2, Radiat Dept, Harbin, Peoples R China	Shanghai Jiao Tong University; Harbin Medical University	Fu, GH (corresponding author), Shanghai Jiao Tong Univ, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Sch Med,Inst Med Sci,Dept Pathol, 280 S Chong Qing Rd, Shanghai 200025, Peoples R China.	fuguhu@263.net		Wu, Jun/0000-0003-2515-6418	National Natural Science Foundation of China [NO30570697, NO30770960]; National High Technology Research and Development Program of China [NO2008AA02Z120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported in part by the National Natural Science Foundation of China (NO30570697, NO30770960) and National High Technology Research and Development Program of China (863 Program) (NO2008AA02Z120).	ALPER SL, 1994, J CLIN INVEST, V93, P1430, DOI 10.1172/JCI117120; An XL, 2005, BIOCHEMISTRY-US, V44, P10681, DOI 10.1021/bi047331z; Durham JT, 2009, MICROVASC RES, V77, P281, DOI 10.1016/j.mvr.2008.12.003; ENDO T, 1994, LEUKEMIA RES, V18, P49, DOI 10.1016/0145-2126(94)90008-6; Friis-Hansen L, 2006, SCAND J CLIN LAB INV, V66, P607, DOI 10.1080/00365510600873894; Fu GH, 2005, FEBS LETT, V579, P2105, DOI 10.1016/j.febslet.2005.02.063; Gabrielli BG, 1999, J BIOL CHEM, V274, P13961, DOI 10.1074/jbc.274.20.13961; Galluzzi L, 2001, FEBS LETT, V489, P254, DOI 10.1016/S0014-5793(00)02333-4; Gascard P, 2000, CURR OPIN HEMATOL, V7, P123, DOI 10.1097/00062752-200003000-00009; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Huo XF, 2006, MOL CELL BIOCHEM, V292, P155, DOI 10.1007/s11010-006-9229-0; KUDRYCKI KE, 1990, J BIOL CHEM, V265, P462; KUDRYCKI KE, 1989, J BIOL CHEM, V264, P8185; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; LEHNERT ME, 1988, J CELL BIOL, V107, P413, DOI 10.1083/jcb.107.2.413; LUX SE, 1989, P NATL ACAD SCI USA, V86, P9089, DOI 10.1073/pnas.86.23.9089; McAdams TA, 1998, BRIT J HAEMATOL, V103, P317, DOI 10.1046/j.1365-2141.1998.00975.x; McAdams TA, 1997, BRIT J HAEMATOL, V97, P889, DOI 10.1046/j.1365-2141.1997.1372951.x; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Pavey S, 2001, ONCOGENE, V20, P6103, DOI 10.1038/sj.onc.1204707; Richards SM, 1999, J CELL SCI, V112, P1519; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; SAHR KE, 1994, GENOMICS, V24, P491, DOI 10.1006/geno.1994.1658; SCHOFIELD AE, 1994, BLOOD, V84, P2000; Shapiro GI, 2000, CELL BIOCHEM BIOPHYS, V33, P189, DOI 10.1385/CBB:33:2:189; Shen WW, 2007, NEOPLASIA, V9, P812, DOI 10.1593/neo.07403; SHOWE L C, 1987, Genomics, V1, P71, DOI 10.1016/0888-7543(87)90107-8; Takakuwa Y, 2000, INT J HEMATOL, V72, P298; Walensky LD, 1998, J CELL BIOL, V141, P143, DOI 10.1083/jcb.141.1.143; WANG CC, 1995, J BIOL CHEM, V270, P17892, DOI 10.1074/jbc.270.30.17892; Wang JY, 2009, J CELL PHYSIOL, V219, P617, DOI 10.1002/jcp.21711; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Xu WQ, 2009, J CANCER RES CLIN, V135, P1323, DOI 10.1007/s00432-009-0573-9; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156	35	30	34	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	13					1987	1996		10.1038/onc.2009.481	http://dx.doi.org/10.1038/onc.2009.481			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20062076				2022-12-25	WOS:000276199600011
J	Martinez, E; Hamberg, M; Busquets, M; Diaz, P; Manresa, A; Oliw, EH				Martinez, Eriel; Hamberg, Mats; Busquets, Montse; Diaz, Pilar; Manresa, Angeles; Oliw, Ernst H.			Biochemical Characterization of the Oxygenation of Unsaturated Fatty Acids by the Dioxygenase and Hydroperoxide Isomerase of Pseudomonas aeruginosa 42A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLEIC-ACID; LINOLEIC-ACID; 7,10-DIHYDROXY-8(E)-OCTADECENOIC ACID; MASS-SPECTROMETRY; RICINOLEIC ACID; STERIC ANALYSIS; LIPOXYGENASE; IDENTIFICATION; OXIDATION; COMPOUND	We have studied oxygenation of fatty acids by cell extract of Pseudomonas aeruginosa 42A2. Oleic acid ((9Z)-18:1) was transformed to (10S)-hydroperoxy-(8E)-octadecenoic acid ((10S)-HPOME) and to (7S, 10S)-dihydroxy-(8E)-octadecenoic acid (7,10-DiHOME). Experiments under oxygen-18 showed that 7,10-DiHOME contained oxygen from air and was formed sequentially from (10S)-HPOME by isomerization. (10R)-HPOME was not isomerized. The (10S)-dioxygenase and hydroperoxide isomerase activities co-eluted on ion exchange chromatography and on gel filtration with an apparent molecular size of similar to 50 kDa. 16: 1n-7, 18: 2n-6, and 20: 1n-11 were also oxygenated to 7,10-dihydroxy fatty acids, and (8Z)-18: 1 was oxygenated to 6,9-dihydroxy-(7E)-octadecenoic acid. A series of fatty acids with the double bond positioned closer to ((6Z)-18: 1, (5Z, 9Z)- 18: 2) or more distant from the carboxyl group ((11Z)-, (13Z)-, and (15Z)- 18: 1) were poor substrates. The oxygenation mechanism was studied with [7S-H-2] 18: 1n-9, [7R-H-2] 18: 2n-6, and [8R-H-2] 18: 2n-6 as substrates. The pro-R hydrogen at C-8 was lost in the biosynthesis of (10S)- HPODE, whereas the pro-S hydrogen was lost and the pro-R hydrogen was retained at C-7 during biosynthesis of the 7,10-dihydroxy metabolites. Analysis of the fatty acid composition of P. aeruginosa revealed relatively large amounts of (9E/Z)- 16: 1 and (11E/Z)- 18: 1 and only traces of 18: 1n-9. We found that (11Z)- 18: 1 (vaccenic acid) was transformed to (11S, 14S)- dihydroxy-(12E)-octadecenoic acid and to a mixture of 11- and 12-HPOME, possibly due to reverse orientation of (11Z)- 18: 1 at the active site compared with oleic acid. The reaction mechanism of the hydroperoxide isomerase suggests catalytic similarities to cytochrome P450.	[Martinez, Eriel; Oliw, Ernst H.] Uppsala Biomed Ctr, Div Biochem Pharmacol, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; [Martinez, Eriel; Manresa, Angeles] Univ Barcelona, Microbiol Lab, Fac Farm, E-08028 Barcelona, Spain; [Diaz, Pilar] Univ Barcelona, Microbiol Lab, Fac Biol, E-08028 Barcelona, Spain; [Busquets, Montse] Univ Barcelona, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	University of Barcelona; University of Barcelona; University of Barcelona; Karolinska Institutet	Oliw, EH (corresponding author), Uppsala Biomed Ctr, Div Biochem Pharmacol, Dept Pharmaceut Biosci, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se	; Diaz, Pilar/I-2465-2014	Manresa, Angeles/0000-0003-2337-9060; Diaz, Pilar/0000-0003-4008-0669; Hamberg, Mats/0000-0002-8910-7810; Oliw, Ernst/0000-0002-7986-8130	Comision Interministerial de Ciencia y Tecnologia, Spain (CICYT) [CTQ2007-60749/PPQ]; Vetenskapsradet Natur och Teknik; Comissio Interdepartamental de Recerca i Tecnologia [2005GR00143]; Vetenskapsradet Medicin [3X-06523]; Formas [222-2005-1733]; Knut and Alice Wallenberg Foundation [2004.0123]	Comision Interministerial de Ciencia y Tecnologia, Spain (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Vetenskapsradet Natur och Teknik; Comissio Interdepartamental de Recerca i Tecnologia; Vetenskapsradet Medicin; Formas(Swedish Research Council Formas); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	Supported by a scholarship from Comision Interministerial de Ciencia y Tecnologia, Spain (CICYT) Project CTQ2007-60749/PPQ.; Supported by Vetenskapsradet Natur och Teknik.; Supported by CICYT Project CTQ2007-60749/PPQ and Comissio Interdepartamental de Recerca i Tecnologia Project 2005GR00143.; Supported by Vetenskapsradet Medicin (project 3X-06523), Formas (222-2005-1733), and The Knut and Alice Wallenberg Foundation (2004.0123).	Bae JH, 2007, APPL MICROBIOL BIOT, V75, P435, DOI 10.1007/s00253-006-0832-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; Chacon JN, 2000, CHEM PHYS LIPIDS, V107, P107, DOI 10.1016/S0009-3084(00)00157-2; Clapp CH, 2001, J AM CHEM SOC, V123, P747, DOI 10.1021/ja0032071; El-Kattan Ayman F, 2008, Drug Metab Lett, V2, P120, DOI 10.2174/187231208784041004; Gardner HW, 1999, J AM OIL CHEM SOC, V76, P1151, DOI 10.1007/s11746-999-0088-1; Garscha U, 2008, J CHROMATOGR B, V872, P90, DOI 10.1016/j.jchromb.2008.07.013; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; Guerrero A, 1997, BBA-LIPID LIPID MET, V1347, P75, DOI 10.1016/S0005-2760(97)00056-8; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; HAMBERG M, 1971, ANAL BIOCHEM, V43, P515, DOI 10.1016/0003-2697(71)90282-X; Hou CT, 2009, NEW BIOTECHNOL, V26, P2, DOI 10.1016/j.nbt.2009.05.001; HOU CT, 1991, J AM OIL CHEM SOC, V68, P99, DOI 10.1007/BF02662326; Kim H, 2000, J AM OIL CHEM SOC, V77, P95, DOI 10.1007/s11746-000-0015-7; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; Kuo TM, 2004, CURR MICROBIOL, V49, P261, DOI 10.1007/s00284-004-4296-5; Kuo TM, 2001, CURR MICROBIOL, V43, P198, DOI 10.1007/s002840010287; Kuo TM, 1998, J AM OIL CHEM SOC, V75, P875, DOI 10.1007/s11746-998-0240-3; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MERCADE E, 1988, J AM OIL CHEM SOC, V65, P1915, DOI 10.1007/BF02546006; NING D, 2009, BIODEGRADAT IN PRESS; OLIW EH, 1994, PROG LIPID RES, V33, P329, DOI 10.1016/0163-7827(94)90029-9; Oliw EH, 2001, BIOCHEM PHARMACOL, V62, P407, DOI 10.1016/S0006-2952(01)00683-9; Porta H, 2001, MICROBIOL-SGM, V147, P3199, DOI 10.1099/00221287-147-12-3199; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Vidal-Mas J, 2005, ANTON LEEUW INT J G, V87, P245, DOI 10.1007/s10482-004-4021-1; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Yetkin G, 2006, AM J INFECT CONTROL, V34, P188, DOI 10.1016/j.ajic.2005.11.010	35	39	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9339	9345		10.1074/jbc.M109.078147	http://dx.doi.org/10.1074/jbc.M109.078147			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20075076	hybrid, Green Published			2022-12-25	WOS:000276165900005
J	Kamimura, Y; Devreotes, PN				Kamimura, Yoichiro; Devreotes, Peter N.			Phosphoinositide-dependent Protein Kinase (PDK) Activity Regulates Phosphatidylinositol 3,4,5-Trisphosphate-dependent and -independent Protein Kinase B Activation and Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM-DISCOIDEUM; MEDIATES CHEMOTAXIS; CELL POLARITY; LEADING-EDGE; AKT/PKB; PHOSPHORYLATION; PATHWAYS; RECEPTOR; INSULIN; TORC2	Chemotactic cells must sense shallow extracellular gradients and produce localized intracellular responses. We previously showed that the temporal and spatial activation of two protein kinase B (PKB) homologues, PkbA and PkbR1, in Dictyostelium discoideum by phosphorylation of activation loops (ALs) and hydrophobic motifs had important roles in chemotaxis. We found that hydrophobic motif phosphorylation depended on regulation of TorC2 (target of rapamycin complex 2); however, the regulation of AL phosphorylation remains to be determined at a molecular level. Here, we show that two PDK (phosphoinositide-dependent protein kinase) homologues, PdkA and PdkB, function as the key AL kinases. Cells lacking both PdkA and PdkB are defective in PKB activation, chemotaxis, and fruiting body formation upon nutrient deprivation. The pleckstrin homology domain of PdkA is sufficient to localize it to the membrane, but transient activation of PdkA is independent of PIP3 as well as TorC2 and dispensable for full function. These results confirm the importance of the TorC2-PDK-PKB pathway in chemotaxis and point to a novel mechanism of regulation of PDKs by chemoattractant.	[Kamimura, Yoichiro; Devreotes, Peter N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Devreotes, PN (corresponding author), 725 N Wolfe St,Wood Bas Sci Bldg,Rm 114, Baltimore, MD 21205 USA.	pnd@jhmi.edu	Kamimura, Yoichiro/M-2585-2017		National Institutes of Health [GM 28007, GM 34933]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028007, R01GM034933, R01GM028007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 28007 and GM 34933 (to P. N. D.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bayascas JR, 2008, CELL CYCLE, V7, P2978, DOI 10.4161/cc.7.19.6810; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chen MY, 1997, GENE DEV, V11, P3218, DOI 10.1101/gad.11.23.3218; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Franca-Koh J, 2006, CURR OPIN GENET DEV, V16, P333, DOI 10.1016/j.gde.2006.06.001; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kamimura Y, 2009, METHODS MOL BIOL, V571, P255, DOI 10.1007/978-1-60761-198-1_17; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Meili R, 2000, CURR BIOL, V10, P708, DOI 10.1016/S0960-9822(00)00536-4; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134	25	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7938	7946		10.1074/jbc.M109.089235	http://dx.doi.org/10.1074/jbc.M109.089235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075071	hybrid, Green Published			2022-12-25	WOS:000275413800011
J	Nakamura, K; Sasajima, J; Mizukami, Y; Sugiyama, Y; Yamazaki, M; Fujii, R; Kawamoto, T; Koizumi, K; Sato, K; Fujiya, M; Sasaki, K; Tanno, S; Okumura, T; Shimizu, N; Kawabe, J; Karasaki, H; Kono, T; Ii, M; Bardeesy, N; Chung, DC; Kohgo, Y				Nakamura, Kazumasa; Sasajima, Junpei; Mizukami, Yusuke; Sugiyama, Yoshiaki; Yamazaki, Madoka; Fujii, Rie; Kawamoto, Toru; Koizumi, Kazuya; Sato, Kazuya; Fujiya, Mikihiro; Sasaki, Katsunori; Tanno, Satoshi; Okumura, Toshikatsu; Shimizu, Norihiko; Kawabe, Jun-ichi; Karasaki, Hidenori; Kono, Toru; Ii, Masaaki; Bardeesy, Nabeel; Chung, Daniel C.; Kohgo, Yutaka			Hedgehog Promotes Neovascularization in Pancreatic Cancers by Regulating Ang-1 and IGF-1 Expression in Bone-Marrow Derived Pro-Angiogenic Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; SONIC HEDGEHOG; BRANCHING MORPHOGENESIS; GENE-THERAPY; FACTOR-I; GROWTH; TUMOR; DIFFERENTIATION; LUNG	Background: The hedgehog (Hh) pathway has been implicated in the pathogenesis of cancer including pancreatic ductal adenocarcinoma (PDAC). Recent studies have suggested that the oncogenic function of Hh in PDAC involves signaling in the stromal cells rather than cell autonomous effects on the tumor cells. However, the origin and nature of the stromal cell type(s) that are responsive to Hh signaling remained unknown. Since Hh signaling plays a crucial role during embryonic and postnatal vasculogenesis, we speculated that Hh ligand may act on tumor vasculature specifically focusing on bone marrow (BM)-derived cells. Methodology/Principal Findings: Cyclopamine was utilized to inhibit the Hh pathway in human PDAC cell lines and their xenografts. BM transplants, co-culture systems of tumor cells and BM-derived pro-angiogenic cells (BMPCs) were employed to assess the role of tumor-derived Hh in regulating the BM compartment and the contribution of BM-derived cells to angiogenesis in PDAC. Cyclopamine administration attenuated Hh signaling in the stroma rather than in the cancer cells as reflected by decreased expression of full length Gli2 protein and Gli1 mRNA specifically in the compartment. Cyclopamine inhibited the growth of PDAC xenografts in association with regression of the tumor vasculature and reduced homing of BM-derived cells to the tumor. Host-derived Ang-1 and IGF-1 mRNA levels were downregulated by cyclopamine in the tumor xenografts. In vitro co-culture and matrigel plug assays demonstrated that PDAC cell-derived Shh induced Ang-1 and IGF-1 production in BMPCs, resulting in their enhanced migration and capillary morphogenesis activity. Conclusions/Significance: We identified the BMPCs as alternative stromal targets of Hh-ligand in PDAC suggesting that the tumor vasculature is an attractive therapeutic target of Hh blockade. Our data is consistent with the emerging concept that BM-derived cells make important contributions to epithelial tumorigenesis.	[Nakamura, Kazumasa; Sasajima, Junpei; Mizukami, Yusuke; Sugiyama, Yoshiaki; Yamazaki, Madoka; Fujii, Rie; Kawamoto, Toru; Koizumi, Kazuya; Sato, Kazuya; Fujiya, Mikihiro; Sasaki, Katsunori; Tanno, Satoshi; Kohgo, Yutaka] Asahikawa Med Coll, Div Gastroenterol & Hematol Oncol, Dept Med, Asahikawa, Hokkaido 078, Japan; [Tanno, Satoshi; Okumura, Toshikatsu] Asahikawa Med Coll, Dept Gen Med, Asahikawa, Hokkaido 078, Japan; [Shimizu, Norihiko] Asahikawa Med Coll, Dept Anim Facil, Asahikawa, Hokkaido 078, Japan; [Kawabe, Jun-ichi] Asahikawa Med Coll, Dept Cardiovasc Regenerat & Innovat, Asahikawa, Hokkaido 078, Japan; [Karasaki, Hidenori; Kono, Toru] Asahikawa Med Coll, Div Gastroenterol & Gen Surg, Dept Surg, Asahikawa, Hokkaido 078, Japan; [Ii, Masaaki] Inst Biomed Res & Innovat, Grp Vasc Regenerat Res, Kobe, Hyogo, Japan; [Bardeesy, Nabeel; Chung, Daniel C.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Bardeesy, Nabeel; Chung, Daniel C.] Harvard Univ, Sch Med, Boston, MA USA; [Chung, Daniel C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Institute for Biomedical Research & Innovation (IBRI); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Nakamura, K (corresponding author), Asahikawa Med Coll, Div Gastroenterol & Hematol Oncol, Dept Med, Asahikawa, Hokkaido 078, Japan.	mizu@asahikawa-med.ac.jp	Kohgo, Yutaka/AAN-4863-2020; Mizukami, Yusuke/AAU-1767-2021; Mizukami, Yusuke/AAB-1777-2019	Mizukami, Yusuke/0000-0002-1068-7024; Okumura, Toshikatsu/0000-0003-1810-007X	New Energy and Industrial Technology Development Organization of Japan [07A05010a]; NATIONAL CANCER INSTITUTE [R01CA133557] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22590754] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant to Y. M. from the New Energy and Industrial Technology Development Organization of Japan (07A05010a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Conejo-Garcia JR, 2005, BLOOD, V105, P679, DOI 10.1182/blood-2004-05-1906; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Guimaraes AR, 2008, PANCREAS, V37, P440, DOI 10.1097/MPA.0b013e31817c5113; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Ijichi H, 2001, BIOCHEM BIOPH RES CO, V289, P350, DOI 10.1006/bbrc.2001.5988; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kawahira H, 2005, DEV BIOL, V280, P111, DOI 10.1016/j.ydbio.2005.01.008; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Lee SW, 2007, INT J MOL MED, V19, P445; Lin N, 2008, BIOCHEM BIOPH RES CO, V372, P260, DOI 10.1016/j.bbrc.2008.05.029; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsuno S, 2004, PANCREAS, V28, P219, DOI 10.1097/00006676-200404000-00002; McCarty MF, 2007, J CLIN INVEST, V117, P2114, DOI 10.1172/JCI31334; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Nielsen SK, 2008, DEV DYNAM, V237, P2039, DOI 10.1002/dvdy.21610; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ohuchida K, 2006, J PATHOL, V210, P42, DOI 10.1002/path.2019; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Saif MW, 2007, J PANCREAS, V8, P365; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; van Tuyl M, 2007, DEV BIOL, V303, P514, DOI 10.1016/j.ydbio.2006.11.029; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yamazaki M, 2008, CANCER SCI, V99, P1131, DOI 10.1111/j.1349-7006.2008.00795.x; YANG SH, 2008, NAT GENET; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhu GF, 1999, DEV BIOL, V215, P118, DOI 10.1006/dbio.1999.9431	60	59	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8824	10.1371/journal.pone.0008824	http://dx.doi.org/10.1371/journal.pone.0008824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098680	Green Submitted, gold, Green Published			2022-12-25	WOS:000273779100016
J	Poduslo, JF; Gilles, EJ; Ramakrishnan, M; Howell, KG; Wengenack, TM; Curran, GL; Kandimalla, KK				Poduslo, Joseph F.; Gilles, Emily J.; Ramakrishnan, Muthu; Howell, Kyle G.; Wengenack, Thomas M.; Curran, Geoffry L.; Kandimalla, Karunya K.			HH Domain of Alzheimer's Disease A beta Provides Structural Basis for Neuronal Binding in PC12 and Mouse Cortical/Hippocampal Neurons	PLOS ONE			English	Article							AMYLOID-BETA; IN-VIVO; PEPTIDE; BRAIN; PLAQUES; PROTEIN; NEUROTOXICITY; ACCUMULATION; AGGREGATION; ENDOCYTOSIS	A key question in understanding AD is whether extracellular A beta deposition of parenchymal amyloid plaques or intraneuronal A beta accumulation initiates the AD process. Amyloid precursor protein (APP) is endocytosed from the cell surface into endosomes where it is cleaved to produce soluble A beta which is then released into the brain interstitial fluid. Intraneuronal A beta accumulation is hypothesized to predominate from the neuronal uptake of this soluble extracellular A beta rather than from ER/Golgi processing of APP. We demonstrate that substitution of the two adjacent histidine residues of A beta 40 results in a significant decrease in its binding with PC12 cells and mouse cortical/hippocampal neurons. These substitutions also result in a dramatic enhancement of both thioflavin-T positive fibril formation and binding to preformed A beta fibrils while maintaining its plaque-binding ability in AD transgenic mice. Hence, alteration of the histidine domain of A beta prevented neuronal binding and drove A beta to enhanced fibril formation and subsequent amyloid plaque deposition - a potential mechanism for removing toxic species of A beta. Substitution or even masking of these A beta histidine residues might provide a new therapeutic direction for minimizing neuronal uptake and subsequent neuronal degeneration and maximizing targeting to amyloid plaques.	[Poduslo, Joseph F.; Gilles, Emily J.; Ramakrishnan, Muthu; Howell, Kyle G.; Wengenack, Thomas M.; Curran, Geoffry L.; Kandimalla, Karunya K.] Mayo Clin, Coll Med, Mol Neurobiol Lab, Dept Neurol, Rochester, MN 55905 USA; [Poduslo, Joseph F.; Gilles, Emily J.; Ramakrishnan, Muthu; Howell, Kyle G.; Wengenack, Thomas M.; Curran, Geoffry L.; Kandimalla, Karunya K.] Mayo Clin, Coll Med, Mol Neurobiol Lab, Dept Neurobiol, Rochester, MN USA; [Poduslo, Joseph F.; Gilles, Emily J.; Ramakrishnan, Muthu; Howell, Kyle G.; Wengenack, Thomas M.; Curran, Geoffry L.; Kandimalla, Karunya K.] Mayo Clin, Coll Med, Mol Neurobiol Lab, Dept Biochem Mol Biol, Rochester, MN USA; [Kandimalla, Karunya K.] Florida A&M Univ, Dept Pharm & Pharmacol, Tallahassee, FL USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; State University System of Florida; Florida A&M University	Poduslo, JF (corresponding author), Mayo Clin, Coll Med, Mol Neurobiol Lab, Dept Neurol, Rochester, MN 55905 USA.	poduslo.joseph@mayo.edu			Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008111] Funding Source: NIH RePORTER	Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnham KJ, 2008, P NATL ACAD SCI USA, V105, P6813, DOI 10.1073/pnas.0800712105; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; CICCOTOSTO GD, 2009, NEUROBIOL A IN PRESS; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; COLLINGRIDGE GL, 1995, J NEUROSCI METH, V59, P5, DOI 10.1016/0165-0270(94)00187-L; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Diaz JC, 2006, BIOL RES, V39, P447, DOI 10.4067/S0716-97602006000300007; Echeverria V, 2002, MOL NEUROBIOL, V26, P299, DOI 10.1385/MN:26:2-3:299; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; Fukuda M, 2004, J BIOCHEM, V136, P245, DOI 10.1093/jb/mvh116; Fung J, 2004, J NEUROCHEM, V91, P1398, DOI 10.1111/j.1471-4159.2004.02828.x; Giulian D, 1998, J BIOL CHEM, V273, P29719, DOI 10.1074/jbc.273.45.29719; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gredell JA, 2004, BRIT J ANAESTH, V93, P810, DOI 10.1093/bja/aeh272; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kennedy JL, 2003, SCIENCE, V302, P822, DOI 10.1126/science.1092132; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee G, 2002, PEPTIDES, V23, P1249, DOI 10.1016/S0196-9781(02)00060-8; Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Poduslo JF, 2004, BIOCHEMISTRY-US, V43, P6064, DOI 10.1021/bi0359574; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Tickler AK, 2005, J BIOL CHEM, V280, P13355, DOI 10.1074/jbc.M414178200; Tseng Bertrand P., 2004, Current Alzheimer Research, V1, P231, DOI 10.2174/1567205043332045; Wengenack TM, 2000, NAT BIOTECHNOL, V18, P868, DOI 10.1038/78482; Winkler K, 1999, J LIPID RES, V40, P447; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Xu HX, 1996, P NATL ACAD SCI USA, V93, P4081, DOI 10.1073/pnas.93.9.4081; Yang DS, 2000, EUR J BIOCHEM, V267, P6692, DOI 10.1046/j.1432-1327.2000.01767.x	46	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8813	10.1371/journal.pone.0008813	http://dx.doi.org/10.1371/journal.pone.0008813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098681	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100007
J	Rai, M; Soragni, E; Chou, CJ; Barnes, G; Jones, S; Rusche, JR; Gottesfeld, JM; Pandolfo, M				Rai, Myriam; Soragni, Elisabetta; Chou, C. James; Barnes, Glenn; Jones, Steve; Rusche, James R.; Gottesfeld, Joel M.; Pandolfo, Massimo			Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; EPIGENETIC CHANGES; GENE; VORINOSTAT; INTRON-1; REPEATS; SLOW; DNA	Background: Friedreich's ataxia (FRDA), the most common recessive ataxia in Caucasians, is due to severely reduced levels of frataxin, a highly conserved protein, that result from a large GAA triplet repeat expansion within the first intron of the frataxin gene (FXN). Typical marks of heterochromatin are found near the expanded GAA repeat in FRDA patient cells and mouse models. Histone deacetylase inhibitors (HDACIs) with a pimelic diphenylamide structure and HDAC3 specificity can decondense the chromatin structure at the FXN gene and restore frataxin levels in cells from FRDA patients and in a GAA repeat based FRDA mouse model, KIKI, providing an appealing approach for FRDA therapeutics. Methodology/Principal Findings: In an effort to further improve the pharmacological profile of pimelic diphenylamide HDACIs as potential therapeutics for FRDA, we synthesized additional compounds with this basic structure and screened them for HDAC3 specificity. We characterized two of these compounds, 136 and 109, in FRDA patients' peripheral blood lymphocytes and in the KIKI mouse model. We tested their ability to upregulate frataxin at a range of concentrations in order to determine a minimal effective dose. We then determined in both systems the duration of effect of these drugs on frataxin mRNA and protein, and on total and local histone acetylation. The effects of these compounds exceeded the time of direct exposure in both systems. Conclusions/Significance: Our results support the pre-clinical development of a therapeutic approach based on pimelic diphenylamide HDACIs for FRDA and provide information for the design of future human trials of these drugs, suggesting an intermittent administration of the drug.	[Rai, Myriam; Pandolfo, Massimo] Free Univ Brussels, Hop Erasme, Lab Neurol Expt, B-1070 Brussels, Belgium; [Soragni, Elisabetta; Chou, C. James; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Barnes, Glenn; Jones, Steve; Rusche, James R.] Repligen Corp, Waltham, MA USA	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Scripps Research Institute	Rai, M (corresponding author), Free Univ Brussels, Hop Erasme, Lab Neurol Expt, 808 Route Lennik, B-1070 Brussels, Belgium.	massimo.pandolfo@ulb.ac.be	Chou, C. James/I-6563-2012; Pandolfo, Massimo/B-2853-2010	Gottesfeld, Joel/0000-0002-4643-5777	GoFar; Fondazione CRT (Italy); Kyle Bryant translational research award; Association Francaise Ataxie de Friedreich (AFAF); Fonds de la Recherche Scientifique - FNRS; Fonds Erasme; Friedreich's Ataxia Research Alliance (FARA); National Ataxia Foundation (NAF); National Institutes of Neurological Disorders and Stroke (NINDS); Repligen Corporation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062856] Funding Source: NIH RePORTER	GoFar; Fondazione CRT (Italy); Kyle Bryant translational research award; Association Francaise Ataxie de Friedreich (AFAF); Fonds de la Recherche Scientifique - FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme; Friedreich's Ataxia Research Alliance (FARA); National Ataxia Foundation (NAF); National Institutes of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Repligen Corporation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from GoFar and the Fondazione CRT (Italy), from the Kyle Bryant translational research award, the Association Francaise Ataxie de Friedreich (AFAF), the Fonds de la Recherche Scientifique - FNRS and the Fonds Erasme - Jean Van Damme to MP; from the Kyle Bryant translational research award to JRR; from the Friedreich's Ataxia Research Alliance (FARA), the National Ataxia Foundation (NAF), the National Institutes of Neurological Disorders and Stroke (NINDS) to JMG. Repligen Corporation partly funded the work described in this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Pandolfo M, 2009, J NEUROL, V256, P1, DOI 10.1007/s00415-009-1001-4; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	19	106	112	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8825	10.1371/journal.pone.0008825	http://dx.doi.org/10.1371/journal.pone.0008825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098685	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779100017
J	Shen, YY; Liu, J; Irwin, DM; Zhang, YP				Shen, Yong-Yi; Liu, Jie; Irwin, David M.; Zhang, Ya-Ping			Parallel and Convergent Evolution of the Dim-Light Vision Gene RH1 in Bats (Order: Chiroptera)	PLOS ONE			English	Article							VISUAL PIGMENTS; COLOR-VISION; PHYLOGENETIC ANALYSIS; TRICHROMATIC VISION; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; EATING BATS; BRANCH-SITE; ECHOLOCATION; MAMMALS	Rhodopsin, encoded by the gene Rhodopsin (RH1), is extremely sensitive to light, and is responsible for dim-light vision. Bats are nocturnal mammals that inhabit poor light environments. Megabats (Old-World fruit bats) generally have well-developed eyes, while microbats (insectivorous bats) have developed echolocation and in general their eyes were degraded, however, dramatic differences in the eyes, and their reliance on vision, exist in this group. In this study, we examined the rod opsin gene (RH1), and compared its evolution to that of two cone opsin genes (SWS1 and M/LWS). While phylogenetic reconstruction with the cone opsin genes SWS1 and M/LWS generated a species tree in accord with expectations, the RH1 gene tree united Pteropodidae (Old-World fruit bats) and Yangochiroptera, with very high bootstrap values, suggesting the possibility of convergent evolution. The hypothesis of convergent evolution was further supported when nonsynonymous sites or amino acid sequences were used to construct phylogenies. Reconstructed RH1 sequences at internal nodes of the bat species phylogeny showed that: (1) Old-World fruit bats share an amino acid change (S270G) with the tomb bat; (2) Miniopterus share two amino acid changes (V104I, M183L) with Rhinolophoidea; (3) the amino acid replacement I123V occurred independently on four branches, and the replacements L99M, L266V and I286V occurred each on two branches. The multiple parallel amino acid replacements that occurred in the evolution of bat RH1 suggest the possibility of multiple convergences of their ecological specialization (i.e., various photic environments) during adaptation for the nocturnal lifestyle, and suggest that further attention is needed on the study of the ecology and behavior of bats.	[Shen, Yong-Yi; Liu, Jie; Zhang, Ya-Ping] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China; [Shen, Yong-Yi; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; [Shen, Yong-Yi; Liu, Jie] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5S 1A1, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Toronto; University of Toronto	Shen, YY (corresponding author), Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Shen, Yongyi/GWU-8031-2022	Irwin, David/0000-0001-6131-4933	National Basic Research Program of China [2007CB411600]; National Natural Science Foundation of China [30621092]; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province	This work was supported by the National Basic Research Program of China (973 Program, 2007CB411600), National Natural Science Foundation of China (30621092), and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KK, 1998, BEHAV PROCESS, V44, P59, DOI 10.1016/S0376-6357(98)00028-X; Calderone JB, 1999, VISUAL NEUROSCI, V16, P53, DOI 10.1017/S0952523899161029; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Fure Alison, 2006, London Naturalist, V85, P93; HARGRAVE PA, 1983, BIOPHYS STRUCT MECH, V9, P235, DOI 10.1007/BF00535659; Heffner RS, 2001, J ACOUST SOC AM, V109, P412, DOI 10.1121/1.1329620; Huelsenbeck J. P., 2001, MRBAYES BAYESIAN INF, P754; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; JACOBS GH, 1992, J COMP PHYSIOL A, V171, P351; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Kim TJ, 2008, MOL CELLS, V26, P373; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; LI WH, 1985, MOL BIOL EVOL, V2, P150; Luft S, 2003, NATURWISSENSCHAFTEN, V90, P84, DOI 10.1007/s00114-002-0393-0; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; Peichl L, 2000, INVEST OPHTH VIS SCI, V41, pS494; Phillips CJ, 2000, THEORETICAL CONSIDER; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Sanchez F, 2006, J CHEM ECOL, V32, P1289, DOI 10.1007/s10886-006-9085-0; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schnitzler HU, 1998, ECHOLOCATING BATS SE; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; SWOFFORD DL, PAUP PHYLOGENETIC AN; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yokoyama S, 1996, ANNU REV ECOL SYST, V27, P543, DOI 10.1146/annurev.ecolsys.27.1.543; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	37	25	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8838	10.1371/journal.pone.0008838	http://dx.doi.org/10.1371/journal.pone.0008838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098620	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100029
J	Williams, CM; Kramer, EM				Williams, Christopher M.; Kramer, Eric M.			The Advantages of a Tapered Whisker	PLOS ONE			English	Article							ACTIVE TOUCH; MYSTACIAL VIBRISSAE; RADIAL DISTANCE; SENSORY SYSTEM; RAT; CONTACT; RESONANCE; BEHAVIOR; FEATURES; HAIR	The role of facial vibrissae (whiskers) in the behavior of terrestrial mammals is principally as a supplement or substitute for short-distance vision. Each whisker in the array functions as a mechanical transducer, conveying forces applied along the shaft to mechanoreceptors in the follicle at the whisker base. Subsequent processing of mechanoreceptor output in the trigeminal nucleus and somatosensory cortex allows high accuracy discriminations of object distance, direction, and surface texture. The whiskers of terrestrial mammals are tapered and approximately circular in cross section. We characterize the taper of whiskers in nine mammal species, measure the mechanical deflection of isolated felid whiskers, and discuss the mechanics of a single whisker under static and oscillatory deflections. We argue that a tapered whisker provides some advantages for tactile perception (as compared to a hypothetical untapered whisker), and that this may explain why the taper has been preserved during the evolution of terrestrial mammals.	[Williams, Christopher M.; Kramer, Eric M.] Bard Coll Simons Rock, Dept Phys, Great Barrington, MA USA		Williams, CM (corresponding author), Bard Coll Simons Rock, Dept Phys, Great Barrington, MA USA.	ekramer@simons-rock.edu	Kramer, Eric M/B-9752-2008	Kramer, Eric/0000-0002-1424-2356	Bard College at Simon's Rock	Bard College at Simon's Rock	Bard College at Simon's Rock (www.simons-rock.edu) provided a summer research fellowship to CMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHL AS, 1987, J MAMMAL, V68, P848, DOI 10.2307/1381563; AHL AS, 1986, VET RES COMMUN, V10, P245, DOI 10.1007/BF02213989; Andermann ML, 2008, BRAIN RES, V1235, P74, DOI 10.1016/j.brainres.2008.06.054; Andermann ML, 2006, NAT NEUROSCI, V9, P543, DOI 10.1038/nn1671; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; BARBER DJ, 1989, INTRO PROPERTIES CON; Barnes TG, 2001, J APPL MECH-T ASME, V68, P948, DOI 10.1115/1.1406955; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; CAUNA N, 1954, ANAT RECORD, V119, P449, DOI 10.1002/ar.1091190405; Chernova OF, 2006, BIOL BULL+, V33, P43, DOI 10.1134/S1062359006010067; Conway H.D., 1964, J APPL MECH-T ASME, V31, P329; Dehnhardt G, 1998, NATURE, V394, P235, DOI 10.1038/28303; DEHNHARDT G, 1995, J EXP BIOL, V198, P2317; GOTTSCHALDT KM, 1973, J PHYSIOL-LONDON, V235, P287, DOI 10.1113/jphysiol.1973.sp010388; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hausman LA, 1920, AM NAT, V54, P496, DOI 10.1086/279782; Hipp J, 2006, J NEUROPHYSIOL, V95, P1792, DOI 10.1152/jn.01104.2005; IBRAHIM L, 1975, J EMBRYOL EXP MORPH, V33, P831; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Kaneko M, 1998, IEEE T ROBOTIC AUTOM, V14, P278, DOI 10.1109/70.681246; KERNAN MJ, 2007, EUROPEAN J PHYSL, V454, P703; Kim D, 2007, ROBOT AUTON SYST, V55, P229, DOI 10.1016/j.robot.2006.08.001; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Maeno T, 1998, JSME INT J C-MECH SY, V41, P94, DOI 10.1299/jsmec.41.94; MCIVER SB, 1975, ANNU REV ENTOMOL, V20, P381, DOI 10.1146/annurev.en.20.010175.002121; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Neimark MA, 2003, J NEUROSCI, V23, P6499; Pearson MJ, 2007, ADAPT BEHAV, V15, P223, DOI 10.1177/1059712307082089; Perrin WF, 2008, ENCY MARINE MAMMALS, V2nd; POCOCK RI, 1914, P ZOOL SOC LOND, V84, P889; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; SOKOLOV VE, 1987, MAMMALIA, V51, P125, DOI 10.1515/mamm.1987.51.1.125; Solomon JH, 2006, NATURE, V443, P525, DOI 10.1038/443525a; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Tilney LG, 2005, P NATL ACAD SCI USA, V102, P18785, DOI 10.1073/pnas.0509437102; Vetterling W.T., 1989, NUMERICAL RECIPES; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Yanli B, 1998, J FORESTRY RES, V9, P273	48	56	56	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8806	10.1371/journal.pone.0008806	http://dx.doi.org/10.1371/journal.pone.0008806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098714	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779000032
J	Lloyd, KG; Albert, DB; Biddle, JF; Chanton, JP; Pizarro, O; Teske, A				Lloyd, Karen G.; Albert, Daniel B.; Biddle, Jennifer F.; Chanton, Jeffrey P.; Pizarro, Oscar; Teske, Andreas			Spatial Structure and Activity of Sedimentary Microbial Communities Underlying a Beggiatoa spp. Mat in a Gulf of Mexico Hydrocarbon Seep	PLOS ONE			English	Article							COENZYME-M REDUCTASE; METHANE-OXIDIZING ARCHAEA; SULFATE-REDUCING BACTERIA; MARINE SUBSURFACE SEDIMENTS; GAS HYDRATE DEPOSIT; ANAEROBIC OXIDATION; DEEP-SEA; CONTINENTAL-SLOPE; RIBOSOMAL-RNA; COLD SEEPS	Background: Subsurface fluids from deep-sea hydrocarbon seeps undergo methane-and sulfur-cycling microbial transformations near the sediment surface. Hydrocarbon seep habitats are naturally patchy, with a mosaic of active seep sediments and non-seep sediments. Microbial community shifts and changing activity patterns on small spatial scales from seep to non-seep sediment remain to be examined in a comprehensive habitat study. Methodology/Principal Findings: We conducted a transect of biogeochemical measurements and gene expression related to methane-and sulfur-cycling at different sediment depths across a broad Beggiatoa spp. mat at Mississippi Canyon 118 (MC118) in the Gulf of Mexico. High process rates within the mat (similar to 400 cm and similar to 10 cm from the mat's edge) contrasted with sharply diminished activity at similar to 50 cm outside the mat, as shown by sulfate and methane concentration profiles, radiotracer rates of sulfate reduction and methane oxidation, and stable carbon isotopes. Likewise, 16S ribosomal rRNA, dsrAB (dissimilatory sulfite reductase) and mcrA (methyl coenzyme M reductase) mRNA transcripts of sulfate-reducing bacteria (Desulfobacteraceae and Desulfobulbaceae) and methane-cycling archaea (ANME-1 and ANME-2) were prevalent at the sediment surface under the mat and at its edge. Outside the mat at the surface, 16S rRNA sequences indicated mostly aerobes commonly found in seawater. The seep-related communities persisted at 12-20 cm depth inside and outside the mat. 16S rRNA transcripts and V6-tags reveal that bacterial and archaeal diversity underneath the mat are similar to each other, in contrast to oxic or microoxic habitats that have higher bacterial diversity. Conclusions/Significance: The visual patchiness of microbial mats reflects sharp discontinuities in microbial community structure and activity over sub-meter spatial scales; these discontinuities have to be taken into account in geochemical and microbiological inventories of seep environments. In contrast, 12-20 cm deep in the sediments microbial communities performing methane-cycling and sulfate reduction persist at lower metabolic rates regardless of mat cover, and may increase activity rapidly when subsurface flow changes.	[Lloyd, Karen G.; Albert, Daniel B.; Biddle, Jennifer F.; Teske, Andreas] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Chanton, Jeffrey P.] Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; [Pizarro, Oscar] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia	University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; Florida State University; University of Sydney	Lloyd, KG (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.	karen.lloyd@biology.au.dk	Teske, Andreas/AAQ-9577-2021; Biddle, Jennifer F/F-8323-2010; Lloyd, Karen/A-4165-2011	Biddle, Jennifer F/0000-0002-4344-8724; Pizarro, Oscar/0000-0001-6612-2738; Lloyd, Karen/0000-0003-0914-6375	National Aeronautics and Space Administration (NASA) Astrobiology Institutes [NCC 21054, NCC 2-1275]; Environmental Protection Agency (EPA) [91671401-0]; University of Mississippi Gulf of Mexico Hydrate Research Consortium; Department of Energy; United States Minerals Management Services; Keck Foundation	National Aeronautics and Space Administration (NASA) Astrobiology Institutes(National Aeronautics & Space Administration (NASA)); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); University of Mississippi Gulf of Mexico Hydrate Research Consortium; Department of Energy(United States Department of Energy (DOE)); United States Minerals Management Services; Keck Foundation(W.M. Keck Foundation)	Funding: This study was supported by the National Aeronautics and Space Administration (NASA) Astrobiology Institutes "Environmental genomes'' (NCC 21054) and "Subsurface Biospheres'' (NCC 2-1275) (A. T) and an Environmental Protection Agency (EPA) STAR fellowship # 91671401-0 (K. G. L.) and through a grant from the University of Mississippi Gulf of Mexico Hydrate Research Consortium and Department of Energy. This portion of the Gulf of Mexico Gas Hydrate Research Consortium cruise was funded by United States Minerals Management Services. Tagged sequencing was supported by the W. M. Keck Foundation through the International Census of Marine Microbes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller JY, 2008, FEMS MICROBIOL ECOL, V65, P74, DOI 10.1111/j.1574-6941.2008.00498.x; Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Amend JP, 2005, PALAEOGEOGR PALAEOCL, V219, P131, DOI 10.1016/j.palaeo.2004.10.018; Arvidson RS, 2004, MAR CHEM, V87, P97, DOI 10.1016/j.marchem.2003.11.004; Barry JP, 1997, LIMNOL OCEANOGR, V42, P318, DOI 10.4319/lo.1997.42.2.0318; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; BERDALET E, 1993, MAR BIOL, V117, P163, DOI 10.1007/BF00346439; Berner R.A., 1980, EARLY DIAGENESIS THE; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Blum SAE, 1997, SYST APPL MICROBIOL, V20, P513, DOI 10.1016/S0723-2020(97)80021-5; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; CARUSO S, 2007, INTEGRATED GEOLOGICA; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chin KJ, 2008, MICROB ECOL, V55, P489, DOI 10.1007/s00248-007-9294-2; Colwell RK, 2013, ESTIMATES STAT ESTIM; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Dell'Anno A, 1998, APPL ENVIRON MICROB, V64, P3238; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; DURBIN A, 2009, MICROBIAL DIVERSITY; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; Felske A, 1996, APPL ENVIRON MICROB, V62, P4162, DOI 10.1128/AEM.62.11.4162-4167.1996; Friedrich MW, 2005, METHOD ENZYMOL, V397, P428, DOI 10.1016/S0076-6879(05)97026-2; Fry JC, 2008, FEMS MICROBIOL ECOL, V66, P181, DOI 10.1111/j.1574-6941.2008.00566.x; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; HENNIGAN AN, 1994, MOL MICROBIOL, V11, P655, DOI 10.1111/j.1365-2958.1994.tb00344.x; Hill TM, 2006, P NATL ACAD SCI USA, V103, P13570, DOI 10.1073/pnas.0601304103; Hoefs J., 1987, STABLE ISOTOPE GEOCH, V3rd; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Inagaki F, 2004, APPL ENVIRON MICROB, V70, P7445, DOI 10.1128/AEM.70.12.7445-7455.2004; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kaneko R, 2007, MAR BIOTECHNOL, V9, P429, DOI 10.1007/s10126-007-9003-7; KARL DM, 1981, APPL ENVIRON MICROB, V42, P802, DOI 10.1128/AEM.42.5.802-810.1981; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kendall MM, 2007, APPL ENVIRON MICROB, V73, P407, DOI 10.1128/AEM.01154-06; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lapham LL, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001944; Leloup J, 2007, ENVIRON MICROBIOL, V9, P131, DOI 10.1111/j.1462-2920.2006.01122.x; Lloyd KG, 2006, APPL ENVIRON MICROB, V72, P7218, DOI 10.1128/AEM.00886-06; LUTKEN CB, 2006, OFFSHORE TECHNOLOGY; MacDonald IR, 2005, EARTH PLANET SC LETT, V233, P45, DOI 10.1016/j.epsl.2005.02.002; MacDonald IR, 2003, MAR GEOL, V198, P133, DOI 10.1016/S0025-3227(03)00098-7; MacGregor BJ, 1997, APPL ENVIRON MICROB, V63, P1178, DOI 10.1128/AEM.63.3.1178-1181.1997; Martens CS, 1999, AM J SCI, V299, P589, DOI 10.2475/ajs.299.7-9.589; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Mills HJ, 2005, APPL ENVIRON MICROB, V71, P3235, DOI 10.1128/AEM.71.6.3235-3247.2005; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Nercessian O, 2003, ENVIRON MICROBIOL, V5, P492, DOI 10.1046/j.1462-2920.2003.00437.x; Neretin LN, 2003, ENVIRON MICROBIOL, V5, P660, DOI 10.1046/j.1462-2920.2003.00452.x; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Orcutt B, 2005, GEOCHIM COSMOCHIM AC, V69, P4267, DOI 10.1016/j.gca.2005.04.012; Orcutt BN, 2004, CHEM GEOL, V205, P239, DOI 10.1016/j.chemgeo.2003.12.020; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Peng C, 2007, J ENVIRON SCI-CHINA, V19, P1326, DOI 10.1016/S1001-0742(07)60216-2; Pizarro O, 2003, IEEE J OCEANIC ENG, V28, P651, DOI 10.1109/JOE.2003.819154; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Raskin L, 1996, APPL ENVIRON MICROB, V62, P3847, DOI 10.1128/AEM.62.10.3847-3857.1996; Rice AL, 2001, ANAL CHEM, V73, P4104, DOI 10.1021/ac0155106; Roberts HH, 1997, ECON GEOL BULL SOC, V92, P863, DOI 10.2113/gsecongeo.92.7-8.863; Rother M, 2005, J BACTERIOL, V187, P5552, DOI 10.1128/JB.187.16.5552-5559.2005; Sassen R, 2003, ORG GEOCHEM, V34, P1455, DOI 10.1016/S0146-6380(03)00135-9; Sassen R, 2004, CHEM GEOL, V205, P195, DOI 10.1016/j.chemgeo.2003.12.032; SASSEN R, 2006, MISSISSIPPI CANYON 1; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Solomon EA, 2008, EARTH PLANET SC LETT, V270, P95, DOI 10.1016/j.epsl.2008.03.024; Solomon EA, 2009, NAT GEOSCI, V2, P561, DOI 10.1038/NGEO574; Sorensen KB, 2006, APPL ENVIRON MICROB, V72, P4596, DOI 10.1128/AEM.00562-06; SPRINGER E, 1995, INT J SYST BACTERIOL, V45, P554, DOI 10.1099/00207713-45-3-554; SRIVASTAVA AK, 1990, ANNU REV MICROBIOL, V44, P105, DOI 10.1146/annurev.mi.44.100190.000541; STAHL DA, 1988, APPL ENVIRON MICROB, V54, P1079, DOI 10.1128/AEM.54.5.1079-1084.1988; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Takai K, 1999, GENETICS, V152, P1285; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Teske A, 1996, APPL ENVIRON MICROB, V62, P1405, DOI 10.1128/AEM.62.4.1405-1415.1996; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Thomsen TR, 2001, APPL ENVIRON MICROB, V67, P1646, DOI 10.1128/AEM.67.4.1646-1656.2001; Ussler W, 2008, EARTH PLANET SC LETT, V266, P271, DOI 10.1016/j.epsl.2007.10.056; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Wagner M, 2005, METHOD ENZYMOL, V397, P469, DOI 10.1016/S0076-6879(05)97029-8; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; WALLACE PJ, 2000, P OCEAN DRILLING PRO, V164; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Zhang CL, 2005, APPL ENVIRON MICROB, V71, P2106, DOI 10.1128/AEM.71.4.2106-2112.2005	95	93	97	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8738	10.1371/journal.pone.0008738	http://dx.doi.org/10.1371/journal.pone.0008738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090951	gold, Green Published			2022-12-25	WOS:000273714900018
J	Daigneault, M; Preston, JA; Marriott, HM; Whyte, MKB; Dockrell, DH				Daigneault, Marc; Preston, Julie A.; Marriott, Helen M.; Whyte, Moira K. B.; Dockrell, David H.			The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN ALVEOLAR MACROPHAGES; MONONUCLEAR PHAGOCYTES; BLOOD MONOCYTES; NITRIC-OXIDE; FACTOR-ALPHA; STREPTOCOCCUS-PNEUMONIAE; BRONCHOALVEOLAR LAVAGE; VITRO DIFFERENTIATION; DENDRITIC CELLS	Differentiated macrophages are the resident tissue phagocytes and sentinel cells of the innate immune response. The phenotype of mature tissue macrophages represents the composite of environmental and differentiation-dependent imprinting. Phorbol-12-myristate-13-acetate (PMA) and 1,25-dihydroxyvitamin D3 (VD3) are stimuli commonly used to induce macrophage differentiation in monocytic cell lines but the extent of differentiation in comparison to primary tissue macrophages is unclear. We have compared the phenotype of the promonocytic THP-1 cell line after various protocols of differentiation utilising VD3 and PMA in comparison to primary human monocytes or monocyte-derived macrophages (MDM). Both stimuli induced changes in cell morphology indicative of differentiation but neither showed differentiation comparable to MDM. In contrast, PMA treatment followed by 5 days resting in culture without PMA (PMAr) increased cytoplasmic to nuclear ratio, increased mitochondrial and lysosomal numbers and altered differentiation-dependent cell surface markers in a pattern similar to MDM. Moreover, PMAr cells showed relative resistance to apoptotic stimuli and maintained levels of the differentiation-dependent anti-apoptotic protein Mcl-1 similar to MDM. PMAr cells retained a high phagocytic capacity for latex beads, and expressed a cytokine profile that resembled MDM in response to TLR ligands, in particular with marked TLR2 responses. Moreover, both MDM and PMAr retained marked plasticity to stimulus-directed polarization. These findings suggest a modified PMA differentiation protocol can enhance macrophage differentiation of THP-1 cells and identify increased numbers of mitochondria and lysosomes, resistance to apoptosis and the potency of TLR2 responses as important discriminators of the level of macrophage differentiation for transformed cells.	[Daigneault, Marc; Preston, Julie A.; Marriott, Helen M.; Whyte, Moira K. B.; Dockrell, David H.] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield	Daigneault, M (corresponding author), Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England.	d.h.dockrell@sheffield.ac.uk	Whyte, Moira/E-6210-2010	Marriott, Helen/0000-0003-1070-0054; Dockrell, David/0000-0002-2718-4861; Preston, Julie/0000-0001-5289-3160	Wellcome Trust [076945]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust (www.Wellcome.ac.uk) Senior Clinical Fellowship to DHD, 076945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINTON DF, 1980, MACROPHAGE, P1; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; BLUSSEVANOUDALBLAS A, 1979, J EXP MED, V149, P1504, DOI 10.1084/jem.149.6.1504; BURCHETT SK, 1988, J IMMUNOL, V140, P3473; COHN ZA, 1965, J EXP MED, V121, P153, DOI 10.1084/jem.121.1.153; COHN ZA, 1966, J EXP MED, V123, P757, DOI 10.1084/jem.123.4.757; COLLINS SJ, 1987, BLOOD, V70, P1233; DEMACOUILLARDPO.G, 1998, CYTOMETRY, V33, P333; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Dockrell DH, 2001, J INFECT DIS, V184, P713, DOI 10.1086/323084; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Gantner F, 1997, BRIT J PHARMACOL, V121, P221, DOI 10.1038/sj.bjp.0701124; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GESSANI S, 1993, J IMMUNOL, V151, P3758; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon SB, 2000, INFECT IMMUN, V68, P2286, DOI 10.1128/IAI.68.4.2286-2293.2000; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Heo SK, 2006, J LEUKOCYTE BIOL, V79, P330, DOI 10.1189/jlb.1104694; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; KRADIN RL, 1986, J LEUKOCYTE BIOL, V40, P407, DOI 10.1002/jlb.40.4.407; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; LEPEZUNIGA JL, 1990, LYMPHOKINE RES, V9, P309; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANGAN DF, 1991, J IMMUNOL, V146, P1541; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marriott HM, 2005, J CLIN INVEST, V115, P359, DOI 10.1172/JCI200521766; Marriott HM, 2004, FASEB J, V18, P1126, DOI 10.1096/fj.03-1450fje; McCullough KC, 1999, IMMUNOLOGY, V98, P203, DOI 10.1046/j.1365-2567.1999.00867.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNN DH, 1995, J EXP MED, V181, P127, DOI 10.1084/jem.181.1.127; MURAO S, 1983, CANCER RES, V43, P4989; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; NETEA MG, 2008, BLOOD; NICHOLS BA, 1971, J CELL BIOL, V50, P498, DOI 10.1083/jcb.50.2.498; OLSSON I, 1983, CANCER RES, V43, P5862; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Pham TNQ, 2003, NITRIC OXIDE-BIOL CH, V9, P123, DOI 10.1016/j.niox.2003.09.006; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; ROVERA G, 1979, SCIENCE, V204, P868, DOI 10.1126/science.286421; Sabroe I, 2003, J IMMUNOL, V171, P1630, DOI 10.4049/jimmunol.171.4.1630; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; SOKOL RJ, 1987, J ANAT, V151, P27; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; STEINBACH F, 1994, J IMMUNOL METHODS, V174, P109, DOI 10.1016/0022-1759(94)90015-9; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Surewicz K, 2004, CELL IMMUNOL, V228, P34, DOI 10.1016/j.cellimm.2004.03.007; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; VANHAARST JMW, 1994, AM J RESP CELL MOL, V11, P344, DOI 10.1165/ajrcmb.11.3.8086170; WEWERS MD, 1984, J CLIN INVEST, V74, P2208, DOI 10.1172/JCI111647	57	733	758	12	257	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8668	10.1371/journal.pone.0008668	http://dx.doi.org/10.1371/journal.pone.0008668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084270	Green Published, gold			2022-12-25	WOS:000273554600021
J	Myles, S; Chia, JM; Hurwitz, B; Simon, C; Zhong, GY; Buckler, E; Ware, D				Myles, Sean; Chia, Jer-Ming; Hurwitz, Bonnie; Simon, Charles; Zhong, Gan Yuan; Buckler, Edward; Ware, Doreen			Rapid Genomic Characterization of the Genus Vitis	PLOS ONE			English	Article							REDUCED REPRESENTATION; SNP DISCOVERY; GENETIC-STRUCTURE; VINIFERA L.; WIDE ASSOCIATION; CHALLENGES; LIBRARIES; SUCCESS; TRAITS; MAIZE	Next-generation sequencing technologies promise to dramatically accelerate the use of genetic information for crop improvement by facilitating the genetic mapping of agriculturally important phenotypes. The first step in optimizing the design of genetic mapping studies involves large-scale polymorphism discovery and a subsequent genome-wide assessment of the population structure and pattern of linkage disequilibrium (LD) in the species of interest. In the present study, we provide such an assessment for the grapevine (genus Vitis), the world's most economically important fruit crop. Reduced representation libraries (RRLs) from 17 grape DNA samples (10 cultivated V. vinifera and 7 wild Vitis species) were sequenced with sequencing-by-synthesis technology. We developed heuristic approaches for SNP calling, identified hundreds of thousands of SNPs and validated a subset of these SNPs on a 9K genotyping array. We demonstrate that the 9K SNP array provides sufficient resolution to distinguish among V. vinifera cultivars, between V. vinifera and wild Vitis species, and even among diverse wild Vitis species. We show that there is substantial sharing of polymorphism between V. vinifera and wild Vitis species and find that genetic relationships among V. vinifera cultivars agree well with their proposed geographic origins using principal components analysis (PCA). Levels of LD in the domesticated grapevine are low even at short ranges, but LD persists above background levels to 3 kb. While genotyping arrays are useful for assessing population structure and the decay of LD across large numbers of samples, we suggest that whole-genome sequencing will become the genotyping method of choice for genome-wide genetic mapping studies in high-diversity plant species. This study demonstrates that we can move quickly towards genome-wide studies of crop species using next-generation sequencing. Our study sets the stage for future work in other high diversity crop species, and provides a significant enhancement to current genetic resources available to the grapevine genetic community.	[Myles, Sean; Buckler, Edward] Cornell Univ, Inst Genom Divers, Ithaca, NY 14850 USA; [Chia, Jer-Ming; Hurwitz, Bonnie; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Simon, Charles; Zhong, Gan Yuan] Cornell Univ, New York State Agr Expt Stn, Geneva, NY 14456 USA; [Simon, Charles; Zhong, Gan Yuan; Buckler, Edward; Ware, Doreen] ARS, USDA, Ithaca, NY USA	Cornell University; Cold Spring Harbor Laboratory; Cornell University; United States Department of Agriculture (USDA)	Myles, S (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14850 USA.	esb33@cornell.edu; ware@cshl.edu	Buckler, Edward/L-7651-2019; Chia, Jer-Ming/C-9992-2012; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; Myles, Sean/0000-0001-9754-5987	United States Department of Agriculture [1907-21000-030-00D]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work is funded by the United States Department of Agriculture (CRIS#: 1907-21000-030-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barbazuk WB, 2005, BIOESSAYS, V27, P839, DOI 10.1002/bies.20262; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Clark AG, 2005, GENOME RES, V15, P1463, DOI 10.1101/gr.4244005; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Emberton J, 2005, GENOME RES, V15, P1441, DOI 10.1101/gr.3362105; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GORE MA, 2009, PLANT J IN PRESS; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; LANDER E S, 1988, Genomics, V2, P231; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Malhis N, 2009, BIOINFORMATICS, V25, P6, DOI 10.1093/bioinformatics/btn565; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Muir William M, 2008, P NATL ACAD SCI; MYLES S, PLANT CELL IN PRESS; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Olmo H., 1995, EVOLUTION CROP PLANT, V1, P485; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; R Core Team, 2022, R LANG ENV STAT COMP; Salmaso M, 2004, MOL BREEDING, V14, P385, DOI 10.1007/s11032-004-0261-z; This P, 2007, THEOR APPL GENET, V114, P723, DOI 10.1007/s00122-006-0472-2; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Warnes G., 2008, GENETICS POPULATION; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; ZOHARY D, 1997, ORIGINS ANCIENT HIST, P23	34	159	163	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8219	10.1371/journal.pone.0008219	http://dx.doi.org/10.1371/journal.pone.0008219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084295	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000273554600001
J	Nakano, MM; Lin, A; Zuber, CS; Newberry, KJ; Brennan, RG; Zuber, P				Nakano, Michiko M.; Lin, Ann; Zuber, Cole S.; Newberry, Kate J.; Brennan, Richard G.; Zuber, Peter			Promoter Recognition by a Complex of Spx and the C-Terminal Domain of the RNA Polymerase alpha Subunit	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL CONTROL; SIGNAL-TRANSDUCTION SYSTEM; BACILLUS-SUBTILIS; DISULFIDE STRESS; COMPETENCE DEVELOPMENT; STAPHYLOCOCCUS-AUREUS; SIGMA-70 SUBUNIT; OXIDATIVE STRESS; GENE-EXPRESSION; P-3 PROMOTER	Background: Spx, an ArsC (arsenate reductase) family member, is a global transcriptional regulator of the microbial stress response and is highly conserved amongst Gram-positive bacteria. Bacillus subtilis Spx protein exerts positive and negative control of transcription through its interaction with the C-terminal domain of the RNA polymerase (RNAP) alpha subunit (alpha CTD). Spx activates trxA (thioredoxin) and trxB (thioredoxin reductase) in response to thiol stress, and bears an N-terminal C10XXC13 redox disulfide center that is oxidized in active Spx. Methodology/Principal Findings: The structure of mutant Spx(C10S) showed a change in the conformation of helix alpha 4. Amino acid substitutions R60E and K62E within and adjacent to helix alpha 4 conferred defects in Spx-activated transcription but not Spx-dependent repression. Electrophoretic mobility-shift assays showed alpha CTD interaction with trxB promoter DNA, but addition of Spx generated a supershifted complex that was disrupted in the presence of reductant (DTT). Interaction of alpha CTD/Spx complex with promoter DNA required the cis-acting elements -45AGCA-42 and -34AGCG-31 of the trxB promoter. The Spx(G52R) mutant, defective in alpha CTD binding, did not interact with the alpha CTD-trxB complex. Spx R60E not only failed to complex with alpha CTD-trxB, but also disrupted alpha CTD-trxB DNA interaction. Conclusions/Significance: The results show that Spx and alpha CTD form a complex that recognizes the promoter DNA of an Spx-controlled gene. A conformational change during oxidation of Spx to the disulfide form likely alters the structure of Spx alpha helix alpha 4, which contains residues that function in transcriptional activation and alpha CTD/Spx-promoter interaction. The results suggest that one of these residues, R60 of the alpha 4 region of oxidized Spx, functions in alpha CTD/Spx-promoter contact but not in alpha CTD interaction.	[Nakano, Michiko M.; Lin, Ann; Zuber, Cole S.; Zuber, Peter] Oregon Hlth & Sci Univ, Sch Med, Dept Sci & Engn, Beaverton, OR USA; [Newberry, Kate J.; Brennan, Richard G.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX USA	Oregon Health & Science University; University of Texas System; UTMD Anderson Cancer Center	Nakano, MM (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Sci & Engn, Beaverton, OR USA.	pzuber@ebs.ogi.edu		Brennan, Richard/0000-0001-7647-485X; Zuber, Peter/0000-0003-1757-7837; Nakano, Michiko/0000-0002-0635-8535	Welch Foundation [G-0040]; National Institutes of Health [GM045898]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045898] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by grants G-0040 from the Welch Foundation (to RGB) and GM045898 from the National Institutes of Health (to PZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNER CDB, 1983, J MOL BIOL, V168, P351, DOI 10.1016/S0022-2836(83)80023-0; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Bergman NH, 2007, APPL ENVIRON MICROB, V73, P846, DOI 10.1128/AEM.01686-06; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; DAHL MK, 1994, GENE, V145, P151, DOI 10.1016/0378-1119(94)90341-7; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; FRISBY D, 1991, J BACTERIOL, V173, P7557, DOI 10.1128/jb.173.23.7557-7564.1991; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Garg SK, 2009, J BACTERIOL, V191, P1268, DOI 10.1128/JB.01289-08; Geng H, 2007, METHOD ENZYMOL, V422, P448, DOI 10.1016/S0076-6879(06)22023-8; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Harwood C.R., 1990, MOL BIOL METHODS BAC; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; Lamour V, 2009, J STRUCT BIOL, V168, P352, DOI 10.1016/j.jsb.2009.07.001; Larsson JT, 2007, MOL MICROBIOL, V66, P669, DOI 10.1111/j.1365-2958.2007.05949.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leelakriangsak M, 2007, J BACTERIOL, V189, P1727, DOI 10.1128/JB.01519-06; Leelakriangsak M, 2007, J BACTERIOL, V189, P1736, DOI 10.1128/JB.01520-06; Leslie AGW, 1992, RECENT CHANGES MOSFL; Liu JJ, 1999, MOL MICROBIOL, V33, P415, DOI 10.1046/j.1365-2958.1999.01489.x; Liu JJ, 2000, MOL MICROBIOL, V37, P885, DOI 10.1046/j.1365-2958.2000.02053.x; Miller J.H., 1972, EXPT MOL GENETICS; Moch C, 2000, J BACTERIOL, V182, P4384, DOI 10.1128/JB.182.16.4384-4393.2000; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Nakano MM, 2000, MOL MICROBIOL, V37, P869, DOI 10.1046/j.1365-2958.2000.02052.x; NAKANO MM, 1991, J BACTERIOL, V173, P5487, DOI 10.1128/jb.173.17.5487-5493.1991; Nakano MM, 2001, MOL MICROBIOL, V42, P383, DOI 10.1046/j.1365-2958.2001.02639.x; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Qi Y, 1998, MOL MICROBIOL, V28, P1187, DOI 10.1046/j.1365-2958.1998.00882.x; Reyes DY, 2008, MOL MICROBIOL, V69, P765, DOI 10.1111/j.1365-2958.2008.06330.x; ROGGIANI M, 1993, J BACTERIOL, V175, P3182, DOI 10.1128/JB.175.10.3182-3187.1993; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Tam LT, 2006, PROTEOMICS, V6, P4565, DOI 10.1002/pmic.200600100; Turlan C, 2009, MOL MICROBIOL, V73, P492, DOI 10.1111/j.1365-2958.2009.06789.x; Zenno S, 1998, BIOSCI BIOTECH BIOCH, V62, P1978, DOI 10.1271/bbb.62.1978; Zhang Y, 2007, J BACTERIOL, V189, P7669, DOI 10.1128/JB.00745-07; Zhang Y, 2006, J BACTERIOL, V188, P4300, DOI 10.1128/JB.00220-06; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	49	41	42	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8664	10.1371/journal.pone.0008664	http://dx.doi.org/10.1371/journal.pone.0008664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084284	Green Published, gold, Green Submitted			2022-12-25	WOS:000273554600017
J	Oliveira, AF; Ruas, LP; Cardoso, SA; Soares, SG; Roque-Barreira, MC				Oliveira, Aline F.; Ruas, Luciana P.; Cardoso, Silvia A.; Soares, Sandro G.; Roque-Barreira, Maria-Cristina			Vaccination of Mice with Salmonella Expressing VapA: Mucosal and Systemic Th1 Responses Provide Protection against Rhodococcus equi Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CD8(+) T-LYMPHOCYTES; PROTEIN-A; PULMONARY CLEARANCE; HYPERIMMUNE PLASMA; ORAL IMMUNIZATION; IMMUNE-RESPONSES; INTERFERON-GAMMA; ADULT HORSES; VIRULENCE	Conventional vaccines to prevent the pneumonia caused by Rhodococcus equi have not been successful. We have recently demonstrated that immunization with Salmonella enterica Typhimurium expressing the VapA antigen protects mice against R. equi infection. We now report that oral vaccination of mice with this recombinant strain results in high and persistent fecal levels of antigen-specific IgA, and specific proliferation of the spleen cells of immunized mice in response to the in vitro stimulation with R. equi antigen. After in vitro stimulation, spleen cells of immunized mice produce high levels of Th1 cytokines and show a prominent mRNA expression of the Th1 transcription factor T-bet, in detriment of the Th2 transcription factor GATA-3. Following R. equi challenge, a high H2O2, NO, IL-12, and IFN-gamma content is detected in the organs of immunized mice. On the other hand, TNF-alpha and IL-4 levels are markedly lower in the organs of vaccinated mice, compared with the non-vaccinated ones. The IL-10 content and the mRNA transcription level of TGF-beta are also higher in the organs of immunized mice. A greater incidence of CD4(+) and CD8(+) T cells and B lymphocytes is verified in vaccinated mice. However, there is no difference between vaccinated and non-vaccinated mice in terms of the frequency of CD4(+)CD25(+)Foxp3(+) T cells. Finally, we show that the vaccination confers a long-term protection against R. equi infection. Altogether, these data indicate that the oral vaccination of mice with S. enterica Typhimurium expressing VapA induces specific and long-lasting humoral and cellular responses against the pathogen, which are appropriately regulated and allow tissue integrity after challenge.	[Oliveira, Aline F.; Ruas, Luciana P.; Cardoso, Silvia A.; Soares, Sandro G.; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil	Universidade de Sao Paulo	Oliveira, AF (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil.	mcrbarre@fmrp.usp.br	Soares, Sandro/O-7114-2016; de Oliveira Pereira, Aline Ferreira/AAT-5134-2020; Ruas, Luciana/A-4259-2013; Roque-Barreira, Maria-Cristina/A-4552-2008; Gomes Soares, Sandro/AGA-3968-2022; Cardoso, Silvia Almeida/I-8351-2015; Soares, Sandro/B-3601-2008	Soares, Sandro/0000-0001-7205-2510; Ruas, Luciana/0000-0002-1028-7872; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Gomes Soares, Sandro/0000-0001-7205-2510; Cardoso, Silvia Almeida/0000-0001-6586-6591; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). A.F.O. received a scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 2002, BRIT J BIOMED SCI, V59, P173, DOI 10.1080/09674845.2002.11783656; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; Cong H, 2005, PARASITE IMMUNOL, V27, P29, DOI 10.1111/j.1365-3024.2005.00738.x; Criscione LG, 2002, CURR OPIN RHEUMATOL, V14, P204, DOI 10.1097/00002281-200205000-00002; CURTISS R, 1987, INFECT IMMUN, V55, P3035, DOI 10.1128/IAI.55.12.3035-3043.1987; Darrah PA, 2000, INFECT IMMUN, V68, P3587, DOI 10.1128/IAI.68.6.3587-3593.2000; Dietrich G, 2001, VACCINE, V19, P2506, DOI 10.1016/S0264-410X(00)00480-1; DONG C, 2000, SCI STKE, V49, P1; Donisi A, 1996, AIDS, V10, P359, DOI 10.1097/00002030-199604000-00002; Du AF, 2005, INT J PARASITOL, V35, P777, DOI 10.1016/j.ijpara.2005.03.005; Giguere S, 1999, INFECT IMMUN, V67, P3548; Giguere S, 1997, VET MICROBIOL, V56, P313, DOI 10.1016/S0378-1135(97)00099-0; Giguere S, 2002, J AM VET MED ASSOC, V220, P59, DOI 10.2460/javma.2002.220.59; Hines SA, 2003, CLIN DIAGN LAB IMMUN, V10, P208, DOI 10.1128/CDLI.10.2.208-215.2003; Hines SA, 1997, VET MICROBIOL, V56, P177, DOI 10.1016/S0378-1135(97)00086-2; HOCHADEL JF, 1977, J INFECT DIS, V135, P813, DOI 10.1093/infdis/135.5.813; Hondalus MK, 1997, VET MICROBIOL, V56, P257, DOI 10.1016/S0378-1135(97)00094-1; Hooper-McGrevy KE, 2001, AM J VET RES, V62, P1307, DOI 10.2460/ajvr.2001.62.1307; HURLEY JR, 1995, AUST VET J, V72, P418, DOI 10.1111/j.1751-0813.1995.tb06192.x; Jain S, 2003, MOL MICROBIOL, V50, P115, DOI 10.1046/j.1365-2958.2003.03689.x; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; KANALY ST, 1993, INFECT IMMUN, V61, P4929, DOI 10.1128/IAI.61.11.4929-4932.1993; KANALY ST, 1995, INFECT IMMUN, V63, P3037, DOI 10.1128/IAI.63.8.3037-3041.1995; Kanaly ST, 1996, INFECT IMMUN, V64, P1126, DOI 10.1128/IAI.64.4.1126-1132.1996; Kasuga-Aoki H, 1999, IMMUNOLOGY, V96, P122, DOI 10.1046/j.1365-2567.1999.00657.x; Kotton CN, 2004, INFECT IMMUN, V72, P5535, DOI 10.1128/IAI.72.10.5535-5547.2004; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lopez AM, 2003, VACCINE, V21, P3815, DOI 10.1016/S0264-410X(03)00329-3; MADIGAN JE, 1991, J REPROD FERTIL, P571; Magnusson H., 1923, ARCH WISS PRAKTI TIE, V50, P22; MARTENS RJ, 1989, EQUINE VET J, V21, P249, DOI 10.1111/j.2042-3306.1989.tb02161.x; MASTROENI P, 1992, MICROB PATHOGENESIS, V13, P477, DOI 10.1016/0882-4010(92)90014-F; Meijer WG, 2004, VET RES, V35, P383, DOI 10.1051/vetres:2004024; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; NORDMANN P, 1992, INFECT IMMUN, V60, P2748, DOI 10.1128/IAI.60.7.2748-2752.1992; Oliveira AF, 2007, MICROBES INFECT, V9, P382, DOI 10.1016/j.micinf.2006.12.019; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Patton KM, 2004, INFECT IMMUN, V72, P7073, DOI 10.1128/IAI.72.12.7073-7083.2004; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; Prescott JF, 1997, VET MICROBIOL, V56, P213, DOI 10.1016/S0378-1135(97)00090-4; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Shiau AL, 2005, VACCINE, V23, P5563, DOI 10.1016/j.vaccine.2005.07.004; TAKAI S, 1992, INFECT IMMUN, V60, P2995, DOI 10.1128/IAI.60.7.2995-2997.1992; Takai S, 2000, INFECT IMMUN, V68, P6840, DOI 10.1128/IAI.68.12.6840-6847.2000; Wyszynska A, 2004, VACCINE, V22, P1379, DOI 10.1016/j.vaccine.2003.11.001; YAGER JA, 1991, VET MICROBIOL, V28, P363, DOI 10.1016/0378-1135(91)90071-M; Yang XH, 2007, J IMMUNOL, V178, P1059, DOI 10.4049/jimmunol.178.2.1059	49	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8644	10.1371/journal.pone.0008644	http://dx.doi.org/10.1371/journal.pone.0008644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072623	Green Published, gold, Green Submitted			2022-12-25	WOS:000273554600008
J	Mumby, PJ; Harborne, AR				Mumby, Peter J.; Harborne, Alastair R.			Marine Reserves Enhance the Recovery of Corals on Caribbean Reefs	PLOS ONE			English	Article							CLIMATE-CHANGE; CONSERVATION; RESILIENCE; COMPETITION; FISHERY; GROWTH; SIZE; POPULATIONS; MACROALGAE; HERBIVORY	The fisheries and biodiversity benefits of marine reserves are widely recognised but there is mounting interest in exploiting the importance of herbivorous fishes as a tool to help ecosystems recover from climate change impacts. This approach might be particularly suitable for coral reefs, which are acutely threatened by climate change, yet the trophic cascades generated by reserves are strong enough that they might theoretically enhance the rate of coral recovery after disturbance. However, evidence for reserves facilitating coral recovery has been lacking. Here we investigate whether reductions in macroalgal cover, caused by recovery of herbivorous parrotfishes within a reserve, have resulted in a faster rate of coral recovery than in areas subject to fishing. Surveys of ten sites inside and outside a Bahamian marine reserve over a 2.5-year period demonstrated that increases in coral cover, including adjustments for the initial size-distribution of corals, were significantly higher at reserve sites than those in non-reserve sites. Furthermore, macroalgal cover was significantly negatively correlated with the change in total coral cover over time. Recovery rates of individual species were generally consistent with small-scale manipulations on coral-macroalgal interactions, but also revealed differences that demonstrate the difficulties of translating experiments across spatial scales. Size-frequency data indicated that species which were particularly affected by high abundances of macroalgae outside the reserve had a population bottleneck restricting the supply of smaller corals to larger size classes. Importantly, because coral cover increased from a heavily degraded state, and recovery from such states has not previously been described, similar or better outcomes should be expected for many reefs in the region. Reducing herbivore exploitation as part of an ecosystem-based management strategy for coral reefs appears to be justified.	[Mumby, Peter J.; Harborne, Alastair R.] Univ Exeter, Marine Spatial Ecol Lab, Sch BioSci, Hatherly Lab, Exeter, Devon, England	University of Exeter	Mumby, PJ (corresponding author), Univ Exeter, Marine Spatial Ecol Lab, Sch BioSci, Hatherly Lab, Exeter, Devon, England.	P.J.Mumby@ex.ac.uk	Harborne, Alastair R/F-6155-2013; Mumby, Peter/F-9914-2010	Harborne, Alastair R/0000-0002-6818-8615; Mumby, Peter/0000-0002-6297-9053	Khalid bin Sultan Living Oceans Foundation; National Science Foundation; Environmental Protection Agency; Natural Environment Research Council; National Oceanic and Atmospheric Administration; Natural Environment Research Council [NE/F015704/1, NE/E00606X/1] Funding Source: researchfish; NERC [NE/E00606X/1, NE/F015704/1] Funding Source: UKRI	Khalid bin Sultan Living Oceans Foundation; National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this study was provided by the Khalid bin Sultan Living Oceans Foundation (http://www.livingoceansfoundation.org/); the National Science Foundation (NSF-http://www.nsf.gov/); the Environmental Protection Agency (EPA-http://www.epa.gov/); the Natural Environment Research Council (NERC http://www.nerc.ac.uk/); the Undersea Research Program of the National Oceanic and Atmospheric Administration (NURP-http://www.nurp.noaa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Chiappone M, 2000, B MAR SCI, V66, P691; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; Cowling RM, 2008, P NATL ACAD SCI USA, V105, P9483, DOI 10.1073/pnas.0706559105; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Halpern BS, 2003, ECOL APPL, V13, pS117; Harborne AR, 2008, J APPL ECOL, V45, P1010, DOI 10.1111/j.1365-2664.2008.01490.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kramer PA., 2003, ATOLL RES BULL, V496, P77, DOI DOI 10.5479/SI.00775630.496-5.76; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Mumby PJ, 2008, CONSERV BIOL, V22, P941, DOI 10.1111/j.1523-1739.2008.00933.x; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Ray C, 1958, REPORT EXUMA C UNPUB; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sary Z, 1997, MAR ECOL PROG SER, V154, P107, DOI 10.3354/meps154107; Skirving W, 2006, RE S D I PR, V9, P11, DOI 10.1007/1-4020-3968-9_2; SMITH SR, 2008, CONTINUING DECLINE M; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; VANMOORSEL GWNM, 1988, MAR ECOL PROG SER, V50, P127, DOI 10.3354/meps050127; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Wilkinson C, 2008, STATUS CARIBBEAN COR	39	211	216	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8657	10.1371/journal.pone.0008657	http://dx.doi.org/10.1371/journal.pone.0008657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20066158	Green Published, gold			2022-12-25	WOS:000273456300007
J	Babai, N; Kanevsky, N; Dascal, N; Rozanski, GJ; Singh, DP; Fatma, N; Thoreson, WB				Babai, Norbert; Kanevsky, Nataly; Dascal, Nathan; Rozanski, George J.; Singh, Dhirendra P.; Fatma, Nigar; Thoreson, Wallace B.			Anion-Sensitive Regions of L-Type CaV1.2 Calcium Channels Expressed in HEK293 Cells	PLOS ONE			English	Article							CA2+ CHANNEL; OPEN PROBABILITY; BETA-SUBUNITS; SYNAPTIC-TRANSMISSION; INSULIN-SECRETION; LYOTROPIC ANIONS; CA(V)1.2 CHANNEL; PATCH-CLAMP; CHLORIDE; MODULATION	L-type calcium currents (I-Ca) are influenced by changes in extracellular chloride, but sites of anion effects have not been identified. Our experiments showed that CaV1.2 currents expressed in HEK293 cells are strongly inhibited by replacing extracellular chloride with gluconate or perchlorate. Variance-mean analysis of I-Ca and cell-attached patch single channel recordings indicate that gluconate-induced inhibition is due to intracellular anion effects on Ca2+ channel open probability, not conductance. Inhibition of CaV1.2 currents produced by replacing chloride with gluconate was reduced from similar to 75%-80% to similar to 50% by omitting beta subunits but unaffected by omitting alpha(2)delta subunits. Similarly, gluconate inhibition was reduced to similar to 50% by deleting an alpha 1 subunit N-terminal region of 15 residues critical for beta subunit interactions regulating open probability. Omitting beta subunits with this mutant alpha 1 subunit did not further diminish inhibition. Gluconate inhibition was unchanged with expression of different beta subunits. Truncating the C terminus at AA1665 reduced gluconate inhibition from similar to 75%-80% to similar to 50% whereas truncating it at AA1700 had no effect. Neutralizing arginines at AA1696 and 1697 by replacement with glutamines reduced gluconate inhibition to similar to 60% indicating these residues are particularly important for anion effects. Expressing CaV1.2 channels that lacked both N and C termini reduced gluconate inhibition to similar to 25% consistent with additive interactions between the two tail regions. Our results suggest that modest changes in intracellular anion concentration can produce significant effects on CaV1.2 currents mediated by changes in channel open probability involving beta subunit interactions with the N terminus and a short C terminal region.	[Babai, Norbert; Singh, Dhirendra P.; Fatma, Nigar; Thoreson, Wallace B.] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; [Rozanski, George J.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA; [Kanevsky, Nataly; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Babai, N (corresponding author), Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA.	wbthores@unmc.edu	Dascal, Nathan/O-3915-2015; Thoreson, Wallace B./F-6172-2010; Babai, Norbert/T-2952-2019	Dascal, Nathan/0000-0002-5397-4146; Thoreson, Wallace B./0000-0001-7104-042X; 	NIH [EY-10542, HL-66446]; Binational Science Foundation [2005340]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R29EY010542, R55EY010542, R01EY010542] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066446] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH (EY-10542, HL-66446), the Binational Science Foundation (#2005340), and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekar LK, 1999, J NEUROPHYSIOL, V82, P248, DOI 10.1152/jn.1999.82.1.248; Bekar LK, 2002, GLIA, V39, P207, DOI 10.1002/glia.10096; Bell DC, 2001, J NEUROPHYSIOL, V85, P816, DOI 10.1152/jn.2001.85.2.816; Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Best L, 2005, J PHYSIOL-LONDON, V568, P137, DOI 10.1113/jphysiol.2005.093740; Best L, 1996, PFLUG ARCH EUR J PHY, V431, P363, DOI 10.1007/BF02207273; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; Chub N, 2001, J NEUROPHYSIOL, V85, P2166, DOI 10.1152/jn.2001.85.5.2166; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; DANI JA, 1983, J GEN PHYSIOL, V81, P255, DOI 10.1085/jgp.81.2.255; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; DELAY M, 1990, J PHYSIOL-LONDON, V425, P449, DOI 10.1113/jphysiol.1990.sp018113; DJAMGOZ MBA, 1987, VISION RES, V27, P1481, DOI 10.1016/0042-6989(87)90157-X; Doering CJ, 2005, BIOPHYS J, V89, P3042, DOI 10.1529/biophysj.105.067124; Doughty JM, 1998, J PHYSIOL-LONDON, V507, P433, DOI 10.1111/j.1469-7793.1998.433bt.x; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Drews G, 1998, BBA-BIOMEMBRANES, V1370, P8, DOI 10.1016/S0005-2736(97)00240-X; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FRY CH, 1993, CARDIOVASC RES, V27, P856, DOI 10.1093/cvr/27.5.856; GALLANT EM, 1993, AM J PHYSIOL, V264, pC559, DOI 10.1152/ajpcell.1993.264.3.C559; Garcia L, 1997, AM J PHYSIOL-CELL PH, V272, pC1178, DOI 10.1152/ajpcell.1997.272.4.C1178; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P3597; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kobayashi T, 2007, J PHARMACOL SCI, V103, P347, DOI 10.1254/jphs.CR0070012; Kurokawa J, 2007, BIOL PHARM BULL, V30, P2231, DOI 10.1248/bpb.30.2231; Larsson-Nyren G, 2001, PFLUG ARCH EUR J PHY, V441, P587, DOI 10.1007/s004240000426; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; MA J, 1993, J GEN PHYSIOL, V102, P423, DOI 10.1085/jgp.102.3.423; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; MCLAUGHLIN S, 1975, BIOCHIM BIOPHYS ACTA, V394, P304, DOI 10.1016/0005-2736(75)90267-9; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Numoto N, 2008, BIOCHEMISTRY-US, V47, P11231, DOI 10.1021/bi8012609; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; PERUTZ MF, 1993, J MOL BIOL, V233, P536, DOI 10.1006/jmbi.1993.1530; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Rabl K, 2003, VISUAL NEUROSCI, V20, P557, DOI 10.1017/S0952523803205095; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Rozanski GJ, 2002, AM J PHYSIOL-HEART C, V282, pH2346, DOI 10.1152/ajpheart.00894.2001; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; SALA S, 1990, BIOPHYS J, V58, P567, DOI 10.1016/S0006-3495(90)82400-0; SCATCHARD G, 1957, J AM CHEM SOC, V79, P12, DOI 10.1021/ja01558a003; Sheader EA, 2001, MOL CELL ENDOCRINOL, V181, P179, DOI 10.1016/S0303-7207(01)00509-3; SLESINGER PA, 1991, J PHYSIOL-LONDON, V439, P301, DOI 10.1113/jphysiol.1991.sp018668; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; Thoreson WB, 2000, VISUAL NEUROSCI, V17, P197, DOI 10.1017/S0952523800172025; Thoreson WB, 1997, J NEUROPHYSIOL, V77, P2175, DOI 10.1152/jn.1997.77.4.2175; Thoreson WB, 2003, J NEUROPHYSIOL, V90, P1747, DOI 10.1152/jn.00932.2002; Thoreson WB, 2000, BBA-BIOMEMBRANES, V1464, P142, DOI 10.1016/S0005-2736(99)00257-6; Thoreson WB, 1996, J GEN PHYSIOL, V107, P631, DOI 10.1085/jgp.107.5.631; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; Zhou SS, 2002, J APPL PHYSIOL, V93, P1660, DOI 10.1152/japplphysiol.00220.2002; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3	67	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8602	10.1371/journal.pone.0008602	http://dx.doi.org/10.1371/journal.pone.0008602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066046	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338600020
J	Wang, XL; Gou, DM; Xu, SY				Wang, Xiaolong; Gou, Deming; Xu, Shuang-yong			Polymerase-Endonuclease Amplification Reaction (PEAR) for Large-Scale Enzymatic Production of Antisense Oligonucleotides	PLOS ONE			English	Article							ISOTHERMAL DNA AMPLIFICATION; CIRCLE AMPLIFICATION; RESTRICTION ENZYME; MICRORNA; CHROMATOGRAPHY; PURIFICATION; INHIBITION; DUPLEXES; DISEASE; SYSTEM	Antisense oligonucleotides targeting microRNAs or their mRNA targets prove to be powerful tools for molecular biology research and may eventually emerge as new therapeutic agents. Synthetic oligonucleotides are often contaminated with highly homologous failure sequences. Synthesis of a certain oligonucleotide is difficult to scale up because it requires expensive equipment, hazardous chemicals and a tedious purification process. Here we report a novel thermocyclic reaction, polymerase-endonuclease amplification reaction (PEAR), for the amplification of oligonucleotides. A target oligonucleotide and a tandem repeated antisense probe are subjected to repeated cycles of denaturing, annealing, elongation and cleaving, in which thermostable DNA polymerase elongation and strand slipping generate duplex tandem repeats, and thermostable endonuclease (PspGI) cleavage releases monomeric duplex oligonucleotides. Each round of PEAR achieves over 100-fold amplification. The product can be used in one more round of PEAR directly, and the process can be further repeated. In addition to avoiding dangerous materials and improved product purity, this reaction is easy to scale up and amenable to full automation. PEAR has the potential to be a useful tool for large-scale production of antisense oligonucleotide drugs.	[Wang, Xiaolong] Ocean Univ China, Dept Biotechnol, Qingdao, Shandong, Peoples R China; [Gou, Deming] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Xu, Shuang-yong] New England Biolabs Inc, Ipswich, MA USA	Ocean University of China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; New England Biolabs	Wang, XL (corresponding author), Ocean Univ China, Dept Biotechnol, Qingdao, Shandong, Peoples R China.	xiaolong@ouc.edu.cn	Wang, Xiaolong/F-3704-2010		National Science Foundation of China [30500379]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation of China through grant 30500379. SYX is employed at NEB. Thus, although NEB did not provide direct financial support, it can be considered as an indirect funder for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Astriab-Fisher A, 2004, BIOCHEM PHARMACOL, V68, P403, DOI 10.1016/j.bcp.2004.03.040; Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; BALOTTA C, 1993, J VIROL, V67, P4409, DOI 10.1128/JVI.67.7.4409-4414.1993; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Brown E L, 1979, Methods Enzymol, V68, P109; Butler M, 2005, NEUROSCIENCE, V131, P705, DOI 10.1016/j.neuroscience.2004.11.038; CASTLEBERRY CM, 2008, ELECTROSPRAY IONIZAT, V35; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; Davis S, 2006, NUCLEIC ACIDS RES, V34, P2294, DOI 10.1093/nar/gkl183; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Gilar M, 2001, ANAL BIOCHEM, V298, P196, DOI 10.1006/abio.2001.5386; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Krotz AH, 2000, ORG PROCESS RES DEV, V4, P190, DOI 10.1021/op990183d; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Lohmann JS, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-49; Lu YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1053; Masud MM, 2003, CHEMBIOCHEM, V4, P584, DOI 10.1002/cbic.200200539; Morgan R, 1998, APPL ENVIRON MICROB, V64, P3669; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Pingoud V, 2003, J MOL BIOL, V329, P913, DOI 10.1016/S0022-2836(03)00523-0; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rayburn ER, 2008, DRUG DISCOV TODAY, V13, P513, DOI 10.1016/j.drudis.2008.03.014; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Shanagar J, 2005, J BIOCHEM BIOPH METH, V64, P216, DOI 10.1016/j.jbbm.2005.08.004; Tan E, 2008, BIOCHEMISTRY-US, V47, P9987, DOI 10.1021/bi800746p; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, NUCLEOS NUCLEOT NUCL, V26, P1207, DOI 10.1080/15257770701527844; Veedu RN, 2009, ORG BIOMOL CHEM, V7, P1404, DOI 10.1039/b819946a; Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200; WALKER GT, 1992, P NATL ACAD SCI USA, V89, P392, DOI 10.1073/pnas.89.1.392; Weiler J, 2006, GENE THER, V13, P496, DOI 10.1038/sj.gt.3302654	36	7	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8430	10.1371/journal.pone.0008430	http://dx.doi.org/10.1371/journal.pone.0008430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20062528	Green Published, Green Submitted, gold			2022-12-25	WOS:000273225000003
J	Herman, MA; She, PX; Peroni, OD; Lynch, CJ; Kahn, BB				Herman, Mark A.; She, Pengxiang; Peroni, Odile D.; Lynch, Christopher J.; Kahn, Barbara B.			Adipose Tissue Branched Chain Amino Acid (BCAA) Metabolism Modulates Circulating BCAA Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; S6 KINASE; LEUCINE; EXPRESSION; MECHANISMS; PATHWAY; ENZYMES; OBESITY; MUSCLE; CONTRIBUTES	Whereas the role of adipose tissue in glucose and lipid homeostasis is widely recognized, its role in systemic protein and amino acid metabolism is less well-appreciated. In vitro and ex vivo experiments suggest that adipose tissue can metabolize substantial amounts of branched chain amino acids (BCAAs). However, the role of adipose tissue in regulating BCAA metabolism in vivo is controversial. Interest in the contribution of adipose tissue to BCAA metabolism has been renewed with recent observations demonstrating down-regulation of BCAA oxidation enzymes in adipose tissue in obese and insulin-resistant humans. Using gene set enrichment analysis, we observe alterations in adipose-tissue BCAA enzyme expression caused by adipose-selective genetic alterations in the GLUT4 glucose-transporter expression. We show that the rate of adipose tissue BCAA oxidation per mg of tissue from normal mice is higher than in skeletal muscle. In mice overexpressing GLUT4 specifically in adipose tissue, we observe coordinate down-regulation of BCAA metabolizing enzymes selectively in adipose tissue. This decreases BCAA oxidation rates in adipose tissue, but not in muscle, in association with increased circulating BCAA levels. To confirm the capacity of adipose tissue to modulate circulating BCAA levels in vivo, we demonstrate that transplantation of normal adipose tissue into mice that are globally defective in peripheral BCAA metabolism reduces circulating BCAA levels by 30% (fasting)-50% (fed state). These results demonstrate for the first time the capacity of adipose tissue to catabolize circulating BCAAs in vivo and that coordinate regulation of adiposetissue BCAA enzymes may modulate circulating BCAA levels.	[Herman, Mark A.; Peroni, Odile D.; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Herman, Mark A.; Peroni, Odile D.; Kahn, Barbara B.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [She, Pengxiang; Lynch, Christopher J.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kahn, BB (corresponding author), 330 Brookline Ave, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Lynch, Christopher J./E-6875-2010; Herman, Mark/H-3232-2012	Lynch, Christopher J./0000-0003-2453-5838; Herman, Mark/0000-0001-6979-103X	National Institutes of Health [R01DK43051, P30DK57521, K08DK076726, R01DK062880]; Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R01DK062880, R01DK043051, K08DK076726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK43051 and P30DK57521 (to B.B.K.), Grant K08DK076726 (to M.A.H.), and Grant R01DK062880 (to C.J.L.). This work was also supported by a grant from the Picower Foundation (to B.B.K.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; BLOCK KP, 1987, AM J PHYSIOL, V252, pE396, DOI 10.1152/ajpendo.1987.252.3.E396; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; CROFFORD OB, 1964, P SOC EXP BIOL MED, V117, P11, DOI 10.3181/00379727-117-29483; FAJANS SS, 1965, NEW ENGL J MED, V272, P1224, DOI 10.1056/NEJM196506102722308; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fell DA, 2005, J EXP BOT, V56, P267, DOI 10.1093/jxb/eri011; FRAYN KN, 1991, CLIN SCI, V80, P471, DOI 10.1042/cs0800471; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; GOODMAN HM, 1977, AM J PHYSIOL, V233, pE97, DOI 10.1152/ajpendo.1977.233.2.E97; GOODMAN HM, 1986, PROBLEMS POTENTIAL B, P173; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; HARRIS RA, 1988, METHOD ENZYMOL, V166, P114; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; Harris RA, 2001, J NUTR, V131, p841S, DOI 10.1093/jn/131.3.841S; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUTSON SM, 1987, J BIOL CHEM, V262, P9629; ICHIHARA A, 1966, J BIOCHEM-TOKYO, V59, P160, DOI 10.1093/oxfordjournals.jbchem.a128277; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kowalski TJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE613, DOI 10.1152/ajpendo.1997.273.3.E613; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE824, DOI 10.1152/ajpendo.00085.2002; MEIKLE AW, 1972, AM J PHYSIOL, V222, P1246, DOI 10.1152/ajplegacy.1972.222.5.1246; Mitsubuchi H, 2005, J NUTR, V135, p1565S, DOI 10.1093/jn/135.6.1565S; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Norton LE, 2006, J NUTR, V136, p533S, DOI 10.1093/jn/136.2.533S; ODESSEY R, 1986, PROBLEMS POTENTIAL B, P49; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; POPOV KM, 1995, ARCH BIOCHEM BIOPHYS, V316, P148, DOI 10.1006/abbi.1995.1022; ROSENTHA.J, 1974, AM J PHYSIOL, V226, P411, DOI 10.1152/ajplegacy.1974.226.2.411; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SNELL K, 1977, BIOCHEM BIOPH RES CO, V77, P925, DOI 10.1016/S0006-291X(77)80066-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; TISCHLER ME, 1980, J BIOL CHEM, V255, P8074; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; WAHREN J, 1976, J CLIN INVEST, V57, P987, DOI 10.1172/JCI108375; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; ZINNEMAN HH, 1966, DIABETES, V15, P5, DOI 10.2337/diab.15.1.5	49	257	263	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11348	11356		10.1074/jbc.M109.075184	http://dx.doi.org/10.1074/jbc.M109.075184			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20093359	Green Published, hybrid			2022-12-25	WOS:000276286200041
J	Novakovic, B; Wong, NC; Sibson, M; Ng, HK; Morley, R; Manuelpillai, U; Down, T; Rakyan, VK; Beck, S; Hiendleder, S; Roberts, CT; Craig, JM; Saffery, R				Novakovic, Boris; Wong, Nick C.; Sibson, Mandy; Ng, Hong-Kiat; Morley, Ruth; Manuelpillai, Ursula; Down, Thomas; Rakyan, Vardhman K.; Beck, Stephan; Hiendleder, Stefan; Roberts, Claire T.; Craig, Jeffrey M.; Saffery, Richard			DNA Methylation-mediated Down-regulation of DNA Methyltransferase-1 (DNMT1) Is Coincident with, but Not Essential for, Global Hypomethylation in Human Placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; 5-METHYLCYTOSINE CONTENT; CHORIOCARCINOMA CELLS; REPETITIVE DNA; NORMAL-TISSUES; LUNG-CANCER; CPG ISLANDS; GENE; HYPERMETHYLATION; OVEREXPRESSION	The genome of extraembryonic tissue, such as the placenta, is hypomethylated relative to that in somatic tissues. However, the origin and role of this hypomethylation remains unclear. The DNA methyltransferases DNMT1, -3A, and -3B are the primary mediators of the establishment and maintenance of DNA methylation in mammals. In this study, we investigated promoter methylation-mediated epigenetic down-regulation of DNMT genes as a potential regulator of global methylation levels in placental tissue. Although DNMT3A and -3B promoters lack methylation in all somatic and extraembryonic tissues tested, we found specific hypermethylation of the maintenance DNA methyltransferase (DNMT1) gene and found hypomethylation of the DNMT3L gene in full term and first trimester placental tissues. Bisulfite DNA sequencing revealed monoallelic methylation of DNMT1, with no evidence of imprinting (parent of origin effect). In vitro reporter experiments confirmed that DNMT1 promoter methylation attenuates transcriptional activity in trophoblast cells. However, global hypomethylation in the absence of DNMT1 down-regulation is apparent in non-primate placentas and in vitro derived human cytotrophoblast stem cells, suggesting that DNMT1 down-regulation is not an absolute requirement for genomic hypomethylation in all instances. These data represent the first demonstration of methylation-mediated regulation of the DNMT1 gene in any system and demonstrate that the unique epigenome of the human placenta includes down-regulation of DNMT1 with concomitant hypomethylation of the DNMT3L gene. This strongly implicates epigenetic regulation of the DNMT gene family in the establishment of the unique epigenetic profile of extraembryonic tissue in humans.	[Novakovic, Boris; Wong, Nick C.; Sibson, Mandy; Ng, Hong-Kiat; Morley, Ruth; Craig, Jeffrey M.; Saffery, Richard] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Novakovic, Boris; Craig, Jeffrey M.; Saffery, Richard] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Down, Thomas] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; [Down, Thomas] Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; [Rakyan, Vardhman K.] Inst Cell & Mol Sci Barts & London, London E1 2AT, England; [Beck, Stephan] UCL, Inst Canc, London WC1E 6BT, England; [Hiendleder, Stefan] Univ Adelaide, JS Davies Epigenet & Genet Grp, Adelaide, SA 5005, Australia; [Roberts, Claire T.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; University of Cambridge; University of Cambridge; University of London; Queen Mary University London; University of London; University College London; University of Adelaide; University of Adelaide	Saffery, R (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	richard.saffery@mcri.edu.au	Novakovic, Boris/D-8018-2013; Saffery, Richard/GLS-1976-2022; Hiendleder, Stefan/J-8008-2012; Craig, Jeffrey M/B-3484-2012; Wong, Nick Wong/AAF-8627-2021; Roberts, Claire/A-1205-2007	Novakovic, Boris/0000-0002-5623-9008; Saffery, Richard/0000-0002-9510-4181; Craig, Jeffrey M/0000-0003-3979-7849; Wong, Nick Wong/0000-0003-4393-7541; Roberts, Claire/0000-0002-9250-2192	National Health and Medical Research Council (NHMRC) (Australia); Wellcome Trust [084071]	National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a National Health and Medical Research Council (NHMRC) (Australia) Dora Lush scholarship.; Supported by NHMRC research fellowships.; Supported by Wellcome Trust Grant 084071.	Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Arima T, 2006, DEV BIOL, V297, P361, DOI 10.1016/j.ydbio.2006.05.003; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brueckner B, 2007, CANCER J, V13, P17, DOI 10.1097/PPO.0b013e31803c7245; Campbell PM, 2003, CARCINOGENESIS, V24, P17, DOI 10.1093/carcin/24.1.17; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Cotton AM, 2009, HUM MOL GENET, V18, P3544, DOI 10.1093/hmg/ddp299; Cui M, 2009, MOL BIOL REP, V36, P2201, DOI 10.1007/s11033-008-9435-9; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fan H, 2009, WORLD J GASTROENTERO, V15, P2020, DOI 10.3748/wjg.15.2020; FEINBERG AP, 1988, CANCER RES, V48, P1159; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P3087, DOI 10.1093/nar/11.10.3087; Guilleret I, 2009, EPIGENETICS-US, V4, P62, DOI 10.4161/epi.4.1.7471; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Hata K, 2002, DEVELOPMENT, V129, P1983; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Jackson K, 2004, CANCER BIOL THER, V3, P1225, DOI 10.4161/cbt.3.12.1222; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Medstrand P, 2005, CYTOGENET GENOME RES, V110, P342, DOI 10.1159/000084966; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; Peng DF, 2006, CARCINOGENESIS, V27, P1160, DOI 10.1093/carcin/bgi361; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Saikawa Y, 2004, ONCOL REP, V12, P527; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sato N, 2003, JNCI-J NATL CANCER I, V95, P327, DOI 10.1093/jnci/95.4.327; Serman L, 2007, PLACENTA, V28, P803, DOI 10.1016/j.placenta.2007.04.001; Slack A, 1999, EUR J BIOCHEM, V264, P191, DOI 10.1046/j.1432-1327.1999.00603.x; Slack A, 2001, GENE, V268, P87, DOI 10.1016/S0378-1119(01)00427-9; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Tsien F, 2002, CYTOGENET GENOME RES, V98, P13, DOI 10.1159/000068543; Vallbohmer D, 2006, CLIN LUNG CANCER, V8, P39, DOI 10.3816/CLC.2006.n.031; Wagschal A, 2006, CYTOGENET GENOME RES, V113, P90, DOI 10.1159/000090819; Widschwendter M, 2004, CANCER RES, V64, P4472, DOI 10.1158/0008-5472.CAN-04-0238; Wong NC, 2008, CANCER LETT, V268, P56, DOI 10.1016/j.canlet.2008.03.033; Wong NC, 2006, PLOS GENET, V2, P172, DOI 10.1371/journal.pgen.0020017; Yaqinuddin A, 2009, J UROLOGY, V182, P756, DOI 10.1016/j.juro.2009.03.082	61	70	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9583	9593		10.1074/jbc.M109.064956	http://dx.doi.org/10.1074/jbc.M109.064956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20071334	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000276165900031
J	Lin, YM; Wu, SJ; Chang, TW; Wang, CF; Suen, CS; Hwang, MJ; Chang, MDT; Chen, YT; Liao, YD				Lin, Yu-Min; Wu, Shih-Jung; Chang, Ting-Wei; Wang, Chiu-Feng; Suen, Ching-Shu; Hwang, Ming-Jing; Chang, Margaret Dah-Tsyr; Chen, Yuan-Tsong; Liao, You-Di			Outer Membrane Protein I of Pseudomonas aeruginosa Is a Target of Cationic Antimicrobial Peptide/Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HOST-DEFENSE; LIPOPROTEIN; PEPTIDES; EXPRESSION; PATHOGENS; RNASE-7; BINDING; MODEL; SKIN	Cationic antimicrobial peptides/proteins (AMPs) are important components of the host innate defense mechanisms against invading microorganisms. Here we demonstrate that OprI (outer membrane protein I) of Pseudomonas aeruginosa is responsible for its susceptibility to human ribonuclease 7 (hRNase 7) and alpha-helical cationic AMPs, instead of surface lipopolysaccharide, which is the initial binding site of cationic AMPs. The antimicrobial activities of hRNase 7 and alpha-helical cationic AMPs against P. aeruginosa were inhibited by the addition of exogenous OprI or anti-OprI antibody. On modification and internalization of OprI by hRNase 7 into cytosol, the bacterial membrane became permeable to metabolites. The lipoprotein was predicted to consist of an extended loop at the N terminus for hRNase 7/lipopolysaccharide binding, a trimeric alpha-helix, and a lysine residue at the C terminus for cell wall anchoring. Our findings highlight a novel mechanism of antimicrobial activity and document a previously unexplored target of alpha-helical cationic AMPs, which may be used for screening drugs to treat antibiotic-resistant bacterial infection.	[Lin, Yu-Min; Wu, Shih-Jung; Chang, Ting-Wei; Wang, Chiu-Feng; Suen, Ching-Shu; Hwang, Ming-Jing; Chen, Yuan-Tsong; Liao, You-Di] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Lin, Yu-Min; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan; [Wu, Shih-Jung; Chen, Yuan-Tsong] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei 106, Taiwan; [Chang, Ting-Wei; Liao, You-Di] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Taiwan University; National Yang Ming Chiao Tung University	Liao, YD (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	ydliao@ibms.sinica.edu.tw	Hwang, Ming-jing/E-9210-2012; Liao, You-Di/S-7018-2018	Hwang, Ming-jing/0000-0002-9657-5663; Liao, You-Di/0000-0001-5527-4736	National Science Council [NSC95-2311-B-001-067-MY3]; Academia Sinica (Taiwan)	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica (Taiwan)(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant NSC95-2311-B-001-067-MY3 and funds from the Academia Sinica (Taiwan).	Boix E, 2007, MOL BIOSYST, V3, P317, DOI 10.1039/b617527a; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Brogden KA, 2001, ANTIMICROB AGENTS CH, V45, P331, DOI 10.1128/AAC.45.1.331-334.2001; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cote-Sierra J, 1998, GENE, V221, P25, DOI 10.1016/S0378-1119(98)00437-5; DUCHENE M, 1989, J BACTERIOL, V171, P4130; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; FUNG J, 1978, J BACTERIOL, V133, P1467, DOI 10.1128/JB.133.3.1467-1471.1978; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Giamarellou H, 2002, J ANTIMICROB CHEMOTH, V49, P229, DOI 10.1093/jac/49.2.229; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; INOUYE M, 1974, P NATL ACAD SCI USA, V71, P2396, DOI 10.1073/pnas.71.6.2396; INOUYE M, 1972, J BIOL CHEM, V247, P8154; INOUYE S, 1976, J BACTERIOL, V127, P555, DOI 10.1128/JB.127.1.555-563.1976; Liu J, 2003, BIOCHEMISTRY-US, V42, P5657, DOI 10.1021/bi026828a; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MIZUNO T, 1979, J BIOCHEM-TOKYO, V85, P115, DOI 10.1093/oxfordjournals.jbchem.a132300; PETERSON AA, 1987, ANTIMICROB AGENTS CH, V31, P230, DOI 10.1128/AAC.31.2.230; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; ROSENBERG HF, 1995, J BIOL CHEM, V270, P30234; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; Shu W, 2000, J MOL BIOL, V299, P1101, DOI 10.1006/jmbi.2000.3776; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Tack BF, 2002, EUR J BIOCHEM, V269, P1181, DOI 10.1046/j.0014-2956.2002.02751.x; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Yang CWO, 2007, J ALLERGY CLIN IMMUN, V120, P870, DOI 10.1016/j.jaci.2007.06.017; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357; Zhang JZ, 2003, NUCLEIC ACIDS RES, V31, P602, DOI 10.1093/nar/gkg157	34	67	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8985	8994		10.1074/jbc.M109.078725	http://dx.doi.org/10.1074/jbc.M109.078725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20100832	Green Published, hybrid			2022-12-25	WOS:000275553700050
J	Pi, JB; Leung, L; Xue, P; Wang, WP; Hou, YY; Liu, DX; Yehuda-Shnaidman, E; Lee, C; Lau, J; Kurtz, TW; Chan, JY				Pi, Jingbo; Leung, Laura; Xue, Peng; Wang, Weiping; Hou, Yongyong; Liu, Dianxin; Yehuda-Shnaidman, Einav; Lee, Candy; Lau, Jackie; Kurtz, Theodore W.; Chan, Jefferson Y.			Deficiency in the Nuclear Factor E2-related Factor-2 Transcription Factor Results in Impaired Adipogenesis and Protects against Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; HIGH-FAT DIET; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; OXIDATIVE STRESS; UNCOUPLING PROTEINS; ECTOPIC EXPRESSION; C/EBP-ALPHA; BINDING; GENE	Nuclear factor E2-related factor 2 (Nrf2) is a cap-n-collar basic leucine zipper (CNC-bZIP) transcription factor that is well established as a master regulator of phase II detoxification and antioxidant gene expression and is strongly expressed in tissues involved in xenobiotic metabolism including liver and kidney. Nrf2 is also abundantly expressed in adipose tissue; however, the exact function of Nrf2 in adipocyte biology is unclear. In the current study we show that targeted knock-out of Nrf2 in mice decreases adipose tissue mass, promotes formation of small adipocytes, and protects against weight gain and obesity otherwise induced by a high fat diet. In mouse embryonic fibroblasts, 3T3-L1 cells, and human subcutaneous preadipocytes, selective deficiency of Nrf2 impairs adipocyte differentiation. Deficiency of Nrf2 also leads to decreased expression of peroxisome proliferator-activated receptor gamma (PPAR gamma), CCAAT enhancer-binding protein alpha (C/EBP alpha), and their downstream targets during adipocyte differentiation. Conversely, activation of Nrf2 in 3T3-L1 cells by stable knockdown of its negative regulator Keap1 enhances and accelerates hormone-induced adipocyte differentiation. Transfection of Nrf2 stimulates Ppar gamma promoter activity, and stable knockdown of Keap1 enhances PPAR gamma expression in 3T3-L1 cells. In addition, chromatin immunoprecipitation studies show that Nrf2 associates with consensus binding sites for Nrf2 in the Ppar gamma promoter. These findings demonstrate a novel biologic role for Nrf2 beyond its participation in detoxification and antioxidant pathways and place Nrf2 within the limited network of transcription factors that control adipocyte differentiation by regulating expression of PPAR gamma.	[Pi, Jingbo; Xue, Peng; Hou, Yongyong; Liu, Dianxin; Yehuda-Shnaidman, Einav] Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA; [Leung, Laura; Wang, Weiping; Lee, Candy; Lau, Jackie; Chan, Jefferson Y.] Univ Calif Irvine, Dept Lab Med & Pathol, Irvine, CA 92697 USA; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	The Hamner Institutes for Health Sciences; University of California System; University of California Irvine; University of California System; University of California San Francisco	Pi, JB (corresponding author), Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA.	jpi@thehamner.org; jchan@uci.edu	xue, peng/K-4159-2015; Liu, Dianxin/O-5053-2018; PI, JINGBO/GWC-2514-2022; Longo, Kenneth A/A-5631-2010	Liu, Dianxin/0000-0003-2282-7386; PI, JINGBO/0000-0003-0227-8041; 	National Institutes of Health [DK76788, ES016005, CA091907]; NATIONAL CANCER INSTITUTE [R01CA091907, R56CA091907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK76788 and ES016005 (to J.P.) and CA091907 (to J.Y.C.).	CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Gummersbach C, 2009, DIFFERENTIATION, V77, P115, DOI 10.1016/j.diff.2008.09.009; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yoshinari K, 2006, DRUG METAB DISPOS, V34, P1081, DOI 10.1124/dmd.105.007286; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	32	204	219	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9292	9300		10.1074/jbc.M109.093955	http://dx.doi.org/10.1074/jbc.M109.093955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089859	Green Published, hybrid			2022-12-25	WOS:000275553700077
J	Huang, YZ; McNamara, JO				Huang, Yang Z.; McNamara, James O.			Mutual Regulation of Src Family Kinases and the Neurotrophin Receptor TrkB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE; AUTOPHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; ACTIVATION; TRANSACTIVATION; PLASTICITY; TARGET; DOMAIN; ROLES	The neurotrophin receptor tyrosine kinase TrkB is critical to diverse biological processes. We investigated the interplay of Src family kinases (SFKs) and TrkB to better understand mechanisms of TrkB signaling in physiological and pathological conditions. We compared and contrasted the role of SFKs in TrkB signaling following activation of TrkB by two mechanisms, its transactivation by zinc, and its activation by its prototypic neurotrophin ligand, brain-derived neurotrophic factor (BDNF). Using biochemical, pharmacological, and chemical genetic studies of cultured rodent neurons, we found that zinc promotes preferential phosphorylation of Tyr-705/Tyr-706 of TrkB by a SFK-dependent but TrkB kinase-independent mechanism, a signaling event critical for transactivation of TrkB by zinc. By contrast, SFK activity is not essential for BDNF-mediated activation of TrkB, yet SFK activity is increased as a consequence of TrkB activation by BDNF. Moreover, BDNF-induced phosphorylation of Tyr-705/Tyr-706 of TrkB was inhibited by SFK inhibitors, implicating a regulatory role of SFKs in TrkB activation by BDNF. In sum, SFKs are activated by TrkB and, in turn, SFKs can promote TrkB activation. We propose models depicting the mutual regulation of SFKs and TrkB following activation of TrkB by zinc and BDNF.	[McNamara, James O.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [McNamara, James O.] Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; [McNamara, James O.] Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	McNamara, JO (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, 401 Bryan Res Bldg, Durham, NC 27710 USA.	jmc@neuro.duke.edu			NINDS [NS056217]; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056217] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS056217 (to J.O.M.) from NINDS. This work was also supported by an Epilepsy Foundation postdoctoral fellowship (to Y.Z.H.).	Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; GUITON M, 1994, J BIOL CHEM, V269, P30370; GULTON M, 1995, BIOCHEM SOC T, V23, pS176; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Iwasaki Y, 1998, J NEUROCHEM, V71, P106; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McCarty JH, 1998, ONCOGENE, V16, P1691, DOI 10.1038/sj.onc.1201688; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAMARA JO, 2006, SCI STKE, pRE12, DOI DOI 10.1126/STKE.3562006RE12; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336	27	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8207	8217		10.1074/jbc.M109.091041	http://dx.doi.org/10.1074/jbc.M109.091041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064930	Green Published, hybrid			2022-12-25	WOS:000275413800039
J	Tian, YY; Luo, AP; Cai, YR; Su, Q; Ding, F; Chen, HY; Liu, ZH				Tian, Yanyan; Luo, Aiping; Cai, Yiran; Su, Qin; Ding, Fang; Chen, Hongyan; Liu, Zhihua			MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-4; HUMAN BREAST-CANCER; TUMOR-SUPPRESSOR; DOWN-REGULATION; COLORECTAL-CANCER; MESSENGER-RNA; MICRO-RNA; EXPRESSION; CARCINOMA; GROWTH	Recently, microRNAs have emerged as regulators of cancer metastasis through acting on multiple signaling pathways involved in metastasis. In this study, we have analyzed the level of miR-10b and cell motility and invasiveness in several human esophageal squamous cell carcinoma cell lines. Our results reveal a significant correlation of miR-10b level with cell motility and invasiveness. Overexpression of miR-10b in KYSE140 cells increased cell motility and invasiveness, whereas inhibition of miR-10b in EC9706 cells reduced cell invasiveness, although it did not alter cell motility. Additionally, we identified KLF4, a known tumor suppressor gene that has been reported to suppress esophageal cancer cell migration and invasion, as a direct target of miR-10b. Furthermore, overexpression of miR-10b in KYSE140 and KYSE450 cells led to a reduction of endogenous KLF4 protein, whereas silencing of miR-10b in EC9706 cells caused up-regulation of KLF4 protein. Coexpression of miR-10b and KLF4 in KYSE140 cells and coexpression of small interfering RNA for KLF4 mRNA and miR-10b-AS in EC9706 cells partially abrogated the effect of miR-10b on cell migration and invasion. Finally, analyses of the miR-10b level in 40 human esophageal cancer samples and their paired normal adjacent tissues revealed an elevated expression of miR-10b in 95% (38 of 40) of cancer tissues, although no significant correlation of the miR-10b level with clinical metastasis status was observed in these samples.	[Liu, Zhihua] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Cai, Yiran; Su, Qin] Chinese Acad Med Sci, Inst Canc, Dept Pathol, Beijing 100021, Peoples R China; [Cai, Yiran; Su, Qin] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, ZH (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn			National Basic Research Program of China [2006CB910407]; National Natural Science Foundation of China [30721001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2006CB910407 and National Natural Science Foundation of China Grant 30721001.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianchi F, 2004, CLIN CANCER RES, V10, P6023, DOI 10.1158/1078-0432.CCR-04-0619; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; KANDA Y, 1994, INT J CANCER, V58, P291, DOI 10.1002/ijc.2910580224; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tan YL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-12; Tanzer A, 2005, J EXP ZOOL PART B, V304B, P75, DOI 10.1002/jez.b.21021; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345	54	247	271	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7986	7994		10.1074/jbc.M109.062877	http://dx.doi.org/10.1074/jbc.M109.062877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075075	hybrid, Green Published			2022-12-25	WOS:000275413800016
J	Lorier, AR; Funk, GD; Greer, JJ				Lorier, Amanda R.; Funk, Gregory D.; Greer, John J.			Opiate-Induced Suppression of Rat Hypoglossal Motoneuron Activity and Its Reversal by Ampakine Therapy	PLOS ONE			English	Article							PRE-BOTZINGER COMPLEX; MU-OPIOID RECEPTORS; IN-VITRO; RESPIRATORY DEPRESSION; ALLOSTERIC MODULATORS; SLEEP-APNEA; NEURONS; CURRENTS; MUSCLE; RHYTHM	Background: Hypoglossal (XII) motoneurons innervate tongue muscles and are vital for maintaining upper-airway patency during inspiration. Depression of XII nerve activity by opioid analgesics is a significant clinical problem, but underlying mechanisms are poorly understood. Currently there are no suitable pharmacological approaches to counter opiate-induced suppression of XII nerve activity while maintaining analgesia. Ampakines accentuate alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor responses. The AMPA family of glutamate receptors mediate excitatory transmission to XII motoneurons. Therefore the objectives were to determine whether the depressant actions of mu-opioid receptor activation on inspiratory activity includes a direct inhibitory action at the inspiratory premotoneuron to XII motoneuron synapse, and to identify underlying mechanism(s). We then examined whether ampakines counteract opioid-induced depression of XII motoneuron activity. Methodology/Principal Findings: A medullary slice preparation from neonatal rat that produces inspiratory-related output in vitro was used. Measurements of inspiratory burst amplitude and frequency were made from XII nerve roots. Whole-cell patch recordings from XII motoneurons were used to measure membrane currents and synaptic events. Application of the m-opioid receptor agonist, DAMGO, to the XII nucleus depressed the output of inspiratory XII motoneurons via presynaptic inhibition of excitatory glutamatergic transmission. Ampakines (CX614 and CX717) alleviated DAMGO-induced depression of XII MN activity through postsynaptic actions on XII motoneurons. Conclusions/Significance: The inspiratory-depressant actions of opioid analgesics include presynaptic inhibition of XII motoneuron output. Ampakines counteract mu-opioid receptor-mediated depression of XII motoneuron inspiratory activity. These results suggest that ampakines may be beneficial in countering opiate-induced suppression of XII motoneuron activity and resultant impairment of airway patency.	[Lorier, Amanda R.; Funk, Gregory D.; Greer, John J.] Univ Alberta, Div Neurosci, Edmonton, AB T6G 2S2, Canada	University of Alberta	Lorier, AR (corresponding author), Univ Alberta, Div Neurosci, Edmonton, AB T6G 2S2, Canada.	john.greer@ualberta.ca		Funk, Gregory/0000-0001-5848-0631	Canadian Institutes for Health Research; Cortex Pharmaceuticals; Alberta Science and Research Authority; Alberta Heritage Foundation for Medical Research (AHFMR)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cortex Pharmaceuticals; Alberta Science and Research Authority; Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	Research was supported by the Canadian Institutes for Health Research (Ottawa, Ontario, Canada), Cortex Pharmaceuticals (Irvine, California), and the Alberta Science and Research Authority (Edmonton, Alberta, Canada). ARL received a postdoctoral fellowship from the Alberta Heritage Foundation for Medical Research (AHFMR). JJG and GDF are scientists of the AHFMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2005, J APPL PHYSIOL, V98, P1297, DOI 10.1152/japplphysiol.00977.2004; Arai A, 1996, J PHARMACOL EXP THER, V278, P627; Arai AC, 2007, CURR DRUG TARGETS, V8, P583, DOI 10.2174/138945007780618490; Arai AC, 2000, MOL PHARMACOL, V58, P802, DOI 10.1124/mol.58.4.802; Arai AC, 2002, J PHARMACOL EXP THER, V303, P1075, DOI 10.1124/jpet.102.040360; BARTLETT D, 1986, RESP PHYSIOL, V64, P289, DOI 10.1016/0034-5687(86)90122-2; Bellingham MC, 1996, J NEUROPHYSIOL, V76, P3758, DOI 10.1152/jn.1996.76.6.3758; Bellingham MC, 2000, CLIN EXP PHARMACOL P, V27, P132, DOI 10.1046/j.1440-1681.2000.03192.x; Boushra NN, 1996, CAN J ANAESTH, V43, P599, DOI 10.1007/BF03011774; Brown KA, 2006, ANESTHESIOLOGY, V105, P665, DOI 10.1097/00000542-200610000-00009; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; Ding YQ, 1996, J COMP NEUROL, V367, P375; Doraiswamy PM, 2006, EXPERT OPIN PHARMACO, V7, P1, DOI 10.1517/14656566.7.1.1; Funk GD, 1995, CURR OPIN NEUROBIOL, V5, P778, DOI 10.1016/0959-4388(95)80106-5; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; FUNK GD, 1995, J NEUROSCI, V15, P4046; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Hajiha M, 2009, J PHYSIOL-LONDON, V587, P2677, DOI 10.1113/jphysiol.2009.171678; Horner RL, 2007, AM J RESP CRIT CARE, V175, P426, DOI 10.1164/rccm.200701-043UP; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Kivell BM, 2004, DEV BRAIN RES, V148, P185, DOI 10.1016/j.devbrainres.2003.12.002; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; Lalley PM, 2003, AM J PHYSIOL-REG I, V285, pR1287, DOI 10.1152/ajpregu.00199.2003; Lape R, 2000, J NEUROPHYSIOL, V83, P2987, DOI 10.1152/jn.2000.83.5.2987; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; LENAL FC, 2007, SOC NEUR ABSTR, V597; Liu X, 2005, J PHYSIOL-LONDON, V565, P965, DOI 10.1113/jphysiol.2005.084657; Lorier AR, 2007, J NEUROSCI, V27, P993, DOI 10.1523/JNEUROSCI.3948-06.2007; Lynch G, 2006, CURR OPIN PHARMACOL, V6, P82, DOI 10.1016/j.coph.2005.09.005; Lynch G, 2004, CURR OPIN PHARMACOL, V4, P4, DOI 10.1016/j.coph.2003.09.009; Mitchell NA, 2007, BIOPHYS J, V92, P2392, DOI 10.1529/biophysj.106.095091; Moos Daniel D, 2006, J Perianesth Nurs, V21, P103, DOI 10.1016/j.jopan.2006.02.001; MOOS DD, 2006, J PERIANESTH NURS, V21, P116; Ostermeier AM, 1997, ANESTH ANALG, V85, P452, DOI 10.1097/00000539-199708000-00037; Pagliardini S, 2005, J NEUROSCI, V25, P2591, DOI 10.1523/JNEUROSCI.4930-04.2005; Porrino LJ, 2005, PLOS BIOL, V3, P1639, DOI 10.1371/journal.pbio.0030299; Ren J, 2008, ADV EXP MED BIOL, V605, P149; Ren J, 2006, AM J RESP CRIT CARE, V174, P1384, DOI 10.1164/rccm.200606-778OC; Ren J, 2009, ANESTHESIOLOGY, V110, P1364, DOI 10.1097/ALN.0b013e31819faa2a; Richardson KA, 2005, BRAIN RES, V1032, P23, DOI 10.1016/j.brainres.2004.10.045; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; Skulsky EM, 2007, SLEEP, V30, P566, DOI 10.1093/sleep/30.5.566; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Swarm RA, 2001, CURR PROB SURG, V38, P845, DOI 10.1067/msg.2001.118495; Waters KA, 2002, J APPL PHYSIOL, V92, P1987, DOI 10.1152/japplphysiol.00619.2001; Wesensten NJ, 2007, AVIAT SPACE ENVIR MD, V78, P937, DOI 10.3357/ASEM.2055.2007; WILLIAMS JT, 1988, J NEUROSCI, V8, P4299	48	44	45	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8766	10.1371/journal.pone.0008766	http://dx.doi.org/10.1371/journal.pone.0008766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098731	Green Published, Green Submitted, gold			2022-12-25	WOS:000273778900010
J	Niehuis, O; Gibson, JD; Rosenberg, MS; Pannebakker, BA; Koevoets, T; Judson, AK; Desjardins, CA; Kennedy, K; Duggan, D; Beukeboom, LW; van de Zande, L; Shuker, DM; Werren, JH; Gadau, J				Niehuis, Oliver; Gibson, Joshua D.; Rosenberg, Michael S.; Pannebakker, Bart A.; Koevoets, Tosca; Judson, Andrea K.; Desjardins, Christopher A.; Kennedy, Kathleen; Duggan, David; Beukeboom, Leo W.; van de Zande, Louis; Shuker, David M.; Werren, John H.; Gadau, Juergen			Recombination and Its Impact on the Genome of the Haplodiploid Parasitoid Wasp Nasonia	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; SHOWING SEGREGATION DISTORTION; MAXIMUM-LIKELIHOOD MODELS; X-CHROMOSOME CENTROMERE; BIASED GENE CONVERSION; NATURAL-SELECTION; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; MEIOTIC RECOMBINATION; CROSSING-OVER	Homologous meiotic recombination occurs in most sexually reproducing organisms, yet its evolutionary advantages are elusive. Previous research explored recombination in the honeybee, a eusocial hymenopteran with an exceptionally high genome-wide recombination rate. A comparable study in a non-social member of the Hymenoptera that would disentangle the impact of sociality from Hymenoptera-specific features such as haplodiploidy on the evolution of the high genome-wide recombination rate in social Hymenoptera is missing. Utilizing single-nucleotide polymorphisms (SNPs) between two Nasonia parasitoid wasp genomes, we developed a SNP genotyping microarray to infer a high-density linkage map for Nasonia. The map comprises 1,255 markers with an average distance of 0.3 cM. The mapped markers enabled us to arrange 265 scaffolds of the Nasonia genome assembly 1.0 on the linkage map, representing 63.6% of the assembled N. vitripennis genome. We estimated a genome-wide recombination rate of 1.4-1.5 cM/Mb for Nasonia, which is less than one tenth of the rate reported for the honeybee. The local recombination rate in Nasonia is positively correlated with the distance to the center of the linkage groups, GC content, and the proportion of simple repeats. In contrast to the honeybee genome, gene density in the parasitoid wasp genome is positively associated with the recombination rate; regions of low recombination are characterized by fewer genes with larger introns and by a greater distance between genes. Finally, we found that genes in regions of the genome with a low recombination frequency tend to have a higher ratio of non-synonymous to synonymous substitutions, likely due to the accumulation of slightly deleterious non-synonymous substitutions. These findings are consistent with the hypothesis that recombination reduces interference between linked sites and thereby facilitates adaptive evolution and the purging of deleterious mutations. Our results imply that the genomes of haplodiploid and of diploid higher eukaryotes do not differ systematically in their recombination rates and associated parameters.	[Niehuis, Oliver; Gibson, Joshua D.; Rosenberg, Michael S.; Judson, Andrea K.; Gadau, Juergen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Rosenberg, Michael S.] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Funct Genom, Tempe, AZ USA; [Pannebakker, Bart A.; Shuker, David M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Pannebakker, Bart A.; Koevoets, Tosca; Beukeboom, Leo W.; van de Zande, Louis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Haren, Netherlands; [Desjardins, Christopher A.; Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Kennedy, Kathleen; Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Shuker, David M.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Edinburgh; University of Groningen; University of Rochester; Translational Genomics Research Institute; University of St Andrews	Niehuis, O (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	oliver.niehuis@gmail.com	Pannebakker, Bart A./D-3823-2012; Shuker, David M/E-8827-2013; Rosenberg, Michael S/A-4621-2008; Beukeboom, L.W./D-1808-2012; Pannebakker, Bart/D-1479-2010	Pannebakker, Bart A./0000-0001-8503-3896; Rosenberg, Michael S/0000-0001-7882-2467; Desjardins, Christopher/0000-0002-3160-4734; van de Zande, Louis/0000-0001-5687-3220; Gibson, Joshua/0000-0002-0193-2307; Werren, John/0000-0001-9353-2070	Alexander von Humboldt Foundation; Netherlands Organization for Scientific Research NWO/ALW [863.08.008, 816.01.004, 833.02.003]; Natural Environment Research Council [NE/C51932X/1, NE/D009979/1]; National Institutes of Health [NIH 5R01GM070026, NIH 1R21 RR024199-01]; NERC [NE/D009979/1, NE/D009979/2] Funding Source: UKRI; Natural Environment Research Council [NE/D009979/2] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070026, R24GM084917] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Netherlands Organization for Scientific Research NWO/ALW(Netherlands Organization for Scientific Research (NWO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ON acknowledges the Alexander von Humboldt Foundation for a Feodor Lynen Research Fellowship for Postdoctoral Researchers. BAP, TK, and LWB acknowledge the Netherlands Organization for Scientific Research NWO/ALW (grants 863.08.008, 816.01.004, and 833.02.003). BAP and DMS were supported by the Natural Environment Research Council (NE/C51932X/1 and NE/D009979/1). Computational work by CAD was supported by a grant from the National Institutes of Health to JHW (NIH 5R01GM070026). This research was enabled by a grant to JG from the National Institutes of Health (NIH 1R21 RR024199-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antolin MF, 1996, GENETICS, V143, P1727; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Bagshaw AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-49; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; BARTON NH, 1995, GENETICS, V140, P821; Beadle GW, 1932, P NATL ACAD SCI USA, V18, P160, DOI 10.1073/pnas.18.2.160; Betancourt AJ, 2002, P NATL ACAD SCI USA, V99, P13616, DOI 10.1073/pnas.212277199; Beukeboom LW, 2007, SCIENCE, V315, P206, DOI 10.1126/science.1133388; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Bordenstein SR, 1998, GENETICS, V148, P1833; Borrmann L, 2003, ONCOGENE, V22, P756, DOI 10.1038/sj.onc.1206073; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Choo KHA, 1998, GENOME RES, V8, P81, DOI 10.1101/gr.8.2.81; Colombo PC, 1997, HEREDITY, V79, P214, DOI 10.1038/sj.hdy.6881930; Comeron JM, 2000, GENETICS, V156, P1175; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Curi RA, 2005, ANIM GENET, V36, P58, DOI 10.1111/j.1365-2052.2004.01226.x; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Drapeau MD, 1999, EVOL ECOL RES, V1, P223; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; EPPLEN JT, 2005, ENCY LIFE SCI ELS; FELSENSTEIN J, 1974, GENETICS, V78, P737; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gadau J, 1999, GENETICS, V153, P1731; Gadau J, 2000, NATURWISSENSCHAFTEN, V87, P87, DOI 10.1007/s001140050016; Gadau Juergen, 2008, V1, P27, DOI 10.1007/978-3-540-73833-6_3; Galtier N, 2001, GENETICS, V159, P907; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; Gendrel CG, 2000, GENE DEV, V14, P1261; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; GIBSON JD, 2010, HEREDITY IN PRESS; Gokhman Vladimir E., 2000, Beitraege zur Entomologie, V50, P193; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Haldane JBS, 1919, J GENET, V8, P299; Hammock EAD, 2004, MOL BIOL EVOL, V21, P1057, DOI 10.1093/molbev/msh104; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; HAWLEY RS, 1993, TRENDS GENET, V9, P310; Hey J, 2002, GENETICS, V160, P595; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Holloway AK, 2000, GENETICS, V154, P205; HUNT GJ, 1995, GENETICS, V139, P1371; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Kirkpatrick DT, 1999, MOL CELL BIOL, V19, P7661; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; KLIMAN RM, 1993, MOL BIOL EVOL, V10, P1239; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; KOROL AB, 1989, GENETIKA+, V25, P2225; Kulathinal RJ, 2008, P NATL ACAD SCI USA, V105, P10051, DOI 10.1073/pnas.0801848105; LAMBIE EJ, 1986, GENETICS, V114, P769; Laurent V, 1998, GENETICS, V150, P275; Leonard JE, 2006, ANIM BEHAV, V71, P641, DOI 10.1016/j.anbehav.2005.07.010; Li W. H, 1997, MOL EVOLUTION; Liu B.-H., 1998, STAT GENOMICS LINKAG; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; MAHTANI MM, 1990, GENOMICS, V7, P607, DOI 10.1016/0888-7543(90)90206-A; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Mather K, 1939, GENETICS, V24, P413; Mester D, 2003, GENETICS, V165, P2269; Mester DI, 2004, COMPUT BIOL CHEM, V28, P281, DOI 10.1016/j.compbiolchem.2004.08.003; Mester DI, 2003, THEOR APPL GENET, V107, P1102, DOI 10.1007/s00122-003-1305-1; Michod R. E., 1988, THE EVOLUTION OF SEX; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Niehuis O, 2007, J ECON ENTOMOL, V100, P1033, DOI 10.1603/0022-0493(2007)100[1033:SSPASS]2.0.CO;2; Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523; Otto SP, 1997, GENETICS, V147, P879; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Pal C, 2001, MOL BIOL EVOL, V18, P2323, DOI 10.1093/oxfordjournals.molbev.a003779; PECK JR, 1994, GENETICS, V137, P597; Peng J, 2000, GENOME RES, V10, P1509, DOI 10.1101/gr.150300; PIETSCH C, 2005, THESIS U WURZBURG WU; Prachumwat A, 2004, GENETICS, V166, P1585, DOI 10.1534/genetics.166.3.1585; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROSENBERG MS, 2008, PASSAGE PATTERN ANAL; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Rutten KB, 2004, CYTOGENET GENOME RES, V105, P126, DOI 10.1159/000078019; SCHULTES NP, 1991, MOL CELL BIOL, V11, P322, DOI 10.1128/MCB.11.1.322; Sirvio A, 2006, J EVOLUTION BIOL, V19, P1475, DOI 10.1111/j.1420-9101.2006.01131.x; Smith KN, 1998, CURR OPIN GENET DEV, V8, P200, DOI 10.1016/S0959-437X(98)80142-1; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THURIAUX P, 1977, NATURE, V268, P460, DOI 10.1038/268460a0; THURSTON MI, 2005, MSATFINDER DETECTION; TRECO D, 1986, MOL CELL BIOL, V6, P3934, DOI 10.1128/MCB.6.11.3934; True JR, 1996, GENETICS, V142, P507; Uhlemann AC, 2004, J INFECT DIS, V189, P2227, DOI 10.1086/421242; Velthuis BJ, 2005, ANIM BEHAV, V69, P1107, DOI 10.1016/j.anbehav.2004.06.032; Wang Y, 2006, GENETICS, V172, P2529, DOI 10.1534/genetics.106.055772; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Weston RF, 1999, J EVOLUTION BIOL, V12, P586, DOI 10.1046/j.1420-9101.1999.00048.x; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801; YAMAMOTO M, 1978, CHROMOSOMA, V66, P71, DOI 10.1007/BF00285817; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	106	50	50	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8597	10.1371/journal.pone.0008597	http://dx.doi.org/10.1371/journal.pone.0008597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20087411	Green Published, gold, Green Submitted			2022-12-25	WOS:000273778900001
J	Okuda, H; Kuwahara, R; Matsuzaki, S; Miyata, S; Kumamoto, N; Hattori, T; Shimizu, S; Yamada, K; Kawamoto, K; Hashimoto, R; Takeda, M; Katayama, T; Tohyama, M				Okuda, Hiroaki; Kuwahara, Ryusuke; Matsuzaki, Shinsuke; Miyata, Shingo; Kumamoto, Natsuko; Hattori, Tsuyoshi; Shimizu, Shoko; Yamada, Kohei; Kawamoto, Keisuke; Hashimoto, Ryota; Takeda, Masatoshi; Katayama, Taiichi; Tohyama, Masaya			Dysbindin Regulates the Transcriptional Level of Myristoylated Alanine-Rich Protein Kinase C Substrate via the Interaction with NF-YB in Mice Brain	PLOS ONE			English	Article							HIGH-RISK HAPLOTYPE; SUSCEPTIBILITY GENE; DTNBP1 GENE; NEUROTRANSMITTER RELEASE; CHRONIC-SCHIZOPHRENIA; ANTIPSYCHOTIC-DRUGS; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; DOWN-REGULATION; FINGER PROTEIN	Background: An accumulating body of evidence suggests that Dtnbp1 (Dysbindin) is a key susceptibility gene for schizophrenia. Using the yeast-two-hybrid screening system, we examined the candidate proteins interacting with Dysbindin and revealed one of these candidates to be the transcription factor NF-YB. Methods: We employed an immunoprecipitation (IP) assay to demonstrate the Dysbindin-NF-YB interaction. DNA chips were used to screen for altered expression of genes in cells in which Dysbindin or NF-YB was down regulated, while Chromatin IP and Reporter assays were used to confirm the involvement of these genes in transcription of Myristoylated alanine-rich protein kinase C substrate (MARCKS). The sdy mutant mice with a deletion in Dysbindin, which exhibit behavioral abnormalities, and wild-type DBA2J mice were used to investigate MARCKS expression. Results: We revealed an interaction between Dysbindin and NF-YB. DNA chips showed that MARCKS expression was increased in both Dysbindin knockdown cells and NF-YB knockdown cells, and Chromatin IP revealed interaction of these proteins at the MARCKS promoter region. Reporter assay results suggested functional involvement of the interaction between Dysbindin and NF-YB in MARCKS transcription levels, via the CCAAT motif which is a NF-YB binding sequence. MARCKS expression was increased in sdy mutant mice when compared to wild-type mice. Conclusions: These findings suggest that abnormal expression of MARCKS via dysfunction of Dysbindin might cause impairment of neural transmission and abnormal synaptogenesis. Our results should provide new insights into the mechanisms of neuronal development and the pathogenesis of schizophrenia.	[Okuda, Hiroaki; Kuwahara, Ryusuke; Matsuzaki, Shinsuke; Miyata, Shingo; Kumamoto, Natsuko; Hattori, Tsuyoshi; Shimizu, Shoko; Yamada, Kohei; Kawamoto, Keisuke; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan; [Okuda, Hiroaki] Nara Med Univ, Fac Med, Dept Anat 2, Nara, Japan; [Matsuzaki, Shinsuke; Miyata, Shingo; Hattori, Tsuyoshi; Hashimoto, Ryota; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Osaka, Japan; [Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Osaka, Japan; [Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan	Osaka University; Nara Medical University; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine; Osaka University	Okuda, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan.	s-matsuzaki@anat2.med.osaka-u.ac.jp	Hashimoto, Ryota/P-8572-2014; Kuwahara, Ryusuke/J-5024-2015; Okuda, Hiroaki/S-4959-2019; Hashimoto, Ryota/AAE-3200-2019; Okuda, Hiroaki/E-9418-2018	Hashimoto, Ryota/0000-0002-5941-4238; Kuwahara, Ryusuke/0000-0002-7041-0828; Okuda, Hiroaki/0000-0002-6252-9634; Hashimoto, Ryota/0000-0002-5941-4238; Okuda, Hiroaki/0000-0002-6252-9634	Osaka Medical Research Foundation; Twenty- First Century Center of Excellence (COE) program; Global COE program	Osaka Medical Research Foundation; Twenty- First Century Center of Excellence (COE) program; Global COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Osaka Medical Research Foundation For Incurable Diseases (Shinsuke Matsuzaki) and the Twenty- First Century Center of Excellence (COE) program and the Global COE program (Hiroaki Okuda, Ryusuke Kuwahara, Shinsuke Matsuzaki, Shingo Miyata, Natsuko Kumamoto, Tsuyoshi Hattori, Shoko Shimizu, Kohei Yamada, Taiichi Katayama and Masaya Tohyama). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Chen XN, 2004, AM J MED GENET B, V129B, P23, DOI 10.1002/ajmg.b.30078; Chiba S, 2006, J NEURAL TRANSM, V113, P1337, DOI 10.1007/s00702-005-0414-1; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Corvin A, 2008, NEUROSCI LETT, V431, P146, DOI 10.1016/j.neulet.2007.11.031; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Donohoe G, 2007, NEUROPSYCHOLOGIA, V45, P454, DOI 10.1016/j.neuropsychologia.2006.06.016; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Garver DL, 2006, CURR DRUG TARGETS, V7, P1205, DOI 10.2174/138945006778226543; GORNICK MC, 2005, J AUTISM DEV DISORD, V10, P1; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; LUCIANO M, 2008, GENES BRAIN BEHAV; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Manji HK, 1999, BIOL PSYCHIAT, V46, P1328, DOI 10.1016/S0006-3223(99)00235-8; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Morris DW, 2004, AM J MED GENET B, V125B, P50, DOI 10.1002/ajmg.b.20109; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; Murotani T, 2007, NEUROSCI LETT, V421, P47, DOI 10.1016/j.neulet.2007.05.019; Nian H, 2007, ARCH BIOCHEM BIOPHYS, V465, P157, DOI 10.1016/j.abb.2007.05.013; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Park YS, 2006, J NEUROSCI, V26, P8999, DOI 10.1523/JNEUROSCI.2828-06.2006; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sasaki Y, 2003, J PHARMACOL SCI, V93, P35, DOI 10.1254/jphs.93.35; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Sillitoe RV, 2003, J NEUROSCI, V23, P6576; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; Sokolov BP, 2000, BIOL PSYCHIAT, V48, P184, DOI 10.1016/S0006-3223(00)00875-1; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Trifaro JM, 2000, BIOCHIMIE, V82, P339, DOI 10.1016/S0300-9084(00)00193-0; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Williams NM, 2004, BIOL PSYCHIAT, V55, P192, DOI 10.1016/j.biopsych.2003.11.002; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Zinkstok JR, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-19	64	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8773	10.1371/journal.pone.0008773	http://dx.doi.org/10.1371/journal.pone.0008773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098743	Green Published, gold, Green Submitted			2022-12-25	WOS:000273778900016
J	Cheli, Y; Williams, SA; Ballotti, R; Nugent, DJ; Kunicki, TJ				Cheli, Yann; Williams, Shirley A.; Ballotti, Robert; Nugent, Diane J.; Kunicki, Thomas J.			Enhanced Binding of Poly(ADP-ribose)polymerase-1 and Ku80/70 to the ITGA2 Promoter via an Extended Cytosine-Adenosine Repeat	PLOS ONE			English	Article							INTEGRIN ALPHA(2) GENE; DNA-BINDING; COLLAGEN RECEPTOR; KU AUTOANTIGEN; EXPRESSION; POLYMERASE; TRANSCRIPTION; ASSOCIATION; SEQUENCE; POLYMORPHISMS	Background: We have identified a cytosine-adenosine (CA) repeat length polymorphism in the 5'-regulatory region of the human integrin alpha 2 gene ITGA2 that begins at -605. Our objective was to establish the contribution of this polymorphism to the regulation of integrin alpha 2 beta 1 expression, which is known to vary several-fold among normal individuals, and to investigate the underlying mechanism(s). Methodology/Principal Findings: In combination with the SNP C-52T, previously identified by us as a binding site for the transcription factor Sp1, four ITGA2 haplotypes can be distinguished, in the order in which they enhance ITGA2 transcription: (CA)(12)/-52C>(CA)(11)/-52C>(CA)(11)/-52T>(CA)(10)/-52T. By DNA affinity chromatography and chromatin immunoprecipitation (ChIP) assays, we show that poly (ADP-ribose) polymerase-1 (PARP-1) and Ku80/70 bind specifically and with enhanced affinity to the longer (CA)(12) repeat alleles. Conclusions/Significance: The increased binding of PARP-1 and Ku80/70, known components of transcription co-activator complexes, to the longer (CA)(12) alleles of ITGA2 coincides with enhanced alpha 2 beta 1 expression. The most likely explanation for these findings is that PARP-1 and Ku80/70 contribute to the transcriptional regulation of ITGA2. These observations provide new insight into the mechanisms(s) underlying haplotype-dependent variability in integrin alpha 2 beta 1 expression in human platelets and other cells.	[Cheli, Yann; Kunicki, Thomas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Cheli, Yann; Ballotti, Robert] Univ Nice, Inst Natl Sante & Rech Med, U895, Nice, France; [Williams, Shirley A.; Nugent, Diane J.] Childrens Hosp Orange Cty, Div Hematol, Orange, CA 92668 USA	Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Childrens Hospital of Orange County	Cheli, Y (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tomk@scripps.edu	Cheli, Yann/O-5783-2016; BALLOTTI, Robert/F-8825-2013	Cheli, Yann/0000-0001-9839-4332; BALLOTTI, Robert/0000-0002-7322-4908	National Heart, Lung and Blood Institute [HL075821, HL086904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075821, R01HL086904] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This study was supported by grants HL075821 and HL086904 from the National Heart, Lung and Blood Institute awarded to TJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheli Y, 2007, BBA-GENE STRUCT EXPR, V1769, P546, DOI 10.1016/j.bbaexp.2007.06.004; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; COLLER BS, 1989, BLOOD, V74, P182; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Di Paola J, 2005, J THROMB HAEMOST, V3, P1511, DOI 10.1111/j.1538-7836.2005.01273.x; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Furihata K, 2002, ARTERIOSCL THROM VAS, V22, P1733, DOI 10.1161/01.ATV.0000034493.76465.FF; Giffin W, 1997, J BIOL CHEM, V272, P5647, DOI 10.1074/jbc.272.9.5647; Grote J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-48; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Jacquelin B, 2001, J BIOL CHEM, V276, P23518, DOI 10.1074/jbc.M102019200; Jacquelin B, 2001, BLOOD, V97, P1721, DOI 10.1182/blood.V97.6.1721; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KALB R, 1994, THROMB HAEMOSTASIS, V71, P651; Kannan P, 1999, NUCLEIC ACIDS RES, V27, P866, DOI 10.1093/nar/27.3.866; Kelavkar UP, 2000, GENES IMMUN, V1, P237, DOI 10.1038/sj.gene.6363665; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kritzik M, 1998, BLOOD, V92, P2382, DOI 10.1182/blood.V92.7.2382; Kunicki TJ, 2009, J THROMB HAEMOST, V7, P2116, DOI 10.1111/j.1538-7836.2009.03610.x; Kunicki TJ, 1997, BLOOD, V89, P1939, DOI 10.1182/blood.V89.6.1939; Kunicki TJ, 2004, BLOOD, V104, P2359, DOI 10.1182/blood-2004-01-0349; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Meisterernst M, 1997, P NATL ACAD SCI USA, V94, P2261, DOI 10.1073/pnas.94.6.2261; PIDARD D, 1983, J BIOL CHEM, V258, P2582; PISCHEL KD, 1987, J IMMUNOL, V138, P226; Reiner AP, 2003, THROMB HAEMOSTASIS, V89, P142; Reiner AP, 2000, STROKE, V31, P1628, DOI 10.1161/01.STR.31.7.1628; Rose JL, 2005, MOL PHARMACOL, V68, P439, DOI 10.1124/mol.104.010876; Santoso S, 1999, BLOOD, V93, P2449, DOI 10.1182/blood.V93.8.2449.408k34_2449_2453; Schild-Poulter C, 2003, DNA CELL BIOL, V22, P65, DOI 10.1089/104454903321515887; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; SYDOR WJ, 2003, J THROMBOSIS HAEM S1, V1; Torrance H, 1998, J BIOL CHEM, V273, P20810, DOI 10.1074/jbc.273.33.20810; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; ZUTTER MM, 1994, J BIOL CHEM, V269, P463	36	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8743	10.1371/journal.pone.0008743	http://dx.doi.org/10.1371/journal.pone.0008743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090957	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714900023
J	Giel, JL; Sorg, JA; Sonenshein, AL; Zhu, J				Giel, Jennifer L.; Sorg, Joseph A.; Sonenshein, Abraham L.; Zhu, Jun			Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficile	PLOS ONE			English	Article							HUMAN INTESTINAL BACTERIA; ANION-EXCHANGE RESINS; ANTIBIOTIC-TREATMENT; ESCHERICHIA-COLI; GNOTOBIOTIC MICE; TOXIN PRODUCTION; CYTO-TOXIN; DISEASE; ACIDS; INFECTION	Clostridium difficile, a spore-forming bacterium, causes antibiotic-associated diarrhea. In order to produce toxins and cause disease, C. difficile spores must germinate and grow out as vegetative cells in the host. Although a few compounds capable of germinating C. difficile spores in vitro have been identified, the in vivo signal(s) to which the spores respond were not previously known. Examination of intestinal and cecal extracts from untreated and antibiotic-treated mice revealed that extracts from the antibiotic-treated mice can stimulate colony formation from spores to greater levels. Treatment of these extracts with cholestyramine, a bile salt binding resin, severely decreased the ability of the extracts to stimulate colony formation from spores. This result, along with the facts that the germination factor is small, heat-stable, and water-soluble, support the idea that bile salts stimulate germination of C. difficile spores in vivo. All extracts able to stimulate high level of colony formation from spores had a higher proportion of primary to secondary bile salts than extracts that could not. In addition, cecal flora from antibiotic-treated mice was less able to modify the germinant taurocholate relative to flora from untreated mice, indicating that the population of bile salt modifying bacteria differed between the two groups. Taken together, these data suggest that an in vivo-produced compound, likely bile salts, stimulates colony formation from C. difficile spores and that levels of this compound are influenced by the commensal gastrointestinal flora.	[Sorg, Joseph A.; Sonenshein, Abraham L.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Giel, Jennifer L.; Zhu, Jun] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	Tufts University; University of Pennsylvania	Giel, JL (corresponding author), UBC Envis Grp, Philadelphia, PA USA.	junzhu@mail.med.upenn.edu	Zhu, Jun/A-1324-2007	Sorg, Joseph/0000-0001-7822-2656	National Institutes of Health [R01AI072479, N01 AI60050]; National Institutes of Health Federal Training in Education and Critical Research Skills (TEACRS) [K12 GM074869]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050, R01AI072479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM074869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Federal Training in Education and Critical Research Skills (TEACRS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by National Institutes of Health grant R01AI072479 to J. Z. A. L. S. acknowledges funding from the National Institutes of Health contract N01 AI60050 (S. Tzipori, principal investigator). J. A. S. acknowledges support through National Institutes of Health Federal Training in Education and Critical Research Skills (TEACRS) fellowship K12 GM074869. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; ARIANO RE, 1990, CAN MED ASSOC J, V142, P1049; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Blossom DB, 2007, CLIN INFECT DIS, V45, P222, DOI 10.1086/518874; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; CORTHIER G, 1985, APPL ENVIRON MICROB, V49, P250, DOI 10.1128/AEM.49.1.250-252.1985; EDENHARDER R, 1984, J STEROID BIOCHEM, V21, P413, DOI 10.1016/0022-4731(84)90304-2; EYSSEN HJ, 1976, EUR J BIOCHEM, V66, P507, DOI 10.1111/j.1432-1033.1976.tb10576.x; FEKETY R, 1979, AM J CLIN NUTR, V32, P244, DOI 10.1093/ajcn/32.1.244; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Hashimoto S, 1996, LIPIDS, V31, P601, DOI 10.1007/BF02523830; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Jarvis WR, 2009, AM J INFECT CONTROL, V37, P263, DOI 10.1016/j.ajic.2009.01.001; Keel MK, 2006, VET PATHOL, V43, P225, DOI 10.1354/vp.43-3-225; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Liacouras CA, 1996, J CLIN GASTROENTEROL, V22, P186, DOI 10.1097/00004836-199604000-00007; MACDONALD IA, 1980, J LIPID RES, V21, P381; Merrigan M, 2003, ANAEROBE, V9, P91, DOI 10.1016/S1075-9964(03)00063-5; Monaghan T, 2009, POSTGRAD MED J, V85, P152, DOI 10.1136/gut.2007.128157; Murphy C, 2006, AGE AGEING, V35, P85, DOI 10.1093/ageing/afi212; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Nerandzic MM, 2009, ANTIMICROB AGENTS CH, V53, P4133, DOI 10.1128/AAC.00252-09; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; ONDERDONK AB, 1980, INFECT IMMUN, V28, P277, DOI 10.1128/IAI.28.1.277-282.1980; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; POWELL RC, 1962, AM J CLIN NUTR, V11, P156, DOI 10.1093/ajcn/11.2.156; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005; Razavi B, 2007, INFECTION, V35, P300, DOI 10.1007/s15010-007-6113-0; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; SAMUEL P, 1973, CIRC RES, V33, P393, DOI 10.1161/01.RES.33.4.393; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Stiefel U, 2008, J ANTIMICROB CHEMOTH, V62, P1105, DOI 10.1093/jac/dkn298; TAYLOR NS, 1980, J INFECT DIS, V141, P92, DOI 10.1093/infdis/141.1.92; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988; WILSON KH, 1982, J CLIN MICROBIOL, V15, P443, DOI 10.1128/JCM.15.3.443-446.1982; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983	44	131	136	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8740	10.1371/journal.pone.0008740	http://dx.doi.org/10.1371/journal.pone.0008740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090901	Green Published, Green Submitted, gold			2022-12-25	WOS:000273714900020
J	Garcia-Ayllon, MS; Riba-Llena, I; Serra-Basante, C; Alom, J; Boopathy, R; Saez-Valero, J				Garcia-Ayllon, Maria-Salud; Riba-Llena, Iolanda; Serra-Basante, Carol; Alom, Jordi; Boopathy, Rathnam; Saez-Valero, Javier			Altered Levels of Acetylcholinesterase in Alzheimer Plasma	PLOS ONE			English	Article							MOLECULAR ISOFORM DISTRIBUTION; BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID; SENILE DEMENTIA; HUMAN BUTYRYLCHOLINESTERASE; CHOLINESTERASE ACTIVITY; MONOCLONAL-ANTIBODIES; VYSYA COMMUNITY; SELECTIVE LOSS; DISEASE	Background: Many studies have been conducted in an extensive effort to identify alterations in blood cholinesterase levels as a consequence of disease, including the analysis of acetylcholinesterase (AChE) in plasma. Conventional assays using selective cholinesterase inhibitors have not been particularly successful as excess amounts of butyrylcholinesterase (BuChE) pose a major problem. Principal Findings: Here we have estimated the levels of AChE activity in human plasma by first immunoprecipitating BuChE and measuring AChE activity in the immunodepleted plasma. Human plasma AChE activity levels were similar to 20 nmol/min/mL, about 160 times lower than BuChE. The majority of AChE species are the light G(1)+G(2) forms and not G(4) tetramers. The levels and pattern of the molecular forms are similar to that observed in individuals with silent BuChE. We have also compared plasma AChE with the enzyme pattern obtained from human liver, red blood cells, cerebrospinal fluid (CSF) and brain, by sedimentation analysis, Western blotting and lectin-binding analysis. Finally, a selective increase of AChE activity was detected in plasma from Alzheimer's disease (AD) patients compared to age and gender-matched controls. This increase correlates with an increase in the G(1)+G(2) forms, the subset of AChE species which are increased in Alzheimer's brain. Western blot analysis demonstrated that a 78 kDa immunoreactive AChE protein band was also increased in Alzheimer's plasma, attributed in part to AChE-T subunits common in brain and CSF. Conclusion: Plasma AChE might have potential as an indicator of disease progress and prognosis in AD and warrants further investigation.	[Garcia-Ayllon, Maria-Salud; Riba-Llena, Iolanda; Serra-Basante, Carol; Saez-Valero, Javier] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain; [Garcia-Ayllon, Maria-Salud; Riba-Llena, Iolanda; Serra-Basante, Carol; Alom, Jordi; Saez-Valero, Javier] Ctr Invest Biomed Res Enfermedades Neurodegenerat, Madrid, Spain; [Riba-Llena, Iolanda; Alom, Jordi] Hosp Gen Univ Elche, Serv Neurol, Alicante, Spain; [Boopathy, Rathnam] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Bharathiar University	Garcia-Ayllon, MS (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain.	j.saez@umh.es	Sáez, Javier/K-5756-2014; GARCIA-AYLLON, MARIA-SALUD/M-4387-2019	Sáez, Javier/0000-0001-7480-320X; , Iolanda/0000-0002-7276-0979; Garcia-Ayllon, Maria-Salud/0000-0001-5140-9752	CIEN Foundation; Fondo de Investigaciones Sanitarias [PI06/0181]; CIBERNED; Instituto de Salud Carlos III from Spain	CIEN Foundation; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); CIBERNED(Instituto de Salud Carlos III); Instituto de Salud Carlos III from Spain(Instituto de Salud Carlos III)	This work was supported by grants from CIEN Foundation (http://www.fundacioncien.es/), Fondo de Investigaciones Sanitarias (PI06/0181), and CIBERNED, Instituto de Salud Carlos III from Spain (http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEYARD ME, 1983, LANCET, V2, P452; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ATACK JR, 1987, J NEUROCHEM, V48, P1845, DOI 10.1111/j.1471-4159.1987.tb05746.x; ATACK JR, 1985, J NEUROL SCI, V70, P1, DOI 10.1016/0022-510X(85)90182-0; ATACK JR, 1988, ANN NEUROL, V23, P161, DOI 10.1002/ana.410230209; ATACK JR, 1983, NEUROSCI LETT, V40, P199, DOI 10.1016/0304-3940(83)90302-6; Boschetti N, 1996, CLIN CHEM, V42, P19; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BRIMIJOIN S, 1988, J NEUROCHEM, V51, P1227, DOI 10.1111/j.1471-4159.1988.tb03091.x; Carvalho FA, 2005, FEBS J, V272, P5584, DOI 10.1111/j.1742-4658.2005.04953.x; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; Darreh-Shori T, 2004, J NEUROCHEM, V88, P1102, DOI 10.1046/j.1471-4159.2003.02230.x; Darreh-Shori T, 2002, NEUROLOGY, V59, P563, DOI 10.1212/WNL.59.4.563; DAVIES P, 1976, LANCET, V2, P1403; Flores-Flores C, 1997, NEUROSCI LETT, V239, P101, DOI 10.1016/S0304-3940(97)00902-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia-Ayllon MS, 2008, BRAIN, V131, P2946, DOI 10.1093/brain/awn209; Garcia-Ayllon MS, 2007, J NEUROCHEM, V101, P1701, DOI 10.1111/j.1471-4159.2007.04461.x; Garcia-Ayllon MS, 1999, NEUROSCI LETT, V265, P211, DOI 10.1016/S0304-3940(99)00252-9; Garcia-Ayllon MS, 2006, HEPATOLOGY, V43, P444, DOI 10.1002/hep.21071; Garcia-Ayllon MS, 2001, NEUROSCIENCE, V107, P199, DOI 10.1016/S0306-4522(01)00355-4; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; HODGSON AJ, 1983, J NEUROCHEM, V41, P654, DOI 10.1111/j.1471-4159.1983.tb04791.x; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Jaganathan L, 1998, INDIAN J BIOCHEM BIO, V35, P142; Kalaria RN, 1999, ANN NY ACAD SCI, V893, P113, DOI 10.1111/j.1749-6632.1999.tb07821.x; LADU BN, 1991, CELL MOL NEUROBIOL, V11, P79, DOI 10.1007/BF00712801; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; Li B, 2005, BIOCHEM PHARMACOL, V70, P1673, DOI 10.1016/j.bcp.2005.09.002; LIAO J, 1994, J NEUROCHEM, V63, P1446; MADER M, 1991, EUR J CLIN CHEM CLIN, V29, P51; Manoharan I, 2007, J NEURAL TRANSM, V114, P939, DOI 10.1007/s00702-007-0631-x; Manoharan I, 2007, CLIN CHIM ACTA, V378, P128, DOI 10.1016/j.cca.2006.11.005; Manoharan I, 2006, PHARMACOGENET GENOM, V16, P461; MARQUIS JK, 1985, BIOL PSYCHIAT, V20, P605, DOI 10.1016/0006-3223(85)90095-2; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MEFLAH K, 1984, BIOCHIMIE, V66, P59, DOI 10.1016/0300-9084(84)90192-5; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; MESULAM MM, 1987, ANN NEUROL, V22, P223, DOI 10.1002/ana.410220206; MINTZ KP, 1985, J NEUROCHEM, V45, P284, DOI 10.1111/j.1471-4159.1985.tb05505.x; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; PERRY EK, 1977, LANCET, V1, P189; PERRY RH, 1982, LANCET, V1, P174; RAKONCZAY Z, 1985, BIOCHIM BIOPHYS ACTA, V832, P127, DOI 10.1016/0167-4838(85)90323-1; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Santos SCR, 2007, J BIOL CHEM, V282, P25597, DOI 10.1074/jbc.M700569200; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; Saez-Valero J, 2005, NEUROSCI LETT, V383, P93, DOI 10.1016/j.neulet.2005.03.045; Saez-Valero J, 1999, J NEUROCHEM, V72, P1600, DOI 10.1046/j.1471-4159.1999.721600.x; Saez-Valero J, 2002, NEUROSCI LETT, V325, P199, DOI 10.1016/S0304-3940(02)00282-3; Saez-Valero J, 2000, ACTA NEUROL SCAND, V102, P49, DOI 10.1034/j.1600-0404.2000.00307.x; Sberna G, 1998, J NEUROCHEM, V71, P723; Silveyra MX, 2008, MOL CELL BIOL, V28, P2908, DOI 10.1128/MCB.02065-07; SIRVIO J, 1989, J NEURAL TRANSM, V75, P119, DOI 10.1007/BF01677425; SORENSEN K, 1986, CLIN CHIM ACTA, V158, P1, DOI 10.1016/0009-8981(86)90109-9; STCLAIR DM, 1986, J NEUROL SCI, V73, P169, DOI 10.1016/0022-510X(86)90128-0; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; STIEGER S, 1987, J NEUROCHEM, V49, P460, DOI 10.1111/j.1471-4159.1987.tb02887.x; SZILAGYI AK, 1987, EUR ARCH PSY CLIN N, V236, P309, DOI 10.1007/BF00380958; Toiber D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003108; TSIM KWK, 1988, EMBO J, V7, P2451, DOI 10.1002/j.1460-2075.1988.tb03091.x; ULRICH J, 1990, ACTA NEUROPATHOL, V80, P624, DOI 10.1007/BF00307630; YAMAMOTO Y, 1990, ANN CLIN BIOCHEM, V27, P321, DOI 10.1177/000456329002700407	64	77	78	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8701	10.1371/journal.pone.0008701	http://dx.doi.org/10.1371/journal.pone.0008701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090844	Green Published, gold, Green Submitted			2022-12-25	WOS:000273714600004
J	Mosha, JF; Conteh, L; Tediosi, F; Gesase, S; Bruce, J; Chandramohan, D; Gosling, R				Mosha, Jacklin F.; Conteh, Lesong; Tediosi, Fabrizio; Gesase, Samwel; Bruce, Jane; Chandramohan, Daniel; Gosling, Roly			Cost Implications of Improving Malaria Diagnosis: Findings from North-Eastern Tanzania	PLOS ONE			English	Article							COMBINATION THERAPY; AFRICAN CHILDREN; FEBRILE ILLNESS; CASE-MANAGEMENT; ECONOMIC COSTS; TESTS; KENYA; AREA; ERA; OVERDIAGNOSIS	Background: Over diagnosis of malaria contributes to improper treatment, wastage of drugs and resistance to the few available drugs. This paper attempts to estimate the rates of over diagnosis of malaria among children attending dispensaries in rural Tanzania and examines the potential cost implications of improving the quality of diagnosis. Methodology/Principal Findings: The magnitude of over diagnosis of malaria was estimated by comparing the proportion of outpatient attendees of all ages clinically diagnosed as malaria to the proportion of attendees having a positive malaria rapid diagnostic test over a two month period. Pattern of causes of illness observed in a <2 year old cohort of children over one year was compared to the pattern of causes of illness in <5 year old children recorded in the routine health care system during the same period. Drug and diagnostic costs were modelled using local and international prices. Over diagnosis of malaria by the routine outpatient care system compared to RDT confirmed cases of malaria was highest among <5 year old children in the low transmission site (RR 17.9, 95% CI 5.8-55.3) followed by the >= 5 year age group in the lower transmission site (RR 14.0.95% CI 8.2-24.2). In the low transmission site the proportion of morbidity attributable to malaria was substantially lower in <2 year old cohort compared to children seen at routine care system. (0.08% vs 28.2%; p<0.001). A higher proportion of children were diagnosed with ARI in the <2 year old cohort compared to children seen at the routine care system (42% vs 26%; p<0.001). Using a RDT reduced overall drug and diagnostic costs by 10% in the high transmission site and by 15% in the low transmission site compared to total diagnostic and drug costs of treatment based on clinical judgment in routine health care system. Implications: The introduction of RDTs is likely to lead to financial savings. However, improving diagnosis to one disease may lead to over diagnosis of another illness. Quality improvement is complex but introducing RDTs for the diagnosis of malaria is a good start.	[Mosha, Jacklin F.] Natl Inst Med Res, Mwanza, Tanzania; [Conteh, Lesong; Bruce, Jane; Chandramohan, Daniel; Gosling, Roly] London Sch Hyg & Trop Med, London WC1, England; [Conteh, Lesong; Tediosi, Fabrizio] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Tediosi, Fabrizio] Univ Bocconi, Milan, Italy; [Gesase, Samwel] Natl Inst Med Res, Tanga, Tanzania	National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute; Bocconi University	Mosha, JF (corresponding author), Natl Inst Med Res, Mwanza, Tanzania.	jfmosha@yahoo.com	Tediosi, Fabrizio/AAD-4805-2022; Conteh, Lesong/ABE-9550-2020; Tediosi, Fabrizio/ABC-7880-2020	Tediosi, Fabrizio/0000-0001-8671-9400; Conteh, Lesong/0000-0002-0719-3672; Mosha, Jacklin/0000-0001-7940-8903	Bill and Melinda Gates Foundation [28579]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill and Melinda Gates Foundation funded this work. Grant no. 28579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Elgayoum SME, 2009, DIAGN MICR INFEC DIS, V64, P20, DOI 10.1016/j.diagmicrobio.2009.01.029; Abeku TA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-202; [Anonymous], 2007, LANCET, V370, P1459; [Anonymous], COST EFF RESOUR ALLO, DOI DOI 10.1186/1478-7547-7-3; Chanda Pascalina, 2009, Cost Eff Resour Alloc, V7, P5, DOI 10.1186/1478-7547-7-5; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Chuma JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-76; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; De Savigny D, 2004, AM J TROP MED HYG, V71, P224, DOI 10.4269/ajtmh.2004.71.224; Drakeley C, 2009, T ROY SOC TROP MED H, V103, P333, DOI 10.1016/j.trstmh.2008.10.003; Gosling RD, 2009, TROP MED INT HEALTH, V14, P1003, DOI 10.1111/j.1365-3156.2009.02303.x; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; *MED STOR DEP, 2007, PRIC CAT ESS MED HOS; Mwanziva C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-232; Ndyomugyenyi R, 2007, T ROY SOC TROP MED H, V101, P209, DOI 10.1016/j.trstmh.2006.06.004; NJUNWA KJ, 1991, ACTA TROP, V49, P87, DOI 10.1016/0001-706X(91)90056-P; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rolland E, 2006, TROP MED INT HEALTH, V11, P398, DOI 10.1111/j.1365-3156.2006.01580.x; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Uzochukwu BSC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-265; Zikusooka CM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-176; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884; 2007, INT DRUG PRICE INDIC	35	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8707	10.1371/journal.pone.0008707	http://dx.doi.org/10.1371/journal.pone.0008707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090933	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000273714600010
J	Landrum, ML; Fieberg, AM; Chun, HM; Crum-Cianflone, NF; Marconi, VC; Weintrob, AC; Ganesan, A; Barthel, RV; Wortmann, G; Agan, BK				Landrum, Michael L.; Fieberg, Ann M.; Chun, Helen M.; Crum-Cianflone, Nancy F.; Marconi, Vincent C.; Weintrob, Amy C.; Ganesan, Anuradha; Barthel, Robert V.; Wortmann, Glenn; Agan, Brian K.			The Effect of Human Immunodeficiency Virus on Hepatitis B Virus Serologic Status in Co-Infected Adults	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; HIV-INFECTION; HBV; SEROCONVERSION; RECOMMENDATIONS; COMPLICATIONS; MANAGEMENT; MORTALITY	Background: Factors associated with serologic hepatitis B virus (HBV) outcomes in HIV-infected individuals remain incompletely understood, yet such knowledge may lead to improvements in the prevention and treatment of chronic HBV infection. Methods and Findings: HBV-HIV co-infected cohort participants were retrospectively analyzed. HBV serologic outcomes were classified as chronic, resolved, and isolated-HBcAb. Chronic HBV (CHBV) was defined as the presence of HBsAg on two or more occasions at least six months apart. Risk factors for HBV serologic outcome were assessed using logistic regression. Of 2037 participants with HBV infection, 281 (14%) had CHBV. Overall the proportions of HBV infections classified as CHBV were 11%, 16%, and 19% for CD4 cell count strata of >= 500, 200-499, and,200, respectively (p<0.0001). Risk of CHBV was increased for those with HBV infection occurring after HIV diagnosis (OR 2.62; 95% CI 1.78-3.85). This included the subset with CD4 count >= 500 cells/mu L where 21% of those with HBV after HIV diagnosis had CHBV compared with 9% for all other cases of HBV infection in this stratum (p = 0.0004). Prior receipt of HAART was associated with improved HBV serologic outcome overall (p = 0.012), and specifically among those with HBV after HIV (p = 0.002). In those with HBV after HIV, HAART was associated with reduced risk of CHBV overall (OR 0.18; 95% CI 0.04-0.79); including reduced risk in the subsets with CD4 >= 350 cells/mu L (p<0.001) and CD4 >= 500 cells/mu L (p = 0.01) where no cases of CHBV were seen in those with a recent history of HAART use. Conclusions: Clinical indicators of immunologic status in HIV-infected individuals, such as CD4 cell count, are associated with HBV serologic outcome. These data suggest that immunologic preservation through the increased use of HAART to improve functional anti-HBV immunity, whether by improved access to care or earlier initiation of therapy, would likely improve HBV infection outcomes in HIV-infected individuals.	[Landrum, Michael L.; Fieberg, Ann M.; Weintrob, Amy C.; Ganesan, Anuradha; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Landrum, Michael L.; Crum-Cianflone, Nancy F.; Marconi, Vincent C.] San Antonio Mil Med Ctr, Infect Dis Serv, Ft Sam Houston, TX USA; [Fieberg, Ann M.] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Chun, Helen M.] USN, Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA USA; [Crum-Cianflone, Nancy F.] USN, Med Ctr, Infect Dis Clin, San Diego, CA USA; [Weintrob, Amy C.; Wortmann, Glenn] Walter Reed Army Med Ctr, Infect Dis Serv, Washington, DC 20307 USA; [Ganesan, Anuradha] Natl Naval Med Ctr, Div Infect Dis, Bethesda, MD USA; [Barthel, Robert V.] USN, Med Ctr, Div Infect Dis, Portsmouth, VA USA	Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; United States Navy; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy	Landrum, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.	mlandrum@idcrp.org	Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Marconi, Vincent/GRJ-4553-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Agan, Brian/0000-0002-5114-1669	IDCRP [G187YS-RV198]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER	IDCRP; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work (IDCRP# G187YS-RV198) was provided by the Infectious Disease Clinical Research Program (IDCRP, www. idcrp. org), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. The IDCRP reviewed the study design, collected the data, and provided salary support to investigators (M. L. L. A. M. F., N. F. C., A. C. W., A. G., and B. K. A.). The analyses, conclusions and decision to submit the manuscript are the independent work and decision of the authors. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; BODSWORTH NJ, 1991, J INFECT DIS, V163, P1138, DOI 10.1093/infdis/163.5.1138; Brodine SK, 2003, AIDS, V17, P2521, DOI 10.1097/00002030-200311210-00016; Carr A, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(05)62892-9; Centers for Disease Control and Prevention, 1992, MMWR, V41; Chun HM, 2007, INFECT DIS CLIN PRAC, V15, P38, DOI 10.1097/01.idc.0000246152.78893.40; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hoff J, 2001, CLIN INFECT DIS, V32, P963, DOI 10.1086/319368; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; LANDRUM ML, 2009, AIDS, V23, DOI DOI 10.1097/QAD.1090-B1013E32832CD32899E; Lascar RM, 2003, J INFECT DIS, V188, P1815, DOI 10.1086/379896; Lascar RM, 2005, J INFECT DIS, V191, P1169, DOI 10.1086/428502; Miailhes P, 2007, CLIN INFECT DIS, V45, P624, DOI 10.1086/520752; Nunez M, 2006, AIDS RES HUM RETROV, V22, P842, DOI 10.1089/aid.2006.22.842; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Piroth L, 2000, J ACQ IMMUN DEF SYND, V23, P356; Piroth L, 2002, J HEPATOL, V36, P681, DOI 10.1016/S0168-8278(02)00019-3; Piroth L, 2007, AIDS, V21, P1323, DOI 10.1097/QAD.0b013e32810c8bcf; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Rouphael NG, 2007, AIDS, V21, P771, DOI 10.1097/QAD.0b013e3280ad47f5; Sheng WH, 2007, CLIN INFECT DIS, V45, P1221, DOI 10.1086/522173; Soriano V, 2008, AIDS, V22, P1399, DOI 10.1097/QAD.0b013e3282f8b46f; Sulkowski MS, 2008, J INFECT DIS, V197, pS279, DOI 10.1086/533414; Tedaldi E, 2008, CLIN INFECT DIS, V47, P1468, DOI 10.1086/593102; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Velasco M, 1999, NEW ENGL J MED, V340, P1765, DOI 10.1056/NEJM199906033402215; Vierling John M, 2007, Clin Liver Dis, V11, P727, DOI 10.1016/j.cld.2007.08.001; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Weintrob AC, 2008, JAIDS-J ACQ IMM DEF, V49, P40, DOI 10.1097/QAI.0b013e31817bec05	33	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8687	10.1371/journal.pone.0008687	http://dx.doi.org/10.1371/journal.pone.0008687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084275	Green Submitted, Green Published, gold			2022-12-25	WOS:000273554600036
J	Wanner, KW; Nichols, AS; Allen, JE; Bunger, PL; Garczynski, SF; Linn, CE; Robertson, HM; Luetje, CW				Wanner, Kevin W.; Nichols, Andrew S.; Allen, Jean E.; Bunger, Peggy L.; Garczynski, Stephen F.; Linn, Charles E., Jr.; Robertson, Hugh M.; Luetje, Charles W.			Sex Pheromone Receptor Specificity in the European Corn Borer Moth, Ostrinia nubilalis	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; NEURON RESPONSIVENESS; OLFACTORY RECEPTORS; SPP. LEPIDOPTERA; EVOLUTION; RESPONSES; GENES; FURNACALIS; EXPRESSION; COMPONENTS	Background: The European corn borer (ECB), Ostrinia nubilalis (Hubner), exists as two separate sex pheromone races. ECB(Z) females produce a 97:3 blend of Z11- and E11-tetradecenyl acetate whereas ECB(E) females produce an opposite 1:99 ratio of the Z and E isomers. Males of each race respond specifically to their conspecific female's blend. A closely related species, the Asian corn borer (ACB), O. furnacalis, uses a 3:2 blend of Z12- and E12-tetradecenyl acetate, and is believed to have evolved from an ECB-like ancestor. To further knowledge of the molecular mechanisms of pheromone detection and its evolution among closely related species we identified and characterized sex pheromone receptors from ECB(Z). Methodology: Homology-dependent (degenerate PCR primers designed to conserved amino acid motifs) and homology-independent (pyrophosphate sequencing of antennal cDNA) approaches were used to identify candidate sex pheromone transcripts. Expression in male and female antennae was assayed by quantitative real-time PCR. Two-electrode voltage clamp electrophysiology was used to functionally characterize candidate receptors expressed in Xenopus oocytes. Conclusion: We characterized five sex pheromone receptors, OnOrs1 and 3-6. Their transcripts were 14-100 times more abundant in male compared to female antennae. OnOr6 was highly selective for Z11-tetradecenyl acetate (EC50 = 0.86 +/- 0.27 mu M) and was at least three orders of magnitude less responsive to E11-tetradecenyl acetate. Surprisingly, OnOr1, 3 and 5 responded to all four pheromones tested (Z11- and E11-tetradecenyl acetate, and Z12- and E12-tetradecenyl acetate) and to Z9-tetradecenyl acetate, a behavioral antagonist. OnOr1 was selective for E12-tetradecenyl acetate based on an efficacy that was at least 5-fold greater compared to the other four components. This combination of specifically-and broadly-responsive pheromone receptors corresponds to published results of sensory neuron activity in vivo. Receptors broadly-responsive to a class of pheromone components may provide a mechanism for variation in the male moth response that enables population level shifts in pheromone blend use.	[Wanner, Kevin W.; Allen, Jean E.; Bunger, Peggy L.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Nichols, Andrew S.; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Garczynski, Stephen F.] ARS, Yakima Agr Res Lab, USDA, Wapato, WA USA; [Linn, Charles E., Jr.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Barton Lab, Geneva, NY 14456 USA; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	Montana State University System; Montana State University Bozeman; University of Miami; United States Department of Agriculture (USDA); Cornell University; University of Illinois System; University of Illinois Urbana-Champaign	Wanner, KW (corresponding author), Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA.	kwanner@montana.edu			Montana State University; United States Department of Agriculture (USDA) [2007-35604-17756, 2008-35302-18815]; National Institutes of Health (NIH) [DC008119]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091, R01DC008119] Funding Source: NIH RePORTER	Montana State University; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	K. W. W. gratefully acknowledges the support of Montana State University. This work was funded in part by United States Department of Agriculture (USDA) grants 2007-35604-17756 and 2008-35302-18815 to H. M. R. and National Institutes of Health (NIH) grant DC008119 to C. W. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BRINDLEY TA, 1975, ANNU REV ENTOMOL, V20, P221, DOI 10.1146/annurev.en.20.010175.001253; Carde RT, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P283, DOI 10.1017/CBO9780511542664.009; CARDE RT, 1978, SCIENCE, V199, P555, DOI 10.1126/science.199.4328.555; Domingue MJ, 2008, J INSECT PHYSIOL, V54, P1261, DOI 10.1016/j.jinsphys.2008.06.001; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P1063, DOI 10.1016/j.jinsphys.2007.05.013; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P488, DOI 10.1016/j.jinsphys.2007.01.009; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Grimaldi David, 2005, pi; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HANSSON BS, 1995, J INSECT PHYSIOL, V41, P171, DOI 10.1016/0022-1910(94)00086-V; HANSSON BS, 1994, TISSUE CELL, V26, P503, DOI 10.1016/0040-8166(94)90003-5; HANSSON BS, 1987, NATURWISSENSCHAFTEN, V74, P497, DOI 10.1007/BF00447935; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Karpati Z, 2008, J EXP BIOL, V211, P2841, DOI 10.1242/jeb.017319; KLUN JA, 1980, LIFE SCI, V27, P1603, DOI 10.1016/0024-3205(80)90570-6; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2005, EUR J NEUROSCI, V21, P2167, DOI 10.1111/j.1460-9568.2005.04058.x; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2002, J EXP BIOL, V205, P989; Linn CE, 2007, J CHEM ECOL, V33, P909, DOI 10.1007/s10886-007-9268-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOFSTEDT C, 1993, PHILOS T R SOC B, V340, P167, DOI 10.1098/rstb.1993.0055; LOFSTEDT C, 1989, GENETICS, V123, P553; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2009, INT J BIOL SCI, V5, P319; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Pelozuelo L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000555; Phelan PL, 1997, INSECT PHEROMONE RESEARCH, P563; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; ROELOFS WL, 1985, J CHEM ECOL, V11, P829, DOI 10.1007/BF01012071; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SCHNEIDER D, 1992, NATURWISSENSCHAFTEN, V79, P241, DOI 10.1007/BF01175388; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; VANDERPERS JNC, 1978, J INSECT PHYSIOL, V24, P337, DOI 10.1016/0022-1910(78)90033-1; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; WANNER KW, 2009, MOL BIOL GENETICS LE, P153; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104	50	110	123	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8685	10.1371/journal.pone.0008685	http://dx.doi.org/10.1371/journal.pone.0008685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084285	Green Submitted, gold, Green Published			2022-12-25	WOS:000273554600034
J	Sahasrabuddhe, VV; Bhosale, RA; Joshi, SN; Kavatkar, AN; Nagwanshi, CA; Kelkar, RS; Jenkins, CA; Shepherd, BE; Sahay, S; Risbud, AR; Vermund, SH; Mehendale, SM				Sahasrabuddhe, Vikrant V.; Bhosale, Ramesh A.; Joshi, Smita N.; Kavatkar, Anita N.; Nagwanshi, Chandraprabha A.; Kelkar, Rohini S.; Jenkins, Cathy A.; Shepherd, Bryan E.; Sahay, Seema; Risbud, Arun R.; Vermund, Sten H.; Mehendale, Sanjay M.			Prevalence and Predictors of Colposcopic-Histopathologically Confirmed Cervical Intraepithelial Neoplasia in HIV-Infected Women in India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; ANTIRETROVIRAL THERAPY; REGRESSION-MODELS; HPV; LESIONS; REPRODUCIBILITY; PREVENTION; GUIDELINES; MANAGEMENT	Background: Prevalence estimates of cervical intraepithelial neoplasia (CIN) among HIV-infected women in India have been based on cervical cytology, which may have underestimated true disease burden. We sought to better establish prevalence estimates and evaluate risk factors of CIN among HIV-infected women in Pune, India using colposcopy and histopathology as diagnostic tools. Methodology: Previously unscreened, non-pregnant HIV-infected women underwent cervical cancer screening evaluation including standardized diagnostic colposcopy by a gynecologist. Histopathologic confirmation was conducted among consenting women with clinical suspicion of CIN. The prevalence of CIN was evaluated by a composite diagnosis based on colposcopy and histopathology results. Multivariable ordinal logistic regression analysis was conducted to determine independent predictors of increasing severity of CIN. Results: The median age of the n = 303 enrolled HIV-infected women was 30 years (interquartile range, 27-34). A majority of the participants were widowed or separated (187/303, 61.7%), more than one-third (114/302, 37.7%) were not educated beyond primary school, and nearly two-thirds (196/301, 64.7%) had a family per capita income of <1,000 Indian Rupees (similar to US$22) per month. Cervical high-risk HPV-DNA was detected in 41.7% (124/297) of participants. The composite colposcopic-histopathologic diagnoses revealed no evidence of CIN in 220 out of 303 (72.6%) women, CIN1 in 33/303 (10.9%), CIN2 in 31/303 (10.2%), CIN3 in 18/303 (5.9%) and 1 (0.3%) woman was diagnosed with ICC. Thus, over a quarter of the participants [83/303: 27.7% (95% CI: 22.7-33.1)] had >= CIN1 lesions and a sixth [50/303: 16.5% (95% CI: 12.2-21.9)] had evidence of advanced (>= CIN2) neoplastic disease. The independent predictors of increasing severity of CIN as revealed by a proportional odds model using multivariable ordinal logistic regression included (i) currently receiving antiretroviral therapy [adjusted odds ratios (aOR): 2.24 (1.17, 4.26), p = 0.01] and (ii) presence of cervical high-risk HPV-DNA [aOR: 1.93 (1.13, 3.28), p = 0.02]. Conclusions: HIV-infected women in Pune, India have a substantial burden of cervical precancerous lesions, which may progress to invasive cervical cancer unless appropriately detected and treated. Increased attention should focus on recognizing and addressing this entirely preventable cancer among HIV-infected women, especially in the context of increasing longevity due to antiretroviral therapy.	[Sahasrabuddhe, Vikrant V.; Vermund, Sten H.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA; [Bhosale, Ramesh A.] Byramjee Jeejeebhoy Med Coll, Dept Obstet & Gynecol, Pune, Maharashtra, India; [Joshi, Smita N.; Mehendale, Sanjay M.] Natl AIDS Res Inst, Dept Epidemiol, Pune, Maharashtra, India; [Kavatkar, Anita N.; Nagwanshi, Chandraprabha A.] Byramjee Jeejeebhoy Med Coll, Dept Pathol, Pune, Maharashtra, India; [Kelkar, Rohini S.] Tata Mem Hosp, Dept Microbiol, Mumbai, Maharashtra, India; [Jenkins, Cathy A.; Shepherd, Bryan E.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Sahay, Seema] Natl AIDS Res Inst, Dept Social & Behav Sci, Pune, Maharashtra, India; [Risbud, Arun R.] Natl AIDS Res Inst, Dept Microbiol, Pune, Maharashtra, India	Vanderbilt University; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Tata Memorial Centre (TMC); Tata Memorial Hospital; Vanderbilt University; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Sahasrabuddhe, VV (corresponding author), Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA.	vikrant.sahasrabuddhe@vanderbilt.edu	Joshi, Smita/S-2716-2019; Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Sahay, Seema/0000-0001-6064-827X	National Institutes of Health (NIH), National Cancer Institute [R21CA113465]; National Institutes of Health (NIH), Fogarty International Center [D43TW001035]; National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases [P30AI54999]; Indian Council of Medical Research (ICMR); FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA113465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH), Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following grants from the National Institutes of Health (NIH): R21CA113465 (from the National Cancer Institute), D43TW001035 (from the Fogarty International Center) and P30AI54999 (from the National Institute of Allergy and Infectious Diseases). Additional support was received from intramural resources of the Indian Council of Medical Research (ICMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG BG, 1989, AM J EPIDEMIOL, V129, P191, DOI 10.1093/oxfordjournals.aje.a115109; Ballagh S, 2004, JAIDS-J ACQ IMM DEF, V37, pS152, DOI 10.1097/00126334-200410013-00003; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; Dexeus S, 2002, EUR J GYNAECOL ONCOL, V23, P269; Dhir AA, 2008, CURR OPIN ONCOL, V20, P517, DOI 10.1097/CCO.0b013e32830a4c87; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; GHATE M, 2008, INT J INFECT DIS; Gravitt PE, 2008, VACCINE, V26, pK42, DOI 10.1016/j.vaccine.2008.05.002; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Harrell FE, 2001, REGRESSION MODELING; Hawes SE, 2006, J NATL CANCER I, V98, P100, DOI 10.1093/jnci/djj010; Heard I, 2004, ANTIVIR THER, V9, P13; Jeronimo J, 2006, AM J OBSTET GYNECOL, V195, P349, DOI 10.1016/j.ajog.2006.01.091; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; JOSHI J, 1993, CYTOPATHOLOGY, V4, P63, DOI 10.1111/j.1365-2303.1993.tb00076.x; Joshi S, 2001, INDIAN J MED RES, V113, P161; Joshi SN, 2005, J MED VIROL, V76, P470, DOI 10.1002/jmv.20385; Kosinski AS, 2003, BIOMETRICS, V59, P163, DOI 10.1111/1541-0420.00019; Massad L S, 2001, J Low Genit Tract Dis, V5, P212; Massad LS, 2005, OBSTET GYNECOL, V106, P525, DOI 10.1097/01.AOG.0000172429.45130.1f; McCluggage WG, 1998, BRIT J OBSTET GYNAEC, V105, P206, DOI 10.1111/j.1471-0528.1998.tb10054.x; McCluggage WG, 1996, J CLIN PATHOL, V49, P833, DOI 10.1136/jcp.49.10.833; Minkoff H, 2001, AIDS, V15, P2157, DOI 10.1097/00002030-200111090-00011; Mwanahamuntu M.H., 2008, B WHO, V86; Mwanahamuntu MH, 2009, NEW ENGL J MED, V361, P305; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Over M, 2006, SEX TRANSM DIS, V33, pS145, DOI 10.1097/01.olq.0000238457.93426.0d; Palefsky Joel M, 2003, J Natl Cancer Inst Monogr, P41; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patro B K, 2007, Indian J Public Health, V51, P216; Peedicayil A, 2009, J LOW GENIT TRACT DI, V13, P159, DOI 10.1097/LGT.0b013e31818fb40d; Pretorius RG, 2007, INT J CANCER, V121, P2218, DOI 10.1002/ijc.22991; Pretorius RG, 2004, AM J OBSTET GYNECOL, V191, P430, DOI 10.1016/j.ajog.2004.02.065; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Richart R M, 1973, Pathol Annu, V8, P301; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009; Sankaranarayanan R, 2008, VACCINE, V26, pM43, DOI 10.1016/j.vaccine.2008.05.005; Sellors J. W., 2003, COLPOSCOPY TREATMENT; STIGMA, 2019, GUID MAN SEX TRANSM; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Terry G, 2001, J MED VIROL, V65, P155, DOI 10.1002/jmv.2015; *UNAIDS, 2007, 2007 AIDS EP UPD JOI; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047	47	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8634	10.1371/journal.pone.0008634	http://dx.doi.org/10.1371/journal.pone.0008634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072610	Green Published, Green Submitted, gold			2022-12-25	WOS:000273414200012
J	Yamada, K; Matsuzaki, S; Hattori, T; Kuwahara, R; Taniguchi, M; Hashimoto, H; Shintani, N; Baba, A; Kumamoto, N; Yamada, K; Yoshikawa, T; Katayama, T; Tohyama, M				Yamada, Kohei; Matsuzaki, Shinsuke; Hattori, Tsuyoshi; Kuwahara, Ryusuke; Taniguchi, Manabu; Hashimoto, Hitoshi; Shintani, Norihito; Baba, Akemichi; Kumamoto, Natsuko; Yamada, Kazuo; Yoshikawa, Takeo; Katayama, Taiichi; Tohyama, Masaya			Increased Stathmin1 Expression in the Dentate Gyrus of Mice Causes Abnormal Axonal Arborizations	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; IN-SITU HYBRIDIZATION; MICROTUBULE DESTABILIZER; NEURITE OUTGROWTH; DEFICIENT MICE; GENE FAMILY; SCHIZOPHRENIA; PACAP; CELLS; RECEPTOR	Pituitary adenylate cyclase-activating polypeptide (PACAP) is involved in multiple brain functions. To clarify the cause of abnormal behavior in PACAP deficient-mice, we attempted the identification of genes whose expression was altered in the dentate gyrus of PACAP-deficient mice using the differential display method. Expression of stathmin1 was up-regulated in the dentate gyrus at both the mRNA and protein levels. PACAP stimulation inhibited stathmin1 expression in PC12 cells, while increased stathmin1expression in neurons of the subgranular zone and in primary cultured hippocampal neurons induced abnormal arborization of axons. We also investigated the pathways involved in PACAP deficiency. Ascl1 binds to E10 box of the stathmin1 promoter and increases stathmin1 expression. Inhibitory bHLH proteins (Hes1 and Id3) were rapidly up-regulated by PACAP stimulation, and Hes1 could suppress Ascl1 expression and Id3 could inhibit Ascl1 signaling. We also detected an increase of stathmin1 expression in the brains of schizophrenic patients. These results suggest that up-regulation of stathmin1 in the dentate gyrus, secondary to PACAP deficiency, may create abnormal neuronal circuits that cause abnormal behavior.	[Yamada, Kohei; Kuwahara, Ryusuke; Taniguchi, Manabu; Kumamoto, Natsuko; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan; [Matsuzaki, Shinsuke; Hashimoto, Hitoshi; Katayama, Taiichi; Tohyama, Masaya] Osaka Univ, United Grad Sch Child Dev, Osaka, Japan; [Matsuzaki, Shinsuke; Hashimoto, Hitoshi; Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Osaka, Japan; [Matsuzaki, Shinsuke; Hashimoto, Hitoshi; Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan; [Hattori, Tsuyoshi; Shintani, Norihito] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Osaka, Japan; [Hashimoto, Hitoshi; Shintani, Norihito; Baba, Akemichi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Osaka, Japan; [Yamada, Kazuo; Yoshikawa, Takeo] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan	Osaka University; Osaka University; Kanazawa University; Hamamatsu University School of Medicine; Osaka University; Osaka University; RIKEN	Yamada, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan.	katayama@ugscd.osaka-u.ac.jp	Shintani, Norihito/N-1600-2019; Shintani, Norihito/D-5860-2014; Hashimoto, Hitoshi/D-1209-2010; Yoshikawa, Takeo/F-9599-2019	Shintani, Norihito/0000-0002-7850-9064; Shintani, Norihito/0000-0002-7850-9064; Hashimoto, Hitoshi/0000-0001-6548-4016; 	Osaka University	Osaka University	This work was supported in part by Osaka University operating budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCKE B, 2009, AM J MED GE IN PRESS; Cardinaux JR, 1997, MOL BRAIN RES, V51, P220, DOI 10.1016/S0169-328X(97)00241-6; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Clark D, 2006, MOL PSYCHIATR, V11, P459, DOI 10.1038/sj.mp.4001806; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; Ghzili H, 2006, REGUL PEPTIDES, V137, P89, DOI 10.1016/j.regpep.2006.06.015; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; HASHIMOTO H, 1993, NEURON, V11, P333, DOI 10.1016/0896-6273(93)90188-W; Hashimoto H, 1996, J COMP NEUROL, V371, P567; Hashimoto H, 2006, ANN NY ACAD SCI, V1070, P75, DOI 10.1196/annals.1317.038; Hashimoto H, 2009, J NEUROCHEM, V110, P595, DOI 10.1111/j.1471-4159.2009.06168.x; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Heinz A, 2003, PHARMACOPSYCHIATRY, V36, pS152; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Liu AX, 2005, J NEUROSCI, V25, P737, DOI 10.1523/JNEUROSCI.4174-04.2005; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Martel G, 2008, P NATL ACAD SCI USA, V105, P14620, DOI 10.1073/pnas.0807507105; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millsap RE, 2001, STRUCT EQU MODELING, V8, P1, DOI 10.1207/S15328007SEM0801_1; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Nicot A, 2004, J NEUROSCI, V24, P8786, DOI 10.1523/JNEUROSCI.1910-04.2004; Ohkawa N, 2007, NEUROSCI RES, V59, P93, DOI 10.1016/j.neures.2007.06.1464; Ohkawa N, 2007, J CELL SCI, V120, P1447, DOI 10.1242/jcs.001461; Otto C, 2001, MOL BRAIN RES, V92, P78, DOI 10.1016/S0169-328X(01)00153-X; Pierri JN, 2001, ARCH GEN PSYCHIAT, V58, P466, DOI 10.1001/archpsyc.58.5.466; Polzin RG, 2004, GENE, V341, P209, DOI 10.1016/j.gene.2004.06.052; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; ROWLANDS DC, 1995, LAB INVEST, V72, P100; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Shintani N, 2002, REGUL PEPTIDES, V109, P45, DOI 10.1016/S0167-0115(02)00169-6; Shintani N, 2006, ANN NY ACAD SCI, V1070, P545, DOI 10.1196/annals.1317.079; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; VONVISGER JR, 1994, EXP NEUROL, V128, P34, DOI 10.1006/exnr.1994.1110; Weickert CS, 2000, J COMP NEUROL, V423, P359, DOI 10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0; Yamanaka H, 2005, NEUROSCIENCE, V132, P183, DOI 10.1016/j.neuroscience.2004.12.003	47	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8596	10.1371/journal.pone.0008596	http://dx.doi.org/10.1371/journal.pone.0008596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062533	Green Published, gold			2022-12-25	WOS:000273338600016
J	Mader, I; Wabitsch, M; Debatin, KM; Fischer-Posovszky, P; Fulda, S				Mader, Isabelle; Wabitsch, Martin; Debatin, Klaus-Michael; Fischer-Posovszky, Pamela; Fulda, Simone			Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis	FASEB JOURNAL			English	Article						cell death; preadipocytes; death receptor	DEATH-RECEPTOR; GLIOBLASTOMA CELLS; ADIPOSE-TISSUE; MODULATION; ADIPOCYTES; INSULIN; INHIBITION; EXPRESSION; OBESITY; SIRT1	The phytochemical resveratrol has recently gained attention for its protection against metabolic disease and for extension of life span, which have been linked to its metabolic effects and SIRT1 activation in fat cells. However, little is known about the effect of resveratrol on fat cell apoptosis. Here, we identify a novel, SIRT1-independent mechanism by which resveratrol regulates fat cell numbers. We demonstrate for the first time that resveratrol enhances TNF-related apoptosis-inducing ligand (TRAIL)-or CD95-induced apoptosis of human preadipocytes in a highly synergistic manner (EC50 at 72 h: resveratrol, > 300 mu M; TRAIL, > 100 ng/ml; combination: 30 mu M resveratrol and 10 ng/ml TRAIL, combination index 0.4). Similar results in primary human preadipocytes prepared from subcutaneous white adipose tissue and mature human adipocytes underline the relevance to human physiology. Mechanistic studies reveal that resveratrol inhibits PI3K-driven phosphorylation of Akt, leading to increased Bax activation, loss of mitochondrial membrane potential, cytochrome c release, and caspase-dependent apoptosis. The synergistic interaction of resveratrol and TRAIL depends on the intrinsic apoptosis pathway and caspases, since Bcl-2 overexpression and the caspase inhibitor zVAD.fmk inhibit apoptosis, whereas knockdown of SIRT1 by RNA interference has no effect. The discovery of this novel activity of resveratrol significantly advances the knowledge of fat tissue regulation by resveratrol and has important implications for its use in metabolic and age-related diseases.-Mader, I., Wabitsch, M., Debatin, K.-M., Fischer-Posovszky, P., Fulda, S. Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis. FASEB J. 24, 1997-2009 (2010). www.fasebj.org	[Wabitsch, Martin; Fischer-Posovszky, Pamela] Univ Childrens Hosp, Div Pediat Endocrinol & Diabetol, D-89075 Ulm, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Fischer-Posovszky, P (corresponding author), Univ Childrens Hosp, Div Pediat Endocrinol & Diabetol, Eythstr 24, D-89075 Ulm, Germany.	pamela.fischer@uniklinik-ulm.de; simone.fulda@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014; Fulda, Simone/D-5864-2011	Debatin, Klaus-Michael/0000-0002-8397-1886; Fulda, Simone/0000-0002-0459-6417; Fischer-Posovszky, Pamela/0000-0003-3402-9840	Deutsche Forschungsgemeinschaft [WA 1096/3-2]; Deutsche Krebshilfe; Wilhelm-Sander-Stiftung; Novartis Stiftung fur Therapeutische Forschung [IAP6/18]; Baden-Wuerttemberg Ministry of Science, Research and Arts; European Social Fund; University of Ulm; European Community	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Sander-Stiftung; Novartis Stiftung fur Therapeutische Forschung; Baden-Wuerttemberg Ministry of Science, Research and Arts; European Social Fund(European Social Fund (ESF)); University of Ulm; European Community(European Commission)	This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft (WA 1096/3-2) to M. W. and the Deutsche Krebshilfe, Wilhelm-Sander-Stiftung, Novartis Stiftung fur Therapeutische Forschung, IAP6/18 and the European Community (ApopTrain, APO-SYS) to S.F. P.F.P. is funded by a Margarete von Wrangell scholarship financed by the Baden-Wuerttemberg Ministry of Science, Research and Arts, the European Social Fund, and the University of Ulm.	Alcain FJ, 2009, EXPERT OPIN THER PAT, V19, P403, DOI 10.1517/13543770902762893; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Backesjo CM, 2009, CELLS TISSUES ORGANS, V189, P93, DOI 10.1159/000151744; Bai L, 2008, MOL CELL BIOCHEM, V307, P129, DOI 10.1007/s11010-007-9592-5; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Choi JW, 2004, ANN CLIN LAB SCI, V34, P400; Chou TC, 1991, SYNERGISM ANTAGONISM, P61; Delmas D, 2004, ONCOGENE, V23, P8979, DOI 10.1038/sj.onc.1208086; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fischer-Posovszky P, 2007, HORM METAB RES, V39, P314, DOI 10.1055/s-2007-976539; Fischer-Posovszky P, 2004, ENDOCRINOLOGY, V145, P1849, DOI 10.1210/en.2003-0985; Floyd ZE, 2008, METABOLISM, V57, pS32, DOI 10.1016/j.metabol.2008.04.006; Fulda S, 2004, ONCOGENE, V23, P6702, DOI 10.1038/sj.onc.1207630; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2005, EUR J CANCER, V41, P786, DOI 10.1016/j.ejca.2004.12.020; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 2004, CANCER RES, V64, P337, DOI 10.1158/0008-5472.CAN-03-1656; Fulda S, 2006, CANCER DETECT PREV, V30, P217, DOI 10.1016/j.cdp.2006.03.007; Gill C, 2007, PROSTATE, V67, P1641, DOI 10.1002/pros.20653; Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17; Gross K, 2009, AM J PHYSIOL-GASTR L, V296, pG1012, DOI 10.1152/ajpgi.90351.2008; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hambrock A, 2007, J BIOL CHEM, V282, P3347, DOI 10.1074/jbc.M608216200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ivanov VN, 2008, EXP CELL RES, V314, P1163, DOI 10.1016/j.yexcr.2007.12.012; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; La Ferla-Bruhl K, 2007, ONCOGENE, V26, P571, DOI 10.1038/sj.onc.1209841; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin HY, 2006, FASEB J, V20, P1742, DOI 10.1096/fj.06-5743fje; Lockshin RA, 2007, J CELL MOL MED, V11, P1214, DOI 10.1111/j.1582-4934.2007.00150.x; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Park HJ, 2008, J MED FOOD, V11, P773, DOI 10.1089/jmf.2008.0077; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Rayalam S, 2007, J NUTR, V137, P2668, DOI 10.1093/jn/137.12.2668; Shankar Sharmila, 2007, J Mol Signal, V2, P7, DOI 10.1186/1750-2187-2-7; Shankar S, 2007, MOL CELL BIOCHEM, V304, P273, DOI 10.1007/s11010-007-9510-x; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; SZKUDELSKA K, 2009, EUR J CLIN INVEST; Szkudelska K, 2009, J STEROID BIOCHEM, V113, P17, DOI 10.1016/j.jsbmb.2008.11.001; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wabitsch M, 2000, HORM METAB RES, V32, P555, DOI 10.1055/s-2007-978685; Warne JP, 2003, J ENDOCRINOL, V177, P351, DOI 10.1677/joe.0.1770351; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003	64	66	69	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1997	2009		10.1096/fj.09-142943	http://dx.doi.org/10.1096/fj.09-142943			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20097879				2022-12-25	WOS:000278200000034
J	Fujiwara, K; Maita, N; Hosaka, H; Okamura-Ikeda, K; Nakagawa, A; Taniguchi, H				Fujiwara, Kazuko; Maita, Nobuo; Hosaka, Harumi; Okamura-Ikeda, Kazuko; Nakagawa, Atsushi; Taniguchi, Hisaaki			Global Conformational Change Associated with the Two-step Reaction Catalyzed by Escherichia coli Lipoate-Protein Ligase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE CLEAVAGE SYSTEM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; H-PROTEIN; THERMOPLASMA-ACIDOPHILUM; SYNTHETASE; COMPLEX; IDENTIFICATION; SUPERFAMILY; LIPOYLATION	Lipoate-protein ligase A (LplA) catalyzes the attachment of lipoic acid to lipoate-dependent enzymes by a two-step reaction: first the lipoate adenylation reaction and, second, the lipoate transfer reaction. We previously determined the crystal structure of Escherichia coli LplA in its unliganded form and a binary complex with lipoic acid (Fujiwara, K., Toma, S., Okamura-Ikeda, K., Motokawa, Y., Nakagawa, A., and Taniguchi, H. (2005) J Biol. Chem. 280, 33645-33651). Here, we report two new LplA structures, LplA.lipoyl-5'-AMP and LplA.octyl-5'-AMP.apoH-protein complexes, which represent the post-lipoate adenylation intermediate state and the pre-lipoate transfer intermediate state, respectively. These structures demonstrate three large scale conformational changes upon completion of the lipoate adenylation reaction: movements of the adenylate-binding and lipoate-binding loops to maintain the lipoyl-5'-AMP reaction intermediate and rotation of the C-terminal domain by about 180 degrees. These changes are prerequisites for LplA to accommodate apoprotein for the second reaction. The Lys(133) residue plays essential roles in both lipoate adenylation and lipoate transfer reactions. Based on structural and kinetic data, we propose a reaction mechanism driven by conformational changes.	[Fujiwara, Kazuko; Maita, Nobuo; Okamura-Ikeda, Kazuko; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan; [Hosaka, Harumi; Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Tokushima University; Osaka University	Fujiwara, K (corresponding author), Univ Tokushima, Inst Enzyme Res, Kuramotocho 3 Chome, Tokushima 7708503, Japan.	fujiwara@ier.tokushima-u.ac.jp	Taniguchi, Hisaaki/I-9171-2012; Maita, Nobuo/J-1443-2012; Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009	Maita, Nobuo/0000-0003-2260-5783; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861	Japan Society for the Promotion of Science [18570108, 19370041]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research 18570108 (C) and 19370041 (B) and by the National Projects on Protein Structural and Functional Analyses of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bagautdinov B, 2008, J BIOL CHEM, V283, P14739, DOI 10.1074/jbc.M709116200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUJIWARA K, 1992, J BIOL CHEM, V267, P20011; Fujiwara K, 1996, J BIOL CHEM, V271, P12932, DOI 10.1074/jbc.271.22.12932; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; FUJIWARA K, 1986, J BIOL CHEM, V261, P8836; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; KHORANA HG, 1959, J AM CHEM SOC, V81, P4657, DOI 10.1021/ja01526a052; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; OKAMURAIKEDA K, 1993, EUR J BIOCHEM, V216, P539, DOI 10.1111/j.1432-1033.1993.tb18172.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARES S, 1995, ACTA CRYSTALLOGR D, V51, P1041, DOI 10.1107/S0907444995006421; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; REED LJ, 1990, J BIOL CHEM, V265, P8971; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	41	27	28	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9971	9980		10.1074/jbc.M109.078717	http://dx.doi.org/10.1074/jbc.M109.078717			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089862	hybrid, Green Published			2022-12-25	WOS:000276165900066
J	Pitsawong, W; Sucharitakul, J; Prongjit, M; Tan, TC; Spadiut, O; Haltrich, D; Divne, C; Chaiyen, P				Pitsawong, Warintra; Sucharitakul, Jeerus; Prongjit, Methinee; Tan, Tien-Chye; Spadiut, Oliver; Haltrich, Dietmar; Divne, Christina; Chaiyen, Pimchai			A Conserved Active-site Threonine Is Important for Both Sugar and Flavin Oxidations of Pyranose 2-Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; TRAMETES-MULTICOLOR; KINETIC MECHANISM; OXYGEN REACTIVITY; CRYSTAL-STRUCTURE; REDOX PROPERTIES; OXIDASE; SUBSTRATE; FLAVOENZYMES; BINDING	Pyranose 2-oxidase (P2O) catalyzes the oxidation by O-2 of D-glucose and several aldopyranoses to yield the 2-ketoaldoses and H2O2. Based on crystal structures, in one rotamer conformation, the threonine hydroxyl of Thr(169) forms H-bonds to the flavin-N5/O4 locus, whereas, in a different rotamer, it may interact with either sugar or other parts of the P2O center dot sugar complex. Transient kinetics of wild-type (WT) and Thr(169)-> S/N/G/A replacement variants show that D-Glc binds to T169S, T169N, and WT with the same K-d (45-47 mM), and the hydride transfer rate constants (k(red)) are similar (15.3-9.7 s(-1) at 4 degrees C). k(red) of T169G with D-glucose (0.7 s(-1), 4 degrees C) is significantly less than that of WT but not as severely affected as in T169A (k(red) of 0.03 s(-1) at 25 degrees C). Transient kinetics of WT and mutants using D-galactose show that P2O binds D-galactose with a one-step binding process, different from binding of D- glucose. In T169S, T169N, and T169G, the overall turnover with D- Gal is faster than that of WT due to an increase of kred. In the crystal structure of T169S, Ser(169) O gamma assumes a position identical to that of O gamma 1 in Thr(169); in T169G, solvent molecules may be able to rescue H-bonding. Our data suggest that a competent reductive half-reaction requires a side chain at position 169 that is able to form an H-bond within the ES complex. During the oxidative half-reaction, all mutants failed to stabilize a C4a-hydroperoxyflavin intermediate, thus suggesting that the precise position and geometry of the Thr(169) side chain are required for intermediate stabilization.	[Pitsawong, Warintra; Prongjit, Methinee; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Pitsawong, Warintra; Prongjit, Methinee; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok 10300, Thailand; [Tan, Tien-Chye; Spadiut, Oliver; Divne, Christina] Albanova Univ Ctr, Royal Inst Technol, Div Glycosci, SE-10691 Stockholm, Sweden; [Haltrich, Dietmar] Bodenkultur Univ Nat Resource & Appl Life Sci, Dept Food Sci & Technol, A-1190 Vienna, Austria	Mahidol University; Mahidol University; Chulalongkorn University; Royal Institute of Technology	Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.	scpcy@mahidol.ac.th	pitsawong, warintra/G-1760-2018; Chaiyen, Pimchai/A-8236-2010; Chaiyen, Pimchai/R-5052-2019; Divne, Christina/E-8646-2010; Haltrich, Dietmar/N-2624-2019	pitsawong, warintra/0000-0001-5438-1783; Chaiyen, Pimchai/0000-0002-8533-1604; Divne, Christina/0000-0002-5805-2693; Haltrich, Dietmar/0000-0002-8722-8176	Thailand Research Fund [BRG5180002, MRG4980117]; Royal Golden Jubilee Ph.D. program [PHD/0151/2547]; Faculty of Science, Mahidol University; Faculty of Dentistry Chulalongkorn University; Development and Promotion of Science and Technology Talent Project, Thailand; Swedish Research Council Formas; Swedish Research Council Vetenskapsradet; Carl Tryggers Foundation; Swedish Foundation for Strategic Research through the Swedish Center for Biomimetic Fiber Engineering; Austrian Research Foundation [L213-B11]	Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D. program(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Faculty of Dentistry Chulalongkorn University(Chulalongkorn University); Development and Promotion of Science and Technology Talent Project, Thailand; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council Vetenskapsradet(Swedish Research Council); Carl Tryggers Foundation; Swedish Foundation for Strategic Research through the Swedish Center for Biomimetic Fiber Engineering; Austrian Research Foundation(Austrian Science Fund (FWF))	This work was supported in part by the Thailand Research Fund through Grants BRG5180002 (to P. C.), MRG4980117 (to J. S.), and PHD/0151/2547 of the Royal Golden Jubilee Ph.D. program (to M. P.) and by the Faculty of Science, Mahidol University (to P. C.) and from the Faculty of Dentistry Chulalongkorn University (to J. S.).; Supported by the Development and Promotion of Science and Technology Talent Project, Thailand.; Supported by the Swedish Research Council Formas, the Swedish Research Council Vetenskapsradet, the Carl Tryggers Foundation, and the Swedish Foundation for Strategic Research through the Swedish Center for Biomimetic Fiber Engineering ( through Biomime).; Supported by a grant from the Austrian Research Foundation (Fonds zur Forderung der wissenschaftlichen Forschung Translational Project L213-B11).	Albrecht M, 2003, BIOINFORMATICS, V19, P1216, DOI 10.1093/bioinformatics/btg140; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Bannwarth M, 2006, BIOCHEMISTRY-US, V45, P6587, DOI 10.1021/bi052465d; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P2612, DOI 10.1021/bi962325r; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; Forneris F, 2008, BIOCHEMISTRY-US, V47, P978, DOI 10.1021/bi701886t; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Halada P, 2003, ANAL BIOCHEM, V314, P235, DOI 10.1016/S0003-2697(02)00661-9; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Heroux A, 2009, BIOCHEMISTRY-US, V48, P3407, DOI 10.1021/bi8023042; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Leitner C, 2001, APPL ENVIRON MICROB, V67, P3636, DOI 10.1128/AEM.67.8.3636-3644.2001; Mallett TC, 1998, BIOCHEMISTRY-US, V37, P8790, DOI 10.1021/bi9803630; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Rungsrisuriyachai K, 2009, ARCH BIOCHEM BIOPHYS, V483, P10, DOI 10.1016/j.abb.2008.12.018; Salaheddin Clara, 2009, Biotechnology Journal, V4, P535, DOI 10.1002/biot.200800265; Spadiut O, 2009, FEBS J, V276, P776, DOI 10.1111/j.1742-4658.2008.06823.x; Spadiut O, 2008, BIOCATAL BIOTRANSFOR, V26, P120, DOI 10.1080/10242420701789320; Spadiut Oliver, 2009, Biotechnology Journal, V4, P525, DOI 10.1002/biot.200800260; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van den Heuvel RHH, 2000, J BIOL CHEM, V275, P14799, DOI 10.1074/jbc.275.20.14799; Yang KY, 2007, BIOCHEMISTRY-US, V46, P2289, DOI 10.1021/bi0616293; Yue QK, 1999, BIOCHEMISTRY-US, V38, P4277, DOI 10.1021/bi982497j	34	49	50	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9697	9705		10.1074/jbc.M109.073247	http://dx.doi.org/10.1074/jbc.M109.073247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089849	Green Published, hybrid			2022-12-25	WOS:000276165900042
J	Klenk, C; Schulz, S; Calebiro, D; Lohse, MJ				Klenk, Christoph; Schulz, Stefan; Calebiro, Davide; Lohse, Martin J.			Agonist-regulated Cleavage of the Extracellular Domain of Parathyroid Hormone Receptor Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(PTH)/PTH-RELATED PEPTIDE RECEPTOR; HUMAN THYROTROPIN RECEPTOR; PROTEIN-COUPLED-RECEPTOR; PTH-RELATED PEPTIDE; MATRIX METALLOPROTEINASES; 4-AMINOPHENYLMERCURIC ACETATE; PHARMACOLOGICAL CHAPERONES; BIOLOGICAL-ACTIVITY; CELL-SURFACE; KINASE-C	The receptor for parathyroid hormone (PTHR) is a main regulator of calcium homeostasis and bone maintenance. As a member of class B of G protein-coupled receptors, it harbors a large extracellular domain, which is required for ligand binding. Here, we demonstrate that the PTHR extracellular domain is cleaved by a protease belonging to the family of extracellular metalloproteinases. We show that the cleavage takes place in a region of the extracellular domain that belongs to an unstructured loop connecting the ligand-binding parts and that the N-terminal 10-kDa fragment is connected to the receptor core by a disulfide bond. Cleaved receptor revealed reduced protein stability compared with noncleaved receptor, suggesting degradation of the whole receptor. In the presence of the agonistic peptides PTH(1-34), PTH(1-14), or PTH(1-31), the processing of the PTHR extracellular domain was inhibited, and receptor protein levels were stabilized. A processed form of the PTHR was also detected in human kidney. These findings suggest a new model of PTHR processing and regulation of its stability.	[Klenk, Christoph; Calebiro, Davide; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Calebiro, Davide; Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Schulz, Stefan] Univ Jena, Dept Pharmacol & Toxicol, D-07743 Jena, Germany	University of Wurzburg; University of Wurzburg; Friedrich Schiller University of Jena	Klenk, C (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	klenk@toxi.uni-wuerzburg.de	Schulz, Stefan/A-6928-2017; Lohse, Martin J/A-7160-2012; Klenk, Christoph/E-5158-2014	Schulz, Stefan/0000-0002-5997-8885; Lohse, Martin J/0000-0002-0599-3510; Klenk, Christoph/0000-0001-5199-7144; calebiro, davide/0000-0002-3811-1553	Deutsche Forschungsgemeinschaft; European Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the European Research Council (to M. J. L.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Castro M, 2002, ENDOCRINOLOGY, V143, P3854, DOI 10.1210/en.2002-220232; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Galazka G, 1996, BIOCHEMISTRY-US, V35, P11221, DOI 10.1021/bi960618e; GARDELLA TJ, 1994, ENDOCRINOLOGY, V135, P1186, DOI 10.1210/en.135.3.1186; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Geoffroy V, 2004, J BONE MINER RES, V19, P811, DOI 10.1359/JBMR.040119; GOLDRING SR, 1985, BIOCHEMISTRY-US, V24, P513, DOI 10.1021/bi00323a040; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; JOUISHOMME H, 1994, J BONE MINER RES, V9, P943; KARPF DB, 1988, ENDOCRINOLOGY, V123, P2611, DOI 10.1210/endo-123-6-2611; Kawashima-Ohya Y, 1998, ENDOCRINOLOGY, V139, P2120, DOI 10.1210/en.139.4.2120; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; LEE CW, 1994, ENDOCRINOLOGY, V135, P1488, DOI 10.1210/en.135.4.1488; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; Luck MD, 1999, MOL ENDOCRINOL, V13, P670, DOI 10.1210/me.13.5.670; Luo XH, 2004, J BONE MINER METAB, V22, P19, DOI 10.1007/s00774-003-0442-6; LUPP A, 2010, EUR J ENDOC IN PRESS; Merciris D, 2007, BONE, V40, P75, DOI 10.1016/j.bone.2006.07.013; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Offermanns S, 1996, MOL ENDOCRINOL, V10, P566, DOI 10.1210/me.10.5.566; Peeters-Joris C, 1998, BBA-MOL CELL RES, V1405, P14, DOI 10.1016/S0167-4889(98)00094-9; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Santavicca M, 1996, BIOCHEM J, V315, P953, DOI 10.1042/bj3150953; SCHIPANI E, 1993, ENDOCRINOLOGY, V132, P2157, DOI 10.1210/en.132.5.2157; Shimizu N, 2001, J BIOL CHEM, V276, P49003, DOI 10.1074/jbc.M106827200; Tanaka K, 1999, J BIOL CHEM, V274, P33979, DOI 10.1074/jbc.274.48.33979; TREGEAR GW, 1973, ENDOCRINOLOGY, V93, P1349, DOI 10.1210/endo-93-6-1349; Trifilieff A, 2002, BRIT J PHARMACOL, V135, P1655, DOI 10.1038/sj.bjp.0704616; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649	42	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8665	8674		10.1074/jbc.M109.058685	http://dx.doi.org/10.1074/jbc.M109.058685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080964	Green Published, hybrid			2022-12-25	WOS:000275553700019
J	Maier-Peuschel, M; Frolich, N; Dees, C; Hommers, LG; Hoffmann, C; Nikolaev, VO; Lohse, MJ				Maier-Peuschel, Monika; Froelich, Nadine; Dees, Christian; Hommers, Leif G.; Hoffmann, Carsten; Nikolaev, Viacheslav O.; Lohse, Martin J.			A Fluorescence Resonance Energy Transfer-based M-2 Muscarinic Receptor Sensor Reveals Rapid Kinetics of Allosteric Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; ACETYLCHOLINE-RECEPTORS; LIVING CELLS; MOLECULAR-BASIS; ACTIVATION; BINDING; LIGANDS; GALLAMINE; AGONIST; SITE	Allosteric modulators have been identified for several G protein-coupled receptors, most notably muscarinic receptors. To study their mechanism of action, we made use of a recently developed technique to generate fluorescence resonance energy transfer (FRET)-based sensors to monitor G protein-coupled receptor activation. Cyan fluorescent protein was fused to the C terminus of the M-2 muscarinic receptor, and a specific binding sequence for the small fluorescent compound fluorescein arsenical hairpin binder, FlAsH, was inserted into the third intracellular loop; the latter site was labeled in intact cells by incubation with FlAsH. We then measured FRET between the donor cyan fluorescent protein and the acceptor FlAsH in intact cells and monitored its changes in real time. Agonists such as acetylcholine and carbachol induced rapid changes in FRET, indicative of agonist-induced conformational changes. Removal of the agonists or addition of an antagonist caused a reversal of this signal with rate constants between 400 and 1100 ms. The allosteric ligands gallamine and dimethyl-W84 caused no changes in FRET when given alone, but increased FRET when given in the presence of an agonist, compatible with an inactivation of the receptors. The kinetics of these effects were very rapid, with rate constants of 80-100 ms and approximate to 200 ms for saturating concentrations of gallamine and dimethyl-W84, respectively. Because these speeds are significantly faster than the responses to antagonists, these data indicate that gallamine and dimethyl-W84 are allosteric ligands and actively induce a conformation of the M-2 receptor with a reduced affinity for its agonists.	[Nikolaev, Viacheslav O.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; Univ Wurzburg, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Nikolaev, VO (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	nikolaev@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Nikolaev, Vyacheslav/AAT-7746-2020	Lohse, Martin J/0000-0002-0599-3510; 	Deutsche Forschungsgemeinschaft; European Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the European Research Council (to M. J. L.).	Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Birdsall NJM, 2005, MINI-REV MED CHEM, V5, P523, DOI 10.2174/1389557054023251; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Christopoulos A, 2004, BIOCHEM SOC T, V32, P873, DOI 10.1042/BST0320873; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Grossmuller M, 2006, N-S ARCH PHARMACOL, V372, P267, DOI 10.1007/s00210-005-0023-4; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2008, J BIOL CHEM, V283, P30933, DOI 10.1074/jbc.M801472200; Holzgrabe U, 2000, Pharm Acta Helv, V74, P149, DOI 10.1016/S0031-6865(99)00028-X; Hommers LG, 2003, J BIOL CHEM, V278, P1037, DOI 10.1074/jbc.M205325200; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; Jakubik J, 1997, MOL PHARMACOL, V52, P172, DOI 10.1124/mol.52.1.172; Kostenis E, 1997, BIOCHEMISTRY-US, V36, P1487, DOI 10.1021/bi962554d; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; LAZARENO S, 1989, BRIT J PHARMACOL, V98, P309, DOI 10.1111/j.1476-5381.1989.tb16896.x; Li JH, 2007, J BIOL CHEM, V282, P26284, DOI 10.1074/jbc.M704875200; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lohse MJ, 2007, ADV PROTEIN CHEM, V74, P167, DOI 10.1016/S0065-3233(07)74005-6; MAGGIO R, 1993, FEBS LETT, V319, P195, DOI 10.1016/0014-5793(93)80066-4; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; May LT, 2003, CURR OPIN PHARMACOL, V3, P551, DOI 10.1016/S1471-4892(03)00107-3; Mohr K, 2003, RECEPTOR CHANNEL, V9, P229, DOI 10.1080/10606820308264; NARAYANAN TK, 1986, NEUROCHEM RES, V11, P1397, DOI 10.1007/BF00966219; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; PEARCE BD, 1988, NEUROSCI LETT, V88, P281, DOI 10.1016/0304-3940(88)90224-8; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; STOCKTON JM, 1983, MOL PHARMACOL, V23, P551; SZILAGYI M, 1993, PHARMACOLOGY, V47, P223, DOI 10.1159/000139101; Trankle C, 2005, MOL PHARMACOL, V68, P1597, DOI 10.1124/mol.105.017707; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; Trankle C, 1997, LIFE SCI, V60, P1995, DOI 10.1016/S0024-3205(97)00164-1; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	43	60	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8793	8800		10.1074/jbc.M109.098517	http://dx.doi.org/10.1074/jbc.M109.098517			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20083608	Green Published, hybrid			2022-12-25	WOS:000275553700031
J	Kim, S; Kim, Y; Lee, J; Chung, J				Kim, Sunhong; Kim, Yongsung; Lee, Jiwoon; Chung, Jongkyeong			Regulation of FOXO1 by TAK1-Nemo-like Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEMO-LIKE-KINASE; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; NUCLEAR EXCLUSION; GENE-EXPRESSION; MAP KINASE; PHOSPHORYLATION; NLK; COACTIVATOR	The FOXO family of forkhead transcription factors has a variety of important functions in stress response, metabolism, cell cycle, apoptosis, longevity, etc. The transcriptional activity and subcellular localization of FOXO are tightly regulated by post-translational modifications, including phosphorylation by various kinases. Here, we report that the transforming growth factor-beta-activated kinase (TAK1)-Nemo-like kinase (NLK) pathway negatively regulates FOXO1. We show that NLK binds and phosphorylates FOXO1 at Pro-directed Ser/Thr residues in the transactivation domain. The phosphorylation by TAK1-NLK pathway inhibits the transcriptional activity of FOXO1 and excludes FOXO1 from the nucleus, which is independent of phosphatidylinositol 3-kinase/Akt pathway. Consistently, knockdown of TAK1-NLK pathway dephosphorylates FOXO1 and decreases phospho-Ser-329 FOXO1 level. It also induces translocation of FOXO1 into the nucleus and leads to an increase in mRNA levels of FOXO target genes and poly(ADPribose) polymerase cleavage. In addition, we show the interaction between NLK and FOXO1 is evolutionarily conserved in Drosophila. Collectively, these findings provide the first evidence that TAK1-NLK pathway is a novel regulator of FOXO1.	[Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Sunhong] Korea Res Inst Biosci & Biotechnol, Ctr Mol Canc Res, Chungbuk 363883, South Korea; [Kim, Yongsung; Lee, Jiwoon; Chung, Jongkyeong] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat, Ctr Cell Growth Regulat, Taejon 305701, South Korea; [Kim, Yongsung; Lee, Jiwoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Chung, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, San 56-1, Seoul 151742, South Korea.	jchung63@snu.ac.kr			Ministry of Education, Science and Technology [R16-2001-002-01001-0]; National Research Foundation of Korea	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Creative Research Initiatives Grant R16-2001-002-01001-0 from the Ministry of Education, Science and Technology and National Research Foundation of Korea.	Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kortenjann M, 2001, EUR J IMMUNOL, V31, P3580, DOI 10.1002/1521-4141(200112)31:12<3580::AID-IMMU3580>3.0.CO;2-N; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; von Groote-Bidlingmaier F, 2003, BIOCHEM BIOPH RES CO, V300, P764, DOI 10.1016/S0006-291X(02)02914-5; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zeng YA, 2007, DEVELOPMENT, V134, P2061, DOI 10.1242/dev.02853	28	37	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8122	8129		10.1074/jbc.M110.101824	http://dx.doi.org/10.1074/jbc.M110.101824			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061393	Green Published, hybrid			2022-12-25	WOS:000275413800030
J	Krapf, D; Arcelay, E; Wertheimer, EV; Sanjay, A; Pilder, SH; Salicioni, AM; Visconti, PE				Krapf, Dario; Arcelay, Enid; Wertheimer, Eva V.; Sanjay, Archana; Pilder, Stephen H.; Salicioni, Ana M.; Visconti, Pablo E.			Inhibition of Ser/Thr Phosphatases Induces Capacitation-associated Signaling in the Presence of Src Kinase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; MOUSE SPERMATOZOA; ACROSOME REACTION; SPERM PROTEINS; OKADAIC ACID; CALYCULIN-A; EGG WATER; CAMP; PKA; 2A	Signaling events leading to mammalian sperm capacitation rely on activation/deactivation of proteins by phosphorylation. This cascade includes soluble adenylyl cyclase, an atypical bicarbonate-stimulated adenylyl cyclase, and is mediated by protein kinase A and the subsequent stimulation of protein tyrosine phosphorylation. Recently, it has been proposed that the capacitation- associated increase in tyrosine phosphorylation is governed by Src tyrosine kinase activity. This conclusion was based mostly on the observation that Src is present in sperm and that the Src kinase family inhibitor SU6656 blocked the capacitation-associated increase in tyrosine phosphorylation. Results in the present manuscript confirmed these observations and provided evidence that these inhibitors were also able to inhibit protein kinase A phosphorylation, sperm motility, and in vitro fertilization. However, the block of capacitation- associated parameters was overcome when sperm were incubated in the presence of Ser/Thr phosphatase inhibitors such as okadaic acid and calyculin-A at concentrations reported to affect only PP2A. Altogether, these data indicate that Src is not directly involved in the observed increase in tyrosine phosphorylation. More importantly, this work presents strong evidence that capacitation is regulated by two parallel pathways. One of them requiring activation of protein kinase A and the second one involving inactivation of Ser/Thr phosphatases.	[Krapf, Dario; Arcelay, Enid; Wertheimer, Eva V.; Salicioni, Ana M.; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Sanjay, Archana; Pilder, Stephen H.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA	University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Visconti, PE (corresponding author), 427W Integrated Sci Bldg,661 N Pleasant St, Amherst, MA 01003 USA.	pvisconti@vasci.umass.edu	Salicioni, Ana Maria/ABD-8384-2021	Salicioni, Ana Maria/0000-0002-8951-3587; Krapf, Dario/0000-0001-7607-1954	National Institutes of Health [HD38082, HD44044]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044044, R01HD038082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants HD38082 and HD44044 (to P.E.V.).	Arcelay E, 2008, INT J DEV BIOL, V52, P463, DOI 10.1387/ijdb.072555ea; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baker MA, 2009, DEV BIOL, V333, P57, DOI 10.1016/j.ydbio.2009.06.022; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHENG HC, 1992, J BIOL CHEM, V267, P9248; Cheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004861; CHERNOFF J, 1983, J BIOL CHEM, V258, P7852; COHEN P, 1989, J BIOL CHEM, V264, P21435; Etkovitz N, 2009, DEV BIOL, V334, P447, DOI 10.1016/j.ydbio.2009.08.002; Goto N, 2009, J REPROD DEVELOP, V55, P327, DOI 10.1262/jrd.20170; Hao ZL, 2004, MOL HUM REPROD, V10, P433, DOI 10.1093/molehr/gah052; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hu XH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-74; Huang ZH, 2004, BIOL REPROD, V70, P439, DOI 10.1095/biolreprod.103.020024; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kaneto M, 2008, MOL REPROD DEV, V75, P1045, DOI 10.1002/mrd.20839; Krapf D, 2007, DEV BIOL, V306, P516, DOI 10.1016/j.ydbio.2007.03.030; Krapf D, 2006, BIOL CELL, V98, P403, DOI 10.1042/BC20050051; Krapf D, 2009, BIOL REPROD, V80, P311, DOI 10.1095/biolreprod.108.071076; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson C, 2008, BIOL REPROD, V79, P657, DOI 10.1095/biolreprod.108.070367; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Mallozzi C, 2005, FREE RADICAL BIO MED, V38, P1625, DOI 10.1016/j.freeradbiomed.2005.02.021; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Mitchell LA, 2008, MOL HUM REPROD, V14, P235, DOI 10.1093/molehr/gan007; MOORE GD, 1994, DEVELOPMENT, V120, P3313; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; O'Flaherty C, 2004, MOL HUM REPROD, V10, P355, DOI 10.1093/molehr/gah046; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; Si YM, 1999, BIOL REPROD, V61, P240, DOI 10.1095/biolreprod61.1.240; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SRINIVASAN M, 1994, J BIOL CHEM, V269, P12514; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Vanichviriyakit R, 2004, MOL REPROD DEV, V69, P356, DOI 10.1002/mrd.20138; Varano G, 2008, HUM REPROD, V23, P2652, DOI 10.1093/humrep/den314; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Vijayaraghavan Srinivasan, 2007, Soc Reprod Fertil Suppl, V63, P111; VillaMoruzzi E, 1996, BIOCHEM BIOPH RES CO, V219, P863, DOI 10.1006/bbrc.1996.0337; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; Yanagimachi R., 1994, P189; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964	56	110	115	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7977	7985		10.1074/jbc.M109.085845	http://dx.doi.org/10.1074/jbc.M109.085845			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068039	hybrid, Green Published			2022-12-25	WOS:000275413800015
J	Cai, JJ; Crotty, TM; Reichert, E; Carraway, KL; Stafforini, DM; Topham, MK				Cai, Jinjin; Crotty, Tracy M.; Reichert, Ethan; Carraway, Kermit L., III; Stafforini, Diana M.; Topham, Matthew K.			Diacylglycerol Kinase delta and Protein Kinase C alpha Modulate Epidermal Growth Factor Receptor Abundance and Degradation through Ubiquitin-specific Protease 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; MEDIATED ENDOCYTOSIS; EGFR MUTATIONS; LUNG-CANCER; ACTIVATION; PHOSPHORYLATION; INTERNALIZATION; UBPY; ZETA; TRAFFICKING	Many human epithelial cancers are characterized by abnormal activation of the epidermal growth factor receptor (EGFR), which is often caused by its excessive expression in tumor cells. The abundance of EGFR is modulated, in part, by its ubiquitination, which targets it for degradation. The components responsible for adding ubiquitin to EGFR are well characterized, but this is a reversible process, and the mechanisms that modulate the removal of ubiquitin from the EGFR are not well known. We found that de-ubiquitination of EGFR was regulated by diacylglycerol kinase delta (DGK delta), a lipid kinase that terminates diacylglycerol signaling. In DGK delta-deficient cells, ubiquitination of EGFR was enhanced, which attenuated the steady-state levels of EGFR and promoted its ligand-induced degradation. These effects were not caused by changes in the ubiquitinating apparatus, but instead were due to reduced expression of the deubiquitinase, ubiquitin-specific protease 8 (USP8). Depletion of protein kinase C alpha (PKC alpha), a target of diacylglycerol, rescued the levels of USP8 and normalized EGFR degradation in DGK delta-deficient cells. Moreover, the effects of PKC alpha were caused by its inhibition of Akt, which stabilizes USP8. Our data indicate a novel mechanism where DGK delta and PKC delta modulate the levels of ubiquitinated EGFR through Akt and USP8.	[Cai, Jinjin; Crotty, Tracy M.; Reichert, Ethan; Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Cai, Jinjin; Topham, Matthew K.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Carraway, Kermit L., III] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Davis	Topham, MK (corresponding author), 2000 E Circle Hope, Salt Lake City, UT 84112 USA.	matt.topham@hci.utah.edu	cai, jinjin/I-7005-2012		National Institutes of Health [R01-CA95463, P01-CA73992, R01-CA123541]; Huntsman Cancer Foundation; R. Harold Burton Foundation; Cancer Center Support [P30-CA042014]; NATIONAL CANCER INSTITUTE [R01CA095463, P01CA073992, R01CA123541, P30CA042014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntsman Cancer Foundation; R. Harold Burton Foundation; Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA95463 (to M. K. T.), P01-CA73992 to D. M. S.), and R01-CA123541 (to K. L. C.). This work was also supported by the Huntsman Cancer Foundation, the R. Harold Burton Foundation, and by the Cancer Center Support Grant P30-CA042014 for support of core facilities.	Bacchiocchi R, 2005, BLOOD, V106, P2175, DOI 10.1182/blood-2005-01-0316; Baldanzi G, 2004, ONCOGENE, V23, P4828, DOI 10.1038/sj.onc.1207633; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; BEGUINOT L, 1985, P NATL ACAD SCI USA, V82, P2774, DOI 10.1073/pnas.82.9.2774; Buchanan FG, 2007, CANCER RES, V67, P9380, DOI 10.1158/0008-5472.CAN-07-0710; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Chianale F, 2007, MOL BIOL CELL, V18, P4859, DOI 10.1091/mbc.E07-02-0177; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Imai S, 2009, BBA-MOL CELL BIOL L, V1791, P246, DOI 10.1016/j.bbalip.2009.01.024; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LUND KA, 1990, J BIOL CHEM, V265, P20517; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	37	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6952	6959		10.1074/jbc.M109.055731	http://dx.doi.org/10.1074/jbc.M109.055731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20064931	hybrid, Green Published			2022-12-25	WOS:000275415600008
J	Rohrl, J; Yang, D; Oppenheim, JJ; Hehlgans, T				Roehrl, Johann; Yang, De; Oppenheim, Joost J.; Hehlgans, Thomas			Specific Binding and Chemotactic Activity of mBD4 and Its Functional Orthologue hBD2 to CCR6-expressing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-DEFENSINS; HUMAN BETA-DEFENSIN-3; DENDRITIC CELLS; EXPRESSION; IMMUNITY; KERATINOCYTES; INDUCTION; PEPTIDES; IMMATURE; INNATE	beta-Defensins are small antimicrobial polypeptides that are mainly expressed by epithelial cells and play an important role in the antimicrobial innate immune response. In addition to the direct microbicidal effects of these polypeptides, members of the beta-defensin super family have the capacity to promote local innate inflammatory and systemic adaptive immune responses, which are in part mediated by the CC-chemokine receptor CCR6. Here we report the expression of recombinant mBD4 and its human orthologue hBD2 fused to the constant domain of human IgG(1) to obtain correct folding and to increase stability and solubility using the Drosophila S2 expression system. Purified recombinant mBD4:Ig and hBD2: Ig fusion proteins retained potent antimicrobial activity against Gram-negative and Gram-positive bacteria. Furthermore, these beta-defensin fusion proteins showed specific binding to CCR6-expressing cells as revealed by flow cytometry. Interestingly, although hBD2: Ig bound to both human and mouse CCR6-expressing cells, mBD4: Ig did only bind to mCCR6-expressing cells but not to hCCR6-expressing cells. Both beta-defensin fusion proteins demonstrated chemotactic activity for cells expressing the mouse CC-chemokine receptor CCR6. The chemokine ligand CCL20 competed with the beta-defensin fusion proteins for specific binding to CCR6 as analyzed by fluorescence-activated cell sorter analysis. Both beta-defensin fusion proteins demonstrated chemotactic activity for cells expressing the mouse CCR6 receptor, but mBD4: Ig did not induce chemotactic activity of cells expressing human CCR6. This result supports our finding that mBD4 does not interact with human CCR6-expressing cells. Further evidence for specific interaction of the beta-defensin fusion proteins with CCR6-expressing cells is demonstrated by the observation that CCL20 and beta-defensin fusion proteins desensitize each other in inducing chemotactic activity. In addition both mBD4: Ig and hBD2: Ig demonstrated CCR6-independent chemotaxis of freshly isolated mouse resident peritoneal cells and human peripheral blood mononuclear cells, indicating the interaction with another chemotaxis-inducing receptor. Thus, the beta-defensin fusion proteins used in this study retained their biological activity and are a feasible tool to identify and analyze specific beta-defensin receptor interactions.	[Hehlgans, Thomas] Univ Regensburg, Inst Immunol, D-93042 Regensburg, Germany; [Yang, De; Oppenheim, Joost J.] NCI Frederick, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res,Div Basic Sci,NIH, Frederick, MD 21702 USA	University of Regensburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Hehlgans, T (corresponding author), Univ Regensburg, Inst Immunol, Franz Josef Strauss Allee 11, D-93042 Regensburg, Germany.	thomas.hehlgans@klinik.uni-regensburg.de			Bayerische Forschungsstifung [PDOK-62-08]; NATIONAL CANCER INSTITUTE [ZIABC009369] Funding Source: NIH RePORTER	Bayerische Forschungsstifung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by Bayerische Forschungsstifung Grant PDOK-62-08 (to T.H.).	Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Chong KT, 2008, VIROLOGY, V380, P136, DOI 10.1016/j.virol.2008.07.024; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x; Harder J, 2004, J INVEST DERMATOL, V123, P522, DOI 10.1111/j.0022-202X.2004.23234.x; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Hinrichsen K, 2008, ANTIMICROB AGENTS CH, V52, P1876, DOI 10.1128/AAC.01308-07; Ishimoto H, 2006, EUR RESPIR J, V27, P253, DOI 10.1183/09031936.06.00105904; Jia HP, 2000, J BIOL CHEM, V275, P33314, DOI 10.1074/jbc.M006603200; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; PIERS KL, 1993, GENE, V134, P7, DOI 10.1016/0378-1119(93)90168-3; Rivas-Santiago B, 2006, J INFECT DIS, V194, P697, DOI 10.1086/506454; Roehrl J, 2008, J BIOL CHEM, V283, P5414, DOI 10.1074/jbc.M709103200; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Taylor K, 2008, J BIOL CHEM, V283, P6631, DOI 10.1074/jbc.M709238200; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Vargues T, 2009, PROTEIN PEPTIDE LETT, V16, P668, DOI 10.2174/092986609788490122; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yin CY, 2006, INT J ANTIMICROB AG, V28, P352, DOI 10.1016/j.ijantimicag.2006.08.003	25	57	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7028	7034		10.1074/jbc.M109.091090	http://dx.doi.org/10.1074/jbc.M109.091090			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20068036	Green Published, hybrid			2022-12-25	WOS:000275415600016
J	Bauer, M; Su, G; Casper, C; He, R; Rehrauer, W; Friedl, A				Bauer, M.; Su, G.; Casper, C.; He, R.; Rehrauer, W.; Friedl, A.			Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast	ONCOGENE			English	Article						breast neoplasms; tumor stroma; fibroblasts; invasion	CANCER-ASSOCIATED FIBROBLASTS; TISSUE GROWTH-FACTOR; TUMOR-STROMA; STEM-CELLS; AUTOCRINE; TP53; MICROENVIRONMENT; TRANSFORMATION; MUTATIONS	Breast carcinoma invasion is associated with prominent alterations in stromal fibroblasts. Carcinoma-associated fibroblasts (CAF) support and promote tumorigenesis, whereas normal mammary fibroblasts (NF) are thought to suppress tumor progression. Little is known about the difference in gene expression between CAF and NF or the patient-to-patient variability in gene expression. Paired CAF and NF were isolated from six primary human breast carcinoma specimens. RNA was extracted from low-passage cultures of CAF and NF and analyzed with Affymetrix Human Genome U133 Plus 2.0 arrays. The array data were examined with an empirical Bayes model and filtered according to the posterior probability of equivalent expression and fold difference in expression. Twenty-one genes (27 probe sets) were up-regulated in CAF, as compared with NF. Known functions of these genes relate to paracrine or intracellular signaling, transcriptional regulation, extracellular matrix and cell adhesion/migration. Ten genes (14 probe sets) were down-regulated in CAF, including the pluripotency transcription factor KLF4. Quantitative RT-PCR analysis of 10 genes validated the array results. Immunohistochemical staining for three gene products confirmed stromal expression in terms of location and relative quantity. Surprisingly, the variability of gene expression was slightly higher in NF than in CAF, suggesting inter-individual heterogeneity of normal stroma. Oncogene (2010) 29, 1732-1740; doi:10.1038/onc.2009.463; published online 11 January 2010	[Bauer, M.; Su, G.; He, R.; Rehrauer, W.; Friedl, A.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Casper, C.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Friedl, A (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, 1111 Highland Ave,6051 WIMR,Mailcode 2275, Madison, WI 53706 USA.	afriedl@wisc.edu			Dr Mildred Scheel Stiftung; National Institutes of Health [RO1 CA107012]; Wisconsin Partnership program; NATIONAL CANCER INSTITUTE [R01CA107012] Funding Source: NIH RePORTER	Dr Mildred Scheel Stiftung(Deutsche Krebshilfe); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Partnership program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Christina Kendziorski for help with the array analyses and Dr Korise Rasmusson for her assistance with the manuscript preparation. Maret Bauer was supported by a scholarship from the Dr Mildred Scheel Stiftung. This research was funded by National Institutes of Health grant RO1 CA107012 and a grant from the Wisconsin Partnership program.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Briand P, 1996, CANCER RES, V56, P2039; Campbell IG, 2008, NEW ENGL J MED, V358, P1634, DOI 10.1056/NEJMc086024; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Chang CF, 2007, FRONT BIOSCI-LANDMRK, V12, P4393, DOI 10.2741/2396; De Jong JS, 1998, J PATHOL, V184, P44; Duque JL, 2001, J UROLOGY, V165, P284, DOI 10.1097/00005392-200101000-00080; Erickson AC, 2003, EXPERT OPIN THER TAR, V7, P71, DOI 10.1517/14728222.7.1.71; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Iacobuzio-Donahue CA, 2002, CANCER RES, V62, P5351; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji Q, 2004, CANCER RES, V64, P7610, DOI 10.1158/0008-5472.CAN-04-1608; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kim YC, 2008, CANCER RES, V68, P10145, DOI 10.1158/0008-5472.CAN-08-2992; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; LeWitt PA, 2004, CLIN NEUROPHARMACOL, V27, P1, DOI 10.1097/00002826-200401000-00001; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Mercier I, 2008, CANCER BIOL THER, V7, P1212, DOI 10.4161/cbt.7.8.6220; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Narita K, 2007, J BIOL CHEM, V282, P14413, DOI 10.1074/jbc.M611395200; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; R Development Core Team, 2008, LANG ENV STAT COMP; Roukos DH, 2008, NEW ENGL J MED, V358, P1636; Singer CF, 2002, BREAST CANCER RES TR, V72, P69, DOI 10.1023/A:1014918512569; Singer CF, 2008, BREAST CANCER RES TR, V110, P273, DOI 10.1007/s10549-007-9725-2; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sutmuller M, 1997, HISTOL HISTOPATHOL, V12, P557; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang Y, 2004, MOL CANCER RES, V2, P73; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Xie D, 2001, CANCER RES, V61, P8917; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006	45	120	131	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1732	1740		10.1038/onc.2009.463	http://dx.doi.org/10.1038/onc.2009.463			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20062080	Green Accepted			2022-12-25	WOS:000276022800003
J	Penteriani, V; Delgado, MD; Campioni, L; Lourenco, R				Penteriani, Vincenzo; Delgado, Maria del Mar; Campioni, Letizia; Lourenco, Rui			Moonlight Makes Owls More Chatty	PLOS ONE			English	Article							PREDATION RISK; LUNAR CYCLES; BUBO-BUBO; BEHAVIOR; BADGE; BRIGHTNESS; AVOIDANCE; DENSITY; PREY; MOON	Background: Lunar cycles seem to affect many of the rhythms, temporal patterns and behaviors of living things on Earth. Ambient light is known to affect visual communication in animals, with the conspicuousness of visual signals being largely determined by the light available for reflection by the sender. Although most previous studies in this context have focused on diurnal light, moonlight should not be neglected from the perspective of visual communication among nocturnal species. We recently discovered that eagle owls Bubo bubo communicate with conspecifics using a patch of white throat plumage that is repeatedly exposed during each call and is only visible during vocal displays. Methodology/Principal Findings: Here we provide evidence that this species uses moonlight to increase the conspicuousness of this visual signal during call displays. We found that call displays are directly influenced by the amount of moonlight, with silent nights being more frequent during periods with no-moonlight than moonlight. Furthermore, high numbers of calling bouts were more frequent at moonlight. Finally, call posts were located on higher positions on moonlit nights. Conclusions/Significance: Our results support the idea that moon phase affects the visual signaling behavior of this species, and provide a starting point for examination of this method of communication by nocturnal species.	[Penteriani, Vincenzo; Delgado, Maria del Mar; Campioni, Letizia; Lourenco, Rui] CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Penteriani, Vincenzo] Univ Helsinki, Zool Museum, Finnish Museum Nat Hist, Helsinki, Finland; [Delgado, Maria del Mar] Univ Helsinki, Dept Biol & Environm Sci, Lab Ecol & Evolutionary Dynam, Helsinki, Finland; [Lourenco, Rui] Univ Evora, Inst Mediterranean Agr Sci ICAM, Evora, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Helsinki; University of Helsinki; University of Evora	Penteriani, V (corresponding author), CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	penteriani@ebd.csic.es	Lourenço, Rui/AAB-6030-2020; campioni, letizia/AAZ-2888-2020; Lourenço, Rui/B-7148-2012	Lourenço, Rui/0000-0001-7694-0478; campioni, letizia/0000-0002-6319-6931; Lourenço, Rui/0000-0001-7694-0478; Delgado, Maria del Mar/0000-0002-3009-738X	Spanish Ministry of Science and Innovation [CGL2008-02871/BOS]; Spanish Secretaria General de Universidades, Ministry of Education	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Secretaria General de Universidades, Ministry of Education	The work was funded by a research project of the Spanish Ministry of Science and Innovation (CGL2008-02871/BOS); V.P. was granted by the Spanish Secretaria General de Universidades, Ministry of Education (Salvador de Madariaga Program). The authors manipulated and marked owls under Junta de Andalucia Consejeria de Medio Ambiente permits No. SCFFS-AFR/GGG RS-260/02 and SCFFS-AFR/CMM RS-1904/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Dixon DR, 2006, ACTA ETHOL, V9, P59, DOI 10.1007/s10211-006-0016-4; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Gainzarain JA, 2000, BIRD STUDY, V47, P225, DOI 10.1080/00063650009461177; GANEY JL, 1990, CONDOR, V92, P485, DOI 10.2307/1368245; Gannon MR, 1997, BIOTROPICA, V29, P525, DOI 10.1111/j.1744-7429.1997.tb00048.x; James D, 2000, CR ACAD SCI III-VIE, V323, P215, DOI 10.1016/S0764-4469(00)00121-9; Sabato MAL, 2006, BEHAV PROCESS, V73, P228, DOI 10.1016/j.beproc.2006.05.012; Martin G., 1990, BIRDS NIGHT; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; Naylor E, 2001, EARTH MOON PLANETS, V85-6, P291, DOI 10.1023/A:1017088504226; Penteriani V, 2006, J AVIAN BIOL, V37, P110, DOI 10.1111/j.0908-8857.2006.03569.x; Penteriani V, 2008, J AVIAN BIOL, V39, P215, DOI 10.1111/j.0908-8857.2008.04280.x; Penteriani V, 2007, BEHAV ECOL, V18, P143, DOI 10.1093/beheco/arl060; Penteriani V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004960; Rahman MS, 2001, COMP BIOCHEM PHYS B, V129, P367, DOI 10.1016/S1096-4959(01)00323-2; Rosenthal GG, 2007, ANNU REV ECOL EVOL S, V38, P155, DOI 10.1146/annurev.ecolsys.38.091206.095745; Takemura A, 2004, FISH FISH, V5, P317, DOI 10.1111/j.1467-2679.2004.00164.x; Thery M., 2006, BIRD COLORATION, V1, P148; TRILLMICH F, 1981, OECOLOGIA, V48, P85, DOI 10.1007/BF00346992; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019	24	52	55	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8696	10.1371/journal.pone.0008696	http://dx.doi.org/10.1371/journal.pone.0008696			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098700	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779000005
J	Sipe, JC; Scott, TM; Murray, S; Harismendy, O; Simon, GM; Cravatt, BF; Waalen, J				Sipe, Jack C.; Scott, T. Michael; Murray, Sarah; Harismendy, Olivier; Simon, Gabriel M.; Cravatt, Benjamin F.; Waalen, Jill			Biomarkers of Endocannabinoid System Activation in Severe Obesity	PLOS ONE			English	Article							ACID-AMIDE-HYDROLASE; BINGE-EATING DISORDER; MISSENSE POLYMORPHISM; CANNABINOID RECEPTOR; ANANDAMIDE; DERIVATIVES; FAAH; BIOCHEMISTRY; LIGANDS; CB1	Background: Obesity is a worldwide epidemic, and severe obesity is a risk factor for many diseases, including diabetes, heart disease, stroke, and some cancers. Endocannabinoid system (ECS) signaling in the brain and peripheral tissues is activated in obesity and plays a role in the regulation of body weight. The main research question here was whether quantitative measurement of plasma endocannabinoids, anandamide, and related N-acylethanolamines (NAEs), combined with genotyping for mutations in fatty acid amide hydrolase ( FAAH) would identify circulating biomarkers of ECS activation in severe obesity. Methodology/Principal Findings: Plasma samples were obtained from 96 severely obese subjects with body mass index (BMI) of >= 40 kg/m(2), and 48 normal weight subjects with BMI of <= 26 kg/m(2). Triple-quadrupole mass spectroscopy methods were used to measure plasma ECS analogs. Subjects were genotyped for human FAAH gene mutations. The principal analysis focused on the FAAH 385 C -> A (P129T) mutation by comparing plasma ECS metabolite levels in the FAAH 385 minor A allele carriers versus wild-type C/C carriers in both groups. The main finding was significantly elevated mean plasma levels of anandamide (15.1 +/- 1.4 pmol/ml) and related NAEs in study subjects that carried the FAAH 385 A mutant alleles versus normal subjects (13.3 +/- 1.0 pmol/ml) with wild-type FAAH genotype (p = 0.04), and significance was maintained after controlling for BMI. Conclusions/Significance: Significantly increased levels of the endocannabinoid anandamide and related NAEs were found in carriers of the FAAH 385 A mutant alleles compared with wild-type FAAH controls. This evidence supports endocannabinoid system activation due to the effect of FAAH 385 mutant A genotype on plasma AEA and related NAE analogs. This is the first study to document that FAAH 385 A mutant alleles have a direct effect on elevated plasma levels of anandamide and related NAEs in humans. These biomarkers may indicate risk for severe obesity and may suggest novel ECS obesity treatment strategies.	[Sipe, Jack C.; Scott, T. Michael; Harismendy, Olivier; Waalen, Jill] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Simon, Gabriel M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Murray, Sarah; Harismendy, Olivier] Scripps Res Inst, Scripps Genom Med Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Sipe, JC (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jcsipe@scripps.edu	Harismendy, Olivier/AAM-2072-2021	Harismendy, Olivier/0000-0002-8098-9888	National Institutes of Health [DA023448]; Center for AIDS Research [3 P30 AI036214-13S1]; Sanofi-Aventis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research; Sanofi-Aventis(Sanofi-Aventis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by National Institutes of Health grant #DA023448 and in part by Center for AIDS Research core grant 3 P30 AI036214-13S1, as well as a research grant and supply of subject samples from Sanofi-Aventis to JCS and BFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellocchio L, 2008, J NEUROENDOCRINOL, V20, P850, DOI 10.1111/j.1365-2826.2008.01728.x; CHIANG K, 2004, HUM MOL GENET, V13, P1; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; DEVANE WA, 1994, P NATL ACAD SCI USA, V91, P6698, DOI 10.1073/pnas.91.14.6698; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 1998, NEUROBIOL DIS, V5, P386, DOI 10.1006/nbdi.1998.0214; Di Marzo V, 1998, BBA-LIPID LIPID MET, V1392, P153, DOI 10.1016/S0005-2760(98)00042-3; Di Marzo V, 1999, CURR MED CHEM, V6, P721; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Engel Michael S., 2008, Nova Supplementa Entomologica, V20, P1; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Engeli Stefan, 2006, Clin Cornerstone, V8 Suppl 4, pS24, DOI 10.1016/S1098-3597(06)80041-4; Gaetani S, 2008, Eat Weight Disord, V13, pe42; Gonthier MP, 2007, OBESITY, V15, P837, DOI 10.1038/oby.2007.581; Jensen DP, 2007, J MOL MED, V85, P445, DOI 10.1007/s00109-006-0139-0; Jesudason D, 2008, CURR OPIN LIPIDOL, V19, P344, DOI 10.1097/MOL.0b013e328304b62b; Kaufmann I, 2008, PSYCHONEUROENDOCRINO, V33, P676, DOI 10.1016/j.psyneuen.2008.02.009; Kirkham TC, 2005, BEHAV PHARMACOL, V16, P297, DOI 10.1097/00008877-200509000-00004; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Martin BR, 1999, LIFE SCI, V65, P573, DOI 10.1016/S0024-3205(99)00281-7; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Mechoulam R, 1999, FORSCH KOMPLEMENTMED, V6, P16, DOI 10.1159/000057151; Monteleone P, 2005, NEUROPSYCHOPHARMACOL, V30, P1216, DOI 10.1038/sj.npp.1300695; Monteleone P, 2008, PSYCHONEUROENDOCRINO, V33, P546, DOI 10.1016/j.psyneuen.2008.01.004; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Palandra J, 2009, J CHROMATOGR B, V877, P2052, DOI 10.1016/j.jchromb.2009.05.043; Papazoglou D, 2008, HORM METAB RES, V40, P907, DOI 10.1055/s-0028-1087169; Roche R, 2006, HISTOCHEM CELL BIOL, V126, P177, DOI 10.1007/s00418-005-0127-4; Sipe JC, 2005, INT J OBESITY, V29, P755, DOI 10.1038/sj.ijo.0802954; Walker JM, 2002, CHEM PHYS LIPIDS, V121, P159, DOI 10.1016/S0009-3084(02)00152-4	34	92	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8792	10.1371/journal.pone.0008792	http://dx.doi.org/10.1371/journal.pone.0008792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098695	gold, Green Submitted, Green Published			2022-12-25	WOS:000273779000020
J	Sjodin, P; Bataillon, T; Schierup, MH				Sjodin, Per; Bataillon, Thomas; Schierup, Mikkel H.			Insertion and Deletion Processes in Recent Human History	PLOS ONE			English	Article							HUMAN GENOME; RECOMBINATION RATES; MAMMALIAN GENOMES; EVOLUTION; SEQUENCES; ARABIDOPSIS; DIVERGENCE; MECHANISMS; EXPANSION; MAJORITY	Background: Although insertions and deletions (indels) account for a sizable portion of genetic changes within and among species, they have received little attention because they are difficult to type, are alignment dependent and their underlying mutational process is poorly understood. A fundamental question in this respect is whether insertions and deletions are governed by similar or different processes and, if so, what these differences are. Methodology/Principal Findings: We use published resequencing data from Seattle SNPs and NIEHS human polymorphism databases to construct a genomewide data set of short polymorphic insertions and deletions in the human genome (n = 6228). We contrast these patterns of polymorphism with insertions and deletions fixed in the same regions since the divergence of human and chimpanzee (n = 10546). The macaque genome is used to resolve all indels into insertions and deletions. We find that the ratio of deletions to insertions is greater within humans than between human and chimpanzee. Deletions segregate at lower frequency in humans, providing evidence for deletions being under stronger purifying selection than insertions. The insertion and deletion rates correlate with several genomic features and we find evidence that both insertions and deletions are associated with point mutations. Finally, we find no evidence for a direct effect of the local recombination rate on the insertion and deletion rate. Conclusions/Significance: Our data strongly suggest that deletions are more deleterious than insertions but that insertions and deletions are otherwise generally governed by the same genomic factors.	[Sjodin, Per; Bataillon, Thomas; Schierup, Mikkel H.] Bioinformat Res Ctr, Aarhus, Denmark	Aarhus University	Sjodin, P (corresponding author), Bioinformat Res Ctr, CF Mollers Alle, Aarhus, Denmark.	persj@cs.au.dk	Bataillon, Thomas/AAJ-7652-2020; Schierup, Mikkel H/F-1675-2010; Schierup, Mikkel Heide/AAM-4997-2020; Bataillon, Thomas/AAK-1822-2020	Bataillon, Thomas/0000-0002-4730-2538; Schierup, Mikkel H/0000-0002-5028-1790; Schierup, Mikkel Heide/0000-0002-5028-1790; 	Carl Trygger's Foundation [CTS 06: 417]; Danish Council for Natural Science [95092886]; Danish Council for Technology and Production [LSHC-CT-2005-018827]	Carl Trygger's Foundation; Danish Council for Natural Science; Danish Council for Technology and Production	PS was supported by a post doctoral grant (grant number CTS 06: 417, URL http://www.carltryggersstiftelse.se/) from Carl Trygger's Foundation. TB was supported by a Steno Fellowship (grant number 95092886, URL http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research/) from the Danish Council for Natural Science (FNU). MHS was supported by a grant (grant number LSHC-CT-2005-018827, URL http://en.fi.dk/councils-commissions/the danish council-for-independent-research/) from the Danish Council for Technology and Production. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Ball EV, 2005, HUM MUTAT, V26, P205, DOI 10.1002/humu.20212; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Chen WL, 1999, GENETICS, V151, P1299; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Duval A, 2002, CANCER RES, V62, P2447; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Galtier N, 2001, GENETICS, V159, P907; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000330; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kvikstad EM, 2007, PLOS COMPUT BIOL, V3, P1772, DOI 10.1371/journal.pcbi.0030176; Lunter G, 2008, GENOME RES, V18, P298, DOI 10.1101/gr.6725608; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Lynch M, 2007, ORIGINS GENOME ARCHI; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean G, 2002, GENETICS, V160, P1231; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Messer PW, 2007, MOL BIOL EVOL, V24, P1190, DOI 10.1093/molbev/msm035; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Opperman R, 2004, GENETICS, V168, P2207, DOI 10.1534/genetics.104.032896; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; R Development Core Team, 2007, R LANG ENV STAT COMP; Tanay A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r37; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	31	23	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8650	10.1371/journal.pone.0008650	http://dx.doi.org/10.1371/journal.pone.0008650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098729	Green Submitted, Green Published, gold			2022-12-25	WOS:000273778900004
J	Amano, M; Tsumura, Y; Taki, K; Harada, H; Mori, K; Nishioka, T; Kato, K; Suzuki, T; Nishioka, Y; Iwamatsu, A; Kaibuchi, K				Amano, Mutsuki; Tsumura, Yuta; Taki, Kentaro; Harada, Hidenori; Mori, Kazutaka; Nishioka, Tomoki; Kato, Katsuhiro; Suzuki, Takeshi; Nishioka, Yosuke; Iwamatsu, Akihiro; Kaibuchi, Kozo			A Proteomic Approach for Comprehensively Screening Substrates of Protein Kinases Such as Rho-Kinase	PLOS ONE			English	Article							MIGRATING NEURONS; PHOSPHORYLATION; PHOSPHATASE; IDENTIFICATION; SPECIFICITY; AFFINITY; BALANCE; TAU	Background: Protein kinases are major components of signal transduction pathways in multiple cellular processes. Kinases directly interact with and phosphorylate downstream substrates, thus modulating their functions. Despite the importance of identifying substrates in order to more fully understand the signaling network of respective kinases, efficient methods to search for substrates remain poorly explored. Methodology/Principal Findings: We combined mass spectrometry and affinity column chromatography of the catalytic domain of protein kinases to screen potential substrates. Using the active catalytic fragment of Rho-kinase/ROCK/ROK as the model bait, we obtained about 300 interacting proteins from the rat brain cytosol fraction, which included the proteins previously reported as Rho-kinase substrates. Several novel interacting proteins, including doublecortin, were phosphorylated by Rho-kinase both in vitro and in vivo. Conclusions/Significance: This method would enable identification of novel specific substrates for kinases such as Rho-kinase with high sensitivity.	[Amano, Mutsuki; Tsumura, Yuta; Taki, Kentaro; Harada, Hidenori; Mori, Kazutaka; Nishioka, Tomoki; Kato, Katsuhiro; Suzuki, Takeshi; Nishioka, Yosuke; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan; [Mori, Kazutaka; Kato, Katsuhiro] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Iwamatsu, Akihiro] Prot Res Network Inc, Yokohama, Kanagawa, Japan; [Kaibuchi, Kozo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Amano, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan.	kaibuchi@med.nagoya-u.ac.jp	Kato, Katsuhiro/AAV-8356-2020; Amano, Mutsuki/M-4820-2014; Nishioka, Tomoki/M-4976-2014	Amano, Mutsuki/0000-0002-0662-1524; 	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [20058012, 17024024, 20227006, 20590308]; Japan Science and Technology Agency, CREST [26-J-Jc08]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This research was supported in part by Grant-in-Aid for Scientific Research on Priority Areas (20058012, 17024024) and Grant-in-Aid for Scientific Research (S) (20227006) and (C) (20590308) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). This research was also supported in part by Japan Science and Technology Agency, CREST (26-J-Jc08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Futer O, 2006, BIOCHEMISTRY-US, V45, P7913, DOI 10.1021/bi052468q; HIKITA T, 2009, J NEUROCHEM; Inada H, 1999, J BIOL CHEM, V274, P34932, DOI 10.1074/jbc.274.49.34932; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Machida M, 2007, FEBS J, V274, P1576, DOI 10.1111/j.1742-4658.2007.05705.x; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Schmezle K, 2006, CURR OPIN BIOTECH, V17, P406, DOI 10.1016/j.copbio.2006.06.004; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taniguchi T, 2001, J BIOL CHEM, V276, P10025, DOI 10.1074/jbc.M007427200; Tedford NC, 2009, PROTEOMICS, V9, P1469, DOI 10.1002/pmic.200800468; Trauger JW, 2002, BIOCHEMISTRY-US, V41, P8948, DOI 10.1021/bi0258243; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203	20	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8704	10.1371/journal.pone.0008704	http://dx.doi.org/10.1371/journal.pone.0008704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090853	Green Published, gold, Green Submitted			2022-12-25	WOS:000273714600007
J	Sanokawa-Akakura, R; Cao, WH; Allan, K; Patel, K; Ganesh, A; Heiman, G; Burke, R; Kemp, FW; Bogden, JD; Camakaris, J; Birge, RB; Konsolaki, M				Sanokawa-Akakura, Reiko; Cao, Weihuan; Allan, Kirsten; Patel, Khyati; Ganesh, Anupama; Heiman, Gary; Burke, Richard; Kemp, Francis W.; Bogden, John D.; Camakaris, James; Birge, Raymond B.; Konsolaki, Mary			Control of Alzheimer's Amyloid Beta Toxicity by the High Molecular Weight Immunophilin FKBP52 and Copper Homeostasis in Drosophila	PLOS ONE			English	Article							A-BETA; PROTEIN; EXPRESSION; MODEL; MELANOGASTER; MECHANISMS; DISEASE; BRAIN; PHOSPHORYLATION; PIGMENTATION	FK506 binding proteins (FKBPs), also called immunophilins, are prolyl-isomerases (PPIases) that participate in a wide variety of cellular functions including hormone signaling and protein folding. Recent studies indicate that proteins that contain PPIase activity can also alter the processing of Alzheimer's Amyloid Precursor Protein (APP). Originally identified in hematopoietic cells, FKBP52 is much more abundantly expressed in neurons, including the hippocampus, frontal cortex, and basal ganglia. Given the fact that the high molecular weight immunophilin FKBP52 is highly expressed in CNS regions susceptible to Alzheimer's, we investigated its role in A beta toxicity. Towards this goal, we generated A beta transgenic Drosophila that harbor gain of function or loss of function mutations of FKBP52. FKBP52 overexpression reduced the toxicity of A beta and increased lifespan in A beta flies, whereas loss of function of FKBP52 exacerbated these A beta phenotypes. Interestingly, the A beta pathology was enhanced by mutations in the copper transporters Atox1, which interacts with FKBP52, and Ctr1A and was suppressed in FKBP52 mutant flies raised on a copper chelator diet. Using mammalian cultures, we show that FKBP52 (-/-) cells have increased intracellular copper and higher levels of A beta. This effect is reversed by reconstitution of FKBP52. Finally, we also found that FKBP52 formed stable complexes with APP through its FK506 interacting domain. Taken together, these studies identify a novel role for FKBP52 in modulating toxicity of A beta peptides.	[Cao, Weihuan; Patel, Khyati; Ganesh, Anupama; Heiman, Gary; Konsolaki, Mary] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Sanokawa-Akakura, Reiko; Birge, Raymond B.] Univ Med & Dent New Jersey, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Allan, Kirsten; Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Kemp, Francis W.; Bogden, John D.] Univ Med & Dent New Jersey, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA; [Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Monash University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Melbourne	Konsolaki, M (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.	konsolaki@biology.rutgers.edu	Heiman, Gary A/K-2366-2018; BOGDEN, JOHN D./ABG-6718-2020	Heiman, Gary A/0000-0001-5859-0259; Burke, Richard/0000-0003-0086-0767	Johnson & Johnson Focused; National Institutes of Health (NIH) [AG027198]; National Health and Medical Research Council (NHMRC); NATIONAL INSTITUTE ON AGING [R21AG027198] Funding Source: NIH RePORTER	Johnson & Johnson Focused; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Johnson & Johnson Focused Giving grants to RBB and MK, as well as National Institutes of Health (NIH) AG027198 to RBB and National Health and Medical Research Council (NHMRC) project grant to RB and JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brecht S, 2003, NEUROSCIENCE, V120, P1037, DOI 10.1016/S0306-4522(03)00404-4; Breiman A, 2002, TRANSGENIC RES, V11, P321, DOI 10.1023/A:1016331814412; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Davies P, 2008, BIOCHEM SOC T, V36, P1299, DOI 10.1042/BST0361299; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Goel M, 2001, J BIOL CHEM, V276, P38762, DOI 10.1074/jbc.M104125200; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kemp FW, 2007, ENVIRON HEALTH PERSP, V115, P630, DOI 10.1289/ehp.9389; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; Kong GKW, 2007, ACTA CRYSTALLOGR F, V63, P819, DOI 10.1107/S1744309107041139; Li F, 2004, J NEUROSCI RES, V76, P383, DOI 10.1002/jnr.20067; Liu FL, 2006, BIOCHEM BIOPH RES CO, V350, P472, DOI 10.1016/j.bbrc.2006.09.073; LYONS WE, 1994, P NATL ACAD SCI USA, V91, P3191, DOI 10.1073/pnas.91.8.3191; LYONS WE, 1995, J NEUROSCI, V15, P2985; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; Norgate M, 2007, BIOMETALS, V20, P683, DOI 10.1007/s10534-006-9075-2; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; Sanokawa-Akakura R, 2004, J BIOL CHEM, V279, P27845, DOI 10.1074/jbc.C400118200; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; SMITH DF, 1993, J BIOL CHEM, V268, P18356; STEINER JP, 1992, NATURE, V358, P584, DOI 10.1038/358584a0; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; Tatro ET, 2009, BRAIN RES, V1286, P1, DOI 10.1016/j.brainres.2009.06.036; van der Burg JW, 2009, AIAA J, V47, P60, DOI 10.2514/1.34300; VELDHUIS NA, 2009, INT J BIOCH CEL 0701; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Willnow TE, 2006, MOL INTERV, V6, P137, DOI 10.1124/mi.6.3.4; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zaffran S, 2000, GENE, V246, P103, DOI 10.1016/S0378-1119(00)00058-5; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	43	51	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8626	10.1371/journal.pone.0008626	http://dx.doi.org/10.1371/journal.pone.0008626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084280	Green Published, gold			2022-12-25	WOS:000273554600007
J	Lightowler, JVJ; Cooke, GS; Mutevedzi, P; Lessells, RJ; Newell, ML; Dedicoat, M				Lightowler, Josephine V. J.; Cooke, Graham S.; Mutevedzi, Portia; Lessells, Richard J.; Newell, Marie-Louise; Dedicoat, Martin			Treatment of Cryptococcal Meningitis in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; AIDS-ASSOCIATED CRYPTOCOCCOSIS; ACTIVE ANTIRETROVIRAL THERAPY; COHORT; UGANDA; FLUCONAZOLE; INFECTIONS; MORTALITY; DISEASE; BURDEN	Background: Cryptococcal meningitis (CM) remains a leading cause of death for HIV-infected individuals in sub-Saharan Africa. Improved treatment strategies are needed if individuals are to benefit from the increasing availability of antiretroviral therapy. We investigated the factors associated with mortality in routine care in KwaZulu-Natal, South Africa. Methodology/Principal Findings: A prospective year long, single-center, consecutive case series of individuals diagnosed with cryptococcal meningitis 190 patients were diagnosed with culture positive cryptococcal meningitis, of whom 186 were included in the study. 52/186 (28.0%) patients died within 14 days of diagnosis and 60/186 (32.3%) had died by day 28. In multivariable cox regression analysis, focal neurology (aHR 11 95%C.I. 3.08-39.3, P < 0.001), diastolic blood pressure <60 mmHg (aHR 2.37 95%C.I. 1.11-5.04, P = 0.025), concurrent treatment for tuberculosis (aHR 2.11 95%C.I. 1.02-4.35, P = 0.044) and use of fluconazole monotherapy (aHR 3.69 95%C.I. 1.74-7.85, P < 0.001) were associated with increased mortality at 14 and 28 days. Conclusions: Even in a setting where amphotericin B is available, mortality from cryptococcal meningitis in this setting is high, particularly in the immediate period after diagnosis. This highlights the still unmet need not only for earlier diagnosis of HIV and timely access to treatment of opportunistic infections, but for better treatment strategies of cryptococcal meningitis.	[Lightowler, Josephine V. J.; Dedicoat, Martin] Ngwelezane Hosp, Empangeni, Kwazulu Natal, South Africa; [Lightowler, Josephine V. J.] John Radcliffe Hosp, Oxford OX3 9DU, England; [Cooke, Graham S.; Mutevedzi, Portia; Lessells, Richard J.; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Cooke, Graham S.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England; [Newell, Marie-Louise] UCL Inst Child Hlth, London, England; [Dedicoat, Martin] Univ Limpopo, Limpopo, South Africa	University of Oxford; University of Kwazulu Natal; Imperial College London; University of London; University College London; University of Limpopo	Lightowler, JVJ (corresponding author), Ngwelezane Hosp, Empangeni, Kwazulu Natal, South Africa.	gcooke@africacentre.ac.za	Dedicoat, Martin/AFC-7815-2022; Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Cooke, Graham/0000-0001-6475-5056; Lessells, Richard/0000-0003-0926-710X; Dedicoat, Martin/0000-0001-9833-4882	Wellcome Trust [GR085957]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded in part by Wellcome Trust grant (GR085957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Antinori S, 2009, HIV MED, V10, P6, DOI 10.1111/j.1468-1293.2008.00645.x; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bisson GP, 2008, JAIDS-J ACQ IMM DEF, V49, P227, DOI 10.1097/QAI.0b013e318183181e; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Dickson SJ, 2007, THORAX, V62, P964, DOI 10.1136/thx.2006.072256; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Lawn SD, 2005, AIDS, V19, P2050, DOI 10.1097/01.aids.0000191232.16111.f9; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Lortholary O, 2006, AIDS, V20, P2183, DOI 10.1097/01.aids.0000252060.80704.68; MAKADZANGE A, 2009, EARLY VS DELAYED ART; MCCARTHY K, 2007, S AFR J HIV MED, P25; Okongo M, 1998, INT J EPIDEMIOL, V27, P698, DOI 10.1093/ije/27.4.698; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; UNAIDS, 2008, REP GLOB AIDS EP; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	23	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8630	10.1371/journal.pone.0008630	http://dx.doi.org/10.1371/journal.pone.0008630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062814	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000273414100014
J	Senderovich, Y; Izhaki, I; Halpern, M				Senderovich, Yigal; Izhaki, Ido; Halpern, Malka			Fish as Reservoirs and Vectors of Vibrio cholerae	PLOS ONE			English	Article							CHIRONOMID EGG MASSES; III SECRETION SYSTEM; NON-O1; CHITIN; POPULATION; STRAINS; WATER	Vibrio cholerae, the etiologic agent of cholera, is autochthonous to various aquatic environments, but despite intensive efforts its ecology remains an enigma. Recently, it was suggested that copepods and chironomids, both considered as natural reservoirs of V. cholerae, are dispersed by migratory waterbirds, thus possibly distributing the bacteria between water bodies within and between continents. Although fish have been implicated in the scientific literature with cholera cases, as far as we know, no study actually surveyed the presence of the bacteria in the fish. Here we show for the first time that fish of various species and habitats contain V. cholerae in their digestive tract. Fish (n = 110) were randomly sampled from freshwater and marine habitats in Israel. Ten different fish species sampled from freshwater habitats (lake, rivers and fish ponds), and one marine species, were found to carry V. cholerae. The fish intestine of Sarotherodon galilaeus harboured ca. 56x10(3) V. cholerae cfu per 1 gr intestine content-high rates compared with known V. cholerae cfu numbers in the bacteria's natural reservoirs. Our results, combined with evidence from the literature, suggest that fish are reservoirs of V. cholerae. As fish carrying the bacteria swim from one location to another (some fish species move from rivers to lakes or sea and vice versa), they serve as vectors on a small scale. Nevertheless, fish are consumed by waterbirds, which disseminate the bacteria on a global scale. Moreover, V. cholerae isolates had the ability to degrade chitin, indicating a commensal relationship between V. cholerae and fish. Better understanding of V. cholerae ecology can help reduce the times that human beings come into contact with this pathogen and thus minimize the health risk this poses.	[Senderovich, Yigal; Izhaki, Ido; Halpern, Malka] Univ Haifa, Dept Evolutionary & Environm Biol, Fac Sci & Sci Educ, IL-31999 Haifa, Israel; [Halpern, Malka] Univ Haifa, Dept Biol Educ, Fac Sci & Sci Educ, Oranim, Tivon, Israel	University of Haifa; University of Haifa	Senderovich, Y (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, Fac Sci & Sci Educ, IL-31999 Haifa, Israel.	mhalpern@research.haifa.ac.il	Halpern, Malka/AAH-1498-2019; Izhaki, Ido/D-5586-2011; Izhaki, Ido/I-9712-2019	Halpern, Malka/0000-0002-3407-2198; Izhaki, Ido/0000-0002-4525-4683; Izhaki, Ido/0000-0002-4525-4683	University of Haifa, Israel	University of Haifa, Israel	This study was supported by the Research Authority, University of Haifa, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CJ, 2001, EMERG INFECT DIS, V7, P583; BOOTH LV, 1990, J INFECTION, V20, P55, DOI 10.1016/S0163-4453(90)92346-M; Broza M, 2001, NATURE, V412, P40, DOI 10.1038/35083691; CARVAJAL GH, 1988, J GEN APPL MICROBIOL, V44, P27; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Cheasty T, 1999, LANCET, V354, P89, DOI 10.1016/S0140-6736(99)00151-8; Colwell R, 2001, HYDROBIOLOGIA, V460, P141, DOI 10.1023/A:1013111016642; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; Debellis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005074; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; FINCH MJ, 1987, AM J TROP MED HYG, V36, P393, DOI 10.4269/ajtmh.1987.36.393; Forssman B, 2007, MED J AUSTRALIA, V187, P345, DOI 10.5694/j.1326-5377.2007.tb01278.x; Halpern M, 2006, FEMS MICROBIOL ECOL, V55, P98, DOI 10.1111/j.1574-6941.2005.00020.x; Halpern M, 2004, MICROB ECOL, V47, P341, DOI 10.1007/s00248-003-2007-6; Halpern M, 2003, APPL ENVIRON MICROB, V69, P4200, DOI 10.1128/AEM.69.7.4200-4204.2003; Halpern M, 2007, MICROB ECOL, V53, P285, DOI 10.1007/s00248-006-9094-0; Halpern M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000173; HSU SC, 1975, APPL MICROBIOL, V29, P422, DOI 10.1128/AEM.29.3.422-426.1975; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; KAMAL AM, 1971, J EGYPT PUBLIC HLTH, V46, P125; KIIYUKIA C, 1992, APPL ENVIRON MICROB, V58, P3078, DOI 10.1128/AEM.58.9.3078-3082.1992; Lewin S. M., 1996, P228; Maggi P, 1997, EUR J EPIDEMIOL, V13, P95, DOI 10.1023/A:1007329700125; MCINTYRE RC, 1979, LANCET, V10, P311; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Mukhopadhyay AK, 1996, J CLIN MICROBIOL, V34, P2537, DOI 10.1128/JCM.34.10.2537-2543.1996; Nandi B, 2000, J CLIN MICROBIOL, V38, P4145, DOI 10.1128/JCM.38.11.4145-4151.2000; PANDIT CG, 1951, INDIAN J MED SCI, V15, P343; Plesnik V., 2006, Epidemiologie Mikrobiologie Imunologie, V55, P30; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Schurmann D, 2002, EUR J CLIN MICROBIOL, V21, P827, DOI 10.1007/s10096-002-0832-z; Senderovich Y, 2008, ISME J, V2, P276, DOI 10.1038/ismej.2007.114; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005	35	103	104	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8607	10.1371/journal.pone.0008607	http://dx.doi.org/10.1371/journal.pone.0008607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066040	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338600025
J	Wells, JV; Robertson, B; Rosenberg, KV; Mehlman, DW				Wells, Jeffrey V.; Robertson, Bruce; Rosenberg, Kenneth V.; Mehlman, David W.			Global versus Local Conservation Focus of US State Agency Endangered Bird Species Lists	PLOS ONE			English	Article							PRIORITIES; PARTNERS; PAROCHIALISM; POPULATIONS; LANDBIRDS; SYSTEMS; RARE	The development of species priorities for conservation at local or regional scales (for example, within a state or province) poses an interesting paradox. One the one hand, locally or regionally-derived species priorities may lead to greater interest in and resources directed to biodiversity conservation by local or regional institutions. On the other hand, locally or regionally-derived species priorities could overlook national or global priorities. We assessed U. S. state government agency endangered-threatened bird lists to determine the comparative representation of species of global versus local conservation significance on them. State lists tended to be represented primarily by species of low global risk-low global responsibility (range: 15-100%; mean 51%) and high global risk-high global responsibility (range: 0-73%; mean 35%). In 25 states, more than half of the species on the state lists were in the low global risk-low global responsibility category. Most U.S. state agency lists represent a combined strategy of highlighting species of both local and global conservation significance. Even with this combined local-global strategy, most state lists were predominated by species that represent local but not global conservation significance. Such a strategy could have profound negative consequences for many species that are not formally recognized under national endangered species protections but that are also left off of state-level endangered species lists.	[Wells, Jeffrey V.] Boreal Songbird Initiat, Seattle, WA USA; [Robertson, Bruce] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Rosenberg, Kenneth V.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Mehlman, David W.] Nature Conservancy, Albuquerque, NM USA	Michigan State University; Cornell University	Wells, JV (corresponding author), Boreal Songbird Initiat, Seattle, WA USA.	jeffwells@borealbirds.org						Andelman SJ, 2004, ACTA OECOL, V26, P75, DOI 10.1016/j.actao.2004.04.005; Atwood Jonathan L., 1994, Studies in Avian Biology, V15, P328; Beissinger SR, 2000, AUK, V117, P549, DOI 10.1642/0004-8038(2000)117[0549:ROTACC]2.0.CO;2; Belanger D., 1988, MANAGING AM WILDLIFE; Bunnell FL, 2004, CAN J FOREST RES, V34, P2240, DOI [10.1139/x04-102, 10.1139/X04-102]; Carter MF, 2000, AUK, V117, P541, DOI 10.1642/0004-8038(2000)117[0541:SCPFLI]2.0.CO;2; CARTER MF, 1993, STATUS MANAGEMENT NE; CRAIG RJ, 2006, AVIAN CONSERVATION E; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; DUDLEY JP, 1995, CONSERV BIOL, V9, P1332, DOI 10.1046/j.1523-1739.1995.9051329.x-i1; Dunn EH, 1999, CONSERV BIOL, V13, P1404, DOI 10.1046/j.1523-1739.1999.98400.x; Gardenfors U, 2001, TRENDS ECOL EVOL, V16, P511, DOI 10.1016/S0169-5347(01)02214-5; Gardenfors U, 2001, CONSERV BIOL, V15, P1206, DOI 10.1046/j.1523-1739.2001.00112.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; GEORGE S, 1998, STATE ENDANGERED SPE; HUNTER ML, 1994, CONSERV BIOL, V8, P1163, DOI 10.1046/j.1523-1739.1994.08041163.x; HUNTER WC, 1993, STATUS MANAGEMENT NE; IUCN, 2003, IUCN SPEC SURV COMM; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Mehlman DW, 2004, BIOL CONSERV, V120, P383, DOI 10.1016/j.biocon.2004.03.013; MILLSAP BA, 1990, WILDLIFE MONOGR, P1; Nuttle T, 2003, AUK, V120, P541, DOI 10.1642/0004-8038(2003)120[0541:ACVOBC]2.0.CO;2; Panjabi A., 2001, PARTNERS FLIGHT HDB; RICHIE D, 1998, STATE WILDLIFE DIVER; Rodrigues ASL, 2002, CONSERV BIOL, V16, P674, DOI 10.1046/j.1523-1739.2002.00455.x; Rosenberg K. V., 2005, BIRD CONSERVATION IM, V1, P57; ROSENBERG KV, 2000, GLOBAL PERSPECTIVES; Sagarin RD, 2006, OIKOS, V115, P386, DOI 10.1111/j.2006.0030-1299.14438.x; VICKERY PD, 1992, T NE SECT WILDL SOC, V48, P1; Wells J. V., 2007, BIRDERS CONSERVATION; WELLS JV, 1995, WILDLIFE SOC B, V23, P458; Wells JV, 1999, STUD AVIAN BIOL-SER, P72; Wild M, 2006, DIVERS DISTRIB, V12, P749, DOI [10.1111/j.1472-4642.2006.00287.x, 10.1111/j.1366-9516.2006.00287.x]; [No title captured]; 2005, STATE WILDLIFE ACTIO	35	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8608	10.1371/journal.pone.0008608	http://dx.doi.org/10.1371/journal.pone.0008608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062538	Green Submitted, Green Published, gold			2022-12-25	WOS:000273338600026
J	Hanelt, I; Lochte, S; Sundermann, L; Elbers, K; Vor der Bruggen, M; Bakker, EP				Haenelt, Inga; Loechte, Sara; Sundermann, Lea; Elbers, Katharina; Vor der Brueggen, Marc; Bakker, Evert P.			Gain of Function Mutations in Membrane Region M-2C2 of KtrB Open a Gate Controlling K+ Transport by the KtrAB System from Vibrio alginolyticus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; ESCHERICHIA-COLI K-12; POTASSIUM-TRANSPORT; GLYCINE RESIDUES; KDPFABC COMPLEX; HIGH-AFFINITY; CHANNEL; SELECTIVITY; PROTEIN; ADAPTATION	KtrB, the K+-translocating subunit of the Na+-dependent bacterial K+ uptake system KtrAB, consists of four M1PM2 domains, in which M-1 and M-2 are transmembrane helices and P indicates a p-loop that folds back from the external medium into the cell membrane. The transmembrane stretch M-2C is, with its 40 residues, unusually long. It consists of three parts, the hydrophobic helices M-2C1 and M-2C3, which are connected by a nonhelical M-2C2 region, containing conserved glycine, alanine, serine, threonine, and lysine residues. Several point mutations in M-2C2 led to a huge gain of function of K+ uptake by KtrB from the bacterium Vibrio alginolyticus. This effect was exclusively due to an increase in V-max for K+ transport. Na+ translocation by KtrB was not affected. Partial to complete deletions of M-2C2 also led to enhanced Vmax values for K+ uptake via KtrB. However, several deletion variants also exhibited higher Km values for K+ uptake and at least one deletion variant, KtrB(Delta 326-328), also transported Na+ faster. The presence of KtrA did not suppress any of these effects. For the deletion variants, this was due to a diminished binding of KtrA to KtrB. PhoA studies indicated that M-2C2 forms a flexible structure within the membrane allowing M-2C3 to be directed either to the cytoplasm or (artificially) to the periplasm. These data are interpreted to mean (i) that region M-2C2 forms a flexible gate controlling K+ translocation at the cytoplasmic side of KtrB, and (ii) that M-2C2 is required for the interaction between KtrA and KtrB.	[Haenelt, Inga; Loechte, Sara; Sundermann, Lea; Elbers, Katharina; Vor der Brueggen, Marc; Bakker, Evert P.] Univ Osnabruck, Abt Mikrobiol, D-49076 Osnabruck, Germany	University Osnabruck	Hanelt, I (corresponding author), Univ Osnabruck, Abt Mikrobiol, Barbarastr 11, D-49076 Osnabruck, Germany.	haenelt@biologie.uni-osnabrueck.de	Hänelt, Inga/N-2982-2016	Hänelt, Inga/0000-0003-1495-3163	Deutsche Forschungsgemeinschaft;  [SFB431]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by SFB431, Teilprojekt P6 from the Deutsche Forschungsgemeinschaft.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; Bertrand J, 2004, J BACTERIOL, V186, P5519, DOI 10.1128/JB.186.16.5519-5522.2004; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Durell SR, 2000, BIOPHYS J, V78, P188, DOI 10.1016/S0006-3495(00)76584-2; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Durell SR, 1999, BIOPHYS J, V77, P789, DOI 10.1016/S0006-3495(99)76932-8; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; EPSTEIN W, 1986, FEMS MICROBIOL LETT, V39, P73; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P475; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gadsby DC, 2004, NATURE, V427, P795, DOI 10.1038/427795a; GIFFARD PM, 1985, J BACTERIOL, V164, P904, DOI 10.1128/JB.164.2.904-910.1985; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Kawano M, 2000, J BACTERIOL, V182, P2507, DOI 10.1128/JB.182.9.2507-2512.2000; Kroning N, 2007, J BIOL CHEM, V282, P14018, DOI 10.1074/jbc.M609084200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MILLER JH, 1972, EXPT MOL GENETICS, P401; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Sakuma T, 1998, BBA-BIOENERGETICS, V1363, P231, DOI 10.1016/S0005-2728(97)00102-3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; STUMPE S, 1996, HDB BIOL PHYS, V2, P473; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; van der Laan M, 2002, J BACTERIOL, V184, P5491, DOI 10.1128/JB.184.19.5491-5494.2002; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	43	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10318	10327		10.1074/jbc.M109.089870	http://dx.doi.org/10.1074/jbc.M109.089870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20097755	Green Published, hybrid			2022-12-25	WOS:000276264600016
J	Murayama-Hosokawa, S; Oda, K; Nakagawa, S; Ishikawa, S; Yamamoto, S; Shoji, K; Ikeda, Y; Uehara, Y; Fukayama, M; McCormick, F; Yano, T; Taketani, Y; Aburatani, H				Murayama-Hosokawa, S.; Oda, K.; Nakagawa, S.; Ishikawa, S.; Yamamoto, S.; Shoji, K.; Ikeda, Y.; Uehara, Y.; Fukayama, M.; McCormick, F.; Yano, T.; Taketani, Y.; Aburatani, H.			Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway	ONCOGENE			English	Article						chromosomal instability; microsatellite instability; copy number neutral LOH; homozygous deletions; Ras-PI3K pathway; endometrial carcinoma	ACQUIRED UNIPARENTAL DISOMY; PLECKSTRIN HOMOLOGY DOMAIN; ACUTE MYELOID LEUKEMIAS; RESOLUTION COPY NUMBER; MICROSATELLITE INSTABILITY; OVARIAN-CANCER; MUTATIONS; HETEROZYGOSITY; PIK3CA; GENES	Endometrial cancer is one of the tumor types in which either chromosomal instability (CIN) or microsatellite instability (MSI) may occur. It is known to possess mutations frequently in the Ras-PI3K (phosphatidylinositol 30-kinase) pathway. We performed a comprehensive genomic survey in 31 endometrial carcinomas with paired DNA for chromosomal imbalances (25 by the 50K and 6 by the 250K single-nucleotide polymorphism (SNP) array), and screened 25 of the 31 samples for MSI status and mutational status in the Ras-PI3K pathway genes. We detected five or more copy number changes (classified as CIN-extensive) in 9 (29%), 1 to 4 changes (CIN-intermediate) in 17 (55%) and no changes (CIN-negative) in 5 (16%) tumors. Positive MSI was less common in CIN-extensive tumors (14%), compared with CIN-intermediate/negative tumors (50%), and multivariate analysis showed that CIN-extensive is an independent poor prognostic factor. SNP array analysis unveiled copy number neutral LOH at 54 loci in 13 tumors (42%), including four at the locus of PTEN. In addition to eight (26%) tumors with PTEN deletions, we detected chromosomal imbalances of NF1, K-Ras and PIK3CA in four (13%), four (13%) and six (19%) tumors, respectively. In all, 7 of the 9 CIN-extensive tumors harbor deletions in the loci of PTEN and/or NF1, whereas all the 10 MSI-positive tumors possess PTEN, PIK3CA and/or K-Ras mutations. Our results showed that genomic alterations in the Ras-PI3K pathway are remarkably widespread in endometrial carcinomas, regardless of the type of genomic instability, and suggest that the degree of CIN is a useful biomarker for prognosis in endometrial carcinomas. Oncogene (2010) 29, 1897-1908; doi:10.1038/onc.2009.474; published online 11 January 2010	[Aburatani, H.] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan; [Murayama-Hosokawa, S.; Oda, K.; Nakagawa, S.; Shoji, K.; Ikeda, Y.; Uehara, Y.; Yano, T.; Taketani, Y.] Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan; [Ishikawa, S.; Fukayama, M.] Univ Tokyo, Dept Pathol, Tokyo, Japan; [McCormick, F.] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [McCormick, F.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	University of Tokyo; University of Tokyo; University of Tokyo; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Aburatani, H (corresponding author), Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Komaba 4-6-1, Tokyo 1538904, Japan.	haburata-tky@umin.ac.jp			Ministry of Education, Science, Sports and Culture [16101006, 17015008]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20014007, 19599005, 21791544, 20018005]; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); New Energy and Industrial Technology Development Organization (NEDO) of Japan	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	We thank Hiroko Meguro, Akira Watanabe, Jennifer Okada, Toshiharu Yasugi, Kei Kawana, Takahide Arimoto, Akira Tsuchiya, Osamu Hiraike-Wada, Kenbun Sone, Yuichiro Miyamoto, Haruko Hiraike, Katsuyuki Adachi, Shiho Miura and Ayako Tomio for support and assistance. This work was supported by the Ministry of Education, Science, Sports and Culture Grant Number: Scientific Research (S) 16101006, Scientific Research on Priority Areas 17015008, Ministry of Education, Culture, Sports, Science and Technology of Japan on Priority Area; Grant Number: 20014007, and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST) (to H Aburatani); by the Grant-in-Aid for Scientific Research (C), Grant Number 19599005 and the Grant-in-Aid for Young Scientists (B), Grant Number 21791544 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K Oda); by the Grant-in-Aid for Scientific Research on Priority Areas 'Applied Genomics', Grant Number 20018005, from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Industrial Technology Research Grant Program from New Energy and Industrial Technology Development Organization (NEDO) of Japan (to S Ishikawa).	An HJ, 2004, MODERN PATHOL, V17, P530, DOI 10.1038/modpathol.3800057; Arabi H, 2009, GYNECOL ONCOL, V113, P153, DOI 10.1016/j.ygyno.2009.02.004; Atkin NB, 2001, CYTOGENET CELL GENET, V92, P177, DOI 10.1159/000056898; Bacolod MD, 2009, CANCER RES, V69, P723, DOI 10.1158/0008-5472.CAN-08-3543; Bilbao C, 2006, INT J CANCER, V119, P563, DOI 10.1002/ijc.21862; Black D, 2006, J CLIN ONCOL, V24, P1745, DOI 10.1200/JCO.2005.04.1574; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi SW, 2002, CLIN CANCER RES, V8, P2311; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; ENOMOTO T, 1991, CANCER RES, V51, P5308; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; Flotho C, 2007, ONCOGENE, V26, P5816, DOI 10.1038/sj.onc.1210361; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Gorringe KL, 2008, GENE CHROMOSOME CANC, V47, P933, DOI 10.1002/gcc.20595; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2009, GENE CHROMOSOME CANC, V48, P931, DOI 10.1002/gcc.20694; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; Hirasawa A, 2003, CLIN CANCER RES, V9, P5675; Ishikawa S, 2005, BIOCHEM BIOPH RES CO, V333, P1309, DOI 10.1016/j.bbrc.2005.06.040; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kratz CP, 2007, HUM MOL GENET, V16, P374, DOI 10.1093/hmg/ddl458; Levan K, 2006, CYTOGENET GENOME RES, V115, P16, DOI 10.1159/000094796; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Loukola A, 2001, CANCER RES, V61, P4545; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maira SM, 2009, BIOCHEM SOC T, V37, P265, DOI 10.1042/BST0370265; MCCONNELL JD, 1995, BR J UROL S, V1, P5; Melcher R, 2007, CYTOGENET GENOME RES, V118, P214, DOI 10.1159/000108303; Micci F, 2004, GENE CHROMOSOME CANC, V40, P229, DOI 10.1002/gcc.20038; Midorikawa Y, 2006, ONCOGENE, V25, P5581, DOI 10.1038/sj.onc.1209537; Minaguchi T, 2001, CLIN CANCER RES, V7, P2636; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Onda T, 1997, BRIT J CANCER, V75, P1836, DOI 10.1038/bjc.1997.313; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Raghavan M, 2005, CANCER RES, V65, P375; Rowan A, 2005, CLIN GASTROENTEROL H, V3, P1115, DOI 10.1016/S1542-3565(05)00618-X; Ryan AJ, 2005, CELL TISSUE RES, V322, P53, DOI 10.1007/s00441-005-1109-5; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Sirchia SM, 2000, CANCER GENET CYTOGEN, V121, P156, DOI 10.1016/S0165-4608(00)00240-5; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Suehiro Y, 2000, GENE CHROMOSOME CANC, V29, P75, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1010>3.3.CO;2-T; Tashiro H, 1997, AM J PATHOL, V150, P75; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Toda T, 2001, CANCER GENET CYTOGEN, V126, P120, DOI 10.1016/S0165-4608(00)00400-3; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Walsh CS, 2008, CLIN CANCER RES, V14, P7645, DOI 10.1158/1078-0432.CCR-08-1291; Weber JC, 2007, INT J CANCER, V120, P524, DOI 10.1002/ijc.22343; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421	62	32	35	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	13					1897	1908		10.1038/onc.2009.474	http://dx.doi.org/10.1038/onc.2009.474			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20062086				2022-12-25	WOS:000276199600003
J	Landles, C; Sathasivam, K; Weiss, A; Woodman, B; Moffitt, H; Finkbeiner, S; Sun, BH; Gafni, J; Ellerby, LM; Trottier, Y; Richards, WG; Osmand, A; Paganetti, P; Bates, GP				Landles, Christian; Sathasivam, Kirupa; Weiss, Andreas; Woodman, Ben; Moffitt, Hilary; Finkbeiner, Steve; Sun, Banghua; Gafni, Juliette; Ellerby, Lisa M.; Trottier, Yvon; Richards, William G.; Osmand, Alex; Paganetti, Paolo; Bates, Gillian P.			Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN MOUSE MODEL; N-TERMINAL FRAGMENTS; TRANSGENIC MICE; POLYGLUTAMINE AGGREGATION; DEPENDENT PROTEOLYSIS; WILD-TYPE; LENGTH; CLEAVAGE; BRAIN; LOCALIZATION	Huntingtin proteolysis has been implicated in the molecular pathogenesis of Huntington disease (HD). Despite an intense effort, the identity of the pathogenic smallest N-terminal fragment has not been determined. Using a panel of anti-huntingtin antibodies, we employed an unbiased approach to generate proteolytic cleavage maps of mutant and wild-type huntingtin in the HdhQ150 knock-in mouse model of HD. We identified 14 prominent N-terminal fragments, which, in addition to the full-length protein, can be readily detected in cytoplasmic but not nuclear fractions. These fragments were detected at all ages and are not a consequence of the pathogenic process. We demonstrated that the smallest fragment is an exon 1 huntingtin protein, known to contain a potent nuclear export signal. Prior to the onset of behavioral phenotypes, the exon 1 protein, and possibly other small fragments, accumulate in neuronal nuclei in the form of a detergent insoluble complex, visualized as diffuse granular nuclear staining in tissue sections. This methodology can be used to validate the inhibition of specific proteases as therapeutic targets for HD by pharmacological or genetic approaches.	[Landles, Christian; Sathasivam, Kirupa; Woodman, Ben; Moffitt, Hilary; Bates, Gillian P.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Weiss, Andreas; Paganetti, Paolo] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Finkbeiner, Steve] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Finkbeiner, Steve] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Finkbeiner, Steve] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Sun, Banghua; Richards, William G.] Dept Metab Disorders, Thousand Oaks, CA 91320 USA; [Gafni, Juliette; Ellerby, Lisa M.] Buck Inst Age Res, Novato, CA 94945 USA; [Trottier, Yvon] CNRS, INSERM Uds, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Osmand, Alex] Univ Tennessee, Dept Med, Grad Sch Med, Knoxville, TN 37920 USA	University of London; King's College London; Novartis; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Buck Institute for Research on Aging; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Tennessee System; University of Tennessee Health Science Center	Bates, GP (corresponding author), Kings Coll London, Sch Med, Dept Med & Mol Genet, Guys Hosp, 8th Floor Tower Wing, London SE1 9RT, England.	gillian.bates@kcl.ac.uk	Bates, Gillian P/E-1146-2012; Trottier, Yvon/H-8852-2016; Paganetti, Paolo/AAF-8039-2020	Bates, Gillian P/0000-0002-4041-6305; Landles, Christian/0000-0001-9715-6447; Trottier, Yvon/0000-0001-7230-4810; Paganetti, Paolo/0000-0003-1896-6324	National Institutes of Health [NS40251]; Huntington's Disease Society of America Coalition for the Cure; CHDI Foundation; Hereditary Disease Foundation; Medical Research Council [G9800001]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040251] Funding Source: NIH RePORTER; Medical Research Council [G0801314] Funding Source: researchfish; MRC [G0801314, G9800001] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntington's Disease Society of America Coalition for the Cure; CHDI Foundation; Hereditary Disease Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant NS40251 (to L. M. E.). This work was also supported by the Huntington's Disease Society of America Coalition for the Cure (to G. P. B.), the CHDI Foundation, the Hereditary Disease Foundation (to A. O.), and the Medical Research Council (Grant G9800001).	BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Davies SW, 1999, METHOD ENZYMOL, V309, P687; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Osmand AP, 2006, METHOD ENZYMOL, V412, P106, DOI 10.1016/S0076-6879(06)12008-X; Paganetti P, 2009, CHEMBIOCHEM, V10, P1678, DOI 10.1002/cbic.200900131; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Smith DL, 2001, NEUROBIOL DIS, V8, P1017, DOI 10.1006/nbdi.2001.0438; Sun B, 2002, NEUROBIOL DIS, V11, P111, DOI 10.1006/nbdi.2002.0539; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wang J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-1; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	41	223	228	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8808	8823		10.1074/jbc.M109.075028	http://dx.doi.org/10.1074/jbc.M109.075028			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086007	Green Published, hybrid			2022-12-25	WOS:000275553700033
J	Li, GD; Chiara, DC; Cohen, JB; Olsen, RW				Li, Guo-Dong; Chiara, David C.; Cohen, Jonathan B.; Olsen, Richard W.			Numerous Classes of General Anesthetics Inhibit Etomidate Binding to gamma-Aminobutyric Acid Type A (GABA(A)) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; SITES; PROPOFOL; ALCOHOL; GLYCINE; PHARMACOLOGY; ISOFLURANE; SUBTYPES; DISTINCT; MODELS	Enhancement of gamma-aminobutyric acid type A receptor (GABA(A)R)-mediated inhibition is a property of most general anesthetics and a candidate for a molecular mechanism of anesthesia. Intravenous anesthetics, including etomidate, propofol, barbiturates, and neuroactive steroids, as well as volatile anesthetics and long-chain alcohols, all enhance GABA(A)R function at anesthetic concentrations. The implied existence of a receptor site for anesthetics on the GABA(A)R protein was supported by identification, using photoaffinity labeling, of a binding site for etomidate within the GABA(A)R transmembrane domain at the beta-alpha subunit interface; the etomidate analog [H-3]azietomidate photolabeled in a pharmacologically specific manner two amino acids, alpha 1Met-236 in the M1 helix and beta Met-286 in the M3 helix (Li, G. D., Chiara, D. C., Sawyer, G. W., Husain, S. S., Olsen, R. W., and Cohen, J. B. (2006) J. Neurosci. 26, 11599-11605). Here, we use [H-3]azietomidate photolabeling of bovine brain GABA(A)Rs to determine whether other structural classes of anesthetics interact with the etomidate binding site. Photolabeling was inhibited by anesthetic concentrations of propofol, barbiturates, and the volatile agent isoflurane, at low millimolar concentrations, but not by octanol or ethanol. Inhibition by barbiturates, which was pharmacologically specific and stereospecific, and by propofol was only partial, consistent with allosteric interactions, whereas isoflurane inhibition was nearly complete, apparently competitive. Protein sequencing showed that propofol inhibited to the same extent the photolabeling of alpha 1Met-236 and beta Met-286. These results indicate that several classes of general anesthetics modulate etomidate binding to the GABA(A)R: isoflurane binds directly to the site with millimolar affinity, whereas propofol and barbiturates inhibit binding but do not bind in a mutually exclusive manner with etomidate.	[Li, Guo-Dong; Olsen, Richard W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School	Li, GD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	guodongli@mednet.ucla.edu; rolsen@mednet.ucla.edu			National Institutes of Health [GM 58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 58448 ( to R.W.O., J.B.C., and Keith W. Miller).	Altomare C, 2003, EUR J PHARM SCI, V20, P17, DOI 10.1016/S0928-0987(03)00161-1; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bonin RP, 2008, PHARMACOL BIOCHEM BE, V90, P105, DOI 10.1016/j.pbb.2007.12.011; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Hall AC, 2004, ANESTH ANALG, V98, P1297, DOI 10.1213/01.ANE.0000111108.78745.AD; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Harrison NL, 2000, GABA IN THE NERVOUS SYSTEM: THE VIEW AT FIFTY YEARS, P167; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jia F, 2008, J PHARMACOL EXP THER, V324, P1127, DOI 10.1124/jpet.107.134569; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Krasowski MD, 1998, J PHARMACOL EXP THER, V284, P934; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; LEEBLUNDBERG F, 1982, MOL PHARMACOL, V21, P320; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; OLSEN RW, 1986, MOL CELLULAR MECHANI, P165; Reynolds DS, 2003, J NEUROSCI, V23, P8608; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; STEWART DS, 2009, SOC NEUR OCT 17 21 2; TICKU MK, 1978, LIFE SCI, V22, P1643, DOI 10.1016/0024-3205(78)90061-9; TICKU MK, 1986, MOL CELLULAR MECHANI, P179; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; WONG EHF, 1984, EUR J PHARMACOL, V102, P205, DOI 10.1016/0014-2999(84)90252-8; Yamakura T, 2001, ANNU REV PHARMACOL, V41, P23, DOI 10.1146/annurev.pharmtox.41.1.23	39	71	72	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8615	8620		10.1074/jbc.M109.074708	http://dx.doi.org/10.1074/jbc.M109.074708			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20083606	hybrid, Green Published			2022-12-25	WOS:000275553700013
J	Buescher, JL; Phiel, CJ				Buescher, Jessica L.; Phiel, Christopher J.			A Noncatalytic Domain of Glycogen Synthase Kinase-3 (GSK-3) Is Essential for Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; DIFFERENTIAL REGULATION; SUBSTRATE-SPECIFICITY; TAU-PHOSPHORYLATION; MICROTUBULE-BINDING; STRUCTURAL BASIS; XENOPUS EMBRYOS; 3-BETA; DISEASE	Glycogen synthase kinase-3 (GSK-3) isoforms, GSK-3 alpha and GSK-3 beta, are serine/threonine kinases involved in numerous cellular processes and diverse diseases, including Alzheimer disease, cancer, and diabetes. GSK-3 isoforms function redundantly in some settings, while, in others, they exhibit distinct activities. Despite intensive investigation into the physiological roles of GSK-3 isoforms, the basis for their differential activities remains unresolved. A more comprehensive understanding of the mechanistic basis for GSK-3 isoform-specific functions could lead to the development of isoform-specific inhibitors. Here, we describe a structure-function analysis of GSK-3 alpha and GSK-3 beta in mammalian cells. We deleted the noncatalytic N and C termini in both GSK-3 isoforms and generated point mutations of key regulatory residues. We examined the effect of these mutations on GSK-3 activity toward Tau, activity in Wnt signaling, interaction with Axin, and GSK-3 alpha/beta Tyr(279/216) phosphorylation. We found that the N termini of both GSK-3 isoforms were dispensable, whereas progressive C-terminal deletions resulted in protein misfolding exhibited by deficient activity, impaired ability to interact with Axin, and a loss of Tyr(279/216) phosphorylation. Our data predict that small molecules targeting the divergent C terminus may lead to isoform-specific GSK-3 inhibition through destabilization of the GSK-3 structure.	[Phiel, Christopher J.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; Ohio State Univ, Coll Med, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Phiel, CJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, 700 Childrens Dr W432, Columbus, OH 43205 USA.	phiel.1@osu.edu			National Institutes of Health NIA [R01AG031883]; NATIONAL INSTITUTE ON AGING [R01AG031883] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant R01AG031883 (to C.J.P.) from NIA.	Aoki M, 2004, ACTA CRYSTALLOGR D, V60, P439, DOI [10.1107/S090744490302938X, 10.1107/S090744490302938x]; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; GOODE N, 1992, J BIOL CHEM, V267, P16878; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009; Lau KF, 1999, J PEPT RES, V54, P85, DOI 10.1034/j.1399-3011.1999.00083.x; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; PIERCE SB, 1995, DEVELOPMENT, V121, P755; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	40	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7957	7963		10.1074/jbc.M109.091603	http://dx.doi.org/10.1074/jbc.M109.091603			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080974	hybrid, Green Published			2022-12-25	WOS:000275413800013
J	Seeger, MA; Rice, SE				Seeger, Mark A.; Rice, Sarah E.			Microtubule-associated Protein-like Binding of the Kinesin-1 Tail to Microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN; TERMINAL DOMAIN; MOTOR PROTEIN; TRANSPORT; TUBULIN; DYNEIN; LOCALIZATION; MOLECULE; SITES; TAU	The kinesin-1 molecular motor contains an ATP-dependent microtubule-binding site in its N-terminal head domain and an ATP-independent microtubule-binding site in its C-terminal tail domain. Here we demonstrate that a kinesin-1 tail fragment associates with microtubules with submicromolar affinity. Binding is largely electrostatic in nature, and is facilitated by a region of basic amino acids in the tail and the acidic E-hook at the C terminus of tubulin. The tail binds to a site on tubulin that is independent of the head domain-binding site but overlaps with the binding site of the microtubule-associated protein Tau. Surprisingly, the kinesin tail domain stimulates microtubule assembly and stability in a manner similar to Tau. The biological function of this strong kinesin tail-microtubule interaction remains to be seen, but it is likely to play an important role in kinesin regulation due to the close proximity of the microtubule- binding region to the conserved regulatory and cargobinding domains of the tail.	[Seeger, Mark A.; Rice, Sarah E.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University	Rice, SE (corresponding author), 303 E Chicago Ave,Ward 8-321, Chicago, IL 60611 USA.	s-rice@northwestern.edu	Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir I/0000-0002-6361-2798; Seeger, Mark/0000-0001-8149-947X	National Institutes of Health [GM072656]; Northwestern University Molecular Biophysics Training Program [5T32 GM008382]; Northwestern University Malkin Scholarship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072656, T32GM008382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Molecular Biophysics Training Program; Northwestern University Malkin Scholarship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM072656 (to S. E. R.), Northwestern University Molecular Biophysics Training Program Grant 5T32 GM008382 (to M. A. S.), and the Northwestern University Malkin Scholarship Program (to M. A. S.).	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Hackney DD, 2009, BIOCHEMISTRY-US, V48, P3448, DOI 10.1021/bi8022575; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Karabay A, 2003, BIOCHEM BIOPH RES CO, V305, P523, DOI 10.1016/S0006-291X(03)00827-1; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; Karabay A, 1999, BIOCHEM BIOPH RES CO, V258, P39, DOI 10.1006/bbrc.1999.0572; LEE JC, 1978, BIOCHEMISTRY-US, V17, P2783, DOI 10.1021/bi00607a013; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Marx A, 2006, J MUSCLE RES CELL M, V27, P125, DOI 10.1007/s10974-005-9051-4; NAVONE F, 1992, J CELL BIOL, V117, P1263, DOI 10.1083/jcb.117.6.1263; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; RODIONOV VI, 1990, J BIOL CHEM, V265, P5702; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Straube A, 2006, MOL BIOL CELL, V17, P907, DOI 10.1091/mbc.E05-06-0542; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376; Yonekura H, 2006, BIOCHEM BIOPH RES CO, V343, P420, DOI 10.1016/j.bbrc.2006.02.169	35	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8155	8162		10.1074/jbc.M109.068247	http://dx.doi.org/10.1074/jbc.M109.068247			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071331	Green Published, hybrid			2022-12-25	WOS:000275413800034
J	Carr, RW; Sittl, R; Fleckenstein, J; Grafe, P				Carr, Richard W.; Sittl, Ruth; Fleckenstein, Johannes; Grafe, Peter			GABA Increases Electrical Excitability in a Subset of Human Unmyelinated Peripheral Axons	PLOS ONE			English	Article							ROOT GANGLION NEURONS; GAMMA-AMINOBUTYRIC-ACID; PRIMARY AFFERENT NEURONS; HUMAN SKIN; C-FIBERS; CHLORIDE REGULATION; SENSORY NEURONS; NERVOUS-SYSTEM; RECEPTORS; RAT	Background: A proportion of small diameter primary sensory neurones innervating human skin are chemosensitive. They respond in a receptor dependent manner to chemical mediators of inflammation as well as naturally occurring algogens, thermogens and pruritogens. The neurotransmitter GABA is interesting in this respect because in animal models of neuropathic pain GABA pre-synaptically regulates nociceptive input to the spinal cord. However, the effect of GABA on human peripheral unmyelinated axons has not been established. Methodology/Principal Findings: Electrical stimulation was used to assess the effect of GABA on the electrical excitability of unmyelinated axons in isolated fascicles of human sural nerve. GABA (0.1-100 mu M) increased electrical excitability in a subset (ca. 40%) of C-fibres in human sural nerve fascicles suggesting that axonal GABA sensitivity is selectively restricted to a sub-population of human unmyelinated axons. The effects of GABA were mediated by GABA(A) receptors, being mimicked by bath application of the GABA(A) agonist muscimol (0.1-30 mu M) while the GABA(B) agonist baclofen (10-30 mu M) was without effect. Increases in excitability produced by GABA (10-30 mu M) were blocked by the GABA(A) antagonists gabazine (10-20 mu M), bicuculline (10-20 mu M) and picrotoxin (10-20 mu M). Conclusions/Significance: Functional GABA(A) receptors are present on a subset of unmyelinated primary afferents in humans and their activation depolarizes these axons, an effect likely due to an elevated intra-axonal chloride concentration. GABA(A) receptor modulation may therefore regulate segmental and peripheral components of nociception.	[Carr, Richard W.; Sittl, Ruth; Grafe, Peter] Univ Munich, Inst Physiol, D-8000 Munich, Germany; [Fleckenstein, Johannes] Univ Munich, Dept Anaesthesiol, D-8000 Munich, Germany	University of Munich; University of Munich	Carr, RW (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-8000 Munich, Germany.	Richard.Carr@med.uni-muenchen.de	Carr, Richard/GSD-4859-2022; Fleckenstein, Johannes/AAL-1315-2021; Carr, Richard/AAE-9188-2020	Carr, Richard/0000-0001-8617-9133; Fleckenstein, Johannes/0000-0003-3442-0380	Deutsche Forschungsgemeinschaft [GR 801/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (GR 801/3-1). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZLEEFMANS FJ, 1988, J PHYSIOL-LONDON, V406, P225, DOI 10.1113/jphysiol.1988.sp017378; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BALLANYI K, 1985, J PHYSIOL-LONDON, V365, P41, DOI 10.1113/jphysiol.1985.sp015758; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; BOWERY NG, 1976, BRIT J PHARMACOL, V57, P73, DOI 10.1111/j.1476-5381.1976.tb07658.x; BOWERY NG, 1979, J PHYSIOL-LONDON, V293, P51, DOI 10.1113/jphysiol.1979.sp012878; BROWN DA, 1979, TRENDS NEUROSCI, V2, P271, DOI 10.1016/0166-2236(79)90107-3; BROWN DA, 1979, J PHYSIOL-PARIS, V75, P667; BROWN DA, 1978, BRAIN RES, V156, P187, DOI 10.1016/0006-8993(78)90098-7; Campero M, 2004, ACTA PHYSIOL SCAND, V182, P305, DOI 10.1111/j.1365-201X.2004.01357.x; Carlton SM, 1999, NEUROSCIENCE, V93, P713, DOI 10.1016/S0306-4522(99)00101-3; CHOI DW, 1981, J NEUROPHYSIOL, V45, P632, DOI 10.1152/jn.1981.45.4.632; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; DESARMENIEN M, 1984, EXP BRAIN RES, V54, P521; DESCHENES M, 1976, BRAIN RES, V118, P494, DOI 10.1016/0006-8993(76)90319-X; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Freysoldt A, 2009, BRIT J PHARMACOL, V158, P797, DOI 10.1111/j.1476-5381.2009.00347.x; Funk K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-32; GALLAGHER JP, 1978, J PHYSIOL-LONDON, V275, P263, DOI 10.1113/jphysiol.1978.sp012189; Ito K, 2007, BBA-GEN SUBJECTS, V1770, P291, DOI 10.1016/j.bbagen.2006.09.017; JORUM E, 1989, J PHYSIOL-LONDON, V416, P291, DOI 10.1113/jphysiol.1989.sp017761; Kocsis Jeffery D., 1995, P281; Lang PM, 2006, J NEUROPHYSIOL, V96, P2963, DOI 10.1152/jn.00716.2006; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Maddox FN, 2004, DEV BRAIN RES, V149, P143, DOI 10.1016/j.devbrainres.2004.01.001; Magnaghi V, 2006, J MOL NEUROSCI, V28, P89, DOI 10.1385/JMN:28:1:89; Magnaghi V, 2004, EUR J NEUROSCI, V19, P2641, DOI 10.1111/j.0953-816X.2004.03368.x; Mayer C, 1999, PAIN, V81, P317, DOI 10.1016/S0304-3959(99)00015-9; Moalem-Taylor G, 2007, MUSCLE NERVE, V36, P172, DOI 10.1002/mus.20793; MORITA K, 1993, J NEUROPHYSIOL, V70, P1874, DOI 10.1152/jn.1993.70.5.1874; MORRIS ME, 1983, BRAIN RES, V278, P117, DOI 10.1016/0006-8993(83)90230-5; Munro G, 2009, TRENDS PHARMACOL SCI, V30, P453, DOI 10.1016/j.tips.2009.06.004; Murinson BB, 2005, J COMP NEUROL, V484, P392, DOI 10.1002/cne.20506; OCHOA J, 1969, ACTA NEUROPATHOL, V13, P197, DOI 10.1007/BF00690642; Pawson L, 2009, J NEUROSCI, V29, P2695, DOI 10.1523/JNEUROSCI.5974-08.2009; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; RANG HP, 1968, J PHYSIOL-LONDON, V196, P183, DOI 10.1113/jphysiol.1968.sp008502; RAYMOND SA, 1990, BRAIN RES, V526, P318, DOI 10.1016/0006-8993(90)91239-D; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Serra J, 1999, J PHYSIOL-LONDON, V515, P799, DOI 10.1111/j.1469-7793.1999.799ab.x; Soleng AF, 2003, J PHYSIOL-LONDON, V552, P459, DOI 10.1113/jphysiol.2003.048058; Sung KW, 2000, J NEUROSCI, V20, P7531; Trigo FF, 2008, EUR J NEUROSCI, V28, P841, DOI 10.1111/j.1460-9568.2008.06404.x; Valeyev AY, 1996, J NEUROPHYSIOL, V76, P3555, DOI 10.1152/jn.1996.76.5.3555; Valeyev AY, 1999, J NEUROPHYSIOL, V82, P1; Verdier D, 2003, J NEUROSCI, V23, P2002; WALLIS DI, 1982, NEUROPHARMACOLOGY, V21, P31, DOI 10.1016/0028-3908(82)90207-6; Weidner C, 1999, J NEUROSCI, V19, P10184; Zeilhofer HU, 2009, TRENDS PHARMACOL SCI, V30, P397, DOI 10.1016/j.tips.2009.05.007	50	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8780	10.1371/journal.pone.0008780	http://dx.doi.org/10.1371/journal.pone.0008780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098693	gold, Green Published, Green Submitted			2022-12-25	WOS:000273779000010
J	Qiang, M; Denny, A; Chen, JG; Ticku, MK; Yan, B; Henderson, G				Qiang, Mei; Denny, Ashley; Chen, Jiguo; Ticku, Maharaj K.; Yan, Bo; Henderson, George			The Site Specific Demethylation in the 5 '-Regulatory Area of NMDA Receptor 2B Subunit Gene Associated with CIE-Induced Up-Regulation of Transcription	PLOS ONE			English	Article							CHRONIC ETHANOL TREATMENT; MESSENGER-RNA EXPRESSION; D-ASPARTATE RECEPTORS; DNA METHYLATION; CORTICAL-NEURONS; EPIGENETIC MECHANISMS; MEMORY FORMATION; NERVOUS-SYSTEM; GABAERGIC INTERNEURONS; ALCOHOL-WITHDRAWAL	Background: The NMDA receptor represents a particularly important site of ethanol action in the CNS. We recently reported that NMDA receptor 2B (NR2B) gene expression was persistently up-regulated following chronic intermittent ethanol (CIE) treatment. Increasing evidence that epigenetic mechanisms are involved in dynamic and long-lasting regulation of gene expression in multiple neuroadaptive processes prompted us to investigate the role of DNA methylation in mediating CIE-induced up-regulation of NR2B gene transcription. To dissect the changes of DNA methylation in the NR2B gene, we have screened a large number of CpG sites within its 5'-regulatory area following CIE treatment. Methods: Primary cortical cultured neurons were subjected to ethanol treatment in a CIE paradigm. Bisulfite conversion followed by pyrosequencing was used for quantitative measurement and analysis of CpG methylation status within the 5'-regulatory area of the NR2B gene; chromatin immunoprecipitation (ChIP) assay was used to examine DNA levels associated with methylation and transcription factor binding. Electrophoretic mobility shift assay (EMSA) and in vitro DNA methylation assays were performed to determine the direct impact of DNA methylation on the interaction between DNA and transcription factor and promoter activity. Results: Analysis of individual CpG methylation sites within the NR2B 5'-regulatory area revealed three regions with clusters of site-specific CpG demethylation following CIE treatment and withdrawal. This was confirmed by ChIP showing similar decreases of methylated DNA in the same regions. The CIE-induced demethylation is characterized by being located near certain transcription factor binding sequences, AP-1 and CRE, and occurred during treatment as well as after ethanol withdrawal. Furthermore, the increase in vitro of methylated DNA decreased transcription factor binding activity and promoter activity. An additional ChIP assay indicated that the CIE-induced DNA demethylation is accompanied by increased occupation by transcription factors. Conclusions: These results suggest an important role of DNA demethylation in mediating CIE-induced NR2B gene up-regulation, thus implicating a novel molecular site of alcohol action.	[Qiang, Mei; Denny, Ashley; Ticku, Maharaj K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Yan, Bo] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol, San Antonio, TX 78229 USA; [Chen, Jiguo] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; [Henderson, George] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Mississippi State University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Qiang, M (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	qiang@uthscsa.edu		Chen, Jack/0000-0001-7528-4835	National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism [RO1 AA017362]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017362] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by funding provided by National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov) RO1 AA017362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629; Cagetti E, 2003, MOL PHARMACOL, V63, P53, DOI 10.1124/mol.63.1.53; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; FOLLESA P, 1995, MOL BRAIN RES, V29, P99, DOI 10.1016/0169-328X(94)00235-7; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Inano K, 2000, J BIOCHEM-TOKYO, V128, P315, DOI 10.1093/oxfordjournals.jbchem.a022755; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; KOKKA N, 1993, ALCOHOL CLIN EXP RES, V17, P525, DOI 10.1111/j.1530-0277.1993.tb00793.x; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mattson MP, 2003, AGEING RES REV, V2, P329, DOI 10.1016/S1568-1637(03)00013-8; Meaney MJ, 2005, TRENDS NEUROSCI, V28, P456, DOI 10.1016/j.tins.2005.07.006; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Nagy J, 2004, NEUROCHEM INT, V44, P17, DOI 10.1016/S0197-0186(03)00100-1; Nagy J, 2002, NEUROCHEM INT, V40, P585, DOI 10.1016/S0197-0186(01)00131-0; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Narita M, 2000, EUR J PHARMACOL, V401, P191, DOI 10.1016/S0014-2999(00)00428-3; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Nelson TE, 2005, BRAIN RES, V1048, P69, DOI 10.1016/j.brainres.2005.04.041; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; NIEUWENHUYS R, 1994, ANAT EMBRYOL, V190, P307; Noh JS, 2005, P NATL ACAD SCI USA, V102, P1749, DOI 10.1073/pnas.0409648102; Ogata J, 2006, J PHARMACOL EXP THER, V318, P434, DOI 10.1124/jpet.106.101691; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; PASCALE RM, 1991, ANTICANCER RES, V11, P1617; Qiang M, 2005, J NEUROCHEM, V95, P1332, DOI 10.1111/j.1471-4159.2005.03464.x; Qiang M, 2005, MOL PHARMACOL, V67, P2115, DOI 10.1124/mol.104.010751; QIANG M, 2007, MOL PHARM; Ramchandani S, 1999, P NATL ACAD SCI USA, V96, P6107, DOI 10.1073/pnas.96.11.6107; Rani CSS, 2006, ALCOHOL, V38, P89, DOI 10.1016/j.alcohol.2006.05.002; Rani CSS, 2005, MOL PHARMACOL, V67, P2126, DOI 10.1124/mol.104.007872; Ravindran CRM, 2004, MOL BRAIN RES, V121, P19, DOI 10.1016/j.molbrainres.2003.10.025; ROBERTSON KD, 1995, MOL CELL BIOL, V15, P6150; RON D, 2005, SCI STKE, pRE14; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Ruzicka WB, 2007, MOL PSYCHIATR, V12, P385, DOI 10.1038/sj.mp.4001954; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Satta R, 2008, P NATL ACAD SCI USA, V105, P16356, DOI 10.1073/pnas.0808699105; Shi HD, 2003, CANCER RES, V63, P2164; Szyf M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P533, DOI 10.1007/s10541-005-0147-7; Szyf M, 2004, BIOCHEM PHARMACOL, V68, P1187, DOI 10.1016/j.bcp.2004.04.030; Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999; TREVISAN L, 1994, J NEUROCHEM, V62, P1635; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Veldic M, 2004, P NATL ACAD SCI USA, V101, P348, DOI 10.1073/pnas.2637013100; Veldic M, 2007, SCHIZOPHR RES, V91, P51, DOI 10.1016/j.schres.2006.11.029; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wu H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe17; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07	76	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8798	10.1371/journal.pone.0008798	http://dx.doi.org/10.1371/journal.pone.0008798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098704	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000025
J	Gonzalo, V; Lozano, JJ; Munoz, J; Balaguer, F; Pellise, M; de Miguel, CR; Andreu, M; Jover, R; Llor, X; Giraldez, MD; Ocana, T; Serradesanferm, A; Alonso-Espinaco, V; Jimeno, M; Cuatrecasas, M; Sendino, O; Castellvi-Bel, S; Castells, A				Gonzalo, Victoria; Jose Lozano, Juan; Munoz, Jenifer; Balaguer, Francesc; Pellise, Maria; Rodriguez de Miguel, Cristina; Andreu, Montserrat; Jover, Rodrigo; Llor, Xavier; Dolores Giraldez, M.; Ocana, Teresa; Serradesanferm, Anna; Alonso-Espinaco, Virginia; Jimeno, Mireya; Cuatrecasas, Miriam; Sendino, Oriol; Castellvi-Bel, Sergi; Castells, Antoni		Spanish Gastroenterological Assoc	Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; REVISED BETHESDA GUIDELINES; K-RAS MUTATIONS; DNA METHYLATION; ULCERATIVE-COLITIS; COLON; RASSF1A; MULTICENTER; IDENTIFICATION; SURVEILLANCE	Background: Colorectal cancer (CRC) multiplicity has been mainly related to polyposis and non-polyposis hereditary syndromes. In sporadic CRC, aberrant gene promoter methylation has been shown to play a key role in carcinogenesis, although little is known about its involvement in multiplicity. To assess the effect of methylation in tumor multiplicity in sporadic CRC, hypermethylation of key tumor suppressor genes was evaluated in patients with both multiple and solitary tumors, as a proof-of-concept of an underlying epigenetic defect. Methodology/Principal Findings: We examined a total of 47 synchronous/metachronous primary CRC from 41 patients, and 41 gender, age (5-year intervals) and tumor location-paired patients with solitary tumors. Exclusion criteria were polyposis syndromes, Lynch syndrome and inflammatory bowel disease. DNA methylation at the promoter region of the MGMT, CDKN2A, SFRP1, TMEFF2, HS3ST2 (3OST2), RASSF1A and GATA4 genes was evaluated by quantitative methylation specific PCR in both tumor and corresponding normal appearing colorectal mucosa samples. Overall, patients with multiple lesions exhibited a higher degree of methylation in tumor samples than those with solitary tumors regarding all evaluated genes. After adjusting for age and gender, binomial logistic regression analysis identified methylation of MGMT2 (OR, 1.48; 95% CI, 1.10 to 1.97; p = 0.008) and RASSF1A (OR, 2.04; 95% CI, 1.01 to 4.13; p = 0.047) as variables independently associated with tumor multiplicity, being the risk related to methylation of any of these two genes 4.57 (95% CI, 1.53 to 13.61; p = 0.006). Moreover, in six patients in whom both tumors were available, we found a correlation in the methylation levels of MGMT2 (r = 0.64, p = 0.17), SFRP1 (r = 0.83, 0.06), HPP1 (r = 0.64, p = 0.17), 3OST2 (r = 0.83, p = 0.06) and GATA4 (r = 0.6, p = 0.24). Methylation in normal appearing colorectal mucosa from patients with multiple and solitary CRC showed no relevant difference in any evaluated gene. Conclusions: These results provide a proof-of-concept that gene promoter methylation is associated with tumor multiplicity. This underlying epigenetic defect may have noteworthy implications in the prevention of patients with sporadic CRC.	[Gonzalo, Victoria; Munoz, Jenifer; Balaguer, Francesc; Pellise, Maria; Rodriguez de Miguel, Cristina; Dolores Giraldez, M.; Ocana, Teresa; Alonso-Espinaco, Virginia; Sendino, Oriol; Castellvi-Bel, Sergi; Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Inst Malalties Digest & Metab,IDIBAPS, Hosp Clin,Ctr Invest Biomed Red Area Temat Enferm, Barcelona, Catalonia, Spain; [Jose Lozano, Juan] Ctr Invest Biomed Red Area Temat Enfermedades Hep, Barcelona, Catalonia, Spain; [Andreu, Montserrat] Hosp del Mar, Dept Gastroenterol, Barcelona, Catalonia, Spain; [Jover, Rodrigo] Gen Hosp Univ Alicante, Dept Gastroenterol, E-03080 Alicante, Spain; [Llor, Xavier] Univ Illinois, Sect Digest Dis & Nutr, Chicago, IL USA; [Serradesanferm, Anna] Univ Barcelona, Prevent Med & Epidemiol Unit, IDIBAPS, Hosp Clin,Ctr Invest Biomed Red Area Temat Enferm, Barcelona, Catalonia, Spain; [Jimeno, Mireya; Cuatrecasas, Miriam] Univ Barcelona, Dept Pathol,IDIBAPS, Inst Malalties Digest & Metab,Ctr Diagnost Biomed, Hosp Clin,Ctr Invest Biomed Red Area Temat Enferm, Barcelona, Catalonia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; General University Hospital of Alicante; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Gonzalo, V (corresponding author), Univ Barcelona, Dept Gastroenterol, Inst Malalties Digest & Metab,IDIBAPS, Hosp Clin,Ctr Invest Biomed Red Area Temat Enferm, Barcelona, Catalonia, Spain.	castells@clinic.ub.es	Dolz Abadía, Carlos/I-1757-2017; CUBIELLA, JOAQUIN/G-7692-2017; Balaguer, Francesc/GPX-7801-2022; Giraldez, Maria D/E-7395-2018; Castells, Antoni/ABC-1002-2021; Felis, Carmen Pinol/C-6397-2011; Cuatrecasas, Miriam/C-9156-2019; Andreu, Montserrat/D-9911-2015; BALAGUER, FRANCESC/G-2389-2016; Pellise, Maria/ABC-3246-2021; Jover, Rodrigo/ABC-3258-2021; Padillo-Ruiz, Javier/AAF-9792-2021; Bujanda, Luis/AAB-2485-2021; Carballo, Fernando/M-4668-2016	CUBIELLA, JOAQUIN/0000-0002-9994-4831; Giraldez, Maria D/0000-0001-6829-7603; Castells, Antoni/0000-0001-8431-2033; Felis, Carmen Pinol/0000-0003-0626-1298; Cuatrecasas, Miriam/0000-0003-3063-0110; Andreu, Montserrat/0000-0003-4286-1098; Jover, Rodrigo/0000-0003-3742-3413; Padillo-Ruiz, Javier/0000-0002-1220-0822; Bujanda, Luis/0000-0002-4353-9968; Sanchez Hernandez, Eloy/0000-0003-2493-8303; Pellise, Maria/0000-0001-9739-4998; Fernandez-Banares, Fernando/0000-0002-1489-504X; ESTEVE, MARIA/0000-0001-7716-0027; Pinol, Virginia/0000-0003-3669-6989; Lozano, Juan Jose/0000-0001-7613-3908; Balaguer, Francesc/0000-0002-0206-0539; Bessa Caserras, Xavier/0000-0003-4680-1228; Carballo, Fernando/0000-0003-1152-1517; Rodriguez de Miguel, Cristina/0000-0002-5576-0854; Castellvi-Bel, Sergi/0000-0003-1217-5097; Sendino, Oriol/0000-0002-2235-6927; Alenda, Cristina/0000-0002-0560-1759	Ministerio de Ciencia e Innovacion [SAF 07-64873]; Fondo de Investigacio n Sanitaria [PI061384, PI080024]; Asociacio n Espanola Contra el Cancer; Fundacion Investigacio n Medica Mutua Madrilena [PI040296]; Fundacio n Olga Torres [PI040212]; Olympus Medical Systems-Europe; Instituto de Salud Carlos III [PI016017]; Fundacion Alfonso Martin Escudero; Fondo de Investigacion Sanitaria [CP 03-0070]; Instituto de Salud Carlos III	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigacio n Sanitaria(Instituto de Salud Carlos III); Asociacio n Espanola Contra el Cancer; Fundacion Investigacio n Medica Mutua Madrilena; Fundacio n Olga Torres; Olympus Medical Systems-Europe; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Alfonso Martin Escudero; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (SAF 07-64873), Fondo de Investigacio n Sanitaria (PI061384 and PI080024), Asociacio n Espanola Contra el Cancer (Fundacion Cientifi ca and Junta de Barcelona), Fundacion Investigacio n Medica Mutua Madrilena (PI040296), Fundacio n Olga Torres (PI040212), and Accionen Cancer (Instituto de Salud Carlos III). Victoria Gonzalo was supported by a grant from the Hospital Clinic, Cristina Rodriguez by a grant from Olympus Medical Systems-Europe, Mireya Jimeno by a grant from the Instituto de Salud Carlos III (PI016017), Francesc Balaguer by a grant from Fundacion Alfonso Martin Escudero, and Sergi Castellvi-Bel by a contract from the Fondo de Investigacion Sanitaria (CP 03-0070). Centro de Investigacio n Biome dica en Red en el A rea tema tica de Enfermedades Hepa ticas y Digestivas (CIBERehd) is funded by Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; [Anonymous], 2008, CLIN GASTROENTEROL H, V6, P206, DOI 10.1016/j.cgh.2007.10.011; Balaguer F, 2008, GASTROENTEROLOGY, V134, P39, DOI 10.1053/j.gastro.2007.10.042; Balaguer F, 2007, CLIN GASTROENTEROL H, V5, P379, DOI 10.1016/j.cgh.2006.12.025; Belshaw NJ, 2008, BRIT J CANCER, V99, P136, DOI 10.1038/sj.bjc.6604432; Burt R, 2005, GASTROENTEROLOGY, V128, P1696, DOI 10.1053/j.gastro.2005.03.036; Caldwell GM, 2006, BRIT J CANCER, V94, P922, DOI 10.1038/sj.bjc.6602967; Eads CA, 1999, CANCER RES, V59, P2302; Eads CA, 2000, CANCER RES, V60, P5021; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Esteller M, 2000, CANCER RES, V60, P2368; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Greenspan EJ, 2006, CARCINOGENESIS, V27, P1316, DOI 10.1093/carcin/bgi373; Guan RJ, 1999, GASTROENTEROLOGY, V116, P1063, DOI 10.1016/S0016-5085(99)70009-0; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Huang EH, 2008, TRENDS MOL MED, V14, P503, DOI 10.1016/j.molmed.2008.09.005; Itzkowitz SH, 2005, INFLAMM BOWEL DIS, V11, P314, DOI 10.1097/01.MIB.0000160811.76729.d5; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940; Konishi K, 2009, CANCER PREV RES, V2, P814, DOI 10.1158/1940-6207.CAPR-09-0054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llor X, 2005, CLIN CANCER RES, V11, P7304, DOI 10.1158/1078-0432.CCR-05-0965; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Nagasaka T, 2008, INT J CANCER, V122, P2429, DOI 10.1002/ijc.23398; Nosho K, 2007, CARCINOGENESIS, V28, P1364, DOI 10.1093/carcin/bgl246; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2007, GUT, V56, P1564, DOI 10.1136/gut.2007.119750; Ogino S, 2006, MODERN PATHOL, V19, P1083, DOI 10.1038/modpathol.3800618; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Oliveira C, 2005, ONCOGENE, V24, P7630, DOI 10.1038/sj.onc.1208906; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Pinol V, 2004, EUR J GASTROEN HEPAT, V16, P39, DOI 10.1097/00042737-200401000-00007; Rodriguez-Moranta F, 2006, J CLIN ONCOL, V24, P386, DOI 10.1200/JCO.2005.02.0826; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Sakamoto N, 2004, ONCOGENE, V23, P8900, DOI 10.1038/sj.onc.1207993; Sato F, 2002, CANCER RES, V62, P6820; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Takahashi T, 2006, INT J CANCER, V118, P924, DOI 10.1002/ijc.21453; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; van Engeland M, 2002, ONCOGENE, V21, P3792, DOI 10.1038/sj.onc.1205466; Wagner KJ, 2002, ONCOGENE, V21, P7277, DOI 10.1038/sj.onc.1205922; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Xicola RM, 2007, JNCI-J NATL CANCER I, V99, P244, DOI 10.1093/jnci/djk033; Xiong ZG, 2001, CANCER EPIDEM BIOMAR, V10, P799; Young J, 2001, P NATL ACAD SCI USA, V98, P265, DOI 10.1073/pnas.011415298	51	51	53	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8777	10.1371/journal.pone.0008777	http://dx.doi.org/10.1371/journal.pone.0008777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098741	gold, Green Published, Green Submitted			2022-12-25	WOS:000273778900020
J	Notari, S; Moleres, FJ; Hunter, SB; Belay, ED; Schonberger, LB; Cali, I; Parchi, P; Shieh, WJ; Brown, P; Zaki, S; Zou, WQ; Gambetti, P				Notari, Silvio; Moleres, Francisco J.; Hunter, Stephen B.; Belay, Ermias D.; Schonberger, Lawrence B.; Cali, Ignazio; Parchi, Piero; Shieh, Wun-Ju; Brown, Paul; Zaki, Sherif; Zou, Wen-Quan; Gambetti, Pierluigi			Multiorgan Detection and Characterization of Protease-Resistant Prion Protein in a Case of Variant CJD Examined in the United States	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SPONGIFORM ENCEPHALOPATHY PRIONS; CLINICAL-FEATURES; TRUNCATED FORMS; URINE; TRANSMISSION; ACCUMULATION; PRPSC; BSE; LOCALIZATION	Background: Variant Creutzfeldt-Jakob disease (vCJD) is a prion disease thought to be acquired by the consumption of prion-contaminated beef products. To date, over 200 cases have been identified around the world, but mainly in the United Kingdom. Three cases have been identified in the United States; however, these subjects were likely exposed to prion infection elsewhere. Here we report on the first of these subjects. Methodology/Principal Findings: Neuropathological and genetic examinations were carried out using standard procedures. We assessed the presence and characteristics of protease-resistant prion protein (PrP(res)) in brain and 23 other organs and tissues using immunoblots performed directly on total homogenate or following sodium phosphotungstate precipitation to increase PrP(res) detectability. The brain showed a lack of typical spongiform degeneration and had large plaques, likely stemming from the extensive neuronal loss caused by the long duration (32 months) of the disease. The PrP(res) found in the brain had the typical characteristics of the PrP(res) present in vCJD. In addition to the brain and other organs known to be prion positive in vCJD, such as the lymphoreticular system, pituitary and adrenal glands, and gastrointestinal tract, PrP(res) was also detected for the first time in the dura mater, liver, pancreas, kidney, ovary, uterus, and skin. Conclusions/Significance: Our results indicate that the number of organs affected in vCJD is greater than previously realized and further underscore the risk of iatrogenic transmission in vCJD.	[Notari, Silvio; Moleres, Francisco J.; Cali, Ignazio; Zou, Wen-Quan; Gambetti, Pierluigi] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; [Hunter, Stephen B.] Emory Univ Hosp, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Belay, Ermias D.; Schonberger, Lawrence B.; Shieh, Wun-Ju; Zaki, Sherif] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA USA; [Parchi, Piero] Univ Bologna, Dipartimento Sci Neurol, I-40126 Bologna, Italy; [Brown, Paul] SEPIA, iMETI, DSV, CEA, Paris, France	Case Western Reserve University; Emory University; Centers for Disease Control & Prevention - USA; University of Bologna; CEA; UDICE-French Research Universities; Universite Paris Saclay	Notari, S (corresponding author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	pxg13@case.edu	Zou, Wenquan/ABF-2875-2020; cali, ignazio/AAS-1127-2020; Parchi, Piero/L-9833-2015; Zou, Wenquan/GWQ-3489-2022; Belay, Ermias/A-8829-2013	cali, ignazio/0000-0001-5770-3848; Parchi, Piero/0000-0002-9444-9524; Belay, Ermias/0000-0002-9837-0960	National Institutes of Health [AG14359]; Centers for Disease Control and Prevention ( [CCU515004]; Charles S. Britton Fund; NIH [R01 NS062787]; Creutzfeldt-Jakob Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention ((United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Charles S. Britton Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creutzfeldt-Jakob Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by National Institutes of Health grant AG14359, Centers for Disease Control and Prevention (CCU515004), and the Charles S. Britton Fund to PG; grant NIH R01 NS062787 and the Creutzfeldt-Jakob Disease Foundation to WQZ, as for cost of supplies and salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrievskaia O, 2008, J VET DIAGN INVEST, V20, P141, DOI 10.1177/104063870802000201; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Belay ED, 2005, EMERG INFECT DIS, V11, P1351, DOI 10.3201/eid1109.050371; BIGNAMI A, 1970, BRAIN, V93, P89, DOI 10.1093/brain/93.1.89; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cali I, 2009, BRAIN IN PRESS; Castilla J, 2005, J VIROL, V79, P8665, DOI 10.1128/JVI.79.13.8665-8668.2005; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Head MW, 2003, INVEST OPHTH VIS SCI, V44, P342, DOI 10.1167/iovs.01-1273; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Ironside JW, 2004, CURR TOP MICROBIOL, V284, P133; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl A, P3; MURRAY K, 2009, J NEUROL NE IN PRESS; Narang HK, 2005, EXP BIOL MED, V230, P343, DOI 10.1177/153537020523000508; *NAT CJD SURV UN, 2007, CREUTZF JAK DIS SURV; Noguchi-Shinohara M, 2007, NEUROLOGY, V69, P360, DOI 10.1212/01.wnl.0000266624.63387.4a; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; PARCHI P, 2009, ACTA NERUOP IN PRESS; Pastore M, 2005, AM J PATHOL, V167, P1729, DOI 10.1016/S0002-9440(10)61254-0; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Peden AH, 2007, J GEN VIROL, V88, P1068, DOI 10.1099/vir.0.81913-0; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Siso S, 2008, J PATHOL, V215, P126, DOI 10.1002/path.2336; Spencer MD, 2002, BRIT MED J, V324, P1479, DOI 10.1136/bmj.324.7352.1479; Thomzig A, 2007, PLOS PATHOG, V3, P659, DOI 10.1371/journal.ppat.0030066; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 2003, BRIT MED BULL, V66, P255, DOI 10.1093/bmb/66.1.255; Will RG, 2000, ANN NEUROL, V47, P575; Will RG, 2004, CURR TOP MICROBIOL, V284, P121; WILL RG, 1996, LANCET, V347, P925; Xiao XZ, 2009, AM J PATHOL, V174, P1602, DOI 10.2353/ajpath.2009.081045; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Zou S, 2008, TRANSFUS MED REV, V22, P58, DOI 10.1016/j.tmrv.2007.09.003; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	54	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8765	10.1371/journal.pone.0008765	http://dx.doi.org/10.1371/journal.pone.0008765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098730	Green Submitted, gold, Green Published			2022-12-25	WOS:000273778900009
J	Grossman, EJ; Lee, DD; Tao, J; Wilson, RA; Park, SY; Bell, GI; Chong, AS				Grossman, Eric J.; Lee, David D.; Tao, Jing; Wilson, Raphael A.; Park, Soo-Young; Bell, Graeme I.; Chong, Anita S.			Glycemic Control Promotes Pancreatic Beta-Cell Regeneration in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							MASS; REVERSAL; APOPTOSIS; RECOVERY; GROWTH; RATS	Background: Pancreatic beta-cells proliferate following administration of the beta-cell toxin streptozotocin. Defining the conditions that promote beta-cell proliferation could benefit patients with diabetes. We have investigated the effect of insulin treatment on pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice, and, in addition, report on a new approach to quantify beta-cell regeneration in vivo. Methodology/Principal Findings: Streptozotocin-induced diabetic were treated with either syngeneic islets transplanted under the kidney capsule or subcutaneous insulin implants. After either 60 or 120 days of insulin treatment, the islet transplant or insulin implant were removed and blood glucose levels monitored for 30 days. The results showed that both islet transplants and insulin implants restored normoglycemia in the 60 and 120 day treated animals. However, only the 120-day islet and insulin implant groups maintained euglycemia (<200 mg/dl) following discontinuation of insulin treatment. The beta-cell was significantly increased in all the 120 day insulin-treated groups (insulin implant, 0.69 +/- 0.23 mg; and islet transplant, 0.91 +/- 0.23 mg) compared non-diabetic control mice (1.54 +/- 0.25 mg). We also show that we can use bioluminescent imaging to monitor beta-cell regeneration in living MIP-luc transgenic mice. Conclusions/Significance: The results show that insulin treatment can promote beta-cell regeneration. Moreover, the extent of restoration of beta-cell function and mass depend on the length of treatment period and overall level of glycemic control with better control being associated with improved recovery. Finally, real-time bioluminescent imaging can be used to monitor beta-cell recovery in living MIP-luc transgenic mice.	[Grossman, Eric J.; Lee, David D.; Tao, Jing; Wilson, Raphael A.; Chong, Anita S.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Park, Soo-Young; Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lee, David D.] Rush Presbyterian St Lukes Med Ctr, Dept Gen Surg, Chicago, IL USA	University of Chicago; University of Chicago; Rush University	Grossman, EJ (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	eric.grossman@uchospitals.edu	Lee, David/ABH-1406-2021; Lee, David/ABA-4123-2021	Lee, David/0000-0002-2086-0150; Wilson, Raphael/0000-0003-3325-6734	National Institute of Diabetes and Digestive And Kidney Diseases [R21DK073529, P60DK020595]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R21DK073529] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported in part by awards R21DK073529 and P60DK020595 (University of Chicago Diabetes Research and Training Center) from the National Institute of Diabetes and Digestive And Kidney Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes And Digestive and Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Guo ZG, 1997, TRANSPLANTATION, V63, P711, DOI 10.1097/00007890-199703150-00017; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Karges B, 2004, DIABETES CARE, V27, P1207, DOI 10.2337/diacare.27.5.1207; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; LOHR M, 1987, DIABETOLOGIA, V30, P757; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; NAKANISHI K, 1993, METABOLISM, V42, P196, DOI 10.1016/0026-0495(93)90035-M; Park SY, 2009, HORM METAB RES, V41, P1, DOI 10.1055/s-0028-1087209; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Smith SJ, 2006, MOL IMAGING, V5, P65, DOI 10.2310/7290.2006.00007; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; VIROSTKO J, 2009, MOL IMAGING BIOL; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yin DP, 2006, DIABETES, V55, P3256, DOI 10.2337/db05-1275; Zhao HL, 2006, DIABETOLOGIA, V49, P2801, DOI 10.1007/s00125-006-0411-4	27	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8749	10.1371/journal.pone.0008749	http://dx.doi.org/10.1371/journal.pone.0008749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090914	Green Published, gold, Green Submitted			2022-12-25	WOS:000273715000008
J	Cudaback, E; Marrs, W; Moeller, T; Stella, N				Cudaback, Eiron; Marrs, William; Moeller, Thomas; Stella, Nephi			The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas	PLOS ONE			English	Article							REGULATED KINASE ACTIVATION; CANNABINOID RECEPTOR; GLIOMA-CELLS; HUNTINGTONS-DISEASE; PROTEIN-KINASES; CANCER; BRAIN; ENDOCANNABINOIDS; IDENTIFICATION; PATHWAY	Background: Cannabinoids represent unique compounds for treating tumors, including astrocytomas. Whether CB1 and CB2 receptors mediate this therapeutic effect is unclear. Principal Findings: We generated astrocytoma subclones that express set levels of CB1 and CB2, and found that cannabinoids induce apoptosis only in cells expressing low levels of receptors that couple to ERK1/2. In contrast, cannabinoids do not induce apoptosis in cells expressing high levels of receptors because these now also couple to the prosurvival signal AKT. Remarkably, cannabinoids applied at high concentration induce apoptosis in all subclones independently of CB1, CB2 and AKT, but still through a mechanism involving ERK1/2. Significance: The high expression level of CB1 and CB2 receptors commonly found in malignant astrocytomas precludes the use of cannabinoids as therapeutics, unless AKT is concomitantly inhibited, or cannabinoids are applied at concentrations that bypass CB1 and CB2 receptors, yet still activate ERK1/2.	[Cudaback, Eiron; Marrs, William; Stella, Nephi] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Marrs, William] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Stella, Nephi] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cudaback, E (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nstella@u.washington.edu			National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA) [R01 DA014486]; University of Washington Royalty Research; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014486] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of Washington Royalty Research(University of Washington); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by research grants from the National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) (grant number R01 DA014486; http://www.nida.nih.gov/index.html) and the University of Washington Royalty Research (http://www.washington.edu/research/main.php?page=rrf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, SCI MARIJUANA; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Cudaback E, 2007, MOL NEUROBIOL, V36, P36, DOI 10.1007/s12035-007-0016-z; Derkinderen P, 2001, J NEUROCHEM, V77, P957, DOI 10.1046/j.1471-4159.2001.00333.x; Ellert-Miklaszewska A, 2005, CELL SIGNAL, V17, P25, DOI 10.1016/j.cellsig.2004.05.011; Galve-Roperh I, 2002, MOL PHARMACOL, V62, P1385, DOI 10.1124/mol.62.6.1385; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; GLASS M, 1993, NEUROSCIENCE, V56, P523, DOI 10.1016/0306-4522(93)90352-G; GOMEZ DP, 2000, BIOCHEM J, V347, P369; Gonsiorek W, 2006, J BIOL CHEM, V281, P28143, DOI 10.1074/jbc.M602364200; Guzman M, 2005, HANDB EXP PHARMACOL, V168, P627; Guzman M, 2006, BRIT J CANCER, V95, P197, DOI 10.1038/sj.bjc.6603236; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Held-Feindt J, 2006, J NEUROCHEM, V98, P886, DOI 10.1111/j.1471-4159.2006.03911.x; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; KUMANISHI T, 1967, JPN J EXP MED, V37, P461; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Massi P, 2006, CELL MOL LIFE SCI, V63, P2057, DOI 10.1007/s00018-006-6156-x; McCaw EA, 2004, EUR J BIOCHEM, V271, P4909, DOI 10.1111/j.1432-1033.2004.04460.x; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nickl K, 2008, NEUROSCI LETT, V447, P68, DOI 10.1016/j.neulet.2008.09.078; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Pei Y, 2008, CHEM BIOL, V15, P1207, DOI 10.1016/j.chembiol.2008.10.011; Petitet F, 1996, NEUROREPORT, V7, P789, DOI 10.1097/00001756-199602290-00026; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Sanchez C, 2001, CANCER RES, V61, P5784; Sanchez C, 1998, FEBS LETT, V436, P6, DOI 10.1016/S0014-5793(98)01085-0; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Shoemaker JL, 2005, J PHARMACOL EXP THER, V315, P828, DOI 10.1124/jpet.105.089474; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Widmer M, 2008, J NEUROSCI RES, V86, P3212, DOI 10.1002/jnr.21757	41	67	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8702	10.1371/journal.pone.0008702	http://dx.doi.org/10.1371/journal.pone.0008702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090845	gold, Green Submitted, Green Published			2022-12-25	WOS:000273714600005
J	Fuentes-Calvo, I; Blazquez-Medela, AM; Santos, E; Lopez-Novoa, JM; Martinez-Salgado, C				Fuentes-Calvo, Isabel; Blazquez-Medela, Ana M.; Santos, Eugenio; Lopez-Novoa, Jose M.; Martinez-Salgado, Carlos			Analysis of K-Ras Nuclear Expression in Fibroblasts and Mesangial Cells	PLOS ONE			English	Article							N-RAS; H-RAS; PROTEINS; MOUSE; TARGETS; GROWTH; FAMILY; GENE; LINE	Background: Ras GTPases are considered cytoplasmic proteins that must be localized to cell membranes for activation, and there are few evidences of the presence of any Ras isoform in nuclei of eukaryotic cells. Methodology/Principal Findings: Using conventional antibodies and inmunocytochemistry, differential centrifugation and western blot, we have observed the putative presence of K-Ras isoform in the nuclei of fibroblasts and mesangial cells. In order to avoid cross-reactions with other Ras isoforms, and using antibodies against K-Ras (R-3400, H3845-M01, sc-30) or pan-Ras (05-516, OP40) in cells that only expressed the K-Ras isoform (fibroblasts obtained from H-ras(-/-), N-ras(-/-) mice) we also detected some nuclear positive expression. To further probe the identity of nuclear K-Ras, we have generated K-Ras knockout (K-ras(-/-)) embrionary fibroblasts by mating of K-ras(+/-) heterozygote mice. Using specific antibodies, only H- and N-Ras isoforms were observed in the cytoplasm of K-ras(-/-) fibroblasts. However, both K-Ras4A and K-Ras4B positive signals were detected by immunocytochemistry and Western blot with two commercial antibodies (sc-522 and sc-521 against each isoforms, respectively) in both cytoplasm and nuclei from K-ras(-/-) fibroblasts. Conclusions/Significance: We show that the presence of K-Ras4B in fibroblast nuclei, already described by other authors, is probably due to a cross-reaction of the antibody with an undetermined nucleolar protein. Although this study also shows the possible nuclear expression of K-Ras isoform in fibroblasts or in mesangial cells, it also reveals the importance of being cautious in these studies about distribution of protein isoforms due to some important limitations imposed by the unspecificity of the antibodies or contaminations in cellular preparations.	[Fuentes-Calvo, Isabel; Blazquez-Medela, Ana M.; Lopez-Novoa, Jose M.; Martinez-Salgado, Carlos] Univ Salamanca, Inst Reina Sofia Invest Nefrol, Unidad Fisiopatol Renal & Cardiovasc, E-37008 Salamanca, Spain; [Santos, Eugenio] Univ Salamanca, CSIC, Ctr Invest Canc IBMCC, E-37008 Salamanca, Spain; [Martinez-Salgado, Carlos] Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Fuentes-Calvo, I (corresponding author), Univ Salamanca, Inst Reina Sofia Invest Nefrol, Unidad Fisiopatol Renal & Cardiovasc, E-37008 Salamanca, Spain.	carloms@usal.es	IBSAL, Secretaría/H-3719-2011; Lopez-Novoa, Jose M/A-3672-2008; Fuentes-Calvo, Isabel/A-6900-2016; Blázquez-Medela, Ana/K-3142-2014; Blázquez-Medela, Ana/ABC-1517-2021; Martinez-Salgado, Carlos/E-7299-2012	Fuentes-Calvo, Isabel/0000-0003-1406-346X; Blázquez-Medela, Ana/0000-0003-3829-6997; Lopez-Novoa, Jose M./0000-0002-6211-7269; Martinez-Salgado, Carlos/0000-0003-4641-6717	Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo) [CP03/00094, PI041817, PI021570, C03/10]; Comision Interministerial de Ciencia y Tecnologi-a [BFU-2004-00285/BFI, SAF2003-04177]; Junta de Castilla y Leon [SA001/C05, SA029A05, GRS 167/A/07, GR100]	Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo)(Instituto de Salud Carlos III); Comision Interministerial de Ciencia y Tecnologi-a(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by grants from Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo, CP03/00094, PI041817, PI021570 and C03/10), Comision Interministerial de Ciencia y Tecnologi-a (BFU-2004-00285/BFI;SAF2003-04177), and Junta de Castilla y Leon (SA001/C05; SA029A05; GRS 167/A/07 and excellence group GR100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas B, 1999, J AM SOC NEPHROL, V10, P2314; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Birchenall-Roberts MC, 2006, BIOCHEM BIOPH RES CO, V348, P540, DOI 10.1016/j.bbrc.2006.07.094; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; DYER RB, 1995, BIOTECHNIQUES, V19, P192; Elam C, 2005, CANCER RES, V65, P3117, DOI 10.1158/0008-5472.CAN-04-0749; Ellis CA, 2000, CELL SIGNAL, V12, P425, DOI 10.1016/S0898-6568(00)00084-X; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kerkhoff E, 1998, ONCOGENE, V17, P1457, DOI 10.1038/sj.onc.1202185; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Martinez-Salgado C, 2006, EXP CELL RES, V312, P2093, DOI 10.1016/j.yexcr.2006.03.008; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Plowman SJ, 2006, J EXP CLIN CANC RES, V25, P259; PUDDINGTON L, 1985, J BIOL CHEM, V260, P5641; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wurzer G, 2001, J CELL BIOCHEM, P1	21	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8703	10.1371/journal.pone.0008703	http://dx.doi.org/10.1371/journal.pone.0008703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090846	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714600006
J	Melzer, D; Rice, NE; Lewis, C; Henley, WE; Galloway, TS				Melzer, David; Rice, Neil E.; Lewis, Ceri; Henley, William E.; Galloway, Tamara S.			Association of Urinary Bisphenol A Concentration with Heart Disease: Evidence from NHANES 2003/06	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; ENDOCRINE DISRUPTORS; ENDOTHELIAL-CELLS; RECEPTOR-GAMMA; HUMAN EXPOSURE; US POPULATION; HUMAN HEALTH; ATHEROSCLEROSIS; PLASMA; RAT	Background: Bisphenol A (BPA) is a high production volume chemical widely used in food and drinks packaging. Associations have previously been reported between urinary BPA concentrations and heart disease, diabetes and liver enzymes in adult participants of the National Health and Nutrition Examination Survey (NHANES) 2003/04. We aimed to estimate associations between urinary BPA concentrations and health measures in NHANES 2005/06 and in data pooled across collection years. Methodology and Findings: A cross-sectional analysis of NHANES: subjects were n = 1455 (2003/04) and n = 1493 (2005/06) adults aged 18-74 years, representative of the general adult population of the United States. Regression models were adjusted for age, sex, race/ethnicity, education, income, smoking, BMI, waist circumference, and urinary creatinine concentration. Main outcomes were reported diagnoses of heart attack, coronary heart disease, angina and diabetes and serum liver enzyme levels. Urinary BPA concentrations in 2005/06 (geometric mean 1.79 ng/ml, 95% CI: 1.64 to 1.96) were lower than in 2003/04 (2.49 ng/ml, CI: 2.20 to 2.83, difference p-value = 0.00002). Higher BPA concentrations were associated with coronary heart disease in 2005/06 (OR per z-score increase in BPA = 1.33, 95% CI: 1.01 to 1.75, p = 0.043) and in pooled data (OR = 1.42, CI: 1.17 to 1.72, p = 0.001). Associations with diabetes did not reach significance in 2005/06, but pooled estimates remained significant (OR = 1.24, CI: 1.10 to 1.40, p = 0.001). There was no overall association with gamma glutamyl transferase concentrations, but pooled associations with alkaline phosphatase and lactate dehydrogenase remained significant. Conclusions: Higher BPA exposure, reflected in higher urinary concentrations of BPA, is consistently associated with reported heart disease in the general adult population of the USA. Studies to clarify the mechanisms of these associations are urgently needed.	[Melzer, David; Rice, Neil E.] Univ Exeter, Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter, Devon, England; [Lewis, Ceri; Galloway, Tamara S.] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Henley, William E.] Univ Plymouth, Sch Math & Stat, Plymouth PL4 8AA, Devon, England	University of Exeter; University of Exeter; University of Plymouth	Melzer, D (corresponding author), Univ Exeter, Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter, Devon, England.	david.melzer@pms.ac.uk	Galloway, Tamara/C-1662-2009	Lewis, Ceri/0000-0002-3564-2906; Melzer, David/0000-0002-0170-3838	Peninsula Medical School	Peninsula Medical School	This work was funded internally by the Peninsula Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Bisphenol A, 2003, EUR CHEM NEWS, p14e20; BOMBICK DW, 1984, BIOCHEM BIOPH RES CO, V118, P548, DOI 10.1016/0006-291X(84)91337-8; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Centers for Disease Control and Prevention (CDC), 2004, NAT HLTH NUTR EX SUR; Drobna Z, 2002, FASEB J, V16, P67, DOI 10.1096/fj.02-0287fje; Elsby R, 2001, J PHARMACOL EXP THER, V297, P103; Eto K, 2001, EUR J PHARMACOL, V423, P1, DOI 10.1016/S0014-2999(01)01047-0; Goodman JE, 2006, CRIT REV TOXICOL, V36, P387, DOI 10.1080/10408440600758317; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Hennig B, 2002, INT J HYG ENVIR HEAL, V205, P95, DOI 10.1078/1438-4639-00134; Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; LOVATI MR, 1984, TOXICOL APPL PHARM, V75, P91, DOI 10.1016/0041-008X(84)90079-6; Mahadik Sujata R., 2008, Metabolic Syndrome and Related Disorders, V6, P121, DOI 10.1089/met.2007.0034; Martin D, 2006, AM J EPIDEMIOL, V163, P467, DOI 10.1093/aje/kwj060; Melzer D, 2008, EPIDEMIOLOGY, V19, pS379; Melzer D, 2009, JAMA-J AM MED ASSOC, V301, P721; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Nakagawa Y, 2000, ARCH TOXICOL, V74, P99, DOI 10.1007/s002040050659; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Simeonova PP, 2004, TOXICOL APPL PHARM, V198, P444, DOI 10.1016/j.taap.2003.10.018; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; STEGEMAN JJ, 1995, MOL PHARMACOL, V47, P296; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Teeguarden JG, 2005, TOXICOL SCI, V85, P823, DOI 10.1093/toxsci/kfi135; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; UNION E, 2003, EU RISK ASSESSMENT R; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wada K, 2007, J PHARMACOL SCI, V105, P133, DOI 10.1254/jphs.FM0070034; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wood SN, 2006, AUST NZ J STAT, V48, P445, DOI 10.1111/j.1467-842X.2006.00450.x; Wozniak AL, 2005, ENVIRON HEALTH PERSP, V113, P431, DOI 10.1289/ehp.7505; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014	54	390	407	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8673	10.1371/journal.pone.0008673	http://dx.doi.org/10.1371/journal.pone.0008673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084273	Green Published, gold			2022-12-25	WOS:000273554600025
J	Pollock, S; Antrobus, R; Newton, L; Kampa, B; Rossa, J; Latham, S; Nichita, NB; Dwek, RA; Zitzmann, N				Pollock, Stephanie; Antrobus, Robin; Newton, Laura; Kampa, Bettina; Rossa, Jan; Latham, Sally; Nichita, Norica Branza; Dwek, Raymond A.; Zitzmann, Nicole			Uptake and trafficking of liposomes to the endoplasmic reticulum	FASEB JOURNAL			English	Article						drug delivery; lipid trafficking; imaging tool; purification tool	HEPATITIS-C VIRUS; N-BUTYL-DEOXYNOJIRIMYCIN; PLASMA-MEMBRANE; BUTYLDEOXYNOJIRIMYCIN; CHOLESTEROL; INFECTION; MACROPHAGES; COMBINATION; ENDOSOMES; PATHWAY	Liposomes are vesicular structures consisting of an aqueous core surrounded by a lipid bilayer. Apart from the cytosol and lysosomes, no other intracellular compartment has been successfully targeted using liposomal delivery. Here, we report the development of liposomes capable of specific targeting to the endoplasmic reticulum (ER) and associated membranes. Using competition and inhibitor assays along with confocal microscopy, we have determined that ER liposomes utilize scavenger and low-density lipoprotein receptors for endocytosis and enter cells through a caveolin- and microtubule-dependent mechanism. They traffic intact to the ER, where fusion with the ER membrane occurs after 22-25 min, which was confirmed by fluorescence-dequenching assays. Once inside the ER, tagged lipids intercalate with the ER membrane and are subsequently incorporated into ER-assembling entities, such as the ER-budding viruses hepatitis C virus (HCV) and bovine viral diarrhea virus (BVDV), lipid droplets, and secreted lipoproteins. ER liposomes are superior to cytosolic liposome formulations for the intracellular delivery of aqueous cargo, such as HIV-1 antivirals, and are especially suited for the prolonged delivery of lipids and lipophilic drugs into human cells.-Pollock, S., Antrobus, R., Newton, L., Kampa, B., Rossa, J., Latham, S., Branza Nichita, N., Dwek, R. A., Zitzmann, N. Uptake and trafficking of liposomes to the endoplasmic reticulum. FASEB J. 24, 1866-1878 (2010). www.fasebj.org	[Pollock, Stephanie; Antrobus, Robin; Newton, Laura; Kampa, Bettina; Rossa, Jan; Latham, Sally; Dwek, Raymond A.; Zitzmann, Nicole] Univ Oxford, Oxford Antiviral Drug Discovery Unit, Dept Biochem, Oxford OX1 3QU, England; [Nichita, Norica Branza] Romanian Univ, Inst Biochem, Bucharest, Romania	University of Oxford; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; University of Bucharest	Zitzmann, N (corresponding author), Univ Oxford, Oxford Antiviral Drug Discovery Unit, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	nicole.zitzmann@bioch.ox.ac.uk		Newton, Laura/0000-0002-5328-8314	Oxford Glycobiology Endowment; Canadian Institutes of Health Research; United Therapeutics Corp.; IDEI [84]	Oxford Glycobiology Endowment; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); United Therapeutics Corp.; IDEI	The authors thank Takaji Wakita (Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan), Jens Bukh (U. S. National Institutes of Health, Bethesda, MD, USA), Charles M. Rice (The Rockefeller University, New York, NY, USA) and Ralf Bartenschlager (University of Heidelberg, Heidelberg, Germany) for reagents. This work is funded by the Oxford Glycobiology Endowment, by the Canadian Institutes of Health Research (to S. P.), and by a Blue Skies research grant from United Therapeutics Corp., of which R. A. D is a director and member of the scientific board. N. Z. is a senior research fellow of Linacre College, Oxford. N. B. N. was financially supported by IDEI grant ID_84 [Consiliului National al Cercetarii Stiintifice din Invatamantul Superior (CNCSIS)].	BLOCK TM, 1994, P NATL ACAD SCI USA, V91, P2235, DOI 10.1073/pnas.91.6.2235; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Chapel C, 2007, J GEN VIROL, V88, P1133, DOI 10.1099/vir.0.82465-0; FISCHER P, 1995, J VIROL, V69, P5791, DOI 10.1128/JVI.69.9.5791-5797.1995; FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Huth US, 2006, J CONTROL RELEASE, V110, P490, DOI 10.1016/j.jconrel.2005.10.018; KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H; Macovei A, 2010, J VIROL, V84, P243, DOI 10.1128/JVI.01207-09; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; Pollock S, 2008, AIDS, V22, P1961, DOI 10.1097/QAD.0b013e32830efd96; Schwendener RA, 2007, ADV EXP MED BIOL, V620, P117; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; SWIFT LL, 1995, J LIPID RES, V36, P395; TIERNEY M, 1995, J ACQ IMMUN DEF SYND, V10, P549, DOI 10.1097/00042560-199510050-00008; Torchilin VP, 1993, J LIPOSOME RES, V3, P201, DOI DOI 10.3109/08982109309148213]; Woodhouse SD, 2008, ANTIMICROB AGENTS CH, V52, P1820, DOI 10.1128/AAC.01181-07	25	61	72	0	40	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1866	1878		10.1096/fj.09-145755	http://dx.doi.org/10.1096/fj.09-145755			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20097877				2022-12-25	WOS:000278200000022
J	Wang, JD; Chen, JJ				Wang, Jiadong; Chen, Junjie			SIRT1 Regulates Autoacetylation and Histone Acetyltransferase Activity of TIP60	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; ACTIVATES ATM; P53; ACETYLATION; COMPLEX; FOXO	The histone acetyltransferase TIP60, a frequent target of monoallelic loss in human carcinomas, can acetylate many substrates, including histones and p53, and thus promote apoptosis following UV radiation. Here we showed that TIP60 is autoacetylated in response to UV damage, which is critically important for TIP60 activation. Mechanistically we demonstrated that TIP60 autoacetylation leads to the dissociation of TIP60 oligomer and enhances its interaction with substrates. Moreover, we identified SIRT1 that specifically deacetylates TIP60 and negatively regulates TIP60 activity in vivo. Taken together, our data reveal TIP60 autoacetylation as a key step in the control of its histone acetyltransferase activity and function in response to DNA damage.	[Wang, Jiadong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org			National Institutes of Health [CA089239, CA092312, CA100109]; NATIONAL CANCER INSTITUTE [R01CA100109, R01CA092312, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J.C.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Chailleux C, 2010, BIOCHEM J, V426, P365, DOI 10.1042/BJ20091329; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kranz D, 2008, J CELL BIOL, V182, P197, DOI 10.1083/jcb.200712014; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	31	79	87	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11458	11464		10.1074/jbc.M109.087585	http://dx.doi.org/10.1074/jbc.M109.087585			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20100829	Green Published, hybrid			2022-12-25	WOS:000276286200052
J	Nian, ZQ; Sun, ZQ; Yu, LX; Toh, SY; Sang, JL; Li, P				Nian, Zongqian; Sun, Zhiqi; Yu, Luxin; Toh, Shen Yon; Sang, Jianli; Li, Peng			Fat-specific Protein 27 Undergoes Ubiquitin-dependent Degradation Regulated by Triacylglycerol Synthesis and Lipid Droplet Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; WHITE ADIPOSE-TISSUE; POSTTRANSLATIONAL REGULATION; INSULIN SENSITIVITY; DEFICIENT MICE; MOUSE-LIVER; CIDEA; STORAGE; ADIPOCYTES; EXPRESSION	The fat-specific protein 27 (Fsp27), a protein localized to lipid droplets (LDs), plays an important role in controlling lipid storage and mitochondrial activity in adipocytes. Fsp27-null mice display increased energy expenditure and are resistant to high fat diet-induced obesity and diabetes. However, little is known about how the Fsp27 protein is regulated. Here, we show that Fsp27 stability is controlled by the ubiquitin-dependent proteasomal degradation pathway in adipocytes. The ubiquitination of Fsp27 is regulated by three lysine residues located in the C-terminal region. Substitution of these lysine residues with alanines greatly increased Fsp27 stability and enhanced lipid storage in adipocytes. Furthermore, Fsp27 was stabilized and rapidly accumulated following treatment with beta-agonists that induce lipolysis and fatty acid re-esterification in adipocytes. More importantly, Fsp27 stabilization was dependent on triacylglycerol synthesis and LD formation, because knockdown of diacylglycerol acyltransferase in adipocytes significantly reduced Fsp27 accumulation in adipocytes. Finally, we observed that increased Fsp27 during beta-agonist treatment preferentially associated with LDs. Taken together, our data revealed that Fsp27 can be stabilized by free fatty acid availability, triacylglycerol synthesis, and LD formation. The stabilization of Fsp27 when free fatty acids are abundant further enhances lipid storage, providing positive feedback to regulate lipid storage in adipocytes.	[Nian, Zongqian; Sun, Zhiqi; Li, Peng] Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Yu, Luxin; Sang, Jianli] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Toh, Shen Yon] Inst Mol & Cell Biol, Singapore 138673, Singapore	Tsinghua University; Beijing Normal University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Li, P (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	li-peng@mail.tsinghua.edu.cn	Sun, Zhiqi/E-9303-2012	Sun, Zhiqi/0000-0002-2792-2158; Toh, Shen Yon/0000-0002-6421-0862	National Natural Science Foundation of China [30530350, 30925017]; Ministry of Education of China [704002]; Ministry of Science and Technology of China [2006CB503909, 2007CB914404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (Grants 30530350 and 30925017 to P. L.), the Ministry of Education of China (Grant 704002 to P. L.), and the National Basic Research program of China (Grants 2006CB503909 and 2007CB914404) from the Ministry of Science and Technology of China. This work was also supported by the Program for Changjiang Scholars and the Innovative Research Team in University from the Ministry of Education in China.	Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Chan SC, 2007, BIOCHEM J, V408, P259, DOI 10.1042/BJ20070690; CROZE EM, 1984, J CELL PHYSIOL, V119, P46, DOI 10.1002/jcp.1041190109; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Joost HG, 2000, METH MOL B, V155, P77; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kovsan J, 2007, J BIOL CHEM, V282, P21704, DOI 10.1074/jbc.M702223200; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; MAYOREK N, 1985, J BIOL CHEM, V260, P6528; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Orlicky DJ, 2008, J CELL SCI, V121, P2921, DOI 10.1242/jcs.026153; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Suzuki R, 2005, J BIOL CHEM, V280, P3331, DOI 10.1074/jbc.M410955200; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	31	51	59	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9604	9615		10.1074/jbc.M109.043786	http://dx.doi.org/10.1074/jbc.M109.043786			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089860	Green Published, hybrid			2022-12-25	WOS:000276165900033
J	Trazzi, S; Steger, M; Mitrugno, VM; Bartesaghi, R; Ciani, E				Trazzi, Stefania; Steger, Martin; Mitrugno, Valentina Maria; Bartesaghi, Renata; Ciani, Elisabetta			CB1 Cannabinoid Receptors Increase Neuronal Precursor Proliferation through AKT/Glycogen Synthase Kinase-3 beta/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; MESSENGER-RNA EXPRESSION; ENDOCANNABINOID SYSTEM; RAT-BRAIN; ACTIVATION; DIFFERENTIATION; PATHWAY; MOUSE; INVOLVEMENT; INHIBITORS	The endocannabinoid system is involved in the regulation of many physiological effects in the central and peripheral nervous system. Recent findings have demonstrated the presence of a functional endocannabinoid system within neuronal progenitors located in the hippocampus and ventricular/subventricular zone that participates in the regulation of cell proliferation. It is presently unknown whether the endocannabinoid system exerts a widespread effect on neuronal precursors from different neurogenic regions, and very little is known about the signaling by which it regulates neuronal precursor proliferation. Herein, we demonstrate the presence of cannabinoid CB1 receptors in granule cell precursors (GCPs) during early cerebellar development. Activation of CB1 receptors by HU-210 promoted GCP proliferation in vitro, an effect that was prevented by a selective CB1 antagonist. Accordingly, in vivo experiments showed that GCP proliferation was increased by chronic HU-210 treatment and that in CB1-deficient mice cell proliferation was significantly lower than in wild-type littermates, indicating that the endocannabinoid system is physiologically involved in regulation of GCP proliferation. The pro-proliferative effect of cannabinoids in GCPs was mediated through the CB1/AKT/glycogen synthase kinase-3 beta/beta-catenin pathway. Involvement of this pathway was also observed in cultures of neuronal precursors from the subventricular zone, suggesting that this pathway may be a general mechanism by which endocannabinoids regulate proliferation of neuronal precursors. These observations suggest that endocannabinoids constitute a new family of lipid signaling cues that may exert a widespread effect on neuronal precursor proliferation during brain development.	[Trazzi, Stefania; Steger, Martin; Mitrugno, Valentina Maria; Bartesaghi, Renata; Ciani, Elisabetta] Univ Bologna, Dept Human & Gen Physiol, I-40126 Bologna, Italy; [Ciani, Elisabetta] S Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res, I-40138 Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Ciani, E (corresponding author), Univ Bologna, Dept Human & Gen Physiol, Piazza Porta San Donato 2, I-40126 Bologna, Italy.	elisabetta.ciani@unibo.it	Ciani, Elisabetta/AAL-6462-2020	ciani, elisabetta/0000-0003-3130-5168; Trazzi, Stefania/0000-0003-2623-2769				Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Altman J., 1982, CEREBELLUM NEW VISTA, V47, P8; Behesti H, 2009, INT J BIOCHEM CELL B, V41, P435, DOI 10.1016/j.biocel.2008.06.017; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Berrendero F, 1998, DEVELOPMENT, V125, P3179; Bianchi P, 2010, BRAIN PATHOL, V20, P106, DOI 10.1111/j.1750-3639.2008.00246.x; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Breivogel CS, 2004, NEUROPHARMACOLOGY, V47, P81, DOI 10.1016/j.neuropharm.2004.02.017; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Buckley NE, 1998, NEUROSCIENCE, V82, P1131; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Childers SR, 1998, DRUG ALCOHOL DEPEN, V51, P173, DOI 10.1016/S0376-8716(98)00075-1; Contestabile A, 2005, J BIOL CHEM, V280, P33541, DOI 10.1074/jbc.M413323200; Contestabile A, 2009, BRAIN PATHOL, V19, P224, DOI 10.1111/j.1750-3639.2008.00168.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dalton GD, 2009, CNS NEUROL DISORD-DR, V8, P422, DOI 10.2174/187152709789824615; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Downer EJ, 2007, BRAIN RES, V1175, P39, DOI 10.1016/j.brainres.2007.07.076; Fernandez-Ruiz J, 2000, TRENDS NEUROSCI, V23, P14, DOI 10.1016/S0166-2236(99)01491-5; Fernandez-Ruiz JJ, 1999, LIFE SCI, V65, P725, DOI 10.1016/S0024-3205(99)00295-7; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HOWLETT AC, 1995, ANNU REV PHARMACOL, V35, P607, DOI 10.1146/annurev.pharmtox.35.1.607; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; KOPPEL H, 1983, NEUROPATH APPL NEURO, V9, P207, DOI 10.1111/j.1365-2990.1983.tb00108.x; Li J, 2005, BIOL REPROD, V72, P700, DOI 10.1095/biolreprod.104.033837; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundholt BK, 2005, J BIOMOL SCREEN, V10, P20, DOI 10.1177/108705710429989; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; MARES V, 1970, BRAIN RES, V23, P343, DOI 10.1016/0006-8993(70)90061-2; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1994, BIOCHEM PHARMACOL, V48, P1537, DOI 10.1016/0006-2952(94)90197-X; Mechoulam R, 2002, Sci STKE, V2002, pre5, DOI 10.1126/stke.2002.129.re5; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Porter AC, 2001, PHARMACOL THERAPEUT, V90, P45, DOI 10.1016/S0163-7258(01)00130-9; Pozzoli G, 2006, J NEUROSCI RES, V83, P1058, DOI 10.1002/jnr.20794; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rueda D, 2000, MOL PHARMACOL, V58, P814, DOI 10.1124/mol.58.4.814; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Sanchez C, 1998, MOL PHARMACOL, V54, P834, DOI 10.1124/mol.54.5.834; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sim-Selley Laura J., 2003, Critical Reviews in Neurobiology, V15, P91, DOI 10.1615/CritRevNeurobiol.v15.i2.10; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Vallano ML, 2006, NEUROPHARMACOLOGY, V50, P651, DOI 10.1016/j.neuropharm.2005.11.012; Viti J, 2003, J NEUROSCI, V23, P5919; Vogt PK, 1999, CELL GROWTH DIFFER, V10, P777; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Weiss S, 1996, J NEUROSCI, V16, P7599; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; ZHENG TM, 1994, P NATL ACAD SCI USA, V91, P10952, DOI 10.1073/pnas.91.23.10952; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	73	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10098	10109		10.1074/jbc.M109.043711	http://dx.doi.org/10.1074/jbc.M109.043711			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20083607	hybrid, Green Published			2022-12-25	WOS:000276165900077
J	Bintintan, I; Meyers, G				Bintintan, Ioana; Meyers, Gregor			A New Type of Signal Peptidase Cleavage Site Identified in an RNA Virus Polyprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-DIARRHEA-VIRUS; SWINE-FEVER VIRUS; GLYCOPROTEIN E-RNS; BREFELDIN-A; PESTIVIRUS GLYCOPROTEIN; SECRETORY PROTEINS; INTRACELLULAR-TRANSPORT; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION	Pestiviruses, a group of enveloped positive strand RNA viruses belonging to the family Flaviviridae, express their genes via a polyprotein that is subsequently processed by proteases. The structural protein region contains typical signal peptidase cleavage sites. Only the site at the C terminus of the glycoprotein E-rns is different because it does not contain a hydrophobic transmembrane region but an amphipathic helix functioning as the Erns membrane anchor. Despite the absence of a hydrophobic region, the site between the C terminus of E-rns and E1, the protein located downstream in the polyprotein, is cleaved by signal peptidase, as demonstrated by mutagenesis and inhibitor studies. Thus, E(rns)E1 is processed at a novel type of signal peptidase cleavage site showing a different membrane topology. Prevention of glycosylation or introduction of mutations into the C-terminal region of E-rns severely impairs processing, presumably by preventing proper membrane interaction or disturbing a conformation critical for the protein to be accepted as a substrate by signal peptidase.	[Bintintan, Ioana; Meyers, Gregor] Friedrich Loeffler Inst, Inst Immunol, D-72001 Tubingen, Germany	Friedrich Loeffler Institute	Meyers, G (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Paul Ehrlich Str 28, D-72001 Tubingen, Germany.	gregor.meyers@fli.bund.de			Deutsche Forschungsgemeinschaft [Me1367/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Me1367/4.	BOLIN S, 1988, ARCH VIROL, V99, P117, DOI 10.1007/BF01311029; Casanova CL, 2006, MOL BIOCHEM PARASIT, V149, P144, DOI 10.1016/j.molbiopara.2006.05.005; CHOO KH, 2008, BMC BIOINFORMATI S12, V9, pS15; COLLETT MS, 1989, J GEN VIROL, V70, P253, DOI 10.1099/0022-1317-70-2-253; COLLETT MS, 1988, VIROLOGY, V165, P200, DOI 10.1016/0042-6822(88)90673-3; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONIS RO, 1988, J GEN VIROL, V69, P77, DOI 10.1099/0022-1317-69-1-77; Elbers K, 1996, J VIROL, V70, P4131, DOI 10.1128/JVI.70.6.4131-4135.1996; Fetzer C, 2005, J VIROL, V79, P11901, DOI 10.1128/JVI.79.18.11901-11913.2005; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Harada T, 2000, J VIROL, V74, P9498, DOI 10.1128/JVI.74.20.9498-9506.2000; Hausmann Y, 2004, J VIROL, V78, P5507, DOI 10.1128/JVI.78.10.5507-5512.2004; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; HEINZ FX, 2000, VIRUS TAXONOMY, P859; HORIUCHI H, 1988, J BIOCHEM-TOKYO, V103, P408, DOI 10.1093/oxfordjournals.jbchem.a122284; HULST MM, 1994, VIROLOGY, V200, P558, DOI 10.1006/viro.1994.1218; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Jackson R C, 1980, Ann N Y Acad Sci, V343, P391, DOI 10.1111/j.1749-6632.1980.tb47268.x; JACKSON RC, 1977, P NATL ACAD SCI USA, V74, P5598, DOI 10.1073/pnas.74.12.5598; Karla A, 2005, J BIOL CHEM, V280, P6731, DOI 10.1074/jbc.M413019200; Kessler S W, 1981, Methods Enzymol, V73, P442; KONIG M, 1995, J VIROL, V69, P6479; Lackner T, 2005, J VIROL, V79, P9746, DOI 10.1128/JVI.79.15.9746-9755.2005; Langedijk JPM, 2002, J BIOL CHEM, V277, P5308, DOI 10.1074/jbc.M104147200; LAU JTY, 1983, J BIOL CHEM, V258, P5255; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lively MO, 1989, CURR OPIN CELL BIOL, V1, P1188, DOI 10.1016/S0955-0674(89)80070-5; LIVELY MO, 1994, METHOD ENZYMOL, V244, P301; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Matzener P, 2009, VIRUS RES, V140, P15, DOI 10.1016/j.virusres.2008.10.015; Meyer C, 2002, J VIROL, V76, P8494, DOI 10.1128/JVI.76.16.8494-8503.2002; Meyers G, 1999, J VIROL, V73, P10224, DOI 10.1128/JVI.73.12.10224-10235.1999; Meyers G, 1996, J VIROL, V70, P8606, DOI 10.1128/JVI.70.12.8606-8613.1996; Meyers G, 1996, J VIROL, V70, P1588, DOI 10.1128/JVI.70.3.1588-1595.1996; Meyers G, 2007, J VIROL, V81, P3327, DOI 10.1128/JVI.02372-06; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; NILSSON I, 1994, J CELL BIOL, V126, P1127, DOI 10.1083/jcb.126.5.1127; Nilsson I, 2003, J BIOL CHEM, V278, P29389, DOI 10.1074/jbc.M212310200; Nilsson I, 2002, FEBS LETT, V516, P106, DOI 10.1016/S0014-5793(02)02511-5; ODA K, 1987, FEBS LETT, V214, P135, DOI 10.1016/0014-5793(87)80028-5; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Reimann I, 2007, VIROLOGY, V366, P377, DOI 10.1016/j.virol.2007.05.006; RUMENAPF T, 1993, J VIROL, V67, P3288; Sambrook J, 2001, MOL CLONING LAB MANU; SCHNEIDER R, 1993, SCIENCE, V261, P1169, DOI 10.1126/science.8356450; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Tautz N, 1997, J VIROL, V71, P5415, DOI 10.1128/JVI.71.7.5415-5422.1997; Tews BA, 2007, J BIOL CHEM, V282, P32730, DOI 10.1074/jbc.M706803200; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; van Geest M, 1999, J BIOL CHEM, V274, P2816, DOI 10.1074/jbc.274.5.2816; von Heijne G, 1998, NATURE, V396, P111, DOI 10.1038/24036; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wegelt A, 2009, J GEN VIROL, V90, P2462, DOI 10.1099/vir.0.012559-0; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; WEILAND E, 1990, J VIROL, V64, P3563, DOI 10.1128/JVI.64.8.3563-3569.1990; WEILAND E, 1992, J VIROL, V66, P3677, DOI 10.1128/JVI.66.6.3677-3682.1992; Weiland F, 1999, J GEN VIROL, V80, P1157, DOI 10.1099/0022-1317-80-5-1157; Widjojoatmodjo MN, 2000, J VIROL, V74, P2973, DOI 10.1128/JVI.74.7.2973-2980.2000; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Windisch JM, 1996, J VIROL, V70, P352, DOI 10.1128/JVI.70.1.352-358.1996; WISKERCHEN M, 1991, J VIROL, V65, P4508, DOI 10.1128/JVI.65.8.4508-4514.1991; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Xu JA, 1997, J VIROL, V71, P5312, DOI 10.1128/JVI.71.7.5312-5322.1997	70	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8572	8584		10.1074/jbc.M109.083394	http://dx.doi.org/10.1074/jbc.M109.083394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093364	Green Published, hybrid			2022-12-25	WOS:000275553700009
J	Joshi, B; Li, L; Nabi, IR				Joshi, Bharat; Li, Lei; Nabi, Ivan R.			A Role for KAI1 in Promotion of Cell Proliferation and Mammary Gland Hyperplasia by the gp78 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOCRINE MOTILITY FACTOR; RETICULUM-ASSOCIATED DEGRADATION; TRANSGENIC MOUSE MODEL; FACTOR-RECEPTOR; ENDOPLASMIC-RETICULUM; METASTATIC-DISEASE; CARCINOMA CELLS; PROTEIN LIGASE; HUMAN BREAST; EXPRESSION	Expression of gp78, an E3 ubiquitin ligase in endoplasmic reticulum-associated degradation, is associated with tumor malignancy. To study gp78 overexpression in mammary gland development and tumorigenicity, we generated murine mammary tumor virus (MMTV) long terminal repeat-driven gp78 transgenic mice. Embryos carrying the gp78 transgene cassette were implanted in FVB surrogate mothers, and two founders with high copy integration showed elevated gp78 expression at both transcript and protein levels at the virgin stage and at 12 days gestation. Transgenic mammary glands showed increased ductal branching, dense alveolar lobule formation, and secondary terminal end bud development. Bromodeoxyuridine staining showed increased proliferation in hyperplastic ductal regions at the virgin stage and at 12 days gestation compared with wild type mice. Reduced expression of the metastasis suppressor KAI1, a gp78 endoplasmic reticulum-associated degradation substrate, demonstrates that gp78 ubiquitin ligase activity is increased in MMTV-gp78 mammary gland. Similarly, metastatic MDA-435 cells exhibit increased gp78 expression, decreased KAI1 expression, and elevated proliferation compared with nonmetastatic MCF7 cells whose proliferation was enhanced upon knockdown of KAI1. Importantly, stable gp78 knockdown HEK293 cells showed increased KAI1 expression and reduced proliferation that was rescued upon KAI1 knockdown, demonstrating that gp78 regulation of cell proliferation is mediated by KAI1. Mammary tumorigenesis was not observed in repeatedly pregnant MMTV-long terminal repeat-gp78 transgenic mice over a period of 18 months post-birth. Elevated gp78 ubiquitin ligase activity is therefore not sufficient for mammary tumorigenesis. However, the hyperplastic phenotype observed in mammary glands of MMTV-gp78 transgenic mice identifies a novel role for gp78 expression in enhancing mammary epithelial cell proliferation and nontumorigenic ductal outgrowth.	[Joshi, Bharat; Li, Lei; Nabi, Ivan R.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Nabi, IR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	irnabi@interchange.ubc.ca	Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513	Canadian Institutes of Health Research [CIHR MOP-64333, MT-15132]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants CIHR MOP-64333 and MT-15132.	Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Chiu CG, 2008, EXPERT REV ANTICANC, V8, P207, DOI 10.1586/14737140.8.2.207; Choi UJ, 2009, CELL BIOCHEM FUNCT, V27, P40, DOI 10.1002/cbf.1532; Christgen M, 2008, INT J CANCER, V123, P2239, DOI 10.1002/ijc.23806; Fairbank M, 2009, MOL BIOSYST, V5, P793, DOI 10.1039/b820820b; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Guo XZ, 2005, ONCOL REP, V14, P59; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hirono Y, 1996, BRIT J CANCER, V74, P2003, DOI 10.1038/bjc.1996.667; Jackson P, 2005, INT J BIOCHEM CELL B, V37, P530, DOI 10.1016/j.biocel.2004.08.009; JANSSEN PJ, 1994, J HISTOCHEM CYTOCHEM, V42, P1169, DOI 10.1177/42.8.8027537; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kojic LD, 2007, J BIOL CHEM, V282, P29305, DOI 10.1074/jbc.M704069200; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; MARUYAMA K, 1995, INT J CANCER, V64, P316, DOI 10.1002/ijc.2910640506; MATSUI Y, 1990, CELL, V61, P1147, DOI 10.1016/0092-8674(90)90077-R; Medina D, 2000, J MAMMARY GLAND BIOL, V5, P393, DOI 10.1023/A:1009529928422; Miranti CK, 2009, CELL SIGNAL, V21, P196, DOI 10.1016/j.cellsig.2008.08.023; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; NABI IR, 1990, CANCER RES, V50, P409; Nagai Y, 1996, DERMATOLOGY, V192, P8, DOI 10.1159/000246304; NAKAMORI S, 1994, CANCER-AM CANCER SOC, V74, P1855, DOI 10.1002/1097-0142(19941001)74:7<1855::AID-CNCR2820740705>3.0.CO;2-1; OTTO T, 1994, CANCER RES, V54, P3120; Registre M, 2004, BIOCHEM BIOPH RES CO, V320, P1316, DOI 10.1016/j.bbrc.2004.06.089; Ruseva Z, 2009, EXP CELL RES, V315, P1759, DOI 10.1016/j.yexcr.2009.01.007; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SILLETTI S, 1993, BIOCHEM BIOPH RES CO, V194, P446, DOI 10.1006/bbrc.1993.1840; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsutsumi S, 2003, CANCER RES, V63, P242; van Rossum AGSH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-58; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	38	27	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8830	8839		10.1074/jbc.M109.074344	http://dx.doi.org/10.1074/jbc.M109.074344			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089858	Green Published, hybrid			2022-12-25	WOS:000275553700035
J	Kim, JA; Lee, J; Margolis, RL; Fotedar, R				Kim, J. A.; Lee, J.; Margolis, R. L.; Fotedar, R.			SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition	ONCOGENE			English	Article						Cdk1 activation; endoreplication; G2/M progression; JNK; polyploidy; SP600125	POLO-LIKE KINASES; CELL-CYCLE PROGRESSION; N-TERMINAL KINASE; DNA-REPLICATION; DEPENDENT KINASE; MAMMALIAN-CELLS; AURORA-A; CANCER-CELLS; HISTONE H3; MITOSIS	Cell cycle controls ensure that DNA replication (S phase) follows mitosis resulting in two precise copies of the genome. A failure of the control mechanisms can result in multiple rounds of DNA replication without cell division. In endoreplication, cells with replicated genomes bypass mitosis, then replicate their DNA again, resulting in polyploidy. Endoreplication from G2 phase lacks all hallmarks of mitosis. Using synchronized cells, we show that the c-Jun N-terminal kinase (JNK) inhibitor, SP600125, prevents the entry of cells into mitosis and leads to endoreplication of DNA from G2 phase. We show that cells proceed from G2 phase to replicate their DNA in the absence of mitosis. This effect of SP600125 is independent of its suppression of JNK activity. Instead, the inhibitory effect of SP600125 on mitotic entry predominantly occurs upstream of Aurora A kinase and Polo-like kinase 1, resulting in a failure to remove the inhibitory phosphorylation of Cdk1. Importantly, our results directly show that the inhibition of Cdk1 activity and the persistence of Cdk2 activity in G2 cells induces endoreplication without mitosis. Furthermore, endoreplication from G2 phase is independent of p53 control. Oncogene (2010) 29, 1702-1716; doi:10.1038/onc.2009.464; published online 11 January 2010	[Margolis, R. L.; Fotedar, R.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Kim, J. A.; Lee, J.; Margolis, R. L.; Fotedar, R.] Sidney Kimmel Canc Ctr, San Diego, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Fotedar, R (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rfotedar@burnham.org			National Institutes of Health [CA108947, CA101810, GM068107, GM088716]; NATIONAL CANCER INSTITUTE [R01CA101810, R01CA108947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088716, R01GM068107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this paper in fond memory of Arun Fotedar, a colleague and friend, whose laughter infected us all. We thank Kristian Helin (European Institute of Oncology, Italy) for Cdc6 antibody, Hideo Nishitani (Kyushu University) for Cdt1 antibody and Robert J Schultz (NCI, Bethesda, MD) for UCN-01. This work was supported by grants from the National Institutes of Health to RF (CA108947 and CA101810) and to RM (GM068107 and GM088716).	ANDREASSEN PR, 1994, J CELL BIOL, V127, P789, DOI 10.1083/jcb.127.3.789; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Busby EC, 2000, CANCER RES, V60, P2108; Cai DP, 2006, CANCER RES, V66, P9270, DOI 10.1158/0008-5472.CAN-06-1758; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Damiens E, 2001, ONCOGENE, V20, P3786, DOI 10.1038/sj.onc.1204503; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Diffley JFX, 2002, J CELL SCI, V115, P869; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Fotedar A, 1996, J BIOL CHEM, V271, P31627, DOI 10.1074/jbc.271.49.31627; Georgatos SD, 1997, J CELL SCI, V110, P2129; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; HAMILTON BT, 1982, EUR J CELL BIOL, V28, P190; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Jin SQ, 2002, ONCOGENE, V21, P8696, DOI 10.1038/sj.onc.1206034; Kiang L, 2009, MOL CELL BIOL, V29, P4025, DOI 10.1128/MCB.00185-09; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; L'Italien L, 2006, CELL CYCLE, V5, P984, DOI 10.4161/cc.5.9.2721; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee J, 2009, MOL BIOL CELL, V20, P1891, DOI 10.1091/mbc.E08-08-0818; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; Miyamoto-Yamasaki Y, 2007, CELL BIOL INT, V31, P1501, DOI 10.1016/j.cellbi.2007.07.002; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Roshak AK, 2000, CELL SIGNAL, V12, P405, DOI 10.1016/S0898-6568(00)00080-2; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Uetake Y, 2007, CURR BIOL, V17, P2081, DOI 10.1016/j.cub.2007.10.065; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wang M, 2009, J PATHOL, V218, P95, DOI 10.1002/path.2521; Yu Q, 2002, CANCER RES, V62, P5743; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	60	47	49	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 18	2010	29	11					1702	1716		10.1038/onc.2009.464	http://dx.doi.org/10.1038/onc.2009.464			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	20062077	Green Accepted			2022-12-25	WOS:000275694700015
J	Hommers, LG; Klenk, C; Dees, C; Bunemann, M				Hommers, Leif G.; Klenk, Christoph; Dees, Christian; Buenemann, Moritz			G Proteins in Reverse Mode RECEPTOR-MEDIATED GTP RELEASE INHIBITS G PROTEIN AND EFFECTOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTORS; LIVING CELLS; K+ CHANNEL; SUBUNIT DISSOCIATION; HIGH-AFFINITY; ACTIVATION; LOCALIZATION; NUCLEOTIDES; GUANOSINE; MECHANISM	Active G protein-coupled receptors activate heterotrimeric G alpha beta gamma proteins by catalyzing the exchange of GDP by GTP at the G alpha subunit. A paradoxical attenuation of G(o) protein-activated inwardly rectifying potassium channels (GIRK) upon stimulation of native cells with high concentrations of agonist is known. However, a deactivation of activated G(o) proteins by active receptors has not been experimentally studied in intact cells. We monitored GIRK currents and G(o) protein activation by means of fluorescence resonance energy transfer (FRET) in parallel. The results suggested that GIRK currents were paradoxically attenuated due to an inactivation of G(o) proteins by active alpha(2A)-adrenergic receptors. To study the mechanisms, G(o) protein activation and receptor-G protein interactions were analyzed as a function of nucleotide type and nucleotide concentrations by means of FRET, while controlling intracellular nucleotides upon permeabilization of the cell membrane. Results suggested a receptor-catalyzed dissociation of GTP from activated heterotrimeric G alpha beta gamma. Consequently, nucleotide-free G proteins were sequestrated in heterotrimeric conformation at the active receptor, thus attenuating downstream signaling in an agonist-dependent manner.	[Hommers, Leif G.; Klenk, Christoph; Dees, Christian; Buenemann, Moritz] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany	University of Wurzburg	Bunemann, M (corresponding author), Karl von Frisch Str 1, D-35043 Marburg, Germany.	moritz.buenemann@staff.uni-marburg.de	Klenk, Christoph/E-5158-2014	Klenk, Christoph/0000-0001-5199-7144	Deutsch Forschungsgemeinschaft [SFB 487 TP A10]	Deutsch Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsch Forschungsgemeinschaft Grant SFB 487 TP A10 (to M. B.).	ASANO T, 1995, J BIOCHEM-TOKYO, V117, P183, DOI 10.1093/oxfordjournals.jbchem.a124707; BIERNBAUM MS, 1979, J GEN PHYSIOL, V74, P649, DOI 10.1085/jgp.74.6.649; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Bornheimer SJ, 2004, P NATL ACAD SCI USA, V101, P15899, DOI 10.1073/pnas.0407009101; Bosche LI, 2003, J PHYSIOL-LONDON, V550, P707, DOI 10.1113/jphysiol.2003.041962; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Chidiac P, 1998, BIOCHEM PHARMACOL, V55, P549, DOI 10.1016/S0006-2952(97)00361-4; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; HILF G, 1992, EUR J BIOCHEM, V204, P725, DOI 10.1111/j.1432-1033.1992.tb16687.x; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; KAGAWA H, 1980, J BIOL CHEM, V255, P7106; Leaney JL, 2004, AM J PHYSIOL-CELL PH, V287, pC182, DOI 10.1152/ajpcell.00540.2003; LEFKOWITZ RJ, 1981, ADV CYCLIC NUCL PROT, V14, P145; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MACKINNON AC, 1989, BRIT J PHARMACOL, V98, P1143, DOI 10.1111/j.1476-5381.1989.tb12658.x; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Tsien Roger Y., 1993, Trends in Cell Biology, V3, P242, DOI 10.1016/0962-8924(93)90124-J; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838	33	12	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8227	8233		10.1074/jbc.M109.015388	http://dx.doi.org/10.1074/jbc.M109.015388			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075078	Green Published, hybrid			2022-12-25	WOS:000275413800041
J	Roy, A; Zhou, XD; Chong, MZ; D'hoedt, D; Foo, CS; Rajagopalan, N; Nirthanan, S; Bertrand, D; Sivaraman, J; Kini, RM				Roy, Amrita; Zhou, Xingding; Chong, Ming Zhi; D'hoedt, Dieter; Foo, Chun Shin; Rajagopalan, Nandhakishore; Nirthanan, Selvanayagam; Bertrand, Daniel; Sivaraman, J.; Kini, R. Manjunatha			Structural and Functional Characterization of a Novel Homodimeric Three-finger Neurotoxin from the Venom of Ophiophagus hannah (King Cobra)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; KRAIT BUNGARUS-CANDIDUS; DENDROPHILA MANGROVE CATSNAKE; SITE-DIRECTED MUTAGENESIS; KAPPA-BUNGAROTOXIN; PHARMACOLOGICAL CHARACTERIZATION; POSTSYNAPTIC NEUROTOXIN; ALPHA-NEUROTOXINS; CRYSTAL-STRUCTURE; MUSCARINIC RECEPTORS	Snake venoms are a mixture of pharmacologically active proteins and polypeptides that have led to the development of molecular probes and therapeutic agents. Here, we describe the structural and functional characterization of a novel neurotoxin, haditoxin, from the venom of Ophiophagus hannah (King cobra). Haditoxin exhibited novel pharmacology with antagonism toward muscle (alpha beta gamma delta) and neuronal (alpha(7), alpha(3)beta(2), and alpha(4)beta(2)) nicotinic acetylcholine receptors (nAChRs) with highest affinity for alpha(7)-nAChRs. The high resolution (1.5 angstrom) crystal structure revealed haditoxin to be a homodimer, like kappa-neurotoxins, which target neuronal alpha(3)beta(2)- and alpha(4)beta(2)-nAChRs. Interestingly however, the monomeric subunits of haditoxin were composed of a three-finger protein fold typical of curaremimetic shortchain alpha-neurotoxins. Biochemical studies confirmed that it existed as a non-covalent dimer species in solution. Its structural similarity to short-chain alpha-neurotoxins and kappa-neurotoxins notwithstanding, haditoxin exhibited unique blockade of alpha(7)-nAChRs (IC50 180 nM), which is recognized by neither shortchain alpha-neurotoxins nor alpha-neurotoxins. This is the first report of a dimeric short-chain alpha-neurotoxin interacting with neuronal alpha(7)-nAChRs as well as the first homodimeric three-finger toxin to interact with muscle nAChRs.	[Kini, R. Manjunatha] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Prot Sci Lab, Singapore 117543, Singapore; [D'hoedt, Dieter; Bertrand, Daniel] Univ Geneva, Fac Med, Dept Neurosci, CH-1211 Geneva 4, Switzerland; [Nirthanan, Selvanayagam] Griffith Univ, Sch Med Sci, Griffith, Qld 4222, Australia; [Nirthanan, Selvanayagam] Natl Univ Singapore, Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA	National University of Singapore; University of Geneva; Griffith University; National University of Singapore; Virginia Commonwealth University	Kini, RM (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Prot Sci Lab, Singapore 117543, Singapore.	dbskinim@nus.edu.sg	Nirthanan, Selvanayagam/ABI-4281-2020; Sivaraman, J/H-8028-2012; Kini, Manjunatha/H-8029-2012	J, Sivaraman/0000-0001-9781-5326; Kini, Manjunatha/0000-0002-6100-3251; Nirthanan, S. Niru/0000-0001-9888-8447				Aird SD, 1999, TOXICON, V37, P609, DOI 10.1016/S0041-0101(98)00199-8; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bulbring E, 1997, BRIT J PHARMACOL, V120, P3; CHANGEUX JP, 1990, TRENDS PHARMACOL SCI, V11, P485, DOI 10.1016/0165-6147(90)90049-E; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; CHIAPPINELLI VA, 1989, BIOCHEMISTRY-US, V28, P8543, DOI 10.1021/bi00447a041; CHIAPPINELLI VA, 1985, J BIOL CHEM, V260, P6182; COBORN J, 1991, ATLAS SNAKES WORLD, P452; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; Coulson FR, 2004, J PHARMACOL EXP THER, V308, P760, DOI 10.1124/jpet.103.057570; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DEWAN JC, 1994, BIOCHEMISTRY-US, V33, P13147, DOI 10.1021/bi00248a026; DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo T., 1991, P165; FIORDALISI JJ, 1994, BIOCHEMISTRY-US, V33, P3872, DOI 10.1021/bi00179a011; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; GINSBORG BL, 1960, BRIT J PHARM CHEMOTH, V15, P410, DOI 10.1111/j.1476-5381.1960.tb01264.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; GRANT GA, 1985, BIOCHEMISTRY-US, V24, P1532, DOI 10.1021/bi00327a036; Grant GA, 1997, BIOCHEMISTRY-US, V36, P3353, DOI 10.1021/bi9629687; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Harvey AL, 2002, NEUROCHEM RES, V27, P1543, DOI 10.1023/A:1021660708187; Harvey AL, 2002, TRENDS PHARMACOL SCI, V23, P201, DOI 10.1016/S0165-6147(02)02012-6; Harvey AL., 1991, SNAKE TOXINS, P1; HERZ JM, 1989, J BIOL CHEM, V264, P12439; Hogg RC, 2008, J NEUROSCI METH, V169, P65, DOI 10.1016/j.jneumeth.2007.11.028; JIANG M, 1987, TOXICON, V25, P1019, DOI 10.1016/0041-0101(87)90167-X; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar TKS, 1997, J BIOMOL STRUCT DYN, V15, P431, DOI 10.1080/07391102.1997.10508957; Kuruppu S, 2005, BIOCHEM PHARMACOL, V70, P794, DOI 10.1016/j.bcp.2005.06.003; Langley JN, 1907, J PHYSIOL-LONDON, V36, P347; Laothong C, 2001, TOXICON, V39, P1353, DOI 10.1016/S0041-0101(01)00087-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lumsden NG, 2005, TOXICON, V45, P329, DOI 10.1016/j.toxicon.2004.11.003; Mackessy SP, 2006, TOXICON, V47, P537, DOI 10.1016/j.toxicon.2006.01.007; MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004; MEHRTENS J, 1987, LIVING SNAKES WORLD, P245; MENEZ A, 1980, BIOCHEMISTRY-US, V19, P4166, DOI 10.1021/bi00559a005; Nirthanan S, 2004, J PHARMACOL SCI, V94, P1, DOI 10.1254/jphs.94.1; Nirthanan S, 2003, BRIT J PHARMACOL, V139, P832, DOI 10.1038/sj.bjp.0705299; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; Olianas MC, 1999, J PHARMACOL EXP THER, V288, P164; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; OSWALD RE, 1991, BIOCHEMISTRY-US, V30, P4901, DOI 10.1021/bi00234a010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pahari S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-175; Pahari S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-115; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; Pawlak J, 2006, J BIOL CHEM, V281, P29030, DOI 10.1074/jbc.M605850200; Pawlak J, 2009, FASEB J, V23, P534, DOI 10.1096/fj.08-113555; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pung YF, 2005, J BIOL CHEM, V280, P13137, DOI 10.1074/jbc.M414137200; Rajagopalan N, 2007, FASEB J, V21, P3685, DOI 10.1096/fj.07-8658com; Ricciardi A, 2000, J BIOL CHEM, V275, P18302, DOI 10.1074/jbc.275.24.18302; Servent D, 2000, EUR J PHARMACOL, V393, P197, DOI 10.1016/S0014-2999(00)00095-9; Servent D, 1998, TOXICOL LETT, V103, P199, DOI 10.1016/S0378-4274(98)00307-5; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; Starkov V G, 2009, Bioorg Khim, V35, P15; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; Tan LC, 2006, NEUROPHARMACOLOGY, V51, P782, DOI 10.1016/j.neuropharm.2006.05.020; Taylor P, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P271; Teixeira-Clerc F, 2002, J BIOL CHEM, V277, P25741, DOI 10.1074/jbc.M200534200; Torres AM, 2001, BIOCHEM J, V360, P539, DOI 10.1042/0264-6021:3600539; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WARRELL DA, 1983, BRIT MED J, V286, P678, DOI 10.1136/bmj.286.6366.678; Weiser M, 1997, N-S ARCH PHARMACOL, V356, P671, DOI 10.1007/PL00005104; WOLF KM, 1988, BRAIN RES, V439, P249, DOI 10.1016/0006-8993(88)91481-3	83	60	63	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8302	8315		10.1074/jbc.M109.074161	http://dx.doi.org/10.1074/jbc.M109.074161			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071329	Green Published, hybrid			2022-12-25	WOS:000275413800047
J	Tajima, M; Crane, JM; Verkman, AS				Tajima, Masato; Crane, Jonathan M.; Verkman, A. S.			Aquaporin-4 (AQP4) Associations and Array Dynamics Probed by Photobleaching and Single-molecule Analysis of Green Fluorescent Protein-AQP4 Chimeras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORTHOGONAL ARRAYS; WATER CHANNELS; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANES; KNOCKOUT MICE; SPINAL-CORD; BRAIN; DIFFUSION; CELLS; ISOFORMS	The plasma membrane assembly of aquaporin-4 (AQP4) water channels into orthogonal arrays of particles (OAPs) involves interactions of AQP4 N-terminal domains. To study in live cells the site of OAP assembly, the size and dynamics of plasma membrane OAPs, and the heterotetrameric associations of AQP4, we constructed green fluorescent protein (GFP)-labeled AQP4 "long" (M1) and "short" (M23) isoforms in which GFP was inserted at the cytoplasm-facing N or C terminus or between Val-141 and Val-142 in the second extracellular loop of AQP4. The C-terminal and extracellular loop GFP insertions did not interfere with the rapid unrestricted membrane diffusion of GFP-labeled M1 or the restricted diffusion and OAP assembly of GFP-labeled M23. Photobleaching of brefeldin A-treated cells showed comparable and minimally restricted diffusion of M1 and M23, indicating that OAP assembly occurs post-endoplasmic reticulum. Single-molecule step photobleaching and intensity analysis of GFP-labeled M1 in the absence versus presence of excess unlabeled M1 or M23 with an OAP-disrupting mutation indicated heterotetrameric AQP4 association. Time-lapse total internal reflection fluorescence imaging of M23 in live cells at 37 degrees C indicated that OAPs diffuse slowly (D similar to 10(-12) cm(2)/s) and rearrange over tens of minutes. Our biophysical measurements in live cells thus reveal extensive AQP4 monomer-monomer and tetramertetramer interactions.	[Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [EB00415, HL73856, DK35124, EY13574, DK72517]; Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, P30DK072517, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants EB00415, HL73856, DK35124, EY13574, and DK72517 and by a grant from the Guthy-Jackson Charitable Foundation.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Crane JM, 2009, BIOPHYS J, V97, P3010, DOI 10.1016/j.bpj.2009.09.017; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Haggie PM, 2008, J BIOL CHEM, V283, P23510, DOI 10.1074/jbc.C800100200; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levin MH, 2001, J BIOL CHEM, V276, P21331, DOI 10.1074/jbc.M101901200; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Umenishi F, 2000, BIOPHYS J, V78, P1024, DOI 10.1016/S0006-3495(00)76661-6; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; WOLBURG H, 1995, J BRAIN RES, V36, P239; Yang BX, 1996, J BIOL CHEM, V271, P4577	27	34	36	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8163	8170		10.1074/jbc.M109.093948	http://dx.doi.org/10.1074/jbc.M109.093948			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071343	Green Published, hybrid			2022-12-25	WOS:000275413800035
J	Karbassi, F; Quiros, V; Pancholi, V; Kornblatt, MJ				Karbassi, Farhad; Quiros, Veronica; Pancholi, Vijay; Kornblatt, Mary J.			Dissociation of the Octameric Enolase from S. Pyogenes - One Interface Stabilizes Another	PLOS ONE			English	Article							MITOCHONDRIAL CREATINE-KINASE; STREPTOCOCCAL SURFACE ENOLASE; TRYPANOSOMA-BRUCEI ENOLASE; YEAST ENOLASE; CRYSTAL-STRUCTURE; ALPHA-ENOLASE; PLASMINOGEN-BINDING; ACTIVE MONOMERS; FORMIMINOTRANSFERASE-CYCLODEAMINASE; CELL-SURFACE	Most enolases are homodimers. There are a few that are octamers, with the eight subunits arranged as a tetramer of dimers. These dimers have the same basic fold and same subunit interactions as are found in the dimeric enolases. The dissociation of the octameric enolase from S. pyogenes was examined, using NaClO4, a weak chaotrope, to perturb the quaternary structure. Dissociation was monitored by sedimentation velocity. NaClO4 dissociated the octamer into inactive monomers. There was no indication that dissociation of the octamer into monomers proceeded via formation of significant amounts of dimer or any other intermediate species. Two mutations at the dimer-dimer interface, F137L and E363G, were introduced in order to destabilize the octameric structure. The double mutant was more easily dissociated than was the wild type. Dissociation could also be produced by other salts, including tetramethylammonium chloride (TMACl) or by increasing pH. In all cases, no significant amounts of dimers or other intermediates were formed. Weakening one interface in this protein weakened the other interface as well. Although enolases from most organisms are dimers, the dimeric form of the S. pyogenes enzyme appears to be unstable.	[Karbassi, Farhad; Quiros, Veronica; Kornblatt, Mary J.] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; [Pancholi, Vijay] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	Concordia University - Canada; Ohio State University	Kornblatt, MJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	judithk@alcor.concordia.ca	Pancholi, Vijay/E-3810-2011		Natural Sciences and Engineering Research Council of Canada [RGPIN 451-02]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada (www.nserc.crsng.gc.ca), grant RGPIN 451-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrell J, 2009, BIOCHEMISTRY-US, V48, P3915, DOI 10.1021/bi900075d; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; BREWER JM, 1995, PHYS ASPECTS PROTEIN, P57; Brown CK, 1998, J PROTEIN CHEM, V17, P855, DOI 10.1023/A:1020790604887; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Chai GQ, 2004, J MOL BIOL, V341, P1015, DOI 10.1016/j.jmb.2004.05.068; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; DUQUERROY S, 1995, BIOCHEMISTRY-US, V34, P12513, DOI 10.1021/bi00039a005; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; FINDLAY WA, 1987, BIOCHEMISTRY-US, V26, P1948, DOI 10.1021/bi00381a024; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; Giotto MTD, 2003, J MOL BIOL, V331, P653, DOI 10.1016/S0022-2836(03)00752-6; Giovanni P, 2007, BBA-MOL CELL RES, V1773, P1774, DOI 10.1016/j.bbamcr.2007.09.002; GROSS M, 1993, BIOCHEMISTRY-US, V32, P13933, DOI 10.1021/bi00213a024; HOLLEMAN WH, 1973, BIOCHIM BIOPHYS ACTA, V327, P176, DOI 10.1016/0005-2744(73)90115-0; KERESZTESNAGY S, 1971, BIOCHEMISTRY-US, V10, P2506, DOI 10.1021/bi00789a013; KORNBLATT MJ, 1990, ARCH BIOCHEM BIOPHYS, V277, P301, DOI 10.1016/0003-9861(90)90583-K; Kornblatt MJ, 1998, EUR J BIOCHEM, V251, P775, DOI 10.1046/j.1432-1327.1998.2510775.x; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Mao YX, 2004, EMBO J, V23, P2963, DOI 10.1038/sj.emboj.7600327; Marcus Y, 2009, CHEM REV, V109, P1346, DOI 10.1021/cr8003828; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Navarro MVDS, 2007, FEBS J, V274, P5077, DOI 10.1111/j.1742-4658.2007.06027.x; Pace C. N., 1997, PROTEIN STRUCTURE PR, P253; Pal-Bhowmick I, 2007, FEBS J, V274, P1932, DOI 10.1111/j.1742-4658.2007.05738.x; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pandey AK, 2009, MOL GENET GENOMICS, V281, P135, DOI 10.1007/s00438-008-0397-3; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHURIG H, 1995, PROTEIN SCI, V4, P228; Sims PA, 2005, J MOL CATAL B-ENZYM, V32, P77, DOI 10.1016/j.molcatb.2004.10.002; STEC B, 1990, J MOL BIOL, V211, P235, DOI 10.1016/0022-2836(90)90023-F; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; VERONESE FM, 1984, INT J PEPT PROT RES, V24, P557; WHITE MF, 1993, BIOCHEM J, V295, P743, DOI 10.1042/bj2950743; Zhao SP, 2008, FEBS J, V275, P97, DOI 10.1111/j.1742-4658.2007.06177.x	36	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8810	10.1371/journal.pone.0008810	http://dx.doi.org/10.1371/journal.pone.0008810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098674	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100004
J	Corti, D; Langedijk, JPM; Hinz, A; Seaman, MS; Vanzetta, F; Fernandez-Rodriguez, BM; Silacci, C; Pinna, D; Jarrossay, D; Balla-Jhagjhoorsingh, S; Willems, B; Zekveld, MJ; Dreja, H; O'Sullivan, E; Pade, C; Orkin, C; Jeffs, SA; Montefiori, DC; Davis, D; Weissenhorn, W; McKnight, A; Heeney, JL; Sallusto, F; Sattentau, QJ; Weiss, RA; Lanzavecchia, A				Corti, Davide; Langedijk, Johannes P. M.; Hinz, Andreas; Seaman, Michael S.; Vanzetta, Fabrizia; Fernandez-Rodriguez, Blanca M.; Silacci, Chiara; Pinna, Debora; Jarrossay, David; Balla-Jhagjhoorsingh, Sunita; Willems, Betty; Zekveld, Maria J.; Dreja, Hanna; O'Sullivan, Eithne; Pade, Corinna; Orkin, Chloe; Jeffs, Simon A.; Montefiori, David C.; Davis, David; Weissenhorn, Winfried; McKnight, Aine; Heeney, Jonathan L.; Sallusto, Federica; Sattentau, Quentin J.; Weiss, Robin A.; Lanzavecchia, Antonio			Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL REGION; TYPE-1 INFECTION; SUBTYPE-B; ENVELOPE GLYCOPROTEIN; HIV-1 NEUTRALIZATION; PASSIVE TRANSFER; BINDING-SITE; ENV CLONES; IN-VITRO	Background: The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-1 isolates and the characterization of the human neutralizing antibody B cell response to HIV-1 infection are important goals that are central to the design of an effective antibody-based vaccine. Methods and Findings: We immortalized IgG(+) memory B cells from individuals infected with diverse clades of HIV-1 and selected on the basis of plasma neutralization profiles that were cross-clade and relatively potent. Culture supernatants were screened using various recombinant forms of the envelope glycoproteins (Env) in multiple parallel assays. We isolated 58 mAbs that were mapped to different Env surfaces, most of which showed neutralizing activity. One mAb in particular (HJ16) specific for a novel epitope proximal to the CD4 binding site on gp120 selectively neutralized a multi-clade panel of Tier-2 HIV-1 pseudoviruses, and demonstrated reactivity that was comparable in breadth, but distinct in neutralization specificity, to that of the other CD4 binding site-specific neutralizing mAb b12. A second mAb (HGN194) bound a conserved epitope in the V3 crown and neutralized all Tier-1 and a proportion of Tier-2 pseudoviruses tested, irrespective of clade. A third mAb (HK20) with broad neutralizing activity, particularly as a Fab fragment, recognized a highly conserved epitope in the HR-1 region of gp41, but showed striking assay-dependent selectivity in its activity. Conclusions: This study reveals that by using appropriate screening methods, a large proportion of memory B cells can be isolated that produce mAbs with HIV-1 neutralizing activity. Three of these mAbs show unusual breadth of neutralization and therefore add to the current panel of HIV-1 neutralizing antibodies with potential for passive protection and template-based vaccine design.	[Corti, Davide; Vanzetta, Fabrizia; Fernandez-Rodriguez, Blanca M.; Silacci, Chiara; Pinna, Debora; Jarrossay, David; Sallusto, Federica; Lanzavecchia, Antonio] Biomed Res Inst, Bellinzona, Switzerland; [Langedijk, Johannes P. M.; Zekveld, Maria J.] Pepscan Therapeut BV, Lelystad, Netherlands; [Hinz, Andreas; Weissenhorn, Winfried] UJF, EMBL, CNRS, Unit Virus Host Cell Interact,UMI 3265, Grenoble, France; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Balla-Jhagjhoorsingh, Sunita; Willems, Betty] Inst Trop Med, B-2000 Antwerp, Belgium; [Dreja, Hanna; O'Sullivan, Eithne; Pade, Corinna; McKnight, Aine] Queen Mary Univ, London, England; [Orkin, Chloe] Barts & London NHS Trust, London, England; [Jeffs, Simon A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Wright Fleming Inst, Fac Med, London, England; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Davis, David] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands; [Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Sattentau, Quentin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Weiss, Robin A.] UCL, Div Infect & Immun, London, England	Universita della Svizzera Italiana; Pepscan Therapeutics B.V.; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Harvard University; Beth Israel Deaconess Medical Center; Institute of Tropical Medicine (ITM); University of London; Queen Mary University London; Barts Health NHS Trust; Imperial College London; Duke University; University of Cambridge; University of Oxford; University of London; University College London	Corti, D (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	R.Weiss@ucl.ac.uk; Lanzavecchia@irb.unisi.ch		Pade, Corinna/0000-0003-0626-2346; Zatta, Fabrizia/0000-0003-4945-8058; McKnight, Aine/0000-0002-8113-817X; Heeney, Jonathan/0000-0003-2702-1621	Bill and Melinda Gates Foundation; Medical Research Council [G0000635, G117/547] Funding Source: researchfish; MRC [G0000635, G117/547] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was conducted as part of the Collaboration for AIDS Vaccine Discovery funded by the Bill and Melinda Gates Foundation. QJS is a Jenner Vaccine Institute Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2000, MOL CELL BIOCHEM, V206, P1, DOI 10.1023/A:1007007626813; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Davis D, 2006, J MED VIROL, V78, P864, DOI 10.1002/jmv.20635; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Jeffs SA, 2004, VACCINE, V22, P1032, DOI 10.1016/j.vaccine.2003.08.042; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Langedijk JPM, 1997, J VIROL, V71, P4055, DOI 10.1128/JVI.71.5.4055-4061.1997; Larcher C, 1990, FEMS Microbiol Immunol, V2, P103; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; MANN AM, 2009, AIDS; Manrique A, 2007, J VIROL, V81, P8793, DOI 10.1128/JVI.00598-07; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; MONTEFIORI D, 2004, CURRENT PROTOCOLS IM; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Robertson MJ, 2000, CELL IMMUNOL, V199, P8, DOI 10.1006/cimm.1999.1601; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Stewart KD, 2007, J COMPUT AID MOL DES, V21, P121, DOI 10.1007/s10822-007-9107-1; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2009, SCIENCE; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu XL, 2008, VIROLOGY, V380, P285, DOI 10.1016/j.virol.2008.07.007; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	71	360	383	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8805	10.1371/journal.pone.0008805	http://dx.doi.org/10.1371/journal.pone.0008805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098712	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000031
J	Pan-Montojo, F; Anichtchik, O; Dening, Y; Knels, L; Pursche, S; Jung, R; Jackson, S; Gille, G; Spillantini, MG; Reichmann, H; Funk, RHW				Pan-Montojo, Francisco; Anichtchik, Oleg; Dening, Yanina; Knels, Lilla; Pursche, Stefan; Jung, Roland; Jackson, Sandra; Gille, Gabriele; Spillantini, Maria Grazia; Reichmann, Heinz; Funk, Richard H. W.			Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; NEURONS; EXPOSURE; MODEL; GENE; NEURODEGENERATION; NEUROPATHOLOGY; DYSFUNCTION; MECHANISMS	In patients with Parkinson's disease (PD), the associated pathology follows a characteristic pattern involving inter alia the enteric nervous system (ENS), the dorsal motor nucleus of the vagus (DMV), the intermediolateral nucleus of the spinal cord and the substantia nigra, providing the basis for the neuropathological staging of the disease. Here we report that intragastrically administered rotenone, a commonly used pesticide that inhibits Complex I of the mitochondrial respiratory chain, is able to reproduce PD pathological staging as found in patients. Our results show that low doses of chronically and intragastrically administered rotenone induce alpha-synuclein accumulation in all the above-mentioned nervous system structures of wild-type mice. Moreover, we also observed inflammation and alpha-synuclein phosphorylation in the ENS and DMV. HPLC analysis showed no rotenone levels in the systemic blood or the central nervous system (detection limit [rotenone]<20 nM) and mitochondrial Complex I measurements showed no systemic Complex I inhibition after 1.5 months of treatment. These alterations are sequential, appearing only in synaptically connected nervous structures, treatment time-dependent and accompanied by inflammatory signs and motor dysfunctions. These results strongly suggest that the local effect of pesticides on the ENS might be sufficient to induce PD-like progression and to reproduce the neuroanatomical and neurochemical features of PD staging. It provides new insight into how environmental factors could trigger PD and suggests a transsynaptic mechanism by which PD might spread throughout the central nervous system.	[Pan-Montojo, Francisco; Dening, Yanina; Knels, Lilla; Funk, Richard H. W.] Tech Univ Dresden, Inst Anat, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Pan-Montojo, Francisco; Jackson, Sandra; Gille, Gabriele; Reichmann, Heinz] Tech Univ Dresden, Dept Neurol, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Anichtchik, Oleg; Spillantini, Maria Grazia] Univ Cambridge, Ctr Brain Repair, Cambridge, England; [Pursche, Stefan] Tech Univ Dresden, Dept Internal Med 1, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Jung, Roland] Tech Univ Dresden, Expt Ctr, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Pan-Montojo, Francisco] Int Max Planck Res Sch, Max Planck Inst Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Cambridge; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society	Pan-Montojo, F (corresponding author), Tech Univ Dresden, Inst Anat, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany.	pan-montojo@mpi-cbg.de; richard.funk@tu-dresden.de	Anichtchik, Oleg/AAJ-3783-2021; Anichtchik, Oleg/G-3671-2014	Anichtchik, Oleg/0000-0003-0772-7475	Pedro Barrie de la Maza Foundation; UK Parkinson's Disease Society; Parkinson&quot;s UK [G-0701] Funding Source: researchfish	Pedro Barrie de la Maza Foundation; UK Parkinson's Disease Society(Parkinson's UK); Parkinson&quot;s UK(Parkinson&apos;s UK)	F. P.-M. is the recipient of a grant from the Pedro Barrie de la Maza Foundation. O.A. and M. G. S. are recipients of a grant from the UK Parkinson's Disease Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Adler CH, 2005, NEUROLOGY, V64, pS12, DOI 10.1212/WNL.64.12_suppl_3.S12; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BIRCHMACHIN MA, 1993, STUDY SKELETAL MUSCL, P58; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2007, ACTA NEUROPATHOL, V113, P421, DOI 10.1007/s00401-007-0193-x; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Buzas B, 2004, NEUROLOGY, V62, P2156, DOI 10.1212/01.WNL.0000130384.56476.75; Chaudhuri KR, 2008, EUR J NEUROL, V15, P2, DOI 10.1111/j.1468-1331.2008.02212.x; CROSSMAN AR, 1989, COMP BIOCHEM PHYS A, V93, P141, DOI 10.1016/0300-9629(89)90201-6; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Goetz C G, 1986, Mov Disord, V1, P45, DOI 10.1002/mds.870010106; Goldstein DS, 2006, CLIN AUTON RES, V16, P46, DOI 10.1007/s10286-006-0317-8; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hawkes CH, 1999, QJM-MON J ASSOC PHYS, V92, P473, DOI 10.1093/qjmed/92.8.473; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Huang J, 2006, BIOMATERIALS, V27, P937, DOI 10.1016/j.biomaterials.2005.07.005; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kadar A, 2009, J NEUROSCI METH, V184, P115, DOI 10.1016/j.jneumeth.2009.07.010; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lang AE, 2004, ANN NEUROL, V55, P761, DOI 10.1002/ana.20102; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; McGeer PL, 2008, EXP NEUROL, V212, P235, DOI 10.1016/j.expneurol.2008.04.008; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pfeiffer RF, 2003, LANCET NEUROL, V2, P107, DOI 10.1016/S1474-4422(03)00307-7; Phillips RJ, 2008, NEUROSCIENCE, V153, P733, DOI 10.1016/j.neuroscience.2008.02.074; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Porta EA, 2002, ANN NY ACAD SCI, V959, P57, DOI 10.1111/j.1749-6632.2002.tb02083.x; Richter F, 2007, J NEUROSCI RES, V85, P681, DOI 10.1002/jnr.21159; Rojo AI, 2007, EXP NEUROL, V208, P120, DOI 10.1016/j.expneurol.2007.07.022; Ross GW, 2006, MOVEMENT DISORD, V21, P2062, DOI 10.1002/mds.21076; Schapira A, 2004, LANCET NEUROL, V3, P362, DOI 10.1016/S1474-4422(04)00769-0; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; WAKABAYASHI K, 1990, ACTA NEUROPATHOL, V79, P581, DOI 10.1007/BF00294234; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337	60	344	351	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8762	10.1371/journal.pone.0008762	http://dx.doi.org/10.1371/journal.pone.0008762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098733	Green Published, Green Submitted, gold			2022-12-25	WOS:000273778900007
J	Riedel, M; Goldbaum, O; Schwarz, L; Schmitt, S; Richter-Landsberg, C				Riedel, Michael; Goldbaum, Olaf; Schwarz, Lisa; Schmitt, Sebastian; Richter-Landsberg, Christiane			17-AAG Induces Cytoplasmic alpha-Synuclein Aggregate Clearance by Induction of Autophagy	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; RAT-BRAIN OLIGODENDROCYTES; MULTIPLE SYSTEM ATROPHY; HEAT-SHOCK RESPONSE; NEURODEGENERATIVE DISEASES; PROTEIN AGGREGATION; PROTEOLYTIC STRESS; FIBRIL FORMATION; NEURONAL CELLS; PROTEASOME	Background: The accumulation and aggregation of alpha-synuclein in nerve cells and glia are characteristic features of a number of neurodegenerative diseases termed synucleinopathies. alpha-Synuclein is a highly soluble protein which in a nucleation dependent process is capable of self-aggregation. The causes underlying aggregate formation are not yet understood, impairment of the proteolytic degradation systems might be involved. Methodology/Principal Findings: In the present study the possible aggregate clearing effects of the geldanamycin analogue 17-AAG (17-(Allylamino)-17-demethoxygeldanamycin) was investigated. Towards this, an oligodendroglial cell line (OLN-93 cells), stably expressing human alpha-synuclein (A53T mutation) was used. In these cells small punctate aggregates, not staining with thioflavine S, representing prefibrillary aggregates, occur characteristically. Our data demonstrate that 17-AAG attenuated the formation of alpha-synuclein aggregates by stimulating macroautophagy. By blocking the lysosomal compartment with NH4Cl the aggregate clearing effects of 17-AAG were abolished and alpha-synuclein deposits were enlarged. Analysis of LC3-II immunoreactivity, which is an indicator of autophagosome formation, further revealed that 17-AAG led to the recruitment of LC3-II and to the formation of LC3 positive puncta. This effect was also observed in cultured oligodendrocytes derived from the brains of newborn rats. Inhibition of macroautophagy by 3-methyladenine prevented 17-AAG induced occurrence of LC3 positive puncta as well as the removal of alpha-synuclein aggregates in OLN-A53T cells. Conclusions: Our data demonstrate for the first time that 17-AAG not only causes the upregulation of heat shock proteins, but also is an effective inducer of the autophagic pathway by which alpha-synuclein can be removed. Hence geldanamycin derivatives may provide a means to modulate autophagy in neural cells, thereby ameliorating pathogenic aggregate formation and protecting the cells during disease and aging.	[Riedel, Michael; Goldbaum, Olaf; Schwarz, Lisa; Schmitt, Sebastian; Richter-Landsberg, Christiane] Carl von Ossietzky Univ Oldenburg, Dept Biol, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Riedel, M (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Biol, D-2900 Oldenburg, Germany.	Christiane.Richter.Landsberg@Uni-Oldenburg.de			Deutsche Forschungsgemeinschaft, Germany; Tonjes-Vagt Stiftung (Bremen, Germany)	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); Tonjes-Vagt Stiftung (Bremen, Germany)	This work was supported by the Deutsche Forschungsgemeinschaft, Germany, and the Tonjes-Vagt Stiftung (Bremen, Germany). These funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Bandhyopadhyay U, 2007, EXP GERONTOL, V42, P120, DOI 10.1016/j.exger.2006.05.019; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Burn DJ, 2001, J CLIN PATHOL-MOL PA, V54, P419; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chin SSM, 1996, J NEUROPATH EXP NEUR, V55, P499; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Dickson DW, 1999, BRAIN PATHOL, V9, P721; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Goedert M, 2001, CURR OPIN GENET DEV, V11, P343, DOI 10.1016/S0959-437X(00)00200-8; Goldbaum O, 2004, J NEUROSCI, V24, P5748, DOI 10.1523/JNEUROSCI.1307-04.2004; Goldbaum O, 2003, J NEUROSCI, V23, P8872; Goldbaum O, 2008, GLIA, V56, P1736, DOI 10.1002/glia.20720; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kumar B, 2004, CANCER LETT, V204, P53, DOI 10.1016/j.canlet.2003.09.017; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lantos PL, 1998, J NEUROPATH EXP NEUR, V57, P1099, DOI 10.1097/00005072-199812000-00001; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lu AG, 2002, J NEUROCHEM, V81, P355, DOI 10.1046/j.1471-4159.2002.00835.x; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mori F, 2002, EXP NEUROL, V176, P98, DOI 10.1006/exnr.2002.7929; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Neckers L, 2003, NATURE, V425, P357, DOI 10.1038/425357a; NEUHOFF V, 1979, H-S Z PHYSIOL CHEM, V360, P1657, DOI 10.1515/bchm2.1979.360.2.1657; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Richter-Landsberg C, 2000, J NEUROSCI RES, V62, P9, DOI 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U; Richter-Landsberg C, 2003, CELL MOL LIFE SCI, V60, P337, DOI 10.1007/s000180300028; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Riedel M, 2009, J MOL NEUROSCI, V39, P226, DOI 10.1007/s12031-009-9190-y; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winklhofer KF, 2001, J BIOL CHEM, V276, P45160, DOI 10.1074/jbc.M104873200; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	56	70	71	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8753	10.1371/journal.pone.0008753	http://dx.doi.org/10.1371/journal.pone.0008753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090920	Green Submitted, gold, Green Published			2022-12-25	WOS:000273715000011
J	Benard, C; Cultrone, A; Michel, C; Rosales, C; Segain, JP; Lahaye, M; Galmiche, JP; Cherbut, C; Blottiere, HM				Benard, Claudine; Cultrone, Antonietta; Michel, Catherine; Rosales, Carlos; Segain, Jean-Pierre; Lahaye, Marc; Galmiche, Jean-Paul; Cherbut, Christine; Blottiere, Herve M.			Degraded Carrageenan Causing Colitis in Rats Induces TNF Secretion and ICAM-1 Upregulation in Monocytes through NF-kappa B Activation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; MOLECULAR-WEIGHT-DISTRIBUTION; NUCLEAR FACTOR ACTIVATION; TUMOR-NECROSIS-FACTOR; CROHNS-DISEASE; GUINEA-PIGS; INTERLEUKIN-8 PRODUCTION; GASTROINTESTINAL-TRACT; ADHESION MOLECULES	Carrageenan (CGN) is a high molecular weight sulphated polysaccharide derived from red seaweeds. In rodents, its degraded forms (dCGN) can induce intestinal inflammation associated with macrophage recruitment and activation. The aim of this study was: 1) to analyze the size-dependent effects of dCGN on colon inflammation in vivo, and 2) to correlate these effects with monocyte/macrophage proliferation, cytokine production and expression of various cell surface antigens including ICAM-1 adhesion molecule. Peripheral blood monocytes (PBM) and THP-1 monocytic cells were cultured in the presence of either 10 or 40 kDa, dCGN. The 40 kDa, but not the 10 kDa dCGN, induced colitis in in vivo. Degraded CGN inhibited THP-1 cell proliferation in vitro, arresting the cells in G1 phase. In addition, dCGN increased ICAM-1 expression in both PBM and THP-1 cells with a major effect seen after 40 kDa dCGN exposure. Also, dCGN stimulated monocyte aggregation in vitro that was prevented by incubation with anti-ICAM-1 antibody. Finally, dCGN stimulated TNF-alpha expression and secretion by both PBM and THP-1 cells. All these effects were linked to NF-kappa B activation. These data strongly suggest that the degraded forms of CGN have a pronounced effect on monocytes, characteristic of an inflammatory phenotype.	[Benard, Claudine; Michel, Catherine; Segain, Jean-Pierre; Cherbut, Christine] Univ Nantes, INRA, UMR PHAN 1280, CHU Hotel Dieu, Nantes, France; [Cultrone, Antonietta; Blottiere, Herve M.] INRA, UEPSD UR910, Jouy En Josas, France; [Galmiche, Jean-Paul] CHU Hotel Dieu, INSERM, U913, Nantes, France; [Lahaye, Marc] INRA, BIA, F-44026 Nantes, France; [Rosales, Carlos] Univ Nacl Autonoma Mexico, Dept Immunol, Inst Invest Biomed, Mexico City 04510, DF, Mexico	INRAE; Nantes Universite; CHU de Nantes; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; INRAE; Universidad Nacional Autonoma de Mexico	Benard, C (corresponding author), Univ Nantes, INRA, UMR PHAN 1280, CHU Hotel Dieu, Nantes, France.	Herve.Blottiere@jouy.inra.fr	MICHEL, Catherine D/Q-2879-2018; ROSALES, CARLOS/AAA-5206-2019; BLOTTIERE, Hervé M/C-6120-2011; LAHAYE, Marc/C-6324-2009; Lahaye, Marc/C-6324-2009	MICHEL, Catherine D/0000-0001-7695-1038; ROSALES, CARLOS/0000-0003-2568-5723; BLOTTIERE, Hervé M/0000-0002-8390-0607; LAHAYE, Marc/0000-0001-8380-0334; Lahaye, Marc/0000-0002-7752-4158	INRA; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [48573-M]	INRA; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by INRA and in part by grant 48573-M from Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico (to CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; ANEGON I, 1993, J LEUKOCYTE BIOL, V53, P390, DOI 10.1002/jlb.53.4.390; Axelsson LG, 1996, INFLAMM RES, V45, P181, DOI 10.1007/BF02285159; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barbier M, 1998, GUT, V43, P783, DOI 10.1136/gut.43.6.783; Basile JR, 2003, MOL CANCER RES, V1, P262; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2008, J NUTR, V138, P469, DOI 10.1093/jn/138.3.469; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Cohen SM, 2002, CRIT REV TOXICOL, V32, P413, DOI 10.1080/20024091064282; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; EKSTROM LG, 1983, CARBOHYD RES, V116, P89, DOI 10.1016/S0008-6215(00)90956-X; EKSTROM LG, 1985, CARBOHYD RES, V135, P283, DOI 10.1016/S0008-6215(00)90779-1; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; Feng Jun-Ming, 2003, Hepatobiliary Pancreat Dis Int, V2, P265; Fiocchi C, 1997, AM J PHYSIOL-GASTR L, V273, pG769, DOI 10.1152/ajpgi.1997.273.4.G769; Garcia-Garcia E, 2007, J IMMUNOL METHODS, V320, P104, DOI 10.1016/j.jim.2006.12.006; Garcia-Garcia E, 2009, J IMMUNOL, V182, P4547, DOI 10.4049/jimmunol.0801468; GRIMM MC, 1995, J GASTROEN HEPATOL, V10, P387, DOI 10.1111/j.1440-1746.1995.tb01589.x; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; KITANO A, 1986, CANCER RES, V46, P1374; KITSUKAWA Y, 1992, GASTROENTEROLOGY, V102, P1859, DOI 10.1016/0016-5085(92)90306-J; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; LING KY, 1988, GASTROENTEROLOGY, V95, P1487, DOI 10.1016/S0016-5085(88)80067-2; Liu ZX, 1996, SCAND J GASTROENTERO, V31, P706, DOI 10.3109/00365529609009154; Liu ZX, 1997, SCAND J GASTROENTERO, V32, P1241, DOI 10.3109/00365529709028154; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MARCUS AJ, 1989, J PHARM PHARMACOL, V41, P423, DOI 10.1111/j.2042-7158.1989.tb06493.x; MARCUS R, 1971, LANCET, V2, P765; Michel C, 1996, J APPL BACTERIOL, V80, P349, DOI 10.1111/j.1365-2672.1996.tb03230.x; MISHRA L, 1993, GASTROENTEROLOGY, V104, P772, DOI 10.1016/0016-5085(93)91012-7; MIURA M, 1987, J CLIN LAB IMMUNOL, V24, P167; Nemeth ZH, 2002, AM J PATHOL, V161, P987, DOI 10.1016/S0002-9440(10)64259-9; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Quemener B, 1997, J APPL PHYCOL, V9, P179, DOI 10.1023/A:1007971023478; Rochet V, 1997, REPROD NUTR DEV, V37, P221, DOI 10.1051/rnd:19970210; Rosales C, 1996, CANCER RES, V56, P2302; RUGVEIT J, 1997, GASTROENTEROLOGY, V112, P1493; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Stanley N., 1987, PRODUCTION UTILIZATI, V288, P116; Stanley N.F., 1990, FOOD GELS, P79; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; VANDERWAAIJ D, 1974, GASTROENTEROLOGY, V67, P460; VIEBKE C, 1995, CARBOHYD POLYM, V27, P145, DOI 10.1016/0144-8617(95)00017-2; Weiner ML, 2007, FOOD CHEM TOXICOL, V45, P98, DOI 10.1016/j.fct.2006.07.033	51	44	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8666	10.1371/journal.pone.0008666	http://dx.doi.org/10.1371/journal.pone.0008666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072622	Green Published, Green Submitted, gold			2022-12-25	WOS:000273554600019
J	Hellmann, JK; Munter, S; Wink, M; Frischknecht, F				Hellmann, Janina K.; Muenter, Sylvia; Wink, Michael; Frischknecht, Friedrich			Synergistic and Additive Effects of Epigallocatechin Gallate and Digitonin on Plasmodium Sporozoite Survival and Motility	PLOS ONE			English	Article							GREEN TEA POLYPHENOL; SAPONINS	Background: Most medicinal plants contain a mixture of bioactive compounds, including chemicals that interact with intracellular targets and others that can act as adjuvants to facilitate absorption of polar agents across cellular membranes. However, little is known about synergistic effects between such potential drug candidates and adjuvants. To probe for such effects, we tested the green tea compound epigallocatechin gallate (EGCG) and the membrane permeabilising digitonin on Plasmodium sporozoite motility and viability. Methodology/Principal Findings: Green fluorescent P. berghei sporozoites were imaged using a recently developed visual screening methodology. Motility and viability parameters were automatically analyzed and IC50 values were calculated, and the synergism of drug and adjuvant was assessed by the fractional inhibitory concentration index. Validating our visual screening procedure, we showed that sporozoite motility and liver cell infection is inhibited by EGCG at nontoxic concentrations. Digitonin synergistically increases the cytotoxicity of EGCG on sporozoite survival, but shows an additive effect on sporozoite motility. Conclusions/Significance: We proved the feasibility of performing highly reliable visual screens for compounds against Plasmodium sporozoites. We thereby could show an advantage of administering mixtures of plant metabolites on inhibition of cell motility and survival. Although the effective concentration of both drugs is too high for use in malaria prophylaxis, the demonstration of a synergistic effect between two plant compounds could lead to new avenues in drug discovery.	[Hellmann, Janina K.; Muenter, Sylvia] Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany; [Wink, Michael; Frischknecht, Friedrich] Heidelberg Univ, Dept Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hellmann, JK (corresponding author), Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany.	wink@uni-hd.de; freddy.frischknecht@med.uni-heidelberg.de	Wink, Michael/E-3803-2012	Wink, Michael/0000-0002-7875-4510; Frischknecht, Friedrich/0000-0002-8332-6668	German Federal Ministry for Education and Research; Cluster of Excellence CellNetworks; Hartmut Hoffmann-Berling International Graduate School for Molecular and Cellular Biology; Medical School at the University of Heidelberg	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence CellNetworks; Hartmut Hoffmann-Berling International Graduate School for Molecular and Cellular Biology; Medical School at the University of Heidelberg	The work was funded by grants from the German Federal Ministry for Education and Research (BMBF, BioFuture, and NGFN) to FF. Support from the Cluster of Excellence CellNetworks, the Hartmut Hoffmann-Berling International Graduate School for Molecular and Cellular Biology, and the Medical School at the University of Heidelberg is gratefully acknowledged. Part of this work constituted the master thesis of JKH within the Molecular Biotechnology Program of Heidelberg University. FF is a member of the European Network of Excellence BioMalPar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797; Benelli R, 2002, BIOL CHEM, V383, P101, DOI 10.1515/BC.2002.010; Buttemeyer R, 2003, TRANSPL P, V35, P3116, DOI 10.1016/j.transproceed.2003.10.055; Chow HHS, 2003, CLIN CANCER RES, V9, P3312; Dormeyer M, 2006, ANTIMICROB AGENTS CH, V50, P724, DOI 10.1128/AAC.50.2.724-730.2006; Fuchs H, 2009, CURR DRUG TARGETS, V10, P140, DOI 10.2174/138945009787354584; Gupta J., 2008, IJP - International Journal of Pharmacology, V4, P314; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Harborne J. B., 1990, CIBA F SYMP, V154, P126; HEGGE S, 2009, BIOTECHNOLOGY J; Hostettmann K, 1995, SAPONINS, DOI 10.1017/CBO9780511565113; Kensil CR, 1996, CRIT REV THER DRUG, V13, P1; Matuschewski K, 2006, CELL MICROBIOL, V8, P1547, DOI 10.1111/j.1462-5822.2006.00778.x; Mota MM, 2002, BIOESSAYS, V24, P149, DOI 10.1002/bies.10050; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rao A V, 2000, Drug Metabol Drug Interact, V17, P211; Sannella AR, 2007, BIOCHEM BIOPH RES CO, V353, P177, DOI 10.1016/j.bbrc.2006.12.005; Schafer Holger, 2009, Biotechnology Journal, V4, P1684, DOI 10.1002/biot.200900229; Sharma SK, 2007, J MED CHEM, V50, P765, DOI 10.1021/jm061154d; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Thathy V, 2002, EMBO J, V21, P1586, DOI 10.1093/emboj/21.7.1586; Tobi SE, 2002, INT J CANCER, V102, P439, DOI 10.1002/ijc.10730; Umeda D, 2005, BIOCHEM BIOPH RES CO, V333, P628, DOI 10.1016/j.bbrc.2005.05.108; Van WykB E, 2004, MED PLANTS WORLD ILL, P480; WATERMAN PG, 1992, CIBA F SYMP, V171, P255; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; WINK M, 2007, MED PLANT BIOTECHNOL, P97; Wink M, 2008, CURR DRUG METAB, V9, P996, DOI 10.2174/138920008786927794; Yoda Yoshiyuki, 2004, Journal of Infection and Chemotherapy, V10, P55, DOI 10.1007/s10156-003-0284-0	34	37	40	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8682	10.1371/journal.pone.0008682	http://dx.doi.org/10.1371/journal.pone.0008682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072627	gold, Green Published, Green Submitted			2022-12-25	WOS:000273554600032
J	Liu, FX; Xu, WY; Wei, Q; Zhang, ZH; Xing, Z; Tan, LB; Di, C; Yao, DX; Wang, CC; Tan, YJ; Yan, H; Ling, Y; Sun, CQ; Xue, YB; Su, Z				Liu, Fengxia; Xu, Wenying; Wei, Qiang; Zhang, Zhenghai; Xing, Zhuo; Tan, Lubin; Di, Chao; Yao, Dongxia; Wang, Chunchao; Tan, Yuanjun; Yan, Hong; Ling, Yi; Sun, Chuanqing; Xue, Yongbiao; Su, Zhen			Gene Expression Profiles Deciphering Rice Phenotypic Variation between Nipponbare (Japonica) and 93-11 (Indica) during Oxidative Stress	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; CINNAMOYL-COA REDUCTASE; ARABIDOPSIS-THALIANA; LIGNIN BIOSYNTHESIS; DRAFT SEQUENCE; GENOME; PLANTS; POLYMORPHISMS; INDUCTION; IDENTIFICATION	Rice is a very important food staple that feeds more than half the world's population. Two major Asian cultivated rice (Oryza sativa L.) subspecies, japonica and indica, show significant phenotypic variation in their stress responses. However, the molecular mechanisms underlying this phenotypic variation are still largely unknown. A common link among different stresses is that they produce an oxidative burst and result in an increase of reactive oxygen species (ROS). In this study, methyl viologen (MV) as a ROS agent was applied to investigate the rice oxidative stress response. We observed that 93-11 (indica) seedlings exhibited leaf senescence with severe lesions under MV treatment compared to Nipponbare (japonica). Whole-genome microarray experiments were conducted, and 1,062 probe sets were identified with gene expression level polymorphisms between the two rice cultivars in addition to differential expression under MV treatment, which were assigned as Core Intersectional Probesets (CIPs). These CIPs were analyzed by gene ontology (GO) and highlighted with enrichment GO terms related to toxin and oxidative stress responses as well as other responses. These GO term-enriched genes of the CIPs include glutathine S-transferases (GSTs), P450, plant defense genes, and secondary metabolism related genes such as chalcone synthase (CHS). Further insertion/deletion (InDel) and regulatory element analyses for these identified CIPs suggested that there may be some eQTL hotspots related to oxidative stress in the rice genome, such as GST genes encoded on chromosome 10. In addition, we identified a group of marker genes individuating the japonica and indica subspecies. In summary, we developed a new strategy combining biological experiments and data mining to study the possible molecular mechanism of phenotypic variation during oxidative stress between Nipponbare and 93-11. This study will aid in the analysis of the molecular basis of quantitative traits.	[Liu, Fengxia; Wei, Qiang; Zhang, Zhenghai; Di, Chao; Yao, Dongxia; Wang, Chunchao; Tan, Yuanjun; Yan, Hong; Ling, Yi; Sun, Chuanqing; Su, Zhen] China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Beijing 100094, Peoples R China; [Xu, Wenying; Xing, Zhuo; Xue, Yongbiao] Chinese Acad Sci, Inst Genet & Dev Biol, Mol & Dev Biol Lab, Beijing, Peoples R China; [Xu, Wenying; Xing, Zhuo; Xue, Yongbiao] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Tan, Lubin; Sun, Chuanqing] China Agr Univ, Dept Plant Genet & Breeding, Beijing 100094, Peoples R China; [Tan, Lubin; Sun, Chuanqing] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; China Agricultural University; China Agricultural University	Liu, FX (corresponding author), China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Beijing 100094, Peoples R China.	ybxue@genetics.ac.cn; zhensu@cau.edu.cn	Tan, Lubin/H-9270-2017; Di, Chao/G-1130-2015; xing, zhuo/L-7165-2016	Tan, Lubin/0000-0003-3775-7720; xing, zhuo/0000-0002-4635-6630	Ministry of Science and Technology of China [30570139, 2006CB100105, 2005CB120804]; China Agriculture University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Agriculture University	This work was supported by grants from the Ministry of Science and Technology of China (30570139, 2006CB100105, and 2005CB120804) and the China Agriculture University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chen WQJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r32; Cheng KS, 1985, RICE GENET NEWSL, V2, P46; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Debnam PM, 2004, PLANT J, V38, P49, DOI 10.1111/j.1365-313X.2004.02017.x; Drost DR, 2009, PLANT J, V58, P1054, DOI 10.1111/j.1365-313X.2009.03828.x; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; GuetaDahan Y, 1997, PLANTA, V203, P460, DOI 10.1007/s004250050215; Han B, 2003, CURR OPIN PLANT BIOL, V6, P134, DOI 10.1016/S1369-5266(03)00004-9; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Kandel S, 2005, J BIOL CHEM, V280, P35881, DOI 10.1074/jbc.M500918200; KATO SHIGEMOTO, 1928, BULT SCI FAK TERK KJUSU IMP UNIV, V3, P132; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kong L, 2005, GENOME, V48, P29, DOI 10.1139/G04-097; Kumar R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000284; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Laloi C, 2007, P NATL ACAD SCI USA, V104, P672, DOI 10.1073/pnas.0609063103; Li L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000294; Lim CE, 2008, MOL CELLS, V25, P368; Liu XH, 2007, PLANT MOL BIOL, V65, P403, DOI 10.1007/s11103-007-9174-7; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; MITRICK AJ, 2007, FUNCT INTEGR GENOMIC, V7, P135; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Morgante M, 2006, CURR OPIN BIOTECH, V17, P168, DOI 10.1016/j.copbio.2006.03.001; MORISHIMA H, 1981, JPN J BREED, V31, P402; Neuefeind T, 1997, BIOL CHEM, V378, P199; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Paolocci F, 2005, J EXP BOT, V56, P1093, DOI 10.1093/jxb/eri101; Plantegenet S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.79; Ray SD, 2004, BIOFACTORS, V21, P223, DOI 10.1002/biof.552210144; Richard S, 2000, PLANT CELL PHYSIOL, V41, P982, DOI 10.1093/pcp/pcd017; Rogers O.S., 1998, PLANT MOL BIOL MAN A, VA6, P1; Santosa IE, 2007, PLANTA, V226, P193, DOI 10.1007/s00425-006-0457-z; Scarpeci TE, 2008, PLANT MOL BIOL, V66, P361, DOI 10.1007/s11103-007-9274-4; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Shin JH, 2009, MOL CELLS, V27, P67, DOI 10.1007/s10059-009-0006-2; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tang T, 2006, PLOS GENET, V2, P1824, DOI 10.1371/journal.pgen.0020199; TSANG EWT, 1991, PLANT CELL, V3, P783, DOI 10.1105/tpc.3.8.783; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wadenback J, 2008, TRANSGENIC RES, V17, P379, DOI 10.1007/s11248-007-9113-z; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zhang X, 2007, CURR OPIN PLANT BIOL, V10, P142, DOI 10.1016/j.pbi.2007.02.002; Zhao MG, 2007, J PLANT PHYSIOL, V164, P737, DOI 10.1016/j.jplph.2006.03.002; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	60	50	53	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8632	10.1371/journal.pone.0008632	http://dx.doi.org/10.1371/journal.pone.0008632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072620	Green Published, Green Submitted, gold			2022-12-25	WOS:000273414200004
J	Uhde, CW; Vives, J; Jaeger, I; Li, M				Uhde, Christopher W.; Vives, Joaquim; Jaeger, Ines; Li, Meng			Rmst Is a Novel Marker for the Mouse Ventral Mesencephalic Floor Plate and the Anterior Dorsal Midline Cells	PLOS ONE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; GENE-EXPRESSION; NERVOUS-SYSTEM; IDENTIFICATION; SPECIFICATION	The availability of specific markers expressed in different regions of the developing nervous system provides a useful tool to illuminate their development, regulation and function. We have identified by expression profiling a putative non-coding RNA, Rmst, that exhibits prominent expression in the midbrain floor plate region, the isthmus and the roof plate of the anterior neural tube. At the developmental stage when the ventral dopaminergic neuron territory is being established, Rmst expression appears to be restricted to the presumptive dopaminergic neurons of the ventral tegmental area that lies close to the ventral midline. Thus this study presents Rmst as a novel marker for the developing dopaminergic neurons in the mesencephalic floor plate as well as a marker for the dorsal midline cells of the anterior neural tube and the isthmic organizer.	[Uhde, Christopher W.; Vives, Joaquim; Jaeger, Ines; Li, Meng] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England	Imperial College London	Uhde, CW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England.	meng.li2@imperial.ac.uk	Li, Meng/I-6941-2013; Vives, Joaquim/J-6303-2019	Vives, Joaquim/0000-0001-9719-5235	UK Medical Research Council; UK Parkinsons Disease Society; European Commission; Medical Research Council [G117/560, MC_U120085817] Funding Source: researchfish; MRC [G117/560, MC_U120085817] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Parkinsons Disease Society(Parkinson's UK); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council, the UK Parkinsons Disease Society and the frame work six programme of the European Commission (Eurostemcell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Bouchard M, 2005, DEVELOPMENT, V132, P2633, DOI 10.1242/dev.01833; Chan AS, 2002, ONCOGENE, V21, P3029, DOI 10.1038/sj.onc.1205460; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Dunston JA, 2005, EUR J HUM GENET, V13, P330, DOI 10.1038/sj.ejhg.5201332; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Failli V, 2002, MECH DEVELOP, V118, P225, DOI 10.1016/S0925-4773(02)00254-X; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Klafke R, 2008, PHARMACOPSYCHIATRY, V41, pS44, DOI 10.1055/s-2008-1080902; Li JYH, 2001, DEVELOPMENT, V128, P4979; Maxwell SL, 2005, DEV BIOL, V282, P467, DOI 10.1016/j.ydbio.2005.03.028; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Rock JR, 2007, GENE EXPR PATTERNS, V8, P19, DOI 10.1016/j.modgep.2007.08.004; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	20	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8641	10.1371/journal.pone.0008641	http://dx.doi.org/10.1371/journal.pone.0008641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062813	Green Submitted, Green Published, gold			2022-12-25	WOS:000273414200018
J	Yu, SW; Khor, TO; Cheung, KL; Li, WG; Wu, TY; Huang, Y; Foster, BA; Kan, YW; Kong, AN				Yu, Siwang; Khor, Tin Oo; Cheung, Ka-Lung; Li, Wenge; Wu, Tien-Yuan; Huang, Ying; Foster, Barbara A.; Kan, Yuet Wai; Kong, Ah-Ng			Nrf2 Expression Is Regulated by Epigenetic Mechanisms in Prostate Cancer of TRAMP Mice	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; GSTP1 CPG ISLAND; DNA METHYLATION; TRANSGENIC ADENOCARCINOMA; OXIDATIVE STRESS; CELL-LINES; INTRAEPITHELIAL NEOPLASIA; INCREASED SUSCEPTIBILITY; CHEMOPREVENTIVE AGENTS; ANTIOXIDANT RESPONSE	Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is a transcription factor which regulates the expression of many cytoprotective genes. In the present study, we found that the expression of Nrf2 was suppressed in prostate tumor of the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice. Similarly, the expression of Nrf2 and the induction of NQO1 were also substantially suppressed in tumorigenic TRAMP C1 cells but not in non-tumorigenic TRAMP C3 cells. Examination of the promoter region of the mouse Nrf2 gene identified a CpG island, which was methylated at specific CpG sites in prostate TRAMP tumor and in TRAMP C1 cells but not in normal prostate or TRAMP C3 cells, as shown by bisulfite genomic sequencing. Reporter assays indicated that methylation of these CpG sites dramatically inhibited the transcriptional activity of the Nrf2 promoter. Chromatin immunopreceipitation (ChIP) assays revealed increased binding of the methyl-CpG-binding protein 2 (MBD2) and trimethyl-histone H3 (Lys9) proteins to these CpG sites in the TRAMP C1 cells as compared to TRAMP C3 cells. In contrast, the binding of RNA Pol II and acetylated histone H3 to the Nrf2 promoter was decreased. Furthermore, treatment of TRAMP C1 cells with DNA methyltransferase (DNMT) inhibitor 5-aza-2'-deoxycytidine (5-aza) and histone deacetylase (HDAC) inhibitor trichostatin A (TSA) restored the expression of Nrf2 as well as the induction of NQO1 in TRAMP C1 cells. Taken together, these results indicate that the expression of Nrf2 is suppressed epigenetically by promoter methylation associated with MBD2 and histone modifications in the prostate tumor of TRAMP mice. Our present findings reveal a novel mechanism by which Nrf2 expression is suppressed in TRAMP prostate tumor, shed new light on the role of Nrf2 in carcinogenesis and provide potential new directions for the detection and prevention of prostate cancer.	[Yu, Siwang; Khor, Tin Oo; Cheung, Ka-Lung; Li, Wenge; Wu, Tien-Yuan; Huang, Ying; Kong, Ah-Ng] Rutgers State Univ, Dept Pharmaceut, Ernest Mario Sch Pharm, Piscataway, NJ USA; [Foster, Barbara A.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Kan, Yuet Wai] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kan, Yuet Wai] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Kan, Yuet Wai] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Rutgers State University New Brunswick; Roswell Park Cancer Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yu, SW (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Beijing 100871, Peoples R China.	KongT@rci.rutgers.edu	Wu, Tien-Yuan/AAV-6964-2020; Kong, Ah-Ng Tony/AAX-2828-2020	Wu, Tien-Yuan/0000-0002-5205-4567; Yu, Siwang/0000-0002-3336-202X	National Institutes of Health [R01-CA118947, R01-094828]; NATIONAL CANCER INSTITUTE [R01CA118947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported in part by the National Institutes of Health grants R01-CA118947 and R01-094828 to A.-N.T. Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranyi T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-431; Barve A, 2009, INT J CANCER, V124, P1693, DOI 10.1002/ijc.24106; Berger J, 2005, BIOCHEM SOC T, V33, P1537, DOI 10.1042/BST0331537; Bostwick DG, 2007, HUM PATHOL, V38, P1394, DOI 10.1016/j.humpath.2007.02.008; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; Camoriano M, 2008, CANCER RES, V68, P4173, DOI 10.1158/0008-5472.CAN-07-6715; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen C, 2005, TRENDS PHARMACOL SCI, V26, P318, DOI 10.1016/j.tips.2005.04.004; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Costa VL, 2007, DIS MARKERS, V23, P31, DOI 10.1155/2007/356742; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Foster BA, 1997, CANCER RES, V57, P3325; Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Khor TO, 2008, PLANTA MED, V74, P1540, DOI 10.1055/s-0028-1088303; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Kotrikadze N., 2008, Experimental Oncology, V30, P244; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lin XH, 2003, CANCER RES, V63, P498; Mavis CK, 2009, PROSTATE, V69, P1312, DOI 10.1002/pros.20976; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; McCabe MT, 2006, CANCER RES, V66, P385, DOI 10.1158/0008-5472.CAN-05-2020; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Minelli A, 2009, BBA-REV CANCER, V1795, P83, DOI 10.1016/j.bbcan.2008.11.001; Morey SR, 2006, CANCER RES, V66, P11659, DOI 10.1158/0008-5472.CAN-06-1937; Nakayama M, 2004, J CELL BIOCHEM, V91, P540, DOI 10.1002/jcb.10740; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nelson WG, 2007, FRONT BIOSCI-LANDMRK, V12, P4254, DOI 10.2741/2385; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Pulukuri SM, 2006, ONCOGENE, V25, P4559, DOI 10.1038/sj.onc.1209462; Rauhala HE, 2008, INT J CANCER, V123, P1601, DOI 10.1002/ijc.23658; Schulz WA, 2006, J CELL MOL MED, V10, P100, DOI 10.1111/j.1582-4934.2006.tb00293.x; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Yossepowitch O, 2007, J UROLOGY, V178, P1238, DOI 10.1016/j.juro.2007.05.145; Yu SW, 2007, CURR CANCER DRUG TAR, V7, P416; Zorn CS, 2007, CLIN CANCER RES, V13, P2136, DOI 10.1158/1078-0432.CCR-06-2381	40	164	174	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8579	10.1371/journal.pone.0008579	http://dx.doi.org/10.1371/journal.pone.0008579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20062804	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338500022
J	Mounien, L; Marty, N; Tarussio, D; Metref, S; Genoux, D; Preitner, F; Foretz, M; Thorens, B				Mounien, Lourdes; Marty, Nell; Tarussio, David; Metref, Salima; Genoux, David; Preitner, Frederic; Foretz, Marc; Thorens, Bernard			Glut2-dependent glucose-sensing controls thermoregulation by enhancing the leptin sensitivity of NPY and POMC neurons	FASEB JOURNAL			English	Article						thermomodulation; glucose detection; central nervous system; glucose transporter; melanocortin pathway	BROWN ADIPOSE-TISSUE; BACTERIAL ARTIFICIAL CHROMOSOME; NUCLEUS-TRACTUS-SOLITARIUS; ADULT-RAT BRAIN; ARCUATE NUCLEUS; GLUCOSE-TRANSPORTER-2 GLUT2; ADAPTIVE THERMOGENESIS; HYPOTHALAMIC NEURONS; MEDIATE INHIBITION; ESCHERICHIA-COLI	The physiological contribution of glucose in thermoregulation is not completely established nor whether this control may involve a regulation of the melanocortin pathway. Here, we assessed thermoregulation and leptin sensitivity of hypothalamic arcuate neurons in mice with inactivation of glucose transporter type 2 (Glut2)-dependent glucose sensing. Mice with inactivation of Glut2-dependent glucose sensors are cold intolerant and show increased susceptibility to food deprivation-induced torpor and abnormal hypothermic response to intracerebroventricular administration of 2-deoxy-D-glucose compared to control mice. This is associated with a defect in regulated expression of brown adipose tissue uncoupling protein I and iodothyronine deiodinase II and with a decreased leptin sensitivity of neuropeptide Y (NPY) and proopiomelanocortin (POMC) neurons, as observed during the unfed-to-refed transition or following i.p. leptin injection. Sites of central Glut-2 expression were identified by a genetic tagging approach and revealed that glucose-sensitive neurons were present in the lateral hypothalamus, the dorsal vagal complex, and the basal medulla but not in the arcuate nucleus. NPY and POMC neurons were, however, connected to nerve terminals from Glut2-expressing neurons. Thus, our data suggest that glucose controls thermoregulation and the leptin sensitivity of NPY and POMC neurons through activation of Glut2-dependent glucose-sensing neurons located outside of the arcuate nucleus.-Mounien, L., Marty, N., Tarussio, D., Metref, S., Genoux, D., Preitner, F., Foretz, M., Thorens, B. Glut2-dependent glucose-sensing controls thermoregulation by enhancing the leptin sensitivity of NPY and POMC neurons. FASEB J. 24, 1747-1758 (2010). www.fasebj.org	[Mounien, Lourdes; Marty, Nell; Tarussio, David; Metref, Salima; Genoux, David; Preitner, Frederic; Foretz, Marc; Thorens, Bernard] Univ Lausanne, Dept Physiol, CH-1015 Lausanne, Switzerland; [Mounien, Lourdes; Marty, Nell; Tarussio, David; Metref, Salima; Genoux, David; Preitner, Frederic; Foretz, Marc; Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Genoux, David] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Computat Neurosci, Lausanne, Switzerland; [Foretz, Marc] Univ Paris 05, CNRS, INSERM,Dept Endocrinol Metab & Canc, Inst Cochin,U567,UMR8104, F-75270 Paris, France	University of Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Thorens, B (corresponding author), Univ Lausanne, Dept Physiol, Genopode Bldg, CH-1015 Lausanne, Switzerland.	bernard.thorens@unil.ch	FORETZ, Marc/O-7334-2017	FORETZ, Marc/0000-0001-7017-9032; Mounien, Lourdes/0000-0002-9221-5783	Swiss National Science Foundation [3100A0-113525]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors gratefully acknowledge expert technical assistance from Martine Emery, Joel Gyger, Magali Joffraud, and Isabelle Bady, and also thank Dr. F. Jeanrenaud for critical reading of the manuscript. This work was supported by grants to B. T. from the Swiss National Science Foundation (3100A0-113525) and the National Competence Center Frontiers in Genetics from the Swiss National Science Foundation.	ADACHI A, 1984, NEUROSCI LETT, V46, P215, DOI 10.1016/0304-3940(84)90444-0; ANAND BK, 1964, AM J PHYSIOL, V207, P1146, DOI 10.1152/ajplegacy.1964.207.5.1146; Arluison M, 2004, J CHEM NEUROANAT, V28, P117, DOI 10.1016/j.jchemneu.2004.05.009; Arluison M, 2004, J CHEM NEUROANAT, V28, P137, DOI 10.1016/j.jchemneu.2004.06.002; Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Briski KP, 2001, NEUROSCI LETT, V306, P141, DOI 10.1016/S0304-3940(01)01826-2; Burdakov D, 2006, NEURON, V50, P711, DOI 10.1016/j.neuron.2006.04.032; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cano G, 2003, J COMP NEUROL, V460, P303, DOI 10.1002/cne.10643; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Dallaporta M, 1999, NEUROREPORT, V10, P2657, DOI 10.1097/00001756-199908200-00040; DiMicco JA, 2007, AM J PHYSIOL-REG I, V292, pR47, DOI 10.1152/ajpregu.00498.2006; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Dunn-Meynell AA, 2002, DIABETES, V51, P2056, DOI 10.2337/diabetes.51.7.2056; EGAWA M, 1989, AM J PHYSIOL, V257, pR1386, DOI 10.1152/ajpregu.1989.257.6.R1386; Fioramonti X, 2004, DIABETES, V53, P2767, DOI 10.2337/diabetes.53.11.2767; Fraley GS, 2003, ENDOCRINOLOGY, V144, P75, DOI 10.1210/en.2002-220659; FREINKEL N, 1972, NEW ENGL J MED, V287, P841, DOI 10.1056/NEJM197210262871702; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Hausberg M, 2002, DIABETES, V51, P2434, DOI 10.2337/diabetes.51.8.2434; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Marty N, 2005, J CLIN INVEST, V115, P3545, DOI 10.1172/JCI26309; Marty N, 2006, DIABETES, V55, pS108, DOI 10.2337/db06-S014; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; MIZUNO Y, 1984, BRAIN RES, V307, P109, DOI 10.1016/0006-8993(84)90466-9; MOBBS CV, 2004, PHYSIOL BEHAV, V19, P2; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; RITTER S, 1994, BRAIN RES, V641, P111, DOI 10.1016/0006-8993(94)91822-8; Ritter S, 2000, BRAIN RES, V856, P37, DOI 10.1016/S0006-8993(99)02327-6; Routh VH, 2002, PHYSIOL BEHAV, V76, P403, DOI 10.1016/S0031-9384(02)00761-8; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Silver IA, 1998, J NEUROPHYSIOL, V79, P1733, DOI 10.1152/jn.1998.79.4.1733; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STE ML, 2000, P NATL ACAD SCI USA, V97, P12339; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; Thorens B, 2001, MOL MEMBR BIOL, V18, P265, DOI 10.1080/09687680110100995; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Wang R, 2004, DIABETES, V53, P1959, DOI 10.2337/diabetes.53.8.1959; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yang XJ, 2004, DIABETES, V53, P67, DOI 10.2337/diabetes.53.1.67; Yasuda T, 2004, EXP BIOL MED, V229, P235, DOI 10.1177/153537020422900303; YETTEFTI K, 1995, J AUTONOM NERV SYST, V51, P191, DOI 10.1016/0165-1838(94)00130-C	54	55	56	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2010	24	6					1747	1758		10.1096/fj.09-144923	http://dx.doi.org/10.1096/fj.09-144923			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20097878				2022-12-25	WOS:000278200000012
J	Hargreaves, VV; Shell, SS; Mazur, DJ; Hess, MT; Kolodner, RD				Hargreaves, Victoria V.; Shell, Scarlet S.; Mazur, Dan J.; Hess, Martin T.; Kolodner, Richard D.			Interaction between the Msh2 and Msh6 Nucleotide-binding Sites in the Saccharomyces cerevisiae Msh2-Msh6 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH REPAIR; ESCHERICHIA-COLI MUTS; MISPAIR-BINDING; ATPASE ACTIVITY; RECOGNITION COMPLEX; DOMINANT MUTATIONS; CRYSTAL-STRUCTURE; PROTEIN MUTS; GENE-PRODUCT; ALPHA	Indirect evidence has suggested that the Msh2-Msh6 mispair-binding complex undergoes conformational changes upon binding of ATP and mispairs, resulting in the formation of Msh2-Msh6 sliding clamps and licensing the formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes. Here, we have studied eight mutant Msh2-Msh6 complexes with defective responses to nucleotide binding and/or mispair binding and used them to study the conformational changes required for sliding clamp formation and ternary complex assembly. ATP binding to the Msh6 nucleotide-binding site results in a conformational change that allows binding of ATP to the Msh2 nucleotide-binding site, although ATP binding to the two nucleotide-binding sites appears to be uncoupled in some mutant complexes. The formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes requires ATP binding to only the Msh6 nucleotide-binding site, whereas the formation of Msh2- Msh6 sliding clamps requires ATP binding to both the Msh2 and Msh6 nucleotide-binding sites. In addition, the properties of the different mutant complexes suggest that distinct conformational states mediated by communication between the Msh2 and Msh6 nucleotide-binding sites are required for the formation of ternary complexes and sliding clamps.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [GM50006, CA92584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50006 and CA92584.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; Drotschmann K, 2001, J BIOL CHEM, V276, P46225, DOI 10.1074/jbc.C100450200; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2000, STRUCTURE, V8, pR237, DOI 10.1016/S0969-2126(00)00545-1; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; MARTINEZ S, 2010, P NATL ACAD IN PRESS; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; Tian L, 2009, J BIOL CHEM, V284, P11557, DOI 10.1074/jbc.M900908200; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; WELSH KM, 1987, J BIOL CHEM, V262, P15624; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659	49	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9301	9310		10.1074/jbc.M109.096388	http://dx.doi.org/10.1074/jbc.M109.096388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089866	Green Published, hybrid			2022-12-25	WOS:000275553700078
J	Turk, EM; Caprara, MG				Turk, Edward M.; Caprara, Mark G.			Splicing of Yeast aI5 beta Group I Intron Requires SUV3 to Recycle MRS1 via Mitochondrial Degradosome-promoted Decay of Excised Intron Ribonucleoprotein (RNP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD-BOX PROTEIN; JUNCTION RESOLVASE YDC2; NUCLEAR GENE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; POSTTRANSCRIPTIONAL PROCESSES; HELICASE; TRANSCRIPTION; SEQUENCE; CHAPERONE	Yeast Suv3p is a member of the DEXH/D box family of RNA helicases and is a critical component of the mitochondrial degradosome, which also includes a 3' --> 5' exonuclease, Dss1p. Defects in the degradosome result in accumulation of aberrant transcripts, unprocessed transcripts, and excised group I introns. In addition, defects in SUV3 result in decreased splicing of the aI5 beta and bI3 group I introns. Whereas a role for Suv3p in RNA degradation is well established, the function of Suv3p in splicing of group I introns has remained elusive. It has been particularly challenging to determine if Suv3p effects group I intron splicing through RNA degradation as part of the degradosome, or has a direct role in splicing as a chaperone, because nearly all perturbations of SUV3 or DSS1 result in loss of the mitochondrial genome. Here we utilized the suv3-1 allele, which is defective in RNA metabolism and yet maintains a stable mitochondrial genome, to investigate the role of Suv3p in splicing of the aI5 beta group I intron. We provide genetic evidence that Mrs1p is a limiting cofactor for aI5 beta splicing, and this evidence also suggests that Suv3p activity is required to recycle the excised aI5 beta ribonucleoprotein. We also show that Suv3p acts indirectly as a component of the degradosome to promote aI5 beta splicing. We present a model whereby defects in Suv3p result in accumulation of stable, excised group I intron ribonucleoproteins, which result in sequestration of Mrs1p, and a concomitant reduction in splicing of aI5 beta.	[Turk, Edward M.; Caprara, Mark G.] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Turk, EM (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	emt11@case.edu			National Institutes of Health [F32GM078969, T32HD007104, GM-62853]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078969, R01GM062853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32GM078969 and T32HD007104 (to E. M. T.) and GM-62853 (to M. G. C.).	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Ahn JS, 2003, J BIOL CHEM, V278, P29121, DOI 10.1074/jbc.M302314200; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Bassi GS, 2003, BIOCHEMISTRY-US, V42, P9980, DOI 10.1021/bi0346906; Bassi GS, 2002, P NATL ACAD SCI USA, V99, P128, DOI 10.1073/pnas.012579299; Bifano AL, 2008, J MOL BIOL, V383, P667, DOI 10.1016/j.jmb.2008.08.070; BOUSQUET I, 1990, CURR GENET, V18, P117, DOI 10.1007/BF00312599; Brachmann CB, 1998, YEAST, V14, P115; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; CAPRARA MG, 2010, SKI2 LIKE D IN PRESS; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; Cliften PF, 2000, MOL CELL BIOL, V20, P7013, DOI 10.1128/MCB.20.18.7013-7023.2000; CONRADWEBB H, 1990, NUCLEIC ACIDS RES, V18, P1369, DOI 10.1093/nar/18.6.1369; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; DMOCHOWSKA A, 1995, CURR GENET, V28, P108, DOI 10.1007/BF00315775; Dmochowska A, 1999, ACTA BIOCHIM POL, V46, P155, DOI 10.18388/abp.1999_4193; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; Hoffmann B, 2008, J MOL BIOL, V377, P1024, DOI 10.1016/j.jmb.2008.01.038; Hua SB, 1997, PLASMID, V38, P91, DOI 10.1006/plas.1997.1305; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Kaspar BJ, 2008, NUCLEIC ACIDS RES, V36, P2958, DOI 10.1093/nar/gkn045; KREIKE J, 1986, CURR GENET, V11, P185, DOI 10.1007/BF00420605; KREIKE J, 1987, EMBO J, V6, P2123, DOI 10.1002/j.1460-2075.1987.tb02479.x; Labbe S, 1999, METHOD ENZYMOL, V306, P145; LAMBOWITZ AM, 1999, RNA WORLD, V2, P451; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Margossian SP, 1996, TRENDS BIOCHEM SCI, V21, P392, DOI 10.1016/S0968-0004(96)90129-2; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Mohr S, 2006, P NATL ACAD SCI USA, V103, P3569, DOI 10.1073/pnas.0600332103; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rogowska AT, 2006, MOL BIOL CELL, V17, P1184, DOI 10.1091/mbc.E05-08-0796; Schafer B, 2005, GENE, V354, P80, DOI 10.1016/j.gene.2005.03.032; SERAPHIN B, 1988, EMBO J, V7, P1455, DOI 10.1002/j.1460-2075.1988.tb02963.x; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; SHADEL GS, 1993, J BIOL CHEM, V268, P16083; Sigala B, 2003, EUR J BIOCHEM, V270, P2837, DOI 10.1046/j.1432-1033.2003.03661.x; STEPIEN PP, 1992, P NATL ACAD SCI USA, V89, P6813, DOI 10.1073/pnas.89.15.6813; VALENCIK ML, 1989, EMBO J, V8, P3899, DOI 10.1002/j.1460-2075.1989.tb08569.x; Wardleworth BN, 2000, J BIOL CHEM, V275, P23725, DOI 10.1074/jbc.M002612200; Wegierski T, 1998, ACTA BIOCHIM POL, V45, P935, DOI 10.18388/abp.1998_4352; Woodson SA, 2005, CURR OPIN STRUC BIOL, V15, P324, DOI 10.1016/j.sbi.2005.05.007; ZHU H, 1989, MOL CELL BIOL, V9, P1507, DOI 10.1128/MCB.9.4.1507	51	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8585	8594		10.1074/jbc.M109.090761	http://dx.doi.org/10.1074/jbc.M109.090761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20064926	hybrid, Green Published			2022-12-25	WOS:000275553700010
J	Zhou, YB; Tzeng, WP; Wong, HC; Ye, YM; Jiang, J; Chen, YY; Huang, Y; Suppiah, S; Frey, TK; Yang, JJ				Zhou, Yubin; Tzeng, Wen-Pin; Wong, Hing-Cheung; Ye, Yiming; Jiang, Jie; Chen, Yanyi; Huang, Yun; Suppiah, Suganthi; Frey, Teryl K.; Yang, Jenny J.			Calcium-dependent Association of Calmodulin with the Rubella Virus Nonstructural Protease Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; ENERGY-TRANSFER; CAPSID PROTEIN; CLEAVAGE SITE; INTACT-CELLS; HIV-1 GP160; TROPONIN-C; AFFINITY; REPLICATION; SEQUENCE	The rubella virus (RUBV) nonstructural (NS) protease domain, a Ca2+- and Zn2+-binding papain-like cysteine protease domain within the nonstructural replicase polyprotein precursor, is responsible for the self-cleavage of the precursor into two mature products, P150 and P90, that compose the replication complex that mediates viral RNA replication; the NS protease resides at the C terminus of P150. Here we report the Ca2+-dependent, stoichiometric association of calmodulin (CaM) with the RUBV NS protease. Co-immunoprecipitation and pull-down assays coupled with site-directed mutagenesis demonstrated that both the P150 protein and a 110-residue minidomain within NS protease interacted directly with Ca2+/CaM. The specific interaction was mapped to a putative CaM-binding domain. A 32-mer peptide (residues 1152-1183, denoted as RUBpep) containing the putative CaM-binding domain was used to investigate the association of RUBV NS protease with CaM or its N- and C-terminal subdomains. We found that RUBpep bound to Ca2+/CaM with a dissociation constant of 100-300 nM. The C-terminal subdomain of CaM preferentially bound to RUBpep with an affinity 12.5-fold stronger than the N-terminal subdomain. Fluorescence, circular dichroism and NMR spectroscopic studies revealed a "wrapping around" mode of interaction between RUBpep and Ca2+/CaM with substantially more helical structure in RUBpep and a global structural change in CaM upon complex formation. Using a site-directed mutagenesis approach, we further demonstrated that association of CaM with the CaM-binding domain in the RUBV NS protease was necessary for NS protease activity and infectivity.	[Tzeng, Wen-Pin; Suppiah, Suganthi; Frey, Teryl K.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Wong, Hing-Cheung; Jiang, Jie; Chen, Yanyi; Huang, Yun; Yang, Jenny J.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Ye, Yiming] Ctr Dis Control & Prevent, Prote Lab, Biotechnol Core Facil Branch, Atlanta, GA 30333 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Centers for Disease Control & Prevention - USA	Frey, TK (corresponding author), Georgia State Univ, Dept Biol, 50 Decatur St, Atlanta, GA 30303 USA.	tfrey@gsu.edu; chejjy@langate.gsu.edu	Zhou, Yubin/D-4748-2011; Chen, Yanyi/H-7096-2013	Zhou, Yubin/0000-0001-7962-0517; Chen, Yanyi/0000-0002-7755-0882; Huang, Yun/0000-0001-5950-9168	National Institutes of Health, NIAID [R01 AI21389]; National Institutes of Health [R01 GM62999, R01 GM081749]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062999, R01GM081749] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or part, by National Institutes of Health Grants R01 AI21389 from NIAID (to T. K. F. and J. J. Y.) and R01 GM62999 and R01 GM081749 (to J. J. Y.).	Balog EM, 2003, J BIOL CHEM, V278, P15615, DOI 10.1074/jbc.M209180200; Barth A, 1998, J BIOL CHEM, V273, P2174, DOI 10.1074/jbc.273.4.2174; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; BRITTAIN HG, 1976, J AM CHEM SOC, V98, P8255, DOI 10.1021/ja00441a060; BRUNO J, 1992, BIOCHEMISTRY-US, V31, P7016, DOI 10.1021/bi00146a002; Chami M, 2006, BBA-MOL CELL RES, V1763, P1344, DOI 10.1016/j.bbamcr.2006.09.025; Chen HH, 2006, ARCH VIROL, V151, P1841, DOI 10.1007/s00705-006-0744-9; Chen JP, 1996, J VIROL, V70, P4707, DOI 10.1128/JVI.70.7.4707-4713.1996; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; IKURA M, 1992, CELL CALCIUM, V13, P391, DOI 10.1016/0143-4160(92)90052-T; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; LAPORTE DC, 1981, BIOCHEMISTRY-US, V20, P3965, DOI 10.1021/bi00517a004; Liang YY, 2001, VIROLOGY, V282, P307, DOI 10.1006/viro.2001.0862; LING KY, 1994, EUR J BIOCHEM, V222, P433, DOI 10.1111/j.1432-1033.1994.tb18882.x; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Liu X, 2000, J VIROL, V74, P5949, DOI 10.1128/JVI.74.13.5949-5956.2000; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Micoli KJ, 2006, VIROLOGY, V344, P468, DOI 10.1016/j.virol.2005.08.033; Micoli KJ, 2000, J BIOL CHEM, V275, P1233, DOI 10.1074/jbc.275.2.1233; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Newman RA, 2008, PROTEINS, V71, P1792, DOI 10.1002/prot.21861; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Pugachev KV, 1997, J VIROL, V71, P562, DOI 10.1128/JVI.71.1.562-568.1997; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ruiz MC, 2000, CELL CALCIUM, V28, P137, DOI 10.1054/ceca.2000.0142; Scheschonka A, 2008, J BIOL CHEM, V283, P5577, DOI 10.1074/jbc.M709505200; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Sham SWS, 2008, AIDS RES HUM RETROV, V24, P607, DOI 10.1089/aid.2007.0202; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Tzeng WP, 2006, J VIROL, V80, P3966, DOI 10.1128/JVI.80.8.3966-3974.2006; Tzeng WP, 2003, J VIROL, V77, P9502, DOI 10.1128/JVI.77.17.9502-9510.2003; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; WALLACE RW, 1982, J BIOL CHEM, V257, P1845; WANG CLA, 1982, J BIOL CHEM, V257, P8372; WANG CLA, 1981, BIOCHEMISTRY-US, V20, P2439, DOI 10.1021/bi00512a012; WANG CLA, 1982, EUR J BIOCHEM, V124, P7, DOI 10.1111/j.1432-1033.1982.tb05900.x; WANG CLA, 1984, BIOCHEMISTRY-US, V23, P6410, DOI 10.1021/bi00321a020; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Ye YM, 2005, J AM CHEM SOC, V127, P3743, DOI 10.1021/ja042786x; YUAN T, 1995, BIOCHEMISTRY-US, V34, P10690, DOI 10.1021/bi00033a045; Yuan T, 2001, BIOPOLYMERS, V58, P50, DOI 10.1002/1097-0282(200101)58:1<50::AID-BIP60>3.0.CO;2-S; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zhou YB, 2007, J VIROL, V81, P7517, DOI 10.1128/JVI.00605-07; Zhou YB, 2009, BIOCHEM J, V417, P477, DOI 10.1042/BJ20081468	54	7	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8855	8868		10.1074/jbc.M109.097063	http://dx.doi.org/10.1074/jbc.M109.097063			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086014	Green Published, hybrid			2022-12-25	WOS:000275553700037
J	Hsu, SC; Chen, CH; Tsai, SH; Kawasaki, H; Hung, CH; Chu, YT; Chang, HW; Zhou, YF; Fu, JR; Plunkett, B; Su, SN; Vieths, S; Lee, RT; Lee, YC; Huang, SK				Hsu, Shih-Chang; Chen, Chien-Ho; Tsai, Shih-Han; Kawasaki, Hirokazu; Hung, Chih-Hsing; Chu, Yu-Te; Chang, Hui-Wen; Zhou, Yufeng; Fu, Jinrong; Plunkett, Beverly; Su, Song-Nan; Vieths, Stefan; Lee, Reiko T.; Lee, Yuan C.; Huang, Shau-Ku			Functional Interaction of Common Allergens and a C-type Lectin Receptor, Dendritic Cell-specific ICAM3-grabbing Non-integrin (DC-SIGN), on Human Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; OLIGOSACCHARIDES; RECOGNITION; GLYCOPROTEIN; PROTEINS; PATHWAY; DER-P-1; INNATE; LIGAND; ROLES	Fucosylated glycans on pathogens are known to shape the immune response through their interaction with pattern recognition receptors, such as C-type lectin receptors (CLRs), on dendritic cells (DCs). Similar fucosylated structures are also commonly found in a variety of allergens, but their functional significance remains unclear. To test a hypothesis that allergen-associated glycans serve as the molecular patterns in functional interaction with CLRs, an enzyme-linked immunosorbent assay-based binding assay was performed to determine the binding activity of purified allergens and allergen extracts. THP-1 cells and monocyte-derived DCs (MDDCs) were investigated as a model for testing the functional effects of allergen-CLR interaction using enzyme-linked immunosorbent assay, Western blotting, and flow cytometry. Significant and saturable bindings of allergens and allergen extracts with variable binding activities to DC- specific ICAM3-grabbing non-integrin (DCSIGN) and its related receptor, L-SIGN, were found. These include bovine serum albumin coupled with a common glycoform (fucosylated glycan lacking the alpha 1,3-linked mannose) of allergens and a panel of purified allergens, including BG60 (Cyn dBG-60; Bermuda grass pollen) and Der p2 (house dust mite). The binding activity was calcium-dependent and inhibitable by fucose and Lewis-x trisaccharides (Lex). In THP-1 cells and human MDDCs, BG60-DC-SIGN interaction led to the activation of Raf-1 and ERK kinases and the induction of tumor necrosis factor-alpha expression. This effect could be blocked, in part, by Raf-1 inhibitor or anti-DC-SIGN antibodies and was significantly reduced in cells with DC-SIGN knockdown. These results suggest that allergens are able to interact with DC- SIGN and induce tumor necrosis factor-alpha expression in MDDCs via, in part, Raf-1 signaling pathways.	[Hsu, Shih-Chang; Kawasaki, Hirokazu; Zhou, Yufeng; Fu, Jinrong; Plunkett, Beverly; Huang, Shau-Ku] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA; [Chen, Chien-Ho; Tsai, Shih-Han] Taipei Med Univ, Dept Med Technol, Taipei 110, Taiwan; [Hung, Chih-Hsing] Kaohsiung Med Univ, Dept Pediat, Kaohsiung 807, Taiwan; [Hung, Chih-Hsing; Huang, Shau-Ku] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan; [Huang, Shau-Ku] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan; [Hung, Chih-Hsing; Chu, Yu-Te; Chang, Hui-Wen] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung 807, Taiwan; [Su, Song-Nan] Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Vieths, Stefan] Paul Ehrlich Inst, Dept Allergol, D-63225 Langen, Germany; [Lee, Reiko T.; Lee, Yuan C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Paul Ehrlich Institute; Johns Hopkins University	Huang, SK (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	skhuang@jhmi.edu	zhou, yufeng/G-6429-2010; Hsu, Shih-Chang/I-4277-2012; Huang, Shau-Ku/F-5509-2010	Hsu, Shih-Chang/0000-0003-1010-1182; zhou, Yufeng/0000-0002-6050-4951	National Institutes of Health [AI052468, AI073610]; Center of Excellence For Environmental Medicine, Kaohsiung Medical University [KMU-EM-98-4.1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073610, R01AI052468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence For Environmental Medicine, Kaohsiung Medical University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI052468 and AI073610. This work was also supported by Center of Excellence For Environmental Medicine, Kaohsiung Medical University Grant KMU-EM-98-4.1.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Foster B, 2003, J ALLERGY CLIN IMMUN, V112, P1132, DOI 10.1016/j.jaci.2003.09.011; Fotisch K, 2001, GLYCOCONJUGATE J, V18, P373, DOI 10.1023/A:1014860030380; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hsu SC, 2007, J ALLERGY CLIN IMMUN, V119, P1522, DOI 10.1016/j.jaci.2007.01.034; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Kawaguchi M, 2007, J ALLERGY CLIN IMMUN, V119, P1408, DOI 10.1016/j.jaci.2007.02.036; Kawasaki N, 1997, ANAL BIOCHEM, V250, P260, DOI 10.1006/abio.1997.2233; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Lauer I, 2004, BIOCHEM J, V383, P327, DOI 10.1042/BJ20041062; LEE YC, 1976, BIOCHEMISTRY-US, V15, P3956, DOI 10.1021/bi00663a008; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Ohsuga H, 1996, J BIOL CHEM, V271, P26653, DOI 10.1074/jbc.271.43.26653; Okano M, 2004, CLIN EXP ALLERGY, V34, P770, DOI 10.1111/j.1365-2222.2004.1948.x; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; Wicklein D, 2004, BIOL CHEM, V385, P397, DOI 10.1515/BC.2004.044	30	71	76	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7903	7910		10.1074/jbc.M109.058370	http://dx.doi.org/10.1074/jbc.M109.058370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080962	hybrid, Green Published			2022-12-25	WOS:000275413800007
J	Jiang, XL; Yu, Y; Yang, HW; Agar, NYR; Frado, L; Johnson, MD				Jiang, Xiuli; Yu, Yi; Yang, Hong Wei; Agar, Nathalie Y. R.; Frado, Laura; Johnson, Mark D.			The Imprinted Gene PEG3 Inhibits Wnt Signaling and Regulates Glioma Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER GENE; WNT/BETA-CATENIN PATHWAY; BETA-CATENIN; APOPTOSIS; P53; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; MEDIATOR; BEHAVIOR	The imprinted gene PEG3 confers parenting and sexual behaviors, alters growth and development, and regulates apoptosis. However, a molecular mechanism that can account for the diverse functions of Peg3/Pw1 is not known. To elucidate Peg3-regulated pathways, we performed a functional screen in zebrafish. Enforced overexpression of PEG3 mRNA during zebrafish embryogenesis decreased beta-catenin protein expression and inhibited Wnt-dependent tail development. Peg3/Pw1 also inhibited Wnt signaling in human cells by binding to beta-catenin and promoting its degradation via a p53/Siah1-dependent, GSK3 beta-independent proteasomal pathway. The inhibition of the Wnt pathway by Peg3/Pw1 suggested a role in tumor suppression. Hypermethylation of the PEG3 promoter in primary human gliomas led to a loss of imprinting and decreased PEG3 mRNA expression that correlated with tumor grade. The decrease in Peg3/Pw1 protein expression increased beta-catenin, promoted proliferation, and inhibited p53-dependent apoptosis in human CD133(+) glioma stem cells. Thus, mammalian imprinting utilizes Peg3/Pw1 to co-opt the Wnt pathway, thereby regulating development and glioma growth.	[Johnson, Mark D.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Johnson, MD (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02215 USA.	mjohnson27@partners.org			National Institutes of Health [K08 NS43482, 1DP2OD002319-01]; American Brain Tumor Association; Sontag Distinguished Scientist award; Hagerty Fund research award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS043482, R01NS062219] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association; Sontag Distinguished Scientist award; Hagerty Fund research award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant K08 NS43482 and National Institutes of Health Director's New Innovator Award 1DP2OD002319-01 (to M. D. J.). This work was also supported by an American Brain Tumor Association fellowship (to X. J.), a Sontag Distinguished Scientist award, and a Hagerty Fund research award (to M. D. J.).	Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Huang ML, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-221; Johnson MD, 2004, J BIOL CHEM, V279, P26685, DOI 10.1074/jbc.M401274200; Johnson MD, 2002, J BIOL CHEM, V277, P23000, DOI 10.1074/jbc.M201907200; Kapsimali M, 2004, DEVELOPMENT, V131, P5923, DOI 10.1242/dev.01453; Kim J, 2000, GENOMICS, V64, P114, DOI 10.1006/geno.1999.6112; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Ledgerwood EC, 2000, LAB INVEST, V80, P1509, DOI 10.1038/labinvest.3780160; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nicolas N, 2005, DEV BIOL, V281, P171, DOI 10.1016/j.ydbio.2005.02.022; Okamoto K, 1997, P NATL ACAD SCI USA, V94, P5367, DOI 10.1073/pnas.94.10.5367; Pantoja C, 2005, CANCER RES, V65, P26; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Sadot E, 2002, J CELL SCI, V115, P2771; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Swaney WT, 2008, BEHAV NEUROSCI, V122, P963, DOI 10.1037/a0012706; Swaney WT, 2007, P NATL ACAD SCI USA, V104, P6084, DOI 10.1073/pnas.0609471104; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Wang ZH, 2003, CANCER RES, V63, P5234; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	37	93	97	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8472	8480		10.1074/jbc.M109.069450	http://dx.doi.org/10.1074/jbc.M109.069450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064927	Green Published, hybrid			2022-12-25	WOS:000275413800062
J	Price, NT; Jackson, VN; Muller, J; Moffat, K; Matthews, KL; Orton, T; Zammit, VA				Price, Nigel T.; Jackson, Vicky N.; Mueller, Juerger; Moffat, Kevin; Matthews, Karen L.; Orton, Tim; Zammit, Victor A.			Alternative Exon Usage in the Single CPT1 Gene of Drosophila Generates Functional Diversity in the Kinetic Properties of the Enzyme DIFFERENTIAL EXPRESSION OF ALTERNATIVELY SPLICED VARIANTS IN DROSOPHILA TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; MALONYL-COA SENSITIVITY; CRYSTAL-STRUCTURE; RAT-LIVER; STRUCTURAL MODEL; SUBSTRATE SELECTIVITY; MUSCLE ISOFORMS; ACETYLTRANSFERASE; OCTANOYLTRANSFERASE; IDENTIFICATION	The Drosophila melanogaster genome contains only one CPT1 gene (Jackson, V. N., Cameron, J. M., Zammit, V. A., and Price, N. T. (1999) Biochem. J. 341, 483-489). We have now extended our original observation to all insect genomes that have been sequenced, suggesting that a single CPT1 gene is a universal feature of insect genomes. We hypothesized that insects may be able to generate kinetically distinct variants by alternative splicing of their single CPT1 gene. Analysis of the insect genomes revealed that (a) the single CPT1 gene in each and every insect genome contains two alternative exons and (ii) in all cases, the putative alternative splicing site occurs within a small region corresponding to 21 amino acid residues that are known to be essential for the binding of substrates and of malonyl-CoA in mammalian CPT1A. We performed PCR analyses of mRNA from different Drosophila tissues; both of the anticipated splice variants of CPT1 mRNA were found to be expressed in all of the tissues tested (both in larvae and adults), with the expression level for one of the splice variants being significantly different between flight muscle and the fat body of adult Drosophila. Heterologous expression of the full-length cDNAs corresponding to the two putative variants of Drosophila CPT1 in the yeast Pichia pastoris revealed two important differences between the properties of the two variants: (i) their affinity (K-0.5) for one of the substrates, palmitoyl-CoA, differed by 5-fold, and (ii) the sensitivity to inhibition by malonyl-CoA at fixed, higher palmitoyl-CoA concentrations was 2-fold different and associated with different kinetics of inhibition. These data indicate that alternative splicing that specifically affects a structurally crucial region of the protein is an important mechanism through which functional diversity of CPT1 kinetics is generated from the single gene that occurs in insects.	[Price, Nigel T.; Jackson, Vicky N.; Mueller, Juerger; Matthews, Karen L.; Orton, Tim; Zammit, Victor A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Moffat, Kevin] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Zammit, VA (corresponding author), Univ Warwick, Warwick Med Sch, Gibbett Hill Rd, Coventry CV4 7AL, W Midlands, England.	v.a.zammit@warwick.ac.uk		Muller, Jurgen/0000-0002-5487-0736	British Heart Foundation	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; Celniker SE, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0079; Gobin S, 2002, HUM GENET, V111, P179, DOI 10.1007/s00439-002-0752-0; Hsiao YS, 2004, J BIOL CHEM, V279, P31584, DOI 10.1074/jbc.M403484200; Hsiao YS, 2006, J BIOL CHEM, V281, P28480, DOI 10.1074/jbc.M602622200; Hsiao YS, 2006, BIOCHEM BIOPH RES CO, V346, P974, DOI 10.1016/j.bbrc.2006.06.006; Jackson VN, 2000, J BIOL CHEM, V275, P38410, DOI 10.1074/jbc.M007722200; Jackson VN, 1999, BIOCHEM J, V341, P483, DOI 10.1042/0264-6021:3410483; Jackson VN, 2000, J BIOL CHEM, V275, P19560, DOI 10.1074/jbc.M002177200; Jackson VN, 2001, BIOCHEMISTRY-US, V40, P14629, DOI 10.1021/bi011632g; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Jogl G, 2005, J BIOL CHEM, V280, P738, DOI 10.1074/jbc.M409894200; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Knudsen J, 2000, J NUTR, V130, p294S, DOI 10.1093/jn/130.2.294S; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Lopez-Vinas E, 2007, J BIOL CHEM, V282, P18212, DOI 10.1074/jbc.M700885200; Morillas M, 2004, BIOCHEM J, V379, P777, DOI 10.1042/BJ20031373; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Morillas M, 2002, J BIOL CHEM, V277, P11473, DOI 10.1074/jbc.M111628200; Morillas M, 2000, FEBS LETT, V466, P183, DOI 10.1016/S0014-5793(99)01788-3; Morillas M, 2001, J BIOL CHEM, V276, P45001, DOI 10.1074/jbc.M106920200; PANDE SV, 1989, BIOCHEM CELL BIOL, V67, P671, DOI 10.1139/o89-100; Park EA, 1998, BIOCHEM J, V330, P217; Price NT, 2003, BIOCHEM J, V372, P871, DOI 10.1042/BJ20030086; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055; van der Leij FR, 2002, J BIOL CHEM, V277, P26994, DOI 10.1074/jbc.M203189200; Wang DC, 1998, GENOMICS, V48, P314, DOI 10.1006/geno.1997.5184; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Yamazaki N, 1997, FEBS LETT, V409, P401, DOI 10.1016/S0014-5793(97)00561-9; Yu GS, 1998, J BIOL CHEM, V273, P32901, DOI 10.1074/jbc.273.49.32901; Zammit VA, 1999, BIOCHEM J, V343, P505, DOI 10.1042/0264-6021:3430505; Zammit VA, 2001, BIOCHEM SOC T, V29, P287, DOI 10.1042/BST0290287	40	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7857	7865		10.1074/jbc.M109.072892	http://dx.doi.org/10.1074/jbc.M109.072892			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061394	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000275413800003
J	Heiner, M; Sriram, K				Heiner, Monika; Sriram, K.			Structural Analysis to Determine the Core of Hypoxia Response Network	PLOS ONE			English	Article							PETRI NETS; OXYGEN; BIOLOGY; SYSTEMS; ROBUSTNESS; EXPRESSION; PROTEIN; MODEL	The advent of sophisticated molecular biology techniques allows to deduce the structure of complex biological networks. However, networks tend to be huge and impose computational challenges on traditional mathematical analysis due to their high dimension and lack of reliable kinetic data. To overcome this problem, complex biological networks are decomposed into modules that are assumed to capture essential aspects of the full network's dynamics. The question that begs for an answer is how to identify the core that is representative of a network's dynamics, its function and robustness. One of the powerful methods to probe into the structure of a network is Petri net analysis. Petri nets support network visualization and execution. They are also equipped with sound mathematical and formal reasoning based on which a network can be decomposed into modules. The structural analysis provides insight into the robustness and facilitates the identification of fragile nodes. The application of these techniques to a previously proposed hypoxia control network reveals three functional modules responsible for degrading the hypoxia-inducible factor (HIF). Interestingly, the structural analysis identifies superfluous network parts and suggests that the reversibility of the reactions are not important for the essential functionality. The core network is determined to be the union of the three reduced individual modules. The structural analysis results are confirmed by numerical integration of the differential equations induced by the individual modules as well as their composition. The structural analysis leads also to a coarse network structure highlighting the structural principles inherent in the three functional modules. Importantly, our analysis identifies the fragile node in this robust network without which the switch-like behavior is shown to be completely absent.	[Heiner, Monika] Brandenburg Tech Univ Cottbus, Dept Comp Sci, Cottbus, Germany; [Sriram, K.] INRIA Rocquencourt, Projet Contraintes, Le Chesnay, France	Brandenburg University of Technology Cottbus	Heiner, M (corresponding author), Brandenburg Tech Univ Cottbus, Dept Comp Sci, Cottbus, Germany.	monika.heiner@tu-cottbus.de	Heiner, Monika/AAG-1022-2019	Heiner, Monika/0000-0003-1815-1205				Bause F, 1999, STOCHASTIC PETRI NET; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bonzanni N, 2009, BIOINFORMATICS, V25, P2049, DOI 10.1093/bioinformatics/btp355; Breitling R, 2008, BRIEF BIOINFORM, V9, P404, DOI 10.1093/bib/bbn026; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; CHEN L, 2009, BMC SYSTEMS BIOL, V3, P42; David R., 2005, DISCRETE CONTINUOUS; Dayan F, 2009, J THEOR BIOL, V259, P304, DOI 10.1016/j.jtbi.2009.03.009; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; GILBERT D, 2008, P 2 IFIP C BIOL INSP, P163; Gilbert D, 2006, LECT NOTES COMPUT SC, V4024, P181; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heiner M, 2004, LECT NOTES COMPUT SC, V3099, P216; HEINER M, 2008, P PNTAP 2008 ASS SIM; HEINER M, 2010, SYMBOLIC SY IN PRESS; Heiner M, 2009, NAT COMPUT SER, P367, DOI 10.1007/978-3-540-88869-7_19; Heiner M, 2008, LECT NOTES COMPUT SC, V5016, P215; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kohn KW, 2004, MOL BIOL CELL, V15, P3042, DOI 10.1091/mbc.e03-12-0897; LAUTENBACH K, 1973, 82 GMD; Los M, 1996, LAB INVEST, V75, P231; Marwan W, 2011, NAT COMPUT, V10, P639, DOI 10.1007/s11047-009-9152-x; Matsuda S, 2006, ELECTRON COMM JPN 1, V89, P11, DOI 10.1002/ecja.20240; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; NAGASAKI M, 2009, FDN SYSTEMS BIOL USI; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Qutub AA, 2006, J CELL SCI, V119, P3467, DOI 10.1242/jcs.03087; Saugstad OD, 2006, J PERINATOL, V26, pS46, DOI 10.1038/sj.jp.7211475; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Yu YH, 2007, PLOS COMPUT BIOL, V3, P1657, DOI 10.1371/journal.pcbi.0030171; 2008, TOOL ANAL PLACE TRAN	38	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8600	10.1371/journal.pone.0008600	http://dx.doi.org/10.1371/journal.pone.0008600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098728	Green Submitted, Green Published, gold			2022-12-25	WOS:000273778900002
J	Poulsen, M; Currie, CR				Poulsen, Michael; Currie, Cameron R.			Symbiont Interactions in a Tripartite Mutualism: Exploring the Presence and Impact of Antagonism between Two Fungus-Growing Ant Mutualists	PLOS ONE			English	Article							LEAF-CUTTING ANTS; ATTA-SEXDENS-RUBROPILOSA; ACTINOMYCETE BACTERIA; GARDENING ANT; HOST; FORMICIDAE; EVOLUTION; AGRICULTURE; HYMENOPTERA; COOPERATION	Mutualistic associations are shaped by the interplay of cooperation and conflict among the partners involved, and it is becoming increasingly clear that within many mutualisms multiple partners simultaneously engage in beneficial interactions. Consequently, a more complete understanding of the dynamics within multipartite mutualism communities is essential for understanding the origin, specificity, and stability of mutualisms. Fungus-growing ants cultivate fungi for food and maintain antibiotic-producing Pseudonocardia actinobacteria on their cuticle that help defend the cultivar fungus from specialized parasites. Within both ant-fungus and ant-bacterium mutualisms, mixing of genetically distinct strains can lead to antagonistic interactions (i.e., competitive conflict), which may prevent the ants from rearing multiple strains of either of the mutualistic symbionts within individual colonies. The success of different ant-cultivar-bacterium combinations could ultimately be governed by antagonistic interactions between the two mutualists, either as inhibition of the cultivar by Pseudonocardia or vice versa. Here we explore cultivar-Pseudonocardia antagonism by evaluating in vitro interactions between strains of the two mutualists, and find frequent antagonistic interactions both from cultivars towards Pseudonocardia and vice versa. To test whether such in vitro antagonistic interactions affect ant colonies in vivo, we performed sub-colony experiments using species of Acromyrmex leaf-cutting ants. We created novel ant-fungus-bacterium pairings in which there was antagonism from one, both, or neither of the ants' microbial mutualists, and evaluated the effect of directional antagonism on cultivar biomass and Pseudonocardia abundance on the cuticle of workers within subcolonies. Despite the presence of frequent in vitro growth suppression between cultivars and Pseudonocardia, antagonism from Pseudonocardia towards the cultivar did not reduce sub-colony fungus garden biomass, nor did cultivar antagonism towards Pseudonocardia reduce bacteria abundance on the cuticle of sub-colony workers. Our findings suggest that inter-mutualist antagonism does not limit what combinations of cultivar and Pseudonocardia strains Acromyrmex fungus-growing ants can maintain within nests.	[Poulsen, Michael; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Poulsen, M (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	Poulsen@bact.wisc.edu	Poulsen, Michael/C-6276-2012	Poulsen, Michael/0000-0002-2839-1715	The Carlsberg Foundation; National Science Foundation [0747002]; Direct For Biological Sciences [0747002] Funding Source: National Science Foundation	The Carlsberg Foundation(Carlsberg Foundation); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: This work was supported by The Carlsberg Foundation to MP and National Science Foundation (CAREER 0747002) to CRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AS, 2009, COMMUNITY ANAL BACTE; Adams RMM, 2000, NATURWISSENSCHAFTEN, V87, P491, DOI 10.1007/s001140050765; BACCI M, 1995, BRAZ J MED BIOL RES, V28, P79; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BASS M, 1994, ECOL ENTOMOL, V19, P215, DOI 10.1111/j.1365-2311.1994.tb00412.x; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Bot ANM, 2001, EVOLUTION, V55, P1980, DOI 10.1111/j.0014-3820.2001.tb01315.x; Brandao CRF, 2001, SOCIOBIOLOGY, V38, P639; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; CAFARO MJ, CODIVERSIFICAT UNPUB; Caldera EJ, 2009, ENVIRON ENTOMOL, V38, P78, DOI 10.1603/022.038.0110; Carreiro SC, 1997, ANTON LEEUW INT J G, V71, P243, DOI 10.1023/A:1000182108648; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, OIKOS, V101, P91, DOI 10.1034/j.1600-0706.2003.12036.x; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Dekker KA, 1998, J ANTIBIOT, V51, P145, DOI 10.7164/antibiotics.51.145; Douglas AE, 1994, SYMBIOTIC INTERACTIO; Fernandez-Marin H, 2004, BIOL J LINN SOC, V81, P39, DOI 10.1111/j.1095-8312.2004.00268.x; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Frank SA, 2003, EVOLUTION, V57, P693; Gaume L, 1998, P ROY SOC B-BIOL SCI, V265, P569, DOI 10.1098/rspb.1998.0332; Gehring C, 2009, ENVIRON ENTOMOL, V38, P93, DOI 10.1603/022.038.0111; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; Haeder S, 2009, P NATL ACAD SCI USA, V106, P4742, DOI 10.1073/pnas.0812082106; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Ivens ABF, 2009, BEHAV ECOL, V20, P378, DOI 10.1093/beheco/arn150; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Lee MY, 2006, J IND MICROBIOL BIOT, V33, P84, DOI 10.1007/s10295-005-0018-7; Little AEF, 2008, ECOLOGY, V89, P1216, DOI 10.1890/07-0815.1; Little AEF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-124; Margulis L., 1993, SYMBIOSIS CELL EVOLU; Mehdiabadi NJ, 2006, BEHAV ECOL, V17, P291, DOI 10.1093/beheco/arj028; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Mueller UG, 2008, EVOLUTION, V62, P2894, DOI 10.1111/j.1558-5646.2008.00501.x; North RD, 1997, TRENDS ECOL EVOL, V12, P386, DOI 10.1016/S0169-5347(97)87381-8; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Poulsen M, 2005, MOL ECOL, V14, P3597, DOI 10.1111/j.1365-294X.2005.02695.x; Poulsen M, 2003, NATURWISSENSCHAFTEN, V90, P406, DOI 10.1007/s00114-003-0450-3; Poulsen M, 2003, FUNCT ECOL, V17, P260, DOI 10.1046/j.1365-2435.2003.00726.x; Poulsen M, 2002, INSECT SOC, V49, P15, DOI 10.1007/s00040-002-8271-5; POULSEN M, 2010, ENV MICRORE IN PRESS; Poulsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000960; Poulsen M, 2009, EVOLUTION, V63, P2235, DOI 10.1111/j.1558-5646.2009.00704.x; Reynolds HT, 2004, MYCOLOGIA, V96, P955, DOI 10.2307/3762079; Richard FJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P1637, DOI 10.1007/s00265-007-0395-1; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Santos AV, 2004, FEMS MICROBIOL LETT, V239, P319, DOI 10.1016/j.femsle.2004.09.005; *SAS STAT, 1994, SAS STAT US GUID, V1; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Seal JN, 2007, FUNCT ECOL, V21, P988, DOI 10.1111/j.1365-2435.2007.01294.x; Sen R, 2009, P NATL ACAD SCI USA, V106, P17805, DOI 10.1073/pnas.0904827106; Stachowicz JJ, 2005, ECOLOGY, V86, P2418, DOI 10.1890/04-0819; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Viana AMM, 2001, CHEMOECOLOGY, V11, P29, DOI 10.1007/PL00001829; von Ihering H., 1898, ZOOL ANZ, V21, P238; WAKSMAN SA, 1950, ACTINOMYCETES THEIR; WEBER NA, 1972, AM ZOOL, V12, P577; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466; Zhang MM, 2007, ISME J, V1, P313, DOI 10.1038/ismej.2007.41	73	29	29	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8748	10.1371/journal.pone.0008748	http://dx.doi.org/10.1371/journal.pone.0008748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090958	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714900024
J	Imlach, WL; Finch, SC; Miller, JH; Meredith, AL; Dalziel, JE				Imlach, Wendy L.; Finch, Sarah C.; Miller, John H.; Meredith, Andrea L.; Dalziel, Julie E.			A Role for BK Channels in Heart Rate Regulation in Rodents	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNEL; LARGE-CONDUCTANCE; BETA-SUBUNIT; STRUCTURE ELUCIDATION; SMOOTH-MUSCLE; LOLITREM-B; TREMORGENIC MYCOTOXIN; GENE-EXPRESSION; MICE LACKING	The heart generates and propagates action potentials through synchronized activation of ion channels allowing inward Na+ and Ca2+ and outward K+ currents. There are a number of K+ channel types expressed in the heart that play key roles in regulating the cardiac cycle. Large conductance calcium-activated potassium (BK) ion channels are not thought to be directly involved in heart function. Here we present evidence that heart rate can be significantly reduced by inhibiting the activity of BK channels. Agents that specifically inhibit BK channel activity, including paxilline and lolitrem B, slowed heart rate in conscious wild-type mice by 30% and 42%, respectively. Heart rate of BK channel knock-out mice (Kcnma1(-/-)) was not affected by these BK channel inhibitors, suggesting that the changes to heart rate were specifically mediated through BK channels. The possibility that these effects were mediated through BK channels peripheral to the heart was ruled out with experiments using isolated, perfused rat hearts, which showed a significant reduction in heart rate when treated with the BK channel inhibitors paxilline (1 mu M), lolitrem B (1 mu M), and iberiotoxin (0.23 mu M), of 34%, 60%, and 42%, respectively. Furthermore, paxilline was shown to decrease heart rate in a dose-dependent manner. These results implicate BK channels located in the heart to be directly involved in the regulation of heart rate.	[Imlach, Wendy L.; Dalziel, Julie E.] AgResearch, Grasslands Res Ctr, Palmerston North, New Zealand; [Finch, Sarah C.] AgResearch, Ruakura Res Ctr, Hamilton, New Zealand; [Miller, John H.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Meredith, Andrea L.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Imlach, Wendy L.] Univ Otago, Dept Pharmacol & Toxicol, Dunedin, New Zealand	AgResearch - New Zealand; AgResearch - New Zealand; Victoria University Wellington; University System of Maryland; University of Maryland Baltimore; University of Otago	Imlach, WL (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Med Ctr, New York, NY 10027 USA.	julie.dalziel@agresearch.co.nz	Imlach, Wendy/G-7609-2011; Finch, Sarah/L-5795-2013	Imlach, Wendy/0000-0002-7521-9969; Finch, Sarah/0000-0003-2765-5843; Dalziel, Julie/0000-0003-3629-2351; Meredith, Andrea/0000-0003-1061-2302	Marsden Fund; Royal Society of New Zealand [AGR302]; Neural Systems Research Theme, University of Otago, New Zealand	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Royal Society of New Zealand(Royal Society of New Zealand); Neural Systems Research Theme, University of Otago, New Zealand	This work was supported by a Marsden Fund, Royal Society of New Zealand (http://marsden.rsnz.org/) grant AGR302 (J.D., S.F., A.M.) and a travel grant from the Neural Systems Research Theme, University of Otago, New Zealand (W.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia J, 2004, NATURE, V427, P853, DOI 10.1038/nature02356; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bilmen JG, 2002, ARCH BIOCHEM BIOPHYS, V406, P55, DOI 10.1016/S0003-9861(02)00240-0; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; CALLEWAERT G, 1986, PFLUG ARCH EUR J PHY, V406, P424, DOI 10.1007/BF00590947; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Chen MY, 2009, J UROLOGY, V182, P374, DOI 10.1016/j.juro.2009.02.109; Dalziel JE, 2005, TOXICOL LETT, V155, P421, DOI 10.1016/j.toxlet.2004.11.011; DeFarias FP, 1996, EUR J PHARMACOL, V314, P123, DOI 10.1016/S0014-2999(96)00540-7; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Franciolini F, 2001, PFLUG ARCH EUR J PHY, V441, P629, DOI 10.1007/s004240000471; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; Gribkoff VK, 2001, NEUROSCIENTIST, V7, P166, DOI 10.1177/107385840100700211; Harrell MD, 2007, PHYSIOL GENOMICS, V28, P273, DOI 10.1152/physiolgenomics.00163.2006; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Imlach WL, 2008, J PHARMACOL EXP THER, V327, P657, DOI 10.1124/jpet.108.143933; Imlach WL, 2009, EUR J PHARMACOL, V605, P36, DOI 10.1016/j.ejphar.2008.12.031; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Longland CL, 2000, EUR J PHARMACOL, V408, P219, DOI 10.1016/S0014-2999(00)00775-5; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; MILES CO, 1994, J AGR FOOD CHEM, V42, P1488, DOI 10.1021/jf00043a018; Munday-Finch SC, 1998, J AGR FOOD CHEM, V46, P590, DOI 10.1021/jf9706787; MundayFinch SC, 1996, J AGR FOOD CHEM, V44, P2782, DOI 10.1021/jf950396b; MUNDAYFINCH SC, 1995, J AGR FOOD CHEM, V43, P1283, DOI 10.1021/jf00053a029; MundayFinch SC, 1997, J AGR FOOD CHEM, V45, P199, DOI 10.1021/jf960396r; MundayFinch SC, 1996, PHYTOCHEMISTRY, V41, P327, DOI 10.1016/0031-9422(95)00515-3; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Oliveira NS, 2002, PHARMACOL RES, V46, P15, DOI 10.1016/S1043-6618(02)00074-9; PLUZNICK JL, 2005, AM J PHYSIOL-RENAL, V288, P57; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Ryckwaert F, 2009, CRIT CARE MED, V37, P876, DOI 10.1097/CCM.0b013e31819b8199; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sausbier M, 2006, J AM SOC NEPHROL, V17, P1275, DOI 10.1681/ASN.2005101111; Sheehan JJ, 2009, EPILEPSIA, V50, P711, DOI 10.1111/j.1528-1167.2008.01888.x; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Sorensen MV, 2008, J PHYSIOL-LONDON, V586, P4251, DOI 10.1113/jphysiol.2008.156968; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Thorneloe KS, 2005, AM J PHYSIOL-RENAL, V289, pF604, DOI 10.1152/ajprenal.00060.2005; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wang L, 2003, RES VET SCI, V74, P93, DOI 10.1016/S0034-5288(02)00153-4; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Wang XY, 2008, J MOL CELL CARDIOL, V44, P105, DOI 10.1016/j.yjmcc.2007.10.006; Werner ME, 2005, J PHYSIOL-LONDON, V567, P545, DOI 10.1113/jphysiol.2005.093823; WILSON MF, 1980, ANN SURG, V191, P494, DOI 10.1097/00000658-198004000-00017; XIMOY SX, 1995, J PHYSIOL-LONDON, V486, P15, DOI 10.1113/jphysiol.1995.sp020787; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Zavala-Tecuapetla C, 2008, EUR J NEUROSCI, V27, P2871, DOI 10.1111/j.1460-9568.2008.06214.x	60	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8698	10.1371/journal.pone.0008698	http://dx.doi.org/10.1371/journal.pone.0008698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090847	Green Submitted, gold, Green Published			2022-12-25	WOS:000273714600002
J	Farzaneh-Far, R; Lin, J; Epel, E; Lapham, K; Blackburn, E; Whooley, MA				Farzaneh-Far, Ramin; Lin, Jue; Epel, Elissa; Lapham, Kyle; Blackburn, Elizabeth; Whooley, Mary A.			Telomere Length Trajectory and Its Determinants in Persons with Coronary Artery Disease: Longitudinal Findings from the Heart and Soul Study	PLOS ONE			English	Article							OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; DEPRESSIVE SYMPTOMS; OBESITY; BLOOD; RISK; ASSOCIATION; HEALTH; WOMEN	Background: Leukocyte telomere length, an emerging marker of biological age, has been shown to predict cardiovascular morbidity and mortality. However, the natural history of telomere length in patients with coronary artery disease has not been studied. We sought to investigate the longitudinal trajectory of telomere length, and to identify the independent predictors of telomere shortening, in persons with coronary artery disease. Methodology/Principal Findings: In a prospective cohort study of 608 individuals with stable coronary artery disease, we measured leukocyte telomere length at baseline, and again after five years of follow-up. We used multivariable linear and logistic regression models to identify the independent predictors of leukocyte telomere trajectory. Baseline and follow-up telomere lengths were normally distributed. Mean telomere length decreased by 42 base pairs per year (p < 0.001). Three distinct telomere trajectories were observed: shortening in 45%, maintenance in 32%, and lengthening in 23% of participants. The most powerful predictor of telomere shortening was baseline telomere length (OR per SD increase = 7.6; 95% CI 5.5, 10.6). Other independent predictors of telomere shortening were age (OR per 10 years = 1.6; 95% CI 1.3, 2.1), male sex (OR = 2.4; 95% CI 1.3, 4.7), and waist-to-hip ratio (OR per 0.1 increase = 1.4; 95% CI 1.0, 2.0). Conclusions/Significance: Leukocyte telomere length may increase as well as decrease in persons with coronary artery disease. Telomere length trajectory is powerfully influenced by baseline telomere length, possibly suggesting negative feedback regulation. Age, male sex, and abdominal obesity independently predict telomere shortening. The mechanisms and reversibility of telomeric aging in cardiovascular disease deserve further study.	[Farzaneh-Far, Ramin] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA; [Farzaneh-Far, Ramin; Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lin, Jue; Lapham, Kyle; Blackburn, Elizabeth] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Epel, Elissa] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Whooley, Mary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Farzaneh-Far, R (corresponding author), San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA.	rfarzanehfar@medicine.ucsf.edu			American Heart Association [0875014N]; Department of Veterans Affairs; National Heart, Lung and Blood Institute [R01 HL079235]; Robert Wood Johnson Foundation; American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; Bernard and Barbro Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; Bernard and Barbro Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Farzaneh-Far is supported by an American Heart Association Fellow-to-Faculty Transition Award (#0875014N). The Heart and Soul study was supported by the Department of Veterans Affairs (Epidemiology Merit Review Program); the National Heart, Lung and Blood Institute (R01 HL079235); the Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program); the American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program); the Ischemia Research and Education Foundation; and the Nancy Kirwan Heart Research Fund. Jue Lin and Kyle Lapham are supported by the Bernard and Barbro Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; den Buijs JO, 2004, MECH AGEING DEV, V125, P437, DOI 10.1016/j.mad.2004.03.007; EHRLENBACH S, 2009, INT J EPIDEMIOL; Epel ES, 2009, AGING-US, V1, P81; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Nordfjall K, 2008, SCAND J PUBLIC HEALT, V36, P744, DOI 10.1177/1403494808090634; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Ruo B, 2004, AM J CARDIOL, V94, P96, DOI 10.1016/j.amjcard.2004.03.035; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986	33	169	173	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8612	10.1371/journal.pone.0008612	http://dx.doi.org/10.1371/journal.pone.0008612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072607	Green Published, gold			2022-12-25	WOS:000273414200008
J	Chen, PW; Randazzo, PA; Parent, CA				Chen, Pei-Wen; Randazzo, Paul A.; Parent, Carole A.			ACAP-A/B Are ArfGAP Homologs in Dictyostelium Involved in Sporulation but Not in Chemotaxis	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTOR; CELL-MIGRATION; ACTIN CYTOSKELETON; BINDING PROTEINS; ASAP1; LOCALIZATION; GAP; CANCER; PHOSPHORYLATION	Arfs and Arf GTPase-activating proteins (ArfGAPs) are regulators of membrane trafficking and actin dynamics in mammalian cells. In this study, we identified a primordial Arf, ArfA, and two ArfGAPs (ACAP-A/B) containing BAR, PH, ArfGAP and Ankyrin repeat domains in the eukaryote Dictyostelium discoideum. In vitro, ArfA has similar nucleotide binding properties as mammalian Arfs and, with GTP bound, is a substrate for ACAP-A and B. We also investigated the physiological functions of ACAP-A/B by characterizing cells lacking both ACAP-A and B. Although ACAP-A/B knockout cells showed no defects in cell growth, migration or chemotaxis, they exhibited abnormal actin protrusions and similar to 50% reduction in spore yield. We conclude that while ACAP-A/B have a conserved biochemical mechanism and effect on actin organization, their role in migration is not conserved. The absence of an effect on Dictyostelium migration may be due to a specific requirement for ACAPs in mesenchymal migration, which is observed in epithelial cancer cells where most studies of mammalian ArfGAPs were performed.	[Chen, Pei-Wen; Randazzo, Paul A.; Parent, Carole A.] NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, PW (corresponding author), NCI, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA.	randazzo@helix.nih.gov	Chen, Pei-Wen/B-7142-2015		National Cancer Institute, National Institutes of Health [Z01-BC-007365]; NATIONAL CANCER INSTITUTE [Z01BC007365, ZIABC010418, ZIABC007365] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the intramural program of the National Cancer Institute, National Institutes of Health, project Z01-BC-007365. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLOT CH, 1987, J BIOL CHEM, V262, P3918; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Furman C, 2002, J BIOL CHEM, V277, P7962, DOI 10.1074/jbc.M109149200; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gotthardt D, 2006, MOL CELL PROTEOMICS, V5, P2228, DOI 10.1074/mcp.M600113-MCP200; Gruschus JM, 2009, STRUCTURE, V17, P2, DOI 10.1016/j.str.2008.12.002; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Ha VL, 2008, ADV CANCER RES, V101, P1, DOI 10.1016/S0065-230X(08)00401-6; HAUN RS, 1993, J BIOL CHEM, V268, P7064; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Koizumi K, 2005, DEVELOPMENT, V132, P1699, DOI 10.1242/dev.01716; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; LOOMIS WF, 1969, J BACTERIOL, V99, P65, DOI 10.1128/JB.99.1.65-69.1969; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Luo R, 2009, CELL SIGNAL, V21, P1169, DOI 10.1016/j.cellsig.2009.03.006; Mahadeo DC, 2006, CURR TOP DEV BIOL, V73, P115, DOI 10.1016/S0070-2153(05)73004-0; Mondal S, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-23; MURTAGH JJ, 1992, J BIOL CHEM, V267, P9654; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Naramoto S, 2009, DEVELOPMENT, V136, P1529, DOI 10.1242/dev.030098; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pilcher KE, 2007, NAT PROTOC, V2, P1325, DOI 10.1038/nprot.2007.180; Ponte E, 2000, MECH DEVELOP, V91, P153, DOI 10.1016/S0925-4773(99)00292-0; RANDAZZO PA, 1992, METHOD ENZYMOL, V219, P362; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Repass SL, 2007, J CELL SCI, V120, P3977, DOI 10.1242/jcs.011213; Srinivasan S, 2000, TRENDS CELL BIOL, V10, P215, DOI 10.1016/S0962-8924(00)01758-X; Srinivasan S, 2001, PROTEOMICS, V1, P1119, DOI 10.1002/1615-9861(200109)1:9<1119::AID-PROT1119>3.3.CO;2-O; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Zhang P, 2001, DIFFERENTIATION, V67, P72, DOI 10.1046/j.1432-0436.2001.067003072.x	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8624	10.1371/journal.pone.0008624	http://dx.doi.org/10.1371/journal.pone.0008624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062541	Green Published, Green Submitted, gold			2022-12-25	WOS:000273414100011
J	Poeggeler, B; Knuever, J; Gaspar, E; Biro, T; Klinger, M; Bodo, E; Wiesner, RJ; Wenzel, BE; Paus, R				Poeggeler, Burkhard; Knuever, Jana; Gaspar, Erzsebet; Biro, Tamas; Klinger, Matthias; Bodo, Eniko; Wiesner, Rudolf J.; Wenzel, Bjoern E.; Paus, Ralf			Thyrotropin powers human mitochondria	FASEB JOURNAL			English	Article						aging; hypothalamic-pituitary-thyroid axis; mitochondrial energy metabolism; oxygen utilization; skin	CORTICOTROPIN-RELEASING HORMONE; HAIR-FOLLICLES; COMPLEX-I; TRANSCRIPTIONAL CONTROL; ENERGY-METABOLISM; GENE-EXPRESSION; HPA AXIS; BIOGENESIS; ANTIOXIDANT; APOPTOSIS	Here we demonstrate that the neuropeptide hormone thyrotropin (TSH), which controls thyroid hormone production, exerts a major nonclassical function in mitochondrial biology. Based on transcriptional, ultrastructural, immunohistochemical, and biochemical evidence, TSH up-regulates mitochondrial biogenesis and consequently activity in organ-cultured normal human epidermis in situ. Mitochondrial activity was assessed by measuring 2 key components of the respiratory chain. The abundance of mitochondria was assessed employing 2 independent morphological techniques: counting their numbers in human epidermis by high-magnification light microscopy of skin sections immunostained for mitochondria-selective cytochromec-oxidase subunit 1 (MTCO1) and transmission electron microscopy (TEM). Treatment with 10 mU/ml of TSH for 6 d strongly up-regulates the number of light-microscopically visualized, MTCO1-demarcated mitochondria. On the ultrastructural level, TEM confirms that TSH indeed stimulates mitochondrial proliferation and biogenesis in the perinuclear region of human skin epidermal keratinocytes. On the transcriptional level, TSH up-regulates MTCO1 mRNA (quantitative RT-PCR) and significantly enhances complex I and IV (cytochrome-c-oxidase) activity. This study pioneers the concept that mitochondrial energy metabolism and biogenesis in a normal, prototypic human epithelial tissue underlies potent neuroendocrine controls and introduces human skin organ culture as a clinically relevant tool for further exploring this novel research frontier in the control of mitochondrial biology.-Poeggeler, B., Knuever, J., Gaspar, E., Biro, T., Klinger, M., Bodo, E., Wiesner, R. J., Wenzel, B. E., Paus, R. Thyrotropin powers human mitochondria. FASEB J. 24, 1525-1531 (2010). www.fasebj.org	[Poeggeler, Burkhard; Knuever, Jana; Gaspar, Erzsebet; Bodo, Eniko; Paus, Ralf] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Klinger, Matthias] Univ Lubeck, Dept Anat, D-23538 Lubeck, Germany; [Wenzel, Bjoern E.] Univ Lubeck, Dept Med 1, D-23538 Lubeck, Germany; [Biro, Tamas] Univ Debrecen, Dept Physiol, Debrecen, Hungary; [Biro, Tamas] Abiol Ltd, Debrecen, Hungary; [Bodo, Eniko] Coll Nyiregyhaza, Agr & Mol Res Inst, Nyiregyhaza, Hungary; [Wiesner, Rudolf J.] Univ Cologne, Dept Vegetat Physiol, Cologne, Germany; [Wiesner, Rudolf J.] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Wiesner, Rudolf J.] CMMC, Cologne, Germany; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester, Lancs, England	University of Lubeck; University of Lubeck; University of Lubeck; University of Debrecen; University of Cologne; University of Cologne; University of Cologne; University of Manchester	Paus, R (corresponding author), Univ Lubeck, Dept Dermatol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	ralf.paus@uk-sh.de	Paus, Ralf/F-6243-2011; Paus, Ralf/B-5279-2015	Paus, Ralf/0000-0002-3492-9358	Manchester National Institute for Health Research (NIHR) Biomedical Research Center	Manchester National Institute for Health Research (NIHR) Biomedical Research Center(National Institute for Health Research (NIHR))	The excellent technical assistance of Gabriele Scheel, Antje Winter-Keil, Astrid Becker, and Silvia Grammerstorf-Rosche (University of Lubeck), as well as the generous contribution of human scalp skin samples by our collaborating surgeons, Dr. Wolfgang Funk (Klinik Dr. Kozlowski & Dr. Dr. Med. Funk, Munich, Germany) and Dr. Yoram Levy (Atrium Klinik GmbH & Co. KG, Holzkirchen, Germany) are most gratefully acknowledged. The authors are most grateful to PD Dr. T. Hellwig-Burgel (Department of Physiology, University of Lubeck) for his collaboration in generating the first pilot data on the TSH modulation of epidermal oxygen consumption, and also thank Prof. Dr. Saleh Ibrahim (University of Lubeck) for his expert advice and editing of the manuscript. This study was supported in part by a grant from the Manchester National Institute for Health Research (NIHR) Biomedical Research Center to R. P.	Anisimov VN, 2006, BBA-BIOENERGETICS, V1757, P573, DOI 10.1016/j.bbabio.2006.03.012; Bahi L, 2005, J CELL PHYSIOL, V203, P589, DOI 10.1002/jcp.20273; Blatt T, 2005, BIOFACTORS, V25, P179, DOI 10.1002/biof.5520250121; BODO E, 2010, ENDOCRINOLO IN PRESS; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; BRAVERMANN LE, 2005, THYROID FUNDAMENTAL, P300; Cianfarani F, 2010, J INVEST DERMATOL, V130, P93, DOI 10.1038/jid.2009.180; Dabbeni-Sala F, 2001, FASEB J, V15, P164, DOI 10.1096/fj.00-0129com; DAVAN CM, 2009, NAT REV ENDOCRINOL, V5, P211; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fernandez-Vizarra E, 2008, CURR GENET, V54, P13, DOI 10.1007/s00294-008-0194-x; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Foitzik K, 2006, AM J PATHOL, V168, P748, DOI 10.2353/ajpath.2006.050468; Franko A, 2008, MOL CELL BIOL, V28, P2446, DOI 10.1128/MCB.00980-07; Gaspar E, 2010, FASEB J, V24, P393, DOI 10.1096/fj.08-126417; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; Havlickova B, 2009, J INVEST DERMATOL, V129, P972, DOI 10.1038/jid.2008.315; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Kramer J, 2005, ANAT EMBRYOL, V210, P175, DOI 10.1007/s00429-005-0020-x; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; LIMAT A, 1994, CELL TISSUE RES, V275, P169, DOI 10.1007/BF00305384; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Lu ZF, 2007, EXP DERMATOL, V16, P37, DOI 10.1111/j.1600-0625.2006.00510.x; Mabalirajan U, 2008, J IMMUNOL, V181, P3540, DOI 10.4049/jimmunol.181.5.3540; Markham A, 2004, EUR J NEUROSCI, V20, P1189, DOI 10.1111/j.1460-9568.2004.03578.x; Mazzio EA, 2004, BIOCHEM PHARMACOL, V67, P1167, DOI 10.1016/j.bcp.2003.11.016; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; Paquet P, 2007, INT J MOL MED, V19, P3; Peeters RP, 2006, EUR J ENDOCRINOL, V155, P655, DOI 10.1530/eje.1.02279; Poeggeler B, 2005, J NEUROCHEM, V95, P962, DOI 10.1111/j.1471-4159.2005.03425.x; Poeggeler B, 2010, EXP DERMATOL, V19, P12, DOI 10.1111/j.1600-0625.2009.00930.x; Ruiz-Romero C, 2009, MOL BIOSYST, V5, P1130, DOI 10.1039/b906296n; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scheller K, 2003, EXP PHYSIOL, V88, P129, DOI 10.1113/eph8802507; Sheehan TE, 2004, AM J PHYSIOL-ENDOC M, V286, pE968, DOI 10.1152/ajpendo.00478.2003; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; STENN KS, 1989, J INVEST DERMATOL, V93, P287, DOI 10.1111/1523-1747.ep12277593; Tiede S, 2009, J INVEST DERMATOL, V129, P2711, DOI 10.1038/jid.2009.148; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Weitzel JM, 2003, EXP PHYSIOL, V88, P121, DOI 10.1113/eph8802506; Wiedemann FR, 2006, INT J BIOCHEM CELL B, V38, P610, DOI 10.1016/j.biocel.2005.10.024	50	28	28	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1525	1531		10.1096/fj.09-147728	http://dx.doi.org/10.1096/fj.09-147728			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20075194				2022-12-25	WOS:000277158900025
J	Rachid, S; Revermann, O; Dauth, C; Kazmaier, U; Muller, R				Rachid, Shwan; Revermann, Ole; Dauth, Christina; Kazmaier, Uli; Mueller, Rolf			Characterization of a Novel Type of Oxidative Decarboxylase Involved in the Biosynthesis of the Styryl Moiety of Chondrochloren from an Acylated Tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYBRID PEPTIDE SYNTHETASES; CRYSTAL-STRUCTURE; MOLECULAR CHARACTERIZATION; POLYKETIDE; SYNTHASE; CATALYZES; PHENYLALANINE; CONSTRUCTION; MECHANISM; MODULE	Myxobacteria are soil-dwelling bacteria notable for several unique behavioral features, such as cellular movement by gliding and the formation of multicellular fruiting bodies. More recently they have gained recognition as producers of several unique polyketide and nonribosomal polypeptide metabolites with potential therapeutic value. The biosynthesis of these compounds often involves highly unusual mechanisms including the formation of the chloro-hydroxy-styryl moiety of the chondrochloren antibiotic produced by Chondromyces crocatus Cm c5. Here it is shown that the final product of the chondrochloren megasynthetase is the novel natural product pre-chondrochloren, a carboxylated and saturated derivative of chondrochloren. This compound was isolated from strains harboring mutants of a hypothetical oxidative decarboxylase (CndG) identified in the chondrochloren gene cluster. CndG was heterologously expressed in Escherichia coli and shown to be an FAD-dependent oxidative decarboxylase. Biochemical characterization of the protein was achieved using the intermediate described above as the substrate and yielded chondrochloren by oxidative decarboxylation. It was also demonstrated that the CndG post-assembly line modification of pre-chondrochloren is essential for the biological activity of chondrochloren.	[Rachid, Shwan; Revermann, Ole; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66041 Saarbrucken, Germany; [Rachid, Shwan; Revermann, Ole; Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res, D-66041 Saarbrucken, Germany; [Dauth, Christina; Kazmaier, Uli] Univ Saarland, Dept Organ Chem, D-66041 Saarbrucken, Germany	Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University	Muller, R (corresponding author), Univ Saarland, Dept Pharmaceut Biotechnol, POB 151150, D-66041 Saarbrucken, Germany.	rom@mx.uni-saarland.de	Kazmaier, Uli/D-2947-2018; Müller, Rolf/B-1559-2008	Müller, Rolf/0000-0002-1042-5665; Rachid, Shwan/0000-0003-0834-5153	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Bundesministerium fur Bildung und Forschung and the Deutsche Forschungsgemeinschaft.	Altena K, 2000, APPL ENVIRON MICROB, V66, P2565, DOI 10.1128/AEM.66.6.2565-2571.2000; Blaesse M, 2003, ACTA CRYSTALLOGR D, V59, P1414, DOI 10.1107/S0907444903011831; Brady SF, 2003, ORG LETT, V5, P121, DOI 10.1021/ol0267681; Brady SF, 2002, J AM CHEM SOC, V124, P9968, DOI 10.1021/ja0268985; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Duerfahrt T, 2003, EUR J BIOCHEM, V270, P4555, DOI 10.1046/j.1432-1033.2003.03858.x; Flatt PM, 2006, J NAT PROD, V69, P938, DOI 10.1021/np050523q; Hoyer KM, 2007, CHEM BIOL, V14, P13, DOI 10.1016/j.chembiol.2006.10.011; Jansen R, 2003, EUR J ORG CHEM, V2003, P2684, DOI 10.1002/ejoc.200200699; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kieser T., 2000, PRACTICAL STREPTOMYC, P162; Kupke T, 2000, J BIOL CHEM, V275, P31838, DOI 10.1074/jbc.M004273200; Liu AM, 2006, BIOCHEMISTRY-US, V45, P10407, DOI 10.1021/bi061031v; Majer F, 2002, J BACTERIOL, V184, P1234, DOI 10.1128/JB.184.5.1234-1243.2002; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; McCubbin JA, 2006, ORG LETT, V8, P2993, DOI 10.1021/ol0609356; Mootz HD, 2000, P NATL ACAD SCI USA, V97, P5848, DOI 10.1073/pnas.100075897; Muller R, 2004, CHEM BIOL, V11, P4, DOI 10.1016/S1074-5521(04)00006-7; Rachid S, 2006, CHEM BIOL, V13, P667, DOI 10.1016/j.chembiol.2006.06.002; Rachid S, 2009, CHEM BIOL, V16, P70, DOI 10.1016/j.chembiol.2008.11.005; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; Reichenbach H, 2000, SPR DESKT EDIT CHEM, P149; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; Salomon CE, 2004, NAT PROD REP, V21, P105, DOI 10.1039/b301384g; Sambrook J, 2001, MOL CLONING LAB MANU; Samel SA, 2008, MOL BIOSYST, V4, P387, DOI 10.1039/b717538h; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; Walsh CT, 2008, ACCOUNTS CHEM RES, V41, P4, DOI 10.1021/ar7000414; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wenzel SC, 2006, ANGEW CHEM INT EDIT, V45, P2296, DOI 10.1002/anie.200503737; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Wenzel SC, 2009, IDRUGS, V12, P220; Xu J, 2005, MICROBIOL-SGM, V151, P2515, DOI 10.1099/mic.0.28138-0; Yoshida M, 2004, J BACTERIOL, V186, P6855, DOI 10.1128/JB.186.20.6855-6863.2004; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105	38	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12482	12489		10.1074/jbc.M109.079707	http://dx.doi.org/10.1074/jbc.M109.079707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20080978	Green Published, hybrid			2022-12-25	WOS:000276787800004
J	Arab, A; Wang, J; Bausch, K; von Schmadel, K; Bode, C; Hehrlein, C				Arab, Amina; Wang, Jin; Bausch, Kathrin; von Schmaedel, Katharina; Bode, Christoph; Hehrlein, Christoph			Transient Hyperoxic Reoxygenation Reduces Cytochrome c Oxidase Activity by Increasing Superoxide Dismutase and Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ISCHEMIA; CELL-SURVIVAL; OXYGEN; RESPIRATION; DISEASE; MITOCHONDRIA; REPERFUSION; INHIBITION; HYPOXIA; O-2	Oxygen therapies have been shown to be cytoprotective in a dose-dependent fashion. Previously, we have characterized the protective effects of moderate hyperoxia on cell viability of ischemic human cardiomyocytes and their mitochondrial membrane potential by transient addition of oxygenated perfluorocarbons to the cell medium. Now, we report that the activity and expression of cytochrome c oxidase (COX) after prolonged ischemia depend on the amount of oxygen delivered during reoxygenation. Transient hyperoxia during reoxygenation results in a decrease of COX activity by 62 +/- 15% and COX expression by 67 +/- 5%, when hyperoxic tensions of approximate to 300 mm Hg are reached in the cell medium. This decrease in COX expression is prevented by the inhibition of inducible nitric-oxide synthase (iNOS). Immunoblot analysis of ischemic human cardiomyocytes revealed that hyperoxic reoxygenation causes a 2-fold increase of iNOS, leading to a rise in nitric oxide production by 140 +/- 45%. Hyperoxic reoxygenation is further responsible for a 2-fold activation of hydrogen peroxide production and an increase in cytosolic superoxide dismutase expression by 35 +/- 10%. NADPH availability has no effect on the hyperoxia-induced decrease of superoxide. Overall, these results indicate that transient hyperoxic reoxygenation in optimal concentrations increases the level of nitric oxide by activation of iNOS and superoxide dismutase, thereby inducing respiration arrest in mitochondria of ischemic cardiomyocytes.	[Arab, Amina; Wang, Jin; Bausch, Kathrin; von Schmaedel, Katharina; Bode, Christoph; Hehrlein, Christoph] Univ Freiburg, Dept Cardiol, D-79106 Freiburg, Germany	University of Freiburg	Arab, A (corresponding author), Hugstetterstr 55, D-79106 Freiburg, Germany.	amina.arab@uniklinik-freiburg.de		Bausch, Kathrin/0000-0002-6253-0854				Arab A, 2008, J PHARMACOL EXP THER, V325, P417, DOI 10.1124/jpet.107.133710; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Beltran B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen HJ, 2001, AM J PHYSIOL-HEART C, V281, pH1035, DOI 10.1152/ajpheart.2001.281.3.H1035; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; Demchenko IT, 2002, CIRC RES, V91, P1031, DOI 10.1161/01.RES.0000043500.03647.81; Eschenfelder CC, 2008, CEREBROVASC DIS, V25, P193, DOI 10.1159/000113856; Evtodienko YV, 1996, FEBS LETT, V393, P86, DOI 10.1016/0014-5793(96)00875-7; Foglieni C, 2001, HISTOCHEM CELL BIOL, V115, P223; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Helms AK, 2005, CEREBROVASC DIS, V20, P417, DOI 10.1159/000088979; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; JOHNSON G, 1990, J PHARMACOL EXP THER, V252, P35; Merante F, 1998, AM J PHYSIOL-HEART C, V275, pH1673, DOI 10.1152/ajpheart.1998.275.5.H1673; OMAR HA, 1991, CIRC RES, V69, P601, DOI 10.1161/01.RES.69.3.601; PAGANO PJ, 1995, AM J PHYSIOL-HEART C, V268, pH2274, DOI 10.1152/ajpheart.1995.268.6.H2274; Reznik ON, 2008, TRANSPL P, V40, P1027, DOI 10.1016/j.transproceed.2008.03.053; Riess JG, 2005, ARTIF CELL BLOOD SUB, V33, P47, DOI 10.1081/BIO-200046659; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Victor VM, 2009, CIRC RES, V104, P1178, DOI 10.1161/CIRCRESAHA.109.197228; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	30	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11172	11177		10.1074/jbc.M109.053181	http://dx.doi.org/10.1074/jbc.M109.053181			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20086011	hybrid, Green Published			2022-12-25	WOS:000276286200022
J	Kracun, S; Chaptal, V; Abramson, J; Khakh, BS				Kracun, Sebastian; Chaptal, Vincent; Abramson, Jeff; Khakh, Baljit S.			Gated Access to the Pore of a P2X Receptor STRUCTURAL IMPLICATIONS FOR CLOSED-OPEN TRANSITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; 2ND TRANSMEMBRANE DOMAIN; CYSTEINE ACCESSIBILITY METHOD; ION-CHANNEL STRUCTURE; ZINC-BINDING SITE; ATP RECEPTOR; ACETYLCHOLINE-RECEPTOR; CATION PERMEABILITY; CYTOSOLIC DOMAIN; POLAR RESIDUES	P2X receptors are ligand-gated cation channels that transition from closed to open states upon binding ATP. The crystal structure of the closed zebrafish P2X4.1 receptor directly reveals that the ion-conducting pathway is formed by three transmembrane domain 2 (TM2) alpha-helices, each being provided by the three subunits of the trimer. However, the transitions in TM2 that accompany channel opening are incompletely understood and remain unresolved. In this study, we quantified gated access to Cd2+ at substituted cysteines in TM2 of P2X2 receptors in the open and closed states. Our data for the closed state are consistent with the zebrafish P2X4.1 structure, with isoleucines and threonines (Ile-332 and Thr-336) positioned one helical turn apart lining the channel wall on approach to the gate. Our data for the open state reveal gated access to deeper parts of the pore (Thr-339, Val-343, Asp-349, and Leu-353), suggesting the closed channel gate is between Thr-336 and Thr-339. We also found unexpected interactions between native Cys-348 and D349C that result in tight Cd2+ binding deep within the intracellular vestibule in the open state. Interpreted with a P2X2 receptor structural model of the closed state, our data suggest that the channel gate opens near Thr-336/Thr-339 and is accompanied by movement of the pore-lining regions, which narrow toward the cytosolic end of TM2 in the open state. Such transitions would relieve the barrier to ion flow and render the intracellular vestibule less splayed during channel opening in the presence of ATP.	[Kracun, Sebastian; Chaptal, Vincent; Abramson, Jeff; Khakh, Baljit S.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, Dept Neurobiol, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu		chaptal, vincent/0000-0003-2603-0294	National Institutes of Health [GM070925-04]; UCLA; American Physiological Society; Stein-Oppenheimer Foundation Endowment Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844, R01GM070925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA(University of California System); American Physiological Society; Stein-Oppenheimer Foundation Endowment Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health Grant GM070925-04. This work was also supported by unrestricted funds from UCLA (to B. S. K.), by a S&R Foundation Ryuji Ueno Award for Ion Channels or Barrier Function Research from the American Physiological Society and by a Stein-Oppenheimer Foundation Endowment Award (to B. S. K.).	Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Burnstock G, 2009, ACTA PHYSIOL, V195, P415, DOI 10.1111/j.1748-1716.2009.01957.x; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Chaumont S, 2008, P NATL ACAD SCI USA, V105, P12063, DOI 10.1073/pnas.0803008105; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Ding S, 1999, J MEMBRANE BIOL, V172, P215, DOI 10.1007/s002329900598; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Duckwitz W, 2006, J BIOL CHEM, V281, P39561, DOI 10.1074/jbc.M606113200; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Evans RJ, 2009, EUR BIOPHYS J BIOPHY, V38, P319, DOI 10.1007/s00249-008-0275-2; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Fountain SJ, 2008, J BIOL CHEM, V283, P15122, DOI 10.1074/jbc.M801512200; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fountain SJ, 2009, PURINERG SIGNAL, V5, P269, DOI 10.1007/s11302-008-9127-x; Fujiwara Y, 2009, J GEN PHYSIOL, V133, P93, DOI 10.1085/jgp.200810002; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Guerlet G, 2008, BIOCHEM BIOPH RES CO, V375, P405, DOI 10.1016/j.bbrc.2008.08.030; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; Haines WR, 2001, J BIOL CHEM, V276, P32793, DOI 10.1074/jbc.M104216200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Keceli B, 2009, J PHYSIOL-LONDON, V587, P5801, DOI 10.1113/jphysiol.2009.182824; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kubo Y, 2009, J PHYSIOL-LONDON, V587, P5317, DOI 10.1113/jphysiol.2009.179309; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 1996, CIBA F SYMP, V198, P91; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Perozo E, 2002, NOVART FDN SYMP, V245, P146; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; RHODES G, 1993, CRYSTALLOGRAPHY MADE, P237; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Sheng SH, 2005, J BIOL CHEM, V280, P8513, DOI 10.1074/jbc.M413880200; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Spencer RH, 2002, ANNU REV BIOPH BIOM, V31, P207, DOI 10.1146/annurev.biophys.31.082901.134329; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Takeda AN, 2007, J BIOL CHEM, V282, P31928, DOI 10.1074/jbc.M700733200; Tittle RK, 2008, J NEUROSCI, V28, P11131, DOI 10.1523/JNEUROSCI.2763-08.2008; Tittle RK, 2007, J BIOL CHEM, V282, P19526, DOI 10.1074/jbc.M701604200; Torres GE, 1998, FEBS LETT, V425, P19, DOI 10.1016/S0014-5793(98)00179-3; Torres GE, 1998, BIOCHEMISTRY-US, V37, P14845, DOI 10.1021/bi981209g; Torres GE, 1999, J BIOL CHEM, V274, P22359, DOI 10.1074/jbc.274.32.22359; Unwin N, 2000, PHILOS T R SOC B, V355, P1813, DOI 10.1098/rstb.2000.0737; VALERA S, 1994, NATURE, V371, P519; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006; Zhou Z, 1998, BIOCHEM BIOPH RES CO, V252, P541, DOI 10.1006/bbrc.1998.9689	74	56	57	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10110	10121		10.1074/jbc.M109.089185	http://dx.doi.org/10.1074/jbc.M109.089185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093367	hybrid, Green Published			2022-12-25	WOS:000276165900078
J	May, V; Lutz, E; MacKenzie, C; Schutz, KC; Dozark, K; Braas, KM				May, Victor; Lutz, Eve; MacKenzie, Christopher; Schutz, Kristin C.; Dozark, Kate; Braas, Karen M.			Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/PAC(1)HOP1 Receptor Activation Coordinates Multiple Neurotrophic Signaling Pathways Akt ACTIVATION THROUGH PHOSPHATIDYLINOSITOL 3-KINASE gamma AND VESICLE ENDOCYTOSIS FOR NEURONAL SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; DEPENDENT PROTEIN-KINASE; NERVE GROWTH-FACTOR; RAT SYMPATHETIC NEURONS; CYCLIC-AMP; PACAP RECEPTOR; PAC(1) RECEPTOR; NEUROPEPTIDE-Y; MAP KINASE; PC12 CELLS	MAPK and Akt pathways are predominant mediators of trophic signaling for many neuronal systems. Among the vasoactive intestinal peptide/secretin/glucagon family of related peptides, pituitary adenylate cyclase-activating polypeptide (PACAP) binding to specific PAC(1) receptor isoforms can engage multiple signaling pathways and promote neuroprotection through mechanisms that are not well understood. Using a primary sympathetic neuronal system, the current studies demonstrate that PACAP activation of PAC(1)HOP1 receptors engages both MAPK and Akt neurotrophic pathways in an integrated program to facilitate neuronal survival after growth factor withdrawal. PACAP not only stimulated prosurvival ERK1/2 and ERK5 activation but also abrogated SAPK/JNK and p38 MAPK signaling in parallel. In contrast to the potent and rapid effects of PACAP in ERK1/2 phosphorylation, PACAP stimulated Akt phosphorylation in a late phase of PAC(1)HOP1 receptor signaling. From inhibitor and immunoprecipitation analyses, the PACAP/PAC(1)HOP1 receptor-mediated Akt responses did not represent transactivation mechanisms but appeared to depend on G alpha(q)/phosphatidylinositol 3-kinase gamma activity and vesicular internalization pathways. Phosphatidylinositol 3-kinase gamma-selective inhibitors blocked PACAP-stimulated Akt phosphorylation in primary neuronal cultures and in PAC(1)HOP1-overexpressing cell lines; RNA interference-mediated knockdown of the receptor effectors attenuated PACAP-mediated Akt activation. Similarly, perturbation of endocytic pathways also blocked Akt phosphorylation. Between ERK and Akt pathways, PACAP-stimulated Akt signaling was the primary cascade that attenuated cultured neuron apoptosis after growth factor withdrawal. The partitioning of PACAP-mediated Akt signaling in endosomes may be a key mechanism contributing to the high spatial and temporal specificity in signal transduction necessary for survival pathways.	[May, Victor; Schutz, Kristin C.; Dozark, Kate; Braas, Karen M.] Univ Vermont, Coll Med, Dept Anat & Neurobiol, Burlington, VT 05405 USA; [May, Victor; Schutz, Kristin C.; Dozark, Kate; Braas, Karen M.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Lutz, Eve; MacKenzie, Christopher] Univ Strathclyde, Royal Coll, Strathclyde Inst Pharm & Biomed Sci, Glasgow G1 1XW, Lanark, Scotland	University of Vermont; University of Vermont; University of Strathclyde	May, V (corresponding author), Univ Vermont, Coll Med, Dept Anat & Neurobiol, 149 Beaumont Ave, Burlington, VT 05405 USA.	victor.may@uvm.edu			National Institutes of Health [HD27468, NS37179]; Wellcome Trust; National Institutes of Health National Center for Research Resources [P20RR16435]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027468] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD27468 and NS37179.; Supported by Wellcome Trust.; The use of the Molecular Biology Core Facility, supported by National Institutes of Health National Center for Research Resources Grant P20RR16435, is also gratefully acknowledged.	Arimura A, 1998, JPN J PHYSIOL, V48, P301, DOI 10.2170/jjphysiol.48.301; Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; BASILLE M, 1994, DEV BRAIN RES, V82, P81, DOI 10.1016/0165-3806(94)90150-3; Beaudet MM, 2000, J NEUROSCI, V20, P7353; Bouschet T, 2003, J BIOL CHEM, V278, P4778, DOI 10.1074/jbc.M204652200; Braas KM, 1999, J BIOL CHEM, V274, P27702, DOI 10.1074/jbc.274.39.27702; Brandenburg CA, 1997, J NEUROSCI, V17, P4045; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Campard PK, 1997, DNA CELL BIOL, V16, P323, DOI 10.1089/dna.1997.16.323; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Carey RG, 2002, J NEUROSCI, V22, P1583, DOI 10.1523/JNEUROSCI.22-05-01583.2002; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chang JY, 1997, NEUROCHEM INT, V31, P161, DOI 10.1016/S0197-0186(96)00145-3; Choi EK, 2004, FEBS LETT, V559, P141, DOI 10.1016/S0014-5793(04)00058-4; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; David C, 2005, J MOL NEUROSCI, V27, P91, DOI 10.1385/JMN:27:01:91; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DiCicco-Bloom E, 2000, DEV BIOL, V219, P197, DOI 10.1006/dbio.2000.9604; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Gayer CP, 2009, J BIOL CHEM, V284, P2001, DOI 10.1074/jbc.M804576200; Girard BM, 2004, REGUL PEPTIDES, V123, P107, DOI 10.1016/j.regpep.2004.05.024; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; Hansel DE, 2001, J NEUROSCI, V21, P4625, DOI 10.1523/JNEUROSCI.21-13-04625.2001; HASHIMOTO H, 1993, NEURON, V11, P333, DOI 10.1016/0896-6273(93)90188-W; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; HOSOYA M, 1993, BIOCHEM BIOPH RES CO, V194, P133, DOI 10.1006/bbrc.1993.1795; Hunker CM, 2006, ARCH BIOCHEM BIOPHYS, V449, P130, DOI 10.1016/j.abb.2006.01.020; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; INAGAKI N, 1994, P NATL ACAD SCI USA, V91, P2679, DOI 10.1073/pnas.91.7.2679; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johnson-Farley NN, 2005, J NEUROCHEM, V92, P72, DOI 10.1111/j.1471-4159.2004.02832.x; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kerchner KR, 2004, J BIOL CHEM, V279, P44554, DOI 10.1074/jbc.M406071200; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lioudyno M, 1998, J NEUROSCI RES, V51, P243, DOI 10.1002/(SICI)1097-4547(19980115)51:2<243::AID-JNR13>3.0.CO;2-9; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; Lu NR, 1998, J NEUROSCI RES, V53, P651, DOI 10.1002/(SICI)1097-4547(19980915)53:6<651::AID-JNR3>3.0.CO;2-4; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; LUTZ EM, 1993, FEBS LETT, V334, P3, DOI 10.1016/0014-5793(93)81668-P; Lutz EM, 2006, MOL CELL NEUROSCI, V31, P193, DOI 10.1016/j.mcn.2005.09.008; Ma YC, 2002, CELL MOL LIFE SCI, V59, P456, DOI 10.1007/s00018-002-8438-2; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; MASUO Y, 1994, NEUROSCI LETT, V170, P43, DOI 10.1016/0304-3940(94)90234-8; May V, 2002, J NEUROSCI, V22, P6980; MAY V, 1995, J NEUROSCI, V15, P4580; MAY V, 1995, J NEUROCHEM, V65, P978; MAY V, 1989, ENDOCRINOLOGY, V124, P157, DOI 10.1210/endo-124-1-157; McCulloch DA, 2002, BIOCHEM SOC T, V30, P441, DOI 10.1042/bst0300441; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Morio H, 1996, BRAIN RES, V741, P82, DOI 10.1016/S0006-8993(96)00920-1; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Mustafa T, 2007, J BIOL CHEM, V282, P8079, DOI 10.1074/jbc.M609638200; Nicot A, 2001, P NATL ACAD SCI USA, V98, P4758, DOI 10.1073/pnas.071465398; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Przywara DA, 1998, J NEUROCHEM, V71, P1889; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Shuto Y, 1996, REGUL PEPTIDES, V67, P79, DOI 10.1016/S0167-0115(96)00116-4; Silveira MS, 2002, J BIOL CHEM, V277, P16075, DOI 10.1074/jbc.M110106200; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Tabuchi A, 2003, J NEUROSCI RES, V71, P504, DOI 10.1002/jnr.10505; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 1998, NEUROSCIENCE, V84, P801, DOI 10.1016/S0306-4522(97)00545-9; Vaudry D, 1999, P NATL ACAD SCI USA, V96, P9415, DOI 10.1073/pnas.96.16.9415; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Waschek JA, 1998, P NATL ACAD SCI USA, V95, P9602, DOI 10.1073/pnas.95.16.9602; Waschek JA, 1996, ANN NY ACAD SCI, V805, P290; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	88	63	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9749	9761		10.1074/jbc.M109.043117	http://dx.doi.org/10.1074/jbc.M109.043117			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093365	Green Published, hybrid			2022-12-25	WOS:000276165900047
J	Balcer, HI; Daugherty-Clarke, K; Goode, BL				Balcer, Heath I.; Daugherty-Clarke, Karen; Goode, Bruce L.			The p40/ARPC1 Subunit of Arp2/3 Complex Performs Multiple Essential Roles in WASp-regulated Actin Nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; INDIVIDUAL SUBUNITS; WASP/SCAR PROTEINS; IN-VIVO; YEAST; BINDING; NUCLEOTIDE; DOMAIN	The Arp2/3 complex is a conserved seven-subunit actin-nucleating machine activated by WASp (Wiskott Aldrich syndrome protein). Despite its central importance in a broad range of cellular processes, many critical aspects of the mechanism of the Arp2/3 complex have yet to be resolved. In particular, some of the individual subunits in the complex have not been assigned clear functional roles, including p40/ARPC1. Here, we dissected the structure and function of Saccharomyces cerevisiae p40/ARPC1, which is encoded by the essential ARC40 gene, by analyzing 39 integrated alleles that target its conserved surfaces. We identified three distinct sites on p40/ARPC1 required for function in vivo: one site contacts p19/ARPC4, one contacts p15/ARPC5, and one site resides in an extended structural "arm" of p40/ARPC1. Using a novel strategy, we purified the corresponding lethal mutant Arp2/3 complexes from yeast and compared their actin nucleation activities. Lethal mutations at the contact with p19/ARPC4 specifically impaired WASp-induced nucleation. In contrast, lethal mutations at the contact with p15/ARPC5 led to unregulated ("leaky") nucleation in the absence of WASp. Lethal mutations in the extended arm drastically reduced nucleation, and the same mutations disrupted the ability of the purified p40/ARPC1 arm domain to bind the VCA domain of WASp. Together, these data indicate that p40/ARPC1 performs at least three distinct, essential functions in regulating Arp2/3 complex-mediated actin assembly: 1) suppression of spontaneous nucleation by the Arp2/3 complex, which requires proper contacts with p15/ARPC5; 2) propagation of WASp activation signals via contacts with p19/ARPC2; and 3) direct facilitation of actin nucleation through interactions of the extended arm with the VCA domain of WASp.	[Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, 415 South St, Waltham, MA 02454 USA.	goode@brandeis.edu			National Institutes of Health [GM63691, GM083137]; March of Dimes [MOD 1-FY07-508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083137, T32GM007596, R01GM063691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM63691 and GM083137 (to B. G.). This work was also supported by March of Dimes Grant MOD 1-FY07-508.	[Anonymous], 1991, Methods Enzymol, V194, P1; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Beltzner CC, 2004, J MOL BIOL, V336, P551, DOI 10.1016/j.jmb.2003.12.017; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Daugherty KM, 2008, J BIOL CHEM, V283, P16950, DOI 10.1074/jbc.M800783200; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kozminski KG, 2000, MOL BIOL CELL, V11, P339, DOI 10.1091/mbc.11.1.339; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Martin AC, 2005, J CELL BIOL, V168, P315, DOI 10.1083/jcb.200408177; Moreau V, 1996, J CELL BIOL, V134, P117, DOI 10.1083/jcb.134.1.117; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pan F, 2004, J BIOL CHEM, V279, P54629, DOI 10.1074/jbc.M402357200; POLLARD TD, 1984, FEBS LETT, V170, P94, DOI 10.1016/0014-5793(84)81376-9; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	34	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8481	8491		10.1074/jbc.M109.054957	http://dx.doi.org/10.1074/jbc.M109.054957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071330	Green Published, hybrid			2022-12-25	WOS:000275413800063
J	Brocker, MJ; Watzlich, D; Saggu, M; Lendzian, F; Moser, J; Jahn, D				Broecker, Markus J.; Waetzlich, Denise; Saggu, Miguel; Lendzian, Friedhelm; Moser, Juergen; Jahn, Dieter			Biosynthesis of (Bacterio) chlorophylls ATP-DEPENDENT TRANSIENT SUBUNIT INTERACTION AND ELECTRON TRANSFER OF DARK OPERATIVE PROTOCHLOROPHYLLIDE OXIDOREDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGENASE IRON PROTEIN; ADP-ALUMINUM FLUORIDE; AZOTOBACTER-VINELANDII; PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; FE-PROTEIN; 4FE-4S CLUSTER; BCHN-BCHB; STATE; REDUCTION; MGATP	Dark operative protochlorophyllide oxidoreductase (DPOR) catalyzes the light-independent two-electron reduction of protochlorophyllide a to form chlorophyllide a, the last common precursor of chlorophyll a and bacteriochlorophyll a biosynthesis. During ATP-dependent DPOR catalysis the homodimeric ChlL(2) subunit carrying a [4Fe-4S] cluster transfers electrons to the corresponding heterotetrameric catalytic subunit (ChlN/ChlB)(2), which also possesses a redox active [4Fe-4S] cluster. To investigate the transient interaction of both subcomplexes and the resulting electron transfer reactions, the ternary DPOR enzyme holocomplex comprising subunits ChlN, ChlB, and ChlL from the cyanobacterium Prochlorococcus marinus was trapped as an octameric (ChlN/ChlB)(2)(ChlL(2))(2) complex after incubation with the nonhydrolyzable ATP analogs adenosine 5'(gamma-thio) triphosphate, adenosine 5'-(beta,gamma-imido) triphosphate, or MgADP in combination with AlF4-. Aitionally, a mutant ChlL(2) protein, with a deleted Leu(153) in the switch II region also allowed for the formation of a stable octameric complex. Furthermore, efficient complex formation required the presence of protochlorophyllide. Electron paramagnetic resonance spectroscopy of ternary DPOR complexes revealed a reduced [4Fe-4S] cluster located on ChlL(2), indicating that complete ATP hydrolysis is a prerequisite for intersubunit electron transfer. Circular dichroism spectroscopic experiments indicated nucleotide-dependent conformational changes for ChlL(2) after ATP binding. A nucleotide-dependent switch mechanism triggering ternary complex formation and electron transfer was concluded. From these results a detailed redox cycle for DPOR catalysis was deduced.	Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, D-38106 Braunschweig, Germany; [Saggu, Miguel; Lendzian, Friedhelm] Tech Univ Berlin, Inst Chem, Max Volmer Lab, D-10623 Berlin, Germany	Braunschweig University of Technology; Technical University of Berlin		j.moser@tu-bs.de	Saggu, Miguel/B-1224-2009	Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Apel K, 2001, ADV PHOTOSYNTH, V11, P235; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Belyaeva OB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P173, DOI 10.1023/A:1002891531118; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; Boll M, 2001, BIOCHEMISTRY-US, V40, P7612, DOI 10.1021/bi002771l; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Chiu HJ, 2001, BIOCHEMISTRY-US, V40, P641, DOI 10.1021/bi001645e; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Duyvis MG, 1998, BIOCHEMISTRY-US, V37, P17345, DOI 10.1021/bi981509y; Duyvis MG, 1996, FEBS LETT, V380, P233, DOI 10.1016/0014-5793(96)00019-1; EBERTH A, 2009, CURRENT PROTOCOLS CE, V43; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Erickson JA, 1999, BIOCHEMISTRY-US, V38, P14279, DOI 10.1021/bi991389+; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; Guo ML, 2002, J AM CHEM SOC, V124, P12100, DOI 10.1021/ja026478f; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; LANZILOTTA WN, 1995, BIOCHEMISTRY-US, V34, P15646, DOI 10.1021/bi00048a007; Leslie AGW, 1999, BIOCHEM SOC T, V27, P37, DOI 10.1042/bst0270037; MARUTA S, 1993, J BIOL CHEM, V268, P7093; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; MOSS GP, 1987, PURE APPL CHEM, V59, P779, DOI 10.1351/pac198759060779; Nomata J, 2008, FEBS LETT, V582, P1346, DOI 10.1016/j.febslet.2008.03.018; RAINBIRD RM, 1984, PLANT PHYSIOL, V75, P49, DOI 10.1104/pp.75.1.49; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Renner KA, 1996, BIOCHEMISTRY-US, V35, P5353, DOI 10.1021/bi960441o; RUDIGER W, 2003, PORPHYRIN HDB, V13, P71; Ryle MJ, 1996, J BIOL CHEM, V271, P1551, DOI 10.1074/jbc.271.3.1551; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P4766, DOI 10.1021/bi960026w; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P9424, DOI 10.1021/bi9608572; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schoefs B, 2001, PHOTOSYNTH RES, V70, P257, DOI 10.1023/A:1014769707404; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Watzlich D, 2009, J BIOL CHEM, V284, P15530, DOI 10.1074/jbc.M901331200; Walther J, 2009, FEMS MICROBIOL LETT, V290, P156, DOI 10.1111/j.1574-6968.2008.01413.x	50	40	40	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8268	8277		10.1074/jbc.M109.087874	http://dx.doi.org/10.1074/jbc.M109.087874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075073	hybrid, Green Published			2022-12-25	WOS:000275413800045
J	Tanno, M; Kuno, A; Yano, T; Miura, T; Hisahara, S; Ishikawa, S; Shimamoto, K; Horio, Y				Tanno, Masaya; Kuno, Atsushi; Yano, Toshiyuki; Miura, Tetsuji; Hisahara, Shin; Ishikawa, Satoko; Shimamoto, Kazuaki; Horio, Yoshiyuki			Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; OXIDATIVE STRESS; DEACETYLASE ACTIVITY; HISTONE DEACETYLASE; DISEASE; MICE; CARDIOMYOPATHY; RESVERATROL; SIRTUINS; PROTEIN	Oxidative stress plays a pivotal role in chronic heart failure. SIRT1, an NAD(+)-dependent histone/protein deacetylase, promotes cell survival under oxidative stress when it is expressed in the nucleus. However, adult cardiomyocytes predominantly express SIRT1 in the cytoplasm, and its function has not been elucidated. The purpose of this study was to investigate the functional role of SIRT1 in the heart and the potential use of SIRT1 in therapy for heart failure. We investigated the subcellular localization of SIRT1 in cardiomyocytes and its impact on cell survival. SIRT1 accumulated in the nucleus of cardiomyocytes in the failing hearts of TO-2 hamsters, postmyocardial infarction rats, and a dilated cardiomyopathy patient but not in control healthy hearts. Nuclear but not cytoplasmic SIRT1-induced manganese superoxide dismutase (Mn-SOD), which was further enhanced by resveratrol, and increased the resistance of C2C12 myoblasts to oxidative stress. Resveratrol's enhancement of MnSOD levels depended on the level of nuclear SIRT1, and it suppressed the cell death induced by antimycin A or angiotensin II. The cell-protective effects of nuclear SIRT1 or resveratrol were canceled by the Mn-SOD small interfering RNA or SIRT1 small interfering RNA. The oral administration of resveratrol to TO-2 hamsters increased Mn-SOD levels in cardiomyocytes, suppressed fibrosis, preserved cardiac function, and significantly improved survival. Thus, Mn-SOD induced by resveratrol via nuclear SIRT1 reduced oxidative stress and participated in cardiomyocyte protection. SIRT1 activators such as resveratrol could be novel therapeutic tools for the treatment of chronic heart failure.	[Horio, Yoshiyuki] Sapporo Med Univ, Dept Pharmacol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Tanno, Masaya; Kuno, Atsushi; Yano, Toshiyuki; Miura, Tetsuji; Ishikawa, Satoko; Shimamoto, Kazuaki] Sapporo Med Univ, Dept Internal Med 2, Sapporo, Hokkaido 0608556, Japan; [Hisahara, Shin] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Horio, Y (corresponding author), Sapporo Med Univ, Dept Pharmacol, Chuo Ku, S1,W17, Sapporo, Hokkaido 0608556, Japan.	horio@sapmed.ac.jp	Hisahara, Shin/AAS-8094-2021	Horio, Yoshiyuki/0000-0002-5021-5929; KUNO, ATSUSHI/0000-0001-6873-1297	Grant-in-aid for scientific research [20590869]; National Project; Knowledge Cluster Initiative; Ministry of Education, Culture, Sports, Science and Technology of Japan; Sapporo Medical University; Sapporo Medical University Foundation; Northern Advancement Center for Science and Technology	Grant-in-aid for scientific research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Project; Knowledge Cluster Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sapporo Medical University; Sapporo Medical University Foundation; Northern Advancement Center for Science and Technology	This work was supported in part by a Grant-in-aid for scientific research (20590869), a grant from a National Project, "Knowledge Cluster Initiative," (2nd stage, "Sapporo Biocluster Bio-S") and Program for developing the supporting system for upgrading the education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grants from The Special Fund for Medical Research from Sapporo Medical University and the Sapporo Medical University Foundation for Promotion of Medical Science, and the Northern Advancement Center for Science and Technology.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Casper RF, 1999, MOL PHARMACOL, V56, P784; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Robb EL, 2008, BIOCHEM BIOPH RES CO, V372, P254, DOI 10.1016/j.bbrc.2008.05.028; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; Sentman ML, 2006, J BIOL CHEM, V281, P6904, DOI 10.1074/jbc.M510764200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Valenti L, 2004, J MED GENET, V41, P946, DOI 10.1136/jmg.2004.019588; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909	36	281	297	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8375	8382		10.1074/jbc.M109.090266	http://dx.doi.org/10.1074/jbc.M109.090266			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20089851	Green Published, hybrid			2022-12-25	WOS:000275413800053
J	Gregersen, LH; Jacobsen, AB; Frankel, LB; Wen, JY; Krogh, A; Lund, AH				Gregersen, Lea H.; Jacobsen, Anders B.; Frankel, Lisa B.; Wen, Jiayu; Krogh, Anders; Lund, Anders H.			MicroRNA-145 Targets YES and STAT1 in Colon Cancer Cells	PLOS ONE			English	Article							SUPPRESSIVE MICRORNAS; COLORECTAL-CANCER; EXPRESSION; GROWTH; SIGNATURES; MECHANISM; MIR-143; IDENTIFICATION; DETERMINANTS; DEREGULATION	Background: MicroRNAs (miRNAs) have emerged as important gene regulators and are recognized as key players in tumorigenesis. miR-145 is reported to be down-regulated in several cancers, but knowledge of its targets in colon cancer remains limited. Methodology/Principal Findings: To investigate the role of miR-145 in colon cancer, we have employed a microarray based approach to identify miR-145 targets. Based on seed site enrichment analyses and unbiased word analyses, we found a significant enrichment of miRNA binding sites in the 3'-untranslated regions (UTRs) of transcripts down-regulated upon miRNA overexpression. Gene Ontology analysis showed an overrepresentation of genes involved in cell death, cellular growth and proliferation, cell cycle, gene expression and cancer. A number of the identified miRNA targets have previously been implicated in cancer, including YES, FSCN1, ADAM17, BIRC2, VANGL1 as well as the transcription factor STAT1. Both YES and STAT1 were verified as direct miR-145 targets. Conclusions/Significance: The study identifies and validates new cancer-relevant direct targets of miR-145 in colon cancer cells and hereby adds important mechanistic understanding of the tumor-suppressive functions of miR-145.	[Gregersen, Lea H.; Frankel, Lisa B.; Krogh, Anders; Lund, Anders H.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Gregersen, Lea H.; Frankel, Lisa B.; Krogh, Anders; Lund, Anders H.] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Gregersen, Lea H.; Jacobsen, Anders B.; Wen, Jiayu; Krogh, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Gregersen, LH (corresponding author), Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Berlin, Germany.	anders.lund@bric.ku.dk	Wen, Jiayu/R-1673-2017; Lund, Anders H./F-4786-2014; Skanderup, Anders Jacobsen/K-1081-2013; Gregersen, Lea H/AAI-2386-2021; Krogh, Anders/M-1541-2014	Wen, Jiayu/0000-0003-1249-6456; Lund, Anders H./0000-0002-7407-3398; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Gregersen, Lea H/0000-0002-1205-604X; Frankel, Lisa/0000-0001-7249-3607; Krogh, Anders/0000-0002-5147-6282	European Commission (EC) [201102]; The Novo Nordisk Foundation; The Lundbeck Foundation; The Danish National Research Foundation; The Danish Medical Research Council; The Danish Cancer Society; Danish National Advanced Technology Foundation	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); The Novo Nordisk Foundation(Novo Nordisk Foundation); The Lundbeck Foundation(Lundbeckfonden); The Danish National Research Foundation(Danmarks Grundforskningsfond); The Danish Medical Research Council(Danish Medical Research Council); The Danish Cancer Society(Danish Cancer Society); Danish National Advanced Technology Foundation	Work in the authors' laboratory is supported by European Commission (EC) FP7 funding (ONCOMIRS, grant agreement number 201102. This publication reflects only authors' views. The commission is not liable for any use that may be made of the information herein), The Novo Nordisk Foundation, The Lundbeck Foundation, The Danish National Research Foundation, The Danish Medical Research Council, The Danish Cancer Society and the Danish National Advanced Technology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Akao Y, 2006, ONCOL REP, V16, P845; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Barraclough J, 2007, NEOPLASIA, V9, P745, DOI 10.1593/neo.07442; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad B, 2005, BIOINFORMATICS COMPU; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; CHRISTOFFERSEN NR, 2009, CELL DEATH DIFFER; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; JOHNSON M, 2009, CELL SIGNAL; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Marstrand TT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001623; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nakagawa Y, 2007, BIOORGAN MED CHEM, V15, P5620, DOI 10.1016/j.bmc.2007.04.071; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; PENA SV, 1995, GASTROENTEROLOGY, V108, P117, DOI 10.1016/0016-5085(95)90015-2; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038	58	142	155	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8836	10.1371/journal.pone.0008836	http://dx.doi.org/10.1371/journal.pone.0008836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098684	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100027
J	Rule, NO; Ambady, N				Rule, Nicholas O.; Ambady, Nalini			Democrats and Republicans Can Be Differentiated from Their Faces	PLOS ONE			English	Article							CATEGORIZATION; APPEARANCE; ELECTIONS; ACCURACY	Background: Individuals' faces communicate a great deal of information about them. Although some of this information tends to be perceptually obvious (such as race and sex), much of it is perceptually ambiguous, without clear or obvious visual cues. Methodology/Principal Findings: Here we found that individuals' political affiliations could be accurately discerned from their faces. In Study 1, perceivers were able to accurately distinguish whether U. S. Senate candidates were either Democrats or Republicans based on photos of their faces. Study 2 showed that these effects extended to Democrat and Republican college students, based on their senior yearbook photos. Study 3 then showed that these judgments were related to differences in perceived traits among the Democrat and Republican faces. Republicans were perceived as more powerful than Democrats. Moreover, as individual targets were perceived to be more powerful, they were more likely to be perceived as Republicans by others. Similarly, as individual targets were perceived to be warmer, they were more likely to be perceived as Democrats. Conclusions/Significance: These data suggest that perceivers' beliefs about who is a Democrat and Republican may be based on perceptions of traits stereotypically associated with the two political parties and that, indeed, the guidance of these stereotypes may lead to categorizations of others' political affiliations at rates significantly more accurate than chance guessing.	[Rule, Nicholas O.; Ambady, Nalini] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Tufts University	Rule, NO (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	nicholas.rule@tufts.edu			National Science Foundation [BCS-0435547]	National Science Foundation(National Science Foundation (NSF))	This study was funded by National Science Foundation grant BCS-0435547 to Nalini Ambady and National Science Foundation Graduate Research Fellowship to Nicholas O. Rule. http://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; Chiao JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003666; COLLINS MA, 1995, J APPL SOC PSYCHOL, V25, P129, DOI 10.1111/j.1559-1816.1995.tb01588.x; Elms A. C., 1976, PERSONALITY POLITICS; Gelman Andrew, 2008, RED STATE BLUE STATE; Hayes D, 2005, AM J POLIT SCI, V49, P908, DOI 10.2307/3647705; HAYES D, 2009, FEMININE DEMOCRATS M; Livingston RW, 2009, PSYCHOL SCI, V20, P1229, DOI 10.1111/j.1467-9280.2009.02431.x; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Poutvaara P, 2009, J EXP SOC PSYCHOL, V45, P1132, DOI 10.1016/j.jesp.2009.06.007; QUANTY MB, 1975, J PERS SOC PSYCHOL, V32, P449, DOI 10.1037/h0077093; Rice DR, 2003, APPL COGNITIVE PSYCH, V17, P1129, DOI 10.1002/acp.990; ROBERTS T, 1988, PERCEPTION, V17, P475, DOI 10.1068/p170475; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; Rule NO, 2009, J EXP SOC PSYCHOL, V45, P1245, DOI 10.1016/j.jesp.2009.07.010; Rule NO, 2009, SEX ROLES, V61, P644, DOI 10.1007/s11199-009-9658-9; Rule NO, 2009, PSYCHOL SCI, V20, P441, DOI 10.1111/j.1467-9280.2009.02314.x; RULE NO, 2010, J PERS SOC IN PRESS; Zebrowitz L. A., 1997, READING FACES WINDOW; ZEBROWITZ LA, 1991, LAW HUMAN BEHAV, V15, P603, DOI 10.1007/BF01065855	25	91	91	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8733	10.1371/journal.pone.0008733	http://dx.doi.org/10.1371/journal.pone.0008733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	545EJ	20090906	Green Submitted, Green Published, gold			2022-12-25	WOS:000273715000004
J	Zhou, ZM; Li, XM; Liu, B; Beutin, L; Xu, JG; Ren, Y; Feng, L; Lan, RT; Reeves, PR; Wang, L				Zhou, Zhemin; Li, Xiaomin; Liu, Bin; Beutin, Lothar; Xu, Jianguo; Ren, Yan; Feng, Lu; Lan, Ruiting; Reeves, Peter R.; Wang, Lei			Derivation of Escherichia coli O157:H7 from Its O55:H7 Precursor	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ENTEROCYTE EFFACEMENT; PATHOGENICITY ISLAND; INDEPENDENT ORIGINS; HEMORRHAGIC COLITIS; PROTEIN SECRETION; GENES; EVOLUTION; EXPRESSION; VIRULENCE	There are 29 E. coli genome sequences available, mostly related to studies of species diversity or mode of pathogenicity, including two genomes of the well-known O157:H7 clone. However, there have been no genome studies of closely related clones aimed at exposing the details of evolutionary change. Here we sequenced the genome of an O55:H7 strain, closely related to the major pathogenic O157:H7 clone, with published genome sequences, and undertook comparative genomic and proteomic analysis. We were able to allocate most differences between the genomes to individual mutations, recombination events, or lateral gene transfer events, in specific lineages. Major differences include a type II secretion system present only in the O55:H7 chromosome, fewer type III secretion system effectors in O55:H7, and 19 phage genomes or phagelike elements in O55:H7 compared to 23 in O157:H7, with only three common to both. Many other changes were found in both O55:H7 and O157:H7 lineages, but in general there has been more change in the O157:H7 lineages. For example, we found 50% more synonymous mutational substitutions in O157:H7 compared to O55:H7. The two strains also diverged at the proteomic level. Mutational synonymous SNPs were used to estimate a divergence time of 400 years using a new clock rate, in contrast to 14,000 to 70,000 years using the traditional clock rates. The same approaches were applied to three closely related extraintestinal pathogenic E. coli genomes, and similar levels of mutation and recombination were found. This study revealed for the first time the full range of events involved in the evolution of the O157:H7 clone from its O55:H7 ancestor, and suggested that O157:H7 arose quite recently. Our findings also suggest that E. coli has a much lower frequency of recombination relative to mutation than was observed in a comparable study of a Vibrio cholerae lineage.	[Zhou, Zhemin; Li, Xiaomin; Liu, Bin; Ren, Yan; Feng, Lu; Wang, Lei] Nankai Univ, Sch Biol Sci & Biotechnol, Tianjin Econ Tech Dev Area, Tianjin 300071, Peoples R China; [Zhou, Zhemin; Liu, Bin; Feng, Lu; Wang, Lei] Tianjin Res Ctr Funct Genom & Biochip, Tianjin, Peoples R China; [Beutin, Lothar] Fed Inst Risk Assessment, Natl Reference Lab Escherichia Coli, Berlin, Germany; [Xu, Jianguo] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Reeves, Peter R.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Wang, Lei] Nankai Univ, Tianjin Key Lab Microbial Funct Gen, Tianjin 300071, Peoples R China	Nankai University; Federal Institute for Risk Assessment; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of New South Wales Sydney; University of Sydney; Nankai University	Zhou, ZM (corresponding author), Nankai Univ, Sch Biol Sci & Biotechnol, Tianjin Econ Tech Dev Area, Tianjin 300071, Peoples R China.	wanglei@nankai.edu.cn	Liu, Bin/C-5083-2009; Zhou, Zhemin/AAX-5539-2020; Wang, Lei/C-5176-2009; Reeves, Peter R/A-6064-2008; feng, lu/M-5113-2015	Zhou, Zhemin/0000-0001-9783-0366; Wang, Lei/0000-0003-4427-0881; Reeves, Peter R/0000-0003-4479-7974; Lan, Ruiting/0000-0001-9834-5258	Tianjin Municipal Special Fund [05FZZDSH00800]; National Natural Science Foundation of China (NSFC) [30530010, 20536040]; Chinese National Science Fund [30788001]; NSFC [30670038, 30870070, 30870078, 30771175, 30900041]; National 863 Program of China [2006AA020703, 2006AA06Z409]; National 973 Program of China [2009CB522603]; National Key Programs for Infectious Diseases of China [2008ZX1004-002, 2008ZX1004-009, 2009ZX10004-108]	Tianjin Municipal Special Fund; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese National Science Fund(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); National 973 Program of China(National Basic Research Program of China); National Key Programs for Infectious Diseases of China	This work was supported by the Tianjin Municipal Special Fund for Science and Technology Innovation Grant 05FZZDSH00800; National Natural Science Foundation of China (NSFC) Key Programs Grants 30530010 and 20536040; the Chinese National Science Fund for Distinguished Young Scholars (30788001); NSFC General Program Grants 30670038, 30870070, 30870078, 30771175, and 30900041; National 863 Program of China Grants 2006AA020703 and 2006AA06Z409; National 973 Program of China Grant 2009CB522603; and National Key Programs for Infectious Diseases of China 2008ZX1004-002, 2008ZX1004-009, and 2009ZX10004-108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Afset JE, 2006, J CLIN MICROBIOL, V44, P3703, DOI 10.1128/JCM.00429-06; An HY, 1999, ADV EXP MED BIOL, V473, P179; Anthony KG, 1999, J BACTERIOL, V181, P5149, DOI 10.1128/JB.181.17.5149-5159.1999; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Beinke C, 1998, INFECT IMMUN, V66, P528, DOI 10.1128/IAI.66.2.528-539.1998; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; BENZ I, 1989, INFECT IMMUN, V57, P1506, DOI 10.1128/IAI.57.5.1506-1511.1989; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brunder W, 2006, INT J MED MICROBIOL, V296, P467, DOI 10.1016/j.ijmm.2006.05.005; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Creuzburg K, 2007, J CLIN MICROBIOL, V45, P2498, DOI 10.1128/JCM.00038-07; Darling Aaron E., 2007, V396, P135; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Drago-Serrano ME, 2006, FEMS MICROBIOL LETT, V265, P35, DOI 10.1111/j.1574-6968.2006.00463.x; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; EMMERT DB, 1994, NUCLEIC ACIDS RES, V22, P3445, DOI 10.1093/nar/22.17.3445; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon DM, 1999, MICROBIOL-SGM, V145, P2663, DOI 10.1099/00221287-145-10-2663; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hill CW, 1999, RES MICROBIOL, V150, P665, DOI 10.1016/S0923-2508(99)00125-4; Ho TD, 2008, INFECT IMMUN, V76, P1858, DOI 10.1128/IAI.01688-07; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kozub-Witkowski E, 2008, J APPL MICROBIOL, V104, P403, DOI 10.1111/j.1365-2672.2007.03545.x; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; LINK CD, 1983, MOL GEN GENET, V189, P337, DOI 10.1007/BF00337827; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McVean G, 2002, GENETICS, V160, P1231; Milkman R, 2003, GENETICS, V163, P475; Morabito S, 2003, INFECT IMMUN, V71, P3343, DOI 10.1128/IAI.71.6.3343-3348.2003; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nie H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-173; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rosenshine I, 1996, INFECT IMMUN, V64, P966, DOI 10.1128/IAI.64.3.966-973.1996; Schmidt H.A., 2007, CURR PROTOC BIOINFOR, V17, p6.6.1, DOI [10.1002/0471250953.bi0606s17, DOI 10.1002/0471250953.BI0606S17]; Souza V, 1999, APPL ENVIRON MICROB, V65, P3373; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; Stevens MP, 2004, INFECT IMMUN, V72, P5402, DOI 10.1128/IAI.72.9.5402-5411.2004; TADDEI F, 1995, SCIENCE, V269, P288, DOI 10.1126/science.269.5222.288-b; Tarr PI, 2000, J BACTERIOL, V182, P6183, DOI 10.1128/JB.182.21.6183-6191.2000; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Wang L, 2002, J BACTERIOL, V184, P2620, DOI 10.1128/JB.184.10.2620-2625.2002; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; WHITTAM TS, 1993, INFECT IMMUN, V61, P1619, DOI 10.1128/IAI.61.5.1619-1629.1993; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	80	83	95	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8700	10.1371/journal.pone.0008700	http://dx.doi.org/10.1371/journal.pone.0008700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090843	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714600003
J	Kodama, T; Gotoh, K; Hiyoshi, H; Morita, M; Izutsu, K; Akeda, Y; Park, KS; Cantarelli, VV; Dryselius, R; Iida, T; Honda, T				Kodama, Toshio; Gotoh, Kazuyoshi; Hiyoshi, Hirotaka; Morita, Mikiharu; Izutsu, Kaori; Akeda, Yukihiro; Park, Kwon-Sam; Cantarelli, Vlademir V.; Dryselius, Rikard; Iida, Tetsuya; Honda, Takeshi			Two Regulators of Vibrio parahaemolyticus Play Important Roles in Enterotoxicity by Controlling the Expression of Genes in the Vp-PAI Region	PLOS ONE			English	Article							THERMOSTABLE DIRECT HEMOLYSIN; III SECRETION SYSTEM; PATHOGENICITY ISLAND; UNITED-STATES; CHOLERAE; IDENTIFICATION; PURIFICATION; PROTEIN; TOXIN; CELLS	Vibrio parahaemolyticus is an important pathogen causing food-borne disease worldwide. An 80-kb pathogenicity island (Vp-PAI), which contains two tdh (thermostable direct hemolysin) genes and a set of genes for the type III secretion system (T3SS2), is closely related to the pathogenicity of this bacterium. However, the regulatory mechanisms of Vp-PAI's gene expression are poorly understood. Here we report that two novel ToxR-like transcriptional regulatory proteins (VtrA and VtrB) regulate the expression of the genes encoded within the Vp-PAI region, including those for TDH and T3SS2-related proteins. Expression of vtrB was under control of the VtrA, as vector-expressed vtrB was able to recover a functional protein secretory capacity for T3SS2, independent of VtrA. Moreover, these regulatory proteins were essential for T3SS2-dependent biological activities, such as in vitro cytotoxicity and in vivo enterotoxicity. Enterotoxic activities of vtrA and/or vtrB deletion strains derived from the wild-type strain were almost absent, showing fluid accumulation similar to non-infected control. Whole genome transcriptional profiling of vtrA or vtrB deletion strains revealed that the expression levels of over 60 genes were downregulated significantly in these deletion mutant strains and that such genes were almost exclusively located in the Vp-PAI region. These results strongly suggest that VtrA and VtrB are master regulators for virulence gene expression in the Vp-PAI and play critical roles in the pathogenicity of this bacterium.	[Kodama, Toshio; Morita, Mikiharu; Akeda, Yukihiro; Park, Kwon-Sam; Cantarelli, Vlademir V.; Honda, Takeshi] Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Osaka, Japan; [Gotoh, Kazuyoshi; Hiyoshi, Hirotaka; Izutsu, Kaori; Dryselius, Rikard; Iida, Tetsuya] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Osaka, Japan; [Park, Kwon-Sam] Kunsan Natl Univ, Coll Ocean Sci & Technol, Dept Food Sci & Technol, Kusan, Jeollabuk Do, South Korea; [Cantarelli, Vlademir V.] Ctr Univ Feevale, Novo Hamburgo, RS, Brazil	Osaka University; Osaka University; Kunsan National University	Kodama, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Osaka, Japan.	kodama@biken.osaka-u.ac.jp	Cantarelli, Vlademir/E-1970-2016	Hiyoshi, Hirotaka/0000-0003-3709-2386; Kodama, Toshio/0000-0002-6511-7301	Ministry of Education, Culture, Sports, Science and Technology of Japan [21790419, 17019058, 18073003]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Young Scientists (21790419, http://kaken.nii.ac.jp/ja/p/21790419) and Scientific Research on Priority Areas Applied Genomics (17019058, http://kaken.nii.ac.jp/ja/p/17019058), and Matrix of Infection Phenomena from the Ministry of Education (18073003, http://kaken.nii.ac.jp/ja/p/18073003), Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Fabbri A, 1999, INFECT IMMUN, V67, P1139, DOI 10.1128/IAI.67.3.1139-1148.1999; GOSHIMA K, 1977, J MOL CELL CARDIOL, V9, P191, DOI 10.1016/0022-2828(77)90029-3; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; HONDA T, 1976, INFECT IMMUN, V13, P163, DOI 10.1128/IAI.13.1.163-171.1976; HONDA T, 1990, CAN J MICROBIOL, V36, P395, DOI 10.1139/m90-069; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; HONDA T, 1976, J JPN ASS INFECT DIS, V50, P216; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; Izutsu K, 2008, INFECT IMMUN, V76, P1016, DOI 10.1128/IAI.01535-07; Kodama T, 2002, CELL MICROBIOL, V4, P213, DOI 10.1046/j.1462-5822.2002.00176.x; Kodama T, 2008, INFECT IMMUN, V76, P4282, DOI 10.1128/IAI.01738-07; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; LIN Z, 1993, J BACTERIOL, V175, P3844, DOI 10.1128/JB.175.12.3844-3855.1993; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Meador CE, 2007, J CLIN MICROBIOL, V45, P1133, DOI 10.1128/JCM.00042-07; Miller J.H., 1972, EXPT MOL GENETICS; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; MIYAMOTO Y, 1969, J BACTERIOL, V100, P1147, DOI 10.1128/JB.100.2.1147-1149.1969; MIYAMOTO Y, 1980, INFECT IMMUN, V28, P567; MORRIS JG, 1985, NEW ENGL J MED, V312, P343, DOI 10.1056/NEJM198502073120604; Naim R, 2001, FEMS MICROBIOL LETT, V195, P237, DOI 10.1016/S0378-1097(01)00015-5; Nakano M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-155; NIIKAWA T, 1972, JPN J MED SCI BIOL, V25, P197; NISHIBUCHI M, 1992, INFECT IMMUN, V60, P3539, DOI 10.1128/IAI.60.9.3539-3545.1992; NISHIBUCHI M, 1995, INFECT IMMUN, V63, P2093, DOI 10.1128/IAI.63.6.2093-2099.1995; Nomura T, 2000, MICROB PATHOGENESIS, V28, P25, DOI 10.1006/mpat.1999.0321; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; PARALES RE, 1993, GENE, V133, P23, DOI 10.1016/0378-1119(93)90220-W; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Raimondi F, 2000, INFECT IMMUN, V68, P3180, DOI 10.1128/IAI.68.6.3180-3185.2000; SAKURAI J, 1973, INFECT IMMUN, V8, P775, DOI 10.1128/IAI.8.5.775-780.1973; SAKURAI J, 1976, INFECT IMMUN, V13, P876, DOI 10.1128/IAI.13.3.876-883.1976; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; Sugiyama T, 2008, J BACTERIOL, V190, P1835, DOI 10.1128/JB.01293-07; Takahashi A, 2001, J MED MICROBIOL, V50, P870, DOI 10.1099/0022-1317-50-10-870; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; TANG GQ, 1995, FEMS MICROBIOL LETT, V134, P233, DOI 10.1016/0378-1097(95)00411-3; Tang GQ, 1997, FEMS MICROBIOL LETT, V150, P289, DOI 10.1016/S0378-1097(97)00133-X; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; ZENYOJI H, 1971, J INFECT DIS, V123, P665, DOI 10.1093/infdis/123.6.665	47	48	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8678	10.1371/journal.pone.0008678	http://dx.doi.org/10.1371/journal.pone.0008678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084267	Green Submitted, gold, Green Published			2022-12-25	WOS:000273554600029
J	Brumfield, KM; Moroney, JV; Moore, TS; Simms, TA; Donze, D				Brumfield, Kristy M.; Moroney, James V.; Moore, Thomas S.; Simms, Tiffany A.; Donze, David			Functional Characterization of the Chlamydomonas reinhardtii ERG3 Ortholog, a Gene Involved in the Biosynthesis of Ergosterol	PLOS ONE			English	Article							MEMBRANE-LIPID BIOSYNTHESIS; CONSERVED DOMAIN DATABASE; C-5 STEROL DESATURASE; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; DRUG-RESISTANCE; YEAST; MUTANTS; PHYTOSTEROLS; EXPRESSION	Background: The predominant sterol in the membranes of the alga Chlamydomonas reinhardtii is ergosterol, which is commonly found in the membranes of fungi, but is rarely found in higher plants. Higher plants and fungi synthesize sterols by different pathways, with plants producing cycloartenol as a precursor to end-product sterols, while non-photosynthesizing organisms like yeast and humans produce lanosterol as a precursor. Analysis of the C. reinhardtii genome sequence reveals that this algae is also likely to synthesize sterols using a pathway resembling the higher plant pathway, indicating that its sterols are synthesized somewhat differently than in fungi. The work presented here seeks to establish experimental evidence to support the annotated molecular function of one of the sterol biosynthetic genes in the Chlamydomonas genome. Methodology/Principal Findings: A gene with homology to the yeast sterol C-5 desaturase, ERG3, is present in the Chlamydomonas genome. To test whether the ERG3 ortholog of C. reinhardtii encodes a sterol C-5 desaturase, Saccharomyces cerevisiae ERG3 knockout strains were created and complemented with a plasmid expressing the Chlamydomonas ERG3. Expression of C. reinhardtii ERG3 cDNA in erg3 null yeast was able to restore ergosterol biosynthesis and reverse phenotypes associated with lack of ERG3 function. Conclusions/Significance: Complementation of the yeast erg3 null phenotypes strongly suggests that the gene annotated as ERG3 in C. reinhardtii functions as a sterol C-5 desaturase.	[Brumfield, Kristy M.] Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA; [Moroney, James V.; Moore, Thomas S.; Simms, Tiffany A.; Donze, David] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Xavier University of Louisiana; Louisiana State University System; Louisiana State University	Brumfield, KM (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA.	ddonze@lsu.edu		Donze, David/0000-0002-7473-5902	National Science Foundation [MCB-0817823, IOS-0816957]; Div Of Molecular and Cellular Bioscience [0817823] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation (Grants to MCB-0817823 to D.D. and IOS-0816957 to J.V.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Methods Enzymol, V194, P1; ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; ArthingtonSkaggs BA, 1996, FEBS LETT, V392, P161, DOI 10.1016/0014-5793(96)00807-1; BAKER BJ, 1993, MARINE NATURAL PRODU, P1; BARD M, 1978, J BACTERIOL, V135, P1146, DOI 10.1128/JB.135.3.1146-1148.1978; BARD M, 1978, LIPIDS, V13, P533, DOI 10.1007/BF02533592; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broach JR, 1991, MOL CELLULAR BIOL YE; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Darnet S, 2001, FEBS LETT, V508, P39, DOI 10.1016/S0014-5793(01)03002-2; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Fernandes P, 2007, BIORESOURCE TECHNOL, V98, P2335, DOI 10.1016/j.biortech.2006.10.006; Gachotte D, 1996, PLANT J, V9, P391, DOI 10.1046/j.1365-313X.1996.09030391.x; GEALT MA, 1981, LIPIDS, V16, P133, DOI 10.1007/BF02535687; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GINER JL, 1993, CHEM REV, V93, P1735, DOI 10.1021/cr00021a004; Griffiths KM, 2003, PHYTOCHEMISTRY, V62, P147, DOI 10.1016/S0031-9422(02)00505-8; HEMMI K, 1995, BIOSCI BIOTECH BIOCH, V59, P482, DOI 10.1271/bbb.59.482; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; JAYASIMHA PBC, 2006, RECENT ADV PHYTOCHEM, V40; KLEINHANS FW, 1979, CHEM PHYS LIPIDS, V23, P143, DOI 10.1016/0009-3084(79)90042-2; LAMPEN JO, 1966, S SOC GENMICR; LEES N D, 1989, Steroids, V53, P567, DOI 10.1016/0039-128X(89)90032-9; LEES ND, 1979, BIOCHIM BIOPHYS ACTA, V553, P469, DOI 10.1016/0005-2736(79)90302-X; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; LUDWIG DL, 1993, GENE, V132, P33, DOI 10.1016/0378-1119(93)90511-Z; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miyazaki Y, 1999, GENE, V236, P43, DOI 10.1016/S0378-1119(99)00263-2; Moghadasian MH, 1999, AM J MED, V107, P588, DOI 10.1016/S0002-9343(99)00285-5; NES WD, 1990, P NATL ACAD SCI USA, V87, P7565, DOI 10.1073/pnas.87.19.7565; NES WR, 1988, J BIOL CHEM, V263, P11844; NORTON RA, 1991, LIPIDS, V26, P247, DOI 10.1007/BF02543980; OSUMI T, 1979, J BIOCHEM-TOKYO, V85, P819; OSUMI T, 1978, J BIOCHEM-TOKYO, V83, P681, DOI 10.1093/oxfordjournals.jbchem.a131961; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; PARKS LW, 1982, LIPIDS, V17, P187, DOI 10.1007/BF02535102; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Salimova E, 1999, PLANT PHYSIOL BIOCH, V37, P241, DOI 10.1016/S0981-9428(99)80022-9; Schrick K, 2000, GENE DEV, V14, P1471; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SMITH SJ, 1993, YEAST, V9, P1177, DOI 10.1002/yea.320091104; Song ZH, 2007, LIPIDS, V42, P15, DOI 10.1007/s11745-006-3017-1; Souter M, 2002, PLANT CELL, V14, P1017, DOI 10.1105/tpc.001248; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P321, DOI 10.1016/S0753-3322(03)00104-5; Taton M, 2000, BIOCHEMISTRY-US, V39, P701, DOI 10.1021/bi991467t; WACH A, 1994, YEAST, V10, P1808; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Yang WY, 2004, ARCH BIOCHEM BIOPHYS, V430, P198, DOI 10.1016/j.abb.2004.07.016; Yang WY, 2004, BIOCHEM J, V382, P51, DOI 10.1042/BJ20040254	56	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8659	10.1371/journal.pone.0008659	http://dx.doi.org/10.1371/journal.pone.0008659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20084111	Green Published, Green Submitted, gold			2022-12-25	WOS:000273456300009
J	Bronsvoort, BMD; von Wissmann, B; Fevre, EM; Handel, IG; Picozzi, K; Welburn, SC				Bronsvoort, Barend Mark de Clare; von Wissmann, Beatrix; Fevre, Eric Maurice; Handel, Ian Graham; Picozzi, Kim; Welburn, Sue Christina			No Gold Standard Estimation of the Sensitivity and Specificity of Two Molecular Diagnostic Protocols for Trypanosoma brucei spp. in Western Kenya	PLOS ONE			English	Article							SLEEPING-SICKNESS; PCR; CATTLE; TESTS; ASSAY	African animal trypanosomiasis is caused by a range of tsetse transmitted protozoan parasites including Trypanosoma vivax, Trypanosoma congolense and Trypansoma brucei. In Western Kenya and other parts of East Africa two subspecies of T. brucei, T.b. brucei and the zoonotic T.b. rhodesiense, co-circulate in livestock. A range of polymerase chain reactions (PCR) have been developed as important molecular diagnostic tools for epidemiological investigations of T. brucei s.l. in the animal reservoir and of its zoonotic potential. Quantification of the relative performance of different diagnostic PCRs is essential to ensure comparability of studies. This paper describes an evaluation of two diagnostic test systems for T. brucei using a T. brucei s.l. specific PCR [1] and a single nested PCR targeting the Internal Transcribed Spacer (ITS) regions of trypanosome ribosomal DNA [2]. A Bayesian formulation of the Hui-Walter latent class model was employed to estimate their test performance in the absence of a gold standard test for detecting T. brucei s.l. infections in ear-vein blood samples from cattle, pig, sheep and goat populations in Western Kenya, stored on Whatman FTA cards. The results indicate that the system employing the T. brucei s.l. specific PCR (Se-1 = 0.760) had a higher sensitivity than the ITS-PCR (Se-2 = 0.640); both have high specificity (Sp(1) = 0.998; Sp(2) = 0.997). The true prevalences for livestock populations were estimated (p(cattle) = 0.091, p(pigs) = 0.066, p(goats) = 0.005, p(sheep) = 0.006), taking into account the uncertainties in the specificity and sensitivity of the two test systems. Implications of test performance include the required survey sample size; due to its higher sensitivity and specificity, the T. brucei s.l. specific PCR requires a consistently smaller sample size than the ITS-PCR for the detection of T. brucei s.l. However the ITS-PCR is able to simultaneously screen samples for other pathogenic trypanosomes and may thus be, overall, a better choice of test in multi-organism studies.	[Bronsvoort, Barend Mark de Clare; Handel, Ian Graham] Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [von Wissmann, Beatrix; Picozzi, Kim; Welburn, Sue Christina] Univ Edinburgh, Royal Dick Sch Vet Studies, Ctr Infect Dis, Edinburgh EH9 1QH, Midlothian, Scotland; [Fevre, Eric Maurice] Univ Edinburgh, Ctr Infect Dis, Sch Biol Sci, Edinburgh EH9 1QH, Midlothian, Scotland; [Fevre, Eric Maurice] Univ Edinburgh, Ctr Infect Immun & Evolut, Sch Biol Sci, Edinburgh EH9 1QH, Midlothian, Scotland; [Bronsvoort, Barend Mark de Clare; Handel, Ian Graham] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Bronsvoort, BMD (corresponding author), Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.	Mark.Bronsvoort@ed.ac.uk		Welburn, Susan/0000-0002-9903-7086; von Wissmann, Beatrix/0000-0002-0980-4545; Fevre, Eric/0000-0001-8931-4986; Bronsvoort, Mark/0000-0002-3271-8485	United Kingdom Department for International Development Animal Health Programme (DFID-AHP); Wellcome Trust [085308]; Biotechnology and Biological Sciences Research Council (BBSRC) [338BDD RA0762]	United Kingdom Department for International Development Animal Health Programme (DFID-AHP); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the United Kingdom Department for International Development Animal Health Programme (DFID-AHP). EMF is funded by the Wellcome Trust (085308). IH is funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (338BDD RA0762). The funding agencies had no role in conducting the study and in preparing the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bronsvoort BMD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005221; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Clausen PH, 1998, ANN NY ACAD SCI, V849, P21, DOI 10.1111/j.1749-6632.1998.tb11029.x; CONNOR RJ, 1994, ONDERSTEPOORT J VET, V61, P379; Cox A, 2005, EXP PARASITOL, V111, P24, DOI 10.1016/j.exppara.2005.03.014; DENWOOD, 2009, RUNJAGS RUN BAYESIAN; EISLER MC, 2004, TRYPANOSOMIASES; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; *INCO DC, 2000, NOV APPR EP RES DRUG; Kabasa JD, 2007, TRENDS PARASITOL, V23, P191, DOI 10.1016/j.pt.2007.03.006; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Machila N, 2003, ACTA TROP, V86, P25, DOI 10.1016/S0001-706X(02)00288-7; Masake RA, 2002, VET PARASITOL, V105, P179, DOI 10.1016/S0304-4017(02)00020-1; MOSER DR, 1989, PARASITOLOGY, V99, P57, DOI 10.1017/S0031182000061023; MURRAY M, 1989, ANN SOC BELG MED TR, V69, P189; MURRAY M, 1977, T ROY SOC TROP MED H, V71, P325, DOI 10.1016/0035-9203(77)90110-9; Ng'ayo Musa O, 2005, Kinetoplastid Biol Dis, V4, P5, DOI 10.1186/1475-9292-4-5; *OIE, 2009, MAN DIAGN TESTS VACC; Picozzi K., 2002, African Journal of Biotechnology, V1, P39; Picozzi K, 2008, EXP PARASITOL, V118, P41, DOI 10.1016/j.exppara.2007.05.014; Pinchbeck GL, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-7; Plummer M., 2003, P 3 INT WORKSH DISTR; PLUMMER M, 2009, OUTPUT ANAL DIAGNOST; R Development Core Team, 2009, R FDN STAT COMP; Solano P, 1999, VET PARASITOL, V86, P95, DOI 10.1016/S0304-4017(99)00137-5; Taylor K., 2004, The trypanosomiases, P331, DOI 10.1079/9780851994758.0331; Thrusfield M., 2005, VET EPIDEMIOLOGY; Thumbi SM, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-46; THURANIRA CM, 2005, THESIS U EDINBURGH E; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Uilenberg G., 1998, FIELD GUIDE DIAGNOSI; Waiswa C, 2003, ANN TROP MED PARASIT, V97, P149, DOI 10.1179/000349803235001688; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; Woo P. T. K., 1970, Acta trop., V27, P384; WHATMAN FTA CARDS PR	37	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8628	10.1371/journal.pone.0008628	http://dx.doi.org/10.1371/journal.pone.0008628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062795	Green Submitted, Green Published, gold			2022-12-25	WOS:000273414100013
J	Meyer-Morse, N; Robbins, JR; Rae, CS; Mochegova, SN; Swanson, MS; Zhao, ZJ; Virgin, HW; Portnoy, D				Meyer-Morse, Nicole; Robbins, Jennifer R.; Rae, Chris S.; Mochegova, Sofia N.; Swanson, Michele S.; Zhao, Zijiang; Virgin, Herbert W.; Portnoy, Daniel			Listeriolysin O Is Necessary and Sufficient to Induce Autophagy during Listeria monocytogenes Infection	PLOS ONE			English	Article							PORE-FORMING TOXIN; INTRACELLULAR GROWTH; BACILLUS-SUBTILIS; PERFRINGOLYSIN-O; VIBRIO-CHOLERAE; PATHOGENESIS; HEMOLYSIN; ACTA; GENE; DEGRADATION	Background: Recent studies have suggested that autophagy is utilized by cells as a protective mechanism against Listeria monocytogenes infection. Methodology/Principal Findings: However we find autophagy has no measurable role in vacuolar escape and intracellular growth in primary cultured bone marrow derived macrophages (BMDMs) deficient for autophagy (atg5(-/-)). Nevertheless, we provide evidence that the pore forming activity of the cholesterol-dependent cytolysin listeriolysin O (LLO) can induce autophagy subsequent to infection by L. monocytogenes. Infection of BMDMs with L. monocytogenes induced microtubule-associated protein light chain 3 (LC3) lipidation, consistent with autophagy activation, whereas a mutant lacking LLO did not. Infection of BMDMs that express LC3-GFP demonstrated that wild-type L. monocytogenes was encapsulated by LC3-GFP, consistent with autophagy activation, whereas a mutant lacking LLO was not. Bacillus subtilis expressing either LLO or a related cytolysin, perfringolysin O (PFO), induced LC3 colocalization and LC3 lipidation. Further, LLO-containing liposomes also recruited LC3-GFP, indicating that LLO was sufficient to induce targeted autophagy in the absence of infection. The role of autophagy had variable effects depending on the cell type assayed. In atg5(-/-) mouse embryonic fibroblasts, L. monocytogenes had a primary vacuole escape defect. However, the bacteria escaped and grew normally in atg5(-/-) BMDMs. Conclusions/Significance: We propose that membrane damage, such as that caused by LLO, triggers bacterial-targeted autophagy, although autophagy does not affect the fate of wild-type intracellular L. monocytogenes in primary BMDMs.	[Meyer-Morse, Nicole; Robbins, Jennifer R.; Rae, Chris S.; Mochegova, Sofia N.; Portnoy, Daniel] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Robbins, Jennifer R.] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA; [Portnoy, Daniel] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Swanson, Michele S.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Zhao, Zijiang; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	University of California System; University of California Berkeley; Xavier University; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Washington University (WUSTL)	Meyer-Morse, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	portnoy@berkeley.edu		Robbins, Jennifer/0000-0002-7414-6702; Swanson, Michele/0000-0003-2542-0266; Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health [P01 AI063302, AI27655, U54 AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, P01AI063302, R01AI027655, R29AI027655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A. P. was supported by National Institutes of Health Grant P01 AI063302 and AI27655. H. W. V. was supported by National Institutes of Health Grant Project 5 of U54 AI057160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; BIELECKI J, 1990, NATURE, V345, P175, DOI 10.1038/345175a0; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; BISHOP DK, 1987, J IMMUNOL, V139, P2005; BOHNE J, 1994, MOL MICROBIOL, V11, P1141, DOI 10.1111/j.1365-2958.1994.tb00390.x; BOLENDER RP, 1973, J CELL BIOL, V56, P746, DOI 10.1083/jcb.56.3.746; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Colombo MI, 2007, IUBMB LIFE, V59, P238, DOI 10.1080/15216540701230503; DABIRI GA, 1990, P NATL ACAD SCI USA, V87, P6068, DOI 10.1073/pnas.87.16.6068; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kayal S, 2006, FEMS MICROBIOL REV, V30, P514, DOI 10.1111/j.1574-6976.2006.00021.x; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lee KD, 1996, J BIOL CHEM, V271, P7249, DOI 10.1074/jbc.271.13.7249; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mandal M, 2002, BBA-BIOMEMBRANES, V1563, P7, DOI 10.1016/S0005-2736(02)00368-1; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Pizarro-Cerda J, 2006, J PATHOL, V208, P215, DOI 10.1002/path.1888; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Swanson MS, 2006, J IMMUNOL, V177, P4945, DOI 10.4049/jimmunol.177.8.4945; Terebiznik MR, 2009, AUTOPHAGY, V5, P370, DOI 10.4161/auto.5.3.7663; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; VEENHUIS M, 1983, ARCH MICROBIOL, V134, P193, DOI 10.1007/BF00407757; Vergne I, 2006, AUTOPHAGY, V2, P175, DOI 10.4161/auto.2830; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zhao ZJ, 2007, AUTOPHAGY, V3, P581, DOI 10.4161/auto.4782	58	78	79	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8610	10.1371/journal.pone.0008610	http://dx.doi.org/10.1371/journal.pone.0008610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062534	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338600027
J	Miller, JE; Hilliard, AT; White, SA				Miller, Julie E.; Hilliard, Austin T.; White, Stephanie A.			Song Practice Promotes Acute Vocal Variability at a Key Stage of Sensorimotor Learning	PLOS ONE			English	Article							SINGING-RELATED ACTIVITY; BASAL GANGLIA; FOXP2 EXPRESSION; GENE-EXPRESSION; SPEECH; NEURONS; LANGUAGE; BIRDSONG; NUCLEUS; CIRCUIT	Background: Trial by trial variability during motor learning is a feature encoded by the basal ganglia of both humans and songbirds, and is important for reinforcement of optimal motor patterns, including those that produce speech and birdsong. Given the many parallels between these behaviors, songbirds provide a useful model to investigate neural mechanisms underlying vocal learning. In juvenile and adult male zebra finches, endogenous levels of FoxP2, a molecule critical for language, decrease two hours after morning song onset within area X, part of the basal ganglia-forebrain pathway dedicated to song. In juveniles, experimental 'knockdown' of area X FoxP2 results in abnormally variable song in adulthood. These findings motivated our hypothesis that low FoxP2 levels increase vocal variability, enabling vocal motor exploration in normal birds. Methodology/Principal Findings: After two hours in either singing or non-singing conditions (previously shown to produce differential area X FoxP2 levels), phonological and sequential features of the subsequent songs were compared across conditions in the same bird. In line with our prediction, analysis of songs sung by 75 day (75d) birds revealed that syllable structure was more variable and sequence stereotypy was reduced following two hours of continuous practice compared to these features following two hours of non-singing. Similar trends in song were observed in these birds at 65d, despite higher overall within-condition variability at this age. Conclusions/Significance: Together with previous work, these findings point to the importance of behaviorally-driven acute periods during song learning that allow for both refinement and reinforcement of motor patterns. Future work is aimed at testing the observation that not only does vocal practice influence expression of molecular networks, but that these networks then influence subsequent variability in these skills.	[Miller, Julie E.; Hilliard, Austin T.; White, Stephanie A.] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; [Hilliard, Austin T.; White, Stephanie A.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Miller, JE (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA.	sawhite@ucla.edu	Hilliard, Austin/AAT-7316-2020; Hilliard, Austin/AAM-1752-2020; White, Stephanie Ann/AAE-7683-2019	Hilliard, Austin/0000-0002-1289-4377; White, Stephanie Ann/0000-0002-3490-2294; Miller, Julie/0000-0003-0371-0342	University of California Los Angeles Mental Retardation Research Center [T32 HD0007032, RO1 MH070712]; ATH [2T32 MH019384-11A2, 1F31 MH082533-01A1]; Tennenbaum Family Creativity Initiative [1RO1 MH070712]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070712, T32MH019384, F31MH082533] Funding Source: NIH RePORTER	University of California Los Angeles Mental Retardation Research Center; ATH; Tennenbaum Family Creativity Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JEM was supported by University of California Los Angeles Mental Retardation Research Center T32 HD0007032 and RO1 MH070712 to SAW. ATH was supported by 2T32 MH019384-11A2 and 1F31 MH082533-01A1. SAW was funded by the Tennenbaum Family Creativity Initiative and 1RO1 MH070712. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Brenowitz EA, 2005, TRENDS NEUROSCI, V28, P127, DOI 10.1016/j.tins.2005.01.004; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Day NF, 2008, J NEUROPHYSIOL, V100, P2956, DOI 10.1152/jn.90501.2008; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dunn AM, 1996, ETHOLOGY, V102, P529; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Farries MA, 2002, J NEUROSCI, V22, P3776; Gale SD, 2005, J NEUROPHYSIOL, V93, P1871, DOI 10.1152/jn.01053.2004; GALE SD, 2009, J CHEM NEUROANATOMY; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HILLIARD AH, 2009, SOC NEUR ABS; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jin H, 1997, NEURON, V19, P1049, DOI 10.1016/S0896-6273(00)80396-7; Johnson F, 2002, BEHAV BRAIN RES, V131, P57, DOI 10.1016/S0166-4328(01)00374-6; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Kojima S, 2009, J NEUROSCI, V29, P4782, DOI 10.1523/JNEUROSCI.4903-08.2009; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Luo MM, 1999, J NEUROSCI, V19, P6700; Luo MM, 2002, J NEUROPHYSIOL, V88, P1903, DOI 10.1152/jn.2002.88.4.1903; Luo MM, 1999, J COMP NEUROL, V403, P68; Markov A., 1971, EXTENSION LIMIT THEO, VVolume 1; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; Miller JE, 2008, J NEUROPHYSIOL, V100, P2015, DOI 10.1152/jn.90415.2008; NOWICKI S, 1991, CONDOR, V93, P1, DOI 10.2307/1368599; Overduin SA, 2006, J NEUROSCI, V26, P11888, DOI 10.1523/JNEUROSCI.1320-06.2006; PANAITOF SC, 2008, SOC NEUR ABS; Poopatanapong A, 2006, J NEUROBIOL, V66, P1613, DOI 10.1002/neu.20329; Rochefort C, 2007, DEV NEUROBIOL, V67, P809, DOI 10.1002/dneu.20393; Sakata JT, 2008, J NEUROPHYSIOL, V99, P1700, DOI 10.1152/jn.01296.2007; Sakata JT, 2009, J NEUROPHYSIOL, V102, P2485, DOI 10.1152/jn.00340.2009; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; Scharff C, 2004, ANN NY ACAD SCI, V1016, P325, DOI 10.1196/annals.1298.032; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Soha JA, 2001, J COMP PSYCHOL, V115, P172, DOI 10.1037//0735-7036.115.2.172; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Whitney O, 2005, J NEUROBIOL, V65, P251, DOI 10.1002/neu.20187; WOOLLEY SC, 2009, SOC NEUR ABS; Yanagihara S, 2006, EUR J NEUROSCI, V24, P3619, DOI 10.1111/j.1460-9568.2006.05228.x; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	72	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8592	10.1371/journal.pone.0008592	http://dx.doi.org/10.1371/journal.pone.0008592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066039	Green Published, gold			2022-12-25	WOS:000273338600015
J	Hliscs, M; Sattler, JM; Tempel, W; Artz, JD; Dong, AP; Hui, R; Matuschewski, K; Schuler, H				Hliscs, Marion; Sattler, Julia M.; Tempel, Wolfram; Artz, Jennifer D.; Dong, Aiping; Hui, Raymond; Matuschewski, Kai; Schuler, Herwig			Structure and Function of a G-actin Sequestering Protein with a Vital Role in Malaria Oocyst Development inside the Mosquito Vector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ASSOCIATED PROTEIN; N-TERMINAL DOMAIN; DICTYOSTELIUM-DISCOIDEUM; ADENYLATE-CYCLASE; CRYSTAL-STRUCTURE; SRV2/CAP COMPLEX; REGULATES ACTIN; CAP; OLIGOMERIZATION; PROFILIN	Cyclase-associated proteins (CAPs) are evolutionary conserved G-actin-binding proteins that regulate microfilament turnover. CAPs have a modular structure consisting of an N-terminal adenylate cyclase binding domain, a central proline-rich segment, and a C-terminal actin binding domain. Protozoan parasites of the phylum Apicomplexa, such as Cryptosporidium and the malaria parasite Plasmodium, express small CAP orthologs with homology to the C-terminal actin binding domain (C-CAP). Here, we demonstrate by reverse genetics that C-CAP is dispensable for the pathogenic Plasmodium blood stages. However, c-cap(-) parasites display a complete defect in oocyst development in the insect vector. By trans-species complementation we show that the Cryptosporidium parvum ortholog complements the Plasmodium gene functions. Purified recombinant C. parvum C-CAP protein binds actin monomers and prevents actin polymerization. The crystal structure of C. parvum C-CAP shows two monomers with a right-handed beta-helical fold intercalated at their C termini to form the putative physiological dimer. Our results reveal a specific vital role for an apicomplexan G-actin-binding protein during sporogony, the parasite replication phase that precedes formation of malaria transmission stages. This study also exemplifies how Plasmodium reverse genetics combined with biochemical and structural analyses of orthologous proteins can offer a fast track toward systematic gene characterization in apicomplexan parasites.	[Hliscs, Marion; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany; [Hliscs, Marion; Sattler, Julia M.; Matuschewski, Kai; Schuler, Herwig] Heidelberg Univ, Sch Med, Dept Parasitol, D-69120 Heidelberg, Germany; [Tempel, Wolfram; Artz, Jennifer D.; Dong, Aiping; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Max Planck Society; Ruprecht Karls University Heidelberg; University of Toronto; Structural Genomics Consortium; Karolinska Institutet	Matuschewski, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Charitepl 1, D-10117 Berlin, Germany.	matuschewski@mpiib-berlin.mpg.de; herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011; Artz, Jennifer/G-5515-2014	Schuler, Herwig/0000-0003-4059-3501; Matuschewski, Kai/0000-0001-6147-8591; Artz, Jennifer/0000-0003-0500-6156	Deutsche Forschungsgemeinschaft [SCHU1561/1-2]; European Commission [BioMalPar 23]; Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SCHU1561/1-2) (to H. S.), and by grants from the European Commission (BioMalPar 23), the Joachim Siebeneicher Foundation, and the Chica and Heinz Schaller Foundation (to K. M.).	Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 1996, MOL CELL BIOL, V16, P548; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; GIESELMANN R, 1992, FEBS LETT, V298, P149, DOI 10.1016/0014-5793(92)80043-G; Gottwald U, 1996, MOL BIOL CELL, V7, P261, DOI 10.1091/mbc.7.2.261; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Ksiazek D, 2003, STRUCTURE, V11, P1171, DOI 10.1016/S0969-2126(03)00180-1; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noegel AA, 1999, J CELL SCI, V112, P3195; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; SINDEN RE, 2005, MOL APPROACHES MALAR, P110; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361; Yusof AM, 2006, J MOL BIOL, V362, P1072, DOI 10.1016/j.jmb.2006.08.008; Yusof AM, 2005, PROTEINS, V58, P255, DOI 10.1002/prot.20314; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243	41	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11572	11583		10.1074/jbc.M109.054916	http://dx.doi.org/10.1074/jbc.M109.054916			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20083609	Green Published, hybrid			2022-12-25	WOS:000276286200063
J	Awad, S; Ryan, D; Prochasson, P; Owen-Hughes, T; Hassan, AH				Awad, Salma; Ryan, Daniel; Prochasson, Philippe; Owen-Hughes, Tom; Hassan, Ahmed H.			The Snf2 Homolog Fun30 Acts as a Homodimeric ATP-dependent Chromatin-remodeling Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATOR; DNA TRANSLOCATION; PROTEIN COMPLEXES; CHROMOSOME-I; HISTONE; NUCLEOSOME; BINDING; GENES; IDENTIFICATION	The Saccharomyces cerevisiae Fun30 (Function unknown now 30) protein shares homology with an extended family of Snf2-related ATPases. Here we report the purification of Fun30 principally as a homodimer with a molecular mass of about 250 kDa. Biochemical characterization of this complex reveals that it has ATPase activity stimulated by both DNA and chromatin. Consistent with this, it also binds to both DNA and chromatin. The Fun30 complex also exhibits activity in ATP-dependent chromatin remodeling assays. Interestingly, its activity in histone dimer exchange is high relative to the ability to reposition nucleosomes. Fun30 also possesses a weakly conserved CUE motif suggesting that it may interact specifically with ubiquitinylated proteins. However, in vitro Fun30 was found to have no specificity in its interaction with ubiquitinylated histones.	[Awad, Salma; Hassan, Ahmed H.] United Arab Emirates Univ, Dept Biochem, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Awad, Salma; Ryan, Daniel; Owen-Hughes, Tom] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Sch Life Sci, Dundee DD1 5EH, Scotland; [Prochasson, Philippe] Stowers Inst Med Res, Kansas City, MO 64110 USA	United Arab Emirates University; University of Dundee; Stowers Institute for Medical Research	Hassan, AH (corresponding author), United Arab Emirates Univ, Dept Biochem, Fac Med & Hlth Sci, POB 17666, Al Ain, U Arab Emirates.	ahmedh@uaeu.ac.ae	Hassan, Ahmed/AAB-7241-2019	Owen-Hughes, Tom/0000-0002-0618-8185; Ryan, Daniel/0000-0001-9842-2620; Al-Marzouqi, Ahmed/0000-0003-4586-5676; Mahmoud, Salma/0000-0003-1475-9483	United Arabs Emirates University Faculty of Medicine and Health Sciences [NP/05/14]; Terry Fox Funds for Cancer Research; Wellcome Trust [064414]	United Arabs Emirates University Faculty of Medicine and Health Sciences; Terry Fox Funds for Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by United Arabs Emirates University Faculty of Medicine and Health Sciences Grant NP/05/14, a grant from the Terry Fox Funds for Cancer Research (to A. H. H.), and by Wellcome Trust Senior Fellowship 064414 (to T. O.-H.).	Adra CN, 2000, GENOMICS, V69, P162, DOI 10.1006/geno.2000.6281; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; CLARK MW, 1992, YEAST, V8, P133, DOI 10.1002/yea.320080208; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2006, J BIOL CHEM, V281, P18126, DOI 10.1074/jbc.M602851200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Okazaki N, 2008, J MOL BIOL, V382, P257, DOI 10.1016/j.jmb.2008.07.031; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Racki LR, 2008, CURR OPIN GENET DEV, V18, P137, DOI 10.1016/j.gde.2008.01.007; SCHOOR M, 1993, DEV DYNAM, V197, P227, DOI 10.1002/aja.1001970307; Schoor M, 1999, MECH DEVELOP, V85, P73, DOI 10.1016/S0925-4773(99)00090-8; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; SOININEN R, 1992, MECH DEVELOP, V39, P111, DOI 10.1016/0925-4773(92)90030-N; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Thastrom A, 2004, BIOCHEMISTRY-US, V43, P736, DOI 10.1021/bi0302043; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004	38	55	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9477	9484		10.1074/jbc.M109.082149	http://dx.doi.org/10.1074/jbc.M109.082149			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20075079	Green Published, hybrid			2022-12-25	WOS:000276165900021
J	Courel, M; Soler-Jover, A; Rodriguez-Flores, JL; Mahata, SK; Elias, S; Montero-Hadjadje, M; Anouar, Y; Giuly, RJ; O'Connor, DT; Taupenot, L				Courel, Maiete; Soler-Jover, Alex; Rodriguez-Flores, Juan L.; Mahata, Sushil K.; Elias, Salah; Montero-Hadjadje, Maiete; Anouar, Youssef; Giuly, Richard J.; O'Connor, Daniel T.; Taupenot, Laurent			Pro-hormone Secretogranin II Regulates Dense Core Secretory Granule Biogenesis in Catecholaminergic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CHROMOGRANIN-A; REFLECTION FLUORESCENCE MICROSCOPY; NERVE GROWTH-FACTOR; PC12 CELLS; MEMBRANE-BINDING; NEUROPEPTIDE-Y; NEUROENDOCRINE CELLS; TARGETED ABLATION; VESICLE MEMBRANE; CHROMAFFIN CELLS	Processes underlying the formation of dense core secretory granules (DCGs) of neuroendocrine cells are poorly understood. Here, we present evidence that DCG biogenesis is dependent on the secretory protein secretogranin (Sg) II, a member of the granin family of pro-hormone cargo of DCGs in neuroendocrine cells. Depletion of SgII expression in PC12 cells leads to a decrease in both the number and size of DCGs and impairs DCG trafficking of other regulated hormones. Expression of SgII fusion proteins in a secretory-deficient PC12 variant rescues a regulated secretory pathway. SgII-containing dense core vesicles share morphological and physical properties with bona fide DCGs, are competent for regulated exocytosis, and maintain an acidic luminal pH through the V-type H+-translocating ATPase. The granulogenic activity of SgII requires a pH gradient along this secretory pathway. We conclude that SgII is a critical factor for the regulation of DCG biogenesis in neuroendocrine cells, mediating the formation of functional DCGs via its pH-dependent aggregation at the trans-Golgi network.	[Courel, Maiete; Soler-Jover, Alex; Rodriguez-Flores, Juan L.; Mahata, Sushil K.; O'Connor, Daniel T.; Taupenot, Laurent] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Courel, Maiete; Elias, Salah; Montero-Hadjadje, Maiete; Anouar, Youssef] Univ Rouen, INSERM, U982, F-76821 Mont St Aignan, France; [Giuly, Richard J.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Mahata, Sushil K.; O'Connor, Daniel T.; Taupenot, Laurent] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92093 USA	University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Courel, M (corresponding author), Univ Rouen, INSERM, U982, F-76821 Mont St Aignan, France.	mcourel@univ-rouen.fr; doconnor@ucsd.edu; ltaupenot@gmail.com	Mahata, Sushil/AAF-8781-2021; Rodriguez-Flores, Juan L/AAJ-7565-2020; Montero-Hadjadje, Maite/AAC-5692-2019; Anouar, Youssef/F-9683-2017	Rodriguez-Flores, Juan L/0000-0002-0394-8062; Montero-Hadjadje, Maite/0000-0001-8859-893X; Taupenot, Laurent/0000-0003-2316-3825; Elias, Salah/0000-0003-1005-438X	National Institutes of Health [HL58120, DK60702, DK59628]; Fondation pour la Recherche Medicale; National Kidney Foundation; Comissionat per Universitat I Recerca of the Departament d'Innovacio, Universitats i Empresa of the Autonomous Government of Catalonia; American Heart Association [0855181F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK059628, R01DK060702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Kidney Foundation; Comissionat per Universitat I Recerca of the Departament d'Innovacio, Universitats i Empresa of the Autonomous Government of Catalonia; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We appreciate the technical assistance of Timo Meerloo during the immunoelectron microscopy (laboratory of Marilyn Farquhar, University of California, San Diego). Digital imaging was performed at the Cancer Center Shared Resource Facilities (University of California, San Diego) and at the National Center for Microscopy and Imaging Research CMIR (funded in part by grants from the National Institutes of Health).; This work was supported, in whole or in part, by National Institutes of Health Grants HL58120, DK60702, and DK59628. This work was also supported by postdoctoral research fellowships from the Fondation pour la Recherche Medicale and the National Kidney Foundation (to M. C.), the Comissionat per Universitat I Recerca of the Departament d'Innovacio, Universitats i Empresa of the Autonomous Government of Catalonia (to A. S.-J.), and by American Heart Association Grant 0855181F.	Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; ASHLEY RH, 1994, EUR BIOPHYS J BIOPHY, V23, P263, DOI 10.1007/BF00213576; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; Brun C, 2006, FASEB J, V20, P732, DOI 10.1096/fj.05-4338fje; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CARNELL L, 1994, J CELL BIOL, V127, P693, DOI 10.1083/jcb.127.3.693; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Chen YQ, 2008, J AM COLL CARDIOL, V52, P1468, DOI 10.1016/j.jacc.2008.07.047; Corradi N, 1996, J BIOL CHEM, V271, P27116, DOI 10.1074/jbc.271.43.27116; Courel M, 2008, J BIOL CHEM, V283, P11807, DOI 10.1074/jbc.M709832200; Courel M, 2006, J BIOL CHEM, V281, P38038, DOI 10.1074/jbc.M604037200; D'Alessandro R, 2008, J NEUROCHEM, V105, P1369, DOI 10.1111/j.1471-4159.2008.05259.x; Day R, 2003, TRENDS ENDOCRIN MET, V14, P10, DOI 10.1016/S1043-2760(02)00011-5; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; El Meskini R, 2001, ENDOCRINOLOGY, V142, P864, DOI 10.1210/endo.142.2.7929; Eskeland NL, 1996, J CLIN INVEST, V98, P148, DOI 10.1172/JCI118760; FISCHERCOLBRIE R, 1987, ANN NY ACAD SCI, V493, P120, DOI 10.1111/j.1749-6632.1987.tb27189.x; Fisher RJ, 1999, PFLUG ARCH EUR J PHY, V437, P754, DOI 10.1007/s004240050842; GERDES HH, 1989, J BIOL CHEM, V264, P12009; GORR SU, 1988, BONE MINER, V4, P17; Grundschober C, 2002, J BIOL CHEM, V277, P36715, DOI 10.1074/jbc.M203777200; HAIGH JR, 1989, BIOCHEM J, V257, P499, DOI 10.1042/bj2570499; Han L, 2008, MOL ENDOCRINOL, V22, P1935, DOI 10.1210/me.2008-0006; Han WP, 1999, J NEUROSCI, V19, P900; Heidrich FM, 2008, CIRC RES, V102, P1230, DOI 10.1161/CIRCRESAHA.107.166033; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Hosaka M, 2004, J BIOL CHEM, V279, P3627, DOI 10.1074/jbc.M310104200; Hosaka M, 2002, MOL BIOL CELL, V13, P3388, DOI 10.1091/mbc.02-03-0040; Hotta K, 2009, J ENDOCRINOL, V202, P111, DOI 10.1677/JOE-08-0531; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; Inomoto C, 2007, J HISTOCHEM CYTOCHEM, V55, P487, DOI 10.1369/jhc.6A7110.2007; Kaipio K, 2005, BIOCHEM BIOPH RES CO, V337, P633, DOI 10.1016/j.bbrc.2005.09.093; Kaipio K, 2009, NEUROSCI LETT, V450, P181, DOI 10.1016/j.neulet.2008.11.018; Kim T, 2006, MOL BIOL CELL, V17, P789, DOI 10.1091/mbc.E05-08-0755; Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005; Kim T, 2002, ANN NY ACAD SCI, V971, P323, DOI 10.1111/j.1749-6632.2002.tb04487.x; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Mahapatra NR, 2008, BIOCHEMISTRY-US, V47, P7167, DOI 10.1021/bi7019996; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahapatra NR, 2004, J BIOL CHEM, V279, P51107, DOI 10.1074/jbc.M408742200; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Montero-Hadjadje M, 2009, J BIOL CHEM, V284, P12420, DOI 10.1074/jbc.M805607200; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; Morvan J, 2008, HISTOCHEM CELL BIOL, V129, P243, DOI 10.1007/s00418-008-0377-z; Mosley CA, 2007, BIOCHEMISTRY-US, V46, P10999, DOI 10.1021/bi700704r; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Pance A, 1999, J NEUROCHEM, V73, P21, DOI 10.1046/j.1471-4159.1999.0730021.x; Pance A, 2006, J NEUROCHEM, V99, P1435, DOI 10.1111/j.1471-4159.2006.04190.x; Park HY, 2002, BIOCHEMISTRY-US, V41, P1259, DOI 10.1021/bi0156963; Park JJ, 2008, MOL ENDOCRINOL, V22, P2583, DOI 10.1210/me.2008-0209; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Prasad P, 2008, J IMMUNOL, V181, P5024, DOI 10.4049/jimmunol.181.7.5024; Reaves BJ, 1996, J CELL SCI, V109, P749; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schoonderwoert VTG, 2000, EUR J BIOCHEM, V267, P5646, DOI 10.1046/j.1432-1327.2000.01648.x; Silva AP, 2003, REGUL PEPTIDES, V116, P71, DOI 10.1016/S0167-0115(03)00191-5; Stettler H, 2009, BIOCHEM J, V418, P81, DOI 10.1042/BJ20071382; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Tanaka S, 1997, J HISTOCHEM CYTOCHEM, V45, P425, DOI 10.1177/002215549704500310; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 2002, J CELL SCI, V115, P4827, DOI 10.1242/jcs.00140; TAUPENOT L, 2007, CURR PROTOC CELL B S, V36; Taylor CV, 2000, J BIOL CHEM, V275, P22905, DOI 10.1074/jbc.M001232200; TISCHLER AS, 1978, LAB INVEST, V39, P77; TOOZE SA, 1991, FEBS LETT, V285, P220, DOI 10.1016/0014-5793(91)80805-D; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; Tsuboi T, 2007, GENES CELLS, V12, P511, DOI 10.1111/j.1365-2443.2007.01070.x; TWISS JL, 1995, J NEUROCHEM, V64, P550; Urbe S, 1998, J CELL BIOL, V143, P1831, DOI 10.1083/jcb.143.7.1831; VIDEEN JS, 1992, J BIOL CHEM, V267, P3066; VOORBERG J, 1993, EMBO J, V12, P749, DOI 10.1002/j.1460-2075.1993.tb05709.x; Wen G, 2007, HUM MOL GENET, V16, P1752, DOI 10.1093/hmg/ddm123; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Xiong J, 2005, P ANN INT IEEE EMBS, P7529; Yajima A, 2008, J PEPT SCI, V14, P773, DOI 10.1002/psc.991; Yoo SH, 2007, BIOCHEMISTRY-US, V46, P14663, DOI 10.1021/bi701339m; YOO SH, 1995, BIOCHEMISTRY-US, V34, P8680, DOI 10.1021/bi00027a017; Yoo SH, 1996, J BIOL CHEM, V271, P17041, DOI 10.1074/jbc.271.29.17041; Yoo SH, 2002, J BIOL CHEM, V277, P16011, DOI 10.1074/jbc.M105594200; YOO SH, 1993, BIOCHEMISTRY-US, V32, P8213, DOI 10.1021/bi00083a023	87	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10030	10043		10.1074/jbc.M109.064196	http://dx.doi.org/10.1074/jbc.M109.064196			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20061385	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000276165900071
J	Shimada, M; Nakadai, T; Fukuda, A; Hisatake, K				Shimada, Miho; Nakadai, Tomoyoshi; Fukuda, Aya; Hisatake, Koji			cAMP-response Element-binding Protein (CREB) Controls MSK1-mediated Phosphorylation of Histone H3 at the c-fos Promoter in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; STRESS-INDUCED PHOSPHORYLATION; EARLY GENE INDUCTION; S6 KINASE-B; MAP KINASE; TRANSCRIPTIONAL ACTIVATION; CHROMOSOMAL-PROTEINS; DNA-BINDING; MITOTIC PHOSPHORYLATION; TARGET GENES	The rapid induction of the c-fos gene correlates with phosphorylations of histone H3 and HMGN1 by mitogen- and stress-activated protein kinases. We have used a cell-free system to dissect the mechanism by which MSK1 phosphorylates histone H3 within the c-fos chromatin. Here, we show that the reconstituted c-fos chromatin presents a strong barrier to histone H3 phosphorylation by MSK1; however, the activators (serum response factor, Elk-1, cAMP-response element-binding protein (CREB), and ATF1) bound on their cognate sites recruit MSK1 to phosphorylate histone H3 at Ser-10 within the chromatin. This activator-dependent phosphorylation of histone H3 is enhanced by HMGN1 and occurs preferentially near the promoter region. Among the four activators, CREB plays a predominant role in MSK1-mediated phosphorylation of histone H3, and the phosphorylation of Ser-133 in CREB is essential for this process. Mutational analyses of MSK1 show that its N-terminal inhibition domain is critical for the kinase to phosphorylate chromatin-embedded histone H3 in a CREB-dependent manner, indicating the presence of an intricate regulatory network for MSK1-mediated phosphorylation of histone H3.	[Shimada, Miho; Nakadai, Tomoyoshi] Saitama Med Univ, Dept Mol Biol, Fac Med, Saitama 3500495, Japan; [Fukuda, Aya; Hisatake, Koji] Univ Tsukuba, Dept Biochem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Fukuda, Aya; Hisatake, Koji] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan	Saitama Medical University; University of Tsukuba; University of Tsukuba	Hisatake, K (corresponding author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	kojihisa@md.tsukuba.ac.jp		Hisatake, Koji/0000-0002-5795-3115	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research (to M.S., T.N., A.F., and K.H.) and special coordination funds for promoting science and technology (to A. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; BARRATT MJ, 1994, P NATL ACAD SCI USA, V91, P4781, DOI 10.1073/pnas.91.11.4781; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DeManno DA, 1999, MOL ENDOCRINOL, V13, P91, DOI 10.1210/me.13.1.91; Ding HF, 1997, MOL CELL BIOL, V17, P5843, DOI 10.1128/MCB.17.10.5843; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Edmunds JW, 2006, SCIENCE, V313, P449, DOI 10.1126/science.1131158; EDWARDS DR, 1992, EMBO J, V11, P2415, DOI 10.1002/j.1460-2075.1992.tb05306.x; Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fukuda A, 2009, J BIOL CHEM, V284, P23472, DOI 10.1074/jbc.M109.013656; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; New L, 1999, J BIOL CHEM, V274, P1026, DOI 10.1074/jbc.274.2.1026; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; PARANJAPE SM, 1995, GENE DEV, V9, P1978, DOI 10.1101/gad.9.16.1978; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; POSTNIKOV YV, 1995, J MOL BIOL, V252, P423, DOI 10.1006/jmbi.1995.0508; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Prymakowska-Bosak M, 2001, MOL CELL BIOL, V21, P5169, DOI 10.1128/MCB.21.15.5169-5178.2001; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Sharma N, 2007, J BIOL CHEM, V282, P19872, DOI 10.1074/jbc.M701435200; Smith KJ, 2004, STRUCTURE, V12, P1067, DOI 10.1016/j.str.2004.02.040; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Tomas-Zuber M, 2001, J BIOL CHEM, V276, P5892, DOI 10.1074/jbc.M005822200; Tomas-Zuber M, 2000, J BIOL CHEM, V275, P23549, DOI 10.1074/jbc.M002586200; Trieschmann L, 1998, P NATL ACAD SCI USA, V95, P5468, DOI 10.1073/pnas.95.10.5468; TRIESCHMANN L, 1995, EMBO J, V14, P1478, DOI 10.1002/j.1460-2075.1995.tb07134.x; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099; Zhang Y, 2004, J BIOL CHEM, V279, P21866, DOI 10.1074/jbc.M400099200	72	20	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9390	9401		10.1074/jbc.M109.057745	http://dx.doi.org/10.1074/jbc.M109.057745			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089855	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000276165900011
J	Tsakraklides, V; Bell, SP				Tsakraklides, Vasiliki; Bell, Stephen P.			Dynamics of Pre-replicative Complex Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; XENOPUS EGG EXTRACTS; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; ATP-HYDROLYSIS; BUDDING YEAST; MCM PROTEINS; INITIATION PROTEINS; CELL-CYCLE; IN-VITRO	The pre-replicative complex (pre-RC) is formed at all potential origins of replication through the action of the origin recognition complex (ORC), Cdc6, Cdt1, and the Mcm2-7 complex. The end result of pre-RC formation is the loading of the Mcm2-7 replicative helicase onto origin DNA. We examined pre-RC formation in vitro and found that it proceeds through separable binding events. Origin-bound ORC recruits Cdc6, and this ternary complex then promotes helicase loading in the presence of a pre-formed Mcm2-7-Cdt1 complex. Using a stepwise pre-RC assembly assay, we investigated the fate of pre-RC components during later stages of the reaction. We determined that helicase loading is accompanied by dissociation of ORC, Cdc6, and Cdt1 from origin DNA. This dissociation requires ATP hydrolysis at a late stage of pre-RC assembly. Our results indicate that pre-RC formation is a dynamic process.	[Tsakraklides, Vasiliki; Bell, Stephen P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Bell, Stephen P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bell, SP (corresponding author), 77 Massachusetts Ave,Rm 68-630, Cambridge, MA 02139 USA.	spbell@mit.edu		Bell, Stephen/0000-0002-2876-610X; Tsakraklides, Vasiliki/0000-0003-1998-1075	National Institutes of Health [GM52339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52339 (to S.P.B.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1995, CURR OPIN GENET DEV, V5, P162, DOI 10.1016/0959-437X(95)80003-4; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gibson DG, 2006, GENES CELLS, V11, P557, DOI 10.1111/j.1365-2443.2006.00967.x; Kan JS, 2008, J BIOL CHEM, V283, P33803, DOI 10.1074/jbc.C800182200; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Rowles A, 1999, J CELL SCI, V112, P2011; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Waga S, 2006, J BIOL CHEM, V281, P10926, DOI 10.1074/jbc.M600299200	29	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9437	9443		10.1074/jbc.M109.072504	http://dx.doi.org/10.1074/jbc.M109.072504			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097898	hybrid, Green Published			2022-12-25	WOS:000276165900016
J	Pena, F; Jansens, A; van Zadelhoff, G; Braakman, I				Pena, Florentina; Jansens, Annemieke; van Zadelhoff, Guus; Braakman, Ineke			Calcium as a Crucial Cofactor for Low Density Lipoprotein Receptor Folding in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH REPEAT; FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS; PROTEIN-DISULFIDE-ISOMERASE; LIGAND-BINDING MODULES; LDL RECEPTOR; MONOCLONAL-ANTIBODIES; INTRACELLULAR-TRANSPORT; INFLUENZA HEMAGGLUTININ; 3-DIMENSIONAL STRUCTURE; QUALITY-CONTROL	The family of low density lipoprotein (LDL) receptors mediate uptake of a plethora of ligands from the circulation and couple this to signaling, thereby performing a crucial role in physiological processes including embryonic development, cancer development, homeostasis of lipoproteins, viral infection, and neuronal plasticity. Structural integrity of individual ectodomain modules in these receptors depends on calcium, and we showed before that the LDL receptor folds its modules late after synthesis via intermediates with abundant non-native disulfide bonds and structure. Using a radioactive pulse-chase approach, we here show that for proper LDL receptor folding, calcium had to be present from the very early start of folding, which suggests at least some native, essential coordination of calcium ions at the still largely non-native folding phase. As long as the protein was in the endoplasmic reticulum (ER), its folding was reversible, which changed only upon both proper incorporation of calcium and exit from the ER. Coevolution of protein folding with the high calcium concentration in the ER may be the basis for the need for this cation throughout the folding process even though calcium is only stably integrated in native repeats at a later stage.	[Pena, Florentina; Jansens, Annemieke; van Zadelhoff, Guus; Braakman, Ineke] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Utrecht University	Braakman, I (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	i.braakman@uu.nl	Jansens, A./L-4409-2015; van Zadelhoff, Guus/F-2260-2010	Pena, Florentina/0000-0002-7127-9219; Braakman, Ineke/0000-0003-1592-4364	Netherlands Heart Foundation; EuroSCOPE; Netherlands Organization for Scientific Research-Chemical Division; Federation of European Biochemical Societies and Marie Curie	Netherlands Heart Foundation(Netherlands Heart Foundation); EuroSCOPE; Netherlands Organization for Scientific Research-Chemical Division; Federation of European Biochemical Societies and Marie Curie	This work was supported by grants from The Netherlands Heart Foundation (to I. B. and A.J.), EuroSCOPE (to I. B. and F. P.), The Netherlands Organization for Scientific Research-Chemical Division (to I. B. and F. P.), and Federation of European Biochemical Societies and Marie Curie (to F. P.).	Abdul-Aziz D, 2005, BIOCHEMISTRY-US, V44, P5075, DOI 10.1021/bi047575j; Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BAUMANN O, 1991, P NATL ACAD SCI USA, V88, P741, DOI 10.1073/pnas.88.3.741; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BIERI S, 1995, FEBS LETT, V371, P341, DOI 10.1016/0014-5793(95)00939-7; Bieri S, 1998, BIOCHEMISTRY-US, V37, P10994, DOI 10.1021/bi980452c; Biswas C, 2007, BIOCHEM J, V405, P233, DOI 10.1042/BJ20061867; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Boswell EJ, 2004, J BIOL CHEM, V279, P30611, DOI 10.1074/jbc.M401412200; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1974, SCIENCE, V185, P61, DOI 10.1126/science.185.4145.61; Chandrashekar R, 1998, P NATL ACAD SCI USA, V95, P531, DOI 10.1073/pnas.95.2.531; Combettes L, 1996, EMBO J, V15, P2086, DOI 10.1002/j.1460-2075.1996.tb00562.x; Conte IL, 2007, BIOCHEMISTRY-US, V46, P4671, DOI 10.1021/bi6026456; Cooper GR, 1997, BIOCHEM J, V325, P601, DOI 10.1042/bj3250601; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; Corbett EF, 2000, J BIOL CHEM, V275, P27177; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Guest PC, 1997, BIOCHEM J, V323, P445, DOI 10.1042/bj3230445; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jansens Annemieke, 2003, Methods Mol Biol, V232, P133; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; JOSEPH SK, 1986, J BIOL CHEM, V261, P4658; KITA T, 1981, P NATL ACAD SCI-BIOL, V78, P2268, DOI 10.1073/pnas.78.4.2268; Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; LODISH HF, 1992, J BIOL CHEM, V267, P12753; Lucero HA, 1999, J BIOL CHEM, V274, P3243, DOI 10.1074/jbc.274.5.3243; MACER DRJ, 1988, J CELL SCI, V91, P61; Malby S, 2001, BIOCHEMISTRY-US, V40, P2555, DOI 10.1021/bi002322l; May Petra, 2003, Sci STKE, V2003, pPE12, DOI 10.1126/stke.2003.176.pe12; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Nguyen AT, 2006, J LIPID RES, V47, P1399, DOI 10.1194/jlr.M600130-JLR200; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Nuss JE, 2008, BIOCHEM BIOPH RES CO, V365, P355, DOI 10.1016/j.bbrc.2007.10.194; Obermoeller LM, 1998, J BIOL CHEM, V273, P22374, DOI 10.1074/jbc.273.35.22374; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; PFEIFFER DR, 1976, BIOCHEMISTRY-US, V15, P935, DOI 10.1021/bi00650a001; Pieren M, 2005, J BIOL CHEM, V280, P28265, DOI 10.1074/jbc.M501020200; Rancy PC, 2008, BIOCHEMISTRY-US, V47, P12047, DOI 10.1021/bi801604x; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SCHNEIDER WJ, 1979, P NATL ACAD SCI USA, V76, P5577, DOI 10.1073/pnas.76.11.5577; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SHORT AD, 1993, J BIOL CHEM, V268, P25887; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TSE FW, 1994, P NATL ACAD SCI USA, V91, P9750, DOI 10.1073/pnas.91.21.9750; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; VANROGGEN JFG, 1995, ARTERIOSCL THROM VAS, V15, P765, DOI 10.1161/01.ATV.15.6.765; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yu XM, 2003, J VIROL, V77, P7517, DOI 10.1128/JVI.77.13.7517-7526.2003	75	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8656	8664		10.1074/jbc.M110.105718	http://dx.doi.org/10.1074/jbc.M110.105718			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089850	Green Published, hybrid			2022-12-25	WOS:000275553700018
J	Cote, MC; Lavoie, JR; Houle, F; Poirier, A; Rousseau, S; Huot, J				Cote, Maxime C.; Lavoie, Jessie R.; Houle, Francois; Poirier, Andree; Rousseau, Simon; Huot, Jacques			Regulation of Vascular Endothelial Growth Factor-induced Endothelial Cell Migration by LIM Kinase 1-mediated Phosphorylation of Annexin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; METASTASIS-ASSOCIATED PROTEINS; P38 MAP KINASE; FOCAL ADHESION KINASE; ACTIN-BASED MOTILITY; CANCER-CELLS; RECEPTOR; ANGIOGENESIS; STRESS; IDENTIFICATION	In this study, we obtained evidence indicating that annexin 1 is a new target of the p38/MAPKAP kinase-2 pathway and that it regulates endothelial cell migration in response to vascular endothelial growth factor (VEGF). These conclusions are supported by a series of substantiating experiments. First, by two-dimensional gel electrophoresis and mass spectrometry, we identified annexin 1 as a protein whose phosphorylation is induced by VEGF and is impaired by inhibiting p38. Second, using in vitro kinase assays and in vivo phosphorylation assays, we found that VEGF-mediated activation of LIM kinase 1 downstream of the p38 pathway triggers the phosphorylation of annexin 1. Third, VEGF-induced cell migration and tube formation in Matrigel are inhibited following small interfering RNA-mediated knockdown of annexin 1. Fourth, both processes are rescued in cells expressing an annexin 1 construct insensitive to the small interfering RNA knockdown. Finally, the VEGF/annexin 1-mediated cell migration is impaired by inhibiting p38. We therefore conclude that phosphorylation of annexin 1 regulates the angiogenic effect that is associated with the activation of the p38/LIM kinase 1 axis by VEGF.	[Cote, Maxime C.; Lavoie, Jessie R.; Houle, Francois; Poirier, Andree; Huot, Jacques] Univ Laval, Canc Res Ctr, Quebec City, PQ G1R 2J6, Canada; [Rousseau, Simon] McGill Univ, Meakins Inst, Montreal, PQ H2X 2P2, Canada	Laval University; McGill University	Huot, J (corresponding author), Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Hotel Dieu Quebec,Canc Res Ctr, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	Jacques.Huot@fmed.ulaval.ca	Rousseau, Simon/A-1800-2009	Rousseau, Simon/0000-0002-8773-575X	The Canadian Institutes of Health Research; Heart Stroke Foundation of Canada	The Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from The Canadian Institutes of Health Research and the Heart Stroke Foundation of Canada (Qc).	Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; CAMPOSGONZALEZ R, 1990, CELL MOTIL CYTOSKEL, V15, P34, DOI 10.1002/cm.970150106; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; Endo M, 2003, J NEUROSCI, V23, P2527; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; HUOT J, 1995, EUR J BIOCHEM, V227, P416, DOI 10.1111/j.1432-1033.1995.tb20404.x; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Jiang DF, 2003, PROTEOMICS, V3, P724, DOI 10.1002/pmic.200300411; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Liao SH, 2009, PROTEOMICS, V9, P3901, DOI 10.1002/pmic.200800922; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Ritchie RH, 2005, BRIT J PHARMACOL, V145, P495, DOI 10.1038/sj.bjp.0706211; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Roviezzo F, 2002, J PHYSIOL PHARMACOL, V53, P541; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Skouteris GG, 1996, J BIOL CHEM, V271, P27266, DOI 10.1074/jbc.271.44.27266; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; Taher MM, 2000, BIOCHEMISTRY-US, V39, P1709, DOI 10.1021/bi9921079; Tong QS, 2006, EXP CELL RES, V312, P3559, DOI 10.1016/j.yexcr.2006.07.024; Traverso V, 1998, J CELL SCI, V111, P1405; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100	53	35	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8013	8021		10.1074/jbc.M109.098665	http://dx.doi.org/10.1074/jbc.M109.098665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061392	hybrid, Green Published			2022-12-25	WOS:000275413800019
J	Hsu, MF; Meng, TC				Hsu, Ming-Fo; Meng, Tzu-Ching			Enhancement of Insulin Responsiveness by Nitric Oxide-mediated Inactivation of Protein-tyrosine Phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; RAT SKELETAL-MUSCLE; S-NITROSYLATION; IN-VIVO; REVERSIBLE OXIDATION; GLUCOSE-TRANSPORT; MICE LACKING; RESISTANCE; SYNTHASE; HYPERTENSION	NO synthesis is a prerequisite for proper insulin sensitivity in insulin-targeted tissues; however, the molecular basis for this process remains unclear. Using a gain-of-function model of endothelial nitric-oxide synthase (eNOS)-transfected COS-7 cells, we have shown a critical role of NO in insulin responsiveness, as evidenced by an NO-dependent increase of tyrosine phosphorylation levels of the insulin receptor and its downstream effectors insulin receptor substrate-1 and PKB/AKT. We hypothesized that NO-induced inactivation of endogenous protein-tyrosine phosphatases (PTPs) would enhance insulin receptor-mediated signaling. To test this hypothesis, we devised a new method of the PTP labeling using a cysteine sulfhydryl-reacted probe. Under the acidic conditions employed in this study, the probe recognized the reduced and active forms but not the S-nitrosylated and inactive forms of endogenous PTPs. Our data suggest that phosphatases SHP-1, SHP-2, and PTP1B, but not TC-PTP, are likely S-nitrosylated at the active site cysteine residue concomitantly with a burst of NO production in signaling response to insulin stimulation. These results were further confirmed by phosphatase activity assays. We investigated further the role of NO as a regulator of insulin signaling by RNA interference that ablates endogenous eNOS expression in endothelial MS-1 cells. We have shown that eNOS-dependent NO production is essential for the activation of insulin signaling. Our findings demonstrate that NO mediates enhancement of insulin responsiveness via the inhibition of insulin receptor phosphatases.	[Meng, Tzu-Ching] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; Natl Taiwan Univ, Coll Life Sci, Taiwan & Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Meng, TC (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	tcmeng@gate.sinica.edu.tw	Meng, Tzu-Ching/G-5426-2019	Meng, Tzu-Ching/0000-0001-7693-2021	Taiwan National Science Council [97-3112-B-002-005, 98-3112-B-001-028]; Academia Sinica	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Taiwan National Science Council Grants 97-3112-B-002-005 and 98-3112-B-001-028). This work was also supported by funding from Academia Sinica (to T.-C. M.).	Asante-Appiah E, 2003, AM J PHYSIOL-ENDOC M, V284, pE663, DOI 10.1152/ajpendo.00462.2002; Balon TW, 1997, J APPL PHYSIOL, V82, P359, DOI 10.1152/jappl.1997.82.1.359; BARON AD, 1995, AM J PHYSIOL-ENDOC M, V269, pE709, DOI 10.1152/ajpendo.1995.269.4.E709; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; CASELLI A, 1994, J BIOL CHEM, V269, P24878; Chen YY, 2007, METHODS, V42, P243, DOI 10.1016/j.ymeth.2007.03.002; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Engeli S, 2004, J LIPID RES, V45, P1640, DOI 10.1194/jlr.M300322-JLR200; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Higaki Y, 2001, DIABETES, V50, P241, DOI 10.2337/diabetes.50.2.241; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kuncewicz T, 2003, MOL CELL PROTEOMICS, V2, P156, DOI 10.1074/mcp.M300003-MCP200; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Ouwens DM, 2001, MOL CELL ENDOCRINOL, V175, P131, DOI 10.1016/S0303-7207(01)00389-6; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Tang SG, 2001, DIABETES, V50, P83, DOI 10.2337/diabetes.50.1.83; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Young ME, 1997, BIOCHEM J, V322, P223, DOI 10.1042/bj3220223; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012	42	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7919	7928		10.1074/jbc.M109.057513	http://dx.doi.org/10.1074/jbc.M109.057513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064934	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000275413800009
J	Hu, W; Xu, RJ; Sun, W; Szulc, ZM; Bielawski, J; Obeid, LM; Mao, CG				Hu, Wei; Xu, Ruijuan; Sun, Wei; Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui			Alkaline Ceramidase 3 (ACER3) Hydrolyzes Unsaturated Long-chain Ceramides, and Its Down-regulation Inhibits Both Cell Proliferation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; MOLECULAR-CLONING; ACID CERAMIDASE; FUNCTIONAL-CHARACTERIZATION; MITOCHONDRIAL CERAMIDASE; SACCHAROMYCES-CEREVISIAE; FARBER-DISEASE; CANCER CELLS; SPHINGOSINE; GENERATION	Ceramides with different fatty acyl chains may vary in their physiological or pathological roles; however, it remains unclear how cellular levels of individual ceramide species are regulated. Here, we demonstrate that our previously cloned human alkaline ceramidase 3 (ACER3) specifically controls the hydrolysis of ceramides carrying unsaturated long acyl chains, unsaturated long-chain (ULC) ceramides. In vitro, ACER3 only hydrolyzed C-18:1-, C-20:1-, C-20:4-ceramides, dihydroceramides, and phytoceramides. In cells, ACER3 overexpression decreased C-18:1- and C-20:1-ceramides and dihydroceramides, whereas ACER3 knockdown by RNA interference had the opposite effect, suggesting that ACER3 controls the catabolism of ULC ceramides and dihydroceramides. ACER3 knockdown inhibited cell proliferation and up-regulated the cyclin-dependent kinase inhibitor p21(CIP1/WAF1). Blocking p21(CIP1/WAF1) up-regulation attenuated the inhibitory effect of ACER3 knockdown on cell proliferation, suggesting that ACER3 knockdown inhibits cell proliferation because of p21(CIP1/WAF1) up-regulation. ACER3 knockdown inhibited cell apoptosis in response to serum deprivation. ACER3 knockdown up-regulated the expression of the alkaline ceramidase 2 (ACER2), and the ACER2 up-regulation decreased non-ULC ceramide species while increasing both sphingosine and its phosphate. Collectively, these data suggest that ACER3 catalyzes the hydrolysis of ULC ceramides and dihydroceramides and that ACER3 coordinates with ACER2 to regulate cell proliferation and survival.	[Mao, Cungui] Med Univ S Carolina, Div Gen Internal Med, Dept Med, Charleston, SC 29425 USA; [Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Hosp, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mao, CG (corresponding author), Med Univ S Carolina, Div Gen Internal Med, Dept Med, 114 Doughty St,Rm 646,STB,POB 250779, Charleston, SC 29425 USA.	maoc@musc.edu	xu, rui/GRX-5734-2022	obeid, lina/0000-0002-0734-0847	National Institutes of Health [P20RR017677, R01CA104834, R01GM062887]; Veterans Affairs Merit award; NATIONAL CANCER INSTITUTE [R01CA104834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR017677 (to C.M.), R01CA104834 (to C.M.), and R01GM062887 (to L.M.O.). This work was also supported by a Veterans Affairs Merit award (to L.M.O.).	Alesse E, 1998, CELL DEATH DIFFER, V5, P381, DOI 10.1038/sj.cdd.4400358; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; CHEN WW, 1982, BIOCHIM BIOPHYS ACTA, V718, P185, DOI 10.1016/0304-4165(82)90218-5; Colombaioni L, 2002, NEUROCHEM INT, V40, P327, DOI 10.1016/S0197-0186(01)00090-0; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Ehlert Karoline, 2007, Pediatr Rheumatol Online J, V5, P15; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 1999, J BIOL CHEM, V274, P27948, DOI 10.1074/jbc.274.39.27948; el Bawab Samer, 2002, Subcell Biochem, V36, P187; Furland NE, 2007, J BIOL CHEM, V282, P18141, DOI 10.1074/jbc.M700708200; Hanna AN, 2001, MOL BIOL CELL, V12, P3618, DOI 10.1091/mbc.12.11.3618; Holman DH, 2008, CANCER CHEMOTH PHARM, V61, P231, DOI 10.1007/s00280-007-0465-0; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; Jafrezou JP, 2001, FASEB J, V15, P123, DOI 10.1096/fj.00-0305com; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Magnoni C, 2002, TOXICOL IN VITRO, V16, P349, DOI 10.1016/S0887-2333(02)00024-3; Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876; Mao CG, 2001, J BIOL CHEM, V276, P26577, DOI 10.1074/jbc.M102818200; Mao CG, 2003, J BIOL CHEM, V278, P31184, DOI 10.1074/jbc.M303875200; Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; MOMOI T, 1982, BIOCHEM J, V205, P419, DOI 10.1042/bj2050419; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Phillips DC, 2007, CELL DEATH DIFFER, V14, P1780, DOI 10.1038/sj.cdd.4402198; Plummer G, 2005, BIOCHEM J, V385, P685, DOI 10.1042/BJ20040929; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Usta J, 2001, BIOCHEMISTRY-US, V40, P9657, DOI 10.1021/bi010535k; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wang J, 2007, WORLD J GASTROENTERO, V13, P1129, DOI 10.3748/wjg.v13.i7.1129; Wassall SR, 2008, CHEM PHYS LIPIDS, V153, P57, DOI 10.1016/j.chemphyslip.2008.02.010; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	42	63	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7964	7976		10.1074/jbc.M109.063586	http://dx.doi.org/10.1074/jbc.M109.063586			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068046	hybrid, Green Published			2022-12-25	WOS:000275413800014
J	Mejias-Luque, R; Linden, SK; Garrido, M; Tye, H; Najdovska, M; Jenkins, BJ; Iglesias, M; Ernst, M; de Bolos, C				Mejias-Luque, R.; Linden, S. K.; Garrido, M.; Tye, H.; Najdovska, M.; Jenkins, B. J.; Iglesias, M.; Ernst, M.; de Bolos, C.			Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors	ONCOGENE			English	Article						gastric tumors; intestinal mucins; inflammatory cytokines; IL-6/gp130	LEWIS ANTIGEN-EXPRESSION; GP130 MUTANT MICE; CANCER-CELLS; HELICOBACTER-PYLORI; HUMAN STOMACH; KAPPA-B; MUC5AC; ACTIVATION; CARCINOMA; GROWTH	Infection of gastric mucosa by Helicobacter pylori induces an inflammatory response with increased levels of proinflammatory cytokines. Among them, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta and IL-6 induce the activation of signaling pathways that regulate genes expression, such as MUC2 and MUC4 intestinal mucins ectopically detected in gastric tumors. This study evaluated if the predominant inflammatory cell type correlates with MUC2 and MUC4 expression in human intestinal gastric tumors (n = 78). In addition, we analyzed the regulatory effects of the associated inflammatory signaling pathways on their expression in gastric cancer cell lines, and in a mouse model with hyperactivated STAT3 signaling pathway. Tumors with predominant lymphoplasmocytic infiltrate (chronic inflammation), presented higher levels of MUC2 and were more differentiated than tumors with predominant polymorphonuclear infiltrate (acute inflammation). These differences can be attributed to specific cytokines, because TNF-alpha and IL-1 beta induced MUC2 but no MUC4 expression in gastric cancer cell lines. The two groups of tumors expressed similar levels of MUC4 that correlated with the expression of STAT3 transcription factor, implicated in the activation of genes through the IL-6 pathway. In gastric tissues from gp130(+/+), gp130(Y757F/Y757F) and gp130(Y757F/Y757F) Stat3(-/+) mice, Muc2 was not detected, whereas Muc4 was found in the gastric tumors developed in the gp130(Y757F/Y757F) mice, with hyperactivated STAT3. These data indicate that the signaling pathways associated with the inflammatory response can modulate the expression of MUC2 and MUC4 intestinal mucin genes, in human and mouse gastric tumors. Oncogene (2010) 29, 1753-1762; doi:10.1038/onc.2009.467; published online 11 January 2010	[Mejias-Luque, R.; Garrido, M.; Iglesias, M.; de Bolos, C.] IMIM Hosp Mar, Programa Recerca Canc, Barcelona 08003, Spain; [Linden, S. K.] Gothenburg Univ, Sahlgrenska Acad, Mucosal Immunobiol & Vaccine Ctr, Gothenburg, Sweden; [Tye, H.; Najdovska, M.; Jenkins, B. J.] Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Gothenburg; Monash University	de Bolos, C (corresponding author), IMIM Hosp Mar, Programa Recerca Canc, Parc Recerca Biomed Barcelona,Dr Aiguader 88, Barcelona 08003, Spain.	cbolos@imim.es	Ernst, Matthias/D-5111-2012; jenkins, brendan/J-7854-2012; Lindén, Sara K/A-3271-2011	Ernst, Matthias/0000-0002-6399-1177; Lindén, Sara K/0000-0002-7751-9586; Jenkins, Brendan/0000-0002-7552-4656; Mejias-Luque, Raquel/0000-0002-4602-4927	Marato de TV3 [050930]; Instituto de Investigacion Carlos III [PI061421]; Swedish Cancer Foundation and Research Counsil (Cancerfonden and Vetenskapsradet); Jeansson foundation; Sylvia and Charles Viertel Charitable Foundation; Monash University; Cancer Council of Victoria; Association for International Cancer Research	Marato de TV3; Instituto de Investigacion Carlos III(Instituto de Salud Carlos III); Swedish Cancer Foundation and Research Counsil (Cancerfonden and Vetenskapsradet); Jeansson foundation; Sylvia and Charles Viertel Charitable Foundation; Monash University(Monash University); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Association for International Cancer Research	We thank the scientists providing the antibodies, Sergi Mojal for statistical analysis, and M Pera, A Dalmases, P Navarro and J Gunnarsson for helpful contributions. This work was supported by Marato de TV3 (050930), Instituto de Investigacion Carlos III (PI061421), the Swedish Cancer Foundation and Research Counsil (Cancerfonden and Vetenskapsradet) and the Jeansson foundation, Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship, Monash University Fellowship, Cancer Council of Victoria Grant-in-aid, and the Association for International Cancer Research Grant awarded to BJJ.	Ahn DH, 2005, CELL PHYSIOL BIOCHEM, V15, P29, DOI 10.1159/000083636; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; DEBOLOS C, 1995, GASTROENTEROLOGY, V109, P723, DOI 10.1016/0016-5085(95)90379-8; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gartner F, 1996, VIRCHOWS ARCH, V428, P91; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Jackson CB, 2007, J PATHOL, V213, P140, DOI 10.1002/path.2218; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Judd LM, 2006, GASTROENTEROLOGY, V131, P1073, DOI 10.1053/j.gastro.2006.07.018; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim DY, 2004, PHARMACOLOGY, V72, P6, DOI 10.1159/000078626; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Leung WK, 2002, J PATHOL, V197, P582, DOI 10.1002/path.1147; Lidell ME, 2008, FEBS J, V275, P481, DOI 10.1111/j.1742-4658.2007.06215.x; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Lopez-Ferrer A, 2000, GUT, V47, P349, DOI 10.1136/gut.47.3.349; Lopez-Ferrer A, 2002, GLYCOCONJUGATE J, V19, P13, DOI 10.1023/A:1022576712961; Lopez-Ferrer A, 2001, AM J RESP CELL MOL, V24, P22, DOI 10.1165/ajrcmb.24.1.4294; Matsuda K, 2008, SCAND J GASTROENTERO, V43, P25, DOI 10.1080/00365520701579795; Mejias-Luque R, 2008, BBA-MOL CELL RES, V1783, P1728, DOI 10.1016/j.bbamcr.2008.05.020; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Piessen G, 2007, BIOCHEM J, V402, P81, DOI 10.1042/BJ20061461; Reis CA, 1999, CANCER RES, V59, P1003; Sell S., 2001, IMMUNOLOGY IMMUNOPAT; Senapati S, 2008, HISTOL HISTOPATHOL, V23, P1541, DOI 10.14670/HH-23.1541; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Yakata Y, 2007, INT J ONCOL, V30, P437; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	33	56	58	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2010	29	12					1753	1762		10.1038/onc.2009.467	http://dx.doi.org/10.1038/onc.2009.467			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20062084				2022-12-25	WOS:000276022800005
J	Hill, EW; Gu, JJ; Eivers, SS; Fonseca, RG; McGivney, BA; Govindarajan, P; Orr, N; Katz, LM; MacHugh, D				Hill, Emmeline W.; Gu, Jingjing; Eivers, Suzanne S.; Fonseca, Rita G.; McGivney, Beatrice A.; Govindarajan, Preethi; Orr, Nick; Katz, Lisa M.; MacHugh, David			A Sequence Polymorphism in MSTN Predicts Sprinting Ability and Racing Stamina in Thoroughbred Horses	PLOS ONE			English	Article							TOOL	Variants of the MSTN gene encoding myostatin are associated with muscle hypertrophy phenotypes in a range of mammalian species, most notably cattle, dogs, mice, and humans. Using a sample of registered Thoroughbred horses (n = 148), we have identified a novel MSTN sequence polymorphism that is strongly associated (g.66493737C>T, P = 4.85 x 10(-8)) with best race distance among elite racehorses (n = 79). This observation was independently validated (P = 1.91 x 10(-6)) in a resampled group of Thoroughbreds (n = 62) and in a cohort of Thoroughbreds (n = 37, P = 0.0047) produced by the same trainer. We observed that C/C horses are suited to fast, short-distance races; C/T horses compete favorably in middle-distance races; and T/T horses have greater stamina. Evaluation of retrospective racecourse performance (n = 142) and stallion progeny performance predict that C/C and C/T horses are more likely to be successful two-year-old racehorses than T/T animals. Here we describe for the first time the identification of a gene variant in Thoroughbred racehorses that is predictive of genetic potential for an athletic phenotype.	[Hill, Emmeline W.; Gu, Jingjing; Eivers, Suzanne S.; Fonseca, Rita G.; McGivney, Beatrice A.; Govindarajan, Preethi; Orr, Nick; Katz, Lisa M.; MacHugh, David] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Anim Genom Lab, Dublin 2, Ireland; [MacHugh, David] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Hill, EW (corresponding author), Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Anim Genom Lab, Dublin 2, Ireland.	emmeline.hill@ucd.ie		MacHugh, David/0000-0002-8112-4704; Katz, Lisa/0000-0001-5547-2089; Garcia da Fonseca, Rita/0000-0003-2249-1608; Hill, Emmeline/0000-0002-1805-2250	Science Foundation Ireland [04-YI1-B539]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work has been financed by a Science Foundation Ireland, President of Ireland Young Researcher Award (04-YI1-B539) to EWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Gunn HM, 1987, EQUINE EXERCISE PHYS, V2; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; PURCELL S, PLINK VERSION 1 05; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 2001, MOL CLONING LAB MANU; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; van Baren MJ, 2004, BIOINFORMATICS, V20, P591, DOI 10.1093/bioinformatics/btg473; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; WEATHERBY S, 1791, INTRO GEN STUD BOOK	16	134	151	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8645	10.1371/journal.pone.0008645	http://dx.doi.org/10.1371/journal.pone.0008645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098749	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000004
J	Lu, CR; Ding, F; Ke, AL				Lu, Changrui; Ding, Fang; Ke, Ailong			Crystal Structure of the S. solfataricus Archaeal Exosome Reveals Conformational Flexibility in the RNA-Binding Ring	PLOS ONE			English	Article							MESSENGER-RNAS; YEAST EXOSOME; ENDONUCLEOLYTIC CLEAVAGE; NUCLEAR SURVEILLANCE; QUALITY-CONTROL; RIBOSOMAL-RNA; DEGRADATION; EXPRESSION; COMPLEXES; RECONSTITUTION	Background: The exosome complex is an essential RNA 3'-end processing and degradation machinery. In archaeal organisms, the exosome consists of a catalytic ring and an RNA-binding ring, both of which were previously reported to assume three-fold symmetry. Methodology/Principal Findings: Here we report an asymmetric 2.9 angstrom Sulfolobus solfataricus archaeal exosome structure in which the three-fold symmetry is broken due to combined rigid body and thermal motions mainly within the RNA-binding ring. Since increased conformational flexibility was also observed in the RNA-binding ring of the related bacterial PNPase, we speculate that this may reflect an evolutionarily conserved mechanism to accommodate diverse RNA substrates for degradation. Conclusion/Significance: This study clearly shows the dynamic structures within the RNA-binding domains, which provides additional insights on mechanism of asymmetric RNA binding and processing.	[Lu, Changrui; Ding, Fang; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lu, CR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ailong.ke@cornell.edu		Lu, Changrui/0000-0002-2171-9888	Cornell MBG	Cornell MBG	Funding: This study is supported by Cornell MBG department grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrios A, 2007, METHODS, V41, P271, DOI 10.1016/j.ymeth.2006.08.007; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evguenieva-Hackenberg E, 2003, EMBO REP, V4, P889, DOI 10.1038/sj.embor.embor929; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Hieronymus H, 2004, GENE DEV, V18, P2652, DOI 10.1101/gad.1241204; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Ke A, 2004, METHODS, V34, P408, DOI 10.1016/j.ymeth.2004.03.027; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2007, EMBO REP, V8, P470, DOI 10.1038/sj.embor.7400945; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Lorentzen E, 2008, METHOD ENZYMOL, V447, P417, DOI 10.1016/S0076-6879(08)02220-9; Makarova KS, 2005, CURR OPIN MICROBIOL, V8, P586, DOI 10.1016/j.mib.2005.08.003; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Navarro MVAS, 2008, J BIOL CHEM, V283, P14120, DOI 10.1074/jbc.M801005200; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Portnoy V, 2005, EMBO REP, V6, P1188, DOI 10.1038/sj.embor.7400571; Selleck W, 2008, CURR PROTOC PROTEIN, DOI DOI 10.1002/0471140864.PS0521S52; Shi ZH, 2008, RNA, V14, P2361, DOI 10.1261/rna.1244308; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vasudevan S, 2003, CURR OPIN CELL BIOL, V15, P332, DOI 10.1016/S0955-0674(03)00051-6; Walter P, 2006, MOL MICROBIOL, V62, P1076, DOI 10.1111/j.1365-2958.2006.05393.x	51	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8739	10.1371/journal.pone.0008739	http://dx.doi.org/10.1371/journal.pone.0008739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090900	Green Published, gold, Green Submitted			2022-12-25	WOS:000273714900019
J	Vandorpe, DH; Xu, C; Shmukler, BE; Otterbein, LE; Trudel, M; Sachs, F; Gottlieb, PA; Brugnara, C; Alper, SL				Vandorpe, David H.; Xu, Chang; Shmukler, Boris E.; Otterbein, Leo E.; Trudel, Marie; Sachs, Frederick; Gottlieb, Philip A.; Brugnara, Carlo; Alper, Seth L.			Hypoxia Activates a Ca2+-Permeable Cation Conductance Sensitive to Carbon Monoxide and to GsMTx-4 in Human and Mouse Sickle Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; CA2+-ACTIVATED K+ TRANSPORT; CALCIUM-CHELATOR ESTERS; TRANSGENIC SAD MICE; GARDOS CHANNEL; DISEASE; DEHYDRATION; DEOXYGENATION; FLUXES; INHIBITION	Background: Deoxygenation of sickle erythrocytes activates a cation permeability of unknown molecular identity (Psickle), leading to elevated intracellular [Ca2+] ([Ca2+](i)) and subsequent activation of K-Ca 3.1. The resulting erythrocyte volume decrease elevates intracellular hemoglobin S (HbSS) concentration, accelerates deoxygenation-induced HbSS polymerization, and increases the likelihood of cell sickling. Deoxygenation-induced currents sharing some properties of Psickle have been recorded from sickle erythrocytes in whole cell configuration. Methodology/Principal Findings: We now show by cell-attached and nystatin-permeabilized patch clamp recording from sickle erythrocytes of mouse and human that deoxygenation reversibly activates a Ca2+- and cation-permeable conductance sensitive to inhibition by Grammastola spatulata mechanotoxin-4 (GsMTx-4; 1 mu M), dipyridamole (100 mu M), DIDS (100 mu M), and carbon monoxide (25 ppm pretreatment). Deoxygenation also elevates sickle erythrocyte [Ca2+](i), in a manner similarly inhibited by GsMTx-4 and by carbon monoxide. Normal human and mouse erythrocytes do not exhibit these responses to deoxygenation. Deoxygenation-induced elevation of [Ca2+](i) in mouse sickle erythrocytes did not require KCa3.1 activity. Conclusions/Significance: The electrophysiological and fluorimetric data provide compelling evidence in sickle erythrocytes of mouse and human for a deoxygenation-induced, reversible, Ca2+- permeable cation conductance blocked by inhibition of HbSS polymerization and by an inhibitor of strctch-activated cation channels. This cation permeability pathway is likely an important source of intracellular Ca2+ for pathologic activation of KCa3.1 in sickle erythrocytes. Blockade of this pathway represents a novel therapeutic approach for treatment of sickle disease.	[Vandorpe, David H.; Xu, Chang; Shmukler, Boris E.; Alper, Seth L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Mol & Vasc Med Unit, Boston, MA 02215 USA; [Vandorpe, David H.; Xu, Chang; Shmukler, Boris E.; Alper, Seth L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Renal, Boston, MA 02215 USA; [Otterbein, Leo E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Brugnara, Carlo] Harvard Univ, Childrens Hosp Boston, Sch Med, Dept Lab Med, Boston, MA 02215 USA; [Vandorpe, David H.; Xu, Chang; Shmukler, Boris E.; Alper, Seth L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Brugnara, Carlo] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Trudel, Marie] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Sachs, Frederick; Gottlieb, Philip A.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Vandorpe, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Mol & Vasc Med Unit, Boston, MA 02215 USA.	salper@bidmc.harvard.edu	Brugnara, Carlo/A-8041-2010; Gottlieb, Philip/C-3113-2019	Brugnara, Carlo/0000-0001-8192-8713; Gottlieb, Philip/0000-0003-3764-9885; Xu, Chang/0000-0002-5524-4550; Trudel, Marie/0000-0003-0057-2669	NIH [HL077765, HL15157, HL071797]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887, R01HL077765, R01HL071797, P60HL015157] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was funded by NIH grants HL077765, HL15157, and HL071797. Additional funding was provided by the Julie Henry Fund at the Transplant Institute of Beth Israel Deaconess Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akel A, 2007, AM J PHYSIOL-CELL PH, V292, pC1759, DOI 10.1152/ajpcell.00158.2006; Alcantara RE, 2007, P NATL ACAD SCI USA, V104, P18451, DOI 10.1073/pnas.0706026104; ALPER SL, 2008, BLOOD CELLS MOL DIS; Andrews DA, 2002, BLOOD, V100, P3392, DOI 10.1182/blood.V100.9.3392; Ataga KI, 2008, BLOOD, V111, P3991, DOI 10.1182/blood-2007-08-110098; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Bennekou P, 2006, BLOOD CELL MOL DIS, V36, P10, DOI 10.1016/j.bcmd.2005.10.004; Bennekou P, 2003, J MEMBRANE BIOL, V195, P1, DOI 10.1007/s00232-003-2036-6; BOOKCHIN RM, 1984, J LAB CLIN MED, V104, P855; Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030; Browning JA, 2007, BLOOD, V109, P2622, DOI 10.1182/blood-2006-03-001404; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; BRUGNARA C, 1993, J BIOL CHEM, V268, P8760; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Brugnara C, 2001, DRUG NEWS PERSPECT, V14, P208, DOI 10.1358/dnp.2001.14.4.858404; Christoph GW, 2005, BIOPHYS J, V88, P1371, DOI 10.1529/biophysj.104.051250; DEFRANCESCHI L, 1994, J CLIN INVEST, V93, P1670, DOI 10.1172/JCI117149; Duranton C, 2002, J PHYSIOL-LONDON, V539, P847, DOI 10.1113/jphysiol.2001.013040; Ellory JC, 2008, BLOOD CELL MOL DIS, V41, P44, DOI 10.1016/j.bcmd.2008.03.003; ETZION Z, 1993, J CLIN INVEST, V92, P2489, DOI 10.1172/JCI116857; Fang J, 2006, NEUROSCI LETT, V404, P213, DOI 10.1016/j.neulet.2006.05.059; FOLLER M, 2008, IUBMB LIFE; GARCIASANCHO J, 1985, BIOCHIM BIOPHYS ACTA, V813, P148, DOI 10.1016/0005-2736(85)90357-8; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; HALPERIN JA, 1989, AM J PHYSIOL, V257, pC986, DOI 10.1152/ajpcell.1989.257.5.C986; Hankins JS, 2008, BRIT J HAEMATOL, V140, P80, DOI 10.1111/j.1365-2141.2007.06884.x; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; Hsu K, 2009, BLOOD, V114, P1919, DOI 10.1182/blood-2008-12-195180; JOINER CH, 1993, AM J PHYSIOL, V264, pC251, DOI 10.1152/ajpcell.1993.264.2.C251; Joiner CH, 2001, BLOOD, V97, P3976, DOI 10.1182/blood.V97.12.3976; JOINER CH, 1995, AM J PHYSIOL-CELL PH, V269, pC403, DOI 10.1152/ajpcell.1995.269.2.C403; JOINER CH, 1990, BLOOD, V76, P212; JOINER CH, 1988, BLOOD CELLS, V13, P339; JOINER CH, 1993, AM J PHYSIOL, V264, pC734, DOI 10.1152/ajpcell.1993.264.3.C734; Joiner CH, 2008, BLOOD, V111, P3918, DOI 10.1182/blood-2008-01-135350; Kaestner L, 2004, THROMB HAEMOSTASIS, V92, P1269, DOI 10.1160/TH04-06-0338; Kiefmann R, 2008, BLOOD, V111, P5205, DOI 10.1182/blood-2007-09-113902; Lew VL, 2007, BLOOD, V110, P1334, DOI 10.1182/blood-2006-11-057232; Lew VL, 2005, PHYSIOL REV, V85, P179, DOI 10.1152/physrev.00052.2003; Lew VL, 1997, J CLIN INVEST, V99, P2727, DOI 10.1172/JCI119462; Lew VL, 2002, BLOOD, V99, P2578, DOI 10.1182/blood.V99.7.2578; MAHAUTSMITH MP, 1995, J PHYSIOL-LONDON, V484, P15, DOI 10.1113/jphysiol.1995.sp020644; MERYMAN HT, 1991, VOX SANG, V60, P88, DOI 10.1111/j.1423-0410.1991.tb00880.x; MERYMAN HT, 1991, VOX SANG, V60, P99, DOI 10.1111/j.1423-0410.1991.tb00881.x; MOZZARELLI A, 1987, SCIENCE, V237, P500, DOI 10.1126/science.3603036; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; Rivera A, 2007, AM J PHYSIOL-CELL PH, V293, pC960, DOI 10.1152/ajpcell.00530.2006; Romero JR, 1997, J MEMBRANE BIOL, V159, P187, DOI 10.1007/s002329900282; Romero PJ, 2003, CELL BIOL INT, V27, P903, DOI 10.1016/j.cellbi.2003.07.002; ROSSI JPFC, 1981, BIOCHIM BIOPHYS ACTA, V648, P145, DOI 10.1016/0005-2736(81)90029-8; Rust MB, 2007, J CLIN INVEST, V117, P1708, DOI 10.1172/JCI30630; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Steinberg MH, 2006, TRENDS PHARMACOL SCI, V27, P204, DOI 10.1016/j.tips.2006.02.007; Steinberg MH, 2003, ANNU REV MED, V54, P89, DOI 10.1146/annurev.med.54.101601.152439; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; TIFFERT T, 1984, BIOCHIM BIOPHYS ACTA, V773, P143, DOI 10.1016/0005-2736(84)90559-5; Tiffert T, 1997, J PHYSIOL-LONDON, V505, P403, DOI 10.1111/j.1469-7793.1997.403bb.x; Tiffert T, 2001, CELL CALCIUM, V30, P337, DOI 10.1054/ceca.2001.0241; Tiffert T, 2007, J GEN PHYSIOL, V129, P429, DOI 10.1085/jgp.200709766; TRUDEL M, 1994, BLOOD, V84, P3189; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	67	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8732	10.1371/journal.pone.0008732	http://dx.doi.org/10.1371/journal.pone.0008732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090940	gold, Green Published, Green Submitted			2022-12-25	WOS:000273714900013
J	Aruna, M; Nagaraja, T; Andal, S; Tarakeswari, S; Sirisha, PVS; Reddy, AG; Thangaraj, K; Singh, L; Reddy, BM				Aruna, Meka; Nagaraja, Theeya; Andal, Sadaranga; Tarakeswari, Surapaneni; Sirisha, Pisapati V. S.; Reddy, Alla G.; Thangaraj, Kumarasamy; Singh, Lalji; Reddy, B. Mohan			Role of Progesterone Receptor Polymorphisms in the Recurrent Spontaneous Abortions: Indian Case	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; GENE POLYMORPHISM; IMPLANTATION FAILURE; UTERINE FIBROIDS; DYDROGESTERONE; PROGINS; ASSOCIATION; MISCARRIAGE; PREGNANCY; DEFECTS	Background: We attempt to ascertain if the 3 linked single nucleotide polymorphisms (SNPs) of the Progesterone Receptor (PR) gene (exon 1: G 1031 C; S344T, exon 4: G 1978 T; L660V and exon 5: C 2310 T; H770H) and the PROGINS insertion in the intron G, between exons 7 and 8, are associated with Recurrent Spontaneous Abortion (RSA) in the Indian population. Methodology/Principal Findings: A total of 143 women with RSA and 150 controls were sequenced for all the 8 exons looking for the above 3 linked SNPs of the PR gene earlier implicated in the RSA, as well as for any new SNPs that may be possibly found in the Indian population. PROGINS insertion was screened by electrophoresis. We did not find any new mutations, not observed earlier, in our population. Further, we did not find significant role of the *2 allele (representing the mutant allele at the three SNP loci) or the T2 allele (PROGINS insertion) in the manifestation of RSA. We also did not find an LD pattern between each of the 3 SNPs and the PROGINS insertion. Conclusions/Significance: The results suggest that the PR gene mutations may not play any exclusive role in the manifestation of RSA, and instead, given significantly higher frequency of the *2 allele among the normal women, we surmise if it does not really confer a protective role among the Indian populations, albeit further studies are required in the heterogeneous populations of this region before making any conclusive statement.	[Aruna, Meka; Nagaraja, Theeya; Sirisha, Pisapati V. S.; Reddy, B. Mohan] Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India; [Andal, Sadaranga] Lakshmi Fertil Clin & Res Ctr, Nellore, Andhra Pradesh, India; [Tarakeswari, Surapaneni] Fernandez Hosp, Hyderabad, Andhra Pradesh, India; [Reddy, Alla G.; Thangaraj, Kumarasamy; Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Statistical Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Aruna, M (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in	Thangaraj, Kumarasamy/G-5596-2010	Thangaraj, Kumarasamy/0000-0002-0075-0106	Indian Statistical Institute	Indian Statistical Institute	This project was funded by Indian Statistical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babalioglu R, 1996, J ASSIST REPROD GEN, V13, P306, DOI 10.1007/BF02070143; BARRETT JC, 2005, BIOINFORMATICS; Beever CL, 2003, AM J HUM GENET, V72, P399, DOI 10.1086/346119; Bouchard P, 1999, J REPROD MED, V44, P153; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; Chakravarty BN, 2005, J STEROID BIOCHEM, V97, P416, DOI 10.1016/j.jsbmb.2005.08.012; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; Coulam CB, 2008, J ASSIST REPROD GEN, V25, P119, DOI 10.1007/s10815-008-9210-9; Cramer DW, 2003, AM J OBSTET GYNECOL, V189, P1085, DOI 10.1067/S0002-9378(03)00517-9; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; El-Zibdeh MY, 2005, J STEROID BIOCHEM, V97, P431, DOI 10.1016/j.jsbmb.2005.08.007; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fernandez-Valdivia R, 2005, SEMIN REPROD MED, V23, P22, DOI 10.1055/s-2005-864031; Govindan S., 2007, Cancer Biomarkers, V3, P73; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Gruber CJ, 2005, J STEROID BIOCHEM, V97, P426, DOI 10.1016/j.jsbmb.2005.08.009; Hickman TN, 2002, FERTIL STERIL, V77, P1001, DOI 10.1016/S0015-0282(02)02953-9; Kieback D. G., 1998, J SOC GYNECOL INVEST, V5, P40; Kurz C, 2001, J SOC GYNECOL INVEST, V8, P295, DOI 10.1016/S1071-5576(01)00123-X; Lanasa MC, 2000, SEMIN REPROD MED, V18, P97, DOI 10.1055/s-2000-13480; LIRA S, 2000, MED SCI MONITOR, V6, P759; Luo G, 2008, REPROD SCI, V15, P147, DOI 10.1177/1933719107310990; MISRAHI M, 1987, BIOCHEM BIOPH RES CO, V143, P740, DOI 10.1016/0006-291X(87)91416-1; MISRAHI M, 1993, BIOCHIM BIOPHYS ACTA, V1216, P289, DOI 10.1016/0167-4781(93)90156-8; Omar MH, 2005, J STEROID BIOCHEM, V97, P421, DOI 10.1016/j.jsbmb.2005.08.013; PEPE GJ, 1995, ENDOCR REV, V16, P608, DOI 10.1210/er.16.5.608; Pisarska MD, 2003, FERTIL STERIL, V80, P651, DOI 10.1016/S0015-0282(03)00755-6; Reddy BM, 2005, HUM BIOL, V77, P803, DOI 10.1353/hub.2006.0018; REISS HE, 1998, REPROD MED A Z; ROUSSEAUMERCK MF, 1987, HUM GENET, V77, P280, DOI 10.1007/BF00284486; Sambrook J., 2002, MOL CLONING LAB MANU; Schweikert A, 2004, EUR J OBSTET GYN R B, V113, P67, DOI 10.1016/j.ejogrb.2003.04.002; Szekeres-Bartho J, 2001, SEMIN IMMUNOL, V13, P229, DOI 10.1006/smim.2000.0318; Szekeres-Bartho J, 2008, HUM REPROD UPDATE, V14, P27, DOI 10.1093/humupd/dmm035; Tong D, 2001, INT J CANCER, V95, P394, DOI 10.1002/1097-0215(20011120)95:6&lt;394::AID-IJC1070&gt;3.0.CO;2-X; Gomes MTV, 2007, FERTIL STERIL, V87, P1116, DOI 10.1016/j.fertnstert.2006.08.099	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8712	10.1371/journal.pone.0008712	http://dx.doi.org/10.1371/journal.pone.0008712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090851	Green Published, Green Submitted, gold			2022-12-25	WOS:000273714600015
J	Nold-Petry, CA; Lehrnbecher, T; Jarisch, A; Schwabe, D; Pfeilschifter, JM; Muhl, H; Nold, MF				Nold-Petry, Claudia A.; Lehrnbecher, Thomas; Jarisch, Andrea; Schwabe, Dirk; Pfeilschifter, Josef M.; Muhl, Heiko; Nold, Marcel F.			Failure of Interferon gamma to Induce the Anti-Inflammatory Interleukin 18 Binding Protein in Familial Hemophagocytosis	PLOS ONE			English	Article							CD8(+) T-CELLS; PERFORIN EXPRESSION; CUTTING EDGE; IFN-GAMMA; LYMPHOHISTIOCYTOSIS; VIRUS; GENE; CYTOKINES; IL-18; TH1	Background: Familial hemophagocytosis (FHL) is a rare disease associated with defects in proteins involved in CD8(+) T-cell cytotoxicity. Hyperactivation of immune cells results in a perilous, Th1-driven cytokine storm. We set out to explore the regulation of cytokines in an FHL patient who was clinically stable on low-dose immunosuppressive therapy after bone marrow transplantation over a six-month period. During this period, chimerism analyses showed that the fraction of host cells was between 1 and 10%. Both parents of the patient as well as healthy volunteers were studied for comparison. Methods/Principal Findings: Using ELISA, quantitative real-time PCR, and clinical laboratory methods, we investigated constitutive and inducible cytokines, polymorphisms, and clinical parameters in whole blood and whole blood cultures. Although routine laboratory tests were within the normal range, the chemokines IP-10 and IL-8 as well as the cytokine IL-27p28 were increased up to 10-fold under constitutive and stimulated conditions compared to healthy controls. Moreover, high levels of IFN gamma and TNF alpha were produced upon stimulation. Unexpectedly, IFNc induction of IL-18 binding protein (IL-18BP) was markedly reduced (1.6-fold vs 5-fold in controls). The patient's mother featured intermediately increased cytokine levels, whereas levels in the father were similar to those in the controls. Conclusions/Significance: Since IL-18 plays a major role in perpetuating hemophagocytosis, the failure of IFNc to induce IL-18BP may constitute a fundamental pathogenetic mechanism. Furthermore, increased production of IL-8 and IL-27 appears to be associated with this disease. Such dysregulation of cytokines was also found in the heterozygous parents, providing a novel insight into genotype-phenotype correlation of FHL which may encourage future research of this rare disease.	[Nold-Petry, Claudia A.; Pfeilschifter, Josef M.; Muhl, Heiko; Nold, Marcel F.] Johann Wolfgang Goethe Univ Hosp, Pharmazentrum Frankfurt, Frankfurt, Germany; [Lehrnbecher, Thomas; Jarisch, Andrea; Schwabe, Dirk] Johann Wolfgang Goethe Univ Hosp, Dept Pediat, Frankfurt, Germany; [Nold-Petry, Claudia A.; Nold, Marcel F.] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Nold-Petry, CA (corresponding author), Johann Wolfgang Goethe Univ Hosp, Pharmazentrum Frankfurt, Frankfurt, Germany.	mfnold@hotmail.com		Nold, Marcel/0000-0001-9682-4618; Nold, Claudia/0000-0002-7439-3834	Deutsche Forschungsgemeinschaft [Mu1284/3-2, 747/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants Mu1284/3-2 (Deutsche Forschungsgemeinschaft) to Dr. Muhl and No747/1-1 to Dr. Nold. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN M, 2008, J CELL MOL MED; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Baz EMK, 2002, THER APHER, V6, P159, DOI 10.1046/j.1526-0968.2002.00362.x; Busiello R, 2004, BLOOD, V103, P4610, DOI 10.1182/blood-2003-10-3551; Caballes RL, 1997, PATHOLOGY, V29, P92, DOI 10.1080/00313029700169644; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; COTE M, 2009, J CLIN INVEST; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; FARQUHAR JW, 1952, ARCH DIS CHILD, V27, P519, DOI 10.1136/adc.27.136.519; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Henter JI, 2002, BLOOD, V100, P2367, DOI 10.1182/blood-2002-01-0172; HENTER JI, 1991, BLOOD, V78, P2918, DOI 10.1182/blood.V78.11.2918.2918; Henter JI, 1997, MED PEDIATR ONCOL, V28, P342, DOI 10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.3.CO;2-Y; Hsieh SM, 2006, J IMMUNOL, V176, P4530, DOI 10.4049/jimmunol.176.8.4530; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; ISHII E, 1991, ACTA HAEMATOL-BASEL, V85, P93; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kaser A, 2002, CLIN EXP IMMUNOL, V129, P332, DOI 10.1046/j.1365-2249.2002.01911.x; Katano H, 2005, BRIT J HAEMATOL, V128, P739, DOI 10.1111/j.1365-2141.2004.05305.x; Kogawa K, 2002, BLOOD, V99, P61, DOI 10.1182/blood.V99.1.61; Kono T, 1997, J PERIODONTOL, V68, P1223, DOI 10.1902/jop.1997.68.12.1223; Lehrnbecher T, 2005, LEUKEMIA, V19, P1745, DOI 10.1038/sj.leu.2403922; Lehrnbecher Thomas, 2003, Methods Mol Biol, V215, P71; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; Muralitharan S, 2007, AM J HEMATOL, V82, P1099, DOI 10.1002/ajh.21009; Novick D, 2009, J CLIN IMMUNOL, V29, P38, DOI 10.1007/s10875-008-9217-0; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; NOVICK D, 2009, J AUTOIMMUN; Osugi Y, 1997, BLOOD, V89, P4100, DOI 10.1182/blood.V89.11.4100; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Smith VP, 2000, J GEN VIROL, V81, P1223, DOI 10.1099/0022-1317-81-5-1223; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Sullivan KE, 1998, PEDIATR RES, V44, P465, DOI 10.1203/00006450-199810000-00001; Takada H, 1999, BRIT J HAEMATOL, V106, P182, DOI 10.1046/j.1365-2141.1999.01504.x; Takada H, 2001, LEUKEMIA LYMPHOMA, V42, P21, DOI 10.3109/10428190109097673; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tamura K, 2008, PEDIATR BLOOD CANCER, V51, P662, DOI 10.1002/pbc.21660	38	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8663	10.1371/journal.pone.0008663	http://dx.doi.org/10.1371/journal.pone.0008663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072626	Green Published, Green Submitted, gold			2022-12-25	WOS:000273554600016
J	Fraser, HB; Schadt, EE				Fraser, Hunter B.; Schadt, Eric E.			The Quantitative Genetics of Phenotypic Robustness	PLOS ONE			English	Article							NATURAL ALLELIC VARIATION; ARABIDOPSIS-THALIANA; TRAIT LOCI; DEVELOPMENTAL STABILITY; DROSOPHILA-MELANOGASTER; FLUCTUATING ASYMMETRY; POPULATION-STRUCTURE; CANALIZATION; HSP90; EVOLVABILITY	Phenotypic robustness, or canalization, has been extensively investigated both experimentally and theoretically. However, it remains unknown to what extent robustness varies between individuals, and whether factors buffering environmental variation also buffer genetic variation. Here we introduce a quantitative genetic approach to these issues, and apply this approach to data from three species. In mice, we find suggestive evidence that for hundreds of gene expression traits, robustness is polymorphic and can be genetically mapped to discrete genomic loci. Moreover, we find that the polymorphisms buffering genetic variation are distinct from those buffering environmental variation. In fact, these two classes have quite distinct mechanistic bases: environmental buffers of gene expression are predominantly sex-specific and trans-acting, whereas genetic buffers are not sex-specific and often cis-acting. Data from studies of morphological and life-history traits in plants and yeast support the distinction between polymorphisms buffering genetic and environmental variation, and further suggest that loci buffering different types of environmental variation do overlap with one another. These preliminary results suggest that naturally occurring polymorphisms affecting phenotypic robustness could be abundant, and that these polymorphisms may generally buffer either genetic or environmental variation, but not both.	[Fraser, Hunter B.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Schadt, Eric E.] Univ Washington, Dept Med Genet, Seattle, WA 98195 USA	Stanford University; University of Washington; University of Washington Seattle	Fraser, HB (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	hbfraser@stanford.edu; eschadt@pacificbiosciences.com			Merck	Merck(Merck & Company)	The study was funded by Merck (http://www.merck.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Alonso-Blanco C, 1998, GENETICS, V149, P749; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Borevitz JO, 2002, GENETICS, V160, P683; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; Cooper TF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-237; Donnelly SM, 1999, AM J PHYS ANTHROPOL, V108, P507, DOI 10.1002/(SICI)1096-8644(199904)108:4<507::AID-AJPA8>3.0.CO;2-0; Dworkin I, 2005, EVOLUTION, V59, P1500; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Gibson G, 2007, CURR BIOL, V17, pR929, DOI 10.1016/j.cub.2007.08.044; Hall MC, 2007, P NATL ACAD SCI USA, V104, P13717, DOI 10.1073/pnas.0701936104; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Houle D, 1998, GENETICA, V102-3, P241, DOI 10.1023/A:1017034925212; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Leamy LJ, 1998, HEREDITY, V80, P509, DOI 10.1046/j.1365-2540.1998.00320.x; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Li Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000105; Mackay TFC, 2005, PHILOS T R SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; MCKENZIE JA, 1988, GENETICS, V120, P213; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Milton CC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000075; Nogami S, 2007, PLOS GENET, V3, P305, DOI 10.1371/journal.pgen.0030031; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; VanderSchaar W, 1997, HEREDITY, V79, P190, DOI 10.1038/sj.hdy.6881880; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Wong JS, 2002, TOXICOL APPL PHARM, V185, P180, DOI 10.1006/taap.2002.9540	33	50	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8635	10.1371/journal.pone.0008635	http://dx.doi.org/10.1371/journal.pone.0008635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072615	Green Submitted, gold, Green Published			2022-12-25	WOS:000273414200013
J	Lluis, JM; Nachbur, U; Cook, WD; Gentle, IE; Moujalled, D; Moulin, M; Wong, WWL; Khan, N; Chau, D; Callus, BA; Vince, JE; Silke, J; Vaux, DL				Lluis, Josep Maria; Nachbur, Ulrich; Cook, Wendy Diane; Gentle, Ian Edward; Moujalled, Donia; Moulin, Maryline; Wong, Wendy Wei-Lynn; Khan, Nufail; Chau, Diep; Callus, Bernard Andrew; Vince, James Edward; Silke, John; Vaux, David Lawrence			TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-kappa B Dependent Induction of cFLIPL	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; C-FLIP; CANCER CELLS; CASPASE-8 ACTIVATION; SIGNALING PATHWAYS; TERMINAL KINASE; DOWN-REGULATION; EXPRESSION; DEATH; INHIBITION	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known as a "death ligand"-a member of the TNF superfamily that binds to receptors bearing death domains. As well as causing apoptosis of certain types of tumor cells, TRAIL can activate both NF-kappa B and JNK signalling pathways. To determine the role of TGF-beta-Activated Kinase-1 (TAK1) in TRAIL signalling, we analyzed the effects of adding TRAIL to mouse embryonic fibroblasts (MEFs) derived from TAK1 conditional knockout mice. TAK1-/- MEFs were significantly more sensitive to killing by TRAIL than wild-type MEFs, and failed to activate NF-kappa B or JNK. Overexpression of IKK2-EE, a constitutive activator of NF-kappa B, protected TAK1-/- MEFs against TRAIL killing, suggesting that TAK1 activation of NF-kappa B is critical for the viability of cells treated with TRAIL. Consistent with this model, TRAIL failed to induce the survival genes cIAP2 and cFlipL in the absence of TAK1, whereas activation of NF-kappa B by IKK2-EE restored the levels of both proteins. Moreover, ectopic expression of cFlipL, but not cIAP2, in TAK1-/- MEFs strongly inhibited TRAIL-induced cell death. These results indicate that cells that survive TRAIL treatment may do so by activation of a TAK1-NF-kappa B pathway that drives expression of cFlipL, and suggest that TAK1 may be a good target for overcoming TRAIL resistance.	[Lluis, Josep Maria; Nachbur, Ulrich; Cook, Wendy Diane; Gentle, Ian Edward; Moujalled, Donia; Moulin, Maryline; Wong, Wendy Wei-Lynn; Khan, Nufail; Chau, Diep; Silke, John; Vaux, David Lawrence] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia; [Callus, Bernard Andrew] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, Australia; [Vince, James Edward] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	La Trobe University; University of Western Australia; University of Lausanne	Lluis, JM (corresponding author), La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia.	D.Vaux@latrobe.edu.au	Silke, John/B-7622-2008; Gentle, Ian/X-2888-2019; Wong, W. Wei-Lynn/A-6851-2015; Cook, Wendy/N-7506-2019; Vaux, David L/C-7249-2013	Silke, John/0000-0002-7611-5774; Gentle, Ian/0000-0002-6707-7809; Wong, W. Wei-Lynn/0000-0003-3155-1211; Vaux, David L/0000-0003-2703-1651; Nachbur, Ueli/0000-0001-5968-2235; Moulin, Maryline/0000-0002-1851-8727	Leukemia and Lymphoma Society; National Health and Medical Research Council [461221]	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work has been funded by the Leukemia and Lymphoma Society, and National Health and Medical Research Council grant #461221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Beraza N, 2009, J EXP MED, V206, P1727, DOI 10.1084/jem.20082152; Bullani RR, 2001, J INVEST DERMATOL, V117, P360, DOI 10.1046/j.0022-202x.2001.01418.x; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Choo MK, 2006, MOL CANCER THER, V5, P2970, DOI 10.1158/1535-7163.MCT-06-0379; Clarke P, 2007, APOPTOSIS, V12, P211, DOI 10.1007/s10495-006-0528-4; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Djerbi M, 2001, SCAND J IMMUNOL, V54, P180, DOI 10.1046/j.1365-3083.2001.00941.x; Geserick P, 2008, ONCOGENE, V27, P3211, DOI 10.1038/sj.onc.1210985; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Harper N, 2001, J BIOL CHEM, V276, P34743, DOI 10.1074/jbc.M105693200; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Kumar-Sinha C, 2002, J BIOL CHEM, V277, P575, DOI 10.1074/jbc.M107795200; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Morioka S, 2009, ONCOGENE, V28, P2257, DOI 10.1038/onc.2009.110; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Noutomi T, 2009, ONCOL REP, V22, P1169, DOI 10.3892/or_00000551; Okano H, 2003, LAB INVEST, V83, P1033, DOI 10.1097/01.LAB.0000079328.76631.28; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Remmelink M, 2005, INT J ONCOL, V26, P247; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Ryu BK, 2001, J PATHOL, V194, P15, DOI 10.1002/path.835; Safwat N, 2005, ENDOCRINOLOGY, V146, P4814, DOI 10.1210/en.2005-0457; Sah NK, 2003, J BIOL CHEM, V278, P20593, DOI 10.1074/jbc.M211010200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Siegmund D, 2002, MOL MED, V8, P725, DOI 10.1007/BF03402036; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang P, 2007, CELL SIGNAL, V19, P2237, DOI 10.1016/j.cellsig.2007.06.001; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585	42	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8620	10.1371/journal.pone.0008620	http://dx.doi.org/10.1371/journal.pone.0008620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062539	Green Published, Green Accepted, gold			2022-12-25	WOS:000273414200001
J	Smyth, DS; McDougal, LK; Gran, FW; Manoharan, A; Enright, MC; Song, JH; de Lencastre, H; Robinson, DA				Smyth, Davida S.; McDougal, Linda K.; Gran, Frode W.; Manoharan, Anand; Enright, Mark C.; Song, Jae-Hoon; de Lencastre, Herminia; Robinson, D. Ashley			Population Structure of a Hybrid Clonal Group of Methicillin-Resistant Staphylococcus aureus, ST239-MRSA-III	PLOS ONE			English	Article							RAPID IDENTIFICATION; EVOLUTIONARY HISTORY; MOLECULAR EVOLUTION; GEOGRAPHIC SPREAD; 2 HOSPITALS; MEC; CHROMOSOME; EPIDEMIC; STRAINS; EMERGENCE	The methicillin-resistant Staphylococcus aureus (MRSA) clonal group known as ST239-MRSA-III is notable for its hybrid origin and for causing sustained hospital epidemics worldwide since the late 1970s. We studied the population structure of this MRSA clonal group using a sample of 111 isolates that were collected over 34 years from 29 countries. Genetic variation was assessed using typing methods and novel ascertainment methods, resulting in approximately 15 kb of sequence from 32 loci for all isolates. A single most parsimonious tree, free of homoplasy, partitioned 28 haplotypes into geographically associated clades, including prominent European, Asian, and South American clades. The rate of evolution was estimated to be approximately 100x faster than standard estimates for bacteria, and dated the most recent common ancestor of these isolates to the mid-20th century. Associations were discovered between the ST239 phylogeny and the ccrB and dru loci of the methicillin resistance genetic element, SCCmec type III, but not with the accessory components of the element that are targeted by multiplex PCR subtyping tools. In summary, the evolutionary history of ST239 can be characterized by rapid clonal diversification that has left strong evidence of geographic and temporal population structure. SCCmec type III has remained linked to the ST239 chromosome during clonal diversification, but it has undergone homoplasious losses of accessory components. These results provide a population genetics framework for the precise identification of emerging ST239 variants, and invite a re-evaluation of the markers used for subtyping SCCmec.	[Smyth, Davida S.; Robinson, D. Ashley] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [McDougal, Linda K.] Ctr Dis Control & Prevent, Off Antimicrobial Resistance, Atlanta, GA USA; [Gran, Frode W.] Univ Trondheim Hosp, Dept Med Microbiol, Trondheim, Norway; [Manoharan, Anand] Christian Med Coll & Hosp, Dept Med Unit & Infect Dis 1, Vellore, Tamil Nadu, India; [Enright, Mark C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Song, Jae-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea; [de Lencastre, Herminia] Univ Nova Lisboa, Mol Genet Lab, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	New York Medical College; Centers for Disease Control & Prevention - USA; Norwegian University of Science & Technology (NTNU); Christian Medical College & Hospital (CMCH) Vellore; Imperial College London; Sungkyunkwan University (SKKU); Samsung Medical Center; Universidade Nova de Lisboa; Rockefeller University	Smyth, DS (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	darobinson@microbio.umsmed.edu	Song, Jae Hoon/C-9602-2011; Smyth, Davida/AAF-5326-2020	/0000-0001-6816-8932; Enright, Mark/0000-0001-5273-8750; Smyth, Davida/0000-0002-4049-0337	American Heart Association; NIH [GM080602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080602] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the American Heart Association and by NIH grant GM080602 ( to D. A. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Alp E, 2009, J INFECTION, V58, P433, DOI 10.1016/j.jinf.2009.04.006; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amaral MM, 2005, J INFECT DIS, V192, P801, DOI 10.1086/432515; Arakere G, 2005, J CLIN MICROBIOL, V43, P3198, DOI 10.1128/JCM.43.7.3198-3202.2005; Arakere G, 2009, FEMS MICROBIOL LETT, V292, P141, DOI 10.1111/j.1574-6968.2008.01482.x; Bartels MD, 2008, EUR J CLIN MICROBIOL, V27, P757, DOI 10.1007/s10096-008-0500-z; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Cha HY, 2005, J CLIN MICROBIOL, V43, P3610, DOI 10.1128/JCM.43.8.3610-3614.2005; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Cirlan Maria, 2005, Infection Genetics and Evolution, V5, P335, DOI 10.1016/j.meegid.2004.09.005; COOKSON BD, 1988, J ANTIMICROB CHEMOTH, V21, P57, DOI 10.1093/jac/21.suppl_C.57; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; de Lencastre Herminia, 1997, Clin Microbiol Infect, V3, P289; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; De Sousa MA, 2001, J CLIN MICROBIOL, V39, P2197, DOI 10.1128/JCM.39.6.2197-2205.2001; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; DUBIN DT, 1992, J GEN MICROBIOL, V138, P169, DOI 10.1099/00221287-138-1-169; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Feil EJ, 2008, J CLIN MICROBIOL, V46, P1520, DOI 10.1128/JCM.02238-07; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hsu LY, 2005, J CLIN MICROBIOL, V43, P2923, DOI 10.1128/JCM.43.6.2923-2925.2005; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lina G, 2006, CLIN MICROBIOL INFEC, V12, P1175, DOI 10.1111/j.1469-0691.2006.01548.x; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; MARPLES RR, 1985, J HOSP INFECT, V6, P342, DOI 10.1016/0195-6701(85)90040-4; Melter O, 1999, J CLIN MICROBIOL, V37, P2798, DOI 10.1128/JCM.37.9.2798-2803.1999; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Nielsen R, 2003, MOL ECOL, V12, P3157, DOI 10.1046/j.1365-294X.2003.01994.x; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Orth D, 2006, EUR J CLIN MICROBIOL, V25, P104, DOI 10.1007/s10096-006-0102-6; PAVILLARD R, 1982, MED J AUSTRALIA, V1, P451, DOI 10.5694/j.1326-5377.1982.tb132413.x; Perez-Losada M, 2007, INFECT GENET EVOL, V7, P271, DOI 10.1016/j.meegid.2006.11.003; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Roman RS, 1997, CLIN INFECT DIS, V25, P698, DOI 10.1086/513758; Sanches IS, 1996, MICROB DRUG RESIST, V2, P319, DOI 10.1089/mdr.1996.2.319; Sheng WH, 2009, DIAGN MICR INFEC DIS, V63, P309, DOI 10.1016/j.diagmicrobio.2008.11.014; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Simor AE, 2002, J INFECT DIS, V186, P652, DOI 10.1086/342292; SLATKIN M, 1989, GENETICS, V123, P603; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Szczepanik A, 2007, EUR J CLIN MICROBIOL, V26, P29, DOI 10.1007/s10096-006-0237-5; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020; TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995; Tohda S, 1997, INTERNAL MED, V36, P694, DOI 10.2169/internalmedicine.36.694; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wisplinghoff H, 2005, J CLIN MICROBIOL, V43, P5445, DOI 10.1128/JCM.43.11.5445-5451.2005; Witte W, 1999, J ANTIMICROB CHEMOTH, V44, P1, DOI 10.1093/jac/44.suppl_1.1; Xu BL, 2009, J HOSP INFECT, V71, P245, DOI 10.1016/j.jhin.2008.10.029; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	73	61	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8582	10.1371/journal.pone.0008582	http://dx.doi.org/10.1371/journal.pone.0008582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20062529	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000273338500024
J	Berry, A; Matthews, L; Jangani, M; Plumb, J; Farrow, S; Buchan, N; Wilson, PA; Singh, D; Ray, DW; Donn, RP				Berry, A.; Matthews, L.; Jangani, M.; Plumb, J.; Farrow, S.; Buchan, N.; Wilson, P. A.; Singh, D.; Ray, D. W.; Donn, R. P.			Interferon-inducible factor 16 is a novel modulator of glucocorticoid action	FASEB JOURNAL			English	Article						IFI16; steroid sensitivity; nuclear receptor; inflammation	NF-KAPPA-B; RECEPTOR FUNCTION; DOCKING PROTEIN; UP-REGULATION; GENE; EXPRESSION; SENSITIVITY; TRANSCRIPTION; IFI16; INHIBITION	Previously, we used cDNA expression profiling to identify genes associated with glucocorticoid (Gc) sensitivity. We now identify which of these directly influence Gc action. Interferon-inducible protein 16 (IFI16), bone morphogenetic protein receptor type II (BMPRII), and regulator of G-protein signaling 14 (RGS14) increased Gc transactivation, whereas sialyltransferase 4B (SIAT4B) had a negative effect. Amyloid beta (A4) precursor-protein binding, family B, member 1 (APBB1/Fe65) and neural cell expressed developmentally down-regulated 9 (NEDD9) were without effect. Only IFI16 potentiated Gc repression of NF-kappa B. In addition, IFI16 affected basal expression, and Gc induction of endogenous target genes. IFI16 did not affect glucocorticoid receptor (GR) expression, ligand-dependent repression of GR expression, or the ligand-dependent induction of GR phosphorylation on Ser-211 or Ser-203. Coimmunoprecipitation revealed an interaction, suggesting that IFI16 modulation of GR function is mediated by protein crosstalk. Transfection analysis with GR mutants showed that the ligand-binding domain of GR binds IFI16 and is the target domain for IFI16 regulation. Analysis of human lung sections identified colocalization of GR and IFI16, suggesting a physiologically relevant interaction. We demonstrate that IFI16 is a novel modulator of GR function and show the importance of analyzing variation in Gc sensitivity in humans, using appropriate technology, to drive discovery.-Berry, A., Matthews, L. Jangani, M., Plumb, J., Farrow, S., Buchan, N., Wilson, P. A., Singh, D., Ray, D., W., Donn, R. P. Interferon-inducible factor 16 is a novel modulator of glucocorticoid action. FASEB J. 24, 1700-1713 (2010). www.fasebj.org	[Berry, A.; Jangani, M.; Donn, R. P.] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Berry, A.; Matthews, L.] Univ Manchester, Endocrine Sci Res Grp, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England; [Plumb, J.; Singh, D.] Univ Manchester, S Manchester Univ Hosp Trust, NW Reg Lung Ctr, Manchester M13 9PT, Lancs, England; [Farrow, S.; Buchan, N.; Wilson, P. A.] GlaxoSmithKline Medicines Res Ctr, Stevenage, Herts, England	University of Manchester; University of Manchester; University of Manchester; GlaxoSmithKline	Donn, RP (corresponding author), Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.w.ray@manchester.ac.uk; rachelle.donn@manchester.ac.uk		Ray, David/0000-0002-4739-6773; Donn, Rachelle/0000-0001-6976-9828; Plumb, Jonathan/0000-0002-7877-8053	Biotechnology and Biological Sciences Research Council; Wellcome Trust; University of Manchester; Arthritis Research Campaign [17552]; Medical Research Council; Manchester University; Manchester Academic Health Sciences Centre; National Institute for Health Research Manchester Biomedical Research Centre	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); University of Manchester; Arthritis Research Campaign(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Manchester University; Manchester Academic Health Sciences Centre; National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	The authors are grateful for help from Ros Cutts, Peter Woollard, and Ian Keddie. The authors also acknowledge Dr. Jorge Iniguez-Lluhi (University of Michigan Medical School, Ann Arbor, MI, USA) for the kind donation of plasmid and give special thanks to Robert Fernandez (University of Manchester Bioimaging Facility). Bioimaging Facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, Wellcome Trust, and University of Manchester Strategic Fund. This work was funded by the Arthritis Research Campaign (grant code 17552) and the Medical Research Council and by a Manchester University Ph.D. studentship award. The Arthritis Research Campaign Epidemiology Unit and Endocrine Research Group Laboratories are supported by the Manchester Academic Health Sciences Centre and by the National Institute for Health Research Manchester Biomedical Research Centre. The authors report no conflicts of interest.	Adcock Ian M, 2005, Proc Am Thorac Soc, V2, P313, DOI 10.1513/pats.200504-035SR; Adcock IM, 1996, AM J RESP CRIT CARE, V154, P771, DOI 10.1164/ajrccm.154.3.8810618; Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Aksentijevich I, 1997, CELL, V90, P797; Alimirah F, 2006, FEBS LETT, V580, P1659, DOI 10.1016/j.febslet.2006.02.015; Alimirah F, 2007, MOL CANCER RES, V5, P251, DOI 10.1158/1541-7786.MCR-06-0269; ALMLOF T, 1995, J BIOL CHEM, V270, P17535, DOI 10.1074/jbc.270.29.17535; Bao JY, 2007, MOL CELL BIOL, V27, P1321, DOI 10.1128/MCB.01280-06; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Cerami EG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-497; Chriguer RS, 2005, J CLIN ENDOCR METAB, V90, P5978, DOI 10.1210/jc.2005-0067; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Doucas V, 2000, P NATL ACAD SCI USA, V97, P11893, DOI 10.1073/pnas.220413297; Fan BJ, 2008, INVEST OPHTH VIS SCI, V49, P1886, DOI 10.1167/iovs.07-0414; Fiorentino L, 2002, J BIOL CHEM, V277, P35333, DOI 10.1074/jbc.M200446200; Franchimont D, 1999, DIGEST DIS SCI, V44, P1208, DOI 10.1023/A:1026644711530; Gariglio M, 2002, J INTERF CYTOK RES, V22, P815, DOI 10.1089/107999002320271413; Gugliesi F, 2005, J LEUKOCYTE BIOL, V77, P820, DOI 10.1189/jlb.0904507; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P47, DOI 10.1210/jc.83.1.47; Ismaili N, 2005, J BIOL CHEM, V280, P11120, DOI 10.1074/jbc.M500059200; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Johnstone RW, 1998, BIOCHEMISTRY-US, V37, P11924, DOI 10.1021/bi981069a; Johnstone RW, 1999, MOL CELL BIOL, V19, P5833; Kimkong I, 2009, LUPUS, V18, P1066, DOI 10.1177/0961203309106699; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kino T, 2001, J ENDOCRINOL, V169, P437, DOI 10.1677/joe.0.1690437; Kudrin A, 2006, J BIOL CHEM, V281, P29641, DOI 10.1074/jbc.M601103200; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Law SF, 1996, MOL CELL BIOL, V16, P3327; Lee EJ, 2008, BMB REP, V41, P41, DOI 10.5483/BMBRep.2008.41.1.041; Ma XY, 2003, J BIOL CHEM, V278, P23008, DOI 10.1074/jbc.M302105200; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Min W, 1996, MOL CELL BIOL, V16, P359; RANGARAJAN PN, 1992, MOL ENDOCRINOL, V6, P1451, DOI 10.1210/me.6.9.1451; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Slatore CG, 2009, AM J MED, V122, P472, DOI 10.1016/j.amjmed.2008.09.048; Stevens A, 2004, J CLIN ENDOCR METAB, V89, P892, DOI 10.1210/jc.2003-031235; Stevens A, 2003, MOL ENDOCRINOL, V17, P845, DOI 10.1210/me.2002-0320; Szapary D, 1999, MOL ENDOCRINOL, V13, P2108, DOI 10.1210/me.13.12.2108; Szatmary Z, 2004, J BIOL CHEM, V279, P43708, DOI 10.1074/jbc.M406568200; TRAPANI JA, 1994, IMMUNOGENETICS, V40, P415; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; van Rossum EFC, 2004, J CLIN ENDOCR METAB, V89, P4004, DOI 10.1210/jc.2003-031422; van Rossum EFC, 2004, RECENT PROG HORM RES, V59, P333, DOI 10.1210/rp.59.1.333; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Waters CE, 2004, J ENDOCRINOL, V183, P375, DOI 10.1677/joe.1.05804; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068	51	13	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1700	1713		10.1096/fj.09-139998	http://dx.doi.org/10.1096/fj.09-139998			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20086048	Green Published, hybrid			2022-12-25	WOS:000278200000008
J	Mouillet, JF; Chu, TJ; Nelson, DM; Mishima, T; Sadovsky, Y				Mouillet, Jean-Francois; Chu, Tianjiao; Nelson, D. Michael; Mishima, Takuya; Sadovsky, Yoel			MiR-205 silences MED1 in hypoxic primary human trophoblasts	FASEB JOURNAL			English	Article						placenta; hypoxia; microRNA; 3 '-UTR	RECEPTOR-BINDING PROTEIN; TERM HUMAN TROPHOBLASTS; MICRORNA EXPRESSION; GENE-EXPRESSION; IN-VITRO; HUMAN CYTOTROPHOBLAST; EMBRYONIC-DEVELOPMENT; MEDIATOR COMPLEX; MESSENGER-RNAS; DIFFERENTIATION	Acting through degradation of target mRNA or inhibition of translation, microRNAs (miRNAs) regulate development, differentiation, and cellular response to diverse cues. We analyzed changes in miRNA expression in human placental trophoblasts exposed to hypoxia, which may result from hypoperfusion and placental injury. Using an miRNA microarray screen, confirmed by Northern blot analysis, we defined a set of seven miRNAs (miR-93, miR-205, miR-224, miR-335, miR-424, miR-451, and miR-491) that are differentially regulated in primary trophoblasts exposed to hypoxia. We combined in silico prediction of miRNA targets with gene expression profiling data to identify a series of potential targets for the miRNAs, which were further analyzed using luciferase reporter assays. Among experimentally confirmed targets, we found that the transcriptional coactivator MED1, which plays an important role in placental development, is a target for miR-205. Using gain- and loss-of-function assays, we confirmed that miR-205 interacts with a specific target in the 3'-UTR sequence of MED1 and silences MED1 expression in human trophoblasts exposed to hypoxia, suggesting that miR-205 plays a role in trophoblast injury.-Mouillet, J.-F., Chu, T., Nelson, D. M., Mishima, T., Sadovsky, Y. MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J. 24, 2030-2039 (2010). www.fasebj.org	[Mouillet, Jean-Francois; Chu, Tianjiao; Mishima, Takuya; Sadovsky, Yoel] Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Sadovsky, Yoel] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Nelson, D. Michael] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Sadovsky, Y (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, 204 Craft Ave, Pittsburgh, PA 15213 USA.	ysadovsky@mwri.magee.edu	Mishima, Takuya/G-1671-2011		National Institutes of Health [R01-HD29190, R21-HD053878, R01-HD45675]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029190, R01HD045675, R21HD053878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Dr. C. H. Graham (Queen's University, Kingston, ON, Canada) for the HTR-8/SVneo cells. The authors also thank Magdalena Jennings and Elena Sadovsky for technical assistance and Lori Rideout for assistance during preparation of the manuscript. The project was supported by grants from the National Institutes of Health (R01-HD29190 to D.M.N; R21-HD053878 and R01-HD45675 to Y.S).	Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anteby EY, 2005, EUR J OBSTET GYN R B, V119, P27, DOI 10.1016/j.ejogrb.2004.05.014; ARNHOLDT H, 1991, VIRCHOWS ARCH B, V60, P365, DOI 10.1007/BF02899568; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Belakavadi M, 2006, REV PHYSIOL BIOCH P, V156, P23, DOI 10.1007/s10254-005-0002-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benyo DF, 1997, J CLIN ENDOCR METAB, V82, P1582, DOI 10.1210/jc.82.5.1582; Bissonauth V, 2006, DEVELOPMENT, V133, P3429, DOI 10.1242/dev.02526; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cartwright JE, 2007, ADV EXP MED BIOL, V618, P113; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen B, 2006, J BIOL CHEM, V281, P2764, DOI 10.1074/jbc.M507330200; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Dijckmeester WA, 2009, J GASTROINTEST SURG, V13, P846, DOI 10.1007/s11605-009-0799-5; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; FOX H, 1970, AM J OBSTET GYNECOL, V107, P1058, DOI 10.1016/0002-9378(70)90629-0; Frade R, 2000, CANCER RES, V60, P6585; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Gordon DF, 2006, MOL ENDOCRINOL, V20, P1073, DOI 10.1210/me.2005-0115; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guimbellot JS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-15; Guller S, 2008, LAB INVEST, V88, P1057, DOI 10.1038/labinvest.2008.74; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Ito S, 2006, CLIN NEPHROL, V66, P160; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jauniaux E, 2001, AM J OBSTET GYNECOL, V184, P998, DOI 10.1067/mob.2001.111935; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kingdom JCP, 1999, ADV EXP MED BIOL, V474, P259; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Landles C, 2003, MOL ENDOCRINOL, V17, P2418, DOI 10.1210/me.2003-0097; Latronico MVG, 2009, J CARDIOVASC ELECTR, V20, P230, DOI 10.1111/j.1540-8167.2008.01357.x; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Levy R, 2000, AM J PHYSIOL-CELL PH, V278, pC982, DOI 10.1152/ajpcell.2000.278.5.C982; Li H, 2008, J BIOL CHEM, V283, P13077, DOI 10.1074/jbc.M800604200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massabbal E, 2005, MOL REPROD DEV, V71, P299, DOI 10.1002/mrd.20272; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Nelson DM, 1999, AM J OBSTET GYNECOL, V180, P896, DOI 10.1016/S0002-9378(99)70661-7; Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; R Development Core Team, 2009, R FDN STAT COMP; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Roh CR, 2005, PLACENTA, V26, P319, DOI 10.1016/j.placenta.2004.06.013; Ryan D, 2006, MOL VIS, V12, P1175; Schaiff WT, 2005, J CLIN ENDOCR METAB, V90, P4267, DOI 10.1210/jc.2004-2265; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Song HS, 2009, BIOCHEM BIOPH RES CO, V388, P400, DOI 10.1016/j.bbrc.2009.08.020; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Udayakumar TS, 2006, J BIOL CHEM, V281, P14691, DOI 10.1074/jbc.M600163200; Wada O, 2004, ONCOGENE, V23, P6000, DOI 10.1038/sj.onc.1207786; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200	92	97	105	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2030	2039		10.1096/fj.09-149724	http://dx.doi.org/10.1096/fj.09-149724			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20065103	Green Published			2022-12-25	WOS:000278200000037
J	Wang, M; Wang, M; Yuan, L; Wu, D; Zhang, Z; Yin, C; Fu, G; Wei, Q; Zhang, Z				Wang, M.; Wang, M.; Yuan, L.; Wu, D.; Zhang, Z.; Yin, C.; Fu, G.; Wei, Q.; Zhang, Z.			A novel XPF-357A > C polymorphism predicts risk and recurrence of bladder cancer	ONCOGENE			English	Article						genetic variation; XPF; bladder cancer; recurrence; molecular epidemiology	EXCISION-REPAIR GENES; DNA-REPAIR; MDM2 PROMOTER; LUNG-CANCER; SUSCEPTIBILITY; PROTEIN; ERCC4; MELANOMA; PATHWAY	Xeroderma pigmentosum group F (XPF) has an essential role in the nucleotide excision repair pathway that removes a wide variety of DNA lesions. We hypothesized that genetic variants in XPF are associated with bladder cancer risk and recurrence. We selected three tagging single nucleotide polymorphisms (tagSNPs) from the HapMap database for the Chinese and genotyped them in a two-stage case-control study to evaluate the association and further examined the functionality of a novel polymorphism in the promoter. The two-stage analysis found that the rs744154 tagSNP in the XPF intron 1, which was linkage disequilibrium with the -357A > C polymorphism in the promoter region, was associated with a protective effect on bladder cancer risk. Electrophoretic mobility shift assay (EMSA) further revealed that the -357C allele decreased the binding ability of transcriptional factors to the XPF promoter. The vector construct containing the -357C allele had a lower luciferase expression than did the -357A allele. The -357C allele in the transcription factor-binding site was also associated with decreased expression levels of both XPF mRNA and protein in bladder cancer tissues. Furthermore, patients with the -357C allele had a shorter overall recurrence-free survival than did patients with the -357A allele. Our results suggest that the XPF promoter -357A > C polymorphism may regulate the expression of XPF and thereby contribute to susceptibility to and prognosis of bladder cancer. Further larger studies with different populations are warranted to confirm these findings. Oncogene (2010) 29, 1920-1928; doi:10.1038/onc.2009.484; published online 11 January 2010	[Wang, M.; Wang, M.; Yuan, L.; Wu, D.; Zhang, Z.] Nanjing Med Univ, Ctr Canc, Dept Mol Toxicol, Nanjing 210029, Peoples R China; [Wang, M.; Wang, M.; Yuan, L.; Wu, D.; Zhang, Z.] Nanjing Med Univ, Ctr Canc, Dept Genet Toxicol, Nanjing 210029, Peoples R China; [Zhang, Z.; Zhang, Z.] Nanjing Med Univ, Ctr Canc, Dept Epidemiol, Nanjing 210029, Peoples R China; [Zhang, Z.; Zhang, Z.] Nanjing Med Univ, Ctr Canc, Dept Biostat, Nanjing 210029, Peoples R China; [Yin, C.] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing 210029, Peoples R China; [Fu, G.] Nanjing Med Univ, Huai An Affiliated Hosp 1, Dept Urol, Huaian, Peoples R China; [Wei, Q.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University of Texas System; UTMD Anderson Cancer Center	Zhang, Z (corresponding author), Nanjing Med Univ, Dept Mol & Genet Toxicol, Sch Publ Hlth, 140 Hanzhong Rd, Nanjing 210029, Peoples R China.	drzdzhang@gmail.com			National Natural Science Foundation of China [30872084, 30800926, 30972444]; Key Program for Basic Research of Jiangsu Provincial Department of Education [08KJA330001]; 'Qinglan Project' Foundation for the Young Academic Leader of Jiangsu Province; Jiangsu Provincial Graduates Innovative Project [CX08B-183Z]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Basic Research of Jiangsu Provincial Department of Education; 'Qinglan Project' Foundation for the Young Academic Leader of Jiangsu Province; Jiangsu Provincial Graduates Innovative Project	This study was partly supported by the National Natural Science Foundation of China (30872084, 30800926 and 30972444), the Key Program for Basic Research of Jiangsu Provincial Department of Education (08KJA330001), 'Qinglan Project' Foundation for the Young Academic Leader of Jiangsu Province (Z Zhang), and Jiangsu Provincial Graduates Innovative Project (CX08B-183Z).	An J, 2007, CANCER EPIDEM BIOMAR, V16, P1633, DOI 10.1158/1055-9965.EPI-07-0252; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; COHEN SM, 1992, UROL CLIN N AM, V19, P421; Cohen SM, 2000, SCAND J UROL NEPHROL, V34, P105, DOI 10.1080/00365590050509869; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Frosina G, 2000, EUR J BIOCHEM, V267, P2135, DOI 10.1046/j.1432-1327.2000.01266.x; Garcia-Closas M, 2006, CANCER EPIDEM BIOMAR, V15, P536, DOI 10.1158/1055-9965.EPI-05-0749; Gu J, 2005, CLIN CANCER RES, V11, P1408, DOI 10.1158/1078-0432.CCR-04-1101; Han JL, 2009, BREAST CANCER RES TR, V115, P613, DOI 10.1007/s10549-008-0089-z; Hecht SS, 2002, ENVIRON MOL MUTAGEN, V39, P119, DOI 10.1002/em.10071; Kim WJ, 2008, CANCER SCI, V99, P646, DOI 10.1111/j.1349-7006.2008.00735.x; Kornguth DG, 2005, INT J RADIAT ONCOL, V62, P665, DOI 10.1016/j.ijrobp.2004.11.026; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; Kruppa M, 2001, MOL CELL, V7, P309, DOI 10.1016/S1097-2765(01)00179-4; Laser H, 2000, P NATL ACAD SCI USA, V97, P13732, DOI 10.1073/pnas.250400997; Lee OKE, 2005, WORLDV EVID-BASED NU, V2, P4, DOI 10.1111/j.1524-475X.2005.04085.x; McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539; Milne RL, 2006, CANCER RES, V66, P9420, DOI 10.1158/0008-5472.CAN-06-1418; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PRYOR WA, 1983, SCIENCE, V220, P425, DOI 10.1126/science.6301009; Shaoa MH, 2008, LUNG CANCER, V60, P332, DOI 10.1016/j.lungcan.2007.10.023; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Smith TR, 2003, CANCER EPIDEM BIOMAR, V12, P1200; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Theodorescu D, 2003, HISTOL HISTOPATHOL, V18, P259, DOI 10.14670/HH-18.259; TRAVERS AA, 1994, CELL, V77, P167, DOI 10.1016/0092-8674(94)90306-9; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; Wang ML, 2008, CLIN CANCER RES, V14, P3633, DOI 10.1158/1078-0432.CCR-07-5155; WATANABE F, 1994, BBA-MOL CELL RES, V1223, P255, DOI 10.1016/0167-4889(94)90234-8; Winsey SL, 2000, CANCER RES, V60, P5612; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154	38	32	35	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	13					1920	1928		10.1038/onc.2009.484	http://dx.doi.org/10.1038/onc.2009.484			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20062074				2022-12-25	WOS:000276199600005
J	Golczak, M; Kiser, PD; Lodowski, DT; Maeda, A; Palczewski, K				Golczak, Marcin; Kiser, Philip D.; Lodowski, David T.; Maeda, Akiko; Palczewski, Krzysztof			Importance of Membrane Structural Integrity for RPE65 Retinoid Isomerization Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL CYCLE; PIGMENT-EPITHELIUM; BINDING-PROTEIN; IN-VITRO; PHOSPHOLIPASE A(2); BIOCHEMICAL-CHARACTERIZATION; ISOMEROHYDROLASE ACTIVITY; SELECTIVE SOLUBILIZATION; DEHYDROGENASE TYPE-1; MICROSOMAL PROTEIN	Regeneration of visual chromophore in the vertebrate visual cycle involves the retinal pigment epithelium-specific protein RPE65, the key enzyme catalyzing the cleavage and isomerization of all-trans-retinyl fatty acid esters to 11-cis-retinol. Although RPE65 has no predicted membrane spanning domains, this protein predominantly associates with microsomal fractions isolated from bovine retinal pigment epithelium (RPE). We have re-examined the nature of RPE65 interactions with native microsomal membranes by using extraction and phase separation experiments. We observe that hydrophobic interactions are the dominant forces that promote RPE65 association with these membranes. These results are consistent with the crystallographic model of RPE65, which features a large lipophilic surface that surrounds the entrance to the catalytic site of this enzyme and likely interacts with the hydrophobic core of the endoplasmic reticulum membrane. Moreover, we report a critical role for phospholipid membranes in preserving the retinoid isomerization activity and physical properties of RPE65. Isomerase activity measured in bovine RPE was highly sensitive to phospholipase A(2) treatment, but the observed decline in 11-cis-retinol production did not directly reflect inhibition by products of lipid hydrolysis. Instead, a direct correlation between the kinetics of phospholipid hydrolysis and retinoid isomerization suggests that the lipid membrane structure is critical for RPE65 enzymatic activity. We also provide evidence that RPE65 operates in a multiprotein complex with retinol dehydrogenase 5 and retinal G protein-coupled receptor in RPE microsomes. Modifications in the phospholipid environment affecting interactions with these protein components may be responsible for the alterations in retinoid metabolism observed in phospholipid-depleted RPE microsomes. Thus, our results indicate that the enzymatic activity of native RPE65 strongly depends on its membrane binding and phospholipid environment.	[Golczak, Marcin; Kiser, Philip D.; Lodowski, David T.; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY019478, EY009339, K08 EY019031, P30 EY11373]; Foundation Fighting Blindness, Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NEI [T32EY007157]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL EYE INSTITUTE [T32EY007157, R01EY009339, R01EY019478, P30EY011373, K08EY019031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness, Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019478, EY009339, K08 EY019031, and P30 EY11373. This work was also supported by Foundation Fighting Blindness, Research to Prevent Blindness Foundation, and Ohio Lions Eye Research Foundation.; Supported by National Institutes of Health Visual Sciences Training Program Grant T32EY007157 from NEI.; We thank Dr. Janna Kiselar from the Center for Proteomics and Bioinformatics at Case Western Reserve University for assistance with MS instruments. We thank the staff at the APS 23-ID-D beamline for technical assistance. GM/CA CAT has been funded, in whole or in part, with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract No. DE-AC02-06CH11357. We also thank Dr. Leslie T. Webster, Jr., and members of the Palczewski laboratory (Case Western Reserve University) for valuable comments about the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BARRY RJ, 1989, J BIOL CHEM, V264, P9231; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BAVIK CO, 1993, J BIOL CHEM, V268, P20540; Bell JD, 1996, BIOCHEMISTRY-US, V35, P4945, DOI 10.1021/bi952274i; Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; BERNSTEIN PS, 1987, J BIOL CHEM, V262, P16848; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; Booth PJ, 2005, CURR OPIN STRUC BIOL, V15, P435, DOI 10.1016/j.sbi.2005.06.002; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BURACK WR, 1995, BIOCHEMISTRY-US, V34, P14819, DOI 10.1021/bi00045a024; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; Choo DW, 1998, FEBS LETT, V440, P195, DOI 10.1016/S0014-5793(98)01459-8; COOKE GM, 1985, J BIOL CHEM, V260, P7489; Crabb JW, 1998, METH MOL B, V89, P91; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forneris F, 2008, SCIENCE, V321, P213, DOI 10.1126/science.1151118; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Hemati N, 2005, MOL VIS, V11, P1151; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jahng WJ, 2002, BIOCHEMISTRY-US, V41, P6311, DOI 10.1021/bi015710b; Jang GF, 2001, J BIOL CHEM, V276, P32456, DOI 10.1074/jbc.M104949200; JENSEN JW, 1989, BIOCHEMISTRY-US, V28, P851, DOI 10.1021/bi00428a066; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; KATSUTA K, 1978, BIOCHIM BIOPHYS ACTA, V507, P271, DOI 10.1016/0005-2736(78)90422-4; KINTER M, 2000, PROTEIN SEQUENCING I, P147, DOI DOI 10.1002/0471721980; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; Ogg D, 2005, J BIOL CHEM, V280, P3789, DOI 10.1074/jbc.M412463200; ORegan MH, 1996, NEUROSCI LETT, V202, P201, DOI 10.1016/0304-3940(95)12238-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Penefsky H. S., 1971, METHOD ENZYMOL, V22, P204; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; RYDSTROM J, 1976, BIOCHIM BIOPHYS ACTA, V455, P24, DOI 10.1016/0005-2736(76)90151-6; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; Takahashi Y, 2009, J BIOL CHEM, V284, P3211, DOI 10.1074/jbc.M807248200; Tatulian SA, 2001, BIOPHYS J, V80, P789, DOI 10.1016/S0006-3495(01)76058-4; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; VESELY DL, 1981, SCIENCE, V213, P359, DOI 10.1126/science.6113689; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; Wenzel A, 2005, J BIOL CHEM, V280, P29874, DOI 10.1074/jbc.M503603200; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Yuan Q, 2010, J BIOL CHEM, V285, P988, DOI 10.1074/jbc.M109.025643; Zhang M, 2004, J BIOL CHEM, V279, P51482, DOI 10.1074/jbc.M409051200; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	65	49	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9667	9682		10.1074/jbc.M109.063941	http://dx.doi.org/10.1074/jbc.M109.063941			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100834	Green Published, hybrid			2022-12-25	WOS:000276165900040
J	Kummer, C; Petrich, BG; Rose, DM; Ginsberg, MH				Kummer, Christiane; Petrich, Brian G.; Rose, David M.; Ginsberg, Mark H.			A Small Molecule That Inhibits the Interaction of Paxillin and alpha 4 Integrin Inhibits Accumulation of Mononuclear Leukocytes at a Site of Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; T-CELL MIGRATION; CYTOPLASMIC DOMAIN; CONTROLLED TRIAL; LD MOTIFS; BINDING; PROTEIN; ACTIVATION; LEUPAXIN; DISEASE	Extracellular antagonists of alpha 4 integrin are an effective therapy for several autoimmune and inflammatory diseases; however, these agents that directly block ligand binding may exhibit mechanism-based toxicities. Inhibition of alpha 4 integrin signaling by mutations of alpha 4 that block paxillin binding inhibits inflammation while limiting mechanism-based toxicities. Here, we test a pharmacological approach by identifying small molecules that inhibit the alpha 4 integrin-paxillin interaction. By screening a large (similar to 40,000-compound) chemical library, we identified a noncytotoxic inhibitor of this interaction that impaired integrin alpha 4-mediated but not alpha L beta 2-mediated Jurkat T cell migration. The identified compound had no effect on alpha 4-mediated migration in cells bearing the alpha 4(Y991A) mutation that disrupts the alpha 4-paxillin interaction, establishing the specificity of its action. Administration of this compound to mice led to impaired recruitment of mononuclear leukocytes to a site of inflammation in vivo, whereas an isomer that does not inhibit the alpha 4-paxillin interaction had no effect on alpha 4-mediated cell migration, cell spreading, or recruitment of leukocytes to an inflammatory site. Thus, a small molecule inhibitor that interferes with alpha 4 integrin signaling reduces alpha 4-mediated T cell migration in vivo, thus providing proof of principle for inhibition of alpha 4 integrin signaling as a target for the pharmacological reduction of inflammation.	[Kummer, Christiane; Petrich, Brian G.; Rose, David M.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, Leichtag Bldg,Rm 181,9500 Gilman Dr,Dept 0726, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu			National Institutes of Health [AR27214, NS059433, AR52367]; Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027214, R01AR027214, R01AR052367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR27214 and NS059433 (to M. H. G.) and AR52367 (to D. M. R.). This work was also supported by an Arthritis Foundation postdoctoral fellowship (to C. K.).	Ambroise Y, 2002, CHEM BIOL, V9, P1219, DOI 10.1016/S1074-5521(02)00246-6; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Ghosh S, 2003, EXPERT OPIN BIOL TH, V3, P995, DOI 10.1517/eobt.3.6.995.21264; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gordon FH, 2001, GASTROENTEROLOGY, V121, P268, DOI 10.1053/gast.2001.26260; Gupta A, 2003, J BONE MINER RES, V18, P669, DOI 10.1359/jbmr.2003.18.4.669; Han JW, 2003, J BIOL CHEM, V278, P34845, DOI 10.1074/jbc.M304691200; James WG, 2003, J IMMUNOL, V170, P520, DOI 10.4049/jimmunol.170.1.520; Jongewaard IN, 1996, CELL ADHES COMMUN, V3, P487, DOI 10.3109/15419069609081025; Lipsky BP, 1998, J BIOL CHEM, V273, P11709, DOI 10.1074/jbc.273.19.11709; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2002, J BIOL CHEM, V277, P20887, DOI 10.1074/jbc.M110928200; Liu SC, 2000, J BIOL CHEM, V275, P22736, DOI 10.1074/jbc.M000388200; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Ramos JW, 2000, MOL BIOL CELL, V11, P2863, DOI 10.1091/mbc.11.9.2863; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rose DM, 2003, J IMMUNOL, V170, P5912, DOI 10.4049/jimmunol.170.12.5912; Rose DM, 2001, J IMMUNOL, V167, P2824, DOI 10.4049/jimmunol.167.5.2824; Sahu SN, 2007, AM J PHYSIOL-CELL PH, V292, pC2288, DOI 10.1152/ajpcell.00503.2006; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sheridan C, 2005, NAT REV DRUG DISCOV, V4, P357, DOI 10.1038/nrd1743; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turner CE, 2000, J CELL SCI, V113, P4139; TURNER CE, 1994, J CELL SCI, V107, P1583; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; YANG JT, 1995, DEVELOPMENT, V121, P549; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	37	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9462	9469		10.1074/jbc.M109.066993	http://dx.doi.org/10.1074/jbc.M109.066993			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097761	Green Published, hybrid			2022-12-25	WOS:000276165900019
J	Shimizu, E; Selvamurugan, N; Westendorf, JJ; Olson, EN; Partridge, NC				Shimizu, Emi; Selvamurugan, Nagarajan; Westendorf, Jennifer J.; Olson, Eric N.; Partridge, Nicola C.			HDAC4 Represses Matrix Metalloproteinase-13 Transcription in Osteoblastic Cells, and Parathyroid Hormone Controls This Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT COLLAGENASE-3 PROMOTER; II HISTONE DEACETYLASES; ACTIVATOR PROTEIN-1; CLEIDOCRANIAL DYSPLASIA; BONE-DEVELOPMENT; RUNX2; DIFFERENTIATION; EXPRESSION; BINDING; CBFA1	Parathyroid hormone (PTH) is a hormone regulating bone remodeling through its actions on both bone formation and bone resorption. Previously we reported that PTH induces matrix metalloproteinase-13 (MMP-13) transcription in osteoblastic cells. Here, we show that histone deacetylase 4 (HDAC4) interacts with Runx2, binds the MMP-13 promoter, and suppresses MMP-13 gene transcription in the rat osteoblastic cell line, UMR 106-01. PTH induces the rapid cAMP-dependent protein kinase-dependent release of HDAC4 from the MMP-13 promoter and subsequent transcription of MMP-13. Knock-out of HDAC4 either by siRNA in vitro or by gene deletion in vivo leads to an increase in MMP-13 expression, and overexpression of HDAC4 decreases the PTH induction of MMP-13. All of these observations indicate that HDAC4 represses MMP-13 gene transcription in bone. Moreover, PTH stimulates HDAC4 gene expression and enzymatic activity at times corresponding to the reassociation of HDAC4 with the MMP-13 promoter and a decline in its transcription. Thus, HDAC4 is a basal repressor of MMP-13 transcription, and PTH regulates HDAC4 to control MMP-13 promoter activity. These data identify a novel and discrete mechanism of regulating HDAC4 levels and, subsequently, gene expression.	[Shimizu, Emi; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Selvamurugan, Nagarajan] Sri Ramaswamy Mem Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	New York University; Mayo Clinic; Mayo Clinic; SRM Institute of Science & Technology Chennai; University of Texas System; University of Texas Southwestern Medical Center Dallas	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 E 24th St, New York, NY 10010 USA.	ncp234@nyu.edu	Selvamurugan, Nagarajan/P-7894-2016	Selvamurugan, Nagarajan/0000-0003-3713-1920; Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [DK47420]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK047420, R01DK047420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47420 (to N. C. P.).	Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; HOCK JM, 1992, J BONE MINER RES, V7, P65, DOI 10.1002/jbmr.5650070110; HOCK JM, 1988, ENDOCRINOLOGY, V122, P2899, DOI 10.1210/endo-122-6-2899; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARTRIDGE NC, 1987, ENDOCRINOLOGY, V120, P1956, DOI 10.1210/endo-120-5-1956; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Weir EC, 1996, J BONE MINER RES, V11, P1474; Westendorf JJ, 2007, J CELL BIOCHEM, V102, P332, DOI 10.1002/jcb.21486; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200; Yamagiwa H, 1999, BONE, V25, P197, DOI 10.1016/S8756-3282(99)00157-X; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhao WG, 1999, J CLIN INVEST, V103, P517, DOI 10.1172/JCI5481	36	65	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9616	9626		10.1074/jbc.M109.094862	http://dx.doi.org/10.1074/jbc.M109.094862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097749	hybrid, Green Published			2022-12-25	WOS:000276165900034
J	Szymanski, MR; Jezewska, MJ; Bujalowski, W				Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Wlodzimierz			The Escherichia coli PriA Helicase Specifically Recognizes Gapped DNA Substrates EFFECT OF THE TWO NUCLEOTIDE-BINDING SITES OF THE ENZYME ON THE RECOGNITION PROCESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; NUCLEOTIDE-BINDING SITES; PHI X174-TYPE PRIMOSOME; SWINE-FEVER VIRUS; QUANTITATIVE-ANALYSIS; NUCLEIC-ACID; HEXAMERIC HELICASE; PLASMID RSF1010; LARGE LIGANDS	Energetics and specificity of interactions between the Escherichia coli PriA helicase and the gapped DNAs have been studied, using the quantitative fluorescence titration and analytical ultracentrifugation methods. The gap complex has a surprisingly low minimum total site size, corresponding to similar to 7 nucleotides of the single-stranded DNA (ssDNA), as compared with the site size of similar to 20 nucleotides of the enzyme-ssDNA complex. The dramatic difference in stoichiometries indicates that the enzyme predominantly engages the strong DNA-binding subsite in interactions with the gap and assumes a very different orientation in the gap complex, as compared with the complex with the ssDNA. The helicase binds the ssDNA gaps with 4-5 nucleotides with the highest affinity, which is similar to 3 and similar to 2 orders of magnitude larger than the affinities for the ssDNA and double-stranded DNA, respectively. In the gap complex, the protein does not engage in cooperative interactions with the enzyme predominantly associated with the surrounding dsDNA. Binding of nucleoside triphosphate to the strong and weak nucleotide-binding sites of the helicase eliminates the selectivity of the enzyme for the size of the gap, whereas saturation of both sites with ADP leads to amplified affinity for the ssDNA gap containing 5 nucleotides and engagement of an additional protein area in interactions with the nucleic acid.	[Bujalowski, Wlodzimierz] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Dept Obstet & Gynecol,Sealy Ctr Struct Biol, Galveston, TX 77555 USA; Univ Texas Galveston, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bujalowski, W (corresponding author), Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Dept Obstet & Gynecol,Sealy Ctr Struct Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	wbujalow@utmb.edu		Szymanski, Michal/0000-0001-9452-8508	National Institutes of Health [GM46679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46679 (to W. B.).	ALLEN GC, 1993, J BIOL CHEM, V268, P19204; BAKER BM, 1978, BIOPOLYMERS, V17, P1361, DOI 10.1002/bip.1978.360170519; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; BUJALOWSKI W, 1989, BIOPOLYMERS, V28, P1637, DOI 10.1002/bip.360280912; Bujalowski W., 2000, SPECTROPHOTOMETRY SP, P141; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P591; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EPSTEIN IR, 1978, BIOPHYS CHEM, V8, P327, DOI 10.1016/0301-4622(78)80015-5; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Galletto R, 2004, BIOCHEMISTRY-US, V43, P11002, DOI 10.1021/bi049378q; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2007, DNA REPAIR, V6, P945, DOI 10.1016/j.dnarep.2007.02.014; Jezewska MJ, 2007, BIOCHEMISTRY-US, V46, P12909, DOI 10.1021/bi700677j; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jezewska MJ, 2006, J MOL BIOL, V356, P121, DOI 10.1016/j.jmb.2005.10.061; Jezewska MJ, 2004, J MOL BIOL, V343, P115, DOI 10.1016/j.jmb.2004.08.021; Jezewska MJ, 2003, BIOCHEMISTRY-US, V42, P11864, DOI 10.1021/bi030111l; Jezewska MJ, 2002, J BIOL CHEM, V277, P20316, DOI 10.1074/jbc.M200918200; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Jezewska MJ, 2000, J BIOL CHEM, V275, P27865; Jezewska MJ, 2000, BIOCHEMISTRY-US, V39, P10454, DOI 10.1021/bi001113y; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; LASKEN RS, 1988, J BIOL CHEM, V263, P5512; LEDNEVA RK, 1978, NUCLEIC ACIDS RES, V5, P4225, DOI 10.1093/nar/5.11.4225; LEE EH, 1990, P NATL ACAD SCI USA, V87, P4620, DOI 10.1073/pnas.87.12.4620; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; Liu J, 1996, J BIOL CHEM, V271, P15656, DOI 10.1074/jbc.271.26.15656; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; LOW RL, 1981, P NATL ACAD SCI-BIOL, V78, P1436, DOI 10.1073/pnas.78.3.1436; Lucius AL, 2006, BIOCHEMISTRY-US, V45, P7217, DOI 10.1021/bi051827e; Lucius AL, 2006, BIOCHEMISTRY-US, V45, P7237, DOI 10.1021/bi0518287; Lucius AL, 2006, BIOCHEMISTRY-US, V45, P7202, DOI 10.1021/bi051826m; Marcinowicz A, 2008, J MOL BIOL, V375, P386, DOI 10.1016/j.jmb.2007.06.051; Marcinowicz A, 2007, BIOCHEMISTRY-US, V46, P13279, DOI 10.1021/bi700729k; Marians KJ, 2000, PROG NUCLEIC ACID RE, V63, P39; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Ng JY, 1996, J BIOL CHEM, V271, P15649, DOI 10.1074/jbc.271.26.15649; North SH, 2005, MOL MICROBIOL, V56, P1601, DOI 10.1111/j.1365-2958.2005.04639.x; NURSE P, 1990, P NATL ACAD SCI USA, V87, P4615, DOI 10.1073/pnas.87.12.4615; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Roychowdhury A, 2009, BIOCHEMISTRY-US, V48, P6712, DOI 10.1021/bi900050x; Sandler SJ, 2001, MOL MICROBIOL, V41, P697, DOI 10.1046/j.1365-2958.2001.02547.x; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; SCHEKMAN R, 1975, J BIOL CHEM, V250, P5859; TOLMAN GL, 1974, BIOCHEMISTRY-US, V13, P4869, DOI 10.1021/bi00721a001; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P4120, DOI 10.1073/pnas.71.10.4120; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3	60	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9683	9696		10.1074/jbc.M109.094789	http://dx.doi.org/10.1074/jbc.M109.094789			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089865	hybrid, Green Published			2022-12-25	WOS:000276165900041
J	Honsho, M; Asaoku, S; Fujiki, Y				Honsho, Masanori; Asaoku, Shunsuke; Fujiki, Yukio			Posttranslational Regulation of Fatty Acyl-CoA Reductase 1, Far1, Controls Ether Glycerophospholipid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYL-DIHYDROXYACETONEPHOSPHATE SYNTHASE; RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; CHO-CELL MUTANT; PLASMALOGEN BIOSYNTHESIS; LIPID BIOSYNTHESIS; ACYLTRANSFERASE; RAT; IDENTIFICATION; PURIFICATION; OXIDOREDUCTASE	Plasmalogens are a major subclass of ethanolamine and choline glycerophospholipids in which a long chain fatty alcohol is attached at the sn-1 position through a vinyl ether bond. This ether-linked alkyl bond is formed in peroxisomes by replacement of a fatty acyl chain in the intermediate 1-acyl-dihydroxyacetone phosphate with a fatty alcohol in a reaction catalyzed by alkyl dihydroxyacetone phosphate synthase. Here, we demonstrate that the enzyme fatty acyl-CoA reductase 1 (Far1) supplies the fatty alcohols used in the formation of ether-linked alkyl bonds. Far1 activity is elevated in plasmalogen-deficient cells, and conversely, the levels of this enzyme are restored to normal upon plasmalogen supplementation. Down-regulation of Far1 activity in response to plasmalogens is achieved by increasing the rate of degradation of peroxisomal Far1 protein. Supplementation of normal cells with ethanolamine and 1-O-hexadecylglycerol, which are intermediates in plasmalogen biosynthesis, accelerates degradation of Far1. Taken together, our results indicate that ether lipid biosynthesis in mammalian cells is regulated by a negative feedback mechanism that senses cellular plasmalogen levels and appropriately increases or decreases Far1.	[Fujiki, Yukio] Kyushu Univ, Fac Sci, Dept Biol, Grad Sch,Higashi Ku, Fukuoka 8128581, Japan; [Asaoku, Shunsuke; Fujiki, Yukio] Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 8128581, Japan; [Fujiki, Yukio] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Grad Sch,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp		Honsho, Masanori/0000-0001-6165-4516	Science and Technology Agency of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Foundation for Applied Enzymology	Science and Technology Agency of Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology	This work was supported in part by a CREST grant from the Science and Technology Agency of Japan (to Y.F.); grants-in-aid for scientific research (to M. H. and Y.F.) and a grant from the Global Center of Excellence Program from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; a grant from the Japan Foundation for Applied Enzymology (to Y.F.).	BISHOP JE, 1981, J BIOL CHEM, V256, P9542; Bleijerveld OB, 2004, BIOCHEM J, V379, P711, DOI 10.1042/BJ20031422; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BURDETT K, 1991, J BIOL CHEM, V266, P12201; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; DAS AK, 1988, FEBS LETT, V227, P187, DOI 10.1016/0014-5793(88)80895-0; DAVIS PA, 1981, ARCH BIOCHEM BIOPHYS, V211, P20, DOI 10.1016/0003-9861(81)90424-0; de Vet ECJM, 1999, J LIPID RES, V40, P1998; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hajra AK, 2000, J BIOL CHEM, V275, P9441, DOI 10.1074/jbc.275.13.9441; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; JAMES PF, 1990, P NATL ACAD SCI USA, V87, P6102, DOI 10.1073/pnas.87.16.6102; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; LEE T, 1979, J BIOL CHEM, V254, P2892; LEE TC, 1980, BIOCHIM BIOPHYS ACTA, V619, P420, DOI 10.1016/0005-2760(80)90091-0; Liu DL, 2005, J LIPID RES, V46, P727, DOI 10.1194/jlr.M400364-JLR200; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; Nagan N, 1997, P NATL ACAD SCI USA, V94, P4475, DOI 10.1073/pnas.94.9.4475; Nagan N, 1998, BIOCHEM J, V332, P273, DOI 10.1042/bj3320273; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nishimukai M, 2003, LIPIDS, V38, P1227, DOI 10.1007/s11745-003-1183-9; RIZZO WB, 1993, BIOCHEM MED METAB B, V50, P93, DOI 10.1006/bmmb.1993.1050; Rizzo WB, 1998, MOL GENET METAB, V65, P63, DOI 10.1006/mgme.1998.2728; Rosenberger TA, 2002, J LIPID RES, V43, P59; Shimozawa N, 1999, J HUM GENET, V44, P123, DOI 10.1007/s100380050123; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Tanaka A, 2006, EXP CELL RES, V312, P1671, DOI 10.1016/j.yexcr.2006.01.028; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; WEBBER KO, 1993, ARCH BIOCHEM BIOPHYS, V300, P88, DOI 10.1006/abbi.1993.1013; Yang JY, 2003, FEBS LETT, V546, P247, DOI 10.1016/S0014-5793(03)00581-7; Zheng H, 2006, J LIPID RES, V47, P633, DOI 10.1194/jlr.M500493-JLR200	31	81	85	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8537	8542		10.1074/jbc.M109.083311	http://dx.doi.org/10.1074/jbc.M109.083311			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071337	hybrid, Green Published			2022-12-25	WOS:000275553700005
J	Nguyen, HM; Goldin, AL				Nguyen, Hai M.; Goldin, Alan L.			Sodium Channel Carboxyl-terminal Residue Regulates Fast Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; ALPHA-SUBUNIT; RAT-BRAIN; EF-HAND; ARRHYTHMOGENIC MECHANISM; MOLECULAR-MECHANISMS; MESSENGER-RNAS; LQT-3 MUTATION; DOMAIN; CALMODULIN	The Na(v)1.2 and Na(v)1.3 voltage-gated sodium channel isoforms demonstrate distinct differences in their kinetics and voltage dependence of fast inactivation when expressed in Xenopus oocytes. Co-expression of the auxiliary beta 1 subunit accelerated inactivation of both the Na(v)1.2 and Na(v)1.3 isoforms, but it did not eliminate the differences, demonstrating that this property is inherent in the alpha subunit. By constructing chimeric channels between Na(v)1.2 and Na(v)1.3, we demonstrate that the carboxyl terminus is responsible for the differences. The Na(v)1.2 carboxyl terminus caused faster inactivation in the Na(v)1.3 backbone, and the Na(v)1.3 carboxyl terminus caused slower inactivation in the Na(v)1.2 channel. Through analysis of truncated channels, we identified a homologous 60-amino acid region within the carboxyl terminus of the Na(v)1.2 and the Na(v)1.3 channels that is responsible for this modulation of fast inactivation. Site-directed replacement of Na(v)1.3 lysine 1826 in this region to its Na(v)1.2 analogue glutamic acid 1880 (K1826E) shifted the voltage dependence of inactivation toward that of Na(v)1.2. The K1826E mutation also accelerated the inactivation kinetics to a level comparable with that of Na(v)1.2. The reverse Na(v)1.2 E1880K mutation exhibited much slower inactivation kinetics and depolarized inactivation voltage dependence. A complementary mutation located within the inactivation linker of Na(v)1.3 (K1453E) caused inactivation changes mirroring those caused by the K1826E mutation in Na(v)1.3. Therefore, we have identified a homologous carboxyl-terminal residue that regulates the kinetics and voltage dependence of fast inactivation in sodium channels, possibly via a charge-dependent interaction with the inactivation linker.	Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Goldin, AL (corresponding author), B240 Med Sci 1, Irvine, CA 92697 USA.	agoldin@uci.edu	Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	National Institutes of Health [NS26729, NS48336]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048336, R01NS026729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS26729 and NS48336.	Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; [Anonymous], [No title captured]; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Bendahhou S, 1999, J PHYSIOL-LONDON, V518, P337, DOI 10.1111/j.1469-7793.1999.0337p.x; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bezzina C, 1999, CIRC RES, V85, P1206; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; BRYSCH W, 1991, EXP BRAIN RES, V86, P562; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Deschenes I, 2001, J MEMBRANE BIOL, V183, P103, DOI 10.1007/s00232-001-0058-5; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; FURUYAMA T, 1993, MOL BRAIN RES, V17, P169, DOI 10.1016/0169-328X(93)90087-6; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; Green DS, 1998, J PHYSIOL-LONDON, V510, P685, DOI 10.1111/j.1469-7793.1998.685bj.x; Hains BC, 2002, J NEUROSCI RES, V70, P546, DOI 10.1002/jnr.10402; Hille B., 2001, ION CHANNELS EXCITAB, P75; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; Keating MT, 1996, SCIENCE, V272, P681, DOI 10.1126/science.272.5262.681; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Kontis KJ, 1997, J GEN PHYSIOL, V110, P391, DOI 10.1085/jgp.110.4.391; Kuhn FJP, 1999, J GEN PHYSIOL, V114, P167, DOI 10.1085/jgp.114.2.167; Makita N, 1998, FEBS LETT, V423, P5, DOI 10.1016/S0014-5793(98)00033-7; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Miloushev VZ, 2009, J BIOL CHEM, V284, P6446, DOI 10.1074/jbc.M807401200; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Mori M, 2003, BIOCHEM BIOPH RES CO, V307, P290, DOI 10.1016/S0006-291X(03)01183-5; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Nabbout R, 2003, NEUROLOGY, V60, P1961, DOI 10.1212/01.WNL.0000069463.41870.2F; OLEARY ME, 1995, J GEN PHYSIOL, V106, P641, DOI 10.1085/jgp.106.4.641; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PATTON DE, 1991, NEURON, V7, P637, DOI 10.1016/0896-6273(91)90376-B; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Tan BH, 2007, CARDIOVASC RES, V76, P409, DOI 10.1016/j.cardiores.2007.08.006; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; WANG Q, 1995, HUM MOL GENET, V4, P1603, DOI 10.1093/hmg/4.9.1603; Wehrens XHT, 2000, CIRCULATION, V102, P584; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737	59	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9077	9089		10.1074/jbc.M109.054940	http://dx.doi.org/10.1074/jbc.M109.054940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089854	Green Published, hybrid			2022-12-25	WOS:000275553700058
J	Swanson, MD; Winter, HC; Goldstein, IJ; Markovitz, DM				Swanson, Michael D.; Winter, Harry C.; Goldstein, Irwin J.; Markovitz, David M.			A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN GP120; INFECTIOUS MOLECULAR CLONE; HEPATITIS-C VIRUS; CYANOVIRIN-N; PLANT-LECTINS; CARBOHYDRATE-BINDING; ANTIBODY 2G12; IN-VITRO; V3 LOOP	BanLec is a jacalin-related lectin isolated from the fruit of bananas, Musa acuminata. This lectin binds to high mannose carbohydrate structures, including those found on viruses containing glycosylated envelope proteins such as human immunodeficiency virus type-1 (HIV-1). Therefore, we hypothesized that BanLec might inhibit HIV-1 through binding of the glycosylated HIV-1 envelope protein, gp120. We determined that BanLec inhibits primary and laboratory-adapted HIV-1 isolates of different tropisms and subtypes. BanLec possesses potent anti-HIV activity, with IC50 values in the low nanomolar to picomolar range. The mechanism for BanLec-mediated antiviral activity was investigated by determining if this lectin can directly bind the HIV-1 envelope protein and block entry of the virus into the cell. Anenzyme-linked immunosorbent assay confirmed direct binding of BanLec to gp120 and indicated that BanLec can recognize the high mannose structures that are recognized by the monoclonal antibody 2G12. Furthermore, BanLec is able to block HIV-1 cellular entry as indicated by temperature-sensitive viral entry studies and by the decreased levels of the strong-stop product of early reverse transcription seen in the presence of BanLec. Thus, our data indicate that BanLec inhibits HIV-1 infection by binding to the glycosylated viral envelope and blocking cellular entry. The relative anti-HIV activity of BanLec compared favorably to other anti-HIV lectins, such as snowdrop lectin and Griffithsin, and to T-20 and mara-viroc, two anti-HIV drugs currently in clinical use. Based on these results, BanLec is a potential component for an anti-viral microbicide that could be used to prevent the sexual transmission of HIV-1.	[Markovitz, David M.] Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; [Swanson, Michael D.; Markovitz, David M.] Univ Michigan, Med Ctr, Program Immunol, Ann Arbor, MI 48109 USA; [Markovitz, David M.] Univ Michigan, Med Ctr, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Winter, Harry C.; Goldstein, Irwin J.] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Markovitz, DM (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, 5220 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	dmarkov@umich.edu			National Institutes of Health [R01 AI062248]; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI062248 (of D. M. M.). This work was also supported by a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Barrientos LG, 2004, J INFECT DIS, V189, P1440, DOI 10.1086/382658; Barrientos LG, 2003, ANTIVIR RES, V58, P47, DOI 10.1016/S0166-3542(02)00183-3; Bertaux C, 2007, VIROLOGY, V366, P40, DOI 10.1016/j.virol.2007.04.008; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; CHESEBRO B, 1991, J INFECT DIS, V163, P64, DOI 10.1093/infdis/163.1.64; CHESEBRO B, 1991, J VIROL, V65, P5782, DOI 10.1128/JVI.65.11.5782-5789.1991; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Crosby R, 2005, J AM COLL HEALTH, V54, P143, DOI 10.3200/JACH.54.3.143-148; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gavrovic-Jankulovic M, 2008, INT J BIOCHEM CELL B, V40, P929, DOI 10.1016/j.biocel.2007.10.033; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GEYER H, 1988, J BIOL CHEM, V263, P11760; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; Gupta GR, 2002, BRIT MED J, V324, P183, DOI 10.1136/bmj.324.7331.183; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Jeyaprakash AA, 2004, J MOL BIOL, V338, P757, DOI 10.1016/j.jmb.2004.03.040; Keyaerts E, 2007, ANTIVIR RES, V75, P179, DOI 10.1016/j.antiviral.2007.03.003; KOSHTE VL, 1990, BIOCHEM J, V272, P721, DOI 10.1042/bj2720721; Kothe DL, 2006, VIROLOGY, V352, P438, DOI 10.1016/j.virol.2006.05.011; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Lis H., 2003, LECTINS; MATTHEWS TJ, 1987, P NATL ACAD SCI USA, V84, P5424, DOI 10.1073/pnas.84.15.5424; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Mo HQ, 2001, EUR J BIOCHEM, V268, P2609, DOI 10.1046/j.1432-1327.2001.02148.x; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nakamura-Tsuruta S, 2008, FEBS J, V275, P1227, DOI 10.1111/j.1742-4658.2008.06282.x; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Randolph ME, 2007, ARCH SEX BEHAV, V36, P844, DOI 10.1007/s10508-007-9213-0; Saidi H, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-28; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Schmidtmayerova H, 1998, J VIROL, V72, P4633, DOI 10.1128/JVI.72.6.4633-4642.1998; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Singh DD, 2005, GLYCOBIOLOGY, V15, P1025, DOI 10.1093/glycob/cwi087; Smee DF, 2008, ANTIVIR RES, V80, P266, DOI 10.1016/j.antiviral.2008.06.003; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; TOOHEY K, 1995, VIROLOGY, V213, P70, DOI 10.1006/viro.1995.1547; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; UNAIDS, 2008, REP GLOB AIDS EP; Underhill K, 2007, BMJ-BRIT MED J, V335, P248, DOI 10.1136/bmj.39245.446586.BE; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Warrilow D, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-77; Warrilow D, 2008, J VIROL, V82, P1425, DOI 10.1128/JVI.01808-07; WATTS C, 2002, MICROBICIDES; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Witvrouw M, 2005, J VIROL, V79, P7777, DOI 10.1128/JVI.79.12.7777-7784.2005; Zappe H, 2008, ADV DRUG DELIVER REV, V60, P79, DOI 10.1016/j.addr.2007.05.016; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	73	134	141	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8646	8655		10.1074/jbc.M109.034926	http://dx.doi.org/10.1074/jbc.M109.034926			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080975	hybrid, Green Published			2022-12-25	WOS:000275553700017
J	Zhao, PS; Nguyen, CH; Chidiac, P				Zhao, Peishen; Nguyen, Chau H.; Chidiac, Peter			The Proline-rich N-terminal Domain of G18 Exhibits a Novel G Protein Regulatory Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; DISSOCIATION INHIBITOR ACTIVITY; GUANINE-NUCLEOTIDE EXCHANGE; G-ALPHA SUBUNITS; GOLOCO MOTIF; STRUCTURAL DETERMINANTS; SIGNAL INTEGRATION; BINDING PROTEIN; RECEPTOR; PINS	The protein G18 (also known as AGS4 or GPSM3) contains three conserved GoLoco/GPR domains in its central and C-terminal regions that bind to inactive G alpha(i), whereas the N-terminal region has not been previously characterized. We investigated whether this domain might itself regulate G protein activity by assessing the abilities of G18 and mutants thereof to modulate the nucleotide binding and hydrolytic properties of G alpha(i1) and G alpha(o). Surprisingly, in the presence of fluoroaluminate (AlF4-) both G proteins bound strongly to full-length G18 (G18wt) and to its isolated N-terminal domain (G18 Delta C) but not to its GoLoco region (Delta NG18). Thus, it appears that its N-terminal domain promotes G18 binding to fluoroaluminate-activated G alpha(i/o). Neither G18wt nor any G18 mutant affected the GTPase activity of G alpha(i1) or G alpha(o). In contrast, complex effects were noted with respect to nucleotide binding. As inferred by the binding of [S-35]GTP gamma S (guanosine 5'-O-[gamma-thio]triphosphate) to G alpha(i1), the isolated GoLoco region as expected acted as a guanine nucleotide dissociation inhibitor, whereas the N-terminal region exhibited a previously unknown guanine nucleotide exchange factor effect on this G protein. On the other hand, the N terminus inhibited [S-35]GTP gamma S binding to G alpha(o), albeit to a lesser extent than the effect of the GoLoco region on G alpha(i1). Taken together, our results identify the N-terminal region of G18 as a novel G protein-interacting domain that may have distinct regulatory effects within the G(i/o) subfamily, and thus, it could potentially play a role in differentiating signals between these related G proteins.	[Chidiac, Peter] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Chidiac, P (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	peter.chidiac@schulich.uwo.ca	Zhao, Peishen/AFQ-6840-2022; Chidiac, Peter/L-5906-2015	Chidiac, Peter/0000-0001-8365-6109	Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by the Canadian Institutes of Health Research. Holds a Career Investigator Award from the Heart and Stroke Foundation of Ontario.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P2209, DOI 10.1016/j.cellsig.2006.05.011; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cladman W, 2002, MOL PHARMACOL, V62, P654, DOI 10.1124/mol.62.3.654; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Garbay C, 2000, BIOCHEM PHARMACOL, V60, P1165, DOI 10.1016/S0006-2952(00)00428-7; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Gruen JR, 2001, FRONT BIOSCI-LANDMRK, V6, pD960, DOI 10.2741/Gruen; Guo XZ, 2009, CELL RES, V19, P838, DOI 10.1038/cr.2009.54; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Kimple Randall J, 2002, Mol Interv, V2, P88, DOI 10.1124/mi.2.2.88; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kinoshita-Kawada M, 2004, MOL BRAIN RES, V132, P73, DOI 10.1016/j.molbrainres.2004.09.007; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Luo Y, 1999, J BIOL CHEM, V274, P10685, DOI 10.1074/jbc.274.16.10685; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Moulds JM, 2001, FRONT BIOSCI-LANDMRK, V6, pD986, DOI 10.2741/Moulds; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oshiro T, 2002, J BIOL CHEM, V277, P38618, DOI 10.1074/jbc.M203453200; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; STRITTMATTER SM, 1991, J BIOL CHEM, V266, P22465; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Willard FS, 2006, CELL SIGNAL, V18, P1226, DOI 10.1016/j.cellsig.2005.10.003; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505	52	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9008	9017		10.1074/jbc.M109.057174	http://dx.doi.org/10.1074/jbc.M109.057174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097748	hybrid, Green Published			2022-12-25	WOS:000275553700052
J	Sridharan, H; Zhao, C; Krug, RM				Sridharan, Haripriya; Zhao, Chen; Krug, Robert M.			Species Specificity of the NS1 Protein of Influenza B Virus NS1 BINDS ONLY HUMAN AND NON-HUMAN PRIMATE UBIQUITIN-LIKE ISG15 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL MOLECULE; STIMULATED GENE-15; UBIQUITIN E2; ISG15; CONJUGATION; ENZYME; IDENTIFICATION; TARGETS; LIGASE; HERC5	Influenza B viruses, which cause a highly contagious respiratory disease every year, are restricted to humans, but the basis for this restriction had not been determined. Here we provide one explanation for this restriction: the species specificity exhibited by the NS1 protein of influenza B virus (NS1B protein). This viral protein combats a major host antiviral response by binding the interferon-alpha/beta-induced, ubiquitin-like ISG15 protein and inhibiting its conjugation to an array of proteins. We demonstrate that the NS1B protein exhibits species-specific binding; it binds human and non-human primate ISG15 but not mouse or canine ISG15. In both transfection assays and virus-infected cells, the NS1B protein binds and relocalizes only human and non-human primate ISG15 from the cytoplasm to nuclear speckles. Human and non-human primate ISG15 proteins consist of two ubiquitin-like domains separated by a short hinge linker of five amino acids. Remarkably, this short hinge plays a large role in the species-specific binding by the NS1B protein. The hinge of human and non-human primate ISG15, which has a sequence that differs from that of other mammalian ISG15 proteins, including mouse and canine ISG15, is absolutely required for binding the NS1B protein. Consequently, the ISG15 proteins of humans and non-human primates are the only mammalian ISG15 proteins that would bind NS1B.	[Sridharan, Haripriya; Zhao, Chen; Krug, Robert M.] Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Krug, RM (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, 2500 Speedway,MBB 2-122, Austin, TX 78712 USA.	rkrug@mail.utexas.edu	Zhao, Chen/A-9987-2011		National Institutes of Health [AI11772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI011772, R01AI011772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI11772 (to R.M.K.).	[Anonymous], FIELDS VIROLOGY; Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Guerra S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000096; Hoffmann E, 2002, P NATL ACAD SCI USA, V99, P11411, DOI 10.1073/pnas.172393399; Hsiang TY, 2009, J VIROL, V83, P5971, DOI 10.1128/JVI.01667-08; Huber VC, 2008, VACCINE, V26, P5381, DOI 10.1016/j.vaccine.2008.07.086; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Schneider J, 2009, J VIROL, V83, P701, DOI 10.1128/JVI.01858-08; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	23	56	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7852	7856		10.1074/jbc.C109.095703	http://dx.doi.org/10.1074/jbc.C109.095703			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20093371	Green Published, hybrid			2022-12-25	WOS:000275413800002
J	Baert, JL; Monte, D; Verreman, K; Degerny, C; Coutte, L; Launoit, Y				Baert, J-L; Monte, D.; Verreman, K.; Degerny, C.; Coutte, L.; de Launoit, Y.			The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity	ONCOGENE			English	Article						ETS; ERM; transcription factor; Ub-modification; COP1; DET1	PHOTOMORPHOGENESIS; IDENTIFICATION; DOMAIN; JUN	In this study, we report that the PEA3 group members interact with the mammalian really interesting new gene (RING) E3 ubiquitin ligase constitutive photomorphogenetic 1 (COP1), which mediates ubiquitylation and subsequent proteasome degradation of the p53 and c-Jun transcription factors. This interaction is mediated by the central region of COP1 including the coiled-coil domain and two COP1-interacting consensus motifs localized in the well-conserved N-terminal transactivation domain of the PEA3 group members. At the transcriptional level, COP1 reduces the transcriptional activity of ERM and the two other PEA3 group proteins on Ets-responsive reporter genes; this effect being dependent on the RING domain of COP1 and the two COP1-interacting motifs of ERM. Reduced transcriptional activity was, however, not related to COP1-induced changes in ERM stability. In fact, increased ubiquitylation and subsequent proteasome-mediated degradation of ERM is achieved only when COP1 is expressed with DET1, a key COP1 partner within the ubiquitylation complex. Conversely, we show that the depletion of COP1 or DET1 by small interference RNA (siRNA) in U2OS cells stabilizes endogenous ERM whereas only COP1 knockdown enhances expression of ICAM-1, a gene regulated by this transcription factor. These results indicate that COP1 is a complex regulator of ERM and the two other PEA3 group members. Oncogene (2010) 29, 1810-1820; doi:10.1038/onc.2009.471; published online 11 January 2010	[Baert, J-L] Univ Lille Nord France, Inst Biol, Inst Pasteur, CNRS,UMR 8161,IFR 142, F-59021 Lille, France; [Degerny, C.] Univ Paris 11, Inst Andre Lwoff, CNRS, FRE 2944, Villejuif, France; [Coutte, L.] Univ Paris 11, Fac Sci, Lab Biol Anim, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Baert, JL (corresponding author), Univ Lille Nord France, Inst Biol, Inst Pasteur, CNRS,UMR 8161,IFR 142, BP 447,1 Rue Calmette, F-59021 Lille, France.	jean-luc.baert@ibl.fr; yvan.delaunoit@ibl.fr		de Launoit, Yvan/0000-0003-1837-9808; coutte, laurent/0000-0002-0031-4742; monte, didier/0000-0002-0613-6203	'Ligue Nationale Contre le Cancer' (Comite Nord, France); 'Association pour la Recherche contre le Cancer' (France); 'Conseil Regional Nord/Pas-de-Calais' (France); European Regional Development Fund	'Ligue Nationale Contre le Cancer' (Comite Nord, France); 'Association pour la Recherche contre le Cancer' (France)(Fondation ARC pour la Recherche sur le Cancer); 'Conseil Regional Nord/Pas-de-Calais' (France)(Region Hauts-de-France); European Regional Development Fund(European Commission)	This work was carried out thanks to grants awarded by the 'Ligue Nationale Contre le Cancer' (Comite Nord, France), the 'Association pour la Recherche contre le Cancer' (France), the 'Conseil Regional Nord/Pas-de-Calais' (France) and the European Regional Development Fund (Intergenes program). We thank E Bianchi and VM Dixit for kind gifts of plasmids.	Baert JL, 2007, ONCOGENE, V26, P415, DOI 10.1038/sj.onc.1209801; Baert JL, 1997, INT J CANCER, V70, P590, DOI 10.1002/(SICI)1097-0215(19970304)70:5<590::AID-IJC17>3.0.CO;2-H; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Coutte L, 1999, ONCOGENE, V18, P6278, DOI 10.1038/sj.onc.1203020; de Launoit Y, 2000, ADV EXP MED BIOL, V480, P107; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Defossez PA, 1997, NUCLEIC ACIDS RES, V25, P4455, DOI 10.1093/nar/25.22.4455; Degerny C, 2005, J BIOL CHEM, V280, P24330, DOI 10.1074/jbc.M411250200; Di Bacco A, 2006, CELL CYCLE, V5, P2310, DOI 10.4161/cc.5.20.3367; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Kato S, 2008, J BIOL CHEM, V283, P35464, DOI 10.1074/jbc.M801011200; Liu Y, 2006, MOL CELL BIOL, V26, P3114, DOI 10.1128/MCB.26.8.3114-3123.2006; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Takahashi A, 2005, BIOCHEM BIOPH RES CO, V327, P575, DOI 10.1016/j.bbrc.2004.12.045; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007	20	35	35	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1810	1820		10.1038/onc.2009.471	http://dx.doi.org/10.1038/onc.2009.471			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20062082	Green Published			2022-12-25	WOS:000276022800010
J	Cha, SK; Huang, CL				Cha, Seung-Kuy; Huang, Chou-Long			WNK4 Kinase Stimulates Caveola-mediated Endocytosis of TRPV5 Amplifying the Dynamic Range of Regulation of the Channel by Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERKALEMIC HYPERTENSION; CA2+ REABSORPTION; MOLECULAR PATHOGENESIS; PARATHYROID-HORMONE; COORDINATED CONTROL; TISSUE KALLIKREIN; PLASMA-MEMBRANE; ADAPTER PROTEIN; EPS15 HOMOLOGY; BLOOD-PRESSURE	WNK4 (with-no-lysine (K) kinase-4) is present in the distal nephron of the kidney and plays an important role in the regulation of renal ion transport. The epithelial Ca2+ channel TRPV5 (transient receptor potential vanilloid 5) is the gatekeeper of transcellular Ca2+ reabsorption in the distal nephron. Previously, we reported that activation of protein kinase C (PKC) increases cell-surface abundance of TRPV5 by inhibiting caveola-mediated endocytosis of the channel. Here, we report that WNK4 decreases cell-surface abundance of TRPV5 by enhancing its endocytosis. Deletion analysis revealed that stimulation of endocytosis of TRPV5 involves amino acids outside the kinase domain of WNK4. We also investigated interplay between WNK4 and PKC regulation of TRPV5. The maximal level of TRPV5 current density stimulated by the PKC activator 1-oleoyl-acetyl-sn- glycerol (OAG) is the same with or without WNK4. The relative increase of TRPV5 current stimulated by OAG, however, is greater in the presence of WNK4 compared with that without WNK4 (similar to 215% increase versus 60% increase above the level without OAG). Moreover, the rate of increase of TRPV5 by OAG is faster with WNK4 than without WNK4. The enhanced increase of TRPV5 in the presence of WNK4 is also observed when PKC is activated by parathyroid hormones. Thus, WNK4 exerts tonic inhibition of TRPV5 by stimulating caveola-mediated endocytosis. The lower basal TRPV5 level in the presence of WNK4 allows amplification of the stimulation of channel by PKC. This interaction between WNK4 and PKC regulation of TRPV5 may be important for physiological regulation of renal Ca2+ reabsorption by parathyroid hormones or the tissue kallikrein in vivo.	[Cha, Seung-Kuy; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, Dallas, TX 75390 USA; [Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Huang, CL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	chou-long.huang@utsouthwestern.edu			National Institutes of Health [DK-20543, DK-85726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085726, P01DK020543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-20543 and DK-85726.	Achard JM, 2003, AM J MED, V114, P495, DOI 10.1016/S0002-9343(03)00054-8; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; Deal C, 2003, CLEV CLIN J MED, V70, P585, DOI 10.3949/ccjm.70.7.585; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Ellison DH, 2003, J AM SOC NEPHROL, V14, P538, DOI 10.1681/ASN.V142538; FIGUEROA CD, 1988, HISTOCHEMISTRY, V89, P437, DOI 10.1007/BF00492599; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hecquet C, 2000, MOL PHARMACOL, V58, P828, DOI 10.1124/mol.58.4.828; Hoenderop JGJ, 1999, KIDNEY INT, V55, P225, DOI 10.1046/j.1523-1755.1999.00228.x; Hoenderop JGJ, 2002, ANNU REV PHYSIOL, V64, P529, DOI 10.1146/annurev.physiol.64.081501.155921; Holden S, 2004, GENE, V335, P109, DOI 10.1016/j.gene.2004.03.009; Huang CL, 2008, CURR OPIN NEPHROL HY, V17, P519, DOI 10.1097/MNH.0b013e32830dd580; Jiang Y, 2008, BIOCHEM BIOPH RES CO, V375, P225, DOI 10.1016/j.bbrc.2008.08.010; Jiang Y, 2007, AM J PHYSIOL-RENAL, V292, pF545, DOI 10.1152/ajprenal.00187.2006; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lambers TT, 2006, KIDNEY INT, V69, P650, DOI 10.1038/sj.ki.5000169; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Mayan H, 2004, J CLIN ENDOCR METAB, V89, P4025, DOI 10.1210/jc.2004-0037; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; van Abel M, 2005, KIDNEY INT, V68, P1708, DOI 10.1111/j.1523-1755.2005.00587.x; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009	44	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6604	6611		10.1074/jbc.M109.056044	http://dx.doi.org/10.1074/jbc.M109.056044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20061383	Green Published, hybrid			2022-12-25	WOS:000275367500065
J	Ichijima, Y; Yoshioka, K; Yoshioka, Y; Shinohe, K; Fujimori, H; Unno, J; Takagi, M; Goto, H; Inagaki, M; Mizutani, S; Teraoka, H				Ichijima, Yosuke; Yoshioka, Ken-ichi; Yoshioka, Yoshiko; Shinohe, Keitaro; Fujimori, Hiroaki; Unno, Junya; Takagi, Masatoshi; Goto, Hidemasa; Inagaki, Masaki; Mizutani, Shuki; Teraoka, Hirobumi			DNA Lesions Induced by Replication Stress Trigger Mitotic Aberration and Tetraploidy Development	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; HUMAN-CELLS; HOMOLOGOUS RECOMBINATION; DAMAGE CHECKPOINT; TUMOR-SUPPRESSOR; CATASTROPHE; TUMORIGENESIS; CYTOKINESIS; ANEUPLOIDY; PHOSPHORYLATION	During tumorigenesis, cells acquire immortality in association with the development of genomic instability. However, it is still elusive how genomic instability spontaneously generates during the process of tumorigenesis. Here, we show that precancerous DNA lesions induced by oncogene acceleration, which induce situations identical to the initial stages of cancer development, trigger tetraploidy/aneuploidy generation in association with mitotic aberration. Although oncogene acceleration primarily induces DNA replication stress and the resulting lesions in the S phase, these lesions are carried over into the M phase and cause cytokinesis failure and genomic instability. Unlike directly induced DNA double-strand breaks, DNA replication stress-associated lesions are cryptogenic and pass through cell-cycle checkpoints due to limited and ineffective activation of checkpoint factors. Furthermore, since damaged M-phase cells still progress in mitotic steps, these cells result in chromosomal mis-segregation, cytokinesis failure and the resulting tetraploidy generation. Thus, our results reveal a process of genomic instability generation triggered by precancerous DNA replication stress.	[Ichijima, Yosuke; Yoshioka, Ken-ichi; Yoshioka, Yoshiko; Shinohe, Keitaro; Fujimori, Hiroaki; Teraoka, Hirobumi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Tokyo, Japan; [Yoshioka, Ken-ichi; Fujimori, Hiroaki] Natl Canc Ctr, Res Inst, Div Biochem, Tokyo 104, Japan; [Unno, Junya; Takagi, Masatoshi; Mizutani, Shuki] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch, Tokyo, Japan; [Goto, Hidemasa; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 464, Japan	Tokyo Medical & Dental University (TMDU); National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); Aichi Cancer Center	Ichijima, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Tokyo, Japan.	kyoshiok@ncc.go.jp	Inagaki, Masaki/B-9920-2016; Takagi, Masatoshi/F-3713-2011	Takagi, Masatoshi/0000-0002-7580-9184; Goto, Hidemasa/0000-0002-6796-4467	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20770136, 20659047]; Grants-in-Aid for Scientific Research [19057010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI (20770136, 20659047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Huang XX, 2005, P NATL ACAD SCI USA, V102, P1065, DOI 10.1073/pnas.0409130102; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McCollum D, 2004, CURR BIOL, V14, pR953, DOI 10.1016/j.cub.2004.10.040; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakada S, 2006, J CLIN INVEST, V116, P80, DOI 10.1172/JCI25716; Narisawa-Saito M, 2007, ONCOGENE, V26, P2988, DOI 10.1038/sj.onc.1210118; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tripathi V, 2007, J CELL BIOL, V178, P9, DOI 10.1083/jcb.200610051; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	34	62	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8821	10.1371/journal.pone.0008821	http://dx.doi.org/10.1371/journal.pone.0008821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098673	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779100013
J	Schutte, A; Hedrich, J; Stocker, W; Becker-Pauly, C				Schuette, Andre; Hedrich, Jana; Stoecker, Walter; Becker-Pauly, Christoph			Let It Flow: Morpholino Knockdown in Zebrafish Embryos Reveals a Pro-Angiogenic Effect of the Metalloprotease Meprin alpha(2)	PLOS ONE			English	Article							BETA-SUBUNIT; DIFFERENTIAL EXPRESSION; MOUSE KIDNEY; ENDOPEPTIDASES; ACTIVATION; CANCER; CELLS	Background: Meprin metalloproteases are thought to be involved in basic physiological functions such as cell proliferation and tissue differentiation. However, the specific functions of these enzymes are still ambiguous, although a variety of growth factors and structural proteins have been identified as meprin substrates. The discovery of meprins alpha(1), alpha(2) and beta in teleost fish provided the basis for uncovering their physiological functions by gene silencing in vivo. Methodology/Principal Findings: A Morpholino knockdown in zebrafish embryos targeting meprin alpha(1) and beta mRNA caused defects in general tissue differentiation. But meprin alpha(2) morphants were affected more specifically and showed severe failures in the formation of the vascular system provoking the hypothesis of a pro-angiogenic effect. The blood circulation was largely diminished resulting in erythrocyte accumulation. These phenotypes mimic a previously described VEGF-A morphant, revealing a possible role of meprin alpha in VEGF-A activation. Indeed, human recombinant meprin alpha processed the vascular endothelial growth factor-A (VEGF-A) specifically, revealing the same cleavage products detectable for VEGF from zebrafish whole lysate. Conclusions/Significance: Our results demonstrate that meprin metalloproteases are important for cell differentiation and proliferation already during embryogenesis, predominantly by the activation of growth factors. Thus, we conclude that meprins play a significant role in VEGF-A processing, subsequently regulating angiogenesis. Therefore, meprin alpha might be a new therapeutic target in cardiovascular diseases or in tumor growth inhibition.	[Schuette, Andre; Hedrich, Jana; Stoecker, Walter; Becker-Pauly, Christoph] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, Mainz, Germany	Johannes Gutenberg University of Mainz	Schutte, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, Mainz, Germany.	beckerpa@uni-mainz.de	Becker-Pauly, Christoph/B-7569-2011; Schütte, Andre/N-6761-2014; Stöcker, Walter/AAB-9704-2019; Schuette, Andre/GXH-6728-2022	Stöcker, Walter/0000-0002-1515-6994; Schutte, Andre/0000-0003-3209-0373	Deutsche Forschungsgemeinschaft [BE-4086/1-1]; EU; Johannes Gutenberg-University of Mainz, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); Johannes Gutenberg-University of Mainz, Germany	This work was supported by the Deutsche Forschungsgemeinschaft (BE-4086/1-1) to CB, the EU FP7 Health IBDase to CB and WS, a start-up grant to CB, and a PhD fellowship to AS from the Johannes Gutenberg-University of Mainz, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE S, 2009, MUCOSAL IMMUNOLOGY; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; BERGIN DA, 2008, J BIOL CHEM; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Elias PM, 2008, AM J PATHOL, V173, P689, DOI 10.2353/ajpath.2008.080088; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Ishmael FT, 2001, J BIOL CHEM, V276, P23207, DOI 10.1074/jbc.M102654200; KANE DA, 1993, DEVELOPMENT, V119, P447; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOUNNAS MZ, 1991, J BIOL CHEM, V266, P17350; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Lottaz D, 2007, BIOL CHEM, V388, P337, DOI 10.1515/BC.2007.038; Matters GL, 2005, CLIN EXP METASTAS, V22, P331, DOI 10.1007/s10585-005-0660-5; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Oneda B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002278; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Schutte A, 2007, BIOL CHEM, V388, P523, DOI 10.1515/BC.2007.060; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; STOCKER W, 1995, PROTEIN SCI, V4, P823; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143	30	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8835	10.1371/journal.pone.0008835	http://dx.doi.org/10.1371/journal.pone.0008835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098618	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779100026
J	Shin, R; Cao, JR; Webb, SM; Ikemoto, S				Shin, Rick; Cao, Junran; Webb, Sierra M.; Ikemoto, Satoshi			Amphetamine Administration into the Ventral Striatum Facilitates Behavioral Interaction with Unconditioned Visual Signals in Rats	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; FREELY-MOVING RATS; OLFACTORY TUBERCLE; LOCOMOTOR-ACTIVITY; PLACE PREFERENCE; TEGMENTAL AREA; CONDITIONED REINFORCEMENT; DOPAMINERGIC-NEURONS; INCENTIVE SALIENCE; DRUG SEEKING	Background: Administration of psychomotor stimulants like amphetamine facilitates behavior in the presence of incentive distal stimuli, which have acquired the motivational properties of primary rewards through associative learning. This facilitation appears to be mediated by the mesolimbic dopamine system, which may also be involved in facilitating behavior in the presence of distal stimuli that have not been previously paired with primary rewards. However, it is unclear whether psychomotor stimulants facilitate behavioral interaction with unconditioned distal stimuli. Principal Findings: We found that noncontingent administration of amphetamine into subregions of the rat ventral striatum, particularly in the vicinity of the medial olfactory tubercle, facilitates lever pressing followed by visual signals that had not been paired with primary rewards. Noncontingent administration of amphetamine failed to facilitate lever pressing when it was followed by either tones or delayed presentation or absence of visual signals, suggesting that visual signals are key for enhanced behavioral interaction. Systemic administration of amphetamine markedly increased locomotor activity, but did not necessarily increase lever pressing rewarded by visual signals, suggesting that lever pressing is not a byproduct of heightened locomotor activity. Lever pressing facilitated by amphetamine was reduced by co-administration of the dopamine receptor antagonists SCH 23390 (D1 selective) or sulpiride (D2 selective). Conclusions: Our results suggest that amphetamine administration into the ventral striatum, particularly in the vicinity of the medial olfactory tubercle, activates dopaminergic mechanisms that strongly enhance behavioral interaction with unconditioned visual stimuli.	[Shin, Rick; Cao, Junran; Webb, Sierra M.; Ikemoto, Satoshi] Natl Inst Drug Abuse, Behav Neurosci Res Branch, NIH, US Dept HHS, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Shin, R (corresponding author), Natl Inst Drug Abuse, Behav Neurosci Res Branch, NIH, US Dept HHS, Baltimore, MD USA.	Satoshi.Ikemoto@nih.gov	Cao, Junran/E-7354-2013	Ikemoto, Satoshi/0000-0002-0732-7386	Intramural Research Program of the National Institute on Drug Abuse; National Institutes of Health [DA000439-10]; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000439, ZIADA000439, K02DA000439] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This research was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health (Project number: DA000439-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona BJ, 2009, EUR J NEUROSCI, V30, P1889, DOI 10.1111/j.1460-9568.2009.07027.x; BADIANI A, 1995, PSYCHOPHARMACOLOGY, V117, P443, DOI 10.1007/BF02246217; Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; BARDO MT, 1989, PHARMACOL BIOCHEM BE, V32, P683, DOI 10.1016/0091-3057(89)90018-X; BERLYNE DE, 1969, ANN NY ACAD SCI, V159, P1059, DOI 10.1111/j.1749-6632.1969.tb12997.x; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Besheer J, 1999, BEHAV BRAIN RES, V103, P35, DOI 10.1016/S0166-4328(99)00021-2; Cadoni C, 2000, EUR J PHARMACOL, V387, pR23, DOI 10.1016/S0014-2999(99)00843-2; Chaudhri N, 2006, PSYCHOPHARMACOLOGY, V184, P353, DOI 10.1007/s00213-005-0178-1; CLARKE PBS, 1985, BRAIN RES, V348, P355, DOI 10.1016/0006-8993(85)90456-1; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; Crombag HS, 1996, BRAIN RES, V722, P227, DOI 10.1016/0006-8993(96)00066-2; CROW TJ, 1973, PSYCHOL MED, V3, P66, DOI 10.1017/S0033291700046353; David V, 2006, NEUROPHARMACOLOGY, V50, P1030, DOI 10.1016/j.neuropharm.2006.02.003; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Donny EC, 2003, PSYCHOPHARMACOLOGY, V169, P68, DOI 10.1007/s00213-003-1473-3; FINK JS, 1979, J COMP PHYSIOL PSYCH, V93, P34, DOI 10.1037/h0077587; Gray JA, 1995, BEHAV BRAIN RES, V71, P19, DOI 10.1016/0166-4328(95)00154-9; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Heimer L, 1975, GOLGI CENTENNIAL S P, P177; Heimer L., 1978, LIMBIC MECHANISMS CO, P95; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; HUSTON JP, 1989, NEUROSCI BIOBEHAV R, V13, P171, DOI 10.1016/S0149-7634(89)80027-2; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ikemoto S, 2006, J NEUROSCI, V26, P723, DOI 10.1523/JNEUROSCI.4542-05.2006; Ikemoto S, 2005, J NEUROSCI, V25, P5061, DOI 10.1523/JNEUROSCI.0892-05.2005; Ikemoto S, 2005, SYNAPSE, V56, P57, DOI 10.1002/syn.20124; Ikemoto S, 2003, J NEUROSCI, V23, P9305; Ikemoto S, 2002, NEUROSCIENCE, V113, P939, DOI 10.1016/S0306-4522(02)00247-6; Ikemoto S, 2001, J NEUROSCI METH, V110, P135, DOI 10.1016/S0165-0270(01)00428-9; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; KAVANAU JL, 1967, SCIENCE, V155, P1623, DOI 10.1126/science.155.3770.1623; KELLEY AE, 1991, PSYCHOPHARMACOLOGY, V103, P187, DOI 10.1007/BF02244202; Kish G. B., 1966, OPERANT BEHAVIOR ARE, P109; KISH GB, 1955, J COMP PHYSIOL PSYCH, V48, P261, DOI 10.1037/h0040782; LANDAUER TK, 1969, PSYCHOL REV, V76, P82, DOI 10.1037/h0026746; MARX MH, 1955, J COMP PHYSIOL PSYCH, V48, P73, DOI 10.1037/h0045062; Miller CA, 2005, NEURON, V47, P873, DOI 10.1016/j.neuron.2005.08.006; NICHOLLS B, 1992, J NEUROSCI METH, V43, P171, DOI 10.1016/0165-0270(92)90026-A; NISELL M, 1995, PHARMACOL TOXICOL, V76, P157, DOI 10.1111/j.1600-0773.1995.tb00123.x; NISELL M, 1994, SYNAPSE, V16, P36, DOI 10.1002/syn.890160105; Olsen CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1685, DOI 10.1038/npp.2008.226; PIJNENBURG AJJ, 1975, PSYCHOPHARMACOLOGIA, V41, P87, DOI 10.1007/BF00421062; Rebec GV, 1997, BRAIN RES, V776, P61, DOI 10.1016/S0006-8993(97)01004-4; Rebec GV, 1997, NEUROSCIENCE, V76, P707, DOI 10.1016/S0306-4522(96)00382-X; ROBBINS T, 1973, PSYCHOPHARMACOLOGIA, V28, P155, DOI 10.1007/BF00421400; ROBBINS TW, 1978, PSYCHOPHARMACOLOGY, V58, P79, DOI 10.1007/BF00426794; ROBBINS TW, 1982, INT REV NEUROBIOL, V23, P303, DOI 10.1016/S0074-7742(08)60628-5; ROBBINS TW, 1989, NEUROSCI BIOBEHAV R, V13, P155, DOI 10.1016/S0149-7634(89)80025-9; Robinson DL, 2004, J NEUROCHEM, V90, P894, DOI 10.1111/j.1471-4159.2004.02559.x; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sellings LHL, 2006, NEUROSCIENCE, V141, P1457, DOI 10.1016/j.neuroscience.2006.04.040; Sellings LHL, 2008, EUR J NEUROSCI, V28, P342, DOI 10.1111/j.1460-9568.2008.06341.x; Shin R, 2008, PSYCHOPHARMACOLOGY, V198, P261, DOI 10.1007/s00213-008-1131-x; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Spina L, 2006, PSYCHOPHARMACOLOGY, V184, P447, DOI 10.1007/s00213-005-0211-4; Staddon JER., 1987, HDB OPERANT BEHAVIOR, P125; STEWART J, 1958, Q J EXP PSYCHOL, V10, P56, DOI 10.1080/17470215808416254; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; TAGHZOUTI K, 1985, BRAIN RES, V344, P9, DOI 10.1016/0006-8993(85)91184-9; TAYLOR JR, 1986, PSYCHOPHARMACOLOGY, V90, P390; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; White NM, 1996, ADDICTION, V91, P921, DOI 10.1111/j.1360-0443.1996.tb03586.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wyvell CL, 2000, J NEUROSCI, V20, P8122; [No title captured]	69	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8741	10.1371/journal.pone.0008741	http://dx.doi.org/10.1371/journal.pone.0008741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090902	Green Published, gold, Green Submitted			2022-12-25	WOS:000273714900021
J	Zhao, YO; Konen-Waisman, S; Taylor, GA; Martens, S; Howard, JC				Zhao, Yang O.; Koenen-Waisman, Stephanie; Taylor, Gregory A.; Martens, Sascha; Howard, Jonathan C.			Localisation and Mislocalisation of the Interferon-Inducible Immunity-Related GTPase, Irgm1 (LRG-47) in Mouse Cells	PLOS ONE			English	Article							P47 RESISTANCE GTPASES; HOST-RESISTANCE; GAMMA; DEFENSE; IIGP1; MYCOBACTERIA; TUBERCULOSIS; MACROPHAGES; MECHANISM; AUTOPHAGY	Irgm1 (LRG-47) is an interferon-inducible Golgi membrane associated GTPase of the mouse whose disruption causes susceptibility to many different intracellular pathogens. Irgm1 has been variously interpreted as a regulator of homologous effector GTPases of the IRG family, a regulator of phagosome maturation and as an initiator of autophagy in interferon-induced cells. We find that endogenous Irgm1 localises to late endosomal and lysosomal compartments in addition to the Golgi membranes. The targeting motif known to be required for Golgi localisation is surprisingly also required for endolysosomal localisation. However, unlike Golgi localisation, localisation to the endolysosomal system also requires the functional integrity of the nucleotide binding site, and thus probably reflects transient activation. Golgi localisation is lost when Irgm1 is tagged at either N- or C-termini with EGFP, while localisation to the endolysosomal system is relatively favoured. N-terminally tagged Irgm1 localises predominantly to early endosomes, while C-terminally tagged Irgm1 localises to late endosomes and lysosomes. Both these anomalous distributions are reversed by inactivation of the nucleotide binding site, and the tagged proteins both revert to Golgi membrane localisation. Irgm1 is the first IRG protein to be found associated with the endolysosomal membrane system in addition to either Golgi (Irgm1 and Irgm2) or ER (Irgm3) membranes, and we interpret the result to be in favour of a regulatory function of IRGM proteins at cellular membrane systems. In future analyses it should be borne in mind that tagging of Irgm1 leads to loss of Golgi localisation and enhanced localisation on endolysosomal membranes, probably as a result of constitutive activation.	[Zhao, Yang O.; Koenen-Waisman, Stephanie; Martens, Sascha; Howard, Jonathan C.] Univ Cologne, Inst Genet, D-5000 Cologne, Germany; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Med, Div Geriatr, Durham, NC 27710 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Div Geriatr, Durham, NC 27710 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Immunol, Div Geriatr, Durham, NC 27710 USA; [Taylor, Gregory A.] VA Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC USA	University of Cologne; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center	Zhao, YO (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-5000 Cologne, Germany.	j.howard@uni-koeln.de	Martens, Sascha/C-3693-2011	Martens, Sascha/0000-0003-3786-8199; Howard, Jonathan/0000-0003-2756-5143	Deusche Forschungsgemeinschaft [SFB635, SFB670, SFB680]; National Institutes of Health [AI57831]; Education Ministry of the Land-Nordrhein-Westfalen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831] Funding Source: NIH RePORTER	Deusche Forschungsgemeinschaft; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Education Ministry of the Land-Nordrhein-Westfalen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by special research area grants SFB635, 670 and 680 from the Deusche Forschungsgemeinschaft to JCH and National Institutes of Health Grant AI57831 to GAT. Sascha Martens and Yang O. Zhao were supported by stipends from graduate schools of the Institute for Genetics supported by the Deutsche Forschungsgemeinschaft and the Education Ministry of the Land-Nordrhein-Westfalen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Henry SC, 2009, J LEUKOCYTE BIOL, V85, P877, DOI 10.1189/jlb.1008599; HUNN JP, 2008, EMBO J; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao YO, 2009, MEM I OSWALDO CRUZ, V104, P234, DOI 10.1590/S0074-02762009000200016	24	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8648	10.1371/journal.pone.0008648	http://dx.doi.org/10.1371/journal.pone.0008648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072621	Green Published, gold			2022-12-25	WOS:000273554600011
J	Chen, YF; Gao, ZY; Kerris, RJ; Wang, WY; Binder, BM; Schaller, GE				Chen, Yi-Feng; Gao, Zhiyong; Kerris, Robert J., III; Wang, Wuyi; Binder, Brad M.; Schaller, G. Eric			Ethylene Receptors Function as Components of High-Molecular-Mass Protein Complexes in Arabidopsis	PLOS ONE			English	Article							HISTIDINE KINASE DOMAIN; RAF-LIKE KINASE; ENDOPLASMIC-RETICULUM; RESPONSE PATHWAY; H+-ATPASE; ETR1; GENE; BINDING; FAMILY; CTR1	Background: The gaseous plant hormone ethylene is perceived in Arabidopsis thaliana by a five-member receptor family composed of ETR1, ERS1, ETR2, ERS2, and EIN4. Methodology/Principal Findings: Gel-filtration analysis of ethylene receptors solubilized from Arabidopsis membranes demonstrates that the receptors exist as components of high-molecular-mass protein complexes. The ERS1 protein complex exhibits an ethylene-induced change in size consistent with ligand-mediated nucleation of protein-protein interactions. Deletion analysis supports the participation of multiple domains from ETR1 in formation of the protein complex, and also demonstrates that targeting to and retention of ETR1 at the endoplasmic reticulum only requires the first 147 amino acids of the receptor. A role for disulfide bonds in stabilizing the ETR1 protein complex was demonstrated by use of reducing agents and mutation of Cys4 and Cys6 of ETR1. Expression and analysis of ETR1 in a transgenic yeast system demonstrates the importance of Cys4 and Cys6 of ETR1 in stabilizing the receptor for ethylene binding. Conclusions/Significance: These data support the participation of ethylene receptors in obligate as well as ligand-dependent non-obligate protein interactions. These data also suggest that different protein complexes may allow for tailoring of the ethylene signal to specific cellular environments and responses.	[Chen, Yi-Feng; Gao, Zhiyong; Kerris, Robert J., III; Schaller, G. Eric] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Wang, Wuyi; Binder, Brad M.] Univ Wisconsin, Dept Bot, Madison, WI USA	Dartmouth College; University of Wisconsin System; University of Wisconsin Madison	Chen, YF (corresponding author), Univ Minnesota, Algal Biofuel Grp, Dept Bioproducts & Biosyst Engn, St Paul, MN 55108 USA.	george.e.schaller@dartmouth.edu		Binder, Brad/0000-0002-8172-2034	Department of Energy [DE-FG02-05ER15704]; National Science Foundation [MCB-0430191]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported by Department of Energy grant DE-FG02-05ER15704 and National Science Foundation grant MCB-0430191 to G. E. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; [Anonymous], 2002, ARABIDOPSIS BOOK; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; Bleecker AB, 1999, TRENDS PLANT SCI, V4, P269, DOI 10.1016/S1360-1385(99)01427-2; Brandizzi F, 2002, PLANT CELL, V14, P1077, DOI 10.1105/tpc.000620; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; Chang C, 1999, CURR OPIN PLANT BIOL, V2, P352, DOI 10.1016/S1369-5266(99)00004-7; Chang C, 2001, BIOESSAYS, V23, P619, DOI 10.1002/bies.1087; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DeWitt ND, 1996, PLANT PHYSIOL, V112, P833, DOI 10.1104/pp.112.2.833; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; Hlavacek WS, 2003, BIOTECHNOL BIOENG, V84, P783, DOI 10.1002/bit.10842; Hong BM, 1999, PLANT PHYSIOL, V119, P1165, DOI 10.1104/pp.119.4.1165; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Hyodo H., 1991, PLANT HORMONE ETHYLE; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORD JM, 1987, METHOD ENZYMOL, V148, P576; LUETHY MH, 1993, PLANT PHYSIOL, V101, P931, DOI 10.1104/pp.101.3.931; MAESHIMA M, 1992, PLANT PHYSIOL, V98, P1248, DOI 10.1104/pp.98.4.1248; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; O'Malley RC, 2005, PLANT J, V41, P651, DOI 10.1111/j.1365-313X.2004.02331.X; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Schaller GE, 2007, METHOD ENZYMOL, V422, P270, DOI 10.1016/S0076-6879(06)22013-5; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; Schaller GE, 1995, METHOD CELL BIOL, V50, P129, DOI 10.1016/S0091-679X(08)61027-4; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schaller GE, 2000, ADV BOT RES, V32, P109, DOI 10.1016/S0065-2296(00)32023-7; Stepanova AN, 2000, CURR OPIN PLANT BIOL, V3, P353, DOI 10.1016/S1369-5266(00)00096-0; Takahashi H, 2002, J EXP BOT, V53, P415, DOI 10.1093/jexbot/53.368.415; Van der Hoorn RAL, 2003, PLANT J, V35, P305, DOI 10.1046/j.1365-313X.2003.01803.x; Voet-van-Vormizeele J, 2008, MOL PLANT, V1, P380, DOI 10.1093/mp/ssn004; Vondriska TM, 2004, J MOL CELL CARDIOL, V37, P391, DOI 10.1016/j.yjmcc.2004.04.021; VONHEIJNE G, 1986, J MOL BIOL, V189, P239, DOI 10.1016/0022-2836(86)90394-3; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635	63	55	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8640	10.1371/journal.pone.0008640	http://dx.doi.org/10.1371/journal.pone.0008640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062808	Green Published, gold			2022-12-25	WOS:000273414200017
J	Ceballos, G; Davidson, A; List, R; Pacheco, J; Manzano-Fischer, P; Santos-Barrera, G; Cruzado, J				Ceballos, Gerardo; Davidson, Ana; List, Rurik; Pacheco, Jesus; Manzano-Fischer, Patricia; Santos-Barrera, Georgina; Cruzado, Juan			Rapid Decline of a Grassland System and Its Ecological and Conservation Implications	PLOS ONE			English	Article							PRAIRIE DOG; CYNOMYS-LUDOVICIANUS; CHIHUAHUAN DESERT; DESERTIFICATION; DIVERSITY; HETEROGENEITY; BIODIVERSITY; COMPLEX; RODENTS; DRIVEN	One of the most important conservation issues in ecology is the imperiled state of grassland ecosystems worldwide due to land conversion, desertification, and the loss of native populations and species. The Janos region of northwestern Mexico maintains one of the largest remaining black-tailed prairie dog (Cynomys ludovicianus) colony complexes in North America and supports a high diversity of threatened and endangered species. Yet, cattle grazing, agriculture, and drought have greatly impacted the region. We evaluated the impact of human activities on the Janos grasslands, comparing changes in the vertebrate community over the last two decades. Our results reveal profound, rapid changes in the Janos grassland community, demonstrating large declines in vertebrate abundance across all taxonomic groups. We also found that the 55,000 ha prairie dog colony complex has declined by 73% since 1988. The prairie dog complex has become increasingly fragmented, and their densities have shown a precipitous decline over the years, from an average density of 25 per ha in 1988 to 2 per ha in 2004. We demonstrated that prairie dogs strongly suppressed woody plant encroachment as well as created open grassland habitat by clearing woody vegetation, and found rapid invasion of shrubland once the prairie dogs disappeared from the grasslands. Comparison of grasslands and shrublands showed markedly different species compositions, with species richness being greatest when both habitats were considered together. Our data demonstrate the rapid decline of a grassland ecosystem, and documents the dramatic loss in biodiversity over a very short time period concomitant with anthropogenic grassland degradation and the decline of a keystone species.	[Ceballos, Gerardo; Davidson, Ana; List, Rurik; Pacheco, Jesus; Manzano-Fischer, Patricia; Cruzado, Juan] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Santos-Barrera, Georgina] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ceballos, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	gceballo@ecologia.unam.mx	Manzano-Fischer, Patricia/AAR-7091-2021	Manzano-Fischer, Patricia/0000-0003-3048-431X; Ceballos, Gerardo/0000-0001-8374-2656	J.M. Kaplan Fund; Direccion General de Asuntos del Personal Academico - Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Teconologi-a (CONACyT); Whitley Fund for Nature; Comision Nacional para el Conocimiento y Uso de la Biodiversidad; Defenders of Wildlife; Dutch Embassy in Mexico; Nature Conservancy; Environmental Flying Services; Foundation for Deep Ecology; National Black-footed Ferret Recovery Foundation; National Fish and Wildlife Foundation; National Wildlife Federation; Naturalia A. C., People's Trust for Endangered Species; Phoenix Zoo; Research Ranch Foundation; U.S. Agency for International Development; Sky Island Alliance; British Council; Wildlands Project; Turner Foundation; Universidad Nacional Autonoma de Mexico; National Science Foundation [OISE-0653296]	J.M. Kaplan Fund; Direccion General de Asuntos del Personal Academico - Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Teconologi-a (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Whitley Fund for Nature; Comision Nacional para el Conocimiento y Uso de la Biodiversidad; Defenders of Wildlife; Dutch Embassy in Mexico; Nature Conservancy; Environmental Flying Services; Foundation for Deep Ecology; National Black-footed Ferret Recovery Foundation; National Fish and Wildlife Foundation; National Wildlife Federation; Naturalia A. C., People's Trust for Endangered Species; Phoenix Zoo; Research Ranch Foundation; U.S. Agency for International Development(United States Agency for International Development (USAID)); Sky Island Alliance; British Council(The British Council in India); Wildlands Project; Turner Foundation; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); National Science Foundation(National Science Foundation (NSF))	This research was supported by the J.M. Kaplan Fund, Direccion General de Asuntos del Personal Academico - Universidad Nacional Autonoma de Mexico, Ecociencia S.C., Consejo Nacional de Ciencia y Teconologi-a (CONACyT), Whitley Fund for Nature, Comision Nacional para el Conocimiento y Uso de la Biodiversidad, Defenders of Wildlife, the Dutch Embassy in Mexico, The Nature Conservancy, Environmental Flying Services, Foundation for Deep Ecology, National Black-footed Ferret Recovery Foundation, National Fish and Wildlife Foundation, National Wildlife Federation, Naturalia A. C., People's Trust for Endangered Species, Phoenix Zoo, Research Ranch Foundation, U.S. Agency for International Development, Sky Island Alliance, British Council, Wildlands Project, and Turner Foundation. ADD was supported by a postdoctoral scholarship by the Universidad Nacional Autonoma de Mexico and the National Science Foundation Grant OISE-0653296. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILAFLORES R, 2009, THESIS U ALBERTA EDM, P1; BIGGINS DE, 2006, CONSERVATION BLACK T; BIGGINS DE, 1993, TECHNIQUE EVALUATING; BOCK CE, 1990, J HERPETOL, V24, P445, DOI 10.2307/1565072; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; CABLE M, 1973, J ARIZONA ACAD SCI, V8, P127; Ceballos G, 1999, J ARID ENVIRON, V41, P161, DOI 10.1006/jare.1998.0479; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; CEBALLOS G, 1993, BIOL CONSERV, V63, P105, DOI 10.1016/0006-3207(93)90497-O; Clark T. W., 1989, 3 WILDL PRES TRUST; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; Curtin CG, 2000, ECOL LETT, V3, P309, DOI 10.1046/j.1461-0248.2000.00166.x; Curtin C, 2008, CONSERV BIOL, V22, P870, DOI 10.1111/j.1523-1739.2008.00945.x; Davidson AD, 2008, J ARID ENVIRON, V72, P1133, DOI 10.1016/j.jaridenv.2007.12.015; Davidson AD, 2007, ECOGRAPHY, V30, P515, DOI 10.1111/j.0906-7590.2007.05032.x; Davidson AD, 2006, ECOGRAPHY, V29, P755, DOI 10.1111/j.2006.0906-7590.04699.x; Degenhardt W. G., 1996, AMPHIBIANS REPTILES; Desmond MJ, 2000, J WILDLIFE MANAGE, V64, P1067, DOI 10.2307/3803217; Drewa PB, 2001, J ARID ENVIRON, V48, P429, DOI 10.1006/jare.2000.0769; *FAO, 2006, 38 FAO UN; Fredrickson E, 1998, J ARID ENVIRON, V39, P191, DOI 10.1006/jare.1998.0390; GARCI A, 1988, MODIFICACIONES SISTE; *GOOGL EARTH, 2005, SPOT DIG GLOB SATT I; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Heady H.F., 1977, TERRESTRIAL VEGETATI, P491; Henwood W. D., 1998, PARKS, V8, P3; Heyer W.R., 1994, MEASURING MONITORING; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; *INEGI, 1995, ESP NAC H12 6 AG AGS; Jones A, 2000, WEST N AM NATURALIST, V60, P155; Kerley GIH, 2000, AM MIDL NAT, V144, P78, DOI 10.1674/0003-0031(2000)144[0078:IOGADI]2.0.CO;2; KNOPF FL, 1994, AUK, V111, P504, DOI 10.2307/4088620; Kotliar Natasha B., 2006, P53; List R, 2003, J ZOOL, V259, P1, DOI 10.1017/S0952836902002959; List R., 1997, THESIS OXFORD U OXFO; List Rurik, 1998, Revista Mexicana de Mastozoologia, V3, P95; Lomolino MV, 2004, BIOL CONSERV, V115, P89, DOI 10.1016/S0006-3207(03)00097-1; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Manzano-Fischer P, 1999, STUD AVIAN BIOL, P263; Manzano-Fischer P, 2006, BIODIVERS CONSERV, V15, P3801, DOI 10.1007/s10531-005-5408-7; McClaran M.P., 1995, DESERT GRASSLAND, p346 p.; MCCUNE B, 1999, PC ORD WIND 4 10; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McGarigal K., 2000, MULTIVARIATE STAT WI; MERCE E, 2001, THESIS U NACL AUTONO; Millennium-Ecosystem-Assessment, 2005, EC HUM WELL BEING DE; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller BJ, 2007, J WILDLIFE MANAGE, V71, P2801, DOI 10.2193/2007-041; Okin GS, 2009, BIOSCIENCE, V59, P237, DOI 10.1525/bio.2009.59.3.8; Peters DPC, 2006, BIOSCIENCE, V56, P491, DOI 10.1641/0006-3568(2006)56[491:DCLNII]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; SAMSON FB, 1998, GRASSLANDS; *SAS I, 1999, SAS STAT US GUID 8 2; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thomas L., 2006, DISTANCE 5 0; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2; WHICKER AD, 1988, BIOSCIENCE, V38, P778, DOI 10.2307/1310787; White R. P., 2000, PILOT ANAL GLOBAL EO; Whitford WG, 1997, J ARID ENVIRON, V37, P709, DOI 10.1006/jare.1997.0313; ZAVALETA ES, 2004, REALISTIC SPECIES LO, V12, P1175; [No title captured]	66	105	115	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8562	10.1371/journal.pone.0008562	http://dx.doi.org/10.1371/journal.pone.0008562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066035	Green Published, gold			2022-12-25	WOS:000273338600009
J	Huber, SK; Owen, JP; Koop, JAH; King, MO; Grant, PR; Grant, BR; Clayton, DH				Huber, Sarah K.; Owen, Jeb P.; Koop, Jennifer A. H.; King, Marisa O.; Grant, Peter R.; Grant, B. Rosemary; Clayton, Dale H.			Ecoimmunity in Darwin's Finches: Invasive Parasites Trigger Acquired Immunity in the Medium Ground Finch (Geospiza fortis)	PLOS ONE			English	Article							PHILORNIS-DOWNSI; INTRODUCED PARASITE; EPIZOOTIOLOGY; CONSERVATION; ANTIBODY; THREATS; POX	Background: Invasive parasites are a major threat to island populations of animals. Darwin's finches of the Galapagos Islands are under attack by introduced pox virus (Poxvirus avium) and nest flies (Philornis downsi). We developed assays for parasite-specific antibody responses in Darwin's finches (Geospiza fortis), to test for relationships between adaptive immune responses to novel parasites and spatial-temporal variation in the occurrence of parasite pressure among G. fortis populations. Methodology/Principal Findings: We developed enzyme-linked immunosorbent assays (ELISAs) for the presence of antibodies in the serum of Darwin's finches specific to pox virus or Philornis proteins. We compared antibody levels between bird populations with and without evidence of pox infection (visible lesions), and among birds sampled before nesting (prior to nest-fly exposure) versus during nesting (with fly exposure). Birds from the Pox-positive population had higher levels of pox-binding antibodies. Philornis-binding antibody levels were higher in birds sampled during nesting. Female birds, which occupy the nest, had higher Philornis-binding antibody levels than males. The study was limited by an inability to confirm pox exposure independent of obvious lesions. However, the lasting effects of pox infection (e. g., scarring and lost digits) were expected to be reliable indicators of prior pox infection. Conclusions/Significance: This is the first demonstration, to our knowledge, of parasite-specific antibody responses to multiple classes of parasites in a wild population of birds. Darwin's finches initiated acquired immune responses to novel parasites. Our study has vital implications for invasion biology and ecological immunology. The adaptive immune response of Darwin's finches may help combat the negative effects of parasitism. Alternatively, the physiological cost of mounting such a response could outweigh any benefits, accelerating population decline. Tests of the fitness implications of parasite-specific immune responses in Darwin's finches are urgently needed.	[Huber, Sarah K.; Koop, Jennifer A. H.; Clayton, Dale H.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Owen, Jeb P.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [King, Marisa O.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Grant, Peter R.; Grant, B. Rosemary] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	Utah System of Higher Education; University of Utah; Washington State University; Washington State University; Princeton University	Huber, SK (corresponding author), Randolph Macon Coll, Dept Biol, Ashland, VA 23005 USA.	sarahhuber@rmc.edu		Owen, Jeb/0000-0002-2042-0526; Koop, Jennifer/0000-0002-5332-3618	NSF [DEB-0118794, DEB-0816877]; Society for the Study of Evolution; Direct For Biological Sciences [0816877] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Society for the Study of Evolution; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Work was supported by NSF (DEB-0118794 and DEB-0816877) and the Society for the Study of Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardia DR, 2008, AVIAN IMMUNOLOGY, P421, DOI 10.1016/B978-012370634-8.50025-1; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; CURRY RL, 1989, J ANIM ECOL, V58, P441, DOI 10.2307/4841; Davison F, 2008, AVIAN IMMUNOLOGY, P107, DOI 10.1016/B978-012370634-8.50009-3; Dudaniec RY, 2007, BIOL CONSERV, V139, P325, DOI 10.1016/j.biocon.2007.07.006; DUSBABEK F, 1989, FOLIA PARASIT, V36, P83; Fessl B, 2002, IBIS, V144, P445, DOI 10.1046/j.1474-919X.2002.00076.x; Fessl B, 2006, BIOL CONSERV, V127, P55, DOI 10.1016/j.biocon.2005.07.013; Fessl B, 2006, PARASITOLOGY, V133, P739, DOI 10.1017/S0031182006001089; Fessl B., 2001, STUDIA DIPTEROLOGICA, V8, P317; Grant B. R., 1989, EVOLUTIONARY DYNAMIC; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Hansen P, 1998, J IMMUNOL METHODS, V215, P1, DOI 10.1016/S0022-1759(98)00050-7; Huber SK, 2008, BIOL CONSERV, V141, P601, DOI 10.1016/j.biocon.2007.11.012; Kleindorfer S, 2006, J AVIAN BIOL, V37, P69, DOI 10.1111/j.0908-8857.2006.03503.x; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; MURANO T, 1989, POULTRY SCI, V68, P842, DOI 10.3382/ps.0680842; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Owen JP, 2007, TRENDS ECOL EVOL, V22, P228, DOI 10.1016/j.tree.2007.02.003; Parker PG, 2006, AUK, V123, P625, DOI 10.1642/0004-8038(2006)123[625:CMOTGI]2.0.CO;2; SCHNITZLEIN WM, 1988, VIRUS RES, V10, P65, DOI 10.1016/0168-1702(88)90058-5; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; VARGAS H, 1987, J FIELD ORNITHOL, V58, P101; Wikelski M, 2004, ECOL SOC, V9	26	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8605	10.1371/journal.pone.0008605	http://dx.doi.org/10.1371/journal.pone.0008605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066052	Green Published, gold			2022-12-25	WOS:000273338600023
J	Indurkhya, S; Beal, J				Indurkhya, Sagar; Beal, Jacob			Reaction Factoring and Bipartite Update Graphs Accelerate the Gillespie Algorithm for Large-Scale Biochemical Systems	PLOS ONE			English	Article							STOCHASTIC SIMULATION	ODE simulations of chemical systems perform poorly when some of the species have extremely low concentrations. Stochastic simulation methods, which can handle this case, have been impractical for large systems due to computational complexity. We observe, however, that when modeling complex biological systems: (1) a small number of reactions tend to occur a disproportionately large percentage of the time, and (2) a small number of species tend to participate in a disproportionately large percentage of reactions. We exploit these properties in LOLCAT Method, a new implementation of the Gillespie Algorithm. First, factoring reaction propensities allows many propensities dependent on a single species to be updated in a single operation. Second, representing dependencies between reactions with a bipartite graph of reactions and species requires only O(n) storage for n reactions, rather than the O(n(2)) required for a graph that includes only reactions. Together, these improvements allow our implementation of LOLCAT Method to execute orders of magnitude faster than currently existing Gillespie Algorithm variants when simulating several yeast MAPK cascade models.	[Indurkhya, Sagar] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Beal, Jacob] BBN Technol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Raytheon Technologies; Raytheon BBN Technologies	Indurkhya, S (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jakebeal@bbn.com		Beal, Jacob/0000-0002-1663-5102	NSF [6898853]	NSF(National Science Foundation (NSF))	This work was supported by NSF Grant 6898853. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Y, 2004, J CHEM PHYS, V121, P4059, DOI 10.1063/1.1778376; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gillespie DT, 2003, J CHEM PHYS, V119, P8229, DOI 10.1063/1.1613254; INDURKHYA S, 2009, CODE LOLCAT METHOD; Li H, 2006, LOGARITHMIC DIRECT M, DOI 10.1.1.79.7703; McCollum JM, 2006, COMPUT BIOL CHEM, V30, P39, DOI 10.1016/j.compbiolchem.2005.10.007; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; SALI H, 2005, J CHEM PHYS, V122; Salwinski L, 2004, NAT BIOTECHNOL, V22, P1017, DOI 10.1038/nbt991; Slepoy A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919546; THOMSON T, 2008, THESIS MIT	12	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8125	10.1371/journal.pone.0008125	http://dx.doi.org/10.1371/journal.pone.0008125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066048	gold, Green Published, Green Submitted			2022-12-25	WOS:000273338600001
J	Lobo, GP; Hessel, S; Eichinger, A; Noy, N; Moise, AR; Wyss, A; Palczewski, K; von Lintig, J				Lobo, Glenn P.; Hessel, Susanne; Eichinger, Anne; Noy, Noa; Moise, Alexander R.; Wyss, Adrian; Palczewski, Krzysztof; von Lintig, Johannes			ISX is a retinoic acid-sensitive gatekeeper that controls intestinal beta,beta-carotene absorption and vitamin A production	FASEB JOURNAL			English	Article						carotenoids; retinoids; nuclear receptors; scavenger receptors	BETA-CAROTENE 15,15'-MONOOXYGENASE; RECEPTOR CLASS-B; I SR-BI; SCAVENGER RECEPTOR; CHOLESTEROL ABSORPTION; DIETARY-CHOLESTEROL; METABOLISM; EXPRESSION; TRANSPORT; ACYLTRANSFERASE	The uptake of dietary lipids from the small intestine is a complex process that depends on the activities of specific membrane receptors with yet unknown regulatory mechanisms. Using both mouse models and human cell lines, we show here that intestinal lipid absorption by the scavenger receptor class B type 1 (SR-BI) is subject to control by retinoid signaling. Retinoic acid via retinoic acid receptors induced expression of the intestinal transcription factor ISX. ISX then repressed the expression of SR-B1 and the carotenoid-15,15'-oxygenase Bcmo1. BCMO1 acts downstream of SR-BI and converts absorbed beta,beta-carotene to the retinoic acid precursor, retinaldehyde. Using BCMO1-knockout mice, we demonstrated increased intestinal SR-BI expression and systemic beta,beta-carotene accumulation. SR-BI-dependent accumulation of beta,beta-carotene was prevented by dietary retinoids that induced ISX expression. Thus, our study revealed a diet-responsive regulatory network that controls beta,beta-carotene absorption and vitamin A production by negative feedback regulation. The role of SR-BI in the intestinal absorption of other dietary lipids, including cholesterol, fatty acids, and tocopherols, implicates retinoid signaling in the regulation of lipid absorption more generally and has clinical implications for diseases associated with dyslipidemia.-Lobo, G. P., Hessel, S., Eichinger, A., Noy, N., Moise, A. R., Wyss, A., Palczewski, K., von Lintig, J. ISX is a retinoic acid-sensitive gatekeeper that controls intestinal beta,beta-carotene absorption and vitamin A production. FASEB J. 24, 1656-1666 (2010). www.fasebj.org	[Lobo, Glenn P.; Hessel, Susanne; Noy, Noa; Moise, Alexander R.; Palczewski, Krzysztof; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44160 USA; [Eichinger, Anne; Wyss, Adrian] DSM Nutr Prod Ltd, R&D Human Nutr & Hlth, Basel, Switzerland	Case Western Reserve University; DSM NV	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol W333, 10900 Euclid Ave, Cleveland, OH 44160 USA.	johannes.vonlintig@case.edu	Moise, Alexander R/C-9498-2009; Lobo, Glenn P./AAI-9736-2020; AR, Moise/P-2474-2019	Moise, Alexander R/0000-0003-2307-6035; AR, Moise/0000-0003-2307-6035; von Lintig, Johannes/0000-0002-2079-2143	U.S. National Institutes of Health [EY019641, EY009339]; NATIONAL EYE INSTITUTE [R01EY020551, R01EY019641, R01EY009339] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. Elwin Morgan (Case Western Reserve University) and Dr. Kristi Bennett (Cleveland Clinic Foundation, Cleveland, OH, USA) for their technical advice in the ChIP assay. This work was supported by U.S. National Institutes of Health grants EY019641 to J.V.L. and EY009339 to K. P.	Bachmann H, 2002, J NUTR, V132, P3616, DOI 10.1093/jn/132.12.3616; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Borel P, 1998, J LIPID RES, V39, P2250; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Cai SF, 2001, J LIPID RES, V42, P902; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Choi MY, 2006, DEVELOPMENT, V133, P4119, DOI 10.1242/dev.02537; During A, 2007, J LIPID RES, V48, P2283, DOI 10.1194/jlr.M700263-JLR200; During A, 2005, J NUTR, V135, P2305, DOI 10.1093/jn/135.10.2305; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Kawada T, 1996, INT J OBESITY, V20, pS52; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Leung WH, 2008, FASEB J, V22; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Mardones P, 2001, J LIPID RES, V42, P170; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MCNAMARA DJ, 1987, J CLIN INVEST, V79, P1729, DOI 10.1172/JCI113013; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Paik J, 2004, J NUTR, V134, p276S, DOI 10.1093/jn/134.1.276S; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Rosenblum SB, 1998, J MED CHEM, V41, P973, DOI 10.1021/jm970701f; Sehayek E, 1998, J LIPID RES, V39, P2415; Seino Y, 2008, J BIOL CHEM, V283, P4905, DOI 10.1074/jbc.M707928200; Takitani K, 2006, EUR J NUTR, V45, P320, DOI 10.1007/s00394-006-0601-3; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; Vaughan LA, 1997, J AM DIET ASSOC, V97, P1275, DOI 10.1016/S0002-8223(97)00305-2; von Lintig J, 2005, BBA-MOL BASIS DIS, V1740, P122, DOI 10.1016/j.bbadis.2004.11.010; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u; Voshol PJ, 2001, BIOCHEM J, V356, P317, DOI 10.1042/0264-6021:3560317; Wang DQH, 2007, ANNU REV PHYSIOL, V69, P221, DOI 10.1146/annurev.physiol.69.031905.160725; Wang L, 2008, AM J CLIN NUTR, V88, P747, DOI 10.1093/ajcn/88.3.747; Webb NR, 1997, J LIPID RES, V38, P1490; WOLFE WS, 1988, J AM DIET ASSOC, V88, P822	39	154	160	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1656	1666		10.1096/fj.09-150995	http://dx.doi.org/10.1096/fj.09-150995			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20061533	Green Published			2022-12-25	WOS:000278200000004
J	Kumawat, K; Pathak, SK; Spetz, AL; Kundu, M; Basu, J				Kumawat, Kuldeep; Pathak, Sushil Kumar; Spetz, Anna-Lena; Kundu, Manikuntala; Basu, Joyoti			Exogenous Nef Is an Inhibitor of Mycobacterium tuberculosis-induced Tumor Necrosis Factor-alpha Production and Macrophage Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-SURFACE EXPRESSION; HUMAN MONOCYTIC CELLS; HIV-1 NEF; GENE-EXPRESSION; DOWN-REGULATION; T-CELLS; C-JUN; HUMAN MONOCYTES/MACROPHAGES; TRANSCRIPTION FACTORS	Human immunodeficiency virus-1 (HIV-1) impairs tumor necrosis factor-alpha (TNF-alpha)-mediated macrophage apoptosis induced by Mycobacterium tuberculosis (Mtb). HIV Nef protein plays an important role in the pathogenesis of AIDS. We have tested the hypothesis that exogenous Nef is a factor that inhibits TNF-alpha production/apoptosis in macrophages infected with Mtb. We demonstrate that Mtb and Nef individually trigger TNF-alpha production in macrophages. However, TNF-alpha production is dampened when the two are present simultaneously, probably through cross-regulation of the individual signaling pathways leading to activation of the TNF-alpha promoter. Mtb induced TNF-alpha production is abrogated upon mutation of the Ets, Egr, Sp1, CRE, or AP1 binding sites on the TNF-alpha promoter, whereas Nef-mediated promoter activation depends only on the CRE and AP1 binding sites, pointing to differences in the mechanisms of activation of the promoter. Mtb-dependent promoter activation depends on the mitogen-activated kinase (MAPK) kinase kinase ASK1 and on MEK/ERK signaling. Nef inhibits ASK1/p38 MAPK-dependent Mtb-induced TNF-alpha production probably by inhibiting binding of ATF2 to the TNF-alpha promoter. It also inhibits MEK/ERK-dependent Mtb-induced binding of FosB to the promoter. Nef-driven TNF-alpha production occurs in an ASK1-independent, Rac1/PAK1/p38 MAPK-dependent, and MEK/ERK-independent manner. The signaling pathways used by Mtb and Nef to trigger TNF-alpha production are therefore distinctly different. In addition to attenuating Mtb-dependent TNF-alpha promoter activation, Nef also reduces Mtb-dependent TNF-alpha mRNA stability probably through its ability to inhibit ASK1/p38 MAPK signaling. These results provide new insight into how HIV Nef probably exacerbates tuberculosis infection by virtue of its ability to dampen Mtb-induced TNF-alpha production.	[Kumawat, Kuldeep; Pathak, Sushil Kumar; Kundu, Manikuntala; Basu, Joyoti] Bose Inst, Dept Chem, Kolkata 700009, India; [Spetz, Anna-Lena] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Huddinge, Sweden	Department of Science & Technology (India); Bose Institute; Karolinska Institutet; Karolinska University Hospital	Basu, J (corresponding author), Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India.	joyoti@vsnl.com	Spetz, Anna-Lena/C-3543-2016	Spetz, Anna-Lena/0000-0003-3964-9512	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Swedish Research Council (to J.B. and A.-L.S.).	Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brambilla A, 1999, VIROLOGY, V259, P349, DOI 10.1006/viro.1999.9783; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; de Jong BC, 2004, ANNU REV MED, V55, P283, DOI 10.1146/annurev.med.55.091902.103753; Dean JLE, 2003, J BIOL CHEM, V278, P39470, DOI 10.1074/jbc.M306345200; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Geist LJ, 1997, AM J RESP CELL MOL, V16, P31, DOI 10.1165/ajrcmb.16.1.8998076; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Kundu M, 2009, NAT IMMUNOL, V10, P918, DOI 10.1038/ni.1754; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Ma W, 2009, J BIOL CHEM, V284, P7578, DOI 10.1074/jbc.M710013200; Mahlknecht U, 2001, TRENDS IMMUNOL, V22, P256, DOI 10.1016/S1471-4906(01)01898-1; Maiti D, 2001, J BIOL CHEM, V276, P329, DOI 10.1074/jbc.M002650200; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; NEWELL CL, 1994, J LEUKOCYTE BIOL, V56, P27, DOI 10.1002/jlb.56.1.27; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Olivetta E, 2006, EXP CELL RES, V312, P890, DOI 10.1016/j.yexcr.2005.12.003; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Varin A, 2003, J BIOL CHEM, V278, P2219, DOI 10.1074/jbc.M209622200; Vigerust DJ, 2005, J LEUKOCYTE BIOL, V77, P522, DOI 10.1189/jlb.0804454; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795	62	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12629	12637		10.1074/jbc.M109.073320	http://dx.doi.org/10.1074/jbc.M109.073320			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20068037	hybrid, Green Published			2022-12-25	WOS:000276787800021
J	Ceru, S; Konjar, S; Maher, K; Repnik, U; Krizaj, I; Bencina, M; Renko, M; Nepveu, A; Zerovnik, E; Turk, B; Kopitar-Jerala, N				Ceru, Slavko; Konjar, Spela; Maher, Katarina; Repnik, Urska; Krizaj, Igor; Bencina, Mojca; Renko, Miha; Nepveu, Alain; Zerovnik, Eva; Turk, Boris; Kopitar-Jerala, Natasa			Stefin B Interacts with Histones and Cathepsin L in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; LYSOSOMAL CYSTEINE PROTEASES; CDP/CUX TRANSCRIPTION FACTOR; CROSS-CLASS INHIBITION; CYSTATIN-B; ENDOSOMAL PROTEOLYSIS; HUMAN GENOME; CELL-CYCLE; S-PHASE; EPM1	Stefin B (cystatin B) is an endogenous inhibitor of cysteine proteinases localized in the nucleus and the cytosol. Loss-of-function mutations in the stefin B gene (CSTB) gene were reported in patients with Unverricht-Lundborg disease (EPM1). We have identified an interaction between stefin B and nucleosomes, specifically with histones H2A.Z, H2B, and H3. In synchronized T98G cells, stefin B co-immunoprecipitated with histone H3, predominantly in the G(1) phase of the cell cycle. Stefin B-deficient mouse embryonic fibroblasts entered S phase earlier than wild type mouse embryonic fibroblasts. In contrast, increased expression of stefin B in the nucleus delayed cell cycle progression in T98G cells. The delay in cell cycle progression was associated with the inhibition of cathepsin L in the nucleus, as judged from the decreased cleavage of the CUX1 transcription factor. In vitro, inhibition of cathepsin L by stefin B was potentiated in the presence of histones, whereas histones alone did not affect the cathepsin L activity. Interaction of stefin B with the Met-75 truncated form of cathepsin L in the nucleus was confirmed by fluorescence resonance energy transfer experiments in the living cells. Stefin B could thus play an important role in regulating the proteolytic activity of cathepsin L in the nucleus, protecting such as transcription factors from its proteolytic processing.	[Ceru, Slavko; Konjar, Spela; Maher, Katarina; Repnik, Urska; Renko, Miha; Zerovnik, Eva; Turk, Boris; Kopitar-Jerala, Natasa] Jozef Stefan Inst, Dept Biochem, SI-1000 Ljubljana, Slovenia; [Ceru, Slavko; Konjar, Spela; Maher, Katarina; Repnik, Urska; Renko, Miha; Zerovnik, Eva; Turk, Boris; Kopitar-Jerala, Natasa] Jozef Stefan Inst, Dept Biol Mol & Struct, SI-1000 Ljubljana, Slovenia; [Krizaj, Igor] Jozef Stefan Inst, Dept Mol & Biomed Sci, SI-1000 Ljubljana, Slovenia; [Bencina, Mojca] Natl Inst Chem, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Nepveu, Alain] McGill Univ, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; National Institute of Chemistry - Slovenia; McGill University	Kopitar-Jerala, N (corresponding author), Jozef Stefan Inst, Dept Biochem, SI-1000 Ljubljana, Slovenia.	natasa.kopitar@ijs.si	/AAB-8315-2020; Zerovnik, Eva/AAB-6498-2022; Konjar, Špela/AAU-6390-2020	Turk, Boris/0000-0002-9007-5764	Slovenian Research Agency [J3-9324, J3-0612, P-0140]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency Grants J3-9324 and J3-0612 (to N.K.J.) and Grant P-0140 (to V.T. and B.T.).	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Alakurtti K, 2005, EUR J HUM GENET, V13, P208, DOI 10.1038/sj.ejhg.5201300; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOLINAR M, 1995, BIOL CHEM H-S, V376, P385; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; ELDRIDGE R, 1983, LANCET, V2, P838, DOI 10.1016/s0140-6736(83)90749-3; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; HANNIGAN G, 1986, EMBO J, V5, P1607, DOI 10.1002/j.1460-2075.1986.tb04403.x; Hiwasa T, 1996, CANCER LETT, V99, P87, DOI 10.1016/0304-3835(95)04041-2; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Hwang SR, 2005, BIOCHEMISTRY-US, V44, P7757, DOI 10.1021/bi050053z; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Istomina NE, 2003, MOL CELL BIOL, V23, P6455, DOI 10.1128/MCB.23.18.6455-6468.2003; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; KASTELIC L, 1994, CANCER LETT, V82, P81, DOI 10.1016/0304-3835(94)90149-X; Kopitar-Jerala NA, 2005, FEBS LETT, V579, P2149, DOI 10.1016/j.febslet.2005.03.002; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; KOPITARJERALA N, 1993, BIOCHIM BIOPHYS ACTA, V1164, P75, DOI 10.1016/0167-4838(93)90114-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lalioti MD, 1997, AM J HUM GENET, V60, P342; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Lehesjoki AE, 2003, EMBO J, V22, P3473, DOI 10.1093/emboj/cdg338; Lenarcic B, 1999, J BIOL CHEM, V274, P563, DOI 10.1074/jbc.274.2.563; MACHLEIDT W, 1989, FEBS LETT, V243, P234, DOI 10.1016/0014-5793(89)80135-8; Maubach G, 2008, MOL BIOL CELL, V19, P4238, DOI 10.1091/mbc.E08-03-0291; Mellgren RL, 1997, BIOCHEM BIOPH RES CO, V236, P555, DOI 10.1006/bbrc.1997.7003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Pol E, 2003, BBA-PROTEINS PROTEOM, V1645, P105, DOI 10.1016/S1570-9639(02)00526-5; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Rabzelj S, 2005, PROTEIN SCI, V14, P2713, DOI 10.1110/ps.051609705; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Riccio M, 2001, EXP CELL RES, V262, P84, DOI 10.1006/excr.2000.5085; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Santamaria I, 1998, CANCER RES, V58, P1624; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	59	65	66	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10078	10086		10.1074/jbc.M109.034793	http://dx.doi.org/10.1074/jbc.M109.034793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20075068	Green Published, hybrid			2022-12-25	WOS:000276165900075
J	Juliana, C; Fernandes-Alnemri, T; Wu, JH; Datta, P; Solorzano, L; Yu, JW; Meng, R; Quong, AA; Latz, E; Scott, CP; Alnemri, ES				Juliana, Christine; Fernandes-Alnemri, Teresa; Wu, Jianghong; Datta, Pinaki; Solorzano, Leobaldo; Yu, Je-Wook; Meng, Rong; Quong, Andrew A.; Latz, Eicke; Scott, Charles P.; Alnemri, Emad S.			Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CYSTEINE PROTEASE INHIBITORS; NALP3 INFLAMMASOME; VINYL SULFONES; CASPASE-1 ACTIVATION; CELL-DEATH; SESQUITERPENE LACTONES; NLRP3 INFLAMMASOME; ASC PYROPTOSOME; MECHANISM	Activation of the inflammasome generates the pro-inflammatory cytokines interleukin-1 beta and -18, which are important mediators of inflammation. Abnormal activation of the inflammasome leads to many inflammatory diseases, including gout, silicosis, neurodegeneration, and genetically inherited periodic fever syndromes. Therefore, identification of small molecule inhibitors that target the inflammasome is an important step toward developing effective therapeutics for the treatment of inflammation. Here, we show that the herbal NF-kappa B inhibitory compound parthenolide inhibits the activity of multiple inflammasomes in macrophages by directly inhibiting the protease activity of caspase-1. Additional investigations of other NF-kappa B inhibitors revealed that the synthetic I kappa B kinase-beta inhibitor Bay 11-7082 and structurally related vinyl sulfone compounds selectively inhibit NLRP3 inflammasome activity in macrophages independent of their inhibitory effect on NF-kappa B activity. In vitro assays of the effect of parthenolide and Bay 11-7082 on the ATPase activity of NLRP3 demonstrated that both compounds inhibit the ATPase activity of NLRP3, suggesting that the inhibitory effect of these compounds on inflammasome activity could be mediated in part through their effect on the ATPase activity of NLRP3. Our results thus elucidate the molecular mechanism for the therapeutic anti-inflammatory activity of parthenolide and identify vinyl sulfones as a new class of potential therapeutics that target the NLRP3 inflammasome.	[Juliana, Christine; Fernandes-Alnemri, Teresa; Wu, Jianghong; Datta, Pinaki; Solorzano, Leobaldo; Yu, Je-Wook; Scott, Charles P.; Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Meng, Rong; Quong, Andrew A.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Latz, Eicke] Univ Massachusetts, Dept Immunol & Infect Dis, Sch Med, Worcester, MA 01605 USA; [Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53012 Bonn, Germany	Jefferson University; Jefferson University; University of Massachusetts System; University of Massachusetts Worcester; University of Bonn	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	E_Alnemri@mail.jci.tju.edu	Alnemri, Emad S/B-4526-2010; Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666; Yu, Je-Wook/0000-0001-5943-4071; Juliana, Christine/0000-0002-4314-1407	National Institutes of Health [AG14357, AR055398]; National Research Service Award [T32-CA09678];  [1R01AI083713];  [R01HL093262]; NATIONAL CANCER INSTITUTE [T32CA009678] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG14357 and AR055398 (to E. S. A.) and Grants 1R01AI083713 and R01HL093262 (to E. L.).; Supported by National Research Service Award T32-CA09678.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chu J, 2009, J LEUKOCYTE BIOL, V86, P1227, DOI 10.1189/jlb.0309164; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; FAROOQUI MYH, 1983, CHEM-BIOL INTERACT, V47, P363, DOI 10.1016/0009-2797(83)90170-9; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, J INNATE IMMUN, V1, P607, DOI 10.1159/000227263; Frankel BA, 2004, J AM CHEM SOC, V126, P3404, DOI 10.1021/ja0390294; Garcia-Pineres AJ, 2004, LIFE SCI, V75, P841, DOI 10.1016/j.lfs.2004.01.024; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; HALL IH, 1980, J PHARM SCI, V69, P537, DOI 10.1002/jps.2600690516; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hehner SP, 1999, J IMMUNOL, V163, P5617; Heinrich M, 1998, ANNU REV PHARMACOL, V38, P539, DOI 10.1146/annurev.pharmtox.38.1.539; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Kiuchi H, 2009, J UROLOGY, V181, P2339, DOI 10.1016/j.juro.2009.01.015; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Liu SJ, 2008, J AM CHEM SOC, V130, P8251, DOI 10.1021/ja711125p; Lopez-Franco O, 2006, ARTERIOSCL THROM VAS, V26, P1864, DOI 10.1161/01.ATV.0000229659.94020.53; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MASRI MS, 1988, J PROTEIN CHEM, V7, P49, DOI 10.1007/BF01025413; Meadows DC, 2006, MED RES REV, V26, P793, DOI 10.1002/med.20074; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Scheidt KA, 1998, BIOORGAN MED CHEM, V6, P2477, DOI 10.1016/S0968-0896(98)80022-9; Schinella GR, 1998, J PHARM PHARMACOL, V50, P1069, DOI 10.1111/j.2042-7158.1998.tb06924.x; Sheehan M, 2002, MOL PHARMACOL, V61, P953, DOI 10.1124/mol.61.5.953; SOROOSH P, 2009, IMMUNITY, V30, P875; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	46	373	408	3	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9792	9802		10.1074/jbc.M109.082305	http://dx.doi.org/10.1074/jbc.M109.082305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093358	Green Published, hybrid			2022-12-25	WOS:000276165900051
J	Chan, MWC; Chaudary, F; Lee, W; Copeland, JW; McCulloch, CA				Chan, Matthew W. C.; Chaudary, Faiza; Lee, Wilson; Copeland, John W.; McCulloch, Christopher A.			Force-induced Myofibroblast Differentiation through Collagen Receptors Is Dependent on Mammalian Diaphanous (mDia)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; SMOOTH MUSCLE ACTIN; MECHANICAL STRETCH; STRESS FIBER; RHO; ACTIVATION; BINDING; CELLS; COACTIVATOR; FIBROBLASTS	The development of fibrosis promotes the differentiation of myofibroblasts, pro-fibrotic cells, which contribute to tissue dysfunction. Myofibroblast differentiation is dependent on actin assembly, which in response to force, is mediated by various actin-binding proteins including the mammalian Diaphanous-related formins (mDia). We examined the role of mDia in the mechano-sensing pathway that leads to force-induced expression of alpha-smooth muscle actin (SMA), a marker and critical determinant of myofibroblast differentiation. In cells treated with siRNA to knockdown mDia and then subjected to tensile force using collagen-coated magnetite beads attached to beta 1 integrins, actin assembly was inhibited at bead contact sites. Force-induced nuclear translocation of MRTF-A, a transcriptional co-activator of SMA, was reduced 50% by mDia knockdown. The expression of the transcriptional co-activator of SMA, serum response factor, was reduced by 50% after siRNA knockdown of mDia or by 100% in cells transfected with catalytically inactive mDia. Force-induced activation of the SMA promoter and SMA expression were blocked by knockdown of siRNA of mDia. In anchored collagen gel assays to measure myofibroblast-mediated contraction, knockdown of mDia reduced contraction by 50%. We conclude that mDia plays an important role in the development of force-induced transcriptional activation of SMA and myofibroblast differentiation.	[Chan, Matthew W. C.; Chaudary, Faiza; Lee, Wilson; McCulloch, Christopher A.] Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; [Copeland, John W.] Univ Ottawa, Ottawa, ON K1H 8M5, Canada	University of Toronto; University of Ottawa	Chan, MWC (corresponding author), Rm 243,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	matthew.chan@utoronto.ca			CIHR [MGP-37783]; Heart and Stroke Foundation [T-6022]; Canada Research Chair (Tier I)	CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Canada Research Chair (Tier I)(Canada Research Chairs)	This work was supported by CIHR Operating Grant MGP-37783, a CIHR resource grant, and Heart and Stroke Foundation Grant T-6022 (to C.A.M.).; Supported by a Canada Research Chair (Tier I).	Arora PD, 2005, MOL BIOL CELL, V16, P5175, DOI 10.1091/mbc.E05-07-0648; Arora PD, 2004, MOL BIOL CELL, V15, P588, DOI 10.1091/mbc.E03-07-0468; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Browning CL, 1998, DEV BIOL, V194, P18, DOI 10.1006/dbio.1997.8808; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chan MWC, 2009, J CELL SCI, V122, P2769, DOI 10.1242/jcs.044008; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; GLOGAUER M, 1995, AM J PHYSIOL-CELL PH, V269, pC1093, DOI 10.1152/ajpcell.1995.269.5.C1093; Glogauer M, 1997, J CELL SCI, V110, P11; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Glogauer M, 1998, PFLUG ARCH EUR J PHY, V435, P320; GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; LESLIE KO, 1991, AM J PATHOL, V139, P207; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sun Y, 1996, CARDIOVASC RES, V31, P518; Syuto T, 2009, WOUND REPAIR REGEN, V17, P589, DOI 10.1111/j.1524-475X.2009.00510.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Unsworth KE, 2004, CELL MICROBIOL, V6, P1041, DOI 10.1111/j.1462-5822.2004.00417.x; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Walsh N, 2008, J PROTEOMICS, V71, P561, DOI 10.1016/j.jprot.2008.09.002; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang JX, 2002, J BIOL CHEM, V277, P22889, DOI 10.1074/jbc.M203130200; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	41	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9273	9281		10.1074/jbc.M109.075218	http://dx.doi.org/10.1074/jbc.M109.075218			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071339	Green Published, hybrid			2022-12-25	WOS:000275553700075
J	Shina, MC; Unal, C; Eichinger, L; Muller-Taubenberger, A; Schleicher, M; Steinert, M; Noegel, AA				Shina, Maria C.; Uenal, Can; Eichinger, Ludwig; Mueller-Taubenberger, Annette; Schleicher, Michael; Steinert, Michael; Noegel, Angelika A.			A Coronin7 Homolog with Functions in Actin-driven Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM-DISCOIDEUM; MONOCLONAL-ANTIBODIES; CAENORHABDITIS-ELEGANS; LEGIONELLA-PNEUMOPHILA; BINDING PROTEINS; F-ACTIN; CHEMOTACTIC STIMULATION; ENDOCYTIC PATHWAY; CELL MOTILITY; MYOSIN-II	Dictyostelium discoideum Coronin7 (DdCRN7) together with human Coronin7 (CRN7) and Pod-1 of Drosophila melanogaster and Caenorhabditis elegans belong to the coronin family of WD-repeat domain-containing proteins. Coronin7 proteins are characterized by two WD-repeat domains that presumably fold into two beta-propeller structures. DdCRN7 shares highest homology with human CRN7, a protein with roles in membrane trafficking. DdCRN7 is present in the cytosol and accumulates in cell surface projections during movement and phago- and pinocytosis. Cells lacking CRN7 have altered chemotaxis and phagocytosis. Furthermore, loss of CRN7 affects the infection process by the pathogen Legionella pneumophila and allows a more efficient internalization of bacteria. To provide a mechanism for CNR7 action, we studied actin-related aspects. We could show that CRN7 binds directly to F-actin and protects actin filaments from depolymerization. CRN7 also associated with F-actin in vivo. It was present in the Triton X-100-insoluble cytoskeleton, colocalized with F-actin, and its distribution was sensitive to drugs affecting the actin cytoskeleton. We propose that the CRN7 role in chemotaxis and phagocytosis is through its effect on the actin cytoskeleton.	[Shina, Maria C.; Eichinger, Ludwig; Noegel, Angelika A.] Univ Cologne, Fac Med, Ctr Mol Med Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Uenal, Can] Univ Wurzburg, Inst Mol Infect Biol, D-97080 Wurzburg, Germany; [Mueller-Taubenberger, Annette; Schleicher, Michael] Univ Munich, Inst Anat & Cell Biol, D-80336 Munich, Germany; [Mueller-Taubenberger, Annette; Schleicher, Michael] Univ Munich, Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Steinert, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany	University of Cologne; University of Wurzburg; University of Munich; University of Munich; Braunschweig University of Technology	Noegel, AA (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	noegel@uni-koeln.de	Müller-Taubenberger, Annette/AAG-8538-2020; Eichinger, Ludwig/AAJ-8895-2021; Müller-Taubenberger, Annette/AAM-3671-2021; Ünal, Can M./H-3796-2012	Müller-Taubenberger, Annette/0000-0003-1163-9232; Eichinger, Ludwig/0000-0003-1594-6117; Unal, Can/0000-0003-4710-9567	Deutsche Forschungsgemeinschaft [SFB 670]; Koln Fortune	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Koln Fortune	This work was supported by grants from the Deutsche Forschungsgemeinschaft, SFB 670, and Koln Fortune.	ADACHI H, 1994, BIOCHEM BIOPH RES CO, V205, P1808, DOI 10.1006/bbrc.1994.2880; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; BERTHOLDT G, 1985, CELL DIFFER DEV, V16, P187, DOI 10.1016/0045-6039(85)90516-0; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; CLAVIEZ M, 1982, EMBO J, V1, P1017, DOI 10.1002/j.1460-2075.1982.tb01287.x; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; DHARMAWARDHANE S, 1989, CELL MOTIL CYTOSKEL, V13, P57, DOI 10.1002/cm.970130107; EICHINGER L, 1992, BIOCHEMISTRY-US, V31, P4779, DOI 10.1021/bi00135a006; EICHINGER L, 1991, J CELL BIOL, V112, P665, DOI 10.1083/jcb.112.4.665; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fajardo M, 2004, MICROBIOL-SGM, V150, P2825, DOI 10.1099/mic.0.27111-0; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Fey P, 2002, J CELL BIOL, V159, P1109, DOI 10.1083/jcb.200206067; FIRTEL RA, 1972, J MOL BIOL, V66, P339, DOI 10.1016/0022-2836(72)90419-6; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; HALL AL, 1988, J CELL BIOCHEM, V37, P285, DOI 10.1002/jcb.240370304; HAUGWITZ M, 1991, J CELL SCI, V100, P481; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jeon TJ, 2007, J CELL BIOL, V176, P1021, DOI 10.1083/jcb.200607072; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; Jin T, 2009, IMMUNOL RES, V43, P118, DOI 10.1007/s12026-008-8056-7; Jung E, 1996, EMBO J, V15, P1238, DOI 10.1002/j.1460-2075.1996.tb00465.x; Korneeva NL, 1996, EUR J CELL BIOL, V71, P351; KREFFT M, 1989, J CELL SCI, V93, P199; Maniak M, 2003, CURR BIOL, V13, pR917, DOI 10.1016/j.cub.2003.11.014; Maniak M, 2003, TRAFFIC, V4, P1, DOI 10.1034/j.1600-0854.2003.40101.x; Maniak M, 2002, INT REV CYTOL, V221, P257; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Maniak M, 2001, BBA-GEN SUBJECTS, V1525, P197, DOI 10.1016/S0304-4165(01)00105-2; MCROBBIE SJ, 1983, BIOCHEM BIOPH RES CO, V115, P351, DOI 10.1016/0006-291X(83)91011-2; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Mondal S, 2008, J CELL BIOL, V181, P747, DOI 10.1083/jcb.200710111; Morgan Reginald O., 2008, V48, P41, DOI 10.1007/978-0-387-09595-0_5; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Rivero Francisco, 2006, V346, P423; Rothenberg ME, 2003, NEURON, V39, P779, DOI 10.1016/S0896-6273(03)00508-7; Rybakin V, 2008, CELL MOL LIFE SCI, V65, P2419, DOI 10.1007/s00018-008-8278-9; Rybakin V, 2004, FEBS LETT, V573, P161, DOI 10.1016/j.febslet.2004.07.066; Rybakin V, 2006, J BIOL CHEM, V281, P31070, DOI 10.1074/jbc.M604680200; SCHLEICHER M, 1988, J CELL SCI, V90, P59; SCHLEICHER M, 1988, DEV GENET, V9, P521, DOI 10.1002/dvg.1020090428; SIMPSON PA, 1984, J CELL BIOL, V99, P287, DOI 10.1083/jcb.99.1.287; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; Solomon JM, 2003, INFECT IMMUN, V71, P3578, DOI 10.1128/IAI.71.6.3578-3586.2003; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Tagawa A, 2001, DEV BIOL, V233, P412, DOI 10.1006/dbio.2001.0234; THILO L, 1980, P NATL ACAD SCI-BIOL, V77, P1015, DOI 10.1073/pnas.77.2.1015; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; VOGEL G, 1980, J CELL BIOL, V86, P456; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989	59	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9249	9261		10.1074/jbc.M109.083725	http://dx.doi.org/10.1074/jbc.M109.083725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071332	hybrid, Green Published			2022-12-25	WOS:000275553700073
J	Pacholec, M; Bleasdale, JE; Chrunyk, B; Cunningham, D; Flynn, D; Garofalo, RS; Griffith, D; Griffor, M; Loulakis, P; Pabst, B; Qiu, XY; Stockman, B; Thanabal, V; Varghese, A; Ward, J; Withka, J; Ahn, K				Pacholec, Michelle; Bleasdale, John E.; Chrunyk, Boris; Cunningham, David; Flynn, Declan; Garofalo, Robert S.; Griffith, David; Griffor, Matt; Loulakis, Pat; Pabst, Brandon; Qiu, Xiayang; Stockman, Brian; Thanabal, Venkataraman; Varghese, Alison; Ward, Jessica; Withka, Jane; Ahn, Kay			SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; SMALL-MOLECULE ACTIVATORS; CALORIE RESTRICTION; INSULIN-RESISTANCE; HISTONE/PROTEIN DEACETYLASES; SACCHAROMYCES-CEREVISIAE; INCREASED DOSAGE; CELL-SURVIVAL; P53; MECHANISM	Sirtuins catalyze NAD(+)-dependent protein deacetylation and are critical regulators of transcription, apoptosis, metabolism, and aging. There are seven human sirtuins (SIRT1-7), and SIRT1 has been implicated as a key mediator of the pathways downstream of calorie restriction that have been shown to delay the onset and reduce the incidence of age-related diseases such as type 2 diabetes. Increasing SIRT1 activity, either by transgenic overexpression of the Sirt1 gene in mice or by pharmacological activation by small molecule activators resveratrol and SRT1720, has shown beneficial effects in rodent models of type 2 diabetes, indicating that SIRT1 may represent an attractive therapeutic target. Herein, we have assessed purported SIRT1 activators by employing biochemical assays utilizing native substrates, including a p53-derived peptide substrate lacking a fluorophore as well as the purified native full-length protein substrates p53 and acetyl-CoA synthetase1. SRT1720, its structurally related compounds SRT2183 and SRT1460, and resveratrol do not lead to apparent activation of SIRT1 with native peptide or full-length protein substrates, whereas they do activate SIRT1 with peptide substrate containing a covalently attached fluorophore. Employing NMR, surface plasmon resonance, and isothermal calorimetry techniques, we provide evidence that these compounds directly interact with fluorophore-containing peptide substrates. Furthermore, we demonstrate that SRT1720 neither lowers plasma glucose nor improves mitochondrial capacity in mice fed a high fat diet. SRT1720, SRT2183, SRT1460, and resveratrol exhibit multiple off-target activities against receptors, enzymes, transporters, and ion channels. Taken together, we conclude that SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.	[Griffith, David; Pabst, Brandon] Pfizer Global Res & Dev, Dept Cardiovasc Metab & Endocrine Dis, Groton, CT 06340 USA; [Chrunyk, Boris; Cunningham, David; Griffor, Matt; Loulakis, Pat; Qiu, Xiayang; Stockman, Brian; Thanabal, Venkataraman; Varghese, Alison; Withka, Jane] Pfizer Global Res & Dev, Dept Biol Struct, Groton, CT 06340 USA	Pfizer; Pfizer		kay.ahn@pfizer.com		Stockman, Brian/0000-0002-8520-9588				Albani D, 2010, J ALZHEIMERS DIS, V19, P11, DOI 10.3233/JAD-2010-1215; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; CHEN L, 2010, J INORG BIO IN PRESS; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; GRACIASANCHO J, CARDIOVASC RES, V85, P514; Groebe DR, 2006, DRUG DISCOV TODAY, V11, P632, DOI 10.1016/j.drudis.2006.05.010; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Heilbronn LK, 2005, OBES RES, V13, P574, DOI 10.1038/oby.2005.61; ISHIKAWA M, 1995, TOHOKU J EXP MED, V175, P55, DOI 10.1620/tjem.175.55; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Ramadori G, 2009, ENDOCRINOLOGY, V150, P5326, DOI 10.1210/en.2009-0528; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sauve AA, 2004, CURR MED CHEM, V11, P807, DOI 10.2174/0929867043455675; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Segel I.H., 1993, ENZYME KINETICS, P227; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, J AM CHEM SOC, V129, P5802, DOI 10.1021/ja070162w; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; SULAIMAN M, 2010, AM J PHYSL IN PRESS; Sun Xiu Zhu, 2003, Methods Mol Biol, V234, P17; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; UM JH, 2010, DIABETES IN PRESS; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang YH, 2003, J BIOL CHEM, V278, P25568, DOI 10.1074/jbc.M212574200; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008	48	711	749	2	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8340	8351		10.1074/jbc.M109.088682	http://dx.doi.org/10.1074/jbc.M109.088682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061378	hybrid, Green Published			2022-12-25	WOS:000275413800050
J	Thomas, CP; Morgan, LT; Maskrey, BH; Murphy, RC; Kuhn, H; Hazen, SL; Goodall, AH; Hamali, HA; Collins, PW; O'Donnell, VB				Thomas, Christopher P.; Morgan, Lloyd T.; Maskrey, Benjamin H.; Murphy, Robert C.; Kuehn, Hartmut; Hazen, Stanley L.; Goodall, Alison H.; Hamali, Hassan A.; Collins, Peter W.; O'Donnell, Valerie B.			Phospholipid-esterified Eicosanoids Are Generated in Agonist-activated Human Platelets and Enhance Tissue Factor-dependent Thrombin Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; OXIDIZED PHOSPHOLIPIDS; LIPID-PEROXIDATION; PROCOAGULANT ACTIVITY; COAGULANT ACTIVITY; ARACHIDONIC-ACID; GLYCOPROTEIN-VI; SCOTT-SYNDROME; LIPOXYGENASE; PHOSPHATIDYLETHANOLAMINE	Here, a group of specific lipids, comprising phosphatidylethanolamine (PE)- or phosphatidylcholine (PC)-esterified 12S-hydroxyeicosatetraenoic acid (12S-HETE), generated by 12-lipoxygenase was identified and characterized. 12S-HETE-PE/PCs were formed within 5 min of activation by thrombin, ionophore, or collagen. Esterified HETE levels generated in response to thrombin were 5.85 +/- 1.42 (PE) or 18.35 +/- 4.61 (PC), whereas free was 65.5 +/- 17.6 ng/4 x 10(7) cells (n = 5 separate donors, mean +/- S.E.). Their generation was stimulated by triggering protease-activated receptors-1 and -4 and signaling via Ca2+ mobilization secretory phospholipase A2, platelet-activating factor-acetylhydrolase, src tyrosine kinases, and protein kinase C. Stable isotope labeling showed that they form predominantly by esterification that occurs on the same time scale as free acid generation. Unlike free 12S-HETE that is secreted, esterified HETEs remain cell-associated, with HETE-PEs migrating to the outside of the plasma membrane. 12-Lipoxygenase inhibition attenuated externalization of native PE and phosphatidylserine and HETE-PEs. Platelets from a patient with the bleeding disorder, Scott syndrome, did not externalize HETE-PEs, and liposomes supplemented with HETE-PC dose-dependently enhanced tissue factor-dependent thrombin generation in vitro. This suggests a role for these novel lipids in promoting coagulation. Thus, oxidized phospholipids form by receptor/agonist mechanisms, not merely as an undesirable consequence of vascular and inflammatory disease.	[Thomas, Christopher P.; Morgan, Lloyd T.; Maskrey, Benjamin H.; O'Donnell, Valerie B.] Cardiff Univ, Dept Infect Immunol & Biochem, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Collins, Peter W.] Cardiff Univ, Dept Hematol, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Kuehn, Hartmut] Humboldt Univ, Inst Biochem, D-10117 Berlin, Germany; [Hazen, Stanley L.] Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Goodall, Alison H.; Hamali, Hassan A.] Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Leicester LE3 9QP, Leics, England	Cardiff University; Cardiff University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Humboldt University of Berlin; Cleveland Clinic Foundation; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	O'Donnell, VB (corresponding author), Cardiff Univ, Dept Infect Immunol & Biochem, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	o-donnellvb@cardiff.ac.uk	O'Donnell, Valerie/C-6948-2012; Thomas, Christopher P/R-5243-2016; Murphy, Robert/AAO-5349-2020; Hazen, Stanley L/ABD-5845-2021	Thomas, Christopher P/0000-0001-5840-8613; Murphy, Robert/0000-0002-9430-6515; /0000-0003-4089-8460; Hamali, Hassan A./0000-0003-3791-460X; Goodall, Alison/0000-0002-7883-9645	Lipid MAPS Large Scale Collaborative; National Institutes of Health [GM069338, P01 HL087018-020001]; Wellcome Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	Lipid MAPS Large Scale Collaborative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Lipid MAPS Large Scale Collaborative Grant, National Institutes of Health GM069338 (to R. C. M.), National Institutes of Health Grant P01 HL087018-020001 (to S. L. H.), and by the Wellcome Trust (V.B.O., C. P. T., and B. H. M.).	ARONSON DL, 1977, J CLIN INVEST, V60, P1410, DOI 10.1172/JCI108902; Bochkov VN, 2007, THROMB HAEMOSTASIS, V97, P348, DOI 10.1160/TH06-08-0474; BRASH AR, 1986, PROSTAG LEUKOTR ESS, V23, P149, DOI 10.1016/0262-1746(86)90178-2; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Coffey MJ, 2004, FEBS LETT, V576, P165, DOI 10.1016/j.febslet.2004.09.007; COMFURIUS P, 1990, BIOCHIM BIOPHYS ACTA, V1026, P153, DOI 10.1016/0005-2736(90)90058-V; COMFURIUS P, 1985, BIOCHIM BIOPHYS ACTA, V815, P143, DOI 10.1016/0005-2736(85)90485-7; COOK WJ, 1976, BIOCHEM BIOPH RES CO, V68, P143, DOI 10.1016/0006-291X(76)90021-8; FAILI A, 1994, BRIT J HAEMATOL, V88, P149, DOI 10.1111/j.1365-2141.1994.tb04990.x; Falls LA, 2000, BIOCHEMISTRY-US, V39, P13216, DOI 10.1021/bi0009789; Greaves M, 2000, BRIT J HAEMATOL, V109, P704, DOI 10.1046/j.1365-2141.2000.02069.x; Hayashi T, 2007, FREE RADICAL BIO MED, V43, P1552, DOI 10.1016/j.freeradbiomed.2007.08.013; Klein S, 2001, ARTERIOSCL THROM VAS, V21, P1695; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Morgan AH, 2009, J BIOL CHEM, V284, P21185, DOI 10.1074/jbc.M109.021634; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; MOUNIER C, 1993, EUR J BIOCHEM, V216, P169, DOI 10.1111/j.1432-1033.1993.tb18129.x; Murphy R. C, 2002, MASS SPECTROMETRY PH; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; Paradies G, 1999, FREE RADICAL BIO MED, V27, P42, DOI 10.1016/S0891-5849(99)00032-5; PARRY DH, 1980, BRIT J HAEMATOL, V44, P323, DOI 10.1111/j.1365-2141.1980.tb01215.x; Pickering W, 2008, J THROMB HAEMOST, V6, P1122, DOI 10.1111/j.1538-7836.2008.02957.x; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Rolla R, 2007, CLIN EXP IMMUNOL, V149, P63, DOI 10.1111/j.1365-2249.2007.03404.x; SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X; Schnurr K, 1996, FREE RADICAL BIO MED, V20, P11, DOI 10.1016/0891-5849(95)02012-8; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2000, FREE RADICAL BIO MED, V28, P1751, DOI 10.1016/S0891-5849(00)00233-1; TAKAHASHI Y, 1993, EUR J BIOCHEM, V218, P165, DOI 10.1111/j.1432-1033.1993.tb18362.x; Tyurin VA, 2008, J NEUROCHEM, V107, P1614, DOI 10.1111/j.1471-4159.2008.05728.x; von Schlieffen E, 2009, ARTERIOSCL THROM VAS, V29, P356, DOI 10.1161/ATVBAHA.108.173799; WEISS HJ, 1994, SEMIN HEMATOL, V31, P312; WEISS HJ, 1979, AM J MED, V67, P206, DOI 10.1016/0002-9343(79)90392-9; Witztum JL, 1998, CURR OPIN LIPIDOL, V9, P441, DOI 10.1097/00041433-199810000-00008; YUAN YP, 1995, BLOOD, V86, P4166, DOI 10.1182/blood.V86.11.4166.bloodjournal86114166; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	40	101	104	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6891	6903		10.1074/jbc.M109.078428	http://dx.doi.org/10.1074/jbc.M109.078428			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20061396	Green Published, hybrid			2022-12-25	WOS:000275415600003
J	Kiya, T; Kubo, T				Kiya, Taketoshi; Kubo, Takeo			Analysis of GABAergic and Non-GABAergic Neuron Activity in the Optic Lobes of the Forager and Re-Orienting Worker Honeybee (Apis mellifera L.)	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GABA-LIKE IMMUNOREACTIVITY; MUSHROOM BODY; FEEDBACK NEURONS; BRAIN; BODIES; BEE; CONNECTIONS; NAVIGATION; SEQUENCE	Background: European honeybee (Apis mellifera L.) foragers have a highly developed visual system that is used for navigation. To clarify the neural basis underlying the highly sophisticated visual ability of foragers, we investigated the neural activity pattern of the optic lobes (OLs) in pollen-foragers and re-orienting bees, using the immediate early gene kakusei as a neural activity marker. Methodology/Principal Findings: We performed double-in situ hybridization of kakusei and Amgad, the honeybee homolog of the GABA synthesizing enzyme GAD, to assess inhibitory neural activity. kakusei-related activity in GABAergic and non-GABAergic neurons was strongly upregulated in the OLs of the foragers and re-orienting bees, suggesting that both types of neurons are involved in visual information processing. GABAergic neuron activity was significantly higher than non-GABAergic neuron activity in a part of the OLs of only the forager, suggesting that unique information processing occurs in the OLs of foragers. In contrast, GABAergic neuron activity in the antennal lobe was significantly lower than that of GABAergic neurons in the OLs in the forager and re-orienting bees, suggesting that kakusei-related visual activity is dominant in the brains of these bees. Conclusions/Significance: The present study provides the first evidence that GABAergic neurons are highly active in the OL neurons of free-moving honeybees and essential clue to reveal neural basis of the sophisticated visual ability that is equipped in the small and simple brain.	[Kiya, Taketoshi; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan	University of Tokyo	Kiya, T (corresponding author), Kanazawa Univ, Biol Course, Inst Sci & Engn, Kanazawa, Ishikawa, Japan.	kiya@staff.kanazawa-u.ac.jp	Kiya, Taketoshi/ABE-6519-2020; KUBO, TAKEO/G-4951-2014; Kiya, Taketoshi/J-9032-2015	Kiya, Taketoshi/0000-0002-5709-8016; Kubo, Takeo/0000-0002-5914-5269	Promotion of Basic Activities for Innovative Bioscience (PRO-BRAIN)	Promotion of Basic Activities for Innovative Bioscience (PRO-BRAIN)	This research was supported by the Promotion of Basic Activities for Innovative Bioscience (PRO-BRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicker G, 1999, MICROSC RES TECHNIQ, V45, P174, DOI 10.1002/(SICI)1097-0029(19990501)45:3<174::AID-JEMT5>3.3.CO;2-L; Bicker G, 1999, MICROSC RES TECHNIQ, V44, P166, DOI 10.1002/(SICI)1097-0029(19990115/01)44:2/3<166::AID-JEMT8>3.0.CO;2-T; BICKER G, 1985, BRAIN RES, V360, P394, DOI 10.1016/0006-8993(85)91262-4; Bornhauser BC, 1997, CELL TISSUE RES, V287, P211, DOI 10.1007/s004410050747; Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; Giurfa M, 1997, CURR OPIN NEUROBIOL, V7, P505, DOI 10.1016/S0959-4388(97)80030-X; Grunewald B, 1999, J COMP NEUROL, V404, P114; Grunewald B, 1999, J COMP PHYSIOL A, V185, P565, DOI 10.1007/s003590050417; Homberg U., 1994, DISTRIBUTION NEUROTR; JACKSON FR, 1990, J NEUROCHEM, V54, P1068, DOI 10.1111/j.1471-4159.1990.tb02359.x; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kiya T, 2008, INSECT MOL BIOL, V17, P531, DOI 10.1111/j.1365-2583.2008.00821.x; MARTIN AR, 2001, NEURON BRAIN; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; PHILLIPS AM, 1993, J NEUROCHEM, V61, P1291, DOI 10.1111/j.1471-4159.1993.tb13621.x; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Ribi W.A., 1975, Quarterly Review of Biology, V50, P1; RIBI WA, 1984, CELL TISSUE RES, V236, P577, DOI 10.1007/BF00217225; RIBI WA, 1981, CELL TISSUE RES, V221, P17, DOI 10.1007/BF00216567; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; SCHAFER S, 1986, J COMP NEUROL, V246, P287, DOI 10.1002/cne.902460302; Seeley T., 1995, WISDOM HIVE SOCIAL P; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; von Frisch K, 1969, DANCE LANGUAGE ORIEN; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Yang EC, 1997, J INSECT PHYSIOL, V43, P329, DOI 10.1016/S0022-1910(96)00111-4; Yang EC, 2004, J INSECT PHYSIOL, V50, P913, DOI 10.1016/j.jinsphys.2004.06.010	34	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8833	10.1371/journal.pone.0008833	http://dx.doi.org/10.1371/journal.pone.0008833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098617	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100024
J	Man, RY; Onodera, T; Komatsu, E; Tsubata, T				Man, Rong-Yong; Onodera, Taishi; Komatsu, Emi; Tsubata, Takeshi			Augmented B Lymphocyte Response to Antigen in the Absence of Antigen-Induced B Lymphocyte Signaling in an IgG-Transgenic Mouse Line	PLOS ONE			English	Article							CELL FATE DECISION; MARGINAL-ZONE; SURFACE-IMMUNOGLOBULIN; CD22-DEFICIENT MICE; NEGATIVE REGULATOR; RECEPTOR; CD22; ANERGY; EXPRESSION; MEMORY	IgG-containing B cell antigen receptor (IgG-BCR), the BCR mostly expressed on memory B cells, contains a distinct signaling function from IgM-BCR or IgD-BCR expressed on naive B cells. Because naive B cells transgenic for IgG exhibit augmented response to antigens similar to memory B cells, the distinct signaling function of IgG-BCR appears to play a role in augmented antibody responses of memory B cells. However, how IgG-BCR signaling augments B cell responses is not yet well understood. Here we demonstrate that B cells from IgG-transgenic mice are anergic with defect in generation of BCR signaling upon BCR ligation. However, these IgG-transgenic B cells generate markedly augmented antibody response to a T cell-dependent antigen, probably due to hyper-responsiveness to a T cell-derived signal through CD40. Both BCR signaling defect and augmented response to CD40 ligation are partially restored in xid IgG-transgenic mice in which BCR signaling is down-modulated due to a loss-of-function mutation in the tyrosine kinase Btk crucial for BCR signaling. Thus, IgG-BCR induces augmented B cell responses in the absence of antigen-induced BCR signaling probably through high ligand-independent BCR signaling that may "idle" B cells to make them ready to respond to T cell help. This finding strongly suggests a crucial role of ligand-independent signaling in receptor function.	[Man, Rong-Yong; Onodera, Taishi; Komatsu, Emi; Tsubata, Takeshi] Tokyo Med & Dent Univ, Immunol Lab, Grad Sch Biomed Sci, Tokyo, Japan; [Man, Rong-Yong; Onodera, Taishi; Komatsu, Emi; Tsubata, Takeshi] Tokyo Med & Dent Univ, Dept Immunol, Med Res Inst, Tokyo, Japan; [Tsubata, Takeshi] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Man, RY (corresponding author), Tokyo Med & Dent Univ, Immunol Lab, Grad Sch Biomed Sci, Tokyo, Japan.	tsubata.imm@mri.tmd.ac.jp	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258	Japan Science and Technology Agency [15390158]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Funding was provided by the Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/crest/en/index.html) and the Japan Society for the Promotion of Science (15390158) (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 1996, EUR J IMMUNOL, V26, P250, DOI 10.1002/eji.1830260139; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Borrero M, 2002, J IMMUNOL, V168, P13, DOI 10.4049/jimmunol.168.1.13; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; COFFMAN RL, 1977, J IMMUNOL, V118, P1806; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Desiderio S, 1997, CURR OPIN IMMUNOL, V9, P534, DOI 10.1016/S0952-7915(97)80107-0; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; Gauld SB, 2006, CURR OPIN IMMUNOL, V18, P292, DOI 10.1016/j.coi.2006.03.015; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Heltemes LM, 2002, J IMMUNOL, V169, P1283, DOI 10.4049/jimmunol.169.3.1283; Hokazono Y, 2003, J IMMUNOL, V171, P1835, DOI 10.4049/jimmunol.171.4.1835; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; KENNY JJ, 1995, J IMMUNOL, V154, P5694; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Li XL, 2001, J IMMUNOL, V166, P3122, DOI 10.4049/jimmunol.166.5.3122; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Marino E, 2008, DIABETES, V57, P395, DOI 10.2337/db07-0589; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Monroe JG, 2004, CURR OPIN IMMUNOL, V16, P288, DOI 10.1016/j.coi.2004.03.010; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Noorchashm H, 1999, INT IMMUNOL, V11, P765, DOI 10.1093/intimm/11.5.765; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Onodera T, 2008, J IMMUNOL, V180, P907, DOI 10.4049/jimmunol.180.2.907; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Poe JC, 2004, J IMMUNOL, V172, P2100, DOI 10.4049/jimmunol.172.4.2100; Pogue SL, 2000, J EXP MED, V191, P1031, DOI 10.1084/jem.191.6.1031; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; ROTH PE, 1993, J EXP MED, V178, P2007, DOI 10.1084/jem.178.6.2007; Sato M, 2007, J IMMUNOL, V178, P2901, DOI 10.4049/jimmunol.178.5.2901; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; YEFENOF E, 1986, J IMMUNOL, V137, P85; YUAN D, 1977, J EXP MED, V145, P1421, DOI 10.1084/jem.145.6.1421	55	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8815	10.1371/journal.pone.0008815	http://dx.doi.org/10.1371/journal.pone.0008815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098688	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779100009
J	Manning, SD; Springman, AC; Million, AD; Milton, NR; McNamara, SE; Somsel, PA; Bartlett, P; Davies, HD				Manning, Shannon D.; Springman, A. Cody; Million, Amber D.; Milton, Nicole R.; McNamara, Sara E.; Somsel, Patricia A.; Bartlett, Paul; Davies, H. Dele			Association of Group B Streptococcus Colonization and Bovine Exposure: A Prospective Cross-Sectional Cohort Study	PLOS ONE			English	Article							CLINICAL MASTITIS; FECAL CARRIAGE; DAIRY-COWS; AGALACTIAE; SEROTYPE; DIVERSITY; PREVALENCE; MILK; TRANSMISSION; STUDENTS	Background: While Group B Streptococcus (GBS) human colonization and infection has long been suspected as originating from cows, several investigators have suggested that ongoing interspecies GBS transmission is unlikely due to genotyping data demonstrating that human and bovine-derived GBS strains represent mostly distinct populations. The possibility of ongoing transmission between humans and their livestock has not been systematically examined. Methodology/Principal Findings: To examine ongoing interspecies transmission, we conducted a prospective cross-sectional cohort study of 68 families and their livestock. Stool specimens were collected from 154 people and 115 livestock; GBS was detected in 19 (12.3%) humans and 2 (1.7%) animals (bovine and sheep). Application of multilocus sequence typing (MLST) identified 8 sequence types (STs or clones), with STs 1 and 23 predominating. There were 11 families in which two members submitted stools and at least one had GBS colonization. In 3 of these families, both members (consisting of couples) were colonized, yielding a co-colonization rate of 27% (95% CI: 7%-61%). Two of these couples had strains with identical MLST, capsule (cps) genotype, susceptibility, and RAPD profiles. One couple co-colonized with ST-1 (cps5) strains also had a bovine colonized with the identical strain type. On multivariate analysis of questionnaire data, cattle exposure was a predictor of GBS colonization, with each unit increase in days of cattle exposure increasing the odds of colonization by 20% (P = 0.02). These results support interspecies transmission with additional evidence for transmission provided by the epidemiological association with cattle exposure. Conclusions/Significance: Although GBS uncommonly colonizes livestock stools, increased frequency of cattle exposure was significantly associated with human colonization and one couple shared the same GBS strains as their bovine suggesting intraspecies transmission. These results set the framework for GBS as a possible zoonotic infection, which has significant public health implications.	[Manning, Shannon D.; Springman, A. Cody; Million, Amber D.; Milton, Nicole R.] Michigan State Univ, Microbial Evolut Lab, E Lansing, MI 48824 USA; [Manning, Shannon D.; Springman, A. Cody; Million, Amber D.; Milton, Nicole R.; Bartlett, Paul] Michigan State Univ, Natl Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA; [Manning, Shannon D.; Springman, A. Cody; Milton, Nicole R.; Davies, H. Dele] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [McNamara, Sara E.; Somsel, Patricia A.] Michigan Dept Community Hlth, Bur Labs, Lansing, MI USA	Michigan State University; Michigan State University; Michigan State University; MDHHS - Michigan Department of Health & Human Services	Manning, SD (corresponding author), Michigan State Univ, Microbial Evolut Lab, E Lansing, MI 48824 USA.	daviesde@msu.edu	Manning, Shannon/GXA-0622-2022	Manning, Shannon/0000-0001-9581-0660	National Institutes of Health (National Institutes of Immunology, Allergy and Infectious Diseases) [AI066081]; National Institutes of Health, Department of Health and Human Services [N01-AI-30058]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066081] Funding Source: NIH RePORTER	National Institutes of Health (National Institutes of Immunology, Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Public Health Service grant AI066081 from the National Institutes of Health (National Institutes of Immunology, Allergy and Infectious Diseases) and a contract from the National Institutes of Health, Department of Health and Human Services, under the Food and Waterborne Diseases Integrated Research Network (NIH Research Contract N01-AI-30058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Bliss SJ, 2002, CLIN INFECT DIS, V34, P184, DOI 10.1086/338258; Bohnsack JF, 2004, EMERG INFECT DIS, V10, P1412, DOI 10.3201/eid1008.030917; BRGLEZ I, 1986, ZBL BAKT MIK HYG B, V182, P401; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; BRUNER DW, 1953, CORNELL VET, V43, P574; Clinical and laboratory standards institute, 2007, PERF STAND ANT SUS S, V27; Duarte RS, 2004, J CLIN MICROBIOL, V42, P4214, DOI 10.1128/JCM.42.9.4214-4222.2004; EASMON CSF, 1983, BRIT J OBSTET GYNAEC, V90, P633, DOI 10.1111/j.1471-0528.1983.tb09280.x; Edwards MS, 2005, CLIN INFECT DIS, V40, P352, DOI 10.1086/426820; FINCH LA, 1984, J APPL BACTERIOL, V57, P273, DOI 10.1111/j.1365-2672.1984.tb01391.x; Foxman B, 2006, AM J EPIDEMIOL, V163, P544, DOI 10.1093/aje/kwj075; HAMMERSCHLAG MR, 1977, PEDIATRICS, V60, P473; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; ISLAM AKMS, 1980, J CLIN PATHOL, V33, P1006, DOI 10.1136/jcp.33.10.1006; Jensen NE, 1996, EPIDEMIOL INFECT, V117, P417, DOI 10.1017/S0950268800059069; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Keefe GP, 1997, CAN VET J, V38, P429; KUBIN V, 1983, FOLIA MICROBIOL, V28, P496, DOI 10.1007/BF02879689; Lin FYC, 2006, J CLIN MICROBIOL, V44, P1257, DOI 10.1128/JCM.44.4.1257-1261.2006; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Manning S D, 2001, Clin Infect Dis, V33, pE137, DOI 10.1086/324588; Manning SD, 2005, J CLIN MICROBIOL, V43, P6113, DOI 10.1128/JCM.43.12.6113-6116.2005; Manning SD, 2004, CLIN INFECT DIS, V39, P380, DOI 10.1086/422321; Manning SD, 2002, EPIDEMIOLOGY, V13, P533, DOI 10.1097/00001648-200209000-00008; Manning SD, 2008, CLIN INFECT DIS, V47, P388, DOI 10.1086/589864; Manning SD, 2008, CLIN INFECT DIS, V46, P1829, DOI 10.1086/588296; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Martinez G, 2000, J CLIN MICROBIOL, V38, P71; Mosabi JM, 1997, EPIDEMIOL INFECT, V118, P215, DOI 10.1017/S0950268897007474; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Oliveira ICM, 2006, CLIN MICROBIOL INFEC, V12, P887, DOI 10.1111/j.1469-0691.2006.01508.x; PERSSON KMS, 1986, EUR J CLIN MICROBIOL, V5, P156, DOI 10.1007/BF02013972; Pitkala A, 2004, J DAIRY SCI, V87, P2433, DOI 10.3168/jds.S0022-0302(04)73366-4; Sargeant JM, 1998, CAN VET J, V39, P33; Springman AC, 2009, J BACTERIOL, V191, P5419, DOI 10.1128/JB.00369-09; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P1177, DOI 10.1128/JCM.43.3.1177-1186.2005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenhagen BA, 2009, J DAIRY RES, V76, P179, DOI 10.1017/S0022029908003786; van der Mee-Marquet N, 2008, J CLIN MICROBIOL, V46, P2906, DOI 10.1128/JCM.00421-08	42	57	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8795	10.1371/journal.pone.0008795	http://dx.doi.org/10.1371/journal.pone.0008795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098699	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000022
J	Olivieri, C; Ermini, L; Rizzi, E; Corti, G; Bonnal, R; Luciani, S; Marota, I; De Bellis, G; Rollo, F				Olivieri, Cristina; Ermini, Luca; Rizzi, Ermanno; Corti, Giorgio; Bonnal, Raoul; Luciani, Stefania; Marota, Isolina; De Bellis, Gianluca; Rollo, Franco			Characterization of Nucleotide Misincorporation Patterns in the Iceman's Mitochondrial DNA	PLOS ONE			English	Article							ANCIENT DNA; MISCODING LESIONS; SEQUENCE-ANALYSIS; GENETIC ANALYSES; DAMAGE; RETRIEVAL; REMAINS; DECAY	Background: The degradation of DNA represents one of the main issues in the genetic analysis of archeological specimens. In the recent years, a particular kind of post-mortem DNA modification giving rise to nucleotide misincorporation ("miscoding lesions") has been the object of extensive investigations. Methodology/Principal Findings: To improve our knowledge regarding the nature and incidence of ancient DNA nucleotide misincorporations, we have utilized 6,859 (629,975 bp) mitochondrial (mt) DNA sequences obtained from the 5,350-5,100-years-old, freeze-desiccated human mummy popularly known as the Tyrolean Iceman or Otzi. To generate the sequences, we have applied a mixed PCR/pyrosequencing procedure allowing one to obtain a particularly high sequence coverage. As a control, we have produced further 8,982 (805,155 bp) mtDNA sequences from a contemporary specimen using the same system and starting from the same template copy number of the ancient sample. From the analysis of the nucleotide misincorporation rate in ancient, modern, and putative contaminant sequences, we observed that the rate of misincorporation is significantly lower in modern and putative contaminant sequence datasets than in ancient sequences. In contrast, type 2 transitions represent the vast majority (85%) of the observed nucleotide misincorporations in ancient sequences. Conclusions/Significance: This study provides a further contribution to the knowledge of nucleotide misincorporation patterns in DNA sequences obtained from freeze-preserved archeological specimens. In the Iceman system, ancient sequences can be clearly distinguished from contaminants on the basis of nucleotide misincorporation rates. This observation confirms a previous identification of the ancient mummy sequences made on a purely phylogenetical basis. The present investigation provides further indication that the majority of ancient DNA damage is reflected by type 2 (cytosine -> thymine/guanine -> adenine) transitions and that type 1 transitions are essentially PCR artifacts.	[Olivieri, Cristina; Luciani, Stefania; Marota, Isolina; Rollo, Franco] Univ Camerino, Lab Archeoantropol Mol DNA Antico, Dipartimento Biol Mol Cellulare & Anim, I-62032 Camerino, Italy; [Ermini, Luca] Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Rizzi, Ermanno; Corti, Giorgio; Bonnal, Raoul; De Bellis, Gianluca] CNR, Ist Tecnol Biomed, I-20133 Milan, Italy	University of Camerino; Newcastle University - UK; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Olivieri, C (corresponding author), Univ Camerino, Lab Archeoantropol Mol DNA Antico, Dipartimento Biol Mol Cellulare & Anim, I-62032 Camerino, Italy.	francougo.rollo@unicam.it	De Bellis, Gianluca/H-9725-2013; Rizzi, Ermanno/J-7448-2012; rizzi, ermanno/Q-3399-2016; Ermini, Luca/O-4813-2016	De Bellis, Gianluca/0000-0002-1622-4477; rizzi, ermanno/0000-0002-9898-2326; Ermini, Luca/0000-0001-8109-6021; Bonnal, Raoul/0000-0002-2123-6536; Olivieri, Cristina/0000-0002-2957-5452; Corti, Giorgio/0000-0001-6379-4117	Eli Lilly donation	Eli Lilly donation(Eli Lilly)	This research was supported by an Eli Lilly donation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Banerjee M, 2004, J ARCHAEOL SCI, V31, P59, DOI 10.1016/S0305-4403(03)00099-2; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; BROWN TA, 1992, ANTIQUITY, V66, P10, DOI 10.1017/S0003598X0008100X; Cooper A, 2000, SCIENCE, V289, P1139; Di Bernardo G, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e16; ECKERT KA, 1990, PCR PRACTICAL APPROA, P225; EGLINTON G, 1991, PHILOS T ROY SOC B, V333, P315, DOI 10.1098/rstb.1991.0081; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Frey JE, 2004, HEREDITAS, V140, P92, DOI 10.1111/j.1601-5223.2004.01748.x; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2005, AM J PHYS ANTHROPOL, V128, P110, DOI 10.1002/ajpa.20045; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; GILBERT MTP, 2005, MOL MARKERS PCR BIOI; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Handt O, 1996, AM J HUM GENET, V59, P368; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Helgason A, 2007, J MOL EVOL, V65, P92, DOI 10.1007/s00239-006-0259-8; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Lamers R, 2009, J MOL EVOL, V68, P40, DOI 10.1007/s00239-008-9184-3; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Spindler K, 1994, MAN ICE; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Ubaldi M, 1998, AM J PHYS ANTHROPOL, V107, P285, DOI 10.1002/(SICI)1096-8644(199811)107:3<285::AID-AJPA5>3.0.CO;2-U; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2004, CURR BIOL, V14, pR9, DOI 10.1016/j.cub.2003.12.012	41	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8629	10.1371/journal.pone.0008629	http://dx.doi.org/10.1371/journal.pone.0008629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	541KO	20072618	Green Published, Green Submitted, gold			2022-12-25	WOS:000273414200002
J	Zhu, HQ; Shan, LM; Schiller, PW; Mai, A; Peng, TQ				Zhu, Huaqing; Shan, Limei; Schiller, Peter W.; Mai, Antonello; Peng, Tianqing			Histone Deacetylase-3 Activation Promotes Tumor Necrosis Factor-alpha (TNF-alpha) Expression in Cardiomyocytes during Lipopolysaccharide Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; MITOCHONDRIAL DYSFUNCTION; INHIBITORS; TRANSCRIPTION; RECEPTOR; OXIDASE; DEATH; GENE; OVEREXPRESSION; SPHINGOSINE	Lipopolysaccharides (LPS) induce tumor necrosis factor-alpha (TNF-alpha) production in cardiomyocytes, which contributes to myocardial depression during sepsis. However, the underlying mechanisms remain not fully understood. This study was undertaken to investigate the contribution of histone deacetylase (HDAC) to TNF- expression in cardiomyocytes and the signaling mechanism of LPS-induced HDAC activation. Here, we show for the first time that LPS increases HDAC activity and that inhibition of HDAC decreases LPS-stimulated TNF-alpha expression via the accumulation of NF-kappa B/p65 at the TNF-alpha promoter in cardiomyocytes. Using a positive screen, we have further identified HDAC3 as a specific member of the HDAC family able to regulate TNF-alpha production. Furthermore, our data reveal that LPS-induced HDAC activity is mediated through reactive oxygen species from mitochondria and c-Src signaling. In summary, this study demonstrates a novel signaling mechanism by which LPS via mitochondrial reactive oxygen species/c-Src/HDAC3 pathways mediate TNF-alpha expression in cardiomyocytes.	[Zhu, Huaqing; Shan, Limei; Peng, Tianqing] Univ Western Ontario, Lawson Hlth Res Inst, London, ON N6A 4G5, Canada; [Zhu, Huaqing; Shan, Limei; Peng, Tianqing] Univ Western Ontario, Dept Med, London, ON N6A 4G5, Canada; [Peng, Tianqing] Univ Western Ontario, Dept Pathol, London, ON N6A 4G5, Canada; [Zhu, Huaqing] Anhui Med Univ, Mol Biol Lab, Hefei 230032, Peoples R China; [Zhu, Huaqing] Anhui Med Univ, Dept Biochem, Hefei 230032, Peoples R China; [Schiller, Peter W.] Clin Res Inst Montreal, Lab Chem Biol & Peptide Res, Montreal, PQ H2W 1R7, Canada; [Mai, Antonello] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Anhui Medical University; Anhui Medical University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Fondazione Cenci Bolognetti; Sapienza University Rome	Peng, TQ (corresponding author), VRL 6th Floor,A6-140,800 Commissioners Rd, London, ON N6A 4G5, Canada.	tpeng2@uwo.ca	Mai, Antonello/AAC-2144-2019; Peng, Tianqing/G-3340-2011	Mai, Antonello/0000-0001-9176-2382	Heart and Stroke Foundation of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Grant-in-aid T6717 (to T.P.) from the Heart and Stroke Foundation of Ontario.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Choi Y, 2008, EXP MOL MED, V40, P574, DOI 10.3858/emm.2008.40.5.574; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Di Lisa F, 2009, BASIC RES CARDIOL, V104, P131, DOI 10.1007/s00395-009-0008-4; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Grandel U, 2000, CIRCULATION, V102, P2758, DOI 10.1161/01.CIR.102.22.2758; Hall G, 2005, AM J PHYSIOL-HEART C, V289, pH2103, DOI 10.1152/ajpheart.00393.2005; Han SB, 2009, ARCH PHARM RES, V32, P613, DOI 10.1007/s12272-009-1418-4; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Li Y, 2009, FREE RADICAL BIO MED, V46, P51, DOI 10.1016/j.freeradbiomed.2008.09.025; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Mahlknecht U, 2004, J IMMUNOL, V173, P3979, DOI 10.4049/jimmunol.173.6.3979; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mai A, 2003, J MED CHEM, V46, P4826, DOI 10.1021/jm034167p; Matteucci E, 2007, MOL CANCER RES, V5, P833, DOI 10.1158/1541-7786.MCR-07-0054; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Oral H, 1997, J BIOL CHEM, V272, P4836, DOI 10.1074/jbc.272.8.4836; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Peng TQ, 2004, FASEB J, V18, P293, DOI 10.1096/fj.04-2289fje; Peng TQ, 2005, CIRCULATION, V111, P1637, DOI 10.1161/01.CIR.0000160366.50210.E9; Peng TQ, 2003, CARDIOVASC RES, V59, P893, DOI 10.1016/S0008-6363(03)00509-1; Peng TQ, 2003, J BIOL CHEM, V278, P8099, DOI 10.1074/jbc.M207288200; Sato H, 2005, CARDIOVASC RES, V67, P714, DOI 10.1016/j.cardiores.2005.04.017; Schiller PW, 2000, EUR J MED CHEM, V35, P895, DOI 10.1016/S0223-5234(00)01171-5; Shang FJ, 2006, BIOCHEM BIOPH RES CO, V351, P947, DOI 10.1016/j.bbrc.2006.10.134; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Suuronen T, 2003, J NEUROCHEM, V87, P407, DOI 10.1046/j.1471-4159.2003.02004.x; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Tibaldi E, 2008, J CELL BIOCHEM, V104, P840, DOI 10.1002/jcb.21670; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	40	68	76	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9429	9436		10.1074/jbc.M109.071274	http://dx.doi.org/10.1074/jbc.M109.071274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097764	Green Published, hybrid			2022-12-25	WOS:000276165900015
J	Bhalla-Gehi, R; Penuela, S; Churko, JM; Shao, Q; Laird, DW				Bhalla-Gehi, Ruchi; Penuela, Silvia; Churko, Jared M.; Shao, Qing; Laird, Dale W.			Pannexin1 and Pannexin3 Delivery, Cell Surface Dynamics, and Cytoskeletal Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; LATERAL MOBILITY; PLASMA-MEMBRANE; BREFELDIN-A; INTERLEUKIN-1-BETA RELEASE; CONNEXIN GENES; CHANNELS; TRAFFICKING; RECEPTORS; MIGRATION	Pannexins (Panx) are a class of integral membrane proteins that have been proposed to exhibit characteristics similar to those of connexin family members. In this study, we utilized Cx43-positive BICR-M1Rk cells to stably express Panx1, Panx3, or Panx1-green fluorescent protein (GFP) to assess their trafficking, cell surface dynamics, and interplay with the cytoskeletal network. Expression of a Sar1 dominant negative mutant revealed that endoplasmic reticulum to Golgi transport of Panx1 and Panx3 was mediated via COPII-dependent vesicles. Distinct from Cx43-GFP, fluorescence recovery after photo-bleaching studies revealed that both Panx1-GFP and Panx3GFP remained highly mobile at the cell surface. Unlike Cx43, Panx1-GFP exhibited no detectable interrelationship with microtubules. Conversely, cytochalasin B-induced disruption of microfilaments caused a severe loss of cell surface Panx1-GFP, a reduction in the recoverable fraction of Panx1-GFP that remained at the cell surface, and a decrease in Panx1-GFP vesicular transport. Furthermore, co-immunoprecipitation and co-sedimentation assays revealed actin as a novel binding partner of Panx1. Collectively, we conclude that although Panx1 and Panx3 share a common endoplasmic reticulum to Golgi secretory pathway to Cx43, their ultimate cell surface residency appears to be independent of cell contacts and the need for intact microtubules. Importantly, Panx1 has an interaction with actin microfilaments that regulates its cell surface localization and mobility.	[Bhalla-Gehi, Ruchi; Penuela, Silvia; Churko, Jared M.; Shao, Qing; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Dent Sci Bldg, London, ON N6A 5C1, Canada.	Dale.Laird@schulich.uwo.ca	Penuela, Silvia/A-6961-2010; Laird, Dale W/AAL-2407-2020; Laird, Dale w/E-4176-2015	Penuela, Silvia/0000-0003-4829-5517; Laird, Dale W/0000-0002-4568-3285; 	Canadian Institutes of Health Research; National Sciences and Engineering Council of Canada studentship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Council of Canada studentship	This work was supported by a Canadian Institutes of Health Research operating grant (to D.W.L.) and a National Sciences and Engineering Council of Canada studentship (to R.B.).	ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Bunse S, 2005, CELL COMMUN ADHES, V12, P231, DOI 10.1080/15419060500511834; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Fan Dominic, 2002, J Exp Ther Oncol, V2, P286, DOI 10.1046/j.1359-4117.2002.01053.x; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Hendriks R, 1999, J NEUROSCI RES, V58, P805, DOI 10.1002/(SICI)1097-4547(19991215)58:6<805::AID-JNR7>3.0.CO;2-V; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Johnson RG, 2002, EXP CELL RES, V275, P67, DOI 10.1006/excr.2002.5480; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; KLAUSNER RD, 1980, J BIOL CHEM, V255, P1286; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Mayo C, 2008, INVEST OPHTH VIS SCI, V49, P4384, DOI 10.1167/iovs.08-1688; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; NIGG EA, 1980, P NATL ACAD SCI-BIOL, V77, P4702, DOI 10.1073/pnas.77.8.4702; PALLER MS, 1994, J MEMBRANE BIOL, V142, P127; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2008, CELL COMMUN ADHES, V15, P133, DOI 10.1080/15419060802014115; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; POO MM, 1982, NATURE, V295, P332, DOI 10.1038/295332a0; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sato K, 2004, J BIOCHEM, V136, P755, DOI 10.1093/jb/mvh184; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Simek J, 2009, J CELL SCI, V122, P554, DOI 10.1242/jcs.036970; SRINIVASAN Y, 1990, J NEUROSCI, V10, P985; Taneja TK, 2009, HUM MOL GENET, V18, P2400, DOI 10.1093/hmg/ddp179; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Unger VM, 1999, NOVART FDN SYMP, V219, P22; UNGER VM, 1999, NOVART FDN SYMP, V219, P31; WANG YJ, 1995, J CELL SCI, V108, P3501; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076	61	82	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9147	9160		10.1074/jbc.M109.082008	http://dx.doi.org/10.1074/jbc.M109.082008			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086016	Green Published, hybrid			2022-12-25	WOS:000275553700064
J	Zhang, M; Wang, MN; Tan, XH; Li, TF; Zhang, YE; Chen, D				Zhang, Ming; Wang, Meina; Tan, Xiaohong; Li, Tian-Fang; Zhang, Ying E.; Chen, Di			Smad3 Prevents beta-Catenin Degradation and Facilitates beta-Catenin Nuclear Translocation in Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL STEM-CELLS; F-BOX PROTEIN; SIGNALING CROSS-TALK; TGF-BETA; UBIQUITIN LIGASE; CARCINOMA CELLS; WNT PATHWAYS; DIFFERENTIATION; BONE	Our previous study demonstrated that transforming growth factor (TGF)-beta activates beta-catenin signaling through Smad3 interaction with beta-catenin in chondrocytes. In the present studies, we further investigated the detailed molecular mechanism of the cross-talk between TGF-beta/Smad3 and Wnt/beta-catenin signaling pathways. We found that C-terminal Smad3 interacted with both the N-terminal region and the middle region of beta-catenin protein in a TGF-beta-dependent manner. Both Smad3 and Smad4 were required for the interaction with beta-catenin and protected beta-catenin from an ubiquitin-proteasome-dependent degradation. In addition, the formation of the Smad3-Smad4-beta-catenin protein complex also mediated beta-catenin nuclear translocation. This Smad3-mediated regulatory mechanism of beta-catenin protein stability enhanced the activity of beta-catenin to activate downstream target genes during chondrogenesis. Our findings demonstrate a novel mechanism between TGF-beta and Wnt/beta-catenin signaling pathways during chondrocyte development.	[Zhang, Ming; Wang, Meina; Tan, Xiaohong; Li, Tian-Fang; Chen, Di] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA; [Zhang, Ying E.] NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, D (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA.	di_chen@urmc.rochester.edu	Zhang, Ying E/G-3657-2015; Zhang, Ming/H-6467-2011; Wang, Meina/K-8915-2012	Zhang, Ying E/0000-0003-2753-7601; 	National Institutes of Health [R01 AR051189, R01 AR054465, K02 AR052411, R01 AR055915]; New York State Department of Health [N08G-070]; Empire State Stem Cell Board; NATIONAL CANCER INSTITUTE [ZIABC010419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR052411, R01AR054465, R01AR051189, R01AR055915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; Empire State Stem Cell Board; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR051189, R01 AR054465, K02 AR052411, and R01 AR055915 (to D. C.). This work was also supported by Grant N08G-070 (to D. C.) from the New York State Department of Health and the Empire State Stem Cell Board.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Ferguson CM, 2000, ENDOCRINOLOGY, V141, P4728, DOI 10.1210/en.141.12.4728; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hirota M, 2008, CELL SIGNAL, V20, P1632, DOI 10.1016/j.cellsig.2008.05.003; Ionescu AM, 2003, EXP CELL RES, V288, P198, DOI 10.1016/S0014-4827(03)00181-2; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jin EJ, 2006, INT J BIOCHEM CELL B, V38, P183, DOI 10.1016/j.biocel.2005.08.013; Kawakami Y, 2006, CURR OPIN CELL BIOL, V18, P723, DOI 10.1016/j.ceb.2006.10.007; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Li TF, 2006, J BONE MINER RES, V21, P4, DOI 10.1359/JBMR.050911; Li TF, 2006, J BIOL CHEM, V281, P21296, DOI 10.1074/jbc.M600514200; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Mishra L, 2005, ONCOGENE, V24, P5775, DOI 10.1038/sj.onc.1208924; Monga SPS, 2002, CANCER RES, V62, P2064; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Romero D, 2008, CARCINOGENESIS, V29, P1070, DOI 10.1093/carcin/bgn054; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Song LN, 2005, J BIOL CHEM, V280, P37853, DOI 10.1074/jbc.M503850200; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	42	71	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8703	8710		10.1074/jbc.M109.093526	http://dx.doi.org/10.1074/jbc.M109.093526			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097766	Green Published, hybrid			2022-12-25	WOS:000275553700023
J	Sharma, A; Kaur, M; Kar, A; Ranade, SM; Saxena, S				Sharma, Aparna; Kaur, Manpreet; Kar, Ananya; Ranade, Sourabh M.; Saxena, Sandeep			Ultraviolet Radiation Stress Triggers the Down-regulation of Essential Replication Factor Mcm10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA POLYMERASE-ALPHA; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION; DAMAGE; ORIGINS; COMPLEX; PROTEOLYSIS; INITIATION; STABILITY	We report that upon UV radiation insult, mammalian cells specifically down-regulate Mcm10, a protein essential for the initiation and elongation phases of DNA replication. The levels of a majority of replication factors remain unaffected under this condition, implying that Mcm10 is a key node in the regulation of the replication machinery. High doses of ionizing gamma radiation and exposure to a combination of DNA-damaging chemicals do not decrease Mcm10 protein levels, demonstrating that Mcm10 down-regulation is triggered only by UV-specific damage. The decrease of Mcm10 protein levels is not caused by transcriptional inhibition or cleavage by apoptotic enzymes, but results from degradation by the 26 S proteasome. UV-triggered degradation of Mcm10 requires its linker or C-terminal domain. In addition, Mcm10 down-regulation is not limited to cells from a particular lineage. Therefore, our study reveals a mechanism by which mammalian cells effectively inhibit the replication machinery during stress to prevent it from drifting toward a catastrophic path of genomic instability.	[Sharma, Aparna; Kaur, Manpreet; Kar, Ananya; Ranade, Sourabh M.; Saxena, Sandeep] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Saxena, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sandeep@nii.res.in		Kar, Ananya/0000-0003-0966-0833	Department of Biotechnology and Science of Technology of the Government of India; NET fellowship	Department of Biotechnology and Science of Technology of the Government of India; NET fellowship	This work was supported by sanctioned projects from the Department of Biotechnology and Science of Technology of the Government of India and a NET fellowship (to A. S. and M. K.).	Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Homesley L, 2000, GENE DEV, V14, P913; Izumi M, 2004, J BIOL CHEM, V279, P32569, DOI 10.1074/jbc.M314017200; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Koppen A, 2007, EUR J CANCER, V43, P2413, DOI 10.1016/j.ejca.2007.07.024; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Park JH, 2008, BIOCHEM BIOPH RES CO, V365, P575, DOI 10.1016/j.bbrc.2007.11.003; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; SOLOMON NA, 1992, YEAST, V8, P273, DOI 10.1002/yea.320080405; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yoshida K, 2004, ONCOGENE, V23, P6250, DOI 10.1038/sj.onc.1207829; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	21	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8352	8362		10.1074/jbc.M109.041129	http://dx.doi.org/10.1074/jbc.M109.041129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064936	Green Published, hybrid			2022-12-25	WOS:000275413800051
J	Ekberg, K; Palmgren, MG; Veierskov, B; Buch-Pedersen, MJ				Ekberg, Kira; Palmgren, Michael G.; Veierskov, Bjarke; Buch-Pedersen, Morten J.			A Novel Mechanism of P-type ATPase Autoinhibition Involving Both Termini of the Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; PLANT PLASMA-MEMBRANE; SINGLE-POINT MUTATIONS; CRYSTAL-STRUCTURE; PROTON PUMP; FUNCTIONAL COMPLEMENTATION; REGULATORY DOMAIN; DELETION ANALYSIS; C-TERMINUS; CA2+ PUMP	The activity of many P-type ATPases is found to be regulated by interacting proteins or autoinhibitory elements located in Nor C-terminal extensions. An extended C terminus of fungal and plant P-type plasma membrane H+-ATPases has long been recognized to be part of a regulatory apparatus involving an autoinhibitory domain. Here we demonstrate that both the N and the C termini of the plant plasma membrane H+-ATPase are directly involved in controlling the pump activity state and that N-terminal displacements are coupled to secondary modifications taking place at the C-terminal end. This identifies the first group of P-type ATPases for which both ends of the polypeptide chain constitute regulatory domains, which together contribute to the autoinhibitory apparatus. This suggests an intricate mechanism of cis-regulation with both termini of the protein communicating to obtain the necessary control of the enzyme activity state.	[Ekberg, Kira; Palmgren, Michael G.; Veierskov, Bjarke; Buch-Pedersen, Morten J.] Univ Copenhagen, Plant Physiol & Anat Lab, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg, Denmark; Univ Copenhagen, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-1871 Frederiksberg, Denmark	University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Buch-Pedersen, MJ (corresponding author), Univ Copenhagen, Plant Physiol & Anat Lab, Dept Plant Biol & Biotechnol, Thorvaldsensvej 40, DK-1871 Frederiksberg, Denmark.	mob@life.ku.dk	Palmgren, Michael/A-9808-2013; Veierskov, Bjarke/H-3024-2014	Palmgren, Michael/0000-0002-9982-6114; Veierskov, Bjarke/0000-0002-3676-5895				Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Buch-Pedersen MJ, 2000, J BIOL CHEM, V275, P39167, DOI 10.1074/jbc.M007537200; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; DeWitt ND, 1995, PLANT CELL, V7, P2053, DOI 10.1105/tpc.7.12.2053; DEWITT ND, 1991, PLANT J, V1, P121, DOI 10.1111/j.1365-313X.1991.00121.x; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Duby G, 2009, J BIOL CHEM, V284, P4213, DOI 10.1074/jbc.M807311200; ENYEDI A, 1993, J BIOL CHEM, V268, P10621; EWING NN, 1994, PLANT PHYSIOL, V106, P547, DOI 10.1104/pp.106.2.547; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Gevaudant F, 2001, PLANTA, V212, P619, DOI 10.1007/s004250000438; HARPER JF, 1990, J BIOL CHEM, V265, P13601; Harper JF, 1998, J BIOL CHEM, V273, P1099, DOI 10.1074/jbc.273.2.1099; Hentzen AE, 1996, PLANT CELL PHYSIOL, V37, P650, DOI 10.1093/oxfordjournals.pcp.a028994; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Mason AB, 1998, BBA-BIOMEMBRANES, V1372, P261, DOI 10.1016/S0005-2736(98)00065-0; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Moriau L, 1999, PLANT J, V19, P31, DOI 10.1046/j.1365-313X.1999.00495.x; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; PALMGREN MG, 1993, FEBS LETT, V317, P216, DOI 10.1016/0014-5793(93)81279-9; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341	43	51	52	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7344	7350		10.1074/jbc.M109.096123	http://dx.doi.org/10.1074/jbc.M109.096123			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20068040	Green Published, hybrid			2022-12-25	WOS:000275415600046
J	Perry, S; de Jong, BC; Solnick, JV; Sanchez, MD; Yang, SF; Lin, PL; Hansen, LM; Talat, N; Hill, PC; Hussain, R; Adegbola, RA; Flynn, J; Canfield, D; Parsonnet, J				Perry, Sharon; de Jong, Bouke C.; Solnick, Jay V.; Sanchez, Maria de la Luz; Yang, Shufang; Lin, Philana Ling; Hansen, Lori M.; Talat, Najeeha; Hill, Philip C.; Hussain, Rabia; Adegbola, Richard A.; Flynn, JoAnne; Canfield, Don; Parsonnet, Julie			Infection with Helicobacter pylori Is Associated with Protection against Tuberculosis	PLOS ONE			English	Article							HEALTHY-YOUNG ADULTS; CYNOMOLGUS MACAQUES; ELISPOT; DISEASE; GAMBIA; ASTHMA; RISK; ACQUISITION; IMMUNOLOGY; STRATEGIES	Background: Helicobacter pylori, a lifelong and typically asymptomatic infection of the stomach, profoundly alters gastric immune responses, and may benefit the host in protection against other pathogens. We explored the hypothesis that H. pylori contributes to the control of infection with Mycobacterium tuberculosis. Methodology/Principal Findings: We first examined M. tuberculosis-specific IFN-gamma and H. pylori antibody responses in 339 healthy Northern Californians undergoing routine tuberculin skin testing. Of 97 subjects (29%) meeting criteria for latent tuberculosis (TB) infection (LTBI), 45 (46%) were H. pylori seropositive. Subjects with LTBI who were H. pylori-seropositive had 1.5-fold higher TB antigen-induced IFN-gamma responses (p = 0.04, ANOVA), and a more Th-1 like cytokine profile in peripheral blood mononuclear cells, compared to those who were H. pylori seronegative. To explore an association between H. pylori infection and clinical outcome of TB exposure, we evaluated H. pylori seroprevalence in baseline samples from two high risk TB case-contact cohorts, and from cynomolgus macaques experimentally challenged with M. tuberculosis. Compared to 513 household contacts who did not progress to active disease during a median 24 months follow-up, 120 prevalent TB cases were significantly less likely to be H. pylori infected (AOR: 0.55, 95% CI 0.0.36-0.83, p = 0.005), though seroprevalence was not significantly different from non-progressors in 37 incident TB cases (AOR: 1.35 [95% CI 0.63-2.9] p = 0.44). Cynomolgus macaques with natural H. pylori infection were significantly less likely to progress to TB 6 to 8 months after M. tuberculosis challenge (RR: 0.31 [95% CI 0.12-0.80], p = 0.04). Conclusions/Significance: H. pylori infection may induce bystander effects that modify the risk of active TB in humans and non-human primates. That immunity to TB may be enhanced by exposure to other microbial agents may have important implications for vaccine development and disease control.	[Perry, Sharon; Sanchez, Maria de la Luz; Yang, Shufang; Parsonnet, Julie] Stanford Univ, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA; [de Jong, Bouke C.; Hill, Philip C.; Adegbola, Richard A.] MRC Labs, Fajara, Gambia; [Flynn, JoAnne] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Flynn, JoAnne] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Solnick, Jay V.; Hansen, Lori M.; Canfield, Don] Univ Calif Davis, Sch Med, Ctr Comparat Med, Dept Med, Davis, CA 95616 USA; [Solnick, Jay V.; Hansen, Lori M.; Canfield, Don] Univ Calif Davis, Sch Med, Ctr Comparat Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Lin, Philana Ling] Univ Pittsburgh, Childrens Hosp, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; [Talat, Najeeha; Hussain, Rabia] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan	Stanford University; MRC Laboratory Molecular Biology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aga Khan University	Perry, S (corresponding author), Stanford Univ, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA.	shnperry@stanford.edu	Flynn, JoAnne/ABC-7371-2020; Hussain, Rabia/E-9982-2015; de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675; Solnick, Jay/0000-0002-7435-8393; Parsonnet, Julie/0000-0001-7342-5366	National Institutes of Health (NIH) [K23-AI054443, R01-AI42801, R01-AI42081, HL075845]; Thrasher Fund; Bill & Melinda Gates Foundation; MRC [MC_U190071468] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI054443, R01AI042081, R01AI042801] Funding Source: NIH RePORTER; Medical Research Council [MC_U190071468] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Fund; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by National Institutes of Health (NIH) K23-AI054443 (S.P.), NIH R01-AI42801 (J.P.), NIH R01-AI42081 (J.S.), NIH HL075845 (J.L.F), the Thrasher Fund, and the Bill & Melinda Gates Foundation. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	AFFIFI AA, 1990, PRINCIPAL COMPONENTS, P371; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Blaser MJ, 2008, GUT, V57, P561, DOI 10.1136/gut.2007.133462; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jackson-Sillah D, 2007, T ROY SOC TROP MED H, V101, P594, DOI 10.1016/j.trstmh.2007.02.001; Jeffries DJ, 2006, INT J TUBERC LUNG D, V10, P192; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; LIN PL, 2009, INFECT IMMUNOL; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; McIntire JJ, 2004, SPRINGER SEMIN IMMUN, V25, P335, DOI 10.1007/s00281-003-0141-3; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; MITCHELL HM, 1992, J INFECT DIS, V166, P149, DOI 10.1093/infdis/166.1.149; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Parsonnet J, 1997, J INFECT DIS, V175, P1240, DOI 10.1086/593680; PerezPerez GI, 1997, INT J CANCER, V72, P453, DOI 10.1002/(SICI)1097-0215(19970729)72:3<453::AID-IJC13>3.0.CO;2-D; Perry S, 2004, J INFECT DIS, V190, P303, DOI 10.1086/421705; Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07; REPLOGLE ML, 1995, AM J EPIDEMIOL, V142, P856, DOI 10.1093/oxfordjournals.aje.a117725; Romero-Gallo J, 2002, CLIN DIAGN LAB IMMUN, V9, P1313, DOI 10.1128/CDLI.9.6.1313-1317.2002; Roussos A, 2006, RESPIRATION, V73, P708, DOI 10.1159/000093816; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Solnick JV, 2003, J CLIN MICROBIOL, V41, P5511, DOI 10.1128/JCM.41.12.5511-5516.2003; Solnick JV, 1999, LAB ANIM SCI, V49, P197; Torres MA, 2003, EPIDEMIOL INFECT, V130, P87, DOI 10.1017/S0950268802007653; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; *WHO, 2008, GLOB TB CONTR SURV P; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336	40	108	114	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8804	10.1371/journal.pone.0008804	http://dx.doi.org/10.1371/journal.pone.0008804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098711	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000273779000030
J	Golemba, MD; Di Lello, FA; Bessone, F; Fay, F; Benetti, S; Jones, LR; Campos, RH				Golemba, Marcelo D.; Di Lello, Federico A.; Bessone, Fernando; Fay, Fabian; Benetti, Silvina; Jones, Leandro R.; Campos, Rodolfo H.			High Prevalence of Hepatitis C Virus Genotype 1b Infection in a Small Town of Argentina. Phylogenetic and Bayesian Coalescent Analysis	PLOS ONE			English	Article							MUTATION-RATE; NON-A; SEQUENCE; HCV; EPIDEMIOLOGY; NOMENCLATURE; PROPOSALS; COMMUNITY; OUTBREAK; GENOME	Previous studies in Argentina have documented a general prevalence of Hepatitis C Virus (HCV) infection close to 2%. In addition, a high prevalence of HCV has been recently reported in different Argentinean small rural communities. In this work, we performed a study aimed at analyzing the origins and diversification patterns of an HCV outbreak in Wheelwright, a small rural town located in Santa Fe province (Argentina). A total of 89 out of 1814 blood samples collected from people living in Wheelwright, were positive for HCV infection. The highest prevalence (4.9%) was observed in people older than 50 years, with the highest level for the group aged between 70-79 years (22%). The RFLP analyses showed that 91% of the positive samples belonged to the HCV-1b genotype. The E1/E2 and NS5B genes were sequenced, and their phylogenetic analysis showed that the HCV-1b sequences from Wheelwright were monophyletic. Bayesian coalescent-based methods were used to estimate substitution rates and time of the most recent common ancestor (tMRCA). The mean estimated substitution rates and the tMRCA for E1/E2 with and without HVR1 and NS5B were 7.41E-03 s/s/y and 61 years, 5.05E-03 s/s/y and 58 years and 3.24E-03 s/s/y and 53 years, respectively. In summary, the tMRCA values, the demographic model with constant population size, and the fact that the highest prevalence of infection was observed in elder people support the hypothesis that the HCV-1b introduction in Wheelwright initially occurred at least five decades ago and that the early epidemic was characterized by a fast rate of virus transmission. The epidemic seems to have been controlled later on down to the standard transmission rates observed elsewhere.	[Golemba, Marcelo D.; Di Lello, Federico A.; Campos, Rodolfo H.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina; [Bessone, Fernando] Univ Nacl Rosario, Serv Gastroenterol & Hepatol, Hosp Prov Centenario, RA-2000 Rosario, Santa Fe, Argentina; [Jones, Leandro R.] Estac Fotobiol Playa Union, Div Mol Biol, RA-9103 Rawson, Chubut, Argentina; [Fay, Fabian; Benetti, Silvina] Lab Cib Rosario, Rosario, Santa Fe, Argentina	University of Buenos Aires; National University of Rosario	Golemba, MD (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina.	rcampos@ffyb.uba.ar		Di Lello, Federico Alejandro/0000-0001-9771-9705; Jones, Leandro/0000-0002-5877-4194	Universidad de Buenos Aires [B037]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [01169]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [25355]	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by grants from Universidad de Buenos Aires (SECyT-UBA 2008, B037, www.ffyb.uba.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP2009, 01169, www.conicet.gov.ar), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; PICT2004, 25355, www.agencia.mincyt.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1992, J GEN VIROL, V73, P2725, DOI 10.1099/0022-1317-73-10-2725; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BESSONE F, 2005, ACTA GASTROENTEROL L, V35; Bracho MA, 2005, J CLIN MICROBIOL, V43, P2750, DOI 10.1128/JCM.43.6.2750-2755.2005; Chiaramonte M, 1996, J HEPATOL, V24, P129, DOI 10.1016/S0168-8278(96)80020-1; Coppola RC, 2000, J VIRAL HEPATITIS, V7, P130; Davidson F, 1999, METH MOLEC MED, V19, P175; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P564; Ferraro D, 2008, J MED VIROL, V80, P1723, DOI 10.1002/jmv.21276; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Golovko AI, 2007, NEUROCHEM J+, V1, P1, DOI 10.1134/S1819712407010011; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halfon P, 2002, J CLIN MICROBIOL, V40, P1541, DOI 10.1128/JCM.40.4.1541-1545.2002; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Idrees M, 2008, J DIGEST DIS, V9, P95, DOI 10.1111/j.1751-2980.2008.00329.x; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; MENGARELLI S, 2006, ACTA GASTROENTEROL L, V36; Mizokami M, 2004, CANCER CHEMOTH PHARM, V54, pS83, DOI 10.1007/s00280-004-0892-0; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Picchio GR, 2006, LIVER INT, V26, P660, DOI 10.1111/j.1478-3231.2006.01290.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; RAMADAN A, 2006, ACTA GASTROENTEROL L, V36; Rambaut A, 2014, TRACER V1 6; Rispeter K, 2000, VIRUS GENES, V21, P179, DOI 10.1023/A:1008135413215; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506	42	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8751	10.1371/journal.pone.0008751	http://dx.doi.org/10.1371/journal.pone.0008751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090919	gold, Green Submitted, Green Published			2022-12-25	WOS:000273715000010
J	Cheng, I; Witte, JS; Jacobsen, SJ; Haque, R; Quinn, VP; Quesenberry, CP; Caan, BJ; Van Den Eeden, SK				Cheng, Iona; Witte, John S.; Jacobsen, Steven J.; Haque, Reina; Quinn, Virginia P.; Quesenberry, Charles P.; Caan, Bette J.; Van Den Eeden, Stephen K.			Prostatitis, Sexually Transmitted Diseases, and Prostate Cancer: The California Men's Health Study	PLOS ONE			English	Article							RISK-FACTORS; COHORT; INFLAMMATION; METAANALYSIS; SYMPTOMS; BEHAVIOR; HISTORY	Background: Prostatitis and sexually transmitted diseases (STDs) have been positively associated with prostate cancer in previous case-control studies. However, results from recent prospective studies have been inconclusive. Methodogy/Principal Findings: We investigated the association between prostatitis, STDs, and prostate cancer among African American, Asian American, Latino, and White participants of the California Men's Health Study. Our analysis included 68,675 men, who completed a detailed baseline questionnaire in 2002-2003. We identified 1,658 incident prostate cancer cases during the follow-up period to June 30, 2006. Cox proportional hazards models were used to estimate relative risks and 95% confidence intervals. Overall, men having a history of prostatitis had an increased risk of prostate cancer than men with no history (RR = 1.30; 95% CI: 1.10-1.54). Longer duration of prostatitis symptoms was also associated with an increased risk of prostate cancer (P trend = 0.003). In addition, among men screened for prostate cancer (1 or 2 PSA tests), a nonsignificant positive association was observed between prostatitis and prostate cancer (RR = 1.10; 95% CI: 0.75-1.63). STDs were not associated with overall prostate cancer risk. In racial/ethnic stratified analysis, Latinos reporting any STDs had an increased risk of disease than those with no STDs (RR = 1.43; 95% CI: 1.07-1.91). Interestingly, foreign-born Latinos displayed a larger risk associated with STDs (RR = 1.87; 95% CI: 1.16-3.02) than U. S. born Latinos (RR = 1.15; 95% CI: 0.76-3.02). Conclusion: In summary, results from this prospective study suggest that prostatitis and STDs may be involved in prostate cancer susceptibility. While we cannot rule out the possible influence of incidental detection, future studies are warranted to further investigate the role of infectious agents related to prostatitis and STDs in prostate cancer development.	[Cheng, Iona] Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96822 USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Jacobsen, Steven J.; Haque, Reina; Quinn, Virginia P.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA; [Quesenberry, Charles P.; Caan, Bette J.; Van Den Eeden, Stephen K.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA	Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente	Cheng, I (corresponding author), Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96822 USA.	icheng@crch.hawaii.edu		Caan, Bette/0000-0002-5803-310X; Jacobsen, Steven/0000-0002-8174-8533	Community Benefits Program of Kaiser Permanente; National Institute of Health [CA 112355-01A1]; NATIONAL CANCER INSTITUTE [R25CA112355] Funding Source: NIH RePORTER	Community Benefits Program of Kaiser Permanente; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This study was funded in part by the California Cancer Research Program and the Community Benefits Program of Kaiser Permanente. IC was supported for this work by National Institute of Health R25T training grant (CA 112355-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2008, CANC FACTS FIG; *CDCP NAT SURV DAT, 2006, TRENDS REP SEX TRANS; Clemens JQ, 2006, J UROLOGY, V176, P593, DOI 10.1016/j.juro.2006.03.089; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dennis LK, 2002, EPIDEMIOLOGY, V13, P72, DOI 10.1097/00001648-200201000-00012; Dennis LK, 2002, UROLOGY, V60, P78, DOI 10.1016/S0090-4295(02)01637-0; Enger SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-172; Fernandez L, 2005, INT J EPIDEMIOL, V34, P193, DOI 10.1093/ije/dyh332; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; HIATT RA, 1994, CANCER CAUSE CONTROL, V5, P66, DOI 10.1007/BF01830728; Huang WY, 2008, CANCER EPIDEM BIOMAR, V17, P2374, DOI 10.1158/1055-9965.EPI-08-0173; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 2008, INT J ANTIMICROB AG, V31, pS85, DOI 10.1016/j.ijantimicag.2007.08.028; Lightfoot N, 2004, ANN EPIDEMIOL, V14, P655, DOI 10.1016/j.annepidem.2003.11.006; Patel DA, 2005, CANCER CAUSE CONTROL, V16, P263, DOI 10.1007/s10552-004-3486-6; Roberts RO, 2004, EPIDEMIOLOGY, V15, P93, DOI 10.1097/01.ede.0000101022.38330.7c; Rosenblatt KA, 2001, AM J EPIDEMIOL, V153, P1152, DOI 10.1093/aje/153.12.1152; Schaeffer AJ, 2002, J UROLOGY, V168, P1048, DOI 10.1016/S0022-5347(05)64572-7; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P2160, DOI 10.1158/1055-9965.EPI-05-0913; Taylor ML, 2005, FAM MED, V37, P506; True LD, 1999, J UROLOGY, V162, P2014, DOI 10.1016/S0022-5347(05)68090-1	22	97	102	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8736	10.1371/journal.pone.0008736	http://dx.doi.org/10.1371/journal.pone.0008736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090948	Green Published, Green Submitted, gold			2022-12-25	WOS:000273714900016
J	Fernandez-Ayala, DJM; Chen, SJ; Kemppainen, E; O'Dell, KMC; Jacobs, HT				Fernandez-Ayala, Daniel J. M.; Chen, Shanjun; Kemppainen, Esko; O'Dell, Kevin M. C.; Jacobs, Howard T.			Gene Expression in a Drosophila Model of Mitochondrial Disease	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLYCOGEN-SYNTHASE KINASE-3; CONTROLLED CLINICAL-TRIAL; MALE COURTSHIP BEHAVIOR; FAT-BODY; ETHYLMALONIC ENCEPHALOPATHY; OXIDATIVE-PHOSPHORYLATION; DNA PHOSPHODIESTERASE; SEX-DETERMINATION; FEEDING-BEHAVIOR	Background: A point mutation in the Drosophila gene technical knockout (tko), encoding mitoribosomal protein S12, was previously shown to cause a phenotype of respiratory chain deficiency, developmental delay, and neurological abnormalities similar to those presented in many human mitochondrial disorders, as well as defective courtship behavior. Methodology/Principal Findings: Here, we describe a transcriptome-wide analysis of gene expression in tko 25t mutant flies that revealed systematic and compensatory changes in the expression of genes connected with metabolism, including upregulation of lactate dehydrogenase and of many genes involved in the catabolism of fats and proteins, and various anaplerotic pathways. Gut-specific enzymes involved in the primary mobilization of dietary fats and proteins, as well as a number of transport functions, were also strongly up-regulated, consistent with the idea that oxidative phosphorylation OXPHOS dysfunction is perceived physiologically as a starvation for particular biomolecules. In addition, many stress-response genes were induced. Other changes may reflect a signature of developmental delay, notably a down-regulation of genes connected with reproduction, including gametogenesis, as well as courtship behavior in males; logically this represents a programmed response to a mitochondrially generated starvation signal. The underlying signalling pathway, if conserved, could influence many physiological processes in response to nutritional stress, although any such pathway involved remains unidentified. Conclusions/Significance: These studies indicate that general and organ-specific metabolism is transformed in response to mitochondrial dysfunction, including digestive and absorptive functions, and give important clues as to how novel therapeutic strategies for mitochondrial disorders might be developed.	[Fernandez-Ayala, Daniel J. M.; Chen, Shanjun; Kemppainen, Esko; Jacobs, Howard T.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Fernandez-Ayala, Daniel J. M.; Chen, Shanjun; Kemppainen, Esko; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [O'Dell, Kevin M. C.; Jacobs, Howard T.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland	Tampere University; Tampere University; Tampere University Hospital; University of Glasgow	Fernandez-Ayala, DJM (corresponding author), Univ Pablo Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain.	howard.t.jacobs@uta.fi	Kemppainen, Esko/AAF-7618-2019; Jacobs, Howard T/G-2434-2011	Jacobs, Howard/0000-0003-1895-6003; Fernandez-Ayala, Daniel Jose Moreno/0000-0001-8176-1431	Academy of Finland [118654, 116056, 119553]; Sigrid Juselius Foundation; Tampere University Hospital Medical Research [9F021]; European Union [LSHM-CT-2004-503116]; European Research Council [232738]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital Medical Research; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission)	This work was funded by Academy of Finland 118654, 116056, and 119553; Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund 9F021; European Union LSHM-CT-2004-503116; and European Research Council 232738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bandi C, 2001, TRENDS PARASITOL, V17, P88, DOI 10.1016/S1471-4922(00)01812-2; BENES H, 1990, DEV BIOL, V142, P138, DOI 10.1016/0012-1606(90)90157-E; Bennett D, 2003, GENETICS, V164, P235; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Boltz KA, 2007, DEV DYNAM, V236, P544, DOI 10.1002/dvdy.21032; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Burmester T, 1999, EUR J BIOCHEM, V262, P49, DOI 10.1046/j.1432-1327.1999.00315.x; CARLSON JR, 1985, DEV BIOL, V108, P341, DOI 10.1016/0012-1606(85)90038-7; CLARK AG, 1983, HEREDITAS, V99, P165, DOI 10.1111/j.1601-5223.1983.tb00888.x; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; DEUTSCH J, 1989, DEV GENET, V10, P220, DOI 10.1002/dvg.1020100311; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dunlop J, 2004, CURR BIOL, V14, P2039, DOI 10.1016/j.cub.2004.10.048; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Fergestad Tim, 2006, Genetics, V173, P1357, DOI 10.1534/genetics.106.057463; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Gagou ME, 2002, INSECT BIOCHEM MOLEC, V32, P141, DOI 10.1016/S0965-1748(01)00101-1; Goto SG, 2001, GENE, V270, P259, DOI 10.1016/S0378-1119(01)00465-6; Graham LA, 2002, GENE, V292, P43, DOI 10.1016/S0378-1119(02)00672-8; Hader T, 2003, EMBO REP, V4, P511, DOI 10.1038/sj.embor.embor837; Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Hou XS, 1997, TRENDS GENET, V13, P105, DOI 10.1016/S0168-9525(97)01006-8; Jacobs HT, 2004, BBA-BIOENERGETICS, V1659, P190, DOI 10.1016/j.bbabio.2004.07.004; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kanuka H, 2005, EMBO J, V24, P3793, DOI 10.1038/sj.emboj.7600822; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; Kemppainen E, 2009, MITOCHONDRION, V9, P353, DOI 10.1016/j.mito.2009.07.002; Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; LEHNINGER A, 2004, PRINCIPLES BIOCH; LEVASHINA EA, 1995, EUR J BIOCHEM, V233, P694, DOI 10.1111/j.1432-1033.1995.694_2.x; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; LORENZ LJ, 1989, DEVELOPMENT, V107, P869; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610; Okabe M, 1997, DEVELOPMENT, V124, P1045; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Prigione A, 2007, AGING CELL, V6, P619, DOI 10.1111/j.1474-9726.2007.00323.x; Rencurel F, 2005, J BIOL CHEM, V280, P4367, DOI 10.1074/jbc.M412711200; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240; Sardiello M, 2003, NUCLEIC ACIDS RES, V31, P322, DOI 10.1093/nar/gkg123; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smeitink JAM, 2003, J INHERIT METAB DIS, V26, P199, DOI 10.1023/A:1024489218004; Spradling AC, 1999, GENETICS, V153, P135; Stacpoole PW, 1998, DRUG METAB REV, V30, P499, DOI 10.3109/03602539808996323; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; TEAGUE BD, 1986, J EXP ZOOL, V240, P95, DOI 10.1002/jez.1402400112; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Todres E, 2000, INSECT MOL BIOL, V9, P581, DOI 10.1046/j.1365-2583.2000.00222.x; Toivonen JM, 2003, MITOCHONDRION, V3, P83, DOI 10.1016/S1567-7249(03)00077-1; Toivonen JM, 1999, MOL MICROBIOL, V31, P1735, DOI 10.1046/j.1365-2958.1999.01307.x; Toivonen JM, 2001, GENETICS, V159, P241; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Uttenweiler-Joseph S, 1998, P NATL ACAD SCI USA, V95, P11342, DOI 10.1073/pnas.95.19.11342; van Waveren C, 2006, CARCINOGENESIS, V27, P409, DOI 10.1093/carcin/bgi242; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Wang SJ, 1999, MOL BIOL EVOL, V16, P1117, DOI 10.1093/oxfordjournals.molbev.a026202; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolf FW, 2007, P NATL ACAD SCI USA, V104, P4653, DOI 10.1073/pnas.0700493104; Wolfner MF, 2003, CURR BIOL, V13, pR101, DOI 10.1016/S0960-9822(03)00038-1; Yagi T, 2006, BBA-BIOENERGETICS, V1757, P708, DOI 10.1016/j.bbabio.2006.01.011; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x; Zarkovic J, 2005, PLANT MOL BIOL, V57, P871, DOI 10.1007/s11103-005-3249-0; Zhang YQ, 1999, GENETICS, V153, P891; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	114	52	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8549	10.1371/journal.pone.0008549	http://dx.doi.org/10.1371/journal.pone.0008549			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066047	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000273338600008
J	Leibiger, B; Moede, T; Uhles, S; Barker, CJ; Creveaux, M; Domin, J; Berggren, PO; Leibiger, IB				Leibiger, Barbara; Moede, Tilo; Uhles, Sabine; Barker, Christopher J.; Creveaux, Marion; Domin, Jan; Berggren, Per-Olof; Leibiger, Ingo B.			Insulin-feedback via PI3K-C2 alpha activated PKB alpha/Akt1 is required for glucose-stimulated insulin secretion	FASEB JOURNAL			English	Article						insulin signaling; diabetes mellitus; fluorescence microscopy; biosensors	II PHOSPHOINOSITIDE 3-KINASE; PROTEIN-KINASE B; PHOSPHATIDYLINOSITOL 3-KINASE; C2 DOMAIN; GENE-TRANSCRIPTION; ALPHA-ISOFORM; CDNA CLONING; RECEPTOR; LOCALIZATION; GLUCOKINASE	Phosphatidylinositide 3-kinases (PI3Ks) play central roles in insulin signal transduction. While the contribution of class Ia PI3K members has been extensively studied, the role of class II members remains poorly understood. The diverse actions of class II PI3K-C2 alpha have been attributed to its lipid product PI(3) P. By applying pharmacological inhibitors, transient overexpression and small-interfering RNA-based knockdown of PI3K and PKB/Akt isoforms, together with PI-lipid profiling and live-cell confocal and total internal reflection fluorescence microscopy, we now demonstrate that in response to insulin, PI3K-C2 alpha generates PI(3,4) P-2, which allows the selective activation of PKB alpha/Akt1. Knockdown of PI3K-C2 alpha expression and subsequent reduction of PKB alpha/Akt1 activity in the pancreatic beta-cell impaired glucose-stimulated insulin release, at least in part, due to reduced glucokinase expression and increased AS160 activity. Hence, our results identify signal transduction via PI3K-C2 alpha as a novel pathway whereby insulin activates PKB/Akt and thus discloses PI3K-C2 alpha as a potential drugable target in type 2 diabetes. The high degree of codistribution of PI3K-C2 alpha and PKB alpha/Akt1 with insulin receptor B type, but not A type, in the same plasma membrane microdomains lends further support to the concept that selectivity in insulin signaling is achieved by the spatial segregation of signaling events.-Leibiger, B., Moede, T., Uhles, S., Barker, C. J., Creveaux, M., Domin, J., Berggren, P.-O., Leibiger, I. B. Insulin-feedback via PI3K-C2 alpha activated PKB alpha/Akt1 is required for glucose-stimulated insulin secretion. FASEB J. 24, 1824-1837 (2010). www.fasebj.org	[Leibiger, Barbara; Moede, Tilo; Uhles, Sabine; Barker, Christopher J.; Creveaux, Marion; Berggren, Per-Olof; Leibiger, Ingo B.] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; [Domin, Jan] Univ London Imperial Coll Sci Technol & Med, Fac Med, Renal Sect, London, England	Karolinska Institutet; Imperial College London	Berggren, PO (corresponding author), Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, L1 03, SE-17176 Stockholm, Sweden.	per-olof.berggren@ki.se; ingo.leibiger@ki.se		Berggren, Per-Olof/0000-0001-8991-413X; Uhles, Sabine/0000-0002-2836-8726; Moede, Tilo/0000-0002-2045-9244	Karolinska Institutet; Swedish Diabetes Association; Swedish Research Council; Novo Nordisk Foundation, Eurodia [FP6-518153]; Berth von Kantzow Foundation; Juvenile Diabetes Research Foundation; Family Erling-Persson Foundation; MRC [G0500936] Funding Source: UKRI; Medical Research Council [G0500936] Funding Source: researchfish	Karolinska Institutet(Karolinska Institutet); Swedish Diabetes Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation, Eurodia(Novo Nordisk Foundation); Berth von Kantzow Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Family Erling-Persson Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank F. Saupe for technical assistance, and Dr. Dario R. Alessi (MRC Protein Phosphorylation Unit, University of Dundee, Dundee, UK), Dr. Harald A. Stenmark (Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway), Dr. Boudewijn M. T. Burgering (University Medical Center Utrecht, Utrecht, The Netherlands), Dr. Roger Y. Tsien (University of California-San Diego, La Jolla, CA, USA), Dr. Anders Tengholm (Uppsala University Biomedical Centre, Uppsala, Sweden), Dr. Georges Bismuth (Institut Cochin, Universite Paris Decartes, Paris, France), and Dr. Morris J. Birnbaum (Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, PA, USA) for sharing expression constructs. This work was supported by funds from Karolinska Institutet and by grants from the Swedish Diabetes Association, the Swedish Research Council, the Novo Nordisk Foundation, Eurodia (FP6-518153), the Berth von Kantzow Foundation, the Juvenile Diabetes Research Foundation, and the Family Erling-Persson Foundation. P.-O.B. is cofounder of BioCrine AB. B. L., I. B. L., and C. J. B. are consultants to BioCrine AB.	Arcaro A, 2000, MOL CELL BIOL, V20, P3817, DOI 10.1128/MCB.20.11.3817-3830.2000; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Barker CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1113, DOI 10.1152/ajpendo.00088.2002; Bouzakri K, 2008, DIABETES, V57, P1195, DOI 10.2337/db07-1469; Brown RA, 1999, J BIOL CHEM, V274, P14529, DOI 10.1074/jbc.274.21.14529; Brown RA, 1997, BIOCHEM BIOPH RES CO, V233, P537, DOI 10.1006/bbrc.1997.6495; Didichenko SA, 2001, J BIOL CHEM, V276, P48135, DOI 10.1074/jbc.M104610200; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Elghazi L, 2006, INT J BIOCHEM CELL B, V38, P157, DOI 10.1016/j.biocel.2005.08.017; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Ho LKF, 1997, BIOCHEM BIOPH RES CO, V235, P130, DOI 10.1006/bbrc.1997.6747; KARPOVA T, 2006, CURR PROTOC CYTOM, V12; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Kohler M, 2003, DIABETES, V52, P2943, DOI 10.2337/diabetes.52.12.2943; Krook A, 1997, J BIOL CHEM, V272, P30208, DOI 10.1074/jbc.272.48.30208; Leibiger B, 1998, P NATL ACAD SCI USA, V95, P9307, DOI 10.1073/pnas.95.16.9307; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; LEIBIGER IB, 1994, FEBS LETT, V337, P161, DOI 10.1016/0014-5793(94)80265-3; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; LEVYTOLEDANO R, 1994, J BIOL CHEM, V269, P31178; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Macdougall LK, 1995, CURR BIOL, V5, P1404, DOI 10.1016/S0960-9822(95)00278-8; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Misawa H, 1998, BIOCHEM BIOPH RES CO, V244, P531, DOI 10.1006/bbrc.1998.8294; Ono F, 1998, J BIOL CHEM, V273, P7731, DOI 10.1074/jbc.273.13.7731; Rozycka M, 1998, GENOMICS, V54, P569, DOI 10.1006/geno.1998.5621; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Soos MA, 2001, ARCH BIOCHEM BIOPHYS, V396, P244, DOI 10.1006/abbi.2001.2587; STAUBS PA, 1994, J BIOL CHEM, V269, P27186; Summers SA, 1999, J BIOL CHEM, V274, P23858, DOI 10.1074/jbc.274.34.23858; Tengholm A, 2002, CURR BIOL, V12, P1871, DOI 10.1016/S0960-9822(02)01223-X; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; Urso B, 1999, FEBS LETT, V460, P423, DOI 10.1016/S0014-5793(99)01388-5; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; VANHORN DJ, 1994, J BIOL CHEM, V269, P29; Virbasius JV, 1996, J BIOL CHEM, V271, P13304, DOI 10.1074/jbc.271.23.13304; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200; Yu J, 2007, MOL ENDOCRINOL, V21, P2775, DOI 10.1210/me.2006-0473	58	88	93	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1824	1837		10.1096/fj.09-148072	http://dx.doi.org/10.1096/fj.09-148072			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20061534				2022-12-25	WOS:000278200000019
J	Wang, QY; Yu, L; Yu, CA				Wang, Qiyu; Yu, Linda; Yu, Chang-An			Cross-talk between Mitochondrial Malate Dehydrogenase and the Cytochrome bc(1) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; ELECTRON-TRANSFER; PROCESSING PEPTIDASE; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; C REDUCTASE; RECONSTITUTION; BINDING; SITE	The interactions between the mitochondrial cytochrome bc(1) complex and matrix-soluble proteins were studied by a precipitation pulldown technique. Purified, detergent-dispersed bc(1) complex was incubated with mitochondrial matrix proteins followed by dialysis in the absence of detergent. The interacting protein(s) was co-precipitated with bc(1) complex upon centrifugation. One of the matrix proteins pulled down by bc(1) complex was identified as mitochondrial malate dehydrogenase (MDH) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and confirmed by Western blotting with anti-MDH antibody. Using a cross-linking technique, subunits I, II (core I and II), and V of the bc(1) complex were identified as the interacting sites for MDH. Incubating purified MDH with the detergent dispersed bc(1) complex results in an increase of the activities of both the bc(1) complex and MDH. The effect of the bc(1) complex on the activities of MDH is unidirectional (oxaloacetate 3 malate). These results suggest that the novel cross-talk between citric acid cycle enzymes and electron transfer chain complexes might play a regulatory role in mitochondrial bioenergetics.	[Wang, Qiyu; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yu, CA (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	cayuq@okstate.edu			National Institutes of Health [GM30721]; Oklahoma Agricultural Experiment Station, Oklahoma State University [1819, 2372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030721, R37GM030721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Agricultural Experiment Station, Oklahoma State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM30721 (to C.-A.Y.). This work was also supported by Oklahoma Agricultural Experiment Station Projects 1819 and 2372 from the Oklahoma State University.	BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Deng K, 2001, J BIOL CHEM, V276, P6499, DOI 10.1074/jbc.M007128200; Deng KP, 1998, J BIOL CHEM, V273, P20752, DOI 10.1074/jbc.273.33.20752; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hunte C, 2002, BBA-BIOENERGETICS, V1555, P21, DOI 10.1016/S0005-2728(02)00249-9; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; LINK TA, 1995, J BIOL CHEM, V270, P25001, DOI 10.1074/jbc.270.42.25001; Morgunov I, 1998, J BIOL CHEM, V273, P29540, DOI 10.1074/jbc.273.45.29540; MULLINAX TR, 1982, J BIOL CHEM, V257, P13233; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; Ovadi Judit, 1994, Journal of Molecular Recognition, V7, P265, DOI 10.1002/jmr.300070405; SCHINDLER PW, 1975, EUR J BIOCHEM, V51, P579, DOI 10.1111/j.1432-1033.1975.tb03959.x; STUMPF DA, 1982, NEUROLOGY, V32, P221, DOI 10.1212/WNL.32.3.221; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; Tso SC, 2006, BBA-BIOENERGETICS, V1757, P1561, DOI 10.1016/j.bbabio.2006.06.010; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2007, PHOTOSYNTH RES, V92, P17, DOI 10.1007/s11120-007-9155-3; YU C, 1980, BIOCHIM BIOPHYS ACTA, V591, P409, DOI 10.1016/0005-2728(80)90172-3; YU CA, 1972, J BIOL CHEM, V247, P1012; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; Yu LD, 2009, METHOD ENZYMOL, V456, P459, DOI 10.1016/S0076-6879(08)04425-X; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	29	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10408	10414		10.1074/jbc.M109.085787	http://dx.doi.org/10.1074/jbc.M109.085787			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20075069	Green Published, hybrid			2022-12-25	WOS:000276264600026
J	Drozak, J; Veiga-da-Cunha, M; Vertommen, D; Stroobant, V; Van Schaftingen, E				Drozak, Jakub; Veiga-da-Cunha, Maria; Vertommen, Didier; Stroobant, Vincent; Van Schaftingen, Emile			Molecular Identification of Carnosine Synthase as ATP-grasp Domain-containing Protein 1 (ATPGD1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ALANYL; BRAIN; SYNTHETASE; HOMOCARNOSINE; MUSCLE; DIPEPTIDES; ANSERINE; PURIFICATION; DEFICIENCY; PEPTIDES	Carnosine (beta-alanyl-L-histidine) and homocarnosine (gamma-aminobutyryl-L-histidine) are abundant dipeptides in skeletal muscle and brain of most vertebrates and some invertebrates. The formation of both compounds is catalyzed by carnosine synthase, which is thought to convert ATP to AMP and inorganic pyrophosphate, and whose molecular identity is unknown. In the present work, we have purified carnosine synthase from chicken pectoral muscle about 1500-fold until only two major polypeptides of 100 and 90 kDa were present in the preparation. Mass spectrometry analysis of these polypeptides did not yield any meaningful candidate. Carnosine formation catalyzed by the purified enzyme was accompanied by a stoichiometric formation, not of AMP, but of ADP, suggesting that carnosine synthase belongs to the "ATP-grasp family" of ligases. A data base mining approach identified ATPGD1 as a likely candidate. As this protein was absent from chicken protein data bases, we reconstituted its sequence from a PCR-amplified cDNA and found it to fit with the 100-kDa polypeptide of the chicken carnosine synthase preparation. Mouse and human ATPGD1 were expressed in HEK293T cells, purified to homogeneity, and shown to catalyze the formation of carnosine, as confirmed by mass spectrometry, and of homocarnosine. Specificity studies carried out on all three enzymes were in agreement with published data. In particular, they acted with 15-25-fold higher catalytic efficiencies on beta-alanine than on gamma-aminobutyrate. The identification of the gene encoding carnosine synthase will help for a better understanding of the biological functions of carnosine and related dipeptides, which still remain largely unknown.	[Drozak, Jakub; Veiga-da-Cunha, Maria; Van Schaftingen, Emile] Catholic Univ Louvain, Physiol Chem Lab, Duve Inst, B-1200 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, Hormone & Metab Res Unit, Duve Inst, B-1200 Brussels, Belgium; [Stroobant, Vincent] Catholic Univ Louvain, Ludwig Inst Canc Res, Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Physiol Chem Lab, Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Drozak, Jakub/0000-0002-3601-3845; Van Schaftingen, Emile/0000-0002-6199-7647; Vertommen, Didier/0000-0001-7648-8282	Belgian Fonds National de la Recherche Scientifique; Interuniversity Attraction Pole Programme Belgian Science Policy Networks [P6/05, P6/28]; Region Wallonne; ASCO Industries; Fonds National de la Recherche Scientifique	Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole Programme Belgian Science Policy Networks; Region Wallonne; ASCO Industries; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by grants from the Belgian Fonds National de la Recherche Scientifique, the Interuniversity Attraction Pole Programme Belgian Science Policy Networks P6/05 and P6/28, the DIANE centre of excellence program of the Region Wallonne, and by ASCO Industries.; Supported by a postdoctoral fellowship from the Fonds National de la Recherche Scientifique.	ACHESON SA, 1988, BIOCHEMISTRY-US, V27, P7371, DOI 10.1021/bi00419a030; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bauer K, 2005, NEUROCHEM RES, V30, P1339, DOI 10.1007/s11064-005-8806-z; Boldyrev A.A., 2007, CARNOSINE OXIDATIVE; Bonfanti L, 1999, PROG NEUROBIOL, V59, P333, DOI 10.1016/S0301-0082(99)00010-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CE, 1980, BIOCHEM BIOPH RES CO, V92, P470, DOI 10.1016/0006-291X(80)90357-5; CAMERON JN, 1989, J EXP BIOL, V143, P543; CRUSH KG, 1970, COMP BIOCHEM PHYSIOL, V34, P3, DOI 10.1016/0010-406X(70)90049-6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83, DOI 10.1152/ajpendo.2000.278.1.E83; Gulewitsch W, 1900, BER DTSCH CHEM GES, V33, P1902, DOI 10.1002/cber.19000330275; Hipkiss AR, 2009, EXP GERONTOL, V44, P237, DOI 10.1016/j.exger.2008.11.001; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; Jackson MC, 1996, INFLAMM RES, V45, P132, DOI 10.1007/BF02265166; KALYANKAR GD, 1959, J BIOL CHEM, V234, P3210; KISH SJ, 1979, J NEUROCHEM, V32, P1629, DOI 10.1111/j.1471-4159.1979.tb02272.x; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; KUMON A, 1970, BIOCHIM BIOPHYS ACTA, V200, P466, DOI 10.1016/0005-2795(70)90103-0; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; MARGOLIS FL, 1987, J NEUROCHEM, V48, P593, DOI 10.1111/j.1471-4159.1987.tb04134.x; MATSUOKA M, 1969, BIOCHIM BIOPHYS ACTA, V177, P169, DOI 10.1016/0304-4165(69)90083-X; Murakami T, 2009, EUR J PHARMACOL, V602, P73, DOI 10.1016/j.ejphar.2008.10.049; MURPHEY WH, 1973, PEDIATR RES, V7, P601, DOI 10.1203/00006450-197307000-00001; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; Nakagawa Y, 1998, AM J HUM GENET, V63, P547, DOI 10.1086/301974; Sauerhofer S, 2007, DIABETES, V56, P2425, DOI 10.2337/db07-0177; SKAPER SD, 1973, J NEUROCHEM, V21, P1429, DOI 10.1111/j.1471-4159.1973.tb06027.x; STENESH JJ, 1960, BIOCHEM J, V77, P575, DOI 10.1042/bj0770575; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Uchisawa H, 2007, BBA-GEN SUBJECTS, V1770, P790, DOI 10.1016/j.bbagen.2006.12.010; van der Zee DC, 1999, SURG ENDOSC-ULTRAS, V13, P925, DOI 10.1007/s004649901136; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Willi SM, 1997, PEDIATR RES, V41, P210, DOI 10.1203/00006450-199702000-00009	37	132	139	6	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9346	9356		10.1074/jbc.M109.095505	http://dx.doi.org/10.1074/jbc.M109.095505			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097752	Green Published, hybrid			2022-12-25	WOS:000276165900006
J	Lionetti, V; Cantoni, S; Cavallini, C; Bianchi, F; Valente, S; Frascari, I; Olivi, E; Aquaro, GD; Bonavita, F; Scarlata, I; Maioli, M; Vaccari, V; Tassinari, R; Bartoli, A; Recchia, FA; Pasquinelli, G; Ventura, C				Lionetti, Vincenzo; Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Valente, Sabrina; Frascari, Irene; Olivi, Elena; Aquaro, Giovanni D.; Bonavita, Francesca; Scarlata, Ignazio; Maioli, Margherita; Vaccari, Valentina; Tassinari, Riccardo; Bartoli, Antonietta; Recchia, Fabio A.; Pasquinelli, Gianandrea; Ventura, Carlo			Hyaluronan Mixed Esters of Butyric and Retinoic Acid Affording Myocardial Survival and Repair without Stem Cell Transplantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; HISTONE DEACETYLASE; BONE-MARROW; IN-VITRO; GROWTH; AKT; EXPRESSION; VEGF; PROLIFERATION; ACTIVATION	Possible cardiac repair by adult stem cell transplantation is currently hampered by poor cell viability and delivery efficiency, uncertain differentiating fate in vivo, the needs of ex vivo cell expansion, and consequent delay in transplantation after the onset of heart attack. By the aid of magnetic resonance imaging, positron emission tomography, and immunohistochemistry, we show that injection of a hyaluronan mixed ester of butyric and retinoic acid (HBR) into infarcted rat hearts afforded substantial cardiovascular repair and recovery of myocardial performance. HBR restored cardiac [F-18]fluorodeoxyglucose uptake and increased capillary density and led to the recruitment of endogenous Stro-1-positive stem cells. A terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling assay demonstrated that HBR-treated hearts exhibited a decrease in the number of apoptotic cardiomyocytes. In isolated rat cardiomyocytes and Stro-1 stem cells, HBR enhanced the transcription of vascular endothelial growth factor, hepatocyte growth factor, kdr, akt, and pim-1. HBR also increased the secretion of vascular endothelial growth factor and hepatocyte growth factor, suggesting that the mixed ester may have recruited both myocardial and Stro-1 cells also. An increase in capillarogenesis was induced in vitro with medium obtained from HBR-exposed cells. In the infarcted myocardium, HBR injection increased histone H4 acetylation significantly. Acetyl-H4 immunoreactivity increased in rat cardiomyocytes and Stro-1 cells exposed to HBR, compared with untreated cells. In conclusion, efficient cardiac regenerative therapy can be afforded by HBR without the need of stem cell transplantation or vector-mediated gene delivery.	[Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Frascari, Irene; Olivi, Elena; Bonavita, Francesca; Scarlata, Ignazio; Vaccari, Valentina; Tassinari, Riccardo; Ventura, Carlo] Univ Bologna, Lab Mol Biol & Stem Cell Engn, Cardiovasc Dept, Natl Inst Biostruct & Biosyst,S Orsola Malpighi H, I-40138 Bologna, Italy; [Lionetti, Vincenzo; Recchia, Fabio A.] Scuola Super Sant Anna, Sector Med, I-56124 Pisa, Italy; [Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Frascari, Irene; Olivi, Elena; Bonavita, Francesca; Scarlata, Ignazio; Vaccari, Valentina; Tassinari, Riccardo; Ventura, Carlo] Biosci Inst, RSM-47891 Falciano, San Marino; [Lionetti, Vincenzo; Aquaro, Giovanni D.] Consiglio Nazl Ric Fdn G Monasterio, Inst Clin Physiol, I-56124 Pisa, Italy; [Maioli, Margherita] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Bartoli, Antonietta] Univ Pisa, Dept Phys, I-56124 Pisa, Italy; [Recchia, Fabio A.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Valente, Sabrina; Pasquinelli, Gianandrea] Univ Bologna, Dept Hematol Oncol & Clin Pathol, I-40138 Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Scuola Superiore Sant'Anna; University of Sassari; University of Pisa; New York Medical College; University of Bologna	Ventura, C (corresponding author), Univ Bologna, Lab Mol Biol & Stem Cell Engn, Cardiovasc Dept, Natl Inst Biostruct & Biosyst,S Orsola Malpighi H, Via Massarenti 9, I-40138 Bologna, Italy.	carlo.ventura@unibo.it	Ventura, Carlo/AAV-3658-2020; Pasquinelli, Gianandrea/I-7088-2012; Recchia, Fabio/F-2315-2010; Lionetti, Vincenzo/AAN-1994-2020; Valente, Sabrina/ABI-1022-2020; Lionetti, Vincenzo/G-9528-2014; Lionetti, Vincenzo/AAH-9503-2020; aquaro, giovanni donato/AAB-8978-2019; Bianchi, Francesca/M-2205-2016; Cantoni, Silvia/H-3938-2011	Pasquinelli, Gianandrea/0000-0003-1506-1829; Lionetti, Vincenzo/0000-0002-0640-8651; Bianchi, Francesca/0000-0001-6732-0533; Scarlata, Ignazio/0000-0002-5490-7834; Cavallini, Claudia/0000-0002-8079-9697; MAIOLI, Margherita/0000-0003-0187-4968; Cantoni, Silvia/0000-0002-3866-3307; VALENTE, SABRINA/0000-0002-4090-291X; aquaro, giovanni donato/0000-0003-0915-915X	Regione Emilia Romagna; Fondazione Luisa Fanti Melloni, Bologna, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Tavola Valdese, Rome, Italy; "Compagnia di San Paolo," Torino, Italy	Regione Emilia Romagna(Regione Emilia Romagna); Fondazione Luisa Fanti Melloni, Bologna, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Tavola Valdese, Rome, Italy; "Compagnia di San Paolo," Torino, Italy(Compagnia di San Paolo)	This work was supported by Regione Emilia Romagna, Programma di Ricerca Regione-Universita 2007/2009, Area 1b "Medicina Rigenerativa," Italy; Fondazione Luisa Fanti Melloni, Bologna, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Tavola Valdese, Rome, Italy; and and "Compagnia di San Paolo," Torino, Italy.	Ancelin M, 2004, LAB INVEST, V84, P502, DOI 10.1038/labinvest.3700053; Bonacchi M, 2009, J CELL MOL MED, V13, P3437, DOI 10.1111/j.1582-4934.2008.00503.x; Bonaros N, 2008, TRANSPLANTATION, V86, P1151, DOI 10.1097/TP.0b013e3181880f9e; Buckley AR, 2000, ANN NY ACAD SCI, V917, P522; Buckley AR, 1996, CELL GROWTH DIFFER, V7, P1713; Choi SC, 2008, STEM CELLS DEV, V17, P725, DOI 10.1089/scd.2007.0230; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Fernandes VRS, 2007, RADIOLOGY, V245, P712, DOI 10.1148/radiol.2452061615; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Guzman MJ, 2008, J SURG RES, V150, P286, DOI 10.1016/j.jss.2007.12.772; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Higuchi T, 2007, J NUCL MED, V48, P288; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; Lai LH, 2003, DEVELOPMENT, V130, P6465, DOI 10.1242/dev.00887; Lee TM, 2007, AM J PHYSIOL-HEART C, V293, pH968, DOI 10.1152/ajpheart.00891.2006; Li YW, 2003, CIRCULATION, V107, P2499, DOI 10.1161/01.CIR.0000065579.19126.B8; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Napoli C, 2007, TRENDS MOL MED, V13, P278, DOI 10.1016/j.molmed.2007.05.004; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Positano V, 2005, J CARDIOV MAGN RESON, V7, P487, DOI 10.1081/JCMR-200053630; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Saito A, 2007, ENDOCRINOLOGY, V148, P1412, DOI 10.1210/en.2006-0900; Santini V, 2007, CURR DRUG METAB, V8, P383, DOI 10.2174/138920007780655397; SHI H, 2006, J NUCL MED S1, V47, pP271; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Spinelli AE, 2007, NUCL INSTRUM METH A, V571, P215, DOI 10.1016/j.nima.2006.10.066; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Thirunavukkarasu M, 2008, J CELL MOL MED, V12, P1284, DOI 10.1111/j.1582-4934.2008.00269.x; Ventura C, 2004, J BIOL CHEM, V279, P23574, DOI 10.1074/jbc.M401869200; Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200	39	43	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9949	9961		10.1074/jbc.M109.087254	http://dx.doi.org/10.1074/jbc.M109.087254			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097747	Green Published, hybrid			2022-12-25	WOS:000276165900064
J	Fu, J; Taubman, MB				Fu, Jian; Taubman, Mark B.			Prolyl Hydroxylase EGLN3 Regulates Skeletal Myoblast Differentiation through an NF-kappa B-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; MUSCLE DIFFERENTIATION; MYOGENIC DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; MICE LACKING; HIF-ALPHA; IKK-ALPHA; ACTIVATION; KINASE; INDUCTION	The egg-laying abnormal-9 (EGLN) prolyl hydroxylases have been shown to regulate the stability and thereby the activity of the alpha subunits of hypoxia-inducible factor (HIF) through its ability to catalyze their hydroxylation. We have previously shown that EGLN3 promotes differentiation of C2C12 skeletal myoblasts. However, the mechanism underlying this effect remains to be fully elucidated. Here, we report that exposure of C2C12 cells to dimethyl oxalylglycine (DMOG), desferrioxamine, and hypoxia, all inhibitors of prolyl hydroxylase activity, led to repression of C2C12 myogenic differentiation. Inactivation of HIF by expression of a HIF dominant-negative mutant or deletion of HIF-1 alpha by RNA interference did not affect the inhibitory effect of DMOG, suggesting that the effect of DMOG is HIF-independent. Pharmacologic inactivation of EGLN3 hydroxylase resulted in activation of the canonical NF-kappa B pathway. The inhibitory effect of DMOG on myogenic differentiation was markedly impaired in C2C12 cells expressing a dominant-negative mutant of I kappa B alpha. Exogenous expression of wild-type EGLN3, but not its catalytically inactive mutant, significantly inhibited NF-kappa B activation induced by overexpressed TRAF2 or I kappa B kinase 2. In contrast, deletion of EGLN3 by small interfering RNAs led to activation of NF-kappa B. These data suggest that EGLN3 is a negative regulator of NF-kappa B, and its prolyl hydroxylase activity is required for this effect. Furthermore, wild-type EGLN3, but not its catalytically inactive mutant, potentiated myogenic differentiation. This study demonstrates a novel role for EGLN3 in the regulation of NF-kappa B and suggests that it is involved in mediating myogenic differentiation, which is HIF-independent.	[Fu, Jian] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Fu, J (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.	jian_fu@urmc.rochester.edu						Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Fu J, 2003, J BIOL CHEM, V278, P52660, DOI 10.1074/jbc.M308036200; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kasiganesan H, 2007, ACTA PHYSIOL, V190, P163, DOI 10.1111/j.1748-1716.2007.01676.x; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lehtinen SK, 1996, BIOCHEM BIOPH RES CO, V229, P36, DOI 10.1006/bbrc.1996.1754; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liang YX, 2002, J BIOL CHEM, V277, P20087, DOI 10.1074/jbc.M201766200; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Lomb DJ, 2007, J NEUROCHEM, V103, P1897, DOI 10.1111/j.1471-4159.2007.04873.x; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Munz B, 2002, MOL CELL BIOL, V22, P5879, DOI 10.1128/MCB.22.16.5879-5886.2002; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Ratan RR, 2007, J MOL MED, V85, P1331, DOI 10.1007/s00109-007-0283-1; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scortegagna M, 2008, BLOOD, V111, P3343, DOI 10.1182/blood-2007-10-115758; Shohet RV, 2007, J MOL MED, V85, P1309, DOI 10.1007/s00109-007-0279-x; Sitcheran R, 2003, GENE DEV, V17, P2368, DOI 10.1101/gad.1114503; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	54	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8927	8935		10.1074/jbc.M109.078600	http://dx.doi.org/10.1074/jbc.M109.078600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089853	Green Published, hybrid			2022-12-25	WOS:000275553700044
J	Lu, TY; Lu, RM; Liao, MY; Yu, J; Chung, CH; Kao, CF; Wu, HC				Lu, Tung-Ying; Lu, Ruei-Min; Liao, Mei-Ying; Yu, John; Chung, Chu-Hung; Kao, Cheng-Fu; Wu, Han-Chung			Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EP-CAM; SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; DEVELOPMENTAL REGULATORS; H3K27 DEMETHYLASES; METHYLATION STATUS; MOUSE DEVELOPMENT; DNA METHYLATION; PROMOTER REGION; C-MYC	Human embryonic stem cells (hESCs) are unique pluripotent cells capable of self-renewal and differentiation into all three germ layers. To date, more cell surface markers capable of reliably identifying hESCs are needed. The epithelial cell adhesion molecule (EpCAM) is a type I transmembrane glycoprotein expressed in several progenitor cell populations and cancers. It has been used to enrich cells with tumor-initiating activity in xenograft transplantation studies. Here, we comprehensively profile the expression of EpCAM by immunofluorescence microscopy, Western blotting, and flow cytometry using an anti-EpCAM monoclonal antibody (mAb) OC98-1. We found EpCAM to be highly and selectively expressed by undifferentiated rather than differentiated hESCs. The protein and transcript level of EpCAM rapidly diminished as soon as hESC had differentiated. This silencing was closely and exclusively associated with the radical transformation of histone modification at the EpCAM promoter. Moreover, we demonstrated that the dynamic pattern of lysine 27 trimethylation of histone 3 was conferred by the interplay of SUZ12 and JMJD3, both of which were involved in maintaining hESC pluripotency. In addition, we used chromatin immunoprecipitation analysis to elucidate the direct regulation by EpCAM of several reprogramming genes, including c-MYC, OCT-4, NANOG, SOX2, and KLF4, to help maintain the undifferentiation of hESCs. Collectively, our results suggest that EpCAM might be used as a surface marker for hESC. The expression of EpCAM may be regulated by epigenetic mechanisms, and it is strongly associated with the maintenance of the undifferentiated state of hESCs.	[Lu, Tung-Ying; Lu, Ruei-Min; Liao, Mei-Ying; Yu, John; Chung, Chu-Hung; Kao, Cheng-Fu; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Yu, John; Wu, Han-Chung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lu, Tung-Ying; Wu, Han-Chung] Natl Taiwan Univ, Inst Pathol, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Kao, CF (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	ckao@gate.sinica.edu.tw; hcw0928@gate.sinica.edu.tw	Lu, Ruei-Min/ABF-4388-2021; yu, john/AAA-9255-2021; Kao, Cheng-Fu/AAE-8400-2022; YU, JOHN/G-8954-2012; Wu, Han-Chung/B-1209-2011	Lu, Ruei-Min/0000-0003-3792-5499; Kao, Cheng-Fu/0000-0002-8875-8152; Wu, Han-Chung/0000-0002-5185-1169; Yu, John/0000-0002-3237-4272	Academia Sinica and National Science Council (Taiwan) [NSC98-2323-B-001-001, NSC98-3111-B-001-004]	Academia Sinica and National Science Council (Taiwan)	This work was supported by Academia Sinica and National Science Council (Taiwan) Grants NSC98-2323-B-001-001 and NSC98-3111-B-001-004 ( to H.-C.W.).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brimble SN, 2007, STEM CELLS, V25, P54, DOI 10.1634/stemcells.2006-0232; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chen YC, 2007, CLIN VACCINE IMMUNOL, V14, P404, DOI 10.1128/CVI.00249-06; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kolle G, 2009, STEM CELLS, V27, P2446, DOI 10.1002/stem.182; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Litvinov SV, 1996, AM J PATHOL, V148, P865; Lu TY, 2009, J CELL BIOCHEM, V108, P315, DOI 10.1002/jcb.22256; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shiah Shine-Gwo, 2009, Oral Oncol, V45, pe1, DOI 10.1016/j.oraloncology.2008.03.003; Spizzo G, 2007, CANCER LETT, V246, P253, DOI 10.1016/j.canlet.2006.03.002; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yu GL, 2008, ONCOL REP, V20, P1061, DOI 10.3892/or_00000110; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	72	96	99	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8719	8732		10.1074/jbc.M109.077081	http://dx.doi.org/10.1074/jbc.M109.077081			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20064925	hybrid, Green Published			2022-12-25	WOS:000275553700025
J	Yu, JJ; Pan, L; Qin, XC; Chen, H; Xu, YL; Chen, YG; Tang, H				Yu, Junjing; Pan, Lei; Qin, Xincheng; Chen, Hua; Xu, Youli; Chen, Yeguang; Tang, Hong			MTMR4 Attenuates Transforming Growth Factor beta (TGF beta) Signaling by Dephosphorylating R-Smads in Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FYVE DOMAIN PROTEIN; RECEPTOR ACTIVATION; PHOSPHATASES; INTERNALIZATION; LOCALIZATION; INTERACTS; ENDOFIN; BINDING; ANCHOR; SARA	Homeostasis of Smad phosphorylation at its C-terminal SXS motif is essential for transforming growth factor beta (TGF beta) signaling. Whereas it is known that TGF beta signaling can be terminated by phosphatases, which dephosphorylate R-Smads in the nucleus, it is unclear whether there are any cytoplasmic phosphatase(s) that can attenuate R-Smad phosphorylation and nuclear translocation. Here we demonstrate that myotubularin-related protein 4 (MTMR4), a FYVE domain-containing dual-specificity protein phosphatase (DSP), attenuates TGF beta signaling by reducing the phosphorylation level of R-Smads in early endosomes. Co-immunoprecipitation experiments showed that endogenous MTMR4 interacts with phosphorylated R-Smads, and that this interaction is correlated with dephosphorylation of R-Smads. Further analysis showed that overexpression of MTMR4 resulted in the sequestration of activated Smad3 in the early endosomes, thus reducing its nuclear translocation. However, both point mutations at the conserved catalytic site of the phosphatase (MTMR4-C407S) and small interference RNA of endogenous Mtmr4 expression led to sustained Smad3 activation. This work therefore suggests that MTMR4 plays an important role in preventing the overactivation of TGF beta signaling by dephosphorylating activated R-Smads that have been trafficked to early endosomes.	[Tang, Hong] Chinese Acad Sci, Key Lab Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China; [Yu, Junjing; Pan, Lei] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China; [Chen, Hua; Chen, Yeguang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University	Tang, H (corresponding author), Chinese Acad Sci, Key Lab Infect & Immun, Inst Biophys, 15 Da Tun Rd, Beijing 100101, Peoples R China.	tanghong@moon.ibp.ac.cn	Chen, Ye-Guang/L-6998-2019	Pan, Lei/0000-0002-0500-8904	MOST [2006CB504300, 2007DFC30190, 2009CB522506, 2004CB720002, 2006CB910100]; NSFC [30428002]	MOST; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the National Basic Research Program of MOST (2006CB504300, 2007DFC30190, 2009CB522506) (to H. T.) and NSFC (30428002) and MOST (2004CB720002, 2006CB910100) (to Y. C.).	Aoki CA, 2005, AUTOIMMUN REV, V4, P450, DOI 10.1016/j.autrev.2005.03.006; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Chen YL, 2006, BIOCHEM BIOPH RES CO, V345, P106, DOI 10.1016/j.bbrc.2006.04.034; Chen YG, 2007, J BIOL CHEM, V282, P9688, DOI 10.1074/jbc.M611704200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Schilling SH, 2006, CELL, V125, P838, DOI 10.1016/j.cell.2006.05.015; Shi WB, 2007, J CELL SCI, V120, P1216, DOI 10.1242/jcs.03400; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tang H, 1999, IMMUNITY, V11, P517, DOI 10.1016/S1074-7613(00)80127-2; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Zhao RX, 2001, EXP CELL RES, V265, P329, DOI 10.1006/excr.2001.5185; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200	37	37	38	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8454	8462		10.1074/jbc.M109.075036	http://dx.doi.org/10.1074/jbc.M109.075036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061380	Green Published, hybrid			2022-12-25	WOS:000275413800060
J	Day, AM; Veal, EA				Day, Alison M.; Veal, Elizabeth A.			Hydrogen Peroxide-sensitive Cysteines in the Sty1 MAPK Regulate the Transcriptional Response to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CANDIDA-ALBICANS; SPC1 KINASE; PATHWAY; PHOSPHORYLATION; ROLES; GENE; EXPRESSION	MAPK are activated by and orchestrate responses to multiple, diverse stimuli. Although these responses involve the increased phosphorylation of substrate effector proteins, e. g. transcription factors, the mechanisms by which responses are tailored to particular stimuli are unclear. In the fission yeast Schizosaccharomyces pombe, the Sty1 MAPK is crucial for changes in gene expression that allow adaptation to many forms of environmental stress. Here, we have identified two cysteine residues in Sty1, Cys-153 and Cys-158, that are important for hydrogen peroxide-induced gene expression and oxidative stress resistance but not for other functions of Sty1. Many Sty1-dependent changes in gene expression are mediated by the Atf1 transcription factor. In response to stress, Sty1 increases Atf1 levels by (i) promoting increases in atf1 mRNA and by (ii) directly phosphorylating and stabilizing Atf1 protein. Although dispensable for phosphorylation and stabilization of Atf1 protein, we find that both Cys-153 and Cys-158 are required for increases in atf1 mRNA levels and Atf1-dependent gene expression in response to hydrogen peroxide but not osmotic stress. Indeed, our data indicate that oxidation of Sty1, by formation of a disulfide bond between Cys-153 and Cys-158, is important for maintaining atf1 mRNA stability at high concentrations of hydrogen peroxide. Together, these data reveal that redox regulation of cysteine thiols in Sty1 is involved in a stress-specific mechanism regulating transcriptional responses to oxidative stress. Intriguingly, the conservation of these cysteine residues in other MAPK raises the possibility that similar mechanisms may ensure appropriate responses to hydrogen peroxide in other eukaryotes.	[Day, Alison M.; Veal, Elizabeth A.] Med Sch Newcastle Upon Tyne, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Veal, EA (corresponding author), Med Sch Newcastle Upon Tyne, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	e.a.veal@ncl.ac.uk		Veal, Elizabeth/0000-0002-1152-5473	Medical Research Council Career Development; Biotechnology and Biological Sciences Research Council [BBF0230651]; BBSRC [BB/F023065/1] Funding Source: UKRI; MRC [G120/817] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F023065/1] Funding Source: researchfish; Medical Research Council [G120/817] Funding Source: researchfish	Medical Research Council Career Development(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council Career Development Award and Biotechnology and Biological Sciences Research Council Grant BBF0230651 ( to E. V.).	Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nguyen AN, 2000, MOL BIOL CELL, V11, P1169, DOI 10.1091/mbc.11.4.1169; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; PARKER R, 1991, METHOD ENZYMOL, V194, P415; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Rodriguez-Gabriel MA, 2003, EMBO J, V22, P6256, DOI 10.1093/emboj/cdg597; Rodriguez-Gabriel MA, 2006, MOL CELL BIOL, V26, P6347, DOI 10.1128/MCB.00286-06; Sambrook I, 1989, MOL CLONING LAB MANU; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Toone WM, 1998, GENES CELLS, V3, P485, DOI 10.1046/j.1365-2443.1998.00211.x; Veal EA, 2002, J BIOL CHEM, V277, P35523, DOI 10.1074/jbc.M111548200; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289	44	38	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7505	7516		10.1074/jbc.M109.040840	http://dx.doi.org/10.1074/jbc.M109.040840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20061379	hybrid, Green Published			2022-12-25	WOS:000275415600062
J	Ha, TY; Chang, KA; Kim, JA; Kim, HS; Kim, S; Chong, YH; Suh, YH				Ha, Tae-Young; Chang, Keun-A; Kim, Jeong A.; Kim, Hye-Sun; Kim, Seonghan; Chong, Young Hae; Suh, Yoo-Hun			S100a9 Knockdown Decreases the Memory Impairment and the Neuropathology in Tg2576 Mice, AD Animal Model	PLOS ONE			English	Article							ALZHEIMER AMYLOID PRECURSOR; MACROPHAGES MICROGLIA; MOUSE MODEL; BETA; PROTEIN; DISEASE; BRAIN; ACTIVATION; EXPRESSION; CALCIUM	Inflammation, insoluble protein deposition and neuronal cell loss are important features in the Alzheimer's disease (AD) brain. To investigate the regulatory genes responsible for the neuropathology in AD, we performed microarray analysis with APP(V717I)-CT100 transgenic mice, an animal model of AD, and isolated the S100a9 gene, which encodes an Winflammation-associated calcium binding protein. In another AD animal model, Tg2576 mouse brain, and in human AD brain, induction of S100a9 was confirmed. The endogenous expression of S100a9 was induced by treatment with A beta or CT peptides in a microglia cell line, BV2 cells. In these cells, silencing study of S100a9 showed that the induction of S100a9 increased the intracellular calcium level and up-regulated the inflammatory cytokines (IL-1 beta and TNF alpha) and iNOS. S100a9 lentiviral short hairpin RNA (sh-S100a9) was injected into the hippocampus region of the brains of 13-month-old Tg2576 mice. At two months after injection, we found that knockdown of S100a9 expression had improved the cognition decline of Tg2576 mice in the water maze task, and had reduced amyloid plaque burden. These results suggest that S100a9 induced by A beta or CT contributes to cause inflammation, which then affects the neuropathology including amyloid plaques burden and impairs cognitive function. Thus, the inhibition of S100a9 is a possible target for AD therapy.	[Ha, Tae-Young; Chang, Keun-A; Kim, Jeong A.; Kim, Hye-Sun; Kim, Seonghan; Suh, Yoo-Hun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Natl Creat Res Initiat Ctr Alzheimers Dementia, Seoul, South Korea; [Ha, Tae-Young; Chang, Keun-A; Kim, Jeong A.; Kim, Hye-Sun; Kim, Seonghan; Suh, Yoo-Hun] Seoul Natl Univ, MRC, Neurosci Res Inst, Seoul, South Korea; [Chong, Young Hae] Ewha Womans Univ, Dept Microbiol, Sch Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Ewha Womans University	Ha, TY (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Natl Creat Res Initiat Ctr Alzheimers Dementia, Seoul, South Korea.	yhsuh@snu.ac.kr	Kim, Hye Sun/J-2752-2012; Suh, Yoo-Hun/J-2761-2012		Korea Ministry of Education, Science and Technology; National Research Foundation of Korea, Korea government [2009-0086201]; ministry of education, Science and Technology [R33-10167]; National Research Foundation of Korea, Ministry of Education, Science and Technology [2009-0082268]	Korea Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea, Korea government(National Research Foundation of KoreaKorean Government); ministry of education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea, Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was financially supported by National Creative Research Initiative Grant (2006-2009) from Korea Ministry of Education, Science and Technology, in part by the National Research Foundation of Korea grant funded by the Korea government (2009-0086201), in part by WCU program (R33-10167) of the ministry of education, Science and Technology, and in part by the Conversing Research Center Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2009-0082268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1999, J NEUROL, V246, P358, DOI 10.1007/s004150050363; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Farber K, 2006, GLIA, V54, P656, DOI 10.1002/glia.20412; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hoozemans JJM, 2006, INT J DEV NEUROSCI, V24, P157, DOI 10.1016/j.ijdevneu.2005.11.001; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; KAMMESHEIDT A, 1992, P NATL ACAD SCI USA, V89, P10857, DOI 10.1073/pnas.89.22.10857; Kar S, 2004, J PSYCHIATR NEUROSCI, V29, P427; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kerkhoff C, 2002, J BIOL CHEM, V277, P41879, DOI 10.1074/jbc.M207990200; Kim CM, 2003, VECTOR-BORNE ZOONOT, V3, P17, DOI 10.1089/153036603765627424; Kuruto-Niwa R, 1998, CELL STRUCT FUNCT, V23, P109, DOI 10.1247/csf.23.109; Lambourne SL, 2005, MOL CELL BIOL, V25, P278, DOI 10.1128/MCB.25.1.278-293.2005; Lue LF, 1996, J NEUROPATH EXP NEUR, V55, P1083, DOI 10.1097/00005072-199655100-00008; MARIGGIO MA, 1994, NEUROSCIENCE, V60, P29, DOI 10.1016/0306-4522(94)90201-1; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Postler E, 1997, GLIA, V19, P27, DOI 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7; Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shepherd CE, 2006, NEUROBIOL AGING, V27, P1554, DOI 10.1016/j.neurobiolaging.2005.09.033; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	35	66	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8840	10.1371/journal.pone.0008840	http://dx.doi.org/10.1371/journal.pone.0008840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098622	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779100031
J	Karpushev, AV; Ilatovskaya, DV; Pavlov, TS; Negulyaev, YA; Staruschenko, A				Karpushev, Alexey V.; Ilatovskaya, Daria V.; Pavlov, Tengis S.; Negulyaev, Yuri A.; Staruschenko, Alexander			Intact Cytoskeleton Is Required for Small G Protein Dependent Activation of the Epithelial Na+ Channel	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; PLANAR LIPID-BILAYERS; COLLECTING DUCT; ACTIN-FILAMENTS; SODIUM-CHANNEL; EXPRESSION SYSTEM; ARACHIDONIC-ACID; SMALL GTPASES; ION CHANNELS; CELL-LINE	Background: The Epithelial Na+ Channel (ENaC) plays a central role in control of epithelial surface hydration and vascular volume. Similar to other ion channels, ENaC activity is regulated, in part, by cortical cytoskeleton. Besides, the cytoskeleton is an established target for small G proteins signaling. Here we studied whether ENaC activity is modulated by changes in the state of the cytoskeleton and whether cytoskeletal elements are involved in small G protein mediated increase of ENaC activity. Methods and Findings: First, the functional importance of the cytoskeleton was established with whole-cell patch clamp experiments recording ENaC reconstituted in CHO cells. Pretreatment with Cytochalasin D (CytD; 10 mu g/ml; 1-2 h) or colchicine (500 mu M; 1-3 h) to disassembly F-actin and destroy microtubules, respectively, significantly decreased amiloride sensitive current. However, acute application of CytD induced rapid increase in macroscopic current. Single channel measurements under cell-attached conditions revealed similar observations. CytD rapidly increased ENaC activity in freshly isolated rat collecting duct, polarized epithelial mouse mpkCCD(c14) cells and HEK293 cells transiently transfected with ENaC subunits. In contrast, colchicine did not have an acute effect on ENaC activity. Small G proteins RhoA, Rac1 and Rab11a markedly increase ENaC activity. 1-2 h treatment with colchicine or CytD abolished effects of these GTPases. Interestingly, when cells were coexpressed with ENaC and RhoA, short-term treatment with CytD decreased ENaC activity. Conclusions: We conclude that cytoskeleton is involved in regulation of ENaC and is necessary for small G protein mediated increase of ENaC activity.	[Karpushev, Alexey V.; Ilatovskaya, Daria V.; Pavlov, Tengis S.; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Staruschenko, Alexander] Med Coll Wisconsin, Kidney Dis Ctr, Milwaukee, WI 53226 USA; [Ilatovskaya, Daria V.; Negulyaev, Yuri A.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Medical College of Wisconsin; Medical College of Wisconsin; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Karpushev, AV (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	Staruschenko@mcw.edu	Negulyaev, Yuri/N-6531-2015; Karpushev, Alexey/K-5371-2014	Negulyaev, Yuri/0000-0002-1773-9798; Ilatovskaya, Daria/0000-0003-4832-4170; Karpushev, Alexey/0000-0001-8437-6424; Staruschenko, Alexander/0000-0002-5190-8356	American Heart Association [0730111N]; American Society of Nephrology Carl W. Gottschalk Research Scholar Grant [RFBR-08-04-00574, RFBR-10-04-00995]; Russian Academy of Sciences	American Heart Association(American Heart Association); American Society of Nephrology Carl W. Gottschalk Research Scholar Grant; Russian Academy of Sciences(Russian Academy of Sciences)	This research was supported by the American Heart Association grant 0730111N and the American Society of Nephrology Carl W. Gottschalk Research Scholar Grant (to A. Staruschenko), RFBR-08-04-00574 (to D. Ilatovskaya), RFBR-10-04-00995 and Molecular and Cell Biology Program of Russian Academy of Sciences (to Y. Negulyaev). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berdiev BK, 2001, BIOPHYS J, V80, P2176, DOI 10.1016/S0006-3495(01)76190-5; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; Copeland SJ, 2001, AM J PHYSIOL-CELL PH, V281, pC231, DOI 10.1152/ajpcell.2001.281.1.C231; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; ELS WJ, 1993, J PHYSIOL-LONDON, V462, P447, DOI 10.1113/jphysiol.1993.sp019563; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hayashi K, 2006, J PHARMACOL SCI, V100, P29, DOI 10.1254/jphs.FMJ05003X6; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Mastroberardino L, 1998, MOL BIOL CELL, V9, P3417, DOI 10.1091/mbc.9.12.3417; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; O'Malley D, 2007, EUR J NEUROSCI, V25, P673, DOI 10.1111/j.1460-9568.2007.05347.x; PEARL M, 1983, AM J PHYSIOL, V245, pC28, DOI 10.1152/ajpcell.1983.245.1.C28; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; PRAT AG, 1993, AM J PHYSIOL, V265, pC224, DOI 10.1152/ajpcell.1993.265.1.C224; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V351, P582, DOI 10.1016/j.bbrc.2006.10.087; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sharpe CC, 2003, J AM SOC NEPHROL, V14, P261, DOI 10.1097/01.ASN.0000048223.05219.E4; Staruschenko A, 2005, BBA-BIOMEMBRANES, V1669, P108, DOI 10.1016/j.bbamem.2005.01.005; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Staruschenko Alexander, 2006, V337, P3; Sun P, 2006, AM J PHYSIOL-RENAL, V291, pF1192, DOI 10.1152/ajprenal.00112.2006; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; WANG WH, 1994, AM J PHYSIOL-RENAL, V267, pF592, DOI 10.1152/ajprenal.1994.267.4.F592; Wei Y, 2006, AM J PHYSIOL-RENAL, V290, pF1163, DOI 10.1152/ajprenal.00301.2005; Wei Y, 2002, AM J PHYSIOL-RENAL, V282, pF680, DOI 10.1152/ajprenal.00229.2001	37	33	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8827	10.1371/journal.pone.0008827	http://dx.doi.org/10.1371/journal.pone.0008827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098689	gold, Green Published, Green Submitted			2022-12-25	WOS:000273779100019
J	Wooten, EC; Iyer, LK; Montefusco, M; Hedgepeth, AK; Payne, DD; Kapur, NK; Housman, DE; Mendelsohn, ME; Huggins, GS				Wooten, Eric C.; Iyer, Lakshmanan K.; Montefusco, Maria Claudia; Hedgepeth, Alyson Kelley; Payne, Douglas D.; Kapur, Navin K.; Housman, David E.; Mendelsohn, Michael E.; Huggins, Gordon S.			Application of Gene Network Analysis Techniques Identifies AXIN1/PDIA2 and Endoglin Haplotypes Associated with Bicuspid Aortic Valve	PLOS ONE			English	Article							NEURAL CREST; EXPRESSION; MUTATIONS; LINKAGE; NOTCH1; POWER; DISEASE; HEART	Bicuspid Aortic Valve (BAV) is a highly heritable congenital heart defect. The low frequency of BAV (1% of general population) limits our ability to perform genome-wide association studies. We present the application of four a priori SNP selection techniques, reducing the multiple-testing penalty by restricting analysis to SNPs relevant to BAV in a genome-wide SNP dataset from a cohort of 68 BAV probands and 830 control subjects. Two knowledge-based approaches, CANDID and STRING, were used to systematically identify BAV genes, and their SNPs, from the published literature, microarray expression studies and a genome scan. We additionally tested Functionally Interpolating SNPs (fitSNPs) present on the array; the fourth consisted of SNPs selected by Random Forests, a machine learning approach. These approaches reduced the multiple testing penalty by lowering the fraction of the genome probed to 0.19% of the total, while increasing the likelihood of studying SNPs within relevant BAV genes and pathways. Three loci were identified by CANDID, STRING, and fitSNPS. A haplotype within the AXIN1-PDIA2 locus (p-value of 2.926x10(-06)) and a haplotype within the Endoglin gene (p-value of 5.881x10(-04)) were found to be strongly associated with BAV. The Random Forests approach identified a SNP on chromosome 3 in association with BAV (p-value 5.061x10(-06)). The results presented here support an important role for genetic variants in BAV and provide support for additional studies in well-powered cohorts. Further, these studies demonstrate that leveraging existing expression and genomic data in the context of GWAS studies can identify biologically relevant genes and pathways associated with a congenital heart defect.	[Wooten, Eric C.; Iyer, Lakshmanan K.; Montefusco, Maria Claudia; Hedgepeth, Alyson Kelley; Kapur, Navin K.; Mendelsohn, Michael E.; Huggins, Gordon S.] MCRI Ctr Translat Genom, Mol Cardiol Res Inst, Boston, MA USA; [Payne, Douglas D.] Tufts Med Ctr, Div Cardiothorac Surg, Boston, MA USA; [Housman, David E.] MIT, Cambridge, MA 02139 USA	Tufts Medical Center; Massachusetts Institute of Technology (MIT)	Wooten, EC (corresponding author), MCRI Ctr Translat Genom, Mol Cardiol Res Inst, Boston, MA USA.	ghuggins@tuftsmedicalcenter.org		Iyer, Lakshmanan/0000-0001-9167-6396; Wooten, Eric/0000-0002-8403-8668	National Institutes of Health [HL077378]; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023387] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077378, K08HL094909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by the National Institutes of Health grants HL077378 (M. E. M.), and the American Heart Association (E. C. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; American Heart Association, 2009, HEART DIS STROK STAT; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Biner S, 2009, J AM COLL CARDIOL, V53, P2288, DOI 10.1016/j.jacc.2009.03.027; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Cripe L, 2004, J AM COLL CARDIOL, V44, P138, DOI 10.1016/j.jacc.2004.03.050; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEANGELIS MM, 2007, OPHTHALMOLOGY; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ellison JW, 2007, J SURG RES, V142, P28, DOI 10.1016/j.jss.2006.04.040; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Hong F, RANKPROD RANK PRODUC; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Hutz JE, 2008, GENET EPIDEMIOL, V32, P779, DOI 10.1002/gepi.20346; *ILL, ILL ICONTROLDB; Jiang XB, 2000, DEVELOPMENT, V127, P1607; KAPPETEIN AP, 1991, J THORAC CARDIOV SUR, V102, P830, DOI 10.1016/S0022-5223(19)33931-5; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Li C, 2008, HUM HERED, V65, P129, DOI 10.1159/000109730; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Loscalzo ML, 2007, AM J MED GENET A, V143A, P1960, DOI 10.1002/ajmg.a.31872; de la Pompa JL, 2009, PEDIATR CARDIOL, V30, P643, DOI 10.1007/s00246-008-9368-z; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Majumdar R, 2007, CARDIOVASC PATHOL, V16, P144, DOI 10.1016/j.carpath.2006.12.001; Mancini ML, 2007, DEV BIOL, V308, P520, DOI 10.1016/j.ydbio.2007.06.009; Martin LJ, 2007, HUM GENET, V121, P275, DOI 10.1007/s00439-006-0316-9; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Pawitan Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007969; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu R, 1998, CELL TISSUE RES, V292, P333, DOI 10.1007/s004410051064; *R DEV COR TEAM, R LANG ENV STAT COMP; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SMYTH GK, 2004, STAT APPL GENETICS M, V3; TRANCHEVENT L, 2008, NUCLEIC ACIDS RES; TURRI M, 1990, EUR J CARDIO-THORAC, V4, P556, DOI 10.1016/1010-7940(90)90145-P; Valeria B, 2008, REPROD SCI, V15, P1018, DOI 10.1177/1933719108322429; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang JK, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-51; Wang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001050; RANDOM JUNGLE FAST I	52	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8830	10.1371/journal.pone.0008830	http://dx.doi.org/10.1371/journal.pone.0008830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098615	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100021
J	Huang, ZG; Yang, JJ; Luo, GX; Gan, CJ; Cheng, WG; Yuan, SZ; Peng, X; Tan, JL; Wang, XJ; Hu, J; Yang, SW; Reisner, Y; Ge, LP; Wei, H; Cheng, P; Wu, J				Huang, Zhenggen; Yang, Junjie; Luo, Gaoxing; Gan, Chengjun; Cheng, Wenguang; Yuan, Shunzong; Peng, Xu; Tan, Jianglin; Wang, Xiaojuan; Hu, Jie; Yang, Shiwei; Reisner, Yair; Ge, Liangpeng; Wei, Hong; Cheng, Ping; Wu, Jun			Embryonic Porcine Skin Precursors Can Successfully Develop into Integrated Skin without Teratoma Formation Posttransplantation in Nude Mouse Model	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; RAT BURN WOUNDS; TRANSPLANTATION; KERATINOCYTES; GENERATION; SURVIVAL; LIVER	How to improve the wound healing quality of severe burn patients is still a challenge due to lack of skin appendages and rete ridges, no matter how much progress has been made in the fields of either stem cell or tissue engineering. We thus systematically studied the growth potential and differentiation capacity of porcine embryonic skin precursors. Implantation of embryonic skin precursors (PESPs) of different gestational ages in nude mice can generate the integrity skin, including epidermis, dermis and skin appendages, such as sweat gland, hair follicle, sebaceous gland, etc.. PESPs of embryonic day 42 possess the maximal growth potential, while, the safe window time of PESPs transplantation for prevention of teratoma risk is E56 or later. In conclusion, PESPs can form the 3 dimensional structures of skin with all necessary skin appendages. Our data strongly indicate that porcine embryonic skin precursors harvested from E56 of minipig may provide new hope for high-quality healing of extensive burns and traumas.	[Huang, Zhenggen; Yang, Junjie; Luo, Gaoxing; Gan, Chengjun; Cheng, Wenguang; Yuan, Shunzong; Peng, Xu; Tan, Jianglin; Wang, Xiaojuan; Hu, Jie; Yang, Shiwei; Wu, Jun] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Huang, Zhenggen; Yang, Junjie; Luo, Gaoxing; Gan, Chengjun; Cheng, Wenguang; Yuan, Shunzong; Peng, Xu; Tan, Jianglin; Wang, Xiaojuan; Hu, Jie; Yang, Shiwei; Wu, Jun] Chongqing Key Lab Prote Dis, Chongqing, Peoples R China; [Reisner, Yair] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Ge, Liangpeng; Wei, Hong] Third Mil Med Univ, Dept Zool, Chongqing, Peoples R China; [Cheng, Ping] Third Mil Med Univ, Dept Clin Lab Sci, Chongqing, Peoples R China	Army Medical University; Weizmann Institute of Science; Army Medical University; Army Medical University	Huang, ZG (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	junwupro1@yahoo.com.cn	Yuan, Shunzong/AAO-3551-2020; Gaoxing, LUO/AAE-4505-2020; Reisner, Yair/AAA-4772-2019	LUO, Gaoxing/0000-0003-4764-3209; Reisner, Yair/0000-0002-3354-6945	National High Technology Research and Development Project of China [2006AA02A121]; National Nature Science Foundation of China [30672174]; State Key Lab Funding [SKLZZ200808, SKLZZ200820]	National High Technology Research and Development Project of China(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Lab Funding	This work was supported by a grant from the National High Technology Research and Development Project of China ("863'' Project)(No. 2006AA02A121) and partly by National Nature Science Foundation of China (NSFC No. 30672174) and State Key Lab Funding (SKLZZ200808 to JW and SKLZZ200820 to GL). There are a total of 4 fundings involved in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Anderson GB, 1996, ANIM REPROD SCI, V45, P231, DOI 10.1016/S0378-4320(96)01581-3; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; Eventov-Friedman S, 2005, P NATL ACAD SCI USA, V102, P2928, DOI 10.1073/pnas.0500177102; Eventov-Friedman S, 2006, PLOS MED, V3, P1165, DOI 10.1371/journal.pmed.0030215; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Hammerman Marc R, 2006, Clin Exp Nephrol, V10, P1, DOI 10.1007/s10157-005-0393-4; Hecht G, 2009, P NATL ACAD SCI USA, V106, P8659, DOI 10.1073/pnas.0812253106; Katchman H, 2008, STEM CELLS, V26, P1347, DOI 10.1634/stemcells.2007-0631; Luo GX, 2005, J TRAUMA, V59, P1209, DOI 10.1097/01.ta.0000189002.59950.dc; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Price RD, 2001, BRIT J PLAST SURG, V54, P687, DOI 10.1054/bjps.2001.3712; Qing Chun, 2004, Zhonghua Shao Shang Za Zhi, V20, P336; Roh C, 2006, PEDIATR RES, V59, p100R, DOI 10.1203/01.pdr.0000203572.51876.ba; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; TCHORSHYUTSIS D, 2009, DIABETES; Wang Y, 2008, J TRAUMA, V65, P154, DOI 10.1097/TA.0b013e31812f6f74	19	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8717	10.1371/journal.pone.0008717	http://dx.doi.org/10.1371/journal.pone.0008717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090918	Green Published, gold, Green Submitted			2022-12-25	WOS:000273715000002
J	Ali, MM; Janic, B; Babajani-Feremi, A; Varma, NRS; Iskander, ASM; Anagli, J; Arbab, AS				Ali, Meser M.; Janic, Branislava; Babajani-Feremi, Abbas; Varma, Nadimpalli R. S.; Iskander, A. S. M.; Anagli, John; Arbab, Ali S.			Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; FACTOR-RECEPTOR; CONTRAST AGENT; BREAST-CANCER; TUMOR-GROWTH; IN-VIVO; GD-DTPA; EXPERIMENTAL-MODEL; MRI	Background: Anti-angiogenic treatments of malignant tumors targeting vascular endothelial growth factor receptors (VEGFR) tyrosine kinase are being used in different early stages of clinical trials. Very recently, VEGFR tyrosine kinase inhibitor (Vetanalib, PTK787) was used in glioma patient in conjunction with chemotherapy and radiotherapy. However, changes in the tumor size, tumor vascular permeability, vascular density, expression of VEGFR2 and other angiogenic factors in response to PTK787 are not well documented. This study was to determine the changes in tumor size, vascular permeability, fractional plasma volume and expression of VEGFR2 in PTK787 treated U-251 glioma rat model by in vivo magnetic resonance imaging (MRI) and single photon emission computed tomography (SPECT). The findings were validated with histochemical and western blot studies. Methodologies and Principal Findings: Seven days after implantation of U251 glioma cells, animals were treated with either PTK787 or vehicle-only for two weeks, and then tumor size, tumor vascular permeability transfer constant (K-trans), fractional plasma volume (fPV) and expression of VEGFR2 and other relevant angiogenic factors were assessed by in vivo MRI and SPECT (Tc-99-HYNIC-VEGF), and by immunohistochemistry and western blot analysis. Dynamic contrast-enhanced MRI (DCE-MRI) using a high molecular weight contrast agent albumin-(GdDTPA) showed significantly increased K-trans at the rim of the treated tumors compared to that of the central part of the treated as well as the untreated (vehicle treated) tumors. Size of the tumors was also increased in the treated group. Expression of VEGFR2 detected by Tc-99m-HYNIC-VEGF SPECT also showed significantly increased activity in the treated tumors. In PTK787-treated tumors, histological staining revealed increase in microvessel density in the close proximity to the tumor border. Western blot analysis indicated increased expression of VEGF, SDF-1, HIF-1 alpha, VEGFR2, VEGFR3 and EGFR at the peripheral part of the treated tumors compared to that of central part of the treated tumors. Similar expression patters were not observed in vehicle treated tumors. Conclusion: These findings indicate that PTK787 treatment induced over expression of VEGF as well as the Flk-1/VEGFR2 receptor tyrosine kinase, especially at the rim of the tumor, as proven by DCE-MRI, SPECT imaging, immunohistochemistry and western blot.	[Ali, Meser M.; Janic, Branislava; Babajani-Feremi, Abbas; Varma, Nadimpalli R. S.; Iskander, A. S. M.; Anagli, John; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Ali, MM (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	saali@rad.hfh.edu	Arbab, Ali/AAS-1933-2020		National Institutes of Health [R01CA122031, 1R21CA129801, 1R21NS066143]; NATIONAL CANCER INSTITUTE [R01CA122031, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: The work is supported by National Institutes of Health grants R01CA122031 and 1R21CA129801, 1R21NS066143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MJ, 1990, J NUCL MED, V31, P2022; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Backer MV, 2007, NAT MED, V13, P504, DOI 10.1038/nm1522; Barboriak DP, 2008, J MAGN RESON IMAGING, V27, P1388, DOI 10.1002/jmri.21344; Barboriak DP, 2005, J DIGIT IMAGING, V18, P91, DOI 10.1007/s10278-004-1879-4; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355; BICKNELL R, 1997, ROLE VASCULAR ENDOTH, P185; Blankenberg FG, 2006, EUR J NUCL MED MOL I, V33, P841, DOI 10.1007/s00259-006-0099-1; Cheng HLM, 2007, J MAGN RESON IMAGING, V25, P137, DOI 10.1002/jmri.20787; Daldrup H, 1998, AM J ROENTGENOL, V171, P941, DOI 10.2214/ajr.171.4.9762973; Dhermain F, 2005, B CANCER, V92, P333; Dietrich J, 2008, CURR OPIN NEUROL, V21, P736, DOI 10.1097/WCO.0b013e3283131370; Drevs J, 2002, CANCER RES, V62, P4015; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Fong TAT, 1999, CANCER RES, V59, P99; Gianfelice D, 2003, RADIOLOGY, V227, P849, DOI 10.1148/radiol.2281012163; Goldbrunner RH, 2004, NEUROSURGERY, V55, P426, DOI 10.1227/01.NEU.0000129551.64651.74; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Knopp MV, 1999, JMRI-J MAGN RESON IM, V10, P260, DOI 10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7; Lamszus K, 2005, CLIN CANCER RES, V11, P4934, DOI 10.1158/1078-0432.CCR-04-2270; Lee I, 2007, IN VIVO, V21, P721; Lee L, 2006, CANCER CHEMOTH PHARM, V57, P761, DOI 10.1007/s00280-005-0120-6; LEVASHOVA Z, 2009, BIOCONJUG CHEM; Levashova Z, 2008, BIOCONJUGATE CHEM, V19, P1049, DOI 10.1021/bc7004818; Lin PN, 1998, CELL GROWTH DIFFER, V9, P49; Los M, 2007, ONCOLOGIST, V12, P443, DOI 10.1634/theoncologist.12-4-443; Marzola P, 2005, CLIN CANCER RES, V11, P5827, DOI 10.1158/1078-0432.CCR-04-2655; Marzola P, 2003, INT J CANCER, V104, P462, DOI 10.1002/ijc.10953; Mussurakis S, 1997, BRIT J RADIOL, V70, P446, DOI 10.1259/bjr.70.833.9227224; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Norden AD, 2008, CURR OPIN ONCOL, V20, P652, DOI 10.1097/CCO.0b013e32831186ba; Norden AD, 2008, LANCET NEUROL, V7, P1152, DOI 10.1016/S1474-4422(08)70260-6; OGAN MD, 1987, INVEST RADIOL, V22, P665, DOI 10.1097/00004424-198708000-00008; Pham CD, 1998, CANCER INVEST, V16, P225, DOI 10.3109/07357909809039771; Preda A, 2004, J MAGN RESON IMAGING, V20, P865, DOI 10.1002/jmri.20184; Raatschen HJ, 2008, RADIOLOGY, V247, P391, DOI 10.1148/radiol.2472070363; Remer Sandra, 2004, Clin J Oncol Nurs, V8, P368, DOI 10.1188/04.CJON.368-376; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Salmon BA, 2007, EUR J CANCER, V43, P1622, DOI 10.1016/j.ejca.2007.03.018; Semple SIK, 2006, ANN ONCOL, V17, P1393, DOI 10.1093/annonc/mdl136; SHAMES DM, 1993, MAGNET RESON MED, V29, P616, DOI 10.1002/mrm.1910290506; Silverman MD, 2007, ARTHRITIS RHEUM-US, V56, P1817, DOI 10.1002/art.22706; Taylor JS, 1999, J MAGN RESON IMAGING, V10, P903, DOI 10.1002/(SICI)1522-2586(199912)10:6<903::AID-JMRI1>3.0.CO;2-A; Turetschek K, 2003, EUR J NUCL MED MOL I, V30, P448, DOI 10.1007/s00259-002-1000-5; vanDijke CF, 1996, RADIOLOGY, V198, P813, DOI 10.1148/radiology.198.3.8628876; Wang ZH, 2001, MAGN RESON IMAGING, V19, P1063, DOI 10.1016/S0730-725X(01)00431-3; Wood JM, 2000, CANCER RES, V60, P2178	51	46	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8727	10.1371/journal.pone.0008727	http://dx.doi.org/10.1371/journal.pone.0008727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090952	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714900008
J	Priyadarshini, D; Gadia, RR; Tripathy, A; Gurukumar, KR; Bhagat, A; Patwardhan, S; Mokashi, N; Vaidya, D; Shah, PS; Cecilia, D				Priyadarshini, D.; Gadia, Rajesh R.; Tripathy, Anuradha; Gurukumar, K. R.; Bhagat, Asha; Patwardhan, Sampada; Mokashi, Nitin; Vaidya, Dhananjay; Shah, Paresh S.; Cecilia, D.			Clinical Findings and Pro-Inflammatory Cytokines in Dengue Patients in Western India: A Facility-Based Study	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; HEMORRHAGIC-FEVER; VIRUS-INFECTION; TNF-ALPHA; IMMUNE ACTIVATION; INTERFERON-GAMMA; RISK-FACTORS; CHILDREN; SEVERITY	Background: Descriptions of dengue immunopathogenesis have largely relied on data from South-east Asia and America, while India is poorly represented. This study characterizes dengue cases from Pune, Western India, with respect to clinical profile and pro-inflammatory cytokines. Methodology/Principal Findings: In 2005, 372 clinically suspected dengue cases were tested by MAC-ELISA and RT-PCR for dengue virus (DENV) aetiology. The clinical profile was recorded at the hospital. Circulating levels of IFN-gamma, TNF-alpha, IL-6, and IL-8 were assessed by ELISA and secondary infections were defined by IgM to IgG ratio. Statistical analysis was carried out using the SPSS 11.0 version. Of the 372 individuals, 221 were confirmed to be dengue cases. Three serotypes, DENV-1, 2 and 3 were co-circulating and one case of dual infection was identified. Of 221 cases, 159 presented with Dengue fever (DF) and 62 with Dengue hemorrhagic fever (DHF) of which six had severe DHF and one died of shock. There was a strong association of rash, abdominal pain and conjunctival congestion with DHF. Levels of IFN-gamma were higher in DF whereas IL-6 and IL-8 were higher in DHF cases (p<0.05). The mean levels of the three cytokines were higher in secondary compared to primary infections. Levels of IFN-gamma and IL-8 were higher in early samples collected 2-5 days after onset than late samples collected 6-15 days after onset. IFN-gamma showed significant decreasing time trend (p = 0.005) and IL-8 levels showed increasing trend towards significance in DHF cases (interaction p = 0.059). There was a significant association of IL-8 levels with thrombocytopenia and both IFN-gamma and IL-8 were positively associated with alanine transaminase levels. Conclusions/Significance: Rash, abdominal pain and conjunctival congestion could be prognostic symptoms for DHF. High levels of IL-6 and IL-8 were shown to associate with DHF. The time trend of IFN-gamma and IL-8 levels had greater significance than absolute values in DHF pathogenesis.	[Priyadarshini, D.; Tripathy, Anuradha; Gurukumar, K. R.; Bhagat, Asha; Shah, Paresh S.; Cecilia, D.] Natl Inst Virol, Pune, Maharashtra, India; [Gadia, Rajesh R.] King Edward Mem Hosp Women, Dept Gen Med, Pune, Maharashtra, India; [Patwardhan, Sampada] Deenanath Mangeshkar Hosp, Dept Microbiol, Pune, Maharashtra, India; [Mokashi, Nitin] Yashwant Rao Chauhan Mem Hosp, Dept Microbiol, Pune, Maharashtra, India; [Vaidya, Dhananjay] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Johns Hopkins University; Johns Hopkins Medicine	Priyadarshini, D (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	cdayaraj@niv.co.in	Vaidya, Dhananjay/AAL-5684-2020	Vaidya, Dhananjay/0000-0002-7164-1601	Indian Council of Medical Research; Indian Council of Medical Research (ICMR); Council of Scientific and Industrial Research (CSIR), Government of India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Indian Council of Medical Research: www.icmr.org.in. Fellowship grants provided to D. Priyadarshini by Indian Council of Medical Research (ICMR) and to K. R. Gurukumar by Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avirutnan P, 1998, J IMMUNOL, V161, P6338; Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Chakravarti A, 2006, INDIAN J MED RES, V123, P25; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x; Chen RF, 2005, FEMS IMMUNOL MED MIC, V44, P43, DOI 10.1016/j.femsim.2004.11.012; CONCEICAO TM, 2009, J INFECT        1015; Dar L, 1999, EMERG INFECT DIS, V5, P589, DOI 10.3201/eid0504.990427; Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Gomber S, 2001, Indian Pediatr, V38, P477; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Gupta R, 2009, IMMUNOL INVEST, V38, P240, DOI 10.1080/08820130902766563; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638; Halstead Scott B., 2008, V5, P285; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Huang YH, 2000, AM J TROP MED HYG, V63, P71, DOI 10.4269/ajtmh.2000.63.71; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Iyngkaran N., 1995, Singapore Medical Journal, V36, P218; Juffrie M, 2001, AM J TROP MED HYG, V65, P70, DOI 10.4269/ajtmh.2001.65.70; Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000; Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Malavige GN, 2006, QJM-INT J MED, V99, P299, DOI 10.1093/qjmed/hcl039; Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019; Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I; Rothman AL, 2009, ANN NY ACAD SCI, V1171, pE36, DOI 10.1111/j.1749-6632.2009.05055.x; SABIN AB, 1952, AM J TROP MED HYG, V1, P363; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Sathish N, 2002, INDIAN J MED RES, V115, P31; Saxena P, 2006, DENGUE B, V30, P283; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Suwandono A, 2006, T ROY SOC TROP MED H, V100, P855, DOI 10.1016/j.trstmh.2005.11.010; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Wali J P, 1999, J Assoc Physicians India, V47, P203; Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5; WHO.,, 2012, DENGUE DENGUE HEMORR; Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680; Wilder-Smith A, 2005, EPIDEMIOL INFECT, V133, P667, DOI 10.1017/S0950268805003821; World Health Organization, 1999, WHO LAB MAN EX HUM S, P11	50	99	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8709	10.1371/journal.pone.0008709	http://dx.doi.org/10.1371/journal.pone.0008709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090849	Green Published, Green Submitted, gold			2022-12-25	WOS:000273714600012
J	Putheti, P; Awasthi, A; Popoola, J; Gao, WD; Strom, TB				Putheti, Prabhakar; Awasthi, Amit; Popoola, Joyce; Gao, Wenda; Strom, Terry B.			Human CD4(+) Memory T Cells Can Become CD4(+)IL-9(+) T Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IL-9 EXPRESSION; TGF-BETA; TRANSCRIPTION FACTOR; HELPER-CELLS; MAST-CELLS; DIFFERENTIATION; INDUCTION; PHENOTYPE; CYTOKINES	Background: IL-9 is a growth factor for T- and mast-cells that is secreted by human Th2 cells. We recently reported that IL-(4+) TGF-beta directs mouse CD4(+)CD25(-)CD62L(+) T cells to commit to inflammatory IL-9 producing CD4(+) T cells. Methodology/Principal Findings: Here we show that human inducible regulatory T cells (iTregs) also express IL-9. IL-4+TGF-beta induced higher levels of IL-9 expression in plate bound-anti-CD3 mAb (pbCD3)/soluble-anti-CD28 mAb (sCD28) activated human resting memory CD4(+)CD25(-)CD45RO(+) T cells as compared to naive CD4(+)CD25(-)CD45RA(+) T cells. In addition, as compared to pbCD3/sCD28 plus TGF-beta stimulation, IL-4(+)TGF-beta stimulated memory CD4(+)D25(-)CD45RO(+) T cells expressed reduced FOXP3 protein. As analyzed by pre-amplification boosted single-cell real-time PCR, human CD4(+)IL-9(+)T cells expressed GATA3 and RORC, but not IL-10, IL-13, IFN gamma or IL-17A/F. Attempts to optimize IL-9 production by pbCD3/sCD28 and IL-4+TGF-beta stimulated resting memory CD4(+) T cells demonstrated that the addition of IL-1 beta, IL-12, and IL-21 further enhance IL-9 production. Conclusions/Significance: Taken together these data show both the differences and similarities between mouse and human CD4(+)IL9(+) T cells and reaffirm the powerful influence of inflammatory cytokines to shape the response of activated CD4(+) T cells to antigen.	[Putheti, Prabhakar; Popoola, Joyce; Gao, Wenda; Strom, Terry B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Transplant Inst, Boston, MA 02215 USA; [Awasthi, Amit] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Putheti, P (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Transplant Inst, Boston, MA 02215 USA.	tstrom@bidmc.harvard.edu	Strom, Terry B./E-9268-2010; Popoola, Joyce/AAP-8481-2020	Strom, Terry B./0000-0002-7570-0736; Popoola, Joyce/0000-0002-3114-3501	Juvenile Diabetes Research Foundation [7-2005-1329]; National Institute of Health [5P01 A1041521-1]; Medical Research Council [G0600698B] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the grants to Terry B. Strom from the Juvenile Diabetes Research Foundation grant 7-2005-1329 and National Institute of Health grant 5P01 A1041521-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Gounni AS, 2000, J ALLERGY CLIN IMMUN, V106, P460, DOI 10.1067/mai.2000.109172; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; HOUSSIAU FA, 1995, J IMMUNOL, V154, P2624; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; Jarnicki AG, 2003, CURR OPIN PHARMACOL, V3, P449, DOI 10.1016/S1471-4892(03)00077-8; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; SCHMITT E, 1994, J IMMUNOL, V153, P3989; SCHMITT E, 1991, J IMMUNOL, V147, P3848; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Voo K., 2009, P NATL ACAD SCI US; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	21	46	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8706	10.1371/journal.pone.0008706	http://dx.doi.org/10.1371/journal.pone.0008706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090929	Green Accepted, Green Published, gold			2022-12-25	WOS:000273714600009
J	Kolliker, M; Ridenhour, BJ; Gaba, S				Koelliker, Mathias; Ridenhour, Benjamin J.; Gaba, Sabrina			Antagonistic Parent-Offspring Co-Adaptation	PLOS ONE			English	Article							BEGGING INTENSITY; MATERNAL-CARE; CONFLICT; SELECTION; SOLICITATION; EVOLUTION; MODELS; NEED	Background: In species across taxa, offspring have means to influence parental investment (PI). PI thus evolves as an interacting phenotype and indirect genetic effects may strongly affect the co-evolutionary dynamics of offspring and parental behaviors. Evolutionary theory focused on explaining how exaggerated offspring solicitation can be understood as resolution of parent-offspring conflict, but the evolutionary origin and diversification of different forms of family interactions remains unclear. Methodology/Principal Findings: In contrast to previous theory that largely uses a static approach to predict how "offspring individuals'' and "parental individuals'' should interact given conflict over PI, we present a dynamic theoretical framework of antagonistic selection on the PI individuals obtain/take as offspring and the PI they provide as parents to maximize individual lifetime reproductive success; we analyze a deterministic and a stochastic version of this dynamic framework. We show that a zone for equivalent co-adaptation outcomes exists in which stable levels of PI can evolve and be maintained despite fast strategy transitions and ongoing co-evolutionary dynamics. Under antagonistic co-adaptation, cost-free solicitation can evolve as an adaptation to emerging preferences in parents. Conclusions/Significance: We show that antagonistic selection across the offspring and parental life-stage of individuals favors co-adapted offspring and parental behavior within a zone of equivalent outcomes. This antagonistic parent-offspring co-adaptation does not require solicitation to be costly, allows for rapid divergence and evolutionary novelty and potentially explains the origin and diversification of the observed provisioning forms in family life.	[Koelliker, Mathias] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Ridenhour, Benjamin J.] Univ Idaho, Dept Biol, Moscow, ID 83843 USA; [Gaba, Sabrina] INRA, Biol & Gest Adventices UMR1210, F-21034 Dijon, France	University of Basel; Idaho; University of Idaho; INRAE	Kolliker, M (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	mathias.koelliker@unibas.ch	Gaba, Sabrina/H-5240-2018; Gaba, Sabrina/N-8428-2013	Gaba, Sabrina/0000-0002-7145-6713; Gaba, Sabrina/0000-0002-7145-6713; Ridenhour, Benjamin/0000-0001-8271-4629	Swiss National Science Foundation [PP00A-119190]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was financially supported by the Swiss National Science Foundation (grant no. PP00A-119190 to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; BATESON P, 1994, TRENDS ECOL EVOL, V9, P399, DOI 10.1016/0169-5347(94)90066-3; Cheverud James M., 1994, P67; CHEVERUD JM, 1984, EVOLUTION, V38, P766, DOI 10.1111/j.1558-5646.1984.tb00349.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Dobler R, 2009, ANIM BEHAV, V77, P1427, DOI 10.1016/j.anbehav.2009.02.013; Dor R, 2009, EVOLUTION, V63, P738, DOI 10.1111/j.1558-5646.2008.00598.x; FELDMAN MW, 1982, AM NAT, V119, P285, DOI 10.1086/283909; Godfray HCJ, 2000, PHILOS T ROY SOC B, V355, P1581, DOI 10.1098/rstb.2000.0719; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Grodzinski U, 2007, P R SOC B, V274, P2449, DOI 10.1098/rspb.2007.0658; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Horn AG, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P127, DOI 10.1007/0-306-47660-6_7; HOULE D, 1992, GENETICS, V130, P195; Karasov WH, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P199, DOI 10.1007/0-306-47660-6_11; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kolliker M, 2005, AM NAT, V166, P506, DOI 10.1086/491687; Kolliker M, 2000, P ROY SOC B-BIOL SCI, V267, P2127, DOI 10.1098/rspb.2000.1259; Kolliker M, 2006, P ROY SOC B-BIOL SCI, V273, P1523, DOI 10.1098/rspb.2006.3475; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Linksvayer TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000994; LYNCH M, 1987, P NATL ACAD SCI USA, V84, P8507, DOI 10.1073/pnas.84.23.8507; Lynch M., 1998, GENETICS ANAL QUANTI; Mas F, 2008, ANIM BEHAV, V76, P1121, DOI 10.1016/j.anbehav.2008.06.011; Mas F, 2009, P R SOC B, V276, P2847, DOI 10.1098/rspb.2009.0498; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Mock D. W., 1997, EVOLUTION SIBLING RI; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Parker GA, 2002, ECOL LETT, V5, P206, DOI 10.1046/j.1461-0248.2002.00301.x; PARKER GA, 1978, ANIM BEHAV, V26, P97, DOI 10.1016/0003-3472(78)90009-X; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Payne RJH, 1998, J THEOR BIOL, V195, P273, DOI 10.1006/jtbi.1998.0798; Price K, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P21, DOI 10.1007/0-306-47660-6_2; Qvarnstrom A, 2007, P R SOC B, V274, P1003, DOI 10.1098/rspb.2006.0255; Rodriguez-Girones MA, 1998, P NATL ACAD SCI USA, V95, P4453, DOI 10.1073/pnas.95.8.4453; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns S.C., 1992, pi; Taylor PD, 2004, P ROY SOC B-BIOL SCI, V271, P669, DOI 10.1098/rspb.2003.2636; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wade MJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P5; Wagner A., 2005, ROBUSTNESS EVOLVABIL; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wilson AJ, 2005, EVOLUTION, V59, P451; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; WOLFRAM S, 1999, MATHEMATICA; [No title captured]	52	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8606	10.1371/journal.pone.0008606	http://dx.doi.org/10.1371/journal.pone.0008606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066041	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000273338600024
J	Yoshida, T; Zhang, HF; Iwase, T; Shen, JK; Semenza, GL; Campochiaro, PA				Yoshida, Tsunehiko; Zhang, Huafeng; Iwase, Takeshi; Shen, Jikui; Semenza, Gregg L.; Campochiaro, Peter A.			Digoxin inhibits retinal ischemia-induced HIF-1 alpha expression and ocular neovascularization	FASEB JOURNAL			English	Article						age-related macular degeneration; angiogenesis; cardiac glycosides; diabetic retinopathy	ENDOTHELIAL GROWTH-FACTOR; SUPPRESSES CHOROIDAL NEOVASCULARIZATION; HYPOXIA-INDUCIBLE FACTOR-1; KINASE INHIBITOR; PROLIFERATIVE RETINOPATHY; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; IN-VIVO; VEGF; ANGIOGENESIS	Digoxin and other cardiac glycosides inhibit hypoxia-inducible factor-1 (HIF-1) transcriptional activity in cultured cells and suppress tumor xenograft growth. We tested the hypothesis that digoxin reduces HIF-1 levels in ischemic tissue in vivo and suppresses neovascularization. Well-established murine models of ocular neovascularization were used to test our hypothesis. In mice with ischemic retinopathy, intraocular or intraperitoneal injection of digoxin markedly reduced retinal levels of HIF-1 alpha protein and mRNAs encoding multiple hypoxia-regulated proangiogenic proteins and their receptors. Daily intraperitoneal injection of 2 mg/kg starting at postnatal day (P) 12 or a single intravitreous injection of 100 ng of digoxin at P12 reduced retinal neovascularization by >70% at P17. Digoxin also reduced the number of CXCR4(+) cells and F4/80(+) macrophages in ischemic retina and significantly reduced choroidal neovascularization at Bruch's membrane rupture sites. Digoxin suppresses retinal and choroidal neovascularization by reducing HIF-1 alpha levels, which blocks several proangiogenic pathways. Since digoxin suppresses multiple pathways in addition to VEGF signaling, it may provide advantages over specific VEGF antagonists for treatment of patients with retinal and choroidal diseases complicated by neovascularization and/or excessive vascular permeability. It may also be useful for treatment of neovascular diseases in other tissues.-Yoshida, T., Zhang, H., Iwase, T., Shen, J., Semenza, G. L., Campochiaro, P. A. Digoxin inhibits retinal ischemia-induced HIF-1 alpha expression and ocular neovascularization. FASEB J. 24, 1759-1767 (2010). www.fasebj.org	[Yoshida, Tsunehiko; Iwase, Takeshi; Shen, Jikui; Campochiaro, Peter A.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Yoshida, Tsunehiko; Iwase, Takeshi; Shen, Jikui; Campochiaro, Peter A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zhang, Huafeng; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Zhang, Huafeng; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Campochiaro, PA (corresponding author), Wilmer Eye Inst, 719 Maumenee,600 N Wolfe St, Baltimore, MD 21287 USA.	gsemenza@jhmi.edu; pcampo@jhmi.edu	Zhang, Huafeng/A-7188-2012; Iwase, Takeshi/H-8110-2015		U.S. National Institutes of Health/National Eye Institute [EY012609]; Johns Hopkins Institute for Cell Engineering; NATIONAL EYE INSTITUTE [R01EY012609] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Johns Hopkins Institute for Cell Engineering; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health/National Eye Institute grant EY012609 (P.A.C.) and the Johns Hopkins Institute for Cell Engineering (G.L.S.) G.L.S. is the C. Michael Armstrong Professor of Johns Hopkins University. P.A.C. is the George and Dolores Eccles Professor of Ophthalmology and Neuroscience.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; Boyer DS, 2009, INVEST OPHTHALMOL VI; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; COUSINS SW, 2009, INVEST OPHTHALMOL VI; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Doukas J, 2008, J CELL PHYSIOL, V216, P29, DOI 10.1002/jcp.21426; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Hackett SF, 2000, J CELL PHYSIOL, V184, P275, DOI 10.1002/1097-4652(200009)184:3<275::AID-JCP1>3.3.CO;2-Z; Hackett SF, 2002, J CELL PHYSIOL, V192, P182, DOI 10.1002/jcp.10128; Jo N, 2006, AM J PATHOL, V168, P2036, DOI 10.2353/ajpath.2006.050588; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Okamoto N, 1997, AM J PATHOL, V151, P281; Oshima Y, 2005, FASEB J, V19, P963, DOI 10.1096/fj.04-2209fje; Oshima Y, 2004, J CELL PHYSIOL, V199, P412, DOI 10.1002/jcp.10442; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Patel TH, 2005, CARDIOVASC RES, V68, P144, DOI 10.1016/j.cardiores.2005.05.002; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Seo MS, 1999, AM J PATHOL, V154, P1743, DOI 10.1016/S0002-9440(10)65430-2; Seo MS, 2000, AM J PATHOL, V157, P995, DOI 10.1016/S0002-9440(10)64612-3; Shen JK, 2007, INVEST OPHTH VIS SCI, V48, P4335, DOI 10.1167/iovs.07-0113; Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Takahashi K, 2009, ARCH OPHTHALMOL-CHIC, V127, P494, DOI 10.1001/archophthalmol.2009.27; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Vinores SA, 2006, J CELL PHYSIOL, V206, P749, DOI 10.1002/jcp.20525; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; Xie B, 2009, J CELL PHYSIOL, V218, P192, DOI 10.1002/jcp.21588; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	46	91	105	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1759	1767		10.1096/fj.09-145664	http://dx.doi.org/10.1096/fj.09-145664			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20065104	Green Published			2022-12-25	WOS:000278200000013
J	Chakraborty, S; Mitra, S; Falk, MM; Caplan, SH; Wheelock, MJ; Johnson, KR; Mehta, PP				Chakraborty, Souvik; Mitra, Shalini; Falk, Matthias M.; Caplan, Steve H.; Wheelock, Margaret J.; Johnson, Keith R.; Mehta, Parmender P.			E-cadherin Differentially Regulates the Assembly of Connexin43 and Connexin32 into Gap Junctions in Human Squamous Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND PDZ DOMAIN; PROTEIN CONNEXIN-43; ZONULA OCCLUDENS-1; PLASMA-MEMBRANE; TRAFFICKING; COMMUNICATION; ORGANIZATION; INTERACTS; CHANNELS; ADHESION	It is as yet unknown how the assembly of connexins (Cx) into gap junctions (GJ) is initiated upon cell-cell contact. We investigated whether the trafficking and assembly of Cx43 and Cx32 into GJs were contingent upon cell-cell adhesion mediated by E-cadherin. We also examined the role of the carboxyl termini of these Cxs in initiating the formation of GJs. Using cadherin and Cx-null cells, and by introducing Cx43 and Cx32, either alone or in combination with E-cadherin, our studies demonstrated that E-cadherin-mediated cell-cell adhesion was neither essential nor sufficient to initiate GJ assembly de novo in A431D human squamous carcinoma cells. However, E-cadherin facilitated the growth and assembly of preformed GJs composed of Cx43, although the growth of cells on Transwell filters was required to initiate the assembly of Cx32. Our results also documented that the carboxyl termini of both Cxs were required in this cell type to initiate the formation of GJs de novo. Our findings also showed that GJ puncta composed of Cx43 co-localized extensively with ZO-1 and actin fibers at cell peripheries and that ZO-1 knockdown attenuated Cx43 assembly. These findings suggest that the assembly of Cx43 and Cx32 into GJs is differentially modulated by E-cadherin-mediated cell-cell adhesion and that direct or indirect cross-talk between carboxyl tails of Cxs and actin cytoskeleton via ZO-1 may regulate GJ assembly and growth.	[Chakraborty, Souvik; Mitra, Shalini; Caplan, Steve H.; Wheelock, Margaret J.; Johnson, Keith R.; Mehta, Parmender P.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol,Eppley Canc Ctr, Omaha, NE 68105 USA; [Falk, Matthias M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	University of Nebraska System; University of Nebraska Medical Center; Lehigh University	Mehta, PP (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol,Eppley Canc Ctr, Omaha, NE 68105 USA.	pmehta@unmc.edu			National Institutes of Health [RO-1 CA113903, RO-1DE12308, RO-1GM074876]; Department of Defense [PC081198]; Nebraska State [LB506]; Nebraska Center for Cellular Signaling; NATIONAL CANCER INSTITUTE [R01CA113903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Nebraska State; Nebraska Center for Cellular Signaling; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO-1 CA113903 (to P. P. M.), RO-1DE12308 (to K. R. J.), and RO-1GM074876 (to S. H. C.). This work was also supported by Department of Defense Grant PC081198 and Nebraska State Grant LB506 (to P. P. M.) and the Nebraska Center for Cellular Signaling graduate fellowship (to S. M. and S. C.).	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Bavamian Sabine, 2009, P511, DOI 10.1007/978-1-59745-489-6_26; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; Crespin Sophie, 2009, P529, DOI 10.1007/978-1-59745-489-6_27; Duffy HS, 2007, J BIOL CHEM, V282, P9789, DOI 10.1074/jbc.M605261200; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; GOURDIE RG, 1991, J CELL SCI, V99, P41; Govindarajan R, 2002, J BIOL CHEM, V277, P50087, DOI 10.1074/jbc.M202652200; Hernandez-Blazquez FJ, 2001, EXP CELL RES, V270, P235, DOI 10.1006/excr.2001.5342; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Holm I, 1999, EUR J CELL BIOL, V78, P856, DOI 10.1016/S0171-9335(99)80087-9; Hunter AW, 2008, CELL COMMUN ADHES, V15, P55, DOI 10.1080/15419060802014370; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Johnson RG, 2002, EXP CELL RES, V275, P67, DOI 10.1006/excr.2002.5480; JONGEN WMF, 1991, J CELL BIOL, V114, P545, DOI 10.1083/jcb.114.3.545; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Jordan K, 2001, J CELL SCI, V114, P763; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kojima T, 2007, J MEMBRANE BIOL, V217, P13, DOI 10.1007/s00232-007-9021-4; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lauf U, 2001, FEBS LETT, V498, P11, DOI 10.1016/S0014-5793(01)02462-0; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mehta P, 1999, DEV GENET, V24, P91, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<91::AID-DVG10>3.0.CO;2-#; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; MEYER RA, 1992, J CELL BIOL, V119, P179, DOI 10.1083/jcb.119.1.179; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Mitra S, 2006, MOL BIOL CELL, V17, P5400, DOI 10.1091/mbc.E06-04-0280; Miyaguchi K, 2000, J STRUCT BIOL, V132, P169, DOI 10.1006/jsbi.2000.4244; Musil Linda S., 2009, P225, DOI 10.1007/978-1-59745-489-6_9; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; RUDNICKI JA, 1987, TERATOCARCINOMAS EMB, P19; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Solan Joell L., 2009, P263, DOI 10.1007/978-1-59745-489-6_11; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Sosinsky Gina E., 2009, P241, DOI 10.1007/978-1-59745-489-6_10; STAGG RB, 1990, ENDOCR REV, V11, P302, DOI 10.1210/edrv-11-2-302; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas T, 2001, CELL COMMUN ADHES, V8, P231, DOI 10.3109/15419060109080729; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; WANG YJ, 1995, J CELL SCI, V108, P3501; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135	68	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10761	10776		10.1074/jbc.M109.053348	http://dx.doi.org/10.1074/jbc.M109.053348			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20086013	Green Published, hybrid			2022-12-25	WOS:000276264600062
J	Thanongsaksrikul, J; Srimanote, P; Maneewatch, S; Choowongkomon, K; Tapchaisri, P; Makino, S; Kurazono, H; Chaicumpa, W				Thanongsaksrikul, Jeeraphong; Srimanote, Potjanee; Maneewatch, Santi; Choowongkomon, Kiattawee; Tapchaisri, Pramuan; Makino, Sou-ichi; Kurazono, Hisao; Chaicumpa, Wanpen			A VHH That Neutralizes the Zinc Metalloproteinase Activity of Botulinum Neurotoxin Type A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-DOMAIN ANTIBODY; HEAVY-CHAIN ANTIBODIES; LIGHT-CHAIN; FRAGMENTS; ENZYME; TOXIN; SUBSTRATE; CAMELIDAE; PROTEINS; PROTEASE	The current treatment of botulism is to administer animal-derived antitoxin, which frequently causes severe adverse reactions in the recipients. In this study, a heavy chain antibody fragment (VH/VHH) phage display library was constructed by amplification of the immunoglobulin genes of a nonimmune camel, Camelus dromedarius, using primers specific to human VH gene segments. A recombinant light chain of type A botulinumtoxin, BoTxA/LC, with zinc endoprotease activity was used in phage bio-panning to select phage clones displaying BoTxA/LC-bound VH/VHH. Soluble VH/VHH were produced and purified from 10 VH/VHH phagemid-transformed E. coli clones. Complementary determining regions (CDRs) and immunoglobulin frameworks (FRs) of the 10 camel VH/VHH-deduced amino acid sequences were determined. FR2 sequences of two clones showed a hallmark of camel VHH, i.e. (F/Y)(ER50)-E-42-R-49(G/F)(52). The remaining eight clones had an FR2 amino acid tetrad of conventional VH, i.e. V(42)G(49)L(50)W(52). VHH of one clone (V(H)H17) neutralized the SNAP25 hydrolytic activity of BoTxA/LC, whereas mouse polyclonal anti-BoTxA/LC did not have such activity. Mimotope sequences of V(H)H17 matched with the 194-206 amino acid residues of BoTxA/LC, which are located near the S'1 subsite of the catalytic cleft of the enzyme. Molecular docking revealed that CDR3 of the V(H)H17 bound to epitope in the toxin enzymatic cleft. Therefore, the BoTxA/LC neutralization by the V(H)H17 should be due to the VHH insertion into the enzymatic cleft of the toxin, which is usually inaccessible to a conventional antibody molecule. This antibody fragment warrants further development as a therapeutic agent for botulism.	[Srimanote, Potjanee; Chaicumpa, Wanpen] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok 10700, Thailand; [Thanongsaksrikul, Jeeraphong] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand; [Srimanote, Potjanee; Tapchaisri, Pramuan] Thammasat Univ, Fac Allied Hlth Sci, Grad Program, Pathum Thani 12120, Thailand; [Maneewatch, Santi] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok 10400, Thailand; [Choowongkomon, Kiattawee] Kasetsart Univ, Fac Sci, Dept Biochem, Bangkok 10900, Thailand; [Makino, Sou-ichi] Obihiro Univ Agr & Vet Med, Res Ctr Anim Hyg & Food Safety, Obihiro, Hokkaido 0808555, Japan; [Kurazono, Hisao] Obihiro Univ Agr & Vet Med, Dept Appl Vet Med & Publ Hlth, Obihiro, Hokkaido 0808555, Japan	Mahidol University; Mahidol University; Thammasat University; Mahidol University; Kasetsart University; Obihiro University of Agriculture & Veterinary Medicine; Obihiro University of Agriculture & Veterinary Medicine	Chaicumpa, W (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok 10700, Thailand.	tmwcc@mahidol.ac.th	Srimanote, Potjanee/W-2221-2019; maneewatchararangsri, santi/K-7898-2015; Thanongsaksrikul, Jeeraphong/AAF-5267-2020; choowongkomon, kiattawee/M-6528-2014	choowongkomon, kiattawee/0000-0002-2421-7859; Thanongsaksrikul, Jeeraphong/0000-0002-7238-9591	Commission on Higher Education (CHE), Ministry of Education, Thailand	Commission on Higher Education (CHE), Ministry of Education, Thailand(Office of Higher Education Commission (OHEC))	This work was supported by the Commission on Higher Education (CHE), Ministry of Education, Thailand.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; BINZ T, 1994, J BIOL CHEM, V269, P1617; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Conrath KE, 2003, DEV COMP IMMUNOL, V27, P87, DOI 10.1016/S0145-305X(02)00071-X; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ekong TAN, 1997, MICROBIOL-SGM, V143, P3337, DOI 10.1099/00221287-143-10-3337; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Joosten V, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-1; Koch-Nolte F, 2007, FASEB J, V21, P3490, DOI 10.1096/fj.07-8661com; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kulkeaw K, 2009, J PROTEOMICS, V72, P270, DOI 10.1016/j.jprot.2008.12.007; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lee J.O., 2008, BOTULINUM J, V1, P135, DOI [10.1504/TBJ.2008.018955, DOI 10.1504/TBJ.2008.018955]; Monegal A, 2009, PROTEIN ENG DES SEL, V22, P273, DOI 10.1093/protein/gzp002; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nguyen VK, 1998, J MOL BIOL, V275, P413, DOI 10.1006/jmbi.1997.1477; NOVOTNY J, 1991, MOL IMMUNOL, V28, P201, DOI 10.1016/0161-5890(91)90062-O; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; SUGIYAMA H, 1980, MICROBIOL REV, V44, P419, DOI 10.1128/MMBR.44.3.419-448.1980; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Thathaisong U, 2008, ASIAN PAC J ALLERGY, V26, P23; Transue TR, 1998, PROTEINS, V32, P515, DOI 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E	42	50	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9657	9666		10.1074/jbc.M109.073163	http://dx.doi.org/10.1074/jbc.M109.073163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093370	Green Published, hybrid			2022-12-25	WOS:000276165900039
J	Lucas, M; Gonzalez-Perez, B; Cabezas, M; Moncalian, G; Rivas, G; de la Cruz, F				Lucas, Maria; Gonzalez-Perez, Blanca; Cabezas, Matilde; Moncalian, Gabriel; Rivas, German; de la Cruz, Fernando			Relaxase DNA Binding and Cleavage Are Two Distinguishable Steps in Conjugative DNA Processing That Involve Different Sequence Elements of the nic Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CONJUGATION; PROTEIN TRWC; ORIGIN; RECOGNITION; MECHANISM; PURIFICATION; TERMINATION; INITIATION; ORIT	TrwC, the relaxase of plasmid R388, catalyzes a series of concerted DNA cleavage and strand transfer reactions on a specific site (nic) of its origin of transfer (oriT). nic contains the cleavage site and an adjacent inverted repeat (IR2). Mutation analysis in the nic region indicated that recognition of the IR2 proximal arm and the nucleotides located between IR2 and the cleavage site were essential for supercoiled DNA processing, as judged either by in vitro nic cleavage or by mobilization of a plasmid containing oriT. Formation of the IR2 cruciform and recognition of the distal IR2 arm and loop were not necessary for these reactions to take place. On the other hand, IR2 was not involved in TrwC single-stranded DNA processing in vitro. For single-stranded DNA nic cleavage, TrwC recognized a sequence embracing six nucleotides upstream of the cleavage site and two nucleotides downstream. This suggests that TrwC DNA binding and cleavage are two distinguishable steps in conjugative DNA processing and that different sequence elements are recognized by TrwC in each step. IR2-proximal arm recognition was crucial for the initial supercoiled DNA binding. Subsequent recognition of the adjacent single-stranded DNA binding site was required to position the cleavage site in the active center of the protein so that the nic cleavage reaction could take place.	[Lucas, Maria; Gonzalez-Perez, Blanca; Cabezas, Matilde; Moncalian, Gabriel; de la Cruz, Fernando] Univ Cantabria, Dept Biol Mol, Santander 39011, Spain; [Lucas, Maria; Gonzalez-Perez, Blanca; Cabezas, Matilde; Moncalian, Gabriel; de la Cruz, Fernando] CSIC, Inst Biomed & Biotecnol Cantabria, UC IDICAN, Santander 39011, Spain; [Rivas, German] CSIC, Ctr Invest Biol, Madrid 28040, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	de la Cruz, F (corresponding author), Univ Cantabria, Dept Biol Mol, C Herrera Oria S-N, Santander 39011, Spain.	delacruz@unican.es	Rivas, German/AFL-7528-2022; Lucas, Maria/G-9788-2012; Moncalian, Gabriel/K-3493-2014; Rivas, German/AAG-7458-2022; de la Cruz, Fernando/L-2812-2014	Rivas, German/0000-0003-3450-7478; Lucas, Maria/0000-0002-7854-4249; Moncalian, Gabriel/0000-0002-3007-6490; Rivas, German/0000-0003-3450-7478; de la Cruz, Fernando/0000-0003-4758-6857	Spanish Ministry of Education [BFU2008-00995/BMC, CIT-010000-2008-4]	Spanish Ministry of Education(Spanish Government)	This work was supported by Spanish Ministry of Education Grants BFU2008-00995/BMC and CIT-010000-2008-4.	Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Becker EC, 2000, J MOL BIOL, V300, P1067, DOI 10.1006/jmbi.2000.3902; Boer R, 2006, J MOL BIOL, V358, P857, DOI 10.1016/j.jmb.2006.02.018; Datta S, 2003, STRUCTURE, V11, P1369, DOI 10.1016/j.str.2003.10.001; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Filutowicz M, 2008, PLASMID, V60, P38, DOI 10.1016/j.plasmid.2008.03.004; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; FUKUDA H, 1995, J BIOL CHEM, V270, P21319, DOI 10.1074/jbc.270.36.21319; GAO Q, 1994, MOL MICROBIOL, V11, P449, DOI 10.1111/j.1365-2958.1994.tb00326.x; Garcillan-Barcia MP, 2007, MOL MICROBIOL, V63, P404, DOI 10.1111/j.1365-2958.2006.05523.x; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gonzalez-Perez B, 2007, EMBO J, V26, P3847, DOI 10.1038/sj.emboj.7601806; Gonzalez-Perez Blanca, 2009, Biotechnology Journal, V4, P554, DOI 10.1002/biot.200800184; GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x; Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; Hekman K, 2008, NUCLEIC ACIDS RES, V36, P4565, DOI 10.1093/nar/gkn422; Jubete Y, 1996, J BIOL CHEM, V271, P30798, DOI 10.1074/jbc.271.48.30798; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; LLOSA M, 1995, J MOL BIOL, V246, P54, DOI 10.1006/jmbi.1994.0065; Llosa M, 2005, RES MICROBIOL, V156, P1, DOI 10.1016/j.resmic.2004.07.008; LLOSA M, 1994, J BACTERIOL, V176, P3210, DOI 10.1128/jb.176.11.3210-3217.1994; LLOSA M, 1991, MOL GEN GENET, V226, P473, DOI 10.1007/BF00260661; Llosa M, 1996, J MOL BIOL, V264, P56, DOI 10.1006/jmbi.1996.0623; Lujan SA, 2007, P NATL ACAD SCI USA, V104, P12282, DOI 10.1073/pnas.0702760104; MARTINEZ E, 1988, MOL GEN GENET, V211, P320, DOI 10.1007/BF00330610; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; MINTON AP, 1994, MODERN ANAL ULTRACEN; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Parker C, 2005, PLASMID, V53, P113, DOI 10.1016/j.plasmid.2004.12.007; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; Potts RG, 2008, FUTURE MICROBIOL, V3, P119, DOI 10.2217/17460913.3.2.119; REYGERS U, 1991, EMBO J, V10, P2689, DOI 10.1002/j.1460-2075.1991.tb07812.x; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; TRASK DK, 1984, EMBO J, V3, P671, DOI 10.1002/j.1460-2075.1984.tb01865.x; Williams SL, 2006, NUCLEIC ACIDS RES, V34, P426, DOI 10.1093/nar/gkj444; Zechner EL, 2000, HORIZONTAL GENE POOL	43	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8918	8926		10.1074/jbc.M109.057539	http://dx.doi.org/10.1074/jbc.M109.057539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20061574	Green Published, hybrid			2022-12-25	WOS:000275553700043
J	Song, JY; Han, HS; Sabapathy, K; Lee, BM; Yu, E; Choi, J				Song, Ji-young; Han, Hye-Sook; Sabapathy, Kanaga; Lee, Byung-Moo; Yu, Eunsil; Choi, Jene			Expression of a Homeostatic Regulator, Wip1 (Wild-type p53-induced Phosphatase), Is Temporally Induced by c-Jun and p53 in Response to UV Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; CELL-CYCLE; NH2-TERMINAL KINASE; PROTEIN PHOSPHATASE; INDUCED APOPTOSIS; PPM1D; ACTIVATION; PATHWAY; GENE; PHOSPHORYLATION	Wild-type p53-induced phosphatase (Wip1) is induced by p53 in response to stress, which results in the dephosphorylation of proteins (i.e. p38 MAPK, p53, and uracil DNA glycosylase) involved in DNA repair and cell cycle checkpoint pathways. p38 MAPK-p53 signaling is a unique way to induce Wip1 in response to stress. Here, we show that c-Jun directly binds to and activates the Wip1 promoter in response to UV irradiation. The binding of p53 to the promoter occurs earlier than that of c-Jun. In experiments, mutation of the p53 response element (p53RE) or c-Jun consensus sites reduced promoter activity in both non-stressed and stressed A549 cells. Overexpression of p53 significantly decreased Wip1 expression in HCT116 p53(+/+) cells but increased it in HCT116 p53(+/+) cells. Adenovirus-mediated p53 overexpression greatly decreased JNK activity. Upregulation of Wip1 via the p38 MAPK-p53 and JNK-c-Jun pathways is specific, as demonstrated by our findings that p38MAPK and JNK inhibitors affected the expression of the Wip1 protein, whereas an ERK inhibitor did not. c-Jun activation occurred much more quickly, and to a greater extent, in A549-E6 cells than in A549 cells, with delayed but fully induced Wip1 expression. These data indicate that Wip1 is activated via both the JNK-c-Jun and p38 MAPK-p53 signaling pathways and that temporal induction of Wip1 depends largely on the balance between c-Jun and p53, which compete for JNK binding. Moreover, our results suggest that JNK-c-Jun-mediated Wip1 induction could serve as a major signaling pathway in human tumors in response to frequent p53 mutation.	[Song, Ji-young; Han, Hye-Sook; Yu, Eunsil; Choi, Jene] Univ Ulsan, Coll Med, Dept Pathol, Seoul 138736, South Korea; [Song, Ji-young] Univ Ulsan, Asan Med Ctr, Asan Inst Life Sci, Seoul 138736, South Korea; [Sabapathy, Kanaga] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore; [Lee, Byung-Moo] Dongguk Univ Seoul, Dept Life Sci, Seoul 100715, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; National Cancer Centre Singapore (NCCS); Dongguk University	Choi, J (corresponding author), Univ Ulsan, Coll Med, Dept Pathol, 388-1 Pungnap 2 Dong, Seoul 138736, South Korea.	jenec@amc.seoul.kr			National Research Foundation of Korea [2007-E00111, 2009-0081016]; Korean government; Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea [A062254]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government); Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Grants 2007-E00111 and 2009-0081016 from the National Research Foundation of Korea and the Korean government. This research was also supported by Grant A062254 from the Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Buschmann T, 2000, CANCER RES, V60, P896; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Choi J, 2000, GENOMICS, V64, P298, DOI 10.1006/geno.2000.6134; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gong XF, 2006, EXP MOL MED, V38, P428, DOI 10.1038/emm.2006.50; Han HS, 2009, MOL CANCER RES, V7, P713, DOI 10.1158/1541-7786.MCR-08-0247; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lo PK, 2004, CANCER RES, V64, P8736, DOI 10.1158/0008-5472.CAN-04-2584; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Rossi M, 2008, NUCLEIC ACIDS RES, V36, P7168, DOI 10.1093/nar/gkn888; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shklyaev SS, 2001, ANTICANCER RES, V21, P2569; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Xia Y, 2009, J BIOL CHEM, V284, P17428, DOI 10.1074/jbc.M109.007823; Xue Y, 2003, MOL CARCINOGEN, V36, P38, DOI 10.1002/mc.10096; Yu E, 2007, BREAST CANCER RES TR, V101, P269, DOI 10.1007/s10549-006-9304-y	41	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9067	9076		10.1074/jbc.M109.070003	http://dx.doi.org/10.1074/jbc.M109.070003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093361	Green Published, hybrid			2022-12-25	WOS:000275553700057
J	Baranova, IN; Bocharov, AV; Vishnyakova, TG; Kurlander, R; Chen, ZG; Fu, D; Arias, IM; Csako, G; Patterson, AP; Eggerman, TL				Baranova, Irina N.; Bocharov, Alexander V.; Vishnyakova, Tatyana G.; Kurlander, Roger; Chen, Zhigang; Fu, Dong; Arias, Irwin M.; Csako, Gyorgy; Patterson, Amy P.; Eggerman, Thomas L.			CD36 Is a Novel Serum Amyloid A (SAA) Receptor Mediating SAA Binding and SAA-induced Signaling in Human and Rodent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; INTERLEUKIN-8 GENE-EXPRESSION; ARTHRITIS SYNOVIAL TISSUE; CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; B SCAVENGER RECEPTOR; N-TERMINAL KINASE; RHEUMATOID-ARTHRITIS; A-PROTEIN	Serum amyloid A (SAA) is a major acute phase protein involved in multiple physiological and pathological processes. This study provides experimental evidence that CD36, a phagocyte class B scavenger receptor, functions as a novel SAA receptor mediating SAA proinflammatory activity. The uptake of Alexa Fluor (R) 488 SAA as well as of other well established CD36 ligands was increased 5-10-fold in HeLa cells stably transfected with CD36 when compared with mock-transfected cells. Unlike other apolipoproteins that bind to CD36, only SAA induced a 10-50-fold increase of interleukin-8 secretion in CD36-overexpressing HEK293 cells when compared with control cells. SAA-mediated effects were thermolabile, inhibitable by anti-SAA antibody, and also neutralized by association with high density lipoprotein but not by association with bovine serum albumin. SAA-induced cell activation was inhibited by a CD36 peptide based on the CD36 hexarelin-binding site but not by a peptide based on the thrombospondin-1-binding site. A pronounced reduction (up to 60-75%) of SAA- induced pro-inflammatory cytokine secretion was observed in cd36(-/-) rat macrophages and Kupffer cells when compared with wild type rat cells. The results of the MAPK phosphorylation assay as well as of the studies with NF-kappa B and MAPK inhibitors revealed that two MAPKs, JNK and to a lesser extent ERK1/2, primarily contribute to elevated cytokine production in CD36-overexpressing HEK293 cells. In macrophages, four signaling pathways involving NF-kappa B and three MAPKs all appeared to contribute to SAA-induced cytokine release. These observations indicate that CD36 is a receptor mediating SAA binding and SAA- induced pro-inflammatory cytokine secretion predominantly through JNK- and ERK1/2-mediated signaling.	[Baranova, Irina N.; Bocharov, Alexander V.; Vishnyakova, Tatyana G.; Kurlander, Roger; Chen, Zhigang; Csako, Gyorgy; Patterson, Amy P.; Eggerman, Thomas L.] NIDDK, Dept Lab Med, Ctr Clin, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Fu, Dong; Arias, Irwin M.] NIDDK, Cell Biol & Metab Branch, NICHD, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Patterson, Amy P.] NIDDK, Off Biotechnol Activ, Off Sci Policy, Off Director,NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Eggerman, Thomas L.] NIDDK, Div Diabet Endocrinol & Metab Dis, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bocharov, AV (corresponding author), 9 Mem Dr,Room 1W115,MSC 0919, Bethesda, MD 20892 USA.	abocharov@mail.cc.nih.gov; Eggermant@niddk.nih.gov	Fu, Dong/J-1426-2012	Fu, Dong/0000-0002-6865-5033	National Institutes of Health Intramural Research Programs of the Clinical Center; NIDDK; NIAID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008807] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Programs of the Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Programs of the Clinical Center, NIDDK, and NIAID.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BENSON MD, 1979, ARTHRITIS RHEUM, V22, P36, DOI 10.1002/art.1780220106; Bocharov AV, 2004, J BIOL CHEM, V279, P36072, DOI 10.1074/jbc.M314264200; Brandenburg LO, 2007, J NEUROCHEM, V101, P718, DOI 10.1111/j.1471-4159.2006.04351.x; Cabana VG, 2004, J LIPID RES, V45, P317, DOI 10.1194/jlr.M300414-JLR200; Calvo D, 1998, J LIPID RES, V39, P777; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Charles-Schoeman C, 2008, CLIN IMMUNOL, V127, P234, DOI 10.1016/j.clim.2008.01.016; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Cunnane G, 2000, J RHEUMATOL, V27, P58; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Demers A, 2004, BIOCHEM J, V382, P417, DOI 10.1042/BJ20040036; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Ebeling P, 1999, DIABETOLOGIA, V42, P1433, DOI 10.1007/s001250051315; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; FAIRWELL T, 1987, P NATL ACAD SCI USA, V84, P4796, DOI 10.1073/pnas.84.14.4796; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Fyfe AI, 1997, CIRCULATION, V96, P2914, DOI 10.1161/01.CIR.96.9.2914; Garber DW, 2001, J LIPID RES, V42, P545; Gon Y, 2004, AM J RESP CELL MOL, V31, P330, DOI 10.1165/rcmb.2003-0438OC; GREENWALT DE, 1992, BLOOD, V80, P1105; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Gupta H, 2005, CIRC RES, V97, P236, DOI 10.1161/01.RES.0000176530.66400.48; Haffner SM, 2000, AM J CARDIOL, V85, P1395, DOI 10.1016/S0002-9149(00)00784-0; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; HUSEBEKK A, 1987, SCAND J IMMUNOL, V25, P375, DOI 10.1111/j.1365-3083.1987.tb02203.x; Jimenez B, 2001, ONCOGENE, V20, P3443, DOI 10.1038/sj.onc.1204464; Jousilahti P, 2001, ATHEROSCLEROSIS, V156, P451, DOI 10.1016/S0021-9150(00)00681-X; Kinkley SM, 2006, AMYLOID, V13, P123, DOI 10.1080/13506120600877201; KISILEVSKY R, 1992, LAB INVEST, V66, P778; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; Kruger AL, 2005, CIRCULATION, V111, P3126, DOI 10.1161/CIRCULATIONAHA.104.517102; Kumon Y, 1999, J RHEUMATOL, V26, P785; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; KUSHNER I, 1994, BAILLIERE CLIN RHEUM, V8, P513, DOI 10.1016/S0950-3579(05)80113-X; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Leinonen ES, 2004, J INTERN MED, V256, P119, DOI 10.1111/j.1365-2796.2004.01350.x; Lepper PM, 2005, CELL MICROBIOL, V7, P519, DOI 10.1111/j.1462-5822.2005.00482.x; Liang JS, 1997, NEUROSCI LETT, V225, P73, DOI 10.1016/S0304-3940(97)00196-1; LIANG JS, 1995, J LIPID RES, V36, P37; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; MAURY CPJ, 1982, ANN RHEUM DIS, V41, P268, DOI 10.1136/ard.41.3.268; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; MERRIFIELD RB, 1969, J AMER MED ASSOC, V210, P1247, DOI 10.1001/jama.210.7.1247; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nanjee MN, 2000, J LIPID RES, V41, P1317; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; O'Brien KD, 2005, ARTERIOSCL THROM VAS, V25, P785, DOI 10.1161/01.ATV.0000158383.65277.2b; O'Hara R, 2000, ARTHRITIS RES, V2, P142, DOI 10.1186/ar78; Patel H, 1998, SCAND J IMMUNOL, V48, P410; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; Schulthess G, 2000, BIOCHEMISTRY-US, V39, P12623, DOI 10.1021/bi0011633; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; SLOOP CH, 1983, ATHEROSCLEROSIS, V49, P9, DOI 10.1016/0021-9150(83)90003-5; SMEDSROD B, 1985, CELL TISSUE RES, V241, P639; STEINMETZ A, 1989, BIOCHIM BIOPHYS ACTA, V1006, P173, DOI 10.1016/0005-2760(89)90192-6; Stonik JA, 2004, BIOCHEM BIOPH RES CO, V321, P936, DOI 10.1016/j.bbrc.2004.07.052; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; XU LL, 1995, J IMMUNOL, V155, P1184; Zaitseva E V, 1994, Biull Eksp Biol Med, V117, P268	93	74	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8492	8506		10.1074/jbc.M109.007526	http://dx.doi.org/10.1074/jbc.M109.007526			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075072	Green Published, hybrid			2022-12-25	WOS:000275413800064
J	Huang, WC; Zhau, HE; Chung, LWK				Huang, Wen-Chin; Zhau, Haiyen E.; Chung, Leland W. K.			Androgen Receptor Survival Signaling Is Blocked by Anti-beta 2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; FATTY-ACID SYNTHASE; GENE-EXPRESSION; GROWTH-FACTOR; KINASE-A; METABOLIC ONCOGENE; RAFT MICRODOMAINS; RESPONSE ELEMENT; BONE METASTASIS; BETA-2-MICROGLOBULIN	A new cis-acting element, sterol regulatory element-binding protein-1 (SREBP-1) binding site, within the 5'-flanking human androgen receptor (AR) promoter region and its binding transcription factor, SREBP-1, was identified to regulate AR transcription in AR-positive human prostate cancer cells. We further characterized the molecular mechanism by which a novel anti-beta 2-microglobulin monoclonal antibody (beta 2MmAb), shown to induce massive cell death in a number of human and mouse cancer cell lines, interrupted multiple cell signaling pathways in human prostate cancer cells. beta 2M mAb decreased AR expression through inactivation of MAPK and SREBP-1. By inactivation of MAPK, beta 2M mAb decreased prostate cancer cell proliferation and survival. By inhibition of SREBP-1, beta 2M mAb reduced fatty acid and lipid levels, an integral component of cell membrane, cell signaling mediators, and energy metabolism. These results provide for the first time a molecular link between the beta 2M intracellular signaling axis mediated by MAPK and SREBP-1 and involving lipid signaling, which collectively regulates AR expression and function. Antagonizing beta 2M by beta 2M mAb may be an effective therapeutic approach simultaneously targeting multiple downstream signaling pathways converging with MAPK, SREBP-1, and AR, important for controlling prostate cancer cell growth, survival, and progression.	[Huang, Wen-Chin; Zhau, Haiyen E.; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Huang, Wen-Chin; Zhau, Haiyen E.; Chung, Leland W. K.] Emory Univ, Sch Med, Mol Urol & Therapeut Program, Dept Urol, Atlanta, GA 30322 USA; [Huang, Wen-Chin; Zhau, Haiyen E.; Chung, Leland W. K.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Cedars Sinai Medical Center; Emory University; Emory University	Huang, WC (corresponding author), Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Samuel Oschin Comprehens Canc Inst, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	wen-chin.huang@cshs.org; leland.chung@cshs.org	Huang, Wen-Chin/X-5879-2019	Huang, Wen-Chin/0000-0003-2342-9099	National Institutes of Health [P01 CA98912]; Department of Defense [W81XWH-07-1-0172, W81XWH-08-1-0321]; Georgia Cancer Coalition-Cancer Research Awards; NATIONAL CANCER INSTITUTE [R01CA122602, P01CA098912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Georgia Cancer Coalition-Cancer Research Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA98912 (to L.W.K.C.). This work was also supported by Department of Defense Grants W81XWH-07-1-0172 (to L.W.K.C.) and W81XWH-08-1-0321 (to W.-C.H.) and Georgia Cancer Coalition-Cancer Research Awards (to W.-C. H.).	Abdul M, 2000, UROL ONCOL, V5, P168, DOI 10.1016/S1078-1439(00)00063-6; Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; BATAILLE R, 1988, CANCER INVEST, V6, P271, DOI 10.3109/07357908809080649; Brooke GN, 2009, CURR GENOMICS, V10, P18, DOI 10.2174/138920209787581307; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002; Chen LJ, 2009, CATAL COMMUN, V10, P981, DOI 10.1016/j.catcom.2008.12.047; Chung LWK, 2006, CLIN GENITOURIN CANC, V5, P162, DOI 10.3816/CGC.2006.n.034; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; CULIG Z, 1994, CANCER RES, V54, P5474; Devlin HL, 2009, CANCER LETT, V274, P177, DOI 10.1016/j.canlet.2008.06.007; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Di Vizio D, 2008, TUMORI J, V94, P633; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Fuhrman B, 2007, ATHEROSCLEROSIS, V195, pE108, DOI 10.1016/j.atherosclerosis.2007.06.025; Golias Ch., 2009, Experimental Oncology, V31, P3; Gross M, 2007, CLIN CANCER RES, V13, P1979, DOI 10.1158/1078-0432.CCR-06-1156; Havel PJ, 2000, P NUTR SOC, V59, P359, DOI 10.1017/S0029665100000410; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hobisch A, 1998, CANCER RES, V58, P4640; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Huang WC, 2008, CLIN CANCER RES, V14, P5341, DOI 10.1158/1078-0432.CCR-08-0793; Huang WC, 2006, CANCER RES, V66, P9108, DOI 10.1158/0008-5472.CAN-06-1996; Kasbohm EA, 2005, J BIOL CHEM, V280, P11583, DOI 10.1074/jbc.M414423200; Klein T, 1996, EUR J IMMUNOGENET, V23, P417, DOI 10.1111/j.1744-313X.1996.tb00132.x; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Menendez JA, 2005, J CELL BIOCHEM, V94, P1, DOI 10.1002/jcb.20310; MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77; Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Nomura T, 2007, J UROLOGY, V178, P292, DOI 10.1016/j.juro.2007.03.007; Nomura T, 2006, CLIN CANCER RES, V12, P7294, DOI 10.1158/1078-0432.CCR-06-2060; Oh HY, 2007, PROSTATE, V67, P1061, DOI 10.1002/pros.20593; Orio F, 2002, MOL CELL ENDOCRINOL, V198, P105, DOI 10.1016/S0303-7207(02)00374-X; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Swinnen JV, 2004, J STEROID BIOCHEM, V92, P273, DOI 10.1016/j.jsbmb.2004.10.013; Takane KK, 1996, MOL CELL ENDOCRINOL, V119, P83, DOI 10.1016/0303-7207(96)03800-2; Taplin ME, 2008, EXPERT REV ANTICANC, V8, P1495, DOI 10.1586/14737140.8.9.1495; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Tsimberidou AM, 2008, CLIN CANCER RES, V14, P721, DOI 10.1158/1078-0432.CCR-07-2063; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Wu JD, 2006, J CELL BIOCHEM, V99, P392, DOI 10.1002/jcb.20929; Yang J, 2006, CANCER CELL, V10, P295, DOI 10.1016/j.ccr.2006.08.025; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Yang L, 2003, BIOCHEM BIOPH RES CO, V305, P462, DOI 10.1016/S0006-291X(03)00792-7; Yang X, 2006, ONCOGENE, V25, P3436, DOI 10.1038/sj.onc.1209366; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; ZILLIACUS J, 1995, MOL ENDOCRINOL, V9, P389, DOI 10.1210/me.9.4.389	57	42	48	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7947	7956		10.1074/jbc.M109.092759	http://dx.doi.org/10.1074/jbc.M109.092759			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071336	Green Published, hybrid			2022-12-25	WOS:000275413800012
J	Govind, G; Mittapalli, O; Griebel, T; Allmann, S; Bocker, S; Baldwin, IT				Govind, Geetha; Mittapalli, Omprakash; Griebel, Thasso; Allmann, Silke; Boecker, Sebastian; Baldwin, Ian Thomas			Unbiased Transcriptional Comparisons of Generalist and Specialist Herbivores Feeding on Progressively Defenseless Nicotiana attenuata Plants	PLOS ONE			English	Article							MANDUCA-SEXTA LEPIDOPTERA; TRYPSIN PROTEINASE-INHIBITOR; SUGAR-TRANSPORT PROTEINS; COLORADO POTATO BEETLES; LARGE-SCALE CHANGES; MOLECULAR-INTERACTIONS; TOBACCO HORNWORM; JASMONIC ACID; MICROARRAY ANALYSIS; MEDIATED DEFENSES	Background: Herbivore feeding elicits dramatic increases in defenses, most of which require jasmonate (JA) signaling, and against which specialist herbivores are thought to be better adapted than generalist herbivores. Unbiased transcriptional analyses of how neonate larvae cope with these induced plant defenses are lacking. Methodology/Principal Findings: We created cDNA microarrays for Manduca sexta and Heliothis virescens separately, by spotting normalized midgut-specific cDNA libraries created from larvae that fed for 24 hours on MeJA-elicited wild-type (WT) Nicotiana attenuata plants. These microarrays were hybridized with labeled probes from neonates that fed for 24 hours on WT and isogenic plants progressively silenced in JA-mediated defenses (N: nicotine; N/PI: N and trypsin protease inhibitors; JA: all JA-mediated defenses). H. virescens neonates regulated 16 times more genes than did M. sexta neonates when they fed on plants silenced in JA-mediated defenses, and for both species, the greater the number of defenses silenced in the host plant (JA. N/PI. N), the greater were the number of transcripts regulated in the larvae. M. sexta larvae tended to down-regulate while H. virescens larvae up-and down-regulated transcripts from the same functional categories of genes. M. sexta larvae regulated transcripts in a diet-specific manner, while H. virescens larvae regulated a similar suite of transcripts across all diet types. Conclusions/Significance: The observations are consistent with the expectation that specialists are better adapted than generalist herbivores to the defense responses elicited in their host plants by their feeding. While M. sexta larvae appear to be better adapted to N. attenuata's defenses, some of the elicited responses remain effective defenses against both herbivore species. The regulated genes provide novel insights into larval adaptations to N. attenuata's induced defenses, and represent potential targets for plant-mediated RNAi to falsify hypotheses about the process of adaptation.	[Govind, Geetha; Mittapalli, Omprakash; Allmann, Silke; Baldwin, Ian Thomas] Max Planck Inst Chem Ecol, Jena, Germany; [Griebel, Thasso; Boecker, Sebastian] Univ Jena, Fac Math & Comp Sci, Jena, Germany	Max Planck Society; Friedrich Schiller University of Jena	Govind, G (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	baldwin@ice.mpg.de	Govind, Geetha/AAB-3203-2021; Baldwin, Ian T/K-1809-2013; Allmann, Silke/Q-6522-2017	Govind, Geetha/0000-0003-0450-0814; Allmann, Silke/0000-0001-6300-3741; Baldwin, Ian/0000-0001-5371-2974; Bocker, Sebastian/0000-0002-9304-8091	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funding: This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JE, 2004, INSECT MOL BIOL, V13, P649, DOI 10.1111/j.0962-1075.2004.00523.x; Alborn HT, 2003, J CHEM ECOL, V29, P1357, DOI 10.1023/A:1024209302628; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; APPEL HM, 1992, ECOLOGY, V73, P216, DOI 10.2307/1938733; BALDWIN IT, 1994, J CHEM ECOL, V20, P2345, DOI 10.1007/BF02033207; Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; Berenbaum MR, 2001, ANN MO BOT GARD, V88, P45, DOI 10.2307/2666131; Bezzerides A, 2004, P NATL ACAD SCI USA, V101, P9029, DOI 10.1073/pnas.0402480101; BIRK Y, 2003, PLANT PROTEASE INHIB, P170; BROADWAY RM, 1995, J INSECT PHYSIOL, V41, P107, DOI 10.1016/0022-1910(94)00101-L; Broadway RM, 1996, ARCH INSECT BIOCHEM, V32, P39, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;39::AID-ARCH3&gt;3.0.CO;2-S; Brunelle F, 2004, ARCH INSECT BIOCHEM, V55, P103, DOI 10.1002/arch.10135; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cloutier C, 2000, ARCH INSECT BIOCHEM, V44, P69, DOI 10.1002/1520-6327(200006)44:2&lt;69::AID-ARCH2&gt;3.0.CO;2-6; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Darwish SA, 2008, PLANT MOL BIOL REP, V26, P12, DOI 10.1007/s11105-008-0019-6; De Leo F, 1998, PLANT PHYSIOL, V118, P997, DOI 10.1104/pp.118.3.997; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Eisner T, 2000, P NATL ACAD SCI USA, V97, P1634, DOI 10.1073/pnas.030532797; EISNER T, 1995, P NATL ACAD SCI US, V92; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; Frey M, 2000, P NATL ACAD SCI USA, V97, P14801, DOI 10.1073/pnas.260499897; Gaquerel E, 2009, PLANT PHYSIOL, V149, P1408, DOI 10.1104/pp.108.130799; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Giri AP, 1998, PLANT PHYSIOL, V116, P393, DOI 10.1104/pp.116.1.393; Glendinning JI, 2002, ENTOMOL EXP APPL, V104, P15, DOI 10.1023/A:1021271717409; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Halitschke R, 2004, PLANT J, V40, P35, DOI 10.1111/j.1365-313X.2004.02185.x; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Hayashi K, 2002, APPL ENVIRON MICROB, V68, P4996, DOI 10.1128/AEM.68.10.4996-5004.2002; HEILING S, 2010, PLANT CELL IN PRESS; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Hermsmeier D, 2001, PLANT PHYSIOL, V125, P683, DOI 10.1104/pp.125.2.683; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hui DQ, 2003, PLANT PHYSIOL, V131, P1877, DOI 10.1104/pp.102.018176; Jansen JJ, 2009, METABOLOMICS, V5, P150, DOI 10.1007/s11306-008-0124-4; Jassbi AR, 2008, PLANT PHYSIOL, V146, P974, DOI 10.1104/pp.107.108811; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Kahl J, 2000, PLANTA, V210, P336, DOI 10.1007/PL00008142; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Karban R, 2002, ANNU REV ECOL SYST, V33, P641, DOI 10.1146/annurev.ecolsys.33.010802.150443; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kliebenstein D, 2002, GENETICS, V161, P325; Koo YD, 2008, INSECT MOL BIOL, V17, P235, DOI 10.1111/j.1365-2583.2008.00799.x; KRIEGER RI, 1971, SCIENCE, V172, P579, DOI 10.1126/science.172.3983.579; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Liu YL, 2004, INSECT BIOCHEM MOLEC, V34, P1069, DOI 10.1016/j.ibmb.2004.06.010; MA RL, 1994, ARCH BIOCHEM BIOPHYS, V310, P332, DOI 10.1006/abbi.1994.1175; MADDRELL SHP, 1976, J EXP BIOL, V64, P267; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mechaber WL, 2000, ANN ENTOMOL SOC AM, V93, P447, DOI 10.1603/0013-8746(2000)093[0447:NNSHRF]2.0.CO;2; Mitra S, 2008, PLANT PHYSIOL, V148, P1128, DOI 10.1104/pp.108.124354; MORRIS CE, 1984, J EXP ZOOL, V229, P361, DOI 10.1002/jez.1402290304; Mozoruk J, 2006, PLANT SCI, V170, P1068, DOI 10.1016/j.plantsci.2006.01.014; MURRAY CL, 1994, J NEUROBIOL, V25, P23, DOI 10.1002/neu.480250103; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; PARR JC, 1972, ANN ENTOMOL SOC AM, V65, P1185, DOI 10.1093/aesa/65.5.1185; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pohnert G, 1999, TETRAHEDRON, V55, P11275, DOI 10.1016/S0040-4020(99)00639-0; Rasmann S, 2009, CURR OPIN PLANT BIOL, V12, P473, DOI 10.1016/j.pbi.2009.05.005; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Rivard D, 2004, ARCH INSECT BIOCHEM, V55, P114, DOI 10.1002/arch.10136; ROSE RL, 1991, COMP BIOCHEM PHYS B, V99, P535, DOI 10.1016/0305-0491(91)90334-A; ROSENTHAL GA, 1982, SCIENCE, V217, P353, DOI 10.1126/science.217.4557.353; ROSENTHAL GA, 1978, SCIENCE, V202, P528, DOI 10.1126/science.202.4367.528; Sasabe M, 2004, GENE, V338, P163, DOI 10.1016/j.gene.2004.04.028; Schwachtje J, 2008, PLANT PHYSIOL, V146, P845, DOI 10.1104/pp.107.112490; SELF LS, 1964, J INSECT PHYSIOL, V10, P907, DOI 10.1016/0022-1910(64)90081-2; Simpson S.J., 1995, P251; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Skibbe M, 2008, PLANT CELL, V20, P1984, DOI 10.1105/tpc.108.058594; SNYDER MJ, 1993, J CHEM ECOL, V19, P2903, DOI 10.1007/BF00980591; Snyder MJ, 1996, J COMP PHYSIOL A, V179, P255, DOI 10.1007/BF00222792; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Steppuhn A, 2008, MOL ECOL, V17, P3717, DOI 10.1111/j.1365-294X.2008.03862.x; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; van Dam NM, 2008, PLANT SIGNAL BEHAV, V3, P91, DOI 10.4161/psb.3.2.5220; Voelckel C, 2004, ECOL LETT, V7, P770, DOI 10.1111/j.1461-0248.2004.00633.x; Voelckel C, 2001, CHEMOECOLOGY, V11, P121, DOI 10.1007/PL00001841; Vogel H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001081; WALDVOGEL M, 1990, EVOLUTION, V44, P1326, DOI 10.2307/2409292; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang L, 2008, PLANT PHYSIOL, V146, P904, DOI 10.1104/pp.107.109264; Wink M, 2002, CHEMOECOLOGY, V12, P29, DOI 10.1007/s00049-002-8324-2; Winterer J, 2001, MOL ECOL, V10, P1069, DOI 10.1046/j.1365-294X.2001.01239.x; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101; Zhu-Salzman K, 2003, INSECT MOL BIOL, V12, P135, DOI 10.1046/j.1365-2583.2003.00395.x	107	77	80	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8735	10.1371/journal.pone.0008735	http://dx.doi.org/10.1371/journal.pone.0008735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090945	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714900015
J	Zeiner, GM; Norman, KL; Thomson, JM; Hammond, SM; Boothroyd, JC				Zeiner, Gusti M.; Norman, Kara L.; Thomson, J. Michael; Hammond, Scott M.; Boothroyd, John C.			Toxoplasma gondii Infection Specifically Increases the Levels of Key Host MicroRNAs	PLOS ONE			English	Article							CELL-CYCLE ARREST; MIR-17-92 CLUSTER; EXPRESSION; MODULATION; ACTIVATION; APOPTOSIS; DISEASE; GROWTH; ROLES	Background: The apicomplexan parasite Toxoplasma gondii can infect and replicate in virtually any nucleated cell in many species of warm-blooded animals; thus, it has evolved the ability to exploit well-conserved biological processes common to its diverse hosts. Here we have investigated whether Toxoplasma modulates the levels of host microRNAs ( miRNAs) during infection. Methodology/Principal Findings: Using microarray profiling and a combination of conventional molecular approaches we report that Toxoplasma specifically modulates the expression of important host microRNAs during infection. We show that both the primary transcripts for miR-17 similar to 92 and miR-106b similar to 25 and the pivotal miRNAs that are derived from miR-17 similar to 92 display increased abundance in Toxoplasma-infected primary human cells; a Toxoplasma-dependent up-regulation of the miR-17 similar to 92 promoter is at least partly responsible for this increase. The abundance of mature miR-17 family members, which are derived from these two miRNA clusters, remains unchanged in host cells infected with the closely related apicomplexan Neospora caninum; thus, the Toxoplasma-induced increase in their abundance is a highly directed process rather than a general host response to infection. Conclusions/Significance: Altered levels of miR-17 similar to 92 and miR-106b similar to 25 are known to play crucial roles in mammalian cell regulation and have been implicated in numerous hyperproliferative diseases although the mechanisms driving their altered expression are unknown. Hence, in addition to the implications of these findings on the host-pathogen interaction, Toxoplasma may represent a powerful probe for understanding the normal mechanisms that regulate the levels of key host miRNAs.	[Zeiner, Gusti M.; Norman, Kara L.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Thomson, J. Michael; Hammond, Scott M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Hammond, Scott M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zeiner, GM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu		Zeiner, Gusti/0000-0001-7815-5588; Boothroyd, John C./0000-0001-9719-745X	NIH [5F32AI066538, 5R01GM070674, AI21423, A173756]; Alberta Heritage Foundation; American Cancer Society [PF-05-152-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021423, R01AI073756, R01AI021423, F32AI066538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070674] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: G. M. Z. was supported by the NIH (5F32AI066538). K. L. N was supported by the Alberta Heritage Foundation for Medical Research postdoctoral fellowship. J.M.T. was supported by the American Cancer Society (PF-05-152-01). S. M. H. was supported by the NIH (5R01GM070674). J.C.B. was supported by the NIH (AI21423 and A173756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Brunet J, 2008, CELL MICROBIOL, V10, P908, DOI 10.1111/j.1462-5822.2007.01093.x; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; DUBEY JP, 1988, J AM VET MED ASSOC, V192, P1269; DVORAK JA, 1981, SCIENCE, V214, P1034, DOI 10.1126/science.7029713; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Lavine MD, 2009, MOL BIOCHEM PARASIT, V164, P95, DOI 10.1016/j.molbiopara.2008.11.014; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Molestina RE, 2008, CELL MICROBIOL, V10, P1153, DOI 10.1111/j.1462-5822.2008.01117.x; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Persson EK, 2007, J IMMUNOL, V179, P8357, DOI 10.4049/jimmunol.179.12.8357; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Phelps ED, 2008, INFECT IMMUN, V76, P4703, DOI 10.1128/IAI.01447-07; PULVERTAFT RJV, 1964, LANCET, V1, P238; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Sarnow P, 2006, NAT REV MICROBIOL, V4, P651, DOI 10.1038/nrmicro1473; Sundermann CA, 1999, INT J PARASITOL, V29, P1725, DOI 10.1016/S0020-7519(99)00114-9; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027	41	72	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8742	10.1371/journal.pone.0008742	http://dx.doi.org/10.1371/journal.pone.0008742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090903	gold, Green Published			2022-12-25	WOS:000273714900022
J	Liao, W; Zhang, ZQ; Pan, ZY; Mantini, D; Ding, JR; Duan, XJ; Luo, C; Lu, GM; Chen, HF				Liao, Wei; Zhang, Zhiqiang; Pan, Zhengyong; Mantini, Dante; Ding, Jurong; Duan, Xujun; Luo, Cheng; Lu, Guangming; Chen, Huafu			Altered Functional Connectivity and Small-World in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							DEFAULT-MODE; RESTING-STATE; HUMAN BRAIN; CINGULATE CORTEX; NEURAL NETWORKS; LOW-FREQUENCY; FMRI; EEG; ATTENTION; MRI	Background: The functional architecture of the human brain has been extensively described in terms of functional connectivity networks, detected from the low-frequency coherent neuronal fluctuations that can be observed in a resting state condition. Little is known, so far, about the changes in functional connectivity and in the topological properties of functional networks, associated with different brain diseases. Methodology/Principal Findings: In this study, we investigated alterations related to mesial temporal lobe epilepsy (mTLE), using resting state functional magnetic resonance imaging on 18 mTLE patients and 27 healthy controls. Functional connectivity among 90 cortical and subcortical regions was measured by temporal correlation. The related values were analyzed to construct a set of undirected graphs. Compared to controls, mTLE patients showed significantly increased connectivity within the medial temporal lobes, but also significantly decreased connectivity within the frontal and parietal lobes, and between frontal and parietal lobes. Our findings demonstrated that a large number of areas in the default-mode network of mTLE patients showed a significantly decreased number of connections to other regions. Furthermore, we observed altered small-world properties in patients, along with smaller degree of connectivity, increased n-to-1 connectivity, smaller absolute clustering coefficients and shorter absolute path length. Conclusions/Significance: We suggest that the mTLE alterations observed in functional connectivity and topological properties may be used to define tentative disease markers.	[Liao, Wei; Pan, Zhengyong; Ding, Jurong; Duan, Xujun; Luo, Cheng; Chen, Huafu] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Zhang, Zhiqiang; Lu, Guangming] Nanjing Univ, Dept Med Imaging, Nanjing Jinling Hosp, Sch Clin,Med Coll, Nanjing 210008, Peoples R China; [Mantini, Dante] Univ G dAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Mantini, Dante] Univ G DAnnunzio, Dept Clin Sci & Bioimaging, Chieti, Italy; [Mantini, Dante] Katholieke Univ Leuven, Sch Med, Lab Neuropsychophysiol, Louvain, Belgium	University of Electronic Science & Technology of China; Nanjing University; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; KU Leuven	Liao, W (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	cjr.luguangming@vip.163.com; chenhf@uestc.edu.cn	Mantini, Dante/D-6989-2014; Luo, Cheng/A-4647-2015; Mantini, Dante/H-3061-2011	Mantini, Dante/0000-0001-6485-5559; Luo, Cheng/0000-0003-0524-5886; 	Natural Science Foundation of China [90820006, 30770590, 30470510, 30800264]; New Century Excellent Talents in University; MOE [107097]; 863 Program [2008AA02Z408]; Flanders Research Foundation (F.W.O.)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); MOE(Ministry of Higher Education & Scientific Research (MHESR)); 863 Program(National High Technology Research and Development Program of China); Flanders Research Foundation (F.W.O.)(FWO)	WL, HC, ZP, JD and CL were supported by the Natural Science Foundation of China, Grant Nos. 90820006 and 30770590, by the New Century Excellent Talents in University, by the Key research project of science and technology of MOE (107097) and by the 863 Program No: 2008AA02Z408. ZZ and GL were supported by the Natural Science Foundation of China, Grant No. 30470510 and 30800264. DM was supported by the Flanders Research Foundation (F.W.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2001, CLIN NEUROPHYSIOL, V112, P1746, DOI 10.1016/S1388-2457(01)00591-0; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Benar CG, 2002, NEUROIMAGE, V17, P1182, DOI 10.1006/nimg.2002.1164; Bernhardt BC, 2008, NEUROIMAGE, V42, P515, DOI 10.1016/j.neuroimage.2008.04.261; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gotman J, 2006, J MAGN RESON IMAGING, V23, P906, DOI 10.1002/jmri.20577; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kobayashi E, 2006, EPILEPSIA, V47, P343, DOI 10.1111/j.1528-1167.2006.00427.x; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Liu YH, 2008, J NEUROL SCI, V268, P117, DOI 10.1016/j.jns.2007.11.019; Lopez L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036107; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Perlbarg V, 2007, MAGN RESON IMAGING, V25, P35, DOI 10.1016/j.mri.2006.09.042; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wendling F, 2003, BRAIN, V126, P1449, DOI 10.1093/brain/awg144; WU J, 1998, CHIN J RADIOL, P224; WU JW, 1998, CHIN J RADIOL, V32, P220; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	66	376	387	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8525	10.1371/journal.pone.0008525	http://dx.doi.org/10.1371/journal.pone.0008525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072616	Green Submitted, Green Published, gold			2022-12-25	WOS:000273414200005
J	Kawabata, D; Venkatesh, J; Ramanujam, M; Davidson, A; Grimaldi, CM; Diamond, B				Kawabata, Daisuke; Venkatesh, Jeganathan; Ramanujam, Meera; Davidson, Anne; Grimaldi, Christine M.; Diamond, Betty			Enhanced Selection of High Affinity DNA-Reactive B Cells Following Cyclophosphamide Treatment in Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CUTTING EDGE; BAFF; TOLERANCE; AUTOANTIBODY; INDUCTION; DEPLETION; SURVIVAL; SLE; LYMPHOCYTES	A major goal for the treatment of patients with systemic lupus erythematosus with cytotoxic therapies is the induction of long-term remission. There is, however, a paucity of information concerning the effects of these therapies on the reconstituting B cell repertoire. Since there is recent evidence suggesting that B cell lymphopenia might attenuate negative selection of autoreactive B cells, we elected to investigate the effects of cyclophosphamide on the selection of the re-emerging B cell repertoire in wild type mice and transgenic mice that express the H chain of an anti-DNA antibody. The reconstituting B cell repertoire in wild type mice contained an increased frequency of DNA-reactive B cells; in heavy chain transgenic mice, the reconstituting repertoire was characterized by an increased frequency of mature, high affinity DNA-reactive B cells and the mice expressed increased levels of serum anti-DNA antibodies. This coincided with a significant increase in serum levels of BAFF. Treatment of transgene-expressing mice with a BAFF blocking agent or with DNase to reduce exposure to autoantigen limited the expansion of high affinity DNA-reactive B cells during B cell reconstitution. These studies suggest that during B cell reconstitution, not only is negative selection of high affinity DNA-reactive B cells impaired by increased BAFF, but also that B cells escaping negative selection are positively selected by autoantigen. There are significant implications for therapy.	[Kawabata, Daisuke; Venkatesh, Jeganathan; Ramanujam, Meera; Davidson, Anne; Grimaldi, Christine M.; Diamond, Betty] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA	Northwell Health	Kawabata, D (corresponding author), Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA.	bdiamond@nshs.edu		Davidson, Anne/0000-0002-4081-6464	NIAID; NIAMS; Arthritis Foundation (Daisuke Kawabata); SLE Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049938] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation (Daisuke Kawabata); SLE Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from NIAID (Anne Davidson) NIAMS (Christine M Grimaldi and Betty Diamond), a fellowship from the Arthritis Foundation (Daisuke Kawabata) and Career Development Awards from the SLE Foundation (Jeganathan Venkatesh and Meera Ramanujam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Ait-Azzouzene D, 2006, EUR J IMMUNOL, V36, P985, DOI 10.1002/eji.200535581; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Austin HA, 1997, J RHEUMATOL, V24, P61; BAKER D, 1987, INT J IMMUNOPHARMACO, V9, P175; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; BOUMPAS DT, 1995, ANN INTERN MED, V122, P940, DOI 10.7326/0003-4819-122-12-199506150-00009; Bynoe MS, 2000, P NATL ACAD SCI USA, V97, P2703, DOI 10.1073/pnas.040577497; Cambridge G, 2008, ANN RHEUM DIS, V67, P1011, DOI 10.1136/ard.2007.079418; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Eisenberg R, 2006, NAT CLIN PRACT RHEUM, V2, P20, DOI 10.1038/ncprheum0042; Grimaldi CM, 2006, J IMMUNOL, V176, P2703, DOI 10.4049/jimmunol.176.5.2703; Hemendinger RA, 1996, IMMUNOPHARMACOLOGY, V35, P71, DOI 10.1016/0162-3109(96)00124-5; Hondowicz BD, 2007, INT IMMUNOL, V19, P465, DOI 10.1093/intimm/dxm011; Leandro MJ, 2005, RHEUMATOLOGY, V44, P1542, DOI 10.1093/rheumatology/kei080; Looney R. John, 2005, V8, P193; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Macanovic M, 1996, CLIN EXP IMMUNOL, V106, P243, DOI 10.1046/j.1365-2249.1996.d01-839.x; OFFEN D, 1992, P NATL ACAD SCI USA, V89, P8332, DOI 10.1073/pnas.89.17.8332; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ray SK, 1996, P NATL ACAD SCI USA, V93, P2019, DOI 10.1073/pnas.93.5.2019; Rolink AG, 2002, CURR OPIN IMMUNOL, V14, P266, DOI 10.1016/S0952-7915(02)00332-1; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Seror R, 2007, ANN RHEUM DIS, V66, P351, DOI 10.1136/ard.2006.057919; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Venkatesh J, 2006, J IMMUNOL, V176, P3311, DOI 10.4049/jimmunol.176.6.3311; Verthelyi D, 1998, LUPUS, V7, P223, DOI 10.1191/096120398678920037; Vlachoyiannopoulos PG, 2008, J RHEUMATOL, V35, P1768; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907	33	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8418	10.1371/journal.pone.0008418	http://dx.doi.org/10.1371/journal.pone.0008418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066044	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338600002
J	Ishii, S; Yano, T; Ebihara, A; Okamoto, A; Manzoku, M; Hayashi, H				Ishii, Seiji; Yano, Takato; Ebihara, Akio; Okamoto, Akihiro; Manzoku, Miho; Hayashi, Hideyuki			Crystal Structure of the Peptidase Domain of Streptococcus ComA, a Bifunctional ATP-binding Cassette Transporter Involved in the Quorum-sensing Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; BIOFILM FORMATION; GENE-EXPRESSION; COMMUNICATION; PROTEINS; BACTERIA; SYSTEM; CRYSTALLOGRAPHY; SPECIFICITY; RECOGNITION	ComA of Streptococcus is a member of the bacteriocin-associated ATP-binding cassette transporter family and is postulated to be responsible for both the processing of the propeptide ComC and secretion of the mature quorum-sensing signal. The 150-amino acid peptidase domain (PEP) of ComA specifically recognizes an extended region of ComC that is 15 amino acids in length. It has been proposed that an amphipathic alpha-helix formed by the N-terminal leader region of ComC, as well as the Gly-Gly motif at the cleavage site, is critical for the PEP-ComC interaction. To elucidate the substrate recognition mechanism, we determined the three-dimensional crystal structure of Streptococcus mutans PEP and then constructed models for the PEP.ComC complexes. PEP had an overall structure similar to the papain-like cysteine proteases as has long been predicted. The active site was located at the bottom of a narrow cleft, which is suitable for binding the Gly-Gly motif. Together with the results from mutational experiments, a shallow hydrophobic concave surface of PEP was proposed as a site that accommodates the N-terminal helix of ComC. This dual mode of substrate recognition would provide the small PEP domain with an extremely high substrate specificity.	[Ishii, Seiji; Yano, Takato; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan; [Ebihara, Akio; Manzoku, Miho] Harima Inst, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Okamoto, Akihiro] Tokai Univ, Dept Biol Sci & Technol, Shizuoka 4100395, Japan; [Ebihara, Akio] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan	Osaka Medical College; RIKEN; Tokai University; Gifu University	Hayashi, H (corresponding author), Osaka Med Coll, Dept Biochem, 2-7 Daigakumachi, Osaka 5698686, Japan.	hayashi@art.osaka-med.ac.jp	Ebihara, Akio/AAI-6155-2020	Ebihara, Akio/0000-0002-1763-9084	Japan Society for the Promotion of Science [19570141]; Osaka Medical Research Foundation for Incurable Diseases	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Medical Research Foundation for Incurable Diseases	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (Category C Grant 19570141 to S. I.) and a grant from the Osaka Medical Research Foundation for Incurable Diseases (to T. Y.)	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CCPR, 1994, ACTA CRYSTALLOGR D, V50, P760; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cvitkovitch DG, 2003, J CLIN INVEST, V112, P1626, DOI 10.1172/JCI200320430; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gilmore KS, 2003, INFECT IMMUN, V71, P4759, DOI 10.1128/IAI.71.8.4759-4766.2003; Gould TA, 2004, MOL MICROBIOL, V53, P1135, DOI 10.1111/j.1365-2958.2004.04211.x; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishii S, 2006, J BIOL CHEM, V281, P4726, DOI 10.1074/jbc.M512516200; Jahan N, 2009, J MOL BIOL, V392, P763, DOI 10.1016/j.jmb.2009.07.042; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kleerebezem M, 2001, PEPTIDES, V22, P1579, DOI 10.1016/S0196-9781(01)00493-4; Kotake Y, 2008, BIOCHEMISTRY-US, V47, P2531, DOI 10.1021/bi702253n; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; Luo P, 2004, MOL MICROBIOL, V54, P172, DOI 10.1111/j.1365-2958.2004.04254.x; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petersen FC, 2004, J BACTERIOL, V186, P6327, DOI 10.1128/JB.186.18.6327-6331.2004; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; Raina S, 2009, BIOTECHNOL APPL BIOC, V54, P65, DOI 10.1042/BA20090072; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Watson WT, 2002, MOL CELL, V9, P685, DOI 10.1016/S1097-2765(02)00480-X; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Wu KH, 2004, J BIOL CHEM, V279, P901, DOI 10.1074/jbc.M308296200; YE Y, 2004, NUCLEIC ACIDS RES, V582, pW585; ZHANG YH, 1995, J CHEM PHYS, V103, P10252, DOI 10.1063/1.469927	47	40	42	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10777	10785		10.1074/jbc.M109.093781	http://dx.doi.org/10.1074/jbc.M109.093781			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20100826	hybrid, Green Published			2022-12-25	WOS:000276264600063
J	Fong, DH; Lemke, CT; Hwang, JY; Xiong, B; Berghuis, AM				Fong, Desiree H.; Lemke, Christopher T.; Hwang, Jiyoung; Xiong, Bing; Berghuis, Albert M.			Structure of the Antibiotic Resistance Factor Spectinomycin Phosphotransferase from Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; AMINOGLYCOSIDE PHOSPHOTRANSFERASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURES; CATALYTIC SUBUNIT; CHOLINE KINASE; BACTERIAL-RESISTANCE; NUCLEOTIDE-BINDING; KINETIC MECHANISM; PURIFICATION	Aminoglycoside phosphotransferases (APHs) constitute a diverse group of enzymes that are often the underlying cause of aminoglycoside resistance in the clinical setting. Several APHs have been extensively characterized, including the elucidation of the three-dimensional structure of two APH(3') isozymes and an APH(2 '') enzyme. Although many APHs are plasmid-encoded and are capable of inactivating numerous 2-deoxystreptmaine aminoglycosides with multiple regiospecificity, APH(9)-Ia, isolated from Legionella pneumophila, is an unusual enzyme among the APH family for its chromosomal origin and its specificity for a single non-2-deoxystreptamine aminoglycoside substrate, spectinomycin. We describe here the crystal structures of APH(9)-Ia in its apo form, its binary complex with the nucleotide, AMP, and its ternary complex bound with ADP and spectinomycin. The structures reveal that APH(9)-Ia adopts the bilobal protein kinase-fold, analogous to the APH(3') and APH(2 '') enzymes. However, APH(9)-Ia differs significantly from the other two types of APH enzymes in its substrate binding area and that it undergoes a conformation change upon ligand binding. Moreover, kinetic assay experiments indicate that APH(9)-Ia has stringent substrate specificity as it is unable to phosphorylate substrates of choline kinase or methylthioribose kinase despite high structural resemblance. The crystal structures of APH(9)-Ia demonstrate and expand our understanding of the diversity of the APH family, which in turn will facilitate the development of new antibiotics and inhibitors.	[Fong, Desiree H.; Hwang, Jiyoung; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Lemke, Christopher T.; Xiong, Bing; Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Berghuis, AM (corresponding author), Rm 466,Bellini Pavilion,3649 Promenade Sir Willia, Montreal, PQ H3G 0B1, Canada.	albert.berghuis@mcgill.ca	Berghuis, Albert M/A-6495-2008; Xiong, Bin/L-7560-2019; Xiong, Bing/B-8849-2008	Xiong, Bin/0000-0001-9776-8136; Xiong, Bing/0000-0001-9776-8136; Berghuis, Albert/0000-0002-2663-025X	Canadian Institutes of Health Research [MOP-13107]; Natural Sciences and Engineering Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-13107.; We thank Dr. Nicholas P. Cianciotto (Norwestern University Medical School, Chicago, IL) for providing the plasmid containing APH(9)-Ia, Dr. Michael Riscoe (VA Medical Center, Portland, OR) for providing the methylthioribose for alternative substrate analysis, and Dr. Clyde Smith (Stanford Synchrotron Radiation Laboratory, Stanford University, Menlo Park, CA) for early access to the coordinates of APH(2 '')-IIa. Beamline X8C at the NSLS-BNL, Upton, NY, was supported in part from the Natural Sciences and Engineering Council of Canada and the Canadian Institutes of Health Research.	Bastida A, 2006, J AM CHEM SOC, V128, P100, DOI 10.1021/ja0543144; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cheng YH, 2005, J AM CHEM SOC, V127, P1553, DOI 10.1021/ja0464084; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Daigle DM, 1997, J BIOL CHEM, V272, P24755, DOI 10.1074/jbc.272.40.24755; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Fong DH, 2009, ANTIMICROB AGENTS CH, V53, P3049, DOI 10.1128/AAC.00062-09; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Fridman M, 2003, ORG LETT, V5, P3575, DOI 10.1021/ol035213i; Gee P, 2003, BBA-PROTEINS PROTEOM, V1648, P33, DOI 10.1016/S1570-9639(03)00106-7; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; Hanessian S, 2007, BIOORG MED CHEM LETT, V17, P3221, DOI 10.1016/j.bmcl.2007.03.014; Hayward S, 2004, J MOL BIOL, V339, P1001, DOI 10.1016/j.jmb.2004.04.004; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kim KR, 2008, CURR MICROBIOL, V57, P371, DOI 10.1007/s00284-008-9204-y; Ku SY, 2007, J BIOL CHEM, V282, P22195, DOI 10.1074/jbc.M611045200; Ku SY, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-70; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemke CT, 2005, ACTA CRYSTALLOGR F, V61, P606, DOI 10.1107/S1744309105016301; Li J, 2005, ORG LETT, V7, P3061, DOI 10.1021/ol051045d; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MCKAY GA, 1995, J BIOL CHEM, V270, P24686, DOI 10.1074/jbc.270.42.24686; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Nakamura A, 2008, BIOSCI BIOTECH BIOCH, V72, P2467, DOI 10.1271/bbb.80285; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; Russell RJM, 2003, J AM CHEM SOC, V125, P3410, DOI 10.1021/ja029736h; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Sekowska A, 2001, BMC Microbiol, V1, P15, DOI 10.1186/1471-2180-1-15; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SIREGAR JJ, 1995, BIOCHEMISTRY-US, V34, P12681, DOI 10.1021/bi00039a026; SIREGAR JJ, 1994, ANTIMICROB AGENTS CH, V38, P641, DOI 10.1128/AAC.38.4.641; Suter TM, 1997, ANTIMICROB AGENTS CH, V41, P1385, DOI 10.1128/AAC.41.6.1385; Thapa LP, 2008, J APPL MICROBIOL, V105, P300, DOI 10.1111/j.1365-2672.2008.03788.x; Thompson PR, 1998, J BIOL CHEM, V273, P14788, DOI 10.1074/jbc.273.24.14788; Thompson PR, 1999, J BIOL CHEM, V274, P30697, DOI 10.1074/jbc.274.43.30697; Toledo LM, 1999, CURR MED CHEM, V6, P775; Toth M, 2007, BIOCHEMISTRY-US, V46, P5570, DOI 10.1021/bi6024512; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; WRIGHT GD, 1999, FRONT BIOSCI, V4, P9; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	61	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9545	9555		10.1074/jbc.M109.038364	http://dx.doi.org/10.1074/jbc.M109.038364			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089863	Green Published, hybrid			2022-12-25	WOS:000276165900028
J	Wei, SO; Kulp, SK; Chen, CS				Wei, Shuo; Kulp, Samuel K.; Chen, Ching-Shih			Energy Restriction as an Antitumor Target of Thiazolidinediones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; UNFOLDED PROTEIN RESPONSE; OVARIAN-CANCER CELLS; GLUCOSE-METABOLISM; CALORIE RESTRICTION; PROSTATE-CANCER; PHARMACOLOGICAL EXPLOITATION; EIF2-ALPHA PHOSPHORYLATION; AEROBIC GLYCOLYSIS; BETA-CATENIN	Cancer cells gain growth advantages in the microenvironment by shifting cellular metabolism to aerobic glycolysis, the so-called Warburg effect. There is a growing interest in targeting aerobic glycolysis for cancer therapy by exploiting the differential susceptibility of malignant versus normal cells to glycolytic inhibition, of which the proof-of-concept is provided by the in vivo efficacy of dietary caloric restriction and natural product-based energy restriction-mimetic agents (ERMAs) such as resveratrol and 2-deoxyglucose in suppressing carcinogenesis in animal models. Here, we identified thiazolidinediones as a novel class of ERMAs in that they elicited hallmark cellular responses characteristic of energy restriction, including transient induction of Sirt1 (silent information regulator 1) expression, activation of the intracellular fuel sensor AMP-activated protein kinase, and endoplasmic reticulum stress, the interplay among which culminated in autophagic and apoptotic death. The translational implications of this finding are multifold. First, the novel function of troglitazone and ciglitazone in targeting energy restriction provides a mechanistic basis to account for their peroxisome proliferator-activated receptor gamma-independent effects on a broad spectrum of signaling targets. Second, we demonstrated that Sirt1-mediated up-regulation of beta-transducin repeat-containing protein-facilitated proteolysis of cell cycle- and apoptosis-regulatory proteins is an energy restriction-elicited signaling event and is critical for the antitumor effects of ERMAs. Third, it provides a molecular rationale for using thiazolidinediones as scaffolds to develop potent ERMAs, of which the proof-of-principle is demonstrated by OSU-CG12. OSU-CG12, a peroxisome proliferator-activated receptor gamma-inactive ciglitazone derivative, exhibits 1- and 3-order of magnitude higher potency in eliciting starvation-like cellular responses relative to resveratrol and 2-deoxyglucose, respectively.	[Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem, 500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu			National Institutes of Health [CA112250]; Department of Defense Prostate Cancer Research Program [W81XWH-09-0198]; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Prostate Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112250. This work was also supported by Department of Defense Prostate Cancer Research Program Grant W81XWH-09-0198.	Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Clemens MJ, 2001, PROG MOLEC, V27, P57; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Faber AC, 2006, BIOCHEM PHARMACOL, V72, P1246, DOI 10.1016/j.bcp.2006.08.009; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Grommes C, 2004, LANCET ONCOL, V5, P419, DOI 10.1016/S1470-2045(04)01509-8; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hisatake J, 2000, CANCER RES, V60, P5494; Huang JW, 2006, J MED CHEM, V49, P4684, DOI 10.1021/jm060057h; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Jiang M, 2004, J CELL BIOCHEM, V91, P513, DOI 10.1002/jcb.10770; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kopelovich L, 2002, MOL CANCER THER, V1, P357; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; LIN AY, 1984, P NATL ACAD SCI-BIOL, V81, P988, DOI 10.1073/pnas.81.4.988; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Panchapakesan U, 2005, NAT CLIN PRACT NEPHR, V1, P33, DOI 10.1038/ncpneph0029; Park JB, 2001, J NAT PROD, V64, P381, DOI 10.1021/np000411t; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; Thompson JE, 2004, J CLIN ONCOL, V22, P4217, DOI 10.1200/jco.2004.01.103; Tsuchihara K, 2009, CANCER LETT, V278, P130, DOI 10.1016/j.canlet.2008.09.040; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Wei S, 2007, MOL PHARMACOL, V72, P725, DOI 10.1124/mol.107.035287; Wei S, 2009, MOL PHARMACOL, V76, P47, DOI 10.1124/mol.109.055376; Wei S, 2009, CANCER LETT, V276, P119, DOI 10.1016/j.canlet.2008.08.008; Weng JR, 2006, ENDOCR-RELAT CANCER, V13, P401, DOI 10.1677/erc.1.01182; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang CC, 2007, CANCER RES, V67, P3229, DOI 10.1158/0008-5472.CAN-06-2759; Yang J, 2008, J MED CHEM, V51, P2100, DOI 10.1021/jm701212m; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhu ZJ, 2005, CANCER RES, V65, P7023, DOI 10.1158/0008-5472.CAN-05-0453	63	66	70	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9780	9791		10.1074/jbc.M109.065466	http://dx.doi.org/10.1074/jbc.M109.065466			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093366	Green Published, hybrid			2022-12-25	WOS:000276165900050
J	De Donatis, GM; Singh, SK; Viswanathan, S; Maurizi, MR				De Donatis, Gian Marco; Singh, Satyendra K.; Viswanathan, Sarada; Maurizi, Michael R.			A Single ClpS Monomer Is Sufficient to Direct the Activity of the ClpA Hexamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; ADAPTER PROTEIN CLPS; SUBSTRATE-BINDING DOMAIN; ATP-DEPENDENT PROTEASES; SSRA-TAGGED PROTEINS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CHAPERONE CLPA; PORE LOOPS; DEGRADATION	ClpS is an adaptor protein that interacts with ClpA and promotes degradation of proteins with N-end rule degradation motifs (N-degrons) by ClpAP while blocking degradation of substrates with other motifs. Although monomeric ClpS forms a 1: 1 complex with an isolated N-domain of ClpA, only one molecule of ClpS binds with high affinity to ClpA hexamers (ClpA(6)). One or two additional molecules per hexamer bind with lower affinity. Tightly bound ClpS dissociates slowly from ClpA(6) with a t(1/2) of similar to 3 min at 37 degrees C. Maximum activation of degradation of the N-end rule substrate, LR-GFP(Venus), occurs with a single ClpS bound per ClpA(6); one ClpS is also sufficient to inhibit degradation of proteins without N-degrons. ClpS competitively inhibits degradation of unfolded substrates that interact with ClpA N-domains and is a non-competitive inhibitor with substrates that depend on internal binding sites in ClpA. ClpS inhibition of substrate binding is dependent on the order of addition. When added first, ClpS blocks binding of both high and low affinity substrates; however, when substrates first form committed complexes with ClpA(6), ClpS cannot displace them or block their degradation by ClpP. We propose that the first molecule of ClpS binds to the N-domain and to an additional functional binding site, sterically blocking binding of non-N-end rule substrates as well as additional ClpS molecules to ClpA(6). Limiting ClpS-mediated substrate delivery to one per ClpA(6) avoids congestion at the axial channel and allows facile transfer of proteins to the unfolding and translocation apparatus.	[De Donatis, Gian Marco; Singh, Satyendra K.; Viswanathan, Sarada; Maurizi, Michael R.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Maurizi, MR (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37 Rm 2128,37 Convent Dr MSC4256, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov			National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC005597] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program.	Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; DASGUPTA S, 1993, J MOL BIOL, V232, P23, DOI 10.1006/jmbi.1993.1367; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Farbman ME, 2008, BIOCHEMISTRY-US, V47, P13497, DOI 10.1021/bi801140y; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; GOTTESMAN S, 1990, J BIOL CHEM, V265, P7886; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Ishikawa T, 2004, J STRUCT BIOL, V146, P180, DOI 10.1016/j.jsb.2003.11.018; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004; Lies M, 2008, J BIOL CHEM, V283, P22918, DOI 10.1074/jbc.M801692200; Lupas AN, 2003, J STRUCT BIOL, V141, P77, DOI 10.1016/S1047-8477(02)00582-8; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ninnis RL, 2009, EMBO J, V28, P1732, DOI 10.1038/emboj.2009.134; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Pak M, 1997, P NATL ACAD SCI USA, V94, P4901, DOI 10.1073/pnas.94.10.4901; Piszczek G, 2005, J BIOL CHEM, V280, P12221, DOI 10.1074/jbc.M411733200; Roman-Hernandez G, 2009, P NATL ACAD SCI USA, V106, P8888, DOI 10.1073/pnas.0903614106; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schmidt R, 2009, MOL MICROBIOL, V72, P506, DOI 10.1111/j.1365-2958.2009.06666.x; Schuenemann VJ, 2009, EMBO REP, V10, P508, DOI 10.1038/embor.2009.62; SHRADER TE, 1993, J BACTERIOL, V175, P4364, DOI 10.1128/JB.175.14.4364-4374.1993; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Xia D, 2004, J STRUCT BIOL, V146, P166, DOI 10.1016/j.jsb.2003.11.025; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	47	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8771	8781		10.1074/jbc.M109.053736	http://dx.doi.org/10.1074/jbc.M109.053736			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20068042	Green Published, hybrid			2022-12-25	WOS:000275553700029
J	Vingtdeux, V; Giliberto, L; Zhao, HT; Chandakkar, P; Wu, QL; Simon, JE; Janle, EM; Lobo, J; Ferruzzi, MG; Davies, P; Marambaud, P				Vingtdeux, Valerie; Giliberto, Luca; Zhao, Haitian; Chandakkar, Pallavi; Wu, Qingli; Simon, James E.; Janle, Elsa M.; Lobo, Jessica; Ferruzzi, Mario G.; Davies, Peter; Marambaud, Philippe			AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-beta Peptide Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; DIETARY RESTRICTION; SIRT1 ACTIVATION; MOUSE MODEL; FOOD-INTAKE; IN-VIVO; AUTOPHAGY; HOMEOSTASIS; EXPRESSION; DEMENTIA	Alzheimer disease is an age-related neurodegenerative disorder characterized by amyloid-beta (A beta) peptide deposition into cerebral amyloid plaques. The natural polyphenol resveratrol promotes anti-aging pathways via the activation of several metabolic sensors, including the AMP-activated protein kinase (AMPK). Resveratrol also lowers A beta levels in cell lines; however, the underlying mechanism responsible for this effect is largely unknown. Moreover, the bioavailability of resveratrol in the brain remains uncertain. Here we show that AMPK signaling controls A beta metabolism and mediates the anti-amyloidogenic effect of resveratrol in non-neuronal and neuronal cells, including in mouse primary neurons. Resveratrol increased cytosolic calcium levels and promoted AMPK activation by the calcium/calmodulin-dependent protein kinase kinase-beta. Direct pharmacological and genetic activation of AMPK lowered extracellular A beta accumulation, whereas AMPK inhibition reduced the effect of resveratrol on A beta levels. Furthermore, resveratrol inhibited the AMPK target mTOR (mammalian target of rapamycin) to trigger autophagy and lysosomal degradation of A beta. Finally, orally administered resveratrol in mice was detected in the brain where it activated AMPK and reduced cerebral A beta levels and deposition in the cortex. These data suggest that resveratrol and pharmacological activation ofAMPKhave therapeutic potential against Alzheimer disease.	[Vingtdeux, Valerie; Giliberto, Luca; Zhao, Haitian; Chandakkar, Pallavi; Davies, Peter; Marambaud, Philippe] Feinstein Inst Med Res, N Shore LIJ, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY 11030 USA; [Wu, Qingli; Simon, James E.] Rutgers State Univ, Dept Plant Biol & Pathol, New Use Agr & Nat Plant Prod Program, New Brunswick, NJ 08901 USA; [Janle, Elsa M.; Ferruzzi, Mario G.] Purdue Univ, Dept Foods & Nutr, W Lafayette, IN 47907 USA; [Lobo, Jessica; Ferruzzi, Mario G.] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Davies, Peter; Marambaud, Philippe] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Northwell Health; Rutgers State University New Brunswick; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Yeshiva University; Albert Einstein College of Medicine	Marambaud, P (corresponding author), Feinstein Inst Med Res, N Shore LIJ, Litwin Zucker Res Ctr Study Alzheimers Dis, 350 Community Dr, Manhasset, NY 11030 USA.	philippe.marambaud@einstein.yu.edu	Vingtdeux, Valerie/C-2463-2012	Vingtdeux, Valerie/0000-0003-4550-503X; Ferruzzi, Mario/0000-0003-1384-2672; Marambaud, Philippe/0000-0002-8983-1497	National Institutes of Health [PO1 AT004511]; Alzheimer's Association; Institute for the Study of Aging; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG022102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Institute for the Study of Aging; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AT004511 (NCCAM Project 2; to P. M.). This work was also supported in part by the Alzheimer's Association (to P. M.) and the Institute for the Study of Aging (Alzheimer's Drug Discovery Foundation (to P. M.)).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertelli AAE, 1998, DRUG EXP CLIN RES, V24, P207; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Campos-Toimil M, 2007, EUR J PHARMACOL, V577, P91, DOI 10.1016/j.ejphar.2007.08.003; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Giliberto L, 2009, J BIOL CHEM, V284, P9027, DOI 10.1074/jbc.M805685200; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Ho L, 2009, J ALZHEIMERS DIS, V16, P59, DOI 10.3233/JAD-2009-0916; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hwang JT, 2007, ANN NY ACAD SCI, V1095, P441, DOI 10.1196/annals.1397.047; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jang JH, 2003, FREE RADICAL BIO MED, V34, P1100, DOI 10.1016/S0891-5849(03)00062-5; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Luchsinger JA, 2004, LANCET NEUROL, V3, P579, DOI 10.1016/S1474-4422(04)00878-6; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Riviere C, 2007, BIOORGAN MED CHEM, V15, P1160, DOI 10.1016/j.bmc.2006.09.069; Roura E, 2005, J AGR FOOD CHEM, V53, P6190, DOI 10.1021/jf050377u; Saeedi R, 2008, AM J PHYSIOL-HEART C, V294, pH2497, DOI 10.1152/ajpheart.00873.2007; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Savaskan E, 2003, GERONTOLOGY, V49, P380, DOI 10.1159/000073766; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; UM JH, 2009, DIABETES IN PRESS; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001; Yilmaz Y, 2004, J AGR FOOD CHEM, V52, P255, DOI 10.1021/jf030117h; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhao Haitian, 2008, BMC Res Notes, V1, P38, DOI 10.1186/1756-0500-1-38; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397	74	473	486	5	90	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9100	9113		10.1074/jbc.M109.060061	http://dx.doi.org/10.1074/jbc.M109.060061			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080969	Green Published, hybrid			2022-12-25	WOS:000275553700060
J	Zhang, PZ; Wang, CJ; Gao, K; Wang, DJ; Mao, J; An, J; Xu, C; Wu, D; Yu, HX; Liu, JO; Yu, L				Zhang, Pingzhao; Wang, Chenji; Gao, Kun; Wang, Dejie; Mao, Jun; An, Jian; Xu, Chen; Wu, Di; Yu, Hongxiu; Liu, Jun O.; Yu, Long			The Ubiquitin Ligase Itch Regulates Apoptosis by Targeting Thioredoxin-interacting Protein for Ubiquitin-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PROLIFERATION; BINDING PROTEIN-2; TXNIP; CANCER; VDUP1; CARCINOMA; FAMILY; GROWTH; SKIN	Thioredoxin interacting protein (TXNIP) was originally characterized as an endogenous inhibitor of thioredoxin, a key regulator in cellular redox homeostasis. TXNIP is also known to play important roles in tumor growth and metastasis, glucose and lipid metabolism. TXNIP expression is induced by various stress stimuli. However, it has been unclear how TXNIP is down-regulated. Here, we report that TXNIP undergoes proteasomal degradation in cells. We identify Itch as the E3 ubiquitin ligase for TXNIP. We demonstrate that Itch mediates polyubiquitination of TXNIP both in vitro and in vivo. Overexpression of Itch leads to TXNIP proteasomal degradation. Knockdown of Itch by small interfering RNA causes an accumulation of the steady-state level of TXNIP. We also show that the PPXY motifs of TXNIP and the WW domains of Itch mediate their interaction. Furthermore, the Itch-TXNIP interaction regulates intracellular reactive oxygen species levels and apoptosis. These findings establish a new mechanism for the negative regulation of TXNIP by Itch and shed new light on the regulation of cellular redox homeostasis.	[Zhang, Pingzhao; Wang, Chenji; Wang, Dejie; Mao, Jun; An, Jian; Xu, Chen; Wu, Di; Yu, Long] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Pingzhao; Yu, Hongxiu; Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Gao, Kun] Sichuan Univ, W China Hosp, Key Lab Transplant Engn & Immunol, Minist Hlth, Chengdu 610041, Peoples R China; [Liu, Jun O.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Liu, Jun O.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Fudan University; Fudan University; Sichuan University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Yu, L (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.	longyu@fudan.edu.cn	Wang, Dejie/AAJ-9461-2020	Wu, Di/0000-0003-4941-563X	National 973 Program of China [2004CB518605]; National 863 Project of China [2006AA020501]; National Key Sci-Tech Special Project of China [2008ZX10002-020]; Shanghai Municipal Science and Technology Commission [03dz14086]; Changjiang Visiting Scholars Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020501] Funding Source: NIH RePORTER	National 973 Program of China(National Basic Research Program of China); National 863 Project of China(National High Technology Research and Development Program of China); National Key Sci-Tech Special Project of China; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Changjiang Visiting Scholars Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National 973 Program of China Grant 2004CB518605, National 863 Project of China Grant 2006AA020501, National Key Sci-Tech Special Project of China Grant 2008ZX10002-020, Project of the Shanghai Municipal Science and Technology Commission Grant 03dz14086, and the Changjiang Visiting Scholars Program.	Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Champliaud MF, 2003, J INVEST DERMATOL, V121, P781, DOI 10.1046/j.1523-1747.2003.12539.x; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chung JW, 2006, J DERMATOL, V33, P662, DOI 10.1111/j.1346-8138.2006.00156.x; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Goldberg SF, 2003, CANCER RES, V63, P432; Hansen TM, 2007, BIOCHEM BIOPH RES CO, V361, P33, DOI 10.1016/j.bbrc.2007.06.104; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ishihara T, 2008, CANCER SCI, V99, P1940, DOI 10.1111/j.1349-7006.2008.00900.x; Kaimul AM, 2007, FREE RADICAL BIO MED, V43, P861, DOI 10.1016/j.freeradbiomed.2007.05.032; Kim KY, 2004, BIOCHEM BIOPH RES CO, V315, P369, DOI 10.1016/j.bbrc.2004.01.047; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yoshioka J, 2006, ANTIOXID REDOX SIGN, V8, P2143, DOI 10.1089/ars.2006.8.2143	38	79	82	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8869	8879		10.1074/jbc.M109.063321	http://dx.doi.org/10.1074/jbc.M109.063321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20068034	Green Published, hybrid			2022-12-25	WOS:000275553700038
J	Carver, KC; Piazza, TM; Schuler, LA				Carver, Kristopher C.; Piazza, Timothy M.; Schuler, Linda A.			Prolactin Enhances Insulin-like Growth Factor I Receptor Phosphorylation by Decreasing Its Association with the Tyrosine Phosphatase SHP-2 in MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PDGF-BETA-RECEPTOR; SRC FAMILY KINASES; MAMMARY NEOPLASIA; IGF-I; MEDIATED ENDOCYTOSIS; INDUCED ACTIVATION; EPITHELIAL-CELLS; FACTOR-ALPHA; PROTEIN	Normal mammary development requires coordinated interactions of numerous factors, including prolactin (PRL) and insulin-like growth factor I (IGF-I), both of which have also been implicated in breast cancer pathogenesis and progression. We previously reported that PRL and IGF-I synergize in breast cancer cells to activate ERK1/2 and AKT, leading to increased proliferation, survival, and invasion. Intriguingly, PRL co-treatment with IGF-I augments IGF-I receptor (IGFIR) phosphorylation 2-fold higher than IGF-I alone. Here, we showed the importance of the tyrosine phosphatase SHP-2 in this cross-talk using pharmacological inhibition and small interfering RNA. SHP-2 recruitment to IGF-IR was significantly attenuated by PRL co-treatment. Src family kinase activity was required for IGF-IR association with SHP-2, ligand-induced IGF-IR internalization, and PRL-enhanced IGF-IR phosphorylation. Inhibition of internalization, via knockdown of the GTPase, dynamin-2, prevented not only IGF-IR dephosphorylation, but also PRL-enhanced IGF-IR phosphorylation. Consistently, PRL diminished IGF-I-induced IGF-IR internalization, which may result from reduced SHP-2 association with IGF-IR, because we demonstrated an essential role for SHP-2 in IGF-IR internalization. Together, these findings describe a novel mechanism of cross- talk between PRL and IGF-I in breast cancer cells, with implications for our understanding of tumor progression and potential therapeutic strategies.	[Schuler, Linda A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA; [Carver, Kristopher C.; Schuler, Linda A.] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53706 USA; [Carver, Kristopher C.; Schuler, Linda A.] Univ Wisconsin, Biotechnol Training Program, Madison, WI 53706 USA; [Piazza, Timothy M.; Schuler, Linda A.] Univ Wisconsin, Comparat Biomed Sci Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Schuler, LA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA.	schulerl@svm.vetmed.wisc.edu			National Institutes of Health [CA78312, DK62783, T32 GM08349]; NATIONAL CANCER INSTITUTE [R01CA078312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA78312 and DK62783 (to L. A. S.) and T32 GM08349 (to K. C. C.).	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Ali S, 2000, J BIOL CHEM, V275, P39073, DOI 10.1074/jbc.M007478200; Arendt LM, 2008, J MAMMARY GLAND BIOL, V13, P29, DOI 10.1007/s10911-008-9073-9; Arendt LM, 2008, AM J PATHOL, V172, P194, DOI 10.2353/ajpath.2008.070597; Arendt LM, 2009, AM J PATHOL, V174, P1065, DOI 10.2353/ajpath.2009.080719; Arendt LM, 2006, AM J PATHOL, V168, P1365, DOI 10.2353/ajpath.2006.050861; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Calvocoressi L, 2008, CANCER-AM CANCER SOC, V112, P473, DOI 10.1002/cncr.23210; Carver KC, 2008, MOL CANCER RES, V6, P634, DOI 10.1158/1541-7786.MCR-07-2069; Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; CLEVENGER CV, 1994, MOL ENDOCRINOL, V8, P674, DOI 10.1210/me.8.6.674; Coyne CB, 2007, EMBO J, V26, P4016, DOI 10.1038/sj.emboj.7601831; Di Guglielmo GM, 1998, MOL CELL BIOCHEM, V182, P59, DOI 10.1023/A:1006883311233; Edderkaoui M, 2007, J BIOL CHEM, V282, P26646, DOI 10.1074/jbc.M702836200; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Gutzman JH, 2005, MOL ENDOCRINOL, V19, P1765, DOI 10.1210/me.2004-0339; Hadsell DL, 2000, J MAMMARY GLAND BIOL, V5, P19, DOI 10.1023/A:1009559014703; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; HERNANDEZSANCHEZ C, 1995, J BIOL CHEM, V270, P29176, DOI 10.1074/jbc.270.49.29176; Huang Y, 2006, ONCOGENE, V25, P7565, DOI 10.1038/sj.onc.1209740; Johnston SRD, 2007, J STEROID BIOCHEM, V106, P180, DOI 10.1016/j.jsbmb.2007.05.019; Jones R, 2008, J MAMMARY GLAND BIOL, V13, P407, DOI 10.1007/s10911-008-9097-1; Kapur S, 2005, J BIOL CHEM, V280, P20163, DOI 10.1074/jbc.M501460200; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Kim HY, 2006, J BIOL CHEM, V281, P11872, DOI 10.1074/jbc.M511706200; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kiyan J, 2009, EXP CELL RES, V315, P1029, DOI 10.1016/j.yexcr.2008.12.011; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Kuemmerle JF, 2006, AM J PHYSIOL-GASTR L, V290, pG1194, DOI 10.1152/ajpgi.00345.2005; Kwon M, 2006, ENDOCRINOLOGY, V147, P1458, DOI 10.1210/en.2005-1115; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lann D, 2008, J MAMMARY GLAND BIOL, V13, P371, DOI 10.1007/s10911-008-9100-x; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2003, CIRC RES, V93, P925, DOI 10.1161/01.RES.0000101754.33652.B7; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maile LA, 2002, ENDOCRINOLOGY, V143, P4259, DOI 10.1210/en.2002-220395; Marshman E, 2002, BREAST CANCER RES, V4, P231, DOI 10.1186/bcr535; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Perry JK, 2008, J MAMMARY GLAND BIOL, V13, P131, DOI 10.1007/s10911-008-9070-z; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Piazza TM, 2009, MOL ENDOCRINOL, V23, P202, DOI 10.1210/me.2008-0341; PRAGER D, 1994, J BIOL CHEM, V269, P11934; Qu CK, 2002, BBA-MOL CELL RES, V1592, P297, DOI 10.1016/S0167-4889(02)00322-1; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; Rowzee A, 2008, J MAMMARY GLAND BIOL, V13, P361, DOI 10.1007/s10911-008-9102-8; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Sachdev D, 2008, J MAMMARY GLAND BIOL, V13, P431, DOI 10.1007/s10911-008-9105-5; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schroeder MD, 2002, MOL ENDOCRINOL, V16, P45, DOI 10.1210/me.16.1.45; Shen MR, 2006, CARCINOGENESIS, V27, P962, DOI 10.1093/carcin/bgi336; Shen Q, 2007, ENDOCRINOLOGY, V148, P4536, DOI 10.1210/en.2007-0513; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wang N, 2006, J BIOL CHEM, V281, P21878, DOI 10.1074/jbc.M605018200; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Yamasaki Y, 2007, BIOCHEM BIOPH RES CO, V361, P7, DOI 10.1016/j.bbrc.2007.06.159; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	75	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8003	8012		10.1074/jbc.M109.066480	http://dx.doi.org/10.1074/jbc.M109.066480			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080972	Green Published, hybrid			2022-12-25	WOS:000275413800018
J	Sun, WJ; Ge, NL; Yu, Y; Burlingame, S; Li, XN; Zhang, M; Ye, SL; Fu, SB; Yang, JH				Sun, Wenjing; Ge, Ningling; Yu, Yang; Burlingame, Susan; Li, Xiaonan; Zhang, Ming; Ye, Shenglong; Fu, Songbin; Yang, Jianhua			Phosphorylation of Thr-516 and Ser-520 in the Kinase Activation Loop of MEKK3 Is Required for Lysophosphatidic Acid-mediated Optimal I kappa B Kinase beta (IKK beta)/Nuclear Factor-kappa B (NF-kappa B) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; IKK-BETA; ALPHA; IDENTIFICATION; ASSOCIATION; RECEPTOR; SUBUNIT; BCL10	MEKK3 serves as a critical intermediate signaling molecule in lysophosphatidic acid-mediated nuclear factor-kappa B (NF-kappa B) activation. However, the precise regulation for MEKK3 activation at the molecular level is still not fully understood. Here we report the identification of two regulatory phosphorylation sites at Thr-516 and Ser-520 within the kinase activation loop that is essential for MEKK3-mediated I kappa B kinase beta (IKK beta)/NF-kappa B activation. Substitution of these two residues with alanine abolished the ability of MEKK3 to activate IKK beta/NF-kappa B, whereas replacement with acidic residues rendered MEKK3 constitutively active. Furthermore, substitution of these two residues with alanine abolished the ability of MEKK3 to mediate lysophosphatidic acid-induced optimal IKK beta/NF-kappa B activation.	[Sun, Wenjing; Ge, Ningling; Yu, Yang; Burlingame, Susan; Li, Xiaonan; Zhang, Ming; Yang, Jianhua] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Sun, Wenjing; Yu, Yang; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin 150081, Peoples R China; [Ge, Ningling; Ye, Shenglong] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200032, Peoples R China	Baylor College of Medicine; Texas Children's Cancer Center; Harbin Medical University; Fudan University	Yang, JH (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, 1 Baylor Plaza,BCM320,6621 Fannin St,MC 3-3320, Houston, TX 77030 USA.	jianhuay@bcm.edu			National Institutes of Health NCI [1R21CA106513-01A2]; American Cancer Society [RSG-06-070-01-TBE]; Virginia and L. E. Simmons Family Foundation Collaborative Research Fund; NATIONAL CANCER INSTITUTE [R21CA106513] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Virginia and L. E. Simmons Family Foundation Collaborative Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA106513-01A2 (to J. Y.) from NCI. This work was also supported by Research Scholar Grant RSG-06-070-01-TBE (to J. Y.) from the American Cancer Society and the Virginia and L. E. Simmons Family Foundation Collaborative Research Fund (to J. Y.).	Adams DG, 2002, ARCH BIOCHEM BIOPHYS, V407, P103, DOI 10.1016/S0003-9861(02)00464-2; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fritz A, 2006, J BIOL CHEM, V281, P6236, DOI 10.1074/jbc.M509249200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yang JH, 2003, J BIOL CHEM, V278, P16797, DOI 10.1074/jbc.M211060200; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	31	9	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7911	7918		10.1074/jbc.M109.051219	http://dx.doi.org/10.1074/jbc.M109.051219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068038	Green Published, hybrid			2022-12-25	WOS:000275413800008
J	Siarheyeva, A; Liu, R; Sharom, FJ				Siarheyeva, Alena; Liu, Ronghua; Sharom, Frances J.			Characterization of an Asymmetric Occluded State of P-glycoprotein with Two Bound Nucleotides IMPLICATIONS FOR CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER HLYB; ATP-BINDING; MULTIDRUG TRANSPORTER; DRUG-BINDING; ADENOSINE-TRIPHOSPHATASE; SULFOLOBUS-SOLFATARICUS; GLUTAMATE RESIDUES; TRANSITION-STATE; HYDROLYSIS; DOMAIN	P-glycoprotein (ABCB1), a member of the ABC superfamily, functions as an ATP-driven multidrug efflux pump. The catalytic cycle of ABC proteins is believed to involve formation of a sandwich dimer in which two ATP molecules are bound at the interface of the nucleotide binding domains (NBDs). However, such dimers have only been observed in isolated NBD subunits and catalytically arrested mutants, and it is still not understood how ATP hydrolysis is coordinated between the two NBDs. We report for the first time the characterization of an asymmetric state of catalytically active native P-glycoprotein with two bound molecules of adenosine 5'-(gamma-thio) triphosphate (ATP gamma S), one of low affinity (K-d 0.74 mM), and one "occluded" nucleotide of 120-fold higher affinity (K-d 6 mu M). ATP gamma S also interacts with P-glycoprotein with high affinity as assessed by inhibition of ATP hydrolysis and protection from covalent labeling of a Walker A Cys residue, whereas other non-hydrolyzable ATP analogues do not. Binding of ATP gamma S (but not ATP) causes Trp residue heterogeneity, as indicated by collisional quenching, suggesting that it may induce conformational asymmetry. Asymmetric ATP gamma S-bound P-glycoprotein does not display reduced binding affinity for drugs, implying that transport is not driven by ATP binding and likely takes place at a later stage of the catalytic cycle. We propose that this asymmetric state with two bound nucleotides represents the next intermediate on the path toward ATP hydrolysis after nucleotide binding, and an alternating sites mode of action is achieved by simultaneous switching of the two active sites between high and low affinity states.	[Siarheyeva, Alena; Liu, Ronghua; Sharom, Frances J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Sharom, FJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex Rm 2255, Guelph, ON N1G 2W1, Canada.	fsharom@uoguelph.ca	Sharom, Frances/A-1613-2010	Sharom, Frances/0000-0002-9521-5367	Canadian Cancer Society	Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by a research grant from the Canadian Cancer Society.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRONNIKOV GE, 1983, ANAL BIOCHEM, V131, P69, DOI 10.1016/0003-2697(83)90136-7; Callaghan R, 2006, FEBS LETT, V580, P1056, DOI 10.1016/j.febslet.2005.11.083; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Lugo MR, 2009, ARCH BIOCHEM BIOPHYS, V492, P17, DOI 10.1016/j.abb.2009.10.002; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; Neumann L, 2002, J MOL BIOL, V324, P965, DOI 10.1016/S0022-2836(02)01148-8; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oloo EO, 2006, J BIOL CHEM, V281, P28397, DOI 10.1074/jbc.M513614200; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Payen L, 2005, MOL PHARMACOL, V67, P1944, DOI 10.1124/mol.104.007708; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pretz MG, 2006, BIOCHEMISTRY-US, V45, P15056, DOI 10.1021/bi061230e; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; QUAY SC, 1985, J BIOL CHEM, V260, P5055; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1998, ACTA PHYSIOL SCAND, V163, P213; Sharom FJ, 1999, BBA-BIOMEMBRANES, V1461, P327, DOI 10.1016/S0005-2736(99)00166-2; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; SHAROM FJ, 2007, DRUG TRANSPORTERS MO, P223, DOI DOI 10.1002/9780470140505.CH10; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; STEKHOVEN FMAHS, 1984, BIOCHIM BIOPHYS ACTA, V774, P277; Tmej C, 1998, ARCH PHARM, V331, P233, DOI 10.1002/(SICI)1521-4184(199807)331:7/8<233::AID-ARDP233>3.0.CO;2-2; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; YASUOKA K, 1982, J BIOCHEM-TOKYO, V91, P1629, DOI 10.1093/oxfordjournals.jbchem.a133854; Zaitseva J, 2005, BIOCHEM SOC T, V33, P990, DOI 10.1042/BST0330990; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	63	91	91	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7575	7586		10.1074/jbc.M109.047290	http://dx.doi.org/10.1074/jbc.M109.047290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20061384	Green Published, hybrid			2022-12-25	WOS:000275415600069
J	Aziz-Zadeh, L; Sheng, T; Gheytanchi, A				Aziz-Zadeh, Lisa; Sheng, Tong; Gheytanchi, Anahita			Common Premotor Regions for the Perception and Production of Prosody and Correlations with Empathy and Prosodic Ability	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; EVENT-RELATED FMRI; SPEECH-PERCEPTION; FUNCTIONAL NEUROANATOMY; MOTOR FACILITATION; EMOTIONAL PROSODY; LATERALIZATION; SOUNDS; CORTEX; TMS	Background: Prosody, the melody and intonation of speech, involves the rhythm, rate, pitch and voice quality to relay linguistic and emotional information from one individual to another. A significant component of human social communication depends upon interpreting and responding to another person's prosodic tone as well as one's own ability to produce prosodic speech. However there has been little work on whether the perception and production of prosody share common neural processes, and if so, how these might correlate with individual differences in social ability. Methods: The aim of the present study was to determine the degree to which perception and production of prosody rely on shared neural systems. Using fMRI, neural activity during perception and production of a meaningless phrase in different prosodic intonations was measured. Regions of overlap for production and perception of prosody were found in premotor regions, in particular the left inferior frontal gyrus (IFG). Activity in these regions was further found to correlate with how high an individual scored on two different measures of affective empathy as well as a measure on prosodic production ability. Conclusions: These data indicate, for the first time, that areas that are important for prosody production may also be utilized for prosody perception, as well as other aspects of social communication and social understanding, such as aspects of empathy and prosodic ability.	[Aziz-Zadeh, Lisa; Sheng, Tong] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; [Aziz-Zadeh, Lisa] Univ So Calif, Dept Occupat Sci, Los Angeles, CA USA; [Aziz-Zadeh, Lisa; Sheng, Tong] Univ So Calif, Grad Program Neurosci, Los Angeles, CA USA; [Gheytanchi, Anahita] Pacific Grad Sch Psychol, Palo Alto, CA USA	University of Southern California; University of Southern California; University of Southern California	Aziz-Zadeh, L (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.	lazizzad@usc.edu	Sheng, Tong/C-6306-2019	Sheng, Tong/0000-0003-1067-7608	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R03HD057594]; James H. Zumberge Individual Award; University of Southern California Brain and Creativity Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); James H. Zumberge Individual Award; University of Southern California Brain and Creativity Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by Award Number R03HD057594 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. This project was also generously funded by a James H. Zumberge Individual Award and the University of Southern California Brain and Creativity Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; BEAUCOUSIN V, 2006, CEREB CORTEX; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Damasio A. R., 1999, FEELING WHAT HAPPENS; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hare R.D., 2003, PSYCHOPATHY CHECKLIS, VON, P412; HARE RD, 1991, J ABNORM PSYCHOL, V100, P391, DOI 10.1037/0021-843X.100.3.391; Heilman KM, 2004, BRAIN LANG, V89, P411, DOI 10.1016/j.bandl.2004.01.006; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Lilienfield S. O., 2005, PSYCHOPATHIC PERSONA; Lotto AJ, 2009, TRENDS COGN SCI, V13, P110, DOI 10.1016/j.tics.2008.11.008; Mayer J., 2002, P INT C SPEECH PROS, P487; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Moelker A, 2003, HUM BRAIN MAPP, V20, P123, DOI 10.1002/hbm.10134; Moineau S, 2005, J SPEECH LANG HEAR R, V48, P884, DOI 10.1044/1092-4388(2005/061); Nebel K, 2005, HUM BRAIN MAPP, V24, P130, DOI 10.1002/hbm.20075; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; van Rijn S, 2005, EUR J NEUROSCI, V21, P3195, DOI 10.1111/j.1460-9568.2005.04130.x; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263	37	74	75	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8759	10.1371/journal.pone.0008759	http://dx.doi.org/10.1371/journal.pone.0008759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	546AI	20098696	Green Submitted, gold, Green Published			2022-12-25	WOS:000273779000008
J	Fenner, BJ; Scannell, M; Prehn, JHM				Fenner, Beau J.; Scannell, Michael; Prehn, Jochen H. M.			Expanding the Substantial Interactome of NEMO Using Protein Microarrays	PLOS ONE			English	Article							KAPPA-B ACTIVATION; GENOTOXIC STIMULI; KINASE COMPLEX; PATHWAY; ALPHA; UBIQUITINATION; DEGRADATION; RECEPTOR; BINDING; STRESS	Signal transduction by the NF-kappaB pathway is a key regulator of a host of cellular responses to extracellular and intracellular messages. The NEMO adaptor protein lies at the top of this pathway and serves as a molecular conduit, connecting signals transmitted from upstream sensors to the downstream NF-kappaB transcription factor and subsequent gene activation. The position of NEMO within this pathway makes it an attractive target from which to search for new proteins that link NF-kappaB signaling to additional pathways and upstream effectors. In this work, we have used protein microarrays to identify novel NEMO interactors. A total of 112 protein interactors were identified, with the most statistically significant hit being the canonical NEMO interactor IKKbeta, with IKKalpha also being identified. Of the novel interactors, more than 30% were kinases, while at least 25% were involved in signal transduction. Binding of NEMO to several interactors, including CALB1, CDK2, SAG, SENP2 and SYT1, was confirmed using GST pulldown assays and coimmunoprecipitation, validating the initial screening approach. Overexpression of CALB1, CDK2 and SAG was found to stimulate transcriptional activation by NF-kappaB, while SYT1 overexpression repressed TNFalpha-dependent NF-kappaB transcriptional activation in human embryonic kidney cells. Corresponding with this finding, RNA silencing of CDK2, SAG and SENP2 reduced NF-kappaB transcriptional activation, supporting a positive role for these proteins in the NF-kappaB pathway. The identification of a host of new NEMO interactors opens up new research opportunities to improve understanding of this essential cell signaling pathway.	[Fenner, Beau J.] Royal Coll Surgeons Ireland, Ctr Human Prote, Dublin 2, Ireland; Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Fenner, BJ (corresponding author), Royal Coll Surgeons Ireland, Ctr Human Prote, Dublin 2, Ireland.	prehn@rcsi.ie	Prehn, Jochen HM/A-3928-2010	Prehn, Jochen HM/0000-0003-3479-7794; Fenner, Beau/0000-0002-5356-7604	Science Foundation of Ireland [08/IN1/1949]; Higher Education Authority; European Union	Science Foundation of Ireland(Science Foundation Ireland); Higher Education Authority; European Union(European Commission)	This work was generously funded by the Science Foundation of Ireland (08/IN1/1949), the Higher Education Authority (PRTLI Cycle 4), and the European Union (FP6-Mobility, Marie Curie Transfer of Knowledge Fellowships; FP7-Health, APO-SYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AU SW, 2009, ANTIOXID REDOX SIGNA; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Carr CM, 2007, EMBO REP, V8, P834, DOI 10.1038/sj.embor.7401051; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Chen EY, 1998, BIOCHEM BIOPH RES CO, V249, P728, DOI 10.1006/bbrc.1998.9224; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Cooke EL, 2001, BIOCHEM J, V359, P403, DOI 10.1042/0264-6021:3590403; Cordier F, 2009, J BIOL CHEM, V284, P2902, DOI 10.1074/jbc.M806655200; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; FENNER BJ, 2009, BIOCH BIOPHYS ACTA; Gu QY, 2007, J CELL BIOL, V178, P1009, DOI 10.1083/jcb.200612067; Hay RT, 2004, NAT CELL BIOL, V6, P89, DOI 10.1038/ncb0204-89; Higashimoto T, 2008, J BIOL CHEM, V283, P35354, DOI 10.1074/jbc.M806258200; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Kim YS, 2003, J BIOL CHEM, V278, P28462, DOI 10.1074/jbc.M302584200; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Kojetin DJ, 2006, NAT STRUCT MOL BIOL, V13, P641, DOI 10.1038/nsmb1112; Levy ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.260pe11; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Madziva MT, 2005, BRIT J PHARMACOL, V144, P761, DOI 10.1038/sj.bjp.0706035; Mankan AK, 2009, J CELL MOL MED, V13, P631, DOI 10.1111/j.1582-4934.2009.00632.x; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Moon KY, 2001, ANAL BIOCHEM, V292, P17, DOI 10.1006/abio.2001.5059; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Satoh J, 2006, J NEUROSCI METH, V152, P278, DOI 10.1016/j.jneumeth.2005.09.015; Satoh J, 2009, NEUROPATH APPL NEURO, V35, P16, DOI 10.1111/j.1365-2990.2008.00947.x; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Tan L., 2006, ACM T ARCHIT CODE OP, V3, P3, DOI DOI 10.1145/1132462.1132464; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Tian Y, 2007, J BIOL CHEM, V282, P16776, DOI 10.1074/jbc.M701913200; Tong Y, 2008, ONCOGENE, V27, P6385, DOI 10.1038/onc.2008.234; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang HJ, 2008, EUR J PHARMACOL, V595, P7, DOI 10.1016/j.ejphar.2008.07.044; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang GY, 2001, J CEREBR BLOOD F MET, V21, P722, DOI 10.1097/00004647-200106000-00010; Yoshihara M, 2004, NEUROSCIENTIST, V10, P566, DOI 10.1177/1073858404268770; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	50	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8799	10.1371/journal.pone.0008799	http://dx.doi.org/10.1371/journal.pone.0008799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098747	Green Submitted, Green Published, gold			2022-12-25	WOS:000273779000026
J	Hasegawa, T; Mikoda, N; Kitazawa, M; LaFerla, FM				Hasegawa, Tohru; Mikoda, Nobuyuki; Kitazawa, Masashi; LaFerla, Frank M.			Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice	PLOS ONE			English	Article							IMMATURE RATS; A-BETA; RECEPTOR; RELEASE; INHIBITION; METHIONINE; CULTURES; STRESS	Alzheimer's disease (AD) is an age-associated progressive neurodegenerative disorder with dementia, the exact pathogenic mechanisms of which remain unknown. We previously reported that homocysteic acid (HA) may be one of the pathological biomarkers in the brain with AD and that the increased levels of HA may induce the accumulation of intraneuronal amyloid-beta (A beta) peptides. In this study, we further investigated the pathological role of HA in a mouse model of AD. Four-monthold prepathological 3xTg-AD mice exhibited higher levels of HA in the hippocampus than did age-matched nontransgenic mice, suggesting that HA accumulation may precede both A beta and tau pathologies. We then fed 3-month-old 3xTg-AD mice with vitamin B6-deficient food for 3 weeks to increase the HA levels in the brain. Concomitantly, mice received either saline or anti-HA antibody intraventricularly via a guide cannula every 3 days during the course of the B6-deficient diet. We found that mice that received anti-HA antibody significantly resisted cognitive impairment induced by vitamin B6 deficiency and that AD-related pathological changes in their brains was attenuated compared with the saline-injected control group. A similar neuroprotective effect was observed in 12-month-old 3xTg-AD mice that received anti-HA antibody injections while receiving the regular diet. We conclude that increased brain HA triggers memory impairment and that this condition deteriorates with amyloid and leads to subsequent neurodegeneration in mouse models of AD.	[Hasegawa, Tohru] Saga Womens Jr Coll, Saga, Japan; [Mikoda, Nobuyuki] Kyudo Ltd, Tosu, Saga, Japan; [Kitazawa, Masashi; LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of California System; University of California Irvine	Hasegawa, T (corresponding author), Saga Womens Jr Coll, Saga, Japan.	hasegawa@yumekobo-shizuka.com	Kitazawa, Masashi/AAI-1721-2021	Kitazawa, Masashi/0000-0003-2165-8197; MIKODA, NOBUYUKI/0000-0002-0708-4329	Arfresa Pharmcology	Arfresa Pharmcology	This experiment was supported by Arfresa Pharmcology (http://www.alfresa-pharma.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari Y, 2004, BIOCHEM BIOPH RES CO, V322, P1145, DOI 10.1016/j.bbrc.2004.07.136; ALSPECTOR E, RELATIONSHIP NEUROGE; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com; DO KQ, 1988, J NEURAL TRANSM, V72, P185, DOI 10.1007/BF01243418; Do KQ, 1997, J NEUROCHEM, V68, P2386, DOI 10.1046/j.1471-4159.1997.68062386.x; Folbergrova J, 2007, EXP NEUROL, V204, P597, DOI 10.1016/j.expneurol.2006.12.010; Hasegawa T, 2005, J NEUROSCI RES, V80, P869, DOI 10.1002/jnr.20514; Hasegawa T, 2007, MED HYPOTHESES, V69, P1135, DOI 10.1016/j.mehy.2007.02.034; Kluska MM, 2005, NEUROSCIENCE, V135, P723, DOI 10.1016/j.neuroscience.2005.06.082; Langmeier M, 2003, EPILEPSIA, V44, P299, DOI 10.1046/j.1528-1157.2003.31702.x; LIEBERMA.M, 1965, BIOCHEM J, V97, P449, DOI 10.1042/bj0970449; Lockhart B, 2000, BRAIN RES, V855, P292, DOI 10.1016/S0006-8993(99)02372-0; McMahon JA, 2006, NEW ENGL J MED, V354, P2764, DOI 10.1056/NEJMoa054025; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; OHMORI S, 1975, H-S Z PHYSIOL CHEM, V356, P1369, DOI 10.1515/bchm2.1975.356.2.1369; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sommer S, 2004, J PROTEOME RES, V3, P572, DOI 10.1021/pr034115o	19	24	24	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8593	10.1371/journal.pone.0008593	http://dx.doi.org/10.1371/journal.pone.0008593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098691	gold, Green Published			2022-12-25	WOS:000273779000003
J	Beck, AH; Weng, ZM; Witten, DM; Zhu, S; Foley, JW; Lacroute, P; Smith, CL; Tibshirani, R; van de Rijn, M; Sidow, A; West, RB				Beck, Andrew H.; Weng, Ziming; Witten, Daniela M.; Zhu, Shirley; Foley, Joseph W.; Lacroute, Phil; Smith, Cheryl L.; Tibshirani, Robert; van de Rijn, Matt; Sidow, Arend; West, Robert B.			3 '-End Sequencing for Expression Quantification (3SEQ) from Archival Tumor Samples	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; GENE-EXPRESSION; RNA-SEQ; BREAST-CANCER; MOLECULAR CLASSIFICATION; DNA MICROARRAYS; DESMOID TUMOR; GENOME; SIGNATURES; RELEVANT	Gene expression microarrays are the most widely used technique for genome-wide expression profiling. However, microarrays do not perform well on formalin fixed paraffin embedded tissue (FFPET). Consequently, microarrays cannot be effectively utilized to perform gene expression profiling on the vast majority of archival tumor samples. To address this limitation of gene expression microarrays, we designed a novel procedure (39-end sequencing for expression quantification (3SEQ)) for gene expression profiling from FFPET using next-generation sequencing. We performed gene expression profiling by 3SEQ and microarray on both frozen tissue and FFPET from two soft tissue tumors (desmoid type fibromatosis (DTF) and solitary fibrous tumor (SFT)) (total n = 23 samples, which were each profiled by at least one of the four platform-tissue preparation combinations). Analysis of 3SEQ data revealed many genes differentially expressed between the tumor types (FDR<0.01) on both the frozen tissue (similar to 9.6K genes) and FFPET (similar to 8.1K genes). Analysis of microarray data from frozen tissue revealed fewer differentially expressed genes (similar to 4.64K), and analysis of microarray data on FFPET revealed very few (69) differentially expressed genes. Functional gene set analysis of 3SEQ data from both frozen tissue and FFPET identified biological pathways known to be important in DTF and SFT pathogenesis and suggested several additional candidate oncogenic pathways in these tumors. These findings demonstrate that 3SEQ is an effective technique for gene expression profiling from archival tumor samples and may facilitate significant advances in translational cancer research.	[Beck, Andrew H.; Weng, Ziming; Zhu, Shirley; Foley, Joseph W.; Lacroute, Phil; Smith, Cheryl L.; van de Rijn, Matt; Sidow, Arend; West, Robert B.] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Weng, Ziming; Foley, Joseph W.; Lacroute, Phil; Smith, Cheryl L.; van de Rijn, Matt; Sidow, Arend] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Witten, Daniela M.; Tibshirani, Robert] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Tibshirani, Robert] Stanford Univ, Med Ctr, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [West, Robert B.] Palo Alto Vet Affairs Hlth Care Syst, Pathol & Lab Serv, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Stanford University	Beck, AH (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA.	arend@stanford.edu; rbwest@stanford.edu		Foley, Joseph/0000-0002-1579-5286; West, Robert/0000-0002-8330-8283; Smith, Cheryl/0000-0003-4323-6382; van de Rijn, Matt/0000-0002-1909-9739	NIH [CA129927, CA112270]; Desmoid Tumor Research Foundation, Inc; Stanford Department of Pathology; NATIONAL CANCER INSTITUTE [R01CA129927, R01CA112270] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Desmoid Tumor Research Foundation, Inc; Stanford Department of Pathology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the NIH, CA129927 (RBW), CA112270 (MvdR), the Desmoid Tumor Research Foundation, Inc (MvdR), and the Stanford Department of Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alman BA, 1997, AM J PATHOL, V151, P329; Beck AH, 2008, LAB INVEST, V88, P591, DOI 10.1038/labinvest.2008.31; Bibikova Marina, 2008, V439, P159, DOI 10.1007/978-1-59745-188-8_11; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeRisi J, 1996, NAT GENET, V14, P457; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Frank M, 2007, VIRCHOWS ARCH, V450, P699, DOI 10.1007/s00428-007-0412-9; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kotiligam D, 2008, HISTOL HISTOPATHOL, V23, P117, DOI 10.14670/HH-23.117; Lakhani SR, 2001, NAT REV CANCER, V1, P151, DOI 10.1038/35101087; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee CH, 2008, CLIN CANCER RES, V14, P1423, DOI 10.1158/1078-0432.CCR-07-1712; Li Y, 2007, J PATHOL, V211, P550, DOI 10.1002/path.2136; Liang P, 2003, NAT REV CANCER, V3, P869, DOI 10.1038/nrc1214; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mohr S, 2002, J CLIN ONCOL, V20, P3165, DOI 10.1200/JCO.2002.12.073; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Penland SK, 2007, LAB INVEST, V87, P383, DOI 10.1038/labinvest.3700529; Polakis P, 2000, GENE DEV, V14, P1837; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shendure Jay A, 2008, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0701s81; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; STEIGEN SE, 2009, MOD PATHOL; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tejpar S, 1999, ONCOGENE, V18, P6615, DOI 10.1038/sj.onc.1203041; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weiss SW, 2008, ENZINGER WEISSS SOFT, P303; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WILHELM BT, 2009, METHODS; Yang JL, 2007, PATHOLOGY, V39, P319, DOI 10.1080/00313020701329823	67	94	96	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8768	10.1371/journal.pone.0008768	http://dx.doi.org/10.1371/journal.pone.0008768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098735	Green Submitted, Green Published, gold			2022-12-25	WOS:000273778900012
J	Guo, R; Ren, J				Guo, Rui; Ren, Jun			Alcohol Dehydrogenase Accentuates Ethanol-Induced Myocardial Dysfunction and Mitochondrial Damage in Mice: Role of Mitochondrial Death Pathway	PLOS ONE			English	Article							CONTRACTILE DYSFUNCTION; CARDIAC OVEREXPRESSION; INTRACELLULAR CA2+; OXIDATIVE STRESS; HEART-FAILURE; CELL-DEATH; APOPTOSIS; ACETALDEHYDE; CARDIOMYOPATHY; DISEASE	Objectives: Binge drinking and alcohol toxicity are often associated with myocardial dysfunction possibly due to accumulation of the ethanol metabolite acetaldehyde although the underlying mechanism is unknown. This study was designed to examine the impact of accelerated ethanol metabolism on myocardial contractility, mitochondrial function and apoptosis using a murine model of cardiac-specific overexpression of alcohol dehydrogenase (ADH). Methods: ADH and wild-type FVB mice were acutely challenged with ethanol (3 g/kg/d, i.p.) for 3 days. Myocardial contractility, mitochondrial damage and apoptosis (death receptor and mitochondrial pathways) were examined. Results: Ethanol led to reduced cardiac contractility, enlarged cardiomyocyte, mitochondrial damage and apoptosis, the effects of which were exaggerated by ADH transgene. In particular, ADH exacerbated mitochondrial dysfunction manifested as decreased mitochondrial membrane potential and accumulation of mitochondrial O-2(center dot-). Myocardium from ethanol-treated mice displayed enhanced Bax, Caspase-3 and decreased Bcl-2 expression, the effect of which with the exception of Caspase-3 was augmented by ADH. ADH accentuated ethanol-induced increase in the mitochondrial death domain components pro-caspase-9 and cytochrome C in the cytoplasm. Neither ethanol nor ADH affected the expression of ANP, total pro-caspase-9, cytosolic and total pro-caspase-8, TNF-alpha, Fas receptor, Fas L and cytosolic AIF. Conclusions: Taken together, these data suggest that enhanced acetaldehyde production through ADH overexpression following acute ethanol exposure exacerbated ethanol-induced myocardial contractile dysfunction, cardiomyocyte enlargement, mitochondrial damage and apoptosis, indicating a pivotal role of ADH in ethanol-induced cardiac dysfunction possibly through mitochondrial death pathway of apoptosis.	[Guo, Rui; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA	University of Wyoming	Guo, R (corresponding author), Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.	jren@uwyo.edu	Ren, Jun/ACG-5366-2022; Guo, Rui/ACH-5568-2022	Ren, Jun/0000-0002-0275-0783; 	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA) [1R01 AA013412]; University of Wyoming Northern Rockies Regional IDeA Networks for Biomedical Excellence (INBRE) [5P20RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013412] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); University of Wyoming Northern Rockies Regional IDeA Networks for Biomedical Excellence (INBRE); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA) 1R01 AA013412 and University of Wyoming Northern Rockies Regional IDeA Networks for Biomedical Excellence (INBRE) (5P20RR016474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2008, ANN THORAC SURG, V86, P109, DOI 10.1016/j.athoracsur.2008.03.057; Brown RA, 1999, CELL MOL BIOL, V45, P453; Cheng W, 1996, EXP CELL RES, V226, P316, DOI 10.1006/excr.1996.0232; DI LF, 1995, J PHYSL, V486, P1; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Duan JH, 2002, AM J PHYSIOL-HEART C, V282, pH1216, DOI 10.1152/ajpheart.00780.2001; Fadeel B, 2000, MED PRIN PRACT, V9, P151, DOI 10.1159/000054240; Gao HK, 2008, J CARDIOVASC PHARM, V52, P286, DOI 10.1097/FJC.0b013e318186a84d; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; Gill C, 2002, FASEB J, V16, P135, DOI 10.1096/fj.01-0629com; GUERRI C, 1994, ADV EXP MED BIOL, V366, P291; Guo R, 2009, J MOL CELL CARDIOL, V47, P228, DOI 10.1016/j.yjmcc.2009.03.018; Hajnoczky G, 2005, ALCOHOL CLIN EXP RES, V29, P693, DOI 10.1097/01.ALC.0000163493.45344.7A; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; Hintz KK, 2003, ALCOHOL CLIN EXP RES, V27, P1090, DOI 10.1097/01.ALC.0000075823.73536.DD; Katoh I, 2004, J BIOL CHEM, V279, P15515, DOI 10.1074/jbc.M311819200; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; Lee SD, 2008, MATURITAS, V61, P268, DOI 10.1016/j.maturitas.2008.07.004; Lee YJ, 2002, J PHARMACOL EXP THER, V301, P908, DOI 10.1124/jpet.301.3.908; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Li SY, 2008, J MOL CELL CARDIOL, V44, P992, DOI 10.1016/j.yjmcc.2008.02.276; Liang QR, 1999, J PHARMACOL EXP THER, V291, P766; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; Lu MC, 2007, OBESITY, V15, P2634, DOI 10.1038/oby.2007.315; Ma H, 2009, J AM COLL CARDIOL, V54, P2187, DOI 10.1016/j.jacc.2009.04.100; Mallat Z, 1996, CIRCULATION, V94, P2493; McDonough Kathleen H., 1999, Frontiers in Bioscience, V4, pd601, DOI 10.2741/mcdonoug; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Patel VB, 1997, ADVERSE DRUG REACT T, V16, P15; Preedy Victor R., 1999, Frontiers in Bioscience, V4, pe58, DOI 10.2741/Preedy; Qin ZH, 2001, J BIOL CHEM, V276, P8079, DOI 10.1074/jbc.M007028200; Ren J, 1997, CELL MOL BIOL, V43, P825; Ren J, 2009, TOXICOL LETT, V187, P149, DOI 10.1016/j.toxlet.2009.02.019; Ren T, 2000, ALCOHOL ALCOHOLISM, V35, P554, DOI 10.1093/alcalc/35.6.554; Richardson PJ, 1998, NOVART FDN SYMP, V216, P35; Russo GL, 2003, NUTR METAB CARDIOVAS, V13, P291, DOI 10.1016/S0939-4753(03)80034-0; Saraste A, 1997, CIRCULATION, V95, P320; Song Ye, 2007, Rev Diabet Stud, V4, P159, DOI 10.1900/RDS.2007.4.159; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; White SJ, 2002, J CARDIAC SURG, V17, P549, DOI 10.1046/j.1540-8191.2002.01013.x; Zhang XC, 2004, ALCOHOL, V32, P175, DOI 10.1016/j.alcohol.2004.01.005	44	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8757	10.1371/journal.pone.0008757	http://dx.doi.org/10.1371/journal.pone.0008757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090911	Green Published, gold, Green Submitted			2022-12-25	WOS:000273715000015
J	Rolli, CG; Seufferlein, T; Kemkemer, R; Spatz, JP				Rolli, Claudio G.; Seufferlein, Thomas; Kemkemer, Ralf; Spatz, Joachim P.			Impact of Tumor Cell Cytoskeleton Organization on Invasiveness and Migration: A Microchannel-Based Approach	PLOS ONE			English	Article							CANCER-CELLS; ADHESION	Cell migration is a fundamental feature of the interaction of cells with their surrounding. The cell's stiffness and ability to deform itself are two major characteristics that rule migration behavior especially in three-dimensional tissue. We simulate this situation making use of a micro-fabricated migration chip to test the active invasive behavior of pancreatic cancer cells (Panc-1) into narrow channels. At a channel width of 7 mm cell migration through the channels was significantly impeded due to size exclusion. A striking increase in cell invasiveness was observed once the cells were treated with the bioactive lipid sphingosylphosphorylcholine (SPC) that leads to a reorganization of the cell's keratin network, an enhancement of the cell's deformability, and also an increase in the cell's migration speed on flat surfaces. The migration speed of the highly deformed cells inside the channels was three times higher than of cells on flat substrates but was not affected upon SPC treatment. Cells inside the channels migrated predominantly by smooth sliding while maintaining constant cell length. In contrast, cells on adhesion mediating narrow lines moved in a stepwise way, characterized by fluctuations in cell length. Taken together, with our migration chip we demonstrate that the dimensionality of the environment strongly affects the migration phenotype and we suggest that the spatial cytoskeletal keratin organization correlates with the tumor cell's invasive potential.	[Rolli, Claudio G.; Spatz, Joachim P.] Max Planck Inst Met Res, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany; [Rolli, Claudio G.; Spatz, Joachim P.] Univ Heidelberg, Inst Phys Chem, Dept Biophys Chem, D-6900 Heidelberg, Germany; [Seufferlein, Thomas] Univ Klin & Poliklin Innere Med 1, Dept Innere Med, Halle, Saale, Germany; [Kemkemer, Ralf] Max Planck Inst Met Res, ZWE Biomat, D-70569 Stuttgart, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Max Planck Society	Rolli, CG (corresponding author), Max Planck Inst Met Res, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany.	ralf.kemkemer@mf.mpg.de	Seufferlein, Thomas TW/P-7147-2018; Spatz, Joachim P/A-1107-2017	Spatz, Joachim P/0000-0003-3419-9807	National Institutes of Health [PN2 EY 016586]; University of Heidelberg; Max Planck Society; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Heidelberg; Max Planck Society(Max Planck Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This publication and the project described herein were partly supported by the National Institutes of Health, through the NIH Roadmap for Medical Research (PN2 EY 016586). The work was also supported by the Excellence Cluster "CellNetwork'' of the University of Heidelberg. The support of the Max Planck Society is highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Greiner C, 2007, LANGMUIR, V23, P3495, DOI 10.1021/la0633987; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; SEUFFERLEIN T, 1995, J BIOL CHEM, V270, P24343, DOI 10.1074/jbc.270.41.24343; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; VEREYCKEN V, 1995, J PHYS III, V5, P1469, DOI 10.1051/jp3:1995204; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Weinberg RA, 2007, BIOL CANC; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002	22	117	121	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8726	10.1371/journal.pone.0008726	http://dx.doi.org/10.1371/journal.pone.0008726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090950	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714900007
J	Cencioni, MT; Chiurchiu, V; Catanzaro, G; Borsellino, G; Bernardi, G; Battistini, L; Maccarrone, M				Cencioni, Maria Teresa; Chiurchiu, Valerio; Catanzaro, Giuseppina; Borsellino, Giovanna; Bernardi, Giorgio; Battistini, Luca; Maccarrone, Mauro			Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID CB1; CELLS; PHARMACOLOGY; ENDOCANNABINOIDS; EXPRESSION; APOPTOSIS; SYSTEM	Background: Anandamide (AEA) is an endogenous lipid mediator that exerts several effects in the brain as well as in peripheral tissues. These effects are mediated mainly by two types of cannabinoid receptors, named CB1R and CB2R, making AEA a prominent member of the "endocannabinoid" family. Also immune cells express CB1 and CB2 receptors, and possess the whole machinery responsible for endocannabinoid metabolism. Not surprisingly, evidence has been accumulated showing manifold roles of endocannabinoids in the modulation of the immune system. However, details of such a modulation have not yet been disclosed in primary human 1-cells. Methodology/Significance: In this investigation we used flow cytometry and ELISA tests, in order to show that AEA suppresses proliferation and release of cytokines like IL-2, TNF-alpha and INF-gamma from activated human peripheral T-lymphocytes. However, AEA did not exert any cytotoxic effect on 1-cells. The immunosuppression induced by AEA was mainly dependent on CB2R, since it could be mimicked by the CB2R selective agonist JWH-015, and could be blocked by the specific CB2R antagonist SR144528. Instead the selective CB1R agonist ACEA, or the selective CB1R antagonist SR141716, were ineffective. Furthermore, we demonstrated an unprecedented immunosuppressive effect of AEA on IL-17 production, a typical cytokine that is released from the unique CD4+ T-cell subset T-helper 17. Conclusions/Significance: Overall, our study investigates for the first time the effects of the endocannabinoid AEA on primary human T-lymphocytes, demonstrating that it is a powerful modulator of immune cell functions. In particular, not only we clarify that CB2R mediates the immunosuppressive activity of AEA, but we are the first to describe such an immunosuppressive effect on the newly identified Th-17 cells. These findings might be of crucial importance for the rational design of new endocannabinoid-based immunotherapeutic approaches.	[Cencioni, Maria Teresa; Chiurchiu, Valerio; Catanzaro, Giuseppina; Borsellino, Giovanna; Bernardi, Giorgio; Battistini, Luca; Maccarrone, Mauro] Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy; [Catanzaro, Giuseppina; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, Teramo, Italy; [Bernardi, Giorgio] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	IRCCS Santa Lucia; University of Teramo; University of Rome Tor Vergata	Battistini, L (corresponding author), Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy.	l.battistini@hsantalucia.it; mmaccarrone@unite.it	catanzaro, giuseppina/AGZ-8080-2022; Cencioni, maria teresa/AAA-1849-2022; Maccarrone, Mauro/K-5398-2012; Borsellino, Giovanna/K-3074-2016; Battistini, Luca/D-6920-2014; Battistini, luca/ABE-1882-2021; Chiurchiu, Valerio/G-6227-2011	catanzaro, giuseppina/0000-0001-8427-9691; Cencioni, maria teresa/0000-0002-2694-2392; Maccarrone, Mauro/0000-0002-3990-2963; Borsellino, Giovanna/0000-0002-4227-6481; Battistini, Luca/0000-0002-6488-4891; Chiurchiu, Valerio/0000-0002-0316-7311	Italian Ministry of Health (Progetto Finalizzato); Fondazione TERCAS [2009-2012]	Italian Ministry of Health (Progetto Finalizzato)(Ministry of Health, Italy); Fondazione TERCAS	We are grateful to Dr. Nicoletta Pasquariello (University of Teramo) for qRT-PCR analysis, and to Dr. Filomena Fezza (University of Rome "Tor Vergata") for [35S]GTP-gamma-S assays. This investigation was partly supported by Italian Ministry of Health (Progetto Finalizzato) to LB, and by Fondazione TERCAS (grants 2009-2012) to MM.	Bari M, 2006, J IMMUNOL, V177, P4971, DOI 10.4049/jimmunol.177.8.4971; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Coffey RG, 1996, BIOCHEM PHARMACOL, V52, P743, DOI 10.1016/0006-2952(96)00356-5; Correa F, 2008, BIOCHEM J, V409, P761, DOI 10.1042/BJ20071329; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Felder CC, 1996, FEBS LETT, V393, P231, DOI 10.1016/0014-5793(96)00891-5; FONSER IA, 2008, IMMUNOL REV, V226, P87; HILLARD CJ, 1989, J PHARMACOL EXP THER, V289, P1127; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; IBENEN K, 2008, EUR J PHARMACOL, V161, P207; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Joseph J, 2004, CANCER IMMUNOL IMMUN, V53, P723, DOI 10.1007/s00262-004-0509-9; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P179, DOI 10.1038/sj.bjp.0707566; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Maccarrone M, 2001, ARCH BIOCHEM BIOPHYS, V393, P321, DOI 10.1006/abbi.2001.2500; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; MARRION KS, 2008, CURR TOP MED CHEM, V3, P187; McAllister SD, 2002, PROSTAG LEUKOTR ESS, V66, P161, DOI 10.1054/plef.2001.0344; Nong L, 2002, J NEUROIMMUNOL, V127, P169, DOI 10.1016/S0165-5728(02)00113-3; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Puffenbarger RA, 2000, GLIA, V29, P58, DOI 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.3.CO;2-N; RIMMERMAN X, 2008, BRIT J PHARMACOL, V133, P380; ROCKWELL GE, 2008, BIOCHEM PHARMACOL, V76, P531; SCHWARZ H, 1994, J NEUROIMMUNOL, V55, P107, DOI 10.1016/0165-5728(94)90152-X; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; TAKAAO F, 2007, LIFE SCI, V80, P1333; Wolf SA, 2008, CURR PHARM DESIGN, V14, P2266, DOI 10.2174/138161208785740090	30	171	174	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8688	10.1371/journal.pone.0008688	http://dx.doi.org/10.1371/journal.pone.0008688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XE	20098669	Green Published, Green Submitted, gold			2022-12-25	WOS:000278099500001
J	Walmsley, GL; Arechavala-Gomeza, V; Fernandez-Fuente, M; Burke, MM; Nagel, N; Holder, A; Stanley, R; Chandler, K; Marks, SL; Muntoni, F; Shelton, GD; Piercy, RJ				Walmsley, Gemma L.; Arechavala-Gomeza, Virginia; Fernandez-Fuente, Marta; Burke, Margaret M.; Nagel, Nicole; Holder, Angela; Stanley, Rachael; Chandler, Kate; Marks, Stanley L.; Muntoni, Francesco; Shelton, G. Diane; Piercy, Richard J.			A Duchenne Muscular Dystrophy Gene Hot Spot Mutation in Dystrophin-Deficient Cavalier King Charles Spaniels Is Amenable to Exon 51 Skipping	PLOS ONE			English	Article							DMD GENE; SKELETAL-MUSCLE; CANINE MODEL; DELETION; EXPRESSION; MICE; DOG; CARDIOMYOPATHY; ORGANIZATION; THERAPY	Background: Duchenne muscular dystrophy (DMD), which afflicts 1 in 3500 boys, is one of the most common genetic disorders of children. This fatal degenerative condition is caused by an absence or deficiency of dystrophin in striated muscle. Most affected patients have inherited or spontaneous deletions in the dystrophin gene that disrupt the reading frame resulting in unstable truncated products. For these patients, restoration of the reading frame via antisense oligonucleotide-mediated exon skipping is a promising therapeutic approach. The major DMD deletion "hot spot" is found between exons 45 and 53, and skipping exon 51 in particular is predicted to ameliorate the dystrophic phenotype in the greatest number of patients. Currently the mdx mouse is the most widely used animal model of DMD, although its mild phenotype limits its suitability in clinical trials. The Golden Retriever muscular dystrophy (GRMD) model has a severe phenotype, but due to its large size, is expensive to use. Both these models have mutations in regions of the dystrophin gene distant from the commonly mutated DMD "hot spot". Methodology/Principal Findings: Here we describe the severe phenotype, histopathological findings, and molecular analysis of Cavalier King Charles Spaniels with dystrophin-deficient muscular dystrophy (CKCS-MD). The dogs harbour a missense mutation in the 59 donor splice site of exon 50 that results in deletion of exon 50 in mRNA transcripts and a predicted premature truncation of the translated protein. Antisense oligonucleotide-mediated skipping of exon 51 in cultured myoblasts from an affected dog restored the reading frame and protein expression. Conclusions/Significance: Given the small size of the breed, the amiable temperament and the nature of the mutation, we propose that CKCS-MD is a valuable new model for clinical trials of antisense oligonucleotide-induced exon skipping and other therapeutic approaches for DMD.	[Walmsley, Gemma L.; Fernandez-Fuente, Marta; Stanley, Rachael; Chandler, Kate; Piercy, Richard J.] Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England; [Arechavala-Gomeza, Virginia; Fernandez-Fuente, Marta; Muntoni, Francesco; Piercy, Richard J.] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Burke, Margaret M.] Harefield Hosp, Pathol Lab, Royal Brompton & Harefield NHS Fdn Trust, Harefield UB9 6JH, Middx, England; [Nagel, Nicole] Alphapet Vet Clin, Bognor Regis, West Sussex, England; [Marks, Stanley L.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Shelton, G. Diane] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of London; University of London Royal Veterinary College; University of London; University College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; University of California System; University of California Davis; University of California System; University of California San Diego	Walmsley, GL (corresponding author), Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England.	rpiercy@rvc.ac.uk	Fernandez-Fuente, Marta/A-1761-2014; Arechavala-Gomeza, Virginia/C-1546-2008	Arechavala-Gomeza, Virginia/0000-0001-7703-3255	Muscular Dystrophy Association (USA); University College London Medical Research Council Neuromuscular translational research centre [G0502130]; Medical Research Council [G0502130, G0601943] Funding Source: researchfish; MRC [G0601943, G0502130] Funding Source: UKRI	Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); University College London Medical Research Council Neuromuscular translational research centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Muscular Dystrophy Association (USA) funds canine studies in the laboratory of one of the authors (GDS). Prof. Muntoni acknowledges the financial support from the Medical Research Coucil (Award G0502130) for antisense oligonucleotide studies and for funding the Biobank of the University College London Medical Research Council Neuromuscular translational research centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; Ambrosio CE, 2008, NEUROMUSCULAR DISORD, V18, P892, DOI 10.1016/j.nmd.2008.06.385; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Bushby K., 2005, CURRENT PAEDIAT, V15, P292, DOI [DOI 10.1016/J.CUPE.2005.04.001, 10.1016/j.cupe.2005.04.001, 10.1016/j.cupe.2005.04.001.4D]; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; CHAPMAN VM, 1989, P NATL ACAD SCI USA, V86, P1292, DOI 10.1073/pnas.86.4.1292; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; Duan DS, 2006, HUM MOL GENET, V15, pR253, DOI 10.1093/hmg/ddl180; Dubowitz V, 2006, NEUROMUSCULAR DISORD, V16, P865, DOI 10.1016/j.nmd.2006.09.003; DUBOWITZ V, 2007, MUSCLE BIOPSY PRACTI, P11; FANIN M, 1995, MUSCLE NERVE, V18, P1115, DOI 10.1002/mus.880181007; Feron M, 2009, AM J PATHOL, V174, P1459, DOI 10.2353/ajpath.2009.080460; Gaschen F, 2001, ACTA NEUROPATHOL, V101, P591; GASCHEN FP, 1992, J NEUROL SCI, V110, P149, DOI 10.1016/0022-510X(92)90022-D; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; KARPATI G, 1993, J NEUROPATH EXP NEUR, V52, P119, DOI 10.1097/00005072-199303000-00004; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nobile C, 1997, GENOMICS, V45, P421, DOI 10.1006/geno.1997.4911; OUDET C, 1992, HUM MOL GENET, V1, P599, DOI 10.1093/hmg/1.8.599; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Rusbridge C, 2004, J VET INTERN MED, V18, P673, DOI 10.1892/0891-6640(2004)18&lt;673:IOOBHC&gt;2.0.CO;2; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Schatzberg SJ, 1998, MUSCLE NERVE, V21, P991, DOI 10.1002/(SICI)1097-4598(199808)21:8<991::AID-MUS2>3.3.CO;2-S; Schatzberg SJ, 2004, VET CLIN N AM-SMALL, V34, P1497, DOI 10.1016/j.cvsm.2004.06.001; Schatzberg SJ, 1999, NEUROMUSCULAR DISORD, V9, P289, DOI 10.1016/S0960-8966(99)00011-5; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Shelton GD, 2005, NEUROMUSCULAR DISORD, V15, P127, DOI 10.1016/j.nmd.2004.10.019; Shimatsu Y, 2003, EXP ANIM TOKYO, V52, P93, DOI 10.1538/expanim.52.93; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Sironi M, 2006, FASEB J, V20, P1910, DOI 10.1096/fj.05-5635fje; VALENTINE BA, 1989, AM J PATHOL, V135, P671; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; WINAND NJ, 1994, NEUROMUSCULAR DISORD, V4, P433, DOI 10.1016/0960-8966(94)90082-5; Yokota T, 2009, ANN NEUROL; Yokota T, 2006, J CELL SCI, V119, P2679, DOI 10.1242/jcs.03000; Yugeta Naoko, 2006, BMC Cardiovasc Disord, V6, P47, DOI 10.1186/1471-2261-6-47	48	85	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8647	10.1371/journal.pone.0008647	http://dx.doi.org/10.1371/journal.pone.0008647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072625	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000273554600010
J	Wilson, AE; Kaul, RB; Sarnelle, O				Wilson, Alan E.; Kaul, RajReni B.; Sarnelle, Orlando			Growth Rate Consequences of Coloniality in a Harmful Phytoplankter	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS-AERUGINOSA; EQUIVALENT SPHERICAL DIAMETER; ALLOMETRIC SCALING LAWS; KUTZ-EMEND-ELENKIN; CELL-SIZE; COLONY SIZE; MARINE-PHYTOPLANKTON; BODY-SIZE; PHAEOCYSTIS-POUCHETII; METABOLIC-RATE	Background: Allometric studies have shown that individual growth rate is inversely related to body size across a broad spectrum of organisms that vary greatly in size. Fewer studies have documented such patterns within species. No data exist directly documenting the influence of colony size on growth rate for microscopic, colonial organisms. Methodology/Principal Findings: To determine if similar negative relationships between growth rate and size hold for colonial organisms, we developed a technique for measuring the growth of individual colonies of a bloom-forming, toxic cyanobacterium, Microcystis aeruginosa using microscopy and digital image analysis. For five out of six genotypes of M. aeruginosa isolated from lakes in Michigan and Alabama, we found significant negative relationships between colony size and growth rate. We found large intraspecific variation in both the slope of these relationships and in the growth rate of colonies at a standard size. In addition, growth rate estimates for individual colonies were generally consistent with population growth rates measured using standard batch culture. Conclusions/Significance: Given that colony size varies widely within populations, our results imply that natural populations of colonial phytoplankton exist as a mosaic of individuals with widely varying ecological attributes (since size strongly affects growth rate, grazing mortality, and migration speed). Quantifying the influence of colony size on growth rate will permit development of more accurate, predictive models of ecological interactions (e. g., competition, herbivory) and their role in the proliferation of harmful algal blooms, in addition to increasing our understanding about why these interactions vary in strength within and across environments.	[Wilson, Alan E.; Kaul, RajReni B.] Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA; [Sarnelle, Orlando] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Auburn University System; Auburn University; Michigan State University	Wilson, AE (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA.	wilson@auburn.edu		Kaul, Rajreni/0000-0003-4820-5972; Wilson, Alan/0000-0003-1080-0354	National Science Foundation [0841864, 0841944]; Alabama Agricultural Experiment Station; United States Environmental Protection Agency [RD83170801]; Division Of Environmental Biology [0841864, 0841944] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Alabama Agricultural Experiment Station; United States Environmental Protection Agency(United States Environmental Protection Agency); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank the Cooperative Institute for Limnology and Ecosystems Research at the University of Michigan, the Great Lakes Environmental Research Laboratory, the Department of Fisheries and Wildlife at Michigan State University, and the Department of Fisheries and Allied Aquacultures at Auburn University for supporting this work. This research was funded by the National Science Foundation (grants 0841864 and 0841944), the Alabama Agricultural Experiment Station, and the United States Environmental Protection Agency's Science to Achieve Results (STAR) Program (grant RD83170801). Although the research described in this article has been funded in part by the United States Environmental Protection Agency through grant/cooperative agreement RD83170801 to O. Sarnelle, it has not been subjected to the Agency's required peer and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS MA, 1991, CAN J FISH AQUAT SCI, V48, P1967, DOI 10.1139/f91-234; ARMBRUST EV, 1992, J PHYCOL, V28, P146, DOI 10.1111/j.0022-3646.1992.00146.x; BANSE K, 1976, J PHYCOL, V12, P135; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; BRAND LE, 1981, EVOLUTION, V35, P1117, DOI 10.1111/j.1558-5646.1981.tb04981.x; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Caraco NF, 2006, LIMNOL OCEANOGR, V51, P664, DOI 10.4319/lo.2006.51.1_part_2.0664; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; Chan F, 2004, LIMNOL OCEANOGR, V49, P2171, DOI 10.4319/lo.2004.49.6.2171; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; COSTELLO J C, 1981, Journal of Plankton Research, V3, P415, DOI 10.1093/plankt/3.3.415; CRUMPTON WG, 1982, ECOLOGY, V63, P1729, DOI 10.2307/1940115; DALEY RJ, 1973, J PHYCOL, V9, P395, DOI 10.1111/j.0022-3646.1973.00395.x; DURBIN EG, 1977, J PHYCOL, V13, P150, DOI 10.1111/j.1529-8817.1977.tb02904.x; ELSER JJ, 1992, ECOLOGY, V72, P887; Finkel ZV, 2000, J THEOR BIOL, V204, P361, DOI 10.1006/jtbi.2000.2020; FURNAS M, 1978, J EXP MAR BIOL ECOL, V34, P97, DOI 10.1016/0022-0981(78)90034-5; Gao KS, 2004, J PHYCOL, V40, P523, DOI 10.1111/j.1529-8817.2004.03155.x; GEIDER RJ, 1986, MAR ECOL PROG SER, V30, P93, DOI 10.3354/meps030093; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Irwin AJ, 2006, J PLANKTON RES, V28, P459, DOI 10.1093/plankt/fbi148; Jacobsen A, 2007, AQUAT MICROB ECOL, V48, P105, DOI 10.3354/ame048105; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; JENNINGS BR, 1988, P ROY SOC LOND A MAT, V419, P137, DOI 10.1098/rspa.1988.0100; Joung SH, 2006, J MICROBIOL, V44, P562; Kim K, 1998, FUNCT ECOL, V12, P646, DOI 10.1046/j.1365-2435.1998.00228.x; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; LEWIS WM, 1976, SCIENCE, V192, P885, DOI 10.1126/science.192.4242.885; Li YG, 2004, EUR J PHYCOL, V39, P9, DOI 10.1080/0967026032000157147; Lurling M, 2000, OIKOS, V88, P111, DOI 10.1034/j.1600-0706.2000.880113.x; Maranon E, 2007, LIMNOL OCEANOGR, V52, P2190, DOI 10.4319/lo.2007.52.5.2190; Nakaya F, 2005, P ROY SOC B-BIOL SCI, V272, P1963, DOI 10.1098/rspb.2005.3143; Nielsen SL, 2006, J PLANKTON RES, V28, P489, DOI 10.1093/plankt/fbi134; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; NUSCH E. A., 1980, ARCH HYDROBIOL BEIH, V14, P14; Oh HM, 2000, APPL ENVIRON MICROB, V66, P176, DOI 10.1128/AEM.66.1.176-179.2000; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; PAERL HW, 1988, LIMNOL OCEANOGR, V33, P823, DOI 10.4319/lo.1988.33.4_part_2.0823; PORTER KG, 1977, AM SCI, V65, P159; Pratt MC, 2005, MAR ECOL PROG SER, V303, P153, DOI 10.3354/meps303153; Prescott G. W., 1962, ALGAE W GREAT LAKES; Reich PB, 2001, TRENDS ECOL EVOL, V16, P674, DOI 10.1016/S0169-5347(01)02306-0; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Reynolds CS, 2007, HYDROBIOLOGIA, V578, P37, DOI 10.1007/s10750-006-0431-6; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; REYNOLDS CS, 1975, BIOL REV, V50, P437, DOI 10.1111/j.1469-185X.1975.tb01060.x; REYNOLDS CS, 1973, PROC R SOC SER B-BIO, V184, P29, DOI 10.1098/rspb.1973.0029; REYNOLDS CS, 1978, BRIT PHYCOL J, V13, P269, DOI 10.1080/00071617800650331; Saker ML, 2005, J APPL MICROBIOL, V99, P749, DOI 10.1111/j.1365-2672.2005.02687.x; Sand-Jensen K, 2009, LIMNOL OCEANOGR, V54, P1282, DOI 10.4319/lo.2009.54.4.1282; Sarnelle O, 2005, LIMNOL OCEANOGR, V50, P896, DOI 10.4319/lo.2005.50.3.0896; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; STEMBERGER RS, 1981, CAN J FISH AQUAT SCI, V38, P721, DOI 10.1139/f81-095; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; TANG EPY, 1995, J PLANKTON RES, V17, P1325, DOI 10.1093/plankt/17.6.1325; Thessen AE, 2009, HARMFUL ALGAE, V8, P792, DOI 10.1016/j.hal.2009.01.003; Thomassen S, 1995, MAR ECOL PROG SER, V128, P239, DOI 10.3354/meps128239; Verity PG, 2007, J PLANKTON RES, V29, P359, DOI 10.1093/plankt/fbm021; Visser PM, 1997, HYDROBIOLOGIA, V349, P99, DOI 10.1023/A:1003001713560; Vuorio K, 2009, LIMNOL OCEANOGR, V54, P925, DOI 10.4319/lo.2009.54.3.0925; WATANABE M, 1996, TOXIC MICROCYSTIS, P13; Watanabe M.F., 1996, TOXIC MICROCYSTIS; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WILLIAMS RICHARD B., 1964, ECOLOGY, V45, P877, DOI 10.2307/1934940; Wilson AE, 2005, APPL ENVIRON MICROB, V71, P6126, DOI 10.1128/AEM.71.10.6126-6133.2005; Wilson AE, 2007, LIMNOL OCEANOGR, V52, P1467, DOI 10.4319/lo.2007.52.4.1467; Wilson AE, 2006, APPL ENVIRON MICROB, V72, P7386, DOI 10.1128/AEM.00834-06; Wilson AE, 2006, LIMNOL OCEANOGR, V51, P1915, DOI 10.4319/lo.2006.51.4.1915; Yang RJ, 2006, J EXP MAR BIOL ECOL, V331, P33, DOI 10.1016/j.jembe.2005.09.015	73	26	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8679	10.1371/journal.pone.0008679	http://dx.doi.org/10.1371/journal.pone.0008679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084114	Green Published, Green Submitted, gold			2022-12-25	WOS:000273554600030
J	Kumar, S; Arankalle, VA				Kumar, Satyendra; Arankalle, Vidya A.			Intracranial Administration of P Gene siRNA Protects Mice from Lethal Chandipura Virus Encephalitis	PLOS ONE			English	Article							RNA INTERFERENCE; MAMMALIAN-CELLS; MATRIX PROTEIN; ANDHRA-PRADESH; EXPRESSION; INFECTION; INDIA; CHILDREN; BRAIN; TRANSCRIPTION	Background: In parts of India, Chandipura Virus (CHPV) has emerged as an encephalitis causing pathogen in both epidemic and sporadic forms. This pediatric disease follows rapid course leading to 55-75% mortality. In the absence of specific treatment, effectiveness of RNA interference (RNAi) was evaluated. Methods and Findings: Efficacy of synthetic short interfering RNA (siRNA) or short hairpin RNA (shRNA) in protecting mice from CHPV infection was assessed. The target genes were P and M genes primarily because important role of the former in viral replication and lethal nature of the latter. Real time one step RT-PCR and plaque assay were used for the assessment of gene silencing. Using pAcGFP1N1-CHPV-P, we showed that P-2 siRNA was most efficient in reducing the expression of P gene in-vitro. Both quantitative assays documented 2logs reduction in the virus titer when P-2, M-5 or M-6 siRNAs were transfected 2hr post infection (PI). Use of these siRNAs in combination did not result in enhanced efficiency. P-2 siRNA was found to tolerate four mismatches in the center. As compared to five different shRNAs, P-2 siRNA was most effective in inhibiting CHPV replication. An extended survival was noted when mice infected intracranially with 100 LD(50) CHPV were treated with cationic lipid complexed 5 mu g P-2 siRNA simultaneously. Infection with 10LD(50) and treatment with two doses of siRNA first, simultaneously and second 24 hr PI, resulted in 70% survival. Surviving mice showed 4logs less CHPV titers in brain without histopathological changes or antibody response. Gene expression profiles of P-2 siRNA treated mice showed no interferon response. First dose of siRNA at 2hr or 4hr PI with second dose at 24hr resulted in 40% and 20% survival respectively suggesting potential application in therapy. Conclusions: The results highlight therapeutic potential of siRNA in treating rapid and fatal Chandipura encephalitis.	[Kumar, Satyendra; Arankalle, Vidya A.] Natl Inst Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Kumar, S (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	varankalle@yahoo.com		Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The study was supported by the Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Ahmed M, 1998, J VIROL, V72, P8413, DOI 10.1128/JVI.72.10.8413-8419.1998; Arankalle VA, 2005, EMERG INFECT DIS, V11, P123, DOI 10.3201/eid1101.040602; Barik S, 2004, VIRUS RES, V102, P27, DOI 10.1016/j.virusres.2004.01.012; Basak S, 2007, BIOSCIENCE REP, V27, P275, DOI 10.1007/s10540-007-9054-z; Bennink JR, 2004, TRENDS MOL MED, V10, P571, DOI 10.1016/j.molmed.2004.10.004; Bernstein E, 2001, RNA, V7, P1509; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chadha MS, 2005, AM J TROP MED HYG, V73, P566, DOI 10.4269/ajtmh.2005.73.566; CHATTOPADHYAY D, 1994, CELL MOL BIOL RES, V40, P693; Clarke P, 2009, J VIROL, V83, P6161, DOI 10.1128/JVI.02488-08; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fulton A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004118; Geisbert TW, 2006, J INFECT DIS, V193, P1650, DOI 10.1086/504267; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Isacson R, 2003, ACTA PHYSIOL SCAND, V179, P173, DOI 10.1046/j.1365-201X.2003.01188.x; Israsena N, 2009, ANTIVIR RES, V84, P76, DOI 10.1016/j.antiviral.2009.07.012; Koterski J, 2007, FEMS IMMUNOL MED MIC, V51, P462, DOI 10.1111/j.1574-695X.2007.00319.x; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Kumar S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-168; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Licata JM, 2003, INT REV IMMUNOL, V22, P451, DOI 10.1080/08830180305217; Lingor P, 2004, BIOCHEM BIOPH RES CO, V315, P1126, DOI 10.1016/j.bbrc.2004.01.170; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Nuovo GJ, 2005, MODERN PATHOL, V18, P62, DOI 10.1038/modpathol.3800274; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; REED LJ, 1938, AM J HYG, V27, P49; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; Tandale BV, 2008, J MED VIROL, V80, P118, DOI 10.1002/jmv.21041; Taylor A, 1999, VIRUS GENES, V19, P223, DOI 10.1023/A:1008188730975; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tripathy A, 2005, SCAND J INFECT DIS, V37, P590, DOI 10.1080/00365540510044067; Trottier MD, 2005, VIROLOGY, V333, P215, DOI 10.1016/j.virol.2005.01.009; Venkateswarlu CH, 2009, VACCINE, V27, P2845, DOI 10.1016/j.vaccine.2009.02.089; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005709; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Zhang Y, 2003, J GENE MED, V5, P1039, DOI 10.1002/jgm.449	46	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8615	10.1371/journal.pone.0008615	http://dx.doi.org/10.1371/journal.pone.0008615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062542	gold, Green Published, Green Submitted			2022-12-25	WOS:000273414100009
J	Pochynyuk, O; Rieg, T; Bugaj, V; Schroth, J; Fridman, A; Boss, GR; Insel, PA; Stockand, JD; Vallon, V				Pochynyuk, Oleh; Rieg, Timo; Bugaj, Vladislav; Schroth, Jana; Fridman, Alla; Boss, Gerry R.; Insel, Paul A.; Stockand, James D.; Vallon, Volker			Dietary Na+ inhibits the open probability of the epithelial sodium channel in the kidney by enhancing apical P2Y(2)-receptor tone	FASEB JOURNAL			English	Article						ATP; aldosterone; distal nephron; blood pressure; nucleotide receptors	CORTICAL COLLECTING DUCT; RECEPTOR-MEDIATED INHIBITION; P2 RECEPTORS; ATP; TRANSPORT; RELEASE; CELLS; ABSORPTION; ACTIVATION; RETENTION	Apical release of ATP and UTP can activate P2Y(2) receptors in the aldosterone-sensitive distal nephron (ASDN) and inhibit the open probability (Po) of the epithelial sodium channel (ENaC). Little is known, however, about the regulation and physiological relevance of this system. Patch-clamp studies in freshly isolated ASDN provide evidence that increased dietary Na+ intake in wild-type mice lowers ENaC P-o, consistent with a contribution to Na+ homeostasis, and is associated with increased urinary concentrations of UTP and the ATP hydrolytic product, ADP. Genetic deletion of P2Y(2) receptors in mice (P2Y(2)(-/-); littermates to wild-type mice) or inhibition of apical P2Y-receptor activation in wild-type mice prevents dietary Na+-induced lowering of ENaC P-o. Although they lack suppression of ENaC P-o by dietary NaCl, P2Y(2)(-/-) mice do not exhibit NaCl-sensitive blood pressure, perhaps as a consequence of compensatory down-regulation of aldosterone levels. Consistent with this hypothesis, clamping mineralocorticoid activity at high levels unmasks greater ENaC activity and NaCl sensitivity of blood pressure in P2Y(2)(-/-) mice. The studies indicate a key role of the apical ATP/UTP-P2Y(2)-receptor system in the inhibition of ENaC Po in the ASDN in response to an increase in Na+ intake, thereby contributing to NaCl homeostasis and blood pressure regulation.Pochynyuk, O., Rieg, T., Bugaj, V., Schroth, J., Fridman, A., Boss, G. R., Insel, P. A., Stockand, J. D., Vallon, V. Dietary Na+ inhibits the open probability of the epithelial sodium channel in the kidney by enhancing apical P2Y(2)-receptor tone. FASEB J. 24, 2056-2065 (2010). www.fasebj.org	[Pochynyuk, Oleh; Bugaj, Vladislav; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Rieg, Timo; Fridman, Alla; Boss, Gerry R.; Insel, Paul A.; Vallon, Volker] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Insel, Paul A.; Vallon, Volker] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Rieg, Timo; Schroth, Jana; Vallon, Volker] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Vallon, V (corresponding author), Univ Calif San Diego, Dept Med, 3350 La Jolla Village Dr 9151, San Diego, CA 92161 USA.	stockand@uthscsa.edu; vvallon@ucsd.edu	Rieg, Timo/W-7478-2019	Rieg, Timo/0000-0001-6082-662X; Stockand, James/0000-0002-3817-4319; Vallon, Volker/0000-0002-9211-2063; Boss, Gerry/0000-0002-9758-8714	U.S. National Institutes of Health [R01DK59594, R01GM66232, R01DK56248, R01DK28602, P30DK079337]; American Heart Association [064005N, 0825062F, 09SDG2230391]; Department of Veterans Affairs; National Kidney Foundation of Southern California; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059594, R01DK056248, R01DK028602, P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); National Kidney Foundation of Southern California; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by the U.S. National Institutes of Health (R01DK59594 to J.D.S.; R01GM66232 to P.A.I.; and R01DK56248, R01DK28602 and P30DK079337 to V.V.), the American Heart Association (064005N to J.D.S. and 0825062F and 09SDG2230391 to O.P.), the Department of Veterans Affairs (to V.V.), and the National Kidney Foundation of Southern California (to T.R.). The authors thank B. Koller and W. Zinzow (University of North Carolina, Chapel Hill, NC, USA) for the P2Y<INF>2</INF><SUP>-/-</SUP> mouse.	BOSS GR, 1982, J BIOL CHEM, V257, P4242; Buscher R, 2006, PHARMACOGENET GENOM, V16, P199; Bugaj V, 2008, AM J PHYSIOL-RENAL, V295, pF1063, DOI 10.1152/ajprenal.90321.2008; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Cuffe JE, 2000, J PHYSIOL-LONDON, V524, P77, DOI 10.1111/j.1469-7793.2000.00077.x; DUCHATELLE P, 1992, MOL CELL BIOCHEM, V114, P27; Geyti CS, 2008, PFLUG ARCH EUR J PHY, V455, P1105, DOI 10.1007/s00424-007-0366-4; Guyton AC, 1992, HYPERTENSION S1, V19, P12; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Homolya L, 1999, J BIOL CHEM, V274, P26454, DOI 10.1074/jbc.274.37.26454; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Hummler E, 2005, J AM SOC NEPHROL, V16, P3160, DOI 10.1681/ASN.2005040450; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; KEMENDY AE, 1992, AM J PHYSIOL, V263, pC825, DOI 10.1152/ajpcell.1992.263.4.C825; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lehrmann H, 2002, J AM SOC NEPHROL, V13, P10, DOI 10.1681/ASN.V13110; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LING BN, 1990, MOL CELL BIOCHEM, V99, P141, DOI 10.1007/BF00230344; Lourdel S, 2005, J AM SOC NEPHROL, V16, P3642, DOI 10.1681/ASN.2005040363; Lu M, 2000, J GEN PHYSIOL, V116, P299, DOI 10.1085/jgp.116.2.299; Ma HP, 2005, J AM SOC NEPHROL, V16, P3182, DOI 10.1681/ASN.2005040434; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; PACHA J, 1993, J GEN PHYSIOL, V102, P25, DOI 10.1085/jgp.102.1.25; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Rieg T, 2007, EUR J PHARMACOL, V555, P174, DOI 10.1016/j.ejphar.2006.10.039; Rieg T, 2009, AM J PHYSIOL-REG I, V296, pR419, DOI 10.1152/ajpregu.90784.2008; Sackmann B., 1995, SINGLE CHANNEL RECOR, VSecond; Schwiebert EM, 2001, AM J PHYSIOL-RENAL, V280, pF945, DOI 10.1152/ajprenal.2001.280.6.F945; Shirley DG, 2005, AM J PHYSIOL-RENAL, V288, pF1243, DOI 10.1152/ajprenal.00152.2004; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Thomas J, 2001, J MEMBRANE BIOL, V183, P115, DOI 10.1007/s00232-001-0059-4; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Vallon V, 2005, AM J PHYSIOL-REG I, V289, pR395, DOI 10.1152/ajpregu.00731.2004; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF10, DOI 10.1152/ajprenal.00432.2007; Vallon V, 2009, J AM SOC NEPHROL, V20, P721, DOI 10.1681/ASN.2008040415; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; Wildman SSP, 2008, J AM SOC NEPHROL, V19, P731, DOI 10.1681/ASN.2007040443	41	75	76	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2056	2065		10.1096/fj.09-151506	http://dx.doi.org/10.1096/fj.09-151506			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20097874	Green Published			2022-12-25	WOS:000278200000039
J	Paquete, CM; Saraiva, IH; Calcada, E; Louro, RO				Paquete, Catarina M.; Saraiva, Ivo H.; Calcada, Eduardo; Louro, Ricardo O.			Molecular Basis for Directional Electron Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAHEME CYTOCHROME-C; SHEWANELLA-FRIGIDIMARINA; KINETICS; IDENTIFICATION; SPECIFICITY; REDUCTION; IRON	Biological macromolecules involved in electron transfer reactions display chains of closely packed redox cofactors when long distances must be bridged. This is a consequence of the need to maintain a rate of transfer compatible with metabolic activity in the framework of the exponential decay of electron tunneling with distance. In this work intermolecular electron transfer was studied in kinetic experiments performed with the small tetraheme cytochrome from Shewanella oneidensis MR-1 and from Shewanella frigidimarina NCIMB400 using non-physiological redox partners. This choice allowed the effect of specific recognition and docking to be eliminated from the measured rates. The results were analyzed with a kinetic model that uses the extensive thermodynamic characterization of these proteins reported in the literature to discriminate the kinetic contribution of each heme to the overall rate of electron transfer. This analysis shows that, in this redox chain that spans 23A, the kinetic properties of the individual hemes establish a functional specificity for each redox center. This functional specificity combined with the thermodynamic properties of these soluble proteins ensures directional electron flow within the cytochrome even outside of the context of a functioning respiratory chain.	[Paquete, Catarina M.; Saraiva, Ivo H.; Calcada, Eduardo; Louro, Ricardo O.] Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal		Louro, RO (corresponding author), Inst Tecnol Quim & Biol, Av Republ EAN, P-2780157 Oeiras, Portugal.	louro@itqb.unl.pt	Paquete, Catarina M./A-6615-2016; Saraiva, Ivo/M-6213-2013; Louro, Ricardo O./AAB-4601-2020	Paquete, Catarina M./0000-0002-1511-3732; Saraiva, Ivo/0000-0002-5833-7699; Louro, Ricardo O./0000-0002-2392-6450; Calcada, Eduardo/0000-0002-3386-1670	Fundacao para a Ciencia e a Tecnologia (FCT)-Portugal [REEQ/336/BIO/2005, MIT-Pt/BS-BB/0014/2008]; FCT-Portugal [SFRH/BDP/34591/2007, SFRH/BD/36582/2007]	Fundacao para a Ciencia e a Tecnologia (FCT)-Portugal(Portuguese Foundation for Science and Technology); FCT-Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT)-Portugal (Grants REEQ/336/BIO/2005 and MIT-Pt/BS-BB/0014/2008) and by FCT-Portugal Grants SFRH/BDP/34591/2007 (to C. M. P.) and SFRH/BD/36582/2007 (to I. H. S.).	Abida O, 2006, PHOTOCH PHOTOBIO SCI, V5, P395, DOI 10.1039/b518211e; BENTO I, 2007, HDB METALLOPROTEINS, P1; Catarino T, 2001, CHEMBIOCHEM, V2, P416, DOI 10.1002/1439-7633(20010601)2:6<416::AID-CBIC416>3.3.CO;2-Q; Davidson VL, 1996, BIOCHEMISTRY-US, V35, P14035, DOI 10.1021/bi961577p; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; Fonseca BM, 2009, J BIOL INORG CHEM, V14, P375, DOI 10.1007/s00775-008-0455-7; Fredrickson JK, 2008, GEOBIOLOGY, V6, P245, DOI 10.1111/j.1472-4669.2008.00146.x; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gordon EHJ, 2000, BIOCHEM J, V349, P153, DOI 10.1042/0264-6021:3490153; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Harada E, 2002, FEBS LETT, V532, P333, DOI 10.1016/S0014-5793(02)03696-7; Hoffman BM, 2005, P NATL ACAD SCI USA, V102, P3564, DOI 10.1073/pnas.0408767102; Kerisit S, 2007, J PHYS CHEM C, V111, P11363, DOI 10.1021/jp072060y; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; LAMBETH DO, 1973, J BIOL CHEM, V248, P6095; Leys D, 2002, J BIOL CHEM, V277, P35703, DOI 10.1074/jbc.M203866200; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MCKENNA CE, 1991, BIOCHIM BIOPHYS ACTA, V1075, P109, DOI 10.1016/0304-4165(91)90082-R; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Paixao VB, 2008, BIOCHEMISTRY-US, V47, P11973, DOI 10.1021/bi801326j; Paquete CM, 2007, BBA-BIOENERGETICS, V1767, P1169, DOI 10.1016/j.bbabio.2007.06.005; Pessanha M, 2003, BIOCHEM J, V370, P489, DOI 10.1042/BJ20021408; Tsapin AI, 2001, APPL ENVIRON MICROB, V67, P3236, DOI 10.1128/AEM.67.7.3236-3244.2001; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08	27	19	19	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10370	10375		10.1074/jbc.M109.078337	http://dx.doi.org/10.1074/jbc.M109.078337			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20089857	hybrid, Green Published			2022-12-25	WOS:000276264600022
J	McMichael, BK; Cheney, RE; Lee, BS				McMichael, Brooke K.; Cheney, Richard E.; Lee, Beth S.			Myosin X Regulates Sealing Zone Patterning in Osteoclasts through Linkage of Podosomes and Microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATIDYLINOSITOL 3-KINASE; ADHESION STRUCTURES; BMP RECEPTORS; ACTIN; CYTOSKELETON; DYNAMICS; FILOPODIA; MEMBRANE	Osteoclasts use actin-rich attachment structures in place of focal adhesions for adherence to bone and non-bone substrates. On glass, osteoclasts generate podosomes, foot-like processes containing a core of F-actin and regulatory proteins that undergo high turnover. To facilitate bone resorption, osteoclasts generate an actin-rich sealing zone composed of densely packed podosome-like units. Patterning of both podosomes and sealing zones is dependent upon an intact microtubule system. A role for unconventional myosin X (Myo10), which can bind actin, microtubules, and integrins, was examined in osteoclasts. Immunolocalization showed Myo10 to be associated with the outer edges of immature podosome rings and sealing zones, suggesting a possible role in podosome and sealing zone positioning. Further, complexes containing both Myo10 and beta-tubulin were readily precipitated from osteoclasts lysates. RNAi-mediated suppression of Myo10 led to decreased cell and sealing zone perimeter, along with decreased motility and resorptive capacity. Further, siRNA-treated cells could not properly position podosomes following microtubule disruption. Osteoclasts over-expressing dominant negative Myo10 microtubule binding domains (MyTH4) showed a similar phenotype. Conversely, overexpression of full-length Myo10 led to increased formation of podosome belts along with larger sealing zones and enhanced bone resorptive capacity. These studies suggest that Myo10 plays a role in osteoclast attachment and podosome positioning by direct linkage of actin to the microtubule network.	[McMichael, Brooke K.; Lee, Beth S.] Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, Columbus, OH 43210 USA; [Cheney, Richard E.] Univ N Carolina, Dept Cell & Mol Physiol, Sch Med, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lee, BS (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387; Cheney, Richard/0000-0001-6565-7888	National Institutes of Health [R01 AR051515, R01 DK052131, P01 HL080166, R01 DC03299]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR051515 and R01 DK052131 (to B. S. L.) and P01 HL080166 and R01 DC03299 (to R. E. C.).	Bennett RD, 2008, BIOCHEM BIOPH RES CO, V369, P654, DOI 10.1016/j.bbrc.2008.02.056; Bennett RD, 2007, J BIOL CHEM, V282, P3205, DOI 10.1074/jbc.M607174200; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Chellaiah M, 1998, J BIOL CHEM, V273, P11908, DOI 10.1074/jbc.273.19.11908; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; HRUSKA KA, 1995, ENDOCRINOLOGY, V136, P2984, DOI 10.1210/en.136.7.2984; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Jeyaraj S, 2005, J BIOL CHEM, V280, P37957, DOI 10.1074/jbc.M502883200; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kopp P, 2006, MOL BIOL CELL, V17, P2811, DOI 10.1091/mbc.E05-11-1010; Kotadiya P, 2008, BONE, V43, P951, DOI 10.1016/j.bone.2008.06.017; Krits I, 2002, CALCIFIED TISSUE INT, V71, P530, DOI 10.1007/s00223-001-1112-0; Lakkakorpi PT, 1997, EXP CELL RES, V237, P296, DOI 10.1006/excr.1997.3797; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Linder S, 2000, J CELL SCI, V113, P4165; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; McMichael BK, 2008, EXP CELL RES, V314, P564, DOI 10.1016/j.yexcr.2007.10.018; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; McMichael BK, 2009, J BIOL CHEM, V284, P12266, DOI 10.1074/jbc.M808621200; Narasimhulu SB, 1998, PLANT CELL, V10, P957, DOI 10.1105/tpc.10.6.957; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; Okumura S, 2006, BONE, V39, P684, DOI 10.1016/j.bone.2006.04.010; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Pilkington MF, 1998, J BONE MINER RES, V13, P688, DOI 10.1359/jbmr.1998.13.4.688; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sousa AD, 2006, J CELL SCI, V119, P184, DOI 10.1242/jcs.02726; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Wutzl A, 2006, J BIOMED MATER RES A, V77A, P75, DOI 10.1002/jbm.a.30615; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	50	45	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9506	9515		10.1074/jbc.M109.017269	http://dx.doi.org/10.1074/jbc.M109.017269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20081229	Green Published, hybrid			2022-12-25	WOS:000276165900024
J	Bourhis, E; Tam, C; Franke, Y; Bazan, JF; Ernst, J; Hwang, J; Costa, M; Cochran, AG; Hannoush, RN				Bourhis, Eric; Tam, Christine; Franke, Yvonne; Bazan, J. Fernando; Ernst, James; Hwang, Jiyoung; Costa, Mike; Cochran, Andrea G.; Hannoush, Rami N.			Reconstitution of a Frizzled8.Wnt3a.LRP6 Signaling Complex Reveals Multiple Wnt and Dkk1 Binding Sites on LRP6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-6; EXPRESSION; DICKKOPF-1; LIGAND; INTERNALIZATION; KINETICS; ENCODES; PATHWAY; FAMILY; GROWTH	Wnt/beta-catenin signaling is initiated at the cell surface by association of secreted Wnt with its receptors Frizzled (Fz) and low density lipoprotein receptor-related protein 5/6 (LRP5/6). The study of these molecular interactions has been a significant technical challenge because the proteins have been inaccessible in sufficient purity and quantity. In this report we describe insect cell expression and purification of soluble mouse Fz8 cysteine-rich domain and human LRP6 extracellular domain and show that they inhibit Wnt/beta-catenin signaling in cellular assays. We determine the binding affinities of Wnts and Dickkopf 1 (Dkk1) to the relevant co-receptors and reconstitute in vitro the Fz8 CRD.Wnt3a.LRP6 signaling complex. Using purified fragments of LRP6, we further show that Wnt3a binds to a region including only the third and fourth beta-propeller domains of LRP6 (E3E4). Surprisingly, we find that Wnt9b binds to a different part of the LRP6 extracellular domain, E1E2, and we demonstrate that Wnt3a and Wnt9b can bind to LRP6 simultaneously. Dkk1 binds to both E1E2 and E3E4 fragments and competes with both Wnt3a and Wnt9b for binding to LRP6. The existence of multiple, independent Wnt binding sites on the LRP6 co-receptor suggests new possibilities for the architecture of Wnt signaling complexes and a model for broad-spectrum inhibition of Wnt/beta-catenin signaling by Dkk1.	[Bourhis, Eric; Bazan, J. Fernando; Ernst, James; Cochran, Andrea G.; Hannoush, Rami N.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Tam, Christine; Franke, Yvonne; Hwang, Jiyoung] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Ernst, James] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Costa, Mike] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Hannoush, RN (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	hannoush.rami@gene.com	Bazan, J. Fernando/B-4562-2010	Cochran, Andrea/0000-0001-6469-795X				Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Koduri V, 2007, BIOCHEMISTRY-US, V46, P6570, DOI 10.1021/bi700049g; Liu CC, 2009, J BIOL CHEM, V284, P15299, DOI 10.1074/jbc.M807285200; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Morrell NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002930; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015	38	143	174	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9172	9179		10.1074/jbc.M109.092130	http://dx.doi.org/10.1074/jbc.M109.092130			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093360	hybrid, Green Published			2022-12-25	WOS:000275553700066
J	Rajala, RVS; Tanito, M; Neel, BG; Rajala, A				Rajala, Raju V. S.; Tanito, Masaki; Neel, Benjamin G.; Rajala, Ammaji			Enhanced Retinal Insulin Receptor-activated Neuroprotective Survival Signal in Mice Lacking the Protein-tyrosine Phosphatase-1B Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; ROD PHOTORECEPTOR CELLS; ENDOPLASMIC-RETICULUM; INCREASED ABUNDANCE; NEGATIVE REGULATOR; IN-VIVO; 1B; PHOSPHORYLATION; PTP1B; EXPRESSION	Protein-tyrosine phosphatase 1B (PTP1B) has been implicated in the negative regulation of insulin signaling. We previously demonstrated that light-induced tyrosine phosphorylation of the retinal insulin receptor (IR) results in the activation of phosphoinositide 3-kinase/Akt survival pathway in rod photoreceptor cells. The molecular mechanism behind light-induced activation of IR is not known. We investigated the in vivo mechanism of IR activation and found that PTP1B activity in dark-adapted retinas was significantly higher than in light-adapted retinas. We made a novel finding in this study that the light-dependent regulation of PTP1B activity is signaled through photobleaching of rhodopsin. Conditional deletion of PTP1B in rod photoreceptors by the Cre-loxP system resulted in enhanced IR signaling. Further PTP1B activity negatively regulated the neuroprotective survival signaling in the retina. One of the challenging questions in the retina research is how mutations in human rhodopsin gene slowly disable and eventually disrupt photoreceptor functions. Our studies suggest that a defect in the photobleaching of rhodopsin and mutation in rhodopsin gene enhances the activity of PTP1B, and this activated activity could down-regulate the IR survival signaling. Our studies suggest that PTP1B antagonists could be potential therapeutic agents to treat stress-induced photoreceptor degenerations and provide further evidence that rhodopsin photoexcitation may trigger signaling events alternative to the classic phototransduction.	[Rajala, Raju V. S.; Tanito, Masaki; Rajala, Ammaji] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.; Tanito, Masaki; Rajala, Ammaji] Univ Oklahoma, Hlth Sci Ctr, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; [Neel, Benjamin G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA; [Neel, Benjamin G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program, Boston, MA 02115 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rajala, RVS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	raju-rajala@ouhsc.edu			National Institutes of Health [EY016507, EY00871, P30-EY12190]; NEI; NCRR [P20-RR17703]; Research to Prevent Blindness Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012190, R01EY000871, R01EY016507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016507 and EY00871. This work was also supported by NEI, NIH Core Grant P30-EY12190, NCRR COBRE core modules P20-RR17703, and Research to Prevent Blindness Inc.	Ahmad F, 1997, METABOLISM, V46, P1140, DOI 10.1016/S0026-0495(97)90206-7; Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552; AHMAD F, 1995, J CLIN INVEST, V95, P2806, DOI 10.1172/JCI117985; AHMAD F, 1995, METABOLISM, V44, P1175, DOI 10.1016/0026-0495(95)90012-8; AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Bleyle LA, 1999, CELL SIGNAL, V11, P719, DOI 10.1016/S0898-6568(99)00043-1; Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841; Byon JCH, 1997, P SOC EXP BIOL MED, V216, P1; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Chen ZX, 2010, CELL DEATH DIFFER, V17, P408, DOI 10.1038/cdd.2009.132; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Goldstein Barry J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P265, DOI 10.2174/1568008013341163; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; Goldstein BJ, 2002, J CLIN ENDOCR METAB, V87, P2474, DOI 10.1210/jc.87.6.2474; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hetman M, 2000, J NEUROSCI, V20, P2567; KENNER KA, 1993, J BIOL CHEM, V268, P25455; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Krishnamoorthy RR, 1999, J BIOL CHEM, V274, P3734, DOI 10.1074/jbc.274.6.3734; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; Le YZ, 2006, MOL VIS, V12, P389; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Li GY, 2008, J NEUROCHEM, V107, P1382, DOI 10.1111/j.1471-4159.2008.05707.x; Maegawa H, 1999, J BIOL CHEM, V274, P30236, DOI 10.1074/jbc.274.42.30236; Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Organisciak DT, 1998, INVEST OPHTH VIS SCI, V39, P1107; Osborne NN, 2008, J NEUROCHEM, V105, P2013, DOI 10.1111/j.1471-4159.2008.05320.x; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rajala A, 2008, J BIOL CHEM, V283, P19781, DOI 10.1074/jbc.M802374200; Rajala A, 2007, J BIOL CHEM, V282, P9865, DOI 10.1074/jbc.M608845200; Rajala RVS, 2010, J LIPID RES, V51, P4, DOI 10.1194/jlr.R000232; Rajala RVS, 2009, INVEST OPHTH VIS SCI, V50, P1033, DOI 10.1167/iovs.08-2851; Rajala RVS, 2005, BIOCHEMISTRY-US, V44, P15461, DOI 10.1021/bi0513148; Rajala RVS, 2002, J BIOL CHEM, V277, P43319, DOI 10.1074/jbc.M206355200; RAPP LM, 1992, INVEST OPHTH VIS SCI, V33, P3367; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Simoncic PD, 2006, CAN J PHYSIOL PHARM, V84, P667, DOI 10.1139/Y06-012; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Tanito M, 2007, FREE RADICAL BIO MED, V42, P1838, DOI 10.1016/j.freeradbiomed.2007.03.018; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1864, DOI 10.1167/iovs.06-1065; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08	71	31	32	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8894	8904		10.1074/jbc.M109.070854	http://dx.doi.org/10.1074/jbc.M109.070854			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20061388	Green Published, hybrid			2022-12-25	WOS:000275553700041
J	Zhang, PL; Andrianakos, R; Yang, Y; Liu, CM; Lu, WG				Zhang, Peilin; Andrianakos, Rose; Yang, Yang; Liu, Chunming; Lu, Wange			Kruppel-like Factor 4 (Klf4) Prevents Embryonic Stem (ES) Cell Differentiation by Regulating Nanog Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; C-MYC; MOUSE; SOX2; PLURIPOTENCY; ACTIVATION; STAT3; OCT4; FIBROBLASTS; INHIBITION	Transcription factor Kruppel-like factor 4 (Klf4) is essential for somatic cell reprogramming. In addition, Klf4 seems to play a redundant role along with other Klf family proteins in embryonic stem (ES) cell self-renewal. However, how Klf4 regulates ES cell self-renewal and somatic cell reprogramming is still poorly understood. Here we report that Klf4 is required for both ES cell self-renewal and maintenance of pluripotency and that the expression of Klf4 prevents ES cell differentiation in response to withdrawal of leukemia inhibitory factor (LIF) or bone morphogenetic protein 4 (BMP4). In addition, Klf4 directly binds to the promoter region of Nanog and regulates its expression. Expression of Nanog prevents ES cell differentiation even when Klf4 gene expression is knocked down. On the other hand, knockdown of Nanog expression induces differentiation of ES cells that overexpress Klf4. Taken together, these results demonstrate that Klf4 functions upstream of Nanog in ES cell self-renewal and in preventing ES cell differentiation.	[Zhang, Peilin; Andrianakos, Rose; Yang, Yang; Lu, Wange] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Liu, Chunming] Univ Kentucky, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40506 USA	University of Southern California; University of Kentucky	Lu, WG (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	wangelu@usc.edu	Yang-Hartwich, Yang/B-3489-2015		California Institute of Regenerative Medicine (CIRM); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from the California Institute of Regenerative Medicine (CIRM).	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McConnell BB, 2007, BIOESSAYS, V29, P946, DOI 10.1002/bies.20622; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Orkin SH, 2005, CELL, V122, P828, DOI 10.1016/j.cell.2005.09.002; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	41	160	166	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9180	9189		10.1074/jbc.M109.077958	http://dx.doi.org/10.1074/jbc.M109.077958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071344	Green Published, hybrid			2022-12-25	WOS:000275553700067
J	Baer, CF; Denver, DR				Baer, Charles F.; Denver, Dee R.			Spontaneous Mutations Decrease Sensitivity of Gene Expression to Random Environmental Variation in Caenorhabditis elegans	PLOS ONE			English	Article							SELECTION; EVOLUTION; CANALIZATION; PLASTICITY	Background: Biological phenotypes are described as "canalized'' if they are robust to minor variation of environment and/or genetic background. The existence of a robust phenotype logically implies that some underlying mechanism must be variable, in the sense of "able to vary'', in order to compensate for variation in the environment and/or genetic effects. Several lines of evidence lead to the conclusion that deleterious mutations predictably render morphological, developmental, and life-history traits more sensitive to small random environmental perturbations - that is, mutations de-canalize the phenotype. Methodology/Principal Findings: Using conventional dye-swap microarray methodology, we compared transcript abundance in a sample of >7,000 genes between four mutation accumulation (MA) lines of the nematode Caenorhabditis elegans and the common (unmutated) ancestor. There was significantly less environmental variance in the MA lines than in the ancestor, both among replicates of the same gene and among genes. Conclusions/Significance: Deleterious mutations consistently decrease the within-line component of variance in transcript abundance, which is straightforwardly interpreted as reducing the sensitivity of gene expression to small random variation in the environment. This finding is consistent with the idea that underlying variability in gene expression might be mechanistically responsible for phenotypic robustness.	[Baer, Charles F.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Baer, Charles F.] Univ Florida, Genet Inst, Gainesville, FL USA; [Denver, Dee R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Denver, Dee R.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Oregon State University; Oregon State University	Baer, CF (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	cbaer@ufl.edu			NIH/NIGMS [1 R01GM072639-01A2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072639] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NIGMS (http://www.nigms.nih.gov/) grant # 1 R01GM072639-01A2 to CFB (PI) and DRD (sub-contract). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer CF, 2008, AM NAT, V172, P272, DOI 10.1086/589455; Braendle C, 2008, DEV CELL, V15, P714, DOI 10.1016/j.devcel.2008.09.011; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; DUN RB, 1958, NATURE, V181, P1018, DOI 10.1038/1811018a0; Falconer D. S., 1989, QUANTITATIVE GENETIC, V3rd; Hill WG, 2004, GENET RES, V83, P121, DOI 10.1017/S0016672304006640; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; LYNCH M, 1998, SINAUER, V16, P980; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; MUKAI T, 1972, GENETICS, V72, P335; Ostrow D, 2007, GENETICS, V176, P1653, DOI 10.1534/genetics.107.074666; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; Proulx SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000911; RENDEL JM, 1959, EVOLUTION, V13, P425, DOI 10.1111/j.1558-5646.1959.tb03033.x; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Vassilieva LL, 1999, GENETICS, V151, P119; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Zhang XS, 2005, EVOLUTION, V59, P1237	24	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8750	10.1371/journal.pone.0008750	http://dx.doi.org/10.1371/journal.pone.0008750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090917	Green Published, Green Submitted, gold			2022-12-25	WOS:000273715000009
J	Daubeuf, S; Aucher, A; Bordier, C; Salles, A; Serre, L; Gaibelet, G; Faye, JC; Favre, G; Joly, E; Hudrisier, D				Daubeuf, Sandrine; Aucher, Anne; Bordier, Christine; Salles, Audrey; Serre, Laurent; Gaibelet, Gerald; Faye, Jean-Charles; Favre, Gilles; Joly, Etienne; Hudrisier, Denis			Preferential Transfer of Certain Plasma Membrane Proteins onto T and B Cells by Trogocytosis	PLOS ONE			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; ANTIGEN-PRESENTING CELLS; INTERCELLULAR TRANSFER; CUTTING EDGE; SURFACE MOLECULES; PROTEOMIC ANALYSIS; IMMUNE SYNAPSE; TARGET-CELLS; MHC; COMPLEXES	T and B cells capture antigens via membrane fragments of antigen presenting cells (APC) in a process termed trogocytosis. Whether (and how) a preferential transfer of some APC components occurs during trogocytosis is still largely unknown. We analyzed the transfer onto murine T and B cells of a large panel of fluorescent proteins with different intra-cellular localizations in the APC or various types of anchors in the plasma membrane (PM). Only the latter were transferred by trogocytosis, albeit with different efficiencies. Unexpectedly, proteins anchored to the PM's cytoplasmic face, or recruited to it via interaction with phosphinositides, were more efficiently transferred than those facing the outside of the cell. For proteins spanning the PM's whole width, transfer efficiency was found to vary quite substantially, with tetraspanins, CD4 and FcR gamma found among the most efficiently transferred proteins. We exploited our findings to set immunodiagnostic assays based on the capture of preferentially transferred components onto T or B cells. The preferential transfer documented here should prove useful in deciphering the cellular structures involved in trogocytosis.	[Daubeuf, Sandrine; Aucher, Anne; Bordier, Christine; Salles, Audrey; Serre, Laurent; Gaibelet, Gerald; Joly, Etienne; Hudrisier, Denis] CNRS, IPBS, Toulouse, France; [Daubeuf, Sandrine; Aucher, Anne; Bordier, Christine; Salles, Audrey; Serre, Laurent; Gaibelet, Gerald; Joly, Etienne; Hudrisier, Denis] Univ Toulouse, UPS, IPBS, Toulouse, France; [Salles, Audrey] Ctr Immunol, Marseille Luminy, France; [Gaibelet, Gerald] Hop Purpan, INSERM, U563, Toulouse, France; [Faye, Jean-Charles; Favre, Gilles] Inst Claudius Regaud, INSERM, U563, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Aix-Marseille Universite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Daubeuf, S (corresponding author), CNRS, IPBS, Toulouse, France.	atn@cict.fr; denis.hudrisier@ipbs.fr	Joly, Etienne/A-5644-2009; FAVRE, Gilles/K-9189-2014	Joly, Etienne/0000-0002-7264-2681; FAVRE, Gilles/0000-0002-2344-1883; Hudrisier, Denis/0000-0002-3631-9561; Salles, Audrey/0000-0002-1890-6957	Agence Nationale pour la Recherche, ANR RIB; Region Midi-Pyrenes, Agro-Bio-Sante; CNRS	Agence Nationale pour la Recherche, ANR RIB(French National Research Agency (ANR)); Region Midi-Pyrenes, Agro-Bio-Sante; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by funds from the Agence Nationale pour la Recherche, ANR RIB program (http://www.agence-nationale-recherche.fr/), Region Midi-Pyrenes, Agro-Bio-Sante program (http://www.midipyrenees.fr/) and CNRS (http://www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold PY, 1999, EUR J IMMUNOL, V29, P1363, DOI 10.1002/(SICI)1521-4141(199904)29:04<1363::AID-IMMU1363>3.0.CO;2-0; Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Barraud-Lange V, 2007, FASEB J, V21, P3446, DOI 10.1096/fj.06-8035hyp; Beadling C, 2006, NAT MED, V12, P1208, DOI 10.1038/nm1413; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Busch A, 2008, J IMMUNOL, V181, P3965, DOI 10.4049/jimmunol.181.6.3965; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; DAUBEUF S, 2008, CYTOM PART A, V75, P380; Daubeuf Sandrine, 2007, Immunol Invest, V36, P687, DOI 10.1080/08820130701674596; Daubeuf S, 2006, NAT PROTOC, V1, P2536, DOI 10.1038/nprot.2006.400; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Delaguillaumie A, 2002, J CELL SCI, V115, P433; Fayolle C, 1999, J IMMUNOL, V162, P4157; Funakoshi T, 2003, ONCOGENE, V22, P674, DOI 10.1038/sj.onc.1206106; Gaibelet G, 2006, J BIOL CHEM, V281, P37921, DOI 10.1074/jbc.M607103200; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hudrisier D, 2005, EUR J IMMUNOL, V35, P2284, DOI 10.1002/eji.200526266; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Hudrisier D, 2009, J IMMUNOL, V183, P6102, DOI 10.4049/jimmunol.0900821; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Hwang I, 2001, J IMMUNOL, V166, P5099, DOI 10.4049/jimmunol.166.8.5099; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; JOLY E, 2007, NAT PRECEDINGS; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Machlenkin A, 2008, CANCER RES, V68, P2006, DOI 10.1158/0008-5472.CAN-07-3119; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Miguet L, 2006, PROTEOMICS, V6, P153, DOI 10.1002/pmic.200500133; Mittelbrunn M, 2002, J IMMUNOL, V169, P6691, DOI 10.4049/jimmunol.169.12.6691; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Pardigon N, 2006, J IMMUNOL, V177, P1590, DOI 10.4049/jimmunol.177.3.1590; Patel DM, 2001, CELL IMMUNOL, V214, P21, DOI 10.1006/cimm.2002.1887; Patel DM, 1999, J IMMUNOL, V163, P5201; Patel DM, 2001, CELL IMMUNOL, V214, P165, DOI 10.1006/cimm.2001.1897; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Puaux AL, 2006, EUR J IMMUNOL, V36, P779, DOI 10.1002/eji.200535407; Quah BJC, 2008, P NATL ACAD SCI USA, V105, P4259, DOI 10.1073/pnas.0800259105; Rechavi O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001204; Roda-Navarro P, 2007, FASEB J, V21, P1636, DOI 10.1096/fj.06-7488rev; Smyth LA, 2007, AM J TRANSPLANT, V7, P1442, DOI 10.1111/j.1600-6143.2007.01816.x; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; SPRENT J, 2005, SCI STKE, V273, P1; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tomaru U, 2003, NAT MED, V9, P469, DOI 10.1038/nm845; Toomre D, 1999, J CELL SCI, V112, P21; Vanherberghen B, 2004, P NATL ACAD SCI USA, V101, P16873, DOI 10.1073/pnas.0406240101; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Wetzel SA, 2006, CRIT REV IMMUNOL, V26, P1; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145	71	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8716	10.1371/journal.pone.0008716	http://dx.doi.org/10.1371/journal.pone.0008716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090930	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714600017
J	Lopez-Fontal, R; Zeini, M; Traves, PG; Gomez-Ferreria, M; Aranda, A; Saez, GT; Cerda, C; Martin-Sanz, P; Hortelano, S; Bosca, L				Lopez-Fontal, Raquel; Zeini, Miriam; Traves, Paqui G.; Gomez-Ferreria, Mariana; Aranda, Ana; Saez, Guillermo T.; Cerda, Concha; Martin-Sanz, Paloma; Hortelano, Sonsoles; Bosca, Lisardo			Mice Lacking Thyroid Hormone Receptor beta Show Enhanced Apoptosis and Delayed Liver Commitment for Proliferation after Partial Hepatectomy	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE ADMA; RAT-LIVER; SYMMETRIC DIMETHYLARGININE; HEPATOCYTE PROLIFERATION; REGENERATING MOUSE; SURVIVAL FACTOR; REGULATORY ROLE; NITRIC-OXIDE; IN-VITRO; EXPRESSION	Background: The role of thyroid hormones and their receptors (TR) during liver regeneration after partial hepatectomy (PH) was studied using genetic and pharmacologic approaches. Roles in liver regeneration have been suggested for T3, but there is no clear evidence distinguishing the contribution of increased amounts of T3 from the modulation by unoccupied TRs. Methodology/Principal Findings: Mice lacking TR alpha 1/TR beta or TR beta alone fully regenerated liver mass after PH, but showed delayed commitment to the initial round of hepatocyte proliferation and transient but intense apoptosis at 48h post-PH, affecting similar to 30% of the remaining hepatocytes. Pharmacologically induced hypothyroidism yielded similar results. Loss of TR activity was associated with enhanced nitrosative stress in the liver remnant, due to an increase in the activity of the nitric oxide synthase (NOS) 2 and 3, caused by a transient decrease in the concentration of asymmetric dimethylarginine (ADMA), a potent NOS inhibitor. This decrease in the ADMA levels was due to the presence of a higher activity of dimethylarginineaminohydrolase-1 (DDAH-1) in the regenerating liver of animals lacking TR alpha 1/TR beta or TR beta. DDAH-1 expression and activity was paralleled by the activity of FXR, a transcription factor involved in liver regeneration and up-regulated in the absence of TR. Conclusions/Significance: We report that TRs are not required for liver regeneration; however, hypothyroid mice and TR beta-or TR alpha 1/TR beta-deficient mice exhibit a delay in the restoration of liver mass, suggesting a specific role for TRb in liver regeneration. Altered regenerative responses are related with a delay in the expression of cyclins D1 and E, and the occurrence of liver apoptosis in the absence of activated TRb that can be prevented by administration of NOS inhibitors. Taken together, these results indicate that TRb contributes significantly to the rapid initial round of hepatocyte proliferation following PH, and improves the survival of the regenerating liver at later times.	[Lopez-Fontal, Raquel; Zeini, Miriam; Hortelano, Sonsoles] CNIC, Madrid, Spain; [Traves, Paqui G.; Gomez-Ferreria, Mariana; Aranda, Ana; Martin-Sanz, Paloma; Bosca, Lisardo] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Saez, Guillermo T.; Cerda, Concha] Hosp Gen Univ, Dept Bioquim & Biol Mol, Serv Anal Clin, Valencia, Spain; [Martin-Sanz, Paloma; Bosca, Lisardo] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Clinic Universitari de Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Lopez-Fontal, R (corresponding author), CNIC, Madrid, Spain.	shortelano@cnic.es; lbosca@iib.uam.es	G. Traves, Paqui/L-5693-2014; Bosca, Lisardo/A-2059-2008; Hortelano, Sonsoles/A-7954-2010; Martín-Sanz, Paloma/K-1303-2014; Aranda, Ana/ABG-8820-2020	G. Traves, Paqui/0000-0001-5749-8426; Bosca, Lisardo/0000-0002-0253-5469; Hortelano, Sonsoles/0000-0003-2528-0072; Aranda, Ana/0000-0002-8338-9589; Saez, Guillermo/0000-0002-8164-4048	MICINN [BFU2008-02161, BFU2007-62402, SAF2007-60511, SAF2007-60551]; Comunidad de Madrid [S-BIO-0283/2006]; FIS-RECAVA [RD06/0014/0025, PI05.0050, PI080070]; Fundacion Mutua Madrilea; Instituto de Salud Carlos III; Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); FIS-RECAVA; Fundacion Mutua Madrilea; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation	This work was supported by grants BFU2008-02161, BFU2007-62402, SAF2007-60511, and SAF2007-60551 from MICINN; S-BIO-0283/2006 from Comunidad de Madrid and FIS-RECAVA RD06/0014/0025 to L. B.; and PI05.0050, PI080070, and the Fundacion Mutua Madrilea to S. H. RECAVA and Ciberehd are funded by the Instituto de Salud Carlos III. R.L-F. is supported by a fellowship from Instituto de Salud Carlos III. The CNIC is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2005, CELL PHYSIOL BIOCHEM, V15, P69, DOI 10.1159/000083639; Callejas NA, 2000, GASTROENTEROLOGY, V119, P493, DOI 10.1053/gast.2000.9374; Chobanyan K, 2007, J CHROMATOGR B, V858, P32, DOI 10.1016/j.jchromb.2007.08.002; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; FALZACAPPA CV, 2006, J CELL PHYSIOL, V206, P309, DOI [10.1002/jcp.20460, DOI 10.1002/jcp.20460, DOI 10.1002/JCP.20460]; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Frey D, 2006, STRUCTURE, V14, P901, DOI 10.1016/j.str.2006.03.006; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Grant N, 2007, MED HYPOTHESES, V68, P641, DOI 10.1016/j.mehy.2006.07.045; Hoeke MO, 2009, HEPATOLOGY, V49, P151, DOI 10.1002/hep.22661; HORTELANO S, 1995, HEPATOLOGY, V21, P776; Hu TH, 2006, J BIOL CHEM, V281, P39831, DOI 10.1074/jbc.M606779200; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Jones SA, 2003, MOL CELL ENDOCRINOL, V199, P49, DOI 10.1016/S0303-7207(02)00296-4; Kariv R, 2003, LIVER INT, V23, P187, DOI 10.1034/j.1600-0676.2003.00827.x; Kester MHA, 2009, ENDOCRINOLOGY, V150, P540, DOI 10.1210/en.2008-0344; Kucharova Silvia, 2002, Endocr Regul, V36, P37; Kumar A, 2007, J HEPATOL, V46, P888, DOI 10.1016/j.jhep.2006.12.015; Laleman W, 2005, HEPATOLOGY, V42, P1382, DOI 10.1002/hep.20968; Laoag-Fernandez JB, 2004, J CLIN ENDOCR METAB, V89, P4069, DOI 10.1210/jc.2003-032208; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; Messarah M, 2007, CR BIOL, V330, P107, DOI 10.1016/j.crvi.2006.11.004; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mojena M, 2001, FASEB J, V15, P583; Nijveldt RJ, 2004, LIVER INT, V24, P510, DOI 10.1111/j.1478-3231.2004.0948.x; Nijveldt RJ, 2004, JPEN-PARENTER ENTER, V28, P382, DOI 10.1177/0148607104028006382; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com; Pope AJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1679, DOI 10.1152/ajpcell.00224.2007; RODD C, 1992, ENDOCRINOLOGY, V131, P2559, DOI 10.1210/en.131.6.2559; Saelim N, 2007, APOPTOSIS, V12, P1781, DOI 10.1007/s10495-007-0109-1; SCHWARTZ HL, 1992, J BIOL CHEM, V267, P11794; Siroen MPC, 2005, HEPATOLOGY, V41, P559, DOI 10.1002/hep.20579; Sukocheva OA, 2006, J ENDOCRINOL, V191, P447, DOI 10.1677/joe.1.07061; Sun YW, 2007, PROTEOMICS, V7, P4398, DOI 10.1002/pmic.200600913; Tien ES, 2007, J PHARMACOL EXP THER, V320, P307, DOI 10.1124/jpet.106.112706; Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9; Vizzutti F, 2007, EUR J CLIN INVEST, V37, P509, DOI 10.1111/j.1365-2362.2007.01814.x; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Wilcken DEL, 2007, MOL GENET METAB, V91, P309, DOI 10.1016/j.ymgme.2007.04.017; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Zeini M, 2005, FASEB J, V19, P995, DOI 10.1096/fj.04-3233fje	46	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8710	10.1371/journal.pone.0008710	http://dx.doi.org/10.1371/journal.pone.0008710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090848	Green Published, gold			2022-12-25	WOS:000273714600013
J	James, CG; Stanton, LA; Agoston, H; Ulici, V; Underhill, TM; Beier, F				James, Claudine G.; Stanton, Lee-Anne; Agoston, Hanga; Ulici, Veronica; Underhill, T. Michael; Beier, Frank			Genome-Wide Analyses of Gene Expression during Mouse Endochondral Ossification	PLOS ONE			English	Article							GROWTH-PLATE CHONDROCYTES; QUANTITATIVE TRAIT LOCI; BONE-MINERAL DENSITY; SKELETAL DEVELOPMENT; CONNECTIVE TISSUES; MESSENGER-RNA; LINKAGE SCAN; LONG BONES; IN-VITRO; CARTILAGE	Background: Endochondral ossification is a complex process involving a series of events that are initiated by the establishment of a chondrogenic template and culminate in its replacement through the coordinated activity of osteoblasts, osteoclasts and endothelial cells. Comprehensive analyses of in vivo gene expression profiles during these processes are essential to obtain a complete understanding of the regulatory mechanisms involved. Methodology/Principal Findings: To address these issues, we completed a microarray screen of three zones derived from manually segmented embryonic mouse tibiae. Classification of genes differentially expressed between each respective zone, functional categorization as well as characterization of gene expression patterns, cytogenetic loci, signaling pathways and functional motifs both confirmed reported data and provided novel insights into endochondral ossification. Parallel comparisons of the microdissected tibiae data set with our previously completed micromass culture screen further corroborated the suitability of micromass cultures for modeling gene expression in chondrocyte development. The micromass culture system demonstrated striking similarities to the in vivo microdissected tibiae screen; however, the micromass system was unable to accurately distinguish gene expression differences in the hypertrophic and mineralized zones of the tibia. Conclusions/Significance: These studies allow us to better understand gene expression patterns in the growth plate and endochondral bones and provide an important technical resource for comparison of gene expression in diseased or experimentally-manipulated cartilages. Ultimately, this work will help to define the genomic context in which genes are expressed in long bones and to understand physiological and pathological ossification.	[James, Claudine G.; Stanton, Lee-Anne; Agoston, Hanga; Ulici, Veronica; Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodelling, London, ON, Canada; [Underhill, T. Michael] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	Western University (University of Western Ontario); University of British Columbia	James, CG (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodelling, London, ON, Canada.	vulici@uwo.ca; fbeier@uwo.ca	Beier, Frank/G-4595-2013; Beier, Frank/T-4734-2019	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537	Canadian Institutes of Health [MOP 43899]; Ontario Graduate Studentship in Science and Technology; Canadian Arthritis Network; Canada Research Chair Award	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Studentship in Science and Technology; Canadian Arthritis Network; Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	CGJ received a doctoral scholarship from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and an Ontario Graduate Studentship in Science and Technology (http://osap.gov.on.ca/eng/Not_Secure/Plan_Grants_full_sepapp_OGS_12345.htm). VU was the recipient of a graduate scholarship from the Canadian Arthritis Network (http://www.arthritisnetwork.ca). HA received Ontario Graduate Studentship awards. FB is the recipient of a Canada Research Chair Award. Work on this project was supported by grants from the Canadian Institutes of Health Research (MOP 43899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Bluteau G, 2007, BONE, V40, P568, DOI 10.1016/j.bone.2006.09.024; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOOTHANDFORD RP, 2009, CELL TISSUE RES; Brandal P, 2005, CANCER GENET CYTOGEN, V160, P15, DOI 10.1016/j.cancergencyto.2004.11.016; Cavalier L, 2000, EUR J HUM GENET, V8, P527, DOI 10.1038/sj.ejhg.5200476; CHEN JK, 1992, J BONE MINER RES, V7, P987; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Dreier R, 2008, MATRIX BIOL, V27, P319, DOI 10.1016/j.matbio.2008.01.006; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Friddle CJ, 2000, P NATL ACAD SCI USA, V97, P6745, DOI 10.1073/pnas.100127897; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gustafsson E, 2003, ANN NY ACAD SCI, V995, P140, DOI 10.1111/j.1749-6632.2003.tb03217.x; Halbert AR, 1998, CANCER GENET CYTOGEN, V104, P52, DOI 10.1016/S0165-4608(97)00450-0; Hayman AR, 2000, J ANAT, V196, P433, DOI 10.1046/j.1469-7580.2000.19630433.x; Hayman DM, 2006, TISSUE ENG, V12, P2573, DOI 10.1089/ten.2006.12.2573; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; HOFSTETTER W, 1995, BONE, V17, P145, DOI 10.1016/S8756-3282(95)00163-8; Horner A, 2002, DEV DYNAM, V225, P35, DOI 10.1002/dvdy.10132; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Incisivo V, 2003, Minerva Stomatol, V52, P457; Jacquet R, 2005, ANAL BIOCHEM, V337, P22, DOI 10.1016/j.ab.2004.09.033; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30; James CG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-205; Kim JO, 2003, J CELL BIOCHEM, V90, P998, DOI 10.1002/jcb.10680; Lee GM, 1997, OSTEOARTHR CARTILAGE, V5, P261, DOI 10.1016/S1063-4584(97)80022-2; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lo IFM, 1998, AM J MED GENET, V78, P55, DOI 10.1002/(SICI)1096-8628(19980616)78:1<55::AID-AJMG11>3.3.CO;2-R; LOCHNER K, 2006, BIOGERONTOLOGY, V6; Lukic IK, 2005, CLIN EXP IMMUNOL, V139, P236, DOI 10.1111/j.1365-2249.2005.02680.x; MacLean HE, 2004, J CLIN INVEST, V113, P1334, DOI 10.1172/JCI200421252; Makihira S, 2003, ENDOCRINOLOGY, V144, P2480, DOI 10.1210/en.2002-220746; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Mikic B, 2004, J ORTHOPAED RES, V22, P552, DOI 10.1016/j.orthres.2003.09.002; Milo M, 2003, BIOCHEM SOC T, V31, P1510; MITROVIC D, 1979, J RHEUMATOL, V6, P124; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mulsant P, 2001, P NATL ACAD SCI USA, V98, P5104, DOI 10.1073/pnas.091577598; OKEEFE RJ, 1994, J BONE MINER RES, V9, P1713; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Rantakokko J, 1999, J BONE MINER RES, V14, P1934, DOI 10.1359/jbmr.1999.14.11.1934; Riminucci M, 1997, AM J PATHOL, V151, P1587; Robinson P, 2002, INFECT IMMUN, V70, P4534, DOI 10.1128/IAI.70.8.4534-4538.2002; Rosado E, 2002, BBA-MOL CELL RES, V1590, P1, DOI 10.1016/S0167-4889(02)00194-5; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Shears DJ, 2004, AM J MED GENET A, V128A, P6, DOI 10.1002/ajmg.a.20640; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; SKERRY TM, 1994, EUR J CLIN NUTR, V48, pS190; Stickens D, 2000, DEV DYNAM, V218, P452, DOI 10.1002/1097-0177(200007)218:3<452::AID-DVDY1000>3.0.CO;2-P; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Streeten EA, 2006, J BONE MINER RES, V21, P1433, DOI 10.1359/JBMR.060602; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugars RV, 2006, BBA-MOL CELL RES, V1763, P1031, DOI 10.1016/j.bbamcr.2006.08.027; Sugimoto M, 1998, CELL TISSUE RES, V292, P325, DOI 10.1007/s004410051063; Suter A, 2001, DEVELOPMENT, V128, P4899; Takahara M, 2004, J ORTHOPAED RES, V22, P1050, DOI 10.1016/j.orthres.2004.01.011; Tchetina EV, 2006, AM J PATHOL, V168, P131, DOI 10.2353/ajpath.2006.050369; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Toyosawa S, 2004, BONE, V35, P553, DOI 10.1016/j.bone.2004.03.030; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Wakui M, 2001, BIOCHEM BIOPH RES CO, V282, P200, DOI 10.1006/bbrc.2001.4550; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Wang Y, 2006, J HISTOCHEM CYTOCHEM, V54, P1327, DOI 10.1369/jhc.6A6923.2006; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Weizmann S, 2005, MATRIX BIOL, V24, P520, DOI 10.1016/j.matbio.2005.07.003; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053; Williams CS, 2001, NEOPLASIA, V3, P428, DOI 10.1038/sj.neo.7900177; Wynne F, 2003, CALCIFIED TISSUE INT, V72, P651, DOI 10.1007/s00223-002-2086-2; Yan W, 2004, BONE, V35, P1273, DOI 10.1016/j.bone.2004.09.009; Yu H, 2007, CALCIFIED TISSUE INT, V80, P103, DOI 10.1007/s00223-006-0187-z; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zori RT, 1998, AM J MED GENET, V78, P450, DOI 10.1002/(SICI)1096-8628(19980806)78:5<450::AID-AJMG10>3.0.CO;2-E	83	31	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8693	10.1371/journal.pone.0008693	http://dx.doi.org/10.1371/journal.pone.0008693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084171	Green Published, Green Submitted, gold			2022-12-25	WOS:000273554600040
J	Paauw, A; Leverstein-van Hall, MA; Verhoef, J; Fluit, AC				Paauw, Armand; Leverstein-van Hall, Maurine A.; Verhoef, Jan; Fluit, Ad C.			Evolution in Quantum Leaps: Multiple Combinatorial Transfers of HPI and Other Genetic Modules in Enterobacteriaceae	PLOS ONE			English	Article							HIGH-PATHOGENICITY ISLAND; ESCHERICHIA-COLI; YERSINIA-ENTEROCOLITICA; NONRIBOSOMAL PEPTIDE; DNA POLYMORPHISM; LIVER-ABSCESS; IRP2 GENE; CLOACAE; BACTERIA; IDENTIFICATION	Horizontal gene transfer is a key step in the evolution of Enterobacteriaceae. By acquiring virulence determinants of foreign origin, commensals can evolve into pathogens. In Enterobacteriaceae, horizontal transfer of these virulence determinants is largely dependent on transfer by plasmids, phages, genomic islands (GIs) and genomic modules (GMs). The High Pathogenicity Island (HPI) is a GI encoding virulence genes that can be transferred between different Enterobacteriaceae. We investigated the HPI because it was present in an Enterobacter hormaechei outbreak strain (EHOS). Genome sequence analysis showed that the EHOS contained an integration site for mobile elements and harbored two GIs and three putative GMs, including a new variant of the HPI (HPI-ICEEh1). We demonstrate, for the first time, that combinatorial transfers of GIs and GMs between Enterobacter cloacae complex isolates must have occurred. Furthermore, the excision and circularization of several combinations of the GIs and GMs was demonstrated. Because of its flexibility, the multiple integration site of mobile DNA can be considered an integration hotspot (IHS) that increases the genomic plasticity of the bacterium. Multiple combinatorial transfers of diverse combinations of the HPI and other genomic elements among Enterobacteriaceae may accelerate the generation of new pathogenic strains.	[Paauw, Armand; Leverstein-van Hall, Maurine A.; Verhoef, Jan; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Paauw, A (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	apaauw@umcutrecht.nl			Microbiology Department of the UMCU	Microbiology Department of the UMCU	The study was funded by the Microbiology Department of the UMCU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 2004, NAT REV MICROBIOL, V2, P510, DOI 10.1038/nrmicro909; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; Brem D, 2001, MICROBIOL-SGM, V147, P1115, DOI 10.1099/00221287-147-5-1115; CARNIEL E, 1989, INFECT IMMUN, V57, P540, DOI 10.1128/IAI.57.2.540-545.1989; CARNIEL E, 1992, MOL MICROBIOL, V6, P379, DOI 10.1111/j.1365-2958.1992.tb01481.x; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DEALMEIDA AMP, 1993, MICROB PATHOGENESIS, V14, P9, DOI 10.1006/mpat.1993.1002; Delmas J, 2006, DIAGN MICR INFEC DIS, V55, P263, DOI 10.1016/j.diagmicrobio.2006.02.003; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Egamberdieva D, 2008, ENVIRON MICROBIOL, V10, P1, DOI 10.1111/j.1462-2920.2007.01424.x; Fluit AC, 2001, EUR J CLIN MICROBIOL, V20, P617; Fu YX, 1997, GENETICS, V147, P915; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; GUILVOUT I, 1993, J BACTERIOL, V175, P5488, DOI 10.1128/JB.175.17.5488-5504.1993; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hoffmann H, 2003, APPL ENVIRON MICROB, V69, P5306, DOI 10.1128/AEM.69.9.5306-5318.2003; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hu J, 2005, WORLD J GASTROENTERO, V11, P5816, DOI 10.3748/wjg.v11.i37.5816; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jores J, 2004, INT J MED MICROBIOL, V294, P103, DOI 10.1016/j.ijmm.2004.06.024; Kampfer P, 2008, INT J HYG ENVIR HEAL, V211, P374, DOI 10.1016/j.ijheh.2007.07.021; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P454, DOI 10.1016/j.mib.2006.07.001; Lesic B, 2004, MOL MICROBIOL, V52, P1337, DOI 10.1111/j.1365-2958.2004.04073.x; Leverstein-van Hall MA, 2006, J CLIN MICROBIOL, V44, P518, DOI 10.1128/JCM.44.2.518-524.2006; Lin TL, 2008, J BACTERIOL, V190, P515, DOI 10.1128/JB.01219-07; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mokracka J, 2004, FEMS IMMUNOL MED MIC, V40, P51, DOI 10.1016/S0928-8244(03)00276-1; Paauw A, 2006, EMERG INFECT DIS, V12, P807; PAAUW A, 2009, MICROBIOL, V155, P1558; Paauw A, 2007, J CLIN MICROBIOL, V45, P1420, DOI 10.1128/JCM.02242-06; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Pelludat C, 1998, J BACTERIOL, V180, P538, DOI 10.1128/JB.180.3.538-546.1998; Pfeifer BA, 2003, APPL ENVIRON MICROB, V69, P6698, DOI 10.1128/AEM.69.11.6698-6702.2003; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Rakin A, 1999, INFECT IMMUN, V67, P5265, DOI 10.1128/IAI.67.10.5265-5274.1999; Rooney AP, 2009, FEMS MICROBIOL LETT, V295, P82, DOI 10.1111/j.1574-6968.2009.01581.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Schubert S, 2002, INFECT IMMUN, V70, P5335, DOI 10.1128/IAI.70.9.5335-5337.2002; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Siddique T, 2007, J ENVIRON QUAL, V36, P621, DOI 10.2134/jeq2006.0357; Suo ZC, 2001, P NATL ACAD SCI USA, V98, P99, DOI 10.1073/pnas.021537498; TAJIMA F, 1989, GENETICS, V123, P585; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; Gomis-Ruth FX, 2006, CURR OPIN STRUC BIOL, V16, P744, DOI 10.1016/j.sbi.2006.10.004	53	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8662	10.1371/journal.pone.0008662	http://dx.doi.org/10.1371/journal.pone.0008662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084283	gold, Green Published, Green Submitted			2022-12-25	WOS:000273554600015
J	Taylor-Blake, B; Zylka, MJ				Taylor-Blake, Bonnie; Zylka, Mark J.			Prostatic Acid Phosphatase Is Expressed in Peptidergic and Nonpeptidergic Nociceptive Neurons of Mice and Rats	PLOS ONE			English	Article							PRIMARY SENSORY NEURONS; GENE-RELATED PEPTIDE; SPINAL-CORD; DORSAL-HORN; PKC-GAMMA; PAIN; RECEPTOR; ECTONUCLEOTIDASE; COEXISTENCE; CAPSAICIN	Thiamine monophosphatase (TMPase, also known as Fluoride-resistant acid phosphatase or FRAP) is a classic histochemical marker of small-to medium-diameter dorsal root ganglia (DRG) neurons and has primarily been studied in the rat. Previously, we found that TMPase was molecularly identical to Prostatic acid phosphatase (PAP) using mice. In addition, PAP was expressed in a majority of nonpeptidergic, isolectin B4-binding (IB4(+)) nociceptive neurons and a subset of peptidergic, calcitonin gene-related peptide-containing (CGRP(+)) nociceptive neurons. At the time, we were unable to determine if PAP was present in rat DRG neurons because the antibody we used did not cross-react with PAP in rat tissues. In our present study, we generated a chicken polyclonal antibody against the secretory isoform of mouse PAP. This antibody detects mouse, rat and human PAP protein on western blots. Additionally, this antibody detects PAP in mouse and rat small-to medium-diameter DRG neurons and axon terminals in lamina II of spinal cord. In the rat, 92.5% of all PAP(+) cells bind the nonpeptidergic marker IB4 and 31.8% of all PAP(+) cells contain the peptidergic marker CGRP. Although PAP is found in peptidergic and nonpeptidergic neurons of mice and rats, the percentage of PAP+ neurons that express these markers differs between species. Moreover, PAP(+) axon terminals in the rat partially overlap with Protein kinase C gamma (PKC gamma(+)) interneurons in dorsal spinal cord whereas PAP(+) axon terminals in the mouse terminate dorsal to PKC gamma(+) interneurons. Collectively, our studies highlight similarities and differences in PAP localization within nociceptive neurons of mice and rats.	[Taylor-Blake, Bonnie; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Taylor-Blake, B (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	zylka@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022		Rita Allen Foundation; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS060725]; National Institute of Child Health and Human Development (NICHD) [P30NS045892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725, P30NS045892] Funding Source: NIH RePORTER	Rita Allen Foundation; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to MJZ from The Searle Scholars Program, Rita Allen Foundation and National Institute of Neurological Disorders and Stroke (NINDS) (R01NS060725). Confocal imaging was performed at the University of North Carolina Chapel Hill (UNC-CH) Confocal Imaging Facility, which is co-funded by NINDS and National Institute of Child Health and Human Development (NICHD) (P30NS045892). MJZ is a Rita Allen Foundation Milton E. Cassel Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The chicken antibody described in this paper will be made commercially available via Aves Labs. The authors received no funding from Aves Labs, nor will they be financially compensated by Aves Labs when this antibody is sold.	Campagnola L, 2008, J NEUROSCI METH, V169, P27, DOI 10.1016/j.jneumeth.2007.11.012; CARR PA, 1990, NEUROSCIENCE, V36, P751, DOI 10.1016/0306-4522(90)90017-X; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; COLMANT H J, 1959, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V199, P60, DOI 10.1007/BF00361100; COOPER JF, 1976, UROL RES, V4, P111; DALSGAARD CJ, 1984, NEUROSCI LETT, V51, P139, DOI 10.1016/0304-3940(84)90275-1; DODD J, 1983, COLD SPRING HARB SYM, V48, P685, DOI 10.1101/SQB.1983.048.01.072; GAMSE R, 1985, EUR J PHARMACOL, V114, P61, DOI 10.1016/0014-2999(85)90520-5; Gutman AB, 1938, J CLIN INVEST, V17, P473, DOI 10.1172/JCI100974; HUNT SP, 1985, PHILOS T ROY SOC B, V308, P283, DOI 10.1098/rstb.1985.0028; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Kaija H, 2006, DYNAMICS BONE CARTIL, P165; KNYIHAR E, 1970, B ASSOC ANAT, V149, P768; KNYIHARCSILLIK E, 1986, J HISTOCHEM CYTOCHEM, V34, P363, DOI 10.1177/34.3.3005391; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; OSTROWSKI WS, 1994, CLIN CHIM ACTA, V226, P121, DOI 10.1016/0009-8981(94)90209-7; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; ROIKO K, 1990, GENE, V89, P223, DOI 10.1016/0378-1119(90)90009-G; SANYAL S, 1974, BRAIN RES, V76, P161, DOI 10.1016/0006-8993(74)90523-X; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P219, DOI 10.3109/07367228809144628; Sowa NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004248; Taira AL, 2007, ONCOLOGY-NY, V21, P1003; VIHKO P, 1982, J UROLOGY, V128, P202, DOI 10.1016/S0022-5347(17)52818-9; WANG H, 1994, NEUROSCIENCE, V62, P539, DOI 10.1016/0306-4522(94)90387-5; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	38	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8674	10.1371/journal.pone.0008674	http://dx.doi.org/10.1371/journal.pone.0008674			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084276	Green Published, Green Submitted, gold			2022-12-25	WOS:000273554600026
J	Carrel, MA; Emch, M; Jobe, RT; Moody, A; Wan, XF				Carrel, Margaret A.; Emch, Michael; Jobe, R. Todd; Moody, Aaron; Wan, Xiu-Feng			Spatiotemporal Structure of Molecular Evolution of H5N1 Highly Pathogenic Avian Influenza Viruses in Vietnam	PLOS ONE			English	Article							DIVERSITY; ORIGIN; CHINA	Background: Vietnam is one of the countries most affected by outbreaks of H5N1 highly pathogenic avian influenza viruses. First identified in Vietnam in poultry in 2001 and in humans in 2004, the virus has since caused 111 cases and 56 deaths in humans. In 2003/2004 H5N1 outbreaks, nearly the entire poultry population of Vietnam was culled. Our earlier study (Wan et al., 2008, PLoS ONE, 3(10): e3462) demonstrated that there have been at least six independent H5N1 introductions into Vietnam and there were nine newly emerged reassortants from 2001 to 2007 in Vietnam. H5N1 viruses in Vietnam cluster distinctly around Hanoi and Ho Chi Minh City. However, the nature of the relationship between genetic divergence and geographic patterns is still unclear. Methodology/Principal Findings: In this study, we hypothesized that genetic distances between H5N1 viruses in Vietnam are correlated with geographic distances, as the result of distinct population and environment patterns along Vietnam's long north to south longitudinal extent. Based on this hypothesis, we combined spatial statistical methods with genetic analytic techniques and explicitly used geographic space to explore genetic evolution of H5N1 highly pathogenic avian influenza viruses at the sub-national scale in Vietnam. Our dataset consisted of 125 influenza viruses (with whole genome sets) isolated in Vietnam from 2003 to 2007. Our results document the significant effect of space and time on genetic evolution and the rise of two regional centers of genetic mixing by 2007. These findings give insight into processes underlying viral evolution and suggest that genetic differentiation is associated with the distance between concentrations of human and poultry populations around Hanoi and Ho Chi Minh City. Conclusions/Significance: The results show that genetic evolution of H5N1 viruses in Vietnamese domestic poultry is highly correlated with the location and spread of those viruses in geographic space. This correlation varies by scale, time, and gene, though a classic isolation by distance pattern is observed. This study is the first to characterize the geographic structure of influenza viral evolution at the sub-national scale in Vietnam and can shed light on how H5N1 HPAIVs evolve in certain geographic settings.	[Carrel, Margaret A.; Emch, Michael; Jobe, R. Todd; Moody, Aaron] Univ N Carolina, Dept Geog, Chapel Hill, NC 27515 USA; [Wan, Xiu-Feng] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	University of North Carolina; University of North Carolina Chapel Hill; Mississippi State University	Carrel, MA (corresponding author), Univ N Carolina, Dept Geog, Chapel Hill, NC 27515 USA.	emch@unc.edu; wan@cvm.msstate.edu			National Science Foundation (NSF) [BCS-0717688]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Science Foundation (NSF) Award BCS-0717688 to ME, XFW, and AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Mai TQL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003339; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; R Core Team, 2022, R LANG ENV STAT COMP; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Small M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.188702; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Wallace RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001697; Wan XF, 2007, BIOINFORMATICS, V23, P2368, DOI 10.1093/bioinformatics/btm354; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; WEBSTER RG, 2005, ARCH VIROL         S, V19, P117, DOI DOI 10.1007/3-211-29981-5_; WHO, 2008, AV INFL SIT PAK UPD; *WHO, 2009, CUM NUMB CONF HUM CA; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhao ZM, 2008, J GEN VIROL, V89, P2182, DOI 10.1099/vir.0.2008/001875-0	25	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8631	10.1371/journal.pone.0008631	http://dx.doi.org/10.1371/journal.pone.0008631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072619	gold, Green Published, Green Submitted			2022-12-25	WOS:000273414200003
J	Dhar, SK; Xu, Y; St Clair, DK				Dhar, Sanjit K.; Xu, Yong; St Clair, Daret K.			Nuclear Factor kappa B- and Specificity Protein 1-dependent p53-mediated Bi-directional Regulation of the Human Manganese Superoxide Dismutase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; TRANSCRIPTIONAL REPRESSION; WILD-TYPE; OXIDATIVE STRESS; CELL-GROWTH; IN-VIVO; P53; EXPRESSION; INDUCTION; IDENTIFICATION	Tumor suppressor p53 is known to activate certain sets of genes while suppressing others. However, whether p53 can both activate and suppress the same gene is unclear. To address this question, concentration-dependent p53 effect on the manganese superoxide dismutase (MnSOD) gene was investigated. By transfecting p53 in PC-3 cells, we demonstrate that low concentrations of p53 increase while high concentrations suppress MnSOD expression. The physiological relevance of this effect was determined in vitro and in vivo using combined UVB-mediated activation and small interference RNA-mediated suppression of p53. Results were consistent with the bi-directional effect of p53 on MnSOD expression. MnSOD-promoter/enhancer analysis demonstrates that p53 is suppressive to the promoter activity regardless of the presence or absence of putative p53 binding sites. However, a low level of p53 increases MnSOD gene transcription in the presence of the intronic-enhancer element, and this effect is dependent on nuclear-factor kappa B (NF-kappa B) binding sites. Expression of p53 enhances nuclear levels of p65 with corresponding increase in the DNA-binding activity of NF-kappa B as detected by electrophoretic mobility shift and chromatin immunoprecipitation assays. Transfection of p65 small interference RNA reduces the positive effect of p53 on MnSOD gene transcription. These data suggest that p65 can overcome the negative effect of p53 on MnSOD expression. However, when the level of p53 was further increased, the suppressive effect of p53 outweighed the positive effect of p65 and led to the suppression of MnSOD gene transcription. These results demonstrated that p53 can both suppress and induce MnSOD expression depending on the balance of promoter and enhancer binding transcription factors.	[Dhar, Sanjit K.; Xu, Yong; St Clair, Daret K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky	St Clair, DK (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA.	dstcl00@uky.edu			National Institutes of Health [CA49797, CA73599]; NATIONAL CANCER INSTITUTE [R01CA073599, R29CA049797, R01CA049797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA49797 and CA73599 (to D.K.S.C.).	Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Decraene D, 2005, J INVEST DERMATOL, V125, P1026, DOI 10.1111/j.0022-202X.2005.23909.x; Dhar SK, 2007, CARCINOGENESIS, V28, P2605, DOI 10.1093/carcin/bgm163; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Dhar SK, 2009, J BIOL CHEM, V284, P16409, DOI 10.1074/jbc.M109.005736; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Drane P, 2001, ONCOGENE, V20, P430, DOI 10.1038/sj.onc.1204101; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Farmer G, 1996, NUCLEIC ACIDS RES, V24, P4281, DOI 10.1093/nar/24.21.4281; Goodman RH, 2000, GENE DEV, V14, P1553; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hu YM, 2005, J BIOL CHEM, V280, P39485, DOI 10.1074/jbc.M503296200; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kiningham KK, 2001, BIOCHEM J, V353, P147, DOI 10.1042/bj3530147; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nakano T, 1996, CANCER RES, V56, P2771; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ravi R, 1998, CANCER RES, V58, P4531; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Ruiz-Lozano P, 1999, CELL GROWTH DIFFER, V10, P295; SUBLER MA, 1992, J VIROL, V66, P4757, DOI 10.1128/JVI.66.8.4757-4762.1992; SUN Y, 1993, MOL CARCINOGEN, V8, P49, DOI 10.1002/mc.2940080111; Tan MJ, 1999, J BIOL CHEM, V274, P12061, DOI 10.1074/jbc.274.17.12061; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yamabe Y, 1998, MOL CELL BIOL, V18, P6191, DOI 10.1128/MCB.18.11.6191	40	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9835	9846		10.1074/jbc.M109.060715	http://dx.doi.org/10.1074/jbc.M109.060715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20061391	Green Published, hybrid			2022-12-25	WOS:000276165900055
J	Martin, MS; Dutt, K; Papale, LA; Dube, CM; Dutton, SB; de Haan, G; Shankar, A; Tufik, S; Meisler, MH; Baram, TZ; Goldin, AL; Escayg, A				Martin, Melinda S.; Dutt, Karoni; Papale, Ligia A.; Dube, Celine M.; Dutton, Stacey B.; de Haan, Georgius; Shankar, Anupama; Tufik, Sergio; Meisler, Miriam H.; Baram, Tallie Z.; Goldin, Alan L.; Escayg, Andrew			Altered Function of the SCN1A Voltage-gated Sodium Channel Leads to gamma-Aminobutyric Acid-ergic (GABAergic) Interneuron Abnormalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEBRILE SEIZURES PLUS; SEVERE MYOCLONIC EPILEPSY; CAUSE GENERALIZED EPILEPSY; FAST INACTIVATION; CORTICAL-NEURONS; GENE MUTATION; MOUSE MODEL; MICE; EXCITABILITY; INFANCY	Voltage-gated sodium channels are required for the initiation and propagation of action potentials. Mutations in the neuronal voltage-gated sodium channel SCN1A are associated with a growing number of disorders including generalized epilepsy with febrile seizures plus (GEFS+),(7) severe myoclonic epilepsy of infancy, and familial hemiplegic migraine. To gain insight into the effect of SCN1A mutations on neuronal excitability, we introduced the human GEFS+ mutation SCN1A-R1648H into the orthologous mouse gene. Scn1a(RH/RH) mice homozygous for the R1648H mutation exhibit spontaneous generalized seizures and premature death between P16 and P26, whereas Scn1a(RH/+) heterozygous mice exhibit infrequent spontaneous generalized seizures, reduced threshold and accelerated propagation of febrile seizures, and decreased threshold to flurothyl-induced seizures. Inhibitory cortical interneurons from P5-P15 Scn1a(RH/+) and Scn1a(RH/RH) mice demonstrated slower recovery from inactivation, greater use-dependent inactivation, and reduced action potential firing compared with wild-type cells. Excitatory cortical pyramidal neurons were mostly unaffected. These results suggest that this SCN1A mutation predominantly impairs sodium channel activity in interneurons, leading to decreased inhibition. Decreased inhibition may be a common mechanism underlying clinically distinct SCN1A-derived disorders.	[Dutt, Karoni; Goldin, Alan L.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Dube, Celine M.; Baram, Tallie Z.; Goldin, Alan L.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Dube, Celine M.; Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Martin, Melinda S.; Papale, Ligia A.; Dutton, Stacey B.; Shankar, Anupama; Escayg, Andrew] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Papale, Ligia A.; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psychobiol, BR-04024000 Sao Paulo, Brazil; [de Haan, Georgius; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Emory University; Universidade Federal de Sao Paulo (UNIFESP); University of Michigan System; University of Michigan	Goldin, AL (corresponding author), B240 Med Sci 1, Irvine, CA 92697 USA.	agoldin@uci.edu; aescayg@emory.edu	Baram, Tallie Z/J-6447-2014; Tufik, Sergio/D-7606-2012; Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	National Institutes of Health [NS046484, NS051834, NS48336, NS34509, NS35437]; McKnight Foundation [34653]; Epilepsy Foundation; Associacao Fundo de Incentivo a Psico-farmacologia; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [07/50534-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051834, R01NS048336, R01NS046484, R01NS034509, R01NS035437, R01NS065187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; Epilepsy Foundation; Associacao Fundo de Incentivo a Psico-farmacologia; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS046484 and NS051834 (to A. E.), NS48336 (to A. L. G.), NS34509 (to M. H. M.), and NS35437 (to T.Z.B.). This work was also supported by McKnight Foundation Grant 34653 (to A. L. G.). The mouse model of GEFS+ described in this article has been licensed to Allergan. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policy.; Supported by a fellowship from the Epilepsy Foundation.; Supported by fellowships from the Associacao Fundo de Incentivo a Psico-farmacologia and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 07/50534-0.	Alekov AK, 2000, J PHYSIOL-LONDON, V529, P533, DOI 10.1111/j.1469-7793.2000.00533.x; Barela AJ, 2006, J NEUROSCI, V26, P2714, DOI 10.1523/JNEUROSCI.2977-05.2006; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Fong AY, 2005, J COMP NEUROL, V493, P274, DOI 10.1002/cne.20758; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hilgenberg LGW, 1999, J NEUROSCI, V19, P7384, DOI 10.1523/JNEUROSCI.19-17-07384.1999; Kearney JA, 2002, HUM MOL GENET, V11, P2765, DOI 10.1093/hmg/11.22.2765; Kuhn FJP, 1999, J GEN PHYSIOL, V114, P167, DOI 10.1085/jgp.114.2.167; Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lossin C, 2003, J NEUROSCI, V23, P11289; Mahoney K, 2009, SEIZURE-EUR J EPILEP, V18, P492, DOI 10.1016/j.seizure.2009.04.009; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Naritoku DK, 2003, EPILEPSIA, V44, P912, DOI 10.1046/j.1528-1157.2003.48302.x; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Osaka H, 2007, EPILEPSY RES, V75, P46, DOI 10.1016/j.eplepsyres.2007.03.018; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Schank JR, 2005, EPILEPSY RES, V65, P23, DOI 10.1016/j.eplepsyres.2005.03.010; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Spampanato J, 2004, J NEUROPHYSIOL, V91, P2040, DOI 10.1152/jn.00982.2003; Spampanato J, 2003, NEUROSCIENCE, V116, P37, DOI 10.1016/S0306-4522(02)00698-X; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Vanmolkot Kaate R J, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9486; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	32	156	163	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9823	9834		10.1074/jbc.M109.078568	http://dx.doi.org/10.1074/jbc.M109.078568			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100831	hybrid, Green Published			2022-12-25	WOS:000276165900054
J	Xie, ZW; Gong, MC; Su, W; Xie, DP; Turk, J; Guo, ZH				Xie, Zhongwen; Gong, Ming C.; Su, Wen; Xie, Dongping; Turk, John; Guo, Zhenheng			Role of Calcium-independent Phospholipase A(2)beta in High Glucose-induced Activation of RhoA, Rho Kinase, and CPI-17 in Cultured Vascular Smooth Muscle Cells and Vascular Smooth Muscle Hypercontractility in Diabetic Animals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED DISCRIMINATION; ARACHIDONIC-ACID RELEASE; UP-REGULATION; MYOSIN PHOSPHATASE; MOLECULAR-BIOLOGY; PHOSPHORYLATION; MICE; DIACYLGLYCEROL; INHIBITION; RABBIT	Previous studies suggest that high glucose-induced RhoA/Rho kinase/CPI-17 activation is involved in diabetes-associated vascular smooth muscle hypercontractility. However, the upstream signaling that links high glucose and RhoA/Rho kinase/CPI-17 activation is unknown. Here we report that calcium-independent phospholipase A(2)beta (iPLA(2)beta) is required for high glucose-induced RhoA/Rho kinase/CPI-17 activation and thereby contributes to diabetes-associated vascular smooth muscle hypercontractility. We demonstrate that high glucose increases iPLA(2)beta mRNA, protein, and iPLA(2) activity in a time-dependent manner. Protein kinase C is involved in high glucose-induced iPLA(2)beta protein up-regulation. Inhibiting iPLA(2)beta activity with bromoenol lactone or preventing its expression by genetic deletion abolishes high glucose-induced RhoA/Rho kinase/CPI-17 activation, and restoring expression of iPLA(2)beta in iPLA(2)beta-deficient cells also restores high glucose-induced CPI-17 phosphorylation. Pharmacological and genetic inhibition of 12/15-lipoxygenases has effects on high glucose-induced CPI-17 phosphorylation similar to iPLA(2)beta inhibition. Moreover, increases in iPLA2 activity and iPLA(2)beta protein expression are also observed in both type 1 and type 2 diabetic vasculature. Pharmacological and genetic inhibition of iPLA(2)beta, but not iPLA(2)beta, diminishes diabetes-associated vascular smooth muscle hypercontractility. In summary, our results reveal a novel mechanism by which high glucose-induced, protein kinase C-mediated iPLA(2)beta up-regulation activates the RhoA/Rho kinase/CPI-17 via 12/15-lipoxygenases and thereby contributes to diabetes-associated vascular smooth muscle hypercontractility.	[Su, Wen; Guo, Zhenheng] Univ Kentucky, Sch Med, Dept Internal Med, Lexington, KY 40536 USA; [Xie, Zhongwen; Gong, Ming C.; Xie, Dongping] Univ Kentucky, Sch Med, Dept Physiol, Lexington, KY 40536 USA; [Turk, John] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Kentucky; University of Kentucky; Washington University (WUSTL)	Guo, ZH (corresponding author), Univ Kentucky, Sch Med, Dept Internal Med, 515 Wethington Bldg,900 S Limestone, Lexington, KY 40536 USA.	zguo2@uky.edu			National Institutes of Health [HL088389, HL082791]; Commonwealth of Kentucky Diabetes Research Trust Fund; American Diabetes Association [1-04-CD-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082791, R01HL088389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Kentucky Diabetes Research Trust Fund; American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088389 (to Z. G.) and HL082791 (to M. C. G.). This work was also supported by funds from the Commonwealth of Kentucky Diabetes Research Trust Fund (to Z. G.) and American Diabetes Association Career Development Award 1-04-CD-04 (to M. C. G.).	Akiba S, 2002, BIOCHEM PHARMACOL, V63, P1969, DOI 10.1016/S0006-2952(02)00988-7; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bolick DT, 2006, ARTERIOSCL THROM VAS, V26, P1260, DOI 10.1161/01.ATV.0000217909.09198.d6; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chang SH, 2006, AM J PHYSIOL-RENAL, V290, pF650, DOI 10.1152/ajprenal.00235.2005; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Fatima S, 2001, J PHARMACOL EXP THER, V298, P331; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; GONG MC, 1995, J PHYSIOL-LONDON, V486, P113, DOI 10.1113/jphysiol.1995.sp020795; GONG MC, 1992, J BIOL CHEM, V267, P21492; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Guo ZH, 2003, J BIOL CHEM, V278, P1856, DOI 10.1074/jbc.M211075200; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Huang W, 2004, J LIPID RES, V45, P1519, DOI 10.1194/jlr.M400088-JLR200; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Ji X, 2007, EUR J PHARMACOL, V577, P109, DOI 10.1016/j.ejphar.2007.08.011; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Maeda A, 2006, GENES CELLS, V11, P1071, DOI 10.1111/j.1365-2443.2006.01001.x; McHowat J, 2000, AM J PHYSIOL-ENDOC M, V279, pE25, DOI 10.1152/ajpendo.2000.279.1.E25; Meyer MC, 2005, AM J PHYSIOL-CELL PH, V288, pC475, DOI 10.1152/ajpcell.00306.2004; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Mueed I, 2005, BRIT J PHARMACOL, V146, P972, DOI 10.1038/sj.bjp.0706398; Muller A, 2002, IMMUNOBIOLOGY, V205, P35, DOI 10.1078/0171-2985-00109; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Nobe K, 2002, BRIT J PHARMACOL, V136, P441, DOI 10.1038/sj.bjp.0704722; Pang H, 2006, AM J PHYSIOL-CELL PH, V290, pC892, DOI 10.1152/ajpcell.00378.2005; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Park KM, 2008, AM J PHYSIOL-HEART C, V294, pH1183, DOI 10.1152/ajpheart.01148.2007; Ramana KV, 2005, DIABETES, V54, P818, DOI 10.2337/diabetes.54.3.818; Seashols SJ, 2004, BBA-MOL CELL BIOL L, V1684, P29, DOI 10.1016/j.bbalip.2004.05.003; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STEER SA, 1983, AM J PHYSIOL-CELL PH, V283, pC1621; Teng HJ, 2009, J BIOL CHEM, V284, P26368, DOI 10.1074/jbc.M109.021360; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Way KJ, 2001, DIABETIC MED, V18, P945, DOI 10.1046/j.0742-3071.2001.00638.x; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002	49	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8628	8638		10.1074/jbc.M109.057711	http://dx.doi.org/10.1074/jbc.M109.057711			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086008	hybrid, Green Published			2022-12-25	WOS:000275553700015
J	Janowiak, BE; Fischer, A; Collier, RJ				Janowiak, Blythe E.; Fischer, Audrey; Collier, R. John			Effects of Introducing a Single Charged Residue into the Phenylalanine Clamp of Multimeric Anthrax Protective Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR LIPID-BILAYERS; LETHAL FACTOR; PROTEIN TRANSLOCATION; PORE FORMATION; TOXIN PORE; RECEPTOR; CHANNEL; BINDING; MUTATIONS; CELLS	Multimeric pores formed in the endosomal membrane by the Protective Antigen moiety of anthrax toxin translocate the enzymatic moieties of the toxin to the cytosolic compartment of mammalian cells. There is evidence that the side chains of the Phe(427) residues come into close proximity with one another in the lumen of the pore and form a structure, termed the Phe clamp, that catalyzes the translocation process. In this report we describe the effects of replacing Phe427 in a single subunit of the predominantly heptameric pore with a basic or an acidic amino acid. Incorporating any charged residue at this position inhibited cytotoxicity >= 1,000-fold in our standard assay and caused strong inhibition of translocation in a planar phospholipid bilayer system. His and Glu were the most strongly inhibitory residues, ablating both cytotoxicity and translocation. Basic residues at position 427 prevented the Phe clamp from interacting with a translocation substrate to form a seal against the passage of ions and accelerated dissociation of the substrate from the pore. Acidic residues, in contrast, allowed the seal to form and the substrate to remain firmly bound, but blocked its passage, perhaps via electrostatic interactions with the positively charged N-terminal segment. Our findings are discussed in relation to the role of the Phe clamp in a Brownian ratchet model of translocation.	[Janowiak, Blythe E.; Fischer, Audrey; Collier, R. John] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Collier, RJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	jcollier@hms.harvard.edu		Janowiak, Blythe/0000-0001-8103-2474; Collier, R John/0000-0002-2427-4239	National Institutes of Health [1F32 AI077280, 5R01 AI022021]; New England Regional Center of Excellence [A1057159]; PharmAthene, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077280, R01AI022021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PharmAthene, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F32 AI077280 (to B. E. J.) and 5R01 AI022021 (to R. J. C.). This work was also supported by New England Regional Center of Excellence Grant A1057159. RJC holds equity in PharmAthene, Inc.	Alfano RW, 2008, MOL CANCER THER, V7, P1218, DOI 10.1158/1535-7163.MCT-08-0024; Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; BERNARD AR, 1995, CURRENT PROTOCOLS PR; Chen D, 2008, BIOORGAN MED CHEM, V16, P7225, DOI 10.1016/j.bmc.2008.06.036; EZZELL JW, 1992, J GEN MICROBIOL, V138, P543, DOI 10.1099/00221287-138-3-543; FINKELSTEIN A, 1994, TOXICOLOGY, V87, P29, DOI 10.1016/0300-483X(94)90153-8; Goldman DL, 2008, CLIN VACCINE IMMUNOL, V15, P970, DOI 10.1128/CVI.00064-08; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Janowiak BE, 2009, PROTEIN SCI, V18, P348, DOI 10.1002/pro.35; Katayama H, 2008, NAT STRUCT MOL BIOL, V15, P754, DOI 10.1038/nsmb.1442; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Leppla SH, 2001, NAT MED, V7, P659, DOI 10.1038/89025; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; MUELLER P, 1963, J THEOR BIOL, V4, P268, DOI 10.1016/0022-5193(63)90006-7; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Robinson R.A., 1965, ELECTROLYTE SOLUTION, V2nd; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Singh Y, 1999, INFECT IMMUN, V67, P1853; Singh Y, 2001, J BIOL CHEM, V276, P22090, DOI 10.1074/jbc.M010222200; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; Thoren KL, 2009, P NATL ACAD SCI USA, V106, P21555, DOI 10.1073/pnas.0905880106; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864	39	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8130	8137		10.1074/jbc.M109.093195	http://dx.doi.org/10.1074/jbc.M109.093195			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061382	Green Published, hybrid			2022-12-25	WOS:000275413800031
J	Frei, R; Steinle, J; Birchler, T; Loeliger, S; Roduit, C; Steinhoff, D; Seibl, R; Buchner, K; Seger, R; Reith, W; Lauener, RP				Frei, Remo; Steinle, Johanna; Birchler, Thomas; Loeliger, Susanne; Roduit, Caroline; Steinhoff, Dirk; Seibl, Reinhart; Buechner, Katja; Seger, Reinhard; Reith, Walter; Lauener, Roger P.			MHC Class II Molecules Enhance Toll-Like Receptor Mediated Innate Immune Responses	PLOS ONE			English	Article							LIPID RAFTS; EPITHELIAL-CELLS; MATURATION	Background: Major histocompatibility complex (MHC) class II molecules play crucial roles in immune activation by presenting foreign peptides to antigen-specific T helper cells and thereby inducing adaptive immune responses. Although adaptive immunity is a highly effective defense system, it takes several days to become fully operational and needs to be triggered by danger-signals generated during the preceding innate immune response. Here we show that MHC class II molecules synergize with Toll-like receptor (TLR) 2 and TLR4 in inducing an innate immune response. Methodology/Principal Findings: We found that co-expression of MHC class II molecules and TLR2 or TLR4 in human embryonic kidney (HEK) cells 293 leads to enhanced production of the anti-microbial peptide human-beta-defensin (hBD) 2 after treatment with TLR2 stimulus bacterial lipoprotein (BLP) or TLR4 ligand lipopolysaccharide (LPS), respectively. Furthermore, we found that peritoneal macrophages of MHC class II knock-out mice show a decreased responsiveness to TLR2 and TLR4 stimuli compared to macrophages of wild-type mice. Finally, we show that MHC class II molecules are physically and functionally associated with TLR2 in lipid raft domains of the cell membrane. Conclusions/Significance: These results demonstrate that MHC class II molecules are, in addition to their central role in adaptive immunity, also implicated in generating optimal innate immune responses.	[Frei, Remo; Steinle, Johanna; Loeliger, Susanne; Roduit, Caroline; Steinhoff, Dirk; Seibl, Reinhart; Buechner, Katja; Seger, Reinhard; Lauener, Roger P.] Univ Zurich, Childrens Hosp, Div Immunol Allergol, Zurich, Switzerland; [Birchler, Thomas] Univ Zurich Hosp, Clin Immunol Sect, CH-8091 Zurich, Switzerland; [Reith, Walter] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland	University Children's Hospital Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Geneva	Frei, R (corresponding author), Univ Zurich, Childrens Hosp, Div Immunol Allergol, Zurich, Switzerland.	remo.frei@kispi.uzh.ch; roger.lauener@hgk.ch	Frei, Remo/AAI-9180-2020; Roduit, Caroline/S-4928-2017; Lauener, Roger P/O-8612-2016	Lauener, Roger P/0000-0002-8412-606X; Roduit, Caroline/0000-0002-5988-0570	Swiss National Science Foundation [3200-100324]; Kuehne Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kuehne Foundation	This work was supported by grants from the Swiss National Science Foundation (Nr. 3200-100324; http://www.snf.ch) and by the Kuehne Foundation (http://www.kuehne-stiftung.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Bouillon M, 2003, J BIOL CHEM, V278, P7099, DOI 10.1074/jbc.M211566200; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Hertz CJ, 2001, J IMMUNOL, V166, P2444, DOI 10.4049/jimmunol.166.4.2444; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	18	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8808	10.1371/journal.pone.0008808	http://dx.doi.org/10.1371/journal.pone.0008808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098705	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000273779000034
J	Merrill, JC; Melhuish, TA; Kagey, MH; Yang, SH; Sharrocks, AD; Wotton, D				Merrill, Jacqueline C.; Melhuish, Tiffany A.; Kagey, Michael H.; Yang, Shen-Hsi; Sharrocks, Andrew D.; Wotton, David			A Role for Non-Covalent SUMO Interaction Motifs in Pc2/CBX4 E3 Activity	PLOS ONE			English	Article							NUCLEAR-BODY FORMATION; PROTEIN MODIFICATION; UBIQUITIN LIGASE; POLYCOMB PROTEIN; BINDING MOTIF; SUMOYLATION; MODIFIER; PML; CONJUGATION; UBC9	Background: Modification of proteins by the small ubiquitin like modifier (SUMO) is an essential process in mammalian cells. SUMO is covalently attached to lysines in target proteins via an enzymatic cascade which consists of E1 and E2, SUMO activating and conjugating enzymes. There is also a variable requirement for non-enzymatic E3 adapter like proteins, which can increase the efficiency and specificity of the sumoylation process. In addition to covalent attachment of SUMO to target proteins, specific non-covalent SUMO interaction motifs (SIMs) that are generally short hydrophobic peptide motifs have been identified. Methodology/Principal Findings: Intriguingly, consensus SIMs are present in most SUMO E3s, including the polycomb protein, Pc2/Cbx4. However, a role for SIMs in SUMO E3 activity remains to be shown. We show that Pc2 contains two functional SIMs, both of which contribute to full E3 activity in mammalian cells, and are also required for sumoylation of Pc2 itself. Pc2 forms distinct sub-nuclear foci, termed polycomb bodies, and can recruit partner proteins, such as the corepressor CtBP. We demonstrate that mutation of the SIMs in Pc2 prevents Pc2-dependent CtBP sumoylation, and decreases enrichment of SUMO1 and SUMO2 at polycomb foci. Furthermore, mutational analysis of both SUMO1 and SUMO2 reveals that the SIM-interacting residues of both SUMO isoforms are required for Pc2-mediated sumoylation and localization to polycomb foci. Conclusions/Significance: This work provides the first clear evidence for a role for SIMs in SUMO E3 activity.	[Merrill, Jacqueline C.; Melhuish, Tiffany A.; Kagey, Michael H.; Wotton, David] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Merrill, Jacqueline C.; Melhuish, Tiffany A.; Kagey, Michael H.; Wotton, David] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA; [Yang, Shen-Hsi; Sharrocks, Andrew D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Virginia; University of Virginia; University of Manchester	Merrill, JC (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	dw2p@virginia.edu	Sharrocks, Andrew/J-6756-2013	Wotton, David/0000-0002-4652-5350	National Institutes of Health [HD39926]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant, HD39926, to D.W. S.-H.Y. and A.D.S. were funded by a grant from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LI B, 2007, BIOCH J; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; MACPHERSON MJ, 2008, MOL CELL BIOL; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	47	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8794	10.1371/journal.pone.0008794	http://dx.doi.org/10.1371/journal.pone.0008794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098713	gold, Green Published, Green Submitted			2022-12-25	WOS:000273779000021
J	Chan, RWY; Yuen, KM; Yu, WCL; Ho, CCC; Nicholls, JM; Peiris, JSM; Chan, MCW				Chan, Renee W. Y.; Yuen, Kit M.; Yu, Wendy C. L.; Ho, Carol C. C.; Nicholls, John M.; Peiris, J. S. Malik; Chan, Michael C. W.			Influenza H5N1 and H1N1 Virus Replication and Innate Immune Responses in Bronchial Epithelial Cells Are Influenced by the State of Differentiation	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; CYTOKINE RESPONSES; HUMAN ALVEOLAR; IN-VITRO; INFECTION; MECHANISM; RECEPTOR; MUCIN; PATHOGENESIS; CORONAVIRUS	Influenza H5N1 virus continues to be enzootic in poultry and transmits zoonotically to humans. Although a swine-origin H1N1 virus has emerged to become pandemic, its virulence for humans remains modest in comparison to that seen in zoonotic H5N1 disease. As human respiratory epithelium is the primary target cells for influenza viruses, elucidating the viral tropism and host innate immune responses of influenza H5N1 virus in human bronchial epithelium may help to understand the pathogenesis. Here we established primary culture of undifferentiated and well differentiated normal human bronchial epithelial (NHBE) cells and infected with highly pathogenic influenza H5N1 virus (A/Vietnam/3046/2004) and a seasonal influenza H1N1 virus (A/Hong Kong/54/1998), the viral replication kinetics and cytokine and chemokine responses were compared by qPCR and ELISA. We found that the in vitro culture of the well differentiated NHBE cells acquired the physiological properties of normal human bronchi tissue which express high level of alpha 2-6-linked sialic acid receptors and human airway trypsin-like (HAT) protease, in contrast to the low expression in the non-differentiated NHBE cells. When compared to H1N1 virus, the H5N1 virus replicated more efficiently and induced a stronger type I interferon response in the undifferentiated NHBE cells. In contrast, in well differentiated cultures, H5N1 virus replication was less efficient and elicited a lower interferon-beta response in comparison with H1N1 virus. Our data suggest that the differentiation of bronchial epithelial cells has a major influence in cells' permissiveness to human H1N1 and avian H5N1 viruses and the host innate immune responses. The reduced virus replication efficiency partially accounts for the lower interferon-beta responses in influenza H5N1 virus infected well differentiated NHBE cells. Since influenza infection in the bronchial epithelium will lead to tissue damage and associate with the epithelium regeneration, the data generated from the undifferentiated NHBE cultures may also be relevant to disease pathogenesis.	[Chan, Renee W. Y.; Yuen, Kit M.; Yu, Wendy C. L.; Ho, Carol C. C.; Peiris, J. S. Malik; Chan, Michael C. W.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Chan, Renee W. Y.; Yuen, Kit M.; Nicholls, John M.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Peiris, J. S. Malik] HKU Pasteur Res Ctr, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, RWY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.	mchan@hkucc.hku.hk	Chan, Renee/D-4799-2012; Chan, Michael Chi Wai/C-4212-2009; Chan, Renee Wan Yi/AAA-6598-2020; Nicholls, John Malcolm/C-4375-2009	Chan, Michael Chi Wai/0000-0001-8174-8405; Chan, Renee Wan Yi/0000-0001-6485-0926; Nicholls, John Malcolm/0000-0001-7217-7444	Research Fund for Control of Infectious Disease; Hong Kong SAR Government; General Research Fund [HKU 7612/08M]; Research Grants Council, Hong Kong SAR Government; AoE Funding [AoE/M-12/06]; University Grants Committee	Research Fund for Control of Infectious Disease; Hong Kong SAR Government; General Research Fund; Research Grants Council, Hong Kong SAR Government(Hong Kong Research Grants Council); AoE Funding; University Grants Committee	Funding: This work was supported by Research Fund for Control of Infectious Disease Grant (RFCID grants, reference no: 03040712 and 06060552) from the Research Fund for Control of Infectious Disease, Health, Welfare and Food Bureau, Hong Kong SAR Government and the General Research Fund (HKU 7612/08M), Research Grants Council, Hong Kong SAR Government (to M. C. W. C); and AoE Funding (AoE/M-12/06) from the Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1997, INT ARCH ALLERGY IMM, V113, P307, DOI 10.1159/000237584; Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; BAUM LG, 1990, ACTA HISTOCHEM, P35; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102; CHAN RWY, 2009, DAS181 INHIBITS H5N1, P389; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Danahay H, 2006, AM J PHYSIOL-LUNG C, V290, pL558, DOI 10.1152/ajplung.00351.2005; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; LeSimple P, 2007, AM J RESP CELL MOL, V36, P296, DOI 10.1165/rcmb.2006-0270OC; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Park JA, 2005, AM J PATHOL, V167, P651, DOI 10.1016/S0002-9440(10)62040-8; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; PEREZPADILLA R, 2009, N ENGL J MED; SHUCHIH, 2008, J PHARM SCI, V9999; Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005; Sims AC, 2008, VIRUS RES, V133, P33, DOI 10.1016/j.virusres.2007.03.013; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tseng CTK, 2005, J VIROL, V79, P9470, DOI 10.1128/JVI.79.15.9470-9479.2005; *WHO, 2009, CUM NUMB CONF HUM CA; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	31	72	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8713	10.1371/journal.pone.0008713	http://dx.doi.org/10.1371/journal.pone.0008713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090947	Green Submitted, Green Published, gold			2022-12-25	WOS:000273714900002
J	Russello, MA; Poulakakis, N; Gibbs, JP; Tapia, W; Benavides, E; Powell, JR; Caccone, A				Russello, Michael A.; Poulakakis, Nikos; Gibbs, James P.; Tapia, Washington; Benavides, Edgar; Powell, Jeffrey R.; Caccone, Adalgisa			DNA from the Past Informs Ex Situ Conservation for the Future: An "Extinct'' Species of Galapagos Tortoise Identified in Captivity	PLOS ONE			English	Article							GIANT TORTOISES; POPULATION-STRUCTURE; GENETIC-DIVERGENCE; PHYLOGEOGRAPHY; RELATEDNESS; MANAGEMENT; HISTORY	Background: Although not unusual to find captive relicts of species lost in the wild, rarely are presumed extinct species rediscovered outside of their native range. A recent study detected living descendents of an extinct Galapagos tortoise species (Chelonoidis elephantopus) once endemic to Floreana Island on the neighboring island of Isabela. This finding adds to the growing cryptic diversity detected among these species in the wild. There also exists a large number of Galapagos tortoises in captivity of ambiguous origin. The recently accumulated population-level haplotypic and genotypic data now available for C. elephantopus add a critical reference population to the existing database of 11 extant species for investigating the origin of captive individuals of unknown ancestry. Methodology/Findings: We reanalyzed mitochondrial DNA control region haplotypes and microsatellite genotypes of 156 captive individuals using an expanded reference database that included all extant Galapagos tortoise species as well as the extinct species from Floreana. Nine individuals (six females and three males) exhibited strong signatures of Floreana ancestry and a high probability of assignment to C. elephantopus as detected by Bayesian assignment and clustering analyses of empirical and simulated data. One male with high assignment probability to C. elephantopus based on microsatellite genotypic data also possessed a "Floreana-like'' mitochondrial DNA haplotype. Significance: Historical DNA analysis of museum specimens has provided critical spatial and temporal components to ecological, evolutionary, taxonomic and conservation-related research, but rarely has it informed ex situ species recovery efforts. Here, the availability of population-level genotypic data from the extinct C. elephantopus enabled the identification of nine Galapagos tortoise individuals of substantial conservation value that were previously misassigned to extant species of varying conservation status. As all captive individuals of C. elephantopus ancestry currently reside at a centralized breeding facility on Santa Cruz, these findings permit breeding efforts to commence in support of the reestablishment of this extinct species to its native range.	[Russello, Michael A.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada; [Poulakakis, Nikos] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Poulakakis, Nikos] Univ Crete, Nat Hist Museum Crete, Iraklion, Crete, Greece; [Gibbs, James P.] SUNY Syracuse, Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Tapia, Washington] Galapagos Natl Pk Serv, Puerto Ayora, Galapagos, Ecuador; [Benavides, Edgar; Powell, Jeffrey R.; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	University of British Columbia; University of British Columbia Okanagan; University of Crete; University of Crete; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Yale University	Russello, MA (corresponding author), Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada.	michael.russello@ubc.ca	Poulakakis, Nikos/E-7848-2011; Caccone, Adalgisa/AAE-4238-2021	Caccone, Adalgisa/0000-0002-8949-9260; Tapia, Washington/0000-0002-5222-1804	Paul and Bay Foundation; Turtle Conservation Fund; National Geographic Society; Yale Institute for Biospheric Studies (YIBS)	Paul and Bay Foundation; Turtle Conservation Fund; National Geographic Society(National Geographic Society); Yale Institute for Biospheric Studies (YIBS)	Funding was provided by the Paul and Bay Foundation, Turtle Conservation Fund, National Geographic Society, and Yale Institute for Biospheric Studies (YIBS) Ecosave funds to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beheregaray LB, 2004, P NATL ACAD SCI USA, V101, P6514, DOI 10.1073/pnas.0400393101; Beheregaray LB, 2003, CONSERV GENET, V4, P31, DOI 10.1023/A:1021864214375; Burns CE, 2003, ANIM CONSERV, V6, P329, DOI 10.1017/S1367943003003408; Caccone A, 2002, EVOLUTION, V56, P2052; Ciofi C, 2006, GENETICS, V172, P1727, DOI 10.1534/genetics.105.047860; Ciofi C, 2002, MOL ECOL, V11, P2265, DOI 10.1046/j.1365-294X.2002.01617.x; Ciofi Claudio, 2009, V17, P269; Collins, 1994, CAPTIVE MANAGEMENT C, P297; Cornuet JM, 1999, GENETICS, V153, P1989; Driscoll CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004125; Ernst C.H., 1989, TURTLES WORLD; FRITTS TH, 1984, BIOL J LINN SOC, V21, P165, DOI 10.1111/j.1095-8312.1984.tb02059.x; Gaimard J. P., 1824, VOYAGE AUTOUR MONDE, P174; Hedrick PW, 2009, J HERED, V100, P411, DOI 10.1093/jhered/esp024; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IUCN, 2014, IUCN RED LIST THREAT; Iyengar A, 2007, MOL ECOL, V16, P2436, DOI 10.1111/j.1365-294X.2007.03291.x; Lancaster ML, 2006, MOL ECOL, V15, P3681, DOI 10.1111/j.1365-294X.2006.03041.x; Le M, 2006, MOL PHYLOGENET EVOL, V40, P517, DOI 10.1016/j.ympev.2006.03.003; Lynch M, 1999, GENETICS, V152, P1753; Milinkovitch MC, 2004, P ROY SOC B-BIOL SCI, V271, P341, DOI 10.1098/rspb.2003.2607; Milinkovitch Michel C., 2007, BMC Ecology, V7, P2, DOI 10.1186/1472-6785-7-2; Nicholls H, 2006, LONESOME GEORGE LIFE; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Russello M., 2009, IREL V1 0 ONLINE TOO; Russello MA, 2007, ANIM CONSERV, V10, P304, DOI 10.1111/j.1469-1795.2007.00113.x; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; Russello MA, 2004, MOL ECOL, V13, P2829, DOI 10.1111/j.1365-294X.2004.02266.x; Russello MA, 2007, MOL ECOL, V16, P2405, DOI 10.1111/j.1365-294X.2007.03376.x; Russello MA, 2007, CURR BIOL, V17, pR317, DOI 10.1016/j.cub.2007.03.002; Steeves TE, 2010, BIOL LETTERS, V6, P94, DOI 10.1098/rsbl.2009.0478; Van Denburgh J., 1914, Proceedings of the California Academy of Science (4th Series), V2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WHARTON DC, 1990, BACKCROSSING SPECIES	39	30	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8683	10.1371/journal.pone.0008683	http://dx.doi.org/10.1371/journal.pone.0008683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084268	Green Published, gold, Green Submitted			2022-12-25	WOS:000273554600033
J	Wisniewska, M; Karlberg, T; Lehtio, L; Johansson, I; Kotenyova, T; Moche, M; Schuler, H				Wisniewska, Magdalena; Karlberg, Tobias; Lehtio, Lari; Johansson, Ida; Kotenyova, Tetyana; Moche, Martin; Schuler, Herwig			Crystal Structures of the ATPase Domains of Four Human Hsp70 Isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B ', and HSPA5/BiP/GRP78	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE EXCHANGE; HEAT-SHOCK-PROTEIN-70 FAMILY; GENETIC POLYMORPHISMS; SUBSTRATE-BINDING; EXPRESSION; CHAPERONES; DNAK; SITE	The 70-kDa heat shock proteins (Hsp70) are chaperones with central roles in processes that involve polypeptide remodeling events. Hsp70 proteins consist of two major functional domains: an N-terminal nucleotide binding domain (NBD) with ATPase activity, and a C-terminal substrate binding domain (SBD). We present the first crystal structures of four human Hsp70 isoforms, those of the NBDs of HSPA1L, HSPA2, HSPA5 and HSPA6. As previously with Hsp70 family members, all four proteins crystallized in a closed cleft conformation, although a slight cleft opening through rotation of subdomain IIB was observed for the HSPA5-ADP complex. The structures presented here support the view that the NBDs of human Hsp70 function by conserved mechanisms and contribute little to isoform specificity, which instead is brought about by the SBDs and by accessory proteins.	[Wisniewska, Magdalena; Karlberg, Tobias; Lehtio, Lari; Johansson, Ida; Kotenyova, Tetyana; Moche, Martin; Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden	Karolinska Institutet	Wisniewska, M (corresponding author), Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501; Lehtio, Lari/0000-0001-7250-832X; Moche, Martin/0000-0002-4834-7076	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Brewer JW, 2005, NAT IMMUNOL, V6, P23, DOI 10.1038/ni1149; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng HL, 2001, FERTIL STERIL, V76, P1136, DOI 10.1016/S0015-0282(01)02892-8; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; GAUT JR, 1993, J BIOL CHEM, V268, P12691; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; HENDERSHOT LM, 1994, GENOMICS, V20, P281, DOI 10.1006/geno.1994.1166; Hendrickson WA, 2008, STRUCTURE, V16, P1153, DOI 10.1016/j.str.2008.07.002; ISHIHARA M, 1995, TISSUE ANTIGENS, V46, P59, DOI 10.1111/j.1399-0039.1995.tb02477.x; Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LEUNG TKC, 1990, BIOCHEM J, V267, P125, DOI 10.1042/bj2670125; LEUNG TKC, 1992, GENOMICS, V12, P74, DOI 10.1016/0888-7543(92)90409-L; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P219, DOI 10.1379/CSC-278.1; Osipiuk J, 1999, ACTA CRYSTALLOGR D, V55, P1105, DOI 10.1107/S0907444999002103; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Qi GY, 2005, BIOINFORMATICS, V21, P2832, DOI 10.1093/bioinformatics/bti420; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; SARGENT CA, 1989, P NATL ACAD SCI USA, V86, P1968, DOI 10.1073/pnas.86.6.1968; Sasaki T, 2008, J CELL BIOL, V182, P449, DOI 10.1083/jcb.200802113; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Son WY, 1999, MOL HUM REPROD, V5, P1122, DOI 10.1093/molehr/5.12.1122; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Spagnolo P, 2007, INVEST OPHTH VIS SCI, V48, P3019, DOI 10.1167/iovs.06-1485; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; TING J, 1988, DNA-J MOLEC CELL BIO, V7, P275, DOI 10.1089/dna.1988.7.275; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Wu XJ, 2004, BIOCHEM J, V378, P793, DOI 10.1042/BJ20031680; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Zhu DH, 1997, DEVELOPMENT, V124, P3007; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	51	105	114	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8625	10.1371/journal.pone.0008625	http://dx.doi.org/10.1371/journal.pone.0008625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20072699	gold, Green Published			2022-12-25	WOS:000273456300005
J	Anwari, K; Poggio, S; Perry, A; Gatsos, X; Ramarathinam, SH; Williamson, NA; Noinaj, N; Buchanan, S; Gabriel, K; Purcell, AW; Jacobs-Wagner, C; Lithgow, T				Anwari, Khatira; Poggio, Sebastian; Perry, Andrew; Gatsos, Xenia; Ramarathinam, Sri Harsha; Williamson, Nicholas A.; Noinaj, Nicholas; Buchanan, Susan; Gabriel, Kipros; Purcell, Anthony W.; Jacobs-Wagner, Christine; Lithgow, Trevor			A Modular BAM Complex in the Outer Membrane of the alpha-Proteobacterium Caulobacter crescentus	PLOS ONE			English	Article							PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; BACTERIAL FLAGELLAR MOTOR; ESCHERICHIA-COLI; CELL-ENVELOPE; PSEUDOMONAS-AERUGINOSA; NEISSERIA-MENINGITIDIS; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; OMP85 FAMILY; YAET COMPLEX	Mitochondria are organelles derived from an intracellular alpha-proteobacterium. The biogenesis of mitochondria relies on the assembly of beta-barrel proteins into the mitochondrial outer membrane, a process inherited from the bacterial ancestor. Caulobacter crescentus is an alpha-proteobacterium, and the BAM (beta-barrel assembly machinery) complex was purified and characterized from this model organism. Like the mitochondrial sorting and assembly machinery complex, we find the BAM complex to be modular in nature. A similar to 150 kDa core BAM complex containing BamA, BamB, BamD, and BamE associates with additional modules in the outer membrane. One of these modules, Pal, is a lipoprotein that provides a means for anchorage to the peptidoglycan layer of the cell wall. We suggest the modular design of the BAM complex facilitates access to substrates from the protein translocase in the inner membrane.	[Anwari, Khatira; Perry, Andrew; Gabriel, Kipros; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Poggio, Sebastian; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Poggio, Sebastian; Jacobs-Wagner, Christine] Yale Univ, Microbial Pathogenesis Sect, New Haven, CT USA; [Gatsos, Xenia; Ramarathinam, Sri Harsha; Williamson, Nicholas A.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Noinaj, Nicholas; Buchanan, Susan] NIDDK, NIH, Bethesda, MD USA; [Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Monash University; Yale University; Yale University; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Yale University	Anwari, K (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	trevor.lithgow@med.monash.edu.au	Ramarathinam, Sri H/G-2278-2012; Purcell, Anthony/AAH-1942-2019; Lithgow, Trevor J/H-5925-2017; Perry, Andrew/E-5607-2010; Williamson, Nicholas A/O-9812-2016	Ramarathinam, Sri H/0000-0002-2787-1282; Purcell, Anthony/0000-0003-0532-8331; Lithgow, Trevor J/0000-0002-0102-7884; Perry, Andrew/0000-0001-9256-6068; Williamson, Nicholas A/0000-0002-2173-3452; Jacobs-Wagner, Christine/0000-0003-0980-5334; Poggio, Sebastian/0000-0001-9494-3365	National Health and Medical Research Council [508911]; ARC [LE0882913]; Monash University; Pew Latin American Fellowship; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health [GM065835, GM076698]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076698, R01GM065835] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Monash University(Monash University); Pew Latin American Fellowship; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' laboratories is supported by grants from the National Health and Medical Research Council (508911; to AWP and TL), and an ARC Linkage Infrastructure Equipment and Facilities grant (LE0882913). KA is supported by a Monash University Research Scholarship; AP is supported by a National Health and Medical Research Council Training Fellowship; SP is supported by a Pew Latin American Fellowship. SB and NN are supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. The CJW laboratory is supported by the National Institutes of Health (GM065835 and GM076698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron M, 2007, MOL MICROBIOL, V64, P938, DOI 10.1111/j.1365-2958.2007.05720.x; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Costa T, 2008, MOL MICROBIOL, V70, P634, DOI 10.1111/j.1365-2958.2008.06432.x; DeRosier DJ, 1998, CELL, V93, P17, DOI 10.1016/S0092-8674(00)81141-1; Emelyanov VV, 2003, ARCH BIOCHEM BIOPHYS, V420, P130, DOI 10.1016/j.abb.2003.09.031; Fardini Y, 2007, INFECT IMMUN, V75, P358, DOI 10.1128/IAI.00716-06; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Hellman J, 2002, J BIOL CHEM, V277, P14274, DOI 10.1074/jbc.M109696200; Hizukuri Y, 2009, J BIOCHEM, V146, P219, DOI 10.1093/jb/mvp061; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Hulett JM, 2008, J MOL BIOL, V376, P694, DOI 10.1016/j.jmb.2007.12.021; Jensen GJ, 2007, CURR OPIN STRUC BIOL, V17, P260, DOI 10.1016/j.sbi.2007.03.002; Judd EM, 2005, J BACTERIOL, V187, P6874, DOI 10.1128/JB.187.20.6874-6882.2005; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lewis C, 2008, MICROBIOL-SGM, V154, P979, DOI 10.1099/mic.0.2007/011999-0; Liang MD, 2005, J INFECT DIS, V191, P939, DOI 10.1086/427815; Lueder F, 2009, FEBS LETT, V583, P1475, DOI 10.1016/j.febslet.2009.03.064; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; MIZUNO T, 1981, J BIOCHEM-TOKYO, V89, P1059; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Ochsner UA, 1999, J BACTERIOL, V181, P1099, DOI 10.1128/JB.181.4.1099-1109.1999; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Popov-Celeketic J, 2008, J MOL BIOL, V376, P671, DOI 10.1016/j.jmb.2007.12.006; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Soo PC, 2005, INFECT IMMUN, V73, P6075, DOI 10.1128/IAI.73.9.6075-6084.2005; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	64	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8619	10.1371/journal.pone.0008619	http://dx.doi.org/10.1371/journal.pone.0008619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062535	Green Published, gold, Green Submitted			2022-12-25	WOS:000273414200010
J	Rickman, C; Medine, CN; Dun, AR; Moulton, DJ; Mandula, O; Halemani, ND; Rizzoli, SO; Chamberlain, LH; Duncan, RR				Rickman, Colin; Medine, Claire N.; Dun, Alison R.; Moulton, David J.; Mandula, Ondrej; Halemani, Nagaraj D.; Rizzoli, Silvio O.; Chamberlain, Luke H.; Duncan, Rory R.			t-SNARE Protein Conformations Patterned by the Lipid Microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PC12 CELLS; LIVING CELLS; EXOCYTOSIS; FUSION; DOMAINS; COMPLEX; CHOLESTEROL; MICROSCOPY; SNAP-25	The spatial distribution of the target (t-) SNARE proteins (syntaxin and SNAP-25) on the plasma membrane has been extensively characterized. However, the protein conformations and interactions of the two t-SNAREs in situ remain poorly defined. By using super-resolution optical techniques and fluorescence lifetime imaging microscopy, we observed that within the t-SNARE clusters syntaxin and SNAP-25 molecules interact, forming two distinct conformations of the t-SNARE binary intermediate. These are spatially segregated on the plasma membrane with each cluster exhibiting predominantly one of the two conformations, representing the two-and three-helical forms previously observed in vitro. We sought to explain why these two t-SNARE intermediate conformations exist in spatially distinct clusters on the plasma membrane. By disrupting plasma membrane lipid order, we found that all of the t-SNARE clusters now adopted a single conformational state corresponding to the three helical t-SNARE intermediates. Together, our results define spatially distinct t-SNARE intermediate states on the plasma membrane and how the conformation adopted can be patterned by the underlying lipid environment.	[Medine, Claire N.; Dun, Alison R.; Moulton, David J.; Chamberlain, Luke H.; Duncan, Rory R.] Univ Edinburgh, Ctr Integrat Physiol, Sch Informat, Edinburgh EH8 9XD, Midlothian, Scotland; [Mandula, Ondrej] Univ Edinburgh, Inst Adapt & Neural Computat, Sch Informat, Edinburgh EH8 9XD, Midlothian, Scotland; [Halemani, Nagaraj D.] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Rizzoli, Silvio O.] European Neurosci Inst, D-37077 Gottingen, Germany; [Rickman, Colin] Heriot Watt Univ, Sch Engn & Phys Sci, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Max Planck Society; Heriot Watt University	Duncan, RR (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Sch Informat, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	rory.duncan@ed.ac.uk	Rizzoli, Silvio/ABG-2227-2020	Rickman, Colin/0000-0001-8938-524X; Rizzoli, Silvio/0000-0002-1667-7839; Duncan, Rory/0000-0003-0693-910X	Wellcome Trust; MRC [G0601597] Funding Source: UKRI; Medical Research Council [G0601597] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust grants ( to R. R. D. and L. H. C.).	ALTENBACH K, 2010, FUNGAL BIOL IN PRESS; An SJ, 2004, SCIENCE, V306, P1042, DOI 10.1126/science.1102559; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Becker W, 2005, ADV TIME CORRELATED; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BINZ T, 1994, J BIOL CHEM, V269, P1617; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; HALEMANI ND, 2010, TRAFFIC; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann MW, 2006, J MOL BIOL, V364, P1048, DOI 10.1016/j.jmb.2006.09.077; HOPKINS B, 1954, ANN BOT-LONDON, V18, P213, DOI 10.1093/oxfordjournals.aob.a083391; Kroch AE, 2006, J MOL BIOL, V357, P184, DOI 10.1016/j.jmb.2005.12.060; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lang T, 2008, PROG LIPID RES, V47, P461, DOI 10.1016/j.plipres.2008.08.002; McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Numahara Toshihiko, 1992, Journal of Dermatological Science, V4, P202, DOI 10.1016/0923-1811(92)90020-C; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P50805, DOI 10.1074/jbc.M207988200; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Rickman C, 2004, J BIOL CHEM, V279, P644, DOI 10.1074/jbc.M310879200; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Valkonen M, 2007, J BIOL CHEM, V282, P22775, DOI 10.1074/jbc.M700916200; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010	44	49	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13535	13541		10.1074/jbc.M109.091058	http://dx.doi.org/10.1074/jbc.M109.091058			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20093362	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000276987700026
J	Bermudez, VP; Farina, A; Tappin, I; Hurwitz, J				Bermudez, Vladimir P.; Farina, Andrea; Tappin, Inger; Hurwitz, Jerard			Influence of the Human Cohesion Establishment Factor Ctf4/AND-1 on DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-A BINDS; POLYMERASE-ALPHA; HUMAN-CELLS; CTF4; PROGRESSION; REPLISOME; COMPLEX; MCM10	Ctf4/AND-1 is a highly conserved gene product required for both DNA replication and the establishment of sister chromatid cohesion. In this report, we examined the mechanism of action of human Ctf4 (hCtf4) in DNA replication both in vitro and in vivo. Our findings show that the purified hCtf4 exists as a dimer and that the hCtf4 SepB domain likely plays a primary role determining the dimeric structure. hCtf4 binds preferentially to DNA template-primer structures, interacts directly with the replicative DNA polymerases (alpha, delta, and epsilon), and markedly stimulates the polymerase activities of DNA polymerases alpha and epsilon in vitro. Depletion of hCtf4 in HeLa cells by small interfering RNA resulted in G(1)/S phase arrest. DNA fiber analysis revealed that cells depleted of hCtf4 exhibited a rate of DNA replication slower than cells treated with control small interfering RNA. These findings suggest that in human cells, hCtf4 plays an essential role in DNA replication and its ability to stimulate the replicative DNA polymerases may contribute to this effect.	[Bermudez, Vladimir P.; Farina, Andrea; Tappin, Inger; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Hurwitz, J (corresponding author), 1275 York Ave,Box 97, New York, NY 10065 USA.	j-hurwitz@ski.mskcc.org						Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bermudez VP, 2002, J BIOL CHEM, V277, P36853, DOI 10.1074/jbc.M202897200; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; EKI T, 1992, J BIOL CHEM, V267, P7284; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; HARRIS SD, 1995, EMBO J, V14, P5244, DOI 10.1002/j.1460-2075.1995.tb00209.x; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; KIM C, 1995, BIOCHEMISTRY-US, V34, P2058, DOI 10.1021/bi00006a028; Kohler A, 1997, J CELL SCI, V110, P1051; KOUPRINA N, 1993, YEAST, V9, P11, DOI 10.1002/yea.320090103; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Schlesinger MB, 2000, GENETICS, V155, P1593; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; WAGA S, 1994, J BIOL CHEM, V269, P10923; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	27	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9493	9505		10.1074/jbc.M109.093609	http://dx.doi.org/10.1074/jbc.M109.093609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089864	Green Published, hybrid			2022-12-25	WOS:000276165900023
J	Patino-Lopez, G; Aravind, L; Dong, XY; Kruhlak, MJ; Ostap, EM; Shaw, S				Patino-Lopez, Genaro; Aravind, L.; Dong, Xiaoyun; Kruhlak, Michael J.; Ostap, E. Michael; Shaw, Stephen			Myosin 1G Is an Abundant Class I Myosin in Lymphocytes Whose Localization at the Plasma Membrane Depends on Its Ancient Divergent Pleckstrin Homology (PH) Domain (Myo1PH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TISSUE DISTRIBUTION; STRUCTURAL BASIS; L-SELECTIN; BINDING; TAIL; PROTEIN; CELLS; PHOSPHOINOSITIDES	Class I myosins, which link F-actin to membrane, are largely undefined in lymphocytes. Mass spectrometric analysis of lymphocytes identified two short tail forms: (Myo1G and Myo1C) and one long tail (Myo1F). We investigated Myo1G, the most abundant in T-lymphocytes, and compared key findings with Myo1C and Myo1F. Myo1G localizes to the plasma membrane and associates in an ATP-releasable manner to the actin-containing insoluble pellet. The IQ + tail region of Myo1G (Myo1C and Myo1F) is sufficient for membrane localization, but membrane localization is augmented by the motor domain. The minimal region lacks IQ motifs but includes: 1) a PH-like domain; 2) a "Pre-PH" region; and 3) a "Post-PH" region. The Pre-PH predicted alpha helices may contribute electrostatically, because two conserved basic residues on one face are required for optimal membrane localization. Our sequence analysis characterizes the divergent PH domain family, Myo1PH, present also in long tail myosins, in eukaryotic proteins unrelated to myosins, and in a probable ancestral protein in prokaryotes. The Myo1GMyo1PH domain utilizes the classic lipid binding site for membrane association, because mutating either of two basic residues in the "signature motif" destroys membrane localization. Mutation of each basic residue of the Myo1G Myo1PH domain reveals another critical basic residue in the beta 3 strand, which is shared only by Myo1D. Myo1G differs from Myo1C in its phosphatidylinositol 4,5-bisphosphate dependence for membrane association, because membrane localization of phosphoinositide 5-phosphatase releases Myo1C from the membrane but not Myo1G. Thus Myo1PH domains likely play universal roles in myosin I membrane association, but different isoforms have diverged in their binding specificity.	[Patino-Lopez, Genaro; Dong, Xiaoyun; Kruhlak, Michael J.; Shaw, Stephen] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Ostap, E. Michael] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Ostap, E. Michael] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; University of Pennsylvania; University of Pennsylvania	Shaw, S (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,Rm 4B36,10 Ctr Dr,MSC 1360, Bethesda, MD 20892 USA.	shaws@mail.nih.gov	Patino-Lopez, Genaro/O-3484-2018; Patiño López, Genaro/GQI-4414-2022	Patino-Lopez, Genaro/0000-0002-8716-722X; Aravind, L/0000-0003-0771-253X	National Institutes of Health [GM57247]; NCI; National Library of Medicine; NATIONAL CANCER INSTITUTE [ZICBC010915, ZIABC010993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057247, R37GM057247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57247 and the Intramural Research Program of the National Institutes of Health, NCI. This work was also supported by the National Library of Medicine.	ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; Dwir O, 2001, J CELL BIOL, V155, P145, DOI 10.1083/jcb.200103042; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Hammer J A, 1991, Trends Cell Biol, V1, P50, DOI 10.1016/0962-8924(91)90089-R; Hao JJ, 2008, J PROTEOME RES, V7, P2911, DOI 10.1021/pr800016a; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hwang KJ, 2007, P NATL ACAD SCI USA, V104, P784, DOI 10.1073/pnas.0610231104; INGLEY E, 1994, J CELL BIOCHEM, V56, P436, DOI 10.1002/jcb.240560403; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Jontes JD, 1997, J MOL BIOL, V266, P331, DOI 10.1006/jmbi.1996.0777; Kalhammer G, 2000, Essays Biochem, V35, P33; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Lee WL, 1999, J BIOL CHEM, V274, P35159, DOI 10.1074/jbc.274.49.35159; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; LEY K, 1993, BLOOD, V82, P1632; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Pierce RA, 2001, J IMMUNOL, V167, P3223, DOI 10.4049/jimmunol.167.6.3223; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; RUPPERT C, 1995, J CELL SCI, V108, P3775; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.e04-12-1116; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; WAHL SM, 1984, CELL IMMUNOL, V85, P384, DOI 10.1016/0008-8749(84)90252-1; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17	44	55	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8675	8686		10.1074/jbc.M109.086959	http://dx.doi.org/10.1074/jbc.M109.086959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071333	Green Published, hybrid			2022-12-25	WOS:000275553700020
J	Gokara, M; Sudhamalla, B; Amooru, DG; Subramanyam, R				Gokara, Mahesh; Sudhamalla, Babu; Amooru, Damu G.; Subramanyam, Rajagopal			Molecular Interaction Studies of Trimethoxy Flavone with Human Serum Albumin	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; CRYSTAL-STRUCTURE; POLYPHENOLIC COMPOUNDS; GENETIC ALGORITHM; RETINOIC ACID; BINDING-SITES; FATTY-ACIDS; DOCKING; FLUORESCENCE; INHIBITION	Background: Human serum albumin (HSA) is the most abundant protein in blood plasma, having high affinity binding sites for several endogenous and exogenous compounds. Trimethoxy flavone (TMF) is a naturally occurring flavone isolated from Andrographis viscosula and used in the treatment of dyspepsia, influenza, malaria, respiratory functions and as an astringent and antidote for poisonous stings of some insects. Methodology/Principal Findings: The main aim of the experiment was to examine the interaction between TMF and HSA at physiological conditions. Upon addition of TMF to HSA, the fluorescence emission was quenched and the binding constant of TMF with HSA was found to be K(TMF) = 1.0 +/- 0.01x10(3) M(-1), which corresponds to -5.4 kcal M(-1) of free energy. Micro-TOF Q mass spectrometry results showed a mass increase of from 66,513 Da (free HSA) to 66,823 Da (HAS + Drug), indicating the strong binding of TMF with HSA resulting in decrease of fluorescence. The HSA conformation was altered upon binding of TMF to HSA with decrease in alpha-helix and an increase in beta-sheets and random coils suggesting partial unfolding of protein secondary structure. Molecular docking experiments found that TMF binds strongly with HSA at IIIA domain of hydrophobic pocket with hydrogen bond and hydrophobic interactions. Among which two hydrogen bonds are formed between O (19) of TMF to Arg 410, Tyr 411 and another one from O (7) of TMF to Asn 391, with bond distance of 2.1 angstrom, 3.6 angstrom and 2.6 angstrom, respectively. Conclusions/Significance: In view of the evidence presented, it is imperative to assign a greater role of HSA's as a carrier molecule for many drugs to understand the interactions of HSA with TMF will be pivotal in the design of new TMF-inspired drugs.	[Gokara, Mahesh; Sudhamalla, Babu; Subramanyam, Rajagopal] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Amooru, Damu G.] Yogi Vemana Univ, Dept Chem, Kadapa, India	University of Hyderabad; Yogi Vemana University	Gokara, M (corresponding author), Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500134, Andhra Pradesh, India.	srgsl@uohyd.ernet.in	Gokara, Mahesh/G-1061-2011	Gokara, Mahesh/0000-0001-7095-887X	University of Hyderabad	University of Hyderabad(University of Hyderabad)	The University of Hyderabad provided partial funding of this work (maintenance grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev IB, 2001, BIOCHEM PHARMACOL, V61, P677, DOI 10.1016/S0006-2952(01)00526-3; Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Amic D, 2003, CROAT CHEM ACTA, V76, P55; Beauchemin R, 2007, BIOMACROMOLECULES, V8, P3177, DOI 10.1021/bm700697a; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bian Q., 2004, INT J BIOL MACROMOL, V34, P275, DOI DOI 10.1016/J.IJBIOMAC.2004.09.005; Boege F, 1996, J BIOL CHEM, V271, P2262, DOI 10.1074/jbc.271.4.2262; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; Chopra RN, 1980, GLOSSARY INDIAN MED; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Diniz A, 2008, ANAL BIOANAL CHEM, V391, P625, DOI 10.1007/s00216-008-2046-4; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; HANSEN UK, 1990, DANISH MED B, V37, P57; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; He Y, 2008, J FLUORESC, V18, P433, DOI 10.1007/s10895-007-0283-0; HUSAIN SR, 1987, PHYTOCHEMISTRY, V26, P2489, DOI 10.1016/s0031-9422(00)83860-1; Jagetia GC, 2003, MUTAGENESIS, V18, P337, DOI 10.1093/mutage/geg001; Jiang YL, 2008, BIOORGAN MED CHEM, V16, P6406, DOI 10.1016/j.bmc.2008.05.002; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kanakis CD, 2006, J MOL STRUCT, V798, P69, DOI 10.1016/j.molstruc.2006.03.051; Kandagal PB, 2008, J PHARMACEUT BIOMED, V47, P260, DOI 10.1016/j.jpba.2008.01.027; Karnaukhova E, 2007, BIOCHEM PHARMACOL, V73, P901, DOI 10.1016/j.bcp.2006.11.023; Kirtikar K.R., 1975, INDIAN MED PLANTS, V3, P1884; Kosa T, 1998, PHARMACEUT RES, V15, P449, DOI 10.1023/A:1011932516717; LAING L, 2007, BIOMACROMOLECULES, V9, P50; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Maiti TK, 2008, J PHOTOCH PHOTOBIO A, V194, P297, DOI 10.1016/j.jphotochem.2007.08.028; Middleton E, 2000, PHARMACOL REV, V52, P673; MULLER WE, 1979, PHARMACOLOGY, V19, P59, DOI 10.1159/000137289; N'soukpoe-Kossi CN, 2007, INT J BIOL MACROMOL, V40, P484, DOI 10.1016/j.ijbiomac.2006.11.005; Obach RS, 2000, J PHARMACOL EXP THER, V294, P88; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Rao YK, 2003, CHEM PHARM BULL, V51, P1374, DOI 10.1248/cpb.51.1374; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Sengupta B, 2002, BIOCHEM BIOPH RES CO, V299, P400, DOI 10.1016/S0006-291X(02)02667-0; SHAHPER NK, 2008, J PROTEOMICS BIOIN S, V1, pS20; Sinha SS, 2008, J PHYS CHEM B, V112, P4884, DOI 10.1021/jp709809b; SRIVASTAVA AK, 1985, BIOCHEM BIOPH RES CO, V131, P1, DOI 10.1016/0006-291X(85)91761-9; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V94, P8, DOI 10.1016/j.jphotobiol.2008.09.002; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V95, P81, DOI 10.1016/j.jphotobiol.2009.01.002; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Sulkowska A, 2002, J MOL STRUCT, V614, P227, DOI 10.1016/S0022-2860(02)00256-9; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381; Yi P, 2008, EUR J MED CHEM, V43, P604, DOI 10.1016/j.ejmech.2007.04.020; Yue YY, 2009, J PHARMACEUT BIOMED, V49, P753, DOI 10.1016/j.jpba.2008.12.017; Zsila F, 2003, BIOCHEM PHARMACOL, V65, P447, DOI 10.1016/S0006-2952(02)01521-6; 2009, BIOPOLYMERS, V91, P108	57	94	96	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8834	10.1371/journal.pone.0008834	http://dx.doi.org/10.1371/journal.pone.0008834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098677	Green Published, Green Submitted, gold			2022-12-25	WOS:000273779100025
J	Stimson, RH; Lobley, GE; Maraki, I; Morton, NM; Andrew, R; Walker, BR				Stimson, Roland H.; Lobley, Gerald E.; Maraki, Ioanna; Morton, Nicholas M.; Andrew, Ruth; Walker, Brian R.			Effects of Proportions of Dietary Macronutrients on Glucocorticoid Metabolism in Diet-Induced Obesity in Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; BODY-FAT DISTRIBUTION; HUMAN ADIPOSE-TISSUE; WEIGHT-LOSS; CORTISOL METABOLISM; INSULIN SENSITIZATION; BLOOD-PRESSURE; ZUCKER RATS; EXPRESSION; MEN	Tissue glucocorticoid levels in the liver and adipose tissue are regulated by regeneration of inactive glucocorticoid by 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) and inactivation by 5 alpha- and 5 beta-reductases. A low carbohydrate diet increases hepatic 11 beta-HSD1 and reduces glucocorticoid metabolism during weight loss in obese humans. We hypothesized that similar variations in macronutrient proportions regulate glucocorticoid metabolism in obese rats. Male Lister Hooded rats were fed an obesity-inducing ad libitum 'Western' diet (37% fat, n = 36) for 22 weeks, then randomised to continue this diet (n = 12) or to switch to either a low carbohydrate (n = 12) or a moderate carbohydrate (n = 12) diet for the final 8 weeks. A parallel lean control group were fed an ad libitum control diet (10% fat, n = 12) throughout. The low and moderate carbohydrate diets decreased hepatic 11 beta-HSD1 mRNA compared with the Western diet (both 0.7+/-0.0 vs 0.9+/-0.1 AU; p<0.01), but did not alter 11 beta-HSD1 in adipose tissue. 5 alpha-Reductase mRNA was increased on the low carbohydrate compared with the moderate carbohydrate diet. Compared with lean controls, the Western diet decreased 11 beta-HSD1 activity (1.6+/-0.1 vs 2.8+/-0.1 nmol/mcg protein/hr; p<0.001) and increased 5 alpha-reductase and 5 beta-reductase mRNAs (1.9+/-0.3 vs 1.0+/-0.2 and 1.6+/-0.1 vs 1.0+/-0.1 AU respectively; p<0.01) in the liver, and reduced 11 beta-HSD1 mRNA and activity (both p<0.01) in adipose tissue. Although an obesity-inducing high fat diet in rats recapitulates the abnormal glucocorticoid metabolism associated with human obesity in liver (but not in adipose tissue), a low carbohydrate diet does not increase hepatic 11 beta-HSD1 in obese rats as occurs in humans.	[Stimson, Roland H.; Maraki, Ioanna; Morton, Nicholas M.; Andrew, Ruth; Walker, Brian R.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Lobley, Gerald E.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Div Obes & Metab Hlth, Aberdeen, Scotland	University of Edinburgh; University of Aberdeen	Stimson, RH (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	roland.stimson@ed.ac.uk	Morton, NICHOLAS/ABF-3774-2020; Andrew, Ruth/C-2727-2008	Andrew, Ruth/0000-0002-6916-2994	Scottish Government and the British Heart Foundation	Scottish Government and the British Heart Foundation	This work was funded by the core grant to the Rowett Institute of Nutrition and Health from the Rural and Environment Research Analysis Directorate of the Scottish Government and the British Heart Foundation. The funders had no role in study design, data collection and analysis decision to publish or preparation of the manuscript.	Andrew R, 1998, J CLIN ENDOCR METAB, V83, P1806, DOI 10.1210/jc.83.5.1806; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Benedict C, 2005, J CLIN ENDOCR METAB, V90, P1692, DOI 10.1210/jc.2004-1792; Berger J, 2001, J BIOL CHEM, V276, P12629, DOI 10.1074/jbc.M003592200; Drake AJ, 2005, ENDOCRINOLOGY, V146, P913, DOI 10.1210/en.2004-1063; EICHELER W, 1995, EXP CLIN ENDOCR DIAB, V103, P105, DOI 10.1055/s-0029-1211337; Engeli S, 2004, OBES RES, V12, P9, DOI 10.1038/oby.2004.3; Goedecke JH, 2006, CLIN ENDOCRINOL, V65, P81, DOI 10.1111/j.1365-2265.2006.02552.x; Hermanowski-Vosatka A, 2000, BIOCHEM BIOPH RES CO, V279, P330, DOI 10.1006/bbrc.2000.3966; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Jang C, 2007, J CLIN ENDOCR METAB, V92, P3314, DOI 10.1210/jc.2006-2729; Johnstone AM, 2004, EUR J ENDOCRINOL, V150, P185, DOI 10.1530/eje.0.1500185; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Liu YJ, 2006, ENDOCRINOLOGY, V147, P5061, DOI 10.1210/en.2006-0243; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Livingstone DEW, 2005, OBES RES, V13, P1523, DOI 10.1038/oby.2005.186; Lobley GE, 2007, BRIT J NUTR, V97, P1099, DOI 10.1017/S0007114507691934; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Paulsen SK, 2007, OBESITY, V15, P1954, DOI 10.1038/oby.2007.233; Purnell JQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE351, DOI 10.1152/ajpendo.90769.2008; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Sandeep TC, 2005, DIABETES, V54, P872, DOI 10.2337/diabetes.54.3.872; Stewart PM, 1999, J CLIN ENDOCR METAB, V84, P1022, DOI 10.1210/jc.84.3.1022; Stimson RH, 2007, J CLIN ENDOCR METAB, V92, P4480, DOI 10.1210/jc.2007-0692; Stulnig TM, 2002, DIABETES, V51, P2426, DOI 10.2337/diabetes.51.8.2426; Tomlinson JW, 2008, DIABETES, V57, P1536, DOI 10.2337/db08-0094; Tomlinson JW, 2004, J CLIN ENDOCR METAB, V89, P2711, DOI 10.1210/jc.2003-031376; Tomlinson JW, 2002, J CLIN ENDOCR METAB, V87, P5630, DOI 10.1210/jc.2002-020687; Wake DJ, 2007, CLIN ENDOCRINOL, V66, P440, DOI 10.1111/j.1365-2265.2007.02755.x; Wake DJ, 2007, J CLIN ENDOCR METAB, V92, P1848, DOI 10.1210/jc.2006-2713; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Westerbacka J, 2003, J CLIN ENDOCR METAB, V88, P4924, DOI 10.1210/jc.2003-030596	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8779	10.1371/journal.pone.0008779	http://dx.doi.org/10.1371/journal.pone.0008779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098742	Green Published, gold, Green Submitted			2022-12-25	WOS:000273778900021
J	Singaravelan, N; Pavlicek, T; Beharav, A; Wakamatsu, K; Ito, S; Nevo, E				Singaravelan, Natarajan; Pavlicek, Tomas; Beharav, Alex; Wakamatsu, Kazumasa; Ito, Shosuke; Nevo, Eviatar			Spiny Mice Modulate Eumelanin to Pheomelanin Ratio to Achieve Cryptic Coloration in "Evolution Canyon," Israel	PLOS ONE			English	Article							LOWER NAHAL OREN; PIGMENT TYPES; MOUNT-CARMEL; ADAPTIVE VARIATION; GENETIC-BASIS; PELAGE COLOR; MELANISM; MOUSE; DIVERSITY; MELANOGENESIS	Background: Coat coloration in mammals is an explicit adaptation through natural selection. Camouflaging with the environment is the foremost evolutionary drive in explaining overall coloration. Decades of enquiries on this topic have been limited to repetitive coat color measurements to correlate the morphs with background/habitat blending. This led to an overwhelming endorsement of concealing coloration as a local phenotypic adaptation in animals, primarily rodents to evade predators. However, most such studies overlooked how rodents actually achieve such cryptic coloration. Cryptic coloration could be attained only through optimization between the yellow- to brown-colored "pheomelanin" and gray to black-colored "eumelanin" in the hairs. However, no study has explored this conjecture yet. "Evolution Canyon" (EC) in Israel is a natural microscale laboratory where the relationship between organism and environment can be explored. EC is comprised of an "African" slope (AS), which exhibits a yellowbrownish background habitat, and a "European" slope (ES), exhibiting a dark grayish habitat; both slopes harbor spiny mice (Acomys cahirinus). Here, we examine how hair melanin content of spiny mice living in the opposing slopes of EC evolves toward blending with their respective background habitat. Methodology/Principal Findings: We measured hair-melanin (both eumelanin and pheomelanin) contents of 30 spiny mice from the EC using high-performance liquid chromatography (HPLC) that detects specific degradation products of eumelanin and pheomelanin. The melanin pattern of A. cahirinus approximates the background color of the slope on which they dwell. Pheomelanin is slightly (insignificantly) higher in individuals found on the AS to match the brownish background, whereas individuals of the ES had significantly greater eumelanin content to mimic the dark grayish background. This is further substantiated by a significantly higher eumelanin and pheomelanin ratio on the ES than on the AS. Conclusion/Significance: It appears that rodents adaptively modulate eumelanin and pheomelanin contents to achieve cryptic coloration in contrasting habitats even at a microscale.	[Singaravelan, Natarajan; Pavlicek, Tomas; Beharav, Alex; Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Wakamatsu, Kazumasa; Ito, Shosuke] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Aichi, Japan	University of Haifa; Fujita Health University	Singaravelan, N (corresponding author), Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel.	yoursings@gmail.com	Pavlicek, Tomas/C-4768-2008; Wakamatsu, Kazumasa/AAZ-5877-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001; Ito, Shosuke/0000-0001-9182-5144	University of Haifa; Council of Higher Education, Israel; Ancell Teicher Research Foundation; Israel Discount Bank Chair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS) [20591357]	University of Haifa; Council of Higher Education, Israel; Ancell Teicher Research Foundation; Israel Discount Bank Chair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	NS acknowledges his postdoctoral fellowship support by University of Haifa and the Council of Higher Education, Israel. EN acknowledges the financial support of the Ancell Teicher Research Foundation for Genetics and Molecular Evolution, and the Israel Discount Bank Chair of Evolutionary Biology. KW and SI acknowledge the funding supported by the Japan Society for the Promotion of Science (JSPS) (No. 20591357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIEV G, 1990, PIGM CELL RES, V3, P177, DOI 10.1111/j.1600-0749.1990.tb00286.x; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Belk MC, 1996, J MAMMAL, V77, P882, DOI 10.2307/1382694; BENSON SETH B., 1933, UNIV CALIFORNIA PUBL ZOOL, V40, P1; Blaustein L, 1996, ISRAEL J ZOOL, V42, P327; BRADBURY MW, 1988, J HERED, V79, P133, DOI 10.1093/oxfordjournals.jhered.a110471; Camargo CR, 2006, AN ACAD BRAS CIENC, V78, P77, DOI 10.1590/S0001-37652006000100009; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Cecchi T, 2004, PIGM CELL RES, V17, P307, DOI 10.1111/j.1600-0749.2004.00139.x; CHAPPELL MA, 1984, P NATL ACAD SCI-BIOL, V81, P5484, DOI 10.1073/pnas.81.17.5484; Cott H.B., 1940, ADAPTIVE COLORATION; COWLES RB, 1967, SCIENCE, V158, P1340, DOI 10.1126/science.158.3806.1340; Darwin C, 1859, ORIGINS SPECIES MEAN; Dice L. R., 1938, Occasional Papers of the Museum of Zoology University of Michigan Ann Arbor, Vno. 375, P1; Dice L. R., 1930, Occasional Papers of the Museum of Zoology University of Michigan Ann Arbor, V213, P1; Endler J.A., 1977, Monographs in Population Biology, pi; Endler J.A., 1986, Monographs in Population Biology, pviii; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; GAUSE G. F., 1947, TRANS CONNECTICUT ACAD ARTS AND SCI, V37, P17; Gloger, 1833, ABANDERN VOGEL DURCH; Hall E. R., 1942, J MAMMAL, V23, P51, DOI DOI 10.2307/1374855; HETH G, 1988, OECOLOGIA, V74, P617, DOI 10.1007/BF00380062; Hoekstra HE, 2003, MOL ECOL, V12, P1185, DOI 10.1046/j.1365-294X.2003.01788.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; ITO S, 1994, PIGM CELL RES, V7, P141, DOI 10.1111/j.1600-0749.1994.tb00041.x; ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2; Ito S, 2003, PIGM CELL RES, V16, P523, DOI 10.1034/j.1600-0749.2003.00072.x; Ito S, 2001, PIGM CELL RES, V14, P180, DOI 10.1034/j.1600-0749.2001.140307.x; ITO S, 1984, J INVEST DERMATOL, V83, P12, DOI 10.1111/1523-1747.ep12261634; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; KETTLEWELL HBD, 1956, PROC R SOC SER B-BIO, V145, P297, DOI 10.1098/rspb.1956.0037; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Krupa JJ, 2000, J MAMMAL, V81, P86, DOI 10.1644/1545-1542(2000)081<0086:MTCOES>2.0.CO;2; Lai YC, 2008, J ZOOL, V274, P270, DOI 10.1111/j.1469-7998.2007.00382.x; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Majerus M, 1998, MELANISM EVOLUTION A; Monks NJ, 1998, AFR J ECOL, V36, P102, DOI 10.1046/j.1365-2028.1998.108-89108.x; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Mundy NI, 2007, PLOS BIOL, V5, P1842, DOI 10.1371/journal.pbio.0050250; Nachman MW, 2005, GENETICA, V123, P125, DOI 10.1007/s10709-004-2723-y; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 1998, ACTA THERIOL, P9; Nevo E, 1998, CATENA, V33, P241, DOI 10.1016/S0341-8162(98)00071-X; NEVO E, 2009, TRENDS EVOL BIOL, V1, P1; NEVO E, 1985, ACTA ZOOL FENN, V170, P131; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Roulin A, 2003, HEREDITY, V90, P359, DOI 10.1038/sj.hdy.6800260; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Schmalhausen II., 1949, FACTORS EVOLUTION TH, P327; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; SPONENBERG DP, 1988, PIGM CELL RES, V1, P410, DOI 10.1111/j.1600-0749.1988.tb00144.x; SPONENBERG DP, 1988, PIGM CELL RES, V1, P414, DOI 10.1111/j.1600-0749.1988.tb00145.x; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Tchernov E., 1968, SUCCESSION RODENT FA; Thayer GH, 1909, CONCEALING COLORATIO; ULMER FA, 1989, J MAMMAL, V22, P285; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x	65	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8708	10.1371/journal.pone.0008708	http://dx.doi.org/10.1371/journal.pone.0008708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090935	Green Published, gold, Green Submitted			2022-12-25	WOS:000273714600011
J	Andrews, J; Kennette, W; Pilon, J; Hodgson, A; Tuck, AB; Chambers, AF; Rodenhiser, DI				Andrews, Joseph; Kennette, Wendy; Pilon, Jenna; Hodgson, Alexandra; Tuck, Alan B.; Chambers, Ann F.; Rodenhiser, David I.			Multi-Platform Whole-Genome Microarray Analyses Refine the Epigenetic Signature of Breast Cancer Metastasis with Gene Expression and Copy Number	PLOS ONE			English	Article							CARCINOMA CELL-LINES; DNA METHYLATION; WIDE; THERAPY; MODEL; 14-3-3-SIGMA; VALIDATION; MDA-MB-468; REVEALS; VARIANT	Background: We have previously identified genome-wide DNA methylation changes in a cell line model of breast cancer metastasis. These complex epigenetic changes that we observed, along with concurrent karyotype analyses, have led us to hypothesize that complex genomic alterations in cancer cells (deletions, translocations and ploidy) are superimposed over promoter-specific methylation events that are responsible for gene-specific expression changes observed in breast cancer metastasis. Methodology/Principal Findings: We undertook simultaneous high-resolution, whole-genome analyses of MDA-MB-468GFP and MDA-MB-468GFP-LN human breast cancer cell lines (an isogenic, paired lymphatic metastasis cell line model) using Affymetrix gene expression (U133), promoter (1.0R), and SNP/CNV (SNP 6.0) microarray platforms to correlate data from gene expression, epigenetic (DNA methylation), and combination copy number variant/single nucleotide polymorphism microarrays. Using Partek Software and Ingenuity Pathway Analysis we integrated datasets from these three platforms and detected multiple hypomethylation and hypermethylation events. Many of these epigenetic alterations correlated with gene expression changes. In addition, gene dosage events correlated with the karyotypic differences observed between the cell lines and were reflected in specific promoter methylation patterns. Gene subsets were identified that correlated hyper (and hypo) methylation with the loss (or gain) of gene expression and in parallel, with gene dosage losses and gains, respectively. Individual gene targets from these subsets were also validated for their methylation, expression and copy number status, and susceptible gene pathways were identified that may indicate how selective advantage drives the processes of tumourigenesis and metastasis. Conclusions/Significance: Our approach allows more precisely profiling of functionally relevant epigenetic signatures that are associated with cancer progression and metastasis.	[Andrews, Joseph; Kennette, Wendy; Pilon, Jenna; Hodgson, Alexandra; Tuck, Alan B.; Chambers, Ann F.; Rodenhiser, David I.] London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada; [Pilon, Jenna; Hodgson, Alexandra; Rodenhiser, David I.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Tuck, Alan B.; Chambers, Ann F.; Rodenhiser, David I.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada; [Rodenhiser, David I.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada; [Tuck, Alan B.; Chambers, Ann F.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol, London, ON, Canada; [Rodenhiser, David I.] Childrens Hlth Res Inst, EpiGenWestern Res Grp, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Andrews, J (corresponding author), London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada.	drodenhi@uwo.ca	Chambers, Ann F/L-6285-2015	Chambers, Ann F/0000-0002-9509-5123	Canadian Breast Cancer Research Alliance [016506]; Canadian Breast Cancer Foundation; Cancer Research Society	Canadian Breast Cancer Research Alliance; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Cancer Research Society	Financial support gratefully acknowledged by grant #016506 from the Canadian Breast Cancer Research Alliance, with special funding support from the Canadian Breast Cancer Foundation and the Cancer Research Society. AFC is Canada Research Chair in Oncology, supported by the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, AFF NETTF TOOL; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chari R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-324; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-243; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fadlelmola FM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-2; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FENG Y, 2006, BREAST CANC RES TREA; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Johnson N, 2008, BREAST CANCER RES TR, V111, P55, DOI 10.1007/s10549-007-9758-6; Juric Dejan, 2007, Methods Mol Biol, V377, P187; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lodygin D, 2006, SEMIN CANCER BIOL, V16, P214, DOI 10.1016/j.semcancer.2006.03.008; MARGARETO J, 2009, CANC INVEST, P1; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Momparler RL, 2005, SEMIN ONCOL, V32, P443, DOI 10.1053/j.seminoncol.2005.07.008; Pulukuri SM, 2006, ONCOGENE, V25, P4559, DOI 10.1038/sj.onc.1209462; Pusztai L, 2006, CLIN CANCER RES, V12, P7209, DOI 10.1158/1078-0432.CCR-06-2649; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Rodenhiser DI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2121; RODENHISER DI, 2008, CLIN EXP METASTASIS; Sadikovic B, 2008, J BIOL CHEM, V283, P4051, DOI 10.1074/jbc.M707506200; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vantyghem SA, 2005, CLIN EXP METASTAS, V22, P351, DOI 10.1007/s10585-005-0745-1; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Welch DR, 2004, BREAST CANCER RES, V6, P61, DOI 10.1186/bcr736; Woelfle U, 2003, CANCER RES, V63, P5679; Xu J, 2008, CANCER GENET CYTOGEN, V181, P1, DOI 10.1016/j.cancergencyto.2007.05.030; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; ZHANG RD, 1991, INVAS METAST, V11, P204; EXONPRIMER SOFTWARE; PRIMERQUEST SOFTWARE	47	40	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8665	10.1371/journal.pone.0008665	http://dx.doi.org/10.1371/journal.pone.0008665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084286	Green Submitted, gold, Green Published			2022-12-25	WOS:000273554600018
J	Walther, FJ; Waring, AJ; Hernandez-Juviel, JM; Gordon, LM; Wang, ZD; Jung, CL; Ruchala, P; Clark, AP; Smith, WM; Sharma, S; Notter, RH				Walther, Frans J.; Waring, Alan J.; Hernandez-Juviel, Jose M.; Gordon, Larry M.; Wang, Zhengdong; Jung, Chun-Ling; Ruchala, Piotr; Clark, Andrew P.; Smith, Wesley M.; Sharma, Shantanu; Notter, Robert H.			Critical Structural and Functional Roles for the N-Terminal Insertion Sequence in Surfactant Protein B Analogs	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CAPTIVE BUBBLE METHOD; TRANSFORM INFRARED-SPECTROSCOPY; HELICAL PEPTOID ANALOGS; SAPOSIN-LIKE PROTEINS; PULMONARY SURFACTANT; LUNG-SURFACTANT; SECONDARY STRUCTURE; SP-C; SYNTHETIC SURFACTANT	Background: Surfactant protein B (SP-B; 79 residues) belongs to the saposin protein superfamily, and plays functional roles in lung surfactant. The disulfide cross-linked, N- and C-terminal domains of SP-B have been theoretically predicted to fold as charged, amphipathic helices, suggesting their participation in surfactant activities. Earlier structural studies with Mini-B, a disulfide-linked construct based on the N- and C-terminal regions of SP-B (i.e., similar to residues 8-25 and 63-78), confirmed that these neighboring domains are helical; moreover, Mini-B retains critical in vitro and in vivo surfactant functions of the native protein. Here, we perform similar analyses on a Super Mini-B construct that has native SP-B residues (1-7) attached to the N-terminus of Mini-B, to test whether the N-terminal sequence is also involved in surfactant activity. Methodology/Results: FTIR spectra of Mini-B and Super Mini-B in either lipids or lipid-mimics indicated that these peptides share similar conformations, with primary alpha-helix and secondary beta-sheet and loop-turns. Gel electrophoresis demonstrated that Super Mini-B was dimeric in SDS detergent-polyacrylamide, while Mini-B was monomeric. Surface plasmon resonance (SPR), predictive aggregation algorithms, and molecular dynamics (MD) and docking simulations further suggested a preliminary model for dimeric Super Mini-B, in which monomers self-associate to form a dimer peptide with a "saposin-like" fold. Similar to native SP-B, both Mini-B and Super Mini-B exhibit in vitro activity with spread films showing near-zero minimum surface tension during cycling using captive bubble surfactometry. In vivo, Super Mini-B demonstrates oxygenation and dynamic compliance that are greater than Mini-B and compare favorably to full-length SP-B. Conclusion: Super Mini-B shows enhanced surfactant activity, probably due to the self-assembly of monomer peptide into dimer Super Mini-B that mimics the functions and putative structure of native SP-B.	[Walther, Frans J.; Waring, Alan J.; Hernandez-Juviel, Jose M.; Gordon, Larry M.] Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst Harbor, Torrance, CA 90509 USA; [Walther, Frans J.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; [Waring, Alan J.; Jung, Chun-Ling; Ruchala, Piotr] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Wang, Zhengdong; Notter, Robert H.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Clark, Andrew P.; Smith, Wesley M.; Sharma, Shantanu] Calif State Polytech Univ Pomona, Dept Chem, Pomona, CA 91768 USA; [Clark, Andrew P.; Smith, Wesley M.; Sharma, Shantanu] Calif State Polytech Univ Pomona, Ctr Macromol Modeling & Mat Design, Pomona, CA 91768 USA; [Notter, Robert H.] Univ Rochester, Dept Environm Med, Rochester, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; University of Rochester; California State University System; California State Polytechnic University Pomona; California State University System; California State Polytechnic University Pomona; University of Rochester	Walther, FJ (corresponding author), Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst Harbor, Torrance, CA 90509 USA.	fwalther@lumc.nl		Walther, Frans/0000-0003-1931-159X; RUCHALA, PIOTR/0000-0002-5574-2779	National Institutes of Health [HL-092158, ES-015330, HL-080775, HL-094641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094641, R44HL080775, R43HL080775, R01HL092158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors gratefully acknowledge the financial support of the National Institutes of Health through grants HL-092158, ES-015330, HL-080775, and HL-094641. NIH had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Aguilar MI, 2005, NEUROTOX RES, V7, P17, DOI 10.1007/BF03033773; Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Alattia JR, 2006, J MOL BIOL, V362, P943, DOI 10.1016/j.jmb.2006.08.009; ANDERSSON M, 1995, FEBS LETT, V362, P328, DOI 10.1016/0014-5793(95)00268-E; Audie J, 2009, BIOPHYS CHEM, V139, P84, DOI 10.1016/j.bpc.2008.10.007; BAATZ JE, 1991, CHEM PHYS LIPIDS, V60, P163, DOI 10.1016/0009-3084(91)90039-E; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Biswas N, 2007, BBA-BIOMEMBRANES, V1768, P1070, DOI 10.1016/j.bbamem.2007.01.020; Booth V, 2004, BIOCHEMISTRY-US, V43, P15187, DOI 10.1021/bi0481895; Bourbigot S, 2009, BIOPOLYMERS, V91, P1, DOI 10.1002/bip.21071; Bridges JP, 2006, J CELL BIOL, V172, P395, DOI 10.1083/jcb.200508016; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; BRUNI R, 1991, P NATL ACAD SCI USA, V88, P7451, DOI 10.1073/pnas.88.16.7451; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cairo CW, 2002, BIOCHEMISTRY-US, V41, P8620, DOI 10.1021/bi0156254; Castillo V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000476; Chang YS, 2005, CHEM PHYS LIPIDS, V137, P77, DOI 10.1016/j.chemphyslip.2005.07.002; Chang YS, 2004, BIOORG MED CHEM LETT, V14, P5983, DOI 10.1016/j.bmcl.2004.10.001; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; CHESS P, 2005, LUNG INJURY MECH PAT, P617; COCHRANE CG, 1991, SCIENCE, V254, P566, DOI 10.1126/science.1948032; Cockshutt AM, 1992, PULMONARY SURFACTANT, P339; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Creuwels LAJM, 1997, LUNG, V175, P1, DOI 10.1007/PL00007554; CRUZ A, 1995, BBA-LIPID LIPID MET, V1255, P68, DOI 10.1016/0005-2760(94)00210-P; Curstedt T, 2006, BIOL NEONATE, V89, P336, DOI 10.1159/000092871; de Groot NS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-18; de Groot NS, 2006, FEBS J, V273, P658, DOI 10.1111/j.1742-4658.2005.05102.x; Dluhy RA, 2003, BIOPHYS J, V85, P2417, DOI 10.1016/S0006-3495(03)74665-7; FAN BR, 1990, ANAL BIOCHEM, V186, P41, DOI 10.1016/0003-2697(90)90569-U; FAN BR, 1991, FEBS LETT, V282, P220, DOI 10.1016/0014-5793(91)80481-H; FIELDS C G, 1991, Peptide Research, V4, P95; Fioroni M, 2001, J PHYS CHEM B, V105, P10967, DOI 10.1021/jp012476q; Freites JA, 2003, BIOPHYS J, V84, P2169, DOI 10.1016/S0006-3495(03)75023-1; Gast K, 2001, EUR BIOPHYS J BIOPHY, V30, P273, DOI 10.1007/s002490100148; Gerig JT, 2004, BIOPHYS J, V86, P3166, DOI 10.1016/S0006-3495(04)74364-7; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Gordon LM, 2008, BBA-BIOMEMBRANES, V1778, P2127, DOI 10.1016/j.bbamem.2008.05.002; Gordon LM, 2000, J PEPT RES, V55, P330, DOI 10.1034/j.1399-3011.2000.00693.x; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Gray JJ, 2003, PROTEINS, V52, P118, DOI 10.1002/prot.10384; Gustafsson M, 1999, FEBS LETT, V464, P138, DOI 10.1016/S0014-5793(99)01692-0; Hawgood S, 2004, BIOL NEONATE, V85, P285, DOI 10.1159/000078169; Hawkins CA, 2005, J MOL BIOL, V346, P1381, DOI 10.1016/j.jmb.2004.12.045; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; IMAMURA T, 2006, ENCY SURFACE COLLOID, P5251; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; JOHANSSON J, 1991, BIOCHEMISTRY-US, V30, P6917, DOI 10.1021/bi00242a015; JOHANSSON J, 1994, EUR RESPIR J, V7, P372, DOI 10.1183/09031936.94.07020372; JOHANSSON J, 1995, BIOCHEM J, V307, P535, DOI 10.1042/bj3070535; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAHN MC, 1995, AM J PHYSIOL-LUNG C, V269, pL567, DOI 10.1152/ajplung.1995.269.5.L567; Kandasamy SK, 2005, BIOPHYS J, V88, P1577, DOI 10.1529/biophysj.104.038430; Kang JH, 1996, BIOCHEM MOL BIOL INT, V40, P617; Kaznessis YN, 2002, J MOL BIOL, V322, P569, DOI 10.1016/S0022-2836(02)00774-X; Kim W, 2005, J BIOL CHEM, V280, P35069, DOI 10.1074/jbc.M505763200; Kurutz JW, 2002, BIOCHEMISTRY-US, V41, P9627, DOI 10.1021/bi016077x; Lee H, 2005, BIOPHYS J, V89, P3807, DOI 10.1529/biophysj.105.066241; Lee KYC, 1997, COLLOID SURFACE A, V128, P225, DOI 10.1016/S0927-7757(96)03919-2; Lee KYC, 2001, BIOPHYS J, V81, P572, DOI 10.1016/S0006-3495(01)75724-4; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lipp MM, 1996, SCIENCE, V273, P1196, DOI 10.1126/science.273.5279.1196; Lipp MM, 1998, PHYS REV LETT, V81, P1650, DOI 10.1103/PhysRevLett.81.1650; LONGO ML, 1993, SCIENCE, V261, P453, DOI 10.1126/science.8332910; LUND S, 1989, J BIOL CHEM, V264, P4907; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; MALCOLM JD, 1980, CAN J CHEM ENG, V58, P151, DOI 10.1002/cjce.5450580203; MCDONNELL PA, 1993, J MAGN RESON SER B, V102, P120, DOI 10.1006/jmrb.1993.1073; Mingarro I, 2008, CURR MED CHEM, V15, P393, DOI 10.2174/092986708783497364; MUNFORD RS, 1995, J LIPID RES, V36, P1653; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; NOTTER RH, 2000, LUNG SURFACTANTS BAS; Notter RH, 2007, MINI-REV MED CHEM, V7, P932, DOI 10.2174/138955707781662627; PastranaRios B, 1995, BIOPHYS J, V69, P2531, DOI 10.1016/S0006-3495(95)80124-4; Perez-Gil J, 2002, BIOL NEONATE, V81, P6, DOI 10.1159/000056765; PEREZGIL J, 1991, BIOCHEM INT, V25, P715; POSSMAYER F, 1988, AM REV RESPIR DIS, V138, P990, DOI 10.1164/ajrccm/138.4.990; Power JHT, 1999, J EXP BIOL, V202, P2543; REVAK SD, 1991, PEDIATR RES, V29, P460, DOI 10.1203/00006450-199105010-00010; REYNOLDS JA, 1970, P NATL ACAD SCI USA, V66, P1002, DOI 10.1073/pnas.66.3.1002; Roccatano D, 2005, PROTEIN SCI, V14, P2582, DOI 10.1110/ps.051426605; Ryan MA, 2005, BIOCHEMISTRY-US, V44, P861, DOI 10.1021/bi0485575; Sammalkorpi M, 2007, J PHYS CHEM B, V111, P11722, DOI 10.1021/jp072587a; Sarker M, 2007, BIOCHEMISTRY-US, V46, P11047, DOI 10.1021/bi7011756; SCHOEL WM, 1994, BBA-GEN SUBJECTS, V1200, P281, DOI 10.1016/0304-4165(94)90169-4; SCHURCH S, 1989, J APPL PHYSIOL, V67, P2389, DOI 10.1152/jappl.1989.67.6.2389; SCHURCH S, 1992, BIOCHIM BIOPHYS ACTA, V1103, P127, DOI 10.1016/0005-2736(92)90066-U; Schurch S, 2001, COMP BIOCHEM PHYS A, V129, P195, DOI 10.1016/S1095-6433(01)00316-6; Serrano AG, 2006, BIOPHYS J, V90, P238, DOI 10.1529/biophysj.105.073403; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Seurynck SL, 2005, CHEM BIOL, V12, P77, DOI 10.1016/j.chembiol.2004.10.014; Seurynck-Servoss SL, 2006, BIOCHEMISTRY-US, V45, P11809, DOI 10.1021/bi060617e; Small D. M., 1986, PHYS CHEM LIPIDS ALK; Stenger PC, 2009, BBA-BIOMEMBRANES, V1788, P358, DOI 10.1016/j.bbamem.2008.11.021; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; VANDENBUSSCHE G, 1992, BIOCHEMISTRY-US, V31, P9169, DOI 10.1021/bi00153a008; Walther FJ, 1998, PEDIATR RES, V43, P666, DOI 10.1203/00006450-199805000-00016; Walther FJ, 2005, EXP LUNG RES, V31, P563, DOI 10.1080/019021490951531; Walther FJ, 2002, EXP LUNG RES, V28, P623, DOI 10.1080/01902140260426733; Walther FJ, 2002, BIOL NEONATE, V82, P181, DOI 10.1159/000063607; Walther FJ, 2000, MOL GENET METAB, V71, P342, DOI 10.1006/mgme.2000.3053; Walther FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001039; Walther FJ, 2007, NEONATOLOGY, V91, P303, DOI 10.1159/000101346; Wang YD, 2003, BIOCHEMISTRY-US, V42, P4015, DOI 10.1021/bi027344h; WARING A, 1989, Peptide Research, V2, P308; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; Waring AJ, 1996, PEPTIDE RES, V9, P28; WILLSON DF, 2005, PEDIAT CRITICAL CARE, P453; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Zaltash S, 2000, BBA-BIOMEMBRANES, V1466, P179, DOI 10.1016/S0005-2736(00)00199-1; Zaltash S, 2001, BIOL CHEM, V382, P933, DOI 10.1515/BC.2001.116	117	37	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8672	10.1371/journal.pone.0008672	http://dx.doi.org/10.1371/journal.pone.0008672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084172	Green Published, gold, Green Submitted			2022-12-25	WOS:000273554600024
J	Heikkila, JE; Vaha-Koskela, MJV; Ruotsalainen, JJ; Martikainen, MW; Stanford, MM; McCart, JA; Bell, JC; Hinkkanen, AE				Heikkila, Jari E.; Vaha-Koskela, Markus J. V.; Ruotsalainen, Janne J.; Martikainen, Miika W.; Stanford, Marianne M.; McCart, J. Andrea; Bell, John C.; Hinkkanen, Ari E.			Intravenously Administered Alphavirus Vector VA7 Eradicates Orthotopic Human Glioma Xenografts in Nude Mice	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; CANCER STEM-CELL; MALIGNANT GLIOMAS; GLIOBLASTOMA-MULTIFORME; ONCOLYTIC VIRUS; IMMUNODEFICIENT MICE; GENE-EXPRESSION; A7(74) STRAIN; TUMOR; THERAPY	Background: VA7 is a neurotropic alphavirus vector based on an attenuated strain of Semliki Forest virus. We have previously shown that VA7 exhibits oncolytic activity against human melanoma xenografts in immunodeficient mice. The purpose of this study was to determine if intravenously administered VA7 would be effective against human glioma. Methodology/Principal Findings: In vitro, U87, U251, and A172 human glioma cells were infected and killed by VA7-EGFP. In vivo, antiglioma activity of VA7 was tested in Balb/c nude mice using U87 cells stably expressing firefly luciferase in subcutaneous and orthotopic tumor models. Intravenously administered VA7-EGFP completely eradicated 100% of small and 50% of large subcutaneous U87Fluc tumors. A single intravenous injection of either VA7-EGFP or VA7 expressing Renilla luciferase (VA7-Rluc) into mice bearing orthotopic U87Fluc tumors caused a complete quenching of intracranial firefly bioluminescence and long-term survival in total 16 of 17 animals. In tumor-bearing mice injected with VA7-Rluc, transient intracranial and peripheral Renilla bioluminescence was observed. Virus was well tolerated and no damage to heart, liver, spleen, or brain was observed upon pathological assessment at three and ninety days post injection, despite detectable virus titers in these organs during the earlier time point. Conclusion: VA7 vector is apathogenic and can enter and destroy brain tumors in nude mice when administered systemically. This study warrants further elucidation of the mechanism of tumor destruction and attenuation of the VA7 virus.	[Heikkila, Jari E.; Vaha-Koskela, Markus J. V.; Hinkkanen, Ari E.] Abo Akad Univ, Dept Biochem & Pharm, SF-20500 Turku, Finland; [Vaha-Koskela, Markus J. V.; Stanford, Marianne M.; Bell, John C.] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Ruotsalainen, Janne J.; Martikainen, Miika W.; Hinkkanen, Ari E.] Univ Kuopio, Dept Biotechnol & Mol Med, AI Virtanen Inst, FIN-70211 Kuopio, Finland; [McCart, J. Andrea] Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON, Canada	Abo Akademi University; University of Ottawa; Ottawa Hospital Research Institute; University of Eastern Finland; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Heikkila, JE (corresponding author), Abo Akad Univ, Dept Biochem & Pharm, SF-20500 Turku, Finland.	jari.heikkila@abo.fi		Ruotsalainen, Janne/0000-0002-5312-5486; Stanford, Marianne/0000-0003-0432-3707; Vaha-Koskela, Markus/0000-0001-7764-7820	K. Albin Johanssons Stiftelse; Medicinska Understodsforeningen Liv och Halsa; Stiftelsens for Abo Akademi Forskningsinstitut; Finnish Cancer Organizations; Cancer Society of South-Western Finland; Canadian Institutes of Health Research; Terry Fox Foundation	K. Albin Johanssons Stiftelse; Medicinska Understodsforeningen Liv och Halsa; Stiftelsens for Abo Akademi Forskningsinstitut; Finnish Cancer Organizations; Cancer Society of South-Western Finland; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation	This study was funded by K. Albin Johanssons Stiftelse, Medicinska Understodsforeningen Liv och Halsa, Stiftelsens for Abo Akademi Forskningsinstitut, The Finnish Cancer Organizations, and The Cancer Society of South-Western Finland. JCB is supported by the Canadian Institutes of Health Research and Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 1996, J GEN VIROL, V77, P281, DOI 10.1099/0022-1317-77-2-281; Annabi B, 2008, MOL CANCER RES, V6, P907, DOI 10.1158/1541-7786.MCR-07-2184; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BRADISH CJ, 1971, J GEN VIROL, V12, P114, DOI 10.1099/0022-1317-12-2-141; Camphausen K, 2005, P NATL ACAD SCI USA, V102, P8287, DOI 10.1073/pnas.0502887102; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Currier MA, 2005, CANCER GENE THER, V12, P407, DOI 10.1038/sj.cgt.7700799; FAZAKERLEY JK, 1993, VIROLOGY, V195, P627, DOI 10.1006/viro.1993.1414; Fragkoudis R, 2007, J GEN VIROL, V88, P3373, DOI 10.1099/vir.0.83191-0; Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Geoerger B, 2004, CANCER RES, V64, P5753, DOI 10.1158/0008-5472.CAN-04-0499; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Grote D, 2001, BLOOD, V97, P3746, DOI 10.1182/blood.V97.12.3746; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8; KOLUJOHN EO, 1983, T R SOC TROP MED HYG, V77, P149; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Lun XQ, 2009, CLIN CANCER RES, V15, P2777, DOI 10.1158/1078-0432.CCR-08-2342; Lun X, 2006, JNCI-J NATL CANCER I, V98, P1546, DOI 10.1093/jnci/djj413; Maatta AM, 2007, INT J CANCER, V121, P863, DOI 10.1002/ijc.22758; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; MATHIOT CC, 1990, AM J TROP MED HYG, V42, P386, DOI 10.4269/ajtmh.1990.42.386; MATSUKADO Y, 1961, J NEUROSURG, V18, P636, DOI 10.3171/jns.1961.18.5.0636; McCart JA, 2001, CANCER RES, V61, P8751; McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6; MINETA T, 1995, NAT MED, V1, P938, DOI 10.1038/nm0995-938; Otto-Duessel M, 2006, MOL IMAGING, V5, P57, DOI 10.2310/7290.2006.00006; Ozduman K, 2008, J NEUROSCI, V28, P1882, DOI 10.1523/JNEUROSCI.4905-07.2008; Pang BC, 2007, ANN ACAD MED SINGAP, V36, P358; Phuong LK, 2003, CANCER RES, V63, P2462; Rodriguez-Madoz JR, 2007, MOL THER, V15, P2164, DOI 10.1038/sj.mt.6300274; Shah AC, 2007, GENE THER, V14, P1045, DOI 10.1038/sj.gt.3302942; Singh SK, 2003, CANCER RES, V63, P5821; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tuittila MT, 2000, J VIROL, V74, P4579, DOI 10.1128/JVI.74.10.4579-4589.2000; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Vaha-Koskela MJV, 2006, CANCER RES, V66, P7185, DOI 10.1158/0008-5472.CAN-05-2214; Vaha-Koskela MJV, 2003, J NEUROVIROL, V9, P1, DOI 10.1080/13550280390173382; Wilcox ME, 2001, J NATL CANCER I, V93, P903, DOI 10.1093/jnci/93.12.903	46	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8603	10.1371/journal.pone.0008603	http://dx.doi.org/10.1371/journal.pone.0008603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066051	Green Submitted, Green Published, gold			2022-12-25	WOS:000273338600021
J	Yi, HG; Xi, YL; Liu, J; Wang, JR; Wu, JY; Xu, T; Chen, W; Chen, BB; Lin, ML; Wang, H; Zhou, MM; Li, JS; Xu, ZY; Jin, SG; Bao, QY				Yi, Huiguang; Xi, Yali; Liu, Jing; Wang, Junrong; Wu, Jinyu; Xu, Teng; Chen, Wei; Chen, Biaobang; Lin, Meili; Wang, Huan; Zhou, Mingming; Li, Jinsong; Xu, Zuyuan; Jin, Shouguang; Bao, Qiyu			Sequence Analysis of pKF3-70 in Klebsiella pneumoniae: Probable Origin from R100-Like Plasmid of Escherichia coli	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; NUCLEOTIDE-SEQUENCE; COMPARATIVE GENOMICS; DNA-SEQUENCE; GENE; REPLICATION; R1; MOBILIZATION; BLA(CTX-M); RESISTANCE	Background: Klebsiella pneumoniae is a clinically significant species of bacterium which causes a variety of diseases. Clinical treatment of this bacterial infection is greatly hindered by the emergence of multidrug-resistant strains. The resistance is largely due to the acquisition of plasmids carrying drug-resistant as well as pathogenic genes, and its conjugal transfer facilitates the spread of resistant phenotypes. Methodology/Principal Findings: The 70,057 bp plasmid pKF3-70, commonly found in Klebsiella pneumoniae, is composed of five main functional modules, including regions involved in replication, partition, conjugation, transfer leading, and variable regions. This plasmid is more similar to several Escherichia coli plasmids than any previously reported K. pneumoniae plasmids and pKF3-70 like plasmids share a common and conserved backbone sequence. The replication system of the pKF3-70 is 100% identical to that of RepFII plasmid R100 from E. coli. A beta-lactamase gene ctx-m-14 with its surrounding insertion elements (ISEcp1, truncated IS903 and a 20 bp inverted repeat sequence) may compose an active transposon which is directly bordered by two putative target repeats "ATTAC.'' Conclusions/Significance: The K. pneumoniae plasmid pKF3-70 carries an extended-spectrum beta-lactamase gene, ctx-m14. The conjugative characteristic makes it a widespread plasmid among genetically relevant genera which poses significant threat to public health.	[Yi, Huiguang; Xi, Yali; Liu, Jing; Wang, Junrong; Wu, Jinyu; Xu, Teng; Chen, Wei; Chen, Biaobang; Lin, Meili; Wang, Huan; Zhou, Mingming; Li, Jinsong; Xu, Zuyuan; Bao, Qiyu] Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Yi, Huiguang] Fudan Univ, T Life Res Ctr, Shanghai 200433, Peoples R China; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Wenzhou Medical University; Fudan University; State University System of Florida; University of Florida	Yi, HG (corresponding author), Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.	baoqy@genomics.org.cn	Bao, Qiyu/AAH-6113-2020; Jin, Shouguang/N-5548-2016	Bao, Qiyu/0000-0001-6523-8763; li, Jinsong/0000-0003-0764-3706; Yi, Huiguang/0000-0002-9676-7438	Science and Technology Foundation of Zhejiang Province, China [2008C23074]; Science and Technology Foundation of Wenzhou City, China [Y2006B002]; Wenzhou Science and Technology Development Program [Y20080105]; Foundation of Wenzhou Medical College, China [XNK06006]	Science and Technology Foundation of Zhejiang Province, China; Science and Technology Foundation of Wenzhou City, China; Wenzhou Science and Technology Development Program; Foundation of Wenzhou Medical College, China	This work was supported by the Science and Technology Foundation of Zhejiang Province, China (2008C23074); Science and Technology Foundation of Wenzhou City, China (Y2006B002); Wenzhou Science and Technology Development Program (Y20080105); and Foundation of Wenzhou Medical College, China (XNK06006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambe J P, 2007, Niger J Clin Pract, V10, P290; BARTHELEMY M, 1992, BIOCHIM BIOPHYS ACTA, V1122, P15, DOI 10.1016/0167-4838(92)90121-S; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bidet P, 2005, ANTIMICROB AGENTS CH, V49, P3562, DOI 10.1128/AAC.49.8.3562-3565.2005; Bistue AJCS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001800; BLOMBERG P, 1992, EMBO J, V11, P2675, DOI 10.1002/j.1460-2075.1992.tb05333.x; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bouet JY, 2007, MOL MICROBIOL, V65, P1405, DOI 10.1111/j.1365-2958.2007.05882.x; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Brilli M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-551; Camacho EM, 2005, INT MICROBIOL, V8, P279; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Chanawong A, 2002, ANTIMICROB AGENTS CH, V46, P630, DOI 10.1128/AAC.46.3.630-637.2002; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Decousser JW, 2001, ANTIMICROB AGENTS CH, V45, P3595, DOI 10.1128/AAC.45.12.3595-3598.2001; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELICIELLO I, 1993, ANAL BIOCHEM, V212, P394, DOI 10.1006/abio.1993.1346; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; JENSEN RB, 1994, J MOL BIOL, V236, P1299, DOI 10.1016/0022-2836(94)90059-0; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Jurczak A, 2007, Adv Med Sci, V52 Suppl 1, P30; Karami N, 2007, J ANTIMICROB CHEMOTH, V60, P1142, DOI 10.1093/jac/dkm327; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Lartigue MF, 2006, ANTIMICROB AGENTS CH, V50, P1282, DOI 10.1128/AAC.50.4.1282-1286.2006; Lawley T, 2004, PLASMID BIOLOGY, P203; Ma L, 2002, ANTIMICROB AGENTS CH, V46, P1985, DOI 10.1128/AAC.46.6.1985-1988.2002; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Manwaring NP, 1999, PLASMID, V41, P219, DOI 10.1006/plas.1999.1390; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Montague MG, 2000, P NATL ACAD SCI USA, V97, P5334, DOI 10.1073/pnas.97.10.5334; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; NORDSTROM M, 1985, PLASMID, V13, P81, DOI 10.1016/0147-619X(85)90060-5; Ohtsubo H, 1986, Adv Biophys, V21, P115, DOI 10.1016/0065-227X(86)90018-3; Poirel L, 2003, ANTIMICROB AGENTS CH, V47, P2938, DOI 10.1128/AAC.47.9.2938-2945.2003; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; TABUCHI A, 1988, J MOL BIOL, V202, P511, DOI 10.1016/0022-2836(88)90282-3; Taylor DE, 2004, PLASMID BIOLOGY, P473; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venkatesan MM, 2004, PLASMID BIOLOGY, P395; Xiong ZZ, 2002, DIAGN MICR INFEC DIS, V44, P195, DOI 10.1016/S0732-8893(02)00441-8; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	50	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8601	10.1371/journal.pone.0008601	http://dx.doi.org/10.1371/journal.pone.0008601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066042	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338600019
J	Bektas, M; Allende, ML; Lee, BG; Chen, WP; Amar, MJ; Remaley, AT; Saba, JD; Proia, RL				Bektas, Meryem; Allende, Maria Laura; Lee, Bridgin G.; Chen, WeiPing; Amar, Marcelo J.; Remaley, Alan T.; Saba, Julie D.; Proia, Richard L.			Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOLIPID METABOLISM; SPHINGOSINE-1-PHOSPHATE LYASE; SALVAGE PATHWAY; BIOSYNTHESIS; INHIBITION; SPHINGOMYELIN; CHOLESTEROL; SPECIFICITY; INSIGHTS; DISEASE	The cleavage of sphingoid base phosphates by sphingosine-1-phosphate (S1P) lyase to produce phosphoethanolamine and a fatty aldehyde is the final degradative step in the sphingolipid metabolic pathway. We have studied mice with an inactive S1P lyase gene and have found that, in addition to the expected increase of sphingoid base phosphates, other sphingolipids (including sphingosine, ceramide, and sphingomyelin) were substantially elevated in the serum and/or liver of these mice. This latter increase is consistent with a reutilization of the sphingosine backbone for sphingolipid synthesis due to its inability to exit the sphingolipid metabolic pathway. Furthermore, the S1P lyase deficiency resulted in changes in the levels of serum and liver lipids not directly within the sphingolipid pathway, including phospholipids, triacyglycerol, diacylglycerol, and cholesterol. Even though lipids in serum and lipid storage were elevated in liver, adiposity was reduced in the S1P lyase-deficient mice. Microarray analysis of lipid metabolism genes in liver showed that the S1P lyase deficiency caused widespread changes in their expression pattern, with a significant increase in the expression of PPAR gamma, a master transcriptional regulator of lipid metabolism. However, the mRNA expression of the genes encoding the sphingosine kinases and S1P phosphatases, which directly control the levels of S1P, were not significantly changed in liver of the S1P lyase-deficient mice. These results demonstrate that S1P lyase is a key regulator of the levels of multiple sphingolipid substrates and reveal functional links between the sphingolipid metabolic pathway and other lipid metabolic pathways that may be mediated by shared lipid substrates and changes in gene expression programs. The disturbance of lipid homeostasis by altered sphingolipid levels may be relevant to metabolic diseases.	[Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, Bethesda, MD 20892 USA; [Chen, WeiPing] NIDDK, Microarray Core Lab, Bethesda, MD 20892 USA; [Amar, Marcelo J.; Remaley, Alan T.] NIH, Pulm & Vasc Med Branch, NHLBI, Bethesda, MD 20892 USA; [Saba, Julie D.] CHORI, Oakland, CA 94609 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Children's Hospital Oakland Research Institute	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, Bethesda, MD 20892 USA.	proia@nih.gov	Chen, Weiping/C-9550-2011; Amar, Marcelo/AAD-5599-2019; Proia, Richard L/A-7908-2012	Bektas, Meryem/0000-0001-8080-7557; Proia, Richard/0000-0003-0456-1270	NIDDK, National Institutes of Health; NHLBI, National Institutes of Health; National Institutes of Health [CA77528, C06 RR018823]; NATIONAL CANCER INSTITUTE [R01CA077528, R01CA129438] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015, ZIADK056018, ZIADK056017] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDDK and NHLBI, National Institutes of Health, and by National Institutes of Health Grants CA77528 (to J. D. S.) and C06 RR018823 (to the MUSC Lipomics Core).	Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Cowart LA, 2009, TRENDS ENDOCRIN MET, V20, P34, DOI 10.1016/j.tem.2008.09.004; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; FOLCH J, 1957, J BIOL CHEM, V226, P497; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Fyrst H, 2008, BBA-MOL CELL BIOL L, V1781, P448, DOI 10.1016/j.bbalip.2008.05.005; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Obert LA, 2007, TOXICOL PATHOL, V35, P728, DOI 10.1080/01926230701481956; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Simha V, 2009, CURR OPIN LIPIDOL, V20, P300, DOI 10.1097/MOL.0b013e32832d4a33; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Witting SR, 2003, J BIOL CHEM, V278, P40121, DOI 10.1074/jbc.M305193200; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200; Worgall Tilla S., 2008, V49, P371, DOI 10.1007/978-1-4020-8830-8_14; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565	39	139	143	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10880	10889		10.1074/jbc.M109.081489	http://dx.doi.org/10.1074/jbc.M109.081489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20097939	Green Published, hybrid			2022-12-25	WOS:000276264600073
J	Ohama, T; Brautigan, DL				Ohama, Takashi; Brautigan, David L.			Endotoxin Conditioning Induces VCP/p97-mediated and Inducible Nitric-oxide Synthase-dependent Tyr(284) Nitration in Protein Phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; KINASE PHOSPHATASE-1; REGULATORY SUBUNITS; TYROSINE PHOSPHORYLATION; CATALYTIC SUBUNIT; CELL-SURVIVAL; EXPRESSION; MACROPHAGES; GROWTH; ALPHA	Endotoxins activate Toll-like receptors and reprogram cells to be refractory to secondary exposure. Here we found that activation of different Toll-like receptors elicited a time-and dose-dependent increase in the levels of the protein phosphatase 2A catalytic subunit (PP2Ac) but not its partner A subunit. We purified the lipopolysaccharide-induced form of PP2A by chromatography plus immunoprecipitation and used mass spectrometry to identify VCP/p97 as a novel partner for PP2Ac. Endogenous VCP/p97 and PP2Ac were co-immunoprecipitated from primary murine macrophages and human lymphocytes. GST-VCP/p97 bound purified PP2A in pulldown assays, showing direct protein-protein interaction. Endotoxin conditioning of macrophages induced formation of 3-nitrotyrosine in the PP2Ac associated with VCP/p97, a response severely reduced in macrophages from iNOS knock-out mice. The reaction of purified PP2A with peroxynitrite dissociated the A subunit, and 3-nitro-Tyr(284) was identified in PP2Ac by mass spectrometry. Myc-PP2Ac (Y284F) expressed in cells was resistant to peroxynitrite-induced nitration and reduction of A subunit binding. Transient expression of either VCP/p97 or PP2Ac was sufficient to elevate levels of the dual specificity phosphatase DUSP1, reduce p38 MAPK activation, and suppress tumor necrosis factor-alpha release. We propose that VCP/p97-mediated Tyr nitration of PP2A increases the levels of phosphatases PP2A and DUSP1 to contribute to the refractory response of conditioned cells.	[Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Brautigan, DL (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Box 800577,W Complex MSB 7225, Charlottesville, VA 22908 USA.	db8g@virginia.edu			National Institutes of Health [CA40042, GM56362]; University of Virginia Pratt Committee; NATIONAL CANCER INSTITUTE [P01CA040042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Pratt Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA40042 and GM56362 ( to D. L. B.). This work was also supported by the University of Virginia Pratt Committee.	Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Calvisi DF, 2008, CANCER RES, V68, P4192, DOI 10.1158/0008-5472.CAN-07-6157; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Gao JJ, 2003, J ENDOTOXIN RES, V9, P237, DOI 10.1179/096805103225001431; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nimah M, 2005, SHOCK, V23, P80, DOI 10.1097/01.shk.0000145206.28812.60; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Park SK, 2009, MOL IMMUNOL, V46, P492, DOI 10.1016/j.molimm.2008.10.011; Price NE, 2000, BIOCHEMISTRY-US, V39, P11312, DOI 10.1021/bi0008478; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wu F, 2009, CARDIOVASC RES, V81, P38, DOI 10.1093/cvr/cvn246; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zweitzig D R, 2008, Mol Biol Cell, V19, P5029, DOI 10.1091/mbc.E08-01-0067	40	31	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8711	8718		10.1074/jbc.M109.099788	http://dx.doi.org/10.1074/jbc.M109.099788			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20100830	Green Published, hybrid			2022-12-25	WOS:000275553700024
J	Telford, JE; Kilbride, SM; Davey, GP				Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.			Decylubiquinone Increases Mitochondrial Function in Synaptosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-Q DEFICIENCY; COMPLEX-I DEFICIENCY; AGE-RELATED-CHANGES; RESPIRATORY-CHAIN; Q(10); BIOENERGETICS; MUTATIONS; DISEASES; PROTEIN; MERRF	The effects of decylubiquinone, a ubiquinone analogue, on mitochondrial function and inhibition thresholds of the electron transport chain enzyme complexes in synaptosomes were investigated. Decylubiquinone increased complex I/III and complex II/III activities by 64 and 80%, respectively, and attenuated reductions in oxygen consumption at high concentrations of the complex III inhibitor myxothiazol. During inhibition of complex I, decylubiquinone attenuated reductions in synaptosomal oxygen respiration rates, as seen in the complex I inhibition threshold. Decylubiquinone increased the inhibition thresholds of complex I/III, complex II/III, and complex III over oxygen consumption in the nerve terminal by 25-50%, when myxothiazol was used to inhibit complex III. These results imply that decylubiquinone increases mitochondrial function in the nerve terminal during complex I or III inhibition. The potential benefits of decylubiquinone in diseases where complex I, I/III, II/III, or III activities are deficient are discussed.	[Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.] Trinity Coll Dublin, Inst Neurosci, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Davey, GP (corresponding author), Trinity Coll Dublin, Inst Neurosci, Sch Biochem & Immunol, Dublin 2, Ireland.	gdavey@tcd.ie	Davey, Gavin/HGB-4233-2022		Programme for Research in Third-level Institutions; Science Foundation Ireland; Marie Curie Transfer of Knowledge [MTKD-CT-2005-030005]	Programme for Research in Third-level Institutions; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Marie Curie Transfer of Knowledge(European Commission)	This work was supported by the Programme for Research in Third-level Institutions, Science Foundation Ireland, and Marie Curie Transfer of Knowledge Grant MTKD-CT-2005-030005.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Beal MF, 1998, BRAIN RES, V783, P109, DOI 10.1016/S0006-8993(97)01192-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Cleren C, 2008, J NEUROCHEM, V104, P1613, DOI 10.1111/j.1471-4159.2007.05097.x; Esposti MD, 1996, BIOCHEM J, V313, P327, DOI 10.1042/bj3130327; Galpern WR, 2007, MITOCHONDRION, V7, pS146, DOI 10.1016/j.mito.2007.01.004; Hano N, 2003, J BIOENERG BIOMEMBR, V35, P257, DOI 10.1023/A:1024663715931; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kilbride SM, 2008, BBA-BIOENERGETICS, V1777, P783, DOI 10.1016/j.bbabio.2008.05.445; Kilbride SM, 2008, J NEUROCHEM, V106, P826, DOI 10.1111/j.1471-4159.2008.05441.x; King T., 1967, METHOD ENZYMOL, V10, P217; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; Lenaz G, 1997, MOL ASPECTS MED, V18, pS25; Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013; Mackey DA, 1996, AM J HUM GENET, V59, P481; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001; Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Powers WJ, 2007, NEUROBIOL DIS, V27, P99, DOI 10.1016/j.nbd.2007.04.008; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, J BIOL CHEM, V276, P37861; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Shults CW, 2005, PHARMACOL THERAPEUT, V107, P120, DOI 10.1016/j.pharmthera.2005.02.002; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Telford JE, 2009, J BIOL CHEM, V284, P9109, DOI 10.1074/jbc.M809101200; VONJAGOW G, 1984, J BIOL CHEM, V259, P6318; Wharton DC., 1967, METHOD ENZYMOL, P245; Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807	38	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8639	8645		10.1074/jbc.M109.079780	http://dx.doi.org/10.1074/jbc.M109.079780			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080966	Green Published, hybrid			2022-12-25	WOS:000275553700016
J	Rebeck, GW; Hoe, HS; Moussa, CEH				Rebeck, G. William; Hoe, Hyang-Sook; Moussa, Charbel E. -H.			beta-Amyloid(1-42) Gene Transfer Model Exhibits Intraneuronal Amyloid, Gliosis, Tau Phosphorylation, and Neuronal Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC ALZHEIMERS-DISEASE; TRIPLE-TRANSGENIC MODEL; A-BETA; TANGLE FORMATION; GOLGI NETWORK; PROTEIN; PATHOLOGY; CDK5; ACCUMULATION; INFLAMMATION	Alzheimer disease is characterized by extracellular beta-amyloid (A beta) plaques and intracellular inclusions containing neurofibrillary tangles of phospho-Tau and intraneuronal A beta associated with neuronal cell death. We generated a novel gene transfer animal model using lentiviral A beta(1-42) that resulted in intracellular but not extracellular A beta accumulations in the targeted rat primary motor cortex. Expression of intracellular A beta(1-42) led to pathological changes seen in human Alzheimer disease brains, including cell death, inflammatory signs, activation of two Tau kinases, and Tau hyperphosphorylation. Promoting clearance of lentiviral A beta(1-42) reversed these effects, demonstrating that intraneuronal A beta(1-42) is a toxic peptide that lies upstream of Tau modification. These studies reveal the role of intracellular A beta(1-42) in a novel gene transfer animal model, which is a useful tool to study intraneuronal A beta(1-42)-induced pathology in the absence of extracellular plaques. Targeted delivery of A beta will allow speedy delineation of pathological mechanisms associated with specific neurodegenerative lesions.	Georgetown Univ, Dept Neurosci, Washington, DC 20007 USA; [Moussa, Charbel E. -H.] Georgetown Univ, Dept Biochem & Mol & Cell Biol, Washington, DC 20007 USA	Georgetown University; Georgetown University	Moussa, CEH (corresponding author), Georgetown Univ, Dept Neurosci, Dept Biochem & Mol & Cell Biol, Sch Med, 3970 Reservoir Rd,NW,TRB,Rm WP26B, Washington, DC 20057 USA.	cem46@georgetown.edu	Rebeck, George William/J-2192-2012	Rebeck, George William/0000-0001-6276-248X	NATIONAL INSTITUTE ON AGING [P01AG030128] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG030128] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73; Augustinack JC, 2002, J NEUROPATH EXP NEUR, V61, P557, DOI 10.1093/jnen/61.6.557; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Burns MP, 2009, HUM MOL GENET, V18, P3206, DOI 10.1093/hmg/ddp258; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 1997, J NEUROSCI, V17, P6142; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Griffin WST, 1998, BRAIN PATHOL, V8, P65; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hof Patrick R., 1994, P197; Imahori K, 1997, J BIOCHEM, V121, P179; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lee MS, 2003, J ALZHEIMERS DIS, V5, P127, DOI 10.3233/JAD-2003-5207; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002; Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734; MASLIAH E, 1991, ACTA NEUROPATHOL, V83, P12, DOI 10.1007/BF00294425; MCGEER EG, 2003, BIOL PSYCHIAT, V27, P741; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Moussa CEH, 2009, J MOL NEUROSCI, V37, P25, DOI 10.1007/s12031-008-9099-x; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Octave J N, 2005, Bull Mem Acad R Med Belg, V160, P445; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SELKOE DJ, 1989, CELL, V58, P611, DOI 10.1016/0092-8674(89)90093-7; Sheng JG, 1998, J NEUROPATH EXP NEUR, V57, P714, DOI 10.1097/00005072-199807000-00008; Sheng JG, 1998, J NEUROPATH EXP NEUR, V57, P323, DOI 10.1097/00005072-199804000-00003; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; Trojanowski JQ, 2000, ANN NY ACAD SCI, V924, P62; Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	50	45	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7440	7446		10.1074/jbc.M109.083915	http://dx.doi.org/10.1074/jbc.M109.083915			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20071340	Green Published, hybrid			2022-12-25	WOS:000275415600056
J	Anaclet, C; Pedersen, NP; Fuller, PM; Lu, J				Anaclet, Christelle; Pedersen, Nigel P.; Fuller, Patrick M.; Lu, Jun			Brainstem Circuitry Regulating Phasic Activation of Trigeminal Motoneurons during REM Sleep	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; ORAL MOTOR NUCLEI; MUSCLE-ACTIVITY; ACTIVE SLEEP; HORSERADISH-PEROXIDASE; SOMATIC MOTONEURONS; RETICULAR-FORMATION; LUMBAR MOTONEURONS; PARADOXICAL SLEEP; WAKE STATES	Background: Rapid eye movement sleep (REMS) is characterized by activation of the cortical and hippocampal electroencephalogram (EEG) and atonia of non-respiratory muscles with superimposed phasic activity or twitching, particularly of cranial muscles such as those of the eye, tongue, face and jaw. While phasic activity is a characteristic feature of REMS, the neural substrates driving this activity remain unresolved. Here we investigated the neural circuits underlying masseter (jaw) phasic activity during REMS. The trigeminal motor nucleus (Mo5), which controls masseter motor function, receives glutamatergic inputs mainly from the parvocellular reticular formation (PCRt), but also from the adjacent paramedian reticular area (PMnR). On the other hand, the Mo5 and PCRt do not receive direct input from the sublaterodorsal (SLD) nucleus, a brainstem region critical for REMS atonia of postural muscles. We hypothesized that the PCRt-PMnR, but not the SLD, regulates masseter phasic activity during REMS. Methodology/Principal Findings: To test our hypothesis, we measured masseter electromyogram (EMG), neck muscle EMG, electrooculogram (EOG) and EEG in rats with cell-body specific lesions of the SLD, PMnR, and PCRt. Bilateral lesions of the PMnR and rostral PCRt (rPCRt), but not the caudal PCRt or SLD, reduced and eliminated REMS phasic activity of the masseter, respectively. Lesions of the PMnR and rPCRt did not, however, alter the neck EMG or EOG. To determine if rPCRt neurons use glutamate to control masseter phasic movements, we selectively blocked glutamate release by rPCRt neurons using a Crelox mouse system. Genetic disruption of glutamate neurotransmission by rPCRt neurons blocked masseter phasic activity during REMS. Conclusions/Significance: These results indicate that (1) premotor glutamatergic neurons in the medullary rPCRt and PMnR are involved in generating phasic activity in the masseter muscles, but not phasic eye movements, during REMS; and (2) separate brainstem neural circuits control postural and cranial muscle phasic activity during REMS.	[Anaclet, Christelle] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Sleep Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Anaclet, C (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Sleep Med, Boston, MA 02215 USA.	jlu@bidmc.harvard.edu		Anaclet, Christelle/0000-0002-0526-8132; Pedersen, Nigel/0000-0002-8494-0635	NIH [NS 051609, NS 062727, NS 061841]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061841, R01NS051609, R01NS062727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NS 051609, NS 062727 and NS 061841. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; Brooks PL, 2008, J NEUROSCI, V28, P3535, DOI 10.1523/JNEUROSCI.5023-07.2008; Burgess C, 2008, J NEUROSCI, V28, P4649, DOI 10.1523/JNEUROSCI.0334-08.2008; Chan E, 2006, AM J RESP CRIT CARE, V174, P1264, DOI 10.1164/rccm.200605-597OC; CHASE MH, 1989, J NEUROSCI, V9, P743; Elmquist JK, 1996, J COMP NEUROL, V374, P315, DOI 10.1002/(SICI)1096-9861(19961021)374:3<315::AID-CNE1>3.0.CO;2-4; Fay RA, 1997, BRAIN RES REV, V25, P255, DOI 10.1016/S0165-0173(97)00026-X; Fenik VB, 2008, NEUROSCIENCE, V157, P473, DOI 10.1016/j.neuroscience.2008.08.069; Fenik VB, 2005, AM J RESP CRIT CARE, V172, P1322, DOI 10.1164/rccm.200412-1750OC; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; GROSSER GS, 1971, PSYCHOL BULL, V75, P60, DOI 10.1037/h0030303; HENDRICKS JC, 1982, BRAIN RES, V239, P81, DOI 10.1016/0006-8993(82)90835-6; JOUVET M, 1959, CR SOC BIOL, V153, P422; JOUVET M., 1965, PROGR BRAIN RES, V18, P20; JOUVET M, 1959, CR SOC BIOL, V153, P1024; Kato T, 2007, NEUROSCI RES, V58, P265, DOI 10.1016/j.neures.2007.03.008; KODAMA T, 1990, NEUROSCI LETT, V114, P277, DOI 10.1016/0304-3940(90)90576-U; Lai YY, 2001, J NEUROSCI, V21, P7384, DOI 10.1523/JNEUROSCI.21-18-07384.2001; LAI YY, 1993, J COMP NEUROL, V336, P321, DOI 10.1002/cne.903360302; Lavigne GJ, 2001, J DENT RES, V80, P443, DOI 10.1177/00220345010800020801; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lu JW, 2005, RESP PHYSIOL NEUROBI, V147, P191, DOI 10.1016/j.resp.2005.05.007; Marciano C. R., 2001, Revista Brasileira de Ciencia do Solo, V25, P1, DOI 10.1590/S0100-06832001000100001; Neuzeret PC, 2009, J SLEEP RES, V18, P113, DOI 10.1111/j.1365-2869.2008.00708.x; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PEDROARENA C, 1994, BRAIN RES, V653, P31, DOI 10.1016/0006-8993(94)90368-9; SASTRE JP, 1979, PHYSIOL BEHAV, V22, P979; Scammell T, 1998, P NATL ACAD SCI USA, V95, P7754, DOI 10.1073/pnas.95.13.7754; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; SHAMMAHLAGNADO SJ, 1992, NEUROSCIENCE, V50, P403, DOI 10.1016/0306-4522(92)90433-3; SOJA PJ, 1991, J NEUROSCI, V11, P2804; Taepavarapruk N, 2008, J NEUROPHYSIOL, V100, P598, DOI 10.1152/jn.01231.2007; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; TRAVERS JB, 1983, J COMP NEUROL, V220, P280, DOI 10.1002/cne.902200303; Travers JB, 2005, J COMP NEUROL, V488, P28, DOI 10.1002/cne.20604; Vetrivelan R, 2009, J NEUROSCI, V29, P9361, DOI 10.1523/JNEUROSCI.0737-09.2009; Volgin DV, 2008, J APPL PHYSIOL, V105, P1576, DOI 10.1152/japplphysiol.90670.2008; Zhang X, 2009, SLEEP MED, V10, P143, DOI 10.1016/j.sleep.2007.12.002	42	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8788	10.1371/journal.pone.0008788	http://dx.doi.org/10.1371/journal.pone.0008788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098748	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000016
J	Benayoun, BA; Caburet, S; Dipietromaria, A; Georges, A; D'Haene, B; Pandaranayaka, PJE; L'Hote, D; Todeschini, AL; Krishnaswamy, S; Fellous, M; De Baere, E; Veitia, RA				Benayoun, Berenice A.; Caburet, Sandrine; Dipietromaria, Aurelie; Georges, Adrien; D'Haene, Barbara; Pandaranayaka, P. J. Eswari; L'Hote, David; Todeschini, Anne-Laure; Krishnaswamy, Sankaran; Fellous, Marc; De Baere, Elfride; Veitia, Reiner A.			Functional Exploration of the Adult Ovarian Granulosa Cell Tumor-Associated Somatic FOXL2 Mutation p.Cys134Trp (c.402C > G)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; FORKHEAD DOMAIN; EXPRESSION; GENE; BLEPHAROPHIMOSIS; IDENTIFICATION; AGGREGATION; EVOLUTION; PITUITARY; RECEPTOR	Background: The somatic mutation in the FOXL2 gene c.402C>G (p.Cys134Trp) has recently been identified in the vast majority of adult ovarian granulosa cell tumors (OGCTs) studied. In addition, this mutation seems to be specific to adult OGCTs and is likely to be a driver of malignant transformation. However, its pathogenic mechanisms remain elusive. Methodology/Principal Findings: We have sequenced the FOXL2 open reading frame in a panel of tumor cell lines (NCI-60, colorectal carcinoma cell lines, JEG-3, and KGN cells). We found the FOXL2 c.402C>G mutation in the adult OGCT-derived KGN cell line. All other cell lines analyzed were negative for the mutation. In order to gain insights into the pathogenic mechanism of the p.Cys134Trp mutation, the subcellular localization and mobility of the mutant protein were studied and found to be no different from those of the wild type (WT). Furthermore, its transactivation ability was in most cases similar to that of the WT protein, including in conditions of oxidative stress. A notable exception was an artificial promoter known to be coregulated by FOXL2 and Smad3, suggesting a potential modification of their interaction. We generated a 3D structural model of the p.Cys134Trp variant and our analysis suggests that homodimer formation might also be disturbed by the mutation. Conclusions/Significance: Here, we confirm the specificity of the FOXL2 c.402C>G mutation in adult OGCTs and begin the exploration of its molecular significance. This is the first study demonstrating that the p.Cys134Trp mutant does not have a strong impact on FOXL2 localization, solubility, and transactivation abilities on a panel of proven target promoters, behaving neither as a dominant-negative nor as a loss-of-function mutation. Further studies are required to understand the specific molecular effects of this outstanding FOXL2 mutation.	[Benayoun, Berenice A.; Caburet, Sandrine; Dipietromaria, Aurelie; Georges, Adrien; L'Hote, David; Todeschini, Anne-Laure; Veitia, Reiner A.] Inst Jacques Monod, Programme Pathol Mol & Cellulaire, F-75251 Paris, France; [Benayoun, Berenice A.; Caburet, Sandrine; Dipietromaria, Aurelie; Georges, Adrien; L'Hote, David; Todeschini, Anne-Laure; Veitia, Reiner A.] Univ Paris 07, Paris, France; [Georges, Adrien] Ecole Normale Super, F-75231 Paris, France; [D'Haene, Barbara; De Baere, Elfride] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Pandaranayaka, P. J. Eswari; Krishnaswamy, Sankaran] Kamaraj Univ, Sch Biotechnol, Madurai, Tamil Nadu, India; [Fellous, Marc] Inst Cochin, Dept Genet & Dev, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Ghent University; Ghent University Hospital; Madurai Kamaraj University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benayoun, BA (corresponding author), Inst Jacques Monod, Programme Pathol Mol & Cellulaire, 2 Pl Jussieu, F-75251 Paris, France.	veitia.reiner@ijm.univ-paris-diderot.fr	Benayoun, Bérénice A./K-7048-2012; Georges, Adrien/ABD-6348-2021; De Baere, Elfride/E-7405-2017; Caburet, Sandrine/AAH-3435-2019; LHOTE, David/AAD-5390-2020; L'Hote, David/L-2653-2017	Benayoun, Bérénice A./0000-0002-7401-4777; De Baere, Elfride/0000-0002-5609-6895; L'Hote, David/0000-0001-5658-5018; Caburet, Sandrine/0000-0002-7404-8213; Georges, Adrien/0000-0003-4208-2393; Pandaranayaka, Eswari/0000-0003-3021-853X; Krishnaswamy, Sankaran/0000-0002-6797-4614	AMN/University Paris Diderot-Paris 7; Fondation de la Recherche Medicale; Ecole Normale Superieure; Government of India; Centre National de la Recherche Scientifique; Institut Universitaire de France; Association pour la Recherche contre le Cancer [1140]; Ghent University [01SB1409]	AMN/University Paris Diderot-Paris 7; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Ecole Normale Superieure; Government of India; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Universitaire de France; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ghent University(Ghent University)	B.A.B. is supported by an AMN/University Paris Diderot-Paris 7 fellowship. S.C., D.L., and A.L.T. are supported by University Paris Diderot-Paris 7. A.D. is supported by a Fondation de la Recherche Medicale fellowship. A. G. is supported by an Ecole Normale Superieure fellowship. P.J.E.P. is supported by a Government of India fellowship. E.D.B. is a senior clinical investigator from Research Foundation Flanders. R.A.V. is supported by University Paris Diderot-Paris 7, the Centre National de la Recherche Scientifique, the Institut Universitaire de France, and the Association pour la Recherche contre le Cancer. The Bioinformatics facilities at Madurai Kamaraj University are funded by the Department of Biotechnology, Government of India. This work was funded by a grant from the Association pour la Recherche contre le Cancer (1140) and by BOF-BILA grant 01SB1409 from Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Benayoun BA, 2010, BBA-REV CANCER, V1805, P1, DOI 10.1016/j.bbcan.2009.09.002; Benayoun BA, 2009, ADV EXP MED BIOL, V665, P207; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Beysen D, 2005, AM J HUM GENET, V77, P205, DOI 10.1086/432083; Beysen D, 2008, HUM MOL GENET, V17, P2030, DOI 10.1093/hmg/ddn100; Beysen D, 2008, HUM MUTAT, V29, pE205, DOI 10.1002/humu.20819; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Caburet S, 2004, J MED GENET, V41, P932, DOI 10.1136/jmg.2004.024356; Cocquet J, 2003, CYTOGENET GENOME RES, V101, P206, DOI 10.1159/000074338; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; D'haene B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000522; Dipietromaria A, 2009, HUM MOL GENET, V18, P3324, DOI 10.1093/hmg/ddp273; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Grundker C, 2002, J CLIN ENDOCR METAB, V87, P1427, DOI 10.1210/jc.87.3.1427; Hamelin V, 2006, BLOOD, V107, P3106, DOI 10.1182/blood-2005-07-2953; Kalfa N, 2005, J PEDIATR ENDOCR MET, V18, P25; Kalfa N, 2007, FERTIL STERIL, V87, P896, DOI 10.1016/j.fertnstert.2006.11.016; Kawai S, 2005, BIOCHEM BIOPH RES CO, V328, P306, DOI 10.1016/j.bbrc.2004.12.173; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kim SG, 2005, MOL BIOL CELL, V16, P4672, DOI 10.1091/mbc.E05-01-0054; Laissue P, 2009, J MED GENET, V46, P455, DOI 10.1136/jmg.2008.065086; Litichever N, 2009, J MOL NEUROSCI, V39, P78, DOI 10.1007/s12031-009-9185-8; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Moumne L, 2008, MOL CELL ENDOCRINOL, V282, P2, DOI 10.1016/j.mce.2007.11.006; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Murdoch WJ, 2005, BIOL REPROD, V73, P586, DOI 10.1095/biolreprod.105.042622; Nallathambi Jeyabalan, 2008, Hum Mutat, V29, pE123, DOI 10.1002/humu.20809; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Pectasides D, 2008, CANCER TREAT REV, V34, P1, DOI 10.1016/j.ctrv.2007.08.007; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; Qian XQ, 2004, MUTAT RES-FUND MOL M, V554, P19, DOI 10.1016/j.mrfmmm.2004.02.014; Rigourd V, 2009, J REPROD IMMUNOL, V82, P174, DOI 10.1016/j.jri.2009.05.001; Sambrook J, 2001, MOL CLONING LAB MANU; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	44	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8789	10.1371/journal.pone.0008789	http://dx.doi.org/10.1371/journal.pone.0008789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098707	Green Published, gold, Green Submitted			2022-12-25	WOS:000273779000017
J	Sansom, SL; Prabhu, VS; Hutchinson, AB; An, Q; Hall, HI; Shrestha, RK; Lasry, A; Taylor, AW				Sansom, Stephanie L.; Prabhu, Vimalanand S.; Hutchinson, Angela B.; An, Qian; Hall, H. Irene; Shrestha, Ram K.; Lasry, Arielle; Taylor, Allan W.			Cost-Effectiveness of Newborn Circumcision in Reducing Lifetime HIV Risk among US Males	PLOS ONE			English	Article							NEONATAL CIRCUMCISION; YOUNG MEN; INFECTION; PREVENTION; HERPES; SEROCONVERSION; DISEASE; HEALTH; STATES; RAKAI	Background: HIV incidence was substantially lower among circumcised versus uncircumcised heterosexual African men in three clinical trials. Based on those findings, we modeled the potential effect of newborn male circumcision on a U. S. male's lifetime risk of HIV, including associated costs and quality-adjusted life-years saved. Methodology/Principal Findings: Given published estimates of U. S. males' lifetime HIV risk, we calculated the fraction of lifetime risk attributable to heterosexual behavior from 2005-2006 HIV surveillance data. We assumed 60% efficacy of circumcision in reducing heterosexually-acquired HIV over a lifetime, and varied efficacy in sensitivity analyses. We calculated differences in lifetime HIV risk, expected HIV treatment costs and quality-adjusted life years (QALYs) among circumcised versus uncircumcised males. The main outcome measure was cost per HIV-related QALY saved. Circumcision reduced the lifetime HIV risk among all males by 15.7% in the base case analysis, ranging from 7.9% for white males to 20.9% for black males. Newborn circumcision was a cost-saving HIV prevention intervention for all, black and Hispanic males. The net cost of newborn circumcision per QALY saved was $87,792 for white males. Results were most sensitive to the discount rate, and circumcision efficacy and cost. Conclusions/Significance: Newborn circumcision resulted in lower expected HIV-related treatment costs and a slight increase in QALYs. It reduced the 1.87% lifetime risk of HIV among all males by about 16%. The effect varied substantially by race and ethnicity. Racial and ethnic groups who could benefit the most from circumcision may have least access to it due to insurance coverage and state Medicaid policies, and these financial barriers should be addressed. More data on the long-term protective	[Sansom, Stephanie L.; Prabhu, Vimalanand S.; Hutchinson, Angela B.; An, Qian; Hall, H. Irene; Shrestha, Ram K.; Lasry, Arielle; Taylor, Allan W.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Sansom, SL (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	sos9@cdc.gov		Taylor, Allan/0000-0001-7496-8768				Alanis MC, 2004, OBSTET GYNECOL SURV, V59, P379, DOI 10.1097/00006254-200405000-00026; [Anonymous], 2006, STAT HLTH NOT CIRC I; [Anonymous], 2007, HEIGHT NAT RESP HIV; [Anonymous], NATL VITAL STAT REPO; [Anonymous], WORLD FACTB; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Centers for Disease Control and Prevention, 2006, HIV AIDS SURVEILLANC, V18; Christakis DA, 2000, PEDIATRICS, V105, P246; GANIATS TG, 1991, MED DECIS MAKING, V11, P282, DOI 10.1177/0272989X9101100406; Gold MR, 1996, COST EFFECTIVENESS H; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000187; Grulich AE, 2001, AIDS, V15, P1188, DOI 10.1097/00002030-200106150-00020; Hall HI, 2008, JAIDS-J ACQ IMM DEF, V49, P294, DOI 10.1097/QAI.0b013e3181893f17; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; *HJ KAIS FAM FDN, 2007, KEY FACTS RAC ETHN M; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; KRIESS JK, 1993, J INFECT DIS, V168, P1404, DOI 10.1093/infdis/168.6.1404; KUNG HC, 2007, DEATHS FINAL DATA 20; Lannon CM, 1999, PEDIATRICS, V103, P686; Lawler F H, 1991, Fam Med, V23, P587; Leibowitz AA, 2009, AM J PUBLIC HEALTH, V99, P138, DOI 10.2105/AJPH.2008.134403; MANSFIELD CJ, 1995, J FAM PRACTICE, V41, P370; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; MILLETT GA, 2007, J ACQ IMMUN DEF SYND, V45, P643; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Prejean J., 2008, Morbidity and Mortality Weekly Report, V57, P985; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Schoen EJ, 2006, J UROLOGY, V175, P1111, DOI 10.1016/S0022-5347(05)00399-X; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; TELZAK EE, 1993, ANN INTERN MED, V119, P1181, DOI 10.7326/0003-4819-119-12-199312150-00005; Templeton DJ, 2009, AIDS, V23, P2347, DOI 10.1097/QAD.0b013e32833202b8; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Van Howe RS, 2004, MED DECIS MAKING, V24, P584, DOI 10.1177/0272989X04271039; Warner L, 2009, J INFECT DIS, V199, P59, DOI 10.1086/595569; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; *WHO, 2009, MAL CIRC HIV PREV; *WHO, 2009, CHOOSING INT AR COST; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Xu F, 2007, SEX TRANSM DIS, V34, P479, DOI 10.1097/01.olq.0000253335.41841.04; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; 2005, MARKETSCAN DATABASE	50	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8723	10.1371/journal.pone.0008723	http://dx.doi.org/10.1371/journal.pone.0008723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090910	Green Published, Green Submitted, gold			2022-12-25	WOS:000273715000003
J	Yoshikawa, T; Hill, TE; Yoshikawa, N; Popov, VL; Galindo, CL; Garner, HR; Peters, CJ; Tseng, CT				Yoshikawa, Tomoki; Hill, Terence E.; Yoshikawa, Naoko; Popov, Vsevolod L.; Galindo, Cristi L.; Garner, Harold R.; Peters, C. J.; Tseng, Chien-Te (Kent)			Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection	PLOS ONE			English	Article							INTERFERON-INDUCIBLE PROTEIN-10; DHORI-VIRUS ORTHOMYXOVIRIDAE; MOUSE HEPATITIS-VIRUS; HOST GENE-EXPRESSION; TRANSCRIPTION FACTORS; I INTERFERON; THOGOTOVIRUS INFECTION; POSITIVE FEEDBACK; IFN-ALPHA/BETA; INDUCTION	Human lung epithelial cells are likely among the first targets to encounter invading severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Not only can these cells support the growth of SARS-CoV infection, but they are also capable of secreting inflammatory cytokines to initiate and, eventually, aggravate host innate inflammatory responses, causing detrimental immune-mediated pathology within the lungs. Thus, a comprehensive evaluation of the complex epithelial signaling to SARS-CoV is crucial for paving the way to better understand SARS pathogenesis. Based on microarray-based functional genomics, we report here the global gene response of 2B4 cells, a cloned bronchial epithelial cell line derived from Calu-3 cells. Specifically, we found a temporal and spatial activation of nuclear factor (NF)kappa B, activator protein (AP)-1, and interferon regulatory factor (IRF)-3/7 in infected 2B4 cells at 12-, 24-, and 48-hrs post infection (p.i.), resulting in the activation of many antiviral genes, including interferon (IFN)-beta, -lambda s, inflammatory mediators, and many IFN-stimulated genes (ISGs). We also showed, for the first time, that IFN-beta and IFN-lambda s were capable of exerting previously unrecognized, non-redundant, and complementary abilities to limit SARS-CoV replication, even though their expression could not be detected in infected 2B4 bronchial epithelial cells until 48 hrs p.i. Collectively, our results highlight the mechanics of the sequential events of antiviral signaling pathway/s triggered by SARS-CoV in bronchial epithelial cells and identify novel cellular targets for future studies, aiming at advancing strategies against SARS.	[Yoshikawa, Tomoki; Hill, Terence E.; Yoshikawa, Naoko; Peters, C. J.; Tseng, Chien-Te (Kent)] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Popov, Vsevolod L.; Peters, C. J.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Popov, Vsevolod L.; Peters, C. J.; Tseng, Chien-Te (Kent)] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yoshikawa, T (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA.	sktseng@utmb.edu		Yoshikawa, Tomoki/0000-0001-7601-4036	National Institutes of Health [R21AI072201]; Western Regional Center [U54 AI057156]; Viral Respiratory Pathogens Research Unit [NO1 AI3009]; US Based Collaboration in Emerging Viral and Prior Diseases [NO1 AI25489]; James W. McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025489, R21AI072201, U54AI057156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Western Regional Center; Viral Respiratory Pathogens Research Unit; US Based Collaboration in Emerging Viral and Prior Diseases; James W. McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by National Institutes of Health (http://www3.niaid.nih.gov/) Grant R21AI072201, a Career Development Grant award through the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (U54 AI057156), as well as Subcontract awards on SARS from the Viral Respiratory Pathogens Research Unit (NO1 AI3009) (to CKT), and US Based Collaboration in Emerging Viral and Prior Diseases (NO1 AI25489). T. Y. was supported by the James W. McLaughlin Fellowship Fund (http://research.utmb.edu/intramural_funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; ANDERSON CR, 1973, INDIAN J MED RES, V61, P1416; Barnard Dale L., 2006, Antiviral Chemistry & Chemotherapy, V17, P275; BASBAUM CB, 1990, AM REV RESPIR DIS, V141, pS141, DOI 10.1164/ajrccm/141.3_Pt_2.S141; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen PCH, 2004, J PATHOL, V203, P729, DOI 10.1002/path.1575; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Cinatl J, 2004, CELL MOL LIFE SCI, V61, P2100, DOI 10.1007/s00018-004-4222-9; De Lang A, 2007, PLOS PATHOG, V3, P1129, DOI 10.1371/journal.ppat.0030112; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DUTTA SK, 1983, CAN J COMP MED, V47, P64; FINKBEINER WE, 1993, AM J RESP CELL MOL, V9, P547, DOI 10.1165/ajrcmb/9.5.547; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Glass WG, 2004, J IMMUNOL, V173, P4030, DOI 10.4049/jimmunol.173.6.4030; Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hensley LE, 2004, EMERG INFECT DIS, V10, P317, DOI 10.3201/eid1002.030482; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Imai Y, 2008, EXP PHYSIOL, V93, P543, DOI 10.1113/expphysiol.2007.040048; Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kopecky-Bromberg SA, 2006, J VIROL, V80, P785, DOI 10.1128/JVI.80.2.785-793.2006; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lang ZW, 2003, CHINESE MED J-PEKING, V116, P976; Langford M P, 1981, Methods Enzymol, V78, P339; Leong WF, 2005, MICROBES INFECT, V7, P248, DOI 10.1016/j.micinf.2004.11.004; Li GY, 2008, AM J TROP MED HYG, V78, P675, DOI 10.4269/ajtmh.2008.78.675; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Martin LD, 1997, EUR RESPIR J, V10, P2139, DOI 10.1183/09031936.97.10092139; Mateo RI, 2007, AM J TROP MED HYG, V76, P785, DOI 10.4269/ajtmh.2007.76.785; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Morgenstern B, 2005, BIOCHEM BIOPH RES CO, V326, P905, DOI 10.1016/j.bbrc.2004.11.128; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Ng LF, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-34; Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Polito AJ, 1998, J ALLERGY CLIN IMMUN, V102, P714, DOI 10.1016/S0091-6749(98)70008-9; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Roth-Cross JK, 2007, J VIROL, V81, P7189, DOI 10.1128/JVI.00013-07; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Spiegel M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-17; Tang BSF, 2005, J VIROL, V79, P6180, DOI 10.1128/JVI.79.10.6180-6193.2005; Tang NLS, 2005, CLIN CHEM, V51, P2333, DOI 10.1373/clinchem.2005.054460; TAUB DD, 1995, J IMMUNOL, V155, P3877; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; To K, 2004, J PATHOL, V202, P157, DOI 10.1002/path.1510; Tseng CTK, 2007, J VIROL, V81, P1162, DOI 10.1128/JVI.01702-06; Tseng CTK, 2005, J VIROL, V79, P9470, DOI 10.1128/JVI.79.15.9470-9479.2005; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; Yan KW, 2003, INT J SURG PATHOL, V11, P118, DOI 10.1177/106689690301100208; Yoshikawa N, 2009, J VIROL, V83, P5451, DOI 10.1128/JVI.02272-08; Yoshikawa T, 2009, J VIROL, V83, P3039, DOI 10.1128/JVI.01792-08; Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004; Zheng BJ, 2004, J INTERF CYTOK RES, V24, P388, DOI 10.1089/1079990041535610; Zhong B, 2006, VIROLOGY, V352, P14, DOI 10.1016/j.virol.2006.04.029; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	79	118	122	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8729	10.1371/journal.pone.0008729	http://dx.doi.org/10.1371/journal.pone.0008729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090954	gold, Green Published, Green Submitted			2022-12-25	WOS:000273714900010
J	Vogelgesang, A; May, VEL; Grunwald, U; Bakkeboe, M; Langner, S; Wallaschofski, H; Kessler, C; Broker, BM; Dressel, A				Vogelgesang, Antje; May, Verena E. L.; Grunwald, Uwe; Bakkeboe, Maren; Langner, Soenke; Wallaschofski, Henry; Kessler, Christof; Broeker, Barbara M.; Dressel, Alexander			Functional Status of Peripheral Blood T-Cells in Ischemic Stroke Patients	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MOBILITY GROUP BOX-1; INDUCED IMMUNODEPRESSION; PROTEIN HMGB1; INFECTION; ACTIVATION; RELEASE; BRAIN; EXPRESSION; MONOCYTES	Stroke is a major cause of disability and leading cause of death in the northern hemisphere. Only recently it became evident that cerebral ischemia not only leads to brain tissue damage and subsequent local inflammation but also to a dramatic loss of peripheral blood T-cells with subsequent infections. However, only scarce information is available on the activation status of surviving T cells. This study therefore addressed the functional consequences of immunological changes induced by stroke in humans. For this purpose peripheral blood T-cells were isolated from 93 stroke patients and the expression of activation makers was determined. In addition ex vivo stimulation assays were applied to asses the functionality of T cells derived from blood of stroke patients. Compared to healthy controls, stroke patients demonstrated an enhanced surface expression of HLA-DR (p<0.0001) and CD25 (p = 0.02) on T cells, revealing that stroke leads to T cell activation, while CTLA-4 remained undetectable. In vitro studies revealed that catecholamines inhibit CTLA-4 upregulation in activated T cells. Ex vivo, T cells of stroke patients proliferated unimpaired and released increased amounts of the proinflammatory cytokine TNF-alpha (p<0.01) and IL-6 (p<0.05). Also, in sera of stroke patients HMGB1 concentrations were increased (p = 0.0002). The data demonstrate that surviving T cells in stroke patients remain fully functional and are primed towards a TH1 response, in addition we provide evidence that catecholamine mediated inhibition of CTLA-4 expression and serum HMGB1 release are possible mediators in stroke induced activation of T cells.	[Vogelgesang, Antje; May, Verena E. L.; Bakkeboe, Maren; Kessler, Christof; Dressel, Alexander] Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany; [Grunwald, Uwe; Broeker, Barbara M.] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Langner, Soenke] Ernst Moritz Arndt Univ Greifswald, Dept Radiol, Greifswald, Germany; [Wallaschofski, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Vogelgesang, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany.	adressel@uni-greifswald.de	Vogelgesang, Antje/AAQ-1194-2021; Bröker, Barbara M/O-4850-2015; Langner, Soenke/ABB-6744-2021; Dressel, Alexander/F-9142-2015	Vogelgesang, Antje/0000-0003-2984-0831; Bröker, Barbara M/0000-0002-5020-8542; Langner, Soenke/0000-0001-7241-1173; Dressel, Alexander/0000-0002-9055-4327	German Federal Ministry for Education and Research [01-ZZ-0403]; German Research Foundation	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Federal Ministry for Education and Research (NBL3 program, reference 01-ZZ-0403) and the German Research Foundation, Research Training Group 840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2007, J NEUROL SCI, V252, P29, DOI 10.1016/j.jns.2006.10.001; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; PETERSEN CM, 1992, EXP CELL RES, V201, P160, DOI 10.1016/0014-4827(92)90360-K; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sundberg E, 2009, IMMUNOBIOLOGY, V214, P303, DOI 10.1016/j.imbio.2008.09.006; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; Urra X, 2009, STROKE, V40, P1262, DOI 10.1161/STROKEAHA.108.532085; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Zhang DP, 2009, EUR J NEUROL, V16, P498, DOI 10.1111/j.1468-1331.2008.02512.x; ZHENG Y, 2008, ACQUISITION SUPPRESS, P1683	26	70	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8718	10.1371/journal.pone.0008718	http://dx.doi.org/10.1371/journal.pone.0008718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090932	gold, Green Submitted, Green Published			2022-12-25	WOS:000273714600018
J	Becker, D; Tetens, J; Brunner, A; Burstel, D; Ganter, M; Kijas, J; Drogemuller, C				Becker, Doreen; Tetens, Jens; Brunner, Adrian; Buerstel, Daniela; Ganter, Martin; Kijas, James; Droegemueller, Cord		Int Sheep Genomics Consortium	Microphthalmia in Texel Sheep Is Associated with a Missense Mutation in the Paired-Like Homeodomain 3 (PITX3) Gene	PLOS ONE			English	Article							HOMEOBOX GENE; RIEGER-SYNDROME; APHAKIA MICE; LINKAGE MAP; GENOME; ANOPHTHALMIA; CATARACTS; DEFECTS; LENS; MALFORMATIONS	Microphthalmia in sheep is an autosomal recessive inherited congenital anomaly found within the Texel breed. It is characterized by extremely small or absent eyes and affected lambs are absolutely blind. For the first time, we use a genome-wide ovine SNP array for positional cloning of a Mendelian trait in sheep. Genotyping 23 cases and 23 controls using Illumina's OvineSNP50 BeadChip allowed us to localize the causative mutation for microphthalmia to a 2.4 Mb interval on sheep chromosome 22 by association and homozygosity mapping. The PITX3 gene is located within this interval and encodes a homeodomain-containing transcription factor involved in vertebrate lens formation. An abnormal development of the lens vesicle was shown to be the primary event in ovine microphthalmia. Therefore, we considered PITX3 a positional and functional candidate gene. An ovine BAC clone was sequenced, and after full-length cDNA cloning the PITX3 gene was annotated. Here we show that the ovine microphthalmia phenotype is perfectly associated with a missense mutation (c.338G>C, p.R113P) in the evolutionary conserved homeodomain of PITX3. Selection against this candidate causative mutation can now be used to eliminate microphthalmia from Texel sheep in production systems. Furthermore, the identification of a naturally occurring PITX3 mutation offers the opportunity to use the Texel as a genetically characterized large animal model for human microphthalmia.	[Becker, Doreen; Brunner, Adrian; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Buerstel, Daniela; Ganter, Martin] Univ Vet Med Hannover, Clin Pigs & Small Ruminants, Forens Med & Ambulatory Serv Small Anim, Hannover, Germany; [Kijas, James] Commonwealth Sci & Ind Res Org Livestock Ind, Brisbane, Qld, Australia	University of Bern; University of Kiel; University of Veterinary Medicine Hannover, Foundation; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Becker, D (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	Cord.Droegemueller@itz.unibe.ch	Becker, Doreen/AAF-9108-2020; Tetens, Jens/H-5344-2012; Simianer, Henner/A-6574-2015; Kijas, James W/A-4656-2011	Becker, Doreen/0000-0003-0425-6284; Simianer, Henner/0000-0002-7551-3797; Kijas, James W/0000-0002-1417-8278; Drogemuller, Cord/0000-0001-9773-522X; Tetens, Jens/0000-0001-5352-464X	Swiss National Science Foundation (SNSF), Berne, Switzerland [3100A0-116247]; H.W. Schaumann Stiftung, Hamburg, Germany	Swiss National Science Foundation (SNSF), Berne, Switzerland(Swiss National Science Foundation (SNSF)); H.W. Schaumann Stiftung, Hamburg, Germany	This study was financed by research grants of the Swiss National Science Foundation (SNSF), Berne, Switzerland (grant no. 3100A0-116247), and the H. W. Schaumann Stiftung, Hamburg, Germany, to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AR, 2009, GENOMICS, V94, P55, DOI 10.1016/j.ygeno.2009.04.001; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; ASO S, 1995, LAB ANIM SCI, V45, P41; Beever JE, 2006, ANIM GENET, V37, P66, DOI 10.1111/j.1365-2052.2005.01398.x; Bidinost C, 2006, INVEST OPHTH VIS SCI, V47, P1274, DOI 10.1167/iovs.05-1095; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Chaney BA, 2005, BIOCHEMISTRY-US, V44, P7497, DOI 10.1021/bi0473253; Chang B, 2005, VISUAL NEUROSCI, V22, P587, DOI 10.1017/S0952523805225075; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Cockett NE, 1999, MAMM GENOME, V10, P35, DOI 10.1007/s003359900938; Cockett NE, 2003, CYTOGENET GENOME RES, V102, P76, DOI 10.1159/000075728; Cook Cynthia S., 1995, Veterinary and Comparative Ophthalmology, V5, P109; CRAWFORD AM, 1995, GENETICS, V140, P703; Dalrymple BP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r152; DE GROOT T., 1957, Landbouwkundig Tijdschrift, V69, P819; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; HANSET R., 1961, ANN MED VET, V105, P443; HARING F, 1970, Zuechtungskunde, V42, P385; JACKSON EKM, 1990, VET REC, V126, P650; Jolly RD, 2004, NEW ZEAL VET J, V52, P52, DOI 10.1080/00480169.2004.36405; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; L'Honore A, 2007, DEV BIOL, V307, P421, DOI 10.1016/j.ydbio.2007.04.034; Maddox JF, 2001, GENOME RES, V11, P1275, DOI 10.1101/gr.GR-1350R; Medina-Martinez O, 2009, DEV DYNAM, V238, P2193, DOI 10.1002/dvdy.21924; Murphy AM, 2007, MAMM GENOME, V18, P43, DOI 10.1007/s00335-006-0016-8; Nezamzadeh R, 2005, ANIM GENET, V36, P297, DOI 10.1111/j.1365-2052.2005.01301.x; PATTERSON DF, 1988, J AM VET MED ASSOC, V193, P1131; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Rieger DK, 2001, GENOMICS, V72, P61, DOI 10.1006/geno.2000.6464; Roe WD, 2003, NEW ZEAL VET J, V51, P194, DOI 10.1080/00480169.2003.36364; Sakazume S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-84; Semina EV, 2000, HUM MOL GENET, V9, P1575, DOI 10.1093/hmg/9.11.1575; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shi XH, 2005, MECH DEVELOP, V122, P513, DOI 10.1016/j.mod.2004.11.012; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; Tetens J, 2007, TIERAERZTL PRAX G N, V35, P211; Tetens J, 2007, INVEST OPHTH VIS SCI, V48, P3506, DOI 10.1167/iovs.07-0041; Valleix S, 2006, AM J HUM GENET, V79, P358, DOI 10.1086/505654; van der Linde-Sipman JS, 2003, J COMP PATHOL, V128, P269, DOI 10.1053/jcpa.2002.0632; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; 2009, HOMEPAGE ILLUMINA; 2009, HOMEPAGE SPIDEY; 2009, HOMEPAGE POLYPHEN; 2009, HOMEPAGE PMUT; 2009, HOMEPAGE PFIZER ANIM; 2009, HOMEPAGE PLINK; 2009, HOMEPAGE PDB	54	43	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8689	10.1371/journal.pone.0008689	http://dx.doi.org/10.1371/journal.pone.0008689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084168	Green Published, gold, Green Submitted			2022-12-25	WOS:000273554600037
J	De Weer, A; Poppe, B; Vergult, S; Van Vlierberghe, P; Petrick, M; De Bock, R; Benoit, Y; Noens, L; De Paepe, A; Van Roy, N; Menten, B; Speleman, F				De Weer, An; Poppe, Bruce; Vergult, Sarah; Van Vlierberghe, Pieter; Petrick, Marjan; De Bock, Robrecht; Benoit, Yves; Noens, Lucien; De Paepe, Anne; Van Roy, Nadine; Menten, Bjorn; Speleman, Frank			Identification of Two Critically Deleted Regions within Chromosome Segment 7q35-q36 in EVI1 Deregulated Myeloid Leukemia Cell Lines	PLOS ONE			English	Article							GENE; ESTABLISHMENT; INACTIVATION; DELETIONS; COMMON; LOCUS	Chromosomal rearrangements involving the EVI1 proto-oncogene are a recurrent finding in myeloid leukemias and are indicative of a poor prognosis. Rearrangements of the EVI1 locus are often associated with monosomy 7 or cytogenetic detectable deletions of part of 7q. As EVI1 overexpression alone is not sufficient to induce leukemia, loss of a 7q tumour suppressor gene might be a required cooperating event. To test this hypothesis, we performed high-resolution array comparative genomic hybridization analysis of twelve EVI1 overexpressing patients and three EVI1 deregulated cell lines to search for 7q submicroscopic deletions. This analysis lead to the delineation of two critical regions, one of 0.39 Mb on 7q35 containing the CNTNAP2 gene and one of 1.33 Mb on chromosome bands 7q35-q36 comprising nine genes in EVI1 deregulated cell lines. These findings open the way to further studies aimed at identifying the culprit EVI1 implicated tumour suppressor genes on 7q.	[De Weer, An; Poppe, Bruce; Vergult, Sarah; Van Vlierberghe, Pieter; De Paepe, Anne; Van Roy, Nadine; Menten, Bjorn; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Petrick, Marjan] AZ Sint Lucas, Dept Radiotherapy Oncol & Hematol, Ghent, Belgium; [De Bock, Robrecht] ZNA Middelheim, Dept Hematol, Antwerp, Belgium; [Benoit, Yves] Ghent Univ Hosp, Dept Pediat Hematooncol, B-9000 Ghent, Belgium; [Noens, Lucien] Ghent Univ Hosp, Dept Hematol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; ZNA Middelheim Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	De Weer, A (corresponding author), Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.	franki.speleman@ugent.be	speleman, frank/AAR-5184-2020; Menten, Björn/B-3072-2013; Van Vlierberghe, Pieter/G-8894-2013	speleman, frank/0000-0002-6628-8559; Van Vlierberghe, Pieter/0000-0001-9063-7205; Vergult, Sarah/0000-0002-0816-6262; Menten, Bjorn/0000-0001-8182-659X	BOF [01D28905]; FWO-Vlaanderen [G. 0106.05]; GOA-UGent [12051203]; IWT-Vlaanderen [060848]	BOF; FWO-Vlaanderen(FWO); GOA-UGent; IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	A. De Weer is the recipient of a BOF grant (Bijzonder Onderzoeksfonds UGent, grant no. 01D28905). B. Poppe is a senior clinical investigator of Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen, P. Van Vlierberghe is a post-doc of FWO-Vlaanderen and S. Vergult is an aspirant of FWO-Vlaanderen. This study was supported by the FWO-Vlaanderen, grant no. G. 0106.05, by GOA-UGent, grant no. 12051203 and by IWT-Vlaanderen SBO grant no. 060848. This text presents research results of the Belgian Program of Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming. The scientific responsibility is assumed by the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASNAFI V, 2008, BLOOD; Asou H, 1996, JPN J CANCER RES, V87, P269, DOI 10.1111/j.1349-7006.1996.tb00216.x; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cardoso C, 2000, EUR J HUM GENET, V8, P174, DOI 10.1038/sj.ejhg.5200439; De Weer A, 2008, HAEMATOL-HEMATOL J, V93, P1903, DOI 10.3324/haematol.13192; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Giefing M, 2008, CANCER GENET CYTOGEN, V184, P38, DOI 10.1016/j.cancergencyto.2008.03.004; Hu ZB, 1996, LEUKEMIA, V10, P1025; Kolomietz E, 2001, BLOOD, V97, P3581, DOI 10.1182/blood.V97.11.3581; LeBeau MM, 1996, BLOOD, V88, P1930; Liu Y, 2006, MOL CELL BIOL, V26, P3114, DOI 10.1128/MCB.26.8.3114-3123.2006; Lopingco MC, 1996, CURR TOP MICROBIOL, V211, P211; LUGTHART S, 2008, BLOOD; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Nucifora G, 1997, LEUKEMIA, V11, P2022, DOI 10.1038/sj.leu.2400880; Omura N, 2008, CANCER BIOL THER, V7, P1146, DOI 10.4161/cbt.7.7.6208; Poppe B, 2006, GENE CHROMOSOME CANC, V45, P349, DOI 10.1002/gcc.20295; Suzuki E, 2004, P NATL ACAD SCI USA, V101, P14788, DOI 10.1073/pnas.0406536101; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1	26	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8676	10.1371/journal.pone.0008676	http://dx.doi.org/10.1371/journal.pone.0008676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084277	Green Submitted, gold, Green Published			2022-12-25	WOS:000273554600028
J	Just, MA; Cherkassky, VL; Aryal, S; Mitchell, TM				Just, Marcel Adam; Cherkassky, Vladimir L.; Aryal, Sandesh; Mitchell, Tom M.			A Neurosemantic Theory of Concrete Noun Representation Based on the Underlying Brain Codes	PLOS ONE			English	Article							EVENT-RELATED FMRI; NEURAL REPRESENTATIONS; CORTEX; RECOGNITION; OBJECTS; TOOLS; HUMANS; STATES; LOBE; AREA	This article describes the discovery of a set of biologically-driven semantic dimensions underlying the neural representation of concrete nouns, and then demonstrates how a resulting theory of noun representation can be used to identify simple thoughts through their fMRI patterns. We use factor analysis of fMRI brain imaging data to reveal the biological representation of individual concrete nouns like apple, in the absence of any pictorial stimuli. From this analysis emerge three main semantic factors underpinning the neural representation of nouns naming physical objects, which we label manipulation, shelter, and eating. Each factor is neurally represented in 3-4 different brain locations that correspond to a cortical network that co-activates in non-linguistic tasks, such as tool use pantomime for the manipulation factor. Several converging methods, such as the use of behavioral ratings of word meaning and text corpus characteristics, provide independent evidence of the centrality of these factors to the representations. The factors are then used with machine learning classifier techniques to show that the fMRI-measured brain representation of an individual concrete noun like apple can be identified with good accuracy from among 60 candidate words, using only the fMRI activity in the 16 locations associated with these factors. To further demonstrate the generativity of the proposed account, a theory-based model is developed to predict the brain activation patterns for words to which the algorithm has not been previously exposed. The methods, findings, and theory constitute a new approach of using brain activity for understanding how object concepts are represented in the mind.	[Just, Marcel Adam; Cherkassky, Vladimir L.; Aryal, Sandesh] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Mitchell, Tom M.] Carnegie Mellon Univ, Sch Comp Sci, Machine Learning Dept, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Just, MA (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	just@cmu.edu		Just, Marcel/0000-0003-1245-3050	W. M. Keck Foundation; National Science Foundation [IIS-0835797]; Direct For Computer & Info Scie & Enginr [0835797] Funding Source: National Science Foundation	W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported by the W. M. Keck Foundation and the National Science Foundation, Grant No. IIS-0835797. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; FILLENBAUM S, 1971, STRUCTURES SUBJECTIV; GORSUCH R, 1983, FACTOR ANAL, P239; Hanson SJ, 2004, NEUROIMAGE, V23, P156, DOI 10.1016/j.neuroimage.2004.05.020; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hermsdorfer J, 2007, NEUROIMAGE, V36, pT109, DOI 10.1016/j.neuroimage.2007.03.037; Lacquaniti F, 1997, NEUROIMAGE, V5, P129, DOI 10.1006/nimg.1996.0254; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; MILLER GA, 1987, LANGUAGE PERCEPTION; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; RIPS LJ, 1973, J VERB LEARN VERB BE, V12, P1, DOI 10.1016/S0022-5371(73)80056-8; ROMNEY AK, 1964, AM ANTHROPOL, V66, P146; SHEPARD RN, 1992, PSYCHOL SCI, V3, P97, DOI 10.1111/j.1467-9280.1992.tb00006.x; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978	27	130	130	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8622	10.1371/journal.pone.0008622	http://dx.doi.org/10.1371/journal.pone.0008622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	543EV	20084104	Green Published, gold			2022-12-25	WOS:000273554600006
J	Berney, M; Cook, GM				Berney, Michael; Cook, Gregory M.			Unique Flexibility in Energy Metabolism Allows Mycobacteria to Combat Starvation and Hypoxia	PLOS ONE			English	Article							CYTOPLASMIC MALATE-DEHYDROGENASES; CITRIC-ACID CYCLE; GENE-EXPRESSION; STATIONARY-PHASE; TUBERCULOSIS; HYDROGEN; ADAPTATION; SMEGMATIS; MODEL; TRANSFORMATION	Mycobacteria are a group of obligate aerobes that require oxygen for growth, but paradoxically have the ability to survive and metabolize under hypoxia. The mechanisms responsible for this metabolic plasticity are unknown. Here, we report on the adaptation of Mycobacterium smegmatis to slow growth rate and hypoxia using carbon-limited continuous culture. When M. smegmatis is switched from a 4.6 h to a 69 h doubling time at a constant oxygen saturation of 50%, the cells respond through the down regulation of respiratory chain components and the F1F0-ATP synthase, consistent with the cells lower demand for energy at a reduced growth rate. This was paralleled by an up regulation of molecular machinery that allowed more efficient energy generation (i.e. Complex I) and the use of alternative electron donors (e. g. hydrogenases and primary dehydrogenases) to maintain the flow of reducing equivalents to the electron transport chain during conditions of severe energy limitation. A hydrogenase mutant showed a 40% reduction in growth yield highlighting the importance of this enzyme in adaptation to low energy supply. Slow growing cells at 50% oxygen saturation subjected to hypoxia (0.6% oxygen saturation) responded by switching on oxygen scavenging cytochrome bd, proton-translocating cytochrome bc(1)-aa(3) supercomplex, another putative hydrogenase, and by substituting NAD(+)-dependent enzymes with ferredoxin-dependent enzymes thus highlighting a new pattern of mycobacterial adaptation to hypoxia. The expression of ferredoxins and a hydrogenase provides a potential conduit for disposing of and transferring electrons in the absence of exogenous electron acceptors. The use of ferredoxin-dependent enzymes would allow the cell to maintain a high carbon flux through its central carbon metabolism independent of the NAD(+)/NADH ratio. These data demonstrate the remarkable metabolic plasticity of the mycobacterial cell and provide a new framework for understanding their ability to survive under low energy conditions and hypoxia.	[Berney, Michael; Cook, Gregory M.] Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, Dunedin, New Zealand	University of Otago	Berney, M (corresponding author), Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, Dunedin, New Zealand.	michael.berney@otago.ac.nz; gregory.cook@otago.ac.nz	Cook, Gregory/E-5665-2011; Berney, Michael/GQZ-2111-2022; Berney, Michael/C-2731-2009	Berney, Michael/0000-0002-4833-0573; 	New Zealand Lottery Health; Health Research Council NZ; Maurice Wilkins Centre for Molecular Biodiscovery; Swiss National Science Foundation; National Institute of Allergy and Infectious Diseases	New Zealand Lottery Health; Health Research Council NZ(Health Research Council of New Zealand); Maurice Wilkins Centre for Molecular Biodiscovery; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	New Zealand Lottery Health, Health Research Council NZ, The Maurice Wilkins Centre for Molecular Biodiscovery, Swiss National Science Foundation and National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Baughn AD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000662; Best Corliss A, 2009, Hand (N Y), V4, P165, DOI 10.1007/s11552-008-9147-6; Beste DJV, 2007, J BACTERIOL, V189, P3969, DOI 10.1128/JB.01787-06; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453; da Silva SM, 2008, ANTON LEEUW INT J G, V93, P381, DOI 10.1007/s10482-007-9215-x; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; GARLAND PB, 1962, NATURE, V196, P987, DOI 10.1038/196987a0; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ihssen J, 2005, ENVIRON MICROBIOL, V7, P1568, DOI 10.1111/j.1462-2920.2005.00846.x; Kana Bavesh D., 2009, P35; Kana BD, 2001, J BACTERIOL, V183, P7076, DOI 10.1128/JB.183.24.7076-7086.2001; King GM, 2003, APPL ENVIRON MICROB, V69, P7266, DOI 10.1128/AEM.69.12.7266-7272.2003; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; Mnatsakanyan N, 2004, CELL BIOCHEM BIOPHYS, V41, P357, DOI 10.1385/CBB:41:3:357; Molenaar D, 2000, J BACTERIOL, V182, P6884, DOI 10.1128/JB.182.24.6884-6891.2000; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Ratledge C., 1999, MYCOBACTERIA MOL BIO, P260; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Schwartz E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P496, DOI 10.1007/0-387-30742-7_17; Sherman DR, 2004, J INFECT DIS, V190, P123, DOI 10.1086/421472; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tang YJ, 2009, BIOTECHNOL LETT, V31, P1233, DOI 10.1007/s10529-009-9991-7; Tran SL, 2005, J BACTERIOL, V187, P5023, DOI 10.1128/JB.187.14.5023-5028.2005; Vaerewijck MJM, 2005, FEMS MICROBIOL REV, V29, P911, DOI 10.1016/j.femsre.2005.02.001; van der Rest ME, 2000, J BACTERIOL, V182, P6892, DOI 10.1128/JB.182.24.6892-6899.2000; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Villas-Boas SG, 2007, ANAL BIOCHEM, V370, P87, DOI 10.1016/j.ab.2007.06.028; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Zbell AL, 2007, MICROBIOL-SGM, V153, P3508, DOI 10.1099/mic.0.2007/009027-0; Zbell AL, 2009, APPL ENVIRON MICROB, V75, P1456, DOI 10.1128/AEM.02064-08	48	135	138	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8614	10.1371/journal.pone.0008614	http://dx.doi.org/10.1371/journal.pone.0008614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062806	gold, Green Published, Green Submitted			2022-12-25	WOS:000273414100008
J	Horwitz, GC; Lelli, A; Geleoc, GSG; Holt, JR				Horwitz, Geoffrey C.; Lelli, Andrea; Geleoc, Gwenaelle S. G.; Holt, Jeffrey R.			HCN Channels Are Not Required for Mechanotransduction in Sensory Hair Cells of the Mouse Inner Ear	PLOS ONE			English	Article							PACEMAKER CHANNELS; MECHANOELECTRICAL TRANSDUCTION; DEVELOPMENTAL ACQUISITION; CYCLIC-AMP; ADAPTATION; ACTIVATION; TURTLE	The molecular composition of the hair cell transduction channel has not been identified. Here we explore the novel hypothesis that hair cell transduction channels include HCN subunits. The HCN family of ion channels includes four members, HCN1-4. They were orginally identified as the molecular correlates of the hyperpolarization-activated, cyclic nucleotide gated ion channels that carry currents known as I(f), I(Q) or I(h). However, based on recent evidence it has been suggested that HCN subunits may also be components of the elusive hair cell transduction channel. To investigate this hypothesis we examined expression of mRNA that encodes HCN1-4 in sensory epithelia of the mouse inner ear, immunolocalization of HCN subunits 1, 2 and 4, uptake of the transduction channel permeable dye, FM1-43 and electrophysiological measurement of mechanotransduction current. Dye uptake and transduction current were assayed in cochlear and vestibular hair cells of wildtype mice exposed to HCN channel blockers or a dominant-negative form of HCN2 that contained a pore mutation and in mutant mice that lacked HCN1, HCN2 or both. We found robust expression of HCNs 1, 2 and 4 but little evidence that localized HCN subunits in hair bundles, the site of mechanotransduction. Although high concentrations of the HCN antagonist, ZD7288, blocked 50-70% of the transduction current, we found no reduction of transduction current in either cochlear or vestibular hair cells of HCN1- or HCN2-deficient mice relative to wild-type mice. Furthermore, mice that lacked both HCN1 and HCN2 also had normal transduction currents. Lastly, we found that mice exposed to the dominant-negative mutant form of HCN2 had normal transduction currents as well. Taken together, the evidence suggests that HCN subunits are not required for mechanotransduction in hair cells of the mouse inner ear.	[Horwitz, Geoffrey C.] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Otolaryngol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Horwitz, GC (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA.	jeffholt@virginia.edu			National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD) [DC05439]; Physik Instruments; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005439, R56DC005439, R01DC008853] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Physik Instruments; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD) grants DC05439 (J.R.H.) and a NanoInnovation Grant from Physik Instruments ( A. L., E. A. Stauffer, and J.R.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakondi G, 2009, NEUROSCIENCE, V158, P1469, DOI 10.1016/j.neuroscience.2008.10.056; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; CAO X, 2009, ARO ABSTR; Cho WJ, 2003, NEUROSCIENCE, V118, P525, DOI 10.1016/S0306-4522(02)00913-2; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; Lin W, 2007, BIOPHYS J, V92, P1559, DOI 10.1529/biophysj.106.092478; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P3227, DOI 10.1074/jbc.M806177200; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Rusch A, 1998, J NEUROSCI, V18, P7487; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Stauffer EA, 2007, J NEUROPHYSIOL, V98, P3360, DOI 10.1152/jn.00914.2007; Stieber J, 2003, J BIOL CHEM, V278, P33672, DOI 10.1074/jbc.M305318200; Yu HG, 2004, PFLUG ARCH EUR J PHY, V447, P392, DOI 10.1007/s00424-003-1204-y	23	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8627	10.1371/journal.pone.0008627	http://dx.doi.org/10.1371/journal.pone.0008627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062532	Green Submitted, Green Published, gold			2022-12-25	WOS:000273414100012
J	Salzer, CL; Kumar, JP				Salzer, Claire L.; Kumar, Justin P.			Identification of Retinal Transformation Hot Spots in Developing Drosophila Epithelia	PLOS ONE			English	Article							EYE DEVELOPMENT; IMAGINAL DISCS; ECTOPIC EYES; MORPHOGENETIC FURROW; TARGETED EXPRESSION; GENE HEDGEHOG; EYELESS GENE; SINE-OCULIS; WINGLESS; TRANSDETERMINATION	Background: The retinal determination (RD) network is an evolutionarily conserved regulatory circuit that governs early events in the development of eyes throughout the animal kingdom. Ectopic expression of many members of this network leads to the transformation of non-retinal epithelia into eye tissue. An often-overlooked observation is that only particular cell-populations within a handful of tissues are capable of having their primary developmental instructions superseded and overruled. Methodology/Preliminary Findings: Here we confirm that indeed, only a discrete number of cell populations within the imaginal discs that give rise to the head, antenna, legs, wings and halteres have the cellular plasticity to have their developmental fates altered. In contrast to previous reports, we find that all transformable cell populations do not lie within the TGF beta or Hedgehog signaling domains. Additionally neither signaling cascade alone is sufficient for non-retinal cell types to be converted into retinal tissue. The transformation "hot spots'' that we have identified appear to coincide with several previously defined transdetermination "weak spots'', suggesting that ectopic eye formation is less the result of one network overriding the orders of another, as previously thought, but rather is the physical manifestation of redirecting cell populations of enormous cellular plasticity. We also demonstrate that the initiation of eye formation in non-retinal tissues occurs asynchronously compared to that of the normal eye suggesting that retinal development is not under the control of a global developmental clock. Conclusions/Significance: We conclude that the subregions of non-retinal tissues that are capable of supporting eye formation represent specialized cell-populations that have a different level of plasticity than other cells within these tissues and may be the founder cells of each tissue.	[Salzer, Claire L.; Kumar, Justin P.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Salzer, CL (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jkumar@indiana.edu			National Institutes of Health (NIH) [R01 EY014863]; NATIONAL EYE INSTITUTE [R01EY014863] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health (NIH) R01 EY014863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096; Bessa J, 2009, DEV DYNAM, V238, P19, DOI 10.1002/dvdy.21808; Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Braid LR, 2008, GENETICS, V180, P283, DOI 10.1534/genetics.108.092155; Chen R, 1999, DEVELOPMENT, V126, P935; Curtiss J, 2007, DEV BIOL, V306, P685, DOI 10.1016/j.ydbio.2007.04.006; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Datta RR, 2009, DEV DYN; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Kango-Singh M, 2003, DEV BIOL, V256, P48, DOI 10.1016/S0012-1606(02)00123-9; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Kumar JP, 2009, BBA-GENE REGUL MECH, V1789, P306, DOI 10.1016/j.bbagrm.2008.10.001; Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Maves L, 1998, DEVELOPMENT, V125, P115; Maves L, 1999, CURR TOP DEV BIOL, V43, P115; Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006; MAVES L, 1995, DEVELOPMENT, V121, P1263; Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999; Pan D, 1998, P NATL ACAD SCI USA, V95, P15508, DOI 10.1073/pnas.95.26.15508; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Salzer CL, 2009, DEV BIOL, V326, P121, DOI 10.1016/j.ydbio.2008.10.048; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Shen WP, 1997, DEVELOPMENT, V124, P45; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; WEASNER BM, 2009, DEV BIOL; Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040; WOLFF T, 1991, DEVELOPMENT, V113, P841	35	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8510	10.1371/journal.pone.0008510	http://dx.doi.org/10.1371/journal.pone.0008510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062803	gold, Green Submitted, Green Published			2022-12-25	WOS:000273414100003
J	Lambert, C; Chang, CY; Capeness, MJ; Sockett, RE				Lambert, Carey; Chang, Chien-Yi; Capeness, Michael J.; Sockett, R. Elizabeth			The First Bite- Profiling the Predatosome in the Bacterial Pathogen Bdellovibrio	PLOS ONE			English	Article							INTRAPERIPLASMIC GROWTH; BACTERIOVORUS 109J; ELONGATION; PROTEINS; MUTANTS; CYCLE; IDENTIFICATION; PREDATION; CLEAVAGE; MOTILITY	Bdellovibrio bacteriovorus is a Gram-negative bacterium that is a pathogen of other Gram-negative bacteria, including many bacteria which are pathogens of humans, animals and plants. As such Bdellovibrio has potential as a biocontrol agent, or living antibiotic. B. bacteriovorus HD100 has a large genome and it is not yet known which of it encodes the molecular machinery and genetic control of predatory processes. We have tried to fill this knowledge-gap using mixtures of predator and prey mRNAs to monitor changes in Bdellovibrio gene expression at a timepoint of early-stage prey infection and prey killing in comparison to control cultures of predator and prey alone and also in comparison to Bdellovibrio growing axenically (in a prey-or host independent "HI'' manner) on artificial media containing peptone and tryptone. From this we have highlighted genes of the early predatosome with predicted roles in prey killing and digestion and have gained insights into possible regulatory mechanisms as Bdellovibrio enter and establish within the prey bdelloplast. Approximately seven percent of all Bdellovibrio genes were significantly up-regulated at 30 minutes of infection-but not in HI growth-implicating the role of these genes in prey digestion. Five percent were down-regulated significantly, implicating their role in free-swimming, attack-phase physiology. This study gives the first post-genomic insight into the predatory process and reveals some of the important genes that Bdellovibrio expresses inside the prey bacterium during the initial attack.	[Lambert, Carey; Chang, Chien-Yi; Capeness, Michael J.; Sockett, R. Elizabeth] Univ Nottingham, Queens Med Ctr, Inst Genet, Sch Biol, Nottingham NG7 2RD, England	University of Nottingham	Lambert, C (corresponding author), Univ Nottingham, Queens Med Ctr, Inst Genet, Sch Biol, Nottingham NG7 2RD, England.	liz.sockett@nottingham.ac.uk	Chang, Chien-Yi/E-1338-2012; Lambert, Carey/AAY-9270-2020; Chang, Chien-Yi/ABH-6848-2020	Chang, Chien-Yi/0000-0003-3570-4019; Chang, Chien-Yi/0000-0003-3570-4019; Lambert, Carey/0000-0002-1844-457X	Wellcome Trust [AL-077459]; Human Frontier Science Programme [RGP0057/2005/C]	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Programme(Human Frontier Science Program)	This work was funded by Wellcome Trust Grant AL-077459 to RES for CL and by Human Frontier Science Programme Grant RGP0057/2005/C to RES for C-YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabote RD, 2007, GENOMICS, V90, P424, DOI 10.1016/j.ygeno.2007.06.002; Barel G, 2001, ARCH MICROBIOL, V176, P211, DOI 10.1007/s002030100312; BLUM P, 1992, J BACTERIOL, V174, P7436, DOI 10.1128/jb.174.22.7436-7444.1992; Chaudhuri RR, 2006, NUCLEIC ACIDS RES, V34, pD335, DOI 10.1093/nar/gkj140; COTTER TW, 1992, J BACTERIOL, V174, P6018, DOI 10.1128/JB.174.19.6018-6024.1992; Ding BJ, 2005, BIOCHEM J, V389, P797, DOI 10.1042/BJ20050405; Dori-Bachash M, 2008, APPL ENVIRON MICROB, V74, P7152, DOI 10.1128/AEM.01736-08; Dori-Bachash M, 2009, FUNCT INTEGR GENOMIC, V9, P153, DOI 10.1007/s10142-008-0106-7; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Flower AM, 2007, TRENDS MICROBIOL, V15, P203, DOI 10.1016/j.tim.2007.03.001; Fussenegger M, 1996, MOL MICROBIOL, V19, P1095, DOI 10.1046/j.1365-2958.1996.457984.x; Galbis-Martinez M, 2004, GENETICS, V167, P1585, DOI 10.1534/genetics.104.029207; Golbik R, 2005, BIOCHEMISTRY-US, V44, P16026, DOI 10.1021/bi051442w; GOSHIMA N, 1994, GENE, V141, P17; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kaplan HB, 2003, CURR OPIN MICROBIOL, V6, P572, DOI 10.1016/j.mib.2003.10.006; Karring H, 2004, J BIOL CHEM, V279, P1878, DOI 10.1074/jbc.M306605200; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Lambert C, 2006, MOL MICROBIOL, V60, P274, DOI 10.1111/j.1365-2958.2006.05081.x; Lambert C, 2003, ENVIRON MICROBIOL, V5, P127, DOI 10.1046/j.1462-2920.2003.00385.x; Lambert Carey, 2008, Curr Protoc Microbiol, VChapter 7, DOI 10.1002/9780471729259.mc07b02s9; Lambert C, 2009, ADV MICROB PHYSIOL, V54, P313, DOI 10.1016/S0065-2911(08)00005-2; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Lee S, 2006, J AM CHEM SOC, V128, P11545, DOI 10.1021/ja063073c; Li X, 2007, MOL MICROBIOL, V63, P116, DOI 10.1111/j.1365-2958.2006.05498.x; MEDINA AA, 2009, RES MICROBIOL; Medina AA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-33; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; ROSSON RA, 1979, J BACTERIOL, V140, P620, DOI 10.1128/JB.140.2.620-633.1979; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; SRIVATSAN A, 2008, CURR OPIN MICROBIOL; Steyert SR, 2008, J BACTERIOL, V190, P8215, DOI 10.1128/JB.01009-08; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; THOMASHOW MF, 1978, J BACTERIOL, V135, P1008, DOI 10.1128/JB.135.3.1008-1014.1978; THOMASHOW MF, 1978, J BACTERIOL, V135, P998, DOI 10.1128/JB.135.3.998-1007.1978; Torres M, 2004, J BACTERIOL, V186, P1304, DOI 10.1128/JB.186.5.1304-1310.2004; Tudor JJ, 2008, APPL ENVIRON MICROB, V74, P5436, DOI 10.1128/AEM.00256-08; VARON M, 1975, J BACTERIOL, V124, P1191, DOI 10.1128/JB.124.3.1191-1197.1975; Williams HN, 1995, CAN J MICROBIOL, V41, P1142, DOI 10.1139/m95-159	46	66	66	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8599	10.1371/journal.pone.0008599	http://dx.doi.org/10.1371/journal.pone.0008599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20062540	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338600018
J	Wu, H; Min, JR; Lunin, VV; Antoshenko, T; Dombrovski, L; Zeng, H; Allali-Hassani, A; Campagna-Slater, V; Vedadi, M; Arrowsmith, CH; Plotnikov, AN; Schapira, M				Wu, Hong; Min, Jinrong; Lunin, Vladimir V.; Antoshenko, Tatiana; Dombrovski, Ludmila; Zeng, Hong; Allali-Hassani, Abdellah; Campagna-Slater, Valerie; Vedadi, Masoud; Arrowsmith, Cheryl H.; Plotnikov, Alexander N.; Schapira, Matthieu			Structural Biology of Human H3K9 Methyltransferases	PLOS ONE			English	Article							HISTONE LYSINE METHYLTRANSFERASES; PRODUCT SPECIFICITY; PROTEIN METHYLTRANSFERASES; MOLECULAR REPLACEMENT; METHYLATION; DOMAIN; RECOGNITION; MECHANISM; CATALYSIS; CHROMATIN	SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity.	[Wu, Hong; Min, Jinrong; Lunin, Vladimir V.; Antoshenko, Tatiana; Dombrovski, Ludmila; Zeng, Hong; Allali-Hassani, Abdellah; Campagna-Slater, Valerie; Vedadi, Masoud; Arrowsmith, Cheryl H.; Plotnikov, Alexander N.; Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Wu, H (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	alexander.plotnikov@mssm.edu; matthieu.schapira@utoronto.ca	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work is supported by the Structural Genomics Consortium (SGC), a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Spannhoff A, 2009, CHEMMEDCHEM, V4, P1568, DOI 10.1002/cmdc.200900301; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	39	206	217	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8570	10.1371/journal.pone.0008570	http://dx.doi.org/10.1371/journal.pone.0008570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20967253	gold, Green Published			2022-12-25	WOS:000273456300003
J	Sun, J; Wang, XT; Lau, A; Liao, TYA; Bucci, C; Hmama, Z				Sun, Jim; Wang, Xuetao; Lau, Alice; Liao, Ting-Yu Angela; Bucci, Cecilia; Hmama, Zakaria			Mycobacterial Nucleoside Diphosphate Kinase Blocks Phagosome Maturation in Murine Raw 264.7 Macrophages	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; TUBERCULOSIS PHAGOSOME; RAB7; TRANSPORT; RILP; VIRULENCE; DISTINCT; IDENTIFICATION; MANIPULATION	Background: Microorganisms capable of surviving within macrophages are rare, but represent very successful pathogens. One of them is Mycobacterium tuberculosis (Mtb) whose resistance to early mechanisms of macrophage killing and failure of its phagosomes to fuse with lysosomes causes tuberculosis (TB) disease in humans. Thus, defining the mechanisms of phagosome maturation arrest and identifying mycobacterial factors responsible for it are key to rational design of novel drugs for the treatment of TB. Previous studies have shown that Mtb and the related vaccine strain, M. bovis bacille Calmette-Guerin (BCG), disrupt the normal function of host Rab5 and Rab7, two small GTPases that are instrumental in the control of phagosome fusion with early endosomes and late endosomes/lysosomes respectively. Methodology/Principal Findings: Here we show that recombinant Mtb nucleoside diphosphate kinase (Ndk) exhibits GTPase activating protein (GAP) activity towards Rab5 and Rab7. Then, using a model of latex bead phagosomes, we demonstrated that Ndk inhibits phagosome maturation and fusion with lysosomes in murine RAW 264.7 macrophages. Maturation arrest of phagosomes containing Ndk-beads was associated with the inactivation of both Rab5 and Rab7 as evidenced by the lack of recruitment of their respective effectors EEA1 (early endosome antigen 1) and RILP (Rab7-interacting lysosomal protein). Consistent with these findings, macrophage infection with an Ndk knocked-down BCG strain resulted in increased fusion of its phagosome with lysosomes along with decreased survival of the mutant. Conclusion: Our findings provide evidence in support of the hypothesis that mycobacterial Ndk is a putative virulence factor that inhibits phagosome maturation and promotes survival of mycobacteria within the macrophage.	[Sun, Jim; Wang, Xuetao; Lau, Alice; Liao, Ting-Yu Angela; Hmama, Zakaria] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada; [Sun, Jim; Wang, Xuetao; Lau, Alice; Liao, Ting-Yu Angela; Hmama, Zakaria] Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Bucci, Cecilia] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy	University of British Columbia; Vancouver Coastal Health Research Institute; University of Salento	Sun, J (corresponding author), Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada.	hmama@interchange.ubc.ca	Bucci, Cecilia/F-6699-2012	Bucci, Cecilia/0000-0002-6232-6183; Amdur, Richard/0000-0002-4900-653X; Sun, Jim/0000-0002-6873-6052	Canadian Institutes of Health Research [MOP-84557]; British Columbia Lung Association; Michael Smith Foundation for Health Research; TBVets Charitable Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); TBVets Charitable Foundation	This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP-84557) and British Columbia Lung Association. Z. Hmama was supported by scholar awards from the Michael Smith Foundation for Health Research and the TBVets Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar P, 2006, MICROBES INFECT, V8, P2855, DOI 10.1016/j.micinf.2006.09.004; Astarie-Dequeker C, 2002, J CELL SCI, V115, P81; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Chopra P, 2004, FEBS LETT, V571, P212, DOI 10.1016/j.febslet.2004.06.073; Chopra P, 2003, EUR J BIOCHEM, V270, P625, DOI 10.1046/j.1432-1033.2003.03402.x; Chow Chung-Wai, 2004, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1507s22; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Clemens DL, 2000, INFECT IMMUN, V68, P5154, DOI 10.1128/IAI.68.9.5154-5166.2000; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hayakawa A, 2007, BIOCHEM SOC SYMP, V74, P95, DOI 10.1042/BSS2007c09; Hestvik ALK, 2005, FEMS MICROBIOL REV, V29, P1041, DOI 10.1016/j.femsre.2005.04.013; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kimura N, 2003, J BIOENERG BIOMEMBR, V35, P41, DOI 10.1023/A:1023489722460; LEE BY, 1995, J CLIN INVEST, V96, P245, DOI 10.1172/JCI118028; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lewin A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-91; LoBue P, 2009, CURR OPIN INFECT DIS, V22, P167, DOI 10.1097/QCO.0b013e3283229fab; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; PAWELRAMMINGEN U, 2000, MOL MICROBIOL, V36, P737; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Ramachandra L, 1999, CELL MICROBIOL, V1, P205, DOI 10.1046/j.1462-5822.1999.00026.x; Roberts RL, 1999, J CELL SCI, V112, P3667; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Saini AK, 2004, J BIOL CHEM, V279, P50142, DOI 10.1074/jbc.M409944200; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Teitelbaum R, 1999, P NATL ACAD SCI USA, V96, P15190, DOI 10.1073/pnas.96.26.15190; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Yoshikai Y, 2006, CRIT REV IMMUNOL, V26, P515, DOI 10.1615/CritRevImmunol.v26.i6.40	60	106	111	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8769	10.1371/journal.pone.0008769	http://dx.doi.org/10.1371/journal.pone.0008769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20613869	Green Submitted, Green Published, gold			2022-12-25	WOS:000273778900013
